PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Weintraub, RG; Semsarian, C				Weintraub, Robert G.; Semsarian, Christopher			Paediatric cardiomyopathy: getting to the heart of the matter	LANCET			English	Editorial Material							HYPERTROPHIC CARDIOMYOPATHY; CHILDREN; EPIDEMIOLOGY; OUTCOMES; REGISTRY		[Weintraub, Robert G.] Royal Childrens Hosp, Dept Cardiol, Melbourne, Vic 3052, Australia; [Weintraub, Robert G.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Semsarian, Christopher] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Semsarian, Christopher] Univ Sydney, Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW 2006, Australia; [Semsarian, Christopher] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Sydney; University of Sydney; Centenary Institute; University of Sydney	Weintraub, RG (corresponding author), Royal Childrens Hosp, Dept Cardiol, Melbourne, Vic 3052, Australia.	robert.weintraub@rch.org.au						Colan SD, 2007, CIRCULATION, V115, P773, DOI 10.1161/CIRCULATIONAHA.106.621185; Cox GF, 2006, PEDIATRICS, V118, P1519, DOI 10.1542/peds.2006-0163; Dipchand AI, 2009, J HEART LUNG TRANSPL, V28, P1312, DOI 10.1016/j.healun.2009.05.019; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Lipshultz SE, 2013, LANCET; Maron BJ, 2013, J AM COLL CARDIOL, V61, P1527, DOI 10.1016/j.jacc.2013.01.037; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; Nugent AW, 2005, CIRCULATION, V112, P1332, DOI 10.1161/CIRCULATIONAHA.104.530303; Wilkinson JD, 2012, AM HEART J, V164, P442, DOI 10.1016/j.ahj.2012.04.018	9	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					1866	1867		10.1016/S0140-6736(13)61799-7	http://dx.doi.org/10.1016/S0140-6736(13)61799-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269DX	24011546				2022-12-28	WOS:000328222400012
J	Whiteford, HA; Degenhardt, L; Rehm, J; Baxter, AJ; Ferrari, AJ; Erskine, HE; Charlson, FJ; Norman, RE; Flaxman, AD; Johns, N; Burstein, R; Murray, CJL; Vos, T				Whiteford, Harvey A.; Degenhardt, Louisa; Rehm, Juergen; Baxter, Amanda J.; Ferrari, Alize J.; Erskine, Holly E.; Charlson, Fiona J.; Norman, Rosana E.; Flaxman, Abraham D.; Johns, Nicole; Burstein, Roy; Murray, Christopher J. L.; Vos, Theo			Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010	LANCET			English	Article							ILLICIT DRUG-USE; SYSTEMATIC ANALYSIS; COST-EFFECTIVENESS; LOW-INCOME; 187 COUNTRIES; RISK-FACTORS; 21 REGIONS; HEALTH 3; DISABILITY; PREVALENCE	Background We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to estimate the burden of disease attributable to mental and substance use disorders in terms of disability-adjusted life years (DALYs), years of life lost to premature mortality (YLLs), and years lived with disability (YLDs). Methods For each of the 20 mental and substance use disorders included in GBD 2010, we systematically reviewed epidemiological data and used a Bayesian meta-regression tool, DisMod-MR, to model prevalence by age, sex, country, region, and year. We obtained disability weights from representative community surveys and an internet-based survey to calculate YLDs. We calculated premature mortality as YLLs from cause of death estimates for 1980-2010 for 20 age groups, both sexes, and 187 countries. We derived DALYs from the sum of YLDs and YLLs. We adjusted burden estimates for comorbidity and present them with 95% uncertainty intervals. Findings In 2010, mental and substance use disorders accounted for 183.9 million DALYs (95% UI 153.5 million216 .7 million), or 7.4% (6.2-8.6) of all DALYs worldwide. Such disorders accounted for 8.6 million YLLs (6.5 million-12.1 million; 0.5% [0.4-0.7] of all YLLs) and 175.3 million YLDs (144.5 million-207.8 million; 22.9% [18.6-27.2] of all YLDs). Mental and substance use disorders were the leading cause of YLDs worldwide. Depressive disorders accounted for 40.5% (31.7-49.2) of DALYs caused by mental and substance use disorders, with anxiety disorders accounting for 14.6% (11.2-18.4), illicit drug use disorders for 10.9% (8.9-13.2), alcohol use disorders for 9.6% (7.7-11.8), schizophrenia for 7.4% (5.0-9.8), bipolar disorder for 7.0% (4.4-10.3), pervasive developmental disorders for 4.2% (3.2-5.3), childhood behavioural disorders for 3.4% (2.2-4.7), and eating disorders for 1.2% (0.9-1.5). DALYs varied by age and sex, with the highest proportion of total DALYs occurring in people aged 10-29 years. The burden of mental and substance use disorders increased by 37.6% between 1990 and 2010, which for most disorders was driven by population growth and ageing. Interpretation Despite the apparently small contribution of YLLs-with deaths in people with mental disorders coded to the physical cause of death and suicide coded to the category of injuries under self-harm-our fi ndings show the striking and growing challenge that these disorders pose for health systems in developed and developing regions. In view of the magnitude of their contribution, improvement in population health is only possible if countries make the prevention and treatment of mental and substance use disorders a public health priority.	[Whiteford, Harvey A.; Baxter, Amanda J.; Ferrari, Alize J.; Erskine, Holly E.; Charlson, Fiona J.; Norman, Rosana E.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Norman, Rosana E.] Univ Queensland, Queensland Childrens Med Res Inst, Herston, Qld, Australia; [Whiteford, Harvey A.; Baxter, Amanda J.; Ferrari, Alize J.; Erskine, Holly E.; Charlson, Fiona J.] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Degenhardt, Louisa] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Rehm, Juergen] Ctr Addict & Mental Hlth, Social & Epidemiol Res Dept, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Epidemiol Res Unit, D-01062 Dresden, Germany; [Flaxman, Abraham D.; Johns, Nicole; Burstein, Roy; Murray, Christopher J. L.; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	University of Queensland; University of Queensland; Queensland Centre for Mental Health Research; University of New South Wales Sydney; University of Melbourne; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Technische Universitat Dresden; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Whiteford, HA (corresponding author), Univ Queensland, Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Wacol, Qld 4076, Australia.	h.whiteford@uq.edu.au	Ferrari, Alize J/G-1746-2011; Degenhardt, Louisa J/D-4515-2012; PACELLA, ROSANA E./F-2774-2010; Charlson, Fiona/R-8963-2019; Whiteford, Harvey A/A-4840-2009; Baxter, Amanda/E-5449-2011; Charlson, Fiona J/F-5290-2011; Erskine, Holly/K-5244-2012	Ferrari, Alize J/0000-0002-7863-9117; Degenhardt, Louisa J/0000-0002-8513-2218; PACELLA, ROSANA E./0000-0002-9742-1957; Charlson, Fiona/0000-0003-2876-5040; Whiteford, Harvey A/0000-0003-4667-6623; Baxter, Amanda/0000-0001-8198-9022; Charlson, Fiona J/0000-0003-2876-5040; O'donnell, Colm/0000-0002-8004-450X; Erskine, Holly/0000-0003-3119-9211; Johns, Nicole/0000-0003-4513-4582	Queensland Department of Health; National Health and Medical Research Council of Australia; National Drug and Alcohol Research Centre-University of New South Wales; Bill & Melinda Gates Foundation; University of Toronto; Technische Universitat; Ontario Ministry of Health and Long Term Care; US National Institute of Alcohol Abuse and Alcoholism	Queensland Department of Health; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Drug and Alcohol Research Centre-University of New South Wales; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); University of Toronto(University of Toronto); Technische Universitat; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); US National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Queensland Department of Health, National Health and Medical Research Council of Australia, National Drug and Alcohol Research Centre-University of New South Wales, Bill & Melinda Gates Foundation, University of Toronto, Technische Universitat, Ontario Ministry of Health and Long Term Care, and the US National Institute of Alcohol Abuse and Alcoholism.	Agency for Healthcare Research and Quality, 2009, US MED EXP PAN SURV; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andrews G, 2004, BRIT J PSYCHIAT, V184, P526, DOI 10.1192/bjp.184.6.526; [Anonymous], INTEGRATIVE METAREGR; Australian Bureau of Statistics, 1998, MENT HLTH WELLB PROF; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Baxter AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065514; Bucello C, 2010, WHAT DO WE KNOW EXTE; Calabria B, 2010, WHAT DO WE KNOW EXTE; Calabria B, 2010, ADDICT BEHAV, V35, P741, DOI 10.1016/j.addbeh.2010.03.019; Calabria B, 2010, DRUG ALCOHOL REV, V29, P318, DOI 10.1111/j.1465-3362.2009.00149.x; Chang SM, 2008, J AFFECT DISORDERS, V106, P159, DOI 10.1016/j.jad.2007.07.023; Chisholm D, 2004, BRIT J PSYCHIAT, V184, P393, DOI 10.1192/bjp.184.5.393; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Chisholm D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e609; Degenhardt L, 2013, LANCET; Degenhardt L., 2010, WHAT DO WE KNOW EXTE; Degenhardt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076635; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V113, P88, DOI 10.1016/j.drugalcdep.2010.07.026; Degenhardt L, 2009, ADDICTION, V104, P1466, DOI 10.1111/j.1360-0443.2009.02715.x; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Ezpeleta L, 2001, J CHILD PSYCHOL PSYC, V42, P901, DOI 10.1111/1469-7610.00786; Ferrari AJ, 2013, PSYCHOL MED, V43, P471, DOI 10.1017/S0033291712001511; Ferrari AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-16; Ferrari AJ, 2011, J AFFECT DISORDERS, V134, P1, DOI 10.1016/j.jad.2010.11.007; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Janu-Llopis E., GLOBAL EC BURDEN NON; Kessler R. C., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P511; Kleinman A, 2009, LANCET, V374, P603, DOI 10.1016/S0140-6736(09)61510-5; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mathers CD., 2002, GLOBAL BURDEN DIS 20; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P481; Nelson P, 2010, WHAT DO WE KNOW EXTE; Ngo VK, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001443; Patel V, 2008, LANCET, V372, P1354, DOI 10.1016/S0140-6736(08)61556-1; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rehm J, 2013, EUR NEUROPSYCHOPHARM, V23, P89, DOI 10.1016/j.euroneuro.2012.08.001; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Schopflocher DP, 2013, LANCET, V381, P130; Scott David, 2011, Issues Ment Health Nurs, V32, P589, DOI 10.3109/01612840.2011.569846; Simpson KRS, 2012, CAN J PSYCHIAT, V57, P324, DOI 10.1177/070674371205700508; Tol WA, 2011, LANCET, V378, P1581, DOI 10.1016/S0140-6736(11)61094-5; United Nations, 2011, WORLD POP PROSP 2020; US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism, 2006, NAT EP SURV ALC REL; Ustun TB, 1999, AM J PUBLIC HEALTH, V89, P1315, DOI 10.2105/AJPH.89.9.1315; Vos T, 2000, B WORLD HEALTH ORGAN, V78, P427; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Whiteford HA, 2013, CURR OPIN PSYCHIATR, V26, P376, DOI 10.1097/YCO.0b013e328361e60f; WHO, 2020, MENT HLTH ATL 2011; WHO, AGE STANDARDIZATION; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; Yoshimasu Kouichi, 2008, Environmental Health and Preventive Medicine, V13, P243, DOI 10.1007/s12199-008-0037-x; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160	76	3522	3634	34	826	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1575	1586		10.1016/S0140-6736(13)61611-6	http://dx.doi.org/10.1016/S0140-6736(13)61611-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247NE	23993280				2022-12-28	WOS:000326623900029
J	Lauer, MS; D'Agostino, RB				Lauer, Michael S.; D'Agostino, Ralph B., Sr.			The Randomized Registry Trial - The Next Disruptive Technology in Clinical Research?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The registry-based randomized trial may make less expensive, more efficient clinical studies possible. But before the new study design can be widely used, questions about the quality of the underlying data sets must be addressed. The randomized trial is one of the most powerful tools clinical researchers possess, a tool that enables them to evaluate the effectiveness of new (or established) therapies while accounting for the effects of unmeasured confounders and selection bias by indication. Randomized trials, especially huge megatrials, have transformed medical practice. Thanks to randomized trials, we no longer, for example, treat acute myocardial infarction with lidocaine and nitrates. Instead we use rapid revascularization, anticoagulants, and antiplatelet agents, and during long-term follow-up we routinely prescribe statins, beta-blockers, and angiotensin-converting-enzyme inhibitors. But the reputation of randomized trials has suffered of late,(1) owing to reasonable ...	[Lauer, Michael S.] NHLBI, Off Director, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [D'Agostino, Ralph B., Sr.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [D'Agostino, Ralph B., Sr.] Harvard Clin Res Inst, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Harvard Medical School	Lauer, MS (corresponding author), NHLBI, Off Director, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA.							Antman EM, 2012, JAMA-J AM MED ASSOC, V308, P1743, DOI 10.1001/jama.2012.14841; Frobert O, 2010, AM HEART J, V160, P1042, DOI 10.1016/j.ahj.2010.08.040; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511	3	413	420	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1579	1581		10.1056/NEJMp1310102	http://dx.doi.org/10.1056/NEJMp1310102			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	23991657				2022-12-28	WOS:000326031100004
J	You, DZ; Wardlaw, T; Newby, H; Anthony, D; Rogers, K				You, Danzhen; Wardlaw, Tessa; Newby, Holly; Anthony, David; Rogers, Katherine			Renewing the promise of survival for children	LANCET			English	Editorial Material									[You, Danzhen; Wardlaw, Tessa; Newby, Holly; Anthony, David] UNICEF, Div Policy & Strategy, New York, NY 10017 USA; [Rogers, Katherine] UNICEF, Promise Renewed Secretariat A, New York, NY 10017 USA	UNICEF; UNICEF	You, DZ (corresponding author), UNICEF, Div Policy & Strategy, New York, NY 10017 USA.	dyou@unicef.org						Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; The UN Inter-agency Group for Child Mortality Estimation, 2013, LEVELS AND TRENDS IN; UNICEF, 2013, COMMITTING TO CHILD	4	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 21	2013	382	9897					1002	1004		10.1016/S0140-6736(13)61895-4	http://dx.doi.org/10.1016/S0140-6736(13)61895-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	222PB	24035252				2022-12-28	WOS:000324742200005
J	Grotta, JC				Grotta, James C.			Carotid Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE PROFESSIONALS; ISCHEMIC-STROKE; ENDARTERECTOMY; PREVENTION; GUIDELINES; MECHANISMS	A 53-year-old woman who smoked and had hypertension had brief numbness of the right side of her body. Six months later, aphasia and right hemiparesis suddenly developed, and they resolved after 48 hours. Computed tomographic angiography (CTA) showed left internal-carotid-artery stenosis of 70% just distal to the bifurcation. Magnetic resonance imaging (MRI) confirmed a left frontotemporal infarct without hemorrhagic transformation or cerebral edema. Cardiac evaluation was normal. What is the appropriate management of this patient's carotid stenosis?	[Grotta, James C.] Univ Texas Med Sch Houston, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Grotta, JC (corresponding author), Univ Texas Med Sch Houston, Dept Neurol, 6431 Fannin St,7-044, Houston, TX 77030 USA.	james.c.grotta@uth.tmc.edu	Grotta, James/AAH-7423-2021	grotta, james/0000-0002-3667-4248	Merck; Haemonetics; Genentech; Janssen; Pfizer; Lundbeck; Ferrer; IPG; Vindico	Merck(Merck & Company); Haemonetics; Genentech(Roche HoldingGenentech); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Lundbeck(Lundbeck Corporation); Ferrer; IPG; Vindico	Dr. Grotta reports receiving consulting fees from Merck, Haemonetics, Genentech, Janssen, Pfizer, Lundbeck, and Ferrer; lecture fees from IPG and Vindico; a grant to his institution from Haemonetics; and royalties from patents regarding a method for treating cerebral ischemia. No other potential conflict of interest relevant to this article was reported.	Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BOGOUSSLAVSKY J, 1992, NEUROL CLIN, V10, P113, DOI 10.1016/S0733-8619(18)30236-6; BRICE JG, 1964, BRIT MED J, V2, P1363, DOI 10.1136/bmj.2.5421.1363; Brott TG, 2013, CATHETER CARDIO INTE, V81, pE75, DOI 10.1002/ccd.22983; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Brown MM, 2001, LANCET, V357, P1729; CARPENTER DA, 1990, NEUROLOGY, V40, P1587, DOI 10.1212/WNL.40.10.1587; Davis SM, 2012, NEW ENGL J MED, V366, P1914, DOI 10.1056/NEJMcp1107281; DEBRAY JM, 1995, CEREBROVASC DIS, V5, P414, DOI 10.1159/000107895; DIENER HC, 1991, STROKE, V22, P1229; Dzialowski I, 2011, STROKE PATHOPHYSIOLO, P870; Ederle J, 2010, LANCET, V375, P985, DOI 10.1016/S0140-6736(10)60239-5; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; FISHER CM, 1959, NEUROLOGY, V9, P333, DOI 10.1212/WNL.9.5.333; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gagne PJ, 1996, J VASC SURG, V24, P449, DOI 10.1016/S0741-5214(96)70201-X; GOES E, 1990, J CLIN ULTRASOUND, V18, P611, DOI 10.1002/jcu.1990.18.8.611; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Halliday A, 2004, LANCET, V363, P1491; Henderson RD, 2001, J NEUROSURG, V95, P964, DOI 10.3171/jns.2001.95.6.0964; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Lal BK, 2012, LANCET NEUROL, V11, P755, DOI 10.1016/S1474-4422(12)70159-X; LENNIHAN L, 1987, STROKE, V18, P879, DOI 10.1161/01.STR.18.5.879; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Markus HS, 2005, STROKE; Markus H, 2007, INT J STROKE, V2, P292, DOI 10.1111/j.1747-4949.2007.00165.x; MARZEWSKI DJ, 1982, STROKE, V13, P821, DOI 10.1161/01.STR.13.6.821; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; MAYBERG MR, 1991, JAMA-J AM MED ASSOC, V266, P3289, DOI 10.1001/jama.266.23.3289; Meairs S, 2011, STROKE PATHOPHYSIOLO, P831; MOHR JP, 1978, NEUROLOGY, V28, P754, DOI 10.1212/WNL.28.8.754; Mohr JP, 2011, STROKE PATHOPHYSIOLO, P334; PESSIN MS, 1977, NEW ENGL J MED, V296, P358, DOI 10.1056/NEJM197702172960703; PESSIN MS, 1979, ANN NEUROL, V6, P245, DOI 10.1002/ana.410060311; Ratchford EV, 2009, NEUROL RES, V31, P748, DOI 10.1179/174313209X382458; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Sattenberg RJ, 2011, STROKE PATHOPHYSIOLO, P910; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; U-King-Im JM, 2008, J NEUROL NEUROSUR PS, V79, P905, DOI 10.1136/jnnp.2007.127969; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Warach S, 2011, STROKE PATHOPHYSIOLO, P882; White RA, 2005, J VASC SURG, V42, P213, DOI 10.1016/j.jvs.2005.04.023; WIEBERS DO, 1992, MAYO CLIN PROC, V67, P513; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Young B, 1996, STROKE, V27, P2216, DOI 10.1161/01.STR.27.12.2216; Zweifler RM, 2011, STROKE PATHOPHYSIOLO, P661	50	50	52	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1143	1150		10.1056/NEJMcp1214999	http://dx.doi.org/10.1056/NEJMcp1214999			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047063				2022-12-28	WOS:000324554800012
J	Huang, J				Huang, Jing			Tracking Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A method for measuring the extent to which a drug binds its intended target in vivo involves determining the thermostability of the target. Historically, knowledge of drug targets has largely lagged far behind the administration of drugs to patients, often with harmful or even deadly results. Various advances suggest that the identification and validation of drug-target interactions can be made with greater ease, efficiency, and accuracy.(1) A new label-free strategy (one that uses the native drug without requiring chemical tagging or modification) devised by Molina and colleagues,(2) dubbed the cellular thermal shift assay (CETSA), is capable of measuring drug-target binding inside cells, facilitating the studies of variables such as drug transport, activation, tissue distribution, target specificity, and resistance. When proteins in their native ...	[Huang, Jing] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Huang, Jing] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Huang, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.							Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Senisterra G, 2012, ASSAY DRUG DEV TECHN, V10, P128, DOI 10.1089/adt.2011.0390; West GM, 2010, P NATL ACAD SCI USA, V107, P9078, DOI 10.1073/pnas.1000148107	5	3	3	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1168	1169		10.1056/NEJMcibr1308868	http://dx.doi.org/10.1056/NEJMcibr1308868			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047067				2022-12-28	WOS:000324554800018
J	Shaukat, A; Mongin, SJ; Geisser, MS; Lederle, FA; Bond, JH; Mandel, JS; Church, TR				Shaukat, Aasma; Mongin, Steven J.; Geisser, Mindy S.; Lederle, Frank A.; Bond, John H.; Mandel, Jack S.; Church, Timothy R.			Long-Term Mortality after Screening for Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED TRIAL; FOLLOW-UP; GENDER-DIFFERENCES; UNITED-STATES; COLONOSCOPY; NEOPLASIA; DEATHS; TESTS	BackgroundIn randomized trials, fecal occult-blood testing reduces mortality from colorectal cancer. However, the duration of the benefit is unknown, as are the effects specific to age and sex. MethodsIn the Minnesota Colon Cancer Control Study, 46,551 participants, 50 to 80 years of age, were randomly assigned to usual care (control) or to annual or biennial screening with fecal occult-blood testing. Screening was performed from 1976 through 1982 and from 1986 through 1992. We used the National Death Index to obtain updated information on the vital status of participants and to determine causes of death through 2008. ResultsThrough 30 years of follow-up, 33,020 participants (70.9%) died. A total of 732 deaths were attributed to colorectal cancer: 200 of the 11,072 deaths (1.8%) in the annual-screening group, 237 of the 11,004 deaths (2.2%) in the biennial-screening group, and 295 of the 10,944 deaths (2.7%) in the control group. Screening reduced colorectal-cancer mortality (relative risk with annual screening, 0.68; 95% confidence interval [CI], 0.56 to 0.82; relative risk with biennial screening, 0.78; 95% CI, 0.65 to 0.93) through 30 years of follow-up. No reduction was observed in all-cause mortality (relative risk with annual screening, 1.00; 95% CI, 0.99 to 1.01; relative risk with biennial screening, 0.99; 95% CI, 0.98 to 1.01). The reduction in colorectal-cancer mortality was larger for men than for women in the biennial-screening group (P=0.04 for interaction). ConclusionsThe effect of screening with fecal occult-blood testing on colorectal-cancer mortality persists after 30 years but does not influence all-cause mortality. The sustained reduction in colorectal-cancer mortality supports the effect of polypectomy.	[Shaukat, Aasma; Bond, John H.] Minneapolis Vet Affairs Hlth Care Syst, Div Gastroenterol, Minneapolis, MN USA; [Lederle, Frank A.] Minneapolis Vet Affairs Hlth Care Syst, Div Internal Med, Minneapolis, MN USA; [Shaukat, Aasma; Lederle, Frank A.; Bond, John H.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Mongin, Steven J.; Geisser, Mindy S.; Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA; [Mandel, Jack S.] Exponent, Menlo Pk, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Exponent	Shaukat, A (corresponding author), 1 Vet Dr,111-D, Minneapolis, MN 55417 USA.		Church, Timothy/AAH-7017-2020	Church, Timothy/0000-0003-3292-5035	Veterans Affairs Merit Review Award Program; DIVISION OF CANCER BIOLOGY AND DIAGNOSIS [N01CB095613, N01CB061005, N01CB053862] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA065728] Funding Source: NIH RePORTER	Veterans Affairs Merit Review Award Program; DIVISION OF CANCER BIOLOGY AND DIAGNOSIS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Veterans Affairs Merit Review Award Program and others.	Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Brenner H, 2007, BRIT J CANCER, V96, P828, DOI 10.1038/sj.bjc.6603628; Church TR, 2004, JNCI-J NATL CANCER I, V96, P770, DOI 10.1093/jnci/djh134; Cuzick J, 2007, STAT MED, V26, P3821, DOI 10.1002/sim.2922; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; Forsberg AM, 2012, SCAND J GASTROENTERO, V47, P184, DOI 10.3109/00365521.2011.647062; German RR, 2011, CANCER EPIDEMIOL, V35, P126, DOI 10.1016/j.canep.2010.09.005; GILBERTSEN VA, 1980, J CHRON DIS, V33, P107, DOI 10.1016/0021-9681(80)90034-X; Greenwood M., 1926, REPORTS PUBLIC HLTH, V33, P1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KEWENTER J, 1994, SCAND J GASTROENTERO, V29, P468, DOI 10.3109/00365529409096840; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Limburg PJ, 2003, AM J GASTROENTEROL, V98, P2299, DOI 10.1016/S0002-9270(03)00541-0; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; McCashland TM, 2001, AM J GASTROENTEROL, V96, P882, DOI 10.1111/j.1572-0241.2001.03638.x; Moayyedi P, 2006, AM J GASTROENTEROL, V101, P380, DOI 10.1111/j.1572-0241.2006.00537.x; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Scholefield JH, 2012, GUT, V61, P1036, DOI 10.1136/gutjnl-2011-300774; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Shaukat A, 2009, CLIN GASTROENTEROL H, V7, P1335, DOI 10.1016/j.cgh.2009.07.027; Siegel RL, 2012, CANCER EPIDEM BIOMAR, V21, P411, DOI 10.1158/1055-9965.EPI-11-1020; THOMAS W, 1995, AM J EPIDEMIOL, V142, P176, DOI 10.1093/oxfordjournals.aje.a117616; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	30	550	585	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1106	1114		10.1056/NEJMoa1300720	http://dx.doi.org/10.1056/NEJMoa1300720			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047060				2022-12-28	WOS:000324554800008
J	Fantin, VR; Abraham, RT				Fantin, Valeria R.; Abraham, Robert T.			Self-Eating Limits EGFR-Dependent Tumor Growth	CELL			English	Editorial Material							AUTOPHAGY; PROGRESSION; CANCER	Autophagy is a cell-autonomous, catabolic process that plays context-dependent roles in tumor growth and progression. Wei et al. report that EGFR signaling promotes tumor growth through phosphorylation and functional inactivation of Beclin 1 and the consequent suppression of autophagy.	[Fantin, Valeria R.; Abraham, Robert T.] Pfizer Worldwide Res & Dev, Oncol Res Unit, La Jolla, CA 92121 USA	Pfizer	Abraham, RT (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res Unit, La Jolla, CA 92121 USA.	robert.abraham@pfizer.com						Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Filosso PL, 2011, LUNG CANCER, V74, P25, DOI 10.1016/j.lungcan.2011.01.030; Fung C, 2012, CANCER BIOL THER, V13, P1417, DOI 10.4161/cbt.22002; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Lorin S, 2013, SEMIN CANCER BIOL, V23, P361, DOI 10.1016/j.semcancer.2013.06.007; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262	10	7	7	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1184	1186		10.1016/j.cell.2013.08.040	http://dx.doi.org/10.1016/j.cell.2013.08.040			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034240	Bronze			2022-12-28	WOS:000324239300006
J	Miller, P				Miller, Peter			Energy drinks and alcohol: research supported by industry may be downplaying harms	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; PATTERNS; RISK		Deakin Univ, Sch Psychol, Geelong, Vic 3220, Australia	Deakin University	Miller, P (corresponding author), Deakin Univ, Sch Psychol, Geelong, Vic 3220, Australia.	Peter.Miller@deakin.edu.au		Miller, Peter/0000-0002-6896-5437				Alford C, 2012, DRUG ALCOHOL REV, V31, P46; [Anonymous], 1979, BMJ-BRIT MED J, V1, P532; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Benson S, 2012, DRUG ALCOHOL REV, V31, P47; Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003; De Haan L, 2012, DRUG ALCOHOL REV, V31, P50; Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35; Miller P.G., 2013, PATRON OFFENDING INT; Oteri A, 2007, ALCOHOL CLIN EXP RES, V31, P1677, DOI 10.1111/j.1530-0277.2007.00464.x; Peacock A, 2011, MOTIVATIONS CONSEQUE; Pennay A, 2011, AUST FAM PHYSICIAN, V40, P104; Thombs DL, 2010, ADDICT BEHAV, V35, P325, DOI 10.1016/j.addbeh.2009.11.004; Verster J, 2012, DRUG ALCOHOL REV, V31, P7	13	13	13	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2013	347								f5345	10.1136/bmj.f5345	http://dx.doi.org/10.1136/bmj.f5345			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	219SU	24030480				2022-12-28	WOS:000324530500003
J	Read, TRH; Hocking, JS; Bradshaw, CS; Morrow, A; Grulich, AE; Fairley, CK; Chen, MY				Read, Tim R. H.; Hocking, Jane S.; Bradshaw, Catriona S.; Morrow, Andrea; Grulich, Andrew E.; Fairley, Christopher K.; Chen, Marcus Y.			Provision of rapid HIV tests within a health service and frequency of HIV testing among men who have sex with men: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMMUNITY SAMPLE; GAY MEN; INFECTION; TRANSMISSION; STRATEGIES; AUSTRALIA; BARRIERS; PREVALENCE; PREVENTION; EPIDEMIC	Objective To determine if the provision of rapid HIV testing to men who have sex with men attending a health service would increase their frequency of HIV testing over time. Design Non-blinded randomised controlled trial. Setting Public sexual health service in Australia. Participants Men who reported having a male sexual partner within the previous year and an HIV test within the previous two years. Of 400 men entered, 370 (92.5%) completed the study. Interventions Men attending the service between September 2010 and March 2011 were randomised 1: 1 to either ongoing access to rapid HIV testing obtained with finger prick or to conventional HIV serology with venepuncture, over 18 months. Main outcome measure The incidence of all HIV testing after enrolment, including testing outside the study clinic, analysed by intention to treat. Results Of 200 men randomised to the rapid testing arm, 196 were followed for 288 person years. Of 200 men randomised to the conventional testing arm, 194 were followed for 278 person years. Median time since the last HIV test was six months for both arms. Men in the rapid test arm had 469 tests (mean 1.63 tests a year), and men in the conventional test arm had 396 tests (mean 1.42 tests a year); incidence rate ratio 1.15, 95% confidence interval 0.96 to 1.38; P=0.12. In a post hoc analysis, rates of initial HIV testing during follow-up were 1.32 and 1.01 tests a year, respectively (1.32, 1.05 to 1.65; P=0.02). Conclusions Provision of access to rapid HIV testing in a health service did not result in a sustained increase over time in HIV testing by men who have sex with men; however, the rate of initial HIV testing did increase by a third. Further research is required to determine how to achieve sustained increases in the frequency of HIV testing by populations at risk.	[Read, Tim R. H.; Bradshaw, Catriona S.; Morrow, Andrea; Fairley, Christopher K.; Chen, Marcus Y.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic 3053, Australia; [Read, Tim R. H.; Bradshaw, Catriona S.; Fairley, Christopher K.; Chen, Marcus Y.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Hocking, Jane S.] Univ Melbourne, Ctr Womens Hlth Gender & Soc, Melbourne, Vic 3010, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Grulich, Andrew E.] Univ New S Wales, Kirby Inst, Kensington, NSW 2052, Australia	University of Melbourne; University of Melbourne; Monash University; University of New South Wales Sydney; Kirby Institute	Read, TRH (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Carlton, Vic 3053, Australia.	tread@mshc.org.au	Hocking, Jane/AAD-5203-2021	Hocking, Jane/0000-0001-9329-8501; bradshaw, catriona/0000-0002-6643-5678; Christopher, Fairley/0000-0001-9081-1664	National Health and Medical Research Council of Australia program [568971]; Australian postgraduate award	National Health and Medical Research Council of Australia program(National Health and Medical Research Council (NHMRC) of Australia); Australian postgraduate award(Australian Government)	The study was funded by National Health and Medical Research Council of Australia program grant No 568971. TRHR is the recipient of an Australian postgraduate award. Only the Melbourne Sexual Health Centre had access to the study data, and the authors had sole responsibility of decision for publication.	Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; [Anonymous], 2012, ANNUAL SURVEILLANCE; [Anonymous], 2013, FDA APPROVES FIRST O; Apanovitch AM, 2003, HEALTH PSYCHOL, V22, P60, DOI 10.1037/0278-6133.22.1.60; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Birrell F, 2010, SEX HEALTH, V7, P11, DOI 10.1071/SH09029; Brown AE, 2009, SEX TRANSM INFECT, V85, P4, DOI 10.1136/sti.2008.031831; Burns F, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e501; CDC, 2012, HIV SURVEILLANCE REP, V22; Charlebois ED, 2011, CLIN INFECT DIS, V52, P1046, DOI 10.1093/cid/cir085; Chen MY, 2010, INT J STD AIDS, V21, P428, DOI 10.1258/ijsa.2010.009552; Chibo D, 2012, AIDS RES HUM RETROV, V28, P460, DOI [10.1089/AID.2011.0137, 10.1089/aid.2011.0137]; Chow EPF, 2012, HIV MED, V13, P255, DOI 10.1111/j.1468-1293.2011.00974.x; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Donnell-Fink LA, 2012, JAIDS-J ACQ IMM DEF, V61, P588, DOI [10.1097/QAI.0b013e31826a6d67., 10.1097/QAI.0b013e31826a6d67]; Fox J, 2009, HIV MED, V10, P432, DOI 10.1111/j.1468-1293.2009.00708.x; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; Mallitt KA, 2012, SEX HEALTH, V9, P138, DOI 10.1071/SH10141; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Metsch LR, 2012, AM J PUBLIC HEALTH, V102, P1160, DOI 10.2105/AJPH.2011.300460; Moore DM, 2012, CAN J PUBLIC HEALTH, V103, P142, DOI 10.1007/BF03404220; Myers JJ, 2009, J GEN INTERN MED, V24, P1269, DOI 10.1007/s11606-009-1070-1; Pedrana AE, 2012, JAIDS-J ACQ IMM DEF, V59, P94, DOI 10.1097/QAI.0b013e3182396869; Prestage G, 2012, SEX HEALTH, V9, P453, DOI 10.1071/SH12033; Saxton PJW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-92; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Spielberg F, 2005, JAIDS-J ACQ IMM DEF, V38, P348; Spielberg F, 2003, JAIDS-J ACQ IMM DEF, V32, P318, DOI 10.1097/00126334-200303010-00012; STIGMA, 2010, SEXUALLY TRANSMITTED; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231; Wilson DP, 2011, SEX TRANSM INFECT, V87, P588, DOI 10.1136/sextrans-2011-050002; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Zablotska I, 2012, AIDS BEHAV, V16, P1887, DOI 10.1007/s10461-012-0184-3	38	32	32	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2013	347								f5086	10.1136/bmj.f5086	http://dx.doi.org/10.1136/bmj.f5086			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215NL	24004988	Green Published, hybrid			2022-12-28	WOS:000324216800007
J	Cibas, ES; Baloch, ZW; Fellegara, G; LiVolsi, VA; Raab, SS; Rosai, J; Diggans, J; Friedman, L; Kennedy, GC; Kloos, RT; Lanman, RB; Mandel, SJ; Sindy, N; Steward, DL; Zeiger, MA; Haugen, BR; Alexander, EK				Cibas, Edmund S.; Baloch, Zubair W.; Fellegara, Giovanni; LiVolsi, Virginia A.; Raab, Stephen S.; Rosai, Juan; Diggans, James; Friedman, Lyssa; Kennedy, Giulia C.; Kloos, Richard T.; Lanman, Richard B.; Mandel, Susan J.; Sindy, Nicole; Steward, David L.; Zeiger, Martha A.; Haugen, Bryan R.; Alexander, Erik K.			A Prospective Assessment Defining the Limitations of Thyroid Nodule Pathologic Evaluation	ANNALS OF INTERNAL MEDICINE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; INTRAOBSERVER REPRODUCIBILITY; INTEROBSERVER REPRODUCIBILITY; PAPILLARY CARCINOMA; FOLLICULAR VARIANT; OBSERVER VARIATION; 2ND OPINION; DIAGNOSIS; CYTOPATHOLOGY; LESIONS	Background: Clinical management of thyroid neoplasms is based on light microscopic diagnosis, but its accuracy and precision are poorly defined. Objective: To assess inter-and intraobserver variability of preoperative cytopathologic and postoperative histopathologic thyroid diagnoses. Design: Samples were collected in a prospective, multicenter trial validating a gene expression classifier between June 2009 and December 2010. Setting: 14 academic and 35 community clinical sites. Patients: 653 patients with 776 surgically resected thyroid nodules of 1 cm or greater. Measurements: Intraobserver concordance among 2 or more central histopathologists who independently read histopathology slides was calculated. Interobserver concordance between the diagnoses made by the central histopathologists and those made by local pathologists were calculated. Intra-and interobserver concordance for cytopathology was similarly calculated by comparing diagnoses made by local pathologists with those made by a central panel of 3 cytopathologists. Results: Concordance on the histopathologic distinction between benign and malignant diagnoses was 91% comparing local with central histopathologists and 90% comparing 2 central histopathologists. Using the 6-category Bethesda System, 64.0% of diagnoses made by local and central cytopathologists and 74.7% of intraobserver diagnoses were concordant. Central cytopathologists made fewer indeterminate diagnoses than local pathologists (41.2% vs. 55.0%). Limitations: Many local pathologists did not use the Bethesda System, so their reports were translated to allow comparison. The study required histopathology, and the study population and specimens did not encompass all newly evaluated patients with a thyroid nodule. Conclusion: Substantial inter-and intraobserver variability exists in the cytopathologic and histopathologic evaluation of thyroid nodules, confirming an inherent limitation of visual microscopic diagnosis.	[Alexander, Erik K.] Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; Ctr Diagnost Italiano, Milan, Italy; Univ Washington, Sch Med, Seattle, WA USA; Veracyte, San Francisco, CA USA; Ohio State Univ, Columbus, OH 43210 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Univ Colorado, Sch Med, Aurora, CO USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati; Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus	Alexander, EK (corresponding author), Brigham & Womens Hosp, 75 Francis St,PBB-B4, Boston, MA 02115 USA.	ekalexander@partners.org	Kloos, Richard/Q-9963-2019; Lanman, Richard B/D-8290-2016	Lanman, Richard B/0000-0001-8122-4329	Veracyte	Veracyte	Veracyte.	Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Bajaj J, 2012, DIAGN CYTOPATHOL, V40, P422, DOI 10.1002/dc.21820; Baloch ZW, 2008, DIAGN CYTOPATHOL, V36, P425, DOI 10.1002/dc.20830; Bergenfelz A, 2008, LANGENBECK ARCH SURG, V393, P667, DOI 10.1007/s00423-008-0366-7; Bongiovanni M, 2012, CANCER CYTOPATHOL, V120, P117, DOI 10.1002/cncy.20195; Chudova D, 2010, J CLIN ENDOCR METAB, V95, P5296, DOI 10.1210/jc.2010-1087; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davidov T, 2010, SURGERY, V148, P1294, DOI 10.1016/j.surg.2010.09.029; Dralle H, 2011, LANGENBECK ARCH SURG, V396, P1137, DOI 10.1007/s00423-011-0809-4; Elsheikh TM, 2008, AM J CLIN PATHOL, V130, P736, DOI 10.1309/AJCPKP2QUVN4RCCP; Franc B, 2003, HUM PATHOL, V34, P1092, DOI 10.1016/S0046-8177(03)00403-9; Gerhard R, 2007, CYTOPATHOLOGY, V18, P105, DOI 10.1111/j.1365-2303.2006.00430.x; Hamady ZZR, 2005, EJSO-EUR J SURG ONC, V31, P74, DOI 10.1016/j.ejso.2004.08.010; Hirokawa M, 2002, AM J SURG PATHOL, V26, P1508, DOI 10.1097/00000478-200211000-00014; Jing X, 2012, DIAGN CYTOPATHOL, V40, pE74, DOI 10.1002/dc.21726; Kocjan G, 2011, AM J CLIN PATHOL, V135, P852, DOI 10.1309/AJCPZ33MVMGZKEWU; Lange Dariusz, 2006, Endokrynol Pol, V57, P336; LiVolsi Virginia A., 2007, SURG PATHOLOGY THYRO, V22; Lloyd RV, 2004, AM J SURG PATHOL, V28, P1336, DOI 10.1097/01.pas.0000135519.34847.f6; Olson MT, 2013, J CLIN ENDOCR METAB, V98, P1450, DOI 10.1210/jc.2012-3898; Park S J, 2012, Ultraschall Med, V33, pE186, DOI 10.1055/s-0032-1325404; Rosai J, 1993, ATLAS TUMOR PATHOLOG; Sawka AM, 2009, THYROID, V19, P451, DOI 10.1089/thy.2008.0392; Schlomer BJ, 2010, J UROLOGY, V183, P62, DOI 10.1016/j.juro.2009.08.157; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Sosa JA, 1998, ANN SURG, V228, P320, DOI 10.1097/00000658-199809000-00005; Tan YY, 2007, J AM COLL SURGEONS, V205, P8, DOI 10.1016/j.jamcollsurg.2007.02.075; Tetikkurt US, 2012, DIAGN CYTOPATHOL, V40, P388, DOI 10.1002/dc.21658; Wallander M, 2010, APPL IMMUNOHISTO M M, V18, P231, DOI 10.1097/PAI.0b013e3181c61cdd; Walts AE, 2012, DIAGN CYTOPATHOL, V40, pE62, DOI 10.1002/dc.21697; Williams ED, 2000, INT J SURG PATHOL, V8, P181, DOI 10.1177/106689690000800304; Yassa L, 2007, CANCER CYTOPATHOL, V111, P508, DOI 10.1002/cncr.23116	33	136	138	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2013	159	5					325	+		10.7326/0003-4819-159-5-201309030-00006	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215YA	24026318				2022-12-28	WOS:000324245900003
J	Furukawa, H; Cordova, KE; O'Keeffe, M; Yaghi, OM				Furukawa, Hiroyasu; Cordova, Kyle E.; O'Keeffe, Michael; Yaghi, Omar M.			The Chemistry and Applications of Metal-Organic Frameworks	SCIENCE			English	Review							COORDINATION POLYMER CRYSTALS; HIGH H-2 ADSORPTION; CARBON-DIOXIDE; SURFACE-AREAS; HYDROGEN ADSORPTION; CATALYTIC-ACTIVITY; PROTON CONDUCTION; HIGH-CAPACITY; THIN-FILMS; STORAGE	Crystalline metal-organic frameworks (MOFs) are formed by reticular synthesis, which creates strong bonds between inorganic and organic units. Careful selection of MOF constituents can yield crystals of ultrahigh porosity and high thermal and chemical stability. These characteristics allow the interior of MOFs to be chemically altered for use in gas separation, gas storage, and catalysis, among other applications. The precision commonly exercised in their chemical modification and the ability to expand their metrics without changing the underlying topology have not been achieved with other solids. MOFs whose chemical composition and shape of building units can be multiply varied within a particular structure already exist and may lead to materials that offer a synergistic combination of properties.	[Furukawa, Hiroyasu; Cordova, Kyle E.; Yaghi, Omar M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Furukawa, Hiroyasu; Cordova, Kyle E.; Yaghi, Omar M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [O'Keeffe, Michael] Arizona State Univ, Dept Chem, Tempe, AZ 87240 USA; [O'Keeffe, Michael; Yaghi, Omar M.] NanoCentury KAIST Inst, Taejon 305701, South Korea; [O'Keeffe, Michael; Yaghi, Omar M.] World Class Univ, Grad Sch Energy Environm Water & Sustainabil, Taejon 305701, South Korea	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Arizona State University; Arizona State University-Tempe; Korea Advanced Institute of Science & Technology (KAIST)	Yaghi, OM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	yaghi@berkeley.edu	Yaghi, Omar M/C-6749-2013; EFRC, CGS/I-6680-2012; Furukawa, Hiroyasu/C-5910-2008; Stangl, Kristin/D-1502-2015; Cordova, Kyle/I-2556-2014	Furukawa, Hiroyasu/0000-0002-6082-1738; Cordova, Kyle/0000-0002-4988-0497; Yaghi, Omar/0000-0002-5611-3325	BASF SE (Ludwigshafen, Germany); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Energy Frontier Research Center [DE-SC0001015]; U.S. Department of Defense, Defense Threat Reduction Agency [HDTRA 1-12-1-0053]; Ministry of Education, Science and Technology (Korea), WCU Program [NRF R-31-2008-000-10055-0]	BASF SE (Ludwigshafen, Germany); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Energy Frontier Research Center; U.S. Department of Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Ministry of Education, Science and Technology (Korea), WCU Program	We acknowledge the original contributions made by members of the Yaghi research group as cited in the references. In particular, preliminary work on this manuscript was done by W. Morris, F. Gandara, H. Deng, and Y. Zhang. Supported by BASF SE (Ludwigshafen, Germany); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Energy Frontier Research Center grant DE-SC0001015; U.S. Department of Defense, Defense Threat Reduction Agency grant HDTRA 1-12-1-0053; and the Ministry of Education, Science and Technology (Korea), WCU Program grant NRF R-31-2008-000-10055-0.	Alaerts L, 2006, CHEM-EUR J, V12, P7353, DOI 10.1002/chem.200600220; Alkordi MH, 2008, J AM CHEM SOC, V130, P12639, DOI 10.1021/ja804703w; [Anonymous], 2012, CHEM REV, V112, P673; Bloch ED, 2012, SCIENCE, V335, P1606, DOI 10.1126/science.1217544; Botas JA, 2010, LANGMUIR, V26, P5300, DOI 10.1021/la100423a; Bradshaw D, 2012, CHEM SOC REV, V41, P2344, DOI 10.1039/c1cs15276a; Britt D, 2009, P NATL ACAD SCI USA, V106, P20637, DOI 10.1073/pnas.0909718106; Bu F, 2012, ANGEW CHEM INT EDIT, V51, P8538, DOI 10.1002/anie.201203425; Bureekaew S, 2009, NAT MATER, V8, P831, DOI [10.1038/NMAT2526, 10.1038/nmat2526]; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Cavka JH, 2008, J AM CHEM SOC, V130, P13850, DOI 10.1021/ja8057953; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Chen BL, 2008, J AM CHEM SOC, V130, P6411, DOI 10.1021/ja710144k; Chen BL, 2006, ANGEW CHEM INT EDIT, V45, P1390, DOI 10.1002/anie.200502844; Chen BL, 2000, J AM CHEM SOC, V122, P11559, DOI 10.1021/ja003159k; Chen BL, 2005, ANGEW CHEM INT EDIT, V44, P4745, DOI 10.1002/anie.200462787; Choi KM, 2011, J AM CHEM SOC, V133, P11920, DOI 10.1021/ja204818q; Chui SSY, 1999, SCIENCE, V283, P1148, DOI 10.1126/science.283.5405.1148; Cohen SM, 2012, CHEM REV, V112, P970, DOI 10.1021/cr200179u; Colombo V, 2011, CHEM SCI, V2, P1311, DOI 10.1039/c1sc00136a; Cravillon J, 2011, CHEM MATER, V23, P2130, DOI 10.1021/cm103571y; Cravillon J, 2009, CHEM MATER, V21, P1410, DOI 10.1021/cm900166h; Deng HX, 2012, SCIENCE, V336, P1018, DOI 10.1126/science.1220131; Deng HX, 2010, NAT CHEM, V2, P439, DOI [10.1038/NCHEM.654, 10.1038/nchem.654]; Deng HX, 2010, SCIENCE, V327, P846, DOI 10.1126/science.1181761; Dinca M, 2007, J AM CHEM SOC, V129, P11172, DOI 10.1021/ja072871f; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Eryazici I, 2012, CRYST GROWTH DES, V12, P1075, DOI 10.1021/cg201520z; Farha OK, 2012, J AM CHEM SOC, V134, P15016, DOI 10.1021/ja3055639; Farha OK, 2012, J AM CHEM SOC, V134, P9860, DOI 10.1021/ja302623w; Farha OK, 2010, NAT CHEM, V2, P944, DOI [10.1038/nchem.834, 10.1038/NCHEM.834]; FUJITA M, 1994, J AM CHEM SOC, V116, P1151, DOI 10.1021/ja00082a055; Furukawa H, 2011, INORG CHEM, V50, P9147, DOI 10.1021/ic201376t; Furukawa H, 2010, SCIENCE, V329, P424, DOI 10.1126/science.1192160; Furukawa H, 2009, J AM CHEM SOC, V131, P8875, DOI 10.1021/ja9015765; Furukawa S, 2009, ANGEW CHEM INT EDIT, V48, P1766, DOI 10.1002/anie.200804836; Gassensmith JJ, 2011, J AM CHEM SOC, V133, P15312, DOI 10.1021/ja206525x; Grzelczak M, 2010, ACS NANO, V4, P3591, DOI 10.1021/nn100869j; Han SS, 2007, J AM CHEM SOC, V129, P8422, DOI 10.1021/ja072599+; Henschel A, 2008, CHEM COMMUN, P4192, DOI 10.1039/b718371b; Horike S, 2008, J AM CHEM SOC, V130, P5854, DOI 10.1021/ja800669j; Huang LM, 2003, MICROPOR MESOPOR MAT, V58, P105, DOI 10.1016/S1387-1811(02)00609-1; Hurd JA, 2009, NAT CHEM, V1, P705, DOI [10.1038/nchem.402, 10.1038/NCHEM.402]; Hwang YK, 2008, ANGEW CHEM INT EDIT, V47, P4144, DOI 10.1002/anie.200705998; Jacoby M, 2008, CHEM ENG NEWS, V86, P13; Kandiah M, 2010, CHEM MATER, V22, P6632, DOI 10.1021/cm102601v; KINOSHITA Y, 1959, B CHEM SOC JPN, V32, P1221, DOI 10.1246/bcsj.32.1221; Kondo M, 1997, ANGEW CHEM INT EDIT, V36, P1725, DOI 10.1002/anie.199717251; Kozachuk O, 2011, CHEM COMMUN, V47, P8509, DOI 10.1039/c1cc11107h; Kramer M, 2006, J MATER CHEM, V16, P2245, DOI 10.1039/b601811d; Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f; Li BY, 2012, ANGEW CHEM INT EDIT, V51, P1412, DOI 10.1002/anie.201105966; Li H, 1998, J AM CHEM SOC, V120, P8571, DOI 10.1021/ja981669x; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Li QF, 2003, CHEM MATER, V15, P4896, DOI 10.1021/cm0310519; Li QW, 2009, SCIENCE, V325, P855, DOI 10.1126/science.1175441; Llewellyn PL, 2008, LANGMUIR, V24, P7245, DOI 10.1021/la800227x; Lu G, 2013, CHEM-ASIAN J, V8, P69, DOI 10.1002/asia.201200754; Lu JJ, 2001, ANGEW CHEM INT EDIT, V40, P2113, DOI 10.1002/1521-3773(20010601)40:11<2113::AID-ANIE2113>3.0.CO;2-3; Lu Y, 2008, Z ANORG ALLG CHEM, V634, P2411, DOI 10.1002/zaac.200800158; Ma BQ, 2005, INORG CHEM, V44, P4912, DOI 10.1021/ic050452i; Ma SQ, 2008, J AM CHEM SOC, V130, P1012, DOI 10.1021/ja0771639; Ma SQ, 2007, J AM CHEM SOC, V129, P1858, DOI 10.1021/ja067435s; Maksimchuk NV, 2008, J CATAL, V257, P315, DOI 10.1016/j.jcat.2008.05.014; Matsuda R, 2005, NATURE, V436, P238, DOI 10.1038/nature03852; McDonald TM, 2011, CHEM SCI, V2, P2022, DOI 10.1039/c1sc00354b; Millward AR, 2005, J AM CHEM SOC, V127, P17998, DOI 10.1021/ja0570032; Morris W, 2008, J AM CHEM SOC, V130, P12626, DOI 10.1021/ja805222x; Morris W, 2012, INORG CHEM, V51, P6443, DOI 10.1021/ic300825s; Morris W, 2011, INORG CHEM, V50, P6853, DOI 10.1021/ic200744y; Mueller U, 2006, J MATER CHEM, V16, P626, DOI 10.1039/b511962f; Mulfort KL, 2009, J AM CHEM SOC, V131, P3866, DOI 10.1021/ja809954r; Murray LJ, 2010, J AM CHEM SOC, V132, P7856, DOI 10.1021/ja1027925; Nagao Y, 2002, MOL CRYST LIQ CRYST, V379, P89, DOI [10.1080/713738672, 10.1080/10587250290090318]; Narayan TC, 2012, J AM CHEM SOC, V134, P12932, DOI 10.1021/ja3059827; Noro S, 2000, ANGEW CHEM INT EDIT, V39, P2082; O'Keeffe M, 2008, ACCOUNTS CHEM RES, V41, P1782, DOI 10.1021/ar800124u; Pang ML, 2012, J AM CHEM SOC, V134, P13176, DOI 10.1021/ja3049282; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Phan A, 2011, INORG CHEM, V50, P7388, DOI 10.1021/ic201396m; Rabone J, 2010, SCIENCE, V329, P1053, DOI 10.1126/science.1190672; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440; Rowsell JLC, 2006, J AM CHEM SOC, V128, P1304, DOI 10.1021/ja056639q; Rowsell JLC, 2005, SCIENCE, V309, P1350, DOI 10.1126/science.1113247; Sadakiyo M, 2009, J AM CHEM SOC, V131, P9906, DOI 10.1021/ja9040016; Saravanan K, 2010, J MATER CHEM, V20, P8329, DOI 10.1039/c0jm01671c; Seo JS, 2000, NATURE, V404, P982, DOI 10.1038/35010088; Shah M, 2012, IND ENG CHEM RES, V51, P2179, DOI 10.1021/ie202038m; Shekhah O, 2011, CHEM SOC REV, V40, P1081, DOI 10.1039/c0cs00147c; Shigematsu A, 2011, J AM CHEM SOC, V133, P2034, DOI 10.1021/ja109810w; Stock N, 2012, CHEM REV, V112, P933, DOI 10.1021/cr200304e; Suh MP, 2012, CHEM REV, V112, P782, DOI 10.1021/cr200274s; Sun CY, 2009, J AM CHEM SOC, V131, P1883, DOI 10.1021/ja807357r; Sun DF, 2006, J AM CHEM SOC, V128, P3896, DOI 10.1021/ja058777l; Suslick KS, 2005, ACCOUNTS CHEM RES, V38, P283, DOI 10.1021/ar040173j; Tanabe KK, 2011, CHEM SOC REV, V40, P498, DOI 10.1039/c0cs00031k; Tanabe KK, 2009, ANGEW CHEM INT EDIT, V48, P7424, DOI 10.1002/anie.200903433; Taylor JM, 2013, J AM CHEM SOC, V135, P1193, DOI 10.1021/ja310435e; Taylor KML, 2008, J AM CHEM SOC, V130, P14358, DOI 10.1021/ja803777x; Umemura A, 2011, J AM CHEM SOC, V133, P15506, DOI 10.1021/ja204233q; Umeyama D, 2011, ANGEW CHEM INT EDIT, V50, P11706, DOI 10.1002/anie.201102997; Vairaprakash P, 2011, J AM CHEM SOC, V133, P759, DOI 10.1021/ja1097644; Walton KS, 2007, J AM CHEM SOC, V129, P8552, DOI 10.1021/ja071174k; Wang C, 2012, J AM CHEM SOC, V134, P7211, DOI 10.1021/ja300539p; Wang XS, 2006, J AM CHEM SOC, V128, P16474, DOI 10.1021/ja066616r; Wang XS, 2009, INORG CHEM, V48, P7519, DOI 10.1021/ic901073w; Wang ZQ, 2007, J AM CHEM SOC, V129, P12368, DOI 10.1021/ja074366o; Wang ZQ, 2010, CHEM-EUR J, V16, P212, DOI 10.1002/chem.200902158; Wells A.F., 1984, STRUCTURAL INORGANIC; Wong-Foy AG, 2006, J AM CHEM SOC, V128, P3494, DOI 10.1021/ja058213h; Wu CD, 2005, J AM CHEM SOC, V127, P8940, DOI 10.1021/ja052431t; Wu H, 2011, J AM CHEM SOC, V133, P11406, DOI 10.1021/ja202303b; Xiao B, 2007, J ORGANOMET CHEM, V692, P2014, DOI 10.1016/j.jorganchem.2007.01.010; Xie LH, 2007, INORG CHEM, V46, P7782, DOI 10.1021/ic062273m; Xue M, 2009, INORG CHEM, V48, P4649, DOI 10.1021/ic900486r; YAGHI OM, 1995, J AM CHEM SOC, V117, P10401, DOI 10.1021/ja00146a033; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yamada T, 2009, J AM CHEM SOC, V131, P3144, DOI 10.1021/ja808681m; Yan Y, 2010, J AM CHEM SOC, V132, P4092, DOI 10.1021/ja1001407; Yan Y, 2009, CHEM COMMUN, P1025, DOI 10.1039/b900013e; Yanai N, 2013, J AM CHEM SOC, V135, P34, DOI 10.1021/ja309361d; Yanai N, 2012, ANGEW CHEM INT EDIT, V51, P5638, DOI 10.1002/anie.201109132; Yoon M, 2013, ANGEW CHEM INT EDIT, V52, P2688, DOI 10.1002/anie.201206410; Yuan BZ, 2010, ANGEW CHEM INT EDIT, V49, P4054, DOI 10.1002/anie.201000576; Yuan DQ, 2011, INORG CHEM, V50, P10528, DOI 10.1021/ic201744n; Yuan DQ, 2010, ANGEW CHEM INT EDIT, V49, P5357, DOI 10.1002/anie.201001009; Zhao D, 2009, J AM CHEM SOC, V131, P9186, DOI 10.1021/ja901109t; Zheng BS, 2011, J AM CHEM SOC, V133, P748, DOI 10.1021/ja110042b; Zheng ST, 2011, ANGEW CHEM INT EDIT, V50, P8034, DOI 10.1002/anie.201103155; Zhou W, 2008, J AM CHEM SOC, V130, P15268, DOI 10.1021/ja807023q; Zou Y, 2008, CHEM COMMUN, P2340, DOI 10.1039/b801103f	132	9489	9650	1141	17481	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					974	+		10.1126/science.1230444	http://dx.doi.org/10.1126/science.1230444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990564				2022-12-28	WOS:000323652300033
J	Bird, A				Bird, Adrian			Genome Biology: Not Drowning but Waving	CELL			English	Editorial Material							EPIGENETIC MEMORY; C. ELEGANS; GERMLINE		Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	apbird@staffmail.ed.ac.uk		Bird, Adrian/0000-0002-8600-0372	Wellcome Trust [092076] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Ball P, 2013, NATURE, V496, P419, DOI 10.1038/496419a; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020	11	12	12	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					951	952		10.1016/j.cell.2013.08.010	http://dx.doi.org/10.1016/j.cell.2013.08.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993086	Bronze			2022-12-28	WOS:000323767300006
J	Pulido, T; Adzerikho, I; Channick, RN; Delcroix, M; Galie, N; Ghofrani, HA; Jansa, P; Jing, ZC; Le Brun, FO; Mehta, S; Mittelholzer, CM; Perchenet, L; Sastry, BKS; Sitbon, O; Souza, R; Torbicki, A; Zeng, XF; Rubin, LJ; Simonneau, G				Pulido, Tomas; Adzerikho, Igor; Channick, Richard N.; Delcroix, Marion; Galie, Nazzareno; Ghofrani, Hossein-Ardeschir; Jansa, Pavel; Jing, Zhi-Cheng; Le Brun, Franck-Olivier; Mehta, Sanjay; Mittelholzer, Camilla M.; Perchenet, Loic; Sastry, B. K. S.; Sitbon, Olivier; Souza, Rogerio; Torbicki, Adam; Zeng, Xiaofeng; Rubin, Lewis J.; Simonneau, Gerald		SERAPHIN Investigators	Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							6-MINUTE WALK DISTANCE; DOUBLE-BLIND; AMBRISENTAN THERAPY; INHALED ILOPROST; BOSENTAN; TREPROSTINIL; EPOPROSTENOL; SILDENAFIL	Background Current therapies for pulmonary arterial hypertension have been adopted on the basis of short-term trials with exercise capacity as the primary end point. We assessed the efficacy of macitentan, a new dual endothelin-receptor antagonist, using a primary end point of morbidity and mortality in a long-term trial. Methods We randomly assigned patients with symptomatic pulmonary arterial hypertension to receive placebo once daily, macitentan at a once-daily dose of 3 mg, or macitentan at a once-daily dose of 10 mg. Stable use of oral or inhaled therapy for pulmonary arterial hypertension, other than endothelin-receptor antagonists, was allowed at study entry. The primary end point was the time from the initiation of treatment to the first occurrence of a composite end point of death, atrial septostomy, lung transplantation, initiation of treatment with intravenous or subcutaneous prostanoids, or worsening of pulmonary arterial hypertension. Results A total of 250 patients were randomly assigned to placebo, 250 to the 3-mg macitentan dose, and 242 to the 10-mg macitentan dose. The primary end point occurred in 46.4%, 38.0%, and 31.4% of the patients in these groups, respectively. The hazard ratio for the 3-mg macitentan dose as compared with placebo was 0.70 (97.5% confidence interval [CI], 0.52 to 0.96; P=0.01), and the hazard ratio for the 10-mg macitentan dose as compared with placebo was 0.55 (97.5% CI, 0.39 to 0.76; P<0.001). Worsening of pulmonary arterial hypertension was the most frequent primary end-point event. The effect of macitentan on this end point was observed regardless of whether the patient was receiving therapy for pulmonary arterial hypertension at baseline. Adverse events more frequently associated with macitentan than with placebo were headache, nasopharyngitis, and anemia. Conclusions Macitentan significantly reduced morbidity and mortality among patients with pulmonary arterial hypertension in this event-driven study. (Funded by Actelion Pharmaceuticals; SERAPHIN ClinicalTrials.gov number, NCT00660179.)	[Pulido, Tomas] Ignacio Chavez Natl Heart Inst, Cardiopulm Dept, Mexico City, DF, Mexico; [Adzerikho, Igor] Republican Sci Pract Ctr Cardiol, Minsk, BELARUS; [Channick, Richard N.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Delcroix, Marion] Univ Hosp Gasthuisberg, Dept Pneumol, B-3000 Louvain, Belgium; [Galie, Nazzareno] Bologna Univ Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Ghofrani, Hossein-Ardeschir] Univ Giessen, D-35390 Giessen, Germany; [Ghofrani, Hossein-Ardeschir] Marburg Lung Ctr, Giessen, Germany; [Ghofrani, Hossein-Ardeschir] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Jansa, Pavel] Charles Univ Prague, Dept Med 2, Fac Med 1, Clin Dept Cardiol & Angiol, Prague, Czech Republic; [Jing, Zhi-Cheng] Chinese Acad Med Sci, Fu Wai Hosp, State Key Lab Cardiovasc Dis, Thrombosis Med Ctr, Beijing 100730, Peoples R China; [Zeng, Xiaofeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China; [Le Brun, Franck-Olivier; Mittelholzer, Camilla M.; Perchenet, Loic] Actelion Pharmaceut, Allschwil, Switzerland; [Mehta, Sanjay] Western Univ, Victoria Hosp, London Hlth Sci Ctr, Div Respirol,Dept Med, London, ON, Canada; [Sastry, B. K. S.] CARE Hosp, Dept Cardiol, Hyderabad, Andhra Pradesh, India; [Sitbon, Olivier; Simonneau, Gerald] Univ Paris 11, Hop Bicetre, AP HP,Serv Pneumol, Lab Excellence Rech Medicament & Innovat Therapeu, Le Kremlin Bicetre, France; [Sitbon, Olivier; Simonneau, Gerald] INSERM, U999, F-94275 Le Kremlin Bicetre, France; [Souza, Rogerio] Univ Sao Paulo, Sch Med, Inst Heart, Dept Pulm, Sao Paulo, Brazil; [Torbicki, Adam] European Hlth Ctr Otwock, Med Ctr Postgrad Educ, Dept Pulm Circulat & Thromboembol Dis, Otwock, Poland; [Rubin, Lewis J.] Univ Calif San Diego, Div Pulm & Crit Care Med, La Jolla, CA 92093 USA	National Institute of Cardiology - Mexico; Republican Scientific & Practical Center Cardiology; Harvard University; Massachusetts General Hospital; KU Leuven; University Hospital Leuven; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Justus Liebig University Giessen; Imperial College London; Charles University Prague; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Actelion Pharmaceuticals Ltd; London Health Sciences Centre; University of Victoria; Western University (University of Western Ontario); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidade de Sao Paulo; University of California System; University of California San Diego	Pulido, T (corresponding author), Ignacio Chavez Natl Heart Inst, Cardiopulm Dept, Juan Badiano 1,4th Fl, Mexico City, DF, Mexico.	tpulido@prodigy.net.mx	Delcroix, Marion/AAE-2712-2022; Arkhipov, Mikhail V/Q-2316-2015; Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Vizza, Carmine Dario/AAC-5540-2020; Chazova, Irina/B-8688-2017; Galie, Nazzareno/F-7004-2014; Evtushenko, Alexey/H-8346-2014; Sitbon, Olivier/I-3623-2019; Souza, Rogerio/I-3584-2013; Austin, Eric Douglas/A-6070-2013; Jansa, Pavel/O-2302-2017; Mehta, Sanjay/G-3332-2011; Evtushenko, Alexey/J-4544-2017; Jing, Zhi-Cheng/AAT-9081-2021; sharma, kamal/AAG-7271-2019; Simonneau, Gerald/ABE-6614-2020; Moiseeva, Olga/A-4580-2014	Delcroix, Marion/0000-0001-8394-9809; Arkhipov, Mikhail V/0000-0002-7924-7668; Ghofrani, Ardeschir/0000-0002-2029-4419; Vizza, Carmine Dario/0000-0002-3540-4983; Chazova, Irina/0000-0002-9822-4357; Galie, Nazzareno/0000-0003-4271-8670; Evtushenko, Alexey/0000-0002-0519-783X; Sitbon, Olivier/0000-0002-1942-1951; Souza, Rogerio/0000-0003-2789-9143; Austin, Eric Douglas/0000-0002-1709-9022; Jansa, Pavel/0000-0002-3711-7064; Mehta, Sanjay/0000-0002-7707-1056; Evtushenko, Alexey/0000-0001-8475-4667; Jing, Zhi-Cheng/0000-0003-0493-0929; sharma, kamal/0000-0001-5866-2566; Moiseeva, Olga/0000-0002-7817-3847; Nicod, Laurent P/0000-0002-0905-916X; Adzeriho, Igor'/0000-0001-6572-8842; Torbicki, Adam/0000-0003-3475-8832	Actelion Pharmaceuticals	Actelion Pharmaceuticals	Funded by Actelion Pharmaceuticals; SERAPHIN ClinicalTrials.gov number, NCT00660179.	Badesch DB, 2012, CARDIOVASC THER, V30, P93, DOI 10.1111/j.1755-5922.2011.00279.x; Barst RJ, 2011, J HEART LUNG TRANSPL, V30, P632, DOI 10.1016/j.healun.2010.11.009; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Bolli MH, 2012, J MED CHEM, V55, P7849, DOI 10.1021/jm3009103; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Committee for Medicinal Products for Human Use, 2009, GUID CLIN INV MED PR; Cuzick J, 2005, LANCET, V365, P1308, DOI 10.1016/S0140-6736(05)61026-4; Gabler NB, 2012, CIRCULATION, V126, P349, DOI 10.1161/CIRCULATIONAHA.112.105890; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Galie N, 2005, J AM COLL CARDIOL, V46, P529, DOI 10.1016/j.jacc.2005.04.050; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Galie N, 2011, EUR HEART J, V32, P926; Galie N, 2010, CURR OPIN PULM MED, V16, pS11, DOI 10.1097/01.mcp.0000370206.61003.7e; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Gatfield J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047662; Humbert M, 2004, EUR RESPIR J, V24, P353, DOI 10.1183/09031936.04.00028404; Iglarz M, 2008, J PHARMACOL EXP THER, V327, P736, DOI 10.1124/jpet.108.142976; McLaughlin VV, 2006, AM J RESP CRIT CARE, V174, P1257, DOI 10.1164/rccm.200603-358OC; McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027; McLaughlin VV, 2009, J AM COLL CARDIOL, V54, pS97, DOI 10.1016/j.jacc.2009.04.007; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Savarese G, 2012, J AM COLL CARDIOL, V60, P1192, DOI 10.1016/j.jacc.2012.01.083; Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079; Simonneau G, 2008, ANN INTERN MED, V149, P521, DOI 10.7326/0003-4819-149-8-200810210-00004	26	840	884	4	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					809	818		10.1056/NEJMoa1213917	http://dx.doi.org/10.1056/NEJMoa1213917			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208KB	23984728	Green Published			2022-12-28	WOS:000323676100008
J	Maciejewski, ML; Arterburn, DE				Maciejewski, Matthew L.; Arterburn, David E.			Cost-effectiveness of Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPACT	IMPORTANCE Bariatric surgery is a well-documented treatment for obesity, but there are uncertainties about the degree to which such surgery is associated with health care cost reductions that are sustained over time. OBJECTIVE To provide a comprehensive, multiyear analysis of health care costs by type of procedure within a large cohort of privately insured persons who underwent bariatric surgery compared with a matched nonsurgical cohort. DESIGN Longitudinal analysis of 2002-2008 claims data comparing a bariatric surgery cohort with a matched nonsurgical cohort. SETTING Seven BlueCross BlueShield health insurance plans with a total enrollment of more than 18 million persons. PARTICIPANTS A total of 29 820 planmembers who underwent bariatric surgery between January 1, 2002, and December 31, 2008, and a 1:1 matched comparison group of persons not undergoing surgery but with diagnoses closely associated with obesity. MAIN Outcome Measures Standardized costs (overall and by type of care) and adjusted ratios of the surgical group's costs relative to those of the comparison group. RESULTS Total costs were greater in the bariatric surgery group during the second and third years following surgery but were similar in the later years. However, the bariatric group's prescription and office visit costs were lower and their inpatient costs were higher. Those under going laparoscopic surgery had lower costs in the first few years after surgery, but these differences did not persist. CONCLUSIONS AND RELEVANCE Bariatric surgery does not reduce over-all health care costs in the long term. Also, there is no evidence that any one type of surgery is more likely to reduce long-term healthcare costs. To assess the value of bariatric surgery, future studies should focus on the potential benefit of improved health and well-being of persons undergoing the procedure rather than on cost savings.	[Maciejewski, Matthew L.] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; [Maciejewski, Matthew L.] Duke Univ, Dept Med, Div Gen Internal Med, Durham, NC USA; [Arterburn, David E.] Grp Hlth Res Inst, Seattle, WA USA; [Arterburn, David E.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of Washington; University of Washington Seattle	Maciejewski, ML (corresponding author), Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care 152, 411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA.	matthew.maciejewski@va.gov			NIDDK NIH HHS [R01 DK092317-01, R01 DK092317, R01 DK089528, R01 DK089528-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092317, R01DK089528] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cremieux PY, 2008, AM J MANAG CARE, V14, P589; Finkelstein EA, 2011, SURG OBES RELAT DIS, V7, P295, DOI 10.1016/j.soard.2010.10.011; Himpens J, 2011, ARCH SURG-CHICAGO, V146, P802, DOI 10.1001/archsurg.2011.45; Maciejewski ML, 2012, ARCH SURG-CHICAGO, V147, P633, DOI 10.1001/archsurg.2012.818; Neovius M, 2012, JAMA-J AM MED ASSOC, V308, P1132, DOI 10.1001/2012.jama.11792; Padwal R, 2011, J GEN INTERN MED, V26, P1183, DOI 10.1007/s11606-011-1721-x; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Spivak H, 2012, SURG ENDOSC, V26, P1909, DOI 10.1007/s00464-011-2125-z; Weiner JP, 2013, JAMA SURG, V148, P555, DOI 10.1001/jamasurg.2013.1504	10	30	30	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					742	743		10.1001/jama.2013.276131	http://dx.doi.org/10.1001/jama.2013.276131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989885	Green Accepted			2022-12-28	WOS:000323254500024
J	Gitlin, LN; Harris, LF; McCoy, MC; Chernett, NL; Pizzi, LT; Jutkowitz, E; Hess, E; Hauck, WW				Gitlin, Laura N.; Harris, Lynn Fields; McCoy, Megan C.; Chernett, Nancy L.; Pizzi, Laura T.; Jutkowitz, Eric; Hess, Edward; Hauck, Walter W.			A Home-Based Intervention to Reduce Depressive Symptoms and Improve Quality of Life in Older African Americans A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-SERVICE UTILIZATION; PRIMARY-CARE; ADULTS; SEVERITY; PROGRAM; MANAGEMENT; MINORITY; IDEAS	Background: Effective care models for treating older African Americans with depressive symptoms are needed. Objective: To determine whether a home-based intervention alleviates depressive symptoms and improves quality of life in older African Americans. Design: Parallel, randomized trial stratified by recruitment site. Interviewers assessing outcomes were blinded to treatment assignment. (ClinicalTrials.gov: NCT00511680) Setting: A senior center and participants' homes from 2008 to 2010. Patients: African Americans aged 55 years or older with depressive symptoms. Intervention: A multicomponent, home-based intervention delivered by social workers or a wait-list control group that received the intervention at 4 months. Measurements: Self-reported depression severity at 4 months (primary outcome) and depression knowledge, quality of life, behavioral activation, anxiety, function, and remission at 4 and 8 months. Results: Of 208 participants (106 and 102 in the intervention and wait-list groups, respectively), 182 (89 and 93, respectively) completed 4 months and 160 (79 and 81, respectively) completed 8 months. At 4 months, participants in the intervention group showed reduced depression severity (difference in mean change in Patient Health Questionnaire-9 score from baseline, -2.9 [95% CI, -4.6 to -1.2]; difference in mean change in Center for Epidemiologic Studies Depression Scale score from baseline, -3.7 [CI, -5.4 to -2.1]); improved depression knowledge, quality of life, behavioral activation, and anxiety (P < 0.001); and improved function (P = 0.014) compared with wait-list participants. More intervention than wait-list participants entered remission at 4 months (43.8% vs. 26.9%). After treatment, control participants showed benefits similar in magnitude to those of participants in the initial intervention group. Those in the initial intervention group maintained benefits at 8 months. Limitation: The study had a small sample, short duration, and differential withdrawal rate. Conclusion: A home-based intervention delivered by social workers could reduce depressive symptoms and enhance quality of life in most older African Americans.			Gitlin, LN (corresponding author), Johns Hopkins Univ, Sch Nursing, Ctr Innovat Care Aging, 525 Wolfe St,Suite 316, Baltimore, MD 21205 USA.	lgitlin1@jhu.edu			National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079814] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institute of Mental Health	Akincigil A, 2012, AM J PUBLIC HEALTH, V102, P319, DOI 10.2105/AJPH.2011.300349; Alexopoulos GS, 2009, INT J GERIATR PSYCH, V24, P1325, DOI 10.1002/gps.2287; Alexopoulos GS, 2005, AM J PSYCHIAT, V162, P718, DOI 10.1176/appi.ajp.162.4.718; Arean PA, 2005, MED CARE, V43, P381; Arean PA, 2003, J AM GERIATR SOC, V51, P1808, DOI 10.1046/j.1532-5415.2003.51569.x; Bartels SJ, 2013, NEW ENGL J MED, V368, P493, DOI 10.1056/NEJMp1211456; Brugha T, 2007, INT J PUBLIC HEALTH, V52, P135, DOI 10.1007/s00038-007-7022-9; Callahan CM, 2010, AM J GERIAT PSYCHIAT, V18, P460, DOI 10.1097/JGP.0b013e3181db6d9a; Casado BL, 2008, GERONTOLOGIST, V48, P828, DOI 10.1093/geront/48.6.828; Ciechanowski P, 2004, JAMA-J AM MED ASSOC, V291, P1569, DOI 10.1001/jama.291.13.1569; Cooper LA, 2003, MED CARE, V41, P479, DOI 10.1097/00005650-200304000-00004; Cooper-Patrick L, 1999, MED CARE, V37, P1034, DOI 10.1097/00005650-199910000-00007; Cretin S, 2004, EVALUATION REV, V28, P28, DOI 10.1177/0193841X03256298; Cuijpers P, 2012, JAMA-J AM MED ASSOC, V307, P1033, DOI 10.1001/jama.2012.271; Ell Kathleen, 2006, Home Health Care Serv Q, V25, P115, DOI 10.1300/J027v25n01_07; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gallo JJ, 2007, ANN INTERN MED, V146, P689, DOI 10.7326/0003-4819-146-10-200705150-00002; George LK, 2003, J HEALTH SOC BEHAV, V44, P353, DOI 10.2307/1519784; Gitlin Laura N, 2006, Am J Alzheimers Dis Other Demen, V21, P304, DOI 10.1177/1533317506292283; Gitlin LN, 2012, AM J GERIAT PSYCHIAT, V20, P973, DOI 10.1097/JGP.0b013e31825463ce; Gitlin LN, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-4; Gitlin LN., OXFORD HDB IN PRESS; Glaser R, 2003, ARCH GEN PSYCHIAT, V60, P1009, DOI 10.1001/archpsyc.60.10.1009; Gum AM, 2010, AM J GERIAT PSYCHIAT, V18, P491, DOI 10.1097/JGP.0b013e3181c29495; Hopko DR, 2003, CLIN PSYCHOL REV, V23, P699, DOI 10.1016/S0272-7358(03)00070-9; Joo JH, 2010, J AM GERIATR SOC, V58, P154, DOI 10.1111/j.1532-5415.2009.02623.x; Kanter JW, 2004, BEHAV ACTIVATION SCA; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Klug G, 2010, BRIT J PSYCHIAT, V197, P463, DOI 10.1192/bjp.bp.110.083121; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurlowicz LH, 2005, ARCH PSYCHIAT NURS, V19, P3, DOI 10.1016/j.apnu.2004.11.001; Lee SY, 2012, ARCH GERONTOL GERIAT, V55, P522, DOI 10.1016/j.archger.2012.03.003; Lenze EJ, 2001, AM J GERIAT PSYCHIAT, V9, P113, DOI 10.1176/appi.ajgp.9.2.113; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; Miller DK, 2004, J AM GERIATR SOC, V52, P741, DOI 10.1111/j.1532-5415.2004.52211.x; Neighbors HW, 2008, AM J GERIAT PSYCHIAT, V16, P948, DOI 10.1097/JGP.0b013e318187ddd3; Quijano LM, 2007, J APPL GERONTOL, V26, P139, DOI 10.1177/0733464807299354; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; Samad Z, 2011, INT J GERIATR PSYCH, V26, P1211, DOI 10.1002/gps.2680; Santor DA, 1997, PSYCHOL ASSESSMENT, V9, P233, DOI 10.1037/1040-3590.9.3.233; Sirey JA, 2005, AM J PSYCHIAT, V162, P184, DOI 10.1176/appi.ajp.162.1.184; Spielberger C. D., 1983, MIND GARDEN; Steinman LE, 2007, AM J PREV MED, V33, P175, DOI 10.1016/j.amepre.2007.04.034; Tai-Seale M, 2007, J AM GERIATR SOC, V55, P1903, DOI 10.1111/j.1532-5415.2007.01467.x; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836	49	40	40	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					243	+		10.7326/0003-4819-159-4-201308200-00005	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	205DM	24026257	Green Accepted			2022-12-28	WOS:000323421700014
J	Mather, AE; Reid, SWJ; Maskell, DJ; Parkhill, J; Fookes, MC; Harris, SR; Brown, DJ; Coia, JE; Mulvey, MR; Gilmour, MW; Petrovska, L; de Pinna, E; Kuroda, M; Akiba, M; Izumiya, H; Connor, TR; Suchard, MA; Lemey, P; Mellor, DJ; Haydon, DT; Thomson, NR				Mather, A. E.; Reid, S. W. J.; Maskell, D. J.; Parkhill, J.; Fookes, M. C.; Harris, S. R.; Brown, D. J.; Coia, J. E.; Mulvey, M. R.; Gilmour, M. W.; Petrovska, L.; de Pinna, E.; Kuroda, M.; Akiba, M.; Izumiya, H.; Connor, T. R.; Suchard, M. A.; Lemey, P.; Mellor, D. J.; Haydon, D. T.; Thomson, N. R.			Distinguishable Epidemics of Multidrug-Resistant Salmonella Typhimurium DT104 in Different Hosts	SCIENCE			English	Article							NONTYPHOIDAL SALMONELLA; ENTERICA; INFECTIONS; OUTBREAK; ANIMALS	The global epidemic of multidrug-resistant Salmonella Typhimurium DT104 provides an important example, both in terms of the agent and its resistance, of a widely disseminated zoonotic pathogen. Here, with an unprecedented national collection of isolates collected contemporaneously from humans and animals and including a sample of internationally derived isolates, we have used whole-genome sequencing to dissect the phylogenetic associations of the bacterium and its antimicrobial resistance genes through the course of an epidemic. Contrary to current tenets supporting a single homogeneous epidemic, we demonstrate that the bacterium and its resistance genes were largely maintained within animal and human populations separately and that there was limited transmission, in either direction. We also show considerable variation in the resistance profiles, in contrast to the largely stable bacterial core genome, which emphasizes the critical importance of integrated genotypic data sets in understanding the ecology of bacterial zoonoses and antimicrobial resistance.	[Mather, A. E.; Parkhill, J.; Fookes, M. C.; Harris, S. R.; Connor, T. R.; Thomson, N. R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Reid, S. W. J.] Royal Vet Coll, Hatfield AL9 7TA, Herts, England; [Maskell, D. J.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Brown, D. J.; Coia, J. E.] Stobhill Gen Hosp, Scottish Salmonella Shigella & Clostridium Diffic, Glasgow G21 3UW, Lanark, Scotland; [Mulvey, M. R.; Gilmour, M. W.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; [Petrovska, L.] Anim Hlth & Vet Labs Agcy, Weybridge KT15 3NB, Surrey, England; [de Pinna, E.] Publ Hlth England, Gastrointestinal Bacteria Reference Unit, London NW9 5EQ, England; [Kuroda, M.] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo 1628640, Japan; [Akiba, M.] Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Ibaraki 3050856, Japan; [Izumiya, H.] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo 1628640, Japan; [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Suchard, M. A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Suchard, M. A.] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Lemey, P.] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, B-3000 Louvain, Belgium; [Mellor, D. J.; Haydon, D. T.] Univ Glasgow, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland	Wellcome Trust Sanger Institute; University of London; University of London Royal Veterinary College; University of Cambridge; Public Health Agency of Canada; Veterinary Laboratories Agency; Public Health England; National Institute of Infectious Diseases (NIID); National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Institute of Infectious Diseases (NIID); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; KU Leuven; University of Glasgow	Reid, SWJ (corresponding author), Royal Vet Coll, Hatfield AL9 7TA, Herts, England.	swjreid@rvc.ac.uk; nrt@sanger.ac.uk	Connor, Thomas/ABE-5989-2020; Thomson, Nicholas R/P-5988-2014; Lemey, Philippe/C-3755-2018; Parkhill, Julian/G-4703-2011; Connor, Thomas/ABD-6533-2021; Petrovska, Liljana/D-7319-2011; Coia, John/AAP-5379-2020; Brown, Derek/AAE-5597-2020; Harris, Simon R/K-1318-2013	Connor, Thomas/0000-0003-2394-6504; Thomson, Nicholas R/0000-0002-4432-8505; Lemey, Philippe/0000-0003-2826-5353; Parkhill, Julian/0000-0002-7069-5958; Coia, John/0000-0002-4966-8453; Brown, Derek/0000-0003-3742-8257; Harris, Simon R/0000-0003-1512-6194; Gilmour, Matthew/0000-0002-6005-3628; Haydon, Daniel/0000-0002-1240-1886; Reid, Stuart/0000-0002-6872-9071	William Stewart Fellowship; Wellcome Trust [098051]; European Union under European Research Council [260864]; NIH [AI107034, HG006139]; NSF [DMS-1264153]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086887] Funding Source: NIH RePORTER	William Stewart Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); European Union under European Research Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.E.M. was funded by the William Stewart Fellowship while at the University of Glasgow. A.E.M., S.R.H., M.C.F., T.R.C., J.P., and N.R.T. are supported by Wellcome Trust grant 098051. P.L. and M.A.S. acknowledge funding from the European Union Seventh Framework Programme (FP7/2007-2013) under European Research Council Grant agreement no. 260864. M.A.S. is supported in part by NIH R01 grants AI107034 and HG006139 and NSF grant DMS-1264153. The authors would like to thank J. Cotton (Wellcome Trust Sanger Institute) for helpful discussions and assistance. Genome sequences are deposited with the European Nucleotide Archive (study accessions ERP000244, ERP000270, ERP000994) and DNA Data Bank of Japan (accession DRA000942). The finished chromosome and plasmid for Salmonella Typhimurium DT104 are submitted to the European Molecular Biology Laboratory, accessions HF937208 and HF937209, respectively.	Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; [Anonymous], 2012, FOOD DRINK SCOTL KEY; Besser TE, 2000, EPIDEMIOL INFECT, V124, P193, DOI 10.1017/S0950268899003283; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Cacciolatti, 2009, ANAL RED PROCESSED M; Calvert N, 1998, VET REC, V143, P351, DOI 10.1136/vr.143.13.351; Davies S. C, 2014, ANN REPORT CHIEF MED; Davis MA, 2002, J LAB CLIN MED, V140, P135, DOI 10.1067/mlc.2002.126411; Dechet AM, 2006, CLIN INFECT DIS, V42, P747, DOI 10.1086/500320; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; European Food Safety Authority (EFSA), 2011, SALM; Fone D L, 1994, Commun Dis Rep CDR Rev, V4, pR136; Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901; Helms M, 2005, EMERG INFECT DIS, V11, P859, DOI 10.3201/eid1106.041017; Herikstad H, 2002, EPIDEMIOL INFECT, V129, P1, DOI 10.1017/S0950268802006842; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mather AE, 2012, P ROY SOC B-BIOL SCI, V279, P1630, DOI 10.1098/rspb.2011.1975; Molbak K, 1999, NEW ENGL J MED, V341, P1420, DOI 10.1056/NEJM199911043411902; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; S Department of Agriculture, 2011, FOODB ILLN COST CALC; Skjot-Rasmussen L, 2009, INT J FOOD MICROBIOL, V131, P277, DOI 10.1016/j.ijfoodmicro.2009.03.006; Summers AO, 2006, ANIM BIOTECHNOL, V17, P125, DOI 10.1080/10495390600957217; Threlfall EJ, 2000, J ANTIMICROB CHEMOTH, V46, P7, DOI 10.1093/jac/46.1.7; WALL PG, 1995, VET REC, V136, P591, DOI 10.1136/vr.136.23.591; Wallis T. S., 2005, ECOSAL ESCHERICHIA C; Zhao S, 2006, J FOOD PROTECT, V69, P500, DOI 10.4315/0362-028X-69.3.500	29	226	230	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1514	1517		10.1126/science.1240578	http://dx.doi.org/10.1126/science.1240578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24030491	Green Accepted			2022-12-28	WOS:000324894600051
J	Aaron, HJ; Lucia, KW				Aaron, Henry J.; Lucia, Kevin W.			Only the Beginning - What's Next at the Health Insurance Exchanges?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Aaron, Henry J.] Brookings Inst, Washington, DC 20036 USA; [Lucia, Kevin W.] Georgetown Univ, Ctr Hlth Insurance Reforms, Washington, DC USA; [Aaron, Henry J.; Lucia, Kevin W.] DC Hlth Benefit Exchange Author, Washington, DC USA	Brookings Institution; Georgetown University	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.							Dash S., 2013, IMPLEMENTING AFFORDA	1	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1185	1187		10.1056/NEJMp1308032	http://dx.doi.org/10.1056/NEJMp1308032			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	224LT	24004069				2022-12-28	WOS:000324888200002
J	Liang, Y; Cao, YR; Tanaka, K; Thibivilliers, S; Wan, JR; Choi, J; Kang, CH; Qiu, J; Stacey, G				Liang, Yan; Cao, Yangrong; Tanaka, Kiwamu; Thibivilliers, Sandra; Wan, Jinrong; Choi, Jeongmin; Kang, Chang Ho; Qiu, Jing; Stacey, Gary			Nonlegumes Respond to Rhizobial Nod Factors by Suppressing the Innate Immune Response	SCIENCE			English	Article							DEFENSE RESPONSES; RECEPTOR KINASE; NODULATION; ARABIDOPSIS; LEGUME; RECOGNITION; EXPRESSION; PERCEPTION; RESISTANCE; MOLECULES	Virtually since the discovery of nitrogen-fixing Rhizobium-legume symbioses, researchers have dreamed of transferring this capability into nonlegume crop species (for example, corn). In general, nonlegumes were assumed to lack the ability to respond to the rhizobial lipo-chitin Nod factors, which are the essential signal molecules that trigger legume nodulation. However, our data indicate that Arabidopsis thaliana plants, as well as other nonlegumes, recognize the rhizobial Nod factor via a mechanism that results in strong suppression of microbe-associated molecular pattern (MAMP)-triggered immunity. The mechanism of action leads to reduced levels of pattern-recognition receptors on the plasma membrane involved in MAMP recognition.	[Liang, Yan; Cao, Yangrong; Tanaka, Kiwamu; Thibivilliers, Sandra; Choi, Jeongmin; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Plant Sci, Columbia, MO 65211 USA; [Liang, Yan; Cao, Yangrong; Tanaka, Kiwamu; Thibivilliers, Sandra; Choi, Jeongmin; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Biochem, Columbia, MO 65211 USA; [Wan, Jinrong] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Kang, Chang Ho] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, Gyeongsangnam D, South Korea; [Qiu, Jing] Univ Missouri, Dept Stat, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Gyeongsang National University; University of Missouri System; University of Missouri Columbia	Stacey, G (corresponding author), Univ Missouri, Christopher S Bond Life Sci Ctr, Natl Ctr Soybean Biotechnol, Div Plant Sci, Columbia, MO 65211 USA.	staceyg@missouri.edu	Tanaka, Kiwamu/E-9942-2013; poinssot, benoit/B-2569-2009	Tanaka, Kiwamu/0000-0001-5045-560X; poinssot, benoit/0000-0001-5890-4318; Kang, Chang Ho/0000-0003-4342-5247	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-08ER15309]; Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea [PJ009068]; Novozymes	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea; Novozymes	We thank A. Bent for providing the anti-FLS2 antibody and EFR::EFR:HA transgenic seeds, M. R. Knight for aequorin transgenic seeds, S. Robatzek for FLS2::FLS2:GFP transgenic seeds, Novozymes (Bagsvaerd, Denmark) for the purified Nod factor, and S. Peck for critical comments to improve the manuscript. This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-08ER15309 and by the Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea (grant PJ009068 to G. S). Additional support was provided by Novozymes.	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Beatty PH, 2011, SCIENCE, V333, P416, DOI 10.1126/science.1209467; BELIVEAU C, 1991, J BACTERIOL, V173, P5619, DOI 10.1128/jb.173.18.5619-5623.1991; Broghammer A, 2012, P NATL ACAD SCI USA, V109, P13859, DOI 10.1073/pnas.1205171109; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DENARIE J, 1993, CELL, V74, P951, DOI 10.1016/0092-8674(93)90717-5; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; Indrasumunar A, 2011, PLANT J, V65, P39, DOI 10.1111/j.1365-313X.2010.04398.x; Indrasumunar A, 2010, PLANT CELL PHYSIOL, V51, P201, DOI 10.1093/pcp/pcp178; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kouchi H, 2004, DNA RES, V11, P263, DOI 10.1093/dnares/11.4.263; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Long SR, 1996, PLANT CELL, V8, P1885, DOI 10.1105/tpc.8.10.1885; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Minami E, 1996, MOL PLANT MICROBE IN, V9, P574, DOI 10.1094/MPMI-9-0574; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nakagawa T, 2011, PLANT J, V65, P169, DOI 10.1111/j.1365-313X.2010.04411.x; Op den Camp R., 2011, SCIENCE, V331, P909; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	29	159	164	7	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1384	1387		10.1126/science.1242736	http://dx.doi.org/10.1126/science.1242736			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24009356				2022-12-28	WOS:000324597200044
J	Hsiang, SM; Burke, M; Miguel, E				Hsiang, Solomon M.; Burke, Marshall; Miguel, Edward			Quantifying the Influence of Climate on Human Conflict	SCIENCE			English	Article							ECONOMIC-GROWTH; CIVIL CONFLICT; SOCIAL-CONFLICT; TEMPERATURE; WEATHER; VIOLENCE; SHOCKS; ENVIRONMENT; VARIABILITY; COLLAPSE	A rapidly growing body of research examines whether human conflict can be affected by climatic changes. Drawing from archaeology, criminology, economics, geography, history, political science, and psychology, we assemble and analyze the 60 most rigorous quantitative studies and document, for the first time, a striking convergence of results. We find strong causal evidence linking climatic events to human conflict across a range of spatial and temporal scales and across all major regions of the world. The magnitude of climate's influence is substantial: for each one standard deviation (1 sigma) change in climate toward warmer temperatures or more extreme rainfall, median estimates indicate that the frequency of interpersonal violence rises 4% and the frequency of intergroup conflict rises 14%. Because locations throughout the inhabited world are expected to warm 2 sigma to 4 sigma by 2050, amplified rates of human conflict could represent a large and critical impact of anthropogenic climate change.	[Hsiang, Solomon M.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Program Sci Technol & Environm Policy, Princeton, NJ 08544 USA; [Hsiang, Solomon M.; Miguel, Edward] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Burke, Marshall] Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA; [Miguel, Edward] Univ Calif Berkeley, Dept Econ, Berkeley, CA 94720 USA	Princeton University; National Bureau of Economic Research; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Hsiang, SM (corresponding author), Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA.	shsiang@berkeley.edu		Miguel, Edward/0000-0001-6927-709X; Burke, Marshall/0000-0003-4288-5858	Postdoctoral Fellowship in Science, Technology and Environmental Policy at Princeton University; NSF; Oxfam Faculty Chair in Environmental and Resource Economics at UC Berkeley	Postdoctoral Fellowship in Science, Technology and Environmental Policy at Princeton University; NSF(National Science Foundation (NSF)); Oxfam Faculty Chair in Environmental and Resource Economics at UC Berkeley	We thank C. Almer, D. Blakeslee, D. Card, P. Burke, H. Buhaug, P. deMenocal, N. P. Gleditsch, M. Harari, G. Haug, R. Larrick, H. Lee, L. Lefgren, M. Levy, S. Naidu, J. O'Loughlin, M. Ranson, O. M. Theisen, and N. von Uexkull for providing results and data. We also thank three anonymous reviewers, I. Bannon, D. Card, M. Cane, M. Kremer, D. Lobell, K. Meng, S. Mullainathan, M. Oppenheimer, M. Roberts, I. Salehyan, W. Schlenker, J. Shapiro, R. Singh, D. Stahle, L. Thompson, D. Zhang, and seminar participants at Columbia University, Harvard University, the International Studies Association Annual Meeting, Oxford University, the Pacific Development Conference, Princeton University, University of California (UC) Berkeley, UC San Diego, and the World Bank for comments, suggestions, and references. We thank C. Baysan and F. Gonzalez for excellent research assistance. S.M.H. was funded by a Postdoctoral Fellowship in Science, Technology and Environmental Policy at Princeton University. M.B. was funded by a Graduate Research Fellowship from the NSF. E.M. was funded by the Oxfam Faculty Chair in Environmental and Resource Economics at UC Berkeley. S.M.H. served as consultant for Scitor, a company that has been analyzing security risks that emerge from climatic changes. Data and replication code for all results in this paper are available for download at: http://cega.berkeley.edu/assets/miscellaneous_files/HsiangBurkeMiguel-2013-data.zip. Author contributions: S.M.H. and M.B. conceived of and designed the study; S.M.H. and M.B. collected and analyzed data; S.M.H., M.B., and E.M. interpreted the findings and wrote the paper.	Achen C. H., 2004, BLIND RETROSPE UNPUB; Almer C., 2012, DP1203; Anderson CA, 1997, J PERS SOC PSYCHOL, V73, P1213, DOI 10.1037/0022-3514.73.6.1213; Anderson CA, 2000, ADV EXP SOC PSYCHOL, V32, P63, DOI 10.1016/S0065-2601(00)80004-0; Anderson RW., 2013, PERSECUTING PROTECTV; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Angrist JD, 2008, REV ECON STAT, V90, P191, DOI 10.1162/rest.90.2.191; Angrist JD, 2010, J ECON PERSPECT, V24, P3, DOI 10.1257/jep.24.2.3; [Anonymous], RAINFALL SHOCKS PROP; [Anonymous], 2012, MAN RISKS EXTR EV DI; Anttila-Hughes J. K., 2012, WORKING PAPER; Arezki R, 2011, 1162 IMF; Auffhammer M, 2013, REV ENV ECON POLICY, V7, P181, DOI 10.1093/reep/ret016; AULICIEMS A, 1995, INT J BIOMETEOROL, V39, P34, DOI 10.1007/BF01320891; Bai Y, 2011, REV ECON STAT, V93, P970, DOI 10.1162/REST_a_00106; Barrett C. B., 2013, FOOD CONSEQUENCES FO; Barrios S, 2006, J URBAN ECON, V60, P357, DOI 10.1016/j.jue.2006.04.005; Barrios S, 2010, REV ECON STAT, V92, P350, DOI 10.1162/rest.2010.11212; Bergholt D, 2012, J PEACE RES, V49, P147, DOI 10.1177/0022343311426167; Berman E, 2011, J POLIT ECON, V119, P766, DOI 10.1086/661983; Bernauer T, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015601; Blattman C, 2010, J ECON LIT, V48, P3, DOI 10.1257/jel.48.1.3; Bohlken AT, 2010, J PEACE RES, V47, P589, DOI 10.1177/0022343310373032; Bruckner M, 2011, ECONOMETRICA, V79, P923, DOI 10.3982/ECTA8183; Buckley BM, 2010, P NATL ACAD SCI USA, V107, P6748, DOI 10.1073/pnas.0910827107; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Buhaug H., 2010, SENSITIVITY ANAL CLI; Buhaug H, 2010, P NATL ACAD SCI USA, V107, pE186, DOI 10.1073/pnas.1015796108; Buhaug H, 2010, P NATL ACAD SCI USA, V107, P16477, DOI 10.1073/pnas.1005739107; Burke M, 2013, ADAPTATION CLIMATE C; Burke M, 2010, 16440 NBER; Burke MB, 2010, P NATL ACAD SCI USA, V107, pE185, DOI 10.1073/pnas.1014879107; Burke MB, 2010, P NATL ACAD SCI USA, V107, pE103, DOI 10.1073/pnas.1005748107; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Burke PJ, 2012, BE J MACROECON, V12, DOI 10.1515/1935-1690.2398; Burke PJ, 2010, AM ECON J-MACROECON, V2, P124, DOI 10.1257/mac.2.4.124; Bushman BJ, 2005, J PERS SOC PSYCHOL, V89, P74, DOI 10.1037/0022-3514.89.1.74; Butler CK, 2012, J PEACE RES, V49, P23, DOI 10.1177/0022343311426166; Butzer KW, 2012, P NATL ACAD SCI USA, V109, P3632, DOI 10.1073/pnas.1114845109; CARD D, 1995, AM ECON REV, V85, P238; Card D, 2011, Q J ECON, V126, P103, DOI 10.1093/qje/qjr001; Carter B., 2012, PUBLIC POLICY PRICE; Cervellati M., 2011, IZA Discussion Papers - Forschungsinstitut zur Zukunft der Arbeit; Chaney E., ECONOMETRIC IN PRESS; Chassang S, 2009, Q J POLIT SCI, V4, P211, DOI 10.1561/100.00008072; Ciccone A, 2011, AM ECON J-APPL ECON, V3, P215, DOI 10.1257/app.3.4.215; Cohn EG, 1997, J PERS SOC PSYCHOL, V72, P1322; Couttenier M., 2013, ECON J, V124, P201, DOI DOI 10.1111/ECOJ.12042; Cullen HM, 2000, GEOLOGY, V28, P379, DOI 10.1130/0091-7613(2000)28<379:CCATCO>2.0.CO;2; D'Anjou RM, 2012, P NATL ACAD SCI USA, V109, P20332, DOI 10.1073/pnas.1212730109; Dal Bo E, 2011, J EUR ECON ASSOC, V9, P646, DOI 10.1111/j.1542-4774.2011.01025.x; Deligiannis T, 2012, GLOBAL ENVIRON POLIT, V12, P78, DOI 10.1162/GLEP_a_00098; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Dube O, 2013, REV ECON STUD, V80, P1384, DOI 10.1093/restud/rdt009; Fearon JD, 2003, AM POLIT SCI REV, V97, P75, DOI 10.1017/S0003055403000534; Feng S, 2012, W17734 NAT BUR EC RE, DOI DOI 10.3386/W17734; Fjelde H, 2012, POLIT GEOGR, V31, P444, DOI 10.1016/j.polgeo.2012.08.004; FREEDMAN DA, 1991, SOCIOL METHODOL, V21, P291, DOI 10.2307/270939; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A., 2006, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gleditsch NP, 2012, J PEACE RES, V49, P3, DOI 10.1177/0022343311431288; Gleditsch NP, 1998, J PEACE RES, V35, P381, DOI 10.1177/0022343398035003007; Greene H., 2003, ECONOMETRIC ANAL; Grove RH, 2007, MEDIEV HIST J, V10, P75, DOI 10.1177/097194580701000203; Harari M, 2013, CONFLICT CLIMATE CEL; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Healy AJ, 2010, P NATL ACAD SCI USA, V107, P12804, DOI 10.1073/pnas.1007420107; Hedges L. V., 1985, STAT METHOD METAANAL; Hendrix CS, 2012, J PEACE RES, V49, P35, DOI 10.1177/0022343311426165; Hidalgo FD, 2010, REV ECON STAT, V92, P505, DOI 10.1162/REST_a_00007; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; Homer-Dixon T.F., 1999, ENV SCARCITY VIOLENC; Hornbeck R, 2012, AM ECON REV, V102, P1477, DOI 10.1257/aer.102.4.1477; Hsiang SM, 2012, CLIM CHANG ECON, V3, DOI 10.1142/S201000781250011X; Hsiang SM, 2014, CLIMATIC CHANGE, V123, P39, DOI 10.1007/s10584-013-0868-3; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Hsiang SM, 2010, P NATL ACAD SCI USA, V107, P15367, DOI 10.1073/pnas.1009510107; Huntington E, 1917, Q J ECON, V31, P173, DOI 10.2307/1883908; Jacob B, 2007, J HUM RESOUR, V42, P489, DOI 10.3368/jhr.XLII.3.489; Jensen PS, 2009, DEFENCE PEACE ECON, V20, P359, DOI 10.1080/10242690902868277; Jia R., 2013, ECON J, DOI [10.1111/ecoj.12037, DOI 10.1111/EC0J.12037]; Jones BF, 2010, AM ECON REV, V100, P454, DOI 10.1257/aer.100.2.454; Kelly RL, 2013, P NATL ACAD SCI USA, V110, P443, DOI 10.1073/pnas.1201341110; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; KENRICK DT, 1986, ENVIRON BEHAV, V18, P179, DOI 10.1177/0013916586182002; Kung J. K., 2012, WORKING PAPER; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Lagi M., 2011, ARXIV11082455; Larrick RP, 2011, PSYCHOL SCI, V22, P423, DOI 10.1177/0956797611399292; Lee HF, 2013, CLIM RES, V56, P1, DOI 10.3354/cr01129; LEGATES DR, 1990, THEOR APPL CLIMATOL, V41, P11, DOI 10.1007/BF00866198; Lei Y., 2011, DO GIANT OILFIELD DI; LEVY MA, 1995, INT SECURITY, V20, P35, DOI 10.2307/2539228; Levy MA, 2005, INT WORKSH HUM SEC C; Libecap G.D., 2011, EC CLIMATE CHANGE AD; Lobell D, 2010, ADV GLOB CHANGE RES, V37, P1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manacorda M, 2011, AM ECON J-APPL ECON, V3, P1, DOI 10.1257/app.3.3.1; Mares D, 2013, J URBAN HEALTH, V90, P768, DOI 10.1007/s11524-013-9791-1; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Maystadt J. F., 2013, IFPRI - Discussion Papers; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mehlum H, 2006, J URBAN ECON, V59, P370, DOI 10.1016/j.jue.2005.09.007; Miguel E, 2005, REV ECON STUD, V72, P1153, DOI 10.1111/0034-6527.00365; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; Miguel E, 2011, AM ECON J-APPL ECON, V3, P228, DOI 10.1257/app.3.4.228; Nadaraya E.A., 1964, THEOR PROBAB APPL+, V9, P141, DOI [10.1137/1110024, DOI 10.1137/1109020]; Neidell M., J LABOR EC IN PRESS; O'Loughlin J, 2012, P NATL ACAD SCI USA, V109, P18344, DOI 10.1073/pnas.1205130109; ORTLOFF CR, 1993, J ARCHAEOL SCI, V20, P195, DOI 10.1006/jasc.1993.1014; Patterson WP, 2010, P NATL ACAD SCI USA, V107, P5306, DOI 10.1073/pnas.0902522107; Ranson M., J ENV EC MA IN PRESS; Rotton J, 2000, J PERS SOC PSYCHOL, V78, P1074, DOI 10.1037//0022-3514.78.6.1074; Salehyan I, 2012, ANN CONV INT STUD AS; Sarsons H., 2011, RAINFALL CONFLICT; SCHEFFRAN J, 2012, CLIMATE CHANGE HUMAN, V8; Scheffran J, 2012, SCIENCE, V336, P869, DOI 10.1126/science.1221339; Schlenker W, 2006, REV AGR ECON, V28, P391, DOI 10.1111/j.1467-9353.2006.00304.x; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Sekhri S., 2012, WORKING PAPER; Solomon Hsiang, 2013, VISUALLY WEIGHTED RE, DOI 10.2139/ssrn.2265501; Stahle DW, 1998, SCIENCE, V280, P564, DOI 10.1126/science.280.5363.564; Sutton AE, 2010, P NATL ACAD SCI USA, V107, pE102, DOI 10.1073/pnas.1005278107; Theisen OM, 2012, J PEACE RES, V49, P81, DOI 10.1177/0022343311425842; Theisen OM, 2011, INT SECURITY, V36, P79; Tol RSJ, 2010, CLIMATIC CHANGE, V99, P65, DOI 10.1007/s10584-009-9659-2; VRIJ A, 1994, J COMMUNITY APPL SOC, V4, P365, DOI 10.1002/casp.2450040505; Watson GS., 1964, SANKHYA A, V26, P359, DOI DOI 10.2307/25049340; Witschi H, 2001, TOXICOL SCI, V64, P4, DOI 10.1093/toxsci/64.1.4; Wittman Donald A., 2006, OXFORD HDB POLITICAL, P565; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104; Zhang DD, 2006, CLIMATIC CHANGE, V76, P459, DOI 10.1007/s10584-005-9024-z; Zhang DD, 2011, P NATL ACAD SCI USA, V108, P17296, DOI 10.1073/pnas.1104268108	139	787	802	33	534	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1212	+		10.1126/science.1235367	http://dx.doi.org/10.1126/science.1235367			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215ZA	24031020				2022-12-28	WOS:000324248800034
J	Knapp, S				Knapp, Sandra			What, Where, and When?	SCIENCE			English	Editorial Material							WALLACES ZOOGEOGRAPHIC REGIONS; BIOGEOGRAPHY; UPDATE		Nat Hist Museum, London SW7 5BD, England	Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, Cromwell Rd, London SW7 5BD, England.	s.knapp@nhm.ac.uk	Knapp, Sandra/A-4856-2011	Knapp, Sandra/0000-0001-7698-3945				Arroyo-Santos A, 2014, BIOL PHILOS, V29, P833, DOI 10.1007/s10539-013-9391-1; Gould J., 1869, THE BIRDS OF AUSTRAL; Heads M, 2012, SPEC SYST, V4, P1; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Humphries C. J., 1986, CLADISTIC BIOGEOGRAP; Kreft H, 2013, SCIENCE, V341, DOI 10.1126/science.1237471; Lexer C, 2013, J BIOGEOGR, V40, P1013, DOI 10.1111/jbi.12076; Nelson G., 1981, VICARIANCE BIOGEOGRA; Parenti L. R., 2009, COMPARATIVE BIOGEOGR; Rull V, 2013, J BIOGEOGR, V40, P1413, DOI 10.1111/jbi.12141; Saerkinen Tiina, 2011, BMC Ecology, V11, P27, DOI 10.1186/1472-6785-11-27; Wallace A. R., 1860, J LINN SOC LOND, V4, P172, DOI DOI 10.1111/J.1096-3642.1860.TB00090.X; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; Wallace A. R., 1876, THE GEOGRAPHICAL DIS, V2; Wallace AR, 1880, ISLAND LIFE; Wallace AR, 1855, ANN MAGAZINE NATURAL, V16, P184, DOI DOI 10.1080/037454809495509; Wallace AR, 1876, THE GEOGRAPHICAL DIS, V1; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x	18	3	3	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1182	1184		10.1126/science.1240880	http://dx.doi.org/10.1126/science.1240880			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215ZA	23989953				2022-12-28	WOS:000324248800025
J	Le Couteur, DG; Doust, J; Creasey, H; Brayne, C				Le Couteur, David G.; Doust, Jenny; Creasey, Helen; Brayne, Carol			Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; PRIMARY-CARE; PATIENTS ATTITUDES; MEMORY CLINICS; PROGRESSION; RISK; RECOMMENDATIONS; METAANALYSIS		[Le Couteur, David G.] Univ Sydney & Sydney Res, Ctr Educ & Res Ageing, ANZAC Med Res Inst, Concord 2139, Australia; [Le Couteur, David G.] Univ Sydney & Sydney Res, Charles Perkins Ctr, Concord 2139, Australia; [Doust, Jenny] Bond Univ, Ctr Res Evidence Based Practice, Robina, Australia; [Creasey, Helen] Concord RG Hosp, Ctr Educ & Res Ageing, Concord, NSW, Australia; [Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	University of Sydney; ANZAC Research Institute; University of Sydney; Bond University; Concord Repatriation General Hospital; University of Cambridge	Le Couteur, DG (corresponding author), Univ Sydney & Sydney Res, Ctr Educ & Res Ageing, ANZAC Med Res Inst, Concord 2139, Australia.	david.lecouteur@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Doust, Jenny/AGI-8773-2022; Brayne, Carol/AAA-4285-2020; Ekanayake, Kanchana/P-8817-2016	Doust, Jenny/0000-0002-4024-9308; Brayne, Carol/0000-0001-5307-663X; Le Couteur, David/0000-0002-4227-5817	National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ashford JW, 2007, ALZHEIMERS DEMENT, V3, P75, DOI 10.1016/j.jalz.2006.02.005; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Borson S, 2013, ALZHEIMERS DEMENT, V9, P151, DOI 10.1016/j.jalz.2012.08.008; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Boustani M, 2008, INT J GERIATR PSYCH, V23, P812, DOI 10.1002/gps.1983; Brakhus Anne, 2011, Tidsskr Nor Laegeforen, V131, P2254, DOI 10.4045/tidsskr.11.0786; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Brayne C, 2012, LANCET, V380, P1441, DOI 10.1016/S0140-6736(12)61803-0; Brunet MD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8588; Brunet MD, 2012, EARLY DIAGNOSIS DEME; Bunn F, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001331; Carrillo MC, 2012, ALZHEIMERS DEMENT, V8, P337, DOI 10.1016/j.jalz.2012.04.007; Chinthapalli K, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8533; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; Coombes R., 2009, BMJ-BRIT MED J, V338, P375; Corbyn Z, 2013, LANCET, V381, P614, DOI 10.1016/S0140-6736(13)60330-X; Department of Health, 2013, POL IMPR CAR PEOPL D; Draper B, 2010, ALZHEIMERS DEMENT, V6, P75, DOI 10.1016/j.jalz.2009.04.1229; Dubois B, 2013, INT PSYCHOGERIATR, V25, P175, DOI 10.1017/S1041610212002098; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Eaton J., 2009, BMJ-BRIT MED J, V338, pb464; Esiri MM, 2001, LANCET, V357, P169; Flicker LA, 2012, MED J AUSTRALIA, V196, P114, DOI 10.5694/mja11.11399; Gill SS, 2009, ARCH INTERN MED, V169, P867, DOI 10.1001/archinternmed.2009.43; Hilmer SN, 2007, FUND CLIN PHARMACOL, V21, P217, DOI 10.1111/j.1472-8206.2007.00473.x; Justiss MD, 2009, INT J GERIATR PSYCH, V24, P632, DOI 10.1002/gps.2173; Kmietowicz Z, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2347; Knopman DS, NEUROLOGY IN PRESS; Lane HP, 2013, AGE AGEING, V42, P281, DOI 10.1093/ageing/aft011; Le Couteur DG, 2012, AUSTRALAS J AGEING, V31, P164, DOI 10.1111/j.1741-6612.2011.00564.x; Lind S, 2013, PULSE           0124; Lindesay J, 2002, INT J GERIATR PSYCH, V17, P41, DOI 10.1002/gps.522; Lopez OL, 2011, CURR OPIN NEUROL, V24, P532, DOI 10.1097/WCO.0b013e32834cd45b; Manthorpe J, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660805; Marchant NL, 2013, JAMA NEUROL, V70, P488, DOI 10.1001/2013.jamaneurol.405; Masoodi N, 2013, ANN INTERN MED, V158, DOI 10.7326/0003-4819-158-4-201302190-02003; Mattsson N, 2012, NEUROLOGY, V78, P468, DOI 10.1212/WNL.0b013e3182477eed; Meeuwsen EJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3086; Meulen EFJ, 2004, J NEUROL NEUROSUR PS, V75, P700, DOI 10.1136/jnnp.2003.021055; Mitchell AJ, 2008, J NEUROL NEUROSUR PS, V79, P1386, DOI 10.1136/jnnp.2007.142679; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mitchell AJ, 2011, ACTA PSYCHIAT SCAND, V124, P165, DOI 10.1111/j.1600-0447.2011.01730.x; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P1099, DOI 10.1001/jama.2013.2101; Naylor MD, 2012, ALZHEIMERS DEMENT, V8, P445, DOI 10.1016/j.jalz.2012.08.001; Noel-Storr Anna H, 2013, Alzheimers Dement, V9, pe96, DOI 10.1016/j.jalz.2012.01.014; O'Brien JT, 2011, J PSYCHOPHARMACOL, V25, P997, DOI 10.1177/0269881110387547; Prince M, WORLD ALZHEIMER REPO; Richards M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4670; Ritchie LJ, 2013, INT ENCY REHABILITAT; Rosness TA, 2009, INT J GERIATR PSYCH, V24, P1143, DOI 10.1002/gps.2238; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Schneider LS, 2013, LANCET NEUROL, V12, P327, DOI 10.1016/S1474-4422(13)70050-4; Senior PsychCare, 2013, EARL DIAGN 7 MIN ALZ; Social Market Foundation, 2012, THINK TANK CALLS FIN; Song XW, 2013, J NEUROL NEUROSUR PS, V84, P71, DOI 10.1136/jnnp-2012-303579; Sperling RA, 2013, NAT REV NEUROL, V9, P54, DOI 10.1038/nrneurol.2012.241; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spies PE, 2011, EUR J NEUROL, V18, P1014, DOI 10.1111/j.1468-1331.2010.03222.x; Stephan BCM, 2012, MOL PSYCHIATR, V17, P1056, DOI 10.1038/mp.2011.147; Stephan BCM, 2008, INT J GERIATR PSYCH, V23, P863, DOI 10.1002/gps.2013; The Royal Australian College of General Practitioners, 2012, GUID PREV ACT GEN PR; UK National Screening Committee, 2010, UK NSC POL ALZH DIS; US Preventive Services Task Force, 2003, SCREEN DEM; Waldorff FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4693; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002; Wharton SB, 2011, J ALZHEIMERS DIS, V25, P359, DOI 10.3233/JAD-2011-091402; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Wimo A, 2013, INT J GERIATR PSYCHI; Winblad B, 2008, NEUROLOGY, V70, P2024, DOI 10.1212/01.wnl.0000303815.69777.26	71	138	140	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2013	347								f5125	10.1136/bmj.f5125	http://dx.doi.org/10.1136/bmj.f5125			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	219RJ	24018000				2022-12-28	WOS:000324526000004
J	MacMahon, S; Perkovic, V; Patel, A				MacMahon, Stephen; Perkovic, Vlado; Patel, Anushka			Industry-Sponsored Clinical Trials in Emerging Markets Time to Review the Terms of Engagement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[MacMahon, Stephen; Perkovic, Vlado; Patel, Anushka] George Inst Global Hlth, Sydney, NSW 2050, Australia; [MacMahon, Stephen] Univ Oxford, Oxford, England; [MacMahon, Stephen; Perkovic, Vlado; Patel, Anushka] Univ Sydney, Sydney, NSW 2006, Australia	George Institute for Global Health; University of Sydney; University of Oxford; University of Sydney	MacMahon, S (corresponding author), George Inst Global Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	smacmahon@georgeinstitute.org	Perkovic, Vlado/AAY-1933-2021	MacMahon, Stephen/0000-0003-2064-7699; Perkovic, Vlado/0000-0002-4257-7620; Patel, Anushka/0000-0003-3825-4092				Ana J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001315; Barboza D., 2013, NEW YORK TIMES; Kass N, 2001, ETHICAL AND POLICY I, V2; Page Alice K, 2002, Yale J Health Policy Law Ethics, V3, P35; Perel P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001696; Shah S., 2006, THE BODY HUNTERS TES; Thomas K., 2013, NY TIMES	7	10	10	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					907	908		10.1001/jama.2013.276913	http://dx.doi.org/10.1001/jama.2013.276913			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002272				2022-12-28	WOS:000323885700016
J	Young, SD; Cumberland, WG; Lee, SJ; Jaganath, D; Szekeres, G; Coates, T				Young, Sean D.; Cumberland, William G.; Lee, Sung-Jae; Jaganath, Devan; Szekeres, Greg; Coates, Thomas			Social Networking Technologies as an Emerging Tool for HIV Prevention A Cluster Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							INTERNET; INTERVENTION; FEASIBILITY; INFECTION; EDUCATION; MEN	Background: Social networking technologies are an emerging tool for HIV prevention. Objective: To determine whether social networking communities can increase HIV testing among African American and Latino men who have sex with men (MSM). Design: Randomized, controlled trial with concealed allocation. (ClinicalTrials.gov: NCT01701206) Setting: Online. Patients: 112 MSM based in Los Angeles, more than 85% of whom were African American or Latino. Intervention: Sixteen peer leaders were randomly assigned to deliver information about HIV or general health to participants via Facebook groups over 12 weeks. After participants accepted a request to join the group, participation was voluntary. Group participation and engagement were monitored. Participants could request a free, home-based HIV testing kit and completed questionnaires at baseline and 12-week follow-up. Measurements: Participant acceptance of and engagement in the intervention and social network participation, rates of home-based HIV testing, and sexual risk behaviors. Results: Almost 95% of intervention participants and 73% of control participants voluntarily communicated using the social platform. Twenty-five of 57 intervention participants (44%) requested home-based HIV testing kits compared with 11 of 55 control participants (20%) (difference, 24 percentage points [95% CI, 8 to 41 percentage points]). Nine of the 25 intervention participants (36%) who requested the test took it and mailed it back compared with 2 of the 11 control participants (18%) who requested the test. Retention at study follow-up was more than 93%. Limitation: Only 2 Facebook communities were included for each group. Conclusion: Social networking communities are acceptable and effective tools to increase home-based HIV testing among at-risk populations.	Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Young, SD (corresponding author), Univ Calif Los Angeles, Dept Family Med, David Geffen Sch Med, 10880 Wilshire Blvd,Suite 1800, Los Angeles, CA 90024 USA.	sdyoung@mednet.ucla.edu		Jaganath, Devan/0000-0002-8555-5667; Young, Sean D./0000-0001-6052-4875	National Institute of Mental Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107, K01MH090884, K01MH085503] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institute of Mental Health.	Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Bowen AM, 2008, J BEHAV MED, V31, P463, DOI 10.1007/s10865-008-9171-6; Bull S, 2009, AIDS BEHAV, V13, P474, DOI 10.1007/s10461-008-9487-9; County of Los Angeles Department of Public Health Division of HIV and STD Programs, 2013, 2012 ANN HIV SURV RE; FOX S, 2003, WIRED HLTH CALIFORNI; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Harris Interactive, 2007, GAYS LESB BIS LEAD U; Horrigan J.B., 2007, HOME BROADBAND ADOPT; Jaganath D, 2012, AIDS CARE, V24, P593, DOI 10.1080/09540121.2011.630355; Kalichman SC, 2003, HEALTH PSYCHOL, V22, P111, DOI 10.1037/0278-6133.22.1.111; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; Maiorana A, 2007, EVAL PROGRAM PLANN, V30, P82, DOI 10.1016/j.evalprogplan.2006.10.004; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Rosser BRS, 2005, 17 WORLD C SEX MONTR; Smith A, 2010, MOBILE ACCESS 2010; Smith A, 2011, WHOS WHAT SOCIAL MED; STLAWRENCE JS, 1994, AM J PUBLIC HEALTH, V84, P2027, DOI 10.2105/AJPH.84.12.2027; Tashima KT, 2003, INT J STD AIDS, V14, P285, DOI 10.1258/095646203321264926; Young SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062271; Young SD, 2013, HEALTH EDUC J, V72, P276, DOI 10.1177/0017896912440768; Young SD, 2013, SEX TRANSM DIS, V40, P162, DOI 10.1097/OLQ.0b013e318278bd12; Young SD, 2012, AIDS BEHAV, V16, P1743, DOI 10.1007/s10461-012-0251-9	24	122	124	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2013	159	5					318	+		10.7326/0003-4819-159-5-201309030-00005	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215YA	24026317	Green Accepted, Green Published			2022-12-28	WOS:000324245900002
J	Setvin, M; Aschauer, U; Scheiber, P; Li, YF; Hou, WY; Schmid, M; Selloni, A; Diebold, U				Setvin, Martin; Aschauer, Ulrich; Scheiber, Philipp; Li, Ye-Fei; Hou, Weiyi; Schmid, Michael; Selloni, Annabella; Diebold, Ulrike			Reaction of O-2 with Subsurface Oxygen Vacancies on TiO2 Anatase (101)	SCIENCE			English	Article							SURFACE SCIENCE; TITANIA	Oxygen (O-2) adsorbed on metal oxides is important in catalytic oxidation reactions, chemical sensing, and photocatalysis. Strong adsorption requires transfer of negative charge from oxygen vacancies (V(O)s) or dopants, for example. With scanning tunneling microscopy, we observed, transformed, and, in conjunction with theory, identified the nature of O-2 molecules on the (101) surface of anatase (titanium oxide, TiO2) doped with niobium. V(O)s reside exclusively in the bulk, but we pull them to the surface with a strongly negatively charged scanning tunneling microscope tip. O-2 adsorbed as superoxo (O-2(-)) at fivefold-coordinated Ti sites was transformed to peroxo (O-2(2-)) and, via reaction with a V-O, placed into an anion surface lattice site as an (O-2)(O) species. This so-called bridging dimer also formed when O-2 directly reacted with V(O)s at or below the surface.	[Setvin, Martin; Scheiber, Philipp; Schmid, Michael; Diebold, Ulrike] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria; [Aschauer, Ulrich; Li, Ye-Fei; Hou, Weiyi; Selloni, Annabella] Princeton Univ, Dept Chem, Frick Lab, Princeton, NJ 08544 USA	Technische Universitat Wien; Princeton University	Diebold, U (corresponding author), Vienna Univ Technol, Inst Appl Phys, Wiedner Hauptstr 8-10-134, A-1040 Vienna, Austria.	diebold@iap.tuwien.ac.at	Setvin, Martin/G-4879-2016; Setvin, Martin/G-5629-2014; Diebold, Ulrike/A-3681-2010; Aschauer, Ulrich/C-1023-2009	Setvin, Martin/0000-0002-1210-7740; Setvin, Martin/0000-0001-8636-921X; Diebold, Ulrike/0000-0003-0319-5256; Aschauer, Ulrich/0000-0002-1165-6377; Schmid, Michael/0000-0003-3373-9357	Austrian Science Fund (FWF) [F45]; European Research Council; U.S. Department of Energy (DOE)-office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-FG02-12ER16286]; National Energy Research Scientific Computing Center (DOE) [DE-AC02-05CH11231]; Terascale Infrastructure for Groundbreaking Research in Science and Engineering High-Performance Computer Center at Princeton University	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); U.S. Department of Energy (DOE)-office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); National Energy Research Scientific Computing Center (DOE)(United States Department of Energy (DOE)); Terascale Infrastructure for Groundbreaking Research in Science and Engineering High-Performance Computer Center at Princeton University	The experimental work was supported by the Austrian Science Fund (FWF; project F45) and the European Research Council Advanced Grant "OxideSurfaces." The theoretical work was supported by the U.S. Department of Energy (DOE)-office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences under award DE-FG02-12ER16286. We used resources of the National Energy Research Scientific Computing Center (DOE contract DE-AC02-05CH11231) and the Terascale Infrastructure for Groundbreaking Research in Science and Engineering High-Performance Computer Center at Princeton University.	Aschauer U, 2010, PROC SPIE, V7758, DOI 10.1117/12.862241; Aschauer U, 2010, PHYS CHEM CHEM PHYS, V12, P12956, DOI 10.1039/c0cp00116c; AUGUSTYNSKI J, 1993, ELECTROCHIM ACTA, V38, P43, DOI 10.1016/0013-4686(93)80008-N; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Dohnalek Z, 2010, PROG SURF SCI, V85, P161, DOI 10.1016/j.progsurf.2010.03.001; Dulub O, 2007, SCIENCE, V317, P1052, DOI 10.1126/science.1144787; Etacheri V, 2011, ADV FUNCT MATER, V21, P3744, DOI 10.1002/adfm.201100301; He YB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.106105; Henderson MA, 2011, SURF SCI REP, V66, P185, DOI 10.1016/j.surfrep.2011.01.001; Kimmel GA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.196102; Li YF, 2013, J AM CHEM SOC, V135, P9195, DOI 10.1021/ja404044t; Li YF, 2010, J AM CHEM SOC, V132, P13008, DOI 10.1021/ja105340b; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Na-Phattalung S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125205; Nakaoka Y, 1997, J PHOTOCH PHOTOBIO A, V110, P299, DOI 10.1016/S1010-6030(97)00208-6; Onishi H, 1996, PHYS REV LETT, V76, P791, DOI 10.1103/PhysRevLett.76.791; Pang CL, 2008, CHEM SOC REV, V37, P2328, DOI 10.1039/b719085a; Petrik NG, 2011, J PHYS CHEM C, V115, P152, DOI 10.1021/jp108909p; Scheiber P, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.136103; Scheiber P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.216101; Sclafani A, 1996, J PHYS CHEM-US, V100, P13655, DOI 10.1021/jp9533584; Szot K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254001; Wendt S, 2008, SCIENCE, V320, P1755, DOI 10.1126/science.1159846; Xu MC, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.138302; Yamada Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754831	26	389	395	35	956	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					988	991		10.1126/science.1239879	http://dx.doi.org/10.1126/science.1239879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990556	Green Submitted			2022-12-28	WOS:000323652300038
J	Basu, A; Bodycombe, NE; Cheah, JH; Price, EV; Liu, K; Schaefer, GI; Ebright, RY; Stewart, ML; Ito, D; Wang, S; Bracha, AL; Liefeld, T; Wawer, M; Gilbert, JC; Wilson, AJ; Stransky, N; Kryukov, GV; Dancik, V; Barretina, J; Garraway, LA; Hon, CSY; Munoz, B; Bittker, JA; Stockwell, BR; Khabele, D; Stern, AM; Clemons, PA; Shamji, AF; Schreiber, SL				Basu, Amrita; Bodycombe, Nicole E.; Cheah, Jaime H.; Price, Edmund V.; Liu, Ke; Schaefer, Giannina I.; Ebright, Richard Y.; Stewart, Michelle L.; Ito, Daisuke; Wang, Stephanie; Bracha, Abigail L.; Liefeld, Ted; Wawer, Mathias; Gilbert, Joshua C.; Wilson, Andrew J.; Stransky, Nicolas; Kryukov, Gregory V.; Dancik, Vlado; Barretina, Jordi; Garraway, Levi A.; Hon, C. Suk-Yee; Munoz, Benito; Bittker, Joshua A.; Stockwell, Brent R.; Khabele, Dineo; Stern, Andrew M.; Clemons, Paul A.; Shamji, Alykhan F.; Schreiber, Stuart L.			An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules	CELL			English	Article							INHIBITION; IDENTIFICATION; SENSITIVITY; RESISTANCE; THERAPIES; SURVIVAL; PATHWAY; KINASE; CELLS; BCL-2	The high rate of clinical response to protein-kinase-targeting drugs matched to cancer patients with specific genomic alterations has prompted efforts to use cancer cell line (CCL) profiling to identify additional biomarkers of small-molecule sensitivities. We have quantitatively measured the sensitivity of 242 genomically characterized CCLs to an Informer Set of 354 small molecules that target many nodes in cell circuitry, uncovering protein dependencies that: (1) associate with specific cancer-genomic alterations and (2) can be targeted by small molecules. We have created the Cancer Therapeutics Response Portal (http://www.broadinstitute.org/ctrp) to enable users to correlate genetic features to sensitivity in individual lineages and control for confounding factors of CCL profiling. We report a candidate dependency, associating activating mutations in the oncogene beta-catenin with sensitivity to the Bcl-2 family antagonist, navitoclax. The resource can be used to develop novel therapeutic hypotheses and to accelerate discovery of drugs matched to patients by their cancer genotype and lineage.	[Basu, Amrita; Bodycombe, Nicole E.; Cheah, Jaime H.; Price, Edmund V.; Liu, Ke; Schaefer, Giannina I.; Ebright, Richard Y.; Stewart, Michelle L.; Ito, Daisuke; Wang, Stephanie; Bracha, Abigail L.; Liefeld, Ted; Wawer, Mathias; Gilbert, Joshua C.; Stransky, Nicolas; Kryukov, Gregory V.; Dancik, Vlado; Barretina, Jordi; Garraway, Levi A.; Hon, C. Suk-Yee; Munoz, Benito; Bittker, Joshua A.; Stern, Andrew M.; Clemons, Paul A.; Shamji, Alykhan F.; Schreiber, Stuart L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Wilson, Andrew J.; Khabele, Dineo] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; [Stockwell, Brent R.] Columbia Univ, New York, NY 10027 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Vanderbilt University; Columbia University	Clemons, PA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	pclemons@broadinstitute.org; ashamji@broadinstitute.org; stuart_schreiber@harvard.edu	Stockwell, Brent R/AAE-7200-2019; Kryukov, Gregory V/A-9592-2008; Barretina, Jordi/A-7192-2013	Stockwell, Brent R/0000-0002-3532-3868; Kryukov, Gregory/0000-0002-6131-9483; Barretina, Jordi/0000-0002-3478-4080; Stern, Andrew/0000-0002-8437-2957; Price, Edmund/0000-0001-6495-4725	NCI's Cancer Target Discovery and Development Network [RC2-CA148399]; Novartis; NATIONAL CANCER INSTITUTE [R01CA097061, K08CA148887, R01CA161061, RC2CA148399] Funding Source: NIH RePORTER	NCI's Cancer Target Discovery and Development Network; Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NCI's Cancer Target Discovery and Development Network (RC2-CA148399, awarded to S. L. S.). We acknowledge the following colleagues for contributing compounds and for valuable critique: Drs. D. Adams, A. Beeler, J. Bradner, P. Brown, S. Chattopadhyay, C. Chen, A. Choudhury, J. Clardy, E. J. Corey, M. Dai, K. Hartwell, E. Holson, C. Johannessen, A. Koehler, T. Luo, A. G. Myers, J. Paulk, J. Porco, G. Ramachandran, A. Ramanathan, S. Schaus, K. P. Seiler, M. D. Shair, B. Wagner, Q. Wang, and PharmaMar. We thank J. McGrath, G. Wendel, and the Broad Compound Management team for handling the Informer Set; D.-K. Jang, A. Li, and M. Reich for supporting web portal development; and the Biological Samples Platform for providing CCLs. The project was enabled by the Broad Institute Chemical Biology Program and Platform. L. A. G. is a consultant for and equity holder in Foundation Medicine, Inc. and received sponsored research from Novartis. The authors are grateful for the leadership of the CTD<SUP>2</SUP> Network by Daniela Gerhard (Director, Office of Cancer Genomics, NCI). S. L. S. is an Investigator at the Howard Hughes Medical Institute.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Corcoran RB, 2011, ONCOTARGET, V2, P336; Cormen T, 2000, THEOR COMPUT SYST, V33, P335, DOI 10.1007/s002240010016; de Castro DG, 2013, CLIN PHARMACOL THER, V93, P252, DOI 10.1038/clpt.2012.237; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Ju J, 2005, CANCER RES, V65, P10623, DOI 10.1158/0008-5472.CAN-05-1949; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; Larsen JE, 2011, CANCER J, V17, P512, DOI 10.1097/PPO.0b013e31823e701a; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Pan HL, 2012, ANTI-CANCER AGENT ME, V12, P247, DOI 10.2174/187152012800228814; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Ran ZH, 2005, CHINESE MED J-PEKING, V118, P1330; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smalley KSM, 2010, CURR OPIN INVEST DR, V11, P699; Sparks AB, 1998, CANCER RES, V58, P1130; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Tahir SK, 2010, MOL CANCER THER, V9, P545, DOI 10.1158/1535-7163.MCT-09-0651; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Weiwer M, 2012, BIOORG MED CHEM LETT, V22, P1822, DOI 10.1016/j.bmcl.2011.09.047; Yoon J, 2011, CANCER RES, V71, P445, DOI 10.1158/0008-5472.CAN-10-3058; Zhu J, 2004, BIOSTATISTICS, V5, P427, DOI 10.1093/biostatistics/kxg046	45	409	412	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1151	1161		10.1016/j.cell.2013.08.003	http://dx.doi.org/10.1016/j.cell.2013.08.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993102	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000323767300026
J	Bernstein, R				Bernstein, Rachel			Science on Set	CELL			English	Editorial Material																			0	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					949	950		10.1016/j.cell.2013.08.011	http://dx.doi.org/10.1016/j.cell.2013.08.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993085	Bronze			2022-12-28	WOS:000323767300005
J	Guise, TA				Guise, Theresa A.			Breast Cancer Bone Metastases: It's All about the Neighborhood	CELL			English	Editorial Material							SURVIVAL		Indiana Univ, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Guise, TA (corresponding author), Indiana Univ, Dept Med, Div Endocrinol, Indianapolis, IN 46202 USA.	tguise@iu.edu			NCI NIH HHS [U01CA143057, R01CA69158, U01 CA143057] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069158, U01CA143057] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anders CK, 2013, HEMATOL ONCOL CLIN N, V27, P737, DOI 10.1016/j.hoc.2013.05.003; Campone M, 2012, ANN ONCOL, V23, P610, DOI 10.1093/annonc/mdr261; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rucci N, 2006, J PHARMACOL EXP THER, V318, P161, DOI 10.1124/jpet.106.102004; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	9	31	31	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					957	959		10.1016/j.cell.2013.08.020	http://dx.doi.org/10.1016/j.cell.2013.08.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993088	Bronze			2022-12-28	WOS:000323767300009
J	Hajek, P				Hajek, Peter			Electronic cigarettes for smoking cessation	LANCET			English	Editorial Material									[Hajek, Peter] Queen Mary Univ London, Wolfson Inst Prevent Med, London E1 2AD, England; [Hajek, Peter] Queen Mary Univ London, UK Ctr Tobacco & Alcohol Studies, London E1 2AD, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Hajek, P (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, London E1 2AD, England.	p.hajek@qmul.ac.uk						Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Dockrell M, 2013, NICOTINE TOB RES, V15, P1737, DOI 10.1093/ntr/ntt057; Douptcheva N, 2013, J EPIDEMIOL COMMUNIT, DOI 10.1136/jech-2013-203152; European Commission, 2012, PROP DIR EUR PARL CO; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; McCauley L, 2012, CHEST, V141, P1110, DOI 10.1378/chest.11-1334	7	25	26	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1614	1616		10.1016/S0140-6736(13)61534-2	http://dx.doi.org/10.1016/S0140-6736(13)61534-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	24029168				2022-12-28	WOS:000327140700007
J	Weinstein, SL; Dolan, LA; Wright, JG; Dobbs, MB				Weinstein, Stuart L.; Dolan, Lori A.; Wright, James G.; Dobbs, Matthew B.			Effects of Bracing in Adolescents with Idiopathic Scoliosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RELIABILITY; PROGRESSION; PEDSQL(TM)-4.0; QUESTIONNAIRE; VALIDITY	BackgroundThe role of bracing in patients with adolescent idiopathic scoliosis who are at risk for curve progression and eventual surgery is controversial. MethodsWe conducted a multicenter study that included patients with typical indications for bracing due to their age, skeletal immaturity, and degree of scoliosis. Both a randomized cohort and a preference cohort were enrolled. Of 242 patients included in the analysis, 116 were randomly assigned to bracing or observation, and 126 chose between bracing and observation. Patients in the bracing group were instructed to wear the brace at least 18 hours per day. The primary outcomes were curve progression to 50 degrees or more (treatment failure) and skeletal maturity without this degree of curve progression (treatment success). ResultsThe trial was stopped early owing to the efficacy of bracing. In an analysis that included both the randomized and preference cohorts, the rate of treatment success was 72% after bracing, as compared with 48% after observation (propensity-score-adjusted odds ratio for treatment success, 1.93; 95% confidence interval [CI], 1.08 to 3.46). In the intention-to-treat analysis, the rate of treatment success was 75% among patients randomly assigned to bracing, as compared with 42% among those randomly assigned to observation (odds ratio, 4.11; 95% CI, 1.85 to 9.16). There was a significant positive association between hours of brace wear and rate of treatment success (P<0.001). ConclusionsBracing significantly decreased the progression of high-risk curves to the threshold for surgery in patients with adolescent idiopathic scoliosis. The benefit increased with longer hours of brace wear. (Funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases and others; BRAIST ClinicalTrials.gov number, NCT00448448.)	[Weinstein, Stuart L.; Dolan, Lori A.] Univ Iowa, Dept Orthoped & Rehabil, Iowa City, IA 52242 USA; [Wright, James G.] Hosp Sick Children, Dept Orthoped Surg, Toronto, ON M5G 1X8, Canada; [Dobbs, Matthew B.] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63130 USA; [Dobbs, Matthew B.] St Louis Shriners Hosp Children, St Louis, MO USA	University of Iowa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Washington University (WUSTL)	Weinstein, SL (corresponding author), Univ Iowa, Dept Orthoped & Rehabil, 200 Hawkins Dr, Iowa City, IA 52242 USA.	stuart-weinstein@uiowa.edu		Dolan, Lori/0000-0003-2455-2187; Weinstein, Stuart/0000-0002-3676-6687	National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052113, R21AR049587] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases and others; BRAIST ClinicalTrials.gov number, NCT00448448.	[Anonymous], 2004, SCREEN ID SCOL AD; Danielsson AJ, 2007, SPINE, V32, P2198, DOI 10.1097/BRS.0b013e31814b851f; Dolan LA, 2010, ANN M PED ORTH SOC N; Dolan LA, 2009, EVIDENCE BASED ORTHO; Dolan LA, 2007, SPINE, V32, pS91, DOI 10.1097/BRS.0b013e318134ead9; Dolan LA, 2008, J BONE JOINT SURG AM, V90A, P2594, DOI 10.2106/JBJS.G.01460; FOCARILE FA, 1991, SPINE, V16, P395, DOI 10.1097/00007632-199104000-00001; Healthcare Cost and Utilization Project (HCUP), 2009, HCUP KIDS INP DAT KI; Helfenstein A, 2006, SPINE, V31, P339, DOI 10.1097/01.brs.0000197412.70050.0d; LAN KKG, 1989, BIOMETRICS, V45, P1017, DOI 10.2307/2531701; Landgraf JM, 1996, CHQ USERS MANUAL; Lenssinck MLB, 2005, PHYS THER, V85, P1329, DOI 10.1093/ptj/85.12.1329; NACHEMSON AL, 1995, J BONE JOINT SURG AM, V77A, P815, DOI 10.2106/00004623-199506000-00001; Nachemson AL., 1982, REPORT PREVALANCE NA; Negrini S, 2010, COCHRANE DB SYST REV, V1, DOI [DOI 10.1002/14651858.CD006850, 10.1002/14651858.CD006850.pub2]; PETERSEN AC, 1984, J YOUTH ADOLESCENCE, V13, P93, DOI 10.1007/BF02089104; Richards BS, 2005, SPINE, V30, P2068, DOI 10.1097/01.brs.0000178819.90239.d0; Risser JC, 2010, CLIN ORTHOP RELAT R, V468, P646, DOI 10.1007/s11999-009-1096-z; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rowe DE, 1997, J BONE JOINT SURG AM, V79A, P664, DOI 10.2106/00004623-199705000-00005; Sanders JO, 2008, J BONE JOINT SURG AM, V90A, P540, DOI 10.2106/JBJS.G.00004; Sanders JO, 2007, SPINE, V32, P2719, DOI 10.1097/BRS.0b013e31815a5959; Terminology Committee of the Scoliosis Research Society, 1976, SPINE, V1, P57, DOI 10.1097/00007632-197603000-00008; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; Weinstein SL, 2013, SPINE; Ylikoski M, 2005, J PEDIATR ORTHOP B, V14, P320, DOI 10.1097/01202412-200509000-00002	28	544	562	16	126	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1512	1521		10.1056/NEJMoa1307337	http://dx.doi.org/10.1056/NEJMoa1307337			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	24047455	Green Accepted, Green Published			2022-12-28	WOS:000328101700008
J	Scirica, BM; Bhatt, DL; Braunwald, E; Steg, PG; Davidson, J; Hirshberg, B; Ohman, P; Frederich, R; Wiviott, SD; Hoffman, EB; Cavender, MA; Udell, JA; Desai, NR; Mosenzon, O; McGuire, DK; Ray, KK; Leiter, LA; Raz, I; Braunwald, E; Bhatt, DL; Scirica, BM; Udell, JA; Cavender, MA; Desai, N; Abrahamsen, T; Grossman, M; Morin, S; Im, K; Hoffman, E; Gabovitch, D; Pricken, A; Mosenzon, O; Buskila, A; Ohman, P; Hirshberg, B; Stahre, C; Price, D; Billing-Clason, S; Sabel, K; Monyak, J; Sjostrand, M; Wei, C; Lu, J; Miller, E; Raichlen, J; Fitt, S; Frederich, R; Iqbal, N; Donovan, M; Davidson, JA; Steg, PG; Aguilar-Salinas, C; Alvarsson, M; Amerena, J; Ardissino, D; Averkov, O; Avogaro, A; Barnett, A; Bretzel, R; Chiang, CE; Codoceo, V; Corbalan, R; Dalby, A; Darius, H; Deerochanawong, C; Dellborg, M; Eliaschewitz, F; Garcia-Castillo, A; Gomis, R; Henry, P; Hoekstra, J; Jermendy, G; Kastelein, J; Keech, A; Kiss, R; Krempf, M; Laakso, M; Leiter, L; Leitersdorf, E; Lewis, B; Litwak, L; Lopez-Sendon, J; Ma, R; McGuire, D; Medina, F; Moses, R; Nicolau, JC; Opolski, G; Ophuis, TO; Paolasso, E; Ray, KK; Ruda, M; Kumar, KMP; Shestakova, M; Sheu, WHH; Smahelova, A; Bhupathiraju, BSR; Spinar, J; Sritata, P; Strojeck, K; Villena-Chavez, JE; Jia, WP; Huo, Y; Wiviott, SD; Lowe, C; Awtry, E; Berger, C; Desai, AS; Gelfand, E; Leeman, D; Link, M; Ruberg, F; Vita, J; Rost, N; Silverman, S; Greenberger, NJ; Lerch, MM; Gersh, B; Nesto, R; Del Prato, S; Tuomilehto, J; Kelsey, S; Alvarisqueta, A; Cuadrado, J; Rista, L; Hermida, S; Baccaro, C; Luquez, C; Lagrutta, M; Maffei, L; Bartolacci, I; Montana, O; Cutuli, H; Berli, M; Lorenzatti, A; Frechtel, G; La Greca, R; Fretes, O; Diaz, M; Papini, NR; Farias, E; Issa, C; Elbert, A; Lehman, R; Arya, M; Singh, B; Colquhoun, D; Jayasinghe, R; de Looze, F; Blombery, P; Ward, G; Szto, G; Abhayaratna, W; Borges, J; Russo, L; Felicio, J; Santos, F; Guimaraes, F; Castro, ML; Rossi, P; Armaganijan, D; Leaes, P; Bandeira, F; Franken, M; Rassi, N; Rea, R; Zanella, M; Amodeo, C; Cesar, L; Betti, R; Chacra, A; Schmid, H; Bell, A; Syan, G; Zadra, R; Conter, H; Dumas, R; Borts, D; Dattani, I; Poirier, P; Cha, J; Dzongowski, P; Labonte, R; St Pierre, B; Gaudet, D; Kouz, S; Lamy, A; Tishler, S; Chehayeb, R; Bedard, J; Hramiak, I; Teitelbaum, I; Fortin, C; Woo, V; Conway, J; Mehta, P; Robinson, S; Sussex, B; Chiasson, J; Muirhead, N; Bose, S; Ouellet, A; Yale, J; Bhargava, R; Lau, D; Tobe, S; Perron, P; Sigalas, J; Bilodeau, L; Tytus, R; Achyuthan, G; Pearce, M; Steele, A; Bailey, G; Ma, P; St-Maurice, F; Rupka, D; Houlden, R; Bailey, A; Rewa, G; Sohal, P; Ting, R; Prieto, J; Rodriguez, M; Godoy, G; Larenas, G; Pincetti, C; Cobos, L; Saavedra, V; Varleta, P; Lucero, F; Kuzmanic, O; Acevedo, M; Aguirre, M; Florenzano, F; Ma, J; Bao, Y; Jiang, M; Xu, W; Shi, Y; Zheng, M; Li, Y; Dong, Y; Zhao, W; Sun, M; Lei, M; Wang, J; Pistek, Z; Rihacek, I; Kucera, D; Brada, M; Naplava, R; Karasova, J; Vlasicova, H; Skopecek, J; Spinarova, L; Raclavska, L; Sarbochova, R; Okenka, L; Racicka, E; Urbancova, K; Oznerova, M; Lorenc, Z; Wasserburger, B; Zahumensky, E; Grunfeldova, H; Hradec, J; Lukac, M; Svacina, S; Podzimek, J; Hemzsky, L; Mikulkova, I; Pavlickova, J; Brychta, T; Chochola, J; Couffinhal, T; Elbaz, M; Petit, C; Faller, B; Marechaud, R; Moulin, P; Fendri, S; Nazeyrollas, P; Wendisch, U; Busch, K; Klausmann, G; Duengen, H; Appel, K; Toursarkissian, N; Jung, T; Ott, P; Schenkenberger, I; Kuesters, D; Landers, B; Nischik, R; Fischer, H; Tschoepe, D; Paschen, B; Krause, K; Derwahl, K; Wenzl-Bauer, V; Hamann, A; Strotmann, H; Milek, K; Mueller, S; Chu, D; Tan, K; Kung, K; Chu, D; Tsang, C; Chu, D; Tomlinson, B; Kung, K; Koranyi, L; Kerenyi, Z; Benczur, B; Illyes, L; Hidvegi, T; Somogyi, A; Valco, J; Ferenczi, S; Rapi, J; Voros, P; Winkler, G; Sydo, T; Hetey, M; Simon, K; Penzes, J; Kempler, P; Bako, B; Lengyel, Z; Witmann, I; Dudas, M; Vandorfi, G; Takacs, J; Matoltsy, A; Ladanyi, E; Gyimesi, A; Sadikot, S; Parikh, K; Jain, S; Yajnik, C; Sosale, A; Shamanna, P; Srikanta, S; Shah, S; Srinivas, A; Banker, D; Shah, P; Sharda, A; Makkar, B; Desai, N; Rais, N; Mardikar, H; Mishra, A; Bhupati, S; Menon, J; Sathe, S; Gupta, R; Sharma, V; Darawsha, M; Herskovits, T; Hamoud, S; Nikolsky, E; Adawi, F; Zimlichman, R; Tsalihin, D; Wainstein, J; Klainman, E; Mosseri, M; Yerushalmi, Y; Karnieli, E; Knobler, H; Zimlichman, R; Benchetrit, S; Tsur, A; Yagil, Y; Atar, S; Beberashvili, I; Fuchs, S; Stern, N; Pollak, A; Chajek-Shaul, T; Rozenman, Y; Biton, A; Bramucci, E; Fiscella, A; Grassia, V; Piatti, P; De Cosmo, S; Di Lorenzo, L; Merlini, P; Mannucci, E; Frontoni, S; Trevisan, R; Zenari, L; Lambiase, C; Salvioni, A; Silvestri, O; Ambrosio, G; Di Bartolo, P; Fattore, L; Presbitero, P; Calabrese, M; Evola, R; Gamba, MA; Ibarra, MOD; Munoz, EC; Sanchez, DR; Herrera, CH; Rios, JP; Llamas, EB; Esperon, GL; Cantu, EG; Fragoso, JN; Gonzalez, JG; Martinez, GR; Padilla, FP; Mier, GM; Marmolejo, DH; Ruiz, JG; Portilla, NC; Rosas, EL; Machado, GM; Ramos, JC; Briones, IR; van Hessen, MWJ; Strikwerda, S; The, SHK; Kooy, A; Ronner, E; Nierop, PR; Remmen, JJ; Groenemeijer, BE; Hamer, BJB; Basart, DCG; van Lennep, HWOR; Nieuwdorp, M; van Dijk, MPM; Kentgens, S; van Kempen, WW; Hoogendijk, J; Spiering, W; Voors-Pette, C; Kose, V; de Waard, DEP; Gonkel, F; Kaasjager, HAH; Lingan, GMR; Agous, I; Kruik, HJ; Imholz, BPM; Pieterse, M; Manrique, H; Villena, J; Leon, L; Kundert, K; Minchola, J; Pinto, M; Heredia, J; Rodriguez, A; Guerreros, C; Berrospi, P; Zubiate, C; Allemant, A; Arbanil, H; Ponciano, W; Calderon, J; Lisson, R; Segura, L; Sidorowicz-Bialynicka, A; Sciborski, R; Fares, I; Mader, P; Skierkowska, J; Stasinska, T; Pomiecko, W; Skorski, M; Krzyzagorska, E; Polaszewska-Muszynska, M; Sowinski, D; Strojek, K; Rosinska-Migda, J; Romanczuk, P; Golebiowski, G; Kubica, J; Mazurek, T; Wojnowski, L; Pasternak, D; Stachlewski, P; Trzepla, E; Bogdanowicz, G; Uzunow, A; Potakowska, I; Miszczyszyn, Z; Waszyrowski, T; Smolenskaya, O; Lukyanov, Y; Vorokhobina, N; Khalimov, Y; Orlikova, O; Rebrov, A; Kukharchuk, V; Boldueva, S; Arkhipov, M; Zhelninova, T; Pavlysh, E; Antsiferov, M; Panov, A; Pavlova, M; Shustov, S; Demchenko, E; Galyavich, A; Malakhina, E; Semenova, O; Kobalava, Z; Kotova, S; Gavrisheva, I; Oschepkova, E; Karpov, Y; Sidorenko, B; Kislyak, O; Ametov, A; Dreval, A; Grineva, E; Mkrtumyan, A; Tyurina, T; Sazonova, O; Bonnici, F; Ranjith, N; Burgess, L; Nortje, H; Distiller, L; Mitha, I; Moore, R; Conradie, M; Horak, A; Pillay, S; Wellmann, H; Berg, E; Pillai, P; Padayachee, T; Corbett, C; Makan, H; Wing, J; Vawda, Z; Ebrahim, I; Dalby, A; Mitha, E; Bhorat, A; Fernandez, JC; Munoz, C; Cortada, JB; Conde, AC; Calvo, C; Extremera, BG; Delgado, E; Masmiquel, L; Puig, JG; Parreno, LD; Mauricio, D; Redon, J; Brito, M; Lopez, C; de la Morera, JS; Linderfalk, C; Larnefeldt, H; Olsson, A; Lonneborg, L; Ekelund, M; Samad, B; Borgencrantz, B; Nilsson, J; Berglund, O; Svensson, M; Mooe, T; Curiac, D; Albin, J; Angesjo, E; Lannemyr, O; Chiang, C; Sheu, W; Chen, J; Tien, K; Ueng, K; Lai, W; Yin, W; Hung, Y; Shyu, K; Hou, J; Lam, H; Laothavorn, P; Kuanprasert, S; Khovidhunkit, W; Benjasuratwong, Y; Chotinaiwattarakul, C; Mamanasiri, S; Suraamornkul, S; Pratipanawatr, T; Nitiyanant, W; Heller, S; Ray, K; Pieters, R; Strang, C; Bodalia, B; Middleton, A; Hall, T; Chapman, G; Calvert, J; Reed, R; Tam, D; Butcher, G; Jones, N; Takhar, A; Turner, W; McNally, D; Corey, O; Chapman, J; Mohr, S; Edwards, S; Bhatt, D; Davidson, J; Ocampo, A; Kandath, D; Aude, Y; Ervin, W; Savin, V; Anderson, R; Littlefield, R; Oberoi, M; Platt, GE; Yazdani, S; Mangoo-Karim, R; Walder, J; Gogia, H; Chandrashekhar, Y; Boccalandro, F; Rogers, W; Bilazarian, S; Zieve, F; Siage, Y; O'Connor, T; Mudaliar, S; Nikas, A; Giusti, R; Glover, R; Chilka, S; French, W; Roth, E; Singh, N; Christofferson, R; Stich, M; Dagogo-Jack, S; Allison, J; Zengotita, GA; Ison, R; Iteld, B; Sulistio, M; Gonzalez, E; Gorman, T; Hage-Korban, E; Reddy, R; Byars, W; Antonishen, M; Benjamin, S; First, B; Rosado, J; Bruschetta, H; Mehta, P; Poling, T; Rosendorff, C; Kerstein, HJ; Saba, F; Willis, J; Adams, K; Vazquez, EC; Ellison, H; Kahn, B; Kereiakes, D; Powell, S; Raskin, P; Smith, K; Varma, S; Whittier, F; Casanova, R; Isserman, S; Kaye, W; McGuinn, W; Bartkowiak, A; Dworkin, L; Labrador, CA; Podlecki, D; Popovtzer, M; Aronoff, S; Ballantyne, C; Ortiz, EG; Mora, A; Pitts, T; Reinhardt, S; Soucie, G; Wainwright, W; Henson, B; Sklaver, N; Arakaki, R; Brown, J; Chalavarya, G; Chochinov, R; Dixon, T; Kutner, M; Perlman, R; Raisinghani, A; Salacata, A; Awasty, V; Elinoff, V; George, W; LaRochelle-Gryseels, A; Mercado, A; Miller, G; Qureshi, M; Steljes, A; Wefald, F; Wilson, J; Chinn, J; Chuang, RB; Comulada-Rivera, A; Hartman, I; Narayan, P; Pacheco, T; Weiss, R; Beavins, J; Creevy, J; Hamroff, G; Hodson, R; Kosinski, E; Krichmar, P; Patel, R; Schneider, R; Shapiro, J; Sharp, D; Speer, J; Stegemoller, R; Waxman, F; Chang, FY; Braun, E; Eder, F; Minor, S; Albert, M; Carr, KW; Diaczok, B; Gastman, I; Gupta, V; Longshaw, K; Gonzalez-Campoy, JM; Raikhel, M; Thomas, J; Wood, K; Diab, I; Furda, J; Gelernt, M; Halter, M; House, B; Kaster, S; Raad, G; Stamatin, R; Barker, B; Blonder, R; Bloomberg, RJ; Calderon, RB; Carrol, A; Comerota, A; Feinglos, M; Henderson, D; Kastelic, R; Stonesifer, LD; Talano, J; Lee, PV; Brosseau, J; Clark, W; Cohen, E; Fialkow, J; Horton, K; Kozman, H; McGill, J; Mihills, C; Poonawala, R; Shore, K; Tejada, L; Torres, R; Wright, W; Calatayud, G; Chandna, H; Drozdiak, R; Fink, R; Gill, R; Glandt, M; Gottlieb, DW; Hack, T; Kay, J; Mansouri, V; McKnight, T; Mostel, E; Schmidt, L; Seide, H; Sonel, E; Taylor, R; Velasquez, M; Bretton, E; Feldman, R; Hartman, A; Hershon, K; Leach, CR; Martin, E; Mohiuddin, F; Naygandhi, Y; Riske, T; Schima, S; Uzoaga, ER; Ward, H; Weinstock, R; Williams, T; Altschuller, A; Aoki, T; Blumenthal, S; Cash, A; Eisner, G; Gutmann, J; Hagan, M; Kabour, A; Markus, T; McKenzie, W; Moursi, M; Mystkowski, P; Ovalle, F; Perkins, R; Popeil, L; Saniuk, R; Sierra, Y; Alvarado, O; Anderson, J; Bajaj, M; Blank, R; Chu, A; Levinsky, L; Levy, P; Osborne, J; Pavon, H; Sanderlin, D; Schaer, G; Zarich, S; Atassi, K; Bayron, C; Casagrande, M; Das, D; Gimness, M; Handel, F; Kinstrey, T; Leu, S; Osei, K; Nouel, JS; Soltani, Z; Sussman, H; Chiu, K; Duda, R; Farnsworth, K; Lano, M; Lee, F; Levin, P; Pratt, S; Richwine, R; Ruiz-Rivera, L; Turner, J; Wood, J; Zigrang, WD; Baquerizo, HR; Colon, CB; Demattia, J; Desai, V; Fitz-Patrick, D; Goral, S; Odhav, A; Prentiss, A; Ruff, C; Wu, W; Wyne, K; Abbott, LG; Applegate, R; Cabral, J; Kotha, P; Ortega, P; Simmons, D				Scirica, Benjamin M.; Bhatt, Deepak L.; Braunwald, Eugene; Steg, P. Gabriel; Davidson, Jaime; Hirshberg, Boaz; Ohman, Peter; Frederich, Robert; Wiviott, Stephen D.; Hoffman, Elaine B.; Cavender, Matthew A.; Udell, Jacob A.; Desai, Nihar R.; Mosenzon, Ofri; McGuire, Darren K.; Ray, Kausik K.; Leiter, Lawrence A.; Raz, Itamar; Braunwald, Eugene; Bhatt, Deepak L.; Scirica, Benjamin M.; Udell, Jacob A.; Cavender, Matthew A.; Desai, Nihar; Abrahamsen, Timothy; Grossman, Michelle; Morin, Suzanne; Im, Kyungah; Hoffman, Elaine; Gabovitch, Daniel; Pricken, Alexandra; Mosenzon, Ofri; Buskila, Alona; Ohman, Peter; Hirshberg, Boaz; Stahre, Christina; Price, Deborah; Billing-Clason, Solveig; Sabel, Karin; Monyak, John; Sjostrand, Mikalea; Wei, Cheryl; Lu, Jane; Miller, Elinor; Raichlen, Joel; Fitt, Sandy; Frederich, Robert; Iqbal, Nayyar; Donovan, Mark; Davidson, Jaime A.; Steg, Ph. Gabriel; Aguilar-Salinas, Carlos; Alvarsson, Michael; Amerena, John; Ardissino, Diego; Averkov, Oleg; Avogaro, Angelo; Barnett, Anthony; Bretzel, Reinhard; Chiang, Chern-En; Codoceo, Verner; Corbalan, Ramon; Dalby, Anthony; Darius, Harald; Deerochanawong, Chaicharn; Dellborg, Mikael; Eliaschewitz, Freddy; Garcia-Castillo, Armando; Gomis, Ramon; Henry, Patrick; Hoekstra, Joost; Jermendy, Gyorgy; Kastelein, John; Keech, Anthony; Kiss, Robert; Krempf, Michel; Laakso, Markku; Leiter, Lawrence; Leitersdorf, Eran; Lewis, Basil; Litwak, Leon; Lopez-Sendon, Jose; Ma, Ronald; McGuire, Darren; Medina, Felix; Moses, Robert; Nicolau, Jose C.; Opolski, Grzegorz; Ophuis, Ton Oude; Paolasso, Ernesto; Ray, Kausik K.; Ruda, Mikhail; Kumar, K. M. Prasanna; Shestakova, Marina; Sheu, Wayne H-H; Smahelova, Alena; Bhupathiraju, B. Soma Raju; Spinar, Jindrich; Sritata, Piyamitr; Strojeck, Krysztof; Villena-Chavez, Jaime E.; Jia, Weiping; Huo, Young; Wiviott, Stephen D.; Lowe, Cheryl; Awtry, Eric; Berger, Clifford; Desai, Akshay S.; Gelfand, Eli; Leeman, David; Link, Mark; Ruberg, Frederick; Vita, Joseph; Rost, Natalia; Silverman, Scott; Greenberger, Norton J.; Lerch, Markus M.; Gersh, Bernard; Nesto, Richard; Del Prato, Stefano; Tuomilehto, Jaakko; Kelsey, Sheryl; Alvarisqueta, A.; Cuadrado, J.; Rista, L.; Hermida, S.; Baccaro, C.; Luquez, C.; Lagrutta, M.; Maffei, L.; Bartolacci, I.; Montana, O.; Cutuli, H.; Berli, M.; Lorenzatti, A.; Frechtel, G.; La Greca, R.; Fretes, O.; Diaz, M.; Rodriguez Papini, N.; Farias, E.; Issa, C.; Elbert, A.; Lehman, R.; Arya, M.; Singh, B.; Colquhoun, D.; Jayasinghe, R.; de Looze, F.; Blombery, P.; Ward, G.; Szto, G.; Abhayaratna, W.; Borges, J.; Russo, L.; Felicio, J.; Santos, F.; Guimaraes Filho, F.; Lazaretti Castro, M.; Rossi, P.; Armaganijan, D.; Leaes, P.; Bandeira, F.; Franken, M.; Rassi, N.; Rea, R.; Zanella, M.; Amodeo, C.; Cesar, L.; Betti, R.; Chacra, A.; Schmid, H.; Bell, A.; Syan, G.; Zadra, R.; Conter, H.; Dumas, R.; Borts, D.; Dattani, I.; Poirier, P.; Cha, J.; Dzongowski, P.; Labonte, R.; St Pierre, B.; Gaudet, D.; Kouz, S.; Lamy, A.; Tishler, S.; Chehayeb, R.; Bedard, J.; Hramiak, I.; Teitelbaum, I.; Fortin, C.; Woo, V.; Conway, J.; Mehta, P.; Robinson, S.; Sussex, B.; Chiasson, J.; Muirhead, N.; Bose, S.; Ouellet, A.; Yale, J.; Bhargava, R.; Lau, D.; Tobe, S.; Perron, P.; Sigalas, J.; Bilodeau, L.; Tytus, R.; Achyuthan, G.; Pearce, M.; Steele, A.; Bailey, G.; Ma, P.; St-Maurice, F.; Rupka, D.; Houlden, R.; Bailey, A.; Rewa, G.; Sohal, P.; Ting, R.; Prieto, J.; Rodriguez, M.; Godoy, G.; Larenas, G.; Pincetti, C.; Cobos, L.; Saavedra, V.; Varleta, P.; Lucero, F.; Kuzmanic, O.; Acevedo, M.; Aguirre, M.; Florenzano, F.; Ma, J.; Bao, Y.; Jiang, M.; Xu, W.; Shi, Y.; Zheng, M.; Li, Y.; Dong, Y.; Zhao, W.; Sun, M.; Lei, M.; Wang, J.; Pistek, Z.; Rihacek, I.; Kucera, D.; Brada, M.; Naplava, R.; Karasova, J.; Vlasicova, H.; Skopecek, J.; Spinarova, L.; Raclavska, L.; Sarbochova, R.; Okenka, L.; Racicka, E.; Urbancova, K.; Oznerova, M.; Lorenc, Z.; Wasserburger, B.; Zahumensky, E.; Gruenfeldova, H.; Hradec, J.; Lukac, M.; Svacina, S.; Podzimek, J.; Hemzsky, L.; Mikulkova, I.; Pavlickova, J.; Brychta, T.; Chochola, J.; Couffinhal, T.; Elbaz, M.; Petit, C.; Faller, B.; Marechaud, R.; Moulin, P.; Fendri, S.; Nazeyrollas, P.; Wendisch, U.; Busch, K.; Klausmann, G.; Duengen, H.; Appel, K.; Toursarkissian, N.; Jung, T.; Ott, P.; Schenkenberger, I.; Kuesters, D.; Landers, B.; Nischik, R.; Fischer, H.; Tschoepe, D.; Paschen, B.; Krause, K.; Derwahl, K.; Wenzl-Bauer, V.; Hamann, A.; Strotmann, H.; Milek, K.; Mueller, S.; Chu, D.; Tan, K.; Kung, K.; Chu, D.; Tsang, C.; Chu, D.; Tomlinson, B.; Kung, K.; Koranyi, L.; Kerenyi, Z.; Benczur, B.; Illyes, L.; Hidvegi, T.; Somogyi, A.; Valco, J.; Ferenczi, S.; Rapi, J.; Voeroes, P.; Winkler, G.; Sydo, T.; Hetey, M.; Simon, K.; Penzes, J.; Kempler, P.; Bako, B.; Lengyel, Z.; Witmann, I.; Dudas, M.; Vandorfi, G.; Takacs, J.; Matoltsy, A.; Ladanyi, E.; Gyimesi, A.; Sadikot, S.; Parikh, K.; Jain, S.; Yajnik, C.; Sosale, A.; Shamanna, P.; Srikanta, S.; Shah, S.; Srinivas, A.; Banker, D.; Shah, P.; Sharda, A.; Makkar, B.; Desai, N.; Rais, N.; Mardikar, H.; Mishra, A.; Bhupati, S.; Menon, J.; Sathe, S.; Gupta, R.; Sharma, V.; Darawsha, M.; Herskovits, T.; Hamoud, S.; Nikolsky, E.; Adawi, F.; Zimlichman, R.; Tsalihin, D.; Wainstein, J.; Klainman, E.; Mosseri, M.; Yerushalmi, Y.; Karnieli, E.; Knobler, H.; Zimlichman, R.; Benchetrit, S.; Tsur, A.; Yagil, Y.; Atar, S.; Beberashvili, I.; Fuchs, S.; Stern, N.; Pollak, A.; Chajek-Shaul, T.; Rozenman, Y.; Biton, A.; Bramucci, E.; Fiscella, A.; Grassia, V.; Piatti, P.; De Cosmo, S.; Di Lorenzo, L.; Merlini, P.; Mannucci, E.; Frontoni, S.; Trevisan, R.; Zenari, L.; Lambiase, C.; Salvioni, A.; Silvestri, O.; Ambrosio, G.; Di Bartolo, P.; Fattore, L.; Presbitero, P.; Calabrese, M.; Evola, R.; Alcocer Gamba, M.; de los Rios Ibarra, M. Odin; Cardona Munoz, E.; Reyes Sanchez, D.; Hernandez Herrera, C.; Perez Rios, J.; Bayram Llamas, E.; Llamas Esperon, G.; Garcia Cantu, E.; Nunez Fragoso, J.; Gonzalez Gonzalez, J.; Rivera Martinez, G.; Padilla Padilla, F.; Melendez Mier, G.; Herrera Marmolejo, D.; Garza Ruiz, J.; Caracas Portilla, N.; Lopez Rosas, E.; Mendez Machado, G.; Chevaile Ramos, J.; Rodriguez Briones, I.; van Hessen, M. W. J.; Strikwerda, S.; The, S. H. K.; Kooy, A.; Ronner, E.; Nierop, P. R.; Remmen, J. J.; Groenemeijer, B. E.; Hamer, B. J. B.; Basart, D. C. G.; van Lennep, H. W. O. Roeters; Nieuwdorp, M.; van Dijk, M. P. M.; Kentgens, S.; van Kempen, W. W.; Hoogendijk, J.; Spiering, W.; Voors-Pette, C.; Kose, V.; de Waard, D. E. P.; Gonkel, F.; Kaasjager, H. A. H.; Lingan, G. M. Rojas; Agous, I.; Kruik, H. J.; Imholz, B. P. M.; Pieterse, M.; Manrique, H.; Villena, J.; Leon, L.; Kundert, K.; Minchola, J.; Pinto, M.; Heredia, J.; Rodriguez, A.; Guerreros, C.; Berrospi, P.; Zubiate, C.; Allemant, A.; Arbanil, H.; Ponciano, W.; Calderon, J.; Lisson, R.; Segura, L.; Sidorowicz-Bialynicka, A.; Sciborski, R.; Fares, I.; Mader, P.; Skierkowska, J.; Stasinska, T.; Pomiecko, W.; Skorski, M.; Krzyzagorska, E.; Polaszewska-Muszynska, M.; Sowinski, D.; Strojek, K.; Rosinska-Migda, J.; Romanczuk, P.; Golebiowski, G.; Kubica, J.; Mazurek, T.; Wojnowski, L.; Pasternak, D.; Stachlewski, P.; Trzepla, E.; Bogdanowicz, G.; Uzunow, A.; Potakowska, I.; Miszczyszyn, Z.; Waszyrowski, T.; Smolenskaya, O.; Lukyanov, Y.; Vorokhobina, N.; Khalimov, Y.; Orlikova, O.; Rebrov, A.; Kukharchuk, V.; Boldueva, S.; Arkhipov, M.; Zhelninova, T.; Pavlysh, E.; Antsiferov, M.; Panov, A.; Pavlova, M.; Shustov, S.; Demchenko, E.; Galyavich, A.; Malakhina, E.; Semenova, O.; Kobalava, Z.; Kotova, S.; Gavrisheva, I.; Oschepkova, E.; Karpov, Y.; Sidorenko, B.; Kislyak, O.; Ametov, A.; Dreval, A.; Grineva, E.; Mkrtumyan, A.; Tyurina, T.; Sazonova, O.; Bonnici, F.; Ranjith, N.; Burgess, L.; Nortje, H.; Distiller, L.; Mitha, I.; Moore, R.; Conradie, M.; Horak, A.; Pillay, S.; Wellmann, H.; Berg, E.; Pillai, P.; Padayachee, T.; Corbett, C.; Makan, H.; Wing, J.; Vawda, Z.; Ebrahim, I.; Dalby, A.; Mitha, E.; Bhorat, A.; Cruz Fernandez, J.; Munoz, C.; Bruguera Cortada, J.; Castro Conde, A.; Calvo, C.; Gil Extremera, B.; Delgado, E.; Masmiquel, L.; Garcia Puig, J.; de Teresa Parreno, L.; Mauricio, D.; Redon, J.; Brito, M.; Lopez, C.; Segura de la Morera, J.; Linderfalk, C.; Larnefeldt, H.; Olsson, A.; Lonneborg, L.; Ekelund, M.; Samad, B.; Borgencrantz, B.; Nilsson, J.; Berglund, O.; Svensson, M.; Mooe, T.; Curiac, D.; Albin, J.; Angesjo, E.; Lannemyr, O.; Chiang, C.; Sheu, W.; Chen, J.; Tien, K.; Ueng, K.; Lai, W.; Yin, W.; Hung, Y.; Shyu, K.; Hou, J.; Lam, H.; Laothavorn, P.; Kuanprasert, S.; Khovidhunkit, W.; Benjasuratwong, Y.; Chotinaiwattarakul, C.; Mamanasiri, S.; Suraamornkul, S.; Pratipanawatr, T.; Nitiyanant, W.; Heller, S.; Ray, K.; Pieters, R.; Strang, C.; Bodalia, B.; Middleton, A.; Hall, T.; Chapman, G.; Calvert, J.; Reed, R.; Tam, D.; Butcher, G.; Jones, N.; Takhar, A.; Turner, W.; McNally, D.; Corey, O.; Chapman, J.; Mohr, S.; Edwards, S.; Bhatt, D.; Davidson, J.; Ocampo, A.; Kandath, D.; Aude, Y.; Ervin, W.; Savin, V.; Anderson, R.; Littlefield, R.; Oberoi, M.; Platt, George E.; Yazdani, S.; Mangoo-Karim, R.; Walder, J.; Gogia, H.; Chandrashekhar, Y.; Boccalandro, F.; Rogers, W., Jr.; Bilazarian, S.; Zieve, F.; Siage, Y.; O'Connor, T.; Mudaliar, S.; Nikas, A.; Giusti, R.; Glover, R.; Chilka, S.; French, W.; Roth, E.; Singh, N.; Christofferson, R.; Stich, M.; Dagogo-Jack, S.; Allison, J., III; Zengotita, G. Arroyo; Ison, R.; Iteld, B.; Sulistio, M.; Gonzalez, E.; Gorman, T.; Hage-Korban, E.; Reddy, R.; Byars, W.; Antonishen, M.; Benjamin, S.; First, B.; Rosado, J.; Bruschetta, H.; Mehta, P.; Poling, T.; Rosendorff, C.; Kerstein, Howard J.; Saba, F.; Willis, J.; Adams, K.; Vazquez, E. Camilo; Ellison, H.; Kahn, B.; Kereiakes, D.; Powell, S.; Raskin, P.; Smith, K.; Varma, S.; Whittier, F.; Casanova, R.; Isserman, S.; Kaye, W.; McGuinn, W., II; Bartkowiak, A., Jr.; Dworkin, L.; Labrador, Carlos A.; Podlecki, D.; Popovtzer, M.; Aronoff, S.; Ballantyne, C.; Gonzalez-Ortiz, Elena; Mora, A., III; Pitts, T.; Reinhardt, S.; Soucie, G.; Wainwright, W.; Henson, B.; Sklaver, N.; Arakaki, R.; Brown, J.; Chalavarya, G.; Chochinov, R.; Dixon, T.; Kutner, M.; Perlman, R.; Raisinghani, A.; Salacata, A.; Awasty, V.; Elinoff, V.; George, W.; LaRochelle-Gryseels, A.; Mercado, A.; Miller, G.; Qureshi, M.; Steljes, A.; Wefald, F.; Wilson, J.; Chinn, J.; Chuang, Rita B.; Comulada-Rivera, A.; Hartman, I.; Narayan, P.; Pacheco, T.; Weiss, R.; Beavins, J.; Creevy, J.; Hamroff, G.; Hodson, R.; Kosinski, E.; Krichmar, P.; Patel, R.; Schneider, R.; Shapiro, J.; Sharp, D.; Speer, J.; Stegemoller, R.; Waxman, F.; Chang, F. Young; Braun, E.; Eder, F.; Minor, S.; Albert, M.; Carr, Kenneth W.; Diaczok, B.; Gastman, I.; Gupta, V.; Longshaw, K.; Gonzalez-Campoy, J. M.; Raikhel, M.; Thomas, J.; Wood, K.; Diab, I.; Furda, J.; Gelernt, M.; Halter, M.; House, B.; Kaster, S.; Raad, G.; Stamatin, R.; Barker, B.; Blonder, R.; Bloomberg, Robert J.; Calderon, R. Burgos; Carrol, A.; Comerota, A.; Feinglos, M.; Henderson, D.; Kastelic, R.; Stonesifer, Larry D.; Talano, J.; Lee, P. Ver; Brosseau, J.; Clark, W.; Cohen, E.; Fialkow, J.; Horton, K.; Kozman, H.; McGill, J.; Mihills, C.; Poonawala, R.; Shore, K.; Tejada, L.; Torres, R.; Wright, W.; Calatayud, G.; Chandna, H.; Drozdiak, R.; Fink, R.; Gill, R.; Glandt, M.; Gottlieb, Daniel W.; Hack, T.; Kay, J.; Mansouri, V.; McKnight, T.; Mostel, E.; Schmidt, L.; Seide, H.; Sonel, E.; Taylor, R.; Velasquez, M.; Bretton, E.; Feldman, R.; Hartman, A.; Hershon, K.; Leach, Charles R.; Martin, E.; Mohiuddin, F.; Naygandhi, Y.; Riske, T.; Schima, S.; Uzoaga, E. R.; Ward, H.; Weinstock, R.; Williams, T.; Altschuller, A.; Aoki, T.; Blumenthal, S.; Cash, A.; Eisner, Gilbert; Gutmann, J.; Hagan, M.; Kabour, A.; Markus, T.; McKenzie, W.; Moursi, M.; Mystkowski, P.; Ovalle, F.; Perkins, R.; Popeil, L.; Saniuk, R.; Sierra, Y.; Alvarado, O.; Anderson, J.; Bajaj, M.; Blank, R.; Chu, A.; Levinsky, L.; Levy, P.; Osborne, J.; Pavon, H.; Sanderlin, D.; Schaer, G.; Zarich, S.; Atassi, K.; Bayron, C.; Casagrande, M.; Das, D.; Gimness, M.; Handel, F.; Kinstrey, T.; Leu, S.; Osei, K.; Nouel, J. Soba; Soltani, Z.; Sussman, H.; Chiu, K.; Duda, R., Jr.; Farnsworth, K.; Lano, M.; Lee, F.; Levin, P.; Pratt, S.; Richwine, R.; Ruiz-Rivera, L.; Turner, J.; Wood, J.; Zigrang, William D.; Baquerizo, Hernan R.; Colon, Carlos Benitez; Demattia, J.; Desai, V.; Fitz-Patrick, D.; Goral, S.; Odhav, A.; Prentiss, A.; Ruff, C.; Wu, W.; Wyne, K.; Abbott, Lisa G.; Applegate, R.; Cabral, J.; Kotha, P.; Ortega, P.; Simmons, D.		Savor-Timi Steering Comm Investig	Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCOSE CONTROL; CLINICAL-USE; ALL-CAUSE; METAANALYSIS; EVENTS; DEATH; PREVENTION; DISEASE; RISK; MICROALBUMINURIA	BackgroundThe cardiovascular safety and efficacy of many current antihyperglycemic agents, including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear. MethodsWe randomly assigned 16,492 patients with type 2 diabetes who had a history of, or were at risk for, cardiovascular events to receive saxagliptin or placebo and followed them for a median of 2.1 years. Physicians were permitted to adjust other medications, including antihyperglycemic agents. The primary end point was a composite of cardiovascular death, myocardial infarction, or ischemic stroke. ResultsA primary end-point event occurred in 613 patients in the saxagliptin group and in 609 patients in the placebo group (7.3% and 7.2%, respectively, according to 2-year Kaplan-Meier estimates; hazard ratio with saxagliptin, 1.00; 95% confidence interval [CI], 0.89 to 1.12; P=0.99 for superiority; P<0.001 for noninferiority); the results were similar in the on-treatment analysis (hazard ratio, 1.03; 95% CI, 0.91 to 1.17). The major secondary end point of a composite of cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, coronary revascularization, or heart failure occurred in 1059 patients in the saxagliptin group and in 1034 patients in the placebo group (12.8% and 12.4%, respectively, according to 2-year Kaplan-Meier estimates; hazard ratio, 1.02; 95% CI, 0.94 to 1.11; P=0.66). More patients in the saxagliptin group than in the placebo group were hospitalized for heart failure (3.5% vs. 2.8%; hazard ratio, 1.27; 95% CI, 1.07 to 1.51; P=0.007). Rates of adjudicated cases of acute and chronic pancreatitis were similar in the two groups (acute pancreatitis, 0.3% in the saxagliptin group and 0.2% in the placebo group; chronic pancreatitis, <0.1% and 0.1% in the two groups, respectively). ConclusionsDPP-4 inhibition with saxagliptin did not increase or decrease the rate of ischemic events, though the rate of hospitalization for heart failure was increased. Although saxagliptin improves glycemic control, other approaches are necessary to reduce cardiovascular risk in patients with diabetes.	[Bhatt, Deepak L.] VA Boston Healthcare Syst, 1400 VFW Pkwy, Boston, MA 02132 USA; [Scirica, Benjamin M.; Bhatt, Deepak L.; Braunwald, Eugene; Wiviott, Stephen D.; Hoffman, Elaine B.; Cavender, Matthew A.; Udell, Jacob A.; Desai, Nihar R.] Brigham & Womens Hosp, TIMI Study Grp, Cardiovasc Div, Boston, MA 02115 USA; [Scirica, Benjamin M.; Bhatt, Deepak L.; Braunwald, Eugene; Wiviott, Stephen D.; Hoffman, Elaine B.; Cavender, Matthew A.; Udell, Jacob A.; Desai, Nihar R.] Harvard Univ, Sch Med, Boston, MA USA; [Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA 02132 USA; [Steg, P. Gabriel] Univ Paris Diderot, Paris, France; [Steg, P. Gabriel] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, F-75877 Paris, France; [Davidson, Jaime] Univ Texas SW Med Ctr Dallas, Div Endocrinol, Dept Internal Med, Dallas, TX 75390 USA; [McGuire, Darren K.] Univ Texas SW Med Ctr Dallas, Div Cardiovasc Med, Dept Internal Med, Dallas, TX 75390 USA; [Hirshberg, Boaz; Ohman, Peter] AstraZeneca Res & Dev, Wilmington, DE USA; [Frederich, Robert] Bristol Myers Squibb, Princeton, NJ USA; [Mosenzon, Ofri; Raz, Itamar] Hadassah Univ Hosp, Diabet Unit, Dept Internal Med, Jerusalem, Israel; [Ray, Kausik K.] St Georges Univ London, Cardiovasc Sci Res Ctr, London, England; [Leiter, Lawrence A.] Univ Toronto, Div Endocrinol & Metab, Keenan Res Ctr, Li Ka Shing Knowledge Inst,St Michaels Hosp, Toronto, ON, Canada; [Alvarisqueta, A.] Ctr Invest Med, Mar Del Plata, Buenos Aires, Argentina; [Cuadrado, J.] Framingham, La Plata, Buenos Aires, Argentina; [Rista, L.] CEDyN Ctr Diabet & Nutr, Rosario, Santa Fe, Argentina; [Hermida, S.] CIAD Consultorio Integral Atenc Diabet, Moron, Buenos Aires, Argentina; [Baccaro, C.] CIMeL, Lanus, Buenos Aires, Argentina; [Luquez, C.] Ctr Med Luquez Fdn Luquez, Cordoba, Argentina; [Lagrutta, M.] Inst Invest Clin Rosario, Rosario, Santa Fe, Argentina; [Maffei, L.] Consultorios Asociados Endocrionol, Buenos Aires, DF, Argentina; [Bartolacci, I.] Inst Invest Clin Cordoba, Cordoba, Argentina; [Montana, O.] DIM Clin Privada, Ramos Mejia, Buenos Aires, Argentina; [Cutuli, H.] Ctr Urol Ballester SRL, Villa Ballester, Buenos Aires, Argentina; [Berli, M.] CEDIR Ctr Diagnost & Rehabil, San Martin, Santa Fe, Argentina; [Lorenzatti, A.] Fdn Rusculleda, Cordoba, Argentina; [Frechtel, G.] Hosp Sirio Libanes, Buenos Aires, DF, Argentina; [La Greca, R.] Hosp Churruca Visca, Buenos Aires, DF, Argentina; [Fretes, O.] St Deniss Med Grp, Buenos Aires, DF, Argentina; [Diaz, M.] MD Invest, Buenos Aires, DF, Argentina; [Rodriguez Papini, N.] INSARES, Mendoza, Argentina; [Farias, E.] Inst Cardiol Juana F Cabral, Corrientes, Argentina; [Issa, C.] Sanat Guemes, Buenos Aires, DF, Argentina; [Elbert, A.] CEREHA Ctr Enfermedades Renales & Hipertens, Sarandi, Buenos Aires, Argentina; [Lehman, R.] Adelaide Med Res, Ashford, SA, Australia; [Amerena, John] Geelong Hosp, Geelong, Vic, Australia; [Arya, M.] Australian Clin Res Network, Maroubra, NSW, Australia; [Singh, B.] Launceston Gen Hosp, Launceston, Tas, Australia; [Colquhoun, D.] Core Res Grp, Milton, Qld, Australia; [Jayasinghe, R.] Gold Coast Hosp, Southport, Qld, Australia; [de Looze, F.] AusTrials, Auchenflower, Qld, Australia; [Blombery, P.] Ave Cardiovasc Ctr, Windsor, NSW, Australia; [de Looze, F.] AusTrials, Sherwood, Qld, Australia; [Ward, G.] St Vincents Hosp Melbourne, Fitzroy, Vic, Australia; [Szto, G.] Peninsula Heart Ctr, Frankston, Vic, Australia; [Abhayaratna, W.] Canberra Hosp, Clin Trials Unit, Woden, ACT, Australia; [Borges, J.] Ctr Pesquisa Clin Brasil, Brasilia, DF, Brazil; [Russo, L.] CCBR BRASIL Ctr Pesquisas & Anal Clin, Rio De Janeiro, Brazil; [Eliaschewitz, Freddy] CPClin Ctr Pesquisas Clin, Sao Paulo, Brazil; [Felicio, J.] Hosp Univ Joao Barros Barreto, Belem, Para, Brazil; [Santos, F.] Loema Inst Pesquisa Clin, Campinas, SP, Brazil; [Guimaraes Filho, F.] Inst Coracao Marilia, Marilia, SP, Brazil; [Lazaretti Castro, M.] IMA Brasil Inst Med Avancada, Sao Paulo, Brazil; [Rossi, P.] Nucl Pesquisa Clin, Curitiba, Parana, Brazil; [Armaganijan, D.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Leaes, P.] Irm Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil; [Bandeira, F.] Ctr Pesquisas Med Basica & Clin, Recife, PE, Brazil; [Franken, M.; Cesar, L.; Betti, R.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Rassi, N.] Hosp Geral Goiania Dr Alberto Rassi, Goiania, Go, Brazil; [Rea, R.] UFPR, Hosp Clin, Serv Endocrinol, Curitiba, Parana, Brazil; [Zanella, M.] Hosp Rim & Hipertensao, Sao Paulo, Brazil; [Amodeo, C.] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Chacra, A.] Univ Fed Sao Paulo, Ctr Pesquisa Clin Diabet, Sao Paulo, Brazil; [Schmid, H.] Irmandade Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil; [Bell, A.] Keele Med Pl, Toronto, ON, Canada; [Syan, G.] GS Cardiac Lab Med Profess Corp, Sudbury, ON, Canada; [Zadra, R.] Newmarket Cardiol Grp, Newmarket, ON, Canada; [Conter, H.] MSHJ Res Associates Inc, Halifax, NS, Canada; [Dumas, R.] Ctr Rech Clin Laval, Laval, PQ, Canada; [Borts, D.] Brampton Res Associates, Brampton, ON, Canada; [Dattani, I.] Prairie Clin Res Grp, Saskatoon, SK, Canada; [Poirier, P.] Inst Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Dzongowski, P.] Milestone Res, London, ON, Canada; [Labonte, R.] Dr R Labonte Profess Med Corp, Sudbury, ON, Canada; [St Pierre, B.] Ctr Rech Godin & St Pierre, Sherbrooke, PQ, Canada; [Gaudet, D.] Ctr Sante & Serv Sociaux Chicoutimi, ECOGENE Clin Trial Ctr 21, Chicoutimi, PQ, Canada; [Kouz, S.] CSSSNL CHRDL, St Charles Borromee, PQ, Canada; [Lamy, A.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Tishler, S.] Mississauga Clin Res Ctr Inc, Mississauga, ON, Canada; [Chehayeb, R.] Viacar Rech Clin Inc, Greenfield Pk, PQ, Canada; [Bedard, J.] Rech Clin London, Sherbrooke, PQ, Canada; [Hramiak, I.] St Josephs Hlth Care London, London, ON, Canada; [Teitelbaum, I.] JJ DIG Res Ltd, Toronto, ON, Canada; [Fortin, C.] Neufort Inc, St Lambert, PQ, Canada; [Woo, V.] Hlth Sci Ctr, Diabet Res Grp, Winnipeg, MB, Canada; [Conway, J.] Diabet Clin, Smiths Falls, ON, Canada; [Mehta, P.] Laxmi Ctr, Winnipeg, MB, Canada; [Robinson, S.] Victoria Heart Inst Fdn, Victoria, BC, Canada; [Sussex, B.] Hlth Sci Ctr, St John, NF, Canada; [Chiasson, J.] CRCHUM, Montreal, PQ, Canada; [Muirhead, N.] London Hlth Sci Ctr, London, ON, Canada; [Bose, S.] Dr S Bose Med Prof Corp, Saskatoon, SK, Canada; [Ouellet, A.] ViaCar Rech Clin, Longueuil, PQ, Canada; [Yale, J.] MUHC Royal Victoria, Montreal, PQ, Canada; [Bhargava, R.] Heart Care Res, Oshawa, ON, Canada; [Lau, D.] Univ Calgary, Clin Trials Unit, Calgary, AB, Canada; [Tobe, S.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Perron, P.] Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada; [Sigalas, J.] Rouge Valley Metab Res Associates, Scarborough, ON, Canada; [Bilodeau, L.] LEnjeu Med Ctr, Montreal, PQ, Canada; [Tytus, R.] Hamilton Med Res Grp, Hamilton, ON, Canada; [Achyuthan, G.] Regina Med Ctr, Regina, SK, Canada; [Pearce, M.] St Mary Gen Hosp, Kitchener, ON, Canada; [Steele, A.] Comed Res Res Network Inc, Courtice, ON, Canada; [Bailey, G.] Bailey Clin, Red Deer, AB, Canada; [Ma, P.] Heart Hlth Res, Calgary, AB, Canada; [St-Maurice, F.] ViaCar Rech Clin Inc, Brossard, PQ, Canada; [Rupka, D.] Fraser Clin Trials Inc, New Westminster, BC, Canada; [Houlden, R.] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; [Bailey, A.] BioQuest Res, Spruce Grove, AB, Canada; [Rewa, G.] Toronto East Cardiol Res Associates, Toronto, ON, Canada; [Sohal, P.] Surrey Med & Travel Clin, Surrey, BC, Canada; [Ting, R.] Corp Med Ctr, Scarborough, ON, Canada; [Prieto, J.] Univ Chile, Hosp Clin, Santiago, Chile; [Rodriguez, M.] Hosp Dr Sotero del Rio, Santiago, Chile; [Godoy, G.] Serv Med Godoy Ltda, Santiago, Chile; [Larenas, G.] Ctr Med Stockins & Larenas, Temuco, Chile; [Pincetti, C.] Ctr Invest Clin Sur, Temuco, Chile; [Cobos, L.] CARDIOCOB, Santiago, Chile; [Saavedra, V.] CECIM, Santiago, Chile; [Varleta, P.] Hosp DIPRECA, Santiago, Chile; [Lucero, F.] Hosp San Borja Arriaran, Santiago, Chile; [Kuzmanic, O.] Hosp Mil, Santiago, Chile; [Acevedo, M.] Ctr Invest Clin UC, Santiago, Chile; [Aguirre, M.] ADICH, Santiago, Chile; [Florenzano, F.] Psicomedica, Santiago, Chile; [Ma, J.] Nanjing First Hosp, Nanjing, Jiangsu, Peoples R China; [Bao, Y.] Shanghai 6th Peoples Hosp, Shanghai, Peoples R China; [Jiang, M.] Beijing Univ, Affiliated Hosp 1, Beijing 100871, Peoples R China; [Xu, W.] Suchow Univ, Affiliated Hosp 2, Suzhou, Peoples R China; [Shi, Y.] Shanghai Changzheng Hosp, Shanghai, Peoples R China; [Zheng, M.] Tianjin Med Univ, Affiliated Hosp 2, Tianjin, Peoples R China; [Li, Y.; Dong, Y.] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, W.] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Sun, M.] Tianjin Med Univ Gen Hosp, Tianjin, Peoples R China; [Lei, M.] Ctr South Univ, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Li, Y.] Shanghai Huashan Hosp, Shanghai, Peoples R China; [Wang, J.] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Pistek, Z.] Interni & Diabetol Ambulance, Uherske Hradiste, Czech Republic; [Rihacek, I.] Ctr Zdravi Sro, Brno, Czech Republic; [Kucera, D.] Kardiol & Angiol Ambulance, Ostrava, Czech Republic; [Brada, M.] Privatni Diabetol Ambulance, Breclav, Czech Republic; [Naplava, R.] Lunacor Sro, Ctr Choroby Srdce & Cev, Kromeriz, Czech Republic; [Spinar, Jindrich] Fak Nemocnice Brno, Interni Kardiol Klin 1, Brno, Czech Republic; [Karasova, J.] Interni & Diabetol Ordinace, Cheb, Czech Republic; [Vlasicova, H.] Diabetol Ambulance, Zlin, Czech Republic; [Skopecek, J.] Interni & Diabetol Ambulance, Horovice, Czech Republic; [Spinarova, L.] Fak Nemocnice U Sv Anny, Interni Kardioangiol Klin 1, Brno, Czech Republic; [Smahelova, Alena] Fak Nemocnice Hradec Kralove, Klin Gerontol & Metabol, Hradec Kralove, Czech Republic; [Raclavska, L.] Spol Sro, Medictr Beroun, Beroun, Czech Republic; [Sarbochova, R.] Nemocnice Slany, Interni Oddeleni, Slany, Czech Republic; [Okenka, L.] Diabetol Ambulance, Hodonin, Czech Republic; [Racicka, E.] Poliklin Mittal Steel, Interni & Diabetol Ordinace, Ostrava, Czech Republic; [Urbancova, K.] Diabetol & Interni Ambulance, Ostrava, Czech Republic; [Oznerova, M.] Soukroma Diabetol & Interni Ambulance, Ostrava, Czech Republic; [Lorenc, Z.] Kardiol Ordinace, Plzen, Czech Republic; [Wasserburger, B.] DIKa Ctr Sro, Havirov, Czech Republic; [Zahumensky, E.] Interni & Diabetol Ordinace, Zlin, Czech Republic; [Gruenfeldova, H.] Mestska Nemocnice Caslav, Interni Oddileni, Caslav, Czech Republic; [Hradec, J.] Interni & Diabetol Ordinace, Chrudim, Czech Republic; [Lukac, M.] Nefromed Sro, Prague, Czech Republic; [Svacina, S.] Vseobecna Fak Nemocnice, Interni Klin 3, Lekarska Fak UK VFN 1, Prague, Czech Republic; [Podzimek, J.] Diabetol & Interni Ordinace, Jablonec Nad Nisou, Czech Republic; [Hemzsky, L.] Preloucska Poliklin As, Ordinace Diabetol, Prelouc, Czech Republic; [Mikulkova, I.] Nemocnice Blansko, Interni & Diabetol Ambulance, Blansko, Czech Republic; [Pavlickova, J.] Diabetol Ambulance, Pardubice, Czech Republic; [Brychta, T.] Diabetol & Interni Ambulance, Olomouc, Czech Republic; [Chochola, J.] Nemocnice Milosrdnych Sester Sv Karla Boromejskeh, Interni Oddileni, Prague, Czech Republic; [Henry, Patrick] Hop Lariboisiere, F-75475 Paris, France; [Couffinhal, T.] Hop Haut Leveque, Pessac, France; [Krempf, Michel] Hop Nord Laennec, CHU Nantes, Nantes, France; [Elbaz, M.] CHU Rangueil, F-31054 Toulouse, France; [Petit, C.] Ctr Hosp, Corbeil Essonnes, France; [Faller, B.] Hop Civils Colmar, Colmar, France; [Marechaud, R.] CHRU Miletrie, Poitiers, France; [Moulin, P.] Hop Louis Pradel, Bron, France; [Fendri, S.] CHU Amiens, Hop Sud, Amiens, France; [Nazeyrollas, P.] CHR Robert Debre, Reims, France; [Klausmann, G.] Studienzentrum Haematol Onkol Diabetol, Aschaffenburg, Germany; [Duengen, H.] Campus Virchow Klinikum, Charite Berlin Med Klin Schwerpunkt Kardiol Campu, Berlin, Germany; [Appel, K.] Ambulantes Herzzentrum Kassel, Kassel, Germany; [Ott, P.] Teleportalklinik, Dippoldiswalde, Germany; [Schenkenberger, I.] Klin Forsch Berlin, Berlin, Germany; [Nischik, R.] Medamed GmbH, Leipzig, Germany; [Fischer, H.] Facharztzentrum Dresden Neustadt GbR, Zentrum Klin Prufungen, Dresden, Germany; [Tschoepe, D.] Herz & Diabet Zentrum NRW Forsch Leitung Diabet Z, Bad Oeynhausen, Germany; [Derwahl, K.] Inst Klin Forsch, Berlin, Germany; [Derwahl, K.] Entwicklung Berlin GmbHam St Hedwig Krankenhaus E, Berlin, Germany; [Hamann, A.] Diabet Klin Bad Nauheim GmbH, Bad Nauheim, Germany; [Strotmann, H.] Med Consult GmbH, Rotenburg, Germany; [Ma, Ronald; Tomlinson, B.] Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Chu, D.] Chai Wan Hlth Ctr, Hong Kong, Hong Kong, Peoples R China; [Tan, K.] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China; [Kung, K.] Lek Yuen Gen Outpatient Clin, Hong Kong, Hong Kong, Peoples R China; [Chu, D.] Violet Peel Gen Outpatient Clin, Hong Kong, Hong Kong, Peoples R China; [Tsang, C.] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Hong Kong, Peoples R China; [Chu, D.] Sai Wan Ho Hlth Ctr, Hong Kong, Hong Kong, Peoples R China; [Kung, K.] Fanling Family Med Ctr, Shatin, Hong Kong, Peoples R China; [Koranyi, L.] DRC Gyogyszervizsgalo Kozpont, Balatonfured, Hungary; [Kerenyi, Z.] Csepeli Egeszsegugyi Szolgalat Szakorvosi Rendelo, Budapest, Hungary; [Benczur, B.] Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz, Szolnok, Hungary; [Illyes, L.] Kardiol Szakrendeles Miskolc, H-3530 Miskolc, Hungary; [Hidvegi, T.] Petz Aladar Megyei Korhaz, Gyor, Hungary; [Somogyi, A.] Semmelweis Egyet II Belgyogyaszati Klin, Budapest, Hungary; [Valco, J.] Cegledi Toldy Ferenc Korhaz, Cegled, Hungary; [Jermendy, Gyorgy] Bajcsy Zsilinszky Korhaz Med Dept, Budapest, Hungary; [Ferenczi, S.] Petz Aladar Megyei Korhaz Immunnephrol, Gyor, Hungary; [Rapi, J.] Bugat Pal Korhaz Belgyogyaszat, Gyongyos, Hungary; [Voeroes, P.] Fovarosi Onk Szent Istvan Korhaz, Budapest, Hungary; [Winkler, G.] Szent Janos Korhaz II Belgyogyaszati Osztaly, Budapest, Hungary; [Sydo, T.] Jeruzsalemhegy Egeszseghaz, Veszprem, Hungary; [Hetey, M.] Markhot Ferenc Korhaz Egeszsegugyi Szolgaltato No, Eger, Hungary; [Simon, K.] Siofok Varosi Korhaz Rendeloint, Siofok, Hungary; [Penzes, J.] Konszenzus Plusz Kft, Csongrad, Hungary; [Kempler, P.] Semmelweis Egyet I Belgyogyaszati Klin, Budapest, Hungary; [Bako, B.] Borsod Abauj Zemplen Megyei Korhaz, Miskolc, Hungary; [Lengyel, Z.] Szent Margit Korhaz Belgyogyaszat Nephrol, Budapest, Hungary; [Witmann, I.] PTE AOK II Belgyogyaszati Klin, Pecs, Hungary; [Dudas, M.] Pandy Kalman Megyei Korhaz, Gyula, Hungary; [Vandorfi, G.] Veszprem Megyei Csolnoky Ferenc Korhaz, Veszprem, Hungary; [Takacs, J.] Jahn Ferenc Del Pesti Korhaz, Budapest, Hungary; [Matoltsy, A.] Kanizsai Dorottya Korhaz Begyogyaszat Kardiol, Nagykanizsa, Hungary; [Kiss, Robert] Allami Egeszsegugyi Kozpont Kardiol Osztaly, Budapest, Hungary; [Ladanyi, E.] FMC Miskolci Nefrol Kozpont, Miskolc, Hungary; [Gyimesi, A.] Rethy Pal Korhaz II Belgyogyaszati Osztaly, Bekescsaba, Hungary; [Parikh, K.] Care Inst Med Sci, Ahmadabad, Gujarat, India; [Jain, S.] Totall Diabet Hormone Inst, Indore, Madhya Pradesh, India; [Yajnik, C.] KEM Hosp, Pune, Maharashtra, India; [Sosale, A.] DIACON Hosp & Res Ctr, Bangalore, Karnataka, India; [Shamanna, P.] Bangalore Clinisearch, Bangalore, Karnataka, India; [Srikanta, S.] Jnana Sanjeevini Med Ctr, Bangalore, Karnataka, India; [Shah, S.] Diabet Act Ctr, Bombay, Maharashtra, India; [Srinivas, A.] Vikram Hosp Private Ltd, Mysore, Karnataka, India; [Kumar, K. M. Prasanna] Bangalore Diabet Hosp Bengaluru, Bangalore, Karnataka, India; [Banker, D.] Bankers Heart Inst, Vadodara, India; [Shah, P.] Gujarat Endocrine Ctr, Ahmadabad, Gujarat, India; [Sharda, A.] Endocrinol & Diabet Ctr, Bangalore, Karnataka, India; [Makkar, B.] Diabet & Obes Ctr, New Delhi, India; [Desai, N.] Namana Med Ctr, Bangalore, Karnataka, India; [Rais, N.] Chowpatty Med Ctr, Bombay, Maharashtra, India; [Mardikar, H.] Spandan Heart Inst, Nagpur, Maharashtra, India; [Mishra, A.] Fortis Flt Lt Rajan Dhall Hosp, New Delhi, India; [Bhupati, S.] CARE Hosp, Hyderabad, Andhra Pradesh, India; [Menon, J.] Mar Augustine Golden Jubilee Hosp, Mookkannur, Kerala, India; [Sathe, S.] Dr Shireesh Sathe Clin, Pune, Maharashtra, India; [Gupta, R.] Fortis Escorts Hosp, Jaipur, Rajasthan, India; [Sharma, V.] NHIAI Heart Fdn, New Delhi, India; [Darawsha, M.] Diabet & Lipid Dept Linn MC, Haifa, Israel; [Herskovits, T.] Western Galillee Hosp Diabet Inst, Nahariyya, Israel; [Hamoud, S.] Rambam Med Ctr Internal Med Haifa, Haifa, Israel; [Nikolsky, E.] Rambam Hlth Care Campus Dept Cardiol, Haifa, Israel; [Raz, Itamar] Hadassah Ein Karem MC Diabet Unit, Jerusalem, Israel; [Adawi, F.] Ziv Med Ctr, Endocrinol Unit, Safed, Israel; [Zimlichman, R.] Tel Aviv Community Ctr, Tel Aviv, Israel; [Tsalihin, D.] Ben Yair Community Clin Beer Sheva, Beer Sheva, Israel; [Wainstein, J.] Wolfson Med Ctr, Diabet Unit, Holon, Israel; [Klainman, E.] Gefen Cardiac Hlth Ctr, Giv'atayim, Israel; [Mosseri, M.] Meir Med Ctr, Div Cardiol, Kefar Sava, Israel; [Yerushalmi, Y.] Clalit Tel Aviv Diabet Clin, Tel Aviv, Israel; [Karnieli, E.] Rambam Med Ctr, Inst Endocrinol, Haifa, Israel; [Knobler, H.] Kaplan Med Ctr Metabol Unit, Rehovot, Israel; [Zimlichman, R.] Wolfson Med Ctr Med & Hypertens, Holon, Israel; [Benchetrit, S.] Meir MC Blood Pressure & Nephrol, Kefar Sava, Israel; [Tsur, A.] Clalit Hlth Serv Diabet Clin, Jerusalem, Israel; [Yagil, Y.] Barzilai Med Ctr Nephrol, Ashqelon, Israel; [Lewis, Basil] Lady Davis Carmel Med Ctr, Haifa, Israel; [Atar, S.] Western Galilee Hosp Cardiol, Nahriya, Israel; [Beberashvili, I.] Assaf Harofeh Med Ctr Nephrol, Beer Yaagov, Israel; [Fuchs, S.] Beilinson Med Ctr, Dept Internal Med, Petah Tiqwa, Israel; [Stern, N.] Sourasky Med Ctr, Metabol Unit, Tel Aviv, Israel; [Pollak, A.] Hadassah Med Org, Inst Heart, Jerusalem, Israel; [Chajek-Shaul, T.] Hadassah Hosp Mt Scopus Internal Med, Jerusalem, Israel; [Rozenman, Y.] Wolfson Med Ctr Heart Inst, Holon, Israel; [Biton, A.] Clalit Clin Dimona, Dimona, Israel; [Ardissino, Diego] AOU, Parma, Italy; [Bramucci, E.] OP San Matteo, Pavia, Italy; [Fiscella, A.] AO Cannizzaro, Catania, Italy; [Grassia, V.] POS Maria delle Grazie, Pozzuoli, Italy; [Piatti, P.] Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Piatti, P.] Univ Osped San Raffaele, Milan, Italy; [De Cosmo, S.] Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy; [Di Lorenzo, L.] Osped San Rocco, Sessa Aurunca, Italy; [Merlini, P.] Osped Niguarda Ca Granda, Milan, Italy; [Mannucci, E.] AOU Careggi, Florence, Italy; [Frontoni, S.] Osped Fatebenefratelli, Rome, Italy; [Trevisan, R.] Osped Riuniti Bergamo, I-24100 Bergamo, Italy; [Zenari, L.] Osped Sacro Cuore Don Calabria, Negrar, Italy; [Avogaro, Angelo] AO Padova, Padua, Italy; [Lambiase, C.] Osped Amico Gaetano Fucito, Mercato San Severino, Italy; [Salvioni, A.] Osped Cardiol Monzino, Milan, Italy; [Silvestri, O.] AO Cardarelli, Naples, Italy; [Ambrosio, G.] Osped Santa Maria Terni, Terni, Italy; [Di Bartolo, P.] AUSL Ravenna, Ravenna, Italy; [Fattore, L.] PO San Giuseppe, S Maria Capua Vetere, Italy; [Presbitero, P.] Ist Clin Humanitas, Rozzano, Italy; [Calabrese, M.] AUSL 4, Prato, Italy; [Evola, R.] Osped San Vincenzo USL 5, Taormina, Italy; [Alcocer Gamba, M.] Inst Corazon Queretaro, Queretaro, Mexico; [de los Rios Ibarra, M. Odin] Ctr Desarrollo Med & Asistencia Med Especializada, Culiacan, Mexico; [Cardona Munoz, E.] ICLE SC, Guadalajara, Jalisco, Mexico; [Reyes Sanchez, D.] Cardioprevent SC, Durango, Mexico; [Hernandez Herrera, C.] Ctr Desarrollo Med & Asistencia Med Especializada, Monclova, Mexico; [Perez Rios, J.] Oaxaca Site Management Org, Oaxaca De Juarez, Mexico; [Bayram Llamas, E.] Fdn Cardiovasc Aguascalientes AC, Aguascalientes, Mexico; [Llamas Esperon, G.] Hosp Cardiol Aguascalientes, Aguascalientes, Mexico; [Garcia Cantu, E.] Cardiolink Clin Trials SC, Monterrey, Mexico; Hosp Gen Durango, Durango, Mexico; [Gonzalez Gonzalez, J.] Hosp Univ Dr Jose Eleuterio Gonzalez, Monterrey, Mexico; [Rivera Martinez, G.] Hosp Gen Tijuana, Tijuana, Mexico; [Padilla Padilla, F.] Consultorios Tarascos, Guadalajara, Jalisco, Mexico; [Melendez Mier, G.] Ctr Invest Med Mexico MENTRIALS SA de CV, Mexico City, DF, Mexico; [Herrera Marmolejo, D.] Torre Med Prov, Guadalajara, Jalisco, Mexico; [Garza Ruiz, J.] Internal Med Clin Trials, Monterrey, Mexico; [Caracas Portilla, N.] Hosp Angeles Lindavista, Mexico City, DF, Mexico; [Lopez Rosas, E.] Ctr Especialidades Med Estado Veracruz CEMEV, Xalapa, Veracruz, Mexico; [Aguilar-Salinas, Carlos] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Mendez Machado, G.] Med Este, Xalapa, Veracruz, Mexico; [Chevaile Ramos, J.] Hosp Cent Dr Ignacio Morones Prieto, San Luis Potosi, Mexico; [Rodriguez Briones, I.] Cardioarritmias & Invest SC, San Luis Potosi, Mexico; [van Hessen, M. W. J.] Groene Hart Ziekenhuis Locatie Bleuland, Gouda, Netherlands; [Strikwerda, S.] Amphia Ziekenhuis Locatie Molengracht, Breda, Netherlands; Bethesda Ziekenhuis, Hoogeveen, Netherlands; [Kooy, A.] Bethesda Diabet Res Ctr, Hoogeveen, Netherlands; [Ronner, E.] Reinier de Graaf Gasthuis, Delft, Netherlands; [Nierop, P. R.] St Franciscus Gasthuis, Rotterdam, Netherlands; [Remmen, J. J.] Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; [Groenemeijer, B. E.] Gelre Ziekenhuizen Loc Lukas Ziekenhuis, Apeldoorn, Netherlands; [Hamer, B. J. B.] Meander Med Ctr, Amersfoort, Netherlands; [Basart, D. C. G.] Vasc Onderzoeksctr Hoorn BV, Hoorn, Netherlands; [van Lennep, H. W. O. Roeters] Admiraal Ruyterziekenhuis, Goes, Netherlands; [Nieuwdorp, M.] AMC, Amsterdam, Netherlands; [van Dijk, M. P. M.] Julius Ctr UMCU, Utrecht, Netherlands; [Kentgens, S.] Andromed Eindhoven, Eindhoven, Netherlands; [van Kempen, W. W.] Andromed Rotterdam, Rotterdam, Netherlands; [Hoogendijk, J.] Andromed Oost, Velp, Netherlands; [Spiering, W.] UMCU, Utrecht, Netherlands; [Voors-Pette, C.] Andromed Noord, Groningen, Netherlands; [Kose, V.] Andromed Breda, Breda, Netherlands; [de Waard, D. E. P.] Antonius Ziekenhuis, Sneek, Netherlands; [Gonkel, F.] Saxenburgh Grp Ropcke Zweers Ziekenhuis, Hardenberg, Netherlands; [Kaasjager, H. A. H.] Rijnstate Ziekenhuis, Arnhem, Netherlands; [Lingan, G. M. Rojas] Andromed Zoetermeer, Eindhoven, Netherlands; [Agous, I.] Andromed Leiden, Leiderdorp, Netherlands; [Kruik, H. J.] Ziekenhuis Grp Twente Lokatie Almelo, Almelo, Netherlands; [Imholz, B. P. M.] Tweesteden Ziekenhuis, Waalwijk, Netherlands; [Pieterse, M.] Stichting Cardiol Amsterdam, Amsterdam, Netherlands; [Manrique, H.] Ctr Expertos Diabet Obesidad & Nutr, Lima, Peru; [Medina, Felix] Clin Med Cayetano Heredia, Lima, Peru; [Villena, J.] Hosp Nacl Cayetano Heredia, Lima, Peru; [Leon, L.; Heredia, J.] Clin Anglo Am, Lima, Peru; [Kundert, K.] Ctr Invest Ricardo Palma, Lima, Peru; [Minchola, J.] Clin San Gabriel, Lima, Peru; [Pinto, M.] Clin Oftalmolaser, Lima, Peru; [Rodriguez, A.] Hosp Nacl Alberto Sabogal Sologuren, Callao, Peru; [Guerreros, C.] Clin Int, Lima, Peru; [Berrospi, P.] Clin El Golf, Lima, Peru; [Zubiate, C.] METABOLICARE, Lima, Peru; [Allemant, A.] Hosp Nacl Hipolito Unanue, Lima, Peru; [Arbanil, H.] Hosp Nacl Dos de Mayo, Lima, Peru; [Ponciano, W.] Clin San Borja, Lima, Peru; [Calderon, J.] Clin Novocardio, Lima, Peru; [Lisson, R.] Hosp Nacl Edgardo Rebagliati Martins, Lima, Peru; [Segura, L.] Inst Med Miraflores, Lima, Peru; [Sidorowicz-Bialynicka, A.] Synexus SCM, Wroclaw, Poland; [Sciborski, R.] Zespol Opieki Zdrowotnej Olawie SPZOZ, Olawa, Poland; [Fares, I.] NZOZ Medicus, Naklo Nad Notecia, Poland; [Mader, P.] NZOZ Praktyka Dentystyczno Internistyczna, Kamieniec Zabkowicki, Poland; [Skierkowska, J.] NZOZ JUDYTA, Skierniewice, Poland; [Stasinska, T.] NZOZ Regionalna Poradnia Diabetol, Wroclaw, Poland; [Pomiecko, W.] Samodzielny Niepubl ZOZ Mazur Med, Mragowo, Poland; [Skorski, M.] SPZOZ Lecznej Szpital Powiatowy, Leczna, Poland; [Krzyzagorska, E.] Praktyka Lekarska Ewa Krzyzagorska, Poznan, Poland; [Polaszewska-Muszynska, M.] Bydgoskie Ctr Diabetol & Endokrynol SPZOZ, Bydgoszcz, Poland; [Sowinski, D.] Wroclawiu SP ZOZ, Wojewodzki Zespol Specjalistycznej Opieki Zdrowot, Wroclaw, Poland; [Strojek, K.] Wojewodzka Przychodnia Chorych Cukrzyce, Zabrze, Poland; [Rosinska-Migda, J.] NZOZ Mig Med, Wabrzezno, Poland; [Romanczuk, P.] NZOZ Gdanska Poradnia Cukrzycowa, Gdansk, Poland; [Golebiowski, G.] Szpital Specjalisty Sw Wojciecha Adalberta SP ZOZ, Gdansk, Poland; [Kubica, J.] NZOZ MEDICUS Jacek Kubica, Bydgoszcz, Poland; [Mazurek, T.] I Katedra & Klin Kardiol Akad Med, Warsaw, Poland; [Wojnowski, L.] Lecznice Citomed, Torun, Poland; [Pasternak, D.] NZOZ Ctr Zdrowia & Profilaktyki Dabie, Krakow, Poland; [Stachlewski, P.] NZOZ Eskulap, Koluszki, Poland; [Trzepla, E.] Ctr Med Warszawskiego Uniwersytetu Med, Warsaw, Poland; [Bogdanowicz, G.] PS ZOZ Wojewodzkie Ctr Med, Opole, Poland; [Uzunow, A.] Przychodnia Med Rodzinnej Nowy Fordon, Bydgoszcz, Poland; [Potakowska, I.] Zespol Poradni Zdrowie NZOZ, Sieradz, Poland; [Miszczyszyn, Z.] Prywatny Specjalisty Gabinet Lekarski, Przemysl, Poland; [Waszyrowski, T.] Wojewodzka Stacja Ratownictwa Med Lodzi SPZOZ, Lodz, Poland; [Smolenskaya, O.] Hosp 14 Ural State Med Acad Ekat, Ekaterinburg, Russia; [Lukyanov, Y.] State Med Univ Na Pavlov, St Petersburg, Russia; [Vorokhobina, N.] Chair Endocrinol Med Postgrad Acad, St Petersburg, Russia; [Khalimov, Y.] Endocrinol NII Med Postgrad Acad, St Petersburg, Russia; [Orlikova, O.] Res Inst Cardiol Saratov, Saratov, Russia; [Rebrov, A.] SGMU Na Razumovsky Saratov, Saratov, Russia; [Kukharchuk, V.] Atherosclerosis Problems Dept Cardiocomplex, Moscow, Russia; [Boldueva, S.] Cardiol Clin Mechnikov Med Acad, St Petersburg, Russia; [Arkhipov, M.] MO Novaya Ural State Med Acad Ekat, Ekaterinburg, Russia; [Zhelninova, T.] Out Patient Dep Almazov Fed Ctr, St Petersburg, Russia; [Pavlysh, E.] Out Patient Dept 25, St Petersburg, Russia; [Antsiferov, M.] Moscow Endocrinol Dispensary, Moscow, Russia; [Panov, A.] Cardiol Dep Almazov Fed Ctr, St Petersburg, Russia; [Pavlova, M.] MMA Na Sechenov IM, Moscow, Russia; [Shustov, S.] Mil Med Acad Na Kirov, St Petersburg, Russia; [Demchenko, E.] Rehabil Lab Almazov Fed Ctr, St Petersburg, Russia; [Galyavich, A.] KGMU Kazan, Kazan, Russia; [Malakhina, E.] Ctr New Med Technol Novosibirsk, Novosibirsk, Russia; [Semenova, O.] Alexandrovskaya City Hosp, St Petersburg, Russia; [Kobalava, Z.] City Clin Hosp 64, Moscow, Russia; [Shestakova, Marina] Inst Diabet Sci Ctr Endocri, Moscow, Russia; [Kotova, S.] Chair Endocrinol Mechnikov Med Acad, St Petersburg, Russia; [Gavrisheva, I.] OOO AVA Peter, St Petersburg, Russia; [Oschepkova, E.] Arterial Hypertens Dept Cardiocomplex, Moscow, Russia; [Karpov, Y.] Angiol Dept Cardiocomplex, Moscow, Russia; [Sidorenko, B.] Cent Clin Hosp, Moscow, Russia; [Kislyak, O.] City Clin Hosp 79, Moscow, Russia; [Ametov, A.] Chair Endocrinol RMAPO, Moscow, Russia; [Dreval, A.] Moscow Res Clin Inst Na Vladimirsky, Moscow, Russia; [Grineva, E.] Endocrinol Inst Almazov Fed Ctr, St Petersburg, Russia; [Mkrtumyan, A.] MGMSU, Moscow, Russia; [Tyurina, T.] Leningrad Reg Cardiol Dispensary, St Petersburg, Russia; [Sazonova, O.] Novosibirsk State Med Univ, Novosibirsk, Russia; [Ranjith, N.] Dr Nash Ranjith Res Ctr, Durban, South Africa; [Burgess, L.] TREAD Res Tygerberg Hosp, Parow, South Africa; [Nortje, H.] Unit B1 N1 City Mews, Cape Town, South Africa; [Distiller, L.] Ctr Diabet & Endocrinol, Johannesburg, South Africa; [Mitha, I.] Worthwhile Clin Trials Lakeview Hosp, Benoni, South Africa; [Moore, R.] 14 Medigate Med Ctr, Umhlanga Rocks, South Africa; [Conradie, M.] Tygerberg Hosp, Endocrine Unit, Parow, South Africa; [Horak, A.] Vincent Pallotti Hosp, Pinelands, South Africa; [Pillay, S.] Dr SR Pillay Practice, Ottawa, Verulam, South Africa; [Wellmann, H.] Helderberg Diabat & Med Ctr, Cape Town, South Africa; [Berg, E.] Dr EC Van den Berg Practice Zuid Afrikaans Hosp, Pretoria, South Africa; [Pillai, P.] Drs Chetty & Pillai Med Ctr, Phoenix, South Africa; [Padayachee, T.] Aliwal Shoal Med Ctr, Umkomaas, South Africa; [Corbett, C.] Panorama Mediclin, Cape Town, South Africa; [Makan, H.] Seva Sadan, Lenasia, South Africa; [Wing, J.] Charlotte Maxeke Johannesburg Acad Hosp, Johannesburg, South Africa; [Vawda, Z.] Dr ZFA Vawdas Practice, Durban, South Africa; [Ebrahim, I.] Unitas Hosp, Centurion, South Africa; [Dalby, A.] Milpark Hosp, Johannesburg, South Africa; [Mitha, E.] Newgate Ctr, Johannesburg, South Africa; [Bhorat, A.] Soweto Clin Trial Ctr, Soweto, South Africa; [Cruz Fernandez, J.] Hosp Univ Virgen Macarena, Seville, Spain; [Munoz, C.] Hosp Gen Jerez de la Frontera, Jerez De La Frontera Cad, Spain; [Bruguera Cortada, J.] Hosp del Mar, Barcelona, Spain; [Castro Conde, A.] Hosp Cantoblanco La Paz, Madrid, Spain; [Calvo, C.] Hosp Univ Santiago, Santiago De Compostela, Spain; [Gil Extremera, B.] Hosp Clin San Cecilio, Granada, Spain; [Delgado, E.] Hosp Univ Cent Asturias, Oviedo, Spain; [Masmiquel, L.] Hosp Son Llatzer, Palma de Mallorca, Spain; [Garcia Puig, J.] Hosp Univ La Paz, Madrid, Spain; [de Teresa Parreno, L.] Clin Mediterranea Neurociencias, Alicante, Spain; [Mauricio, D.] Hosp Arnau Vilanova, Lerida, Spain; [Redon, J.] Hosp Clin Univ Valencia, Valencia, Spain; [Brito, M.] Hosp Univ Puerta Hierro Majadahonda, Majadahonda Madrid, Spain; [Lopez, C.] Ctr Salud El Cristo, Oviedo, Spain; [Segura de la Morera, J.] Hosp Univ Doce de Octubre, Madrid, Spain; [Linderfalk, C.] Redeby Eksjo, Eksjo, Sweden; [Larnefeldt, H.] Rattvikshalsan, Rattvik, Sweden; [Olsson, A.] Sthlm Heart Ctr, Stockholm, Sweden; [Lonneborg, L.; Albin, J.] Sorakers Vardcent, Soraker, Sweden; [Ekelund, M.] Hbg Lasarett, Helsingborg, Sweden; [Samad, B.] Danderyd, Stockholm, Sweden; [Borgencrantz, B.] Capio Lakargrp AB Orebro, Orebro, Sweden; [Nilsson, J.] Skanes Univ Sjukhus Malmo, Malmo, Sweden; [Berglund, O.] Alidhem Umea, Umea, Sweden; [Svensson, M.] SU SS Gbg, Gothenburg, Sweden; [Mooe, T.] Ostersunds Sjukhus, Ostersund, Sweden; [Alvarsson, Michael] KS Solna, Stockholm, Sweden; [Curiac, D.] Me3and Gbg, Stockholm, Sweden; [Angesjo, E.] Bramhults VC, Bramhult, Sweden; [Lannemyr, O.] Lanssjukhuset Ryhov, Jonkoping, Sweden; [Dellborg, Mikael] SU Ostra Gbg, Gothenburg, Sweden; [Chiang, C.] Taipei Vet Gen Hosp, Taipei, Taiwan; [Sheu, W.] Taichung Vet Gen Hosp, Taichung, Taiwan; [Chen, J.] Chang Gung Med Fdn Kaohsiung Branch, Kaohsiung, Taiwan; [Tien, K.] Chi Mei Med Ctr, Tainan, Taiwan; [Ueng, K.] Chung Shan Med Univ Hosp, Taichung 40201, Taiwan; [Lai, W.] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Yin, W.] Cheng Hsin Gen Hosp, Taipei, Taiwan; [Hung, Y.] Tri Serv Gen Hosp, Taipei, Taiwan; [Shyu, K.] Shin Kong Wu Ho Su Mem Hosp, Taipei, Taiwan; [Hou, J.] Mackay Mem Hosp, Taipei, Taiwan; [Lam, H.] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan; [Laothavorn, P.; Benjasuratwong, Y.] Phramongkutklao Hosp, Bangkok, Thailand; [Sritata, Piyamitr] Ramathibodi Hosp, Bangkok, Thailand; [Kuanprasert, S.] MaharajNakornChiangMai Hosp, Chiangmai, Thailand; [Deerochanawong, Chaicharn] Rajavithi Hosp, Bangkok, Thailand; [Khovidhunkit, W.] King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Chotinaiwattarakul, C.; Nitiyanant, W.] Siriraj Hosp, Bangkok, Thailand; [Mamanasiri, S.] Ratchaburi Hosp, Ratchaburi, Thailand; [Suraamornkul, S.] Vajira Hosp, Bangkok, Thailand; [Pratipanawatr, T.] Srinagarind Hosp, Khon Kaen, Thailand; [Pieters, R.] Estuary View Med Ctr, Whitstable, England; [Strang, C.] Mortimer Surg, Mortimer Reading, England; [Bodalia, B.] Gables Med Ctr, Coventry, W Midlands, England; [Middleton, A.] Fowey River Practice, Fowey, England; [Hall, T.] Knowle House Surg, Plymouth, Devon, England; [Chapman, G.] Sunbury Hlth Ctr, Sunbury On Thames, England; [Calvert, J.] Waterloo Med Ctr, Blackpool, England; [Reed, R.] Westongrove Res Ctr Aston Clinton Surg, Aston Clinton Aylesbur, England; [Tam, D.] Circle Practice, Kenton, England; [Butcher, G.] Ecclesfield Grp Practice, Sheffield, S Yorkshire, England; [Jones, N.] St Chads Surg, Bath, Avon, England; [Takhar, A.] Wansford & Kings Cliffe Practice, Wansford Peterborough, England; [Turner, W.] Burbage Surg, Burbage Leicester, England; [McNally, D.] Ormeau Hlth Ctr, Belfast, Antrim, North Ireland; [Corey, O.] Ave Surg, Warminister, England; [Chapman, J.] Widcombe Surg, Bath, Avon, England; [Mohr, S.] Porch Surg, Bath, Avon, England; [Edwards, S.] Elm Tree Surg, Swindon, Wilts, England; [Ocampo, A.] Future Care Solut LLC, Miami, FL USA; [Kandath, D.] Saratoga Clin Res LLC, Saratoga Springs, NY USA; [Aude, Y.] Valley Heart Consultants, Mcallen, TX USA; [Ervin, W.] InterMed PA, Portland, ME USA; [Savin, V.] Kansas City VA Med Ctr, Kansas City, MO USA; [Anderson, R.] VA Nebraska Western Iowa Healthcare Syst, Omaha, NE USA; [Littlefield, R.] Palmetto Res Ctr LLC, Spartanburg, SC USA; [Oberoi, M.] Cent Jersey Med Res Ctr, Elizabeth, NJ USA; [Yazdani, S.] Virginia Cardiovasc Associates, Manassas, VA USA; [Mangoo-Karim, R.] Gamma Clin Res Inst, Mission, TX USA; [Walder, J.] Black Hills Cardiovasc Res, Rapid City, SD USA; [Gogia, H.] Cardiol Consultants Orange Cty Med Grp Inc, Anaheim, CA USA; [Chandrashekhar, Y.] VA Med Ctr, Minneapolis, MN USA; [Boccalandro, F.] Permian Res Fdn, Odessa, TX USA; [Rogers, W., Jr.] Univ Alabama Birmingham, Med Ctr, Birmingham, AL 35294 USA; [Bilazarian, S.] Pentucket Med Associates, Haverhill, MA USA; [Zieve, F.] McGuire VA Med Ctr, Richmond, VA USA; [Siage, Y.] Deaconess Clin Inc, Evansville, IN USA; [O'Connor, T.] Am Hlth Network Indiana LLC, Greenfield, IN USA; [Mudaliar, S.] VA San Diego Healthcare Syst, San Diego, CA USA; [Nikas, A.] Hlth Texas Res Inst, San Antonio, TX USA; [Giusti, R.] Clin Res Cent Florida, Winter Haven, FL USA; [Glover, R.] Heartland Res Associates LLC, Newton, KS USA; [Chilka, S.] Midland Clin Res Ctr, Midland, TX USA; [French, W.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst Harbor, Torrance, CA 90509 USA; [Roth, E.] Sterling Res Grp Ltd, Cincinnati, OH USA; [Singh, N.] Atlanta Heart Specialists LLC, Cumming, GA USA; [Christofferson, R.] North Ohio Res Ltd, Elyria, OH USA; [Stich, M.] Westside Ctr Clin Res, Jacksonville, FL USA; [Dagogo-Jack, S.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Allison, J., III] Three Rivers Med Associates, Columbia, SC USA; [Zengotita, G. Arroyo] Jardines Loiza, Georgina Arroyo Zengotita Med Familia, Loiza, PR USA; [Ison, R.] Community Hlth Care Inc, Canal Fulton, OH USA; [Iteld, B.] Louisiana Heart Ctr, Slidell, LA USA; [Sulistio, M.; Raskin, P.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Gonzalez, E.] Eastside Clin Res Associates Inc, Los Angeles, CA USA; [Gorman, T.] Great Lakes Med Res, Westfield, NY USA; [Hage-Korban, E.] Kore CV Res, Jackson, TN USA; [Reddy, R.] T&R Clin PA, Ft Worth, TX USA; [Byars, W.] Mt View Clin Res, Greer, SC USA; [Antonishen, M.] Northern Michigan Reg Hosp, Petoskey, MI USA; [Benjamin, S.] Universal Res Grp, Tacoma, WA USA; [First, B.] Ritchken & First MDs, San Diego, CA USA; [Rosado, J.] Florida Heart & Vasc Ctr, Leesburg, FL USA; [Bruschetta, H.] Humberto Rafael Bruschetta, Kingsville, TX USA; [Mehta, P.; Poling, T.] Heartland Res Associates LLC, Wichita, KS USA; [Rosendorff, C.] James J Peters VA Med Ctr, Bronx, NY USA; [Saba, F.] Profess Hlth Care Pinellas Inc, St Petersburg, FL USA; [Willis, J.] San Gabriel Clin Res, Georgetown, TX USA; [Adams, K.] Baptist Heart Specialists, Jacksonville, FL USA; [Vazquez, E. Camilo] Cent Res Clin Puerto Rico, Aguas Buenas, PR USA; [Ellison, H.] Rockdale Med Res Associates, Conyers, GA USA; [Kahn, B.] Overlea Personal Phys, Baltimore, MD USA; [Kereiakes, D.] Christ Hosp, Carl & Edyth Lindner Ctr Res & Educ, Cincinnati, OH 45219 USA; [Powell, S.] PMG Res Bristol, Bristol, TN USA; [Smith, K.] Burke Primary Care, Morganton, NC USA; [Varma, S.] Boice Willis Clin PA, Rocky Mount, NC USA; [Whittier, F.] Clin Res Ltd, Canton, OH USA; [Casanova, R.] South East Med Ctr, Oakland Pk, FL USA; [Isserman, S.] Clin Trials Am Inc, Hickory, NC USA; [Kaye, W.] Metab Res Inst Inc, W Palm Beach, FL USA; [McGuinn, W., II] North Ohio Res Ltd, Sandusky, OH USA; [Bartkowiak, A., Jr.] Blair Med Associates PA, Altoona, PA USA; [Dworkin, L.] Rhode Isl Hosp, Providence, RI USA; [Podlecki, D.] Longmont Med Res Network, Longmont, CO USA; [Popovtzer, M.] Southern Arizona VA Healthcare Syst, Tucson, AZ USA; [Aronoff, S.] Res Inst Dallas PA, Dallas, TX USA; [Ballantyne, C.] Baylor Coll Med, Houston, TX 77030 USA; [Mora, A., III] Southwest Clin, San Antonio, TX USA; [Pitts, T.] Diverse Clin Res Ctr Chicago LLC, Chicago, IL USA; [Reinhardt, S.] Cent Bucks Cardiol, Doylestown, PA USA; [Soucie, G.] Blackfoot Med Ctr, Blackfoot, ID USA; [Wainwright, W.] Baptist Heart Specialists, Jacksonville Beach, FL USA; [Henson, B.] Essentia Inst Rural Hlth, Duluth, MN USA; [Sklaver, N.] Med Specialists Associated, Dallas, TX USA; [Arakaki, R.] Univ Hawaii, Diabet & Endocrinol, Honolulu, HI 96822 USA; [Brown, J.] Internal Med Associates Grand Isl PC, Grand Isl, NE USA; [Chalavarya, G.] Florida Cardiol Grp, Hudson, FL USA; [Dixon, T.] Northport Vet Affairs Med Ctr, Northport, NY USA; [Kutner, M.] Suncoast Res Grp LLC, Miami, FL USA; [Perlman, R.] Associated Cardiovasc Consultants, Voorhess, NJ USA; [Raisinghani, A.] Univ Calif San Diego, Med Ctr, 225 Dickinson St, San Diego, CA 92103 USA; [Salacata, A.] Endeavor Med Res, Alpena, MI USA; [Awasty, V.] Harrison Community Res Ctr, Cadiz, OH USA; [Elinoff, V.] Reg Clin Res Inc, Endwell, NY USA; [George, W.] Cadillac Clin Res LLC, Cadillac, MI USA; [LaRochelle-Gryseels, A.] Sharon Reg Phys Serv, Hermitage, PA USA; [Mercado, A.] Stewart Med Grp, Alhambra, CA USA; [Miller, G.] Clin Res Works, Bristol, CT USA; [Qureshi, M.] Michigan Heart PC, Ypsilanti, MI USA; [Steljes, A.] Steljes Cardiol PC, Henderson, NV USA; [Wefald, F.] Clin Trials Am Inc, Smithfield, NC USA; [Wilson, J.] PMG Res Winston Salem, Winston Salem, NC USA; [Chinn, J.] VA Southern Nevada Hlth Care Syst, N Las Vegas, NV USA; [Chuang, Rita B.] Clin Res Advantage Inc, Henderson, NV USA; [Comulada-Rivera, A.] Inst Endocrinol Diabet & Metab, Bayamon, PR USA; [Hartman, I.] Discovery Clin Trials, Arlington, TX USA; [Narayan, P.] Clin Res Inst Northern Virginia, Burke, VA USA; [Pacheco, T.] North Ohio Res Ltd, Lorain, OH USA; [Weiss, R.] Cent Maine Med Ctr, Lewiston, ME USA; [Beavins, J.] Am Hlth Network Indiana LLC, Franklin, IN USA; [Creevy, J.] Intercoastal Med Grp, Sarasota, FL USA; [Hamroff, G.] NYU Hudson Valley Cardiol, Cortlandt Manor, NY USA; [Hodson, R.] Oregon Clin Gateway, Providence Heart Clin, Portland, OR USA; [Kosinski, E.] Connecticut Clin Res LLC, Bridgeport, CT USA; [Krichmar, P.] Res Phys Network Alliance, Pembroke Pines, FL USA; [Patel, R.] Lycoming Internal Med Inc, Jersey Shore, PA USA; [Schneider, R.] Holy Cross Med Grp, Coral Springs, FL USA; [Shapiro, J.] Philadelphia Hlth Associates Adult Med PC, Philadelphia, PA USA; [Sharp, D.] Clin Res Advantage Inc Internal Med Phys PC, Omaha, NE USA; [Speer, J.] Clin Res Advantage Colorado Springs Hlth Partners, Colorado Springs, CO USA; [Stegemoller, R.] Am Hlth Network Indiana LLC, Avon, IN USA; [Waxman, F.] GSA Med Res, Deerfield Beach, FL USA; [Chang, F. Young] Pasco Cardiol Ctr, Hudson, FL USA; [Braun, E.] Midtown Med Ctr, Tampa, FL USA; [Eder, F.] United Med Associates, Binghamton, NY USA; [Minor, S.] Austin Heart PLLC, San Marcos, TX USA; [Albert, M.] Acadia Clin Res LLC, Bangor, ME USA; [Diaczok, B.] St Joseph Mercy Oakland, Pontiac, MI USA; [Gastman, I.] Waterford Med Associates PC, Waterford, MI USA; [Gupta, V.] Borgess Res Inst Borgess Cardiovasc Res, Kalamazoo, MI USA; [Longshaw, K.] Texas Hlth Phys Grp, Dallas, TX USA; [Gonzalez-Campoy, J. M.] MNCOME Fdn, Eagan, MN USA; [Raikhel, M.] Torrance Clin Res, Lomita, CA USA; [Thomas, J.] Med Univ S Carolina, Charleston, SC 29425 USA; [Wood, K.] Belleville Family Med Associates Ltd, Belleville, IL USA; [Diab, I.] Paramount Med Res & Consulting LLC, Middleburg Hts, OH USA; [Furda, J.] Minneapolis Heart Inst, Baxter, MN USA; [Gelernt, M.] Cardiovasc Associates Delaware Valley PA, Elmer, NJ USA; [Halter, M.] Ilumina Clin Associates, Tyrone, PA USA; [House, B.] Am Hlth Network Indiana LLC, Fishers, IN USA; [Kaster, S.] Wenatchee Valley Med Ctr, Wenatchee, WA USA; [Raad, G.] PMG Res Charlotte, Charlotte, NC USA; [Stamatin, R.] Remedica LLC, Rochester, MI USA; [Barker, B.] Delaware Smith Clin, Delaware, OH USA; [Blonder, R.] Colorado Hlth Med Grp, Colorado Springs, CO USA; [Calderon, R. Burgos] RCMI Clin Res Ctr, Rio Piedras, PR USA; [Carrol, A.] Ctr Thyroid Dis & Endocrinol, Beachwood, OH USA; [Comerota, A.] Jobst Vasc Ctr, Toledo, OH USA; [Feinglos, M.] Duke Univ, Med Ctr, Durham, NC USA; [Henderson, D.] Cardiol Res Associates, Daytona Beach, FL USA; [Kastelic, R.] Ilumina Clin Associates, Johnstown, PA USA; [Talano, J.] Southwest Florida Res LLC, Naples, FL USA; [Lee, P. Ver] EMMC Northeast Cardiol Associates, Bangor, ME USA; [Brosseau, J.] Altru Hlth Syst, Grand Forks, ND USA; [Clark, W.] Oregon Hlth & Sci Univ, Oregon Stroke Ctr, Portland, OR 97201 USA; [Cohen, E.] Metab Res Inst, Boynton Beach, FL USA; [Fialkow, J.] Cardiovasc Res Ctr South Florida, Miami, FL USA; [Horton, K.] IMED Healthcare Associated PLLC, San Antonio, TX USA; [Kozman, H.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [McGill, J.] Washington Univ, St Louis, MO USA; [Mihills, C.] Southlake Clin Trials, Southlake, TX USA; [Poonawala, R.] Family Practice Ctr South, Austin, TX USA; [Shore, K.] Med Clin North Texas, Plano, TX USA; [Tejada, L.] St Lukes Hosp & Hlth Network, Bethlehem, PA USA; [Torres, R.] Caribbean Clin Trials Corp, San Juan, PR USA; [Wright, W.] Esse Hlth Cardiol Consultants, St Louis, MO USA; [Calatayud, G.] Del Rosario Med Ctr Inc, Huntington Pk, CA USA; [Chandna, H.] Victoria Heart & Vasc Ctr, Victoria, TX USA; [Drozdiak, R.] Ilumina Clin Associates, Clymer, PA USA; [Fink, R.] Diabet & Endocrine Associates, La Mesa, CA USA; [Gill, R.] Virginia Commonwealth Univ, Richmond, VA USA; [Glandt, M.] Bronx Lebanon Hosp Ctr, Bronx, NY 10456 USA; [Hack, T.] Primary Care Cardiol Res Inc, Ayer, MA USA; [Kay, J.] Clin Res Advantage Inc, Ridge Family Practice, Council Bluffs, IA USA; [Mansouri, V.] St Thomas Res Inst, Nashville, TN USA; [McKnight, T.] Prairie Fields Family Med PC, Fremont, NE USA; [Mostel, E.] Palm Beach Gardens Res Ctr LLC, Palm Beach Gardens, FL USA; [Schmidt, L.] Genova Clin Res, Tucson, AZ USA; [Seide, H.] Daytona Heart Grp, Daytona Beach, FL USA; [Sonel, E.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Taylor, R.] North Mem Heart & Vasc Inst, Robbinsdale, MN USA; [Velasquez, M.] George Washington Univ, Med Faculty Associates, Washington, DC USA; [Bretton, E.] Albuquerque Clin Trials Inc, Albuquerque, NM USA; [Feldman, R.] MediQuest Res Grp Inc, Munroe Reg Med Ctr, Ocala, FL USA; [Hartman, A.] Virginia Res Ctr LLC, Midlothian, VA USA; [Hershon, K.] North Shore Diabet & Endocrine Associates, New Hyde Pk, NY USA; [Martin, E.] Martin Diagnost Clin, Tomball, TX USA; [Mohiuddin, F.] Apollo Med Res LTD, Niles, IL USA; [Naygandhi, Y.] Northwest Med Care PA, Houston, TX USA; [Riske, T.] Hayden Lake Family Phys, Hayden Lake, ID USA; [Schima, S.] Creighton Univ, Cardiac Ctr, Omaha, NE 68178 USA; [Uzoaga, E. R.] Oxford Clin Res LLC, Houston, TX USA; [Ward, H.] Clin Res Works LLC, Southington, CT USA; [Weinstock, R.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Williams, T.] Texas Hlth Phys Grp, Irving, TX USA; [Altschuller, A.] Hawthorn Med Associates, N Dartmouth, MA USA; [Aoki, T.] Aoki Diabet Res Inst, Sacramento, CA USA; [Blumenthal, S.] Zablocki VAMC, Milwaukee, WI USA; [Cash, A.] Ilumina Clin Associates, Indiana, PA USA; [Gutmann, J.] Deaconess Clin Inc, Evansville, IN USA; [Hagan, M.] Montana Hlth Res Inst Inc, Billings, MT USA; [Kabour, A.] Cardiovasc Res Ctr LLC, Toledo, OH USA; [Markus, T.] Dayton Heart Ctr, Dayton, OH USA; [McKenzie, W.] M&O Clin Res LLC, Ft Lauderdale, FL USA; [Moursi, M.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Mystkowski, P.] Hope Heart Inst, Bellevue, WA USA; [Ovalle, F.] Univ Alabama Birmingham, Birmingham, AL USA; [Perkins, R.] Texas Hlth Phys Grp, Grapevine, TX USA; [Popeil, L.] Magnolia Res Grp Inc, Ocala, FL USA; [Saniuk, R.] Bellevue Family Practice PC, Clin Res Advantage Inc, Bellevue, NE USA; [Sierra, Y.] Med Interna, Toa Baja, PR USA; [Alvarado, O.] Med Grp Texas, Ft Worth, TX USA; [Anderson, J.] Integris Cardiovasc Phys LLC, Oklahoma City, OK USA; [Bajaj, M.] Baylor Coll Med, Houston, TX 77030 USA; [Blank, R.] Presbyterian Novant Heart & Wellness, Southern Peidmont Primary Care, Monroe, NC USA; [Chu, A.] Amarillo Heart Clin Res Inst Inc, Amarillo, TX USA; [Levinsky, L.] CPL Associates LLC, Buffalo, NY USA; [Levy, P.] Phoenix Endocrinol Clin Ltd, Phoenix, AZ USA; [Osborne, J.] State Heart Cardiol, Grapevine, TX USA; [Pavon, H.] Internal Med Kidney & Hypertens Ctr, Norfolk, VA USA; [Sanderlin, D.] Lone Star Clin Res, Houston, TX USA; [Schaer, G.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Zarich, S.] Bridgeport Hosp, Bridgeport, CT USA; [Atassi, K.] Northwest Indiana Cardiovasc Phys PC, Valparaiso, IN USA; [Bayron, C.] Intervent Cardiac Consultants PLC, Trinity, FL USA; [Casagrande, M.] West Houston Area Clin Trial Consultants LLC, Houston, TX USA; [Das, D.] St Vincent Heart Clin Arkansas, Little Rock, AR USA; [Gimness, M.] Clin Res Cent Florida, Plant City, FL USA; [Handel, F.] Schuster Cardiol Associates Inc, Kettering, OH USA; [Kinstrey, T.] Family Med Clin, Shreveport, LA USA; [Leu, S.] Baptist Heart Specialists, Jacksonville, FL USA; [Osei, K.] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Nouel, J. Soba] Jose M Soba Med Gen, Juncos, PR USA; [Soltani, Z.] LSU Hlth Sci Ctr, Dept Internal Med, Sect Nephrol & Hypertens, Kenner, LA USA; [Sussman, H.] Icon Clin Trials, Pembroke Pines, FL USA; [Chiu, K.] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Duda, R., Jr.] Oklahoma Heart Inst, Tulsa, OK USA; [Farnsworth, K.] Northern Indiana Res Alliance, Ft Wayne, IN USA; [Lano, M.] Ridgeview Res, Chaska, MN USA; [Lee, F.] Guthrie Clin Ltd, Sayre, PA USA; [Lee, F.] Robert Packer Hosp, Sayre, PA USA; [Levin, P.] MODEL Clin Res, Baltimore, MD USA; [Pratt, S.] West Coast Res LLC, San Ramon, CA USA; [Richwine, R.] Hlth Phys Grp, Ft Worth, TX USA; [Ruiz-Rivera, L.] Endocrine Lipid Diabet Res Inst, Ponce, PR USA; [Turner, J.] Cardiac Wellness Consultants SC, Chicago, IL USA; [Wood, J.] Texas Hlth Phys Grp, Richardson, TX USA; [Colon, Carlos Benitez] Dr Carlos Benitez Colon Med Interna, San Juan, PR USA; [Demattia, J.] JVC Family Med, Houston, TX USA; [Desai, V.] Charles River Med Associates, Natick, MA USA; [Fitz-Patrick, D.] East West Med Res Inst, Honolulu, HI USA; [Goral, S.] Univ Penn, Philadelphia, PA 19104 USA; [Odhav, A.] West Houston Area Clin Trial Consultants LLC, Houston, TX USA; [Prentiss, A.] Prentiss Family Med, Colleyville, TX USA; [Ruff, C.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Wu, W.] Cent Cardiovasc Res Fdn, San Antonio, TX USA; [Wyne, K.] Methodist Hosp, Res Inst, 6535 Fannin, Houston, TX 77030 USA; [Applegate, R.] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC 27109 USA; [Cabral, J.] Cleveland Clin Florida, Weston, FL USA; [Kotha, P.] Purushotham & Akther Kotha MD Inc, La Mesa, CA USA; [Ortega, P.] Cent Florida Primary Care, Winter Pk, FL USA; [Simmons, D.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; AstraZeneca; Bristol-Myers Squibb; Hebrew University of Jerusalem; St Georges University London; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Buenos Aires; Geelong Hospital; Gold Coast University Hospital; St Vincent's Hospital Melbourne; Australian National University; Canberra Hospital; Center Clinical & Basic Research; Synarc; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Universidade Federal do Parana; Instituto Dante Pazzanese de Cardiologia; Universidade Federal de Sao Paulo (UNIFESP); Laval University; McMaster University; Western University (University of Western Ontario); University of Manitoba; Children's Hospital Research Institute of Manitoba; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Universite de Montreal; London Health Sciences Centre; University of Calgary; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Sherbrooke; Queens University - Canada; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Peking University; Naval Medical University; Tianjin Medical University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Tianjin Medical University; Central South University; Fudan University; Sun Yat Sen University; University Hospital Brno; St Anne's University Hospital Brno (FNUSA-ICRC); University Hospital Hradec Kralove; General University Hospital Prague; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Nantes Universite; CHU de Nantes; CHU de Toulouse; Centre Hospitalier Sud Francilien; CHU Poitiers; Universite de Poitiers; CHU Lyon; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU de Reims; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; Alice Ho Miu Ling Nethersole Hospital; Semmelweis University; Semmelweis University; University of Pecs; Fortis Escorts Hospital; Western Galilee Hospital; Rambam Health Care Campus; Rambam Health Care Campus; Ziv Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; Clalit Health Services; Ben Gurion University; Barzilai Medical Center; Clalit Health Services; Carmel Medical Center; Western Galilee Hospital; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Parma; University Hospital of Parma; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Casa Sollievo Della Sofferenza; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Florence; Azienda Ospedaliero Universitaria Careggi; Ospedali Riuniti di Bergamo; IRCCS Sacro Cuore Don Calabria; University of Padua; Azienda Ospedaliera - Universita di Padova; Antonio Cardarelli Hospital; IRCCS Humanitas Research Hospital; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Hospital Central Dr. Ignacio Morones Prieto; Amphia Hospital; Reinier de Graaf Hospital; Franciscus Gasthuis; Canisius-Wilhelmina Hospital; Gelre Hospitals; Meander Medisch Centrum; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Unilever; Utrecht University; Utrecht University Medical Center; Rijnstate Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Seguro Social de Salud del Peru; Ural State Medical University; Ural State Medical University; Almazov National Medical Research Centre; Almazov National Medical Research Centre; Almazov National Medical Research Centre; Russian Academy of Medical Sciences; Endocrinology Research Centre; Almazov National Medical Research Centre; Novosibirsk State Medical University; Tygerberg Hospital; Tygerberg Hospital; University of Witwatersrand; Hospital Universitario Virgen Macarena; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitario San Cecilio; Central University Hospital Asturias; Hospital Universitari Son Llatzer; Hospital Universitario La Paz; Hospital Clinic Universitari de Valencia; Hospital Puerta de Hierro-Majadahonda; Hospital Universitario 12 de Octubre; Taipei Veterans General Hospital; Taichung Veterans General Hospital; Chi Mei Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Cheng Hsin General Hospital; Tri-Service General Hospital; Shin Kong Wu Ho Su Memorial Hospital; Mackay Memorial Hospital; Kaohsiung Veterans General Hospital; Phramongkutklao Hospital; Mahidol University; Rajavithi Hospital; Chulalongkorn University; Mahidol University; Khon Kaen University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Alabama System; University of Alabama Birmingham; Hunter Holmes McGuire Veterinary Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Christ Hospital - Ohio; Lifespan Health Rhode Island; Rhode Island Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System; Baylor College of Medicine; University of Hawaii System; University of California System; University of California San Diego; Saint Joseph Mercy Health System (SJMHS); Medical University of South Carolina; Minneapolis Heart Institute Foundation; Duke University; Oregon Health & Science University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Washington University (WUSTL); Virginia Commonwealth University; BronxCare Health System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; George Washington University; Creighton University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; Rush University; University System of Ohio; Ohio State University; City of Hope; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; The Methodist Hospital System; The Methodist Hospital - Houston; Wake Forest University; Wake Forest Baptist Medical Center; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, 1400 VFW Pkwy, Boston, MA 02132 USA.	dlbhattmd@post.harvard.edu	Ray, Kausik/Z-2055-2019; Ballantyne, Christie/A-6599-2008; Chiu, Ken/M-6473-2013; STEG, Philippe Gabriel/Z-1567-2019; De Cosmo, Salvatore/J-7420-2016; Nicolau, Jose C/E-1487-2012; Bandeira, Francisco/AAO-1702-2020; Mauricio, Didac/B-7951-2009; Kislyak, Oxana Andreevna/K-8235-2018; Mudaliar, Sunder/R-2781-2019; Di Bartolo, Paolo/AAL-5954-2021; Galyavich, Albert/L-6327-2015; Tomlinson, Brian/P-5365-2015; Piatti, Piermarco/AAN-3115-2020; Del Prato, Stefano/K-3405-2016; Leiter, Lawrence/AAG-4059-2020; Avogaro, Angelo/S-3808-2016; Kobalava, Zhanna/S-3842-2016; Hramiak, Irene/G-3305-2011; Delgado, Elias/B-2634-2013; Redon, Josep/L-5997-2019; Kastelein, John/AAF-7950-2020; Arkhipov, Mikhail V/Q-2316-2015; Ametov, Alexander/ABI-5129-2020; Salinas, Carlos A Aguilar/AAL-4491-2020; Dreval, Alexander V/F-9632-2017; Lerch, Markus M./E-2206-2016; Mannucci, Edoardo/K-6749-2016; Muirhead, Norman/G-3337-2011; Blombery, Peter/AAR-1849-2020; McGuire, Darren K./AAL-4172-2021; Kubica, Jacek/D-6906-2014; Svensson, Maria Eriksson/AAN-6059-2021; Srinivas, ANS/W-5377-2019; Ovalle, Fernando/Q-6647-2019; Svacina, Stepan/C-1962-2017; Ambrosio, Giuseppe/C-6596-2013; Desai, Akshay/ABE-7250-2020; Colquhoun, David M/F-9078-2013; REDON, JOSEP/E-1719-2019; Couffinhal, Thierry/M-6857-2014; Ardissino, Diego/AAC-4041-2022; Grineva, Ele N./V-8221-2018; Tomlinson, Brian/AAD-9404-2019; Mudaliar, Sunder/N-5813-2019; Miller, Elzbieta Dorota/S-9249-2016; Boldueva, Svetlana/AAH-3862-2019; Del+Prato, Stefano/AAC-9197-2021; Řiháček, Ivan/F-7871-2017; Ma, Ronald/C-2788-2009; Gutmann, Jochen/A-5103-2009	Chiu, Ken/0000-0002-2226-1039; De Cosmo, Salvatore/0000-0001-8787-8286; Nicolau, Jose C/0000-0002-9680-3689; Mauricio, Didac/0000-0002-2868-0250; Kislyak, Oxana Andreevna/0000-0002-2028-8748; Del Prato, Stefano/0000-0002-5388-0270; Delgado, Elias/0000-0001-6114-9712; Redon, Josep/0000-0001-8777-6773; Arkhipov, Mikhail V/0000-0002-7924-7668; Lerch, Markus M./0000-0002-9643-8263; Mannucci, Edoardo/0000-0001-9759-9408; Kubica, Jacek/0000-0001-8250-754X; Svensson, Maria Eriksson/0000-0001-7545-5585; Ovalle, Fernando/0000-0002-6711-071X; Svacina, Stepan/0000-0002-0894-4116; Ambrosio, Giuseppe/0000-0002-9677-980X; Couffinhal, Thierry/0000-0002-9217-2533; Tomlinson, Brian/0000-0001-6717-5444; Miller, Elzbieta Dorota/0000-0002-7029-1857; Boldueva, Svetlana/0000-0002-1898-084X; Řiháček, Ivan/0000-0003-2434-5807; Ma, Ronald/0000-0002-1227-803X; Abhayaratna, Walter/0000-0002-4908-0641; Gutmann, Jochen/0000-0002-1394-9202; A. Samad, Bassem/0000-0001-9440-5073; Bhorat, Asad/0000-0002-8764-7020; Ballantyne, Christie/0000-0002-6432-1730; Oschepkova, Elena/0000-0003-4534-9890; STEG, Philippe Gabriel/0000-0001-6896-2941; ELBAZ, Meyer/0000-0002-3520-7883; AVOGARO, ANGELO/0000-0002-1177-0516; Mazurek, Tomasz/0000-0002-3693-8741; Krempf, Michel/0000-0002-4353-9511; Mansouri, Vahid/0000-0001-8472-9058; Ametov, A.S./0000-0002-7936-7619; Udell, Jacob/0000-0001-7402-9584	AstraZeneca; Bristol-Myers Squibb	AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb)	Funded by AstraZeneca and Bristol-Myers Squibb	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bhatt DL, 2007, AM HEART J, V154, P402; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Food and Drug Administration, 2010, STAND DEF END POINT; Food and Drug Administration, 2008, GUID IND DIAB MELL E; Frederich R, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.05.2138; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Glassock RJ, 2010, AM J NEPHROL, V31, P462, DOI 10.1159/000313553; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Inzucchi SE, 2008, CIRCULATION, V117, P574, DOI 10.1161/CIRCULATIONAHA.107.735795; Kahn SE, 2013, DIABETES, V62, P2178, DOI 10.2337/db13-0520; Khan MA, 2013, HEART FAIL REV, V18, P141, DOI 10.1007/s10741-012-9318-y; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; McMURRAY J., 2013, HEART FAIL C 2013 LI; Monami M, 2013, DIABETES OBES METAB, V15, P112, DOI 10.1111/dom.12000; Mosenzon O, 2013, DIABETES-METAB RES, V29, P417, DOI 10.1002/dmrr.2413; Nauck MA, 2013, DIABETES CARE, V36, P2126, DOI 10.2337/dc12-2504; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Scheen AJ, 2013, NAT REV CARDIOL, V10, P73, DOI 10.1038/nrcardio.2012.183; Scirica BM, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.006; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Udell JA, 2012, CLIN CARDIOL, V35, P722, DOI 10.1002/clc.22032	35	2404	2508	10	431	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1317	1326		10.1056/NEJMoa1307684	http://dx.doi.org/10.1056/NEJMoa1307684			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	23992601	Green Published, Bronze			2022-12-28	WOS:000325111200009
J	Manzanillo, PS; Ayres, JS; Watson, RO; Collins, AC; Souza, G; Rae, CS; Schneider, DS; Nakamura, K; Shiloh, MU; Cox, JS				Manzanillo, Paolo S.; Ayres, Janelle S.; Watson, Robert O.; Collins, Angela C.; Souza, Gianne; Rae, Chris S.; Schneider, David S.; Nakamura, Ken; Shiloh, Michael U.; Cox, Jeffery S.			The ubiquitin ligase parkin mediates resistance to intracellular pathogens	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DEFICIENT MICE; BODY FORMATION; AUTOPHAGY; DROSOPHILA; P62/SQSTM1; MITOPHAGY; DISEASE; SUSCEPTIBILITY; ASSOCIATIONS	Ubiquitin-mediated targeting of intracellular bacteria to the autophagy pathway is a key innate defence mechanism against invading microbes, including the important human pathogen Mycobacterium tuberculosis. However, the ubiquitin ligases responsible for catalysing ubiquitin chains that surround intracellular bacteria are poorly understood. The parkin protein is a ubiquitin ligase with a well-established role in mitophagy, and mutations in the parkin gene (PARK2) lead to increased susceptibility to Parkinson's disease. Surprisingly, genetic polymorphisms in the PARK2 regulatory region are also associated with increased susceptibility to intracellular bacterial pathogens in humans, including Mycobacterium leprae and Salmonella enterica serovar Typhi, but the function of parkin in immunity has remained unexplored. Here we show that parkin has a role in ubiquitin-mediated autophagy of M. tuberculosis. Both parkin-deficient mice and flies are sensitive to various intracellular bacterial infections, indicating parkin has a conserved role in metazoan innate defence. Moreover, our work reveals an unexpected functional link between mitophagy and infectious disease.	[Manzanillo, Paolo S.; Watson, Robert O.; Souza, Gianne; Cox, Jeffery S.] Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA; [Ayres, Janelle S.] Salk Inst Biol Studies, Immunobiol & Microbial Pathogenesis Lab, La Jolla, CA 92037 USA; [Collins, Angela C.; Shiloh, Michael U.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Rae, Chris S.] Univ Calif Berkeley, Dept Mol & Cellular Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Schneider, David S.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Nakamura, Ken] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Nakamura, Ken] Univ Calif San Francisco, Grad Program Biomed Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Salk Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cox, JS (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA.	jeffery.cox@ucsf.edu	Shiloh, Michael/AAS-8883-2020	Shiloh, Michael/0000-0003-4329-2253; Nakamura, Ken/0000-0002-9192-182X; Collins, Angela/0000-0001-6392-7151	National Institutes of Health [R01 AI081727, P01 AI063302, R01 AI099439]; NINDS [P30NS069496]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537, R01AI099439, R01AI081727, P01AI063302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Mizushima, S. Cherry, and K. Huynh for mice and reagents. We are grateful to S. Johnson for use of his microscope, members of the Schneider laboratory for assistance with fly work and D. Portnoy, R. Vance and S. Virgin for helpful discussions. This work was supported by National Institutes of Health grants R01 AI081727, P01 AI063302 and R01 AI099439, and NINDS P30NS069496 to K.N.	Ali S, 2006, CLIN EXP IMMUNOL, V144, P425, DOI 10.1111/j.1365-2249.2006.03087.x; Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Chopra R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003578; Collins CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000430; de Leseleuc L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002015; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Johnson BN, 2012, P NATL ACAD SCI USA, V109, P6283, DOI 10.1073/pnas.1113248109; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moy RH, 2013, J INNATE IMMUN, V5, P444, DOI 10.1159/000350326; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	39	364	376	4	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 26	2013	501	7468					512	+		10.1038/nature12566	http://dx.doi.org/10.1038/nature12566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24005326	Green Accepted, Green Submitted			2022-12-28	WOS:000324826300050
J	Sliwkowski, MX; Mellman, I				Sliwkowski, Mark X.; Mellman, Ira			Antibody Therapeutics in Cancer	SCIENCE			English	Review							GROWTH-FACTOR RECEPTOR; METASTATIC BREAST-CANCER; CELL LUNG-CANCER; DRUG CONJUGATE; GEMTUZUMAB OZOGAMICIN; TRASTUZUMAB EMTANSINE; MONOCLONAL-ANTIBODIES; EFFECTOR FUNCTIONS; COLORECTAL-CANCER; CYTOTOXIC DRUG	In a relatively short period of time, monoclonal antibodies have entered the mainstream of cancer therapy. Their first use was as antagonists of oncogenic receptor tyrosine kinases, but today monoclonal antibodies have emerged as long-sought vehicles for the targeted delivery of potent chemotherapeutic agents and as powerful tools to manipulate anticancer immune responses. With ever more promising results from the clinic, the future will likely see continued growth in the discovery and development of therapeutic antibodies and their derivatives.	[Sliwkowski, Mark X.; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Sliwkowski, MX (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	marks@gene.com; mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020					Astsaturov I, 2006, CURR CANCER DRUG TAR, V6, P691, DOI 10.2174/156800906779010191; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Castaigne S, 2013, BLOOD, V121, P4813, DOI 10.1182/blood-2013-05-498683; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Erickson HK, 2012, MOL CANCER THER, V11, P1133, DOI 10.1158/1535-7163.MCT-11-0727; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Garrett CR, 2011, EXPERT OPIN BIOL TH, V11, P937, DOI 10.1517/14712598.2011.582464; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840; Herbst RS, 2013, J CLIN ONCOL S, V31; Hirsch FR, 2013, J THORAC ONCOL, V8, P373, DOI 10.1097/JTO.0b013e31827ed0ff; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hurvitz SA, 2012, CLIN CANCER RES, V18, P3478, DOI 10.1158/1078-0432.CCR-11-2294; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kubota T, 2009, CANCER SCI, V100, P1566, DOI 10.1111/j.1349-7006.2009.01222.x; LEWIS GD, 1993, CANCER IMMUNOL IMMUN, V37, P255, DOI 10.1007/BF01518520; LoRusso PM, 2011, CLIN CANCER RES, V17, P6437, DOI 10.1158/1078-0432.CCR-11-0762; Mathas S, 2000, CANCER RES, V60, P7170; McCormack E, 2013, CANCER IMMUNOL IMMUN, V62, P773, DOI 10.1007/s00262-012-1384-4; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Okeley NM, 2010, CLIN CANCER RES, V16, P888, DOI 10.1158/1078-0432.CCR-09-2069; Olafsen Tove, 2012, Methods Mol Biol, V907, P537, DOI 10.1007/978-1-61779-974-7_31; Park S, 2010, CANCER CELL, V18, P160, DOI 10.1016/j.ccr.2010.06.014; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Ricart AD, 2011, CLIN CANCER RES, V17, P6417, DOI 10.1158/1078-0432.CCR-11-0486; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Rispens T, 2013, MOL IMMUNOL, V53, P35, DOI 10.1016/j.molimm.2012.06.012; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Sievers EL, 2001, CURR OPIN ONCOL, V13, P522, DOI 10.1097/00001622-200111000-00016; Simpson TR, 2013, J EXP MED; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Weickhardt AJ, 2012, J CLIN ONCOL, V30, P1505, DOI 10.1200/JCO.2011.38.6599; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wolf E, 2005, DRUG DISCOV TODAY, V10, P1237, DOI 10.1016/S1359-6446(05)03554-3; Younes A, 2010, NEW ENGL J MED, V363, P1812, DOI 10.1056/NEJMoa1002965	60	410	455	17	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2013	341	6151					1192	1198		10.1126/science.1241145	http://dx.doi.org/10.1126/science.1241145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031011				2022-12-28	WOS:000324248800031
J	Yen, KY; Vinayachandran, V; Pugh, BF				Yen, Kuangyu; Vinayachandran, Vinesh; Pugh, B. Franklin			SWR-C and INO80 Chromatin Remodelers Recognize Nucleosome-free Regions Near+1 Nucleosomes	CELL			English	Article							ACTIN-RELATED PROTEINS; VARIANT HISTONE H2A.Z; CRYSTAL-STRUCTURE; BUDDING YEAST; COMPLEX; GENOME; TRANSCRIPTION; PROMOTERS; GENES; DNA	SWR-C/SWR1 and INO80 are multisubunit complexes that catalyze the deposition and removal, respectively, of histone variant H2A.Z from the first nucleosome at the start of genes. How they target and engage these +1 nucleosomes is unclear. Using ChIP-exo, we identified the subnucleosomal placement of 20 of their subunits across the yeast genome. The Swc2 subunit of SWR-C bound a narrowly defined region in the adjacent nucleosome-free region (NFR), where it positioned the Swr1 subunit over one of two sites of H2A.Z deposition at +1. The genomic binding maps suggest that many subunits have a rather plastic organization that allows subunits to exchange between the two complexes. One outcome of promoting H2A/H2A.Z exchange was an enhanced turnover of entire nucleosomes, thereby creating dynamic chromatin at the start of genes. Our findings provide unifying concepts on how these two opposing chromatin remodeling complexes function selectively at the +1 nucleosome of nearly all genes.	[Yen, Kuangyu; Vinayachandran, Vinesh; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	bfp2@psu.edu	Vinayachandran, Vinesh/ABD-6386-2020	Vinayachandran, Vinesh/0000-0002-2045-6086	NIH [5R01HG4160]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Matt Rossi for valuable suggestions on the figures, Anna Chan-Salis for sequencing, and Yunfei Li for bioinformatics support. This work was funded by NIH grant 5R01HG4160.	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Cheung KLY, 2010, J MOL BIOL, V404, P478, DOI 10.1016/j.jmb.2010.10.003; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Eisen A, 2001, J BIOL CHEM, V276, P3484, DOI 10.1074/jbc.M008159200; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Ganapathi M, 2011, NUCLEIC ACIDS RES, V39, P2032, DOI 10.1093/nar/gkq1161; Gerhold CB, 2012, NUCLEIC ACIDS RES, V40, P11036, DOI 10.1093/nar/gks842; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Grigoletto A, 2011, BBA-REV CANCER, V1815, P147, DOI 10.1016/j.bbcan.2010.11.002; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Huber O, 2008, CANCER RES, V68, P6873, DOI 10.1158/0008-5472.CAN-08-0547; Huen J, 2010, BIOCHEM CELL BIOL, V88, P29, DOI [10.1139/o09-122, 10.1139/O09-122]; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Jonsson ZO, 2001, J BIOL CHEM, V276, P16279, DOI 10.1074/jbc.M011523200; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Schermer UJ, 2005, MOL CELL, V19, P279, DOI 10.1016/j.molcel.2005.05.028; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110	55	128	128	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1246	1256		10.1016/j.cell.2013.08.043	http://dx.doi.org/10.1016/j.cell.2013.08.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034248	Bronze, Green Accepted			2022-12-28	WOS:000324239300014
J	O'Dowd, A				O'Dowd, Adrian			Medical data: does patient privacy trump access for research?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com							0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 11	2013	347								f5516	10.1136/bmj.f5516	http://dx.doi.org/10.1136/bmj.f5516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219SC	24026467				2022-12-28	WOS:000324528300003
J	Bhutta, ZA				Bhutta, Zulfiqar A.			Conflict and Polio Winning the Polio Wars	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bhutta, Zulfiqar A.] Sick Kids Ctr Global Child Hlth, Toronto, ON M5G 1X8, Canada; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Aga Khan University	Bhutta, ZA (corresponding author), Sick Kids Ctr Global Child Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	zulfiqar.bhutta@sickkids.ca						[Anonymous], 2013, SCI AM, V308, P12; Bhutta ZA, 2013, BMJ-BRIT MED J, V346, P280, DOI [10.1136/bmj.f280, DOI 10.1136/BMJ.F280]; Larson HJ, 2013, JAMA INTERN MED, V173, P1393, DOI 10.1001/jamainternmed.2013.7191; Mach A, 1999, BRIT MED J, V318, P756, DOI 10.1136/bmj.318.7186.756; SAGEWorking Group on Vaccination in Humanitarian Emergencies, VACCINATION IN ACUTE; World Health Assembly, GLOBAL ERADICATION O; World Health Organization, GLOBAL POLIO ERADICA; World Health Organization, SOMALIA EMERGENCY HE; World Health Organization, ACTION TO STOP POLIO	9	25	25	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					905	906		10.1001/jama.2013.276583	http://dx.doi.org/10.1001/jama.2013.276583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002271				2022-12-28	WOS:000323885700015
J	Castellucci, LA; Cameron, C; Le Gal, G; Rodger, MA; Coyle, D; Wells, PS; Clifford, T; Gandara, E; Wells, G; Carrier, M				Castellucci, Lana A.; Cameron, Chris; Le Gal, Gregoire; Rodger, Marc A.; Coyle, Doug; Wells, Philip S.; Clifford, Tammy; Gandara, Esteban; Wells, George; Carrier, Marc			Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; RANDOMIZED CONTROLLED-TRIALS; INTENSITY WARFARIN THERAPY; ACUTE CORONARY SYNDROME; CASE-FATALITY RATES; PULMONARY-EMBOLISM; LONG-TERM; 1ST EPISODE; RISK; RECURRENCE	Objective To summarise and compare the efficacy and safety of various oral anticoagulants (dabigatran, rivaroxaban, apixaban, and vitamin K antagonists) and antiplatelet agents (acetylsalicylic acid) for the secondary prevention of venous thromboembolism. Design Systematic review and network meta-analysis. Data sources Literature search using Medline (1950 to present), Embase (1980 to present), and the Cochrane Register of Controlled Trials using the OVID interface. Publications from potentially relevant journals were also searched by hand. Review methods Randomised controlled trials of patients receiving anticoagulants, antiplatelet drugs, or placebo or observation for secondary prevention of venous thromboembolism. Selected outcomes were rates of recurrent venous thromboembolism and major bleeding. Two reviewers independently extracted data onto standardised forms. Results 12 articles met our inclusion criteria, with 11 999 patients evaluated for efficacy and 12 167 for safety. All treatments reduced the risk of recurrent venous thromboembolism. Compared with placebo or observation, vitamin K antagonists at a standard adjusted dose (target international normalised ratio 2.0-3.0) showed the highest risk difference (odds ratio 0.07; 95% credible interval 0.03 to 0.15) and acetylsalicylic acid showed the lowest risk difference (0.65; 0.39 to 1.03). Risk of major bleeding was higher with a standard adjusted dose of vitamin K antagonists (5.24; 1.78 to 18.25) than with placebo or observation. Fatal recurrent venous thromboembolism and fatal bleeding were rare. Detailed subgroup and individual patient level data were not available. Conclusions All oral anticoagulants and antiplatelet agents investigated in this analysis were associated with a reduced recurrence of venous thromboembolism compared with placebo or observation, although acetylsalicylic acid was associated with the lowest risk reduction. Vitamin K antagonists given at a standard adjusted dose was associated with the greatest risk reduction in recurrent venous thromboembolism, but also the greatest risk of major bleeding.	[Castellucci, Lana A.; Le Gal, Gregoire; Rodger, Marc A.; Wells, Philip S.; Gandara, Esteban; Carrier, Marc] Univ Ottawa, Div Hematol, Dept Med, Thrombosis Program, Ottawa, ON K1H 8L6, Canada; [Cameron, Chris; Wells, George] Univ Ottawa, Dept Community Med & Epidemiol, Inst Heart, Ottawa, ON K1H 8L6, Canada; [Coyle, Doug] Univ Ottawa, Dept Community Med & Epidemiol, Ottawa, ON K1H 8L6, Canada; [Clifford, Tammy] Canadian Agcy Drugs & Technol Hlth, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa	Carrier, M (corresponding author), Univ Ottawa, Div Hematol, Dept Med, Thrombosis Program, Ottawa, ON K1H 8L6, Canada.	mcarrier@ottawahospital.on.ca	Gandara, Esteban/H-3336-2019	Gandara, Esteban/0000-0003-0313-9174; Coyle, Doug/0000-0003-3492-2268; Rodger, Marc/0000-0001-8166-3487	Heart and Stroke Foundation of Canada; University of Ottawa; Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research; Canadian Network and Centre for Trials Internationally (CANNeCTIN); Heart and Stroke Foundation of Ontario; Canada research chair in venous thromboembolism	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); University of Ottawa; Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Network and Centre for Trials Internationally (CANNeCTIN); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canada research chair in venous thromboembolism	The study did not receive specific funding. MC is a recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada and holds a T2 research chair in cancer and thrombosis from the University of Ottawa. CC is a recipient of a Vanier Canada Graduate Scholarship from the Canadian Institutes of Health Research and has received funding from Canadian Network and Centre for Trials Internationally (CANNeCTIN). MAR is the recipient of a Career Scientist Award from the Heart and Stroke Foundation of Ontario. PSW is a recipient of a Canada research chair in venous thromboembolism.	Ageno W, 2006, J THROMB HAEMOST, V4, P1914, DOI 10.1111/j.1538-7836.2006.02132.x; Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Dans AL, 2013, CIRCULATION, V127, P634, DOI 10.1161/CIRCULATIONAHA.112.115386; Dias S, 2011, 2 NICE DSU; Dias S, 2013, MED DECIS MAKING, V33, P641, DOI 10.1177/0272989X12455847; Fleurence RL, 2007, PHARMACOECONOMICS, V25, P3, DOI 10.2165/00019053-200725010-00002; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Guyatt GH, 2012, CHEST, V141, pE185S, DOI 10.1378/chest.11-2289; Hansen D, 2010, ANAL SOCIAL MEDIA NE; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Higgins J., 2009, COCHRANE HDB SYSTEMA, V5; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Iorio A, 2010, ARCH INTERN MED, V170, P1710, DOI 10.1001/archinternmed.2010.367; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2008, ANN INTERN MED, V149, P698, DOI 10.7326/0003-4819-149-10-200811180-00004; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Prins MH, 2002, THROMB HAEMOSTASIS, V87, P1; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; RIEDEL M, 1982, CHEST, V81, P151, DOI 10.1378/chest.81.2.151; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Segal JB, 2007, ANN INTERN MED, V146, P211, DOI 10.7326/0003-4819-146-3-200702060-00150; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Spiegelhalter D., 2004, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SUDLOW MF, 1992, LANCET, V340, P873; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Thorlund K, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-2; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	51	136	142	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2013	347								f5133	10.1136/bmj.f5133	http://dx.doi.org/10.1136/bmj.f5133			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CL	23996149	Green Published, hybrid			2022-12-28	WOS:000323881600001
J	Schnittman, JD				Schnittman, Jeremy D.			The Curious Behavior of the Milky Way's Central Black Hole	SCIENCE			English	Editorial Material							SAGITTARIUS-A-ASTERISK; GALACTIC-CENTER		NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Schnittman, JD (corresponding author), NASA, Goddard Space Flight Ctr, 8800 Greenbelt Rd, Greenbelt, MD 20771 USA.	jeremy.d.schnittman@nasa.gov						Baganoff FK, 2003, ASTROPHYS J, V591, P891, DOI 10.1086/375145; Baganoff FK, 2001, NATURE, V413, P45, DOI 10.1038/35092510; BONDI H, 1952, MON NOT R ASTRON SOC, V112, P195, DOI 10.1093/mnras/112.2.195; Doeleman SS, 2008, NATURE, V455, P78, DOI 10.1038/nature07245; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Ghez AM, 2008, ASTROPHYS J, V689, P1044, DOI 10.1086/592738; Gillessen S, 2012, NATURE, V481, P51, DOI 10.1038/nature10652; Narayan R, 1998, ASTROPHYS J, V492, P554, DOI 10.1086/305070; Sazonov S, 2012, MON NOT R ASTRON SOC, V420, P388, DOI 10.1111/j.1365-2966.2011.20043.x; Wang QD, 2013, SCIENCE, V341, P981, DOI 10.1126/science.1240755	10	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					964	965		10.1126/science.1243115	http://dx.doi.org/10.1126/science.1243115			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990547				2022-12-28	WOS:000323652300026
J	Markel, H				Markel, Howard			Patents, Profits, and the American People The Bayh-Dole Act of 1980	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The Bayh-Dole Act of 1980 permitted scientists, universities, and businesses to patent and profit from discoveries made through federally funded research. A review of the law's history supports the idea that such policies merit frequent reappraisal and reform. In June, the U.S. Supreme Court issued a unanimous opinion in Association for Molecular Pathology v. Myriad Genetics that invalidated the claim of ownership of the BRCA1 and BRCA2 genes. On one level, the legal contretemps leading up to this decision grew out of the University and Small Business Patent Procedures Act of 1980, commonly known as the Bayh-Dole Act.(1) Sponsored by Senators Birch Bayh (D-IN) and Robert Dole (R-KS), the law reversed decades of government policy by allowing scientists, universities, and small businesses to patent and profit from discoveries they made through federally funded research like Myriad's research ...	Univ Michigan, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Ctr Hist Med, Ann Arbor, MI 48109 USA.							[Anonymous], 2002, ECONOMIST TECHN 1212; Eisenberg RS, 1996, VA LAW REV, V82, P1663, DOI 10.2307/1073686; Schacht W.H., 2012, BAYH DOLE ACT SELECT; Steven A., 2004, J TECHNOLOGY TRANSFE, V29, P93	4	34	34	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					794	796		10.1056/NEJMp1306553	http://dx.doi.org/10.1056/NEJMp1306553			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	208KB	23984726				2022-12-28	WOS:000323676100004
J	May, AE				May, Andreas E.			Antiplatelet therapy after coronary stenting: for how long?	LANCET			English	Editorial Material							EUROPEAN-SOCIETY; TASK-FORCE; THROMBOSIS; PREDICTORS; CARDIOLOGY; DISCONTINUATION; ASSOCIATION; GUIDELINES		Univ Tubingen, Univ Tubingen Hosp, Dept Cardiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	May, AE (corresponding author), Univ Tubingen, Univ Tubingen Hosp, Dept Cardiol, D-72076 Tubingen, Germany.	may_andreas@yahoo.de	Larramendi, Carlos H/D-1539-2011	Larramendi, Carlos H/0000-0001-9017-1900				Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Cutlip DE, 2001, CIRCULATION, V103, P1967; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; May AE, 2008, THROMB HAEMOSTASIS, V99, P487, DOI 10.1160/TH07-11-0680; Mehran R, 2013, LANCET; Riddell JW, 2007, CIRCULATION, V116, pE378, DOI 10.1161/CIRCULATIONAHA.107.726992; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055	12	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1684	1685		10.1016/S0140-6736(13)61756-0	http://dx.doi.org/10.1016/S0140-6736(13)61756-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259PX	24004643				2022-12-28	WOS:000327539900007
J	Collar, RM; Byrne, PJ				Collar, Ryan M.; Byrne, Patrick J.			Prelaminated Free Flap for Auricular Reconstruction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 42-year-old woman presented with nearly complete defects of the left auricular and lateral temporal bone as a result of advanced basal-cell carcinoma. She did not want an adhesive auricular prosthesis and was not a candidate for traditional repair techniques because of trauma and irradiation damage to the postauricular skin. A prelaminated radial forearm free flap was selected for reconstruction. A 42-year-old woman presented with nearly complete defects of the left auricular and lateral temporal bone as a result of advanced basal-cell carcinoma. She did not want an adhesive auricular prosthesis and was not a candidate for traditional repair techniques because of trauma and irradiation damage to the postauricular skin. A prelaminated radial forearm free flap was selected for reconstruction. The term prelamination refers to the surgical introduction of novel tissue to an existing flap in this case, autologous costal cartilage inserted into the patient's forearm (Panel A). After subsequent integration and neovascularization of the added tissue, the multilayered, ...	[Collar, Ryan M.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Byrne, Patrick J.] Johns Hopkins Sch Med, Baltimore, MD USA	University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins Medicine	Collar, RM (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA.								0	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1151	1151		10.1056/NEJMicm1213320	http://dx.doi.org/10.1056/NEJMicm1213320			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047064				2022-12-28	WOS:000324554800013
J	Gagne, JJ; Bykov, K; Choudhry, NK; Toomey, TJ; Connolly, JG; Avorn, J				Gagne, Joshua J.; Bykov, Katsiaryana; Choudhry, Niteesh K.; Toomey, Timothy J.; Connolly, John G.; Avorn, Jerry			Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; CLOPIDOGREL; PRASUGREL; ASPIRIN; THERAPY; PREVENTION; METABOLISM; TICAGRELOR	Objective To evaluate whether smoking status is associated with the efficacy of antiplatelet treatment in the prevention of cardiovascular events. Design Systematic review, meta-analysis, and indirect comparisons. Data sources Medline (1966 to present) and Embase (1974 to present), with supplementary searches in databases of abstracts from major cardiology conferences, the Cumulative Index to Nursing and Allied Health (CINAHL) and the CAB Abstracts databases, and Google Scholar. Study selection Randomized trials of clopidogrel, prasugrel, or ticagrelor that examined clinical outcomes among subgroups of smokers and nonsmokers. Data extraction Two authors independently extracted all data, including information on the patient populations included in the trials, treatment types and doses, definitions of clinical outcomes and duration of follow-up, definitions of smoking subgroups and number of patients in each group, and effect estimates and 95% confidence intervals for each smoking status subgroup. Results Of nine eligible randomized trials, one investigated clopidogrel compared with aspirin, four investigated clopidogrel plus aspirin compared with aspirin alone, and one investigated double dose compared with standard dose clopidogrel; these trials include 74 489 patients, of whom 21 717 (29%) were smokers. Among smokers, patients randomized to clopidogrel experienced a 25% reduction in the primary composite clinical outcome of cardiovascular death, myocardial infarction, and stroke compared with patients in the control groups (relative risk 0.75, 95% confidence interval 0.67 to 0.83). In nonsmokers, however, clopidogrel produced just an 8% reduction in the composite outcome (0.92, 0.87 to 0.98). Two studies investigated prasugrel plus aspirin compared with clopidogrel plus aspirin, and one study investigated ticagrelor plus aspirin compared with clopidogrel plus aspirin. In smokers, the relative risk was 0.71 (0.61 to 0.82) for prasugrel compared with clopidogrel and 0.83 (0.68 to 1.00) for ticagrelor compared with clopidogrel. Corresponding relative risks were 0.92 (0.83 to 1.01) and 0.89 (0.79 to 1.00) among nonsmokers. Conclusions In randomized clinical trials of antiplatelet drugs, the reported clinical benefit of clopidogrel in reducing cardiovascular death, myocardial infarction, and stroke was seen primarily in smokers, with little benefit in nonsmokers.	[Gagne, Joshua J.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gagne, JJ (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Suite 3030, Boston, MA 02120 USA.	jgagne1@partners.org		Toomey, Timothy/0000-0002-3547-8333; Bykov, Katsiaryna/0000-0003-3336-5412	Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham; Women's Hospital and Harvard Medical School	Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham; Women's Hospital and Harvard Medical School	This study was supported by internal funds within the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School.	Aune E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-97; Berger JS, 2009, CIRCULATION, V120, P2337, DOI 10.1161/CIRCULATIONAHA.109.866533; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bowry ADK, 2008, AM J CARDIOL, V101, P960, DOI 10.1016/j.amjcard.2007.11.057; Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53; Cornel JH, 2012, AM HEART J, V164, P334, DOI 10.1016/j.ahj.2012.06.005; Desai NR, 2009, J AM COLL CARDIOL, V53, P1273, DOI 10.1016/j.jacc.2008.12.044; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farid NA, 2010, J CLIN PHARMACOL, V50, P126, DOI 10.1177/0091270009343005; Ferreiro JL, 2012, J AM COLL CARDIOL, V59, pA62; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gurbel PA, 2013, J AM COLL CARDIOL, V62, P505, DOI 10.1016/j.jacc.2013.03.037; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V307, P2495, DOI 10.1001/jama.2012.5930; Higgins J., 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Hochholzer W, 2011, AM HEART J, V162, P518, DOI 10.1016/j.ahj.2011.06.005; Kroon LA, 2007, AM J HEALTH-SYST PH, V64, P1917, DOI 10.2146/ajhp060414; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Rahmioglu N, 2011, PHARMACOGENET GENOM, V21, P642, DOI 10.1097/FPC.0b013e3283498ecf; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Sabatine MS, 2005, AM HEART J, V149, P227, DOI 10.1016/j.ahj.2004.11.006; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Salek FS, 2010, PHARMACOTHERAPY, V30, p154e; Saraff KY, 2006, J AM COLL CARDIOL, V47, p36B; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wells G, 2009, INDIRECT EVIDENCE IN; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	29	47	49	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2013	347								f5307	10.1136/bmj.f5307	http://dx.doi.org/10.1136/bmj.f5307			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SB	24046285	hybrid, Green Published			2022-12-28	WOS:000324828300002
J	Mccoy, R; Smith, S				Mccoy, Rozalina; Smith, Steven			Insulin pumps with a sensor and threshold-suspend reduced nocturnal hypoglycemia in type 1 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mccoy, Rozalina; Smith, Steven] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Mccoy, R (corresponding author), Mayo Clin, Rochester, MN 55905 USA.		Smith, Steven/HDM-9496-2022					Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480	1	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC7	10.7326/0003-4819-159-6-201309170-02007	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042390				2022-12-28	WOS:000325625900006
J	Abe, S				Abe, Shinzo			Japan's strategy for global health diplomacy: why it matters	LANCET			English	Editorial Material							UNIVERSAL HEALTH; CARE				Abe, S (corresponding author), Chiyoda Ku, Tokyo 1000014, Japan.	shiro.konuma@mofa.go.jp						Abe S., 2013, AFR JOINS PARTN JAP; Acuin J, 2011, LANCET, V377, P534, DOI 10.1016/S0140-6736(10)61426-2; Armitage RL, 2012, ANCHORING STABILITY; Boseley S., 2011, GUARDIAN; Dybul M, 2012, RESHAPING GLOBAL HLT; GARRETT L, 2007, FOREIGN AFFAIRS; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Glassman A, 2012, GLOB HEART, V7, P13, DOI 10.1016/j.gheart.2012.01.007; Global Health Innovative Technology Fund, AB GLOB HLTH INN TEC; Government of Japan, 2013, JAP STRAT GLOB HLTH; Government of Japan, JAP ASS PACK AFR TIC; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Kaberuka D, 2011, LANCET, V378, P1904, DOI 10.1016/S0140-6736(11)61820-5; Koumura M, 2007, LANCET, V370, P1983, DOI 10.1016/S0140-6736(07)61726-7; Liden J, 2013, GRAND DECADE GLOBAL; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Nye Joseph S., 2011, FUTURE POWER; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Takemi Keizo, 2011, GAIKO FORUM, V05, P36; Tamiya N, 2011, LANCET, V378, P1183, DOI 10.1016/S0140-6736(11)61176-8; Tricks H., 2010, ECONOMIST	23	18	20	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					915	916		10.1016/S0140-6736(13)61639-6	http://dx.doi.org/10.1016/S0140-6736(13)61639-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VD	24034284				2022-12-28	WOS:000324238000004
J	Evans, T				Evans, Timothy			The Future Hospital Commission	LANCET			English	Editorial Material									Royal Coll Physicians, Future Hosp Commiss, London NW1 4LE, England	Royal College of Physicians	Evans, T (corresponding author), Royal Coll Physicians, Future Hosp Commiss, London NW1 4LE, England.	Linda.Cuthbertson@rcplondon.ac.uk						Fulop N, 2013, BMJ-BRIT MED J, V347, P4711; Future Hospital Commission Royal College of Physicians of London, 2013, FUT HOSP CAR MED PAT; Goddard A, 2012, BMJ-BRIT MED J, V344, P67; Gregory A, 2013, MIRROR          0801; NHS England, 2019, NHS INT PEOPL PLAN; Robert Francis QC, 2013, REP MIDST NHS FDN TR; Royal College of Physicians, 2013, MED REG EMP UNS HER	7	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 14	2013	382	9896					922	924		10.1016/S0140-6736(13)61894-2	http://dx.doi.org/10.1016/S0140-6736(13)61894-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VD	24034285				2022-12-28	WOS:000324238000008
J	Dammacco, F; Sansonno, D				Dammacco, Franco; Sansonno, Domenico			Therapy for Hepatitis C Virus-Related Cryoglobulinemic Vasculitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ESSENTIAL MIXED CRYOGLOBULINEMIA; ANTI-CD20 MONOCLONAL-ANTIBODY; RANDOMIZED CONTROLLED-TRIAL; HCV-INFECTED PATIENTS; GENOTYPE 1 INFECTION; INTERFERON-ALPHA; LONG-TERM; ANTIVIRAL THERAPY; SYSTEMIC VASCULITIS; FOLLICULAR LYMPHOMA	Cryoglobulins are present in about a quarter of patients with hepatitis C; in some, cryoglobulinemia can become symptomatic or even life-threatening. This review summarizes evolving therapy for the disorder, including new therapeutic options that are becoming available. Cryoglobulins are immunoglobulins characterized by their insolubility at low temperatures and their dissolution after rewarming.(1),(2) On the basis of their immunochemical composition, cryoglobulins are classified as either single (type I), consisting of a monoclonal immunoglobulin, or mixed, comprising two or more immunoglobulin isotypes, with (type II) or without (type III) a monoclonal component.(3) For many years, mixed cryoglobulinemia was referred to as essential because of its undefined cause. In the early 1990s, it became evident that more than 90% of patients with mixed cryoglobulinemia were infected with hepatitis C virus (HCV).(4)-(7) The pathophysiology of mixed cryoglobulinemia, as it ...	[Dammacco, Franco; Sansonno, Domenico] Univ Bari, Dept Internal Med & Clin Oncol, Sch Med, Bari, Italy	Universita degli Studi di Bari Aldo Moro	Dammacco, F (corresponding author), Policlin Bari, Dept Internal Med & Clin Oncol, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	francesco.dammacco@uniba.it	Dammacco, Franco/ABG-5728-2020	Dammacco, Franco/0000-0003-2149-5471; SANSONNO, Domenico Ettore/0000-0001-6520-1653	Schering Plough	Schering Plough(Merck & CompanySchering Plough Corporation)	Drs. Dammacco and Sansonno report receiving consulting fees from Schering Plough. No other potential conflict of interest relevant to this article was reported.	AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Alduaij W, 2011, BLOOD, V117, P4519, DOI 10.1182/blood-2010-07-296913; Asselah T, 2010, LIVER INT, V30, P1259, DOI 10.1111/j.1478-3231.2010.02283.x; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; BONOMO L, 1987, AM J MED, V83, P726, DOI 10.1016/0002-9343(87)90904-1; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; Cacoub P, 2005, ARTHRITIS RHEUM-US, V52, P911, DOI 10.1002/art.20958; CASATO M, 1991, BLOOD, V78, P3142; Cavallo R, 2009, J NEUROL, V256, P1076, DOI 10.1007/s00415-009-5072-z; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Chatel-Chaix L, 2010, VIRUSES-BASEL, V2, P1752, DOI 10.3390/v2081752; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; DAMMACCO F, 1994, BLOOD, V84, P3336, DOI 10.1182/blood.V84.10.3336.bloodjournal84103336; DAMMACCO F, 1992, CLIN EXP IMMUNOL, V87, P352, DOI 10.1111/j.1365-2249.1992.tb03001.x; Dammacco F, 2001, EUR J CLIN INVEST, V31, P628, DOI 10.1046/j.1365-2362.2001.00824.x; Dammacco F, 2010, BLOOD, V116, P343, DOI 10.1182/blood-2009-10-245878; De Vita S, 2012, ARTHRITIS RHEUM-US, V64, P843, DOI 10.1002/art.34331; Dumortier J, 2013, J CLIN VIROL, V56, P146, DOI 10.1016/j.jcv.2012.10.009; Fabbrizzi A, 2012, 63 ANN M AM ASS STUD; Fabris M, 2007, RHEUMATOLOGY, V46, P37, DOI 10.1093/rheumatology/kel174; Fan HB, 2009, WORLD J GASTROENTERO, V15, P1636, DOI 10.3748/wjg.15.1636; FERRI C, 1991, INFECTION, V19, P417, DOI 10.1007/BF01726453; FERRI C, 1993, BLOOD, V81, P1132; Ferri C, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-25; Forero-Torres A, 2012, CLIN CANCER RES, V18, P1395, DOI 10.1158/1078-0432.CCR-11-0850; FRANZIN F, 1995, BRIT J HAEMATOL, V90, P548, DOI 10.1111/j.1365-2141.1995.tb05582.x; Friedberg JW, 2009, ASH ANN M, V114, P3472; GOREVIC PD, 1991, SEMIN HEMATOL, V28, P79; Hagenbeek A, 2008, BLOOD, V111, P5486, DOI 10.1182/blood-2007-10-117671; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lake-Bakaar G, 2007, BLOOD, V109, P845, DOI 10.1182/blood-2006-08-041525; Lamprecht P, 2012, HCV INFECT CRYOGLOBU, P307; Landau DA, 2008, ARTHRITIS RHEUM-US, V58, P604, DOI 10.1002/art.23305; Landau DA, 2010, J RHEUMATOL, V37, P615, DOI 10.3899/jrheum.090790; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Levine JW, 2005, J RHEUMATOL, V32, P1164; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Manganelli P, 2005, CLIN RHEUMATOL, V24, P296, DOI 10.1007/s10067-004-1031-3; Marignani Massimo, 2012, World J Gastrointest Pharmacol Ther, V3, P21, DOI 10.4292/wjgpt.v3.i2.21; Mazzaro C, 2011, CLIN EXP RHEUMATOL, V29, P933; MISIANI R, 1992, ANN INTERN MED, V117, P573, DOI 10.7326/0003-4819-117-7-573; MISIANI R, 1994, NEW ENGL J MED, V330, P751, DOI 10.1056/NEJM199403173301104; Morschhauser F, 2009, J CLIN ONCOL, V27, P3346, DOI 10.1200/JCO.2008.19.9117; Nooka A, 2011, CL LYMPH MYELOM LEUK, V11, P379, DOI 10.1016/j.clml.2011.04.005; Pawlotsky Jean-Michel, 2012, F1000 Biol Rep, V4, P5, DOI 10.3410/B4-5; Perico N, 2009, CLIN J AM SOC NEPHRO, V4, P207, DOI 10.2215/CJN.03710708; Petrarca A, 2010, BLOOD, V116, P335, DOI 10.1182/blood-2009-11-253948; Pietrogrande M, 2011, AUTOIMMUN REV, V10, P444, DOI 10.1016/j.autrev.2011.01.008; Pons-Estel GJ, 2011, AUTOIMMUN REV, V10, P679, DOI 10.1016/j.autrev.2011.04.028; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Racanelli V, 2001, J IMMUNOL, V167, P21, DOI 10.4049/jimmunol.167.1.21; Ramachandran P, 2012, ALIMENT PHARM THER, V35, P647, DOI 10.1111/j.1365-2036.2012.04992.x; Ramos-Casals M, 2012, LANCET, V379, P348, DOI 10.1016/S0140-6736(11)60242-0; Ramunni A., 2012, HCV INFECT CRYOGLOBU, P337, DOI [10.1007/978-88-470-1705-4_43, DOI 10.1007/978-88-470-1705-4_43]; Roccatello D, 2004, NEPHROL DIAL TRANSPL, V19, P3054, DOI 10.1093/ndt/gfh469; Roccatello D, 2008, CLIN REV ALLERG IMMU, V34, P111, DOI 10.1007/s12016-007-8019-0; Rockx MA, 2010, TRANSFUS APHER SCI, V42, P247, DOI 10.1016/j.transci.2010.03.001; Saadoun D, 2012, ARTHRITIS CARE RES H; Saadoun D, 2013, ANN RHEUM DIS; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Saadoun D, 2010, BLOOD, V116, P326, DOI 10.1182/blood-2009-10-248518; Sansonno D, 2003, BLOOD, V101, P3818, DOI 10.1182/blood-2002-10-3162; Sansonno D, 2005, LANCET INFECT DIS, V5, P227, DOI 10.1016/S1473-3099(05)70053-0; Sansonno D, 1998, J IMMUNOL, V160, P3594; Sansonno D, 2008, BLOOD, V112, P1620, DOI 10.1182/blood-2008-02-137455; Shepherd J, 2004, HEALTH TECHNOL ASSES, V8, P1; Sneller MC, 2012, ARTHRITIS RHEUM-US, V64, P835, DOI 10.1002/art.34322; St Clair EW, 2012, ARTHRITIS RHEUM-US, V64, P604, DOI 10.1002/art.34326; Stone MJ, 2012, BLOOD, V119, P2205, DOI 10.1182/blood-2011-04-347690; Terrier B, 2013, AM J CARDIOL, V111, P265, DOI 10.1016/j.amjcard.2012.09.028; Terrier B, 2010, GUT, V59, P1709, DOI 10.1136/gut.2010.218123; Thiel J, 2002, ANN RHEUM DIS, V61, P838, DOI 10.1136/ard.61.9.838; Treitel M, 2012, CLIN PHARMACOKINET, V51, P619, DOI 10.2165/11633440-000000000-00000; Vallat L, 2004, ARTHRITIS RHEUM-US, V50, P3668, DOI 10.1002/art.20594; Vierling JM, 2012, 63 ANN M AM ASS STUD; Visentini M, 2011, AUTOIMMUN REV, V10, P714, DOI 10.1016/j.autrev.2011.04.033; Zaja F, 2003, BLOOD, V101, P3827, DOI 10.1182/blood-2002-09-2856; Zeuzem S, 2011, GASTROENTEROLOGY, V141, P2047, DOI 10.1053/j.gastro.2011.08.051; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	82	116	120	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					1035	1045		10.1056/NEJMra1208642	http://dx.doi.org/10.1056/NEJMra1208642			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	24024840				2022-12-28	WOS:000324304200012
J	Ngai, J				Ngai, John			Intrinsic Activity of Odorant Receptors Guides Sensory Map Formation	CELL			English	Editorial Material								Olfactory sensory neurons innervate the olfactory bulb in stereotyped patterns according to the odorant receptors they express. A study by Nakashima et al. in this issue demonstrates that the odorant receptor's level of intrinsic activity-in the absence of activating odorant-influences the guidance of olfactory axons to their targets.	[Ngai, John] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Ngai, John] Univ Calif Berkeley, Funct Genom Lab QB3, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ngai, J (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jngai@berkeley.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007235] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC007235] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	9	0	0	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1186	1187		10.1016/j.cell.2013.08.037	http://dx.doi.org/10.1016/j.cell.2013.08.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034241	Green Accepted, Bronze			2022-12-28	WOS:000324239300007
J	Orom, UA; Shiekhattar, R				Orom, Ulf Andersson; Shiekhattar, Ramin			Long Noncoding RNAs Usher In a New Era in the Biology of Enhancers	CELL			English	Review							GENE-EXPRESSION; CHROMATIN ARCHITECTURE; TRANSCRIPTION; MEDIATOR; JPX	Enhancer-associated long noncoding RNAs act over long distances and across chromosomes to activate transcription at distal promoters. Here, we address the latest advances made toward understanding the role of long noncoding RNA expression and the involvement of these RNAs in enhancer function through association with protein factors and modulation of chromatin structure.	[Orom, Ulf Andersson] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Shiekhattar, Ramin] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Max Planck Society; The Wistar Institute	Orom, UA (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	oerom@molgen.mpg.de; shiekhattar@wistar.org	ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X; Orom, Ulf/0000-0002-0643-0592	Alexander von Humboldt Foundation Sofja Kovalevskaja Award; NIH [GM078455]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078455] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation Sofja Kovalevskaja Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' laboratories is supported by the Alexander von Humboldt Foundation Sofja Kovalevskaja Award to U.A.O. and NIH grant GM078455 to R.S.	Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Onoguchi M, 2012, P NATL ACAD SCI USA, V109, P16939, DOI 10.1073/pnas.1202956109; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Sun S, 2013, CELL, V153, P1537, DOI 10.1016/j.cell.2013.05.028; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035	15	195	211	4	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1190	1193		10.1016/j.cell.2013.08.028	http://dx.doi.org/10.1016/j.cell.2013.08.028			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034243	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000324239300009
J	Street, RA				Street, R. A.			Unraveling Charge Transport in Conjugated Polymers	SCIENCE			English	Editorial Material							SEMICONDUCTOR; TRANSPARENT; MOBILITY; FILMS		Xerox Corp, Palo Alto Res Ctr, Palo Alto, CA 94304 USA	Xerox	Street, RA (corresponding author), Xerox Corp, Palo Alto Res Ctr, 3333 Coyote Hill Rd, Palo Alto, CA 94304 USA.	street@parc.com						Collins BA, 2012, NAT MATER, V11, P536, DOI [10.1038/nmat3310, 10.1038/NMAT3310]; De S, 2009, ACS NANO, V3, P1767, DOI 10.1021/nn900348c; Li J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00754; Nomura K, 2003, SCIENCE, V300, P1269, DOI 10.1126/science.1083212; Noriega R, 2013, NAT MATER, V12, P1038, DOI [10.1038/nmat3722, 10.1038/NMAT3722]; Northrup JE, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245202; Podzorov V, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086602; Takacs CJ, 2013, NANO LETT, V13, P2522, DOI 10.1021/nl4005805; Zhang XR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3238	9	36	39	4	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1072	1073		10.1126/science.1242935	http://dx.doi.org/10.1126/science.1242935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009381				2022-12-28	WOS:000323933100029
J	Thom, S; Poulter, N; Field, J; Patel, A; Prabhakaran, D; Stanton, A; Grobbee, DE; Bots, ML; Reddy, KS; Cidambi, R; Bompoint, S; Billot, L; Rodgers, A				Thom, Simon; Poulter, Neil; Field, Jane; Patel, Anushka; Prabhakaran, Dorairaj; Stanton, Alice; Grobbee, Diederick E.; Bots, Michiel L.; Reddy, K. Srinath; Cidambi, Raghu; Bompoint, Severine; Billot, Laurent; Rodgers, Anthony		UMPIRE Collaborative Grp	Effects of a Fixed-Dose Combination Strategy on Adherence and Risk Factors in Patients With or at High Risk of CVD The UMPIRE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; BLOOD-PRESSURE; DOUBLE-BLIND; POLYPILL; THERAPY; PARTICIPANTS; CHOLESTEROL; GUIDELINES; MANAGEMENT	IMPORTANCE Most patients with cardiovascular disease (CVD) do not take recommended medications long-term. The use of fixed-dose combinations (FDCs) improves adherence in several clinical areas. Previous trials of cardiovascular FDCs have assessed short-term effects compared with placebo or no treatment. OBJECTIVE To assess whether FDC delivery of aspirin, statin, and 2 blood pressure-lowering agents vs usual care improves long-term adherence to indicated therapy and 2 major CVD risk factors, systolic blood pressure (SBP) and low-density lipoprotein cholesterol (LDL-C). DESIGN, SETTING, AND PARTICIPANTS The UMPIRE trial, a randomized, open-label, blinded-end-point trial among 2004 participants with established CVD or at risk of CVD enrolled July 2010-July 2011 in India and Europe. The trial follow-up concluded in July 2012. INTERVENTIONS Participants were randomly assigned (1: 1) to an FDC-based strategy (n=1002) containing either (1) 75 mg aspirin, 40 mg simvastatin, 10 mg lisinopril, and 50 mg atenolol or (2) 75 mg aspirin, 40 mg simvastatin, 10 mg lisinopril, and 12.5 mg hydrochlorothiazide or to usual care (n=1002). MAIN OUTCOMES AND MEASURES Adherence to medication (defined as self-reported use of antiplatelet, statin, and >= 2 BP-lowering medications) and changes in SBP and LDL-C from baseline. RESULTS At baseline, mean BP was 137/78 mmHg, LDL-C was 91.5 mg/dL, and 1233 (61.5%) of 2004 participants reported use of antiplatelet, statin, and 2 or more BP-lowering medications. Median follow-up was 15 months (interquartile range, 12-18 months). The FDC group had improved adherence vs usual care (86% vs 65%; relative risk [RR] of being adherent, 1.33; 95% CI, 1.26-1.41; P < .001) with concurrent reductions in SBP (-2.6 mm Hg; 95% CI, -4.0 to -1.1 mm Hg; P < .001) and LDL-C (-4.2 mg/dL; 95% CI, -6.6 to -1.9 mg/dL; P < .001) at the end of the study. Although there was consistency of effects across predefined subgroups, evidence existed of larger benefits in patients with lower adherence at baseline. In this subgroup of 727 participants (36%), adherence at the end of study was 77% vs 23% (RR, 3.35; 95% CI, 2.74-4.09; P < .001 for interaction), SBP was reduced by 4.9 mm Hg (95% CI 7.3-2.6 mm Hg; P = .01 for interaction), and LDL-C was reduced by 6.7 mg/dL (95% CI, 10.5-2.8 mg/dL; P = .11 for interaction). There were no significant differences in serious adverse events or cardiovascular events (50 [5%] in the FDC group and 35 [3.5%] in the usual care group; RR, 1.45; 95% CI, 0.94-2.24; P =. 09) between the groups. CONCLUSIONS AND RELEVANCE Among patients with or at high risk of CVD, use of an FDC strategy for blood pressure, cholesterol, and platelet control vs usual care resulted in significantly improved medication adherence at 15 months and statistically significant but small improvements in SBP and LDL-C.	[Thom, Simon; Poulter, Neil; Field, Jane] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London W2 1NY, England; [Patel, Anushka] George Inst Global Hlth, Hyderabad, Andhra Pradesh, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Stanton, Alice] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Grobbee, Diederick E.; Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Cidambi, Raghu] Dr Reddys Labs, Hyderabad, Andhra Pradesh, India; [Patel, Anushka; Bompoint, Severine; Billot, Laurent; Rodgers, Anthony] George Inst Global Hlth, Sydney, NSW, Australia	Imperial College London; Royal College of Surgeons - Ireland; Utrecht University; Utrecht University Medical Center; Public Health Foundation of India; Dr. Reddy's Laboratories Ltd.; George Institute for Global Health; University of Sydney	Thom, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, 59 N Wharf Rd, London W2 1NY, England.	s.thom@imperial.ac.uk	Billot, Laurent/Y-1241-2019; Grobbee, Diederick/C-7651-2014; Rajamani, Karthikeyan/AAH-9265-2019; Prabhakaran, Dorairaj/B-4147-2011; Stanton, Alice V/F-4697-2012; Guggilla, Rama/B-8768-2013	Billot, Laurent/0000-0002-4975-9793; Grobbee, Diederick/0000-0003-4472-4468; Rajamani, Karthikeyan/0000-0001-6533-6689; Prabhakaran, Dorairaj/0000-0002-3172-834X; Patel, Anushka/0000-0003-3825-4092; Chaturvedi, Vivek/0000-0002-1792-4678; Reddy, K Srinath/0000-0003-3416-3548; Bompoint, Severine/0000-0001-5226-4321; Jeemon, Panniyammakal/0000-0003-4172-4307; Thom, Simon/0000-0002-3020-1351; Stanton, Alice/0000-0002-4961-165X; Rodgers, Anthony/0000-0003-1282-1896; Guggilla, Rama/0000-0002-7486-5977; Gupta, Ajay/0000-0001-5807-8503	European Commission [241849]; Medical Research Council [G0401527, G1000143] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project was funded by the European Commission Seventh Framework Programme (grant 241849). Dr Reddy's Laboratories (Hyderabad, India) provided the FDCs and supported the trial start-up meetings in London and India.	[Anonymous], 2011, HIGH LEV EXP GROUP R, P117; [Anonymous], 2003, ADHERENCE LONG TERM; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Elley CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052145; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Grimm R, 2010, VASC HEALTH RISK MAN, V6, P261; Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816; Hulley SB, 2007, DESIGNING CLIN RES; Lafeber M, 2012, EUR J PREV CARDIOL, V19, P1234, DOI 10.1177/1741826711428066; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Liu HM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-458; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Neutel JM, 2009, J CLIN HYPERTENS, V11, P22, DOI 10.1111/j.1751-7176.2008.00058.x; New Zealand Guidelines Group, 2005, NZ CARD GUID HDB SUM; Newby LK, 2006, CIRCULATION, V113, P203, DOI 10.1161/CIRCULATIONAHA.105.505636; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Selak V, 2011, CONTEMP CLIN TRIALS, V32, P909, DOI 10.1016/j.cct.2011.07.006; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Soliman EZ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-3; Thom S, 2012, EUR J PREV CARDIOL; Turnbull F, 2003, LANCET, V362, P1527; Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Webster RJ, 2009, MED J AUSTRALIA, V191, P324, DOI 10.5694/j.1326-5377.2009.tb02816.x; Wells S, 2006, NZ MED J, V119, pU1935; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; World Health Organization, 2012, HLTH 2020 EUR POL HL; World Health Organization, 2002, SEC PREV NONC DIS LO; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2002, LANCET, V360, P2, DOI 10.1016/S0140-6736(02)09358-3; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	40	266	280	0	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					918	929		10.1001/jama.2013.277064	http://dx.doi.org/10.1001/jama.2013.277064			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002278	Bronze			2022-12-28	WOS:000323885700022
J	Roberts, JH; Pryke, R; Murphy, M; Russell, L				Roberts, Jane H.; Pryke, Rachel; Murphy, Margaret; Russell, Lucie			10 MINUTE CONSULTATION Young people who self harm by cutting	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Roberts, Jane H.] Cty Durham & Darlington Fdn Trust, Blackhall Community Hlth Ctr, Hartlepool TS27 4LQ, England; [Roberts, Jane H.] Cty Durham & Darlington Fdn Trust, Blackhall Community Hlth Ctr, Royal Coll Gen Practitioners, Hartlepool TS27 4LQ, England; [Murphy, Margaret] Cambridge Med Directorate, Specialised Serv Mental Hlth Programme, Cambridge, England; [Russell, Lucie] YoungMinds, London, England		Roberts, JH (corresponding author), Cty Durham & Darlington Fdn Trust, Blackhall Community Hlth Ctr, Hartlepool TS27 4LQ, England.	jane.roberts@sunderland.ac.uk						Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2013	347								f5250	10.1136/bmj.f5250	http://dx.doi.org/10.1136/bmj.f5250			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CL	23996150				2022-12-28	WOS:000323881600015
J	Gastanaduy, PA; Curns, AT; Parashar, UD; Lopman, BA				Gastanaduy, Paul A.; Curns, Aaron T.; Parashar, Umesh D.; Lopman, Ben A.			Gastroenteritis Hospitalizations in Older Children and Adults in the United States Before and After Implementation of Infant Rotavirus Vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INDIRECT PROTECTION; NOROVIRUS		[Gastanaduy, Paul A.; Curns, Aaron T.; Parashar, Umesh D.; Lopman, Ben A.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Gastanaduy, PA (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, 1600 Clifton Rd NE,Mailstop A-47, Atlanta, GA 30333 USA.	vid7@cdc.gov						Anderson EJ, 2013, CLIN INFECT DIS, V56, P755, DOI 10.1093/cid/cis1010; Anderson EJ, 2012, J INFECTION, V64, P89, DOI 10.1016/j.jinf.2011.09.003; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Gastanaduy PA, 2013, J INFECT DIS, V207, P1058, DOI 10.1093/infdis/jis942; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Lopman BA, 2011, CLIN INFECT DIS, V52, P466, DOI 10.1093/cid/ciq163	6	64	65	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					851	853		10.1001/jama.2013.170800	http://dx.doi.org/10.1001/jama.2013.170800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982372				2022-12-28	WOS:000323561400026
J	Hirsch, C				Hirsch, Calvin			A 12-month, in-home exercise program delayed functional deterioration in Alzheimer disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NEUROPSYCHIATRIC SYMPTOMS; CONTROLLED-TRIAL		Calif State Univ Sacramento, Davis Med Ctr, Sacramento, CA 95819 USA	California State University System; California State University Sacramento	Hirsch, C (corresponding author), Calif State Univ Sacramento, Davis Med Ctr, Sacramento, CA 95819 USA.							D'Onofrio G, 2012, CURR ALZHEIMER RES, V9, P759; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Stella F, 2011, CLINICS, V66, P1353, DOI 10.1590/S1807-59322011000800008; Vreugdenhil A, 2012, SCAND J CARING SCI, V26, P12, DOI 10.1111/j.1471-6712.2011.00895.x	4	7	7	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC10	10.7326/0003-4819-159-4-201308200-02010	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026274				2022-12-28	WOS:000323421700009
J	Baeten, D; Baraliakos, X; Braun, J; Sieper, J; Emery, P; van der Heijde, D; McInnes, I; van Laar, JM; Landewe, R; Wordsworth, P; Wollenhaupt, J; Kellner, H; Paramarta, J; Wei, JW; Brachat, A; Bek, S; Laurent, D; Li, YL; Wang, YA; Bertolino, AP; Gsteiger, S; Wright, AM; Hueber, W				Baeten, Dominique; Baraliakos, Xenofon; Braun, Juergen; Sieper, Joachim; Emery, Paul; van der Heijde, Desiree; McInnes, Iain; van Laar, Jacob M.; Landewe, Robert; Wordsworth, Paul; Wollenhaupt, Juergen; Kellner, Herbert; Paramarta, Jacqueline; Wei, Jiawei; Brachat, Arndt; Bek, Stephan; Laurent, Didier; Li, Yali; Wang, Ying A.; Bertolino, Arthur P.; Gsteiger, Sandro; Wright, Andrew M.; Hueber, Wolfgang			Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							SEVERE PLAQUE PSORIASIS; PHASE-II; INFLIXIMAB; CELLS; INTERLEUKIN-23; INFLAMMATION; MULTICENTER; INDUCTION; EFFICACY; HLA-B27	Background Ankylosing spondylitis is a chronic immune-mediated inflammatory disease characterised by spinal inflammation, progressive spinal rigidity, and peripheral arthritis. Interleukin 17 (IL-17) is thought to be a key inflammatory cytokine in the development of ankylosing spondylitis, the prototypical form of spondyloarthritis. We assessed the efficacy and safety of the anti-IL-17A monoclonal antibody secukinumab in treating patients with active ankylosing spondylitis. Methods We did a randomised double-blind proof-of-concept study at eight centres in Europe (four in Germany, two in the Netherlands, and two in the UK). Patients aged 18-65 years were randomly assigned (in a 4: 1 ratio) to either intravenous secukinumab (2 x 10 mg/kg) or placebo, given 3 weeks apart. Randomisation was done with a computer-generated block randomisation list without a stratification process. The primary efficacy endpoint was the percentage of patients with a 20% response according to the Assessment of SpondyloArthritis international Society criteria for improvement (ASAS20) at week 6 (Bayesian analysis). Safety was assessed up to week 28. This study is registered with ClinicalTrials.gov, number NCT00809159. Findings 37 patients with moderate-to-severe ankylosing spondylitis were screened, and 30 were randomly assigned to receive either intravenous secukinumab (n=24) or placebo (n=6). The final efficacy analysis included 23 patients receiving secukinumab and six patients receiving placebo, and the safety analysis included all 30 patients. At week 6, ASAS20 response estimates were 59% on secukinumab versus 24% on placebo (99.8% probability that secukinumab is superior to placebo). One serious adverse event (subcutaneous abscess caused by Staphylococcus aureus) occurred in the secukinumab-treated group. Interpretation Secukinumab rapidly reduced clinical or biological signs of active ankylosing spondylitis and was well tolerated. It is the first targeted therapy that we know of that is an alternative to tumour necrosis factor inhibition to reach its primary endpoint in a phase 2 trial.	[Baeten, Dominique; Landewe, Robert; Paramarta, Jacqueline] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Baraliakos, Xenofon; Braun, Juergen] Rheumazentrum Ruhrgebiet, Herne, Germany; [Sieper, Joachim] Charite Campus Benjamin Franklin, Med Rheumatol Dept, Berlin, Germany; [Emery, Paul] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Emery, Paul] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [van der Heijde, Desiree] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [McInnes, Iain] Univ Glasgow, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland; [van Laar, Jacob M.] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Landewe, Robert] Atrium Med Ctr, Heerlen, Netherlands; [Wordsworth, Paul] Nuffield Orthopaed Ctr, Natl Inst Hlth Res, Oxford Musculoskeletal Biomed Res Unit, Oxford OX3 7LD, England; [Wordsworth, Paul] Nuffield Orthopaed Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Wollenhaupt, Juergen] Schon Klin Hamburg Eilbeck, Div Rheumatol, Hamburg, Germany; [Kellner, Herbert] Ctr Inflammatory Joint Dis, Div Rheumatol, Munich, Germany; [Wei, Jiawei] Novartis Pharma AG, Shanghai, Peoples R China; [Brachat, Arndt; Bek, Stephan; Laurent, Didier; Bertolino, Arthur P.; Hueber, Wolfgang] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Li, Yali; Wang, Ying A.] Novartis Inst BioMed Res, Cambridge, MA USA; [Gsteiger, Sandro; Wright, Andrew M.] Novartis Pharma AG, Basel, Switzerland	University of Amsterdam; Academic Medical Center Amsterdam; Rheumazentrum Ruhrgebiet; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Leeds; Leeds Biomedical Research Centre; University of Leeds; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow; Newcastle University - UK; Atrium Medical Center; Nuffield Orthopaedic Centre; Nuffield Orthopaedic Centre; Novartis; Novartis; Novartis	Hueber, W (corresponding author), Novartis Inst BioMed Res, WSJ 386-10-48, CH-4002 Basel, Switzerland.	wolfgang.hueber@novartis.com	LANDEWE, ROBERT B.M./ABD-7388-2021; Wright, Andrew/HDM-9615-2022; Braun, Jürgen/AFT-8107-2022; Baraliakos, Xenofon/AAF-7346-2019; emery, paul/B-3560-2013; van der Heijde, Désirée/I-6774-2019	LANDEWE, ROBERT B.M./0000-0002-0577-6620; Baraliakos, Xenofon/0000-0002-9475-9362; van der Heijde, Désirée/0000-0002-5781-158X; McInnes, Iain/0000-0002-6462-4280; Brachat, Arndt/0000-0001-5768-3429	Novartis; National Institute for Health Research [NF-SI-0508-10299] Funding Source: researchfish; Versus Arthritis [18475, 19356] Funding Source: researchfish	Novartis(Novartis); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	Funding Novartis.	Anderson JJ, 2001, ARTHRITIS RHEUM-US, V44, P1876, DOI 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F; Appel H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3370; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6; Braun J, 2006, ARTHRITIS RHEUM, V54, P1646, DOI 10.1002/art.21790; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Doward LC, 2003, ANN RHEUM DIS, V62, P20, DOI 10.1136/ard.62.1.20; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Genovese MC, 2013, ANN RHEUM DIS, V72, P863, DOI 10.1136/annrheumdis-2012-201601; Glatigny S, 2012, ARTHRITIS RHEUM-US, V64, P110, DOI 10.1002/art.33321; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Kenna TJ, 2012, ARTHRITIS RHEUM-US, V64, P1420, DOI 10.1002/art.33507; Kiltz U, 2012, CURR OPIN RHEUMATOL, V24, P252, DOI 10.1097/BOR.0b013e3283524b82; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lukas C, 2007, J RHEUMATOL, V34, P862; McLeod C, 2007, Health Technol Assess, V11, P1; McLeod C, 2007, HEALTH TECHNOL ASSES, V11, pIX; Neuenschwander B, 2010, CLIN TRIALS, V7, P5, DOI 10.1177/1740774509356002; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112; Rudwaleit M, 2008, ANN RHEUM DIS, V67, P1276, DOI 10.1136/ard.2007.073098; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Song IH, 2010, ARTHRITIS RHEUM-US, V62, P1290, DOI 10.1002/art.27383; Van den Bosch F, 2002, ARTHRITIS RHEUM, V46, P755, DOI 10.1002/art.511; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Zeng L, 2011, ARTHRITIS RHEUM-US, V63, P3807, DOI 10.1002/art.30593	37	435	473	3	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1705	1713		10.1016/S0140-6736(13)61134-4	http://dx.doi.org/10.1016/S0140-6736(13)61134-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259PX	24035250				2022-12-28	WOS:000327539900027
J	Shi, Y; Zhang, W; Wang, F; Qi, JX; Wu, Y; Song, H; Gao, F; Bi, YH; Zhang, YF; Fan, Z; Qin, CF; Sun, HL; Liu, JH; Haywood, J; Liu, WJ; Gong, WM; Wang, DY; Shu, YL; Wang, Y; Yan, JH; Gao, GF				Shi, Yi; Zhang, Wei; Wang, Fei; Qi, Jianxun; Wu, Ying; Song, Hao; Gao, Feng; Bi, Yuhai; Zhang, Yanfang; Fan, Zheng; Qin, Chengfeng; Sun, Honglei; Liu, Jinhua; Haywood, Joel; Liu, Wenjun; Gong, Weimin; Wang, Dayan; Shu, Yuelong; Wang, Yu; Yan, Jinghua; Gao, George F.			Structures and Receptor Binding of Hemagglutinins from Human-Infecting H7N9 Influenza Viruses	SCIENCE			English	Article							A VIRUS; CONFORMATIONAL-ANALYSIS; TRANSMISSION; ORIGIN; COMPLEXES; OUTBREAK; H1	An avian-origin human-infecting influenza (H7N9) virus was recently identified in China. We have evaluated the viral hemagglutinin (HA) receptor-binding properties of two human H7N9 isolates, A/Shanghai/1/2013 (SH-H7N9) (containing the avian-signature residue Gln(226)) and A/Anhui/1/2013 (AH-H7N9) (containing the mammalian-signature residue Leu(226)). We found that SH-H7N9 HA preferentially binds the avian receptor analog, whereas AH-H7N9 HA binds both avian and human receptor analogs. Furthermore, an AH-H7N9 mutant HA (Leu(226) -> Gln) was found to exhibit dual receptor-binding property, indicating that other amino acid substitutions contribute to the receptor-binding switch. The structures of SH-H7N9 HA, AH-H7N9 HA, and its mutant in complex with either avian or human receptor analogs show how AH-H7N9 can bind human receptors while still retaining the avian receptor-binding property.	[Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China; [Shi, Yi; Zhang, Wei; Wang, Fei; Qi, Jianxun; Wu, Ying; Song, Hao; Bi, Yuhai; Haywood, Joel; Liu, Wenjun; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Zhang, Wei; Song, Hao; Gao, George F.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Fei; Sun, Honglei; Liu, Jinhua; Gao, George F.] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Gao, Feng; Gong, Weimin] Chinese Acad Sci, Inst Biophys, Lab Noncoding RNA, Beijing 100101, Peoples R China; [Zhang, Yanfang; Gao, George F.] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin 300308, Peoples R China; [Fan, Zheng] Chinese Acad Sci, Inst Microbiol, Core Facil, Beijing 100101, Peoples R China; [Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China; [Wang, Dayan; Shu, Yuelong; Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China; [Wang, Yu; Gao, George F.] China CDC, Off Director Gen, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Beijing Institute of Microbiology & Epidemiology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China.	gaogf@mail.biols.ac.cn	Qin, Cheng-Feng/I-6839-2019; Song, Hao/AAG-2110-2021; Haywood, Joel/G-8311-2016; Qi, Jianxun/ABF-1646-2021; Gao, George Fu/ABD-5229-2021	Qin, Cheng-Feng/0000-0002-0632-2807; Song, Hao/0000-0002-2811-0370; Haywood, Joel/0000-0003-1576-9704; Bi, Yuhai/0000-0002-5595-363X	China Ministry of Science and Technology National 973 Project [2011CB504703]; National Natural Science Foundation of China (NSFC) [81290342]; Chinese Academy of Sciences [KSZD-EW-Z-002]; NSFC Innovative Research Group [81021003]; NSFC Medical Science Department [81341002]	China Ministry of Science and Technology National 973 Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC Innovative Research Group; NSFC Medical Science Department	Supported by the China Ministry of Science and Technology National 973 Project (grant 2011CB504703), the National Natural Science Foundation of China (NSFC, grant 81290342), and Chinese Academy of Sciences intramural special grant KSZD-EW-Z-002 for influenza virus research. G. F. G. is a leading principal investigator of the NSFC Innovative Research Group (grant 81021003). We thank E. Dong for NSFC Medical Science Department director's special grant 81341002; staff at the Shanghai Synchrotron Radiation Facility (beamline 17U), especially J. He and S. Huang, for assistance; the Genewiz Corporation for rapid synthesis of HA genes; and the Consortium for Functional Glycomics for providing the biotinylated SA analogs. Coordinates and structure factors are deposited in the Protein Data Bank (PDB) with the following codes: 4KOL (AH-H7N9 HA), 4KOM (AH-H7N9 HA-3'SLNLN), 4KON (AH-H7N9 HA-6'SLNLN), 4LCX (SH-H7N9 HA), 4LKG (SH-H7N9 HA-3'SLNLN), 4LKH (SH-H7N9 HA-6'SLNLN), 4LKI (AH-H7N9 mutant HA), 4LKJ (AH-H7N9 mutant HA-3'SLNLN), and 4LKK (AH-H7N9 mutant HA-6'SLNLN).	Belser JA, 2013, J VIROL, V87, P5746, DOI 10.1128/JVI.00154-13; BREG J, 1989, EUR J BIOCHEM, V178, P727, DOI 10.1111/j.1432-1033.1989.tb14504.x; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gambaryan AS, 2012, J VIROL, V86, P4370, DOI 10.1128/JVI.06959-11; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Li JE, 2013, SCI CHINA LIFE SCI, V56, P619, DOI 10.1007/s11427-013-4504-2; Li Q., 2013, NEW ENGL J MED, V368; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Lu XS, 2013, PROTEIN CELL, V4, P502, DOI 10.1007/s13238-013-3906-z; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; MERRITT EA, 1994, PROTEIN SCI, V3, P166; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nguyen-Van-Tam JS, 2006, EUROSURVEILLANCE, V11; POPPE L, 1992, J BIOMOL NMR, V2, P109, DOI 10.1007/BF01875524; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Russell RJ, 2006, GLYCOCONJUGATE J, V23, P85, DOI 10.1007/s10719-006-5440-1; SABESAN S, 1991, CARBOHYD RES, V218, P27, DOI 10.1016/0008-6215(91)84084-R; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Srinivasan K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059550, 10.1371/journal.pone.0049597]; Stehle T, 1996, STRUCTURE, V4, P183, DOI 10.1016/S0969-2126(96)00021-4; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; WRIGHT CS, 1993, J MOL BIOL, V232, P620, DOI 10.1006/jmbi.1993.1415; Wu Y, 2013, SCI CHINA LIFE SCI, V56, P493, DOI 10.1007/s11427-013-4496-y; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787; Zhang W, 2013, J VIROL, V87, P5949, DOI 10.1128/JVI.00545-13	38	209	236	4	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					243	247		10.1126/science.1242917	http://dx.doi.org/10.1126/science.1242917			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24009358				2022-12-28	WOS:000325475200044
J	Parker, J; Tsagkogeorga, G; Cotton, JA; Liu, Y; Provero, P; Stupka, E; Rossiter, SJ				Parker, Joe; Tsagkogeorga, Georgia; Cotton, James A.; Liu, Yuan; Provero, Paolo; Stupka, Elia; Rossiter, Stephen J.			Genome-wide signatures of convergent evolution in echolocating mammals	NATURE			English	Article							PARALLEL EVOLUTION; SEQUENCE EVOLUTION; GENES; ADAPTATION; THOUSANDS; SELECTION; ALIGNMENT; ACCURACY; FLIGHT; SPACE	Evolution is typically thought to proceed through divergence of genes, proteins and ultimately phenotypes(1-3). However, similar traits might also evolve convergently in unrelated taxa owing to similar selection pressures(4,5). Adaptive phenotypic convergence is widespread in nature, and recent results from several genes have suggested that this phenomenon is powerful enough to also drive recurrent evolution at the sequence level(6-9). Where homoplasious substitutions do occur these have long been considered the result of neutral processes. However, recent studies have demonstrated that adaptive convergent sequence evolution can be detected in vertebrates using statistical methods that model parallel evolution(9,10), although the extent to which sequence convergence between genera occurs across genomes is unknown. Here we analyse genomic sequence data in mammals that have independently evolved echolocation and show that convergence is not a rare process restricted to several loci but is instead widespread, continuously distributed and commonly driven by natural selection acting on a small number of sites per locus. Systematic analyses of convergent sequence evolution in 805,053 amino acids within 2,326 orthologous coding gene sequences compared across 22 mammals (including four newly sequenced bat genomes) revealed signatures consistent with convergence in nearly 200 loci. Strong and significant support for convergence among bats and the bottlenose dolphin was seen in numerous genes linked to hearing or deafness, consistent with an involvement in echolocation. Unexpectedly, we also found convergence in many genes linked to vision: the convergent signal of many sensory genes was robustly correlated with the strength of natural selection. This first attempt to detect genome-wide convergent sequence evolution across divergent taxa reveals the phenomenon to be much more pervasive than previously recognized.	[Parker, Joe; Tsagkogeorga, Georgia; Cotton, James A.; Rossiter, Stephen J.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Liu, Yuan] BGI Europe, DK-2200 Copenhagen N, Denmark; [Provero, Paolo; Stupka, Elia] Ist Sci San Raffaele, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Provero, Paolo] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy	University of London; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Turin	Parker, J (corresponding author), Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	j.d.parker@qmul.ac.uk; s.j.rossiter@qmul.ac.uk	Provero, Paolo/AAC-1930-2019; Cotton, James A/B-8806-2008	Cotton, James A/0000-0001-5475-3583; Parker, Joe/0000-0003-3777-2269; Stupka, Elia/0000-0003-3154-4011; Rossiter, Stephen/0000-0002-3881-4515	Biotechnology and Biological Sciences Research [BB/H017178/1]; Biotechnology and Biological Sciences Research Council [BB/H017178/1] Funding Source: researchfish; BBSRC [BB/H017178/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We are grateful to K. Baker, L. Davalos, D. Hayman, E. Koilmani, Y. Liu, A. Peel, R. Ransome and A. Rodriguez for providing material for sequencing. We thank C. Walker (Queen Mary GridPP High Throughput Cluster) and A. Terry and C. Mein (Barts and the London Genome Centre) for providing access to computing facilities, and for assistance with running analyses. We are also grateful to S. Dodsworth, R. Buggs, K. Davies, J. Kirkpatrick, R. Nichols, Y. Wurm and S. Young for comments on the manuscript. This work was funded by Biotechnology and Biological Sciences Research grant BB/H017178/1 awarded to S.J.R., E.S. and J.A.C.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Au WWL, 2007, PHYS TODAY, V60, P40, DOI 10.1063/1.2784683; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Davies KTJ, 2012, HEREDITY, V108, P480, DOI 10.1038/hdy.2011.119; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fasick JI, 2000, VISUAL NEUROSCI, V17, P781, DOI 10.1017/S095252380017511X; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Grant PR, 2004, EVOLUTION, V58, P1588; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hoy RR, 2012, SCIENCE, V338, P894, DOI 10.1126/science.1231169; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kriener K, 2000, IMMUNOGENETICS, V51, P169, DOI 10.1007/s002510050028; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu Y, 2012, MOL BIOL EVOL, V29, P1441, DOI 10.1093/molbev/msr310; Liu Y, 2010, CURR BIOL, V20, P1834, DOI 10.1016/j.cub.2010.09.008; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; Ryan AF, 2003, CURR TOP DEV BIOL, V57, P449, DOI 10.1016/S0070-2153(03)57014-4; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; She R, 2011, BIOINFORMATICS, V27, P2141, DOI 10.1093/bioinformatics/btr342; Shen YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002788; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; STAMATAKIS A., 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun YB, 2013, GENOME BIOL EVOL, V5, P130, DOI 10.1093/gbe/evs123; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Terrinoni A, 2013, P NATL ACAD SCI USA, V110, P7300, DOI 10.1073/pnas.1214498110; Vater M, 2004, ECHOLOCATION BATS DO, P89; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789; Zhao HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008326; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106; Zhou XM, 2012, SYST BIOL, V61, P150, DOI 10.1093/sysbio/syr089	59	225	234	7	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					228	+		10.1038/nature12511	http://dx.doi.org/10.1038/nature12511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24005325	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000325436100049
J	Ruschitzka, F; Abraham, WT; Singh, JP; Bax, JJ; Borer, JS; Brugada, J; Dickstein, K; Ford, I; Gorcsan, J; Gras, D; Krum, H; Sogaard, P; Holzmeister, J				Ruschitzka, Frank; Abraham, William T.; Singh, Jagmeet P.; Bax, Jeroen J.; Borer, Jeffrey S.; Brugada, Josep; Dickstein, Kenneth; Ford, Ian; Gorcsan, John; Gras, Daniel; Krum, Henry; Sogaard, Peter; Holzmeister, Johannes		EchoCRT Study Grp	Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSSYNCHRONY; LONG-TERM SURVIVAL; MECHANICAL DYSSYNCHRONY; RADIAL STRAIN; TRIAL; ECHOCARDIOGRAPHY; DEFIBRILLATOR; PREVALENCE; ASYNCHRONY; REDUCTION	BackgroundCardiac-resynchronization therapy (CRT) reduces morbidity and mortality in chronic systolic heart failure with a wide QRS complex. Mechanical dyssynchrony also occurs in patients with a narrow QRS complex, which suggests the potential usefulness of CRT in such patients. MethodsWe conducted a randomized trial involving 115 centers to evaluate the effect of CRT in patients with New York Heart Association class III or IV heart failure, a left ventricular ejection fraction of 35% or less, a QRS duration of less than 130 msec, and echocardiographic evidence of left ventricular dyssynchrony. All patients underwent device implantation and were randomly assigned to have CRT capability turned on or off. The primary efficacy outcome was the composite of death from any cause or first hospitalization for worsening heart failure. ResultsOn March 13, 2013, the study was stopped for futility on the recommendation of the data and safety monitoring board. At study closure, the 809 patients who had undergone randomization had been followed for a mean of 19.4 months. The primary outcome occurred in 116 of 404 patients in the CRT group, as compared with 102 of 405 in the control group (28.7% vs. 25.2%; hazard ratio, 1.20; 95% confidence interval [CI], 0.92 to 1.57; P=0.15). There were 45 deaths in the CRT group and 26 in the control group (11.1% vs. 6.4%; hazard ratio, 1.81; 95% CI, 1.11 to 2.93; P=0.02). ConclusionsIn patients with systolic heart failure and a QRS duration of less than 130 msec, CRT does not reduce the rate of death or hospitalization for heart failure and may increase mortality. (Funded by Biotronik and GE Healthcare; EchoCRT ClinicalTrials.gov number, NCT00683696.) In a randomized trial, patients with heart failure and a QRS duration of less than 130 msec were assigned to cardiac-resynchronization therapy (CRT) or no CRT. There were no significant differences in rates of death from any cause or hospitalization for heart failure. Despite recent advances, heart failure remains a common cause of death and morbidity. According to current guidelines, cardiac-resynchronization therapy (CRT) is indicated for patients receiving stable medical therapy recommended by current guidelines who have moderate-to-severe heart failure, a left ventricular ejection fraction of 35% or less, and a QRS duration of 120 msec or more as assessed electrocardiographically.(1) However, many patients with heart failure have a QRS duration of less than 120 msec,(2) and it is currently not recommended that they receive CRT. Up to 50% of these patients show echocardiographic evidence of ventricular dyssynchrony(3),(4) and hence might benefit ...	[Ruschitzka, Frank; Holzmeister, Johannes] Univ Zurich Hosp, Clin Cardiol, CH-8091 Zurich, Switzerland; [Abraham, William T.] Ohio State Univ, Med Ctr, Div Cardiovascular Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Singh, Jagmeet P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiac Arrhythmia Serv, Boston, MA USA; [Bax, Jeroen J.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Borer, Jeffrey S.] State Univ New York Downstate Coll Med, Div Cardiovasc Med, New York, NY USA; [Borer, Jeffrey S.] State Univ New York Downstate Coll Med, Howard Gilman & Ron Inst, New York, NY USA; [Borer, Jeffrey S.] State Univ New York Downstate Coll Med, Jean Schiavone Inst, New York, NY USA; [Brugada, Josep] Univ Barcelona, Dept Cardiol, Thorax Inst, Hosp Clin, Barcelona, Spain; [Dickstein, Kenneth] Univ Bergen, Stavanger Univ Hosp, Stavanger, Norway; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Gorcsan, John] Univ Pittsburgh, Pittsburgh, PA USA; [Gras, Daniel] Nouvelles Clin Nantaises, Nantes, France; [Krum, Henry] Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic, Australia; [Sogaard, Peter] Aalborg Univ, Aalborg, Denmark	University of Zurich; University Zurich Hospital; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Barcelona; Stavanger University Hospital; University of Bergen; University of Glasgow; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aalborg University	Holzmeister, J (corresponding author), Univ Zurich Hosp, Clin Cardiol, Raemistr 100, CH-8091 Zurich, Switzerland.	johannes.holzmeister@usz.ch; johannes.holzmeister@usz.ch	Ford, Ian/ABE-6145-2020; Ponikowski, Piotr/O-6454-2015	Ng, G. Andre/0000-0001-5965-0671; BRUGADA, JOSEP/0000-0002-5662-8302; Ponikowski, Piotr/0000-0002-3391-7064	Biotronik; GE Healthcare	Biotronik; GE Healthcare(General ElectricGE Healthcare)	Supported by Biotronik and GE Healthcare.	Achilli A, 2003, J AM COLL CARDIOL, V42, P2117, DOI 10.1016/j.jacc.2003.08.024; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Bleeker GB, 2006, J AM COLL CARDIOL, V48, P2243, DOI 10.1016/j.jacc.2006.07.067; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cazeau SJ, 2008, EUR J HEART FAIL, V10, P273, DOI 10.1016/j.ejheart.2008.02.007; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Delgado V, 2008, J AM COLL CARDIOL, V51, P1944, DOI 10.1016/j.jacc.2008.02.040; Delgado V, 2011, CIRCULATION, V123, P70, DOI 10.1161/CIRCULATIONAHA.110.945345; Dickstein K, 2009, EUR HEART J, V30, P2450, DOI 10.1093/eurheartj/ehp359; Donahue T, 2012, J CARDIOVASC TRANSL, V5, P232, DOI 10.1007/s12265-011-9338-3; Foley PWX, 2011, HEART, V97, P1041, DOI 10.1136/hrt.2010.208355; Garin O, 2009, QUAL LIFE RES, V18, P71, DOI 10.1007/s11136-008-9416-4; Gorcsan J, 2008, J AM SOC ECHOCARDIOG, V21, P191, DOI 10.1016/j.echo.2008.01.003; Gorcsan J, 2007, J AM COLL CARDIOL, V50, P1476, DOI 10.1016/j.jacc.2007.06.043; Gorcsan J, 2010, CIRCULATION, V122, P1910, DOI 10.1161/CIRCULATIONAHA.110.954768; Hawkins NM, 2006, EUR HEART J, V27, P1270, DOI 10.1093/eurheartj/ehi826; Khan FZ, 2012, J AM COLL CARDIOL, V59, P1509, DOI 10.1016/j.jacc.2011.12.030; Khan NK, 2007, EUR J HEART FAIL, V9, P491, DOI 10.1016/j.ejheart.2006.11.003; McMurray JJV, 2013, EUR HEART J, V34, P158, DOI 10.1093/eurheartj/ehs370; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Muto C, 2013, CIRC-ARRHYTHMIA ELEC, V6, P538, DOI 10.1161/CIRCEP.113.000135; Saba S, 2013, CIRC-HEART FAIL, V6, P427, DOI 10.1161/CIRCHEARTFAILURE.112.000078; Sipahi I, 2011, ARCH INTERN MED, V171, P1454, DOI 10.1001/archinternmed.2011.247; Suffoletto MS, 2006, CIRCULATION, V113, P960, DOI 10.1161/CIRCULATIONAHA.105.571455; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Thibault B, 2013, CIRCULATION, V127, P873, DOI 10.1161/CIRCULATIONAHA.112.001239; van Bommel RJ, 2010, EUR HEART J, V31, P3054, DOI 10.1093/eurheartj/ehq334; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Yu CM, 2006, J AM COLL CARDIOL, V48, P2251, DOI 10.1016/j.jacc.2006.07.054; Yu CM, 2003, HEART, V89, P54, DOI 10.1136/heart.89.1.54	32	501	521	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1395	1405		10.1056/NEJMoa1306687	http://dx.doi.org/10.1056/NEJMoa1306687			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	23998714	Green Accepted, Bronze			2022-12-28	WOS:000325431500007
J	Lichterfeld, M; Rosenberg, ES				Lichterfeld, Mathias; Rosenberg, Eric S.			Acute HIV-1 Infection: A Call to Action	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTIRETROVIRAL THERAPY		[Lichterfeld, Mathias; Rosenberg, Eric S.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Rosenberg, ES (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Gray J-504,55 Fruit St, Boston, MA 02114 USA.	erosenberg1@partners.org	Lichterfeld, Mathias/B-2042-2008	Lichterfeld, Mathias/0000-0001-9865-8350	National Institutes of Health [AI098487, AI093203, AI071915]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071915, R21AI093203, R01AI098487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Lichterfeld is supported by grants AI098487 and AI093203 from the National Institutes of Health. Dr. Rosenberg is supported by grant AI071915 from the National Institutes of Health.	Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961	10	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					425	+		10.7326/0003-4819-159-6-201309170-00010	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042369				2022-12-28	WOS:000325625900020
J	Montalescot, G; Bolognese, L; Dudek, D; Goldstein, P; Hamm, C; Tanguay, JF; ten Berg, JM; Miller, DL; Costigan, TM; Goedicke, J; Silvain, J; Angioli, P; Legutko, J; Niethammer, M; Motovska, Z; Jakubowski, JA; Cayla, G; Visconti, LO; Vicaut, E; Widimsky, P				Montalescot, Gilles; Bolognese, Leonardo; Dudek, Dariusz; Goldstein, Patrick; Hamm, Christian; Tanguay, Jean-Francois; ten Berg, Jurrien M.; Miller, Debra L.; Costigan, Timothy M.; Goedicke, Jochen; Silvain, Johanne; Angioli, Paolo; Legutko, Jacek; Niethammer, Margit; Motovska, Zuzana; Jakubowski, Joseph A.; Cayla, Guillaume; Visconti, Luigi Oltrona; Vicaut, Eric; Widimsky, Petr		ACCOAST Investigators	Pretreatment with Prasugrel in Non-ST-Segment Elevation Acute Coronary Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUITY ACUTE CATHETERIZATION; HIGH-DOSE CLOPIDOGREL; MYOCARDIAL-INFARCTION; RECEPTOR ANTAGONIST; PLATELET ACTIVATION; INTERVENTION; INHIBITION; STRATEGY; PCI; AGGREGATION	BackgroundAlthough P2Y(12) antagonists are effective in patients with non-ST-segment elevation (NSTE) acute coronary syndromes, the effect of the timing of administration before or after coronary angiography is not known. We evaluated the effect of administering the P2Y(12) antagonist prasugrel at the time of diagnosis versus administering it after the coronary angiography if percutaneous coronary intervention (PCI) was indicated. MethodsWe enrolled 4033 patients with NSTE acute coronary syndromes and a positive troponin level who were scheduled to undergo coronary angiography within 2 to 48 hours after randomization. Patients were randomly assigned to receive prasugrel (a 30-mg loading dose) before the angiography (pretreatment group) or placebo (control group). When PCI was indicated, an additional 30 mg of prasugrel was given in the pretreatment group at the time of PCI and 60 mg of prasugrel was given in the control group. ResultsThe rate of the primary efficacy end point, a composite of death from cardiovascular causes, myocardial infarction, stroke, urgent revascularization, or glycoprotein IIb/IIIa inhibitor rescue therapy (glycoprotein IIb/IIIa bailout) through day 7, did not differ significantly between the two groups (hazard ratio with pretreatment, 1.02; 95% confidence interval [CI], 0.84 to 1.25; P=0.81). The rate of the key safety end point of all Thrombolysis in Myocardial Infarction (TIMI) major bleeding episodes, whether related or not related to coronary-artery bypass grafting (CABG), through day 7 was increased with pretreatment (hazard ratio, 1.90; 95% CI, 1.19 to 3.02; P=0.006). The rates of TIMI major bleeding and life-threatening bleeding not related to CABG were increased by a factor of 3 and 6, respectively. Pretreatment did not reduce the rate of the primary outcome among patients undergoing PCI (69% of the patients) but increased the rate of TIMI major bleeding at 7 days. All the results were confirmed at 30 days and in prespecified subgroups. ConclusionsAmong patients with NSTE acute coronary syndromes who were scheduled to undergo catheterization, pretreatment with prasugrel did not reduce the rate of major ischemic events up to 30 days but increased the rate of major bleeding complications. (Funded by Daiichi Sankyo and Eli Lilly; ACCOAST ClinicalTrials.gov number, NCT01015287.)	[Montalescot, Gilles; Silvain, Johanne] Univ Paris 06, Ctr Hosp Univ Pitie Salpetriere, AP HP, Inst Cardiol,ACT Grp, Paris, France; [Vicaut, Eric] Univ Paris 07, Ctr Hosp Univ Lariboisiere, AP HP, Methodol & Stat Unit,ACT Grp, Paris, France; [Goldstein, Patrick] Lille Univ Hosp, Serv Aide Med Urgence, Lille, France; [Goldstein, Patrick] Lille Univ Hosp, Emergency Dept, Lille, France; [Cayla, Guillaume] Univ Montpellier I, Ctr Hosp Univ Nimes, Serv Cardiol, ACT Grp, Montpellier, France; [Bolognese, Leonardo; Angioli, Paolo] Azienda Osped Arezzo, Cardiovasc & Neurol Dept, Arezzo, Italy; [Visconti, Luigi Oltrona] Fdn IRCCS Policlin San Matteo, Div Cardiol, Pavia, Italy; [Dudek, Dariusz] Jagiellonian Univ, Inst Cardiol, Coll Med, Univ Hosp, Krakow, Poland; [Legutko, Jacek] Jagiellonian Univ Hosp Krakow, Krakow, Poland; [Hamm, Christian] Kerckhoff Heart & Thoraxctr, Bad Nauheim, Germany; [Hamm, Christian] Univ Giessen, Med Clin 1, D-35390 Giessen, Germany; [Goedicke, Jochen] Eli Lilly Deutschland, Bad Homburg, Germany; [Niethammer, Margit] Johannes Gutenberg Univ Mainz, Univ Med, Med Klin, D-55122 Mainz, Germany; [Tanguay, Jean-Francois] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [ten Berg, Jurrien M.] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Miller, Debra L.; Costigan, Timothy M.; Jakubowski, Joseph A.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Motovska, Zuzana; Widimsky, Petr] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Motovska, Zuzana; Widimsky, Petr] Univ Hosp Royal Vineyards, Prague, Czech Republic	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Nimes; IRCCS Fondazione San Matteo; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Kerckhoff Clinic; Justus Liebig University Giessen; Eli Lilly; Lilly Deutschland GmbH; Johannes Gutenberg University of Mainz; Universite de Montreal; St. Antonius Hospital Utrecht; Eli Lilly; Charles University Prague	Montalescot, G (corresponding author), Ctr Hosp Univ Pitie Salpetriere, Inst Cardiol, ACT Study Grp, 47 Blvd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Lubanda, Jean-Claude/O-1786-2017; De+Servi, Stefano/AAT-2631-2021; De Caterina, Raffaele/K-3857-2016; Hamm, Christian W./I-3155-2017; Bardaji, Alfredo/V-7985-2019; Widimsky, Petr/P-8088-2016; Motovska, Zuzana/J-1122-2016; Gierlotka, Marek/U-6969-2019; Suryapranata, H./H-8095-2014; SILVAIN, Johanne/C-7521-2016	Lubanda, Jean-Claude/0000-0002-0285-9025; De Caterina, Raffaele/0000-0003-1637-574X; Hamm, Christian W./0000-0001-6763-4161; Bardaji, Alfredo/0000-0003-1900-6974; Widimsky, Petr/0000-0001-5686-7752; Motovska, Zuzana/0000-0002-5319-473X; Gierlotka, Marek/0000-0001-5639-2128; Dalby, Miles/0000-0003-0823-5093; Baumbach, Andreas/0000-0001-7707-2254; Airaksinen, Juhani/0000-0002-0193-568X; SILVAIN, Johanne/0000-0002-1901-2808; Hromadka, Milan/0000-0001-7108-5441	Daiichi Sankyo; Eli Lilly	Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly)	Funded by Daiichi Sankyo and Eli Lilly; ACCOAST ClinicalTrials.gov number, NCT01015287.	Bellemain-Appaix A, 2013, JAMA-J AM MED ASSOC, V309, P1461, DOI 10.1001/jama.2013.2680; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Davlouros PA, 2009, AM HEART J, V158, P585, DOI 10.1016/j.ahj.2009.07.029; Di Sciascio G, 2010, J AM COLL CARDIOL, V56, P550, DOI 10.1016/j.jacc.2010.01.067; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Katritsis DG, 2011, EUR HEART J, V32, P32, DOI 10.1093/eurheartj/ehq276; Lincoff AM, 2008, JACC-CARDIOVASC INTE, V1, P639, DOI 10.1016/j.jcin.2008.10.004; Mehta SR, 2010, NEW ENGL J MED, V363, P1585; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Montalescot G, 2011, AM HEART J, V161, P650, DOI 10.1016/j.ahj.2010.10.017; Montalescot G, 2010, THROMB HAEMOSTASIS, V103, P213, DOI 10.1160/TH09-07-0482; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Ndrepepa G, 2012, CIRC-CARDIOVASC INTE, V5, P705, DOI 10.1161/CIRCINTERVENTIONS.112.972869; Sorajja P, 2010, J AM COLL CARDIOL, V55, P1416, DOI 10.1016/j.jacc.2009.11.063; Steinhubl SR, 2006, J AM COLL CARDIOL, V47, P939, DOI 10.1016/j.jacc.2005.10.047; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Widimsky P, 2008, EUR HEART J, V29, P1495, DOI 10.1093/eurheartj/ehn169; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494; 2001, N ENGL J MED, V345, P1506; 2001, N ENGL J MED, V345, P1716	33	405	421	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					999	1010		10.1056/NEJMoa1308075	http://dx.doi.org/10.1056/NEJMoa1308075			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	23991622	Green Published			2022-12-28	WOS:000324304200009
J	Ohki, M				Ohki, Masafumi			Hyperectasis of the Tympanic Membrane	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 44-year-old woman with frequent bilateral ear fullness was given a diagnosis of atelectatic tympanic membranes several years ago. She was told to perform the Valsalva maneuver, which raises air pressure in the nasal cavity and aerates the middle ear through the eustachian tube. A 44-year-old woman presented with bilateral ear fullness. She had been given a diagnosis of atelectatic tympanic membranes several years earlier and had been advised to perform the Valsalva maneuver, which raises the air pressure in the nasal cavity and aerates the middle-ear cavity through the eustachian tube, leading to temporary disappearance of the sensation of ear fullness. She continued to perform the Valsalva maneuver four times a day for 6 years. On examination, the tympanic membranes were ballooned outward with no signs of effusion or inflammation in the tympanic cavity (Panels A and B; 5 hours after the last ...	Saitama Med Ctr, Saitama, Japan		Ohki, M (corresponding author), Saitama Med Ctr, Saitama, Japan.	m-ohki@umin.ac.jp		Ohki, Masafumi/0000-0003-4334-3524					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					1046	1046		10.1056/NEJMicm1213263	http://dx.doi.org/10.1056/NEJMicm1213263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	24024841				2022-12-28	WOS:000324304200013
J	Tinberg, CE; Khare, SD; Dou, JY; Doyle, L; Nelson, JW; Schena, A; Jankowski, W; Kalodimos, CG; Johnsson, K; Stoddard, BL; Baker, D				Tinberg, Christine E.; Khare, Sagar D.; Dou, Jiayi; Doyle, Lindsey; Nelson, Jorgen W.; Schena, Alberto; Jankowski, Wojciech; Kalodimos, Charalampos G.; Johnsson, Kai; Stoddard, Barry L.; Baker, David			Computational design of ligand-binding proteins with high affinity and selectivity	NATURE			English	Article							ANTIBODIES; OPTIMIZATION; SPECIFICITY; REVEAL	The ability to design proteins with high affinity and selectivity for any given small molecule is a rigorous test of our understanding of the physiochemical principles that govern molecular recognition. Attempts to rationally design ligand-binding proteins have met with little success, however, and the computational design of protein-small-molecule interfaces remains an unsolved problem(1). Current approaches for designing ligand-binding proteins for medical(2) and biotechnological uses rely on raising antibodies against a target antigen in immunized animals(3,4) and/or performing laboratory-directed evolution of proteins with an existing low affinity for the desired ligand(5-7), neither of which allows complete control over the interactions involved in binding. Here we describe a general computational method for designing pre-organized and shape complementary small-molecule-binding sites, and use it to generate protein binders to the steroid digoxigenin (DIG). Of seventeen experimentally characterized designs, two bind DIG; the model of the higher affinity binder has the most energetically favourable and pre-organized interface in the design set. A comprehensive binding-fitness landscape of this design, generated by library selections and deep sequencing, was used to optimize its binding affinity to a picomolar level, and X-ray co-crystal structures of two variants show atomic-level agreement with the corresponding computational models. The optimized binder is selective for DIG over the related steroids digitoxigenin, progesterone and beta-oestradiol, and this steroid binding preference can be reprogrammed by manipulation of explicitly designed hydrogen-bonding interactions. The computational design method presented here should enable the development of a new generation of biosensors, therapeutics and diagnostics.	[Tinberg, Christine E.; Khare, Sagar D.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Dou, Jiayi] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Dou, Jiayi] Univ Washington, Grad Program Biol Phys Struct & Design, Seattle, WA 98195 USA; [Doyle, Lindsey; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Nelson, Jorgen W.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Schena, Alberto; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland; [Jankowski, Wojciech; Kalodimos, Charalampos G.] Rutgers State Univ, Ctr Integrat Prote Res, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Rutgers State University New Brunswick; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Kalodimos, Charalampos/Q-9846-2018; johnsson, kai/P-4222-2014; Baker, David/K-8941-2012	Kalodimos, Charalampos/0000-0001-6354-2796; johnsson, kai/0000-0002-8002-1981; Baker, David/0000-0001-7896-6217; Doyle, Lindsey/0000-0002-0008-473X; Nelson, Jorgen/0000-0002-0202-2460	Washington State Life Sciences Discovery Fund; Center for the Intracellular Delivery of Biologics; National Human Genome Research Institute under the Interdisciplinary Training in Genome Sciences program [T32 HG00035]; DTRA; DARPA; Swiss National Science Foundation; National Science Foundation [MCB1121896]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, R01GM049857] Funding Source: NIH RePORTER	Washington State Life Sciences Discovery Fund; Center for the Intracellular Delivery of Biologics; National Human Genome Research Institute under the Interdisciplinary Training in Genome Sciences program; DTRA(United States Department of DefenseDefense Threat Reduction Agency); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E.-M. Strauch and P.-S. Huang for providing the ZZ/pETCON and S2/pETCON plasmids, respectively, and B. Shen for assistance with data processing, modelling and refinement of the X-ray crystal structures. We thank J. P. Sumida for assistance with analytical ultracentrifugation data collection, processing, and analysis. Analytical ultracentrifugation experiments were performed at the University of Washington Analytical Biopharmacy Core, which is supported by the Washington State Life Sciences Discovery Fund and the Center for the Intracellular Delivery of Biologics. We thank S. Fleishman, O. Khersonsky and P.-S. Huang for comments on the manuscript. J.W.N. acknowledges a pre-doctoral fellowship from the National Human Genome Research Institute under the Interdisciplinary Training in Genome Sciences program (T32 HG00035). This work was supported by grants from DTRA and DARPA to D. B., a grant from the Swiss National Science Foundation to K. J., and National Science Foundation grant MCB1121896 to C.G.K.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brustad EM, 2011, CURR OPIN CHEM BIOL, V15, P201, DOI 10.1016/j.cbpa.2010.11.020; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen G, 2001, NAT BIOTECHNOL, V19, P537, DOI 10.1038/89281; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; De Wolf FA, 2000, PHARMACOL REV, V52, P207; Eisel D., 2008, DIG APPL MANUAL NONR; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Flanagan RJ, 2004, DRUG SAFETY, V27, P1115, DOI 10.2165/00002018-200427140-00004; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fleishman SJ, 2011, PROTEIN SCI, V20, P753, DOI 10.1002/pro.604; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Frederick KK, 2007, NATURE, V448, P325, DOI 10.1038/nature05959; HUNTER MM, 1982, J IMMUNOL, V129, P1165; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Khare SD, 2013, FEBS LETT, V587, P1147, DOI 10.1016/j.febslet.2012.12.009; Khersonsky O, 2012, P NATL ACAD SCI USA, V109, P10358, DOI 10.1073/pnas.1121063109; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Perry G, 1997, NEW ENGL J MED, V336, P525; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schreier B, 2009, P NATL ACAD SCI USA, V106, P18491, DOI 10.1073/pnas.0907950106; Shen XY, 2012, CLIN PHARMACOL THER, V91, P60, DOI 10.1038/clpt.2011.281; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Telmer PG, 2005, J MOL BIOL, V354, P829, DOI 10.1016/j.jmb.2005.10.016; Wang L, 2012, J MOL BIOL, V415, P615, DOI 10.1016/j.jmb.2011.10.043; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	38	282	291	12	304	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					212	+		10.1038/nature12443	http://dx.doi.org/10.1038/nature12443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24005320	Green Accepted			2022-12-28	WOS:000324244900039
J	Van Brabandt, H; Neyt, M; Devos, C				Van Brabandt, Hans; Neyt, Mattias; Devos, Carl			Caution over use of catheter ablation for atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIARRHYTHMIC-DRUG THERAPY; PULMONARY-VEIN ABLATION; FOLLOW-UP; RADIOFREQUENCY ABLATION; RHYTHM-CONTROL; GUIDELINES; MANAGEMENT; FAILURE; IMPACT; TRIAL		[Van Brabandt, Hans; Neyt, Mattias; Devos, Carl] Belgian Hlth Care Knowledge Ctr, B-1000 Brussels, Belgium; [Van Brabandt, Hans] Belgian Ctr Evidence Based Med, Leuven, Netherlands; [Van Brabandt, Hans] Branch Dutch Cochrane Ctr, Leuven, Netherlands		Van Brabandt, H (corresponding author), Belgian Hlth Care Knowledge Ctr, B-1000 Brussels, Belgium.	hans.vanbrabandt@kce.fgov.be		Devos, Carl/0000-0002-1110-2366				Atrial Fibrillation Association, 2011, AF REP PREV STROK CR; Bhargava M, 2009, HEART RHYTHM, V6, P1403, DOI 10.1016/j.hrthm.2009.06.014; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; de Denus S, 2005, ARCH INTERN MED, V165, P258, DOI 10.1001/archinte.165.3.258; Forleo GB, 2009, J CARDIOVASC ELECTR, V20, P22, DOI 10.1111/j.1540-8167.2008.01275.x; Gaita F, 2008, CIRC-ARRHYTHMIA ELEC, V1, P269, DOI 10.1161/CIRCEP.108.774885; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hunter RJ, 2010, HEART, V96, P1372, DOI 10.1136/hrt.2009.188128; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Katritsis D, 2008, EUROPACE, V10, P419, DOI 10.1093/europace/eun018; Koch L, 2012, EUROPACE, V14, P1441, DOI 10.1093/europace/eus084; Kojodjojo P, 2011, HEART, V97, P610, DOI 10.1136/hrt.2010.206888; Krittayaphong Rungroj, 2003, J Med Assoc Thai, V86 Suppl 1, pS8; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Lafuente-Lafuente C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub3; MacDonald MR, 2011, HEART, V97, P740, DOI 10.1136/hrt.2010.207340; Medi C, 2011, J CARDIOVASC ELECTR, V22, P137, DOI 10.1111/j.1540-8167.2010.01885.x; Morillo C, 2012, HEART RHYTHM SOC 201; Neven K, 2010, CIRC-ARRHYTHMIA ELEC, V3, P260, DOI 10.1161/CIRCEP.109.922930; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Ouyang F, 2010, CIRCULATION, V122, P2368, DOI 10.1161/CIRCULATIONAHA.110.946806; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Pappone C, 2011, CIRC-ARRHYTHMIA ELEC, V4, P808, DOI 10.1161/CIRCEP.111.966408; Potpara Tatjana S, 2011, Hosp Pract (1995), V39, P17, DOI 10.3810/hp.2011.10.919; Shaneyfelt T, 2012, ARCH INTERN MED, V172, P1633, DOI 10.1001/2013.jamainternmed.335; Sorgente A, 2012, AM J CARDIOL, V109, P1179, DOI 10.1016/j.amjcard.2011.11.058; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Testa L, 2005, EUR HEART J, V26, P2000, DOI 10.1093/eurheartj/ehi306; Van Brabandt H, 2012, CATHETER ABLATION AT; Van Brabandt H, 2013, EUROPACE, V15, P663, DOI 10.1093/europace/eut004; Van Brabandt H, 2013, EUROPACE, V15, P461, DOI 10.1093/europace/eus393; Vinck I, 2011, EUR J HEALTH LAW, V18, P477, DOI 10.1163/157180911X598735; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029	38	7	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2013	347								f5277	10.1136/bmj.f5277	http://dx.doi.org/10.1136/bmj.f5277			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215NK	24014443				2022-12-28	WOS:000324216700002
J	Bauer, F; Heyder, J; Schubert, E; Borowsky, D; Taubert, D; Bruognolo, B; Schuh, D; Wegscheider, W; von Delft, J; Ludwig, S				Bauer, Florian; Heyder, Jan; Schubert, Enrico; Borowsky, David; Taubert, Daniela; Bruognolo, Benedikt; Schuh, Dieter; Wegscheider, Werner; von Delft, Jan; Ludwig, Stefan			Microscopic origin of the '0.7-anomaly' in quantum point contacts	NATURE			English	Article							DIMENSIONAL ELECTRON-GAS; KONDO; CONDUCTANCE; SIGNATURES; DEVICES	Quantum point contacts are narrow, one-dimensional constrictions usually patterned in a two-dimensional electron system, for example by applying voltages to local gates. The linear conductance of a point contact, when measured as function of its channel width, is quantized(1-3) in units of G(Q) = 2e(2)/h, where e is the electron charge and h is Planck's constant. However, the conductance also has an unexpected shoulder at similar to 0.7 G(Q), known as the '0.7-anomaly'(4-12), whose origin is still subject to debate(11-21). Proposed theoretical explanations have invoked spontaneous spin polarization(4,17), ferromagnetic spin coupling(19), the formation of a quasi-bound state leading to the Kondo effect(13,14), Wigner crystallization(16,20) and various treatments of inelastic scattering(18,21). However, explicit calculations that fully reproduce the various experimental observations in the regime of the 0.7-anomaly, including the zero-bias peak that typically accompanies it(6,9-11), are still lacking. Here we offer a detailed microscopic explanation for both the 0.7-anomaly and the zero-bias peak: their common origin is a smeared van Hove singularity in the local density of states at the bottom of the lowest one-dimensional subband of the point contact, which causes an anomalous enhancement in the Hartree potential barrier, the magnetic spin susceptibility and the inelastic scattering rate. We find good qualitative agreement between theoretical calculations and experimental results on the dependence of the conductance on gate voltage, magnetic field, temperature, source-drain voltage (including the zero-bias peak) and interaction strength. We also clarify how the low-energy scale governing the 0.7-anomaly depends on gate voltage and interactions. For low energies, we predict and observe Fermi-liquid behaviour similar to that associated with the Kondo effect in quantum dots(22). At high energies, however, the similarities between the 0.7-anomaly and the Kondo effect end.	[Bauer, Florian; Heyder, Jan; Schubert, Enrico; Borowsky, David; Taubert, Daniela; Bruognolo, Benedikt; von Delft, Jan; Ludwig, Stefan] Univ Munich, Ctr NanoSci, D-80539 Munich, Germany; [Bauer, Florian; Heyder, Jan; Schubert, Enrico; Borowsky, David; Taubert, Daniela; Bruognolo, Benedikt; von Delft, Jan; Ludwig, Stefan] Univ Munich, Fak Phys, D-80539 Munich, Germany; [Bauer, Florian; Heyder, Jan; Bruognolo, Benedikt; von Delft, Jan] Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, D-80333 Munich, Germany; [Schuh, Dieter] Univ Regensburg, Inst Angew Phys, D-93040 Regensburg, Germany; [Wegscheider, Werner] ETH, Solid State Phys Lab, CH-8093 Zurich, Switzerland	University of Munich; University of Munich; University of Munich; University of Regensburg; Swiss Federal Institutes of Technology Domain; ETH Zurich	von Delft, J (corresponding author), Univ Munich, Ctr NanoSci, Geschwister Scholl Pl 1, D-80539 Munich, Germany.	vondelft@lmu.de; ludwig@lmu.de	Ludwig, Stefan/A-5199-2009	Ludwig, Stefan/0000-0002-0978-7458; von Delft, Jan/0000-0002-8655-0999	DFG [SFB-631, SFB-TR12, De730/3-2, De730/4-1, De730/4-2, De730/4-3, HO 4687/1-3, LU819/4-1]; Cluster of Excellence Nanosystems Initiative Munich; Center for NanoScience; US National Science Foundation [NSF PHY05-51164]; DFG	DFG(German Research Foundation (DFG)); Cluster of Excellence Nanosystems Initiative Munich; Center for NanoScience; US National Science Foundation(National Science Foundation (NSF)); DFG(German Research Foundation (DFG))	We thank B. Altshuler, P. Brouwer, R. Egger, J. Folk, L. Glazman, V. Golovach, A. Hamilton, A. Hogele, Y. Imry, M. Kiselev, J. Kotthaus, D. Logan, D. Loss, C. Marcus, Y. Meir, H. Monien, M. Pepper, M. Pustilnik, A. Rosch, K. Scho " nhammer, B. Spivak and A. Yacoby for discussions, and, in particular, S. Andergassen, C. Honerkamp, S. Jakobs, C. Karrasch, V. Meden, M. Pletyukhov and H. Schoeller for FRG-related helpandadvice. Weacknowledge support from the DFG through SFB-631, SFB-TR12, De730/3-2, De730/4-1, De730/4-2, De730/4-3, HO 4687/1-3, LU819/4-1 and the Cluster of Excellence Nanosystems Initiative Munich; from the Center for NanoScience; and from the US National Science Foundation under grant no. NSF PHY05-51164. S. L. acknowledges support through a Heisenberg fellowship of the DFG.	Andergassen S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045125; Appleyard NJ, 2000, PHYS REV B, V62, pR16275, DOI 10.1103/PhysRevB.62.R16275; Aryanpour K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.056805; Burke AM, 2012, NANO LETT, V12, P4495, DOI 10.1021/nl301566d; BUTTIKER M, 1990, PHYS REV B, V41, P7906, DOI 10.1103/PhysRevB.41.7906; Cronenwett SM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.226805; DiCarlo L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.036810; Glazman LI, 2005, LES HOUCH S, V81, P427; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Guclu AD, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.201302; Ihnatsenka S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045338; Karrasch C, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235337; Koop EJ, 2007, J SUPERCOND NOV MAGN, V20, P433, DOI 10.1007/s10948-007-0289-5; Lunde AM, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/023031; Matveev KA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245319; Meir Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.196802; MEIR Y, 1992, PHYS REV LETT, V68, P2512, DOI 10.1103/PhysRevLett.68.2512; Metzner W, 2012, REV MOD PHYS, V84, P299, DOI 10.1103/RevModPhys.84.299; Micolich AP, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/44/443201; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; NOZIERES P, 1974, J LOW TEMP PHYS, V17, P31, DOI 10.1007/BF00654541; Oguri A, 2001, J PHYS SOC JPN, V70, P2666, DOI 10.1143/JPSJ.70.2682; Reilly DJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.033309; Rejec T, 2006, NATURE, V442, P900, DOI 10.1038/nature05054; Ren Y, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.045313; Sarkozy S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.161307; Sloggett C, 2008, EUR PHYS J B, V61, P427, DOI 10.1140/epjb/e2008-00092-2; Thomas KJ, 1996, PHYS REV LETT, V77, P135, DOI 10.1103/PhysRevLett.77.135; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002	30	76	77	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					73	78		10.1038/nature12421	http://dx.doi.org/10.1038/nature12421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23995681	Green Published			2022-12-28	WOS:000323888300034
J	Ezzati, M; Riboli, E				Ezzati, Majid; Riboli, Elio			GLOBAL HEALTH Behavioral and Dietary Risk Factors for Noncommunicable Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BODY-MASS INDEX; CAUSE-SPECIFIC MORTALITY; ISCHEMIC-HEART-DISEASE; SYSTEMATIC ANALYSIS; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; ALCOHOL-CONSUMPTION; RUSSIAN MORTALITY; PHYSICAL-ACTIVITY; STOMACH-CANCER		[Ezzati, Majid; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London W2 1PG, England	Imperial College London	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk; e.riboli@imperial.ac.uk		Riboli, Elio/0000-0001-6795-6080	Medical Research Council [G0801056B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allamani A., 2007, CONTEMP DRUG PROBL, V34, P187, DOI DOI 10.1177/009145090703400203; [Anonymous], 2011, GLOB STAT REP NONC C; Asaria P, 2007, LANCET, V370, P2004; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Cipriani F., 2007, CONTEMP DRUG PROBL, V34, P361; Cobiac LJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000110; Danaei G, 2013, CIRCULATION, V127, P1493, DOI 10.1161/CIRCULATIONAHA.113.001470; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Department of Health and Human Services, 2006, DHHS PUBL; Department of Health and Human Services, 2010, DHHS PUBL, V[CDC] 89-8411; Di Cesare M, 2013, INT J EPIDEMIOL, V42, P838, DOI 10.1093/ije/dyt063; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Gu DF, 2010, NEW ENGL J MED, V363, P2273; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; He F. J., 2013, BMJ, V346; HIRAYAMA T, 1984, JPN J CLIN ONCOL, V14, P159; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Levine JA, 2001, SCIENCE, V294, P812, DOI 10.1126/science.1064627; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; Mhurchu CN, 2006, ASIA PAC J CLIN NUTR, V15, P127; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; MORRIS JN, 1953, LANCET, V265, P1053; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Nakamura K, 2009, TOB CONTROL, V18, P345, DOI 10.1136/tc.2008.028795; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pischon T, 2010, NEW ENGL J MED, V362, P2433; Puska P, 2010, ANNU REV PUBL HEALTH, V31, P315, DOI 10.1146/annurev.publhealth.012809.103658; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294; TUOMILEHTO J, 1984, STROKE, V15, P823, DOI 10.1161/01.STR.15.5.823; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	62	430	452	10	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					954	964		10.1056/NEJMra1203528	http://dx.doi.org/10.1056/NEJMra1203528			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004122				2022-12-28	WOS:000323906900012
J	Frohlich, B; Dynes, JF; Lucamarini, M; Sharpe, AW; Yuan, ZL; Shields, AJ				Froehlich, Bernd; Dynes, James F.; Lucamarini, Marco; Sharpe, Andrew W.; Yuan, Zhiliang; Shields, Andrew J.			A quantum access network	NATURE			English	Article							KEY DISTRIBUTION; FIELD-TEST; COMMUNICATION	The theoretically proven security of quantum key distribution(QKD) could revolutionize the way in which information exchange is protected in the future(1,2). Several field tests of QKD have proven it to be a reliable technology for cryptographic key exchange and have demonstrated nodal networks of point-to-point links(3-5). However, until now no convincing answer has been given to the question of how to extend the scope of QKD beyond niche applications in dedicated high security networks. Here we introduce and experimentally demonstrate the concept of a 'quantum access network': based on simple and cost-effective telecommunication technologies, the scheme can greatly expand the number of users in quantum networks and therefore vastly broaden their appeal. We show that a high-speed single-photon detector positioned at a network node can be shared between up to 64 users for exchanging secret keys with the node, thereby significantly reducing the hardware requirements for each user added to the network. This point-to-multipoint architecture removes one of the main obstacles restricting the widespread application of QKD. It presents a viable method for realizing multi-user QKD networks with efficient use of resources, and brings QKD closer to becoming a widespread technology.	[Froehlich, Bernd; Dynes, James F.; Lucamarini, Marco; Sharpe, Andrew W.; Yuan, Zhiliang; Shields, Andrew J.] Toshiba Res Europe Ltd, Cambridge CB4 0GZ, England; [Froehlich, Bernd; Dynes, James F.; Lucamarini, Marco; Yuan, Zhiliang; Shields, Andrew J.] Toshiba Co Ltd, Corp Res & Dev Ctr, Saiwai Ku, Kawasaki, Kanagawa 2128582, Japan	Toshiba Corporation; Toshiba Corporation	Shields, AJ (corresponding author), Toshiba Res Europe Ltd, 208 Cambridge Sci Pk, Cambridge CB4 0GZ, England.	bernd.frohlich@crl.toshiba.co.uk; zhiliang.yuan@crl.toshiba.co.uk; andrew.shields@crl.toshiba.co.uk	Shields, Andrew J/P-3575-2018; Yuan, Zhiliang/AAY-7430-2021; Lucamarini, Marco/G-4748-2010; Yuan, Zhiliang/C-9609-2010; Yuan, Zhiliang/HHZ-6646-2022	Yuan, Zhiliang/0000-0001-5276-9151; Lucamarini, Marco/0000-0002-7351-4622; Yuan, Zhiliang/0000-0001-5276-9151; Yuan, Zhiliang/0000-0001-5276-9151	Research and Development of Secure Photonic Network Technologies; Commissioned Research of the National Institute of Information and Communications Technology (NICT), Japan	Research and Development of Secure Photonic Network Technologies; Commissioned Research of the National Institute of Information and Communications Technology (NICT), Japan	This research is partly supported by Research and Development of Secure Photonic Network Technologies, the Commissioned Research of the National Institute of Information and Communications Technology (NICT), Japan.	Barnett S., 2011, GCC C EXH GCC 2011 I, P143; Cai RYQ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045024; Chapuran TE, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/105001; Chen TY, 2010, OPT EXPRESS, V18, P27217, DOI 10.1364/OE.18.027217; Dixon AR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3385293; Elliott C, 2005, PROC SPIE, V5815, P138, DOI 10.1117/12.606489; Hayashi M, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.012329; Hughes R. J., 2013, NETWORK CTR QUANTUM; Hwang WY, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.057901; International Telecommunication Union, 2008, G9841 INT TEL UN, V1st; Lo HK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230504; Lo HK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.130503; Lucamarini M., 2012, P SOC PHOTO-OPT INS, V8542; Lutkenhaus N, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045005; Ma XF, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.012326; Nauerth S, 2013, NAT PHOTONICS, V7, P382, DOI [10.1038/nphoton.2013.46, 10.1038/NPHOTON.2013.46]; Patel KA, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041010; Peev M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075001; Sasaki M, 2011, OPT EXPRESS, V19, P10387, DOI 10.1364/OE.19.010387; Scarani V., 2008, SECURITY BOUNDS QUAN; Scarani V, 2009, REV MOD PHYS, V81, P1301, DOI 10.1103/RevModPhys.81.1301; Scarani V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.200501; Toliver P, 2003, IEEE PHOTONIC TECH L, V15, P1669, DOI 10.1109/LPT.2003.818687; Townsend PD, 1997, NATURE, V385, P47, DOI 10.1038/385047a0; Ursin R, 2007, NAT PHYS, V3, P481, DOI 10.1038/nphys629; Wang JY, 2013, NAT PHOTONICS, V7, P387, DOI [10.1038/nphoton.2013.89, 10.1038/NPHOTON.2013.89]; Wang SA, 2010, OPT LETT, V35, P2454, DOI 10.1364/OL.35.002454; Wang XB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.230503; Yuan ZL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2931070; Yuan ZL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2760135	30	178	184	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2013	501	7465					69	+		10.1038/nature12493	http://dx.doi.org/10.1038/nature12493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	24005413	Green Submitted			2022-12-28	WOS:000323888300033
J	Alexandersen, M; Gladman, B; Greenstreet, S; Kavelaars, JJ; Petit, JM; Gwyn, S				Alexandersen, Mike; Gladman, Brett; Greenstreet, Sarah; Kavelaars, J. J.; Petit, Jean-Marc; Gwyn, Stephen			A Uranian Trojan and the Frequency of Temporary Giant-Planet Co-Orbitals	SCIENCE			English	Article							NEAR-EARTH ASTEROIDS; SIZE DISTRIBUTION; COORBITAL MOTION; NEPTUNE TROJANS; KUIPER-BELT; POPULATION; CENTAURS	Trojan objects share a planet's orbit, never straying far from the triangular Lagrangian points, 60 degrees ahead of (L4) or behind (L5) the planet. We report the detection of a Uranian Trojan; in our numerical integrations, 2011 QF(99) oscillates around the Uranian L4 Lagrange point for >70,000 years and remains co-orbital for similar to 1 million years before becoming a Centaur. We constructed a Centaur model, supplied from the transneptunian region, to estimate temporary co-orbital capture frequency and duration (to a factor of 2 accuracy), finding that at any time 0.4 and 2.8% of the population will be Uranian and Neptunian co-orbitals, respectively. The co-orbital fraction (similar to 2.4%) among Centaurs in the International Astronomical Union Minor Planet Centre database is thus as expected under transneptunian supply.	[Alexandersen, Mike; Gladman, Brett; Greenstreet, Sarah] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Kavelaars, J. J.; Gwyn, Stephen] Natl Res Council Canada, Victoria, BC V9E 2E7, Canada; [Petit, Jean-Marc] Observ Besancon, CNRS UMR 6213, Inst UTINAM, F-25010 Besancon, France	University of British Columbia; National Research Council Canada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Alexandersen, M (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.	mikea@astro.ubc.ca	Alexandersen, Mike/AAA-7662-2020	Alexandersen, Mike/0000-0003-4143-8589; Kavelaars, JJ/0000-0001-7032-5255	National Sciences and Engineering Research Council of Canada	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The data are available at the IAU Minor Planet Center's online database under MPEC K13F19. We thank N. Kaib for making the scattering object model available to us. We thank S. Lawler, C. Shankman, and N. Kaib for proofreading and constructive comments. M. A., S. G., and B. G. were supported by the National Sciences and Engineering Research Council of Canada. This work is based on observations obtained at the Canada-France-Hawaii Telescope, operated by the National Research Council of Canada, the Institut National des Sciences de l'Univers of the Centre National de la Recherche Scientifique of France, and the University of Hawaii.	Alexandersen M., 2013, MINOR PLANET ELECTRO, P19; Chiang EI, 2005, ASTROPHYS J, V628, P520, DOI 10.1086/430825; Christou AA, 2000, ICARUS, V144, P1, DOI 10.1006/icar.1999.6278; Dones L, 1999, ICARUS, V142, P509, DOI 10.1006/icar.1999.6220; Dvorak R, 2010, CELEST MECH DYN ASTR, V107, P51, DOI 10.1007/s10569-010-9261-y; Elliot JL, 2005, ASTRON J, V129, P1117, DOI 10.1086/427395; Gladman B, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/1/23; Gladman B., 2008, NOMENCLATURE OUTER S, P43; Horner J, 2006, MON NOT R ASTRON SOC, V367, pL20, DOI 10.1111/j.1745-3933.2006.00131.x; Kaib NA, 2011, ICARUS, V215, P491, DOI 10.1016/j.icarus.2011.07.037; Kortenkamp SJ, 2004, ICARUS, V167, P347, DOI 10.1016/j.icarus.2003.09.021; Kortenkamp SJ, 2011, ICARUS, V215, P669, DOI 10.1016/j.icarus.2011.07.019; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Lykawka PS, 2007, ICARUS, V192, P238, DOI 10.1016/j.icarus.2007.06.007; Mikkola S, 2006, MON NOT R ASTRON SOC, V369, P15, DOI 10.1111/j.1365-2966.2006.10306.x; Morais MHM, 2006, ICARUS, V185, P29, DOI 10.1016/j.icarus.2006.06.009; Morais MHM, 2002, ICARUS, V160, P1, DOI 10.1006/icar.2002.6937; Nesvorny D, 2002, ICARUS, V160, P271, DOI 10.1006/icar.2002.6961; Petit JM, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/131; Shankman C, 2013, ASTROPHYS J LETT, V764, DOI 10.1088/2041-8205/764/1/L2; Sheppard SS, 2010, ASTROPHYS J LETT, V723, pL233, DOI 10.1088/2041-8205/723/2/L233; Tiscareno MS, 2003, ASTRON J, V126, P3122, DOI 10.1086/379554	22	35	37	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					994	997		10.1126/science.1238072	http://dx.doi.org/10.1126/science.1238072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990557	Green Submitted			2022-12-28	WOS:000323652300040
J	Bamber, JL; Siegert, MJ; Griggs, JA; Marshall, SJ; Spada, G				Bamber, Jonathan L.; Siegert, Martin J.; Griggs, Jennifer A.; Marshall, Shawn J.; Spada, Giorgio			Paleofluvial Mega-Canyon Beneath the Central Greenland Ice Sheet	SCIENCE			English	Article							BASAL MELT; GLACIER	Subglacial topography plays an important role in modulating the distribution and flow of basal water. Where topography predates ice sheet inception, it can also reveal insights into former tectonic and geomorphological processes. Although such associations are known in Antarctica, little consideration has been given to them in Greenland, partly because much of the ice sheet bed is thought to be relatively flat and smooth. Here, we present evidence from ice-penetrating radar data for a 750-km-long subglacial canyon in northern Greenland that is likely to have influenced basal water flow from the ice sheet interior to the margin. We suggest that the mega-canyon predates ice sheet inception and will have influenced basal hydrology in Greenland over past glacial cycles.	[Bamber, Jonathan L.; Siegert, Martin J.; Griggs, Jennifer A.] Univ Bristol, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England; [Marshall, Shawn J.] Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada; [Spada, Giorgio] Univ Urbino, Dipartimento Sci Base & Fondamenti, I-61029 Urbino, Italy	University of Bristol; University of Calgary; University of Urbino	Bamber, JL (corresponding author), Univ Bristol, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England.	j.bamber@bristol.ac.uk	Siegert, Martin/M-9939-2019; Bamber, Jonathan/C-7608-2011; Siegert, Martin J/A-3826-2008	Siegert, Martin/0000-0002-0090-4806; Bamber, Jonathan/0000-0002-2280-2819; Siegert, Martin J/0000-0002-0090-4806; Spada, Giorgio/0000-0001-7615-4709	ice2sea program from the European Union [226375]; Natural Environment Research Council [NE/H021078/1]; NSF [ANT-0424589]; NASA [NNX10AT68G]; NASA Operation IceBridge project; Natural Environment Research Council [NE/H021078/2, NE/H020284/1, NE/H020667/1] Funding Source: researchfish; NERC [NE/H021078/2, NE/H020284/1, NE/H020667/1, NE/H021078/1] Funding Source: UKRI	ice2sea program from the European Union; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NASA Operation IceBridge project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J.L.B., J.A.G., and G. S. were supported by funding from the ice2sea program from the European Union 7th Framework Programme, grant 226375. This work is ice2sea contribution number 158. J.L.B. and M.J.S. were supported by Natural Environment Research Council grant NE/H021078/1. We acknowledge the use of data products from CReSIS generated with support from NSF grant ANT-0424589, NASA grant NNX10AT68G, and the NASA Operation IceBridge project. J.L.B. wrote the main text with substantial contributions from M.J.S. and input from all authors. J.A.G. carried out the hydraulic potential calculations. G. S. calculated the isostatically adjusted bed, and S.J.M. produced the LGM ice sheet configuration.	Alley RB, 2010, QUATERNARY SCI REV, V29, P1728, DOI 10.1016/j.quascirev.2010.02.007; Bamber JL, 2013, CRYOSPHERE, V7, P499, DOI 10.5194/tc-7-499-2013; Bartoli G, 2005, EARTH PLANET SC LETT, V237, P33, DOI 10.1016/j.epsl.2005.06.020; Braun A, 2007, EARTH PLANET SC LETT, V262, P138, DOI 10.1016/j.epsl.2007.07.050; Bull W. B., 1977, GEOMORPHOLOGY ARID R, P115; DahlJensen D, 2003, ANN GLACIOL-SER, V37, P207, DOI 10.3189/172756403781815492; DREWRY DJ, 1976, TECTONOPHYSICS, V36, P301, DOI 10.1016/0040-1951(76)90023-8; Ekholm S, 1998, GEOPHYS RES LETT, V25, P3623, DOI 10.1029/98GL02589; Evatt GW, 2006, PHILOS T R SOC A, V364, P1769, DOI 10.1098/rsta.2006.1798; Fahnestock M, 2001, SCIENCE, V294, P2338, DOI 10.1126/science.1065370; Henriksen N., 2009, GEOLOGICAL SURVEY DE, V18, P126; Joughin I, 1996, SCIENCE, V274, P228, DOI 10.1126/science.274.5285.228; Oswald GKA, 2012, IEEE T GEOSCI REMOTE, V50, P585, DOI 10.1109/TGRS.2011.2162072; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031765; Shreve R.L., 1972, J GLACIOL, V11, P205, DOI [DOI 10.3189/S002214300002219X, 10.3189/S002214300002219X]; Straneo F, 2011, NAT GEOSCI, V4, P322, DOI [10.1038/ngeo1109, 10.1038/NGEO1109]; Studinger M, 2001, GEOPHYS RES LETT, V28, P3493, DOI 10.1029/2000GL011788; Summerfield L, 1991, WOMANS PLACE MEMOIRS; Vaughan DG, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2012JF002360	19	57	57	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					997	999		10.1126/science.1239794	http://dx.doi.org/10.1126/science.1239794			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990558				2022-12-28	WOS:000323652300041
J	Swift, J; Ivanovska, IL; Buxboim, A; Harada, T; Dingal, PCDP; Pinter, J; Pajerowski, JD; Spinler, KR; Shin, JW; Tewari, M; Rehfeldt, F; Speicher, DW; Discher, DE				Swift, Joe; Ivanovska, Irena L.; Buxboim, Amnon; Harada, Takamasa; Dingal, P. C. Dave P.; Pinter, Joel; Pajerowski, J. David; Spinler, Kyle R.; Shin, Jae-Won; Tewari, Manorama; Rehfeldt, Florian; Speicher, David W.; Discher, Dennis E.			Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation	SCIENCE			English	Article							SERUM RESPONSE FACTOR; STEM-CELL FATE; B-TYPE LAMINS; RETINOIC ACID; EXTRACELLULAR-MATRIX; STEREOLOGICAL ANALYSIS; SKELETAL-MUSCLE; GENE-EXPRESSION; HIPPO PATHWAY; ACTIN	Tissues can be soft like fat, which bears little stress, or stiff like bone, which sustains high stress, but whether there is a systematic relationship between tissue mechanics and differentiation is unknown. Here, proteomics analyses revealed that levels of the nucleoskeletal protein lamin-A scaled with tissue elasticity, E, as did levels of collagens in the extracellular matrix that determine E. Stem cell differentiation into fat on soft matrix was enhanced by low lamin-A levels, whereas differentiation into bone on stiff matrix was enhanced by high lamin-A levels. Matrix stiffness directly influenced lamin-A protein levels, and, although lamin-A transcription was regulated by the vitamin A/retinoic acid (RA) pathway with broad roles in development, nuclear entry of RA receptors was modulated by lamin-A protein. Tissue stiffness and stress thus increase lamin-A levels, which stabilize the nucleus while also contributing to lineage determination.	[Swift, Joe; Ivanovska, Irena L.; Buxboim, Amnon; Harada, Takamasa; Dingal, P. C. Dave P.; Pinter, Joel; Pajerowski, J. David; Spinler, Kyle R.; Shin, Jae-Won; Tewari, Manorama; Rehfeldt, Florian; Discher, Dennis E.] Univ Penn, Mol & Cell Biophys Lab, Philadelphia, PA 19104 USA; [Speicher, David W.; Discher, Dennis E.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute	Discher, DE (corresponding author), Univ Penn, Mol & Cell Biophys Lab, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu	Swift, Joe/A-5149-2014; Rehfeldt, Florian/A-1078-2007	Swift, Joe/0000-0002-5039-9094; Rehfeldt, Florian/0000-0001-9086-3835; discher, dennis/0000-0001-6163-2229; Buxboim, Amnon/0000-0003-2412-9792	U.S. National Institutes of Health [NIH R01HL062352, P01DK032094, R01EB007049, NCATS-8UL1TR000003]; U.S. National Science Foundation [1200834]; Human Frontier Science Program; Stem Cell Xenograft Core; Microarray Cores [P30-DK090969]; U.S. NIH [HL038794, CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038794, R01HL062352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094, P30DK090969] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); Stem Cell Xenograft Core; Microarray Cores; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We greatly appreciate support from the U.S. National Institutes of Health (NIH R01HL062352, P01DK032094, R01EB007049, and NCATS-8UL1TR000003), the U.S. National Science Foundation (grant 1200834, the University of Pennsylvania's Materials Research Science and Engineering Center, and Nano Science and Engineering Center, Nano/Bio Interface Center), the Human Frontier Science Program (to I. L. I. and D. E. D.), and the Stem Cell Xenograft Core (to A. Secreto, J. Glover, and G. Danet-Desnoyers) and Microarray Cores (P30-DK090969). We thank the Wistar Institute Proteomics Core for assistance with MS and standard data analyses. This work was also supported in part by U.S. NIH grants HL038794 (to D. W. S.) and CA010815 (National Cancer Institute core grant to the Wistar Institute). We thank D. Gilbert (Florida State University, Department of Biological Science), H. Herrmann (Heidelberg, DKFZ), and H. Worman (Columbia University, Department of Medicine), respectively, for GFP-lamin-A, recombinant lamins, and SUN2 plasmids.	Agarwal C, 1996, J BIOL CHEM, V271, P12209, DOI 10.1074/jbc.271.21.12209; Akter R, 2009, J BONE MINER RES, V24, P283, DOI 10.1359/JBMR.081010; Alves RDAM, 2011, J PROTEOME RES, V10, P4725, DOI 10.1021/pr200522n; Ayala-Sumuano JT, 2011, SCI REP-UK, V1, DOI 10.1038/srep00178; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Barnes H.A, 2000, HDB ELEMENTARY RHEOL; Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965; Bertacchini J, 2013, FASEB J, V27, P2145, DOI 10.1096/fj.12-218214; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chen BPC, 2001, PHYSIOL GENOMICS, V7, P55, DOI 10.1152/physiolgenomics.2001.7.1.55; Chen JF, 2012, J BONE MINER RES, V27, P1659, DOI 10.1002/jbmr.1607; Colby R.H., 2003, POLYM PHYS; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; EISENBERG BR, 1975, J ULTRA MOL STRUCT R, V51, P176, DOI 10.1016/S0022-5320(75)80146-8; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Flynn BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012337; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; Heo Y, 2005, J RHEOL, V49, P1117, DOI 10.1122/1.1993595; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; HOPE J, 1970, J ULTRA MOL STRUCT R, V33, P292, DOI 10.1016/S0022-5320(70)90023-7; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Jahn D, 2012, NUCLEUS-AUSTIN, V3, P463, DOI 10.4161/nucl.21676; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kim HJ, 2011, P NATL ACAD SCI USA, V108, P2010, DOI 10.1073/pnas.1018974108; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; Kubben N, 2011, NUCLEUS-PHILA, V2, P195, DOI 10.4161/nucl.2.3.15731; Kubben N, 2010, NUCLEUS-PHILA, V1, P513, DOI 10.4161/nucl.1.6.13512; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lamond A. I., 2009, NUCL ISOLATION PROTO; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; Lu PPY, 2011, J NEUROSCI, V31, P16651, DOI 10.1523/JNEUROSCI.3015-11.2011; Ma X, 2010, MOL BIOL REP, V37, P4003, DOI 10.1007/s11033-010-0059-5; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Okumura K, 2004, BIOCHEM BIOPH RES CO, V320, P487, DOI 10.1016/j.bbrc.2004.05.191; Olins AL, 2001, EXP CELL RES, V268, P115, DOI 10.1006/excr.2001.5269; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Raab M, 2012, J CELL BIOL, V199, P669, DOI 10.1083/jcb.201205056; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Shin JW, 2013, DIFFERENTIATION, V86, P77, DOI 10.1016/j.diff.2013.05.001; Shin JW, 2011, P NATL ACAD SCI USA, V108, P11458, DOI 10.1073/pnas.1017474108; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Simon DN, 2010, NUCLEUS-PHILA, V1, P264, DOI 10.4161/nucl.1.3.11799; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Strobl G., 2007, PHYS POLYM CONCEPTS; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Tunnah D, 2005, J MOL HISTOL, V36, P337, DOI 10.1007/s10735-005-9004-7; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Welch ID, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2604; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Yu SL, 2012, J BIOL CHEM, V287, P42195, DOI 10.1074/jbc.M112.410381; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhang W, 2010, BRAIN RES, V1359, P256, DOI 10.1016/j.brainres.2010.08.072; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	94	1145	1178	20	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149							1240104	10.1126/science.1240104	http://dx.doi.org/10.1126/science.1240104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990565	Green Accepted			2022-12-28	WOS:000323652300034
J	Cotillard, A; Kennedy, SP; Kong, LC; Prifti, E; Pons, N; Le Chatelier, E; Almeida, M; Quinquis, B; Levenez, F; Galleron, N; Gougis, S; Rizkalla, S; Batto, JM; Renault, P; Dore, J; Zucker, JD; Clement, K; Ehrlich, SD				Cotillard, Aurelie; Kennedy, Sean P.; Kong, Ling Chun; Prifti, Edi; Pons, Nicolas; Le Chatelier, Emmanuelle; Almeida, Mathieu; Quinquis, Benoit; Levenez, Florence; Galleron, Nathalie; Gougis, Sophie; Rizkalla, Salwa; Batto, Jean-Michel; Renault, Pierre; Dore, Joel; Zucker, Jean-Daniel; Clement, Karine; Ehrlich, Stanislav Dusko		ANR MicroObes Consortium	Dietary intervention impact on gut microbial gene richness	NATURE			English	Article							INSULIN SENSITIVITY; OBESE; INDEX; INFLAMMATION; RESISTANCE; OVERWEIGHT; MASS	Complex gene-environment interactions are considered important in the development of obesity(1). The composition of the gut microbiota can determine the efficacy of energy harvest from food(2-4) and changes in dietary composition have been associated with changes in the composition of gut microbial populations(5,6). The capacity to explore microbiota composition was markedly improved by the development of metagenomic approaches(7,8), which have already allowed production of the first human gut microbial gene catalogue(9) and stratifying individuals by their gut genomic profile into different enterotypes(10), but the analyses were carried out mainly in nonintervention settings. To investigate the temporal relationships between food intake, gut microbiota and metabolic and inflammatory phenotypes, we conducted diet-induced weight-loss and weight-stabilization interventions in a study sample of 38 obese and 11 overweight individuals. Here we report that individuals with reduced microbial gene richness (40%) present more pronounced dys-metabolism and low-grade inflammation, as observed concomitantly in the accompanying paper(11). Dietary intervention improves low gene richness and clinical phenotypes, but seems to be less efficient for inflammation variables in individuals with lower gene richness. Low gene richness may therefore have predictive potential for the efficacy of intervention.	[Cotillard, Aurelie; Kong, Ling Chun; Prifti, Edi; Rizkalla, Salwa; Zucker, Jean-Daniel; Clement, Karine] Ctr Rech Cordeliers, Inst Natl Sante & Rech Med, U872, Equipe 7, F-75006 Paris, France; [Cotillard, Aurelie; Kong, Ling Chun; Prifti, Edi; Rizkalla, Salwa; Zucker, Jean-Daniel; Clement, Karine] Univ Paris 06, F-75006 Paris, France; [Kennedy, Sean P.; Prifti, Edi; Pons, Nicolas; Le Chatelier, Emmanuelle; Almeida, Mathieu; Quinquis, Benoit; Levenez, Florence; Galleron, Nathalie; Batto, Jean-Michel; Dore, Joel; Ehrlich, Stanislav Dusko] INRA, Metagenopolis, F-78350 Jouy En Josas, France; [Kong, Ling Chun; Gougis, Sophie; Rizkalla, Salwa; Clement, Karine] CRNH Ile France, AP HP, Inst Cardiometab & Nutr, F-75013 Paris, France; [Levenez, Florence; Batto, Jean-Michel; Renault, Pierre; Dore, Joel] INRA, UMR Micalis 1319, F-78350 Jouy En Josas, France; [Zucker, Jean-Daniel] France Nord, UMMISCO, IRD, UMI 209, F-93143 Bondy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I	Ehrlich, SD (corresponding author), INRA, F-78350 Jouy En Josas, France.	karine.clement@psl.aphp.fr; dusko.ehrlich@jouy.inra.fr	ZUCKER, Jean-Daniel/K-3008-2016; Ehrlich, S./Y-2423-2019; Clément, karine/R-1120-2017; Leclerc, Marion/AAZ-3950-2021; Prifti, Edi/F-3967-2019; BLOTTIERE, Hervé M/C-6120-2011; Dore, Joel/ABA-8921-2020; Henegar, Corneliu R/K-9166-2013; Lepage, Patricia/D-4362-2014; LE CHATELIER, Emmanuelle/O-1243-2017	ZUCKER, Jean-Daniel/0000-0002-5597-7922; Ehrlich, S./0000-0002-7563-4046; Leclerc, Marion/0000-0001-8684-2847; Prifti, Edi/0000-0001-8861-1305; BLOTTIERE, Hervé M/0000-0002-8390-0607; Henegar, Corneliu R/0000-0002-8486-5591; Lepage, Patricia/0000-0002-9501-6771; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Loux, Valentin/0000-0002-8268-915X; Le Paslier, Denis/0000-0003-4335-9956; Kennedy, Sean/0000-0002-3932-8922; Pelletier, Eric/0000-0003-4228-1712	Agence Nationale de la Recherche (ANR MICRO-Obes, ANR, Nutra2sens) [ANR-10-IAHU-05]; Metagenopolis grant [ANR-11-DPBS-0001]; KOT-Ceprodi (Florence Massiera); Danone Research (Damien Paineau); association Fondacoeur; association Louis-Bonduelle; European Commission [HEALTH-F4-2007-201052]; METACARDIS	Agence Nationale de la Recherche (ANR MICRO-Obes, ANR, Nutra2sens)(French National Research Agency (ANR)); Metagenopolis grant; KOT-Ceprodi (Florence Massiera); Danone Research (Damien Paineau)(Danone Nutricia); association Fondacoeur; association Louis-Bonduelle; European Commission(European CommissionEuropean Commission Joint Research Centre); METACARDIS	We are grateful to O. Pedersen (Univ. Copenhagen) for helpful comments on this manuscript and to the MetaHIT consortium for providing the gene profiles of the Danish subjects used to test the ROC models in advance of publication and the DNA samples sequenced on the SOLiD platform for comparison with the Illumina platform used in the accompanying manuscript. We thank C. Baudoin, P. Ancel and V. Pelloux who contributed to the clinical investigation study; S. Fellahi and J.-P. Bastard for analyses of inflammatory markers; D. Bonnefont-Rousselot and R. Bittar for help with the analysis of plasma lipid profile. This work was supported by Agence Nationale de la Recherche (ANR MICRO-Obes, ANR, Nutra2sens, ANR-10-IAHU-05), the Metagenopolis grant ANR-11-DPBS-0001, KOT-Ceprodi (Florence Massiera), Danone Research (Damien Paineau) and the associations Fondacoeur, and Louis-Bonduelle. Additional funding came from the European Commission FP7 grant HEALTH-F4-2007-201052 and METACARDIS.	Antuna-Puente B, 2009, EUR J ENDOCRINOL, V161, P51, DOI 10.1530/EJE-09-0091; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouche C, 2002, DIABETES CARE, V25, P822, DOI 10.2337/diacare.25.5.822; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Disse E, 2008, DIABETES METAB, V34, P457, DOI 10.1016/j.diabet.2008.02.009; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Jiang D., 2011, STAT METHODS MED RES; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Mutch DM, 2006, PLOS GENET, V2, P1956, DOI 10.1371/journal.pgen.0020188; National Research Council, 2007, THE NEW SCIENCE OF M; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pons N., 2010, JOURNEES OUVERTES EN; Prat-Larquemin L, 2004, OBES RES, V12, P556, DOI 10.1038/oby.2004.63; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rizkalla SW, 2012, AM J CLIN NUTR, V95, P49, DOI 10.3945/ajcn.111.017277; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silverman B., 1986, DENSITY ESTIMATION S, V175; Tordjman J, 2012, J HEPATOL, V56, P1152, DOI 10.1016/j.jhep.2011.12.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	29	1118	1187	14	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					585	+		10.1038/nature12480	http://dx.doi.org/10.1038/nature12480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23985875				2022-12-28	WOS:000323625900036
J	Le Chatelier, E; Nielsen, T; Qin, JJ; Prifti, E; Hildebrand, F; Falony, G; Almeida, M; Arumugam, M; Batto, JM; Kennedy, S; Leonard, P; Li, JH; Burgdorf, K; Grarup, N; Jorgensen, T; Brandslund, I; Nielsen, HB; Juncker, AS; Bertalan, M; Levenez, F; Pons, N; Rasmussen, S; Sunagawa, S; Tap, J; Tims, S; Zoetendal, EG; Brunak, S; Clement, K; Dore, J; Kleerebezem, M; Kristiansen, K; Renault, P; Sicheritz-Ponten, T; de Vos, WM; Zucker, JD; Raes, J; Hansen, T; Bork, P; Wang, J; Ehrlich, SD; Pedersen, O				Le Chatelier, Emmanuelle; Nielsen, Trine; Qin, Junjie; Prifti, Edi; Hildebrand, Falk; Falony, Gwen; Almeida, Mathieu; Arumugam, Manimozhiyan; Batto, Jean-Michel; Kennedy, Sean; Leonard, Pierre; Li, Junhua; Burgdorf, Kristoffer; Grarup, Niels; Jorgensen, Torben; Brandslund, Ivan; Nielsen, Henrik Bjorn; Juncker, Agnieszka S.; Bertalan, Marcelo; Levenez, Florence; Pons, Nicolas; Rasmussen, Simon; Sunagawa, Shinichi; Tap, Julien; Tims, Sebastian; Zoetendal, Erwin G.; Brunak, Soren; Clement, Karine; Dore, Joel; Kleerebezem, Michiel; Kristiansen, Karsten; Renault, Pierre; Sicheritz-Ponten, Thomas; de Vos, Willem M.; Zucker, Jean-Daniel; Raes, Jeroen; Hansen, Torben; Bork, Peer; Wang, Jun; Ehrlich, S. Dusko; Pedersen, Oluf		MetaHIT Consortium	Richness of human gut microbiome correlates with metabolic markers	NATURE			English	Article							BODY-MASS INDEX; DIET-INDUCED OBESITY; WIDE ASSOCIATION; WEIGHT; INFLAMMATION; LOCI; RESISTANCE; CHILDHOOD; VARIANTS; BACTERIA	We are facing a global metabolic health crisis provoked by an obesity epidemic. Here we report the human gut microbial composition in a population sample of 123 non-obese and 169 obese Danish individuals. We find two groups of individuals that differ by the number of gut microbial genes and thus gut bacterial richness. They contain known and previously unknown bacterial species at different proportions; individuals with a low bacterial richness (23% of the population) are characterized by more marked overall adiposity, insulin resistance and dyslipidaemia and a more pronounced inflammatory phenotype when compared with high bacterial richness individuals. The obese individuals among the lower bacterial richness group also gain more weight over time. Only a few bacterial species are sufficient to distinguish between individuals with high and low bacterial richness, and even between lean and obese participants. Our classifications based on variation in the gut microbiome identify subsets of individuals in the general white adult population who may be at increased risk of progressing to adiposity-associated co-morbidities.	[Le Chatelier, Emmanuelle; Prifti, Edi; Almeida, Mathieu; Batto, Jean-Michel; Kennedy, Sean; Leonard, Pierre; Levenez, Florence; Pons, Nicolas; Tap, Julien; Dore, Joel] INRA, Metagenopolis US1367, F-78350 Jouy En Josas, France; [Nielsen, Trine; Arumugam, Manimozhiyan; Burgdorf, Kristoffer; Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Qin, Junjie; Arumugam, Manimozhiyan; Li, Junhua] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Hildebrand, Falk; Falony, Gwen; Raes, Jeroen] VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Hildebrand, Falk; Falony, Gwen; Raes, Jeroen] Vrije Univ Brussel, Dept Biosci Engn, B-1050 Brussels, Belgium; [Arumugam, Manimozhiyan; Sunagawa, Shinichi; Tap, Julien; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Li, Junhua] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou 510006, Guangdong, Peoples R China; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2900 Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Inst Publ Hlth, DK-9100 Aalborg, Denmark; [Brandslund, Ivan] Vejle Hosp, Dept Clin Biochem, DK-7100 Vejle, Denmark; [Brandslund, Ivan] Univ Southern Denmark, Inst Reg Hlth Res, DK-8200 Odense, Denmark; [Nielsen, Henrik Bjorn; Juncker, Agnieszka S.; Bertalan, Marcelo; Rasmussen, Simon; Brunak, Soren; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Nielsen, Henrik Bjorn; Juncker, Agnieszka S.; Bertalan, Marcelo; Rasmussen, Simon; Brunak, Soren; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Tims, Sebastian; Zoetendal, Erwin G.; Kleerebezem, Michiel; de Vos, Willem M.] Wageningen Univ, Lab Microbiol, NL-6710 BA Ede, Netherlands; [Clement, Karine] Ctr Rech Cordeliers, Inst Natl Sante & Rech Med, U872, Equipe 7, F-75006 Paris, France; [Clement, Karine; Zucker, Jean-Daniel] Univ Paris 06, F-75006 Paris, France; [Clement, Karine] CRNH Ile France, Inst Cardiometab & Nutr, AP HP, F-75013 Paris, France; [Dore, Joel; Renault, Pierre] INRA, MICALIS, UMR14121, F-78350 Jouy En Josas, France; [Kristiansen, Karsten] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Zucker, Jean-Daniel] Inst Rech Dev, UMI 209, Unite Modelisat Math & Informat Syst Complexes, F-93143 Bondy, France; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, DK-8200 Odense, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Wang, Jun] Aarhus Univ, Ctr Sequencing, DK-8000 Aarhus C, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, DK-2820 Gentofte, Denmark; [Pedersen, Oluf] Univ Copenhagen, Fac Hlth & Med Sci, Inst Biomed Sci, DK-2200 Copenhagen, Denmark; [Pedersen, Oluf] Aarhus Univ, Fac Hlth, DK-8000 Aarhus, Denmark	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Novo Nordisk Foundation; University of Copenhagen; Beijing Genomics Institute (BGI); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; European Molecular Biology Laboratory (EMBL); South China University of Technology; University of Copenhagen; University of Copenhagen; Aalborg University; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Technical University of Denmark; Novo Nordisk Foundation; Technical University of Denmark; Wageningen University & Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Copenhagen; University of Helsinki; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; University of Southern Denmark; King Abdulaziz University; Novo Nordisk Foundation; University of Copenhagen; Aarhus University; Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Aarhus University	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bork@embl.de; wangj@genomics.org.cn; dusko.ehrlich@jouy.inra.fr; oluf@sund.ku.dk	Leclerc, Marion/AAZ-3950-2021; Knol, Jan/A-2178-2010; Li, Junhua/AAG-3919-2019; Arumugam, Manimozhiyan/AAJ-2394-2020; Kristiansen, Karsten/J-5148-2014; Arumugam, Manimozhiyan/E-1211-2011; Hildebrand, Falk/K-1914-2014; Guédon, Eric/AAP-4143-2021; GUEDON, Eric/N-8624-2019; Wang, Jun/A-7261-2013; Falony, Gwen/AAN-5011-2020; Dore, Joel/ABA-8921-2020; Guedon, Eric/S-5635-2016; van Hylckama Vlieg, Johan/F-7887-2014; Knol, Jan/AAL-6487-2020; Pedersen, Oluf/AAG-8015-2020; BLOTTIERE, Hervé M/C-6120-2011; Pedersen, Oluf/Z-1731-2019; Tap, Julien/E-5760-2010; Jørgensen, Torben/Z-1335-2018; Veiga, Patrick/A-9862-2011; Grarup, Niels/K-2807-2015; LE CHATELIER, Emmanuelle/O-1243-2017; Rescigno, Maria/J-9704-2012; Prifti, Edi/F-3967-2019; raes, jeroen/D-7835-2018; Sunagawa, Shinichi/Q-5950-2019; Guarner, Francisco/ABF-1192-2020; Rasmussen, Simon/G-6258-2016; Ehrlich, S./Y-2423-2019; ZUCKER, Jean-Daniel/K-3008-2016; Rasmussen, Simon/AAA-2308-2020; Nielsen, Henrik/B-8961-2019; Clément, karine/R-1120-2017; Bork, Peer/F-1813-2013; Kleerebezem, Michiel/AAT-2078-2021; Borruel, Natalia/AFO-6891-2022; Brunak, Soren/O-6621-2016; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Sicheritz-Ponten, Thomas/A-4325-2017	Leclerc, Marion/0000-0001-8684-2847; Knol, Jan/0000-0002-2103-5961; Li, Junhua/0000-0001-6784-1873; Arumugam, Manimozhiyan/0000-0002-0886-9101; Kristiansen, Karsten/0000-0002-6024-0917; Arumugam, Manimozhiyan/0000-0002-0886-9101; Hildebrand, Falk/0000-0002-0078-8948; GUEDON, Eric/0000-0002-0901-4447; Falony, Gwen/0000-0003-2450-0782; Guedon, Eric/0000-0002-0901-4447; van Hylckama Vlieg, Johan/0000-0001-6656-8668; Knol, Jan/0000-0002-2103-5961; BLOTTIERE, Hervé M/0000-0002-8390-0607; Pedersen, Oluf/0000-0002-3321-3972; Tap, Julien/0000-0001-8998-5413; Veiga, Patrick/0000-0001-6318-8547; Grarup, Niels/0000-0001-5526-1070; LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Rescigno, Maria/0000-0002-6464-509X; Prifti, Edi/0000-0001-8861-1305; raes, jeroen/0000-0002-1337-041X; Sunagawa, Shinichi/0000-0003-3065-0314; Guarner, Francisco/0000-0002-4051-0836; Rasmussen, Simon/0000-0001-6323-9041; Ehrlich, S./0000-0002-7563-4046; ZUCKER, Jean-Daniel/0000-0002-5597-7922; Rasmussen, Simon/0000-0001-6323-9041; Nielsen, Henrik/0000-0003-2281-5713; Bork, Peer/0000-0002-2627-833X; Borruel, Natalia/0000-0002-4449-2292; TORREJON, ANTONIO/0000-0002-3126-1532; Delorme, Christine/0000-0002-5208-7238; Brunak, Soren/0000-0003-0316-5866; Jorgensen, Torben/0000-0001-9453-2830; Varela Castro, Encarna/0000-0001-6334-9320; Chaysavanh, Manichanh/0000-0002-2287-4003; Burgdorf, Kristoffer/0000-0001-5814-6844; Wang, Jun/0000-0002-8540-8931; Derrien, Muriel/0000-0001-8841-9153; Brandslund, Ivan/0000-0002-4203-5442; Kleerebezem, Michiel/0000-0001-8552-2235; Nielsen, Trine/0000-0002-2066-7895; Pelletier, Eric/0000-0003-4228-1712; Wang, Jun/0000-0002-2113-5874; Hansen, Torben/0000-0001-8748-3831; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Kennedy, Sean/0000-0002-3932-8922	European Community [HEALTH-F4-2007-201052]; Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp); ANR MicroObes, the Metagenopolis grant [ANR-11-DPBS-0001]; Region Ile de France (CODDIM); Fondacoeur; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	European Community(European Commission); Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp); ANR MicroObes, the Metagenopolis grant(French National Research Agency (ANR)); Region Ile de France (CODDIM)(Region Ile-de-France); Fondacoeur; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors wish to thank A. Forman, T. Lorentzen, B. Andreasen, G. J. Klavsen and M. M. Andersen for technical assistance; A. L. Nielsen, G. Lademann and M. M. H. Kristensen for management assistance, K. Kiil for discussions and assistance, and A. Walker for comments on the manuscript. This research has received funding from European Community's Seventh Framework Program (FP7/2007-2013): MetaHIT, grant agreement HEALTH-F4-2007-201052. Additional funding came from The Lundbeck Foundation Centre for Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LuCamp, http://www.lucamp.org), ANR MicroObes, the Metagenopolis grant ANR-11-DPBS-0001, Region Ile de France (CODDIM) and Fondacoeur. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (http://www.metabol.ku.dk).	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Allison DB, 1996, INT J OBESITY, V20, P501; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chevaleyre Y., 2013, P 30 INT C MACH LEAR, V28, P651; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Obesity and Overweight, 2006, OB OV FACT SHEET 311; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; TREUTH MS, 1995, AM J CLIN NUTR, V62, P527, DOI 10.1093/ajcn/62.3.527; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S5; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	56	2577	2656	29	967	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					541	+		10.1038/nature12506	http://dx.doi.org/10.1038/nature12506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23985870				2022-12-28	WOS:000323625900026
J	Kremer, J; Li, ZG; Hall, S; Fleischmann, R; Genovese, M; Martin-Mola, E; Isaacs, JD; Gruben, D; Wallenstein, G; Krishnaswami, S; Zwillich, SH; Koncz, T; Riese, R; Bradley, J				Kremer, Joel; Li, Zhan-Guo; Hall, Stephen; Fleischmann, Roy; Genovese, Mark; Martin-Mola, Emilio; Isaacs, John D.; Gruben, David; Wallenstein, Gene; Krishnaswami, Sriram; Zwillich, Samuel H.; Koncz, Tamas; Riese, Richard; Bradley, John			Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							INADEQUATE RESPONSE; JAK INHIBITOR; METHOTREXATE; CP-690,550; PLACEBO; ADALIMUMAB; MALIGNANCY; EFFICACY; SAFETY; RISK	Background: Many patients with rheumatoid arthritis (RA) do not achieve adequate and safe responses with disease-modifying antirheumatic drugs (DMARDs). Tofacitinib is a novel, oral, Janus kinase inhibitor that treats RA. Objective: To evaluate the efficacy and safety of tofacitinib in combination with nonbiologic DMARDs. Design: 1-year, double-blind, randomized trial (ClinicalTrials.gov:NCT00856544). Setting: 114 centers in 19 countries. Patients: 792 patients with active RA despite nonbiologic DMARD therapy. Intervention: Patients were randomly assigned 4:4:1:1 to oral tofacitinib, 5 mg or 10 mg twice daily, or placebo advanced to tofacitinib, 5 mg or 10 mg twice daily. Measurements: Primary end points were 20% improvement in American College of Rheumatology (ACR20) criteria; Disease Activity Score for 28-joint counts based on the erythrocyte sedimentation rate (DAS28-4[ESR]) of less than 2.6; DAS28-4(ESR)-defined remission, change in Health Assessment Questionnaire Disability Index (HAQ-DI) score, and safety assessments. Results: Mean treatment differences for ACR20 response rates (month 6) for the 5-mg and 10-mg tofacitinib groups compared with the combined placebo groups were 21.2% (95% CI, 12.2% to 30.3%; P < 0.001) and 25.8% (CI, 16.8% to 34.8%; P < 0.001), respectively. The HAQ-DI scores (month 3) and DAS28-4( ESR) less than 2.6 response rates (month 6) were also superior in the tofacitinib groups versus placebo. The incidence rates of serious adverse events for patients receiving 5-mg tofacitinib, 10-mg tofacitinib, or placebo were 6.9, 7.3, or 10.9 events per 100 patient-years of exposure, respectively. In the tofacitinib groups, 2 cases of tuberculosis, 2 cases of other opportunistic infections, 3 cardiovascular events, and 4 deaths occurred. Neutrophil counts decreased, hemoglobin and low-and high-density lipoprotein cholesterol levels increased, and serum creatinine levels had small increases in the tofacitinib groups Limitations: Placebo groups were smaller and of shorter duration. Patients received primarily methotrexate. The ability to assess drug combinations other than tofacitinib plus methotrexate was limited. Conclusion: Tofacitinib improved disease control in patients with active RA despite treatment with nonbiologic DMARDs, primarily methotrexate.	Albany Med Coll, Albany, NY 12208 USA; Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; Cabrini Med Ctr, Malvern, Vic, Australia; Metroplex Clin Res Ctr, Dallas, TX USA; Stanford Univ, Stanford, CA 94305 USA; Hosp Univ La Paz, Madrid, Spain; Newcastle Univ, Newcastle Biomed Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Newcastle Tyne Hosp NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Riese, Richard] Pfizer Inc, Groton, CT 06340 USA; Pfizer, New York, NY USA	Albany Medical College; Peking University; Cabrini Health; Metroplex Clinical Research Center; Stanford University; Hospital Universitario La Paz; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Pfizer; Pfizer	Riese, R (corresponding author), Pfizer Inc, 558 Eastern Point Rd, Groton, CT 06340 USA.	Richard.J.Riese@Pfizer.com		Isaacs, John/0000-0002-6103-7056; Li, Zhanguo/0000-0002-2590-6242	Pfizer	Pfizer(Pfizer)	Pfizer	ALARCON GS, 1989, ARTHRITIS RHEUM, V32, P671, DOI 10.1002/anr.1780320603; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Askling J, 2008, CURR OPIN RHEUMATOL, V20, P334, DOI 10.1097/BOR.0b013e3282f7c706; Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X; Choy E, 2009, ANN RHEUM DIS, V68, P460, DOI 10.1136/ard.2008.101964; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fleischmann R, 2012, ARTHRITIS RHEUM-US, V64, P617, DOI 10.1002/art.33383; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Khraishi M, 2009, J RHEUMATOL, V36, P25, DOI 10.3899/jrheum.090128; Kremer JM, 2012, ARTHRITIS RHEUM-US, V64, P970, DOI 10.1002/art.33419; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Martin-Mola E, 2009, RHEUM DIS CLIN N AM, V35, P183, DOI 10.1016/j.rdc.2009.03.009; McInnes IB, 2013, ANN RHEUM DIS; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Saiki O, 2007, J RHEUMATOL, V34, P1997; Tanaka Y, 2011, ARTHRIT CARE RES, V63, P1150, DOI 10.1002/acr.20494; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; van der Kooij SM, 2007, ANN RHEUM DIS, V66, P1356, DOI 10.1136/ard.2006.066662; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864; World Health Organization, 2011, TUB COUNTR PROF	24	313	335	1	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					253	+		10.7326/0003-4819-159-4-201308200-00006	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026258				2022-12-28	WOS:000323421700015
J	Shyer, AE; Tallinen, T; Nerurkar, NL; Wei, ZY; Gil, ES; Kaplan, DL; Tabin, CJ; Mahadevan, L				Shyer, Amy E.; Tallinen, Tuomas; Nerurkar, Nandan L.; Wei, Zhiyan; Gil, Eun Seok; Kaplan, David L.; Tabin, Clifford J.; Mahadevan, L.			Villification: How the Gut Gets Its Villi	SCIENCE			English	Article							SMOOTH-MUSCLE-CELLS; INTESTINAL VILLI; MORPHOGENESIS; GROWTH; DIFFERENTIATION	The villi of the human and chick gut are formed in similar stepwise progressions, wherein the mesenchyme and attached epithelium first fold into longitudinal ridges, then a zigzag pattern, and lastly individual villi. We find that these steps of villification depend on the sequential differentiation of the distinct smooth muscle layers of the gut, which restrict the expansion of the growing endoderm and mesenchyme, generating compressive stresses that lead to their buckling and folding. A quantitative computational model, incorporating measured properties of the developing gut, recapitulates the morphological patterns seen during villification in a variety of species. These results provide a mechanistic understanding of the formation of these elaborations of the lining of the gut, essential for providing sufficient surface area for nutrient absorption.	[Shyer, Amy E.; Nerurkar, Nandan L.; Tabin, Clifford J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tallinen, Tuomas; Wei, Zhiyan; Mahadevan, L.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Tallinen, Tuomas] Univ Jyvaskyla, Dept Phys, FI-40014 Jyvaskyla, Finland; [Tallinen, Tuomas] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Mahadevan, L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Kavli Inst Nanobio Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; University of Jyvaskyla; University of Jyvaskyla; Tufts University; Harvard University; Harvard University; Harvard University; Harvard University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu; lm@seas.harvard.edu	Wei, Zhiyan/P-7447-2016; Tallinen, Tuomas/J-7065-2013		Academy of Finland; NIH [RO1 HD047360]; MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD047360] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank M. Kirschner for providing Xenopus tadpoles and O. Pourquie for providing snake embryos. D. L. K. and Tufts University hold a series of patents that cover the processing of silk into material structures, including those used in the research reported here. T. T. acknowledges the Academy of Finland for support. Computations were run at CSC-IT Center for Science, Finland. C.J.T. acknowledges the support of a grant from NIH RO1 HD047360. L. M. acknowledges the support of the MacArthur Foundation.	Audoly B, 2008, J MECH PHYS SOLIDS, V56, P2444, DOI 10.1016/j.jmps.2008.03.001; BELL L, 1982, ANAT EMBRYOL, V165, P437, DOI 10.1007/BF00305579; BELLWARE FT, 1970, J EMBRYOL EXP MORPH, V24, P335; Ben Amar M, 2013, P NATL ACAD SCI USA, V110, P10525, DOI 10.1073/pnas.1217391110; Benabdallah H, 2008, PHARMACOL RES, V57, P132, DOI 10.1016/j.phrs.2008.01.002; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; BURGESS DR, 1975, J EMBRYOL EXP MORPH, V34, P723; DAUCA M, 1990, International Journal of Developmental Biology, V34, P205; FERRI S, 1976, J ANAT, V121, P291; Fukuda K, 1998, DEVELOPMENT, V125, P3535; Hannezo E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.078104; HARADA N, 1992, LIFE SCI, V51, P1381, DOI 10.1016/0024-3205(92)90638-6; His W., 1880, ANATOMIE MENSCHLICHE; Krause WJ, 2011, ANAT HISTOL EMBRYOL, V40, P352, DOI 10.1111/j.1439-0264.2011.01092.x; Kurahashi M, 2008, NEUROGASTROENT MOTIL, V20, P521, DOI 10.1111/j.1365-2982.2007.01055.x; Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025; Mahadevan L, 2005, SCIENCE, V307, P1740, DOI 10.1126/science.1105169; MCAVOY JW, 1978, J ANAT, V125, P155; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Moulton DE, 2011, J MECH PHYS SOLIDS, V59, P525, DOI 10.1016/j.jmps.2011.01.005; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; SBARBATI R, 1982, J ANAT, V135, P477; Stahlberg C. A., 1984, VIRCHOWS ARCH B, V47, P27; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tallinen T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.024302; Uni Z, 2003, POULTRY SCI, V82, P320, DOI 10.1093/ps/82.2.320; Walton KD, 2012, P NATL ACAD SCI USA, V109, P15817, DOI 10.1073/pnas.1205669109	30	311	317	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					212	218		10.1126/science.1238842	http://dx.doi.org/10.1126/science.1238842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	23989955	Green Accepted			2022-12-28	WOS:000325475200036
J	Tunis, SR; Messner, DA				Tunis, Sean R.; Messner, Donna A.			Medicare Policy on Bariatric Surgery Decision Making in the Face of Uncertainty	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COVERAGE; OUTCOMES		[Tunis, Sean R.; Messner, Donna A.] Ctr Med Technol Policy, Baltimore, MD USA		Tunis, SR (corresponding author), World Trade Ctr Baltimore, Ctr Med Technol Policy, 401 E Pratt St,Ste 631, Baltimore, MD 21202 USA.	sean.tunis@cmtpnet.org						Dimick JB, 2013, JAMA-J AM MED ASSOC, V309, P792, DOI 10.1001/jama.2013.755; Flum DR, 2011, ANN SURG, V254, P860, DOI 10.1097/SLA.0b013e31822f2101; Kohn GP, 2010, J AM COLL SURGEONS, V210, P909, DOI 10.1016/j.jamcollsurg.2010.03.005; Nguyen NT, 2012, J AM COLL SURGEONS, V215, P467, DOI 10.1016/j.jamcollsurg.2012.05.032; Paserchia L, 2013, CAGOO250R3; Phurrough S, 2006, CAG0025R CTR MED MED; Tunis SR, 2007, HEALTH AFFAIR, V26, pW500, DOI 10.1377/hlthaff.26.4.w500	7	5	5	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1339	1340		10.1001/jama.2013.278849	http://dx.doi.org/10.1001/jama.2013.278849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24030634				2022-12-28	WOS:000325098100014
J	Cruz-Flores, S				Cruz-Flores, Salvador			Early surgery and initial conservative therapy did not differ for outcomes in lobar intracerebral hematomas	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEMORRHAGE		Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, El Paso, TX USA	Texas Tech University System; Texas Tech University	Cruz-Flores, S (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, El Paso, TX USA.		Cruz-Flores, Salvador/AAR-1233-2020	Cruz-Flores, Salvador/0000-0003-4998-1471	Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Mendelow AD, 2005, LANCET, V365, P387; Mould WA, 2013, STROKE, V44, P627, DOI 10.1161/STROKEAHA.111.000411	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC11	10.7326/0003-4819-159-6-201309170-02011	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042382				2022-12-28	WOS:000325625900010
J	Witt, DM				Witt, Daniel M.			Review: Rivaroxaban causes less fatal bleeding, but does not reduce mortality, compared with VKAs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DABIGATRAN		Kaiser Permanente Colorado, Aurora, CO USA	Kaiser Permanente	Witt, DM (corresponding author), Kaiser Permanente Colorado, Aurora, CO USA.							Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Southworth MR, 2013, NEW ENGL J MED, V368, P1272, DOI 10.1056/NEJMp1302834	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC13	10.7326/0003-4819-159-6-201309170-02013	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042384				2022-12-28	WOS:000325625900012
J	Schaedler, TA; Jacobsen, AJ; Carter, WB				Schaedler, Tobias A.; Jacobsen, Alan J.; Carter, Wiliam B.			Toward Lighter, Stiffer Materials	SCIENCE			English	Editorial Material									[Schaedler, Tobias A.; Jacobsen, Alan J.; Carter, Wiliam B.] HRL Labs LLC, Malibu, CA 90265 USA	HRL Laboratories	Schaedler, TA (corresponding author), HRL Labs LLC, Malibu, CA 90265 USA.	taschaedler@hrl.com						[Anonymous], 2013, OPTISTRUCT SOFTW; Ashby MF, 2010, MAT SELECTION MECH D, V4th ed.; Cheung KC, 2013, SCIENCE, V341, P1219, DOI 10.1126/science.1240889; Deshpande VS, 2001, ACTA MATER, V49, P1035, DOI 10.1016/S1359-6454(00)00379-7; Finnegan K, 2007, INT J MATER RES, V98, P1264, DOI 10.3139/146.101594; Gibson J.L., 1997, CELLULAR SOLIDS STRU, DOI [10.1017/cbo9781139878326, DOI 10.1017/CBO9781139878326]; Jacobsen AJ, 2007, ADV MATER, V19, P3892, DOI 10.1002/adma.200700797; Maloney KJ, 2013, APL MATER, V1, DOI 10.1063/1.4818168; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649	10	50	52	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1181	1182		10.1126/science.1243996	http://dx.doi.org/10.1126/science.1243996			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031005				2022-12-28	WOS:000324248800024
J	Hu, DJK; Baffet, AD; Nayak, T; Akhmanova, A; Doye, V; Vallee, RB				Hu, Daniel Jun-Kit; Baffet, Alexandre Dominique; Nayak, Tania; Akhmanova, Anna; Doye, Valerie; Vallee, Richard Bert			Dynein Recruitment to Nuclear Pores Activates Apical Nuclear Migration and Mitotic Entry in Brain Progenitor Cells	CELL			English	Article							NEURAL STEM-CELLS; CYTOPLASMIC DYNEIN; ENVELOPE BREAKDOWN; LIS1; NEUROGENESIS; MICROTUBULE; CENTROSOMES; MECHANISMS; COMPLEXES; INTERACTS	Radial glial progenitors (RGPs) are elongated epithelial cells that give rise to neurons, glia, and adult stem cells during brain development. RGP nuclei migrate basally during G1, apically using cytoplasmic dynein during G2, and undergo mitosis at the ventricular surface. By live imaging of in utero electroporated rat brain, we find that two distinct G2-specific mechanisms for dynein nuclear pore recruitment are essential for apical nuclear migration. The "RanBP2-BicD2'' and "Nup133-CENP-F'' pathways act sequentially, with Nup133 or CENP-F RNAi arresting nuclei close to the ventricular surface in a premitotic state. Forced targeting of dynein to the nuclear envelope rescues nuclear migration and cell-cycle progression, demonstrating that apical nuclear migration is not simply correlated with cell-cycle progression from G2 to mitosis, but rather, is a required event. These results reveal that cell-cycle control of apical nuclear migration occurs by motor protein recruitment and identify a role for nucleus- and centrosome-associated forces in mitotic entry.	[Hu, Daniel Jun-Kit; Baffet, Alexandre Dominique; Nayak, Tania; Vallee, Richard Bert] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Akhmanova, Anna] Univ Utrecht, Cell Biol Program, NL-3584 Utrecht, Netherlands; [Doye, Valerie] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR 7592,Inst Jacques Monod, F-75205 Paris 13, France	Columbia University; Utrecht University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Vallee, RB (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	rv2025@columbia.edu	BAFFET, Alexandre/I-7687-2017	Baffet, Alexandre/0000-0001-9194-4258	NIH [HD40182, GM102347]; ARC; NWO [ALW-VIC1]; AHA;  [ANR-12-BSV2-0008-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARC(Australian Research Council); NWO(Netherlands Organization for Scientific Research (NWO)); AHA(American Heart Association); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. G. Gundersen, G. Luxton, H. Worman, C. Ostlund, and A. Laufer for advice and reagents; the Rockefeller University BIRC for 3D-SIM imaging; and the Foundation des Treilles for providing a venue for stimulating scientific discussions. This project was supported by NIH HD40182 and GM102347 to R.B.V.; ARC and ANR-12-BSV2-0008-01 to V.D.; NWO ALW-VIC1 to A.A.; and AHA postdoctoral fellowships to T.N. and A.D.B.	Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bolhy S, 2011, J CELL BIOL, V192, P855, DOI 10.1083/jcb.201007118; Cadot B, 2012, EMBO REP, V13, P741, DOI 10.1038/embor.2012.89; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118; Fridolfsson HN, 2010, DEV BIOL, V338, P237, DOI 10.1016/j.ydbio.2009.12.004; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hachet V, 2007, DEV CELL, V12, P531, DOI 10.1016/j.devcel.2007.02.015; Hebbar S, 2008, J CELL BIOL, V182, P1063, DOI 10.1083/jcb.200803071; Jodoin JN, 2012, MOL BIOL CELL, V23, P4713, DOI 10.1091/mbc.E12-07-0558; Kishimoto T., 2013, MED MOL MORPHOL; Kosodo Y, 2012, CELL MOL LIFE SCI, V69, P2727, DOI 10.1007/s00018-012-0952-2; Kosodo Y, 2011, EMBO J, V30, P1690, DOI 10.1038/emboj.2011.81; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lee HO, 2013, TRENDS CELL BIOL, V23, P141, DOI 10.1016/j.tcb.2012.11.001; Leung L, 2011, DEVELOPMENT, V138, P5003, DOI 10.1242/dev.071522; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Meyer EJ, 2011, CURR BIOL, V21, P485, DOI 10.1016/j.cub.2011.02.002; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Raaijmakers JA, 2012, EMBO J, V31, P4179, DOI 10.1038/emboj.2012.272; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Spear PC, 2012, DEV GROWTH DIFFER, V54, P306, DOI 10.1111/j.1440-169X.2012.01342.x; Splinter D, 2012, MOL BIOL CELL, V23, P4226, DOI 10.1091/mbc.E12-03-0210; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Taverna E, 2010, NEURON, V67, P906, DOI 10.1016/j.neuron.2010.08.027; Tsai JW, 2010, NAT NEUROSCI, V13, P1463, DOI 10.1038/nn.2665; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wilson MH, 2012, J CELL SCI, V125, P4158, DOI 10.1242/jcs.108688; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	41	107	107	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1300	1313		10.1016/j.cell.2013.08.024	http://dx.doi.org/10.1016/j.cell.2013.08.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034252	Bronze, Green Accepted			2022-12-28	WOS:000324239300018
J	El Anzaoui, J; Elharrech, Y				El Anzaoui, Jihad; Elharrech, Younes			Scrotal Calcinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[El Anzaoui, Jihad; Elharrech, Younes] Marrakech Mil Hosp, Marrakech, Morocco	Cadi Ayyad University of Marrakech; Mohammed VI University Hospital Center of Marrakech	El Anzaoui, J (corresponding author), Marrakech Mil Hosp, Marrakech, Morocco.	jihad.elanzaoui@gmail.com	anzaoui, jihad el/AAQ-9864-2021	anzaoui, jihad el/0000-0003-4882-5100					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					965	965		10.1056/NEJMicm1215846	http://dx.doi.org/10.1056/NEJMicm1215846			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004123				2022-12-28	WOS:000323906900013
J	Chung, BC; Zhao, JS; Gillespie, RA; Kwon, DY; Guan, ZQ; Hong, JY; Zhou, P; Lee, SY				Chung, Ben C.; Zhao, Jinshi; Gillespie, Robert A.; Kwon, Do-Yeon; Guan, Ziqiang; Hong, Jiyong; Zhou, Pei; Lee, Seok-Yong			Crystal Structure of MraY, an Essential Membrane Enzyme for Bacterial Cell Wall Synthesis	SCIENCE			English	Article							LYSIS PROTEIN-E; PENTAPEPTIDE TRANSLOCASE; STEP; INHIBITORS; PHOSPHATE; DOMAIN	MraY (phospho-MurNAc-pentapeptide translocase) is an integral membrane enzyme that catalyzes an essential step of bacterial cell wall biosynthesis: the transfer of the peptidoglycan precursor phospho-MurNAc-pentapeptide to the lipid carrier undecaprenyl phosphate. MraY has long been considered a promising target for the development of antibiotics, but the lack of a structure has hindered mechanistic understanding of this critical enzyme and the enzyme superfamily in general. The superfamily includes enzymes involved in bacterial lipopolysaccharide/teichoic acid formation and eukaryotic N-linked glycosylation, modifications that are central in many biological processes. We present the crystal structure of MraY from Aquifex aeolicus (MraY(AA)) at 3.3 angstrom resolution, which allows us to visualize the overall architecture, locate Mg2+ within the active site, and provide a structural basis of catalysis for this class of enzyme.	[Chung, Ben C.; Zhao, Jinshi; Gillespie, Robert A.; Guan, Ziqiang; Zhou, Pei; Lee, Seok-Yong] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Kwon, Do-Yeon; Hong, Jiyong; Zhou, Pei] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Hong, Jiyong] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Lee, SY (corresponding author), Duke Univ, Med Ctr, Dept Biochem, 2 Genome Ct, Durham, NC 27710 USA.	sylee@biochem.duke.edu	Guan, Ziqiang/AAE-5110-2019; Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416	Duke University Medical Center; Duke University; National Institutes of Health (NIH) [GM-51310, AI-55588, GM-069338]; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100984, R01GM051310, U54GM069338] Funding Source: NIH RePORTER	Duke University Medical Center; Duke University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data for this study were collected at beamlines NE-CAT ID 24-C and SER-CAT BM22/ID22 at the Advanced Photon Source. We thank C. Pemble and N. Nicely from the Duke x-ray crystallography facility for help with remote data collection; F. Murphy for help with data collection at ID 24-C; and Z. Johnson for critical reading of the manuscript. This work was supported by start-up funds from the Duke University Medical Center (S.-Y.L.), Duke University (J.H.), and the National Institutes of Health (NIH) (grants GM-51310 and AI-55588 to P. Z. and Lipid Maps glue grant GM-069338 to Z. G.). S.-Y.L. is a McKnight Scholar, Klingenstein fellow, Alfred P. Sloan Research fellow, Mallinckrodt Scholar, Whitehead Scholar, Basil O'Connor Starter Scholar, and NIH Director's New Innovator awardee. The authors declare no conflict of interest. The coordinates and structure factors are deposited in the Protein Data Bank (4J72). B. C. C. expressed, purified, and crystallized MraY<INF>AA</INF>. B. C. C. and S.-Y. L. collected the crystallographic data, solved the structure, and refined the model. B. C. C. performed the cross-linking studies and prepared all the protein for functional assays. J. Z. and R. A. G. performed the translocase assays (J. Z. performed all the mutational studies, and R. A. G. performed capuramycin and divalent metal experiments) under the guidance of P. Z. D.-Y.K. synthesized capuramycin under the guidance of J.H. Z.G. performed mass spectrometry characterization. B. C. C. and S.-Y.L. wrote the paper.	Al-Dabbagh B, 2008, BIOCHEMISTRY-US, V47, P8919, DOI 10.1021/bi8006274; Amer AO, 2001, MICROBIOL-SGM, V147, P3015, DOI 10.1099/00221287-147-11-3015; Anderson MS, 2000, FEMS MICROBIOL LETT, V191, P169, DOI 10.1111/j.1574-6968.2000.tb09335.x; Auberger N, 2011, ORG BIOMOL CHEM, V9, P8301, DOI 10.1039/c1ob06124k; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Bouhss A, 1999, MOL MICROBIOL, V34, P576, DOI 10.1046/j.1365-2958.1999.01623.x; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Boyle DS, 1998, J BACTERIOL, V180, P6429; Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006; Bugg Timothy D. H., 2006, Infectious Disorders - Drug Targets, V6, P85, DOI 10.2174/187152606784112128; Dini C, 2005, CURR TOP MED CHEM, V5, P1221, DOI 10.2174/156802605774463042; Koga T, 2004, J ANTIMICROB CHEMOTH, V54, P755, DOI 10.1093/jac/dkh417; LEHRMAN MA, 1994, GLYCOBIOLOGY, V4, P768, DOI 10.1093/glycob/4.6.768; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Mendel S, 2006, MICROBIOL-SGM, V152, P2959, DOI 10.1099/mic.0.28776-0; Shapiro AB, 2012, J BIOMOL SCREEN, V17, P662, DOI 10.1177/1087057112436885; Tanaka S, 2012, MOL MICROBIOL, V85, P975, DOI 10.1111/j.1365-2958.2012.08153.x; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h	19	135	138	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1012	1016		10.1126/science.1236501	http://dx.doi.org/10.1126/science.1236501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990562	Green Accepted			2022-12-28	WOS:000323652300046
J	Brown, SGA; Macdonald, SPJ; Hankey, GJ				Brown, Simon G. A.; Macdonald, Stephen P. J.; Hankey, Graeme J.			Do risks outweigh benefits in thrombolysis for stroke?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; SAFE IMPLEMENTATION; CANADIAN ALTEPLASE; COST-EFFECTIVENESS; TRIAL; ONSET; REANALYSIS		[Brown, Simon G. A.; Macdonald, Stephen P. J.] Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Perth, WA 6009, Australia; [Brown, Simon G. A.] Royal Perth Hosp, Emergency Dept, Perth, WA 6847, Australia; [Macdonald, Stephen P. J.] Armadale Hlth Serv, Emergency Dept, Armadale, WA 6992, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Nedlands, WA 6009, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Brown, SGA (corresponding author), Univ Western Australia, Sch Primary Aboriginal & Rural Hlth Care, Perth, WA 6009, Australia.	simon.brown@uwa.edu.au; graeme.hankey@uwa.edu.au	Macdonald, Stephen PJ/H-5339-2014; Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328; Macdonald, Stephen/0000-0001-9921-4620				Ahmed N, 2013, JAMA NEUROL, V70, P837, DOI 10.1001/jamaneurol.2013.406; Ahmed N, 2010, LANCET NEUROL, V9, P866, DOI 10.1016/S1474-4422(10)70165-4; Boudreau DM, 2013, ANN EMERG MED, V61, P46, DOI 10.1016/j.annemergmed.2012.04.020; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Clark WM, 2000, STROKE, V31, P811, DOI 10.1161/01.STR.31.4.811; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Emberson J, 2013, INT J STROKE, V8, P278, DOI 10.1111/ijs.12040; Fatovich DM, 2012, EMERG MED AUSTRALAS, V24, P477, DOI 10.1111/j.1742-6723.2012.01605.x; Ferguson C, 2010, EMERG MED J, V27, P245, DOI 10.1136/emj.2009.089656c; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hill MD, 2005, CAN MED ASSOC J, V172, P1307, DOI 10.1503/cmaj.1041561; Hoffman JR, 2012, EMERG MED AUSTRALAS, V24, P473, DOI 10.1111/j.1742-6723.2012.01604.x; Hoffman JR, 2009, ANN EMERG MED, V54, P329, DOI 10.1016/j.annemergmed.2009.03.019; Ingall TJ, 2004, STROKE, V35, P2418, DOI 10.1161/01.STR.0000140891.70547.56; Lyden PD, 2012, STROKE, V43, P1691, DOI 10.1161/STROKEAHA.112.656876; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mazya MV, 2013, STROKE, V44, P1595, DOI 10.1161/STROKEAHA.113.000794; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Quinn TJ, 2009, STROKE, V40, P3393, DOI [10.1161/STROKEAHA.109.557256, 10.1161/STROKEAHA.108.522516]; Radecki RP, 2013, ANN EMERG MED, V61, P489, DOI 10.1016/j.annemergmed.2012.12.008; Radecki RP, 2012, NAT REV NEUROL, V8, P176, DOI 10.1038/nrneurol.2011.89-c1; Rocco A, 2013, STROKE, V44, P2134, DOI 10.1161/STROKEAHA.111.675918; Sandercock P, 2013, LANCET NEUROL, V12, P768, DOI 10.1016/S1474-4422(13)70130-3; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Saposnik G, 2013, NEUROLOGY, V80, P21, DOI 10.1212/WNL.0b013e31827b1ace; Saposnik G, 2012, STROKE, V43, P1315, DOI 10.1161/STROKEAHA.111.646265; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Saver JL, 2010, STROKE, V41, P2381, DOI 10.1161/STROKEAHA.110.583807; Shobha N, 2011, CEREBROVASC DIS, V31, P223, DOI 10.1159/000321893; Shy BD, 2012, J EMERG MED; Strbian D, 2012, NEUROLOGY, V78, P427, DOI 10.1212/WNL.0b013e318245d2a9; Sung SF, 2013, STROKE, V44, P1561, DOI 10.1161/STROKEAHA.111.000651; Tanny SPT, 2013, STROKE, V44, P2269, DOI 10.1161/STROKEAHA.113.001295; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Whiteley WN, 2012, STROKE, V43, P2904, DOI 10.1161/STROKEAHA.112.665331	36	12	12	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2013	347								f5215	10.1136/bmj.f5215	http://dx.doi.org/10.1136/bmj.f5215			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CI	23990634				2022-12-28	WOS:000323881300009
J	Bao, J; Lopez, JA; Huerta, S				Bao, Jean; Lopez, Jorge A.; Huerta, Sergio			Acute Abdominal Pain and Abnormal CT Findings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SUSPECTED APPENDICITIS; COMPUTED-TOMOGRAPHY		Univ Texas SW Med Ctr Dallas, Dallas, TX 75216 USA; VA North Texas Hlth Care Syst, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Huerta, S (corresponding author), Univ Texas SW Med Ctr Dallas, VA North Texas Hlth Care Syst, 4500 S Lancaster Rd, Dallas, TX 75216 USA.	sergio.huerta@utsouthwestern.edu	Huerta, Sergio/G-3699-2013	Huerta, Sergio/0000-0001-7720-419X				Kim K, 2012, NEW ENGL J MED, V366, P1596, DOI 10.1056/NEJMoa1110734; Livingston EH, 2011, ARCH SURG-CHICAGO, V146, P308, DOI 10.1001/archsurg.2011.2; Parks NA, 2011, SURG CLIN N AM, V91, P141, DOI 10.1016/j.suc.2010.10.017; Paulson EK, 2003, NEW ENGL J MED, V348, P236, DOI 10.1056/NEJMcp013351; Pickhardt PJ, 2011, ANN INTERN MED, V154, P789, DOI 10.7326/0003-4819-154-12-201106210-00006; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589	7	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					848	849		10.1001/jama.2013.276158	http://dx.doi.org/10.1001/jama.2013.276158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982371				2022-12-28	WOS:000323561400025
J	Pagoto, SL; Appelhans, BM				Pagoto, Sherry L.; Appelhans, Bradley M.			A Call for an End to the Diet Debates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOW-FAT DIETS; DIABETES PREVENTION; LIFE-STYLE; FOLLOW-UP; METAANALYSIS; RISK		[Pagoto, Sherry L.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Appelhans, Bradley M.] Rush Univ, Med Ctr, Chicago, IL 60612 USA	University of Massachusetts System; University of Massachusetts Worcester; Rush University	Pagoto, SL (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Prevent & Behav Med, 55 Lake Ave N, Worcester, MA 01655 USA.	sherry.pagoto@umassmed.edu	Pagoto, Sherry L/L-2014-2013	Pagoto, Sherry L/0000-0002-2462-8797				Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; Bacon L, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-9; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bueno NB, 2013, BRIT J NUTR, V110, P1178, DOI 10.1017/S0007114513000548; Hu T, 2012, AM J EPIDEMIOL, V176, pS44, DOI 10.1093/aje/kws264; Kraschnewski JL, 2013, MED CARE, V51, P186, DOI 10.1097/MLR.0b013e3182726c33; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2013, DIABETOLOGIA, V56, P284, DOI 10.1007/s00125-012-2752-5; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321	9	73	74	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					687	688		10.1001/jama.2013.8601	http://dx.doi.org/10.1001/jama.2013.8601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989081				2022-12-28	WOS:000323254500013
J	Xiao, D; Chen, ZM; Wang, C				Xiao, Dan; Chen, Zhengming; Wang, Chen			Effects of a short-term mass-media campaign against smoking	LANCET			English	Editorial Material									[Xiao, Dan] Capital Med Univ, Beijing Chao Yang Hosp, Beijing 100020, Peoples R China; [Xiao, Dan; Wang, Chen] Capital Med Univ, Beijing Inst Resp Med, WHO Collaborating Ctr Tobacco Hlth, Beijing 100020, Peoples R China; [Xiao, Dan; Wang, Chen] Capital Med Univ, Dept Resp Med, Beijing 100020, Peoples R China; [Chen, Zhengming] Univ Oxford, Clin Trials Serv Unit, Oxford, England; [Wang, Chen] Natl Hlth & Family Planning Commiss Peoples Repub, Beijing Hosp, Natl Clin Res Ctr Resp Dis, Med Res & Educ Dept, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; University of Oxford; Beijing Hospital	Xiao, D (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Beijing 100020, Peoples R China.	danxiao@263.net			Medical Research Council [MC_U137686857] Funding Source: Medline; MRC [MC_U137686857] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2010, INTERNATIONAL STATIS; [Anonymous], 2013, ENGLISH NEWS; Chinese Center for Disease Control and Prevention, 2011, GLOBAL ADULT TOBACCO; Federal Trade Commission, 2012, FEDERAL TRADE COMMIS; Hill C, 2012, LA HAUSSE DES PRIX D; McAfee T., 2013, LANCET; Ministry of Health, 2007, NEW ZEALAND SMOKING; Ministry of Health of the People's Republic of China, 2012, CHINA REPORT ON THE; National Health and Family Planning Commission, TOBACCO HEALTH EDUCA; Schar EH, 2001, SMOKING CESSATION ME; U.S. Department of Health and Human Services, 2008, TREATING TOBACCO USE; Wakefield MA, 2011, HEALTH EDUC RES, V26, P988, DOI 10.1093/her/cyr054; WHO Collaborating Center for Tobacco or Health, 2007, CHINA SMOKING CESSAT; World Health Organization, 2009, WHO REPORT ON THE GL	14	6	6	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1964	1966		10.1016/S0140-6736(13)61839-5	http://dx.doi.org/10.1016/S0140-6736(13)61839-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269EI	24029167				2022-12-28	WOS:000328223700010
J	Goldfarb, S; Morrison, G				Goldfarb, Stanley; Morrison, Gail			BECOMING A PHYSICIAN The 3-Year Medical School - Change or Shortchange?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CURRICULUM	Shortening medical school to 3 years, some observers argue, would increase the supply of physicians and reduce the cost of medical training. Data from many years of experiments in shortening medical education, however, suggest that doing so is unwise. Shortening medical school to 3 years, some observers argue, would increase the supply of physicians perhaps particularly primary care physicians and reduce the cost of medical training, without compromising clinical care.(1) Data from many years of experiments in shortening medical education, however, suggest that doing so is unwise a conclusion supported by assessments of the readiness of today's medical school graduates to assume increased clinical responsibility as they enter residency programs.(2) There may be exceptional students capable of accelerated learning and small programs that create unusual opportunities for such students, but we believe that for the typical ...	[Goldfarb, Stanley; Morrison, Gail] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Goldfarb, S (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							Eaglen RH, 2012, ACAD MED, V87, P1600, DOI 10.1097/ACM.0b013e31826b8498; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P1143, DOI 10.1001/jama.2012.292; KETTEL LJ, 1979, J MED EDUC, V54, P210; Lyss-Lerman P, 2009, ACAD MED, V84, P823, DOI 10.1097/ACM.0b013e3181a82426; PAGE RG, 1976, J MED EDUC, V51, P125	5	32	32	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1087	1089		10.1056/NEJMp1306457	http://dx.doi.org/10.1056/NEJMp1306457			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047056				2022-12-28	WOS:000324554800003
J	Anthenelli, RM; Morris, C; Ramey, TS; Dubrava, SJ; Tsilkos, K; Russ, C; Yunis, C				Anthenelli, Robert M.; Morris, Chad; Ramey, Tanya S.; Dubrava, Sarah J.; Tsilkos, Kostas; Russ, Cristina; Yunis, Carla			Effects of Varenicline on Smoking Cessation in Adults With Stably Treated Current or Past Major Depression	ANNALS OF INTERNAL MEDICINE			English	Article							RECEPTOR PARTIAL AGONIST; RANDOMIZED CONTROLLED-TRIAL; SUSTAINED-RELEASE BUPROPION; PSYCHIATRIC ADVERSE EVENTS; PLACEBO-CONTROLLED TRIAL; NICOTINE REPLACEMENT; DOUBLE-BLIND; CIGARETTE-SMOKING; GENERAL-PRACTICE; CLINICAL-TRIALS	Background: Depression is overrepresented in smokers. Objective: To evaluate smoking abstinence and changes in mood and anxiety levels in smokers with depression treated with varenicline versus placebo. Design: Phase 4, multicenter, parallel, 1: 1 allocation, double-blind, randomization trial. Randomization, stratified by antidepressant use and depression score at baseline, was blocked in sizes of 4. (ClinicalTrials. gov: NCT01078298) Setting: 38 centers in 8 countries. Participants: 525 adult smokers with stably treated current or past major depression and no recent cardiovascular events. Intervention: Varenicline, 1 mg twice daily, or placebo for 12 weeks, with 40-week nontreatment follow-up. Measurements: Primary outcome was carbon monoxideconfirmed continuous abstinence rate (CAR) for weeks 9 to 12. Other outcomes included CARs assessed during nontreatment follow-up and ratings of mood, anxiety, and suicidal ideation or behavior. Results: 68.4% versus 66.5% of the varenicline and placebo groups, respectively, completed the study. Varenicline-treated participants had higher CARs versus placebo at weeks 9 to 12 (35.9% vs. 15.6%; odds ratio [OR], 3.35 [95% CI, 2.16 to 5.21]; P < 0.001), 9 to 24 (25.0% vs. 12.3%; OR, 2.53 [CI, 1.56 to 4.10]; P < 0.001), and 9 to 52 (20.3% vs. 10.4%; OR, 2.36 [CI, 1.40 to 3.98]; P < 0.001). There were no clinically relevant differences between groups in suicidal ideation or behavior and no overall worsening of depression or anxiety in either group. The most frequent adverse event was nausea (varenicline, 27.0%; placebo, 10.4%). Two varenicline-group participants died during the nontreatment phase. Limitations: Some data were missing, and power to detect differences between groups was low in rare events. Smokers with untreated depression, with co-occurring psychiatric conditions, or receiving mood stabilizers and antipsychotics were not included. Conclusion: Varenicline increased smoking cessation in smokers with stably treated current or past depression without exacerbating depression or anxiety.	Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Colorado, Aurora, CO USA; Pfizer, Cambridge, MA USA; Pfizer, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; Pfizer; Pfizer	Anthenelli, RM (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	robert.anthenelli@va.gov	Ramey, Tanya/AAW-5981-2021		Pfizer; Department of Veterans Affairs Merit Review award [NEUA-003-08S]; National Institute on Alcohol Abuse and Alcoholism grant [AA019720]; University of California, San Francisco, Smoking Cessation Leadership Center, and Colorado Department of Public Health and Environment; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019720] Funding Source: NIH RePORTER	Pfizer(Pfizer); Department of Veterans Affairs Merit Review award(US Department of Veterans Affairs); National Institute on Alcohol Abuse and Alcoholism grant; University of California, San Francisco, Smoking Cessation Leadership Center, and Colorado Department of Public Health and Environment(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded by Pfizer. Dr. Anthenelli's writing of this manuscript was funded, in part, by a Department of Veterans Affairs Merit Review award (NEUA-003-08S) and by a National Institute on Alcohol Abuse and Alcoholism grant (AA019720). Dr. Morris was supported, in part, by grants from the University of California, San Francisco, Smoking Cessation Leadership Center, and Colorado Department of Public Health and Environment. Drs. Ramey, Tsilkos, Russ, and Yunis and Ms. Dubrava are employees of Pfizer. Editorial support was provided by Abegale Templar, PhD, of Engage Scientific and funded by Pfizer.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anthenelli RM, 2005, CURRENT PSYCHIAT, V4, P77; Anthenelli RM, 2007, CURRENT PSYCHIAT, V6, P91; Ben-Hamou M, 2011, J SLEEP RES, V20, P559, DOI 10.1111/j.1365-2869.2011.00919.x; Bolliger CT, 2011, CLIN THER, V33, P465, DOI 10.1016/j.clinthera.2011.04.013; BRESLAU N, 1993, ARCH GEN PSYCHIAT, V50, P31; BRESLAU N, 1992, AM J PSYCHIAT, V149, P464; Brown RA, 2007, NICOTINE TOB RES, V9, P721, DOI 10.1080/14622200701416955; Cinciripini PM, 2013, JAMA PSYCHIAT, V70, P522, DOI 10.1001/jamapsychiatry.2013.678; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Covey LS, 1998, J ADDICT DIS, V17, P35, DOI 10.1300/J069v17n01_04; Cox LS, 2004, J GEN INTERN MED, V19, P828, DOI 10.1111/j.1525-1497.2004.30423.x; Fiore MC, 2008, TREATING TOBACCO USE; First MB, 2002, STRUCTURED CLIN INTE; Freedman R, 2007, AM J PSYCHIAT, V164, P1269, DOI 10.1176/appi.ajp.2007.07020326; Garza D, 2011, BIOL PSYCHIAT, V69, P1075, DOI 10.1016/j.biopsych.2010.12.005; George TP, 2000, AM J PSYCHIAT, V157, P1835, DOI 10.1176/appi.ajp.157.11.1835; Gierisch JM, 2012, J GEN INTERN MED, V27, P351, DOI 10.1007/s11606-011-1915-2; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; Hall SM, 2007, AM J PREV MED, V33, pS406, DOI 10.1016/j.amepre.2007.09.004; Hall SM, 1998, ARCH GEN PSYCHIAT, V55, P683, DOI 10.1001/archpsyc.55.8.683; Hall SM, 2002, ARCH GEN PSYCHIAT, V59, P930, DOI 10.1001/archpsyc.59.10.930; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hayford KE, 1999, BRIT J PSYCHIAT, V174, P173, DOI 10.1192/bjp.174.2.173; Hitsman B, 2013, ADDICTION, V108, P294, DOI 10.1111/add.12009; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kasliwal R, 2009, DRUG SAFETY, V32, P499, DOI 10.2165/00002018-200932060-00006; Kinnunen T, 1996, J CONSULT CLIN PSYCH, V64, P791, DOI 10.1037/0022-006X.64.4.791; Kinnunen T, 2008, INT J PSYCHIAT MED, V38, P373, DOI 10.2190/PM.38.3.k; Mackay J, 2002, TOBACCO ATLAS; Marcus M., 2012, PAPER DEV WHO DEP ME; Mayet A, 2012, PUBLIC HEALTH, V126, P70, DOI 10.1016/j.puhe.2011.09.025; McClure JB, 2009, J GEN INTERN MED, V24, P563, DOI 10.1007/s11606-009-0926-8; Meyer TE, 2013, ADDICTION, V108, P203, DOI 10.1111/j.1360-0443.2012.04024.x; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moore TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027016; Moore TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015337; Moore TJ, 2010, ANN PHARMACOTHER, V44, P1389, DOI 10.1345/aph.1P172; Morstad AE, 2008, ANN PHARMACOTHER, V42, P288, DOI 10.1345/aph.1K511; Nakamura M, 2007, CLIN THER, V29, P1040, DOI 10.1016/j.clinthera.2007.06.012; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Pasternak B, 2013, ADDICTION, V108, P1336, DOI 10.1111/add.12165; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Rigotti NA, 2010, CIRCULATION, V121, P221, DOI 10.1161/CIRCULATIONAHA.109.869008; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Rollema H, 2007, TRENDS PHARMACOL SCI, V28, P316, DOI 10.1016/j.tips.2007.05.003; Stapleton JA, 2008, ADDICTION, V103, P146, DOI 10.1111/j.1360-0443.2007.02083.x; Tashkin DP, 2011, CHEST, V139, P591, DOI 10.1378/chest.10-0865; Tonstad S, 2010, DRUG SAFETY, V33, P289, DOI 10.2165/11319180-000000000-00000; Tsai ST, 2007, CLIN THER, V29, P1027, DOI 10.1016/j.clinthera.2007.06.011; Tsoh JY, 2000, AM J PSYCHIAT, V157, P368, DOI 10.1176/appi.ajp.157.3.368; Williams JM, 2012, J CLIN PSYCHIAT, V73, P654, DOI 10.4088/JCP.11m07522; World Medical Association, DECL HELS ETH PRINC; Yousefi M. K., 2011, J ADDICT RES THER, pS4	56	104	106	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					390	+		10.7326/0003-4819-159-6-201309170-00005	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042367				2022-12-28	WOS:000325625900015
J	Klein, F; Mouquet, H; Dosenovic, P; Scheid, JF; Scharf, L; Nussenzweig, MC				Klein, Florian; Mouquet, Hugo; Dosenovic, Pia; Scheid, Johannes F.; Scharf, Louise; Nussenzweig, Michel C.			Antibodies in HIV-1 Vaccine Development and Therapy	SCIENCE			English	Review							HUMAN MONOCLONAL-ANTIBODIES; BROADLY NEUTRALIZING ANTIBODIES; MUCOSAL SHIV CHALLENGE; B-CELL RESPONSES; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL EPITOPE; POTENT NEUTRALIZATION; IMMUNOGEN DESIGN; PASSIVE TRANSFER; STRUCTURAL BASIS	Despite 30 years of study, there is no HIV-1 vaccine and, until recently, there was little hope for a protective immunization. Renewed optimism in this area of research comes in part from the results of a recent vaccine trial and the use of single-cell antibody-cloning techniques that uncovered naturally arising, broad and potent HIV-1-neutralizing antibodies (bNAbs). These antibodies can protect against infection and suppress established HIV-1 infection in animal models. The finding that these antibodies develop in a fraction of infected individuals supports the idea that new approaches to vaccination might be developed by adapting the natural immune strategies or by structure-based immunogen design. Moreover, the success of passive immunotherapy in small-animal models suggests that bNAbs may become a valuable addition to the armamentarium of drugs that work against HIV-1.	[Klein, Florian; Dosenovic, Pia; Scheid, Johannes F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Mouquet, Hugo] Inst Pasteur, Dept Immunol, Lab Humoral Response Pathogens, Paris, France; [Scharf, Louise] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst HHMI, New York, NY 10065 USA	Rockefeller University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; California Institute of Technology; Howard Hughes Medical Institute; Rockefeller University	Klein, F (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	fklein@rockefeller.edu; nussen@rockefeller.edu	Dosenovic, Pia/S-6894-2018; Mouquet, Hugo/M-2750-2014; Nussenzweig, Michel/AAE-7292-2019; Cheng, Yushao/E-6256-2011	Dosenovic, Pia/0000-0002-0426-4586; Mouquet, Hugo/0000-0002-4230-610X; 	Robert Mapplethorpe Foundation; Milieu Interieur project [ANR-10-LABX-69-01]; Swedish Research Council; American Cancer Society [PF-13-076-01-MPC]; Bill and Melinda Gates Foundation; NIH [UM1AI100663, AI 100663-01, AI 100148-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, P01AI081677, UM1AI100663] Funding Source: NIH RePORTER	Robert Mapplethorpe Foundation; Milieu Interieur project; Swedish Research Council(Swedish Research CouncilEuropean Commission); American Cancer Society(American Cancer Society); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Bjorkman and Nussenzweig laboratories for discussion. F.K. was supported by the Stavros Niarchos and the Robert Mapplethorpe Foundation, H.M. by the Milieu Interieur project ANR-10-LABX-69-01, P.D. by an International postdoc fellowship from the Swedish Research Council, and L.S. by the American Cancer Society Grant PF-13-076-01-MPC. This work was supported in part by the Bill and Melinda Gates Foundation and NIH awards UM1AI100663, AI 100663-01, and AI 100148-01 to M.C.N. M.C.N. is a HHMI investigator.	Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; EICHBERG JW, 1992, AIDS RES HUM RETROV, V8, P1515, DOI 10.1089/aid.1992.8.1515; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; GORNY MK, 1993, J IMMUNOL, V150, P635; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kaur K, 2011, TRENDS IMMUNOL, V32, P524, DOI 10.1016/j.it.2011.08.007; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mascola JR, 2001, CURR OPIN IMMUNOL, V13, P489, DOI 10.1016/S0952-7915(00)00246-6; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mehandru S, 2007, J VIROL, V81, P11016, DOI 10.1128/JVI.01340-07; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Mouquet H, 2012, CELL MOL LIFE SCI, V69, P1435, DOI 10.1007/s00018-011-0872-6; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Parren PWHI, 1997, IMMUNOL LETT, V57, P105, DOI 10.1016/S0165-2478(97)00043-6; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Scott LJ, 1999, DRUGS, V58, P305, DOI 10.2165/00003495-199958020-00009; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang G, 2013, J EXP MED, V210, P241, DOI 10.1084/jem.20121977; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	105	335	350	5	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1199	1204		10.1126/science.1241144	http://dx.doi.org/10.1126/science.1241144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031012	Green Accepted			2022-12-28	WOS:000324248800032
J	Mathurin, P; Louvet, A; Duhamel, A; Nahon, P; Carbonell, N; Boursier, J; Anty, R; Diaz, E; Thabut, D; Moirand, R; Lebrec, D; Moreno, C; Talbodec, N; Paupard, T; Naveau, S; Silvain, C; Pageaux, GP; Sobesky, R; Canva-Delcambre, V; Dharancy, S; Salleron, J; Dao, T				Mathurin, Philippe; Louvet, Alexandre; Duhamel, Alain; Nahon, Pierre; Carbonell, Nicolas; Boursier, Jerome; Anty, Rodolphe; Diaz, Emmanuel; Thabut, Dominique; Moirand, Romain; Lebrec, Didier; Moreno, Christophe; Talbodec, Nathalie; Paupard, Thierry; Naveau, Sylvie; Silvain, Christine; Pageaux, Georges-Philippe; Sobesky, Rodolphe; Canva-Delcambre, Valerie; Dharancy, Sebastien; Salleron, Julia; Dao, Thong			Prednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic Hepatitis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SHORT-TERM SURVIVAL; DOUBLE-BLIND; THERAPY; CORTICOSTEROIDS; MODEL; MELD	IMPORTANCE Prednisolone or pentoxifylline is recommended for severe alcoholic hepatitis, a life-threatening disease. The benefit of their combination is unknown. OBJECTIVE To determine whether the addition of pentoxifylline to prednisolone is more effective than prednisolone alone. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized, double-blind clinical trial conducted between December 2007 and March 2010 in 1 Belgian and 23 French hospitals of 270 patients aged 18 to 70 years who were heavy drinkers with severe biopsy-proven alcoholic hepatitis, as indicated by recent onset of jaundice in the prior 3 months and a Maddrey score of at least 32. Duration of follow-up was 6 months. The last included patient completed the study in October 2010. None of the patients were lost to follow-up for the main outcome. INTERVENTION Patients were randomly assigned to receive either a combination of 40 mg of prednisolone once a day and 400 mg of pentoxifylline 3 times a day (n=133) for 28 days, or 40 mg of prednisolone and matching placebo (n=137) for 28 days. MAIN OUTCOMES AND MEASURES Six-month survival, with secondary end points of development of hepatorenal syndrome and response to therapy based on the Lille model, which defines treatment nonresponders after 7 days of initiation of treatment. RESULTS In intention-to-treat analysis, 6-month survival was not different in the pentoxifylline-prednisolone and placebo-prednisolone groups (69.9%[95% CI, 62.1%-77.7%] vs 69.2%[95% CI;61.4%-76.9%], P=.91), corresponding to 40 vs 42 deaths, respectively. In multivariable analysis, only the Lille model and the Model for End-Stage Liver Disease score were independently associated with 6-month survival. At 7 days, response to therapy assessed by the Lille model was not significantly different between the 2 groups (Lille model score, 0.41 [95% CI, 0.36-0.46] vs 0.40[95% CI, 0.35-0.45], P =.80). The probability of being a responder was not different in both groups (62.6%[95% CI, 53.9%-71.3%] vs 61.9%[95% CI, 53.7%-70.3%], P =.91). The cumulative incidence of hepatorenal syndrome at 6 months was not significantly different in the pentoxifylline-prednisolone and the placebo-prednisolone groups (8.4%[95% CI, 4.8%-14.8%] vs 15.3%[95% CI, 10.3%-22.7%], P=.07). CONCLUSION AND RELEVANCE In patients with alcoholic hepatitis, 4-week treatment with pentoxifylline and prednisolone, compared with prednisolone alone, did not result in improved 6-month survival. The study may have been underpowered to detect a significant difference in incidence of hepatorenal syndrome, which was less frequent in the group receiving pentoxifylline.	[Mathurin, Philippe; Louvet, Alexandre; Canva-Delcambre, Valerie; Dharancy, Sebastien] Hop Huriez, Serv Malad Appareil Digestif, Lille, France; [Mathurin, Philippe; Louvet, Alexandre; Dharancy, Sebastien] Unite INSERM 995, Lille, France; [Duhamel, Alain; Salleron, Julia] CHU Lille, Biostat Unit, F-59037 Lille, France; [Nahon, Pierre] Assistance Publ Hop Paris, Hopl Jean Verdier, Serv Hepato Gastroentrol, Bondy, France; [Carbonell, Nicolas] Assistance Publ Hop Paris, Hop St Antoine, Serv Hepatol, Paris, France; [Boursier, Jerome] CHU Angers, Serv Hepatogastroenterol, Angers, France; [Anty, Rodolphe] CHU Nice, Serv Hepatogastroenterol, Nice, France; [Diaz, Emmanuel] Serv Hepatogastroenterol, Bethune, France; [Thabut, Dominique] Assistance Publ Hop Paris, Hop Pitie Salpetriere, Serv Hepatogastroenterol, Paris, France; [Moirand, Romain] Hop Pontchaillou, Serv Malad Foie, Rennes, France; [Lebrec, Didier] Ctr Rech Biomed Bichat Beaujon, INSERM, Unite 773, Paris, France; [Lebrec, Didier] Hop Beaujon, Serv Hepatol, Clichy, France; [Moreno, Christophe] Univ Libre Bruxelles, Hop Erasme, Serv Gastroenterol & Hepato Pancreatol, Brussels, Belgium; [Talbodec, Nathalie] Serv Hepatogastroenterol, Tourcoing, France; [Paupard, Thierry] Hop Dunkerque, Serv Hepatogastroenterol, Dunkerque, France; [Naveau, Sylvie] Assistance Publ Hop Paris, Hop Bedere, Serv Hepatogastroenterol, Clamart, France; [Silvain, Christine] CHU Poitiers, Serv Hepatogastroenterol, Poitiers, France; CHU Montpellier, Montpellier, France; [Sobesky, Rodolphe] Assistance Publ Hop Paris, Hop Paul Brousse, Ctr Hepato Biliaire, Villejuif, France; [Dao, Thong] CHU Caen, Serv Hepatogastroenterol, F-14000 Caen, France	Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Poitiers; Universite de Poitiers; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Caen NORMANDIE; Universite de Caen Normandie	Mathurin, P (corresponding author), Hop Huriez, Serv Malad Appareil Digestif, Lille, France.	philippe.mathurin@chru-lille.fr	Louvet, Alexandre/S-4422-2018; Sobesky, Rodolphe/T-7723-2018; Duhamel, Alain/A-4899-2013; Mathurin, Philippe/A-9121-2018; Nahon, Pierre/AAM-9896-2021; Dharancy, Sebastien/M-4357-2018	Louvet, Alexandre/0000-0002-5293-007X; Mathurin, Philippe/0000-0003-3447-2025; Dharancy, Sebastien/0000-0002-8262-5607; Anty, Rodolphe/0000-0001-8194-9805; Moirand, Romain/0000-0002-5346-5755; Nahon, Pierre/0000-0003-2489-0768; Anty, Rodolphe/0000-0002-8053-1957	Hospital-Based Clinical Research Program; French Minister of Health	Hospital-Based Clinical Research Program; French Minister of Health	This work was supported by a Hospital-Based Clinical Research Program, a grant from the French Minister of Health. Pentoxifylline and its matching placebo were both supplied by Sanofi-Aventis Pharmaceuticals.	Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; CARITHERS RL, 1989, ANN INTERN MED, V110, P685, DOI 10.7326/0003-4819-110-9-685; De BK, 2009, WORLD J GASTROENTERO, V15, P1613, DOI 10.3748/wjg.15.1613; Dunn W, 2005, HEPATOLOGY, V41, P353, DOI 10.1002/hep.20503; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; HAN J, 1990, J EXP MED, V172, P391, DOI 10.1084/jem.172.1.391; Lebrec D, 2010, GASTROENTEROLOGY, V138, P1755, DOI 10.1053/j.gastro.2010.01.040; Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607; Louvet A, 2009, GASTROENTEROLOGY, V137, P541, DOI 10.1053/j.gastro.2009.04.062; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; Mathurin P, 2003, HEPATOLOGY, V38, P1363, DOI 10.1016/j.hep.2003.09.038; Mathurin P, 2002, J HEPATOL, V36, P480, DOI 10.1016/S0168-8278(01)00289-6; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; Mathurin P, 2011, NEW ENGL J MED, V365, P1790, DOI 10.1056/NEJMoa1105703; Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097; Naveau S, 2004, HEPATOLOGY, V39, P1390, DOI 10.1002/hep.20206; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Richardet J. P., 1993, Journal of Hepatology, V18, pS75; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Sidhu SS, 2012, DIGEST DIS SCI, V57, P1664, DOI 10.1007/s10620-012-2097-4; Taieb J, 2000, J HEPATOL, V32, P579, DOI 10.1016/S0168-8278(00)80219-6; Therneau TM., 2000, MODELING SURVIVAL DA; Tilg H, 2007, NAT CLIN PRACT GASTR, V4, P24, DOI 10.1038/ncpgasthep0683; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016	27	130	134	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1033	1041		10.1001/jama.2013.276300	http://dx.doi.org/10.1001/jama.2013.276300			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	24026598	Bronze			2022-12-28	WOS:000324133400020
J	Casavecchia, P; Alexander, MH				Casavecchia, Piergiorgio; Alexander, Millard H.			Uncloaking the Quantum Nature of Inelastic Molecular Collisions	SCIENCE			English	Editorial Material							RESONANCES		[Casavecchia, Piergiorgio] Univ Perugia, Dipartimento Chim, I-06123 Perugia, Italy; [Alexander, Millard H.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Alexander, Millard H.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA	University of Perugia; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Casavecchia, P (corresponding author), Univ Perugia, Dipartimento Chim, I-06123 Perugia, Italy.	piero@dyn.unipg.it; mha@umd.edu	Casavecchia, Piergiorgio/F-4175-2014	Casavecchia, Piergiorgio/0000-0003-1934-7891				Chefdeville S, 2013, SCIENCE, V341, P1094, DOI 10.1126/science.1241395; Chefdeville S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.023201; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; Gubbels KB, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3697816; Schatz GC, 2000, SCIENCE, V288, P1599, DOI 10.1126/science.288.5471.1599; WELCH WM, 1972, PHYS REV A-GEN PHYS, V5, P2692, DOI 10.1103/PhysRevA.5.2692; Wikipedia, AB CHEM EL; Wikipedia, LIST INT CIRC MOL; Woodall J, 2007, ASTRON ASTROPHYS, V466, P1197, DOI 10.1051/0004-6361:20064981	9	10	11	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1076	1077		10.1126/science.1244109	http://dx.doi.org/10.1126/science.1244109			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009384				2022-12-28	WOS:000323933100032
J	Shlipak, MG; Matsushita, K; Arnlov, J; Inker, LA; Katz, R; Polkinghorne, KR; Rothenbacher, D; Sarnak, MJ; Astor, BC; Coresh, J; Levey, AS; Gansevoort, RT				Shlipak, Michael G.; Matsushita, Kunihiro; Arnlov, Johan; Inker, Lesley A.; Katz, Ronit; Polkinghorne, Kevan R.; Rothenbacher, Dietrich; Sarnak, Mark J.; Astor, Brad C.; Coresh, Josef; Levey, Andrew S.; Gansevoort, Ron T.		CKD Prognosis Consortium	Cystatin C versus Creatinine in Determining Risk Based on Kidney Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; ESTIMATED GFR; ALL-CAUSE; HEART-FAILURE; CKD-EPI; MORTALITY; ASSOCIATION	BACKGROUND Adding the measurement of cystatin C to that of serum creatinine to determine the estimated glomerular filtration rate (eGFR) improves accuracy, but the effect on detection, staging, and risk classification of chronic kidney disease across diverse populations has not been determined. METHODS We performed a meta-analysis of 11 general-population studies (with 90,750 participants) and 5 studies of cohorts with chronic kidney disease (2960 participants) for whom standardized measurements of serum creatinine and cystatin C were available. We compared the association of the eGFR, as calculated by the measurement of creatinine or cystatin C alone or in combination with creatinine, with the rates of death (13,202 deaths in 15 cohorts), death from cardiovascular causes (3471 in 12 cohorts), and end-stage renal disease (1654 cases in 7 cohorts) and assessed improvement in reclassification with the use of cystatin C. RESULTS In the general-population cohorts, the prevalence of an eGFR of less than 60 ml per minute per 1.73 m(2) of body-surface area was higher with the cystatin C-based eGFR than with the creatinine-based eGFR (13.7% vs. 9.7%). Across all eGFR categories, the reclassification of the eGFR to a higher value with the measurement of cystatin C, as compared with creatinine, was associated with a reduced risk of all three study outcomes, and reclassification to a lower eGFR was associated with an increased risk. The net reclassification improvement with the measurement of cystatin C, as compared with creatinine, was 0.23 (95% confidence interval [CI], 0.18 to 0.28) for death and 0.10 (95% CI, 0.00 to 0.21) for end-stage renal disease. Results were generally similar for the five cohorts with chronic kidney disease and when both creatinine and cystatin C were used to calculate the eGFR. CONCLUSIONS The use of cystatin C alone or in combination with creatinine strengthens the association between the eGFR and the risks of death and end-stage renal disease across diverse populations.	[Shlipak, Michael G.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Shlipak, Michael G.] Univ Calif San Francisco, Dept Med Epidemiol & Biostat, San Francisco, CA 94143 USA; [Matsushita, Kunihiro; Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Arnlov, Johan] Geriatr Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden; [Inker, Lesley A.; Sarnak, Mark J.; Levey, Andrew S.] Tufts Med Ctr, Div Nephrol, Boston, MA USA; [Katz, Ronit] Univ Washington, Seattle, WA 98195 USA; [Polkinghorne, Kevan R.] Monash Univ, Dept Nephrol, Monash Med Ctr, Melbourne, Vic 3004, Australia; [Polkinghorne, Kevan R.] Monash Univ, Dept Med, Melbourne, Vic, Australia; [Rothenbacher, Dietrich] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Astor, Brad C.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Gansevoort, Ron T.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Uppsala University; Dalarna University; Tufts Medical Center; University of Washington; University of Washington Seattle; Monash University; Monash University; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; University of Wisconsin System; University of Wisconsin Madison; University of Groningen	Coresh, J (corresponding author), Chron Kidney Dis Prognosis Consortium Data Coordi, 615 Wolfe St, Baltimore, MD 21205 USA.		Kronenberg, Florian/B-1736-2008; Matsushita, Kunihiro/B-1021-2018; Brenner, Hermann/ABE-6383-2020; Ärnlöv, Johan/AAF-2746-2019; Brenner, Hermann/B-4627-2017; Katz, Ronit/ABA-1880-2021; Wetzels, Jack F.M./A-1720-2014; Schöttker, Ben/F-8183-2014; Matsushita, Kunihiro/AAJ-5817-2020	Kronenberg, Florian/0000-0003-2229-1120; Matsushita, Kunihiro/0000-0002-7179-718X; Brenner, Hermann/0000-0002-6129-1572; Ärnlöv, Johan/0000-0002-6933-4637; Brenner, Hermann/0000-0002-6129-1572; Wetzels, Jack F.M./0000-0002-0650-6921; Schöttker, Ben/0000-0002-1217-4521; Matsushita, Kunihiro/0000-0002-7179-718X; Emberson, Jonathan/0000-0001-7792-9422; Klein, Ronald/0000-0002-4428-6237; Rothenbacher, Dietrich/0000-0002-3563-2791; Polkinghorne, Kevan/0000-0002-9851-002X; Townend, Jonathan/0000-0002-5881-5806	National Kidney Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC085080, N01HC085083, N01HC025195, N01HC095159, N01HC085081, N01HC095169, N01HC085082, N01HC085086] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073217, U01DK035073, K23DK067303, K23DK002904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027002, R01AG023629] Funding Source: NIH RePORTER	National Kidney Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Kidney Foundation and others.	Anderson AH, 2012, AM J KIDNEY DIS, V60, P250, DOI 10.1053/j.ajkd.2012.04.012; Astor BC, 2008, AM J EPIDEMIOL, V167, P1226, DOI 10.1093/aje/kwn033; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Astor BC, 2009, J AM SOC NEPHROL, V20, P2214, DOI 10.1681/ASN.2008090980; Bui AL, 2009, AM J KIDNEY DIS, V53, P389, DOI 10.1053/j.ajkd.2008.06.025; Crowe E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1530; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fox CS, 2013, LANCET, V381, P374; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Ingelsson E, 2007, EUR HEART J, V28, P1739, DOI 10.1093/eurheartj/ehm130; Inker LA, 2012, NEW ENGL J MED, V367, P681; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kronenberg F, 2000, J AM SOC NEPHROL, V11, P105, DOI 10.1681/ASN.V111105; Landray MJ, 2001, AM J KIDNEY DIS, V38, P537, DOI 10.1053/ajkd.2001.26850; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li JN, 2010, CLIN CHEM, V56, P1336, DOI 10.1373/clinchem.2009.141531; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Mathisen UD, 2011, J AM SOC NEPHROL, V22, P927, DOI 10.1681/ASN.2010050479; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; National Collaborating Centre for Chronic Conditions, 2008, CHRON KIDN DIS NAT C; Oterdoom LH, 2009, ATHEROSCLEROSIS, V207, P534, DOI 10.1016/j.atherosclerosis.2009.05.010; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Paynter NP, 2013, MED DECIS MAKING, V33, P154, DOI 10.1177/0272989X12461856; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Rule AD, 2013, KIDNEY INT; Schaeffner ES, 2012, ANN INTERN MED, V157, P471, DOI 10.7326/0003-4819-157-7-201210020-00003; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2006, CURR OPIN NEPHROL HY, V15, P270, DOI 10.1097/01.mnh.0000222694.07336.92; Shlipak MG, 2009, AM J NEPHROL, V30, P171, DOI 10.1159/000212381; Skali H, 2011, AM HEART J, V162, P548, DOI 10.1016/j.ahj.2011.06.006; Stevens LA, 2011, AM J KIDNEY DIS, V57, pS9, DOI 10.1053/j.ajkd.2010.11.007; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; van Zuilen AD, 2012, KIDNEY INT, V82, P710, DOI 10.1038/ki.2012.137; Waheed S, 2012, AM J KIDNEY DIS, V60, P207, DOI 10.1053/j.ajkd.2012.03.011; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; Wright JT, 2006, JAMA-J AM MED ASSOC, V295, P2726; Zhang QL, 2009, PREV MED, V48, P122, DOI 10.1016/j.ypmed.2008.10.026	50	544	573	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					932	943		10.1056/NEJMoa1214234	http://dx.doi.org/10.1056/NEJMoa1214234			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004120	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000323906900010
J	Glass, RI				Glass, Roger I.			What the United States Has to Gain From Global Health Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Glass, RI (corresponding author), NIH, Fogarty Int Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.	glassr@mail.nih.gov						Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lozano R, 2013, LANCET, V381, P628; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Miller M, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1163; Trief PM, 2013, ETHNIC HEALTH, V18, P83, DOI 10.1080/13557858.2012.700915	5	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					903	904		10.1001/jama.2013.276558	http://dx.doi.org/10.1001/jama.2013.276558			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002270				2022-12-28	WOS:000323885700014
J	Vohs, KD				Vohs, Kathleen D.			The Poor's Poor Mental Power	SCIENCE			English	Editorial Material							SELF-REGULATORY FAILURE; STRENGTH MODEL; DEPLETION		Univ Minnesota, Dept Mkt, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Vohs, KD (corresponding author), Univ Minnesota, Dept Mkt, 321 19th Ave South, Minneapolis, MN 55455 USA.	kvohs@umn.edu						Baumeister RF, 1996, PSYCHOL INQ, V7, P1, DOI 10.1207/s15327965pli0701_1; Baumeister RF, 2011, WILLPOWER REDISCOVER; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Finkel EJ, 2009, J PERS SOC PSYCHOL, V97, P483, DOI 10.1037/a0015433; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hofmann W, 2012, PSYCHOL SCI, V23, P582, DOI 10.1177/0956797612437426; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Nes LS, 2010, PAIN, V151, P37, DOI 10.1016/j.pain.2010.05.009; Pocheptsova A, 2009, J MARKETING RES, V46, P344, DOI 10.1509/jmkr.46.3.344; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Vohs KD, 2007, J CONSUM RES, V33, P537, DOI 10.1086/510228; Vohs KD, 2000, PSYCHOL SCI, V11, P249, DOI 10.1111/1467-9280.00250; Wang J, 2010, J MARKETING RES, V47, P910, DOI 10.1509/jmkr.47.5.910; World Bank, 2013, POVERTY	14	58	62	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					969	970		10.1126/science.1244172	http://dx.doi.org/10.1126/science.1244172			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990551				2022-12-28	WOS:000323652300030
J	Juang, BT; Gu, C; Starnes, L; Palladino, F; Goga, A; Kennedy, S; L'Etoile, ND				Juang, Bi-Tzen; Gu, Chen; Starnes, Linda; Palladino, Francesca; Goga, Andrei; Kennedy, Scott; L'Etoile, Noelle D.			Endogenous Nuclear RNAi Mediates Behavioral Adaptation to Odor	CELL			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; EPIGENETIC MEMORY; POLYMERASE-II; GERM-LINE; IN-VITRO; INTERFERENCE; GENES; HETEROCHROMATIN; PLASTICITY	Most eukaryotic cells express small regulatory RNAs. The purpose of one class, the somatic endogenous siRNAs (endo-siRNAs), remains unclear. Here, we show that the endo-siRNA pathway promotes odor adaptation in C. elegans AWC olfactory neurons. In adaptation, the nuclear Argonaute NRDE-3, which acts in AWC, is loaded with siRNAs targeting odr-1, a gene whose downregulation is required for adaptation. Concomitant with increased odr-1 siRNA in AWC, we observe increased binding of the HP1 homolog HPL-2 at the odr-1 locus in AWC and reduced odr-1 mRNA in adapted animals. Phosphorylation of HPL-2, an in vitro substrate of the EGL-4 kinase that promotes adaption, is necessary and sufficient for behavioral adaptation. Thus, environmental stimulation amplifies an endo-siRNA negative feedback loop to dynamically repress cognate gene expression and shape behavior. This class of siRNA may act broadly as a rheostat allowing prolonged stimulation to dampen gene expression and promote cellular memory formation.	[Juang, Bi-Tzen; Gu, Chen; Starnes, Linda; Goga, Andrei; L'Etoile, Noelle D.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Juang, Bi-Tzen; Gu, Chen; Starnes, Linda; Goga, Andrei; L'Etoile, Noelle D.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Gu, Chen] Amunix Inc, Mountain View, CA 94043 USA; [Starnes, Linda] Univ Copenhagen, Fac Hlth Sci, NNF Ctr Prot Res, Chromatin Struct & Funct Grp, DK-2200 Copenhagen N, Denmark; [Palladino, Francesca] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Mol Cell Biol Lab,UMR5239, F-69007 Lyon, France; [Kennedy, Scott] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; University of Wisconsin System; University of Wisconsin Madison	L'Etoile, ND (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	noelle.letoile@ucsf.edu		Kennedy, Scott/0000-0002-7974-8155; Starnes, Linda/0000-0002-7322-9928	NSF [0954258]; NIH [R01DC005991]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088289, R01GM104232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005991] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Maria Gallegos, Mehrdad Matloubian, Bassem Al-Sady, Jonathan Isaiah Gent, Georgia Woods, and Robert Blelloch; members of the L'Etoile lab: Damien O'Halloran, Scott Hamilton, Sarah Gerhart, Mary Bethke, and Chantal Brueggemann; and members of the Kennedy lab: Bethany Buckley and Kirk Burkhart, for critical reading and helpful discussions. We thank ShiYu Chen for purified MUT-7 and HPL-2. We thank Ahmed Elewa and Craig Mello for good discussions, worm strains, and odr-1 22G RNA sequences; Ebenezer Yamoah for use of his qPCR system; and Kohta Ikegami and Susan Strome for ChIP protocols and advice. We also thank Nadia Gronachon, Kim Collins, Christopher Morales, Anu Gupta, and Aarati Asundi for help with worm culture; Bethany Buckley, the Caenorhabditis Genetics Center and the National Bioresource Project for numerous strains, and Yuji Kohara for yk cDNA clones. We thank Leah Frater (Anderson lab), Derek Pavelec (Kennedy lab), Jay Maniar, and Jonathan Gent (Fire lab) for producing and sharing unpublished sequencing reads. N. D. L. acknowledges support from NSF 0954258 and NIH R01DC005991. B.-T. J. conceived of and carried out experiments and cowrote the manuscript. L. S. developed, optimized, and performed kinase assays. CG performed RNA and DNA analysis. L. S. and C. G. contributed equally to the manuscript. A. G., F. P., and S. K. provided unpublished protocols, reagents, support and insight. N. L. analyzed data and wrote the manuscript.	Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Aygun O, 2010, COLD SH Q B, V75, P259, DOI 10.1101/sqb.2010.75.055; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burkhart KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002249; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Coustham V, 2006, DEV BIOL, V297, P308, DOI 10.1016/j.ydbio.2006.04.474; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Dash PK, 2007, LEARN MEMORY, V14, P554, DOI 10.1101/lm.558707; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dernburg AF, 2000, GENE DEV, V14, P1578; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Greco-Stewart VS, 2009, VIROLOGY, V386, P12, DOI 10.1016/j.virol.2009.02.007; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Hao Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002065; Hayashi A, 2012, P NATL ACAD SCI USA, V109, P6159, DOI 10.1073/pnas.1116972109; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Kaye JA, 2009, NEURON, V61, P57, DOI 10.1016/j.neuron.2008.11.012; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee JI, 2010, P NATL ACAD SCI USA, V107, P6016, DOI 10.1073/pnas.1000866107; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; MACIEJEWSKI PM, 1995, J BIOL CHEM, V270, P27661, DOI 10.1074/jbc.270.46.27661; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; O'Halloran DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031614; O'Halloran DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000761; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Rougemaille M, 2012, P NATL ACAD SCI USA, V109, P11258, DOI 10.1073/pnas.1204947109; Shimada A, 2010, EPIGENETICS-US, V5, P30, DOI 10.4161/epi.5.1.10605; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tops BBJ, 2005, NUCLEIC ACIDS RES, V33, P347, DOI 10.1093/nar/gki183; Vasquez-Rifo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033750; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang C, 2011, P NATL ACAD SCI USA, V108, P1201, DOI 10.1073/pnas.1018695108; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200	74	52	63	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1010	1022		10.1016/j.cell.2013.08.006	http://dx.doi.org/10.1016/j.cell.2013.08.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993094	Bronze, Green Accepted			2022-12-28	WOS:000323767300015
J	Thompson, BM; Brodsky, I				Thompson, Bradley Merrill; Brodsky, Ira			Should the FDA regulate mobile medical apps?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Thompson, Bradley Merrill] Epstein Becker & Green, Washington, DC 20037 USA; [Brodsky, Ira] Datacomm Res, St Louis, MO USA		Thompson, BM (corresponding author), Epstein Becker & Green, 1227 25th St NW, Washington, DC 20037 USA.	bthompson@ebglaw.com; ibrodsky@datacommresearch.com							0	10	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2013	347								f5211	10.1136/bmj.f5211	http://dx.doi.org/10.1136/bmj.f5211			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CI	23990633				2022-12-28	WOS:000323881300008
J	Gutierrez, OM; Khodneva, YA; Muntner, P; Rizk, DV; McClellan, WM; Cushman, M; Warnock, DG; Safford, MM				Gutierrez, Orlando M.; Khodneva, Yulia A.; Muntner, Paul; Rizk, Dana V.; McClellan, William M.; Cushman, Mary; Warnock, David G.; Safford, Monika M.		REGARDS Investigators	Association Between Urinary Albumin Excretion and Coronary Heart Disease in Black vs White Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RACIAL-DIFFERENCES; ETHNIC-DIFFERENCES; KIDNEY-FUNCTION; BLOOD-PRESSURE; ESTIMATED GFR; CYSTATIN C; ALL-CAUSE; RISK; MICROALBUMINURIA; POPULATION	IMPORTANCE Excess urinary albumin excretion is more common in black than white individuals and is more strongly associated with incident stroke risk in black vs white individuals. Whether similar associations extend to coronary heart disease (CHD) is unclear. OBJECTIVE To determine whether the association of urinary albumin excretion with CHD events differs by race. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of black and white US adults aged 45 years and older who were enrolled within the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study between 2003 and 2007 with follow-up through December 31, 2009. We examined race-stratified associations of urinary albumin-to-creatinine ratio (ACR) in 2 groups: (1) incident CHD among 23 273 participants free of CHD at baseline; and (2) first recurrent CHD event among 4934 participants with CHD at baseline. MAIN OUTCOMES AND MEASURES Expert-adjudicated incident and recurrent myocardial infarction and acute CHD death. RESULTS A total of 616 incident CHD events (421 nonfatal MIs and 195 CHD deaths) and 468 recurrent CHD events (279 nonfatal MIs and 189 CHD deaths) were observed over a mean time of 4.4 years of follow-up. Among those free of CHD at baseline, age-and sex-adjusted incidence rates of CHD per 1000 person-years of follow-up increased with increasing categories of ACR in black and white participants, with rates being nearly 1.5-fold greater in the highest category of ACR (> 300 mg/g) in black participants (20.59; 95% CI, 14.36-29.51) vs white participants (13.60; 95% CI, 7.60-24.25). In proportional hazards models adjusted for traditional cardiovascular risk factors and medications, higher baseline urinary ACR was associated with greater risk of incident CHD among black participants (hazard ratio [HR] comparing ACR > 300 vs < 10 mg/g, 3.21 [95% CI, 2.02-5.09]) but not white participants (HR comparing ACR > 300 vs < 10 mg/g, 1.49 [95% CI, 0.80-2.76]) (P value for interaction = .03). Among those with CHD at baseline, fully adjusted associations of baseline urinary ACR with first recurrent CHD event were similar between black participants (HR comparing ACR > 300 vs < 10 mg/g, 2.21 [95% CI, 1.22-4.00]) vs white participants (HR comparing ACR > 300 vs < 10 mg/g, 2.48 [95% CI, 1.61-3.78]) (P value for interaction = .53). CONCLUSIONS AND RELEVANCE Higher urinary ACR was associated with greater risk of incident but not recurrent CHD in black individuals when compared with white individuals. These data confirm that black individuals appear more susceptible to vascular injury.	[Gutierrez, Orlando M.; Khodneva, Yulia A.; Muntner, Paul; Rizk, Dana V.; Safford, Monika M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Gutierrez, Orlando M.; Muntner, Paul; Warnock, David G.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA; [McClellan, William M.] Emory Univ, Dept Med, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [McClellan, William M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Cushman, Mary] Univ Vermont, Dept Med, Burlington, VT 05405 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University of Vermont	Gutierrez, OM (corresponding author), Univ Alabama Birmingham, ZRB 614,1720 2nd Ave S, Birmingham, AL 35294 USA.	ogutierr@uab.edu	Cushman, Mary/K-1157-2019; Soliman, Elsayed Z/AAD-7135-2020	Cushman, Mary/0000-0002-7871-6143; Soliman, Elsayed Z/0000-0001-5632-8150; Rizk, Dana/0000-0002-6877-2811	National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS041588]; National Heart, Lung, and Blood Institute (NHLBI) [R01 HL080477]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K23DK081673, R03DK095005]; NINDS [R01NS080850]; Amgen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK095005, K23DK081673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080850, U01NS041588] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Amgen(Amgen); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by a cooperative agreement from the National Institute of Neurological Disorders and Stroke (NINDS, U01 NS041588) and from the National Heart, Lung, and Blood Institute (NHLBI, R01 HL080477). Dr Gutierrez was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, K23DK081673 and R03DK095005) and from NINDS (R01NS080850). Additional funding was provided by an investigator-initiated grant-in-aid from Amgen.	Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Foster MC, 2008, AM J KIDNEY DIS, V52, P859, DOI 10.1053/j.ajkd.2008.04.027; Gutierrez OM, 2012, NEUROLOGY, V79, P1686, DOI 10.1212/WNL.0b013e31826e9af8; Hanevold CD, 2008, HYPERTENSION, V51, P334, DOI 10.1161/HYPERTENSIONAHA.107.098095; Howard G, 2013, JAMA INTERN MED, V173, P46, DOI 10.1001/2013.jamainternmed.857; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; JIANG XZ, 1994, AM J HYPERTENS, V7, P794, DOI 10.1093/ajh/7.9.794; Jolly SE, 2010, AM J KIDNEY DIS, V55, pS15, DOI 10.1053/j.ajkd.2009.09.034; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McClellan WM, 2011, J AM SOC NEPHROL, V22, P1721, DOI 10.1681/ASN.2010101085; Peralta CA, 2006, J AM SOC NEPHROL, V17, P2892, DOI 10.1681/ASN.2005101122; Peralta CA, 2011, J AM SOC NEPHROL, V22, P1327, DOI 10.1681/ASN.2010090960; Plantinga L, 2013, INT J HEALTH GEOGR, P12; Prineas R., 1982, MINNESOTA CODE MANUA; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Shara NM, 2011, AM J CARDIOL, V107, P399, DOI 10.1016/j.amjcard.2010.09.036; Silva AMV, 2010, J ENDOCRINOL INVEST, V33, P696, DOI [10.1007/BF03346672, 10.3275/6955]; Solbu MD, 2009, METABOLISM, V58, P408, DOI 10.1016/j.metabol.2008.10.016; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Waheed S, 2013, CLIN J AM SOC NEPHRO, V8, P434, DOI 10.2215/CJN.04960512; Waheed S, 2012, AM J KIDNEY DIS, V60, P207, DOI 10.1053/j.ajkd.2012.03.011; Wu I, 2008, CLIN J AM SOC NEPHRO, V3, P1895, DOI 10.2215/CJN.02030408	27	31	31	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					706	713		10.1001/jama.2013.8777	http://dx.doi.org/10.1001/jama.2013.8777			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989654	Green Accepted			2022-12-28	WOS:000323254500020
J	Jeschke, MG; Herndon, DN				Jeschke, Marc G.; Herndon, David N.			Burns in children: standard and new treatments	LANCET			English	Review							GROWTH-HORMONE TREATMENT; TRACE-ELEMENT SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; STRESS-INDUCED HYPERGLYCEMIA; ENGINEERED SKIN SUBSTITUTES; RESTING ENERGY-EXPENDITURE; INSULIN-TREATMENT IMPROVES; MUSCLE PROTEIN CATABOLISM; PARTIAL-THICKNESS BURNS	Outcomes of patients with burns have improved substantially over the past two decades. Findings from a 2012 study in The Lancet showed that a burn size of more than 60% total body surface area burned (an increase from 40% a decade ago) is associated with risks and mortality. Similar data have been obtained in adults and elderly people who have been severely burned. We discuss recent and future developments in burn care to improve outcomes of children.	[Jeschke, Marc G.] Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Toronto, ON M4N 3M5, Canada; [Jeschke, Marc G.] Univ Toronto, Dept Immunol, Div Plast Surg, Dept Surg, Toronto, ON M4N 3M5, Canada; [Jeschke, Marc G.] Sunnybrook Res Inst, Toronto, ON, Canada; [Herndon, David N.] Univ Texas Med Branch, Shriners Hosp Children, Galveston, TX 77555 USA; [Herndon, David N.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Jeschke, MG (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	marc.jeschke@sunnybrook.ca	Herndon, David/AAC-3354-2020		Shriners Hospitals for Children [8490, 71008, 8640, 8760, 84080, 79135]; National Institutes of Health [R01-GM56687, R01-GM087285, T32-GM008256, P50-GM60338]; National Institute of Disability and Rehabilitation Research [H133A020102, H133A70019]; Canada Foundation for innovation Leader's Opportunity Fund [25407]; Canadian Institutes of Health Research Grant [123336]; Physicians' Services Incorporated Foundation-Health Research Grant Programme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087285, P50GM060338, T32GM008256, R01GM056687] Funding Source: NIH RePORTER	Shriners Hospitals for Children; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Disability and Rehabilitation Research; Canada Foundation for innovation Leader's Opportunity Fund; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Physicians' Services Incorporated Foundation-Health Research Grant Programme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by Shriners Hospitals for Children (8490, 71008, 8640, 8760, 84080, and 79135), National Institutes of Health (R01-GM56687, R01-GM087285, T32-GM008256, and P50-GM60338), National Institute of Disability and Rehabilitation Research (H133A020102 and H133A70019), the Canada Foundation for innovation Leader's Opportunity Fund (Project 25407), Canadian Institutes of Health Research Grant (123336), and Physicians' Services Incorporated Foundation-Health Research Grant Programme. None of the funding sources had involvement in the collection, analysis, or interpretation of data. We thank Eileen Figueroa and Kasie Cole for assistance in manuscript preparation.	Barret JP, 2001, J TRAUMA, V51, P736, DOI 10.1097/00005373-200110000-00019; Barret JP, 2000, PLAST RECONSTR SURG, V105, P62, DOI 10.1097/00006534-200001000-00010; Barrow RE, 2006, ANN SURG, V243, P115, DOI 10.1097/01.sla.0000193834.07413.91; Barrow RE, 2005, SHOCK, V24, P523, DOI 10.1097/01.shk.0000187981.78901.ee; Belba MK, 2009, AM J EMERG MED, V27, P1091, DOI 10.1016/j.ajem.2008.08.008; Berger MM, 2007, J TRACE ELEM MED BIO, V21, P44, DOI 10.1016/j.jtemb.2007.09.013; Berger Mette M, 2006, Nutr Clin Pract, V21, P438, DOI 10.1177/0115426506021005438; Berger MM, 2007, AM J CLIN NUTR, V85, P1293, DOI 10.1093/ajcn/85.5.1293; Berger MM, 2007, AM J CLIN NUTR, V85, P1301, DOI 10.1093/ajcn/85.5.1301; Berger MM, 2006, CRIT CARE, V10, DOI 10.1186/cc5084; Berger MM, 2006, NUTRITION, V22, P952, DOI 10.1016/j.nut.2006.06.004; Berger MM, 2005, CLIN NUTR, V24, P172, DOI 10.1016/j.clnu.2004.10.003; Boyce ST, 1999, J BURN CARE REHABIL, V20, P453, DOI 10.1097/00004630-199920060-00006; Boyce ST, 1998, MED BIOL ENG COMPUT, V36, P791, DOI 10.1007/BF02518886; Boyce ST, 2012, WOUND REPAIR REGEN, V20, P544, DOI 10.1111/j.1524-475X.2012.00807.x; Branski LK, 2008, BURNS, V34, P393, DOI 10.1016/j.burns.2007.06.007; Branski LK, 2011, CRIT CARE, V15, DOI 10.1186/cc10147; Branski LK, 2009, ANN SURG, V250, P514, DOI [10.1097/SLA06013e3181b819ca, 10.1097/SLA.0b013e3181b8f9ca]; Branski LK, 2009, BURNS, V35, P171, DOI 10.1016/j.burns.2008.03.009; Brooks NC, 2012, MOL MED, V18, P707, DOI 10.2119/molmed.2011.00277; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005; CIOFFI WG, 1994, ANN SURG, V220, P310, DOI 10.1097/00000658-199409000-00007; COOMBES EJ, 1982, BURNS, V8, P333, DOI 10.1016/0305-4179(82)90033-X; Cree MG, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-9; Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986; Demling R, 1999, NEW ENGL J MED, V341, P837, DOI 10.1056/NEJM199909093411110; Demling RH, 2003, BURNS, V29, P793, DOI 10.1016/j.burns.2003.08.003; Demling RH, 2000, WORLD J SURG, V24, P673, DOI 10.1007/s002689910109; DESAI MH, 1990, ANN SURG, V211, P753, DOI 10.1097/00000658-199006000-00015; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Drago H, 2010, TRANSPL P, V42, P345, DOI 10.1016/j.transproceed.2009.11.031; Endorf FW, 2007, J BURN CARE RES, V28, P80, DOI 10.1097/BCR.0B013E31802C889F; Erdman AR, 2007, ANN EMERG MED, V49, P814, DOI 10.1016/j.annemergmed.2007.03.006; Faraklas I, 2011, J BURN CARE RES, V32, P91, DOI 10.1097/BCR.0b013e318204b379; Ferrando AA, 1999, ANN SURG, V229, P11, DOI 10.1097/00000658-199901000-00002; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Finnerty CC, 2013, CRIT CARE MED, V41, P1421, DOI 10.1097/CCM.0b013e31827c072e; Finnerty CC, 2012, CTS-CLIN TRANSL SCI, V5, P243, DOI 10.1111/j.1752-8062.2012.00412.x; Finnerty CC, 2007, CRIT CARE, V11, DOI 10.1186/cc5698; Gamliel Ziv, 1996, Journal of Burn Care and Rehabilitation, V17, P264; Gauglitz GG, 2009, J CLIN ENDOCR METAB, V94, P1656, DOI 10.1210/jc.2008-1947; Ge LP, 2010, BURNS, V36, P533, DOI 10.1016/j.burns.2009.08.001; GOODALL M, 1957, ANN SURG, V145, P479, DOI 10.1097/00000658-195704000-00004; GORE D C, 1990, Journal of Burn Care and Rehabilitation, V11, P400, DOI 10.1097/00004630-199009000-00005; Gore DC, 2005, ANN SURG, V241, P334, DOI 10.1097/01.sla.0000152013.23032.d1; Gore DC, 2003, J TRAUMA, V54, P555, DOI 10.1097/01.TA.0000026990.32856.58; Gore DC, 2003, ARCH SURG-CHICAGO, V138, P169, DOI 10.1001/archsurg.138.2.169; Gore DC, 2002, CRIT CARE MED, V30, P2438, DOI 10.1097/00003246-200211000-00006; Gore DC, 2001, J TRAUMA, V51, P540, DOI 10.1097/00005373-200109000-00021; Gore DC, 2000, J TRAUMA, V49, P673, DOI 10.1097/00005373-200010000-00015; Gravante G, 2007, BURNS, V33, P966, DOI 10.1016/j.burns.2007.04.011; Greenhalgh DG, 2007, J BURN CARE RES, V28, P555, DOI 10.1097/BCR.0B013E318093DF01; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Greenhalgh DG, 2010, BURNS, V36, P176, DOI 10.1016/j.burns.2009.09.004; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Hart DW, 2001, ANN SURG, V233, P556, DOI 10.1097/00000658-200104000-00012; Hart DW, 2000, ANN SURG, V232, P455, DOI 10.1097/00000658-200010000-00001; Heimbach DM, 2003, J BURN CARE REHABIL, V24, P42, DOI 10.1097/00004630-200301000-00009; Hemmila MR, 2008, SURGERY, V144, P629, DOI 10.1016/j.surg.2008.07.001; Herndon DN, 2012, ANN SURG, V256, P402, DOI 10.1097/SLA.0b013e318265427e; Herndon DN, 1999, ANN SURG, V229, P713, DOI 10.1097/00000658-199905000-00014; Herndon DN, 2004, LANCET, V363, P1895, DOI 10.1016/S0140-6736(04)16360-5; HERNDON DN, 1989, ANN SURG, V209, P547, DOI 10.1097/00000658-198905000-00006; HERNDON DN, 1995, ANN SURG, V221, P649, DOI 10.1097/00000658-199506000-00004; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; HERNDON DN, 1986, J TRAUMA, V26, P149, DOI 10.1097/00005373-198602000-00009; Herndon DN., 2017, TOTAL BURN CARE, V5th; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Janzekovic Z, 1972, Panminerva Med, V14, P228; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2008, MOL MED, V14, P11, DOI 10.2119/2007-00062.Jeschke; Jeschke MG, 2007, ANN SURG, V246, P351, DOI 10.1097/SLA.0b013e318146980e; Jeschke MG, 2007, J TRAUMA, V62, P676, DOI 10.1097/TA.0b013e318031afd3; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; Jeschke MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021245; Jeschke MG, 2010, ANN SURG, V252, P521, DOI 10.1097/SLA.0b013e3181f2774c; Jeschke MG, 2010, AM J RESP CRIT CARE, V182, P351, DOI 10.1164/rccm.201002-0190OC; Jeschke MG, 2009, MOL MED, V15, P337, DOI 10.2119/molmed.2009.00005; Jeschke MG, 2004, ANN SURG, V239, P553, DOI 10.1097/01.sla.0000118569.10289.ad; Jeschke MG, 1999, J SURG RES, V85, P171, DOI 10.1006/jsre.1999.5623; Jeschke MG, 2000, ANN SURG, V231, P246, DOI 10.1097/00000658-200002000-00014; Jeschke MG, 1999, J SURG RES, V83, P122, DOI 10.1006/jsre.1999.5577; Jeschke MG, 2012, HDB BURNS, V1; Kita K, 2010, STEM CELLS DEV, V19, P491, DOI 10.1089/scd.2009.0192; Klein D, 2004, ANN SURG, V240, P340, DOI 10.1097/01.sla.0000133353.57674.cd; Klein MB, 2007, ANN SURG, V245, P622, DOI 10.1097/01.sla.0000252572.50684.49; Kolle SFT, 2012, J PLAST SURG HAND SU, V46, P59, DOI 10.3109/2000656X.2012.668326; Kraft R, 2013, J SURG RES, V181, P121, DOI 10.1016/j.jss.2012.05.058; Kraft R, 2012, LANCET, V379, P1013, DOI 10.1016/S0140-6736(11)61345-7; Latenser BA, 2009, CRIT CARE MED, V37, P2819, DOI 10.1097/CCM.0b013e3181b3a08f; Lesher AP, 2011, J PEDIATR SURG, V46, P1759, DOI 10.1016/j.jpedsurg.2011.03.070; Low JFA, 2001, BURNS, V27, P447, DOI 10.1016/S0305-4179(00)00164-9; Martini WZ, 2001, JPEN-PARENTER ENTER, V25, P310, DOI 10.1177/0148607101025006310; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mecott GA, 2010, CRIT CARE, V14, DOI 10.1186/cc9222; Mlcak RP, 2006, ANN SURG, V244, P121, DOI 10.1097/01.sla.0000217678.78472.d3; MOCHIZUKI H, 1984, ANN SURG, V200, P297, DOI 10.1097/00000658-198409000-00007; Moon RJ, 2007, DIABETES OBES METAB, V9, P143, DOI 10.1111/j.1463-1326.2006.00599.x; Morio B, 2002, ANN SURG, V236, P218, DOI 10.1097/00000658-200208000-00010; Norbury WB, 2007, TOTAL BURN CARE, P420; Palmieri TL, 2009, J BURN CARE RES, V30, P206, DOI 10.1097/BCR.0b013e3181923ea4; Peck MD, 2012, BURNS, V38, P630, DOI 10.1016/j.burns.2011.12.028; Peck MD, 2011, BURNS, V37, P1087, DOI 10.1016/j.burns.2011.06.005; Petruzzo P, 2012, TRANSPLANTATION, V93, P236, DOI 10.1097/TP.0b013e31823d4af6; Pham C, 2007, BURNS, V33, P946, DOI 10.1016/j.burns.2007.03.020; Pham TN, 2005, J TRAUMA, V59, P1148, DOI 10.1097/01.ta.0000188933.16637.68; Pierre EJ, 1998, J TRAUMA, V44, P342, DOI 10.1097/00005373-199802000-00019; Pomahac B, 2012, NEW ENGL J MED, V366, P715, DOI 10.1056/NEJMoa1111432; Pomahac Bohdan, 2011, Curr Probl Surg, V48, P293, DOI 10.1067/j.cpsurg.2011.01.003; Porro LJ, 2012, J AM COLL SURGEONS, V214, P489, DOI 10.1016/j.jamcollsurg.2011.12.038; Pruitt BA, 2000, J TRAUMA, V49, P567, DOI 10.1097/00005373-200009000-00030; Przkora R, 2007, PEDIATRICS, V119, pE109, DOI 10.1542/peds.2006-1548; Przkora R, 2006, ANN SURG, V243, P796, DOI 10.1097/01.sla.0000219676.69331.fd; Przkora R, 2006, J TRAUMA, V60, P968, DOI 10.1097/01.ta.0000214580.27501.19; Pushpakumar SB, 2010, BURNS, V36, P951, DOI 10.1016/j.burns.2010.01.011; Rahmanian-Schwarz A, 2011, BURNS, V37, P1343, DOI 10.1016/j.burns.2011.07.010; Ramirez RJ, 1998, ANN SURG, V228, P439, DOI 10.1097/00000658-199810000-00001; RANDLE PJ, 1963, LANCET, V1, P785; Roberts G, 2012, J TRAUMA ACUTE CARE, V72, P251, DOI 10.1097/TA.0b013e31824052bb; ROYALL D, 1994, CRIT CARE MED, V22, P399, DOI 10.1097/00003246-199403000-00008; Ryan CM, 2013, J BURN CARE RES, V34, pE121, DOI 10.1097/BCR.0b013e31827e7ecf; Saffle JR, 2007, J BURN CARE RES, V28, P382, DOI 10.1097/BCR.0B013E318053D3A1; Saffle JR, 2007, TOTAL BURN CARE, P398; Salinas J, 2008, J TRAUMA, V64, pS321, DOI 10.1097/TA.0b013e31816bf4f7; Salinas J, 2011, CRIT CARE MED, V39, P2031, DOI 10.1097/CCM.0b013e31821cb790; Sheridan RL, 2001, NEW ENGL J MED, V345, P1271, DOI 10.1056/NEJM200110253451710; Sheridan RL, 2009, J BURN CARE RES, V30, P162, DOI 10.1097/BCR.0b013e3181923be3; Solomon J R, 1981, Prog Pediatr Surg, V14, P133; Soni CV, 2010, BURNS, V36, P959, DOI 10.1016/j.burns.2010.01.012; Sriwiriyanont P, 2012, EXP DERMATOL, V21, P783, DOI 10.1111/exd.12003; Suman OE, 2006, BURNS, V32, P335, DOI 10.1016/j.burns.2005.10.023; Suman OE, 2001, J APPL PHYSIOL, V91, P1168, DOI 10.1152/jappl.2001.91.3.1168; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tompkins RG, 2012, J TRAUMA ACUTE CARE, V73, pS173, DOI 10.1097/TA.0b013e318265c53e; Wainwright DJ, 2011, AESTHET SURG J, V31, p13S, DOI 10.1177/1090820X11418202; WHO, 2002, INJ CHARTB GRAPH OV; Williams FN, 2009, CRIT CARE, V13, DOI 10.1186/cc8170; Williams FN, 2009, J AM COLL SURGEONS, V208, P489, DOI 10.1016/j.jamcollsurg.2009.01.022; WILMORE DW, 1975, J APPL PHYSIOL, V38, P593, DOI 10.1152/jappl.1975.38.4.593; Wischmeyer PE, 2006, CURR OPIN CRIT CARE, V12, P142, DOI 10.1097/01.ccx.0000216582.87674.a4; Wischmeyer PE, 2001, CRIT CARE MED, V29, P2075, DOI 10.1097/00003246-200111000-00006; Wolf SE, 2006, J BURN CARE RES, V27, P131, DOI 10.1097/01.BCR.0000202620.55751.4F; WOLFE RR, 1977, AM J PHYSIOL, V232, pE415, DOI 10.1152/ajpendo.1977.232.4.E415; Wood F, 2012, BURNS, V38, P830, DOI 10.1016/j.burns.2011.12.020; Wood FM, 2006, BURNS, V32, P395, DOI 10.1016/j.burns.2006.01.008; Wood FM, 2012, BURNS, V38, P44, DOI 10.1016/j.burns.2011.03.001; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899	149	64	76	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 29	2014	383	9923					1168	1178		10.1016/S0140-6736(13)61093-4	http://dx.doi.org/10.1016/S0140-6736(13)61093-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4MH	24034453	Green Accepted			2022-12-28	WOS:000333956000036
J	Hernan, MA; Hernandez-Diaz, S; Robins, JM				Hernan, Miguel A.; Hernandez-Diaz, Sonia; Robins, James M.			Randomized Trials Analyzed as Observational Studies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISKS		[Hernan, Miguel A.; Hernandez-Diaz, Sonia; Robins, James M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hernan, MA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	miguel_hernan@post.harvard.edu		Hernan, Miguel/0000-0003-1619-8456	NHLBI NIH HHS [R01 HL080644] Funding Source: Medline; NIAID NIH HHS [R37 AI032475, R56 AI102634, R01 AI102634] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032475, R56AI102634, R01AI102634] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Hernan MA, 2012, CLIN TRIALS, V9, P48, DOI 10.1177/1740774511420743; Lesko SM, 2012, PHARMACOEPIDEM DR S, P553; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; ROBINS JM, 1994, J AM STAT ASSOC, V89, P737, DOI 10.1080/01621459.1994.10476807; Robins JM, 2009, ADV LONGITUDINAL DAT; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Toh S, 2010, EPIDEMIOLOGY, V21, P528, DOI 10.1097/EDE.0b013e3181df1b69; Toh Sengwee, 2008, Int J Biostat, V4, P22, DOI 10.2202/1557-4679.1117	8	112	114	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					560	+		10.7326/0003-4819-159-8-201310150-00709	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00709			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24018844	Green Accepted			2022-12-28	WOS:000326751200020
J	French, S; Lekic, V; Romanowicz, B				French, Scott; Lekic, Vedran; Romanowicz, Barbara			Waveform Tomography Reveals Channeled Flow at the Base of the Oceanic Asthenosphere	SCIENCE			English	Article							UPPER-MANTLE STRUCTURE; CLUSTER-ANALYSIS; CONVECTION; PLUME; REGION	Understanding the relationship between different scales of convection that drive plate motions and hotspot volcanism still eludes geophysicists. Using full-waveform seismic tomography, we imaged a pattern of horizontally elongated bands of low shear velocity, most prominent between 200 and 350 kilometers depth, which extends below the well-developed low-velocity zone. These quasi-periodic fingerlike structures of wavelength similar to 2000 kilometers align parallel to the direction of absolute plate motion for thousands of kilometers. Below 400 kilometers depth, velocity structure is organized into fewer, undulating but vertically coherent, low-velocity plumelike features, which appear rooted in the lower mantle. This suggests the presence of a dynamic interplay between plate-driven flow in the low-velocity zone and active influx of low-rigidity material from deep mantle sources deflected horizontally beneath the moving top boundary layer.	[French, Scott; Romanowicz, Barbara] Berkeley Seismol Lab, Berkeley, CA 94720 USA; [Lekic, Vedran] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Romanowicz, Barbara] Coll France, F-75005 Paris, France; [Romanowicz, Barbara] Inst Phys Globe Paris, F-752382 Paris 05, France	University System of Maryland; University of Maryland College Park; UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Universite Paris Cite	Romanowicz, B (corresponding author), Berkeley Seismol Lab, 209 McCone Hall, Berkeley, CA 94720 USA.	barbara@seismo.berkeley.edu	Lekic, Vedran/I-8121-2012; Romanowicz, barbara A/H-6726-2017	Lekic, Vedran/0000-0002-3548-272X; Romanowicz, barbara A/0000-0002-6208-6044	National Science Foundation (NSF) [EAR-0738284]; NSF Graduate Research Fellowship; U.S. Department of Energy Office of Science [DE-AC02-05CH11231]	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Graduate Research Fellowship(National Science Foundation (NSF)); U.S. Department of Energy Office of Science(United States Department of Energy (DOE))	We thank A. Davaille, C. Jaupart, and D. Shim for helpful discussions. This work was supported by the National Science Foundation (NSF) (grant EAR-0738284). S. F. acknowledges support from a NSF Graduate Research Fellowship. Our waveform data set was collected from the Incorporated Research Institutions for Seismology (www.iris.edu). Computations were performed at the National Energy Research Scientific Computing Center (supported by the U.S. Department of Energy Office of Science, contract DE-AC02-05CH11231). This is Berkeley Seismological Laboratory contribution 13-13. The SEMum2 model is available at http://seismo.berkeley.edu/similar to sfrench/SEMum2.	Ballmer MD, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002386; Ballmer MD, 2013, GEOLOGY, V41, P479, DOI 10.1130/G33804.1; Colli L, 2013, TECTONOPHYSICS, V604, P26, DOI 10.1016/j.tecto.2013.06.015; Davaille A, 2005, EARTH PLANET SC LETT, V239, P233, DOI 10.1016/j.epsl.2005.07.024; Fichtner A, 2009, GEOPHYS J INT, V179, P1703, DOI 10.1111/j.1365-246X.2009.04368.x; Harmon N, 2011, EARTH PLANET SC LETT, V311, P306, DOI 10.1016/j.epsl.2011.09.038; Hayn M, 2012, GEOPHYS J INT, V189, P1430, DOI 10.1111/j.1365-246X.2012.05455.x; Hillier JK, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003041; Hoink T, 2012, GEOPHYS J INT, V191, P30, DOI 10.1111/j.1365-246X.2012.05621.x; Hofmann A.W., 2003, TREAT GEOCHEM, V2, P61, DOI DOI 10.1016/B0-08-043751-6/02123-X; Katzman R, 1998, J GEOPHYS RES-SOL EA, V103, P17933, DOI 10.1029/98JB00504; Kreemer C, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2009JB006416; Laske G, 2011, GEOPHYS J INT, V187, P1725, DOI 10.1111/j.1365-246X.2011.05238.x; Lekic V, 2011, GEOPHYS J INT, V185, P799, DOI 10.1111/j.1365-246X.2011.04969.x; Lekic V, 2012, EARTH PLANET SC LETT, V357, P68, DOI 10.1016/j.epsl.2012.09.014; Lekic V, 2011, EARTH PLANET SC LETT, V308, P151, DOI 10.1016/j.epsl.2011.05.050; MCNUTT MK, 1987, GEOPHYS MONOGR SER, V43, P25; MORGAN JP, 1995, J GEOPHYS RES-SOL EA, V100, P12753, DOI 10.1029/95JB00041; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Nolet G, 2000, J GEOPHYS RES-SOL EA, V105, P19043, DOI 10.1029/2000JB900161; O'Connor JM, 2012, NAT GEOSCI, V5, P735, DOI [10.1038/NGEO1583, 10.1038/ngeo1583]; RICHARDS MA, 1992, NATURE, V355, P437, DOI 10.1038/355437a0; RICHTER FM, 1975, J GEOPHYS RES, V80, P2529, DOI 10.1029/JB080i017p02529; Rickers F, 2012, GEOPHYS J INT, V190, P650, DOI 10.1111/j.1365-246X.2012.05515.x; Romanowicz B, 2002, SCIENCE, V296, P513, DOI 10.1126/science.1069404; Snyder D, 1998, J FLUID MECH, V369, P1; Steinberger B, 2000, J GEOPHYS RES-SOL EA, V105, P11127, DOI 10.1029/1999JB900398; Tape C, 2009, SCIENCE, V325, P988, DOI 10.1126/science.1175298; Toomey DR, 2002, EARTH PLANET SC LETT, V200, P287, DOI 10.1016/S0012-821X(02)00655-6; Wolfe CJ, 2011, EARTH PLANET SC LETT, V303, P267, DOI 10.1016/j.epsl.2011.01.004	30	162	164	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					227	230		10.1126/science.1241514	http://dx.doi.org/10.1126/science.1241514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232EV	24009355				2022-12-28	WOS:000325475200040
J	Apps, R; Carrington, M				Apps, Richard; Carrington, Mary			Response to Comment on "Influence of HLA-C Expression Level on HIV Control"	SCIENCE			English	Editorial Material							SURFACE EXPRESSION; ASSOCIATION; BINDING		[Apps, Richard; Carrington, Mary] Sci Applicat Int Corp Frederick Inc, Canc & Inflammat Program, Lab Expt Immunol, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Apps, Richard; Carrington, Mary] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Apps, Richard; Carrington, Mary] Harvard Univ, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Carrington, M (corresponding author), Sci Applicat Int Corp Frederick Inc, Canc & Inflammat Program, Lab Expt Immunol, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.	carringm@mail.nih.gov			NCI NIH HHS [HHSN261200800001E] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Blais ME, 2012, J IMMUNOL, V188, P4663, DOI 10.4049/jimmunol.1103472; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Lo Monaco E, 2008, J IMMUNOL, V181, P5442, DOI 10.4049/jimmunol.181.8.5442; Lo Monaco E, 2013, SCIENCE, V341, DOI 10.1126/science.1241266; Ravindranath MH, 2011, MOL IMMUNOL, V48, P423, DOI 10.1016/j.molimm.2010.09.011; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486	9	3	3	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151								10.1126/science.1241854	http://dx.doi.org/10.1126/science.1241854			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215ZA	24031003	Green Accepted, Bronze			2022-12-28	WOS:000324248800020
J	Mueller, KL				Mueller, Kristen L.			The Future Is Now INTRODUCTION	SCIENCE			English	Editorial Material																			0	2	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2013	341	6151					1191	1191		10.1126/science.341.6151.1191	http://dx.doi.org/10.1126/science.341.6151.1191			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215ZA	24031010				2022-12-28	WOS:000324248800030
J	Boyd, I				Boyd, Ian			A standard for policy-relevant science	NATURE			English	Editorial Material							METAANALYSIS		[Boyd, Ian] UK Dept Environm Food & Rural Affairs, London, England; [Boyd, Ian] Univ St Andrews, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Boyd, I (corresponding author), UK Dept Environm Food & Rural Affairs, London, England.	ian.boyd@defra.gsi.gov.uk						Begley CG, 2013, NATURE, V497, P433, DOI 10.1038/497433a; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Doull J, 2007, FOOD CHEM TOXICOL, V45, P2073, DOI 10.1016/j.fct.2007.08.033; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Stokstad E, 2013, SCIENCE, V340, P674, DOI [10.1126/science.340.6133.674, 10.1126/science.340.6133.675]; Zhang Y, 2013, CURR BIOL, V23, P1094, DOI 10.1016/j.cub.2013.04.072	10	25	25	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					159	160		10.1038/501159a	http://dx.doi.org/10.1038/501159a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215XR	24032133	Bronze			2022-12-28	WOS:000324244900015
J	Yin, F; Yu, JZ; Zheng, YG; Chen, Q; Zhang, NL; Pan, DJ				Yin, Feng; Yu, Jianzhong; Zheng, Yonggang; Chen, Qian; Zhang, Nailing; Pan, Duojia			Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2	CELL			English	Article							CELL-PROLIFERATION; PROTEIN-KINASE; TISSUE-GROWTH; NF2 GENE; F-ACTIN; PATHWAY; PHOSPHORYLATION; CONJUNCTION; RESTRICTS; SALVADOR	Although Merlin/NF2 was discovered two decades ago as a tumor suppressor underlying Neurofibromatosis type II, its precise molecular mechanism remains poorly understood. Recent studies in Drosophila revealed a potential link between Merlin and the Hippo pathway by placing Merlin genetically upstream of the kinase Hpo/Mst. In contrast to the commonly depicted linear model of Merlin functioning through Hpo/Mst, here we show that in both Drosophila and mammals, Merlin promotes downstream Hippo signaling without activating the intrinsic kinase activity of Hpo/Mst. Instead, Merlin directly binds and recruits the effector kinase Wts/Lats to the plasma membrane. Membrane recruitment, in turn, promotes Wts phosphorylation by the Hpo-Sav kinase complex. We further show that disruption of the actin cytoskeleton promotes Merlin-Wts interactions, which implicates Merlin in actin-mediated regulation of Hippo signaling. Our findings elucidate an important molecular function of Merlin and highlight the plasma membrane as a critical subcellular compartment for Hippo signal transduction.	[Yin, Feng; Yu, Jianzhong; Zheng, Yonggang; Chen, Qian; Zhang, Nailing; Pan, Duojia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Pan, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	djpan@jhmi.edu	YIN, FENG/AAM-3823-2020	YIN, FENG/0000-0002-8444-1123	National Institutes of Health [EY015708]; Department of Defense [NF093145]; NATIONAL EYE INSTITUTE [R01EY015708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. Rick Fehon for the gift of anti-Mer antibody, Dr. Marco Giovannini for providing FC-912 and FH-912 Schwann cells, and Dr. Vijaya Ramesh for advice on GST-NF2 purification. This study was supported in part by grants from the National Institutes of Health (EY015708) and Department of Defense (NF093145). D.P. is an investigator of the Howard Hughes Medical Institute.	Ahronowitz I, 2007, HUM MUTAT, V28, P1, DOI 10.1002/humu.20393; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bossuyt W, 2014, ONCOGENE, V33, P1218, DOI 10.1038/onc.2013.82; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Giovannini M, 2000, GENE DEV, V14, P1617; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hergovich A, 2005, MOL CELL BIOL, V25, P8259, DOI 10.1128/MCB.25.18.8259-8272.2005; Ho LL, 2010, DEV BIOL, V337, P274, DOI 10.1016/j.ydbio.2009.10.042; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kang BS, 2002, ACTA CRYSTALLOGR D, V58, P381, DOI 10.1107/S0907444901021175; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Metpally RPR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-106; Nguyen R, 2001, J BIOL CHEM, V276, P7621, DOI 10.1074/jbc.M006708200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Surace EI, 2004, ONCOGENE, V23, P580, DOI 10.1038/sj.onc.1207142; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	44	344	355	4	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1342	1355		10.1016/j.cell.2013.08.025	http://dx.doi.org/10.1016/j.cell.2013.08.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24012335	Green Accepted, Bronze			2022-12-28	WOS:000324239300021
J	Yamanaka, N; Romero, NM; Martin, FA; Rewitz, KF; Sun, M; O'Connor, MB; Leopold, P				Yamanaka, Naoki; Romero, Nuria M.; Martin, Francisco A.; Rewitz, Kim F.; Sun, Mu; O'Connor, Michael B.; Leopold, Pierre			Neuroendocrine Control of Drosophila Larval Light Preference	SCIENCE			English	Article							GENE ACTIVITY; MELANOGASTER; NEURONS; PHOTOBEHAVIOR; BEHAVIOR; HORMONE	Animal development is coupled with innate behaviors that maximize chances of survival. Here, we show that the prothoracicotropic hormone (PTTH), a neuropeptide that controls the developmental transition from juvenile stage to sexual maturation, also regulates light avoidance in Drosophila melanogaster larvae. PTTH, through its receptor Torso, acts on two light sensors-the Bolwig's organ and the peripheral class IV dendritic arborization neurons-to regulate light avoidance. We found that PTTH concomitantly promotes steroidogenesis and light avoidance at the end of larval stage, driving animals toward a darker environment to initiate the immobile maturation phase. Thus, PTTH controls the decisions of when and where animals undergo metamorphosis, optimizing conditions for adult development.	[Yamanaka, Naoki; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Romero, Nuria M.; Martin, Francisco A.; Leopold, Pierre] Univ Nice Sophia Antipolis, CNRS, INSERM, Inst Biol Valrose, F-06108 Nice, France; [Rewitz, Kim F.] Univ Copenhagen, Dept Biol Cell & Neurobiol, DK-2200 Copenhagen, Denmark; [Sun, Mu] GlaxoSmithKline Res & Dev Ltd, Neurodegenerat Discovery Performance Unit, Shanghai 201203, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Copenhagen; GlaxoSmithKline	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@umn.edu; leopold@unice.fr	Martin, Francisco A/K-2785-2014; Romero, Nuria/AAG-8686-2021; Rewitz, Kim F/M-6012-2014; Yamanaka, Naoki/F-1358-2010; Sun, Mu/A-6772-2008; O'Connor, Michael B/C-9977-2014	Martin, Francisco A/0000-0002-1916-1934; Rewitz, Kim F/0000-0002-4409-9941; Yamanaka, Naoki/0000-0002-6244-2686; Sun, Mu/0000-0001-8261-3705; O'Connor, Michael B/0000-0002-3067-5506; ROMERO, NURIA/0000-0001-6235-1330	CNRS; INSERM; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; European Research Council [268813]; NIH [K99 HD073239, R01 GM093301]; Danish Council for Independent Research, Natural Sciences [11-105446]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD073239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093301] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Jarretou and B. Polo for technical assistance; F. Casares, J. Bessa, M. Bate, W. Johnson, C. Desplan, F. Pichaud, Y. N. Jan, and stock centers in Kyoto, Bloomington, and Vienna for fly stocks; B. Prud'homme and N. Gompel for wild D. melanogaster isolates; L. Vollborn for antibody to PTTH; P. Baroni for light-emitting diode spectrum analysis; and F. Rouyer, J. Simon, S. Sprecher, and laboratory members from O'Connor and Leopold groups for comments on the manuscript. This work was supported by the CNRS, INSERM, Agence Nationale de la Recherche, Fondation pour la Recherche Medicale, European Research Council (grant 268813) to N. M. R., F. A. M., and P. L.; NIH grant K99 HD073239 to N.Y.; Danish Council for Independent Research, Natural Sciences grant 11-105446 to K. F. R.; and NIH grant R01 GM093301 to M.B.O. Materials are available from CNRS under a material transfer agreement.	Bodenstein D., 1950, BIOL DROSOPHILA, P275; DOMINICK OS, 1985, J EXP BIOL, V117, P45; Gong ZF, 2010, SCIENCE, V330, P499, DOI 10.1126/science.1195993; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hassan J, 2005, J COMP NEUROL, V481, P266, DOI 10.1002/cne.20383; Keene AC, 2012, TRENDS NEUROSCI, V35, P104, DOI 10.1016/j.tins.2011.11.003; MARKOW TA, 1981, BEHAV NEURAL BIOL, V31, P348, DOI 10.1016/S0163-1047(81)91409-6; Mazzoni EO, 2005, NEURON, V45, P293, DOI 10.1016/j.neuron.2004.12.038; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Sanyal S, 2009, GENE EXPR PATTERNS, V9, P371, DOI 10.1016/j.gep.2009.01.002; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; SCHMUCKER D, 1992, NEURON, V9, P1025, DOI 10.1016/0896-6273(92)90063-J; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Warren JT, 2006, DEV DYNAM, V235, P315, DOI 10.1002/dvdy.20626; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608	18	76	77	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1113	1116		10.1126/science.1241210	http://dx.doi.org/10.1126/science.1241210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009394	Green Accepted			2022-12-28	WOS:000323933100045
J	Tucker, JD; von Zinkernagel, DJ; Goosby, EP				Tucker, Joseph D.; von Zinkernagel, Deborah J.; Goosby, Eric P.			An inclusive rights-based foreign policy for health	LANCET			English	Editorial Material							HIV PREVENTION; SEX; MEN		[Tucker, Joseph D.] UNC Project China, Guangzhou 510095, Guangdong, Peoples R China; [von Zinkernagel, Deborah J.; Goosby, Eric P.] US Off Global Hlth Diplomacy, Washington, DC USA		Tucker, JD (corresponding author), UNC Project China, Guangzhou 510095, Guangdong, Peoples R China.	jdtucker@med.unc.edu		Tucker, Joseph/0000-0003-2804-1181	FOGARTY INTERNATIONAL CENTER [K01TW008200] Funding Source: NIH RePORTER; FIC NIH HHS [K01 TW008200] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Dee TS, 2008, ECON J, V118, P1055, DOI 10.1111/j.1468-0297.2008.02160.x; Francis SA, 2009, J RELIG HEALTH, V48, P6, DOI 10.1007/s10943-008-9171-4; Human Rights Campaign, 2013, STAT EMPL LAWS POL; Itaborahy LP, 2013, STATE SPONSORED HOMO; Obama Barack, 2011, COMMUNICATION; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; United Nations Human Rights Council, 2011, DISCR LAWS PRACT ACT	9	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 31	2013	382	9894					745	746		10.1016/S0140-6736(13)61462-2	http://dx.doi.org/10.1016/S0140-6736(13)61462-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VP	23993176	Green Accepted			2022-12-28	WOS:000324239200004
J	Danilchanka, O; Mekalanos, JJ				Danilchanka, Olga; Mekalanos, John J.			Cyclic Dinucleotides and the Innate Immune Response	CELL			English	Review							NF-KAPPA-B; C-DI-GMP; PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; ALPHA UBIQUITINATION; ACETOBACTER-XYLINUM; DNA INTEGRITY; AMP; 2ND-MESSENGER; ACTIVATION	Cyclic dinucleotides (CDNs) have been previously recognized as important secondary signaling molecules in bacteria and, more recently, in mammalian cells. In the former case, they represent secondary messengers affecting numerous responses of the prokaryotic cell, whereas in the latter, they act as agonists of the innate immune response. Remarkable new discoveries have linked these two patterns of utilization of CDNs as secondary messengers and have revealed unexpected influences they likely had on shaping human genetic variation. This Review summarizes these recent insights and provides a perspective on future unanswered questions in this exciting field.	[Danilchanka, Olga; Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	john_mekalanos@hms.harvard.edu			National Institutes of Health [AI-26289, AI-018045]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018045, R37AI018045, R22AI018045, R01AI026289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health grants AI-26289 and AI-018045 to J.J.M. The authors would like to thank Michaela Gack, Daniel Portnoy, and Russell Vance for their helpful comments. J.J.M. is on the scientific advisory board of Aduro BioTech, which is developing dicyclic nucleotide-based adjuvants for vaccines and immunotherapeutics.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Bradford BM, 2012, VIRUSES-BASEL, V4, P3389, DOI 10.3390/v4123389; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Butler SM, 2006, MOL MICROBIOL, V60, P417, DOI 10.1111/j.1365-2958.2006.05096.x; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Chang SJ, 2009, J VIROL, V83, P4140, DOI 10.1128/JVI.01835-08; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Dev A, 2011, CURR TOP MICROBIOL, V349, P115, DOI 10.1007/82_2010_102; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Grundling A, 2004, P NATL ACAD SCI USA, V101, P12318, DOI 10.1073/pnas.0404924101; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Hicks SW, 2013, NAT REV MICROBIOL, V11, P316, DOI 10.1038/nrmicro3009; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kim JC, 2008, FEBS LETT, V582, P2371, DOI 10.1016/j.febslet.2008.05.044; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Le Negrate G, 2008, CELL MICROBIOL, V10, P1879, DOI 10.1111/j.1462-5822.2008.01178.x; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lindenberg S, 2013, EMBO J, V32, P2001, DOI 10.1038/emboj.2013.120; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Manzanillo PS, 2012, CELL HOST MICROBE, V11, P469, DOI 10.1016/j.chom.2012.03.007; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Roelofs KG, 2011, P NATL ACAD SCI USA, V108, P15528, DOI 10.1073/pnas.1018949108; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shisler JL, 2004, J VIROL, V78, P3553, DOI 10.1128/JVI.78.7.3553-3560.2004; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Zhang L, 2013, J BIOL CHEM, V288, P22426, DOI 10.1074/jbc.M113.464883; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	83	149	168	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					962	970		10.1016/j.cell.2013.08.014	http://dx.doi.org/10.1016/j.cell.2013.08.014			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993090	Green Accepted, Bronze			2022-12-28	WOS:000323767300011
J	Maisonneuve, E; Castro-Camargo, M; Gerdes, K				Maisonneuve, Etienne; Castro-Camargo, Manuela; Gerdes, Kenn			RETRACTED: (p)ppGpp Controls Bacterial Persistence by Stochastic Induction of Toxin-Antitoxin Activity (Retracted article. See vol. 172, pg. 1135, 2018)	CELL			English	Article; Retracted Publication							ESCHERICHIA-COLI; STRINGENT RESPONSE; INORGANIC POLYPHOSPHATE; MYCOBACTERIUM-TUBERCULOSIS; CONTROLLED EXPRESSION; PROTEIN-SYNTHESIS; RIBOSOMAL-RNA; IN-VIVO; PPGPP; TRANSCRIPTION	Persistence refers to the phenomenon in which isogenic populations of antibiotic-sensitive bacteria produce rare cells that transiently become multidrug tolerant. Whether slow growth in a rare subset of cells underlies the persistence phenotype has not be examined in wild-type bacteria. Here, we show that an exponentially growing population of wildtype Escherichia coli cells produces rare cells that stochastically switch into slow growth, that the slow-growing cells are multidrug tolerant, and that they are able to resuscitate. The persistence phenotype depends hierarchically on the signaling nucleotide (p)ppGpp, Lon protease, inorganic polyphosphate, and toxin-antitoxins. We show that the level of (p)ppGpp varies stochastically in a population of exponentially growing cells and that the high (p)ppGpp level in rare cells induces slow growth and persistence. (p)ppGpp triggers slow growth by activating toxin-antitoxin loci through a regulatory cascade depending on inorganic polyphosphate and Lon protease.	[Maisonneuve, Etienne; Castro-Camargo, Manuela; Gerdes, Kenn] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK	Gerdes, K (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	kenn.gerdes@ncl.ac.uk	Gerdes, Kenn/M-2420-2014; Gerdes, Kenn/AAS-5548-2021	Gerdes, Kenn/0000-0002-7462-4612; Gerdes, Kenn/0000-0002-7462-4612; maisonneuve, Etienne/0000-0003-3451-1223	European Research Council [294517]; Novo Nordisk Fonden [NNF12OC0000638] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank David Holden, Sophie Helaine, and Heath Murray for critical reading of the manuscript and a reviewer for suggesting the "microstarvation" model. We further thank the members of the Gerdes group and members of the Centre for Bacterial Cell Biology for stimulating discussions. This work was funded by a European Research Council Advanced Investigator Grant (294517; "PERSIST") to K.G.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; AKIYAMA M, 1992, J BIOL CHEM, V267, P22556; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; [Anonymous], PLOS GENET, V9; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bigger JW, 1944, LANCET, V2, P497; BLACK DS, 1991, J BACTERIOL, V173, P5732, DOI 10.1128/jb.173.18.5732-5739.1991; Cataudella I, 2012, NUCLEIC ACIDS RES, V40, P6424, DOI 10.1093/nar/gks297; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; CROOKE E, 1994, J BIOL CHEM, V269, P6290; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Ghosh S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-18; GOURSE RL, 1986, CELL, V44, P197, DOI 10.1016/0092-8674(86)90498-8; HANSEN MT, 1975, J BACTERIOL, V122, P585, DOI 10.1128/JB.122.2.585-591.1975; HARSHMAN RB, 1971, BIOCHEMISTRY-US, V10, P3980, DOI 10.1021/bi00797a027; Kanjee U, 2012, MOL MICROBIOL, V85, P1029, DOI 10.1111/j.1365-2958.2012.08177.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LAFFLER T, 1974, CELL, V3, P47, DOI 10.1016/0092-8674(74)90036-1; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; RODIONOV DG, 1995, J BACTERIOL, V177, P4224, DOI 10.1128/jb.177.15.4224-4229.1995; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; Shyp V, 2012, EMBO REP, V13, P835, DOI 10.1038/embor.2012.106; Sternberg C, 1999, APPL ENVIRON MICROB, V65, P4108; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; TOSA T, 1971, J BACTERIOL, V106, P972, DOI 10.1128/JB.106.3.972-982.1971; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Wexselblatt E, 2010, BIOORGAN MED CHEM, V18, P4485, DOI 10.1016/j.bmc.2010.04.064; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Zhao J, 2008, PLOS BIOL, V6, P1306, DOI 10.1371/journal.pbio.0060150	62	344	363	3	141	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1140	1150		10.1016/j.cell.2013.07.048	http://dx.doi.org/10.1016/j.cell.2013.07.048			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993101	Bronze			2022-12-28	WOS:000323767300025
J	Zhang, XHF; Jin, X; Malladi, S; Zou, YL; Wen, YH; Brogi, E; Smid, M; Foekens, JA; Massague, J				Zhang, Xiang H. -F.; Jin, Xin; Malladi, Srinivas; Zou, Yilong; Wen, Yong H.; Brogi, Edi; Smid, Marcel; Foekens, John A.; Massague, Joan			Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma	CELL			English	Article							BREAST-CANCER METASTASIS; MOLECULAR CHARACTERIZATION; STEM-CELLS; GROWTH; INSIGHTS; PROGRAM; SRC	How organ-specific metastatic traits arise in primary tumors remains unknown. Here, we show a role of the breast tumor stroma in selecting cancer cells that are primed for metastasis in bone. Cancer-associated fibroblasts (CAFs) in triple-negative (TN) breast tumors skew heterogeneous cancer cell populations toward a predominance of clones that thrive on the CAF-derived factors CXCL12 and IGF1. Limiting concentrations of these factors select for cancer cells with high Src activity, a known clinical predictor of bone relapse and an enhancer of PI3K-Akt pathway activation by CXCL12 and IGF1. Carcinoma clones selected in this manner are primed for metastasis in the CXCL12-rich microenvironment of the bone marrow. The evidence suggests that stromal signals resembling those of a distant organ select for cancer cells that are primed for metastasis in that organ, thus illuminating the evolution of metastatic traits in a primary tumor and its distant metastases.	[Zhang, Xiang H. -F.; Jin, Xin; Malladi, Srinivas; Zou, Yilong; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Wen, Yong H.; Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Smid, Marcel; Foekens, John A.] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Med Oncol, NL-3015 CE Rotterdam, Netherlands; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 21205 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org		Smid, Marcel/0000-0003-0605-1901; Zhang, Xiang/0000-0002-5674-8670; Massague, Joan/0000-0001-9324-8408; Zou, Yilong/0000-0001-8198-6067	NIH [CA151293, CA94060]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, K99CA151293, R00CA151293, P01CA094060] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank E. Holland, N.X. Rosen, A. Ventura, and S. Vanharanta for helpful input, A. Viale and N. Socci for support with RNA-seq analysis, N. Fan and M. Turkekul for advice on immunohistochemistry, and R. Somwar for reagents. This work was supported by NIH grants CA151293 (to X.H.-F.Z.) and CA94060 (to J.M.). X.H.-F.Z. is a McNair Scholar and is the recipient of a grant from Breast Cancer Research Foundation. S. M. is an American Cancer Society postdoctoral fellow. J.M. is an investigator of the Howard Hughes Medical Institute.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Collins P, 1999, NAT MED, V5, P1130, DOI 10.1038/13453; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309	40	284	300	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1060	1073		10.1016/j.cell.2013.07.036	http://dx.doi.org/10.1016/j.cell.2013.07.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993096	Green Accepted, Bronze			2022-12-28	WOS:000323767300019
J	Parkes, MJ; Maricar, N; Lunt, M; LaValley, MP; Jones, RK; Segal, NA; Takahashi-Narita, K; Felson, DT				Parkes, Matthew J.; Maricar, Nasimah; Lunt, Mark; LaValley, Michael P.; Jones, Richard K.; Segal, Neil A.; Takahashi-Narita, Kayoko; Felson, David T.			Lateral Wedge Insoles as a Conservative Treatment for Pain in Patients With Medial Knee Osteoarthritis A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE PROGRESSION; ADDUCTION MOMENT; WALKING SHOES; MANAGEMENT; BIAS; RECOMMENDATIONS; PUBLICATION; MECHANICS; ORTHOSES; SYMPTOMS	IMPORTANCE There is no consensus regarding the efficacy of lateral wedge insoles as a treatment for pain in medial knee osteoarthritis. OBJECTIVE To evaluate whether lateral wedge insoles reduce pain in patients with medial knee osteoarthritis compared with an appropriate control. DATA SOURCES Databases searched include the Cochrane Central Register of Controlled Trials, EMBASE, AMED, MEDLINE, CINAHL Plus, ScienceDirect, SCOPUS, Web of Science, and BIOSIS from inception to May 2013, with no limits on study date or language. The metaRegister of Controlled Trials and the NHS Evidence website were also searched. STUDY SELECTION Included were randomized trials comparing shoe-based treatments (lateral heel wedge insoles or shoes with variable stiffness soles) aimed at reducing medial knee load, with a neutral or no wedge control condition in patients with painful medial knee osteoarthritis. Studies must have included patient-reported pain as an outcome. DATA EXTRACTION AND SYNTHESIS Trial data were extracted independently by 2 researchers using a standardized form. Risk of bias was assessed using the Cochrane Risk of Bias tool by 2 observers. Eligible studies were pooled using a random-effects approach. MAIN OUTCOME AND MEASURES Change in self-reported knee pain at follow-up. RESULTS Twelve trials met inclusion criteria with a total of 885 participants of whom 502 received lateral wedge treatment. The pooled standardized mean difference (SMD) suggested a favorable association with lateral wedges compared with control (SMD, -0.47; 95% CI, -0.80 to -0.14); however, substantial heterogeneity was present (I-2 = 82.7%). This effect size represents an effect of -2.12 points on the 20-point Western Ontario and McMaster Universities Arthritis Index (WOMAC) pain scale. Larger trials with a lower risk of bias suggested a null association. Meta-regression analyses showed that higher effect sizes (unstandardized beta, 1.07 [95% CI, 0.28 to 1.87] for trials using a no treatment control) were seen in trials using a no wedge treatment control group (n = 4 trials; SMD, -1.20 [95% CI, -2.09 to -0.30]) and lower effect sizes (unstandardized beta, 0.26 [95% CI, 0.002 to 0.52] for each bias category deemed low risk) when the study method was deemed at low risk of bias. Among trials in which the control treatment was a neutral insole (n = 7), lateral wedges showed no association (SMD, -0.03 [95% CI, -0.18 to 0.12] on WOMAC; this represents an effect of -0.12 points), and results showed little heterogeneity (I-2 = 7.1%). CONCLUSIONS AND RELEVANCE Although meta-analytic pooling of all studies showed a statistically significant association between use of lateral wedges and lower pain in medial knee osteoarthritis, restriction of studies to those using a neutral insole comparator did not show a significant or clinically important association. These findings do not support the use of lateral wedges for this indication.	[Parkes, Matthew J.; Maricar, Nasimah; Lunt, Mark; Jones, Richard K.; Felson, David T.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England; [LaValley, Michael P.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Jones, Richard K.] Univ Salford, Sch Hlth Sci, Salford M5 4WT, Lancs, England; [Segal, Neil A.] Univ Iowa, Dept Orthoped & Rehabil, Iowa City, IA USA; [Segal, Neil A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Segal, Neil A.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Takahashi-Narita, Kayoko] Kitasato Univ, Dept Occupat Therapy, Kanagawa, Japan; [Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Unit, Boston, MA 02118 USA; [Felson, David T.] Cent Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England	University of Manchester; Boston University; University of Salford; University of Iowa; University of Iowa; University of Iowa; Kitasato University; Boston University; University of Manchester	Parkes, MJ (corresponding author), Univ Manchester, Inst Inflammat & Repair, Arthrit Res UK Epidemiol Unit, Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	matthew.parkes@manchester.ac.uk	Lunt, Mark/A-7132-2014; Parkes, Matthew J/I-3799-2019; LaValley, Michael/AAA-2030-2020; Lunt, Mark/N-3413-2019; Segal, Neil A./B-2049-2008	Lunt, Mark/0000-0002-2391-5575; Parkes, Matthew J/0000-0002-1574-9933; Lunt, Mark/0000-0002-2391-5575; Segal, Neil A./0000-0002-8294-080X; Jones, Richard/0000-0001-5242-185X; LaValley, Michael/0000-0002-8488-5170; Maricar, Nasimah/0000-0001-9503-5991; Felson, David/0000-0002-2668-2447	Arthritis Research UK [18676]; National Institute for Health and Clinical Excellence [AR47785]; National Institute for Health Research [CAT CDRF 10-035] Funding Source: researchfish; Versus Arthritis [18676] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER	Arthritis Research UK(Versus Arthritis); National Institute for Health and Clinical Excellence; National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This review was funded by special strategic award grant 18676 from Arthritis Research UK. Drs LaValley and Felson are supported by grant AR47785 from the National Institute for Health and Clinical Excellence.	Akinbo S. R., 2007, Nigerian Journal of Health and Biomedical Sciences, V6, P42; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Baker K, 2005, ARTHRITIS RHEUM-US, V52, pS459; Baker K, 2007, ARTHRITIS RHEUM, V56, P1198, DOI 10.1002/art.22516; Barrios JA, 2010, J ORTHOP SPORT PHYS, V40, pA26; Barrios J, 2006, MED SCI SPORT EXER, V38, pS173, DOI 10.1249/00005768-200605001-00784; Barrios JA, 2013, J ORTHOP RES, V31, P659, DOI 10.1002/jor.22252; Barrios JA, 2009, KNEE, V16, P136, DOI 10.1016/j.knee.2008.10.002; Bennell KL, 2010, OSTEOARTHR CARTILAGE, V18, pS11, DOI 10.1016/S1063-4584(10)60033-7; Bennell K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-96; Bennell KL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2912; Berthelot JM, 2011, JOINT BONE SPINE, V78, P161, DOI 10.1016/j.jbspin.2010.08.006; Brouwer RW, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004020.pub2, 10.1002/14651858.CD004019.pub2]; Butler RJ, 2007, J ORTHOP RES, V25, P1121, DOI 10.1002/jor.20423; Doherty M, 2009, OSTEOARTHR CARTILAGE, V17, P1255, DOI 10.1016/j.joca.2009.03.023; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2000, SYSTEMATIC REVIEWS I; Erhart JC, 2010, J ORTHOP RES, V28, P1548, DOI 10.1002/jor.21183; Erhart JC, 2010, J ORTHOP RES, V28, P873, DOI 10.1002/jor.21077; Erhart-Hledik JC, 2012, J ORTHOP RES, V30, P514, DOI 10.1002/jor.21563; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hinman RS, 2008, ARTHRIT RHEUM-ARTHR, V59, P408, DOI 10.1002/art.23326; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Jones RK, 2013, GAIT POSTURE, V37, P368, DOI 10.1016/j.gaitpost.2012.08.002; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Kakihana W, 2005, ARCH PHYS MED REHAB, V86, P1465, DOI 10.1016/j.apmr.2004.09.033; Keating E M, 1993, Orthop Rev, V22, P921; Kerrigan DC, 2002, ARCH PHYS MED REHAB, V83, P889, DOI 10.1053/apmr.2002.33225; Koca B, 2009, TURK FIZ TIP REHAB D, V55, P158; Lidtke R, 2006, OSTEOARTHR CARTILAGE, V14, pS18; Maillefert JF, 2001, OSTEOARTHR CARTILAGE, V9, P738, DOI 10.1053/joca.2001.0470; Malvankar Seema, 2012, Open Orthop J, V6, P544, DOI 10.2174/1874325001206010544; National Institute for Health and Clinical Excellence, 2008, OSTEOARTHRITIS NATIO; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Ogata K, 1997, INT ORTHOP, V21, P308, DOI 10.1007/s002640050174; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Pham T, 2004, OSTEOARTHR CARTILAGE, V12, P46, DOI 10.1016/j.joca.2003.08.011; Rafiaee M, 2012, INT J PREVENTIVE MED, V3, P693; Raja K, 2011, AM J PHYS MED REHAB, V90, P247, DOI 10.1097/PHM.0b013e318206386b; Reilly KA, 2006, KNEE, V13, P177, DOI 10.1016/j.knee.2006.02.003; Sattari S, 2011, IRAN RED CRESCENT ME, V13, P624, DOI 10.5812/kowsar.20741804.2252; Sedgwick P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5372; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Toda Y, 2008, OSTEOARTHR CARTILAGE, V16, P244, DOI 10.1016/j.joca.2007.06.010; Toda Y, 2005, OSTEOARTHR CARTILAGE, V13, P353, DOI 10.1016/j.joca.2004.12.012; Toda Yoshitaka, 2002, Ryumachi, V42, P795; Wallace D.A., 2007, J BIOMECH, V40, P677, DOI [10.1016/s0021-9290(07)70665-6, DOI 10.1016/S0021-9290(07)70665-6]; Wallace DA, 2006, EFFICACY OF LATERAL; Wang SY, 2012, ANN INTERN MED, V157, P632, DOI 10.7326/0003-4819-157-9-201211060-00007; YASUDA K, 1987, CLIN ORTHOP RELAT R, P162; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	54	79	87	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					722	730		10.1001/jama.2013.243229	http://dx.doi.org/10.1001/jama.2013.243229			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989797	Green Accepted, Green Submitted			2022-12-28	WOS:000323254500022
J	Daugla, DM; Gami, JP; Gamougam, K; Naibei, N; Mbainadji, L; Narbe, M; Toralta, J; Kodbesse, B; Ngadoua, C; Coldiron, ME; Fermon, F; Page, AL; Djingarey, MH; Hugonnet, S; Harrison, OB; Rebbetts, LS; Tekletsion, Y; Watkins, ER; Hill, D; Caugant, DA; Chandramohan, D; Hassan-King, M; Manigart, O; Nascimento, M; Woukeu, A; Trotter, C; Stuart, JM; Maiden, MCJ; Greenwood, BM				Daugla, D. M.; Gami, J. P.; Gamougam, K.; Naibei, N.; Mbainadji, L.; Narbe, M.; Toralta, J.; Kodbesse, B.; Ngadoua, C.; Coldiron, M. E.; Fermon, F.; Page, A-L; Djingarey, M. H.; Hugonnet, S.; Harrison, O. B.; Rebbetts, L. S.; Tekletsion, Y.; Watkins, E. R.; Hill, D.; Caugant, D. A.; Chandramohan, D.; Hassan-King, M.; Manigart, O.; Nascimento, M.; Woukeu, A.; Trotter, C.; Stuart, J. M.; Maiden, M. C. J.; Greenwood, B. M.			Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study	LANCET			English	Article							EPIDEMIC; TIME	Background A serogroup A meningococcal poly saccharide-tetanus toxoid conjugate vaccine (PsA-TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity. This vaccine is now being deployed across the African meningitis belt. We studied the effect of PsA-TT on meningococcal meningitis and carriage in Chad during a serogroup A meningococcal meningitis epidemic. Methods We obtained data for the incidence of meningitis before and after vaccination from national records between January, 2009, and June, 2012. In 2012, surveillance was enhanced in regions where vaccination with PsA-TT had been undertaken in 2011, and in one district where a reactive vaccination campaign in response to an outbreak of meningitis was undertaken. Meningococcal carriage was studied in an age-stratified sample of residents aged 1-29 years of a rural area roughly 13-15 and 2-4 months before and 4-6 months after vaccination. Meningococci obtained from cerebrospinal fluid or oropharyngeal swabs were characterised by conventional microbiological and molecular methods. Findings Roughly 1.8 million individuals aged 1-29 years received one dose of PsA-TT during a vaccination campaign in three regions of Chad in and around the capital N'Djamena during 10 days in December, 2011. The incidence of meningitis during the 2012 meningitis season in these three regions was 2.48 per 100 000 (57 cases in the 2.3 million population), whereas in regions without mass vaccination, incidence was 43.8 per 100 000 (3809 cases per 8.7 million population), a 94% difference in crude incidence (p<0.0001), and an incidence rate ratio of 0.096 (95% CI 0.046-0.198). Despite enhanced surveillance, no case of serogroup A meningococcal meningitis was reported in the three vaccinated regions. 32 serogroup A carriers were identified in 4278 age-stratified individuals (0.75%) living in a rural area near the capital 2-4 months before vaccination, whereas only one serogroup A meningococcus was isolated in 5001 people living in the same community 4-6 months after vaccination (adjusted odds ratio 0.019, 95% CI 0.002-0.138; p<0.0001). Interpretation PSA-TT was highly effective at prevention of serogroup A invasive meningococcal disease and carriage in Chad. How long this protection will persist needs to be established.	[Daugla, D. M.; Gami, J. P.; Gamougam, K.; Naibei, N.; Mbainadji, L.; Narbe, M.; Toralta, J.; Kodbesse, B.] CSSI, Ndjamena, Chad; [Ngadoua, C.] Minist Publ Hlth, Ndjamena, Chad; [Coldiron, M. E.; Fermon, F.; Page, A-L] Epictr, Paris, France; [Djingarey, M. H.] WHO Intercountry Support Team, Ouagadougou, Burkina Faso; [Hugonnet, S.] WHO, Dept Pandem & Epidem Dis, CH-1211 Geneva, Switzerland; [Harrison, O. B.; Rebbetts, L. S.; Tekletsion, Y.; Watkins, E. R.; Hill, D.; Maiden, M. C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Caugant, D. A.] Norwegian Inst Publ Hlth, Oslo, Norway; [Trotter, C.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Chandramohan, D.; Hassan-King, M.; Manigart, O.; Nascimento, M.; Woukeu, A.; Stuart, J. M.; Greenwood, B. M.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England	World Health Organization; University of Oxford; Norwegian Institute of Public Health (NIPH); University of Cambridge; University of London; London School of Hygiene & Tropical Medicine	Greenwood, BM (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	brian.greenwood@lshtm.ac.uk	Maiden, Martin/N-6805-2019; , dcaugant/AAH-6843-2019; Trotter, Caroline L/H-5077-2013; Maiden, Martin C J/C-5055-2014	Maiden, Martin/0000-0001-6321-5138; , dcaugant/0000-0003-2765-9844; Maiden, Martin C J/0000-0001-6321-5138; Trotter, Caroline/0000-0003-4000-2708	The Bill & Melinda Gates Foundation; Wellcome Trust; Medecins Sans Frontieres; M�decins Sans Fronti�res [EPI_pilot_00_Coldiron] Funding Source: researchfish	The Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medecins Sans Frontieres; M�decins Sans Fronti�res	The Bill & Melinda Gates Foundation, the Wellcome Trust, and Medecins Sans Frontieres.	Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125; Bennett JS, 2012, MICROBIOL-SGM, V158, P1570, DOI 10.1099/mic.0.056077-0; Borrow R, 2012, TROP MED INT HEALTH, V17, P1478, DOI 10.1111/j.1365-3156.2012.03085.x; Bregani E R, 2006, Minerva Med, V97, P161; Caini S, 2013, VACCINE, V31, P1597, DOI 10.1016/j.vaccine.2013.01.015; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Caugant DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046019; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; Garcia V, 2004, Bull Soc Pathol Exot, V97, P183; Greenwood B, 2013, VACCINE, V31, P1453, DOI 10.1016/j.vaccine.2012.12.035; Harmsen D, 2001, J CLIN MICROBIOL, V39, P936, DOI 10.1128/JCM.39.3.936-942.2001; Kim SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029116; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Labrie JE, 2010, HUM VACCINES, V6, P360, DOI 10.4161/hv.6.4.11055; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Ledentu Blanchard, 1941, BULL OFF INT DHYG PU, V3, P421; LENGELER C, 1995, ACTA TROP, V59, P211, DOI 10.1016/0001-706X(95)00081-O; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Massenet D, 2011, EMERG INFECT DIS, V17, P2070, DOI 10.3201/eid1711.110468; Medah Isaie, 2012, Morbidity and Mortality Weekly Report, V61, P1022; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Patterson KD, 1984, CEREBROSPINAL MENING; Riou JY, 1996, B WORLD HEALTH ORGAN, V74, P181; Sirol J, 1969, Med Trop (Mars), V29, P443; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; SPIEGEL A, 1993, B WORLD HEALTH ORGAN, V71, P311; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; World Health Organization, 2010, Weekly Epidemiological Record, V85, P57	31	182	185	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					40	47		10.1016/S0140-6736(13)61612-8	http://dx.doi.org/10.1016/S0140-6736(13)61612-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24035220	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000329341200034
J	Nussbaum, JC; Van Dyken, SJ; von Moltke, J; Cheng, LE; Mohapatra, A; Molofsky, AB; Thornton, EE; Krummel, MF; Chawla, A; Liang, HE; Locksley, RM				Nussbaum, Jesse C.; Van Dyken, Steven J.; von Moltke, Jakob; Cheng, Laurence E.; Mohapatra, Alexander; Molofsky, Ari B.; Thornton, Emily E.; Krummel, Matthew F.; Chawla, Ajay; Liang, Hong-Erh; Locksley, Richard M.			Type 2 innate lymphoid cells control eosinophil homeostasis	NATURE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; VPAC(2) RECEPTOR; DEFICIENT MICE; IMMUNITY; LUNG; SIGNALS; MOUSE	Eosinophils are specialized myeloid cells associated with allergy and helminth infections. Blood eosinophils demonstrate circadian cycling, as described over 80 years ago(1), and are abundant in the healthy gastrointestinal tract. Although a cytokine, interleukin (IL)-5, and chemokines such as eotaxins mediate eosinophil development and survival(2), and tissue recruitment(3), respectively, the processes underlying the basal regulation of these signals remain unknown. Here we show that serum IL-5 levels are maintained by long-lived type 2 innate lymphoid cells (ILC2) resident in peripheral tissues. ILC2 cells secrete IL-5 constitutively and are induced to co-express IL-13 during type 2 inflammation, resulting in localized eotaxin production and eosinophil accumulation. In the small intestine where eosinophils and eotaxin are constitutive(4), ILC2 cells co-express IL-5 and IL-13; this co-expression is enhanced after caloric intake. The circadian synchronizer vasoactive intestinal peptide also stimulates ILC2 cells through the VPAC2 receptor to release IL-5, linking eosinophil levels with metabolic cycling. Tissue ILC2 cells regulate basal eosinophilopoiesis and tissue eosinophil accumulation through constitutive and stimulated cytokine expression, and this dissociated regulation can be tuned by nutrient intake and central circadian rhythms.	[Nussbaum, Jesse C.; Van Dyken, Steven J.; von Moltke, Jakob; Chawla, Ajay; Liang, Hong-Erh; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cheng, Laurence E.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Mohapatra, Alexander; Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Mohapatra, Alexander; Locksley, Richard M.] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Thornton, Emily E.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu		Molofsky, Ari/0000-0003-0764-3175; Thornton, Emily/0000-0002-0068-2502; Van Dyken, Steven/0000-0002-9787-0883	NIH [AI026918, AI030663, AI078869, HL107202, AI007641, AI007334]; Diabetes Endocrinology Research Center [DK063720]; Howard Hughes Medical Institute; Sandler Asthma Basic Research Center at the University of California San Francisco; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107202, P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439, R01AI026918, R01AI030663, T32AI007334, T32AI007641, R37AI026918, P01AI078869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sandler Asthma Basic Research Center at the University of California San Francisco; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH Tetramer Core Facility for reagents, B. Sullivan, N. Flores, M. Consengco and Z. Wang for technical expertise, and M. Anderson, C. Lowell and M. McCune for comments on the manuscript. Supported by NIH (AI026918, AI030663, AI078869, HL107202), the Diabetes Endocrinology Research Center grant (DK063720), the Howard Hughes Medical Institute and the Sandler Asthma Basic Research Center at the University of California San Francisco. J.C.N. is supported by NIH training grants (AI007641 and AI007334).	Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Domarus Av, 1931, DTSCH ARCH KLIN MED, V171, P333; HALBERG F, 1953, AM J PHYSIOL, V174, P109, DOI 10.1152/ajplegacy.1953.174.1.109; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Lelievre V, 2007, PEPTIDES, V28, P1688, DOI 10.1016/j.peptides.2007.05.006; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Maywood ES, 2013, P NATL ACAD SCI USA, V110, P9547, DOI 10.1073/pnas.1220894110; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; PAULY JE, 1975, ACTA ANAT, V93, P60; Pope SM, 2001, J ALLERGY CLIN IMMUN, V108, P594, DOI 10.1067/mai.2001.118600; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Samarasinghe AE, 2010, PEPTIDES, V31, P1068, DOI 10.1016/j.peptides.2010.03.001; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Tsutsumi M, 2002, DIABETES, V51, P1453, DOI 10.2337/diabetes.51.5.1453; Voice J, 2004, J IMMUNOL, V172, P7289, DOI 10.4049/jimmunol.172.12.7289; Vomhof-DeKrey EE, 2011, PEPTIDES, V32, P2058, DOI 10.1016/j.peptides.2011.08.014; Yoshida T, 1996, IMMUNITY, V4, P483, DOI 10.1016/S1074-7613(00)80414-8	30	663	687	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					245	+		10.1038/nature12526	http://dx.doi.org/10.1038/nature12526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24037376	Green Accepted, Green Submitted			2022-12-28	WOS:000325436100053
J	Hiatt, WR; Kaul, S; Smith, RJ				Hiatt, William R.; Kaul, Sanjay; Smith, Robert J.			The Cardiovascular Safety of Diabetes Drugs - Insights from the Rosiglitazone Experience	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK	A signal of cardiovascular harm with rosiglitazone led to a new FDA policy on diabetes-drug approval. As that signal has faded in recent analyses, should FDA policy change? The management of type 2 diabetes has been challenged by uncertainty about possible cardiovascular effects related to treatment intensity and choice of drug. Although the Food and Drug Administration (FDA) considers a decrease in glycated hemoglobin an approvable end point, very intensive glycemic control is associated with increased cardiovascular and all-cause mortality.(1) The safety of specific drugs for type 2 diabetes particularly the thiazolidinediones has also been questioned. After rosiglitazone had been approved in the United States in 1999 and in Europe in 2000, a highly publicized meta-analysis in 2007 reported a 43% increase in myocardial infarction (P=0.03) ...	[Hiatt, William R.] Univ Colorado, Div Cardiol, Sch Med, Aurora, CO USA; [Hiatt, William R.] Univ Colorado, Colorado Prevent Ctr Clin Res, Dept Med, Sch Med, Aurora, CO USA; [Kaul, Sanjay] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA; [Kaul, Sanjay] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Smith, Robert J.] Brown Univ, Ocean State Res Inst, Alpert Med Sch, Providence, RI 02912 USA; [Smith, Robert J.] Providence Vet Affairs Med Ctr, Providence, RI USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Hiatt, WR (corresponding author), Univ Colorado, Div Cardiol, Sch Med, Aurora, CO USA.							Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Guidance For Industry, 2008, GUID IND DIAB MELL E; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Kaul S, 2011, CLIN PHARMACOL THER, V89, P773, DOI 10.1038/clpt.2011.65; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761	5	138	138	2	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1285	1287		10.1056/NEJMp1309610	http://dx.doi.org/10.1056/NEJMp1309610			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	23992603				2022-12-28	WOS:000325111200002
J	Woolhouse, MEJ; Ward, MJ				Woolhouse, Mark E. J.; Ward, Melissa J.			Sources of Antimicrobial Resistance	SCIENCE			English	Editorial Material							ANTIBIOTIC-RESISTANCE		[Woolhouse, Mark E. J.; Ward, Melissa J.] Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Woolhouse, MEJ (corresponding author), Univ Edinburgh, Ctr Immunol Infect & Evolut, Kings Bldg,West Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk			Wellcome Trust [093724] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Davison HC, 2000, TRENDS MICROBIOL, V8, P554, DOI 10.1016/S0966-842X(00)01873-4; Department of Health and Department of Environment Food and Rural Affairs, 2013, UK 5 YEAR ANT RES ST; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Hoyle D, 2006, VET MICROBIOL, V115, P250, DOI 10.1016/j.vetmic.2006.01.006; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Mather AE, 2013, SCIENCE, V341, P1514, DOI 10.1126/science.1240578; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Wright GD, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-51	11	70	69	3	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1460	1461		10.1126/science.1243444	http://dx.doi.org/10.1126/science.1243444			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24030495				2022-12-28	WOS:000324894600034
J	Saitz, R; Cheng, DM; Winter, M; Kim, TW; Meli, SM; Allensworth-Davies, D; Lloyd-Travaglini, CA; Samet, JH				Saitz, Richard; Cheng, Debbie M.; Winter, Michael; Kim, Theresa W.; Meli, Seville M.; Allensworth-Davies, Don; Lloyd-Travaglini, Christine A.; Samet, Jeffrey H.			Chronic Care Management for Dependence on Alcohol and Other Drugs The AHEAD Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC DISEASE MANAGEMENT; PRIMARY MEDICAL-CARE; IMPROVING PRIMARY-CARE; SERVICES; ABUSE; INTERVENTIONS; QUESTIONNAIRE; RELIABILITY; DEPRESSION; VALIDITY	IMPORTANCE People with substance dependence have health consequences, high health care utilization, and frequent comorbidity but often receive poor-quality care. Chronic care management (CCM) has been proposed as an approach to improve care and outcomes. OBJECTIVE To determine whether CCM for alcohol and other drug dependence improves substance use outcomes compared with usual primary care. DESIGN, SETTING, AND PARTICIPANTS The AHEAD study, a randomized trial conducted among 563 people with alcohol and other drug dependence at a Boston, Massachusetts, hospital-based primary care practice. Participants were recruited from September 2006 to September 2008 from a freestanding residential detoxification unit and referrals from an urban teaching hospital and advertisements; 95% completed 12-month follow-up. INTERVENTIONS Participants were randomized to receive CCM (n=282) or no CCM (n=281). Chronic care management included longitudinal care coordinated with a primary care clinician; motivational enhancement therapy; relapse prevention counseling; and on-site medical, addiction, and psychiatric treatment, social work assistance, and referrals (including mutual help). The no CCM (control) group received a primary care appointment and a list of treatment resources including a telephone number to arrange counseling. MAIN OUTCOMES AND MEASURES The primary outcome was self-reported abstinence from opioids, stimulants, or heavy drinking. Biomarkers were secondary outcomes. RESULTS There was no significant difference in abstinence from opioids, stimulants, or heavy drinking between the CCM (44%) and control (42%) groups (adjusted odds ratio, 0.84; 95% CI, 0.65-1.10; P=.21). No significant differences were found for secondary outcomes of addiction severity, health-related quality of life, or drug problems. No subgroup effects were found except among those with alcohol dependence, in whom CCM was associated with fewer alcohol problems (mean score, 10 vs 13; incidence rate ratio, 0.85; 95% CI, 0.72-1.00; P=.048). CONCLUSIONS AND RELEVANCE Among persons with alcohol and other drug dependence, CCM compared with a primary care appointment but no CCM did not increase self-reported abstinence over 12 months. Whether more intensive or longer-duration CCM is effective requires further investigation.	[Saitz, Richard; Cheng, Debbie M.; Kim, Theresa W.; Meli, Seville M.; Samet, Jeffrey H.] Boston Med Ctr, Clin Addict Res & Educ Unit, Boston, MA USA; [Saitz, Richard; Cheng, Debbie M.; Kim, Theresa W.; Meli, Seville M.; Samet, Jeffrey H.] Boston Med Ctr, Dept Med, Gen Internal Med Sect, Boston, MA USA; [Saitz, Richard; Cheng, Debbie M.; Kim, Theresa W.; Meli, Seville M.; Samet, Jeffrey H.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Saitz, Richard; Samet, Jeffrey H.] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA; [Cheng, Debbie M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Allensworth-Davies, Don; Lloyd-Travaglini, Christine A.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA	Boston Medical Center; Boston Medical Center; Boston University; Boston University; Boston University; Boston University	Saitz, R (corresponding author), Gen Internal Med Sect, Clin Addict Res & Educ Unit, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA.	rsaitz@bu.edu	Davies, Don Allensworth/AAT-1395-2021	Davies, Don Allensworth/0000-0001-8792-7594; Kim, Theresa/0000-0001-6043-0721; /0000-0002-2535-1427; Samet, Jeffrey/0000-0002-0897-3400	National Institute on Alcohol Abuse and Alcoholism [R01 AA010870]; National Institute on Drug Abuse [R01 DA010019]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010019] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The AHEAD study was funded by grant R01 AA010870 from the National Institute on Alcohol Abuse and Alcoholism and grant R01 DA010019 from the National Institute on Drug Abuse.	Alterman AI, 2009, J STUD ALCOHOL DRUGS, V70, P304, DOI 10.15288/jsad.2009.70.304; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Bindman AB, 2013, JAMA-J AM MED ASSOC, V310, P1125, DOI 10.1001/jama.2013.276525; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Butler M., 2008, AHRQ PUBLICATION 09; Carmen B, 2004, ADDICTION, V99, P811, DOI 10.1111/j.1360-0443.2004.00763.x; Clifford PR, 2012, PSYCHOL ADDICT BEHAV, V26, P773, DOI 10.1037/a0029747; Cone EJ, 2002, J ANAL TOXICOL, V26, P541, DOI 10.1093/jat/26.8.541; Daeppen JB, 2007, ADDICTION, V102, P1224, DOI 10.1111/j.1360-0443.2007.01869.x; Friedmann PD, 2006, J GEN INTERN MED, V21, P1269, DOI 10.1111/j.1525-1497.2006.00611.x; Godfrey C, REVIEW OF THE EFFECT; Green-Hennessy S, 2002, PSYCHIATR SERV, V53, P1592, DOI 10.1176/appi.ps.53.12.1592; Institute of Medicine Committee on Crossing the Quality Chasm, 2006, IMPROVING THE QUALIT; Joseph AM, 2011, ARCH INTERN MED, V171, P1894, DOI 10.1001/archinternmed.2011.500; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kim TW, 2012, J SUBST ABUSE TREAT, V43, P389, DOI 10.1016/j.jsat.2012.06.001; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P2425, DOI 10.1001/jama.2013.6494; Laiteerapong N, 2010, JAMA-J AM MED ASSOC, V304, P899, DOI 10.1001/jama.2010.1209; Longabaugh R, 1995, DHHS PUBLICATION 95, V4; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Mertens JR, 2008, DRUG ALCOHOL DEPEN, V98, P45, DOI 10.1016/j.drugalcdep.2008.04.007; Miller WR, 1996, FORM 90 A STRUCTURED; NAVALINE HA, 1994, AIDS RES HUM RETROV, V10, pS281; Oslin DW, 2006, PSYCHIAT SERV, V57, P954, DOI 10.1176/appi.ps.57.7.954; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; Rychtarik RG, 1992, DHHS PUBLICATION ADM, V92-1894; Saitz R, 2008, J ADDICT MED, V2, P55, DOI 10.1097/ADM.0b013e318166af74; Samet JH, 2003, ADDICTION, V98, P509, DOI 10.1046/j.1360-0443.2003.00328.x; Samet JH, 2001, ARCH INTERN MED, V161, P85, DOI 10.1001/archinte.161.1.85; Smith KL, 2006, DRUG ALCOHOL DEPEN, V82, P231, DOI 10.1016/j.drugalcdep.2005.09.012; Sobell L. C., 1992, MEASURING ALCOHOL CO, P41, DOI [10.1007/978-1-4612-0357-5_3, 10.1007/978-1-4612-0357-5, DOI 10.1007/978-1-4612-0357-5_3]; Substance Abuse and Mental Health Services Administration, 2007, DHHS PUBLICATION SMA, V07-4293; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner E H, 1996, Manag Care Q, V4, P12; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weisner C, 2001, JAMA-J AM MED ASSOC, V286, P1715, DOI 10.1001/jama.286.14.1715; Weiss RD, 2011, ARCH GEN PSYCHIAT, V68, P1238, DOI 10.1001/archgenpsychiatry.2011.121; Willenbring ML, 1999, ARCH INTERN MED, V159, P1946, DOI 10.1001/archinte.159.16.1946	44	97	97	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1156	1167		10.1001/jama.2013.277609	http://dx.doi.org/10.1001/jama.2013.277609			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	219IU	24045740	Bronze, Green Accepted			2022-12-28	WOS:000324500300022
J	Chew, M				Chew, Mabel			Commentary: How the BMJ selects guideline summaries for publication	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mchew@bmj.com						Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Lenzer J, 2013, BMJ-BRIT MED J, V347, pf5513	3	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2013	347								f5536	10.1136/bmj.f5536	http://dx.doi.org/10.1136/bmj.f5536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SB	24046287				2022-12-28	WOS:000324828300005
J	Decker, BK; Palmore, TN				Decker, Brooke K.; Palmore, Tara N.			Universal decolonization was better than MRSA screening and isolation for preventing nosocomial ICU infections	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Decker, Brooke K.; Palmore, Tara N.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Decker, BK (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.			Decker M.D., Brooke K/0000-0002-3404-9115	CLINICAL CENTER [ZIACL004042, ZIACL004041] Funding Source: NIH RePORTER	CLINICAL CENTER		Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Harbarth S, 1999, ANTIMICROB AGENTS CH, V43, P1412, DOI 10.1128/AAC.43.6.1412	2	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC4	10.7326/0003-4819-159-6-201309170-02004	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042387	Green Submitted			2022-12-28	WOS:000325625900003
J	Tarlinton, D; Good-Jacobson, K				Tarlinton, David; Good-Jacobson, Kim			Diversity Among Memory B Cells: Origin, Consequences, and Utility	SCIENCE			English	Review							LIVED PLASMA-CELLS; FOLLICULAR DENDRITIC CELLS; GERMINAL CENTER FORMATION; PRIMARY IMMUNE-RESPONSE; ANTIBODY-FORMING-CELLS; T-CELLS; HUMORAL IMMUNITY; AFFINITY MATURATION; SEROLOGICAL MEMORY; CLONAL SELECTION	Immunological memory is the residuum of a successful immune response that in the B cell lineage comprises long-lived plasma cells and long-lived memory B cells. It is apparent that distinct classes of memory B cells exist, distinguishable by, among other things, immunoglobulin isotype, location, and passage through the germinal center. Some of this variation is due to the nature of the antigen, and some appears to be inherent to the process of forming memory. Here, we consider the heterogeneity in development and phenotype of memory B cells and whether particular functions are partitioned into distinct subsets. We consider also how understanding the details of generating memory may provide opportunities to develop better, functionally targeted vaccines.	[Tarlinton, David; Good-Jacobson, Kim] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Tarlinton, David; Good-Jacobson, Kim] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Tarlinton, D (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	tarlinton@wehi.edu.au		Good-Jacobson, Kim/0000-0003-1891-7274; Tarlinton, David/0000-0001-9928-686X	National Health and Medical Research Council (NHMRC) of Australia; NHMRC; Leukaemia Foundation of Australia; Victorian State Government; NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation of Australia; Victorian State Government; NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS)(National Health and Medical Research Council (NHMRC) of Australia)	We foremost apologize to any colleagues whose work we have not referenced directly due to space constraints. The authors are supported by fellowships from the National Health and Medical Research Council (NHMRC) of Australia. Work from the authors' laboratory is made possible through grants from the NHMRC, the Leukaemia Foundation of Australia, the Victorian State Government Operational Infrastructure Support, and the NHMRC Independent Research Institute Infrastructure Support Scheme (IRIISS).	Ahuja A, 2008, P NATL ACAD SCI USA, V105, P4802, DOI 10.1073/pnas.0800555105; Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Benson MJ, 2009, J EXP MED, V206, P2013, DOI 10.1084/jem.20090667; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Defrance T, 2011, CURR OPIN IMMUNOL, V23, P330, DOI 10.1016/j.coi.2011.03.004; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Good KL, 2007, P NATL ACAD SCI USA, V104, P13420, DOI 10.1073/pnas.0703872104; Good KL, 2009, J IMMUNOL, V182, P890, DOI 10.4049/jimmunol.182.2.890; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; Hou BD, 2011, IMMUNITY, V34, P375, DOI 10.1016/j.immuni.2011.01.011; Inamine A, 2005, INT IMMUNOL, V17, P581, DOI 10.1093/intimm/dxh241; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Joo HM, 2008, P NATL ACAD SCI USA, V105, P3485, DOI 10.1073/pnas.0800003105; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kometani K, 2013, IMMUNITY, V39, P136, DOI 10.1016/j.immuni.2013.06.011; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; LALOR PA, 1992, EUR J IMMUNOL, V22, P3001, DOI 10.1002/eji.1830221136; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; Mohr E, 2010, P NATL ACAD SCI USA, V107, P17292, DOI 10.1073/pnas.1004879107; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Okada T, 2012, IMMUNOL REV, V247, P120, DOI 10.1111/j.1600-065X.2012.01120.x; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Pauli NT, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00077; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; PULENDRAN B, 1995, J IMMUNOL, V155, P1141; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ridderstad A, 1998, J IMMUNOL, V160, P4688; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Scheid JF, 2011, P NATL ACAD SCI USA, V108, P18044, DOI 10.1073/pnas.1113395108; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; SCHITTEK B, 1992, J EXP MED, V176, P427, DOI 10.1084/jem.176.2.427; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Sohn HW, 2011, BLOOD, V118, P6332, DOI 10.1182/blood-2011-05-353102; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomayko MM, 2008, J IMMUNOL, V181, P27, DOI 10.4049/jimmunol.181.1.27; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; VANROOIJEN N, 1986, IMMUNOL TODAY, V7, P193, DOI 10.1016/0167-5699(86)90100-3; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; VIEIRA P, 1990, INT IMMUNOL, V2, P487, DOI 10.1093/intimm/2.6.487; Vikstrom I, 2010, SCIENCE, V330, P1095, DOI 10.1126/science.1191793; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Weill JC, 2013, CURR OPIN IMMUNOL, V25, P334, DOI 10.1016/j.coi.2013.05.004; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Williams MB, 1998, J IMMUNOL, V161, P4227; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Xu HP, 2013, NATURE, V496, P523, DOI 10.1038/nature12058; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x	103	145	148	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1205	1211		10.1126/science.1241146	http://dx.doi.org/10.1126/science.1241146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031013				2022-12-28	WOS:000324248800033
J	Boyle, P				Boyle, Paul			A single market for European research	NATURE			English	Editorial Material									[Boyle, Paul] UK Econ & Social Res Council, Swindon, Wilts, England; [Boyle, Paul] Sci Europe, Brussels, Belgium		Boyle, P (corresponding author), UK Econ & Social Res Council, Swindon, Wilts, England.	esrc.ceo@esrc.ac.uk						[Anonymous], 2009, EUROHORCS ESF VIS GL; Elsevier SciVal Analytics Team, 2013, COMP BENCHM EUR US R	2	4	4	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					157	158		10.1038/501157a	http://dx.doi.org/10.1038/501157a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215XR	24032132	Bronze			2022-12-28	WOS:000324244900014
J	Brown, DFM; Jaffer, FA; Baker, JN; Gurol, ME				Brown, David F. M.; Jaffer, Farouc A.; Baker, Joshua N.; Gurol, M. Edip			Case 28-2013: A 52-Year-Old Man with Cardiac Arrest after an Acute Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THERAPEUTIC HYPOTHERMIA; SURVIVAL; ASSOCIATION	A 52-year-old man was brought to the emergency department with chest pain and ST-segment elevation. Seconds after his arrival, cardiac arrest occurred. CPR was begun, and nine external countershocks were administered, without resolution. Management decisions were made. Presentation of CaseDr. Lisa A. Arvold (Emergency Medicine): A 52-year-old man was brought to the emergency department at this hospital because of chest pain and ST-segment elevations on electrocardiography (ECG). The patient had been in his usual health, with hypertension, dyslipidemia, and coronary artery disease, until approximately 8:30 on the morning of admission, when his girlfriend found him lying on the floor of his home, unresponsive; she called emergency medical services (EMS). Shortly thereafter, he regained consciousness, rose to sit in a chair, and reported chest pain and dizziness. He took two nitroglycerin tablets (sublingually). On examination by EMS ...	[Brown, David F. M.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Jaffer, Farouc A.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Baker, Joshua N.] Massachusetts Gen Hosp, Div Vasc Surg, Boston, MA 02114 USA; [Gurol, M. Edip] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Brown, David F. M.; Baker, Joshua N.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Jaffer, Farouc A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gurol, M. Edip] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Brown, DFM (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.		Jaffer, Farouc/AAK-8803-2020; Gurol, Edip/J-2279-2014	Jaffer, Farouc/0000-0001-7980-384X; Gurol, Edip/0000-0002-2169-4457	Boston Scientific	Boston Scientific(Boston Scientific)	Dr. Jaffer reports receiving consulting fees from Boston Scientific. No other potential conflict of interest relevant to this article was reported.	Arrich J, 2009, COCHRANE DATABASE SY, V4; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brady WJ, 2011, RESUSCITATION, V82, P845, DOI 10.1016/j.resuscitation.2011.02.028; Callans DJ, 2004, NEW ENGL J MED, V351, P632, DOI 10.1056/NEJMp048174; Fugate JE, 2011, NEUROLOGY, V77, P1346, DOI 10.1212/WNL.0b013e318231527d; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Herlitz J, 2006, RESUSCITATION, V71, P40, DOI 10.1016/j.resuscitation.2006.03.006; Holmberg M, 2000, RESUSCITATION, V44, P7, DOI 10.1016/S0300-9572(99)00155-0; Holzer M, 2002, NEW ENGL J MED, V346, P549; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Mashiko K, 2002, RESUSCITATION, V55, P241, DOI 10.1016/S0300-9572(02)00207-1; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2011, CIRCULATION, V124, pE403, DOI 10.1161/CIR.0b013e318235d047; Sheu JJ, 2010, CRIT CARE MED, V38, P1810, DOI 10.1097/CCM.0b013e3181e8acf7; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Wolff B, 2009, INT J CARDIOL, V133, P223, DOI 10.1016/j.ijcard.2007.12.039	19	10	11	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					1047	1054		10.1056/NEJMcpc1304164	http://dx.doi.org/10.1056/NEJMcpc1304164			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	24024842				2022-12-28	WOS:000324304200014
J	van Geen, A; Bostick, BC; Trang, PTK; Lan, VM; Mai, NN; Manh, PD; Viet, PH; Radloff, K; Aziz, Z; Mey, JL; Stahl, MO; Harvey, CF; Oates, P; Weinman, B; Stengel, C; Frei, F; Kipfer, R; Berg, M				van Geen, Alexander; Bostick, Benjamin C.; Pham Thi Kim Trang; Vi Mai Lan; Nguyen-Ngoc Mai; Phu Dao Manh; Pham Hung Viet; Radloff, Kathleen; Aziz, Zahid; Mey, Jacob L.; Stahl, Mason O.; Harvey, Charles F.; Oates, Peter; Weinman, Beth; Stengel, Caroline; Frei, Felix; Kipfer, Rolf; Berg, Michael			Retardation of arsenic transport through a Pleistocene aquifer	NATURE			English	Article							RIVER FLOOD-PLAIN; GEOCHEMICAL PROCESSES; DRINKING-WATER; NOBLE-GASES; GROUNDWATER; BANGLADESH; VIETNAM; RELEASE; DELTA; MIGRATION	Groundwater drawn daily from shallow alluvial sands by millions of wells over large areas of south and southeast Asia exposes an estimated population of over a hundred million people to toxic levels of arsenic(1). Holocene aquifers are the source of widespread arsenic poisoning across the region(2,3). In contrast, Pleistocene sands deposited in this region more than 12,000 years ago mostly do not host groundwater with high levels of arsenic. Pleistocene aquifers are increasingly used as a safe source of drinking water(4) and it is therefore important to understand under what conditions low levels of arsenic can be maintained. Here we reconstruct the initial phase of contamination of a Pleistocene aquifer near Hanoi, Vietnam. We demonstrate that changes in groundwater flow conditions and the redox state of the aquifer sands induced by groundwater pumping caused the lateral intrusion of arsenic contamination more than 120 metres from a Holocene aquifer into a previously uncontaminated Pleistocene aquifer. We also find that arsenic adsorbs onto the aquifer sands and that there is a 16-20-fold retardation in the extent of the contamination relative to the reconstructed lateral movement of groundwater over the same period. Our findings suggest that arsenic contamination of Pleistocene aquifers in south and southeast Asia as a consequence of increasing levels of groundwater pumping may have been delayed by the retardation of arsenic transport.	[van Geen, Alexander; Bostick, Benjamin C.; Radloff, Kathleen; Aziz, Zahid; Mey, Jacob L.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Pham Thi Kim Trang; Vi Mai Lan; Nguyen-Ngoc Mai; Phu Dao Manh; Pham Hung Viet] Vietnam Natl Univ, Hanoi Univ Sci, Res Ctr Environm Technol & Sustainable Dev CETASD, Hanoi, Vietnam; [Mey, Jacob L.] Kingsborough Community Coll, Dept Phys Sci, Brooklyn, NY 11235 USA; [Stahl, Mason O.; Harvey, Charles F.] MIT, Cambridge, MA 02139 USA; [Oates, Peter] Anchor QEA, Montvale, NJ 07645 USA; [Weinman, Beth] Vanderbilt Univ, Nashville, TN 37235 USA; [Stengel, Caroline; Frei, Felix; Kipfer, Rolf; Berg, Michael] Eawag, Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Kipfer, Rolf] Zurich ETHZ, Swiss Fed Inst Technol, Inst Geochem & Petrol, CH-8092 Zurich, Switzerland	Columbia University; Vietnam National University Hanoi; City University of New York (CUNY) System; Massachusetts Institute of Technology (MIT); Vanderbilt University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	van Geen, A (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	avangeen@ldeo.columbia.edu	Pham, Viet H./C-8027-2017; Weinman, Beth/AAY-4156-2020; harvey, charles F/A-8601-2012; Bostick, Benjamin C/F-6299-2018; Mey, Jacob/D-5957-2014; Stahl, Mason/AGT-7430-2022; Berg, Michael/C-3738-2012; Hung, Viet Pham/AAB-5775-2022	harvey, charles F/0000-0002-7759-4447; Bostick, Benjamin C/0000-0002-7513-6469; Mey, Jacob/0000-0003-0116-4149; Stahl, Mason/0000-0001-6379-9890; Berg, Michael/0000-0002-7342-4061; 	NSF [EAR 09-11557]; Swiss Agency for Development and Cooperation [NAFOSTED 105-09-59-09]; NIEHS [P42 ES010349, P42 ES016454]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349, P42ES016454] Funding Source: NIH RePORTER; Directorate For Geosciences [0911557] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Swiss Agency for Development and Cooperation; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by NSF grant EAR 09-11557, the Swiss Agency for Development and Cooperation, grant NAFOSTED 105-09-59-09 to CETASD, and NIEHS grants P42 ES010349 and P42 ES016454. This is Lamont-Doherty Earth Observatory contribution number 7698.	Ahmed MF, 2006, SCIENCE, V314, P1687, DOI 10.1126/science.1133146; Berg M, 2008, CHEM GEOL, V249, P91, DOI 10.1016/j.chemgeo.2007.12.007; Berg M, 2007, SCI TOTAL ENVIRON, V372, P413, DOI 10.1016/j.scitotenv.2006.09.010; Beyerle U, 2000, ENVIRON SCI TECHNOL, V34, P2042, DOI 10.1021/es990840h; *BGS DPHE, 2001, ARS CONT GROUNDW BAN; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Dhar RK, 2011, ENVIRON SCI TECHNOL, V45, P2648, DOI 10.1021/es1022015; Eiche E, 2008, APPL GEOCHEM, V23, P3143, DOI 10.1016/j.apgeochem.2008.06.023; Fendorf S, 2010, SCIENCE, V328, P1123, DOI 10.1126/science.1172974; Frei F., 2007, THESIS ETH ZURICH; Funabiki A, 2007, J ASIAN EARTH SCI, V30, P518, DOI 10.1016/j.jseaes.2006.11.013; Horneman A, 2004, GEOCHIM COSMOCHIM AC, V68, P3459, DOI 10.1016/j.gca.2004.01.026; Islam FS, 2004, NATURE, V430, P68, DOI 10.1038/nature02638; Itai T, 2010, APPL GEOCHEM, V25, P34, DOI 10.1016/j.apgeochem.2009.09.026; Jessen S, 2012, GEOCHIM COSMOCHIM AC, V98, P186, DOI 10.1016/j.gca.2012.07.014; Kipfer R, 2002, REV MINERAL GEOCHEM, V47, P615, DOI 10.2138/rmg.2002.47.14; Klump S, 2006, ENVIRON SCI TECHNOL, V40, P243, DOI 10.1021/es051284w; Koroleff F., 1974, METHODS SEAWATER ANA, P126; Larsen F, 2008, APPL GEOCHEM, V23, P3099, DOI 10.1016/j.apgeochem.2008.06.014; Mailloux BJ, 2013, P NATL ACAD SCI USA, V110, P5331, DOI 10.1073/pnas.1213141110; McArthur JM, 2010, WATER RES, V44, P4171, DOI 10.1016/j.watres.2010.05.010; McArthur JM, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006552; Mukherjee A, 2011, APPL GEOCHEM, V26, P600, DOI 10.1016/j.apgeochem.2011.01.017; Nath B, 2009, J HYDROL, V364, P236, DOI 10.1016/j.jhydrol.2008.10.025; Neumann RB, 2010, NAT GEOSCI, V3, P46, DOI 10.1038/NGEO685; Polizzotto ML, 2008, NATURE, V454, P505, DOI 10.1038/nature07093; Postma D, 2007, GEOCHIM COSMOCHIM AC, V71, P5054, DOI 10.1016/j.gca.2007.08.020; Postma D, 2012, NAT GEOSCI, V5, P656, DOI [10.1038/ngeo1540, 10.1038/NGEO1540]; Radloff KA, 2011, NAT GEOSCI, V4, P793, DOI [10.1038/ngeo1283, 10.1038/NGEO1283]; Ravenscroft P., 2009, RGS IBG BOOK SERIES; Stollenwerk KG, 2007, SCI TOTAL ENVIRON, V379, P133, DOI 10.1016/j.scitotenv.2006.11.029; Stute M, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004499; Thu TM, 2000, CAN GEOTECH J, V37, P621, DOI 10.1139/t99-126; van Geen A, 2008, ENVIRON SCI TECHNOL, V42, P2283, DOI 10.1021/es702316k; van Geen A, 2008, APPL GEOCHEM, V23, P3244, DOI 10.1016/j.apgeochem.2008.07.005; Van Geen A, 2007, J ENVIRON SCI HEAL A, V42, P1729, DOI 10.1080/10934520701564236; Winkel LHE, 2011, P NATL ACAD SCI USA, V108, P1246, DOI 10.1073/pnas.1011915108; Zheng Y, 2005, GEOCHIM COSMOCHIM AC, V69, P5203, DOI 10.1016/j.gca.2005.06.001	38	115	115	6	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					204	+		10.1038/nature12444	http://dx.doi.org/10.1038/nature12444			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24025840	Green Accepted, Green Submitted			2022-12-28	WOS:000324244900037
J	Yang, H; Wang, HY; Shivalila, CS; Cheng, AW; Shi, LY; Jaenisch, R				Yang, Hui; Wang, Haoyi; Shivalila, Chikdu S.; Cheng, Albert W.; Shi, Linyu; Jaenisch, Rudolf			One-Step Generation of Mice Carrying Reporter and Conditional Alleles by CRISPR/Cas-Mediated Genome Engineering	CELL			English	Article							EMBRYO MICROINJECTION; KNOCKOUT RATS; EXPRESSION; BACTERIA	The type II bacterial CRISPR/Cas system is a novel genome-engineering technology with the ease of multiplexed gene targeting. Here, we created reporter and conditional mutant mice by coinjection of zygotes with Cas9 mRNA and different guide RNAs (sgRNAs) as well as DNA vectors of different sizes. Using this one-step procedure we generated mice carrying a tag or a fluorescent reporter construct in the Nanog, the Sox2, and the Oct4 gene as well as Mecp2 conditional mutant mice. In addition, using sgRNAs targeting two separate sites in the Mecp2 gene, we produced mice harboring the predicted deletions of about 700 bps. Finally, we analyzed potential off-targets of five sgRNAs in gene-modified mice and ESC lines and identified off-target mutations in only rare instances.	[Yang, Hui; Wang, Haoyi; Shivalila, Chikdu S.; Cheng, Albert W.; Shi, Linyu; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shivalila, Chikdu S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Cheng, Albert W.; Jaenisch, Rudolf] MIT, Computat & Syst Biol Program, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		yang, hui/0000-0003-3590-722X; Cheng, Albert/0000-0003-2653-5743	Croucher scholarship; NIH [HD 045022, R37CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA084198] Funding Source: NIH RePORTER	Croucher scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ruth Flannery and Kibibi Ganz for support with animal care and experiments. We thank Jaenisch lab members for helpful discussions on the manuscript. We are also grateful to Dina A. Faddah for help with editing the manuscript. A.W.C. is supported by a Croucher scholarship. R.J. is an adviser to Stemgent and a cofounder of Fate Therapeutics. This work was supported by NIH grants HD 045022 and R37CA084198 to R.J.	Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Faddah DA, 2013, CELL STEM CELL, V13, P23, DOI 10.1016/j.stem.2013.04.019; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	28	1108	1290	8	354	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1370	1379		10.1016/j.cell.2013.08.022	http://dx.doi.org/10.1016/j.cell.2013.08.022			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	23992847	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000324239300023
J	Smith, JM				Smith, Jeanette M.			Gooseberries on a Table Adriaen Coorte	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1008	1009		10.1001/jama.2013.5301	http://dx.doi.org/10.1001/jama.2013.5301			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	24026583				2022-12-28	WOS:000324133400001
J	Gask, L; Evans, M; Kessler, D				Gask, Linda; Evans, Mark; Kessler, David			Personality disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DIALECTICAL BEHAVIOR-THERAPY; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; MENTAL-HEALTH; BORDERLINE; COMMUNITY; PSYCHOTHERAPY; IMPACT		[Gask, Linda] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, Manchester M13 9PL, Lancs, England; [Evans, Mark] Manchester Mental Hlth & Social Care NHS Trust, Manchester, Lancs, England; [Kessler, David] Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England	University of Manchester; University of Bristol	Gask, L (corresponding author), Univ Manchester, Inst Populat Hlth, Ctr Primary Care, Manchester M13 9PL, Lancs, England.	Linda.Gask@manchester.ac.uk	Kessler, david/ABB-6489-2021					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bateman A, 2008, AM J PSYCHIAT, V165, P631, DOI 10.1176/appi.ajp.2007.07040636; Bateman A, 2009, AM J PSYCHIAT, V166, P1355, DOI 10.1176/appi.ajp.2009.09040539; Bateman AW, 2012, AM J PSYCHIAT, V169, P560, DOI 10.1176/appi.ajp.2012.12030341; Blum N, 2008, AM J PSYCHIAT, V165, P468, DOI 10.1176/appi.ajp.2007.07071079; Chamberlain IJ, 2013, SCHIZOPHRENIA BULL, V39, P17, DOI 10.1093/schbul/sbs131; Clarke S, 2013, BRIT J PSYCHIAT, V202, P129, DOI 10.1192/bjp.bp.112.108670; Department of Health, 2003, PERS DIS NO LONG DIA; Doering S, 2010, BRIT J PSYCHIAT, V196, P389, DOI 10.1192/bjp.bp.109.070177; Douzenis A, 2012, CURR OPIN PSYCHIATR, V25, P398, DOI 10.1097/YCO.0b013e3283558491; Gibbon S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007668.pub2; Giesen-Bloo J, 2006, ARCH GEN PSYCHIAT, V63, P649, DOI 10.1001/archpsyc.63.6.649; Goodrich J., 2011, SCHWARTZ CTR ROUNDS; Holzel L, 2011, J AFFECT DISORDERS, V129, P1, DOI 10.1016/j.jad.2010.03.025; Jackson HJ, 2004, SOC PSYCH PSYCH EPID, V39, P765, DOI 10.1007/s00127-004-0821-x; Kendall T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b93; Kendell RE, 2002, BRIT J PSYCHIAT, V180, P110, DOI 10.1192/bjp.180.2.110; Khalifa N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007667.pub2; Kjeldmand D, 2008, ANN FAM MED, V6, P138, DOI 10.1370/afm.813; Lieb K, 2010, BRIT J PSYCHIAT, V196, P4, DOI 10.1192/bjp.bp.108.062984; Linehan MM, 2006, ARCH GEN PSYCHIAT, V63, P757, DOI 10.1001/archpsyc.63.7.757; McMain SF, 2012, AM J PSYCHIAT, V169, P650, DOI 10.1176/appi.ajp.2012.11091416; Miller S, 2010, PSYCHIATR BULL, V34, P177, DOI 10.1192/pb.bp.109.026575; Moran P, 2003, BRIT J PSYCHIAT, V183, P228, DOI 10.1192/bjp.183.3.228; Moran P, 2001, PSYCHOL MED, V31, P1447, DOI 10.1017/S003329170105450z; Reichborn-Kjennerud T, 2008, PSYCHIAT CLIN N AM, V31, P421, DOI 10.1016/j.psc.2008.03.012; RUTTER M, 1987, BRIT J PSYCHIAT, V150, P443, DOI 10.1192/bjp.150.4.443; Samuels J, 2011, INT REV PSYCHIATR, V23, P223, DOI 10.3109/09540261.2011.588200; Tyrer P, 2011, PERSONAL MENT HEALTH, V5, P246, DOI 10.1002/pmh.190; Weinberg I, 2006, J PERS DISORD, V20, P482, DOI 10.1521/pedi.2006.20.5.482; Westwood L, 2010, J PSYCHIATR MENT HLT, V17, P657, DOI 10.1111/j.1365-2850.2010.01579.x; Yang M, 2010, BRIT J PSYCHIAT, V197, P193, DOI 10.1192/bjp.bp.110.078956; Young J. E., 2003, SCHEMA THERAPY PRACT; Yu RQ, 2012, J PERS DISORD, V26, P775, DOI 10.1521/pedi.2012.26.5.775; Zanarini MC, 2012, AM J PSYCHIAT, V169, P476, DOI 10.1176/appi.ajp.2011.11101550	35	19	19	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2013	347								f5276	10.1136/bmj.f5276	http://dx.doi.org/10.1136/bmj.f5276			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	219RR	24022034				2022-12-28	WOS:000324527000006
J	Antoine, MW; Hubner, CA; Arezzo, JC; Hebert, JM				Antoine, Michelle W.; Huebner, Christian A.; Arezzo, Joseph C.; Hebert, Jean M.			A Causative Link Between Inner Ear Defects and Long-Term Striatal Dysfunction	SCIENCE			English	Article							COTRANSPORTER; CHILDREN; ERK; IDENTIFICATION; AMPHETAMINE; ACTIVATION; DOPAMINE; DEAFNESS; CASCADE; RAT	There is a high prevalence of behavioral disorders that feature hyperactivity in individuals with severe inner ear dysfunction. What remains unknown is whether inner ear dysfunction can alter the brain to promote pathological behavior. Using molecular and behavioral assessments of mice that carry null or tissue-specific mutations of Slc12a2, we found that inner ear dysfunction causes motor hyperactivity by increasing in the nucleus accumbens the levels of phosphorylated adenosine 3',5'-monophosphate response element-binding protein (pCREB) and phosphorylated extracellular signal-regulated kinase (pERK), key mediators of neurotransmitter signaling and plasticity. Hyperactivity was remedied by local administration of the pERK inhibitor SL327. These findings reveal that a sensory impairment, such as inner ear dysfunction, can induce specific molecular changes in the brain that cause maladaptive behaviors, such as hyperactivity, that have been traditionally considered exclusively of cerebral origin.	[Antoine, Michelle W.; Arezzo, Joseph C.; Hebert, Jean M.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Huebner, Christian A.] Jena Univ Hosp, Inst Human Genet, D-07743 Jena, Germany; [Hebert, Jean M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Friedrich Schiller University of Jena; Yeshiva University; Albert Einstein College of Medicine	Hebert, JM (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA.	jean.hebert@einstein.yu.edu	Hübner, Christian/A-2950-2017	Hübner, Christian/0000-0002-1030-4943	Tourette Syndrome Association; NIH [R21NS073761, R01MH083804]; Deutsche Forschungsgemeinschaft [HU 800/5-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070596, R01MH083804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073761] Funding Source: NIH RePORTER	Tourette Syndrome Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Khodakhah and P. Calderon for support with surgical approaches, rotarod, and early inputs to the project; G. Fishell for the Nestin-CreER mice in which Slc12a2<SUP>K842*</SUP> arose; S. Zukin for Western blotting; C. Heinze for Slc12a2<SUP>fx</SUP> genotyping; University of California at Davis and NIH NeuroMab for antibodies; and the Developmental Studies Hybridoma Bank for the T4 antibody developed by Lytle and Forbush. This work was supported by the Tourette Syndrome Association (J.M.H. and K. Khodakhah), NIH R21NS073761 and R01MH083804 (J.H.), and Deutsche Forschungsgemeinschaft HU 800/5-1 (C.A.H.).	Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Baldessarini R. J., 2006, GOODMAN GILMANS TXB, P317; Choe ES, 2002, NEUROREPORT, V13, P1013, DOI 10.1097/00001756-200206120-00006; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773, DOI 10.1177/002215549704500601; Cushing SL, 2008, LARYNGOSCOPE, V118, P1814, DOI 10.1097/MLG.0b013e31817fadfa; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Deol M S, 1968, J Med Genet, V5, P137, DOI 10.1136/jmg.5.2.137; Dixon MJ, 1999, HUM MOL GENET, V8, P1579, DOI 10.1093/hmg/8.8.1579; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hindley P, 1998, J Deaf Stud Deaf Educ, V3, P64; Kimmel RA, 2000, GENE DEV, V14, P1377; Lambert FM, 2012, CURR BIOL, V22, P1649, DOI 10.1016/j.cub.2012.07.019; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Salzmann J, 2003, BRIT J PHARMACOL, V140, P831, DOI 10.1038/sj.bjp.0705506; Schirmer M, 2007, BRAIN RES, V1155, P179, DOI 10.1016/j.brainres.2007.04.012; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Selz PA, 1996, OTOLARYNG HEAD NECK, V115, P70, DOI 10.1016/S0194-5998(96)70139-0; Shiroyama T, 1999, J COMP NEUROL, V407, P318; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Stenman J, 2003, J NEUROSCI, V23, P167; Stiles L, 2012, BEHAV BRAIN RES, V227, P150, DOI 10.1016/j.bbr.2011.11.006; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Van Eldik T, 2004, AM ANN DEAF, V148, P390, DOI 10.1353/aad.2004.0002; van Gent T, 2007, J CHILD PSYCHOL PSYC, V48, P950, DOI 10.1111/j.1469-7610.2007.01775.x; Vostanis P, 1997, CHILD CARE HLTH DEV, V23, P233, DOI 10.1111/j.1365-2214.1997.tb00966.x	30	25	25	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1120	1123		10.1126/science.1240405	http://dx.doi.org/10.1126/science.1240405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009395	Green Accepted			2022-12-28	WOS:000323933100047
J	Cole, TB				Cole, Thomas B.			Self-portrait Beauford Delaney	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					668	669		10.1001/jama.2013.5262	http://dx.doi.org/10.1001/jama.2013.5262			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989615				2022-12-28	WOS:000323254500001
J	Lee, JH; Ryu, HS; Chung, KS; Pose, D; Kim, S; Schmid, M; Ahn, JH				Lee, Jeong Hwan; Ryu, Hak-Seung; Chung, Kyung Sook; Pose, David; Kim, Soonkap; Schmid, Markus; Ahn, Ji Hoon			Regulation of Temperature-Responsive Flowering by MADS-Box Transcription Factor Repressors	SCIENCE			English	Article							AMBIENT-TEMPERATURE; PHENOTYPIC PLASTICITY; ARABIDOPSIS-THALIANA; CLIMATE-CHANGE; TIME; PLANTS; VERNALIZATION; PROTEIN; SVP; ENCODES	Changes in ambient temperature affect flowering time in plants; understanding this phenomenon will be crucial for buffering agricultural systems from the effects of climate change. Here, we show that levels of FLM-beta, an alternatively spliced form of the flowering repressor FLOWERING LOCUS M, increase at lower temperatures, repressing flowering. FLM-beta interacts with SHORT VEGETATIVE PHASE (SVP); SVP is degraded at high temperatures, reducing the abundance of the SVP-FLM-beta repressor complex and, thus, allowing the plant to flower. The svp and flm mutants show temperature-insensitive flowering in different temperature ranges. Control of SVP-FLM-beta repressor complex abundance via transcriptional and splicing regulation of FLM and posttranslational regulation of SVP protein stability provides an efficient, rapid mechanism for plants to respond to ambient temperature changes.	[Lee, Jeong Hwan; Ryu, Hak-Seung; Chung, Kyung Sook; Kim, Soonkap; Ahn, Ji Hoon] Korea Univ, Dept Life Sci, Creat Res Initiat, Seoul 136701, South Korea; [Pose, David; Schmid, Markus] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Korea University; Max Planck Society	Ahn, JH (corresponding author), Korea Univ, Dept Life Sci, Creat Res Initiat, Seoul 136701, South Korea.	jahn@korea.ac.kr	Posé, David/A-3424-2014; Ahn, Ji Hoon/A-4141-2011; Schmid, Markus/I-4384-2015	Posé, David/0000-0003-3332-4661; Ahn, Ji Hoon/0000-0003-0347-3922; Schmid, Markus/0000-0002-0068-2967	Korea University; ERA-NET Plant Genomics BLOOMNET project [SCHM1560/7-1]; National Research Foundation of Korea; Korea government (Ministry of Science, ICT, and Future Planning) [2008-0061988]	Korea University; ERA-NET Plant Genomics BLOOMNET project; National Research Foundation of Korea(National Research Foundation of Korea); Korea government (Ministry of Science, ICT, and Future Planning)	We thank R. Amasino, C. Dean, I. Lee, I. Hwang, C. M. Park, J. Puterill, D. Weigel, and P. Wigge for kindly providing research materials and D. H. Kim, B. R. Kim, H. J. Cho, S. H. Kim, S. M. Hong, H. S. Jung, and S. J. Yoo for their technical assistance. J. H. L. was supported by a Korea University Grant. D. P. and M. S. were supported by the ERA-NET Plant Genomics BLOOMNET project (SCHM1560/7-1). This work was supported by a National Research Foundation of Korea grant funded by the Korea government (Ministry of Science, ICT, and Future Planning) (2008-0061988) to J. H. A. The authors declare no conflicts of interest. GenBank accession numbers are KF496888 to KF496899 (FLM sequences of Arabidopsis WT accessions). Materials described here are available from J. H. A. The genomic FLM-GFP line will be distributed for noncommercial research under a standard materials transfer agreement by the Max Planck Institute for Developmental Biology.	Anderson JT, 2012, P ROY SOC B-BIOL SCI, V279, P3843, DOI 10.1098/rspb.2012.1051; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Balasubramanian S, 2006, PLANT SIGNAL BEHAV, V1, P227, DOI 10.4161/psb.1.5.3452; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bond DM, 2011, PLANT CELL ENVIRON, V34, P1737, DOI 10.1111/j.1365-3040.2011.02370.x; Cho HJ, 2012, FEBS LETT, V586, P2332, DOI 10.1016/j.febslet.2012.05.035; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Delk NA, 2005, PLANT PHYSIOL, V139, P240, DOI 10.1104/pp.105.062612; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2947; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kim JJ, 2012, PLANT PHYSIOL, V159, P461, DOI 10.1104/pp.111.192369; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Lee JH, 2008, J PLANT BIOL, V51, P321, DOI 10.1007/BF03036133; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee JH, 2012, PLANT SCI, V185, P97, DOI 10.1016/j.plantsci.2011.09.003; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Trevaskis B, 2007, PLANT PHYSIOL, V143, P225, DOI 10.1104/pp.106.090860; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	31	213	231	13	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 1	2013	342	6158					628	632		10.1126/science.1241097	http://dx.doi.org/10.1126/science.1241097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RJ	24030492				2022-12-28	WOS:000326334300051
J	Martinez, FD; Vercelli, D				Martinez, Fernando D.; Vercelli, Donata			Asthma	LANCET			English	Article							INNATE LYMPHOID-CELLS; MILD PERSISTENT ASTHMA; REGULATORY T-CELLS; INTERMITTENT INHALED CORTICOSTEROIDS; GENOME-WIDE ASSOCIATION; ACTING BETA-AGONISTS; STEP-UP THERAPY; CHILDHOOD ASTHMA; DOUBLE-BLIND; LUNG-FUNCTION	Asthma is a heterogeneous group of conditions that result in recurrent, reversible bronchial obstruction. Although the disease can start at any age, the first symptoms occur during childhood in most cases. Asthma has a strong genetic component, and genome-wide association studies have identified variations in several genes that slightly increase the risk of disease. Asthma is often associated with increased susceptibility to infection with rhinoviruses and with changes in the composition of microbial communities colonising the airways, but whether these changes are a cause or consequence of the disease is unknown. There is currently no proven prevention strategy; however, the finding that exposure to microbial products in early life, particularly in farming environments, seems to be protective against asthma offers hope that surrogates of such exposure could be used to prevent the disease. Genetic and immunological studies point to defective responses of lung resident cells, especially those associated with the mucosal epithelium, as crucial elements in the pathogenesis of asthma. Inhaled corticosteroids continue to be the mainstay for the treatment of mild and moderate asthma, but limited adherence to daily inhaled medication is a major obstacle to the success of such therapy. Severe asthma that is refractory to usual treatment continues to be a challenge, but new biological therapies, such as humanised antibodies against IgE, interleukin 5, and interleukin 13, off er hope to improve the quality of life and long-term prognosis of severe asthmatics with specific molecular phenotypes.	[Martinez, Fernando D.; Vercelli, Donata] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85724 USA; [Martinez, Fernando D.; Vercelli, Donata] Univ Arizona, Inst BIO5, Tucson, AZ 85724 USA	University of Arizona; University of Arizona	Martinez, FD (corresponding author), Univ Arizona, Arizona Resp Ctr, 1501 N Campbell, Tucson, AZ 85724 USA.	fernando@arc.arizona.edu			US National Heart, Lung, and Blood Institute; US National Institute of Allergy and Infectious Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098112] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors were funded by grants from the US National Heart, Lung, and Blood Institute and the US National Institute of Allergy and Infectious Diseases.	Akinbami O.J., 2012, TRENDS ASTHMA PREVAL; Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Anees W, 2006, THORAX, V61, P751, DOI 10.1136/thx.2005.054080; Apter AJ, 2011, J ALLERGY CLIN IMMUN, V128, P516, DOI 10.1016/j.jaci.2011.05.010; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bai TR, 2007, EUR RESPIR J, V30, P452, DOI 10.1183/09031936.00165106; Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Beasley R, 2009, EUR RESPIR J, V33, P3, DOI 10.1183/09031936.00163408; Bedouch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050949; BENTLEY AM, 1992, J ALLERGY CLIN IMMUN, V89, P821, DOI 10.1016/0091-6749(92)90437-7; BENTLEY AM, 1993, AM J RESP CELL MOL, V8, P35, DOI 10.1165/ajrcmb/8.1.35; Bisgaard H, 2006, LANCET, V367, P286, DOI 10.1016/S0140-6736(06)68051-3; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2012, AM J RESP CRIT CARE, V185, P1183, DOI 10.1164/rccm.201110-1922OC; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Bosco A, 2010, MUCOSAL IMMUNOL, V3, P399, DOI 10.1038/mi.2010.13; BRADLEY BL, 1991, J ALLERGY CLIN IMMUN, V88, P661, DOI 10.1016/0091-6749(91)90160-P; BURROWS B, 1995, AM J RESP CRIT CARE, V152, P1497, DOI 10.1164/ajrccm.152.5.7582283; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Castro M, 2010, AM J RESP CRIT CARE, V181, P116, DOI 10.1164/rccm.200903-0354OC; Chan-Yeung M, 2005, J ALLERGY CLIN IMMUN, V116, P49, DOI 10.1016/j.jaci.2005.03.029; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chowdhury B., 2010, LONG ACTING BETA AGO; Chu EK, 2005, AM J RESP CELL MOL, V32, P373, DOI 10.1165/rcmb.2004-0266OC; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Covar RA, 2010, J ALLERGY CLIN IMMUN, V125, P359, DOI 10.1016/j.jaci.2009.10.037; Cox G, 2007, NEW ENGL J MED, V356, P1327, DOI 10.1056/NEJMoa064707; Custovic A, 2011, J ALLERGY CLIN IMMUN, V127, P390, DOI 10.1016/j.jaci.2010.10.050; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; Ducharme FM, 2012, THORAX, V67, P102, DOI 10.1136/thoraxjnl-2011-200961; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Fahy JV, 2011, AM J RESP CRIT CARE, V184, P390, DOI 10.1164/rccm.201107-1258ED; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Gauvreau GM, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-140; Gehring U, 2012, ALLERGY, V67, P248, DOI 10.1111/j.1398-9995.2011.02739.x; Gerald LB, 2009, PEDIATRICS, V123, P466, DOI 10.1542/peds.2008-0499; Gowers AM, 2012, RESPIROLOGY, V17, P887, DOI 10.1111/j.1440-1843.2012.02195.x; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hanania NA, 2011, ANN INTERN MED, V154, P573, DOI 10.7326/0003-4819-154-9-201105030-00002; Harrison TW, 2004, LANCET, V363, P271, DOI 10.1016/S0140-6736(03)15384-6; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HOGG JC, 1993, J ALLERGY CLIN IMMUN, V92, P1, DOI 10.1016/0091-6749(93)90029-F; Holberg CJ, 1996, AM J RESP CRIT CARE, V154, P144, DOI 10.1164/ajrccm.154.1.8680670; Holgate ST, 2011, J ALLERGY CLIN IMMUN, V128, P495, DOI 10.1016/j.jaci.2011.06.052; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Horne Rob, 2007, BMC Pulm Med, V7, P8; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Jarjour NN, 2012, AM J RESP CRIT CARE, V185, P356, DOI 10.1164/rccm.201107-1317PP; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kubo S, 2012, INT IMMUNOPHARMACOL, V12, P59, DOI 10.1016/j.intimp.2011.10.011; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Larche M, 2007, CHEST, V132, P1007, DOI 10.1378/chest.06-2434; Lemanske RF, 2010, NEW ENGL J MED, V362, P975, DOI 10.1056/NEJMoa1001278; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; Maier RM, 2010, APPL ENVIRON MICROB, V76, P2663, DOI 10.1128/AEM.01665-09; Mallol J, 2008, THORAX, V63, P167, DOI 10.1136/thx.2006.063180; Marinho Susana, 2006, Prim Care Respir J, V15, P152, DOI 10.1016/j.pcrj.2006.02.005; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Martinez FD, 2011, J ALLERGY CLIN IMMUN, V128, P939, DOI 10.1016/j.jaci.2011.09.020; Martinez FD, 2011, LANCET, V377, P650, DOI 10.1016/S0140-6736(10)62145-9; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Mjosberg J, 2012, EUR J IMMUNOL, V42, P1093, DOI 10.1002/eji.201242549; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Mortimer K, 2008, EPIDEMIOLOGY, V19, P550, DOI 10.1097/EDE.0b013e31816a9dcb; Murray CS, 2006, LANCET, V368, P754, DOI 10.1016/S0140-6736(06)69285-4; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ni Chroinin M, 2009, COCHRANE DB SYST REV, V2009; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Nikander K, 2011, ARCH DIS CHILD, V96, P168, DOI 10.1136/adc.2010.187724; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Oborne J, 2009, AM J RESP CRIT CARE, V180, P598, DOI 10.1164/rccm.200904-0616OC; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Ostergaard MS, 2012, PRIM CARE RESP J, V21, P214, DOI 10.4104/pcrj.2012.00038; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Price D, 2011, NEW ENGL J MED, V364, P1695, DOI 10.1056/NEJMoa1010846; Rabe KF, 2006, LANCET, V368, P744, DOI 10.1016/S0140-6736(06)69284-2; Rachiotis G, 2007, THORAX, V62, P147, DOI 10.1136/thx.2006.061952; Rasmussen F, 2002, J ALLERGY CLIN IMMUN, V110, P220, DOI 10.1067/mai.2002.125295; Reponen T, 2011, ANN ALLERG ASTHMA IM, V107, P120, DOI 10.1016/j.anai.2011.04.018; Rodriguez A, 2011, THORAX, V66, P1043, DOI 10.1136/thoraxjnl-2011-200225; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Scott M, 2012, THORAX, V67, P1046, DOI 10.1136/thoraxjnl-2012-202150; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Solis-Cohen S., 1900, J AM MED ASS, V34, P1164, DOI [10.1001/jama.1900.24610190014001c, DOI 10.1001/JAMA.1900.24610190014001C]; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Stern DA, 2007, J ALLERGY CLIN IMMUN, V120, P835, DOI 10.1016/j.jaci.2007.05.050; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Strickland DH, 2011, MUCOSAL IMMUNOL, V4, P43, DOI 10.1038/mi.2010.43; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; Sullivan PW, 2011, J ALLERGY CLIN IMMUN, V127, P363, DOI 10.1016/j.jaci.2010.10.042; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Szefler SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1043, DOI 10.1016/j.jaci.2007.08.063; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Tattersfield AE, 2002, LANCET, V360, P1313, DOI 10.1016/S0140-6736(02)11312-2; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thamrin C, 2011, J ALLERGY CLIN IMMUN, V127, P1494, DOI 10.1016/j.jaci.2011.01.018; Thamrin C, 2010, THORAX, V65, P403, DOI 10.1136/thx.2009.129668; Toelle BG, 2010, J ALLERGY CLIN IMMUN, V126, P388, DOI 10.1016/j.jaci.2010.04.031; Torgerson DG, 2012, AM J HUM GENET, V90, P273, DOI 10.1016/j.ajhg.2012.01.008; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC; Turpeinen M, 2012, THORAX, V67, P100, DOI 10.1136/thoraxjnl-2011-200246; Umetsu DT, 2003, J ALLERGY CLIN IMMUN, V112, P480, DOI 10.1067/mai.2003.1717; Van Dyken SJ, 2011, J IMMUNOL, V187, P2261, DOI 10.4049/jimmunol.1100972; van Oosterhout AJM, 2005, EUR RESPIR J, V26, P918, DOI 10.1183/09031936.05.00011205; Vonk JM, 2004, THORAX, V59, P925, DOI 10.1136/thx.2003.016246; Wadsworth SJ, 2013, CURR ALLERGY ASTHM R, V13, P118, DOI 10.1007/s11882-012-0325-9; Wahidi MM, 2012, AM J RESP CRIT CARE, V185, P709, DOI 10.1164/rccm.201105-0883CI; WEISS KB, 1992, NEW ENGL J MED, V326, P862, DOI 10.1056/NEJM199203263261304; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Williams LK, 2011, J ALLERGY CLIN IMMUN, V128, P1185, DOI 10.1016/j.jaci.2011.09.011; Wlasiuk G, 2012, CURR OPIN ALLERGY CL, V12, P461, DOI 10.1097/ACI.0b013e328357a3bc; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zar HJ, 2012, PEDIATR DRUGS, V14, P353, DOI 10.2165/11597420-000000000-00000; Zhang YM, 2012, CURR OPIN PULM MED, V18, P6, DOI 10.1097/MCP.0b013e32834dc532	159	372	400	11	186	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 19	2013	382	9901					1360	1372		10.1016/S0140-6736(13)61536-6	http://dx.doi.org/10.1016/S0140-6736(13)61536-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	238UG	24041942				2022-12-28	WOS:000325975700026
J	Klasse, PJ				Klasse, P. J.			A New Bundle of Prospects for Blocking HIV-1 Entry	SCIENCE			English	Editorial Material							CCR5 INHIBITORS; SMALL-MOLECULE; RECEPTOR; RESISTANCE; PEPTIDE; GP120		Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University	Klasse, PJ (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	pek2003@med.cornell.edu	Klasse, P.J./AEX-0142-2022	Klasse, P.J./0000-0001-8222-278X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082362, R01AI041420] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI41420, P01 AI82362] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; Berro R, 2011, J VIROL, V85, P8227, DOI 10.1128/JVI.00767-11; Blois TM, 2009, PROTEIN SCI, V18, P1335, DOI 10.1002/pro.165; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Klasse PJ, 2012, CELL MICROBIOL, V14, P1183, DOI 10.1111/j.1462-5822.2012.01812.x; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Pejchal R, 2010, CURR PHARM DESIGN, V16, P3744, DOI 10.2174/138161210794079173; Rosenkilde MM, 2000, MOL PHARMACOL, V57, P602, DOI 10.1124/mol.57.3.602; Schwartz TW, 2011, NATURE, V477, P540, DOI 10.1038/477540a; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Weiss RA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-57; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	15	4	4	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 20	2013	341	6152					1347	1348		10.1126/science.1245384	http://dx.doi.org/10.1126/science.1245384			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	220PK	24030494				2022-12-28	WOS:000324597200028
J	Liu, MZ; Johnston, MB; Snaith, HJ				Liu, Mingzhen; Johnston, Michael B.; Snaith, Henry J.			Efficient planar heterojunction perovskite solar cells by vapour deposition	NATURE			English	Article							LOW-COST	Many different photovoltaic technologies are being developed for large-scale solar energy conversion(1-4). The wafer-based first-generation photovoltaic devices(1) have been followed by thin-film solid semiconductor absorber layers sandwiched between two charge-selective contacts(3) and nanostructured (or mesostructured) solar cells that rely on a distributed heterojunction to generate charge and to transport positive and negative charges in spatially separated phases(4-6). Although many materials have been used in nanostructured devices, the goal of attaining high-efficiency thin-film solar cells in such a way has yet to be achieved(7). Organometal halide perovskites have recently emerged as a promising material for high-efficiency nanostructured devices(8-11). Here we show that nanostructuring is not necessary to achieve high efficiencies with this material: a simple planar heterojunction solar cell incorporating vapour-deposited perovskite as the absorbing layer can have solar-to-electrical power conversion efficiencies of over 15 per cent (as measured under simulated full sunlight). This demonstrates that perovskite absorbers can function at the highest efficiencies in simplified device architectures, without the need for complex nanostructures.	[Liu, Mingzhen; Johnston, Michael B.; Snaith, Henry J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Snaith, HJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	h.snaith1@physics.ox.ac.uk	Johnston, Michael/B-9813-2008; Snaith, Henry J/A-7367-2016	Johnston, Michael/0000-0002-0301-8033; Snaith, Henry J/0000-0001-8511-790X; Liu, Mingzhen/0000-0001-8017-9706	EPSRC; European Research Council (ERC) 'Hyper Project' [279881]	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council (ERC) 'Hyper Project'(European Research Council (ERC))	This work was funded by EPSRC and the European Research Council (ERC) 'Hyper Project' number 279881. The Oxford University Press (John Fell) Fund provided support for equipment used in this study, specifically the organic light-emitting diode vapour-deposition equipment. We thank S. Sun, E. Crossland, P. Docampo, G. Eperon, J. Zhang and J. Liu for discussions and experimental and technical assistance.	Arici E, 2003, ADV FUNCT MATER, V13, P165, DOI 10.1002/adfm.200390024; Ball JM, 2013, ENERG ENVIRON SCI, V6, P1739, DOI 10.1039/c3ee40810h; Beiley ZM, 2012, ENERG ENVIRON SCI, V5, P9173, DOI 10.1039/c2ee23073a; Cheng ZY, 2010, CRYSTENGCOMM, V12, P2646, DOI 10.1039/c001929a; Chopra KL, 2004, PROG PHOTOVOLTAICS, V12, P69, DOI 10.1002/pip.541; Graetzel M, 2012, NATURE, V488, P304, DOI 10.1038/nature11476; Green MA, 2005, PROG PHOTOVOLTAICS, V13, P447, DOI 10.1002/pip.612; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P606, DOI 10.1002/pip.2267; HALLS JJM, 1995, NATURE, V376, P498, DOI 10.1038/376498a0; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; McDonald SA, 2005, NAT MATER, V4, P138, DOI 10.1038/nmat1299; Mosconi E, 2013, J PHYS CHEM C, V117, P13902, DOI 10.1021/jp4048659; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Riede M, 2011, ADV FUNCT MATER, V21, P3019, DOI 10.1002/adfm.201002760; Sakata H, 2000, IEEE PHOT SPEC CONF, P7, DOI 10.1109/PVSC.2000.915742; Snaith HJ, 2004, ADV MATER, V16, P1640, DOI 10.1002/adma.200305766; Yang F, 2005, J APPL PHYS, V98, DOI 10.1063/1.1941480; You H, 2007, J APPL PHYS, V101, DOI 10.1063/1.2430511; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789	25	6295	6484	182	7136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					395	+		10.1038/nature12509	http://dx.doi.org/10.1038/nature12509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24025775				2022-12-28	WOS:000324545700040
J	Tsai, TC; Joynt, KE; Orav, EJ; Gawande, AA; Jha, AK				Tsai, Thomas C.; Joynt, Karen E.; Orav, E. John; Gawande, Atul A.; Jha, Ashish K.			Variation in Surgical-Readmission Rates and Quality of Hospital Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LENGTH-OF-STAY; HIGH-RISK SURGERY; MEDICARE BENEFICIARIES; PROCEDURE VOLUME; PROGRAM; ARTHROPLASTY; MORTALITY; DISCHARGE; OUTCOMES; CANCER	BackgroundReducing hospital-readmission rates is a clinical and policy priority, but little is known about variation in rates of readmission after major surgery and whether these rates at a given hospital are related to other markers of the quality of surgical care. MethodsUsing national Medicare data, we calculated 30-day readmission rates after hospitalization for coronary-artery bypass grafting, pulmonary lobectomy, endovascular repair of abdominal aortic aneurysm, open repair of abdominal aortic aneurysm, colectomy, and hip replacement. We used bivariate and multivariate techniques to assess the relationships between readmission rates and other measures of surgical quality, including adherence to surgical process measures, procedure volume, and mortality. ResultsFor the six index procedures, there were 479,471 discharges from 3004 hospitals. The median risk-adjusted composite readmission rate at 30 days was 13.1% (interquartile range, 9.9 to 17.1). In a multivariate model adjusting for hospital characteristics, we found that hospitals in the highest quartile for surgical volume had a significantly lower composite readmission rate than hospitals in the lowest quartile (12.7% vs. 16.8%, P<0.001), and hospitals with the lowest surgical mortality rates had a significantly lower readmission rate than hospitals with the highest mortality rates (13.3% vs. 14.2%, P<0.001). High adherence to reported surgical process measures was only marginally associated with reduced readmission rates (highest quartile vs. lowest quartile, 13.1% vs. 13.6%; P=0.02). Patterns were similar when each of the six major surgical procedures was examined individually. ConclusionsNearly one in seven patients hospitalized for a major surgical procedure is readmitted to the hospital within 30 days after discharge. Hospitals with high surgical volume and low surgical mortality have lower rates of surgical readmission than other hospitals.	[Tsai, Thomas C.; Joynt, Karen E.; Gawande, Atul A.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Orav, E. John] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Tsai, Thomas C.; Gawande, Atul A.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Joynt, Karen E.] Brigham & Womens Hosp, Dept Med, Cardiovasc Div, Boston, MA 02115 USA; [Orav, E. John; Jha, Ashish K.] Brigham & Womens Hosp, Dept Gen Internal Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu		Gawande, Atul/0000-0002-1824-9176	NCI NIH HHS [L30 CA171208, R25 CA092203] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R25CA092203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Birkmeyer JD, 2002, HEALTH AFFAIR, V21, P234, DOI 10.1377/hlthaff.21.5.234; Chen LM, 2010, ARCH INTERN MED, V170, P340, DOI 10.1001/archinternmed.2009.511; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Fry DE, 2007, ANN SURG, V246, P875, DOI 10.1097/SLA.0b013e3180cc2e7a; Garcia N, 2012, AM SURGEON, V78, P653; Ghaferi AA, 2011, MED CARE, V49, P1076, DOI 10.1097/MLR.0b013e3182329b97; Goodney PP, 2003, ANN SURG, V238, P161, DOI 10.1097/01.SLA.0000081094.66659.c3; Greenblatt DY, 2012, ANN SURG, V256, P595, DOI 10.1097/SLA.0b013e31826b4bfe; Hannan EL, 2003, JAMA-J AM MED ASSOC, V290, P773, DOI 10.1001/jama.290.6.773; Hendren S, 2011, DIS COLON RECTUM, V54, P1362, DOI 10.1097/DCR.0b013e31822b72d3; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Kassin MT, 2012, J AM COLL SURGEONS, V215, P322, DOI 10.1016/j.jamcollsurg.2012.05.024; LaPar DJ, 2012, ANN SURG, V256, P606, DOI 10.1097/SLA.0b013e31826b4be6; Livingston E, 2010, ARCH SURG-CHICAGO, V145, P1039, DOI 10.1001/archsurg.2010.240; Livingston EH, 2010, JAMA-J AM MED ASSOC, V304, P95, DOI 10.1001/jama.2010.905; Livingston EH, 2009, ARCH SURG-CHICAGO, V144, P706, DOI 10.1001/archsurg.2009.150; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Pouw ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059160; Schneider EB, 2012, J AM COLL SURGEONS, V214, P390, DOI 10.1016/j.jamcollsurg.2011.12.025; Vorhies JS, 2011, J ARTHROPLASTY, V26, P119, DOI 10.1016/j.arth.2011.04.036; Voss R, 2011, ARCH INTERN MED, V171, P1232, DOI 10.1001/archinternmed.2011.278	26	483	483	5	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1134	1142		10.1056/NEJMsa1303118	http://dx.doi.org/10.1056/NEJMsa1303118			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047062	Green Accepted, Bronze			2022-12-28	WOS:000324554800011
J	Thompson, BT				Thompson, B. Taylor			Prone positioning for 16 h/d reduced mortality more than supine positioning in early severe ARDS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; METAANALYSIS		Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Thompson, BT (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Abroug F, 2008, INTENS CARE MED, V34, P1002, DOI 10.1007/s00134-008-1062-3; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Gattinoni L, 2010, MINERVA ANESTESIOL, V76, P448	3	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC2	10.7326/0003-4819-159-6-201309170-02002	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042385				2022-12-28	WOS:000325625900001
J	Bretagnol, A; Tamburini, J; Guedj, M; Denier, C; Pene, F				Bretagnol, Anne; Tamburini, Jerome; Guedj, Mikael; Denier, Charlotte; Pene, Frederic			Profound anaemia and acute blindness in a Jehovah's Witness	LANCET			English	Editorial Material									[Bretagnol, Anne; Pene, Frederic] Hop Cochin, AP HP, Med Intens Care Unit, F-75014 Paris, France; [Tamburini, Jerome] Hop Cochin, AP HP, Haematol Unit, F-75014 Paris, France; [Guedj, Mikael; Denier, Charlotte] Hop Cochin, AP HP, Ophthalmol Unit, F-75014 Paris, France; Paris Descartes Univ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Pene, F (corresponding author), Hop Cochin, 27 Rue Faubourg, F-75014 Paris, France.	frederic.pene@cch.aphp.fr	tamburini, jerome/AAT-9506-2020	Pene, Frederic/0000-0003-3639-3849; Tamburini, Jerome/0000-0002-0167-5996				Al-Nawakil C, 2013, BRIT J HAEMATOL, V161, P738, DOI 10.1111/bjh.12284; HOLT JM, 1969, BRIT J OPHTHALMOL, V53, P145, DOI 10.1136/bjo.53.3.145; Rouge-Maillart C, 2004, Med Law, V23, P715	3	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					998	998		10.1016/S0140-6736(13)61443-9	http://dx.doi.org/10.1016/S0140-6736(13)61443-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VD	24034299				2022-12-28	WOS:000324238000033
J	Pearson, JS; Giogha, C; Ong, SY; Kennedy, CL; Kelly, M; Robinson, KS; Lung, TWF; Mansell, A; Riedmaier, P; Oates, CVL; Zaid, A; Muhlen, S; Crepin, VF; Marches, O; Ang, CS; Williamson, NA; O'Reilly, LA; Bankovacki, A; Nachbur, U; Infusini, G; Webb, AI; Silke, J; Strasser, A; Frankel, G; Hartland, EL				Pearson, Jaclyn S.; Giogha, Cristina; Ong, Sze Ying; Kennedy, Catherine L.; Kelly, Michelle; Robinson, Keith S.; Lung, Tania Wong Fok; Mansell, Ashley; Riedmaier, Patrice; Oates, Clare V. L.; Zaid, Ali; Muehlen, Sabrina; Crepin, Valerie F.; Marches, Olivier; Ang, Ching-Seng; Williamson, Nicholas A.; O'Reilly, Lorraine A.; Bankovacki, Aleksandra; Nachbur, Ueli; Infusini, Giuseppe; Webb, Andrew I.; Silke, John; Strasser, Andreas; Frankel, Gad; Hartland, Elizabeth L.			A type III effector antagonizes death receptor signalling during bacterial gut infection	NATURE			English	Article							APOPTOSIS; VIRULENCE; PROTEINS; ROLES; NLEB	Successful infection by enteric bacterial pathogens depends on the ability of the bacteria to colonize the gut, replicate in host tissues and disseminate to other hosts. Pathogens such as Salmonella, Shigella and enteropathogenic and enterohaemorrhagic (EPEC and EHEC, respectively) Escherichia coli use a type III secretion system(T3SS) to deliver virulence effector proteins into host cells during infection that promote colonization and interfere with antimicrobial host responses(1-3). Here we report that the T3SS effector NleB1 from EPEC binds to host cell death-domain-containing proteins and thereby inhibits death receptor signalling. Protein interaction studies identified FADD, TRADD and RIPK1 as binding partners of NleB1. NleB1 expressed ectopically or injected by the bacterial T3SS prevented Fas ligand or TNF-induced formation of the canonical death-inducing signalling complex (DISC) and proteolytic activation of caspase-8, an essential step in death-receptor-induced apoptosis. This inhibition depended on the N-acetylglucosamine transferase activity of NleB1, which specifically modified Arg 117 in the death domain of FADD. The importance of the death receptor apoptotic pathway to host defence was demonstrated using mice deficient in the FAS signalling pathway, which showed delayed clearance of the EPEC-like mouse pathogen Citrobacter rodentium and reversion to virulence of an nleB mutant. The activity of NleB suggests that EPEC and other attaching and effacing pathogens antagonize death-receptor-induced apoptosis of infected cells, thereby blocking a major antimicrobial host response.	[Pearson, Jaclyn S.; Giogha, Cristina; Ong, Sze Ying; Kennedy, Catherine L.; Kelly, Michelle; Lung, Tania Wong Fok; Riedmaier, Patrice; Oates, Clare V. L.; Zaid, Ali; Muehlen, Sabrina; Hartland, Elizabeth L.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Robinson, Keith S.; Crepin, Valerie F.; Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, London SW7 2AZ, England; [Mansell, Ashley] Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Melbourne, Vic 3010, Australia; [Marches, Olivier] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Immunol & Infect Dis, London E1 2AT, England; [Ang, Ching-Seng; Williamson, Nicholas A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [O'Reilly, Lorraine A.; Bankovacki, Aleksandra; Nachbur, Ueli; Infusini, Giuseppe; Webb, Andrew I.; Silke, John; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [O'Reilly, Lorraine A.; Webb, Andrew I.; Silke, John; Strasser, Andreas] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Hartland, Elizabeth L.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Melbourne; Imperial College London; University of London; Queen Mary University London; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Hartland, EL (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	hartland@unimelb.edu.au	Ang, Ching-Seng/O-9811-2016; Silke, John/B-7622-2008; Williamson, Nicholas A/O-9812-2016; Mansell, Ashley/B-9553-2008; Strasser, Andreas/C-7581-2013; Lung, Tania Wong Fok/ABD-3992-2020; Hartland, Elizabeth/O-2569-2014	Ang, Ching-Seng/0000-0001-7861-6719; Silke, John/0000-0002-7611-5774; Williamson, Nicholas A/0000-0002-2173-3452; Mansell, Ashley/0000-0002-6540-1281; Strasser, Andreas/0000-0002-5020-4891; Lung, Tania Wong Fok/0000-0002-9318-9572; Hartland, Elizabeth/0000-0003-4254-2863; Muehlen, Sabrina/0000-0001-7474-705X; Zaid, Ali/0000-0002-2528-2783; Giogha, Cristina/0000-0002-9075-9840; Pearson, Jaclyn/0000-0002-7358-4479; Kennedy, Catherine/0000-0001-6359-6161; Oates, Clare/0000-0002-3858-019X; Nachbur, Ueli/0000-0001-5968-2235	Australian National Health and Medical Research Council [606788, 637332, 1009145]; Wellcome Trust; Juvenile Diabetes Foundation; Leukaemia; Lymphoma Society (New York; SCOR grant) [7413]; Australian Research Council Future Fellowship; Australian Postgraduate Awards; MRC [MR/J006874/1] Funding Source: UKRI	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); Leukaemia; Lymphoma Society (New York; SCOR grant); Australian Research Council Future Fellowship(Australian Research Council); Australian Postgraduate Awards(Australian Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We gratefully acknowledge P. Bouillet for the gift of Bid<SUP>-/-</SUP> mice and T. Cumming for assistance with animal work. This work was supported by the Australian National Health and Medical Research Council (Program Grant no. 606788 to E. L. H., Project Grants no. 637332, no. 1009145 to A. S., no. 1009145 to L.O.R., Australia Fellowship to A. S.), the Wellcome Trust to G. F., the Juvenile Diabetes Foundation; the Leukaemia and the Lymphoma Society (New York; SCOR grant no. 7413) to A. S. E. L. H was supported by an Australian Research Council Future Fellowship. J.S.P., M. K., T. W., C. G. and P. R. were supported by Australian Postgraduate Awards. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS.	Ashida H, 2011, CURR OPIN MICROBIOL, V14, P16, DOI 10.1016/j.mib.2010.08.014; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Imtiyaz HZ, 2005, J BIOL CHEM, V280, P31360, DOI 10.1074/jbc.M504138200; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mundy R, 2004, INFECT IMMUN, V72, P2288, DOI 10.1128/IAI.72.4.2288-2302.2004; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Srikanth CV, 2011, CELL MOL LIFE SCI, V68, P3687, DOI 10.1007/s00018-011-0841-0; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wickham ME, 2007, CURR BIOL, V17, P783, DOI 10.1016/j.cub.2007.03.067; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690	24	196	207	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					247	+		10.1038/nature12524	http://dx.doi.org/10.1038/nature12524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24025841	Green Accepted, Green Published			2022-12-28	WOS:000324244900046
J	Wei, YJ; Zou, ZJ; Becker, N; Anderson, M; Sumpter, R; Xiao, GH; Kinch, L; Koduru, P; Christudass, CS; Veltri, RW; Grishin, NV; Peyton, M; Minna, J; Bhagat, G; Levine, B				Wei, Yongjie; Zou, Zhongju; Becker, Nils; Anderson, Matthew; Sumpter, Rhea; Xiao, Guanghua; Kinch, Lisa; Koduru, Prasad; Christudass, Christhunesa S.; Veltri, Robert W.; Grishin, Nick V.; Peyton, Michael; Minna, John; Bhagat, Govind; Levine, Beth			EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; CELL LUNG-CANCER; ADENOCARCINOMA; MUTATIONS; CARCINOMA; SERIES	Cell surface growth factor receptors couple environmental cues to the regulation of cytoplasmic homeostatic processes, including autophagy, and aberrant activation of such receptors is a common feature of human malignancies. Here, we defined the molecular basis by which the epidermal growth factor receptor (EGFR) tyrosine kinase regulates autophagy. Active EGFR binds the autophagy protein Beclin 1, leading to its multisite tyrosine phosphorylation, enhanced binding to inhibitors, and decreased Beclin 1-associated VPS34 kinase activity. EGFR tyrosine kinase inhibitor (TKI) therapy disrupts Beclin 1 tyrosine phosphorylation and binding to its inhibitors and restores autophagy in non-small-cell lung carcinoma (NSCLC) cells with a TKI-sensitive EGFR mutation. In NSCLC tumor xenografts, the expression of a tyrosine phosphomimetic Beclin 1 mutant leads to reduced autophagy, enhanced tumor growth, tumor dedifferentiation, and resistance to TKI therapy. Thus, oncogenic receptor tyrosine kinases directly regulate the core autophagy machinery, which may contribute to tumor progression and chemoresistance.	[Wei, Yongjie; Zou, Zhongju; Sumpter, Rhea; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Wei, Yongjie; Zou, Zhongju; Becker, Nils; Anderson, Matthew; Sumpter, Rhea; Peyton, Michael; Minna, John; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Kinch, Lisa; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Koduru, Prasad] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Peyton, Michael; Minna, John] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Wei, Yongjie; Zou, Zhongju; Becker, Nils; Kinch, Lisa; Grishin, Nick V.; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Christudass, Christhunesa S.; Veltri, Robert W.] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Dept Urol, Baltimore, MD 21287 USA; [Bhagat, Govind] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Bhagat, Govind] New York Presbyterian Hosp, New York, NY 10032 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Columbia University; NewYork-Presbyterian Hospital	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Bhagat, Govind/AAE-9493-2021; Sumpter, Jr., Rhea/N-8152-2018	Bhagat, Govind/0000-0001-6250-048X; Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [NCI RO1 84254, NCI RO1 109618]; Lung Cancer SPORE [P50CA70907]; NATIONAL CANCER INSTITUTE [R01CA109618, P50CA070907, R01CA084254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Noboru Mizushima, Tamotsu Yoshimori, and Sandra Schmid for supplying critical reagents, Haley Harrington for assistance with manuscript preparation, and Lori Nguyen for technical assistance. This work was supported by National Institutes of Health grants NCI RO1 84254 and NCI RO1 109618 to B.L. and the Lung Cancer SPORE P50CA70907 to J.M.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Botti J, 2006, AUTOPHAGY, V2, P67, DOI 10.4161/auto.2.2.2458; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Fung C, 2012, CANCER BIOL THER, V13, P1417, DOI 10.4161/cbt.22002; Gazdar AF, 1996, J CELL BIOCHEM, P1; Gorzalczany Y, 2011, CANCER LETT, V310, P207, DOI 10.1016/j.canlet.2011.07.002; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Rekhtman N, 2011, MODERN PATHOL, V24, P1348, DOI 10.1038/modpathol.2011.92; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saad RS, 2004, HUM PATHOL, V35, P3, DOI 10.1016/j.humpath.2003.08.011; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Shim HS, 2011, ARCH PATHOL LAB MED, V135, P1329, DOI 10.5858/arpa.2010-0493-OA; Tang XM, 2011, CLIN CANCER RES, V17, P2434, DOI 10.1158/1078-0432.CCR-10-1412; VanMeter AJ, 2008, MOL CELL PROTEOMICS, V7, P1902, DOI 10.1074/mcp.M800204-MCP200; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Yao YA, 2010, ACTA BIOCH BIOPH SIN, V42, P763, DOI 10.1093/abbs/gmq090	25	375	399	0	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1269	1284		10.1016/j.cell.2013.08.015	http://dx.doi.org/10.1016/j.cell.2013.08.015			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034250	Green Accepted, Bronze			2022-12-28	WOS:000324239300016
J	Yonehara, K; Roska, B				Yonehara, Keisuke; Roska, Botond			Motion Detection: Neuronal Circuit Meets Theory	CELL			English	Editorial Material							DROSOPHILA-MELANOGASTER; INTERNEURONS; MECHANISM	Motion detection in fly vision has been investigated experimentally and theoretically for half of a century, yet mechanistic insights into the neuronal computation have only started to emerge. In a recent issue of Nature, two studies provide major insights into how motion direction is extracted from the image flow projected onto the retina.	[Yonehara, Keisuke; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, CH-4058 Basel, Switzerland.	botond.roska@fmi.ch	Roska, Botond/AAD-7268-2021	Yonehara, Keisuke/0000-0001-9541-6671				BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Reichardt W, 1961, SENS COMMUN, P303; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450	10	4	4	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1188	1189		10.1016/j.cell.2013.08.027	http://dx.doi.org/10.1016/j.cell.2013.08.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034242	Bronze			2022-12-28	WOS:000324239300008
J	Chinthapalli, K				Chinthapalli, Krishna			When a doctor goes wrong	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Surrey Cty Hosp, Guildford, Surrey, England	Royal Surrey County Hospital	Chinthapalli, K (corresponding author), Royal Surrey Cty Hosp, Guildford, Surrey, England.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				[Anonymous], 2012, SYRIAN SURG WHY IM R; Barnett A., 2003, GUARDIAN; Colaianni A, 2012, J MED ETHICS, V38, P435, DOI 10.1136/medethics-2011-100372; Daniszewski J, 2000, LOS ANGELES TIMES; International Rescue Committee, 2013, SYR REG CRIS; Macrae F, 2012, DAILY MAIL; Neumann M, 2011, ACAD MED, V86, P996, DOI 10.1097/ACM.0b013e318221e615; Pettifor T., 2012, MIRROR          1228; The White House, 2013, GOV ASS SYR GOV US C; Yamamoto R., 2011, ASAHI SHIMBUN   1117	10	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2013	347								f5455	10.1136/bmj.f5455	http://dx.doi.org/10.1136/bmj.f5455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219RR	24022037				2022-12-28	WOS:000324527000009
J	McCollum, JT; Cronquist, AB; Silk, BJ; Jackson, KA; O'Connor, KA; Cosgrove, S; Gossack, JP; Parachini, SS; Jain, NS; Ettestad, P; Ibraheem, M; Cantu, V; Joshi, M; DuVernoy, T; Fogg, NW; Gorny, JR; Mogen, KM; Spires, C; Teitell, P; Joseph, LA; Tarr, CL; Imanishi, M; Neil, KP; Tauxe, RV; Mahon, BE				McCollum, Jeffrey T.; Cronquist, Alicia B.; Silk, Benjamin J.; Jackson, Kelly A.; O'Connor, Katherine A.; Cosgrove, Shaun; Gossack, Joe P.; Parachini, Susan S.; Jain, Neena S.; Ettestad, Paul; Ibraheem, Mam; Cantu, Venessa; Joshi, Manjiri; DuVernoy, Tracy; Fogg, Norman W., Jr.; Gorny, James R.; Mogen, Kathryn M.; Spires, Charlotte; Teitell, Paul; Joseph, Lavin A.; Tarr, Cheryl L.; Imanishi, Maho; Neil, Karen P.; Tauxe, Robert V.; Mahon, Barbara E.			Multistate Outbreak of Listeriosis Associated with Cantaloupe	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURVEILLANCE NETWORK FOODNET; UNITED-STATES; MONOCYTOGENES VIRULENCE; FOODBORNE ILLNESS; FRESH PRODUCE; PULSENET; ESTABLISHMENT; EVOLUTION; MELON	BACKGROUND Although new pathogen-vehicle combinations are increasingly being identified in produce-related disease outbreaks, fresh produce is a rarely recognized vehicle for listeriosis. We investigated a nationwide listeriosis outbreak that occurred in the United States during 2011. METHODS We defined an outbreak-related case as a laboratory-confirmed infection with any of five outbreak-related subtypes of Listeria monocytogenes isolated during the period from August 1 through October 31, 2011. Multistate epidemiologic, trace-back, and environmental investigations were conducted, and outbreak-related cases were compared with sporadic cases reported previously to the Listeria Initiative, an enhanced surveillance system that routinely collects detailed information about U.S. cases of listeriosis. RESULTS We identified 147 outbreak-related cases in 28 states. The majority of patients (127 of 147, 86%) were 60 years of age or older. Seven infections among pregnant women and newborns and one related miscarriage were reported. Of 145 patients for whom information about hospitalization was available, 143 (99%) were hospitalized. Thirty-three of the 147 patients (22%) died. Patients with outbreak-related illness were significantly more likely to have eaten cantaloupe than were patients 60 years of age or older with sporadic illness (odds ratio, 8.5; 95% confidence interval, 1.3 to infinity). Cantaloupe and environmental samples collected during the investigation yielded isolates matching all five outbreak-related subtypes, confirming that whole cantaloupe produced by a single Colorado farm was the outbreak source. Unsanitary conditions identified in the processing facility operated by the farm probably resulted in contamination of cantaloupes with L. monocytogenes. CONCLUSIONS Raw produce, including cantaloupe, can serve as a vehicle for listeriosis. This outbreak highlights the importance of preventing produce contamination within farm and processing environments.	[McCollum, Jeffrey T.; O'Connor, Katherine A.; Jain, Neena S.; Ibraheem, Mam; Imanishi, Maho] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30329 USA; [Silk, Benjamin J.; Jackson, Kelly A.; O'Connor, Katherine A.; Joseph, Lavin A.; Tarr, Cheryl L.; Imanishi, Maho; Neil, Karen P.; Tauxe, Robert V.; Mahon, Barbara E.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Atlanta, GA USA; [McCollum, Jeffrey T.; Cronquist, Alicia B.; Cosgrove, Shaun; Gossack, Joe P.; Parachini, Susan S.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Ettestad, Paul; Ibraheem, Mam] New Mexico Dept Hlth, Santa Fe, NM USA; [Cantu, Venessa] Dept State Hlth Serv, Austin, TX USA; [Joshi, Manjiri] Nebraska Dept Hlth & Human Serv, Lincoln, NE USA; [DuVernoy, Tracy; Fogg, Norman W., Jr.; Gorny, James R.; Mogen, Kathryn M.; Spires, Charlotte; Teitell, Paul] US FDA, Silver Spring, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Colorado Department of Public Health & Environment; New Mexico Department of Health; US Food & Drug Administration (FDA)	McCollum, JT (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30329 USA.	jeffrey.mccollum@us.army.mil						[Anonymous], 2011, COL LIST INV NOW MUL; [Anonymous], 2009, GUID IND GUID MIN MI; [Anonymous], 2007, LISTERIOSIS FOOD SAF; [Anonymous], 2012, RAW PROD SEL SERV IT; Behravesh CB, 2011, J INFECT DIS, V204, P263, DOI 10.1093/infdis/jir263; Bell R, 2010, COMMUN DIS INTELL, V34, P345; Bowen A, 2006, EPIDEMIOL INFECT, V134, P675, DOI 10.1017/S0950268805005480; Cartwright EJ, 2013, EMERG INFECT DIS, V19, P1, DOI [10.3201/eid1901.120393, 10.3201/eid1908.121511]; Centers for Disease Control and Prevention, 2011, NAT ENT DIS SURV LIS; de Valk H, 2001, AM J EPIDEMIOL, V154, P944, DOI 10.1093/aje/154.10.944; Food and Drug Administration, 2011, ENV ASS FACT POT CON; Food and Drug Administration, 1998, GUID IND GUID MIN MI; Gagliardi JV, 2003, J FOOD PROTECT, V66, P82, DOI 10.4315/0362-028X-66.1.82; Graves LM, 2005, J CLIN MICROBIOL, V43, P2350, DOI 10.1128/JCM.43.5.2350-2355.2005; Halpin JL, 2010, FOODBORNE PATHOG DIS, V7, P293, DOI 10.1089/fpd.2009.0394; Hitchins AD, 2011, BACTERIOLOGICAL ANAL; Jackson KA, 2011, J FOOD PROTECT, V74, P949, DOI 10.4315/0362-028X.JFP-10-536; Jackson KA, 2010, EPIDEMIOL INFECT, V138, P1503, DOI 10.1017/S0950268810000294; Johnston LM, 2005, J FOOD PROTECT, V68, P1840, DOI 10.4315/0362-028X-68.9.1840; Kathariou S, 2002, J FOOD PROTECT, V65, P1811, DOI 10.4315/0362-028X-65.11.1811; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; McCarthy N, 1999, INT J EPIDEMIOL, V28, P764, DOI 10.1093/ije/28.4.764; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Penteado AL, 2004, INT J FOOD MICROBIOL, V92, P89, DOI 10.1016/j.ijfoodmicro.2003.08.020; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Silk BJ, 2012, CLIN INFECT DIS, V54, pS396, DOI 10.1093/cid/cis268; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Tompkin RB, 2002, J FOOD PROTECT, V65, P709, DOI 10.4315/0362-028X-65.4.709; Ukuku DO, 2002, J FOOD PROTECT, V65, P924, DOI 10.4315/0362-028X-65.6.924; Varma JK, 2007, CLIN INFECT DIS, V44, P521, DOI 10.1086/509920; Velge P, 2010, FUTURE MICROBIOL, V5, P1799, DOI 10.2217/FMB.10.134	35	222	233	3	113	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					944	953		10.1056/NEJMoa1215837	http://dx.doi.org/10.1056/NEJMoa1215837			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004121	Bronze			2022-12-28	WOS:000323906900011
J	Jack, A				Jack, Andrew			DRUG DEVELOPMENT Compound interests: how a partnership between academics and a drug company came unstuck	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				Garattini S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5354; Innovative Medicines Initiative, COMBATTING BACTERIAL	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2013	347								f5356	10.1136/bmj.f5356	http://dx.doi.org/10.1136/bmj.f5356			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215NL	24004997				2022-12-28	WOS:000324216800016
J	Rossi, G				Rossi, Gabriele			Humanitarian power has been hijacked and must regain its reputation for neutrality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Medecins Sans Frontieres, B-1090 Brussels, Belgium	Doctors Without Borders	Rossi, G (corresponding author), Medecins Sans Frontieres, B-1090 Brussels, Belgium.	gab.rossi@tiscali.it						[Anonymous], 2007, CSIS COMM SMART POW; Barnett M., 2008, HUMANITARIANISM QUES; Benelli P, 2012, AFGHANISTAN HUMANITA; Collinson S, 2010, DISASTERS, V34, pS275, DOI 10.1111/j.1467-7717.2010.01206.x; Donini A., 2012, EYES OTHERS PEOPLE C; Humanitarian Outcomes, 2019, AID WORK SEC REP 201; Neumann Michael., 2012, HUMANITARIAN NEGOTIA; Roberts LF, 2013, NEW ENGL J MED, V368, P1073, DOI 10.1056/NEJMp1300197; Stoddard A, 2012, EYES OTHERS PEOPLE C	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2013	347								f5359	10.1136/bmj.f5359	http://dx.doi.org/10.1136/bmj.f5359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ND	23999981				2022-12-28	WOS:000324216000005
J	Goldblatt, F; O'Neill, SG				Goldblatt, Fiona; O'Neill, Sean G.			Autoimmune Rheumatic Diseases 1 Clinical aspects of autoimmune rheumatic diseases	LANCET			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CONNECTIVE-TISSUE DISEASE; INTERSTITIAL LUNG-DISEASE; PRIMARY SJOGRENS-SYNDROME; EULAR SCLERODERMA TRIALS; CLASSIFICATION CRITERIA; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; FOLLOW-UP; PREDICTIVE FACTORS	Multisystem autoimmune rheumatic diseases are heterogeneous rare disorders associated with substantial morbidity and mortality. Efforts to create international consensus within the past decade have resulted in the publication of new classification or nomenclature criteria for several autoimmune rheumatic diseases, specifically for systemic lupus erythematosus, Sjogren's syndrome, and the systemic vasculitides. Substantial progress has been made in the formulation of new criteria in systemic sclerosis and idiopathic inflammatory myositis. Although the autoimmune rheumatic diseases share many common features and clinical presentations, differentiation between the diseases is crucial because of important distinctions in clinical course, appropriate drugs, and prognoses. We review some of the dilemmas in the diagnosis of these autoimmune rheumatic diseases, and focus on the importance of new classification criteria, clinical assessment, and interpretation of autoimmune serology. In this era of improvement of mortality rates for patients with autoimmune rheumatic diseases, we pay particular attention to the effect of leading complications, specifically cardiovascular manifestations and cancer, and we update epidemiology and prognosis.	[Goldblatt, Fiona] Repatriat Gen Hosp, Dept Rheumatol, Adelaide, SA, Australia; [Goldblatt, Fiona] Flinders Med Ctr, Adelaide, SA, Australia; [O'Neill, Sean G.] Univ New S Wales, South Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [O'Neill, Sean G.] Liverpool Hosp, Dept Rheumatol, Liverpool, NSW, Australia	Flinders University South Australia; Flinders Medical Centre; University of New South Wales Sydney; Liverpool Hospital	O'Neill, SG (corresponding author), Liverpool Hosp, Dept Rheumatol, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	sean.oneill@unsw.edu.au		Goldblatt, Fiona/0000-0001-7205-4807; O'Neill, Sean/0000-0002-6739-832X				Al-Dhaher FF, 2010, SEMIN ARTHRITIS RHEU, V39, P269, DOI 10.1016/j.semarthrit.2008.06.002; ALARCON GS, 1991, J RHEUMATOL, V18, P1332; Alonso-Perez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045356; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Aryal BK, 2001, AM J IND MED, V40, P271, DOI 10.1002/ajim.1098; Au K, 2011, ARTHRITIS RHEUM-US, V63, P2078, DOI 10.1002/art.30380; Bernatsky S, 2005, ANN RHEUM DIS, V64, P1507, DOI 10.1136/ard.2004.034504; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; BJERRUM K, 1990, CLIN EXP RHEUMATOL, V8, P283; Bodolay E, 2003, CLIN EXP RHEUMATOL, V21, P313; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Broen JCA, 2012, CURR RHEUMATOL REP, V14, P11, DOI 10.1007/s11926-011-0221-7; Bruce IN, 2005, RHEUMATOLOGY, V44, P1492, DOI 10.1093/rheumatology/kei142; Bussone G, 2011, AUTOIMMUN REV, V10, P248, DOI 10.1016/j.autrev.2010.09.012; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Chifflot H, 2008, SEMIN ARTHRITIS RHEU, V37, P223, DOI 10.1016/j.semarthrit.2007.05.003; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Derk CT, 2006, J RHEUMATOL, V33, P1113; Dias C, 2011, NAT REV RHEUMATOL, V7, P360, DOI 10.1038/nrrheum.2011.62; Diot E, 1999, CHEST, V116, P715, DOI 10.1378/chest.116.3.715; Eriksson C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3258; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Martin JE, 2012, HUM GENET, V131, P1023, DOI 10.1007/s00439-011-1137-z; Feghali-Bostwick C, 2003, ARTHRITIS RHEUM, V48, P1956, DOI 10.1002/art.11173; Fransen J, 2012, ARTHRIT CARE RES, V64, P351, DOI 10.1002/acr.20679; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Hill CL, 2001, LANCET, V357, P96, DOI 10.1016/S0140-6736(00)03540-6; Hochberg MC, 1995, LUPUS, V4, P454, DOI 10.1177/096120339500400606; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoshino K, 2010, RHEUMATOLOGY, V49, P1726, DOI 10.1093/rheumatology/keq153; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; JOHNSON AE, 1995, ARTHRITIS RHEUM, V38, P551, DOI 10.1002/art.1780380415; Johnson SR, 2012, ARTHRIT CARE RES, V64, P358, DOI 10.1002/acr.20684; Julkunen H, 2001, ARTHRITIS RHEUM, V44, P647, DOI 10.1002/1529-0131(200103)44:3<647::AID-ANR113>3.3.CO;2-9; Koenig M, 2008, ARTHRITIS RHEUM-US, V58, P3902, DOI 10.1002/art.24038; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Le Pavec J, 2011, ARTHRITIS RHEUM-US, V63, P2456, DOI 10.1002/art.30423; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; LEROY EC, 1988, J RHEUMATOL, V15, P202; Malladi AS, 2012, ARTHRIT CARE RES, V64, P911, DOI 10.1002/acr.21610; Marie I, 2001, J RHEUMATOL, V28, P2230; McCormic ZD, 2010, INT ARCH OCC ENV HEA, V83, P763, DOI 10.1007/s00420-009-0505-7; MERRELL M, 1955, J Chronic Dis, V1, P12, DOI 10.1016/0021-9681(55)90018-7; Moore OA, 2013, RHEUMATOLOGY, V52, P155, DOI 10.1093/rheumatology/kes289; Mosca M, 2011, AUTOIMMUN REV, V10, P256, DOI 10.1016/j.autrev.2010.09.013; Newton JL, 2012, ANN RHEUM DIS, V71, P1973, DOI 10.1136/annrheumdis-2011-201009; Ngian GS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3445; Nihtyanova SI, 2010, NAT REV RHEUMATOL, V6, P112, DOI 10.1038/nrrheum.2009.238; Ntatsaki E, 2010, RHEUM DIS CLIN N AM, V36, P447, DOI 10.1016/j.rdc.2010.04.002; Nussinovitch U, 2011, AUTOIMMUN REV, V10, P180, DOI 10.1016/j.autrev.2010.09.014; O'Hanlon TP, 2006, MEDICINE, V85, P111, DOI 10.1097/01.md.0000217525.82287.eb; O'Neill S, 2010, BEST PRACT RES CL RH, V24, P841, DOI 10.1016/j.berh.2010.10.006; O'Neill SG, 2009, RHEUMATOLOGY, V48, P573, DOI 10.1093/rheumatology/kep037; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P4021, DOI 10.1002/art.34672; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Plazak W, 2011, ACTA CARDIOL, V66, P159, DOI 10.2143/AC.66.2.2071246; Pontifex EK, 2007, ANN RHEUM DIS, V66, P551, DOI 10.1136/ard.2006.056424; Richards BL, 2010, BEST PRACT RES CL RH, V24, P871, DOI 10.1016/j.berh.2010.10.008; Ruiz-Irastorza G, 2010, ANN RHEUM DIS, V69, P20, DOI 10.1136/ard.2008.101766; Shamim EA, 2002, ARTHRITIS RHEUM, V46, P1885, DOI 10.1002/art.10358; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Shoenfeld Y, 2005, CIRCULATION, V112, P3337, DOI 10.1161/CIRCULATIONAHA.104.507996; SILMAN AJ, 1995, BAILLIERE CLIN RHEUM, V9, P471, DOI 10.1016/S1521-6942(05)80027-0; Singh JA, 2006, ARTHRIT RHEUM-ARTHR, V55, P348, DOI 10.1002/art.22003; Smedby KE, 2008, BLOOD, V111, P4029, DOI 10.1182/blood-2007-10-119974; Steen V, 2012, ARTHRITIS RHEUM-US, V64, P2986, DOI 10.1002/art.34482; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Stockton D, 2001, BRIT J CANCER, V85, P41, DOI 10.1054/bjoc.2001.1699; Sultan SM, 2002, RHEUMATOLOGY, V41, P22, DOI 10.1093/rheumatology/41.1.22; Sutcliffe N, 1998, J RHEUMATOL, V25, P63; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TAN EM, 1980, ARTHRITIS RHEUM, V23, P617, DOI 10.1002/art.1780230602; Theander E, 2006, ANN RHEUM DIS, V65, P796, DOI 10.1136/ard.2005.041186; Trallero-Araguas E, 2012, ARTHRITIS RHEUM-US, V64, P523, DOI 10.1002/art.33379; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Tzioufas AG, 2007, BEST PRACT RES CL RH, V21, P989, DOI 10.1016/j.berh.2007.09.001; Uramoto KM, 1999, ARTHRITIS RHEUM, V42, P46, DOI 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Urowitz MB, 2008, J RHEUMATOL, V35, P2152, DOI 10.3899/jrheum.080214; van der Meulen MFG, 2003, NEUROLOGY, V61, P316, DOI 10.1212/WNL.61.3.316; Villa-Blanco I, 2012, EXPERT REV CLIN IMMU, V8, P353, DOI [10.1586/ECI.12.20, 10.1586/eci.12.20]; Vincze M, 2012, BEST PRACT RES CL RH, V26, P25, DOI 10.1016/j.berh.2012.01.013; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Voss A, 1998, SCAND J RHEUMATOL, V27, P98; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Walker UA, 2009, ANN RHEUM DIS, V68, P856, DOI 10.1136/ard.2008.091348; Ward MM, 2004, J WOMENS HEALTH, V13, P713, DOI 10.1089/jwh.2004.13.713; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Williams HJ, 1999, J RHEUMATOL, V26, P816; Zoller B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033442; Zoller B, 2012, LANCET, V379, P244, DOI 10.1016/S0140-6736(11)61306-8	99	120	135	4	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					797	808		10.1016/S0140-6736(13)61499-3	http://dx.doi.org/10.1016/S0140-6736(13)61499-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23993190				2022-12-28	WOS:000324239200030
J	Rogers, JA				Rogers, John A.			A Clear Advance in Soft Actuators	SCIENCE			English	Editorial Material							STRETCHABLE ELECTRONICS; DIELECTRICS; GRAPHENE		Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61820 USA.	jrogers@illinois.edu	huang, yonggang/O-6236-2019; Rogers, John/L-2798-2016					BARDEEN J, 1964, NOBEL LECTURES PHYSI, P318; Keplinger C, 2013, SCIENCE, V341, P984, DOI 10.1126/science.1240228; Kim DH, 2010, ADV MATER, V22, P2108, DOI 10.1002/adma.200902927; Kim SH, 2013, ADV MATER, V25, P1822, DOI 10.1002/adma.201202790; Lee SK, 2011, NANO LETT, V11, P4642, DOI 10.1021/nl202134z; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Pelrine RE, 1998, SENSOR ACTUAT A-PHYS, V64, P77, DOI 10.1016/S0924-4247(97)01657-9; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Rosset S, 2013, APPL PHYS A-MATER, V110, P281, DOI 10.1007/s00339-012-7402-8; Sekitani T, 2010, ADV MATER, V22, P2228, DOI 10.1002/adma.200904054; Someya T., 2013, STRETCHABLE ELECT; Wagner S, 2012, MRS BULL, V37, P207, DOI 10.1557/mrs.2012.37; Zang JF, 2013, NAT MATER, V12, P321, DOI [10.1038/NMAT3542, 10.1038/nmat3542]	13	39	40	0	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					968	969		10.1126/science.1243314	http://dx.doi.org/10.1126/science.1243314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990550				2022-12-28	WOS:000323652300029
J	Doherty, RB; Crowley, RA				Doherty, Robert B.; Crowley, Ryan A.		Amer Coll Phys	Principles Supporting Dynamic Clinical Care Teams: An American College of Physicians Position Paper	ANNALS OF INTERNAL MEDICINE			English	Article								The U.S. health care system is undergoing a shift from individual clinical practice toward team-based care. This move toward team-based care requires fresh thinking about clinical leadership and responsibilities to ensure that the unique skills of each clinician are used to provide the best care for the patient as the patient's needs dictate, while the team as a whole must work together to ensure that all aspects of a patient's care are coordinated for the benefit of the patient. In. this position paper, the American College of Physicians offers principles, definitions, and examples to dissolve barriers that prevent movement toward dynamic clinical care teams. These principles offer a framework for an evolving, updated approach to health care delivery, providing policy guidance that can be useful to clinical teams in organizing the care processes and clinician responsibilities consistent with professionalism.	[Doherty, Robert B.; Crowley, Ryan A.; Amer Coll Phys] Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Doherty, RB (corresponding author), Amer Coll Physicians, Customer Serv, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	custserv@acponline.org			American College of Physicians operating budget	American College of Physicians operating budget	Financial support for the development of this position paper comes exclusively from the American College of Physicians operating budget.	Altschuler J, 2012, ANN FAM MED, V10, P396, DOI 10.1370/afm.1400; American Academy of Family Physicians; American Academy of Pediatrics; American College of Physicians; American Osteopathic Association, 2007, JOINT PRINC PAT CTR; American Academy of Physician Assistants American College of Physicians, 2010, AM AC PHYS ASS POL M; American College of Physicians, 2009, AM COLL PHYS POL MON; [Anonymous], 2013, P TEAM BASED COMP BU; Braddock CH, 2013, J GEN INTERN MED, V28, P141, DOI 10.1007/s11606-012-2170-x; CNA HealthPro, 2013, UND NURS PRACT LIAB; Donaldson M, 1994, DEFINING PRIMARY CAR; Druss BG, 2003, NEW ENGL J MED, V348, P130, DOI 10.1056/NEJMsa020993; Flanagan L, 1998, Fam Pract Manag, V5, P34; Flanagan L., 1998, FAM PRACT MANAG, V5, P41; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Interprofessional Education Collaborative, 2011, COR COMP INT COLL PR; McCarthy D, 2008, N DAKOTA EXPERIENCE; Medical Society of Virginia, 2011, EXAM FEAS NURS PRACT; Mitchell P, 2012, NAM PERSPECT, DOI DOI 10.31478/201210C; Nesbitt T.S., 2012, ROLE TELEHEALTH EVOL, P11; Snyder L, 2007, ANN INTERN MED, V147, P792, DOI 10.7326/0003-4819-147-11-200712040-00011; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Trilla F., 1998, PHYS NURSE PRACTITIO; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569	22	54	54	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 5	2013	159	9					620	626		10.7326/0003-4819-159-9-201311050-00710	http://dx.doi.org/10.7326/0003-4819-159-9-201311050-00710			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249HX	24042251				2022-12-28	WOS:000326769400006
J	Nicholas, LH; Dimick, JB				Nicholas, Lauren Hersch; Dimick, Justin B.			Bariatric Surgery in Minority Patients Before and After Implementation of a Centers of Excellence Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MORTALITY		[Nicholas, Lauren Hersch] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Dimick, Justin B.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Michigan System; University of Michigan	Nicholas, LH (corresponding author), Hampton House,624 N Broadway, Baltimore, MD 21205 USA.	lnichola@jhsph.edu			AHRQ HHS [K08 HS017765, K08HS017765] Funding Source: Medline; NIA NIH HHS [P30 AG012846, R01 AG039434, K01 AG041763, R01AG039434, K01AG04173] Funding Source: Medline; NICHD NIH HHS [R24 HD041028] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017765] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG041763, R01AG039434, P30AG012846] Funding Source: NIH RePORTER; AHRQ [5K08HS017765-02] Funding Source: Federal RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Dimick JB, 2013, JAMA-J AM MED ASSOC, V309, P792, DOI 10.1001/jama.2013.755; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Livingston EH, 2010, ARCH SURG-CHICAGO, V145, P605, DOI 10.1001/archsurg.2010.83; Pratt Gary M, 2006, Surg Obes Relat Dis, V2, P497, DOI 10.1016/j.soard.2006.07.004; Wallace AE, 2010, OBES SURG, V20, P1354, DOI 10.1007/s11695-009-0054-x	6	34	34	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 2	2013	310	13					1399	1400		10.1001/jama.2013.277915	http://dx.doi.org/10.1001/jama.2013.277915			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227GB	24030558	Green Accepted, Bronze			2022-12-28	WOS:000325098100026
J	Desireddy, A; Conn, BE; Guo, JS; Yoon, B; Barnett, RN; Monahan, BM; Kirschbaum, K; Griffith, WP; Whetten, RL; Landman, U; Bigioni, TP				Desireddy, Anil; Conn, Brian E.; Guo, Jingshu; Yoon, Bokwon; Barnett, Robert N.; Monahan, Bradley M.; Kirschbaum, Kristin; Griffith, Wendell P.; Whetten, Robert L.; Landman, Uzi; Bigioni, Terry P.			Ultrastable silver nanoparticles	NATURE			English	Article							CRYSTAL-STRUCTURE; GROWTH; PLASMONICS; CLUSTER	Noble-metal nanoparticles have had a substantial impact across a diverse range of fields, including catalysis(1), sensing(2), photochemistry(3), optoelectronics(4,5), energy conversion(6) andmedicine(7). Although silver has very desirable physical properties, good relative abundance and low cost, gold nanoparticles have been widely favoured owing to their proved stability and ease of use. Unlike gold, silver is notorious for its susceptibility to oxidation (tarnishing), which has limited the development of important silver-based nanomaterials. Despite two decades of synthetic efforts, silver nanoparticles that are inert or have long-term stability remain unrealized. Here we report a simple synthetic protocol for producing ultrastable silver nanoparticles, yielding a single-sized molecular product in very large quantities with quantitative yield and without the need for size sorting. The stability, purity and yield are substantially better than those for other metal nanoparticles, including gold, owing to an effective stabilization mechanism. The particular size and stoichiometry of the product were found to be insensitive to variations in synthesis parameters. The chemical stability and structural, electronic and optical properties can be understood using first-principles electronic structure theory based on an experimental single-crystal X-ray structure. Although several structures have been determined for protected gold nanoclusters(8-12), none has been reported so far for silver nanoparticles. The total structure of a thiolate-protected silver nanocluster reported here uncovers the unique structure of the silver thiolate protecting layer, consisting of Ag2S5 capping structures. The outstanding stability of the nanoparticle is attributed to a closed-shell 18-electron configuration with a large energy gap between the highest occupied molecular orbital and the lowest unoccupied molecular orbital, an ultrastable 32-silver-atom excavated-dodecahedral(13) core consisting of a hollow 12-silver-atom icosahedron encapsulated by a 20-silver-atom dodecahedron, and the choice of protective coordinating ligands. The straightforward synthesis of large quantities of pure molecular product promises to make this class of materials widely available for further research and technology development(14-18).	[Desireddy, Anil; Conn, Brian E.; Guo, Jingshu; Monahan, Bradley M.; Kirschbaum, Kristin; Griffith, Wendell P.; Bigioni, Terry P.] Univ Toledo, Dept Chem, Toledo, OH 43606 USA; [Yoon, Bokwon; Barnett, Robert N.; Landman, Uzi] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Whetten, Robert L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Whetten, Robert L.] Univ Texas San Antonio, Dept Phys & Astron, San Antonio, TX 78249 USA; [Bigioni, Terry P.] Univ Toledo, Sch Solar & Adv Renewable Energy, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Texas System; University of Texas at San Antonio (UTSA); University System of Ohio; University of Toledo	Bigioni, TP (corresponding author), Univ Toledo, Dept Chem, Toledo, OH 43606 USA.	Terry.Bigioni@utoledo.edu	Yoon, Bokwon/C-5818-2009; Guo, Jingshu/L-7629-2019; Griffith, Wendell/AAG-6193-2020	Guo, Jingshu/0000-0001-8987-6911; Desireddy, Anil/0000-0003-1336-5853	NSF [CBET-0955148, CRIF-0840474]; Wright Center for Photovoltaics Innovation and Commercialization; School of Solar and Advanced Renewable Energy; Office of Basic Energy Sciences of the US Department of Energy [FG05-86ER45234]; Air Force Office of Scientific Research; Div Of Chem, Bioeng, Env, & Transp Sys [0955148] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Wright Center for Photovoltaics Innovation and Commercialization; School of Solar and Advanced Renewable Energy; Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The work at the University of Toledo was supported by NSF grants CBET-0955148 and CRIF-0840474 as well as by the Wright Center for Photovoltaics Innovation and Commercialization and the School of Solar and Advanced Renewable Energy. The work of B.Y. and U. L. was supported by the Office of Basic Energy Sciences of the US Department of Energy under contract no. FG05-86ER45234 and in part by a grant from the Air Force Office of Scientific Research. Computations were made at the GATECH Center for Computational Materials Science. We acknowledge F. Stellacci for discussions and the College of Natural Sciences and Mathematics Instrumentation Center at the University of Toledo for the use of X-ray diffraction instrumentation.	Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Arvizo RR, 2012, CHEM SOC REV, V41, P2943, DOI 10.1039/c2cs15355f; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Bakr OM, 2009, ANGEW CHEM INT EDIT, V48, P5921, DOI 10.1002/anie.200900298; Bernhardt TM, 2007, NANOSCI TECHNOL, P1; BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Cathcart N, 2010, J PHYS CHEM C, V114, P16010, DOI 10.1021/jp101764q; Chakraborty I, 2012, NANO LETT, V12, P5861, DOI 10.1021/nl303220x; DANCE IG, 1986, POLYHEDRON, V5, P1037, DOI 10.1016/S0277-5387(00)84307-7; Dharmaratne AC, 2009, J AM CHEM SOC, V131, P13604, DOI 10.1021/ja906087a; EBBESEN TW, 1992, NATURE, V358, P220, DOI 10.1038/358220a0; Harkness KM, 2012, NANOSCALE, V4, P4269, DOI 10.1039/c2nr30773a; Heaven MW, 2008, J AM CHEM SOC, V130, P3754, DOI 10.1021/ja800561b; HERRON N, 1993, SCIENCE, V259, P1426, DOI 10.1126/science.259.5100.1426; Jadzinsky PD, 2007, SCIENCE, V318, P430, DOI 10.1126/science.1148624; Jana NR, 2001, LANGMUIR, V17, P6782, DOI 10.1021/1a0104323; Jin RC, 2003, NATURE, V425, P487, DOI 10.1038/nature02020; KNIGHT WD, 1984, PHYS REV LETT, V52, P2141, DOI 10.1103/PhysRevLett.52.2141; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Maier SA, 2001, ADV MATER, V13, P1501, DOI 10.1002/1521-4095(200110)13:19<1501::AID-ADMA1501>3.0.CO;2-Z; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; Perdew J. P., 1991, ELECT STRUCTURE SOLI, P11; PERDEW JP, 1993, PHYS REV B, V48, P4978, DOI 10.1103/PhysRevB.48.4978.2; Qian HF, 2010, J AM CHEM SOC, V132, P8280, DOI 10.1021/ja103592z; Shichibu Y, 2007, SMALL, V3, P835, DOI 10.1002/smll.200600611; Williams R., 1979, GEOMETRICAL FDN NATU; Yannouleas C., 2013, RECENT PROGR ORBITAL, P203; Yoon B, 2007, CHEMPHYSCHEM, V8, P157, DOI 10.1002/cphc.200600524; Zeng CJ, 2012, ANGEW CHEM INT EDIT, V51, P13114, DOI 10.1002/anie.201207098; Zhu M, 2008, J AM CHEM SOC, V130, P5883, DOI 10.1021/ja801173r	33	818	819	60	1464	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					399	402		10.1038/nature12523	http://dx.doi.org/10.1038/nature12523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24005327				2022-12-28	WOS:000324545700041
J	Gostin, LO				Gostin, Lawrence O.			PEPFAR's Antiprostitution Pledge Spending Power and Free Speech in Tension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, PREVENTION AND TREAT	1	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1127	1128		10.1001/jama.2013.276527	http://dx.doi.org/10.1001/jama.2013.276527			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	23990033				2022-12-28	WOS:000324500300016
J	Burrows, M; Sutton, G				Burrows, Malcolm; Sutton, Gregory			Interacting Gears Synchronize Propulsive Leg Movements in a Jumping Insect	SCIENCE			English	Article							FLY ORMIA OCHRACEA; DIRECTIONAL HEARING; FROGHOPPER INSECTS; CLOCKWORK CRICKET; HEMIPTERA; ISSIDAE; MECHANICS	Gears are found rarely in animals and have never been reported to intermesh and rotate functionally like mechanical gears. We now demonstrate functional gears in the ballistic jumping movements of the flightless planthopper insect Issus. The nymphs, but not adults, have a row of cuticular gear (cog) teeth around the curved medial surfaces of their two hindleg trochantera. The gear teeth on one trochanter engaged with and sequentially moved past those on the other trochanter during the preparatory cocking and the propulsive phases of jumping. Close registration between the gears ensured that both hindlegs moved at the same angular velocities to propel the body without yaw rotation. At the final molt to adulthood, this synchronization mechanism is jettisoned.	[Burrows, Malcolm; Sutton, Gregory] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Burrows, M (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	mb135@hermes.cam.ac.uk			Human Frontiers Research Program; Alexander von Humboldt Foundation, Germany	Human Frontiers Research Program; Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	G.S. was supported by the Human Frontiers Research Program. Experimental work at the Institut fur Biologie II (Zoologie), Rheinisch-Westfaelische Technische Hochschule Aachen University, Germany, was supported by a grant to M.B. from the Alexander von Humboldt Foundation, Germany. M.B. is especially grateful to P. Braunig for the hospitality of his laboratory. The data presented in this paper and more videos and images are stored on a server at the Department of Zoology, University of Cambridge, CB2 3EJ UK. We thank S. Rogers for comments on the text.	Bennet-Clark HC, 2002, J EXP BIOL, V205, P613; Burrows M, 2010, J EXP BIOL, V213, P469, DOI 10.1242/jeb.037861; Burrows M, 2007, J NEUROPHYSIOL, V97, P320, DOI 10.1152/jn.00719.2006; Burrows M, 2010, J COMP NEUROL, V518, P1349, DOI 10.1002/cne.22280; Burrows M, 2009, J EXP BIOL, V212, P2844, DOI 10.1242/jeb.032326; ELLIOTT CJH, 1985, NATURWISSENSCHAFTEN, V72, P150, DOI 10.1007/BF00490404; Farrel A.P., 1998, BIOL REPTILIA, V19, P375; GREENFIELD LAZAR J., 1961, JOUR SURG RES, V1, P97, DOI 10.1016/S0022-4804(61)80003-6; Heilig S., 1986, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V113, P307; Juvinall R.V, 1991, FUNDAMENTALS MACHINE, VSecond; Mhatre N, 2012, P NATL ACAD SCI USA, V109, pE1444, DOI 10.1073/pnas.1200192109; Miles RN, 1995, J ACOUST SOC AM, V98, P3059, DOI 10.1121/1.413830; Montealegre-Z F, 2005, J EXP BIOL, V208, P1219, DOI 10.1242/jeb.01526; Montealegre ZF, 2009, J EXP BIOL, V212, P257, DOI 10.1242/jeb.022731; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Robert D, 1996, J COMP PHYSIOL A, V179, P29, DOI 10.1007/BF00193432; Sander K., 1956, Zoologische Jahrbuecher Jena Anatomie, V75, P383; Sutton GP, 2010, J EXP BIOL, V213, P1406, DOI 10.1242/jeb.036921; Syme DA, 2002, J EXP BIOL, V205, P1843; van de Kamp T, 2011, SCIENCE, V333, P52, DOI 10.1126/science.1204245; WEBB GJW, 1979, J MORPHOL, V161, P221, DOI 10.1002/jmor.1051610209	21	73	76	5	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1254	1256		10.1126/science.1240284	http://dx.doi.org/10.1126/science.1240284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031019	Green Submitted			2022-12-28	WOS:000324248800047
J	Formoso, G; Paltrinieri, B; Marata, AM; Gagliotti, C; Pan, A; Moro, ML; Capelli, O; Magrini, N				Formoso, Giulio; Paltrinieri, Barbara; Marata, Anna Maria; Gagliotti, Carlo; Pan, Angelo; Moro, Maria Luisa; Capelli, Oreste; Magrini, Nicola		LOCAAL Study Grp	Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MASS-MEDIA CAMPAIGNS; PUBLIC CAMPAIGNS; IMPACT; INTERVENTIONS; ASSOCIATION; RESISTANCE	Objectives To test the hypothesis that a multifaceted, local public campaign could be feasible and influence antibiotic prescribing for outpatients. Design Community level, controlled, non-randomised trial. Setting Provinces of Modena and Parma in Emilia-Romagna, northern Italy, November 2011 to February 2012. Population 1 150 000 residents of Modena and Parma (intervention group) and 3 250 000 residents in provinces in the same region but where no campaign had been implemented (control group). Interventions Campaign materials (mainly posters, brochures, and advertisements on local media, plus a newsletter on local antibiotic resistance targeted at doctors and pharmacists). General practitioners and paediatricians in the intervention area participated in designing the campaign messages. Main outcomes measures Primary outcome was the average change in prescribing rates of antibiotics for outpatient in five months, measured as defined daily doses per 1000 inhabitants/day, using health districts as the unit of analysis. Results Antibiotic prescribing was reduced in the intervention area compared with control area (-4.3%, 95% confidence interval -7.1% to -1.5%). This result was robust to "sensitivity analysis" modifying the baseline period from two months (main analysis) to one month. A higher decrease was observed for penicillins resistant to beta lactamase and a lower decrease for penicillins susceptible to beta lactamase, consistent with the content of the newsletter on antibiotic resistance directed at health professionals. The decrease in expenditure on antibiotics was not statistically significant in a district level analysis with a two month baseline period (main analysis), but was statistically significant in sensitivity analyses using either a one month baseline period or a more powered doctor level analysis. Knowledge and attitudes of the target population about the correct use of antibiotics did not differ between the intervention and control areas. Conclusions A local low cost information campaign targeted at citizens, combined with a newsletter on local antibiotic resistance targeted at doctors and pharmacists, was associated with significantly decreased total rates of antibiotic prescribing but did not affect the population's knowledge and attitudes about antibiotic resistance.	[Formoso, Giulio; Paltrinieri, Barbara; Marata, Anna Maria; Gagliotti, Carlo; Pan, Angelo; Moro, Maria Luisa; Capelli, Oreste; Magrini, Nicola; LOCAAL Study Grp] Emilia Romagna Reg Agcy Hlth & Social Care, I-40127 Bologna, Italy		Formoso, G (corresponding author), Emilia Romagna Reg Agcy Hlth & Social Care, Viale Aldo Moro 21, I-40127 Bologna, Italy.	gformoso@regione.emilia-romagna.it	Formoso, Giulio/H-9350-2018; Moro, Maria Luisa/K-7017-2016	Formoso, Giulio/0000-0002-1819-6887; Moro, Maria Luisa/0000-0003-3586-977X; Gagliotti, Carlo/0000-0003-0684-731X	Italian Medicines Agency	Italian Medicines Agency	This study was funded through an Italian Medicines Agency grant (Bando AIFA 2008), raised through a compulsory contribution requested by law of pharmaceutical companies (5% of total promotional expenses).	Annual Report of the European Antimicrobial Resistance Surveillance Network 7 (EARS-Net), 2012, ANN REP EUR ANT RES; [Anonymous], 2009, BACTERIA CHALLENGE T; [Anonymous], 2010, BMJ, DOI DOI 10.1136/BMJ.C2096; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Bauraind I, 2004, JAMA-J AM MED ASSOC, V292, P2468, DOI 10.1001/jama.292.20.2468-b; Belongia EA, 1998, BRIT MED J, V317, P668, DOI 10.1136/bmj.317.7159.668; Belongia EA, 2005, EMERG INFECT DIS, V11, P912; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Coenen S, 2006, BRIT J GEN PRACT, V56, P183; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; degli Atti MLC, 2006, EUR J CLIN PHARMACOL, V62, P1055, DOI 10.1007/s00228-006-0198-8; Domenighetti G, 1998, INT J TECHNOL ASSESS, V14, P97, DOI 10.1017/S0266462300010552; Edgar T, 2009, J ANTIMICROB CHEMOTH, V63, P230, DOI 10.1093/jac/dkn508; European Food Safety Authority, 2012, EFSA Journal, V10, P2598; Filippini M, 2013, EUR J HEALTH ECON, V14, P587, DOI 10.1007/s10198-012-0404-9; Formoso G, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-816; Gonzales R, 2008, MED CARE, V46, P597, DOI 10.1097/MLR.0b013e3181653d2e; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Goossens H, 2006, EUR J CLIN PHARMACOL, V62, P373, DOI 10.1007/s00228-005-0094-7; Huttner B, 2010, INFECTION, V38, P1, DOI 10.1007/s15010-009-9350-6; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Italian Observatory on Medicines working group, 2011, US FARM IT; KOTLER P, 1971, J MARKETING, V35, P3, DOI 10.2307/1249783; Lambert MF, 2007, J ANTIMICROB CHEMOTH, V59, P537, DOI 10.1093/jac/dkl511; Masiero G, 2010, INT J PUBLIC HEALTH, V55, P469, DOI 10.1007/s00038-010-0167-y; Milandri M, PROGETTO BAMBINI ANT, P115; Muller A, 2007, EURO SURVEILL, V12; Ranji SR, 2008, MED CARE, V46, P847, DOI 10.1097/MLR.0b013e318178eabd; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Second report from the European Commission to the Council of Europe, 2 COUN EUR EUR COMM; Shepperd S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000086; Thackeray R, 2012, HEALTH PROMOT PRACT, V13, P165, DOI 10.1177/1524839911432009; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; WEISS JA, 1994, J POLICY ANAL MANAG, V13, P82, DOI 10.2307/3325092; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; Wutzke SE, 2007, HEALTH PROMOT INT, V22, P53, DOI 10.1093/heapro/dal034	38	46	46	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2013	347								f5391	10.1136/bmj.f5391	http://dx.doi.org/10.1136/bmj.f5391			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219SU	24030722	Green Published, hybrid			2022-12-28	WOS:000324530500004
J	Harvey, BM; Klein, BP; Petridou, N; Dumoulin, SO				Harvey, B. M.; Klein, B. P.; Petridou, N.; Dumoulin, S. O.			Topographic Representation of Numerosity in the Human Parietal Cortex	SCIENCE			English	Article							NUMERICAL INFORMATION; NUMBER; MAGNITUDE; QUANTITY; TIME	Numerosity, the set size of a group of items, is processed by the association cortex, but certain aspects mirror the properties of primary senses. Sensory cortices contain topographic maps reflecting the structure of sensory organs. Are the cortical representation and processing of numerosity organized topographically, even though no sensory organ has a numerical structure? Using high-field functional magnetic resonance imaging (at a field strength of 7 teslas), we described neural populations tuned to small numerosities in the human parietal cortex. They are organized topographically, forming a numerosity map that is robust to changes in low-level stimulus features. The cortical surface area devoted to specific numerosities decreases with increasing numerosity, and the tuning width increases with preferred numerosity. These organizational properties extend topographic principles to the representation of higher-order abstract features in the association cortex.	[Harvey, B. M.; Klein, B. P.; Dumoulin, S. O.] Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, NL-3584 CS Utrecht, Netherlands; [Petridou, N.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Radiol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Harvey, BM (corresponding author), Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, NL-3584 CS Utrecht, Netherlands.	b.m.harvey@uu.nl	Dumoulin, Serge O/A-3603-2012	Dumoulin, Serge O/0000-0001-7474-7711; , Natalia/0000-0002-0783-0387; Harvey, Benjamin/0000-0003-2694-618X	Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi [452.08.008]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi(Netherlands Organization for Scientific Research (NWO))	Processed data reported in the paper are presented in full in the supplementary materials. Raw data and custom analysis code are available on request from the authors. This work was supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek Vidi grant 452.08.008. We thank J. W. Brascamp for critical comments on the manuscript.	Bongard S, 2010, P NATL ACAD SCI USA, V107, P2277, DOI 10.1073/pnas.0909180107; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Cajal SRY, 1999, TEXTURE OF THE NERVOUS SYSTEM OF MAN AND THE VERTEBRATES, VOL I, P1; Cantlon JF, 2007, PLOS BIOL, V5, P2912, DOI 10.1371/journal.pbio.0050328; Cantlon JF, 2009, J COGNITIVE NEUROSCI, V21, P2217, DOI 10.1162/jocn.2008.21159; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Dakin SC, 2011, P NATL ACAD SCI USA, V108, P19552, DOI 10.1073/pnas.1113195108; DEHAENE S, 1991, NEUROPSYCHOLOGIA, V29, P1045, DOI 10.1016/0028-3932(91)90076-K; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S., 2011, NUMBER SENSE MIND CR; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; Eger E, 2009, CURR BIOL, V19, P1608, DOI 10.1016/j.cub.2009.08.047; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pinel P, 1999, NEUROREPORT, V10, P1473, DOI 10.1097/00001756-199905140-00015; Saltzman IJ, 1948, J PSYCHOL, V25, P227, DOI 10.1080/00223980.1948.9917373; STARKEY P, 1992, COGNITION, V43, P93, DOI 10.1016/0010-0277(92)90034-F; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Tokita M, 2010, ATTEN PERCEPT PSYCHO, V72, P1839, DOI 10.3758/APP.72.7.1839; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1	30	272	273	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1123	1126		10.1126/science.1239052	http://dx.doi.org/10.1126/science.1239052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009396	Green Submitted			2022-12-28	WOS:000323933100048
J	Hunter, T				Hunter, Tony			Tony Pawson (1952-2013) RETROSPECTIVE	SCIENCE			English	Biographical-Item									Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Hunter, T (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hunter@salk.edu						PAWSON T, PUBLICATION LIST	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1078	1078		10.1126/science.1244986	http://dx.doi.org/10.1126/science.1244986			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009385				2022-12-28	WOS:000323933100033
J	Wager, E; Williams, P				Wager, Elizabeth; Williams, Peter		OPEN Project Overcome Failure	"Hardly worth the effort"? Medical journals' policies and their editors' and publishers' views on trial registration and publication bias: quantitative and qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OUTCOME REPORTING BIAS; RANDOMIZED-TRIALS; IMPACT; STATEMENT	Objectives To determine the proportion of medical journals requiring trial registration and to understand their reasons for adopting (or not adopting) such policies and other measures designed to reduce publication bias. Design Quantitative study of journals' instructions to authors (in June 2012) and qualitative study of editors' and publishers' views on trial registration and publication bias (carried out in Autumn 2012). Setting Random selection of 200 medical journals publishing clinical trials identified from the Cochrane CENTRAL database. Participants Editors (n=13) and publishers (n=3) of journals with different policies on trial registration (and with recently changed policies) identified from the survey of their instructions to authors. Results Only 55/200 journals (28%) required trial registration according to their instructions and a further three (2%) encouraged it. The editors and publishers interviewed explained their journals' reluctance to require registration in terms of not wanting to lose out to rival journals, not wanting to reject otherwise sound articles or submissions from developing countries, and perceptions that such policies were not relevant to all journals. Some interviewees considered that registration was unnecessary for small or exploratory studies. Conclusions Although many major medical journals state that they will only publish clinical trials that have been prospectively registered, and such policies have been associated with a dramatic increase in the number of trials being registered, most smaller journals have not adopted such policies. Editors and publishers may be reluctant to require registration because they do not understand its benefits or because they fear that adopting such a policy would put their journal at a disadvantage to competitors.	[Wager, Elizabeth] Sideview, Princes Risborough HP27 9DE, Bucks, England; [Williams, Peter] UCL, London, England	University of London; University College London	Wager, E (corresponding author), Sideview, Princes Risborough HP27 9DE, Bucks, England.	liz@sideview.demon.co.uk		Wager, Elizabeth/0000-0002-4202-7813	European Union [FP7-HEALTH.2011.4.1-2, 285453]	European Union(European Commission)	This study was part of the OPEN project (Overcome failure to Publish nEgative fiNdings, www.open-project.eu/) which was funded from the European Union Seventh Framework Programme (FP7-HEALTH.2011.4.1-2) under grant agreement No 285453. The funder had no role in any part of the research.	[Anonymous], BIOMEDICAL J UNPUB; Brice A, 2012, 11 EUR ASS SCI ED C; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; Hopewell S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4178; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Huic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025258; Krleza-Jeric K, 6 INT C PEER REV BIO; Kunath F, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000430; Matarese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002512; Meerpohl JJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-27; Meerpohl JJ, 2010, ARCH PEDIAT ADOL MED, V164, P268, DOI 10.1001/archpediatrics.2009.287; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Pinto RZ, 2013, PHYS THER, V93, P299, DOI 10.2522/ptj.20120206; Reviz L, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-30; Ritchie J., 1994, ANAL QUALITATIVE DAT, P173, DOI [10.4324/9780203413081, DOI 10.4324/9780203413081_CHAPTER_9]; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; van de Wetering FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049599; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	24	98	98	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2013	347								f5248	10.1136/bmj.f5248	http://dx.doi.org/10.1136/bmj.f5248			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215NK	24014339	Green Published, hybrid			2022-12-28	WOS:000324216700001
J	Jucker, M; Walker, LC				Jucker, Mathias; Walker, Lary C.			Self-propagation of pathogenic protein aggregates in neurodegenerative diseases	NATURE			English	Review							TO-NEURON TRANSMISSION; CREUTZFELDT-JAKOB-DISEASE; ALPHA-SYNUCLEIN FIBRILS; PRION-LIKE DOMAINS; ALZHEIMERS-DISEASE; AMYLOID STRUCTURE; BETA-DEPOSITION; MOLECULAR-BASIS; TAU INCLUSIONS; SYNTHETIC TAU	For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biology of the prion diseases. Recently, owing largely to the advent of new disease models, this hypothesis has gained experimental momentum. In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid. Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease. Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin. However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function. As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.	[Jucker, Mathias] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; [Jucker, Mathias] German Ctr Neurodegenerat Dis, DZNE, D-72076 Tubingen, Germany; [Walker, Lary C.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Walker, Lary C.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Emory University; Emory University	Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de; lary.walker@emory.edu	Walker, L C/J-6541-2015	Walker, L C/0000-0001-9166-3261; Jucker, Mathias/0000-0001-9045-1072	Competence Network on Degenerative Dementias [BMBF-01GI0705]; ALZKULT [BMBF-031A198A]; NGFN2 [BMBF-01GS08131]; National Institutes of Health [R21AG040589, P51RR165, P51OD11132]; CART Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG040589] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Competence Network on Degenerative Dementias; ALZKULT; NGFN2; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CART Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Eisenberg, H. LeVine, A. Aguzzi, J. Collinge, R. Rosen, Y. Eisele, A. Mehta, M. Gearing, J. Manson, M. Neumann, and the members of our laboratories for critical discussions and comments. The help of H. Braak with Fig. 1, and the help of S. Eberle with the manuscript and figures is gratefully acknowledged. This work was supported by grants from the Competence Network on Degenerative Dementias (BMBF-01GI0705), ALZKULT (BMBF-031A198A), NGFN2 (BMBF-01GS08131), and anonymous foundations (to M. J.), and by National Institutes of Health grants R21AG040589, P51RR165, P51OD11132, and the CART Foundation (to L. C. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; BAKER HF, 1993, INT J EXP PATHOL, V74, P441; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Blancas-Mejia LM, 2013, ANNU REV BIOCHEM, V82, P745, DOI 10.1146/annurev-biochem-072611-130030; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brettschneider J., 2013, ANN NEUROL; Brown P, 2012, EMERG INFECT DIS, V18, P901, DOI 10.3201/eid1806.120116; Buxbaum JN, 2012, J MOL BIOL, V421, P142, DOI 10.1016/j.jmb.2012.01.024; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Cruts M, 2013, TRENDS NEUROSCI, V36, P450, DOI 10.1016/j.tins.2013.04.010; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; DEARMOND SJ, 1995, AM J PATHOL, V146, P785; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dolev I, 2013, NAT NEUROSCI, V16, P587, DOI 10.1038/nn.3376; Eidelberg D, 2011, J CLIN INVEST, V121, P484, DOI 10.1172/JCI45646; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; GAJDUSEK DC, 1994, MOL NEUROBIOL, V8, P1, DOI 10.1007/BF02778003; Gardner RC, 2013, ANN NEUROL, V73, P603, DOI 10.1002/ana.23844; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goldstein L. E., 2012, SCIENCE TRANSL MED, V4; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Guo JL, 2013, FEBS LETT, V587, P717, DOI 10.1016/j.febslet.2013.01.051; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Head MW, 2012, NEUROPATH APPL NEURO, V38, P296, DOI 10.1111/j.1365-2990.2012.01265.x; Heilbronner G., 2013, EMBO REP; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Holmes BB, 2012, CURR OPIN NEUROL, V25, P721, DOI 10.1097/WCO.0b013e32835a3ee0; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Irwin DJ, 2013, JAMA NEUROL, V70, P462, DOI 10.1001/jamaneurol.2013.1933; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kordower JH, 2011, NEUROBIOL DIS, V43, P552, DOI 10.1016/j.nbd.2011.05.001; Korenaga T, 2006, AM J PATHOL, V168, P898, DOI 10.2353/ajpath.2006.050350; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LeVine H, 2010, NEUROBIOL AGING, V31, P542, DOI 10.1016/j.neurobiolaging.2008.05.026; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nath S, 2012, J NEUROSCI, V32, P8767, DOI 10.1523/JNEUROSCI.0615-12.2012; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rosen RF, 2012, J NEUROCHEM, V120, P660, DOI 10.1111/j.1471-4159.2011.07551.x; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; SAPER CB, 1987, NEUROSCIENCE, V23, P389, DOI 10.1016/0306-4522(87)90063-7; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Uversky Vladimir N, 2013, F1000 Biol Rep, V5, P1, DOI 10.3410/B5-1; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wadsworth JDF, 2011, ACTA NEUROPATHOL, V121, P69, DOI 10.1007/s00401-010-0735-5; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yan JM, 2007, AM J PATHOL, V171, P172, DOI 10.2353/ajpath.2007.060576; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004	125	1024	1039	16	590	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					45	51		10.1038/nature12481	http://dx.doi.org/10.1038/nature12481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	24005412	Green Accepted			2022-12-28	WOS:000323888300029
J	Menees, DS; Peterson, ED; Wang, Y; Curtis, JP; Messenger, JC; Rumsfeld, JS; Gurm, HS				Menees, Daniel S.; Peterson, Eric D.; Wang, Yongfei; Curtis, Jeptha P.; Messenger, John C.; Rumsfeld, John S.; Gurm, Hitinder S.			Door-to-Balloon Time and Mortality among Patients Undergoing Primary PCI	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE-MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR DATA REGISTRY; PRIMARY ANGIOPLASTY; REPERFUSION; STRATEGIES; OUTCOMES; QUALITY; TRENDS; ASSOCIATION	BACKGROUND Current guidelines for the treatment of ST-segment elevation myocardial infarction recommend a door-to-balloon time of 90 minutes or less for patients undergoing primary percutaneous coronary intervention (PCI). Door-to-balloon time has become a performance measure and is the focus of regional and national quality-improvement initiatives. However, it is not known whether national improvements in door-to-balloon times have been accompanied by a decline in mortality. METHODS We analyzed annual trends in door-to-balloon times and in-hospital mortality using data from 96,738 admissions for patients undergoing primary PCI for ST-segment elevation myocardial infarction from July 2005 through June 2009 at 515 hospitals participating in the CathPCI Registry. In a subgroup analysis using a linked Medicare data set, we assessed 30-day mortality. RESULTS Median door-to-balloon times declined significantly, from 83 minutes in the 12 months from July 2005 through June 2006 to 67 minutes in the 12 months from July 2008 through June 2009 (P<0.001). Similarly, the percentage of patients for whom the door-to-balloon time was 90 minutes or less increased from 59.7% in the first year to 83.1% in the last year (P<0.001). Despite improvements in door-to-balloon times, there was no significant overall change in unadjusted in-hospital mortality (4.8% in 2005-2006 and 4.7% in 2008-2009, P=0.43 for trend) or in risk-adjusted in-hospital mortality (5.0% in 2005-2006 and 4.7% in 2008-2009, P=0.34), nor was a significant difference observed in unadjusted 30-day mortality (P=0.64). CONCLUSIONS Although national door-to-balloon times have improved significantly for patients undergoing primary PCI for ST-segment elevation myocardial infarction, in-hospital mortality has remained virtually unchanged. These data suggest that additional strategies are needed to reduce in-hospital mortality in this population.	[Menees, Daniel S.; Gurm, Hitinder S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Menees, Daniel S.; Gurm, Hitinder S.] Vet Affairs VA Ann Arbor Hlth Care Syst, Ann Arbor, MI USA; [Peterson, Eric D.] Duke Univ, Durham, NC USA; [Wang, Yongfei; Curtis, Jeptha P.] Yale Univ, New Haven, CT USA; [Messenger, John C.; Rumsfeld, John S.] Univ Colorado, Sch Med, Aurora, CO USA; [Rumsfeld, John S.] Denver VA Med Ctr, Denver, CO USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Duke University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Menees, DS (corresponding author), Univ Michigan, Dept Internal Med, Div Cardiovasc Med, 1500 East Med Ctr Dr,2A396, Ann Arbor, MI 48109 USA.	dmenees@umich.edu	Peterson, Eric David/ABF-5033-2021	Gurm, Hitinder/0000-0002-1646-0218	National Cardiovascular Data Registry of the American College of Cardiology Foundation	National Cardiovascular Data Registry of the American College of Cardiology Foundation	Funded by the National Cardiovascular Data Registry of the American College of Cardiology Foundation.	Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; BERGER PB, 1994, AM J CARDIOL, V73, P231, DOI 10.1016/0002-9149(94)90225-9; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2001, AM J CARDIOL, V88, P1085, DOI 10.1016/S0002-9149(01)02039-2; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; GARCIADORADO D, 1987, CARDIOVASC RES, V21, P537, DOI 10.1093/cvr/21.7.537; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Jacobs AK, 2006, CIRCULATION, V113, P2152, DOI 10.1161/CIRCULATIONAHA.106.174477; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2011, CIRCULATION, V124, P1038, DOI 10.1161/CIRCULATIONAHA.111.044107; Kumbhani DJ, 2009, JAMA-J AM MED ASSOC, V302, P2207, DOI 10.1001/jama.2009.1715; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; *QUALITYNET, SPEC MAN NAT HOSP QU; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; van't Hof AWJ, 2002, EUR HEART J, V23, P510	23	486	505	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					901	909		10.1056/NEJMoa1208200	http://dx.doi.org/10.1056/NEJMoa1208200			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004117	Bronze			2022-12-28	WOS:000323906900007
J	Chow, CK; Teo, KK; Rangarajan, S; Islam, S; Gupta, R; Avezum, A; Bahonar, A; Chifamba, J; Dagenais, G; Diaz, R; Kazmi, K; Lanas, F; Wei, L; Lopez-Jaramillo, P; Lu, FH; Ismail, NH; Puoane, T; Rosengren, A; Szuba, A; Temizhan, A; Wielgosz, A; Yusuf, R; Yusufali, A; Mckee, M; Liu, LS; Mony, P; Yusuf, S				Chow, Clara K.; Teo, Koon K.; Rangarajan, Sumathy; Islam, Shofiqul; Gupta, Rajeev; Avezum, Alvaro; Bahonar, Ahmad; Chifamba, Jephat; Dagenais, Gilles; Diaz, Rafael; Kazmi, Khawar; Lanas, Fernando; Wei, Li; Lopez-Jaramillo, Patricio; Lu Fanghong; Ismail, Noor Hassim; Puoane, Thandi; Rosengren, Annika; Szuba, Andrzej; Temizhan, Ahmet; Wielgosz, Andy; Yusuf, Rita; Yusufali, Afzalhussein; Mckee, Martin; Liu, Lisheng; Mony, Prem; Yusuf, Salim		Pure Prospective Urban Rural	Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRESSURE-RELATED DISEASE; NONPHYSICIAN CLINICIAN; CARDIOVASCULAR RISK; EPIDEMIOLOGY PURE; GLOBAL BURDEN; HEALTH; NUTRITION; AGREEMENT; ADULTS	IMPORTANCE Hypertension is the most important preventable cause of morbidity and mortality globally, yet there are relatively few data collected using standardized methods. OBJECTIVE To examine hypertension prevalence, awareness, treatment, and control in participants at baseline in the Prospective Urban Rural Epidemiology (PURE) study. DESIGN, SETTING, AND PARTICIPANTS A cross-sectional study of 153 996 adults (complete data for this analysis on 142 042) aged 35 to 70 years, recruited between January 2003 and December 2009. Participants were from 628 communities in 3 high-income countries (HIC), 10 upper-middle-income and low-middle-income countries (UMIC and LMIC), and 4 low-income countries (LIC). MAIN OUTCOMES AND MEASURES Hypertension was defined as individuals with self-reported treated hypertension or with an average of 2 blood pressure measurements of at least 140/90 mm Hg using an automated digital device. Awareness was based on self-reports, treatment was based on the regular use of blood pressure-lowering medications, and control was defined as individuals with blood pressure lower than 140/90 mm Hg. RESULTS Among the 142 042 participants, 57 840 (40.8%; 95% CI, 40.5%-41.0%) had hypertension and 26 877 (46.5%; 95% CI, 46.1%-46.9%) were aware of the diagnosis. Of those who were aware of the diagnosis, the majority (23 510 [87.5%; 95% CI, 87.1%-87.9%] of those who were aware) were receiving pharmacological treatments, but only a minority of those receiving treatment were controlled (7634 [32.5%; 95% CI, 31.9%-33.1%]). Overall, 30.8%, 95% CI, 30.2%-31.4% of treated patients were taking 2 or more types of blood pressure-lowering medications. The percentages aware (49.0% [95% CI, 47.8%-50.3%] in HICs, 52.5%[95% CI, 51.8%-53.2%] in UMICs, 43.6%[95% CI, 42.9%-44.2%] in LMICs, and 40.8%[95% CI, 39.9%-41.8%] in LICs) and treated (46.7%[95% CI, 45.5%-47.9%] in HICs, 48.3%, [95% CI, 47.6%-49.1%] in UMICs, 36.9%, [95% CI, 36.3%-37.6%] in LMICs, and 31.7% [95% CI, 30.8%-32.6%] in LICs) were lower in LICs compared with all other countries for awareness (P < .001) and treatment (P < .001). Awareness, treatment, and control of hypertension were higher in urban communities compared with rural ones in LICs (urban vs rural, P < .001) and LMICs (urban vs rural, P < .001), but similar for other countries. Low education was associated with lower rates of awareness, treatment, and control in LICs, but not in other countries. CONCLUSIONS AND RELEVANCE Among a multinational study population, 46.5% of participants with hypertension were aware of the diagnosis, with blood pressure control among 32.5% of those being treated. These findings suggest substantial room for improvement in hypertension diagnosis and treatment.	[Chow, Clara K.; Teo, Koon K.; Rangarajan, Sumathy; Islam, Shofiqul; Yusuf, Salim] Hamilton Hlth Sci & McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Gupta, Rajeev] Fortis Escorts Hosp, JLN Marg, Jaipur, Rajasthan, India; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Bahonar, Ahmad] Univ Med Sci, Cardiovasc Res Inst, Cardiovas Res Ctr, Esfahan, Iran; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Dept Physiol, Harare, Zimbabwe; [Dagenais, Gilles] Univ Heart & Lung Inst, Quebec City, PQ, Canada; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Argentina; [Kazmi, Khawar] Aga Khan Univ, Karachi, Pakistan; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Wei, Li] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Cardiovasc Inst, Beijing 100730, Peoples R China; [Wei, Li] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Lopez-Jaramillo, Patricio] Univ Santander UDES, Direcc Invest, Desarrollo Innovac Tecnol Fundac Oftalmol Santand, Fac Med, Santander, Colombia; [Lu Fanghong] Shandong Acad Med Sci, Jinan, Shandong, Peoples R China; [Ismail, Noor Hassim] Univ Kebangsaan Malaysia, Med Ctr, Dept Community Hlth, Bangi 43600, Malaysia; [Puoane, Thandi] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Szuba, Andrzej] Wroclaw Med Univ, Wroclaw, Poland; [Temizhan, Ahmet] Turkiye Yuksek Ihtisas Training & Res Hosp, Ankara, Turkey; [Wielgosz, Andy] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Yusuf, Rita] Independent Univ, Dhaka, Bangladesh; [Yusufali, Afzalhussein] Dubai Hlth Author, Dubai Heart Ctr, Dubai, U Arab Emirates; [Mckee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Mony, Prem] St Johns Res Inst, Bangalore, Karnataka, India; [Chow, Clara K.] Univ Sydney, Westmead Hosp, Sydney, NSW 2006, Australia; [Chow, Clara K.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia	McMaster University; Population Health Research Institute; Fortis Escorts Hospital; Instituto Dante Pazzanese de Cardiologia; Isfahan University Medical Science; University of Zimbabwe; Quebec Heart & Lung Institute; Aga Khan University; Universidad de La Frontera; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Universidad Industrial de Santander; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Universiti Kebangsaan Malaysia; University of the Western Cape; University of Gothenburg; Wroclaw Medical University; Turkey Specialized Higher Education & Research Hospital; University of Ottawa; Independent University Bangladesh (IUB); University of London; London School of Hygiene & Tropical Medicine; St. John's National Academy of Health Sciences; St. John's Research Institute; University of Sydney; George Institute for Global Health; University of Sydney	Yusuf, S (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, PURE Project Off, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.	pure@phri.ca	Avezum, Alvaro AA/K-6137-2016; Nawawi, Hapizah Mohd/J-8873-2019; Mckee, Martin/E-6673-2018; Ramli, Anis Safura/U-3548-2018; Nawawi, Hapizah/N-7446-2019; Szuba, Andrzej/AAY-1162-2020; McKee, Marc D/E-2187-2011; Avezum, Alvaro/AAP-7687-2020; Nor-Ashikin, Mohamed Noor Khan/P-2055-2015; Bahonar, Ahmad/Q-7698-2019; Lanas, Fernando/AAE-8842-2022; Igumbor, Ehimario U/B-2652-2012; Kelishadi, Roya/E-6154-2012; Chifamba, Jephat/AHE-4535-2022; Ramli, Anis Safura/K-3322-2014; Mony, Prem K./GRF-4752-2022; Rozanska, Dorota/S-5239-2018; Corsi, Daniel J/S-4689-2018; Gomez-Arbelaez, Diego/K-1883-2013	Avezum, Alvaro AA/0000-0002-3073-6890; Nawawi, Hapizah Mohd/0000-0003-4462-8484; Mckee, Martin/0000-0002-0121-9683; Ramli, Anis Safura/0000-0002-9517-1413; Nawawi, Hapizah/0000-0003-4462-8484; McKee, Marc D/0000-0001-8349-965X; Nor-Ashikin, Mohamed Noor Khan/0000-0002-1325-9236; Igumbor, Ehimario U/0000-0002-6313-6031; Kelishadi, Roya/0000-0001-7455-1495; Chifamba, Jephat/0000-0001-8166-1182; Ramli, Anis Safura/0000-0002-9517-1413; Mony, Prem K./0000-0002-1399-0520; Szuba, Andrzej/0000-0002-7555-6201; Yusuf, Salim/0000-0003-4776-5601; Yusuf, Rita/0000-0002-0151-9571; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Rozanska, Dorota/0000-0002-0561-2749; Regulska-Ilow, Bozena/0000-0002-5941-1715; Corsi, Daniel J/0000-0001-7063-3354; Lanas, Fernando/0000-0003-3595-9759; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Yusufali, Afzalhussein/0000-0003-3378-2646; Teo, Koon/0000-0002-3731-0956; Gulec, Sadi/0000-0002-2685-2522; Jerling, Johann/0000-0003-2600-3536; Rosengren, Annika/0000-0002-5409-6605; Zatonska, Katarzyna/0000-0002-3772-5588; Wolyniec, Maria/0000-0003-2054-1691; Levitt, Naomi/0000-0001-6480-8066; Ismail, Noor Hassim/0000-0003-1547-7904	Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario; AstraZeneca [Sweden]; AstraZeneca [Canada]; Novartis; Sanofi [France]; Sanofi [Canada]; Boehringer Ingelheim [Germany]; Boehringer Ingelheim [Canada]; Servier; King Pharma; GlaxoSmithKline; Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil; Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Universidad de la Frontera; National Center for Cardiovascular Diseases; Colciencias [6566-04-18062]; Indian Council of Medical Research; Ministry of Science, Technology and Innovation of Malaysia [07-05-IFN-MEB010]; Universiti Teknologi MARA; Universiti Kebangsaan Malaysia [UKM-Hejim-Komuniti-15-2010]; Polish Ministry of Science and Higher Education [290/W-PURE/2008/0]; Wroclaw Medical University; North-West University; SANPAD (SA and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of SA; SA Sugar Association (SASA); Faculty of Community and Health Sciences (UWC); Swedish Council for Working Life and Social Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Heart and Lung Foundation; Swedish Research Council; Swedish State under LUA Agreement; Vastra Gotaland Region (FOUU); Metabolic Syndrome Society; AstraZeneca, Turkey; Sanofi, Turkey; Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences; Dubai Health Authority, Dubai UAE	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario; AstraZeneca [Sweden](AstraZeneca); AstraZeneca [Canada](AstraZeneca); Novartis(Novartis); Sanofi [France](Sanofi-Aventis); Sanofi [Canada](Sanofi-Aventis); Boehringer Ingelheim [Germany](Boehringer Ingelheim); Boehringer Ingelheim [Canada](Boehringer Ingelheim); Servier(Servier); King Pharma; GlaxoSmithKline(GlaxoSmithKline); Independent University, Bangladesh; Mitra and Associates; Unilever Health Institute, Brazil; Public Health Agency of Canada; Champlain Cardiovascular Disease Prevention Network; Universidad de la Frontera; National Center for Cardiovascular Diseases; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Ministry of Science, Technology and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Teknologi MARA; Universiti Kebangsaan Malaysia; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Wroclaw Medical University; North-West University; SANPAD (SA and Netherlands Programme for Alternative Development); National Research Foundation; Medical Research Council of SA; SA Sugar Association (SASA); Faculty of Community and Health Sciences (UWC); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish State under LUA Agreement; Vastra Gotaland Region (FOUU); Metabolic Syndrome Society; AstraZeneca, Turkey(AstraZeneca); Sanofi, Turkey(Sanofi-Aventis); Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences; Dubai Health Authority, Dubai UAE	The PURE study is an investigator-initiated study that is funded through a variety of sources including the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, grants from several pharmaceutical companies, and grants from various governmental bodies in different countries. Dr S Yusuf is supported by the Mary W Burke endowed chair of the Heart and Stroke Foundation of Ontario. The PURE study is an investigator-initiated study that is funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario and through unrestricted grants from several pharmaceutical companies (with major contributions from AstraZeneca [Sweden and Canada], Novartis, Sanofi [France and Canada], Boehringer Ingelheim [Germany and Canada], Servier, King Pharma, GlaxoSmithKline), and additionally by various national bodies in different countries: Bangladesh: Independent University, Bangladesh, Mitra and Associates; Brazil: Unilever Health Institute, Brazil Canada: Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de la Frontera; China: National Center for Cardiovascular Diseases; Colombia: Colciencias, Grant number: 6566-04-18062; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology and Innovation of Malaysia: Grant Number 07-05-IFN-MEB010, Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010); Poland: Polish Ministry of Science and Higher Education grant Nr 290/W-PURE/2008/0, Wroclaw Medical University; South Africa: The North-West University, SANPAD (SA and Netherlands Programme for Alternative Development), National Research Foundation, Medical Research Council of SA, The SA Sugar Association (SASA), Faculty of Community and Health Sciences (UWC); Sweden: Swedish Council for Working Life and Social Research, Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Heart and Lung Foundation, Swedish Research Council, Grant from the Swedish State under LUA Agreement, Grant from the Vastra Gotaland Region (FOUU); Turkey: Metabolic Syndrome Society, AstraZeneca, Turkey, Sanofi, Turkey; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences, Dubai Health Authority, Dubai UAE.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; Ahmad OB, 2000, 31 WHO GPE HLTH POL; Axon RN, 2009, J AM SOC HYPERTENS, V3, P35, DOI 10.1016/j.jash.2008.08.005; Bergstrom S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2499; Chow CK, 2009, AM HEART J, V158, P349, DOI 10.1016/j.ahj.2009.05.034; Cushman WC, 2002, J CLIN HYPERTENS GRE, V4, P393; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gaziano TA, 2011, LANCET, V378, P1199, DOI 10.1016/S0140-6736(11)61299-3; Gee ME, 2012, CAN J CARDIOL, V28, P383, DOI 10.1016/j.cjca.2012.01.014; Gupta R, 2012, J HUM HYPERTENS, V26, P585, DOI 10.1038/jhh.2011.79; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; He J, 2009, LANCET, V374, P1765, DOI 10.1016/S0140-6736(09)61199-5; Joshi R, 2012, J AM COLL CARDIOL, V59, P1188, DOI 10.1016/j.jacc.2011.10.901; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; MacMahon S, 2008, LANCET, V371, P1480, DOI 10.1016/S0140-6736(08)60632-7; Mbalilaki JA, 2010, BRIT J SPORT MED, V44, P121, DOI 10.1136/bjsm.2007.044966; Morris JN, 1976, USES EPIDEMIOLOGY; Oksanen T, 2010, ANN EPIDEMIOL, V20, P547, DOI 10.1016/j.annepidem.2010.03.017; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Prince MJ, 2012, J HYPERTENS, V30, P177, DOI 10.1097/HJH.0b013e32834d9eda; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Vasan A, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-75; Wilhelm TJ, 2011, TROP DOCT, V41, P71, DOI 10.1258/td.2010.100272; World Bank, WE CLASS COUNTR; World Health Organisation, 2005, SURF REP 2 SURV CHRO; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2012, WHO STUD GLOB AGEING; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zaman MJ, 2012, INT J EPIDEMIOL, V41, P1302, DOI 10.1093/ije/dyr226	35	1077	1137	4	123	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					959	968		10.1001/jama.2013.184182	http://dx.doi.org/10.1001/jama.2013.184182			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002282	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000323885700026
J	Graves, B				Graves, Bill			HEALTHCARE SYSTEMS Lower costs and better outcomes: a system of care built on relationships	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												billgraves1@frontier.com							0	5	5	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 30	2013	347								f5301	10.1136/bmj.f5301	http://dx.doi.org/10.1136/bmj.f5301			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CL	23996151				2022-12-28	WOS:000323881600018
J	Marco, E; Dorn, JF; Hsu, PH; Jaqaman, K; Sorger, PK; Danuser, G				Marco, Eugenio; Dorn, Jonas F.; Hsu, Pei-hsin; Jaqaman, Khuloud; Sorger, Peter K.; Danuser, Gaudenz			S. cerevisiae Chromosomes Biorient via Gradual Resolution of Syntely between S Phase and Anaphase	CELL			English	Article							KINETOCHORE-MICROTUBULE ATTACHMENT; SPINDLE POLE BODY; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; PROTEIN-KINASE; BI-ORIENTATION; DYNAMICS; METAPHASE; SEGREGATION	Following DNA replication, eukaryotic cells must biorient all sister chromatids prior to cohesion cleavage at anaphase. In animal cells, sister chromatids gradually biorient during prometaphase, but current models of mitosis in S. cerevisiae assume that biorientation is established shortly after S phase. This assumption is based on the observation of a bilobed distribution of yeast kinetochores early in mitosis and suggests fundamental differences between yeast mitosis and mitosis in animal cells. By applying super-resolution imaging methods, we show that yeast and animal cells share the key property of gradual and stochastic chromosome biorientation. The characteristic bilobed distribution of yeast kinetochores, hitherto considered synonymous for biorientation, arises from kinetochores in mixed attachment states to microtubules, the length of which discriminates bioriented from syntelic attachments. Our results offer a revised view of mitotic progression in S. cerevisiae that augments the relevance of mechanistic information obtained in this powerful genetic system for mammalian mitosis.	[Marco, Eugenio; Hsu, Pei-hsin; Danuser, Gaudenz] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Marco, Eugenio; Jaqaman, Khuloud; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Dorn, Jonas F.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Universite de Montreal	Danuser, G (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	gaudenz_danuser@hms.harvard.edu	Marco, Eugenio/F-4583-2011	Jaqaman, Khuloud/0000-0003-3471-1911; Marco, Eugenio/0000-0002-3675-263X; Danuser, Gaudenz/0000-0001-8583-2014; Dorn, Jonas/0000-0001-6696-0117; Sorger, Peter/0000-0002-3364-1838	NIH [R01 GM068956]; Human Frontier Science Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068956] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Warsi, E. Gillett, M. C. Hou, M. Niepel, S. Ventz, A. W. Murray, D. Needleman, and L. Serrano for discussions. E. M. gratefully acknowledges Guo-Cheng Yuan for his encouragement. This work was funded by the grant NIH R01 GM068956 to P. K. S. and G. D. E. M. was supported in part by a long-term fellowship from the Human Frontier Science Program.	Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; CHAN CSM, 1993, GENETICS, V135, P677; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Geiser JR, 1997, MOL BIOL CELL, V8, P1035, DOI 10.1091/mbc.8.6.1035; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Indjeian VB, 2007, CURR BIOL, V17, P1837, DOI 10.1016/j.cub.2007.09.056; Jaqaman K, 2006, BIOPHYS J, V91, P2312, DOI 10.1529/biophysj.106.080333; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Kitagawa K, 2001, NAT REV MOL CELL BIO, V2, P678, DOI 10.1038/35089568; Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870; Maure JF, 2007, CURR BIOL, V17, P2175, DOI 10.1016/j.cub.2007.11.032; MAYER VW, 1990, MUTAT RES, V231, P177, DOI 10.1016/0027-5107(90)90024-X; Meyer RE, 2013, SCIENCE, V339, P1071, DOI 10.1126/science.1232518; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pearson CG, 2001, J CELL BIOL, V152, P1255, DOI 10.1083/jcb.152.6.1255; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; RINES D, 2004, LIVE CELL IMAGING LA, P631; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435; Sprague BL, 2003, BIOPHYS J, V84, P3529, DOI 10.1016/S0006-3495(03)75087-5; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Thomann D, 2003, J MICROSC-OXFORD, V211, P230, DOI 10.1046/j.1365-2818.2003.01223.x; Thomann D, 2002, J MICROSC-OXFORD, V208, P49, DOI 10.1046/j.1365-2818.2002.01066.x; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tytell JD, 2006, J CELL BIOL, V172, P861, DOI 10.1083/jcb.200509101; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415	49	20	21	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1127	1139		10.1016/j.cell.2013.08.008	http://dx.doi.org/10.1016/j.cell.2013.08.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993100	Bronze, Green Accepted			2022-12-28	WOS:000323767300024
J	Weeds, A				Weeds, Alan			Hugh Huxley (1924-2013) OBITUARY	NATURE			English	Biographical-Item									[Weeds, Alan] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Weeds, Alan] Univ Cambridge, Trinity Coll, Cambridge CB2 1TN, England	MRC Laboratory Molecular Biology; University of Cambridge		agw22@cam.ac.uk						HUXLEY HE, PUBLICATION LIST	1	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					530	530		10.1038/500530a	http://dx.doi.org/10.1038/500530a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23985864	Bronze			2022-12-28	WOS:000323625900018
J	DeLoughery, T				DeLoughery, Thomas			Warfarin continuation was better than heparin bridging during pacemaker or ICD surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT		Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	DeLoughery, T (corresponding author), Oregon Hlth & Sci Univ, Portland, OR 97201 USA.							Baron TH, 2013, NEW ENGL J MED, V368, P2113, DOI 10.1056/NEJMra1206531; Rhodes DA, 2010, CLIN ORTHOP RELAT R, V468, P120, DOI 10.1007/s11999-009-1128-8; Tafur AJ, 2012, J THROMB HAEMOST, V10, P261, DOI 10.1111/j.1538-7836.2011.04572.x	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC7	10.7326/0003-4819-159-4-201308200-02007	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026283				2022-12-28	WOS:000323421700006
J	Batterman, SA; Hedin, LO; van Breugel, M; Ransijn, J; Craven, DJ; Hall, JS				Batterman, Sarah A.; Hedin, Lars O.; van Breugel, Michiel; Ransijn, Johannes; Craven, Dylan J.; Hall, Jefferson S.			Key role of symbiotic dinitrogen fixation in tropical forest secondary succession	NATURE			English	Article							NITROGEN-FIXATION; PHOSPHORUS LIMITATION; BIOMASS; DYNAMICS; GROWTH; LAND	Forests contribute a significant portion of the land carbon sink, but their ability to sequester CO2 may be constrained by nitrogen(1-6), a major plant-limiting nutrient. Many tropical forests possess tree species capable of fixing atmospheric dinitrogen (N-2)(7), but it is unclear whether this functional group can supply the nitrogen needed as forests recover from disturbance or previous land use(1), or expand in response to rising CO2 (refs 6, 8). Here we identify a powerful feedback mechanism in which N-2 fixation can overcome ecosystem-scale deficiencies in nitrogen that emerge during periods of rapid biomass accumulation in tropical forests. Over a 300-year chronosequence in Panama, N-2-fixing tree species accumulated carbon up to nine times faster per individual than their non-fixing neighbours (greatest difference in youngest forests), and showed species-specific differences in the amount and timing of fixation. As a result of fast growth and high fixation, fixers provided a large fraction of the nitrogen needed to support net forest growth (50,000 kg carbon per hectare) in the first 12 years. A key element of ecosystem functional diversity was ensured by the presence of different N-2-fixing tree species across the entire forest age sequence. These findings show that symbiotic N-2 fixation can have a central role in nitrogen cycling during tropical forest stand development, with potentially important implications for the ability of tropical forests to sequester CO2.	[Batterman, Sarah A.; Hedin, Lars O.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [van Breugel, Michiel; Hall, Jefferson S.] Smithsonian Trop Res Inst, Panama City, Panama; [Ransijn, Johannes] Wageningen Univ, Ctr Ecosyst Studies, Forest Ecol & Forest Management Grp, NL-6700 AA Wageningen, Netherlands; [Ransijn, Johannes] Univ Copenhagen, Dept Geosci & Nat Resource Management, DK-1958 Frederiksberg C, Denmark; [Craven, Dylan J.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Princeton University; Smithsonian Institution; Smithsonian Tropical Research Institute; Wageningen University & Research; University of Copenhagen; Yale University	Batterman, SA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	sbatterm@princeton.edu	Ransijn, Johannes/D-5324-2015; Craven, Dylan/K-2717-2012; van Breugel, Michiel/A-8453-2017	Ransijn, Johannes/0000-0003-0416-2210; Craven, Dylan/0000-0003-3940-833X; van Breugel, Michiel/0000-0003-2778-7803; Batterman, Sarah/0000-0002-7703-9873	National Science Foundation (NSF) [DEB-0614116]; National Oceanic and Atmospheric Association (NOAA) [NA17RJ262-344]; Cooperative Institute for Climate Science of Princeton University; Carbon Mitigation Initiative of Princeton University; Smithsonian Tropical Research Institute (STRI); HSBC; STRI; Frank Levinson Family Foundation; Motta Family Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Association (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); Cooperative Institute for Climate Science of Princeton University; Carbon Mitigation Initiative of Princeton University(Princeton University); Smithsonian Tropical Research Institute (STRI)(Smithsonian InstitutionSmithsonian Tropical Research Institute); HSBC; STRI(Smithsonian InstitutionSmithsonian Tropical Research Institute); Frank Levinson Family Foundation; Motta Family Foundation	We thank S. Adelberg and K. Zelazny for assisting with data collection, M. Baillon and A. Hernandez for botanical identifications, N. Wurzburger and A. Barron for species-specific N<INF>2</INF> fixation rates, J. Sprent for advice about N<INF>2</INF>-fixing trees and P. Reich for comments. This work was supported by grants to L.O.H. from the National Science Foundation (NSF; DEB-0614116), the National Oceanic and Atmospheric Association (NOAA; grant NA17RJ262-344), the Cooperative Institute for Climate Science of Princeton University and the Carbon Mitigation Initiative of Princeton University; and to S. A. B. from the Smithsonian Tropical Research Institute (STRI). It is a contribution to the Agua Salud Project (ASP), a collaboration among STRI, the Panama Canal Authority (ACP) and the National Environmental Authority of Panama (ANAM). ASP funding came from the HSBC climate partnership, STRI, the Frank Levinson Family Foundation, the Motta Family Foundation and an anonymous donor.	Amazonas NT, 2011, FOREST ECOL MANAG, V262, P1551, DOI 10.1016/j.foreco.2011.07.003; Barron AR, 2011, OECOLOGIA, V165, P511, DOI 10.1007/s00442-010-1838-3; Barron AR, 2009, NAT GEOSCI, V2, P42, DOI 10.1038/NGEO366; BARRON AR, 2007, THESIS PRINCETON U; Batterman S. A., 2002, J ECOLOGY IN PRESS; Binkley D, 2003, FOREST ECOL MANAG, V186, P171, DOI 10.1016/S0378-1127(03)00240-8; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; Chave J, 2004, PHILOS T R SOC B, V359, P409, DOI 10.1098/rstb.2003.1425; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Craven D. J., 2012, THESIS YALE U; Davidson EA, 2004, ECOL APPL, V14, pS150; Davidson EA, 2007, NATURE, V447, P995, DOI 10.1038/nature05900; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; Gehring C, 2005, AGR ECOSYST ENVIRON, V111, P237, DOI 10.1016/j.agee.2005.06.009; Gerber S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003336; Goll DS, 2012, BIOGEOSCIENCES, V9, P3547, DOI 10.5194/bg-9-3547-2012; Hassler SK, 2011, FOREST ECOL MANAG, V261, P1634, DOI 10.1016/j.foreco.2010.06.031; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Houghton RA, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000935; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Martin AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023533; MARTIUS C, 1992, HOLZ ROH WERKST, V50, P300, DOI 10.1007/BF02615357; Menge DNL, 2009, ECOLOGY, V90, P2190, DOI 10.1890/08-0877.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Neumann-Cosel L, 2011, FOREST ECOL MANAG, V261, P1625, DOI 10.1016/j.foreco.2010.07.023; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; Russell AE, 2012, P NATL ACAD SCI USA, V109, P10398, DOI 10.1073/pnas.1204157109; Sprent J.I., 2009, LEGUME NODULATION GL; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wolf A, 2011, ECOL APPL, V21, P1546, DOI 10.1890/10-1201.1; Yang X, 2010, BIOGEOSCIENCES, V7, P3041, DOI 10.5194/bg-7-3041-2010; Zaehle S, 2011, CURR OPIN ENV SUST, V3, P311, DOI 10.1016/j.cosust.2011.08.008	40	220	224	8	309	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					224	+		10.1038/nature12525	http://dx.doi.org/10.1038/nature12525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24037375				2022-12-28	WOS:000325436100048
J	Abramson, SB; Jacob, D; Rosenfeld, M; Buckvar-Keltz, L; Harnik, V; Francois, F; Rivera, R; Hopkins, MA; Triola, M; Grossman, RI				Abramson, Steven B.; Jacob, Dianna; Rosenfeld, Melvin; Buckvar-Keltz, Lynn; Harnik, Victoria; Francois, Fritz; Rivera, Rafael; Hopkins, Mary Ann; Triola, Marc; Grossman, Robert I.			BECOMING A PHYSICIAN A 3-Year M.D. - Accelerating Careers, Diminishing Debt	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICAL-EDUCATION	In recent decades, the length of medical training has increased, slowing the entry of new physicians into practice. Experiments with 3-year medical schools, like the one at New York University, attempt to address this delay. It's been more than 100 years since Abraham Flexner proposed the current model for medical education in North America: 2 years of basic science instruction followed by 2 years of clinical experience.(1) Over the past several decades, major changes have caused the medical community to reconsider current educational models. These changes include increasing education costs, shifts in health care needs, the demographics of the applicant pool, and many scientific, pharmacologic, and technological advances resulting in increased specialization of physicians. Oversight of U.S. medical education is compartmentalized, with standards independently set for undergraduate and graduate accreditation by the Liaison Committee on ...	[Abramson, Steven B.; Jacob, Dianna; Rosenfeld, Melvin; Buckvar-Keltz, Lynn; Harnik, Victoria; Francois, Fritz; Rivera, Rafael; Hopkins, Mary Ann; Triola, Marc; Grossman, Robert I.] NYU Langone Med Ctr, New York, NY USA	NYU Langone Medical Center	Abramson, SB (corresponding author), NYU Langone Med Ctr, New York, NY USA.			Francois, Fritz/0000-0003-4491-2637; Triola, Marc/0000-0002-6303-3112; Abramson, Steven/0000-0002-0668-6344; Harnik, Victoria/0000-0002-1781-0320; hopkins, mary ann/0000-0001-5037-0315				Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P1143, DOI 10.1001/jama.2012.292; Greysen SR, 2011, ACAD MED, V86, P840, DOI 10.1097/ACM.0b013e31821daf03; Irby DM, 2010, ACAD MED, V85, P220, DOI 10.1097/ACM.0b013e3181c88449; Krupka C., 2012, AM MED NEWS; Smart DR, 2013, PHYS CHARACTERISTICS	5	48	48	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1085	1087		10.1056/NEJMp1304681	http://dx.doi.org/10.1056/NEJMp1304681			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047055				2022-12-28	WOS:000324554800002
J	Lancaster, MA; Renner, M; Martin, CA; Wenzel, D; Bicknell, LS; Hurles, ME; Homfray, T; Penninger, JM; Jackson, AP; Knoblich, JA				Lancaster, Madeline A.; Renner, Magdalena; Martin, Carol-Anne; Wenzel, Daniel; Bicknell, Louise S.; Hurles, Matthew E.; Homfray, Tessa; Penninger, Josef M.; Jackson, Andrew P.; Knoblich, Juergen A.			Cerebral organoids model human brain development and microcephaly	NATURE			English	Article							EMBRYONIC STEM-CELLS; OUTER SUBVENTRICULAR ZONE; SPINDLE ORIENTATION; HUMAN NEOCORTEX; IN-VITRO; MAMMALIAN NEUROGENESIS; 3-DIMENSIONAL CULTURE; EXTRINSIC SIGNALS; MOUSE NEOCORTEX; SELF-FORMATION	The complexity of the human brain has made it difficult to study many brain disorders in model organisms, highlighting the need for an in vitro model of human brain development. Here we have developed a human pluripotent stem cell-derived three-dimensional organoid culture system, termed cerebral organoids, that develop various discrete, although interdependent, brain regions. These include a cerebral cortex containing progenitor populations that organize and produce mature cortical neuron subtypes. Furthermore, cerebral organoids are shown to recapitulate features of human cortical development, namely characteristic progenitor zone organization with abundant outer radial glial stem cells. Finally, we use RNA interference and patient-specific induced pluripotent stem cells to model microcephaly, a disorder that has been difficult to recapitulate in mice. We demonstrate premature neuronal differentiation in patient organoids, a defect that could help to explain the disease phenotype. Together, these data show that three-dimensional organoids can recapitulate development and disease even in this most complex human tissue.	[Lancaster, Madeline A.; Renner, Magdalena; Wenzel, Daniel; Penninger, Josef M.; Knoblich, Juergen A.] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Martin, Carol-Anne; Bicknell, Louise S.; Jackson, Andrew P.] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Homfray, Tessa] St Georges Univ, Dept Clin Genet, London SW17 0RE, England	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Edinburgh; Wellcome Trust Sanger Institute; St Georges University London	Knoblich, JA (corresponding author), Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Bicknell, Louise/GLR-4215-2022; Penninger, Josef M/I-6860-2013; Bicknell, Louise/AAL-8003-2020; Knoblich, Juergen A/C-2974-2015; Jackson, Andrew/D-3442-2009	Bicknell, Louise/0000-0001-6899-9322; Penninger, Josef M/0000-0002-8194-3777; Knoblich, Juergen A/0000-0002-6751-3404; Martin, Carol-Anne/0000-0001-5914-2757; Lancaster, Madeline/0000-0003-2324-8853; Jackson, Andrew/0000-0002-8739-2646	Wellcome Trust [WT098051]; Austrian Academy of Sciences; Austrian Science Fund (FWF) [Z153-B09, I552-B19]; ERC; EMBO; Helen Hay Whitney; Medical Research Council; European Research Council (ERC); Lister Institute for Preventative Medicine; Austrian Science Fund (FWF) [Z 153] Funding Source: researchfish; Medical Research Council [MC_PC_U127580972] Funding Source: researchfish; MRC [MC_PC_U127580972] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ERC(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Helen Hay Whitney; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Lister Institute for Preventative Medicine; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to members of the Knoblich laboratory for technical expertise and feedback, A. Peer, P. Moeseneder and N. Corsini for experimental support and M. Repic for help with establishing organoid electroporations. We also thank the Stem Cell and BioOptics core facilities of IMBA/IMP for technical support. We would especially like to thank the patients and their families for participating in this study. We would also like to thank S. McGurk for providing control MRI images. M. A. L. received funding from an EMBO post-doctoral fellowship and a Helen Hay Whitney post-doctoral fellowship. Work in A.P.J.'s laboratory is supported by the Medical Research Council, a starter grant from the European Research Council (ERC) and the Lister Institute for Preventative Medicine. This research was also supported in part by Wellcome Trust grant WT098051. Work in J.A.K.'s laboratory is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF) (projects Z153-B09 and I552-B19) and an advanced grant from ERC.	Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Chedotal A, 2011, CURR OPIN NEUROBIOL, V21, P68, DOI 10.1016/j.conb.2010.07.008; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006; Danjo T, 2011, J NEUROSCI, V31, P1919, DOI 10.1523/JNEUROSCI.5128-10.2011; DECARLOS JA, 1992, J NEUROSCI, V12, P1194; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; LaMonica BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2647; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007; Muguruma K, 2010, NAT NEUROSCI, V13, P1171, DOI 10.1038/nn.2638; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pagnamenta AT, 2012, AM J MED GENET A, V158A, P2577, DOI 10.1002/ajmg.a.35558; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shafit-Zagardo B, 1998, MOL NEUROBIOL, V16, P149, DOI 10.1007/BF02740642; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; SMART IHM, 1973, J ANAT, V116, P67; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; SWANSON LW, 1995, TRENDS NEUROSCI, V18, P471, DOI 10.1016/0166-2236(95)92766-J; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tremml G., 2008, CURR PROTOC STEM CEL, V1; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Willardsen MI, 2011, DEV DYNAM, V240, P1865, DOI 10.1002/dvdy.22684; Xia Xiaofeng, 2009, V549, P51, DOI 10.1007/978-1-60327-931-4_4; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; ZAMENHOF S, 1987, DEV BRAIN RES, V31, P143, DOI 10.1016/0165-3806(87)90094-0; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714	53	2486	2584	66	857	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					373	+		10.1038/nature12517	http://dx.doi.org/10.1038/nature12517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23995685	Green Accepted			2022-12-28	WOS:000324545700036
J	Chang, SS; Stuckler, D; Yip, P; Gunnell, D				Chang, Shu-Sen; Stuckler, David; Yip, Paul; Gunnell, David			Impact of 2008 global economic crisis on suicide: time trend study in 54 countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RATES; HEALTH; RECESSION; MORTALITY; EUROPE; UNEMPLOYMENT; ENGLAND; WELFARE; WORLD; MEN	Objective To investigate the impact of the 2008 global economic crisis on international trends in suicide and to identify sex/age groups and countries most affected. Design Time trend analysis comparing the actual number of suicides in 2009 with the number that would be expected based on trends before the crisis (2000-07). Setting Suicide data from 54 countries; for 53 data were available in the World Health Organization mortality database and for one (the United States) data came the CDC online database. Population People aged 15 or above. Main outcome measures Suicide rate and number of excess suicides in 2009. Results There were an estimated 4884 (95% confidence interval 3907 to 5860) excess suicides in 2009 compared with the number expected based on previous trends (2000-07). The increases in suicide mainly occurred in men in the 27 European and 18 American countries; the suicide rates were 4.2% (3.4% to 5.1%) and 6.4% (5.4% to 7.5%) higher, respectively, in 2009 than expected if earlier trends had continued. For women, there was no change in European countries and the increase in the Americas was smaller than in men (2.3%). Rises in European men were highest in those aged 15-24 (11.7%), while in American countries men aged 45-64 showed the largest increase (5.2%). Rises in national suicide rates in men seemed to be associated with the magnitude of increases in unemployment, particularly in countries with low levels of unemployment before the crisis (Spearman's r(s)=0.48). Conclusions After the 2008 economic crisis, rates of suicide increased in the European and American countries studied, particularly in men and in countries with higher levels of job loss.	[Chang, Shu-Sen; Yip, Paul] Univ Hong Kong, HKJC Ctr Suicide Res & Prevent, Hong Kong Jockey Club Bldg Interdisciplinary Res, Pokfulam, Hong Kong, Peoples R China; [Chang, Shu-Sen; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Chang, Shu-Sen] Ju Shan Hosp, Tao Yuan, Taiwan; [Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England; [Stuckler, David] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Yip, Paul] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Bristol; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Hong Kong	Chang, SS (corresponding author), Univ Hong Kong, HKJC Ctr Suicide Res & Prevent, Hong Kong Jockey Club Bldg Interdisciplinary Res, 5 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	shusen.chang@gmail.com	Gunnell, David/ABE-6653-2020; Chang, Shu-Sen/AAH-6733-2021; Chang, Shu-Sen/B-3518-2012	Gunnell, David/0000-0002-0829-6470; Chang, Shu-Sen/0000-0001-5012-1132; Chang, Shu-Sen/0000-0001-5012-1132; Stuckler, David/0000-0002-1288-8401	Hong Kong Research Grants Council (RCG) [HKU784210M, HKU784012M]; University of Hong Kong [201203159017]; European Research Council; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish	Hong Kong Research Grants Council (RCG)(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); European Research Council(European Research Council (ERC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. S-SC is supported by the Hong Kong Research Grants Council (RCG) general research fund (grants HKU784210M and HKU784012M) and a grant from the University of Hong Kong (Project Code 201203159017). DS is funded by a European Research Council investigator award. DG is a UK National Institute for Health Research senior investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2000, GPE DISCUSS PAP SER; [Anonymous], WORLD EC OUTL DAT; [Anonymous], COMP MACR CONT REG G; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Brainerd E, 2001, EUR ECON REV, V45, P1007, DOI 10.1016/S0014-2921(01)00108-8; Brock A, 2003, HLTH STAT Q, V20, P7; Centers for Disease Control and Prevention, CDC WONDER ONL DAT C; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P321; Chang SS, 2010, PUBLIC HEALTH, V124, P49, DOI 10.1016/j.puhe.2009.11.005; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Crawford MJ, 2010, J EPIDEMIOL COMMUN H, V64, P530, DOI 10.1136/jech.2008.084145; De Vogli R, 2013, J EPIDEMIOL COMMUN H, V67, DOI 10.1136/jech-2012-201607; Economou M., 2012, J AFFECT DISORDERS, V145, P3018; Eurostat European Comission, UN STAT; Gavrilova NS, 2000, POPUL RES POLICY REV, V19, P397, DOI 10.1023/A:1010621601409; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Granados JAT, 2005, INT J EPIDEMIOL, V34, P1194, DOI 10.1093/ije/dyi141; Granados JAT, 2009, P NATL ACAD SCI USA, V106, P17290, DOI 10.1073/pnas.0904491106; Gunnell D, 2003, SOC SCI MED, V57, P595, DOI 10.1016/S0277-9536(02)00408-2; International Labour Organization, ILO GLOB EMPL TRENDS; Kapusta ND, 2011, ARCH GEN PSYCHIAT, V68, P1050, DOI 10.1001/archgenpsychiatry.2011.66; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Katikireddi SV, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001790; Lee S, 2010, J AFFECT DISORDERS, V126, P125, DOI 10.1016/j.jad.2010.03.007; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Luo FJ, 2011, AM J PUBLIC HEALTH, V101, P1139, DOI 10.2105/AJPH.2010.300010; Maki N, 2012, J EPIDEMIOL COMMUN H, V66, P302, DOI 10.1136/jech.2009.105908; MARTUZZI M, 1995, AM J EPIDEMIOL, V141, P369, DOI 10.1093/aje/141.4.369; MORRELL S, 1993, SOC SCI MED, V36, P749, DOI 10.1016/0277-9536(93)90035-3; Ohberg A, 1998, ACTA PSYCHIAT SCAND, V98, P214, DOI 10.1111/j.1600-0447.1998.tb10069.x; Platt S, 2000, INT HDB SUICIDE ATTE, P310, DOI DOI 10.1002/9780470698976.CH20; Rancans E, 2001, ACTA PSYCHIAT SCAND, V103, P275, DOI 10.1034/j.1600-0447.2001.00007.x; Reeves A, 2012, LANCET, V380, P1813, DOI 10.1016/S0140-6736(12)61910-2; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; Shi ZM, 2011, INT J PUBLIC HEALTH, V56, P367, DOI 10.1007/s00038-010-0200-1; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Stuckler D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3311; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; SWINSCOW D, 1951, BRIT MED J, V1, P1417, DOI 10.1136/bmj.1.4720.1417; United Nations Population Division, WORLD POP PROSP 2010; Varnik P, 2012, INT J ENV RES PUB HE, V9, P760, DOI 10.3390/ijerph9030760; World Health Organization, 2009, FIN CRIS GLOB HLTH R; World Health Organization Statistical Information System, WHO MORT DAT; Zimmerman SL, 2002, J NERV MENT DIS, V190, P349, DOI 10.1097/00005053-200206000-00001	45	386	392	6	69	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2013	347								f5239	10.1136/bmj.f5239	http://dx.doi.org/10.1136/bmj.f5239			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	223SB	24046155	Green Published, hybrid			2022-12-28	WOS:000324828300001
J	Kauffman, RP				Kauffman, Robert P.			Review: Levonorgestrel IU system, OCPs, and antifibrinolytics each reduce bleeding in endometrial dysfunction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Texas Tech Univ, HSC Sch Med, Amarillo, TX USA	Texas Tech University System; Texas Tech University	Kauffman, RP (corresponding author), Texas Tech Univ, HSC Sch Med, Amarillo, TX USA.							CLARKE A, 1995, BRIT J OBSTET GYNAEC, V102, P611, DOI 10.1111/j.1471-0528.1995.tb11398.x; Gupta J, 2013, NEW ENGL J MED, V368, P128, DOI 10.1056/NEJMoa1204724; REES MCP, 1991, BRIT J OBSTET GYNAEC, V98, P327, DOI 10.1111/j.1471-0528.1991.tb13406.x	3	2	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC10	10.7326/0003-4819-159-6-201309170-02010	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042381				2022-12-28	WOS:000325625900009
J	Ludman, S; Shah, N; Fox, AT				Ludman, Sian; Shah, Neil; Fox, Adam T.			Managing cows' milk allergy in children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FOOD ALLERGY; ESPGHAN COMMITTEE; INFANTS; PROTEIN; SENSITIZATION; PREVALENCE; MANAGEMENT; DIAGNOSIS; FEATURES; ECZEMA		[Ludman, Sian; Fox, Adam T.] Guys & St Thomas NHS Fdn Trust, Childrens Allergy Serv, London SE1 9RT, England; [Shah, Neil] Great Ormond St Hosp Sick Children, Paediat Gastroenterol Dept, London, England; [Shah, Neil] KU Leuven Univ, TARGID, Louvain, Belgium; [Fox, Adam T.] Kings Coll London, MRC & Asthma UK Ctr Allerg Mech Asthma, Div Asthma Allergy & Lung Biol, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; KU Leuven; University of London; King's College London	Fox, AT (corresponding author), Guys & St Thomas NHS Fdn Trust, Childrens Allergy Serv, London SE1 9RT, England.	adam_fox@btinternet.com	Fox, Adam/O-3547-2015	Fox, Adam/0000-0002-3533-9798; Ludman, Sian/0000-0003-3622-4957	Great Ormond Street Hospital Childrens Charity [W1018A] Funding Source: researchfish	Great Ormond Street Hospital Childrens Charity		Agostoni C, 2009, J PEDIATR GASTR NUTR, V49, P112, DOI 10.1097/MPG.0b013e31819f1e05; Boyano-Martinez T, 2009, J ALLERGY CLIN IMMUN, V123, P883, DOI 10.1016/j.jaci.2008.12.1125; Brozek JL, 2012, CLIN EXP ALLERGY, V42, P363, DOI 10.1111/j.1365-2222.2011.03948.x; Elizur A, 2012, J PEDIAT, V161; Fiocchi A, 2008, ANN ALLERG ASTHMA IM, V101, P166, DOI 10.1016/S1081-1206(10)60205-0; Fiocchi A, 2010, J ALLERGY CLIN IMMUN, V126, P1119, DOI 10.1016/j.jaci.2010.10.011; Goldberg M, 2013, ANN ALLERG ASTHMA IM, V110, P279, DOI 10.1016/j.anai.2013.01.017; Hill DJ, 2008, CLIN EXP ALLERGY, V38, P161, DOI 10.1111/j.1365-2222.2007.02861.x; Hill DJ, 2007, J PEDIATR-US, V151, P359, DOI 10.1016/j.jpeds.2007.04.070; Hill DJ, 2004, PEDIAT ALLERG IMM-UK, V15, P421, DOI 10.1111/j.1399-3038.2004.00178.x; Host A, 1999, ARCH DIS CHILD, V81, P80, DOI 10.1136/adc.81.1.80; HOST A, 1988, ACTA PAEDIATR SCAND, V77, P663, DOI 10.1111/j.1651-2227.1988.tb10727.x; Jarvinen KM, 2009, CURR OPIN ALLERGY CL, V9, P251, DOI 10.1097/ACI.0b013e32832b3f33; Kim JS, 2011, J ALLERGY CLIN IMMUN, V128, P125, DOI 10.1016/j.jaci.2011.04.036; Koletzko S, 2012, J PEDIATR GASTR NUTR, V55, P221, DOI 10.1097/MPG.0b013e31825c9482; Meyer R, 2012, PEDIAT ALLERG IMM-UK, V23, P307, DOI 10.1111/j.1399-3038.2012.01265.x; National Institute for Health and Care Excellence, 2007, NICE GUID 57 AT ECZ; National Institute for Health and Care Excellence, 2011, NICE CLIN GUID 116 F; Nowak-Wegrzyn A, 2008, J ALLERGY CLIN IMMUN, V122, P342; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Saarinen KM, 2005, J ALLERGY CLIN IMMUN, V116, P869, DOI 10.1016/j.jaci.2005.06.018; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1453S, DOI 10.1093/ajcn/68.6.1453S; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1077, DOI 10.1016/j.jaci.2010.02.038; Sicherer SH, 1998, J PEDIATR-US, V133, P214, DOI 10.1016/S0022-3476(98)70222-7; Skripak JM, 2007, J ALLERGY CLIN IMMUN, V120, P1172, DOI 10.1016/j.jaci.2007.08.023; Vandenplas Y, 2007, ARCH DIS CHILD, V92, P902, DOI 10.1136/adc.2006.110999; Venter C, 2008, ALLERGY, V63, P354, DOI 10.1111/j.1398-9995.2007.01570.x; Venter Carina, 2013, Clin Transl Allergy, V3, P23, DOI 10.1186/2045-7022-3-23	28	31	31	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2013	347								f5424	10.1136/bmj.f5424	http://dx.doi.org/10.1136/bmj.f5424			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223RV	24041704				2022-12-28	WOS:000324827300002
J	Hagar, JA; Powell, DA; Aachoui, Y; Ernst, RK; Miao, EA				Hagar, Jon A.; Powell, Daniel A.; Aachoui, Youssef; Ernst, Robert K.; Miao, Edward A.			Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock	SCIENCE			English	Article							INFLAMMASOME ACTIVATION; FRANCISELLA MUTANT; RECOGNITION; PYROPTOSIS; VIRULENCE; BACTERIA; TLR4	Inflammatory caspases, such as caspase-1 and -11, mediate innate immune detection of pathogens. Caspase-11 induces pyroptosis, a form of programmed cell death, and specifically defends against bacterial pathogens that invade the cytosol. During endotoxemia, however, excessive caspase-11 activation causes shock. We report that contamination of the cytoplasm by lipopolysaccharide (LPS) is the signal that triggers caspase-11 activation in mice. Specifically, caspase-11 responds to penta- and hexa-acylated lipid A, whereas tetra-acylated lipid A is not detected, providing a mechanism of evasion for cytosol-invasive Francisella. Priming the caspase-11 pathway in vivo resulted in extreme sensitivity to subsequent LPS challenge in both wild-type and Tlr4-deficient mice, whereas Casp11-deficient mice were relatively resistant. Together, our data reveal a new pathway for detecting cytoplasmic LPS.	[Hagar, Jon A.; Aachoui, Youssef; Miao, Edward A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Hagar, Jon A.; Aachoui, Youssef; Miao, Edward A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Powell, Daniel A.; Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Maryland; University of Maryland Baltimore	Miao, EA (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	emiao@med.unc.edu		Powell, Daniel/0000-0003-0503-3330; Ernst, Robert/0000-0001-5016-8694; Miao, Edward/0000-0001-7295-3490	NIH [AI007273, AI097518, AI057141, AI101685]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007273, R01AI097518, R21AI101685, U54AI057141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank V. Dixit for sharing key mouse strains (Casp11<SUP>-/-</SUP> and Nlrc4<SUP>-/-</SUP>Asc<SUP>-/-</SUP> mice were provided under an materials transfer agreement with Genentech). We also thank R. Flavell, M. Heise, and J. Brickey for sharing mice. We thank D. Mao, L. Zhou, and D. Trinh for managing mouse colonies. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by NIH grants AI007273 (J.A.H.), AI097518 (E.A.M.), AI057141 (E.A.M.), and AI101685 (R.K.E.).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Gao H, 2008, CRIT CARE, V12, DOI 10.1186/cc6862; Gunn JS, 2007, ANN NY ACAD SCI, V1105, P202, DOI 10.1196/annals.1409.006; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Kanistanon D, 2012, INFECT IMMUN, V80, P943, DOI 10.1128/IAI.06109-11; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Li YY, 2012, P NATL ACAD SCI USA, V109, P8716, DOI 10.1073/pnas.1202908109; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Silipo A, 2002, J LIPID RES, V43, P2188, DOI 10.1194/jlr.D200021-JLR200; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104	21	760	786	11	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1250	1253		10.1126/science.1240988	http://dx.doi.org/10.1126/science.1240988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031018	Green Accepted, Green Submitted			2022-12-28	WOS:000324248800046
J	Lo Monaco, E; Tremante, E; Biswas, P; Cranage, MP; Zipeto, D; Beretta, A; Giacomini, P				Lo Monaco, Elisa; Tremante, Elisa; Biswas, Priscilla; Cranage, Martin P.; Zipeto, Donato; Beretta, Alberto; Giacomini, Patrizio			Comment on "Influence of HLA-C Expression Level on HIV Control"	SCIENCE			English	Editorial Material							SURFACE EXPRESSION; RECOGNITION; BINDING		[Lo Monaco, Elisa; Tremante, Elisa; Giacomini, Patrizio] Ist Nazl Tumori Regina Elena, I-00158 Rome, Italy; [Biswas, Priscilla; Beretta, Alberto] IRCCS Osped, I-20132 Milan, Italy; [Biswas, Priscilla; Beretta, Alberto] Ist Sci San Raffaele, I-20132 Milan, Italy; [Cranage, Martin P.] St Georges Univ London, Ctr Infect & Immun, London, England; [Zipeto, Donato] Univ Verona, Dept Life & Reprod Sci, I-37134 Verona, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; St Georges University London; University of Verona	Giacomini, P (corresponding author), Ist Nazl Tumori Regina Elena, Via Messi dOro 156, I-00158 Rome, Italy.	giacomini@ifo.it	Tremante, Elisa/K-5288-2018; Zipeto, Donato/ABE-8251-2021; Zipeto, Donato/P-3041-2019; Giacomini, Patrizio/K-5217-2016	Tremante, Elisa/0000-0002-8584-9913; Zipeto, Donato/0000-0002-2168-4144; Giacomini, Patrizio/0000-0001-6109-1709				Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Blais ME, 2012, J IMMUNOL, V188, P4663, DOI 10.4049/jimmunol.1103472; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Brooks AG, 1999, J IMMUNOL, V162, P305; Corrah TW, 2011, J VIROL, V85, P3367, DOI 10.1128/JVI.02276-10; Lee N, 1998, J IMMUNOL, V160, P4951; Lo Monaco E, 2008, J IMMUNOL, V181, P5442, DOI 10.4049/jimmunol.181.8.5442; Lu W, 2012, CELL REP, V2, P1736, DOI 10.1016/j.celrep.2012.11.016; Romagnani C, 2004, HUM IMMUNOL, V65, P437, DOI 10.1016/j.humimm.2004.02.001; Sibilio L, 2008, J BIOL CHEM, V283, P1267, DOI 10.1074/jbc.M708068200; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486	11	6	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151								10.1126/science.1241266	http://dx.doi.org/10.1126/science.1241266			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215ZA	24031002				2022-12-28	WOS:000324248800019
J	Bernstein, A; Rossant, J				Bernstein, Alan; Rossant, Janet			Anthony James Pawson (1952-2013) OBITUARY	NATURE			English	Biographical-Item									[Bernstein, Alan] Canadian Inst Adv Res, Toronto, ON, Canada; [Rossant, Janet] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Canadian Institute for Advanced Research (CIFAR); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bernstein, A (corresponding author), Canadian Inst Adv Res, Toronto, ON, Canada.	abernstein@cifar.ca; janet.rossant@sickkids.ca		Rossant, Janet/0000-0002-3731-5466				PAWSON AJ, PUBLICATION LIST	1	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					168	168		10.1038/501168a	http://dx.doi.org/10.1038/501168a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24025833	Bronze			2022-12-28	WOS:000324244900024
J	Malenka, RC				Malenka, Robert C.			Rapid Release Revealed: Honoring the Synapse	CELL			English	Editorial Material							PRESYNAPTIC ACTIVE ZONES; MEMBRANE-PROTEIN; SYNAPTOTAGMIN-I; FUSION; SYNTAXIN; DOCKING	This year, the Albert Lasker Basic Medical Research Award will be shared by Richard Scheller and Thomas Sudhof for their elucidation of the molecular mechanisms underlying neurotransmitter release. Their discoveries provided insight into the molecular basis of synaptic transmission and enhanced our understanding of how synaptic dysfunction may cause neuropsychiatric disorders.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA.	malenka@stanford.edu						BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538	15	1	1	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1171	1174		10.1016/j.cell.2013.08.048	http://dx.doi.org/10.1016/j.cell.2013.08.048			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034236	Bronze			2022-12-28	WOS:000324239300001
J	Frisch, PC; Bzowski, M; Livadiotis, G; McComas, DJ; Moebius, E; Mueller, HR; Pryor, WR; Schwadron, NA; Sokol, JM; Vallerga, JV; Ajello, JM				Frisch, P. C.; Bzowski, M.; Livadiotis, G.; McComas, D. J.; Moebius, E.; Mueller, H. -R.; Pryor, W. R.; Schwadron, N. A.; Sokol, J. M.; Vallerga, J. V.; Ajello, J. M.			Decades-Long Changes of the Interstellar Wind Through Our Solar System	SCIENCE			English	Article							HELIUM; PARAMETERS; MARINER-10; GAS	The journey of the Sun through the dynamically active local interstellar medium creates an evolving heliosphere environment. This motion drives a wind of interstellar material through the heliosphere that has been measured with Earth-orbiting and interplanetary spacecraft for 40 years. Recent results obtained by NASA's Interstellar Boundary Explorer mission during 2009-2010 suggest that neutral interstellar atoms flow into the solar system from a different direction than found previously. These prior measurements represent data collected from Ulysses and other spacecraft during 1992-2002 and a variety of older measurements acquired during 1972-1978. Consideration of all data types and their published results and uncertainties, over the three epochs of observations, indicates that the trend for the interstellar flow ecliptic longitude to increase linearly with time is statistically significant.	[Frisch, P. C.] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Bzowski, M.; Sokol, J. M.] Polish Acad Sci, Space Res Ctr, PL-01237 Warsaw, Poland; [Livadiotis, G.; McComas, D. J.] SW Res Inst, San Antonio, TX 78249 USA; [McComas, D. J.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [Moebius, E.; Schwadron, N. A.] Univ New Hampshire, Ctr Space Sci, Durham, NH 03824 USA; [Mueller, H. -R.] Dartmouth Coll, Hanover, NH 03755 USA; [Pryor, W. R.] Cent Arizona Coll, Coolidge, AZ 85128 USA; [Vallerga, J. V.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Ajello, J. M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Chicago; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); University System Of New Hampshire; University of New Hampshire; Dartmouth College; University of California System; University of California Berkeley; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Frisch, PC (corresponding author), Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA.	frisch@oddjob.uchicago.edu	Sokół, Justyna M./K-2892-2015	Sokół, Justyna M./0000-0002-4173-3601; Bzowski, Maciej/0000-0003-3957-2359; Moebius, Eberhard/0000-0002-2745-6978; Mueller, Hans-Reinhard/0000-0001-7364-5377	NASA Explorers Program; Polish Ministry of Science and Higher Education [N-N203-513-038]; NASA [NNX10AC44G]	NASA Explorers Program; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NASA(National Aeronautics & Space Administration (NASA))	We thank everyone who made the IBEX mission a reality. IBEX is primarily funded by the NASA Explorers Program. Polish contributions were supported by a Polish Ministry of Science and Higher Education grant, N-N203-513-038. Additional support was provided by NASA grant NNX10AC44G. We thank R. R. Meier for many helpful comments and D. E. Welty for his reductions of the Sirius Ca<SUP>+</SUP> data. IBEX data have been archived and are available from the IBEX project and the NASA National Space Science Data Center.	AJELLO JM, 1978, ASTROPHYS J, V222, P1068, DOI 10.1086/156224; AJELLO JM, 1979, ASTRON ASTROPHYS, V73, P260; ARMSTRONG JW, 1995, ASTROPHYS J, V443, P209, DOI 10.1086/175515; Bzowski M, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/12; DALAUDIER F, 1984, ASTRON ASTROPHYS, V134, P171; Drews C., 2012, SPACE PHYS, V117, P9106; Frisch PC, 2011, ANNU REV ASTRON ASTR, V49, P237, DOI 10.1146/annurev-astro-081710-102613; Gershman DJ, 2013, J GEOPHYS RES-SPACE, V118, P1389, DOI 10.1002/jgra.50227; Gloeckler G, 2004, ASTRON ASTROPHYS, V426, P845, DOI 10.1051/0004-6361:20035768; McComas DJ, 2012, SCIENCE, V336, P1291, DOI 10.1126/science.1221054; McComas DJ, 2009, SCIENCE, V326, P959, DOI 10.1126/science.1180906; Mobius E, 2004, ASTRON ASTROPHYS, V426, P897, DOI 10.1051/0004-6361:20035834; Mobius E, 2012, ASTROPHYS J SUPPL S, V198, DOI 10.1088/0067-0049/198/2/11; Spangler SR, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/30; Vallerga J, 2004, ASTRON ASTROPHYS, V426, P855, DOI 10.1051/0004-6361:20035887; WELLER CS, 1974, ASTROPHYS J, V193, P471, DOI 10.1086/153182; WELLER CS, 1981, ASTROPHYS J, V246, P386, DOI 10.1086/158936; Witte M, 2004, ASTRON ASTROPHYS, V426, P835, DOI 10.1051/0004-6361:20035956; Zank GP, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/20	19	54	55	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1080	1082		10.1126/science.1239925	http://dx.doi.org/10.1126/science.1239925			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009386				2022-12-28	WOS:000323933100035
J	Fox, MC; Lakdawala, N; Miller, AL; Loscalzo, J				Fox, Michelle C.; Lakdawala, Neal; Miller, Amy Leigh; Loscalzo, Joseph			A Patient with Syncope	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; CHRONIC CHAGAS-DISEASE; HEART-DISEASE; CARDIOMYOPATHY; BENZNIDAZOLE; PREDICTORS; MORTALITY		[Miller, Amy Leigh] Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), Brigham & Womens Hosp, Dept Internal Med, 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Sircar, Monica/W-1023-2019; Loscalzo, Joseph/ABD-8980-2021					[Anonymous], 2002, CONTROL OF CHAGAS DI; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Cardinalli-Neto A, 2007, J CARDIOVASC ELECTR, V18, P1236, DOI 10.1111/j.1540-8167.2007.00954.x; de Andrade JP, 2011, ARQ BRAS CARDIOL, V96, DOI 10.1590/S0066-782X2011000600002; Gayraud M, 2001, ARTHRITIS RHEUM, V44, P666, DOI 10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A; Lakdawala NK, 2010, CIRCULATION, V122, P527, DOI 10.1161/CIRCULATIONAHA.109.892240; Leite L R, 2001, Arq Bras Cardiol, V77, P439; Sarabanda AVL, 2011, PACE, V34, P54, DOI 10.1111/j.1540-8159.2010.02896.x; Marin-Neto JA, 2009, MEM I OSWALDO CRUZ, V104, P319, DOI 10.1590/S0074-02762009000900042; Muratore CA, 2009, EUROPACE, V11, P164, DOI 10.1093/europace/eun325; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A, 2007, J CARDIOVASC ELECTR, V18, P1241, DOI 10.1111/j.1540-8167.2007.01011.x; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Viotti R, 2009, EXPERT REV ANTI-INFE, V7, P157, DOI 10.1586/14787210.7.2.157	15	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					966	972		10.1056/NEJMcps1300093	http://dx.doi.org/10.1056/NEJMcps1300093			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004124				2022-12-28	WOS:000323906900014
J	Wang, QD; Nowak, MA; Markoff, SB; Baganoff, FK; Nayakshin, S; Yuan, F; Cuadra, J; Davis, J; Dexter, J; Fabian, AC; Grosso, N; Haggard, D; Houck, J; Ji, L; Li, Z; Neilsen, J; Porquet, D; Ripple, F; Shcherbakov, RV				Wang, Q. D.; Nowak, M. A.; Markoff, S. B.; Baganoff, F. K.; Nayakshin, S.; Yuan, F.; Cuadra, J.; Davis, J.; Dexter, J.; Fabian, A. C.; Grosso, N.; Haggard, D.; Houck, J.; Ji, L.; Li, Z.; Neilsen, J.; Porquet, D.; Ripple, F.; Shcherbakov, R. V.			Dissecting X-ray-Emitting Gas Around the Center of Our Galaxy	SCIENCE			English	Article							SUPERMASSIVE BLACK-HOLE; SAGITTARIUS-A-ASTERISK; ADVECTION-DOMINATED ACCRETION; GALACTIC-CENTER; NUMERICAL-SIMULATION; GRMHD SIMULATIONS; BRIGHTEST FLARE; CENTRAL PARSEC; FLOWS; EMISSION	Most supermassive black holes (SMBHs) are accreting at very low levels and are difficult to distinguish from the galaxy centers where they reside. Our own Galaxy's SMBH provides an instructive exception, and we present a close-up view of its quiescent x-ray emission based on 3 megaseconds of Chandra observations. Although the x-ray emission is elongated and aligns well with a surrounding disk of massive stars, we can rule out a concentration of low-mass coronally active stars as the origin of the emission on the basis of the lack of predicted iron (Fe) K alpha emission. The extremely weak hydrogen (H)-like Fe K alpha line further suggests the presence of an outflow from the accretion flow onto the SMBH. These results provide important constraints for models of the prevalent radiatively inefficient accretion state.	[Wang, Q. D.; Fabian, A. C.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Wang, Q. D.; Ripple, F.] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; [Nowak, M. A.; Baganoff, F. K.; Davis, J.; Houck, J.; Neilsen, J.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Markoff, S. B.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Nayakshin, S.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Yuan, F.] Chinese Acad Sci, Shanghai Astron Observ, Shanghai 200030, Peoples R China; [Cuadra, J.] Pontificia Univ Catolica Chile, Inst Astrofis, Santiago, Chile; [Dexter, J.] Univ Calif Berkeley, Theoret Astrophys Ctr, Berkeley, CA 94720 USA; [Dexter, J.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Grosso, N.; Porquet, D.] Univ Strasbourg, Observ Astron Strasbourg, CNRS, UMR 7550, Strasbourg, France; [Haggard, D.] Northwestern Univ, Dept Phys & Astron, Ctr Interdisciplinary Explorat & Res Astrophys, Evanston, IL 60208 USA; [Ji, L.] Chinese Acad Sci, Purple Mt Observ, Nanjing 210008, Jiangsu, Peoples R China; [Li, Z.] Nanjing Univ, Sch Astron & Space Sci, Nanjing 210093, Jiangsu, Peoples R China; [Neilsen, J.] Boston Univ, Boston, MA 02215 USA; [Shcherbakov, R. V.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University of Cambridge; University of Massachusetts System; University of Massachusetts Amherst; Massachusetts Institute of Technology (MIT); University of Amsterdam; University of Leicester; Chinese Academy of Sciences; Shanghai Astronomical Observatory, CAS; Pontificia Universidad Catolica de Chile; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Northwestern University; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Nanjing University; Boston University; University System of Maryland; University of Maryland College Park	Wang, QD (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.	wqd@astro.umass.edu	he, shuyi/K-2082-2014; Cuadra, Jorge/GYV-4257-2022	Cuadra, Jorge/0000-0003-1965-3346; Baganoff, Frederick/0000-0003-3852-6545; Porquet, Delphine/0000-0001-9731-0352; Wang, Q. Daniel/0000-0002-9279-4041; Dexter, Jason/0000-0003-3903-0373; Houck, John/0000-0002-6761-6796; Haggard, Daryl/0000-0001-6803-2138	Smithsonian Astrophysical Observatory (SAO) [GO2-13110, NAS8-03060]; Chandra Mission Planning; Raymond and Beverley Sackler Distinguished Visitor fellowship; Netherlands Organization for Scientific Research Vidi Fellowship [639.042.711]; NASA through the Einstein Postdoctoral Fellowship [PF2-130097]; SAO for NASA [SV3-73016]; Hubble Fellowship [HST-HF-51298.01]; CONICYT-Chile through FONDECYT [11100240]; Basal [PFB0609]; Anillo [ACT1101]; National Natural Science Foundation of China; 973 Project of China [2009CB824800]; STFC [ST/K000985/1, ST/J001538/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K000985/1, ST/J001538/1] Funding Source: researchfish	Smithsonian Astrophysical Observatory (SAO); Chandra Mission Planning; Raymond and Beverley Sackler Distinguished Visitor fellowship; Netherlands Organization for Scientific Research Vidi Fellowship(Netherlands Organization for Scientific Research (NWO)); NASA through the Einstein Postdoctoral Fellowship; SAO for NASA; Hubble Fellowship; CONICYT-Chile through FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Anillo(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project of China(National Basic Research Program of China); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank all the members of the Sgr A* Chandra XVP collaboration (www.sgra-star.com/collaboration-members), which is supported by Smithsonian Astrophysical Observatory (SAO) grant GO2-13110 under NAS8-03060, and are grateful to Chandra Mission Planning for support during our 2012 campaign. Q. D. W. thanks the Institute of Astronomy for their hospitality and the award of a Raymond and Beverley Sackler Distinguished Visitor fellowship. We also acknowledge the role of the Lorentz Center, Leiden, and the Netherlands Organization for Scientific Research Vidi Fellowship (639.042.711; S. B. M.). Funding support was from NASA through the Einstein Postdoctoral Fellowship (J.N.), grant PF2-130097, from SAO for NASA under contract SV3-73016; from Hubble Fellowship (R. V. S.), grant HST-HF-51298.01; from CONICYT-Chile through FONDECYT (11100240), Basal (PFB0609) and Anillo (ACT1101) grants (J.C.); and from the National Natural Science Foundation of China and the 973 Project (2009CB824800) of China (F.Y.). The x-ray data used here are available from the Chandra Data Archive at http://asc.harvard.edu.	Allen SW, 2006, MON NOT R ASTRON SOC, V372, P21, DOI 10.1111/j.1365-2966.2006.10778.x; Baganoff FK, 2003, ASTROPHYS J, V591, P891, DOI 10.1086/375145; Begelman MC, 2012, MON NOT R ASTRON SOC, V420, P2912, DOI 10.1111/j.1365-2966.2011.20071.x; Blandford RD, 2004, MON NOT R ASTRON SOC, V349, P68, DOI 10.1111/j.1365-2966.2004.07425.x; Blandford RD, 1999, MON NOT R ASTRON SOC, V303, pL1, DOI 10.1046/j.1365-8711.1999.02358.x; BONDI H, 1952, MON NOT R ASTRON SOC, V112, P195, DOI 10.1093/mnras/112.2.195; Coker RF, 1997, ASTROPHYS J, V488, pL149, DOI 10.1086/310925; Crocker RM, 2012, MON NOT R ASTRON SOC, V423, P3512, DOI 10.1111/j.1365-2966.2012.21149.x; Dibi S, 2012, MON NOT R ASTRON SOC, V426, P1928, DOI 10.1111/j.1365-2966.2012.21857.x; Doeleman SS, 2008, NATURE, V455, P78, DOI 10.1038/nature07245; Drappeau S, 2013, MON NOT R ASTRON SOC, V431, P2872, DOI 10.1093/mnras/stt388; Falcke H, 2000, ASTROPHYS J, V528, pL13, DOI 10.1086/312423; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Ghez AM, 2008, ASTROPHYS J, V689, P1044, DOI 10.1086/592738; Gillessen S, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/78; Gillessen S, 2009, ASTROPHYS J, V692, P1075, DOI 10.1088/0004-637X/692/2/1075; Li J, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/105; Lu JR, 2009, ASTROPHYS J, V690, P1463, DOI 10.1088/0004-637X/690/2/1463; Markoff S, 2010, P NATL ACAD SCI USA, V107, P7196, DOI 10.1073/pnas.0914070107; Marrone DP, 2007, ASTROPHYS J, V654, pL57, DOI 10.1086/510850; Moscibrodzka M, 2009, ASTROPHYS J, V706, P497, DOI 10.1088/0004-637X/706/1/497; Narayan R, 1999, ASTROPHYS J, V515, pL69, DOI 10.1086/311973; NARAYAN R, 1995, NATURE, V374, P623, DOI 10.1038/374623a0; NARAYAN R, 1994, ASTROPHYS J, V428, pL13, DOI 10.1086/187381; Narayan R, 2012, MON NOT R ASTRON SOC, V426, P3241, DOI 10.1111/j.1365-2966.2012.22002.x; Nayakshin S, 2005, ASTRON ASTROPHYS, V429, pL33, DOI 10.1051/0004-6361:200400101; Neilsen J, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/42; Nobukawa M, 2011, ASTROPHYS J LETT, V739, DOI 10.1088/2041-8205/739/2/L52; Nowak MA, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/95; Paumard T, 2006, ASTROPHYS J, V643, P1011, DOI 10.1086/503273; Perna R, 2000, ASTROPHYS J, V541, P898, DOI 10.1086/309466; Porquet D, 2008, ASTRON ASTROPHYS, V488, P549, DOI 10.1051/0004-6361:200809986; Quataert E, 1999, ASTROPHYS J, V517, pL101, DOI 10.1086/312035; REES MJ, 1982, NATURE, V295, P17, DOI 10.1038/295017a0; Sazonov S, 2012, MON NOT R ASTRON SOC, V420, P388, DOI 10.1111/j.1365-2966.2011.20043.x; SHAPIRO SL, 1976, ASTROPHYS J, V204, P187, DOI 10.1086/154162; Terrier R, 2010, ASTROPHYS J, V719, P143, DOI 10.1088/0004-637X/719/1/143; Yuan F, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/129; Yuan F, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/130	42	207	212	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					981	983		10.1126/science.1240755	http://dx.doi.org/10.1126/science.1240755			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990554	Green Submitted			2022-12-28	WOS:000323652300036
J	Schier, AF				Schier, Alexander F.			Should I Stay or Should I Go: Neuromodulators of Behavioral States	CELL			English	Editorial Material							C. ELEGANS; QUIESCENCE; CIRCUIT		Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Schier, AF (corresponding author), Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	schier@fas.harvard.edu		Schier, Alexander Franz/0000-0001-7645-5325	NHLBI NIH HHS [R01 HL109525] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109525] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barrios A, 2012, NAT NEUROSCI, V15, P1675, DOI 10.1038/nn.3253; Ben Arous J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007584; Choi S, 2013, NEURON, V78, P869, DOI 10.1016/j.neuron.2013.04.002; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gallagher T, 2013, J NEUROSCI, V33, P9716, DOI 10.1523/JNEUROSCI.4493-12.2013; Muller P, 2011, DEV CELL, V21, P145, DOI 10.1016/j.devcel.2011.06.001; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032	8	3	3	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					955	956		10.1016/j.cell.2013.08.017	http://dx.doi.org/10.1016/j.cell.2013.08.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993087	Bronze			2022-12-28	WOS:000323767300008
J	Attiah, MA				Attiah, Mark A.			Treat Me Like a Child	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Attiah, MA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	mattiah@mail.med.upenn.edu						Jabre P, 2013, NEW ENGL J MED, V368, P1008, DOI 10.1056/NEJMoa1203366; Wright JD, 2013, JAMA-J AM MED ASSOC, V309, P689, DOI 10.1001/jama.2013.186; Yu JB, 2013, J NATL CANCER I, V105, P25, DOI 10.1093/jnci/djs463	3	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					693	694		10.1001/jama.2013.169412	http://dx.doi.org/10.1001/jama.2013.169412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989923				2022-12-28	WOS:000323254500016
J	Sharma, M				Sharma, Mukul			Patent foramen ovale closure and medical therapy did not differ for recurrence after cryptogenic stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Sharma, M (corresponding author), McMaster Univ, Hamilton, ON, Canada.			Saver, Jeffrey/0000-0001-9141-2251; Sharma, Mukul/0000-0002-6119-342X				Furlan AJ, 2012, NEW ENGL J MED, V366, P991, DOI 10.1056/NEJMoa1009639; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC4	10.7326/0003-4819-159-4-201308200-02004	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026280				2022-12-28	WOS:000323421700003
J	Thiele, H; Zeymer, U; Neumann, FJ; Ferenc, M; Olbrich, HG; Hausleiter, J; de Waha, A; Richardt, G; Hennersdorf, M; Empen, K; Fuernau, G; Desch, S; Eitel, I; Hambrecht, R; Lauer, B; Bohm, M; Ebelt, H; Schneider, S; Werdan, K; Schuler, G				Thiele, Holger; Zeymer, Uwe; Neumann, Franz-Josef; Ferenc, Miroslaw; Olbrich, Hans-Georg; Hausleiter, Joerg; de Waha, Antoinette; Richardt, Gert; Hennersdorf, Marcus; Empen, Klaus; Fuernau, Georg; Desch, Steffen; Eitel, Ingo; Hambrecht, Rainer; Lauer, Bernward; Boehm, Michael; Ebelt, Henning; Schneider, Steffen; Werdan, Karl; Schuler, Gerhard		Intraaortic Balloon Pump Cardiogen	Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial	LANCET			English	Article							EARLY REVASCULARIZATION; TASK-FORCE; PREDICTORS; MANAGEMENT; MORTALITY; SURVIVAL; ASSOCIATION; GUIDELINES; TRENDS; ESC	Background In current international guidelines the recommendation for intra-aortic balloon pump (IABP) use has been downgraded in cardiogenic shock complicating acute myocardial infarction on the basis of registry data. In the largest randomised trial (IABP-SHOCK II), IABP support did not reduce 30 day mortality compared with control. However, previous trials in cardiogenic shock showed a mortality benefit only at extended follow-up. The present analysis therefore reports 6 and 12 month results. Methods The IABP-SHOCK II trial was a randomised, open-label, multicentre trial. Patients with cardiogenic shock complicating acute myocardial infarction who were undergoing early revascularisation and optimum medical therapy were randomly assigned (1:1) to IABP versus control via a central web-based system. The primary efficacy endpoint was 30 day all-cause mortality, but 6 and 12 month follow-up was done in addition to quality-of-life assessment for all survivors with the Euroqol-5D questionnaire. A masked central committee adjudicated clinical outcomes. Patients and investigators were not masked to treatment allocation. Analysis was by intention to treat. This trial is registered at ClinicalTrials.gov, NCT00491036. Findings Between June 16, 2009, and March 3, 2012, 600 patients were assigned to IABP (n=301) or control (n=299). Of 595 patients completing 12 month follow-up, 155 (52%) of 299 patients in the IABP group and 152 (51%) of 296 patients in the control group had died (relative risk [RR] 1.01, 95% CI 0.86-1.18, p=0.91). There were no significant differences in reinfarction (RR 2.60, 95% CI 0.95-7.10, p=0.05), recurrent revascularisation (0.91, 0.58-1.41, p=0.77), or stroke (1.50, 0.25-8.84, p=1.00). For survivors, quality-of-life measures including mobility, self-care, usual activities, pain or discomfort, and anxiety or depression did not differ significantly between study groups. Interpretation In patients undergoing early revascularisation for myocardial infarction complicated by cardiogenic shock, IABP did not reduce 12 month all-cause mortality.	[Thiele, Holger; Fuernau, Georg; Desch, Steffen; Eitel, Ingo; Schuler, Gerhard] Univ Leipzig, Ctr Heart, D-04289 Leipzig, Germany; [Zeymer, Uwe; Schneider, Steffen] Klinikum Ludwigshafen, Ludwigshafen, Germany; [Zeymer, Uwe; Schneider, Steffen] Inst Herzinfarktforsch, Ludwigshafen, Germany; [Neumann, Franz-Josef; Ferenc, Miroslaw] Univ Freiburg, Heart Ctr Bad Krozingen, Bad Krozingen, Germany; [Olbrich, Hans-Georg] Asklepios Clin Langen Seligenstadt, Langen, Germany; [Hausleiter, Joerg] Klinikum Ludwig Maximilians Univ Munchen, Munich, Germany; [de Waha, Antoinette] German Heart Ctr Munich, Munich, Germany; [Richardt, Gert] Segeberger Kliniken, Ctr Heart, Bad Segeberg, Germany; [Hennersdorf, Marcus] SLK Kliniken Heilbronn, Heilbronn, Germany; [Empen, Klaus] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Hambrecht, Rainer] Klinikum Links Weser, Bremen, Germany; [Lauer, Bernward] Zent Klin Bad Berka, Bad Berka, Germany; [Boehm, Michael] Univ Clin Saarland, Homburg, Germany; [Ebelt, Henning; Werdan, Karl] Univ Halle Wittenberg, D-06108 Halle, Saale, Germany	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ludwigshafen Hospital; Institute Heart Attack Research; University of Freiburg; University of Munich; German Heart Centre Munich; Segeberger Kliniken Group; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald; Zentralklinik Bad Berka; Universitatsklinikum des Saarlandes; Martin Luther University Halle Wittenberg	Thiele, H (corresponding author), Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04289 Leipzig, Germany.	thielh@medizin.uni-leipzig.de	Thiele, Holger/ABE-6792-2020; Hausleiter, Jörg/V-4206-2019; Fuernau, Georg/T-8798-2017; Böhm, Michael/C-3638-2011; Fuernau, Georg/HCI-4640-2022	Thiele, Holger/0000-0002-0169-998X; Fuernau, Georg/0000-0002-3813-8772; Fuernau, Georg/0000-0002-3813-8772; Ferrari, Markus/0000-0003-3986-1943	German Research Foundation; German Heart Research Foundation; German Cardiac Society; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte; University of Leipzig-Heart Centre; Maquet Cardiopulmonary; Teleflex Medical	German Research Foundation(German Research Foundation (DFG)); German Heart Research Foundation; German Cardiac Society; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte; University of Leipzig-Heart Centre; Maquet Cardiopulmonary; Teleflex Medical	German Research Foundation; German Heart Research Foundation; German Cardiac Society; Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte; University of Leipzig-Heart Centre; Maquet Cardiopulmonary; Teleflex Medical.	Abdel-Wahab M, 2010, AM J CARDIOL, V105, P967, DOI 10.1016/j.amjcard.2009.11.021; Aissaoui N, 2012, EUR HEART J, V33, P2535, DOI 10.1093/eurheartj/ehs264; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cheng JM, 2013, INT J CARDIOL, V168, P3758, DOI 10.1016/j.ijcard.2013.06.009; Fincke R, 2004, J AM COLL CARDIOL, V44, P340, DOI 10.1016/j.jacc.2004.03.060; Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511; Jeger RV, 2008, ANN INTERN MED, V149, P618, DOI 10.7326/0003-4819-149-9-200811040-00005; Katz JN, 2009, AM HEART J, V158, P680, DOI 10.1016/j.ahj.2009.08.005; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Ohman EM, 2005, J THROMB THROMBOLYS, V19, P33, DOI 10.1007/s11239-005-0938-0; Patel MR, 2011, JAMA-J AM MED ASSOC, V306, P1329, DOI 10.1001/jama.2011.1280; Prondzinsky R, 2012, SHOCK, V37, P378, DOI 10.1097/SHK.0b013e31824a67af; Prondzinsky R, 2010, CRIT CARE MED, V38, P152, DOI 10.1097/CCM.0b013e3181b78671; SCHEIDT S, 1973, NEW ENGL J MED, V288, P979, DOI 10.1056/NEJM197305102881901; Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602; Sleeper LA, 2010, AM HEART J, V160, P443, DOI 10.1016/j.ahj.2010.06.024; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Sutton AGC, 2005, HEART, V91, P339, DOI 10.1136/hrt.2003.021691; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Thiele H, 2012, AM HEART J, V163, P938, DOI 10.1016/j.ahj.2012.03.012; Thiele H, 2010, EUR HEART J, V31, P1828, DOI 10.1093/eurheartj/ehq220; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Werdan K, 2012, DTSCH ARZTEBL INT, V109, P343, DOI 10.3238/arztebl.2012.0343; WIJNS W, 2010, EUR HEART J, V31, P2501, DOI DOI 10.1093/EURHEARTJ/EHQ277; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zeymer U, 2004, EUR HEART J, V25, P322, DOI 10.1016/j.ehj.2003.12.008	30	573	610	1	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1638	1645		10.1016/S0140-6736(13)61783-3	http://dx.doi.org/10.1016/S0140-6736(13)61783-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254CN	24011548				2022-12-28	WOS:000327140700022
J	Lee, JC; Espeli, M; Anderson, CA; Linterman, MA; Pocock, JM; Williams, NJ; Roberts, R; Viatte, S; Fu, B; Peshu, N; Hien, TT; Phu, NH; Wesley, E; Edwards, C; Ahmad, T; Mansfield, JC; Gearry, R; Dunstan, S; Williams, TN; Barton, A; Vinuesa, CG; Parkes, M; Lyons, PA; Smith, KGC				Lee, James C.; Espeli, Marion; Anderson, Carl A.; Linterman, Michelle A.; Pocock, Joanna M.; Williams, Naomi J.; Roberts, Rebecca; Viatte, Sebastien; Fu, Bo; Peshu, Norbert; Tran Tinh Hien; Nguyen Hoan Phu; Wesley, Emma; Edwards, Cathryn; Ahmad, Tariq; Mansfield, John C.; Gearry, Richard; Dunstan, Sarah; Williams, Thomas N.; Barton, Anne; Vinuesa, Carola G.; Parkes, Miles; Lyons, Paul A.; Smith, Kenneth G. C.		UK IBD Genetics Consortium	Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway	CELL			English	Article							FOXO TRANSCRIPTION FACTORS; RHEUMATOID-ARTHRITIS; PREDICTS PROGNOSIS; CELLS; MACROPHAGES; EXPRESSION; MONOCYTES; BETA; HETEROGENEITY; ESTABLISHMENT	The clinical course and eventual outcome, or prognosis, of complex diseases varies enormously between affected individuals. This variability critically determines the impact a disease has on a patient's life but is very poorly understood. Here, we exploit existing genome-wide association study data to gain insight into the role of genetics in prognosis. We identify a noncoding polymorphism in FOXO3A (rs12212067: T > G) at which the minor (G) allele, despite not being associated with disease susceptibility, is associated with a milder course of Crohn's disease and rheumatoid arthritis and with increased risk of severe malaria. Minor allele carriage is shown to limit inflammatory responses in monocytes via a FOXO3-driven pathway, which through TGF beta 1 reduces production of proinflammatory cytokines, including TNF alpha, and increases production of anti-inflammatory cytokines, including IL-10. Thus, we uncover a shared genetic contribution to prognosis in distinct diseases that operates via a FOXO3-driven pathway modulating inflammatory responses.	[Lee, James C.; Espeli, Marion; Linterman, Michelle A.; Pocock, Joanna M.; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Lee, James C.; Espeli, Marion; Linterman, Michelle A.; Pocock, Joanna M.; Parkes, Miles; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; [Anderson, Carl A.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Williams, Naomi J.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Pathogens & Immun, Canberra, ACT 2601, Australia; [Roberts, Rebecca; Gearry, Richard] Univ Otago, Dept Med, Christchurch 8011, New Zealand; [Viatte, Sebastien; Fu, Bo; Barton, Anne] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Fu, Bo] Univ Manchester, Inst Populat Hlth, Ctr Biostat, Manchester M13 9PL, Lancs, England; [Peshu, Norbert; Williams, Thomas N.] Kenya Govt Med Res Ctr, Wellcome Trust Res Program, Ctr Geog Med Res, Kilifi, Kenya; [Tran Tinh Hien; Dunstan, Sarah] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Program, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Nguyen Hoan Phu] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Wesley, Emma; Ahmad, Tariq] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX2 5DW, Devon, England; [Edwards, Cathryn] Torbay Hosp, Dept Gastroenterol, Torquay TQ2 7AA, England; [Mansfield, John C.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Dunstan, Sarah] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Williams, Thomas N.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Australian National University; John Curtin School of Medical Research; University of Otago; University of Manchester; University of Manchester; Kenya Medical Research Institute; University of Oxford; University of Exeter; University of Plymouth; Newcastle University - UK; University of Oxford; Imperial College London	Smith, KGC (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Cambridge Biomed Campus, Cambridge CB2 0XY, England.	kgcs2@cam.ac.uk	Kennedy, Nicholas Alexander/AET-5648-2022; Linterman, Michelle/AAN-4210-2021; Espeli, Marion/AAH-4483-2021; Gearry, Richard B/H-3959-2019; Lee, James/ABD-5920-2020; Dunstan, Sarah/AAO-9597-2020; Viatte, Sebastien/B-4253-2015; Vinuesa, Carola G/B-1108-2010; Barclay, Murray Lindsay/D-9000-2012; Barton, Anne/N-2053-2014	Kennedy, Nicholas Alexander/0000-0003-4368-1961; Linterman, Michelle/0000-0001-6047-1996; Espeli, Marion/0000-0001-5005-1664; Gearry, Richard B/0000-0002-2298-5141; Lee, James/0000-0001-5711-9385; Viatte, Sebastien/0000-0001-6471-3358; Vinuesa, Carola G/0000-0001-9799-0298; Barclay, Murray Lindsay/0000-0003-2944-8338; Barrett, Jeffrey/0000-0002-1152-370X; Edwards, Cathryn/0000-0002-5550-9184; Parkes, Miles/0000-0002-6467-0631; Henderson, Paul/0000-0003-3634-6428; Smith, Kenneth/0000-0003-3829-4326; Dunstan, Sarah/0000-0001-7873-933X; Newman, William/0000-0002-6382-4678; Lees, Charlie/0000-0002-0732-8215; Anderson, Carl/0000-0003-1719-7009; Barton, Anne/0000-0003-3316-2527; Simmons, Alison/0000-0003-3454-0710	NIHR Biomedical Research centers in Cambridge and Manchester; Wellcome Trust [083650/Z/07/Z, 087007/Z/08/Z, 098051, 091758/Z/10/Z]; Arthritis Research UK; Swiss Foundation for Medical Science [PASMP3_134380]; Wellcome Trust Strategic Award [079895]; MRC [G0400929, MC_UU_12010/7, G0800759, G0600329, G0800675] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL9-Lee] Funding Source: researchfish; Medical Research Council [G0800675, G0600329, G0400929, MC_UU_12010/7, G0800759] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/75, ETM/137] Funding Source: researchfish	NIHR Biomedical Research centers in Cambridge and Manchester; Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); Swiss Foundation for Medical Science; Wellcome Trust Strategic Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Crohn&quot;s and Colitis UK; Chief Scientist Office	We gratefully thank the following: Cambridge BioResource (CBR) volunteers, the CBR staff for coordinating volunteer recruitment, and the CBR SAB for support; Emma Whitelaw (QIMR) for providing Foxo3a<SUP>MommeR1</SUP> mice; Prof Adam Young (PI-NOAR) and Prof Deborah Symons (PI-ERAS) for collaboration; Alex W. Macharia, Sophie Uyoga, Carolyne Ndila, Emily Nyatichi, Metrine Tendwa, Johnstone Mkale, Adan Mohamed, Prophet Ingosi, and Mary Njoroge for DNA extraction at the KEMRI-Wellcome Trust Programme; and Gideon Nyutu, Kenneth Magua, and Ruth Mwarabu for database support. This work is published with permission from the director of KEMRI, supported by NIHR Biomedical Research centers in Cambridge and Manchester, and funded by the Wellcome Trust (program grant 083650/Z/07/Z, grants to J.C.L. 087007/Z/08/Z, C.A.A. 098051 and T.N.W. 091758/Z/10/Z), Arthritis Research UK and the Swiss Foundation for Medical Science (grant to S.V. PASMP3_134380). The Cambridge Institute for Medical Research is in receipt of Wellcome Trust Strategic Award (079895).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Eijkelenboom A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.74; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feldmann M, 2008, IMMUNOL REV, V223, P7, DOI 10.1111/j.1600-065X.2008.00626.x; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hehlio T, 2003, GUT, V52, P558, DOI 10.1136/gut.52.4.558; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; Hindorff L., 2013, CATALOG PUBLISHED GE; Hugosson E, 2004, PARASITE IMMUNOL, V26, P111, DOI 10.1111/j.0141-9838.2004.00678.x; James D, 2004, RHEUMATOLOGY, V43, P369, DOI 10.1093/rheumatology/keh059; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Krygier Darin S, 2009, Expert Rev Gastroenterol Hepatol, V3, P407, DOI 10.1586/egh.09.25; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Licastro Federico, 2005, Immun Ageing, V2, P8; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Mulherin D, 1996, ARTHRITIS RHEUM, V39, P115, DOI 10.1002/art.1780390116; MUSSO T, 1990, BLOOD, V76, P2466; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pritchard JK, 2000, GENETICS, V155, P945; Rainbow DB, 2008, BIOCHEM SOC T, V36, P312, DOI 10.1042/BST0360312; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Symmons DPM, 2003, CLIN EXP RHEUMATOL, V21, pS94; Watkins SK, 2011, J CLIN INVEST, V121, P1361, DOI 10.1172/JCI44325; Wildey GM, 2009, J BIOL CHEM, V284, P20227, DOI 10.1074/jbc.M109.027201; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Youngson NA, 2011, MAMM GENOME, V22, P235, DOI 10.1007/s00335-011-9317-7; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	53	166	172	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 26	2013	155	1					57	69		10.1016/j.cell.2013.08.034	http://dx.doi.org/10.1016/j.cell.2013.08.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	224UX	24035192	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000324916700009
J	Adorno, M; Sikandar, S; Mitra, SS; Kuo, A; Di Robilant, BN; Haro-Acosta, V; Ouadah, Y; Quarta, M; Rodriguez, J; Qian, DL; Reddy, VM; Cheshier, S; Garner, CC; Clarke, MF				Adorno, Maddalena; Sikandar, Shaheen; Mitra, Siddhartha S.; Kuo, Angera; Di Robilant, Benedetta Nicolis; Haro-Acosta, Veronica; Ouadah, Youcef; Quarta, Marco; Rodriguez, Jacqueline; Qian, Dalong; Reddy, Vadiyala M.; Cheshier, Samuel; Garner, Craig C.; Clarke, Michael F.			Usp16 contributes to somatic stem-cell defects in Down's syndrome	NATURE			English	Article							MOUSE MODEL; HEMATOPOIETIC STEM; ALZHEIMERS-DISEASE; SELF-RENEWAL; PROLIFERATION; PURIFICATION; EXPRESSION; BMI-1; DISSECTION; BIOMARKER	Down's syndrome results from full or partial trisomy of chromosome 21. However, the consequences of the underlying gene-dosage imbalance on adult tissues remain poorly understood. Here we show that in Ts65Dn mice, which are trisomic for 132 genes homologous to genes on human chromosome 21, triplication of Usp16 reduces the self-renewal of haematopoietic stem cells and the expansion of mammary epithelial cells, neural progenitors and fibroblasts. In addition, Usp16 is associated with decreased ubiquitination of Cdkn2a and accelerated senescence in Ts65Dn fibroblasts. Usp16 can remove ubiquitin from histone H2A on lysine 119, a critical mark for the maintenance of multiple somatic tissues. Downregulation of Usp16, either by mutation of a single normal Usp16 allele or by short interfering RNAs, largely rescues all of these defects. Furthermore, in human tissues overexpression of USP16 reduces the expansion of normal fibroblasts and postnatal neural progenitors, whereas downregulation of USP16 partially rescues the proliferation defects of Down's syndrome fibroblasts. Taken together, these results suggest that USP16 has an important role in antagonizing the self-renewal and/or senescence pathways in Down's syndrome and could serve as an attractive target to ameliorate some of the associated pathologies.	[Adorno, Maddalena; Sikandar, Shaheen; Mitra, Siddhartha S.; Kuo, Angera; Di Robilant, Benedetta Nicolis; Haro-Acosta, Veronica; Ouadah, Youcef; Qian, Dalong; Cheshier, Samuel; Clarke, Michael F.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Di Robilant, Benedetta Nicolis] San Raffaele Univ, Int PhD Sch Mol Med, Milan, Italy; [Ouadah, Youcef] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Quarta, Marco] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Rodriguez, Jacqueline; Garner, Craig C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Reddy, Vadiyala M.] Stanford Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Stanford, CA 94305 USA; [Cheshier, Samuel] Stanford Univ, Sch Med, Dept Neurosurg, Div Pediat Neurosurg, Stanford, CA 94305 USA	Stanford University; Vita-Salute San Raffaele University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Clarke, MF (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mfclarke@stanford.edu		Garner, Craig/0000-0003-1970-5417	California Institute for Regenerative Medicine (CIRM) basic biology award III; National Institutes of Health [CA100225, CA154209]; CIRM bridges fellowship; Fondazione Umberto Veronesi; Breast Cancer Research Program; Department of Defense; The Breast Cancer Research Foundation (BCRF); Stanford Graduate Fellowship; Down Syndrome Research and Treatment Foundation; Fidelity Foundation; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA100225, R01CA104987, U01CA154209] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) basic biology award III; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM bridges fellowship; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Breast Cancer Research Program; Department of Defense(United States Department of Defense); The Breast Cancer Research Foundation (BCRF); Stanford Graduate Fellowship(Stanford University); Down Syndrome Research and Treatment Foundation; Fidelity Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Marro for help in establishing MEF and TTF lines; I. L. Weissman for sharing C57BL/6 CD45.1 mice; the animal core facility of SIM1, in particular A. Valledifiera and M. Alvarez. This study was supported in part by a California Institute for Regenerative Medicine (CIRM) basic biology award III, National Institutes of Health grant numbers CA100225 and CA154209, CIRM bridges fellowship (V. H.-A.), Fondazione Umberto Veronesi (B.N.d.R.), Breast Cancer Research Program sponsored by Department of Defense (S. S.), The Breast Cancer Research Foundation (BCRF), Stanford Graduate Fellowship (Y.O.) and the Down Syndrome Research and Treatment Foundation and the Fidelity Foundation (C.C.G.).	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Cao GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032015; CARMELIET G, 1991, MUTAT RES, V256, P221, DOI 10.1016/0921-8734(91)90013-2; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fischer J, 2011, NAT PROTOC, V6, P1981, DOI 10.1038/nprot.2011.412; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kimura M, 2005, FREE RADICAL BIO MED, V39, P374, DOI 10.1016/j.freeradbiomed.2005.03.023; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Liu Y, 2009, AGING CELL, V8, P439, DOI 10.1111/j.1474-9726.2009.00489.x; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lorenzo LPE, 2011, ANTIOXID REDOX SIGN, V15, P2083, DOI 10.1089/ars.2010.3798; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Negishi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012373; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reinholdt LG, 2011, MAMM GENOME, V22, P685, DOI 10.1007/s00335-011-9357-z; Roth GM, 1996, AM J NEURORADIOL, V17, P1283; Roy A, 2012, P NATL ACAD SCI USA, V109, P17579, DOI 10.1073/pnas.1211405109; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zigman WB, 2007, MENT RETARD DEV D R, V13, P237, DOI 10.1002/mrdd.20163	39	84	92	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					380	+		10.1038/nature12530	http://dx.doi.org/10.1038/nature12530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24025767	Green Accepted, Green Submitted			2022-12-28	WOS:000324545700037
J	Noinaj, N; Kuszak, AJ; Gumbart, JC; Lukacik, P; Chang, HS; Easley, NC; Lithgow, T; Buchanan, SK				Noinaj, Nicholas; Kuszak, Adam J.; Gumbart, James C.; Lukacik, Petra; Chang, Hoshing; Easley, Nicole C.; Lithgow, Trevor; Buchanan, Susan K.			Structural insight into the biogenesis of beta-barrel membrane proteins	NATURE			English	Article							OUTER-MEMBRANE; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; ESSENTIAL COMPONENT; ASSEMBLY MACHINERY; BAMA; BACTERIA; FLEXIBILITY; EVOLUTION; INSERTION	beta-barrel membrane proteins are essential for nutrient import, signalling, motility and survival. InGram-negative bacteria, the beta-barrel assembly machinery (BAM) complex is responsible for the biogenesis of beta-barrel membrane proteins, with homologous complexes found in mitochondria and chloroplasts. Here we describe the structure of BamA, the central and essential component of the BAM complex, from two species of bacteria: Neisseria gonorrhoeae and Haemophilus ducreyi. BamA consists of a large periplasmic domain attached to a 16-strand transmembrane beta-barrel domain. Three structural features shed light on the mechanism by which BamA catalyses beta-barrel assembly. First, the interior cavity is accessible in one BamA structure and conformationally closed in the other. Second, an exterior rim of the beta-barrel has a distinctly narrowed hydrophobic surface, locally destabilizing the outer membrane. And third, the beta-barrel can undergo lateral opening, suggesting a route from the interior cavity in BamA into the outer membrane.	[Noinaj, Nicholas; Kuszak, Adam J.; Chang, Hoshing; Easley, Nicole C.; Buchanan, Susan K.] NIDDK, NIH, Bethesda, MD 20892 USA; [Gumbart, James C.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Lukacik, Petra] Diamond Light Source Ltd, Oxford OX11 0DE, England; [Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Georgia; Georgia Institute of Technology; Diamond Light Source; Monash University	Buchanan, SK (corresponding author), NIDDK, NIH, Bethesda, MD 20892 USA.	skbuchan@helix.nih.gov	Lukacik, Petra/AAY-3775-2021; Lithgow, Trevor/H-5925-2017	Lukacik, Petra/0000-0002-3179-7273; Kuszak, Adam/0000-0001-8719-145X; Lithgow, Trevor/0000-0002-0102-7884	National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases; NIH [K22-AI100927, R01-GM67887]; Diamond Light Source; ARC Discovery Project [DP120101878]; ARC Linkage International Grant [LX0776170]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; Pittsburgh Supercomputing Center [RC2GM093307]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI100927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093307, R01GM067887] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diamond Light Source; ARC Discovery Project(Australian Research Council); ARC Linkage International Grant(Australian Research Council); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); Pittsburgh Supercomputing Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Bernstein and R. Ieva for providing JCM-166 cells, J. Beckwith and R. Misra for providing antibodies, and A. M. Stanley and T. Barnard for discussions and comments on the manuscript. N. N., A. J. K., N. C. E., H. C. and S. K. B. are supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases. J. C. G. acknowledges support from the NIH under grants K22-AI100927 and R01-GM67887. P. L. is supported by a postdoctoral fellowship through the Diamond Light Source. T. L. is an Australian Research Council (ARC) Federation Fellow and acknowledges support from ARC Discovery Project (DP120101878) and ARC Linkage International Grant (LX0776170). We thank the respective staffs at the Southeast Regional Collaborative Access Team (SER-CAT) and General Medicine and Cancer Institute's Collaborative Access Team (GM/CA-CAT) beamlines at the Advanced Photon Source, Argonne National Laboratory and the Diamond Light Source for their assistance during data collection. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38 (SER-CAT), and by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357 (GM/CA-CAT). Anton computer time was provided by the National Resource for Biomedical Supercomputing and the Pittsburgh Supercomputing Center through Grant RC2GM093307 from the NIH, using a machine donated by DE Shaw Research.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agah Sayeh, 2012, Methods Mol Biol, V914, P3, DOI 10.1007/978-1-62703-023-6_1; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnard TJ, 2012, J MOL BIOL, V415, P128, DOI 10.1016/j.jmb.2011.10.049; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Cuesta-Seijo JA, 2010, STRUCTURE, V18, P1210, DOI 10.1016/j.str.2010.06.014; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P95, DOI 10.1107/S0907444911051031; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Elbing Karen, 2002, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0101s59; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairman JW, 2012, STRUCTURE, V20, P1233, DOI 10.1016/j.str.2012.04.011; Fan E, 2012, J BIOL CHEM, V287, P2591, DOI 10.1074/jbc.M111.293068; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gumbart J, 2009, J MOL BIOL, V393, P1129, DOI 10.1016/j.jmb.2009.09.004; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Jiang JH, 2012, INT J MOL SCI, V13, P8038, DOI 10.3390/ijms13078038; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonard-Rivera M, 2012, J BACTERIOL, V194, P4662, DOI 10.1128/JB.00825-12; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Rigel NW, 2012, CURR OPIN MICROBIOL, V15, P189, DOI 10.1016/j.mib.2011.12.007; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Tamm LK, 2001, J BIOL CHEM, V276, P32399, DOI 10.1074/jbc.R100021200; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Ujwal R, 2011, METHODS, V55, P337, DOI 10.1016/j.ymeth.2011.09.020; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang H, 2011, ACTA CRYSTALLOGR F, V67, P734, DOI 10.1107/S1744309111014254	60	299	303	6	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					385	+		10.1038/nature12521	http://dx.doi.org/10.1038/nature12521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23995689	Green Accepted			2022-12-28	WOS:000324545700038
J	Spence, D				Spence, Des			BAD MEDICINE: ATRIAL FIBRILLATION Author's reply to Robson and Lip	BMJ-BRITISH MEDICAL JOURNAL			English	Letter							STROKE		Maryhill Hlth Ctr, Glasgow G20 9DR, Lanark, Scotland		Spence, D (corresponding author), Maryhill Hlth Ctr, Glasgow G20 9DR, Lanark, Scotland.	destwo@yahoo.co.uk						Easton M., 2013, BBC NEWS UK     0803; Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; Robson JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5429; Spence D, 2013, BMJ-BRIT MED J, V347, pf491; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2013	347								f5431	10.1136/bmj.f5431	http://dx.doi.org/10.1136/bmj.f5431			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219SU	24030673				2022-12-28	WOS:000324530500006
J	Morganti, R; Fogasy, J; Paragi, Z; Oosterloo, T; Orienti, M				Morganti, Raffaella; Fogasy, Judit; Paragi, Zsolt; Oosterloo, Tom; Orienti, Monica			Radio Jets Clearing the Way Through a Galaxy: Watching Feedback in Action	SCIENCE			English	Article							WARM OUTFLOW; PKS-1345+12; EMISSION	The energy released by an active galactic nucleus (AGN) has a strong impact on the surrounding interstellar medium (ISM). This feedback is considered to be the regulating factor for the growth of the central massive black hole and for the rate of star formation in a galaxy. We have located, using very-long-baseline interferometry, the fast outflow of neutral hydrogen in the young, restarted radio-loud AGN 4C12.50. The outflow is located 100 parsec from the nucleus where the radio jet interacts with the ISM, as well as around the associated radio lobe. These observations show that the radio plasma drives the outflow and removes gas from the central regions and that jet-driven outflows can play a relevant role in feedback mechanisms.	[Morganti, Raffaella; Oosterloo, Tom] Netherlands Inst Radio Astron, ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Morganti, Raffaella; Oosterloo, Tom] Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; [Fogasy, Judit] Eotvos Lorand Univ, H-1053 Budapest, Hungary; [Paragi, Zsolt] Joint Inst Very Long Baseline Interferometry VLBI, NL-7990 AA Dwingeloo, Netherlands; [Orienti, Monica] Ist Radioastron, Ist Nazl Astrofis INAF, I-40129 Bologna, Italy	University of Groningen; Eotvos Lorand University; Istituto Nazionale Astrofisica (INAF)	Morganti, R (corresponding author), Netherlands Inst Radio Astron, ASTRON, Postbus 2, NL-7990 AA Dwingeloo, Netherlands.	morganti@astron.nl	Oosterloo, Tom/GVU-4543-2022; Morganti, Raffaella/GVU-5894-2022	Oosterloo, Tom/0000-0002-0616-6971; Morganti, Raffaella/0000-0002-9482-6844; Fogasy, Judit/0000-0003-0003-000X; orienti, monica/0000-0003-4470-7094; Paragi, Zsolt/0000-0002-5195-335X	national research councils; Hungarian Scientific Research Fund [OTKA K104539]	national research councils; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The European VLBI Network is a joint facility of European, Chinese, South African, and other radio astronomy institutes funded by their national research councils. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. J.F. acknowledges the ASTRON/JIVE Summer Student Programme during which she carried out this project. Z.P. acknowledges partial support from the Hungarian Scientific Research Fund, grant OTKA K104539.	BAHCALL JN, 1969, ASTROPHYS J, V157, P1055, DOI 10.1086/150135; Batcheldor D, 2007, ASTROPHYS J, V661, P70, DOI 10.1086/515391; Dasyra KM, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201219229; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Holt J, 2006, MON NOT R ASTRON SOC, V370, P1633, DOI 10.1111/j.1365-2966.2006.10604.x; Holt J, 2011, MON NOT R ASTRON SOC, V410, P1527, DOI 10.1111/j.1365-2966.2010.17535.x; Holt J, 2003, MON NOT R ASTRON SOC, V342, P227, DOI 10.1046/j.1365-8711.2003.06532.x; Hopkins PF, 2010, MON NOT R ASTRON SOC, V401, P7, DOI 10.1111/j.1365-2966.2009.15643.x; Lister ML, 2003, ASTROPHYS J, V584, P135, DOI 10.1086/345666; McNamara BR, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/055023; Mellema G, 2002, ASTRON ASTROPHYS, V395, pL13, DOI 10.1051/0004-6361:20021408; Morganti R, 2005, ASTRON ASTROPHYS, V444, pL9, DOI 10.1051/0004-6361:200500197; Morganti R, 2004, ASTRON ASTROPHYS, V424, P119, DOI 10.1051/0004-6361:20041064; Scoville NZ, 2000, ASTRON J, V119, P991, DOI 10.1086/301248; Stanghellini C, 2005, ASTRON ASTROPHYS, V443, P891, DOI 10.1051/0004-6361:20042226; Wagner AY, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/136; Wagner AY, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/29	17	141	141	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1082	1085		10.1126/science.1240436	http://dx.doi.org/10.1126/science.1240436			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009387	Green Submitted			2022-12-28	WOS:000323933100036
J	Pitzer, M; Kunitski, M; Johnson, AS; Jahnke, T; Sann, H; Sturm, F; Schmidt, LPH; Schmidt-Bocking, H; Dorner, R; Stohner, J; Kiedrowski, J; Reggelin, M; Marquardt, S; Schiesser, A; Berger, R; Schoffler, MS				Pitzer, Martin; Kunitski, Maksim; Johnson, Allan S.; Jahnke, Till; Sann, Hendrik; Sturm, Felix; Schmidt, Lothar Ph. H.; Schmidt-Boecking, Horst; Doerner, Reinhard; Stohner, Juergen; Kiedrowski, Julia; Reggelin, Michael; Marquardt, Sebastian; Schiesser, Alexander; Berger, Robert; Schoeffler, Markus S.			Direct Determination of Absolute Molecular Stereochemistry in Gas Phase by Coulomb Explosion Imaging	SCIENCE			English	Article							SPECTROSCOPY; CHIRALITY	Bijvoet's method, which makes use of anomalous x-ray diffraction or dispersion, is the standard means of directly determining the absolute (stereochemical) configuration of molecules, but it requires crystalline samples and often proves challenging in structures exclusively comprising light atoms. Herein, we demonstrate a mass spectrometry approach that directly images the absolute configuration of individual molecules in the gas phase by cold target recoil ion momentum spectroscopy after laser ionization-induced Coulomb explosion. This technique is applied to the prototypical chiral molecule bromochlorofluoromethane and the isotopically chiral methane derivative bromodichloromethane.	[Pitzer, Martin; Kunitski, Maksim; Johnson, Allan S.; Jahnke, Till; Sann, Hendrik; Sturm, Felix; Schmidt, Lothar Ph. H.; Schmidt-Boecking, Horst; Doerner, Reinhard; Schoeffler, Markus S.] Goethe Univ Frankfurt, Inst Nucl Phys, D-60438 Frankfurt, Germany; [Johnson, Allan S.] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Stohner, Juergen] Zurich Univ Appl Sci, Inst Chem & Biol Chem, CH-8820 Wadenswil, Switzerland; [Kiedrowski, Julia; Reggelin, Michael; Marquardt, Sebastian; Schiesser, Alexander; Berger, Robert] Tech Univ Darmstadt, Clemens Schopf Inst, D-64287 Darmstadt, Germany	Goethe University Frankfurt; University of Ottawa; Zurich University of Applied Sciences; Technical University of Darmstadt	Berger, R (corresponding author), Tech Univ Darmstadt, Clemens Schopf Inst, Petersenstr 22, D-64287 Darmstadt, Germany.	robert.berger@tu-darmstadt.de; schoeffler@atom.uni-frankfurt.de	Doerner, Reinhard/A-5340-2008; Jahnke, Till/AGE-4901-2022; Schiesser, Alexander/AAC-7386-2022; Johnson, Allan S/O-5004-2018; Kunitski, Maksim/W-5272-2018; Schießer, Alexander/ABF-3629-2020; Schoeffler, Markus S/B-6261-2008; Stohner, Jürgen/E-4796-2017; Reggelin, Michael/B-2766-2014	Doerner, Reinhard/0000-0002-3728-4268; Schiesser, Alexander/0000-0002-1754-5192; Johnson, Allan S/0000-0002-0711-708X; Kunitski, Maksim/0000-0001-6543-8722; Schoeffler, Markus S/0000-0001-9214-6848; Stohner, Jürgen/0000-0003-0079-7083; Reggelin, Michael/0000-0003-3650-3921; Pitzer, Martin/0000-0002-6151-182X	State Initiative for the Development of Scientific and Economic Excellence (LOEWE) in the LOEWE-Focus ELCH	State Initiative for the Development of Scientific and Economic Excellence (LOEWE) in the LOEWE-Focus ELCH	This paper is dedicated to Helmut Schwarz on the occasion of his 70th birthday. We thank D. Avnir, T. Isaev, and F. Lichtenthaler for discussion; M. Meckel for help with some figures; and A. Czasch for support concerning data analysis. This work was supported by the State Initiative for the Development of Scientific and Economic Excellence (LOEWE) in the LOEWE-Focus ELCH. The momentum data used to draw the figures are provided in the supplementary materials. Raw data are archived at the University of Frankfurt and are available upon request.	Berger R, 2004, RELATIVISTIC ELECTRONIC STRUCTURE THEORY, PT 2, APPLICATIONS, P188; Berger R, 2012, ANGEW CHEM INT EDIT, V51, P8388, DOI 10.1002/anie.201107626; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; Buckingham AD, 2004, CHEM PHYS LETT, V398, P1, DOI 10.1016/j.cplett.2004.08.046; CAHN RS, 1966, ANGEW CHEM INT EDIT, V5, P385, DOI 10.1002/anie.196603851; Daussy C, 1999, PHYS REV LETT, V83, P1554, DOI 10.1103/PhysRevLett.83.1554; Fischer E., 1891, BER DTSCH CHEM GES, V24, P2683; Gagnon J, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/21/215104; Hansen JL, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4719816; HINE J, 1956, J AM CHEM SOC, V78, P479, DOI 10.1021/ja01583a062; Inokuma Y, 2013, NATURE, V495, P461, DOI 10.1038/nature11990; Jagutzki O, 2002, IEEE T NUCL SCI, V49, P2477, DOI 10.1109/TNS.2002.803889; Kitamura T, 2001, J CHEM PHYS, V115, P5, DOI 10.1063/1.1383793; Le Bel JA, 1874, B SOC CHIM FR, V22, P337; LICHTENTHALER FW, 1992, ANGEW CHEM INT EDIT, V31, P1541, DOI 10.1002/anie.199215413; Lux C, 2012, ANGEW CHEM INT EDIT, V51, P5001, DOI 10.1002/anie.201109035; PASTEUR L, 1861, LECONS CHIMIE PROFES, P1; Patterson D, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.023008; Quack M, 2008, ANNU REV PHYS CHEM, V59, P741, DOI 10.1146/annurev.physchem.58.032806.104511; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; VAGER Z, 1989, SCIENCE, V244, P426, DOI 10.1126/science.244.4903.426; Vant Hoff J. H., 1874, ARCH NEERLANDAISES S, V9, P445; Wales B, 2012, NUCL INSTRUM METH A, V667, P11, DOI 10.1016/j.nima.2011.11.082	23	202	204	2	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1096	1100		10.1126/science.1240362	http://dx.doi.org/10.1126/science.1240362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009390				2022-12-28	WOS:000323933100040
J	Singh, P; Chokshi, DA				Singh, Prabhjot; Chokshi, Dave A.			Community Health Workers - A Local Solution to a Global Problem	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERA		[Singh, Prabhjot] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Singh, Prabhjot] Columbia Univ, Earth Inst, New York, NY USA; [Singh, Prabhjot] Mt Sinai Hosp, Dept Med, New York, NY 10029 USA; [Chokshi, Dave A.] Dept Vet Affairs, Washington, DC USA	Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai	Singh, P (corresponding author), Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA.			Chokshi, Dave/0000-0001-7467-4591				Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Kangovi S, 2012, ARCH INTERN MED, V172, P1756, DOI 10.1001/2013.jamainternmed.82; Mason T, 2011, AM J PUBLIC HEALTH, V101, P2211, DOI 10.2105/AJPH.2011.300402; Singh P, 2013, LANCET, V382, P363, DOI 10.1016/S0140-6736(12)62002-9; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0	5	60	60	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					894	896		10.1056/NEJMp1305636	http://dx.doi.org/10.1056/NEJMp1305636			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211KV	24004115				2022-12-28	WOS:000323906900004
J	Bhadula, R				Bhadula, Ragini			The Good Physician	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Loyola Univ, Med Ctr, Dept Pediat, Maywood, IL 60153 USA	Loyola University Chicago	Bhadula, R (corresponding author), Loyola Univ, Med Ctr, Dept Pediat, Maywood, IL 60153 USA.	rabhadula@lumc.edu							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					909	909		10.1001/jama.2013.276135	http://dx.doi.org/10.1001/jama.2013.276135			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002273				2022-12-28	WOS:000323885700017
J	Lane, R				Lane, Richard			Bill Frankland: active allergist at 101	LANCET			English	Biographical-Item																		FRANKLAND B, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 31	2013	382	9894					762	762		10.1016/S0140-6736(13)61821-8	http://dx.doi.org/10.1016/S0140-6736(13)61821-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23993179				2022-12-28	WOS:000324239200014
J	Wahren-Herlenius, M; Dorner, T				Wahren-Herlenius, Marie; Doener, Thomas			Autoimmune Rheumatic Diseases 3 Immunopathogenic mechanisms of systemic autoimmune disease	LANCET			English	Article							REGULATORY T-CELLS; PRIMARY SJOGRENS-SYNDROME; GENOME-WIDE ASSOCIATION; MEMORY B-CELL; LUPUS-ERYTHEMATOSUS; AUTOANTIBODY PRODUCTION; DENDRITIC CELLS; I INTERFERON; ANTIPHOSPHOLIPID SYNDROME; GENETIC SUSCEPTIBILITY	Systemic lupus erythematosus, Sjogren's syndrome, and dermatomyositis are systemic autoimmune diseases that develop after environmental triggering of genetically susceptible individuals. The precise cellular and molecular mechanisms leading to autoimmune disease, and what factors determine which organs are involved, remain poorly understood. Recent insights into genetic susceptibility now make obvious that environmental triggers often act via cellular pathways containing disease-associated polymorphisms. In the breaking of tolerance, the initiating tissue-including dendritic cells-provides a decisive microenvironment that affects immune-cell differentiation, leading to activation of adaptive immunity. Type 1 interferon produced by innate immune cells has a central role in systemic autoimmunity and activates B cells and T cells. In turn, B-cell-derived autoantibodies stimulate dendritic cells to produce type 1 interferon; thus, a positive feedforward loop is formed that includes both the innate and adaptive systems. New treatments could simultaneously and specifically target several such vital pathways in autoimmunity.	[Wahren-Herlenius, Marie] Karolinska Inst, Dept Med, Stockholm, Sweden; [Doener, Thomas] Charite, Dept Med Rheumatol & Clin Immunol CC12, D-10117 Berlin, Germany; [Doener, Thomas] Charite, Deutsch Rheumaforschungszentrum DRFZ, D-10117 Berlin, Germany	Karolinska Institutet; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dorner, T (corresponding author), Charite, D-10117 Berlin, Germany.	thomas.doerner@charite.de	Wahren-Herlenius, Marie/AAN-6942-2021	Wahren-Herlenius, Marie/0000-0002-0915-7245	DFG CRC initiative [(SFB) 633, (SFB) 650]; DFG [Do491/8-1, Do491/8-2, Do491/8-7, Do491/8-3]; SPP Immunobone; Swedish Research Council; Swedish Rheumatism Association; Swedish Heart Lung Foundation; King Gustaf Vth 80-year Foundation; Soderberg Foundation; Karolinska Institute	DFG CRC initiative(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); SPP Immunobone; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf Vth 80-year Foundation; Soderberg Foundation; Karolinska Institute(Karolinska Institutet)	This work was supported by DFG CRC initiative (SFB) 633 and 650, DFG Do491/8-1&2, 7-3, the SPP Immunobone, the Swedish Research Council, the Swedish Rheumatism Association, the Swedish Heart Lung Foundation, the King Gustaf Vth 80-year Foundation, the Soderberg Foundation, and Karolinska Institute.	Alexander T, 2009, BLOOD, V113, P214, DOI 10.1182/blood-2008-07-168286; Alunno A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/823085; Martinez-Zamora MA, 2012, ANN RHEUM DIS, V71, P61, DOI 10.1136/ard.2011.153817; Anolik JH, 2005, BEST PRACT RES CL RH, V19, P859, DOI 10.1016/j.berh.2005.05.006; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Aringer M, 2012, LUPUS, V21, P386, DOI 10.1177/0961203311426569; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Banica L, 2009, AUTOIMMUNITY, V42, P41, DOI 10.1080/08916930802282651; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blomberg S, 2001, LUPUS, V10, P484, DOI 10.1191/096120301678416042; Bolstad AI, 2012, ANN RHEUM DIS, V71, P981, DOI 10.1136/annrheumdis-2011-200446; Borchers AT, 2003, CLIN REV ALLERG IMMU, V25, P89, DOI 10.1385/CRIAI:25:1:89; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; Campbell AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004801; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Chang C, 2010, J AUTOIMMUN, V34, pJ266, DOI 10.1016/j.jaut.2009.11.012; Chinoy H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3327; Chinoy H, 2009, RHEUMATOLOGY, V48, P1213, DOI 10.1093/rheumatology/kep248; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Christodoulou MI, 2008, ANN RHEUM DIS, V67, pA12; Coomes SM, 2010, J IMMUNOL, V184, P5130, DOI 10.4049/jimmunol.0901871; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Dastmalchi M, 2008, ANN RHEUM DIS, V67, P1670, DOI 10.1136/ard.2007.077974; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Dorner T, 2001, ARTHRITIS RHEUM-US, V44, P2715, DOI 10.1002/1529-0131(200112)44:12<2715::AID-ART458>3.0.CO;2-L; Eriksson C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3258; Ettinger R, 2008, IMMUNOL REV, V223, P60, DOI 10.1111/j.1600-065X.2008.00631.x; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gerli R, 2009, AUTOIMMUN REV, V8, P426, DOI 10.1016/j.autrev.2009.01.004; Gigante A, 2011, EUR REV MED PHARMACO, V15, P15; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Gottenberg JE, 2003, ARTHRITIS RHEUM, V48, P2240, DOI 10.1002/art.11103; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Graham RR, 2007, EUR J HUM GENET, V15, P823, DOI 10.1038/sj.ejhg.5201827; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; Gris JC, 2012, BLOOD, V119, P2624, DOI 10.1182/blood-2011-09-381913; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Hutloff A, 2004, ARTHRITIS RHEUM-US, V50, P3211, DOI 10.1002/art.20519; Illei GG, 2010, ARTHRITIS RHEUM-US, V62, P542, DOI 10.1002/art.27221; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jacob CO, 2013, ARTHRITIS RHEUM-US, V65, P1043, DOI 10.1002/art.37846; Jacobi AM, 2010, ANN RHEUM DIS, V69, P305, DOI 10.1136/ard.2008.096495; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jiang C, 2011, J IMMUNOL, V186, P6136, DOI 10.4049/jimmunol.1001931; Joo H, 2012, J EXP MED, V209, P1335, DOI 10.1084/jem.20111644; Juedes AE, 2000, J IMMUNOL, V164, P419, DOI 10.4049/jimmunol.164.1.419; Julkunen H, 2001, ARTHRITIS RHEUM, V44, P647, DOI 10.1002/1529-0131(200103)44:3<647::AID-ANR113>3.3.CO;2-9; Klareskog L, 2010, ANN RHEUM DIS, V69, P2062, DOI 10.1136/ard.2010.142109; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Kwan BCH, 2009, RHEUMATOLOGY, V48, P1491, DOI 10.1093/rheumatology/kep255; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lee J, 2009, J IMMUNOL, V182, P4116, DOI 10.4049/jimmunol.0803391; Lessard CJ, 2012, ARTHRITIS RHEUM-US, V64, pS1133; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; de Padilla CML, 2008, CURR OPIN RHEUMATOL, V20, P669, DOI 10.1097/BOR.0b013e3283157538; Mariette X, 2004, ARTHRITIS RHEUM, V50, P1270, DOI 10.1002/art.20146; Meffre E, 2008, CURR OPIN IMMUNOL, V20, P632, DOI 10.1016/j.coi.2008.09.001; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Miller FW, 2011, ARTHRITIS RHEUM-US, V63, pS656; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Neyt K, 2012, TRENDS IMMUNOL, V33, P297, DOI 10.1016/j.it.2012.04.006; Nguyen CQ, 2008, ARTHRITIS RHEUM-US, V58, P734, DOI 10.1002/art.23214; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; RONNBLOM LE, 1991, ANN INTERN MED, V115, P178, DOI 10.7326/0003-4819-115-3-178; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; Sawalha AH, 2008, ANN RHEUM DIS, V67, P458, DOI 10.1136/ard.2007.075424; Scofield RH, 2009, CURR OPIN RHEUMATOL, V21, P448, DOI 10.1097/BOR.0b013e32832f0861; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Taylor KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001311; Tournadre A, 2012, ARTHRITIS RHEUM-US, V64, P533, DOI 10.1002/art.33350; Valencia X, 2007, NAT CLIN PRACT RHEUM, V3, P619, DOI 10.1038/ncprheum0624; Vaughn SE, 2012, J LEUKOCYTE BIOL, V92, P577, DOI 10.1189/jlb.0212095; Wong CK, 2008, CLIN IMMUNOL, V127, P385, DOI 10.1016/j.clim.2008.01.019; Yang J, 2009, ARTHRITIS RHEUM-US, V60, P1472, DOI 10.1002/art.24499; Youinou P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3348; Yu B, 2011, ARTHRITIS RHEUM-US, V63, P3487, DOI 10.1002/art.30595; Yurasov S, 2005, ANN NY ACAD SCI, V1062, P165, DOI 10.1196/annals.1358.019; Yurasov S, 2006, J EXP MED, V203, P2255, DOI 10.1084/jem.20061446; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	103	310	330	4	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					819	831		10.1016/S0140-6736(13)60954-X	http://dx.doi.org/10.1016/S0140-6736(13)60954-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23993191				2022-12-28	WOS:000324239200032
J	Hampson, NB; Courtney, TG; Holm, JR				Hampson, Neil B.; Courtney, Todd G.; Holm, James R.			Diffusion of Carbon Monoxide Through Gypsum Wallboard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hampson, Neil B.; Courtney, Todd G.; Holm, James R.] Virginia Mason Med Ctr, Ctr Hyperbar Med, Seattle, WA 98101 USA	Virginia Mason Medical Center	Hampson, NB (corresponding author), Virginia Mason Med Ctr, 1100 9th Ave,H4 CHM, Seattle, WA 98101 USA.	neil.hampson@vmmc.org						Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P1309; Emmerich SJ, MODELING AND MEASURI; Keshishian C, 2012, J PUBLIC HEALTH-UK, V34, P477, DOI 10.1093/pubmed/fds023; National Conference of State Legislation, CARBON MONOXIDE DETE; Rosen G, ANALYSIS OF PHYSICAL; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121	6	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					745	746		10.1001/jama.2013.43127	http://dx.doi.org/10.1001/jama.2013.43127			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989964	Bronze			2022-12-28	WOS:000323254500025
J	Chhabra, L; Abraham, GM; McGillicuddy, GT				Chhabra, Lovely; Abraham, George M.; McGillicuddy, Gerald T.			A nail in the head	LANCET			English	Editorial Material									[Chhabra, Lovely; Abraham, George M.] St Vincent Hosp, Dept Internal Med, Worcester, MA 01608 USA; [McGillicuddy, Gerald T.] St Vincent Hosp, Dept Neurosurg, Worcester, MA 01608 USA; Univ Massachusetts, Sch Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Chhabra, L (corresponding author), St Vincent Hosp, Dept Internal Med, Worcester, MA 01608 USA.	lovely.chhabra@hhchealth.org	Chhabra, Lovely/D-4487-2011	Chhabra, Lovely/0000-0002-9193-5981					0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 1	2014	383	9915					E10	E10		10.1016/S0140-6736(13)61899-1	http://dx.doi.org/10.1016/S0140-6736(13)61899-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303KS	24035249				2022-12-28	WOS:000330673700001
J	Lynskey, MT; Strang, J				Lynskey, Michael T.; Strang, John			The global burden of drug use and mental disorders	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; 21 REGIONS; DISEASE; INJURIES		[Lynskey, Michael T.; Strang, John] Kings Coll London, Natl Addict Ctr, London SE5 8BB, England	University of London; King's College London	Lynskey, MT (corresponding author), Kings Coll London, Natl Addict Ctr, London SE5 8BB, England.	Michael.lynskey@kcl.ac.uk	Strang, John/H-5460-2011; Lynskey, michael T/B-9179-2016	Strang, John/0000-0002-5413-2725; Lynskey, Michael/0000-0001-9989-737X				Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Baxter AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065514; Degenhardt L, 2004, COMP QUANTIFICATION, P1109; Degenhardt L, 2013, LANCET; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Degenhardt L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000133; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Frances AJ, 2013, BRIT J PSYCHIAT, V203, P1, DOI 10.1192/bjp.bp.113.127647; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Whiteford H. A., 2013, LANCET	13	12	15	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1540	1542		10.1016/S0140-6736(13)61781-X	http://dx.doi.org/10.1016/S0140-6736(13)61781-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247NE	23993279				2022-12-28	WOS:000326623900008
J	Bender, BS				Bender, Bradley S.			Prophylactic tenofovir reduced HIV infection in injectable drug users	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									North Florida South Georgia Vet Hlth Syst, Gainesville, FL USA		Bender, BS (corresponding author), North Florida South Georgia Vet Hlth Syst, Gainesville, FL USA.							[Anonymous], HIGH IMP HIV PREV CD; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Centers for Diease Control and Prevention, 2011, HIV SURV REP, V23; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC8	10.7326/0003-4819-159-6-201309170-02008	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042391				2022-12-28	WOS:000325625900007
J	Marx, V				Marx, Vivien			THE GENOME JIGSAW	NATURE			English	Editorial Material							EVOLUTION; SEQUENCE											Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Kirby A, 2013, NAT GENET, V45, P299, DOI 10.1038/ng.2543; Loomis EW, 2013, GENOME RES, V23, P121, DOI 10.1101/gr.141705.112; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Schatz MC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-243; Shendure J, 2012, NAT BIOTECHNOL, V30, P1084, DOI 10.1038/nbt.2421; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568	10	34	37	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					263	268		10.1038/501261a	http://dx.doi.org/10.1038/501261a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215XR	24025842	Bronze			2022-12-28	WOS:000324244900052
J	Roland, PS; Tobey, E				Roland, Peter S.; Tobey, Emily			A Tribute to a Remarkably Sound Solution	CELL			English	Editorial Material							COCHLEAR IMPLANTS	For their work on the development of the modern cochlear implant, which bestows hearing to individuals with profound deafness, Ingeborg Hochmair, Graeme Clark, and Blake Wilson are the 2013 recipients of the Lasker similar to DeBakey Clinical Medical Research Award.	[Roland, Peter S.] Univ Texas SW Med Ctr Dallas, Dept Otorhinolaryngol Head & Neck Surg, Dallas, TX 75235 USA; [Tobey, Emily] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75080 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas	Roland, PS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Otorhinolaryngol Head & Neck Surg, Dallas, TX 75235 USA.	peter.roland@Utsouthwestern.edu						Clark GM, 2008, J REHABIL RES DEV, V45, P651, DOI 10.1682/JRRD.2007.05.0064; DJOURNO A, 1957, PRESSE MED, V65, P1417; Keller H., 1933, H KELLER SCOTLAND; Lockwood L, 2003, BEETHOVEN MUSIC LIFE; Loizou PC, 1999, IEEE ENG MED BIOL, V18, P32, DOI 10.1109/51.740962; Mudry A, 2013, JAMA OTOLARYNGOL, V139, P446, DOI 10.1001/jamaoto.2013.293; Wilson BS, 2011, PROG BRAIN RES, V194, P117, DOI 10.1016/B978-0-444-53815-4.00012-1; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0	8	4	5	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1175	1177		10.1016/j.cell.2013.08.047	http://dx.doi.org/10.1016/j.cell.2013.08.047			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034237	Bronze			2022-12-28	WOS:000324239300002
J	Mead, GE; Hsieh, CF; Hackett, M				Mead, Gillian Elizabeth; Hsieh, Cheng-Fang; Hackett, Maree			Selective Serotonin Reuptake Inhibitors for Stroke Recovery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mead, Gillian Elizabeth] Royal Infirm, Dept Geriatr Med, Edinburgh, Midlothian, Scotland; [Hsieh, Cheng-Fang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Geriatr & Gerontol, Kaohsiung, Taiwan; [Hsieh, Cheng-Fang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hackett, Maree] Univ Sydney, George Inst Global Hlth, Neurol & Mental Hlth Div, Mental Hlth & Chron Dis Program, Sydney, NSW 2006, Australia; [Hackett, Maree] Univ Cent Lancashire, Preston PR1 2HE, Lancs, England	Royal Infirmary of Edinburgh; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; George Institute for Global Health; University of Sydney; University of Central Lancashire	Mead, GE (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Royal Infirm, Room S1642, Edinburgh EH16 4SA, Midlothian, Scotland.	Gillian.e.mead@ed.ac.uk	Hsieh, Cheng-Fang/AAD-6950-2019; Hackett, Maree L/O-8752-2016	Hsieh, Cheng-Fang/0000-0002-9101-0233; Hackett, Maree L/0000-0003-1211-9087	Medical Research Council [MR/K026992/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Coupland C, 2011, BMJ-BRIT MED J, V343, P4551; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Labos C, 2011, CAN MED ASSOC J, V183, P1835, DOI 10.1503/cmaj.100912; Mead GE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009286.pub2; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Pariente J, 2001, ANN NEUROL, V50, P718, DOI 10.1002/ana.1257; Royal College of Physicians, NAT CLIN GUID STROK	8	25	27	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1066	1067		10.1001/jama.2013.107828	http://dx.doi.org/10.1001/jama.2013.107828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	24026602	Green Submitted, Green Accepted			2022-12-28	WOS:000324133400024
J	Anguera, JA; Boccanfuso, J; Rintoul, JL; Al-Hashimi, O; Faraji, F; Janowich, J; Kong, E; Larraburo, Y; Rolle, C; Johnston, E; Gazzaley, A				Anguera, J. A.; Boccanfuso, J.; Rintoul, J. L.; Al-Hashimi, O.; Faraji, F.; Janowich, J.; Kong, E.; Larraburo, Y.; Rolle, C.; Johnston, E.; Gazzaley, A.			Video game training enhances cognitive control in older adults	NATURE			English	Article							DOWN SUPPRESSION DEFICIT; WORKING-MEMORY; DEFAULT NETWORK; BRAIN ACTIVITY; EEG DYNAMICS; DUAL-TASK; THETA; PLASTICITY; MULTITASKING; PERFORMANCE	Cognitive control is defined by a set of neural processes that allow us to interact with our complex environment in a goal-directed manner(1). Humans regularly challenge these control processes when attempting to simultaneously accomplish multiple goals (multitasking), generating interference as the result of fundamental information processing limitations(2). It is clear that multitasking behaviour has become ubiquitous in today's technologically dense world(3), and substantial evidence has accrued regarding multitasking difficulties and cognitive control deficits in our ageing population(4). Here we show that multitasking performance, as assessed with a custom-designed three-dimensional video game (NeuroRacer), exhibits a linear age-related decline from 20 to 79 years of age. By playing an adaptive version of NeuroRacer in multitasking training mode, older adults (60 to 85 years old) reduced multitasking costs compared to both an active control group and a no-contact control group, attaining levels beyond those achieved by untrained 20-year-old participants, with gains persisting for 6 months. Furthermore, age-related deficits in neural signatures of cognitive control, as measured with electroencephalography, were remediated by multitasking training (enhanced midline frontal theta power and frontal-posterior theta coherence). Critically, this training resulted in performance benefits that extended to untrained cognitive control abilities (enhanced sustained attention and working memory), with an increase in midline frontal theta power predicting the training-induced boost in sustained attention and preservation of multitasking improvement 6 months later. These findings highlight the robust plasticity of the prefrontal cognitive control system in the ageing brain, and provide the first evidence, to our knowledge, of how a custom-designed video game can be used to assess cognitive abilities across the lifespan, evaluate underlying neural mechanisms, and serve as a powerful tool for cognitive enhancement.	[Anguera, J. A.; Boccanfuso, J.; Rintoul, J. L.; Al-Hashimi, O.; Faraji, F.; Janowich, J.; Kong, E.; Larraburo, Y.; Rolle, C.; Johnston, E.; Gazzaley, A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Anguera, J. A.; Al-Hashimi, O.; Gazzaley, A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Anguera, J. A.; Boccanfuso, J.; Rintoul, J. L.; Al-Hashimi, O.; Faraji, F.; Janowich, J.; Kong, E.; Larraburo, Y.; Rolle, C.; Gazzaley, A.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94158 USA; [Gazzaley, A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Anguera, JA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	joaquin.anguera@ucsf.edu; adam.gazzaley@ucsf.edu		Janowich, Jacqueline/0000-0003-3443-589X; Rintoul, Jean/0000-0002-1963-7023; Anguera, Joaquin A./0000-0002-7216-0674; Claflin, Omar/0000-0003-2298-6571; Faraji, Farshid/0000-0003-3218-1347	Robert Wood Johnson Foundation; National Institute of Aging; UCSF Institutional Research and Career Development Award (IRACDA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040333] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UCSF Institutional Research and Career Development Award (IRACDA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Avila, N. Barbahiya, M. Gugel, B. Jensen, R. Moustafa, Y. Rezaeihaghighi, P. Sztybel, C. Vong, A. Wang, B. Yang and D. Yerukhimov for their help with data collection and analyses, and B. Benson for assistance with the NeuroRacer behavioral analysis stream. Thanks to D. Ellingson, N. Falstein, and M. Omernick for insights and support of NeuroRacer development. Thanks to J. Bollinger, J. Kalkstein, J. Mishra, B. Voytek and T. Zanto for support on ERSP and coherence analyses, and Z. Chadick, W. Clapp, J. Fung, M. Hough, E. Morsella, J. Pa, M. Rubens, P. Wais, C. Walsh, and D. Ziegler for helpful discussions. Thanks to all of our participants whose time and efforts made this work possible, and Apple who generously loaned the Gazzaley laboratory all of the MacBook Pro laptops used in this study. Support for this research was provided by the Robert Wood Johnson Foundation's Pioneer Portfolio through a grant from its national program, 'Health Games Research: Advancing Effectiveness of Interactive Games for Health' (A. G.) and the National Institute of Aging (A. G.). J. A. A. was supported by a UCSF Institutional Research and Career Development Award (IRACDA).	Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Berry AS, 2009, J NEUROPHYSIOL, V102, P1779, DOI 10.1152/jn.00179.2009; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bruns A, 2004, J NEUROSCI METH, V137, P321, DOI 10.1016/j.jneumeth.2004.03.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Clapp WC, 2011, P NATL ACAD SCI USA, V108, P7212, DOI 10.1073/pnas.1015297108; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dux PE, 2009, NEURON, V63, P127, DOI 10.1016/j.neuron.2009.06.005; Dye MWG, 2009, CURR DIR PSYCHOL SCI, V18, P321, DOI 10.1111/j.1467-8721.2009.01660.x; Erickson KI, 2007, NEUROBIOL AGING, V28, P272, DOI 10.1016/j.neurobiolaging.2005.12.012; Foehr U.G., 2006, MEDIA MULTITASKING A; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gazzaley A., 2013, PRINCIPLES FRONTAL L; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Greenberg LM, 1996, TOVA CONTINUOUS PERF; Hedges L.V., 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Klimesch W., 2006, EVENT RELATED DYNAMI, V159; Knapp TR., 2009, PRACT ASSESS RES EVA, V14, P6; Lussier M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00129; Macmillan NA., 1991, DETECTION THEORY USE; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Nigbur R, 2011, CLIN NEUROPHYSIOL, V122, P2185, DOI 10.1016/j.clinph.2011.03.030; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Sauseng P, 2007, EUR J NEUROSCI, V25, P587, DOI 10.1111/j.1460-9568.2006.05286.x; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Strobach T, 2012, ACTA PSYCHOL, V140, P13, DOI 10.1016/j.actpsy.2012.02.001; Tucker-Drob EA, 2008, PSYCHOL AGING, V23, P453, DOI 10.1037/0882-7974.23.2.453; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Wolinsky FD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061624; Zanto TP, 2010, NEUROPSYCHOLOGIA, V48, P13, DOI 10.1016/j.neuropsychologia.2009.08.003; Zelinski EM, 2009, RESTOR NEUROL NEUROS, V27, P455, DOI 10.3233/RNN-2009-0495	43	880	915	45	852	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					97	+		10.1038/nature12486	http://dx.doi.org/10.1038/nature12486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211ER	24005416	Green Submitted, Green Accepted			2022-12-28	WOS:000323888300039
J	Iqbal, MJ; Levy, R; Koop, EJ; Dekker, JB; de Jong, JP; van der Velde, JHM; Reuter, D; Wieck, AD; Aguado, R; Meir, Y; van der Wal, CH				Iqbal, M. J.; Levy, Roi; Koop, E. J.; Dekker, J. B.; de Jong, J. P.; van der Velde, J. H. M.; Reuter, D.; Wieck, A. D.; Aguado, Ramon; Meir, Yigal; van der Wal, C. H.			Odd and even Kondo effects from emergent localization in quantum point contacts	NATURE			English	Article							QUANTIZED CONDUCTANCE; DOT; TRANSPORT; SIGNATURES; FIELD	A quantum point contact (QPC) is a basic nanometre-scale electronic device: a short and narrow transport channel between two electron reservoirs. In clean channels, electron transport is ballistic and the conductance is then quantized as a function of channel width(1,2) with plateaux at integer multiples of 2e(2)/h (where e is the electron charge and h is Planck's constant). This can be understood in a picture where the electron states are propagating waves, without the need to account for electron-electron interactions. Quantized conductance could thus be the signature of ultimate control over nanoscale electron transport. However, even studies with the cleanest QPCs generically show significant anomalies in the quantized conductance traces, and there is consensus that these result from electron many-body effects(3,4). Despite extensive experimental and theoretical studies(4-11), understanding these anomalies is an open problem. Here we report that the many-body effects have their origin in one or more spontaneously localized states that emerge from Friedel oscillations in the electron charge density within the QPC channel. These localized states will have electron spins associated with them, and the Kondo effect-related to electron transport through such localized electron spins-contributes to the formation of the many-body state(5-7). We present evidence for such localization, with Kondo effects of odd or even character, directly reflecting the parity of the number of localized states; the evidence is obtained from experiments with length-tunable QPCs that show a periodic modulation of the many-body properties with Kondo signatures that alternate between odd and even Kondo effects. Our results are of importance for assessing the role of QPCs in more complex hybrid devices(12,13) and for proposals for spintronic and quantum information applications(14,15). In addition, our results show that tunable QPCs offer a versatile platform for investigating many-body effects in nanoscale systems, with the ability to probe such physics at the level of a single site.	[Iqbal, M. J.; Koop, E. J.; Dekker, J. B.; de Jong, J. P.; van der Velde, J. H. M.; van der Wal, C. H.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Levy, Roi; Meir, Yigal] Ben Gurion Univ Negev, Dept Phys, IL-84105 Beer Sheva, Israel; [Reuter, D.; Wieck, A. D.] Ruhr Univ Bochum, D-44780 Bochum, Germany; [Aguado, Ramon] CSIC, ICMM, E-28049 Madrid, Spain; [Meir, Yigal] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, IL-84105 Beer Sheva, Israel	University of Groningen; Ben Gurion University; Ruhr University Bochum; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Ben Gurion University	Iqbal, MJ (corresponding author), Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.	m.j.iqbal@rug.nl; c.h.van.der.wal@rug.nl	van der Wal, Caspar H./D-9206-2013; Institute, Zernike/W-7033-2019; MEIR, YIGAL/F-1888-2012; Aguado, Ramon/B-5516-2008; Wieck, Andreas Dirk D/C-5129-2009; Iqbal, M. Javaid/AAN-8624-2021	van der Wal, Caspar H./0000-0002-9843-3220; Aguado, Ramon/0000-0002-7464-7363; Wieck, Andreas Dirk D/0000-0001-9776-2922; Iqbal, M. Javaid/0000-0001-6073-3052; Meir, Yigal/0000-0003-1606-8969	Research School Ruhr-Universitat Bochum; BMBF QuaHL-Rep [16BQ1035]; Spanish Ministry of Economy and Innovation [FIS2009-08744, FIS2012-33521]; Higher Education Commission of Pakistan; ISF;  [DFG-SPP 1285]	Research School Ruhr-Universitat Bochum; BMBF QuaHL-Rep(Federal Ministry of Education & Research (BMBF)); Spanish Ministry of Economy and Innovation(Spanish Government); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); ISF(Israel Science Foundation); 	We thank B. J. van Wees, A. Aqeel, S. Ludwig, J. von Delft and Y. Komijani for discussions and B. Wolfs, J. Holstein and M. de Roosz for technical assistance. We acknowledge financial support from the German programmes DFG-SPP 1285, Research School Ruhr-Universitat Bochum and BMBF QuaHL-Rep 16BQ1035, and grants FIS2009-08744 and FIS2012-33521 from the Spanish Ministry of Economy and Innovation. M. J. I. acknowledges a scholarship from the Higher Education Commission of Pakistan. Y. M. and R. L. acknowledge support from the ISF.	Aguado R, 2000, PHYS REV LETT, V85, P1946, DOI 10.1103/PhysRevLett.85.1946; Aguado R, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.245307; Aono T, 1998, J PHYS SOC JPN, V67, P1860, DOI 10.1143/JPSJ.67.1860; Bagraev NT, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155315; Bertoni A, 2000, PHYS REV LETT, V84, P5912, DOI 10.1103/PhysRevLett.84.5912; Blaauboer M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160402; Burke AM, 2012, NANO LETT, V12, P4495, DOI 10.1021/nl301566d; Churchill HOH, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241401; Cronenwett SM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.226805; Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540; Georges A, 1999, PHYS REV LETT, V82, P3508, DOI 10.1103/PhysRevLett.82.3508; Goldhaber-Gordon D, 1998, NATURE, V391, P156, DOI 10.1038/34373; Ivanov T, 1997, EUROPHYS LETT, V40, P183, DOI 10.1209/epl/i1997-00443-7; Jeong H, 2001, SCIENCE, V293, P2221, DOI 10.1126/science.1063182; JONES BA, 1989, PHYS REV B, V39, P3415, DOI 10.1103/PhysRevB.39.3415; Kanisawa K, 2001, PHYS REV LETT, V86, P3384, DOI 10.1103/PhysRevLett.86.3384; Komijani Y, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/67010; Koop EJ, 2007, J SUPERCOND NOV MAGN, V20, P433, DOI 10.1007/s10948-007-0289-5; Meir Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.196802; Micolich AP, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/44/443201; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Pohjola T, 1997, EUROPHYS LETT, V40, P189, DOI 10.1209/epl/i1997-00444-0; Rejec T, 2006, NATURE, V442, P900, DOI 10.1038/nature05054; Simion GE, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045127; Thomas KJ, 1996, PHYS REV LETT, V77, P135, DOI 10.1103/PhysRevLett.77.135; Tombros N, 2011, NAT PHYS, V7, P697, DOI [10.1038/NPHYS2009, 10.1038/nphys2009]; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; Vernek E, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.035119; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002; Wu PM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.085305	30	59	59	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					79	+		10.1038/nature12491	http://dx.doi.org/10.1038/nature12491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23995683	Green Submitted			2022-12-28	WOS:000323888300035
J	Darmstadt, GL; Munar, W				Darmstadt, Gary L.; Munar, Wolfgang			Behavior Change and Community Participation Assessing Causal Pathways Affecting Neonatal Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; INTERVENTIONS; BANGLADESH; SETTINGS	IMPORTANCE Community-based interventions can reduce neonatal mortality when health systems are weak. Population coverage of target groups may be an important determinant of their effect on behavior and mortality. A women's group trial at coverage of 1 group per 1414 population in rural Bangladesh showed no effect on neonatal mortality, despite a similar intervention having a significant effect on neonatal and maternal death in comparable settings. OBJECTIVE To assess the effect of a participatory women's group intervention with higher population coverage on neonatal mortality in Bangladesh. DESIGN A cluster randomized controlled trial in 9 intervention and 9 control clusters. SETTING Rural Bangladesh. PARTICIPANTS Women permanently residing in 18 unions in 3 districts and accounting for 19 301 births during the final 24 months of the intervention. INTERVENTIONS Women's groups at a coverage of 1 per 309 population that proceed through a participatory learning and action cycle in which they prioritize issues that affected maternal and neonatal health and design and implement strategies to address these issues. MAIN OUTCOMES AND MEASURES Neonatal mortality rate. RESULTS Analysis included 19 301 births during the final 24 months of the intervention. More than one-third of newly pregnant women joined the groups. The neonatal mortality rate was significantly lower in the intervention arm (21.3 neonatal deaths per 1000 live births vs 30.1 per 1000 in control areas), a reduction in neonatal mortality of 38%(risk ratio, 0.62 [95% CI, 0.43-0.89]) when adjusted for socioeconomic factors. The cost-effectiveness was US $220 to $393 per year of life lost averted. Cause-specific mortality rates suggest reduced deaths due to infections and those associated with prematurity/low birth weight. Improvements were seen in hygienic home delivery practices, newborn thermal care, and breastfeeding practices. CONCLUSIONS AND RELEVANCE Women's group community mobilization, delivered at adequate population coverage, is a highly cost-effective approach to improve newborn survival and health behavior indicators in rural Bangladesh.	[Darmstadt, Gary L.; Munar, Wolfgang] Bill & Melinda Gates Fdn, Family Hlth Program, Div Global Dev, Seattle, WA 98006 USA	Bill & Melinda Gates Foundation	Darmstadt, GL (corresponding author), Bill & Melinda Gates Fdn, POB 23350, Seattle, WA 98006 USA.	gary.darmstadt@gatesfoundation.org	Darmstadt, Gary/AAU-7488-2020; Munar, Wolfgang/R-3484-2018	Darmstadt, Gary/0000-0002-7522-5824; Munar, Wolfgang/0000-0002-9234-987X				Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bryce J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001423; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Fottrell E, 2013, JAMA PEDIATR, V167, P816, DOI 10.1001/jamapediatrics.2013.2534; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Kumar V, 2010, SEMIN PERINATOL, V34, P446, DOI 10.1053/j.semperi.2010.09.006; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0	11	1	1	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					969	970		10.1001/jama.2013.277269	http://dx.doi.org/10.1001/jama.2013.277269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002283				2022-12-28	WOS:000323885700027
J	Atroshi, I; Flondell, M; Hofer, M; Ranstam, J				Atroshi, Isam; Flondell, Magnus; Hofer, Manfred; Ranstam, Jonas			Methylprednisolone Injections for the Carpal Tunnel Syndrome A Randomized, Placebo-Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							LOCAL STEROID INJECTION; SURGERY; HEALTH; HAND; SAFE	Background: Steroid injections are used in idiopathic carpal tunnel syndrome (CTS), but evidence of efficacy beyond 1 month is lacking. Objective: To assess the efficacy of local methylprednisolone injections in CTS. Design: Randomized, placebo-controlled trial. (ClinicalTrials.gov: NCT00806871) Setting: Regional referral orthopedic department in Sweden. Patients: Patients aged 18 to 70 years with CTS but no previous steroid injections. Intervention: Three groups (37 patients each) received 80 mg of methylprednisolone, 40 mg of methylprednisolone, or placebo. The patients and treating surgeons were blinded. Measurements: Primary end points were the change in CTS symptom severity scores at 10 weeks (range, 1 to 5) and rate of surgery at 1 year. Three patients had missing 10-week data. All patients had 1-year data. Results: Improvement in CTS symptom severity scores at 10 weeks was greater in patients who received 80 mg of methylprednisolone and 40 mg of methylprednisolone than in those who received placebo (difference in change from baseline, -0.64 [95% CI, -1.06 to -0.21; P = 0.003] and -0.88 [CI, -1.30 to -0.46; P < 0.001], respectively), but there were no significant differences at 1 year. The 1-year rates of surgery were 73%, 81%, and 92% in the 80-mg methylprednisolone, 40-mg methylprednisolone, and placebo groups, respectively. Compared with patients who received placebo, those who received 80 mg of methylprednisolone were less likely to have surgery (odds ratio, 0.24 [CI, 0.06 to 0.95]; P = 0.042). With time to surgery incorporated, both the 80- and 40-mg methylprednisolone groups had lower likelihood of surgery (hazard ratio, 0.46 [CI, 0.27 to 0.77; P = 0.003] and 0.57 [CI, 0.35 to 0.94; P = 0.026], respectively). Limitation: The study was conducted at 1 center, and wrist splinting had previously failed for all patients. Conclusion: Methylprednisolone injections for CTS have significant benefits in relieving symptoms at 10 weeks and reducing the rate of surgery 1 year after treatment, but 3 out of 4 patients had surgery within 1 year.	Hassleholm Hosp, SE-28125 Hassleholm, Sweden; Kristianstad Hosp, Kristianstad, Sweden; Lund Univ, Lund, Sweden	Lund University	Atroshi, I (corresponding author), Hassleholm Hosp, Dept Orthoped, SE-28125 Hassleholm, Sweden.	Isam.Atroshi@skane.se; jonas.ranstam@med.lu.se	Ranstam, Jonas/A-4386-2009; Flondell, Magnus/AAB-9565-2020	Ranstam, Jonas/0000-0002-8287-7273; Flondell, Magnus/0000-0003-4215-4561	Region of Scania Research and Development Foundation; Hassleholm Hospital Organization	Region of Scania Research and Development Foundation; Hassleholm Hospital Organization	Region of Scania Research and Development Foundation and Hassleholm Hospital Organization.	Armstrong T, 2004, MUSCLE NERVE, V29, P82, DOI 10.1002/mus.10512; Atroshi I, 2007, J HAND SURG-BRIT EUR, V32E, P198, DOI 10.1016/j.jhsb.2006.11.002; Atroshi I, 2006, BRIT MED J, V332, P1473, DOI 10.1136/bmj.38863.632789.1F; Atroshi I, 2011, ARCH INTERN MED, V171, P943, DOI 10.1001/archinternmed.2011.203; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Beaton DE, 2005, J BONE JOINT SURG AM, V87A, P1038, DOI 10.2106/JBJS.D.02060; Benson LS, 2006, ARTHROSCOPY, V22, P919, DOI 10.1016/j.arthro.2006.05.008; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Dammers JWHH, 1999, BRIT MED J, V319, P884, DOI 10.1136/bmj.319.7214.884; Flondell M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-76; Gelfman R, 2009, NEUROLOGY, V72, P33, DOI 10.1212/01.wnl.0000338533.88960.b9; Hui ACF, 2005, NEUROLOGY, V64, P2074, DOI 10.1212/01.WNL.0000169017.79374.93; Huisstede BM, 2010, ARCH PHYS MED REHAB, V91, P981, DOI 10.1016/j.apmr.2010.03.022; Jarvik JG, 2009, LANCET, V374, P1074, DOI 10.1016/S0140-6736(09)61517-8; Kamanli A, 2011, BRATISL MED J, V112, P337; KATZ JN, 1990, J HAND SURG-AM, V15A, P360, DOI 10.1016/0363-5023(90)90124-A; Katz JN, 1998, AM J IND MED, V33, P543, DOI 10.1002/(SICI)1097-0274(199806)33:6<543::AID-AJIM4>3.0.CO;2-R; KAY NRM, 1992, J HAND SURG-AM, V17A, P1160, DOI 10.1016/S0363-5023(09)91085-1; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Leinberry CF, 2012, J HAND SURG-AM, V37A, P1997, DOI 10.1016/j.jhsa.2012.07.016; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; Ly-Pen D, 2005, ARTHRITIS RHEUM-US, V52, P612, DOI 10.1002/art.20767; Marshall S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001554.pub2; Peters-Veluthamaningal C, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-54; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447; Tolonen U, 2007, ACTA NEUROL SCAND, V115, P390, DOI 10.1111/j.1600-0404.2007.00799.x	26	58	63	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2013	159	5					309	+		10.7326/0003-4819-159-5-201309030-00004	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215YA	24026316				2022-12-28	WOS:000324245900001
J	Bolton, CT; Stoll, HM				Bolton, Clara T.; Stoll, Heather M.			Late Miocene threshold response of marine algae to carbon dioxide limitation	NATURE			English	Article							CONCENTRATING MECHANISMS; CO2; IMPACT; PHOTOSYNTHESIS; PHYTOPLANKTON; FRACTIONATION; EVOLUTION	Coccolithophores are marine algae that use carbon for calcification and photosynthesis. The long-term adaptation of these and other marine algae to decreasing carbon dioxide levels during the Cenozoic era(1) has resulted in modern algae capable of actively enhancing carbon dioxide at the site of photosynthesis. This enhancement occurs through the transport of dissolved bicarbonate (HCO3-) and with the help of enzymes whose expression can be modulated by variable aqueous carbon dioxide concentration, [CO2], in laboratory cultures(2,3). Coccolithophores preserve the geological history of this adaptation because the stable carbon and oxygen isotopic compositions of their calcite plates (coccoliths), which are preserved in the fossil record, are sensitive to active carbon uptake and transport by the cell. Here we use a model of cellular carbon fluxes and show that at low [CO2] the increased demand for HCO3- at the site of photosynthesis results in a diminished allocation of HCO3- to calcification, which is most pronounced in larger cells. This results in a large divergence between the carbon isotopic compositions of small versus large coccoliths only at low [CO2]. Our evaluation of the oxygen and carbon isotope record of size-separated fossil coccoliths reveals that this isotopic divergence first arose during the late Miocene to the earliest Pliocene epoch (about 7-5 million years ago). We interpret this to be a threshold response of the cells' carbon acquisition strategies to decreasing [CO2]. The documented coccolithophore response is synchronous with a global shift in terrestrial vegetation distribution between 8 and 5 Myr ago, which has been interpreted by some studies as a floral response to decreasing partial pressures of carbon dioxide (p(CO2)) in the atmosphere(4-6). We infer a global decrease in carbon dioxide levels for this time interval that has not yet been identified in the sparse p(CO2) proxy record(7) but is synchronous with global cooling and progressive glaciations(8,9).	[Bolton, Clara T.; Stoll, Heather M.] Univ Oviedo, Dept Geol, E-33005 Oviedo, Asturias, Spain	University of Oviedo	Bolton, CT (corresponding author), Univ Oviedo, Dept Geol, Jesus Arias de Velasco S-N, E-33005 Oviedo, Asturias, Spain.	cbolton@geol.uniovi.es; hstoll@geol.uniovi.es	Stoll, Heather M/G-9066-2012	Stoll, Heather M/0000-0002-2953-7835; Bolton, Clara/0000-0002-3078-1253	US National Science Foundation; European Research Council [UE-09-ERC-2009-STG-240222-PACE]; DuPont Young Professor Award	US National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); DuPont Young Professor Award	We thank L. Abrevaya and A. Mendez for laboratory assistance, and K. Lawrence for access to unpublished data. This work used samples provided by the (Integrated) Ocean Drilling Program (IODP). The IODP is sponsored by the US National Science Foundation and participating countries under management of the IODP Management International, Inc. Funding for this research was provided by European Research Council grant UE-09-ERC-2009-STG-240222-PACE (H. M. S.) and a DuPont Young Professor Award to H.M.S.	Bach LT, 2013, NEW PHYTOL, V199, P121, DOI 10.1111/nph.12225; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Bolton CT, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002339; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; DUDLEY WC, 1986, MAR MICROPALEONTOL, V10, P1, DOI 10.1016/0377-8398(86)90021-6; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Huang YS, 2007, GEOLOGY, V35, P531, DOI 10.1130/G23666A.1; Kameo K, 2000, MAR MICROPALEONTOL, V39, P201, DOI 10.1016/S0377-8398(00)00021-9; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; LaRiviere JP, 2012, NATURE, V486, P97, DOI 10.1038/nature11200; Laws EA, 2002, FUNCT PLANT BIOL, V29, P323, DOI 10.1071/PP01183; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pagani M, 2011, SCIENCE, V334, P1261, DOI 10.1126/science.1203909; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Preiss-Daimler I, 2012, J MICROPALAEONTOL, V31, P169, DOI 10.1144/0262-821X11-014; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Rickaby REM, 2010, CLIM PAST, V6, P771, DOI 10.5194/cp-6-771-2010; Rost B, 2002, LIMNOL OCEANOGR, V47, P120, DOI 10.4319/lo.2002.47.1.0120; Schneider B, 2006, EARTH PLANET SC LETT, V246, P367, DOI 10.1016/j.epsl.2006.04.028; Stoll H, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001546; Stoll HM, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001046; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P744, DOI 10.4319/lo.2000.45.3.0744; van de Wal RSW, 2011, CLIM PAST, V7, P1459, DOI 10.5194/cp-7-1459-2011; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang CF, 2009, EARTH PLANET SC LETT, V287, P311, DOI 10.1016/j.epsl.2009.08.025; Zhang Y. G., 2002, PHIL T R SO IN PRESS; Ziveri P, 2012, BIOGEOSCIENCES, V9, P1025, DOI 10.5194/bg-9-1025-2012; Ziveri P, 2003, EARTH PLANET SC LETT, V210, P137, DOI 10.1016/S0012-821X(03)00101-8	31	112	112	3	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					558	562		10.1038/nature12448	http://dx.doi.org/10.1038/nature12448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23985873	Green Submitted			2022-12-28	WOS:000323625900030
J	Swedlow, JR				Swedlow, Jason R.			At the (Kineto)chore, Yeast Really Are Like People	CELL			English	Editorial Material							KINETOCHORE-MICROTUBULE ATTACHMENT; BUDDING YEAST; MICROSCOPY		Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Dundee	Swedlow, JR (corresponding author), Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland.	jrswedlow@dundee.ac.uk		Swedlow, Jason/0000-0002-2198-1958	Biotechnology and Biological Sciences Research Council [BB/H013024/1] Funding Source: Medline; Medical Research Council [MR/K015869/1] Funding Source: Medline; Wellcome Trust [095931/Z/11/Z, 095931] Funding Source: Medline; BBSRC [BB/H013024/1] Funding Source: UKRI; MRC [MR/K015869/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Marco E, 2013, CELL, V154, P1127, DOI 10.1016/j.cell.2013.08.008; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5	10	0	0	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					959	961		10.1016/j.cell.2013.08.012	http://dx.doi.org/10.1016/j.cell.2013.08.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993089	Bronze			2022-12-28	WOS:000323767300010
J	Kendall, T; Megnin-Viggars, O; Gould, N; Taylor, C; Burt, LR; Baird, G				Kendall, Tim; Megnin-Viggars, Odette; Gould, Nick; Taylor, Clare; Burt, Lucy R.; Baird, Gillian		Guideline Dev Grp	Management of autism in children and young people: summary of NICE and SCIE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPECTRUM DISORDERS; SPECIAL NEEDS; PREVALENCE		[Kendall, Tim; Megnin-Viggars, Odette; Taylor, Clare; Burt, Lucy R.] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [Kendall, Tim] UCL, London WC1E 7HB, England; [Gould, Nick] Social Care Inst Excellence, London SW1Y 5BH, England; [Gould, Nick] Univ Bath, Dept Social & Policy Sci, Bath BA2 7AY, Avon, England; [Gould, Nick] Griffith Univ, Sch Human Serv & Social Work, Meadowbrook, Qld 4131, Australia; [Baird, Gillian] Guys & St Thomas NHS Fdn Trust, London WC2R 2LS, England; [Baird, Gillian] Kings Coll London, Kings Hlth Partners, London WC2R 2LS, England	University of London; University College London; University of London; University College London; University of Bath; Griffith University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Kendall, T (corresponding author), Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England.	tim2.kendall@virgin.net	Howlin, Patricia/A-7622-2011; MAVRANEZOULI, IFIGENEIA/C-2430-2008	MAVRANEZOULI, IFIGENEIA/0000-0001-9095-3566; Green, Jonathan/0000-0002-0143-181X; Megnin-Viggars, Odette/0000-0002-2152-0721	Medical Research Council [MR/K005863/1, G0401546] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Bancroft K, 2012, WAY WE ARE AUTISM; Charman T, 2011, PSYCHOL MED, V41, P619, DOI 10.1017/S0033291710000991; Department of Health, 2008, REF CAR PROGR APPR; Francis J, 2010, SICE RES BRIEF 32 AC; Knapp M, 2009, AUTISM, V13, P317, DOI 10.1177/1362361309104246; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; National Autistic Society, 2003, NAT AUT PLAN CHILDR NAT AUT PLAN CHILDR; National Autistic Society, 2010, YOU NEED KNWO; National Institute for Health and Care Excellence, 2011, AUT DIAGN CHILDR YOU; National Institute for Health and Care Excellence, 2012, AUT REC REF DIAGN MA; National Institute for Health and Care Excellence, 2013, AUT MAN SUPP CHILDR; Scottish Intercollegiate Guidelines Network, 2007, ASS DIAGN CLIN INT C; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Welsh Assembly Government, 2009, AUT SPECTR DIS ASD S	15	38	39	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2013	347								f4865	10.1136/bmj.f4865	http://dx.doi.org/10.1136/bmj.f4865			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211CC	23985309	Green Published			2022-12-28	WOS:000323880700006
J	Gonzalez, N; Trevino, MG; Martinez, HR; Silva, GR				Gonzalez, Nelly; Guadalupe Trevino, Maria; Martinez, Hector R.; Rivera Silva, Gerardo			Cysticercal encephalitis	LANCET			English	Editorial Material									[Gonzalez, Nelly; Guadalupe Trevino, Maria; Martinez, Hector R.; Rivera Silva, Gerardo] Univ Monterrey, Div Hlth Sci, Monterrey, NL, Mexico	Universidad de Monterrey	Silva, GR (corresponding author), Av I Morones Prieto 4500 Pte, San Pedro Garza Garcia 66238, NL, Mexico.	gerardo.rivera@udem.edu.mx	Silva, Gerardo Rivera/AAH-6871-2021	Silva, Gerardo Rivera/0000-0003-2587-5914					0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 25	2014	383	9914					342	342		10.1016/S0140-6736(13)60691-1	http://dx.doi.org/10.1016/S0140-6736(13)60691-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296VD	23992918				2022-12-28	WOS:000330212600033
J	Clark, GM; Clark, JCM; Furness, JB				Clark, Graeme M.; Clark, Jonathan C. M.; Furness, John B.			The Evolving Science of Cochlear Implants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Clark, Graeme M.; Clark, Jonathan C. M.] Univ Melbourne, Ctr Excellence Life Sci, Parkville, Vic 3010, Australia; [Furness, John B.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Clark, GM (corresponding author), Univ Melbourne, Ctr Excellence Life Sci, Parkville, Vic 3010, Australia.	gclark@unimelb.edu.au	Furness, John B/B-2763-2016	Furness, John B/0000-0002-0219-3438				Allitt BJ, 2012, HEARING RES, V287, P30, DOI 10.1016/j.heares.2012.04.004; Chan WO, 2011, ARCH OPHTHALMOL-CHIC, V129, P1247, DOI 10.1001/archophthalmol.2011.255; Clark G M, 2001, Cochlear Implants Int, V2, P75, DOI 10.1179/cim.2001.2.2.75; Clark G M, 1988, Acta Otolaryngol Suppl, V448, P1; Clark GM, 2006, PHILOS T R SOC B, V361, P791, DOI 10.1098/rstb.2005.1782; Kang SY, 2009, OTOL NEUROTOL, V30, P160, DOI 10.1097/MAO.0b013e318191b6f7; Nomura M, 2011, J PHARMACOL SCI, V117, P243, DOI 10.1254/jphs.11099FP	7	21	22	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1225	1226		10.1001/jama.2013.278142	http://dx.doi.org/10.1001/jama.2013.278142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24018758				2022-12-28	WOS:000324751800013
J	Friedland, GH; Naidoo, P; Abdool-Gafoor, B; Moosa, MYS; Ramdial, PK; Gandhi, RT				Friedland, Gerald H.; Naidoo, Pumersha; Abdool-Gafoor, Bilal; Moosa, Mahomed-Yunus S.; Ramdial, Pratistadevi K.; Gandhi, Rajesh T.			Case 29-2013: A 32-Year-Old HIV-Positive African Man with Dyspnea and Skin Lesions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PULMONARY KAPOSI-SARCOMA; AIDS-RELATED LYMPHOMA; IMMUNE RECONSTITUTION; SOUTH-AFRICA; RISK; TUBERCULOSIS; INFECTION; FEATURES; COHORT	A 32-year-old man with HIV infection was admitted to a hospital in South Africa because of progressively worsening skin lesions, dyspnea, and cough. A CD4+ T-cell count was 268 per cubic millimeter. Diagnostic procedures were performed. Presentation of CaseDr. Emily K. Wong (Medicine, Massachusetts General Hospital): A 32-year-old man with human immunodeficiency virus (HIV) infection was admitted to a hospital in Durban, South Africa, because of dyspnea and cough. The hospital is associated with Massachusetts General Hospital. Five months before admission, the patient was seen in an outpatient clinic in South Africa for evaluation of a lesion on his left upper eyelid. On examination, violaceous, raised lesions were present on the left eyelid and right side of the chest (Figure 1A).Dr. Pratistadevi K. Ramdial: Pathological examination of an excisional biopsy specimen of the chest ...	[Friedland, Gerald H.] Yale New Haven Med Ctr, AIDS Program, New Haven, CT 06504 USA; [Friedland, Gerald H.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Friedland, Gerald H.] Yale Univ, Sch Med, Dept Epidemiol, New Haven, CT 06510 USA; [Friedland, Gerald H.] Yale Univ, Dept Med, Sch Publ Hlth, New Haven, CT 06520 USA; [Friedland, Gerald H.] Yale Univ, Sch Publ Hlth, Dept Epidemiol, New Haven, CT USA; [Naidoo, Pumersha] King Edward VIII Hosp, Dept Radiol, Durban, South Africa; [Abdool-Gafoor, Bilal; Moosa, Mahomed-Yunus S.] King Edward VIII Hosp, Dept Resp Med, Durban, South Africa; [Naidoo, Pumersha] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Radiol, Durban, South Africa; [Abdool-Gafoor, Bilal; Moosa, Mahomed-Yunus S.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Resp Med, Durban, South Africa; [Abdool-Gafoor, Bilal] Inkosi Albert Luthuli Hosp, Dept Resp Med, Durban, South Africa; [Ramdial, Pratistadevi K.] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Dept Anat Pathol, Durban, South Africa; [Ramdial, Pratistadevi K.] Natl Hlth Lab Serv, Durban, South Africa; [Gandhi, Rajesh T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Gandhi, Rajesh T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gandhi, Rajesh T.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA	Yale University; Yale University; Yale University; Yale University; Yale University; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Friedland, GH (corresponding author), Yale New Haven Med Ctr, AIDS Program, 20 York St, New Haven, CT 06504 USA.				Harvard University Center for AIDS Research [NIH P30 AI060354]; McCord Hospital (Durban); University of KwaZulu-Natal; South African HIV Clinicians Society; Department of Health, KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	Harvard University Center for AIDS Research; McCord Hospital (Durban); University of KwaZulu-Natal; South African HIV Clinicians Society; Department of Health, KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Rajesh T. Gandhi, M. D., was the guest editor for this case, which was presented at the Sixth Annual Workshop on Advanced Clinical Care-AIDS in Durban, South Africa (and organized by Drs. Henry Sunpath, Mahomed-Yunus S. Moosa, Francois Venter, and Rajesh T. Gandhi). The workshop was sponsored by the Harvard University Center for AIDS Research (NIH P30 AI060354), McCord Hospital (Durban), the University of KwaZulu-Natal, the South African HIV Clinicians Society, and the Department of Health, KwaZulu-Natal.	Aboulafia DM, 2000, CHEST, V117, P1128, DOI 10.1378/chest.117.4.1128; [Anonymous], 2012, GLOB TUB REP 2012; Bihl F, 2007, AIDS, V21, P1245, DOI 10.1097/QAD.0b013e328182df03; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Borok M, 2010, CLIN INFECT DIS, V51, P342, DOI 10.1086/654800; Bower M, 2009, AIDS, V23, P1701, DOI 10.1097/QAD.0b013e32832d080d; Dezube BJ, 1996, HEMATOL ONCOL CLIN N, V10, P1023, DOI 10.1016/S0889-8588(05)70382-8; Dittmer DP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00141; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Foudraine NA, 1999, AIDS, V13, P177, DOI 10.1097/00002030-199902040-00005; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; GARAY SM, 1987, CHEST, V91, P39, DOI 10.1378/chest.91.1.39; Glesby MJ, 1996, J INFECT DIS, V173, P1477, DOI 10.1093/infdis/173.6.1477; Godoy MCB, 2007, AM J ROENTGENOL, V189, P956, DOI 10.2214/AJR.07.2458; Krown SE, 2011, CURR OPIN ONCOL, V23, P463, DOI 10.1097/CCO.0b013e328349428d; Krown SE, 2011, J INFECT DIS, V203, P1082, DOI 10.1093/infdis/jiq177; Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/eri.11.21, 10.1586/ERI.11.21]; Letang E, 2010, JAIDS-J ACQ IMM DEF, V53, P589, DOI 10.1097/QAI.0b013e3181bc476f; Levine AM, 2000, BLOOD, V96, P4084; Mocroft A, 1996, AIDS, V10, P1101; Mosam A, 2008, INT J STD AIDS, V19, P400, DOI 10.1258/ijsa.2008.007301; Mosam A, 2009, INT J STD AIDS, V20, P553, DOI 10.1258/ijsa.2008.008372; Mosam A, 2012, JAIDS-J ACQ IMM DEF, V60, P150, DOI 10.1097/QAI.0b013e318251aedd; Palmieri C, 2006, HIV MED, V7, P291, DOI 10.1111/j.1468-1293.2006.00378.x; Shah RM, 1997, RADIOGRAPHICS, V17, P804; Shenoi SV, 2010, CLIN INFECT DIS, V50, pS231, DOI 10.1086/651496; SIDER L, 1989, RADIOLOGY, V171, P629, DOI 10.1148/radiology.171.3.2717733; Sullivan SG, 2010, AIDS, V24, P2245, DOI 10.1097/QAD.0b013e32833b7830; Yoo Deok Jong, 2005, Korean Journal of Internal Medicine, V20, P290	29	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1152	1161		10.1056/NEJMcpc1305985	http://dx.doi.org/10.1056/NEJMcpc1305985			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047065				2022-12-28	WOS:000324554800014
J	Stanton, TP; Shaw, WJ; Truffer, M; Corr, HFJ; Peters, LE; Riverman, KL; Bindschadler, R; Holland, DM; Anandakrishnan, S				Stanton, T. P.; Shaw, W. J.; Truffer, M.; Corr, H. F. J.; Peters, L. E.; Riverman, K. L.; Bindschadler, R.; Holland, D. M.; Anandakrishnan, S.			Channelized Ice Melting in the Ocean Boundary Layer Beneath Pine Island Glacier, Antarctica	SCIENCE			English	Article							WEST ANTARCTICA; SHELF; SHEET	Ice shelves play a key role in the mass balance of the Antarctic ice sheets by buttressing their seaward-flowing outlet glaciers; however, they are exposed to the underlying ocean and may weaken if ocean thermal forcing increases. An expedition to the ice shelf of the remote Pine Island Glacier, a major outlet of the West Antarctic Ice Sheet that has rapidly thinned and accelerated in recent decades, has been completed. Observations from geophysical surveys and long-term oceanographic instruments deployed down bore holes into the ocean cavity reveal a buoyancy-driven boundary layer within a basal channel that melts the channel apex by 0.06 meter per day, with near-zero melt rates along the flanks of the channel. A complex pattern of such channels is visible throughout the Pine Island Glacier shelf.	[Stanton, T. P.; Shaw, W. J.] Naval Postgrad Sch, Dept Oceanog, Monterey, CA 93943 USA; [Truffer, M.] Univ Alaska, Inst Geophys, Fairbanks, AK 99775 USA; [Corr, H. F. J.] British Antarctic Survey, Cambridge CB3 OET, England; [Peters, L. E.; Riverman, K. L.; Anandakrishnan, S.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Peters, L. E.; Riverman, K. L.; Anandakrishnan, S.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Bindschadler, R.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Holland, D. M.] NYU, Dept Math, New York, NY 10012 USA	United States Department of Defense; United States Navy; Naval Postgraduate School; University of Alaska System; University of Alaska Fairbanks; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; New York University	Stanton, TP (corresponding author), Naval Postgrad Sch, Dept Oceanog, Monterey, CA 93943 USA.	stanton@nps.edu			NSF's Office of Polar Programs under NSF [ANT-0732926]; NASA's Cryospheric Sciences Program; New York University Abhu Dabi grant [1204]; Natural Environment Research Council-British Antarctic Survey Polar Science for Planet Earth Program; Natural Environment Research Council [bas0100027] Funding Source: researchfish	NSF's Office of Polar Programs under NSF; NASA's Cryospheric Sciences Program(National Aeronautics & Space Administration (NASA)); New York University Abhu Dabi grant; Natural Environment Research Council-British Antarctic Survey Polar Science for Planet Earth Program; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Data presented here are archived with the supplementary materials and also as a MATLAB data structure at www.oc.nps.edu/similar to stanton/pig/data/data.html/PIGSITE1_first35days. The authors acknowledge the contributions of J. Stockel in software development and deployment of the ocean instruments, D. Pomraning in designing and manning the hot-water drill equipment, and M. Shortt for making the British Antarctic Survey pRES field measurements. Outstanding logistic and safety support was provided by K. Gibbon, D. Einerson, E. Steinarsson, F. Mcarthy, S. Consalvi, the PIG support camp personnel, and the NSF Antarctic support team. This research project was supported by NSF's Office of Polar Programs under NSF grants including ANT-0732926, funding from NASA's Cryospheric Sciences Program, New York University Abhu Dabi grant 1204, and the Natural Environment Research Council-British Antarctic Survey Polar Science for Planet Earth Program.	Bamber JL, 2009, SCIENCE, V324, P901, DOI 10.1126/science.1169335; Bindschadler R, 2011, CRYOSPHERE, V5, P569, DOI 10.5194/tc-5-569-2011; Bindschadler R, 2011, J GLACIOL, V57, P581, DOI 10.3189/002214311797409802; Dutrieux P., 2013, CRYOSPHERE DISCUSS, V7, P1591; Gladish CV, 2012, J GLACIOL, V58, P1227, DOI 10.3189/2012JoG12J003; Haran T., 2005, MODERATE RESOLUTION; Jacobs SS, 1996, GEOPHYS RES LETT, V23, P957, DOI 10.1029/96GL00723; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Trowbridge JH, 1998, J PHYS OCEANOGR, V28, P2075, DOI 10.1175/1520-0485(1998)028<2075:DOTBBL>2.0.CO;2; Vaughan DG, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2012JF002360; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126	17	72	73	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 13	2013	341	6151					1236	1239		10.1126/science.1239373	http://dx.doi.org/10.1126/science.1239373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031016				2022-12-28	WOS:000324248800042
J	Pronin, SV; Reiher, CA; Shenvi, RA				Pronin, Sergey V.; Reiher, Christopher A.; Shenvi, Ryan A.			Stereoinversion of tertiary alcohols to tertiary-alkyl isonitriles and amines	NATURE			English	Article							DERIVATIVES; SOLVOLYSIS; CATALYSTS; EXCHANGE; CARBON	The S(N)2 reaction (bimolecular nucleophilic substitution) is a well-known chemical transformation that can be used to join two smaller molecules together into a larger molecule or to exchange one functional group for another. The S(N)2 reaction proceeds in a very predictable manner: substitution occurs with inversion of stereochemistry, resulting from the 'backside attack' of the electrophilic carbon by the nucleophile. A significant limitation of the S(N)2 reaction is its intolerance for tertiary carbon atoms: whereas primary and secondary alcohols are viable precursor substrates, tertiary alcohols and their derivatives usually either fail to react or produce stereochemical mixtures of products(1-3). Here we report the stereochemical inversion of chiral tertiary alcohols with a nitrogenous nucleophile facilitated by a Lewis-acid-catalysed solvolysis. The method is chemoselective against secondary and primary alcohols, thereby complementing the selectivity of the S(N)2 reaction. Furthermore, this method for carbon-nitrogen bond formation mimics a putative biosynthetic step in the synthesis of marine terpenoids(4) and enables their preparation from the corresponding terrestrial terpenes. We expect that the general attributes of the methodology will allow chiral tertiary alcohols to be considered viable substrates for stereoinversion reactions.	[Pronin, Sergey V.; Reiher, Christopher A.; Shenvi, Ryan A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Shenvi, RA (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	rshenvi@scripps.edu	Shenvi, Ryan/AAT-9451-2021	Shenvi, Ryan/0000-0001-8353-6449; Reiher, Christopher/0000-0002-6171-3480	Eli Lilly; Boehringer Ingelheim; Scripps Research Institute	Eli Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); Scripps Research Institute	We thank C. Moore and A. L. Rheingold for X-ray crystallographic analysis. We thank the Yu laboratory for the use of their liquid chromatography-mass spectrometry equipment, the Boger laboratory for the use of their polarimeter, the Baran laboratory for the use of their cold room. Financial support for this work was provided by Eli Lilly, Boehringer Ingelheim and the Scripps Research Institute.	BUNTON CA, 1950, NATURE, V166, P680, DOI 10.1038/166680a0; Castellanos L, 2007, TETRAHEDRON, V63, P1544, DOI 10.1016/j.tet.2006.12.019; COREY EJ, 1987, J AM CHEM SOC, V109, P287, DOI 10.1021/ja00235a052; Dewick P.M., 2009, MED NATURAL PRODUCTS; Ferraris D, 1997, J AM CHEM SOC, V119, P4319, DOI 10.1021/ja963090+; Garson MJ, 2004, NAT PROD REP, V21, P164, DOI 10.1039/b302359c; HAGADONE MR, 1984, J AM CHEM SOC, V106, P2447, DOI 10.1021/ja00320a044; HUGHES ED, 1950, NATURE, V166, P679, DOI 10.1038/166679a0; Jewett J.G., 1965, J AM CHEM SOC, V87, P1384; Kitano Y, 2002, J CHEM SOC PERK T 1, P2251, DOI 10.1039/b206705f; Kitano Y, 1998, TETRAHEDRON LETT, V39, P1911, DOI 10.1016/S0040-4039(98)00045-8; KOBAYASHI S, 1993, TETRAHEDRON LETT, V34, P3755, DOI 10.1016/S0040-4039(00)79220-3; Kobayashi S, 1998, J AM CHEM SOC, V120, P8287, DOI 10.1021/ja980715q; Kochi T, 2004, J AM CHEM SOC, V126, P15652, DOI 10.1021/ja044753n; Lanza G, 2000, J AM CHEM SOC, V122, P12764, DOI 10.1021/ja000571r; Mascal M, 2010, J AM CHEM SOC, V132, P10662, DOI 10.1021/ja103880c; Masutani K, 2006, B CHEM SOC JPN, V79, P1106, DOI 10.1246/bcsj.79.1106; Miyaoka H, 1998, TETRAHEDRON, V54, P13467, DOI 10.1016/S0040-4020(98)00818-7; Nishikawa K, 2010, ORG LETT, V12, P904, DOI 10.1021/ol9027336; Pronin SV, 2012, J AM CHEM SOC, V134, P19604, DOI 10.1021/ja310129b; Pronin SV, 2012, NAT CHEM, V4, P915, DOI [10.1038/nchem.1458, 10.1038/NCHEM.1458]; Rauk A, 2001, J CHEM SOC PERK T 2, P869, DOI 10.1039/b102019f; Richard JP, 2001, ORG LETT, V3, P2225, DOI 10.1021/ol016103j; Rubenbauer P, 2009, CHEM COMMUN, P2130, DOI 10.1039/b901937e; SASAKI T, 1981, J ORG CHEM, V46, P5445, DOI 10.1021/jo00339a050; Srikrishna A, 2009, SYNLETT, P32, DOI 10.1055/s-0028-1087382; Stevens PG, 1939, J AM CHEM SOC, V61, P1295, DOI 10.1021/ja01874a508; White RD, 2004, ORG LETT, V6, P1123, DOI 10.1021/ol049918b; WINSTEIN S, 1956, J AM CHEM SOC, V78, P328, DOI 10.1021/ja01583a022; WINSTEIN S, 1955, J AM CHEM SOC, V77, P5562, DOI 10.1021/ja01626a037	30	107	107	5	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					195	199		10.1038/nature12472	http://dx.doi.org/10.1038/nature12472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24025839				2022-12-28	WOS:000324244900035
J	Zurawski, J; Akhondi, H				Zurawski, Jonathan; Akhondi, Hossein			Tolosa-Hunt syndrome-a rare cause of headache and ophthalmoplegia	LANCET			English	Editorial Material							CAVERNOUS SINUS; CRITERIA		[Zurawski, Jonathan; Akhondi, Hossein] Medstar Washington Hosp Ctr, Dept Med, Washington, DC 20010 USA	MedStar Washington Hospital Center	Zurawski, J (corresponding author), Medstar Washington Hosp Ctr, Dept Med, 110 Irving St NW,2A-38E, Washington, DC 20010 USA.	jdz@georgetown.edu						Cakirer S, 2003, EUR J RADIOL, V45, P83, DOI 10.1016/S0720-048X(02)00012-8; Colnaghi S, 2008, CEPHALALGIA, V28, P577, DOI 10.1111/j.1468-2982.2008.01569.x; HUNT WE, 1961, NEUROLOGY, V11, P56, DOI 10.1212/WNL.11.1.56; Iaconetta G, 2005, CEPHALALGIA, V25, P746, DOI 10.1111/j.1468-2982.2005.00924.x; La Mantia L, 2006, CEPHALALGIA, V26, P772, DOI 10.1111/j.1468-2982.2006.01115.x	5	14	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 7	2013	382	9895					912	912		10.1016/S0140-6736(13)61442-7	http://dx.doi.org/10.1016/S0140-6736(13)61442-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215WE	24012271				2022-12-28	WOS:000324240700033
J	Kim, JY; Chan, M				Kim, Jim Yong; Chan, Margaret			Poverty, Health, and Societies of the Future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kim, Jim Yong] World Bank Grp, Washington, DC 20433 USA; [Chan, Margaret] WHO, CH-1211 Geneva, Switzerland	The World Bank; World Health Organization	Kim, JY (corresponding author), World Bank Grp, 1818 H St NW, Washington, DC 20433 USA.	jdonnelly1@worldbank.org						Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Institute for Health Metrics and Evaluation, THE GLOBAL BURDEN OF; Kim JY, 2013, CALIF SER PUB ANTHR, V26, P184; *WHO, WORLD HEALTH REPORT; World Health Organization, WORLD HEALTH STATIST; World Health Organization, GLOBAL UPDATE ON HIV; Xu K, 2013, DESIGNING HEALTH FIN; Yates R, 2009, LANCET, V373, P2078, DOI 10.1016/S0140-6736(09)60258-0	8	9	9	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					901	902		10.1001/jama.2013.276910	http://dx.doi.org/10.1001/jama.2013.276910			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002269				2022-12-28	WOS:000323885700013
J	von Hillebrandt-Andrade, C				von Hillebrandt-Andrade, Christa			Minimizing Caribbean Tsunami Risk	SCIENCE			English	Editorial Material									US Natl Ocean & Atmospher Adm NOAA, Natl Weather Serv, Caribbean Tsunami Warning Program, Mayaguez, PR 00680 USA	National Oceanic Atmospheric Admin (NOAA) - USA	von Hillebrandt-Andrade, C (corresponding author), US Natl Ocean & Atmospher Adm NOAA, Natl Weather Serv, Caribbean Tsunami Warning Program, 259 Alfonso Valdes Residences 1B-2A, Mayaguez, PR 00680 USA.	christa.vonh@noaa.gov						Braun J. J., 2012, EOS T AGU, V93, P89, DOI [10. 1029/2012EO090001, DOI 10.1029/2012EO090001]; Hoechner A, 2013, NAT HAZARD EARTH SYS, V13, P1285, DOI 10.5194/nhess-13-1285-2013; IOC, 2013, IOC TECHN SER, V73; IOC, 2013, EWS7 ICGCARIBE IOC; McNamara DE, 2009, SEISMOL RES LETT, V80, P628, DOI 10.1785/gssrl.80.4.628; NOAA National Geophysical Data Center, NOAA WDS GLOB HIST T; Proenza XW, 2010, J TSUNAMI SOC INT, V29, P70; UNESCO Intergovernmental Oceanographic Commission (IOC), 2005, 21 SESS ASS REP GOV	8	11	11	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					966	968		10.1126/science.1238943	http://dx.doi.org/10.1126/science.1238943			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990549				2022-12-28	WOS:000323652300028
J	Mehta, SR				Mehta, Shamir R.			Cangrelor: a new CHAMPION for percutaneous coronary intervention	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; PLATELET INHIBITION; CLOPIDOGREL; THERAPY; PCI; PRETREATMENT; TICAGRELOR; PRASUGREL; ASPIRIN		McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; Population Health Research Institute	Mehta, SR (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	smehta@mcmaster.ca						Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Harrington RA, 2009, NEW ENGL J MED, V361, P2318, DOI 10.1056/NEJMoa0908628; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Steg PG, 2013, LANCET, V382, P1981, DOI 10.1016/S0140-6736(13)61615-3; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	15	3	3	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1960	1962		10.1016/S0140-6736(13)61840-1	http://dx.doi.org/10.1016/S0140-6736(13)61840-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269EI	24011550				2022-12-28	WOS:000328223700008
J	Pandit, MK				Pandit, Maharaj K.			The Himalayas must be protected	NATURE			English	Editorial Material									[Pandit, Maharaj K.] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Pandit, Maharaj K.] Univ Delhi, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India	University of Delhi; University of Delhi	Pandit, MK (corresponding author), Univ Delhi, Dept Environm Studies, Delhi 110007, India.	rajkpandit@gmail.com	Pandit, Maharaj K/A-4065-2014	Pandit, Maharaj K/0000-0001-6611-560X					0	16	17	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					283	283		10.1038/501283a	http://dx.doi.org/10.1038/501283a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	219XT	24048033	Bronze			2022-12-28	WOS:000324545700004
J	Erickson, KF; Chertow, GM; Goldhaber-Fiebert, JD				Erickson, Kevin F.; Chertow, Glenn M.; Goldhaber-Fiebert, Jeremy D.			Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; RENAL-DISEASE; HEALTH; PROGRESSION; SURVIVAL	Background: In the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) trial, tolvaptan significantly reduced expansion of kidney volume and loss of kidney function. Objective: To determine how the benefits of tolvaptan seen in TEMPO may relate to longer-term health outcomes, such as progression to end-stage renal disease (ESRD) and death, and cost-effectiveness. Design: A decision-analytic model. Data Sources: Published literature from 1993 to 2012. Target Population: Persons with early autosomal dominant polycystic kidney disease. Time Horizon: Lifetime. Perspective: Societal. Intervention: Patients received tolvaptan therapy until death, development of ESRD, or liver complications or no tolvaptan therapy. Outcome Measures: Median age at ESRD onset, life expectancy, discounted quality-adjusted life-years and lifetime costs (in 2010 U.S. dollars), and incremental cost-effectiveness ratios. Results of Base-Case Analysis: Tolvaptan prolonged the median age at ESRD onset by 6.5 years and increased life expectancy by 2.6 years. At $5760 per month, tolvaptan cost $744 100 per quality-adjusted life-year gained compared with standard care. Results of Sensitivity Analysis: For patients with autosomal dominant polycystic kidney disease that progressed more slowly, the cost per quality-adjusted life-year gained was even greater for tolvaptan. Limitation: Although TEMPO followed patients for 3 years, the main analysis assumed that clinical benefits persisted over patients' lifetimes. Conclusion: Assuming that the benefits of tolvaptan persist in the longer term, the drug may slow progression to ESRD and reduce mortality rates. However, barring an approximately 95% reduction in price, cost-effectiveness does not compare favorably with many other commonly accepted medical interventions.	Stanford Univ, Sch Med, Ctr Hlth Policy, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University	Erickson, KF (corresponding author), Stanford Univ, Sch Med, 117 Encina Commons, Stanford, CA 94305 USA.	kevine1@stanford.edu		Chertow, Glenn/0000-0002-7599-0534; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	Agency for Healthcare Research and Quality [F32 HS019178]; National Institutes of Health [DK085446, AG037593]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS019178] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R33CA094304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK085446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: By the Agency for Healthcare Research and Quality (F32 HS019178) and National Institutes of Health (DK085446 and AG037593).	[Anonymous], 2012, NEPHROLOGY NEWS 1205; [Anonymous], 2010, CLIN LAB FEE SCHED; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Centers for Medicare and Medicaid Services, 2011, PHYS FEE SCHED; Congressional Budget Office, 2005, PRIC BRAND NAM DRUGS; Fick-Brosnahan GM, 2002, AM J KIDNEY DIS, V39, P1127, DOI 10.1053/ajkd.2002.33379; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gorodetskaya I, 2005, KIDNEY INT, V68, P2801, DOI 10.1111/j.1523-1755.2005.00752.x; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Levy M, 2000, KIDNEY INT, V58, P925, DOI 10.1046/j.1523-1755.2000.00250.x; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; NKF, 2012, NEPHROLOGY NEWS 1127; Perkovic V, 2012, NEW ENGL J MED, V367, P2541, DOI 10.1056/NEJMe1212368; Perrone RD, 2001, AM J KIDNEY DIS, V38, P777, DOI 10.1053/ajkd.2001.27720; Rizk D, 2009, CLIN J AM SOC NEPHRO, V4, P560, DOI 10.2215/CJN.02410508; Schrier RW, 2003, KIDNEY INT, V63, P678, DOI 10.1046/j.1523-1755.2003.00776.x; Smith DH, 2007, INTERNET J NEPHROLOG, V4; Thomson PDR, 2010, RED BOOK PHARM FUNDA; Tokiwa S, 2011, CLIN EXP NEPHROL, V15, P539, DOI 10.1007/s10157-011-0428-y; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; U.S. Food and Drug Administration, 2013, FDA DRUG SAF PODC FD; U.S. Renal Data System, 2011, US REN DAT SYST 2011, VOne; US Department of Labor Bureau of Labor Statistics, 2011, CONS PRIC IND ALL UR; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253	26	41	44	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					382	+		10.7326/0003-4819-159-6-201309170-00004	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042366	Green Accepted			2022-12-28	WOS:000325625900014
J	London, AJ; Parker, LS; Aronson, JD				London, Alex John; Parker, Lisa S.; Aronson, Jay D.			DNA Identification After Conflict or Disaster	SCIENCE			English	Editorial Material							REMAINS		[London, Alex John] Carnegie Mellon Univ, Ctr Eth & Policy, Pittsburgh, PA 15213 USA; [Parker, Lisa S.] Univ Pittsburgh, Ctr Bioeth & Hlth Law, Pittsburgh, PA 15260 USA; [Aronson, Jay D.] Carnegie Mellon Univ, Dept Hist, Ctr Human Rights Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	London, AJ (corresponding author), Carnegie Mellon Univ, Ctr Eth & Policy, Pittsburgh, PA 15213 USA.	ajlondon@andrew.cmu.edu		Parker, Lisa/0000-0003-2401-2359; London, Alex/0000-0002-6450-0309	NHGRI NIH HHS [R01 HG005702] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005702] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Berglund Eva C, 2011, Investig Genet, V2, P23, DOI 10.1186/2041-2223-2-23; Corach D, 1997, ELECTROPHORESIS, V18, P1608, DOI 10.1002/elps.1150180921; Crettol Monique, 2006, INT REV RED CROSS, V88, P355, DOI DOI 10.1017/S1816383106000567; ICRC, 2009, MISS PEOPL DNA AN ID; ICRC, 2003, INT C MISS THEIR FAM; Knoppers BM, 2006, J LAW MED ETHICS, V34, P352, DOI 10.1111/j.1748-720X.2006.00040.x; McEntire D.A., 2012, INT J MASS EMERGENCI, V30, P301; Morgan OW, 2006, PLOS MED, V3, P809, DOI 10.1371/journal.pmed.0030195; Parker LS, 2013, FORENSIC SCI INT-GEN, V7, P221, DOI 10.1016/j.fsigen.2012.10.002; Robins S., 2013, FAMILIES MISSING TES; Stover E., 2002, INT REV RED CROSS, V84, P845, DOI DOI 10.1017/S1560775500104201; Wagner Sarah, 2008, KNOW HE LIES DNA TEC; Weitz S, 2009, FORENS SCI INT-GEN S, V2, P245, DOI 10.1016/j.fsigss.2009.08.135; Yardley Jim, 2013, NEW YORK TIMES  0630, pA1	14	8	8	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1178	1179		10.1126/science.1238085	http://dx.doi.org/10.1126/science.1238085			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215ZA	24031004				2022-12-28	WOS:000324248800023
J	Ran, FA; Hsu, PD; Lin, CY; Gootenberg, JS; Konermann, S; Trevino, AE; Scott, DA; Inoue, A; Matoba, S; Zhang, Y; Zhang, F				Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Trevino, Alexandro E.; Scott, David A.; Inoue, Azusa; Matoba, Shogo; Zhang, Yi; Zhang, Feng			Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity	CELL			English	Article							NUCLEASE; SYSTEM; CELLS; GENERATION; KNOCKOUT; BACTERIA	Targeted genome editing technologies have enabled a broad range of research and medical applications. The Cas9 nuclease from the microbial CRISPR-Cas system is targeted to specific genomic loci by a 20 nt guide sequence, which can tolerate certain mismatches to the DNA target and thereby promote undesired off-target mutagenesis. Here, we describe an approach that combines a Cas9 nickase mutant with paired guide RNAs to introduce targeted double-strand breaks. Because individual nicks in the genome are repaired with high fidelity, simultaneous nicking via appropriately offset guide RNAs is required for double-stranded breaks and extends the number of specifically recognized bases for target cleavage. We demonstrate that using paired nicking can reduce off-target activity by 50- to 1,500-fold in cell lines and to facilitate gene knockout in mouse zygotes without sacrificing on-target cleavage efficiency. This versatile strategy enables a wide variety of genome editing applications that require high specificity.	[Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Trevino, Alexandro E.; Scott, David A.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Scott, David A.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Scott, David A.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Ran, F. Ann; Hsu, Patrick D.; Lin, Chie-Yu; Gootenberg, Jonathan S.; Konermann, Silvana; Scott, David A.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Ran, F. Ann; Hsu, Patrick D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lin, Chie-Yu] Harvard Univ, Sch Med, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; [Inoue, Azusa; Matoba, Shogo; Zhang, Yi] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Inoue, Azusa; Matoba, Shogo; Zhang, Yi] Harvard Univ, Sch Med, Program Cellular & Mol Med, Boston, MA 02115 USA; [Inoue, Azusa; Matoba, Shogo; Zhang, Yi] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Inoue, Azusa; Matoba, Shogo; Zhang, Yi] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Gootenberg, Jonathan/AAY-8174-2021; Hsu, Patrick/ABD-5749-2021; MATOBA, Shogo/D-9995-2016; Macrae, Rhiannon/AAX-1536-2020	Gootenberg, Jonathan/0000-0003-2757-2175; MATOBA, Shogo/0000-0003-0474-232X; Hsu, Patrick/0000-0002-9380-2648; Zhang, Yi/0000-0002-2789-0811	National Institute of General Medical Sciences [T32GM007753]; NIH [GM68804, U01DK089565, 1DP1-MH100706, 1R01-DK097768]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK089565, R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Joshua Weinstein and Yinqing Li for statistical consultation, Xuebing Wu and Phillip Sharp for assistance with northern blotting experiments, Su Vora for help with the manuscript, and the entire Zhang lab for their support and advice. P.D.H. is a James Mills Pierce Fellow. C.-Y.L. is supported by T32GM007753 from the National Institute of General Medical Sciences. D.A.S. is an NSF predoctoral fellow. A.I. and S.M. are research fellows for Research Abroad of the Japan Society for the Promotion of Science. Y.Z. is supported by NIH grants GM68804 and U01DK089565 and is an Investigator of the Howard Hughes Medical Institute. F.Z. is supported by an NIH Director's Pioneer Award (1DP1-MH100706), a NIH Transformative R01 grant (1R01-DK097768), the Keck, McKnight, Damon Runyon, Searle Scholars, Klingen-stein, Vallee, and Simons Foundations, Bob Metcalfe, and Jane Pauley.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hsu PD, 2012, ACS CHEM NEUROSCI, V3, P603, DOI 10.1021/cn300089k; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Shirogane Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2252; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	40	2179	2639	30	1213	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1380	1389		10.1016/j.cell.2013.08.021	http://dx.doi.org/10.1016/j.cell.2013.08.021			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	23992846	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000324239300024
J	Van Laethem, F; Tikhonova, AN; Pobezinsky, LA; Tai, XG; Kimura, MY; Le Saout, C; Guinter, TI; Adams, A; Sharrow, SO; Bernhardt, G; Feigenbaum, L; Singer, A				Van Laethem, Francois; Tikhonova, Anastasia N.; Pobezinsky, Leonid A.; Tai, Xuguang; Kimura, Motoko Y.; Le Saout, Cecile; Guinter, Terry I.; Adams, Anthony; Sharrow, Susan O.; Bernhardt, Guenter; Feigenbaum, Lionel; Singer, Alfred			Lck Availability during Thymic Selection Determines the Recognition Specificity of the T Cell Repertoire	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TYROSINE KINASE P56(LCK); ANTIGEN RECEPTOR; AMINO-ACIDS; GAMMA-DELTA; CD4; MHC; ACTIVATION; ADHESION; P56LCK	Thymic selection requires signaling by the protein tyrosine kinase Lck to generate T cells expressing alpha beta T cell antigen receptors (TCR). For reasons not understood, the thymus selects only alpha beta TCR that are restricted by major histocompatibility complex (MHC)-encoded determinants. Here, we report that Lck proteins that were coreceptor associated promoted thymic selection of conventionally MHC-restricted TCR, but Lck proteins that were coreceptor free promoted thymic selection of MHC-independent TCR. Transgenic TCR with MHC-independent specificity for CD155 utilized coreceptor-free Lck to signal thymic selection in the absence of MHC, unlike any transgenic TCR previously described. Thus, the thymus can select either MHC-restricted or MHC-independent alpha beta TCR depending on whether Lck is coreceptor associated or coreceptor free. We conclude that the intracellular state of Lck determines the specificity of thymic selection and that Lck association with coreceptor proteins during thymic selection is the mechanism by which MHC restriction is imposed on a randomly generated alpha beta TCR repertoire.	[Van Laethem, Francois; Tikhonova, Anastasia N.; Pobezinsky, Leonid A.; Tai, Xuguang; Kimura, Motoko Y.; Guinter, Terry I.; Adams, Anthony; Sharrow, Susan O.; Singer, Alfred] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Le Saout, Cecile] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany; [Feigenbaum, Lionel] NCI Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp Frederick, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Singer, A (corresponding author), NCI, Expt Immunol Branch, Bethesda, MD 20892 USA.	singera@nih.gov	Tikhonova, Anastasia/F-1186-2015; Bernhardt, Günter/F-6946-2012	Bernhardt, Günter/0000-0002-0510-2853	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC009273, ZIABC011114, ZIABC011112, ZIABC011116, ZIABC011111, ZIABC011106, ZIABC011113] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Richard Hodes, Hyun Park, and Ruth Etzensperger for critically reading the manuscript; Joy Williams for thymic epithelial cell preparations; and Peter Sun and Jinghua Lu for helpful discussion. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; Chien YH, 2007, IMMUNOL REV, V215, P46, DOI 10.1111/j.1600-065X.2006.00470.x; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Gray DHD, 2008, J IMMUNOL METHODS, V329, P56, DOI 10.1016/j.jim.2007.09.010; Hanada KI, 2011, BLOOD, V117, P4816, DOI 10.1182/blood-2010-11-317743; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Holland SJ, 2012, P NATL ACAD SCI USA, V109, pE3111, DOI 10.1073/pnas.1210882109; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Lee YJ, 2011, TRENDS IMMUNOL, V32, P50, DOI 10.1016/j.it.2010.12.004; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PAIGE LA, 1993, J BIOL CHEM, V268, P8669; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAO A, 1984, CELL, V36, P879, DOI 10.1016/0092-8674(84)90037-0; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Van Laethem F, 2012, TRENDS IMMUNOL, V33, P437, DOI 10.1016/j.it.2012.05.006; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Wiest DL, 1996, IMMUNITY, V4, P495, DOI 10.1016/S1074-7613(00)80415-X	38	79	80	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1326	1341		10.1016/j.cell.2013.08.009	http://dx.doi.org/10.1016/j.cell.2013.08.009			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034254	Green Accepted, Bronze			2022-12-28	WOS:000324239300020
J	Metzelthin, SF; van Rossum, E; de Witte, LP; Ambergen, AW; Hobma, SO; Sipers, W; Kempen, GIJM				Metzelthin, Silke F.; van Rossum, Erik; de Witte, Luc P.; Ambergen, Antonius W.; Hobma, Sjoerd O.; Sipers, Walther; Kempen, Gertrudis I. J. M.			Effectiveness of interdisciplinary primary care approach to reduce disability in community dwelling frail older people: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FUNCTIONAL DECLINE; ELDERLY-PEOPLE; UNITED-STATES; HOME VISITS; HEALTH-CARE; SCALE; MANAGEMENT; PROGRAM; INTERVENTIONS; SUPPORT	Objective To evaluate whether an interdisciplinary primary care approach for community dwelling frail older people is more effective than usual care in reducing disability and preventing (further) functional decline. Design Cluster randomised controlled trial. Setting 12 general practices in the south of the Netherlands Participants 346 frail older people (score >= 5 on Groningen Frailty Indicator) were included; 270 (78%) completed the study. Interventions General practices were randomised to the intervention or control group. Practices in the control group delivered care as usual. Practices in the intervention group implemented the "Prevention of Care" (PoC) approach, in which frail older people received a multidimensional assessment and interdisciplinary care based on a tailor made treatment plan and regular evaluation and follow-up. Main outcome measures The primary outcome was disability, assessed at 24 months by means of the Groningen Activity Restriction Scale. Secondary outcomes were depressive symptomatology, social support interactions, fear of falling, and social participation. Outcomes were measured at baseline and at 6, 12, and 24 months' follow-up. Results 193 older people in the intervention group (six practices) received the PoC approach; 153 older people in the control group (six practices) received care as usual. Follow-up rates for patients were 91% (n=316) at six months, 86% (n=298) at 12 months, and 78% (n=270) at 24 months. Mixed model multilevel analyses showed no significant differences between the two groups with regard to disability (primary outcome) and secondary outcomes. Pre-planned subgroup analyses confirmed these results. Conclusions This study found no evidence for the effectiveness of the PoC approach. The study contributes to the emerging body of evidence that community based care in frail older people is a challenging task. More research in this field is needed.	[Metzelthin, Silke F.; Kempen, Gertrudis I. J. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Serv Res Focusing Chron Care & Ageing, NL-6200 MD Maastricht, Netherlands; [van Rossum, Erik] Zuyd Univ Appl Sci, Ctr Res Auton & Participat, NL-6400 AN Heerlen, Netherlands; [de Witte, Luc P.] Zuyd Univ Appl Sci, Ctr Res Technol Care, Heerlen, Netherlands; [Ambergen, Antonius W.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Methodol & Stat, NL-6200 MD Maastricht, Netherlands; [Hobma, Sjoerd O.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Sipers, Walther] Orbis Med Ctr, NL-6130 MB Sittard, Netherlands	Maastricht University; Maastricht University; Maastricht University; Orbis Medical Center	Metzelthin, SF (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Serv Res Focusing Chron Care & Ageing, POB 616, NL-6200 MD Maastricht, Netherlands.	s.metzelthin@maastrichtuniversity.nl	Kempen, Gertrudis I/H-5978-2016; De+Witte, Luc/AAI-3518-2020; Kempen, Gertrudis/Y-8796-2019	Kempen, Gertrudis I/0000-0002-7053-2198; De+Witte, Luc/0000-0002-3013-2640; Kempen, Gertrudis/0000-0002-7053-2198; Sipers, Walther/0000-0003-3031-5735	Dutch National Care for the Elderly Programme by The Netherlands Organisation for Health Research and Development [ZonMw 311070301]; Netherlands Organisation for Scientific Research (NWO)	Dutch National Care for the Elderly Programme by The Netherlands Organisation for Health Research and Development; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research is funded by the Dutch National Care for the Elderly Programme by The Netherlands Organisation for Health Research and Development (ZonMw 311070301). It is an initiative of the Dutch Ministry of Health, Welfare and Sport to improve the quality of care for frail older people (www.nationaalprogrammaouderenzorg.nl). Open access of this publication was financed by the Netherlands Organisation for Scientific Research (NWO).	Bergman H, 2002, AGING CLIN EXP RES, V14, P223; Bernabei R, 1998, BMJ-BRIT MED J, V316, P1348, DOI 10.1136/bmj.316.7141.1348; Bouman A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-74; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Coleman EA, 2002, AGING CLIN EXP RES, V14, P233; Daniels R., 2011, THESIS MAASTRICHT U; Daniels R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-69; Daniels R, 2011, CLIN REHABIL, V25, P963, DOI 10.1177/0269215511410728; Daniels R, 2010, EUR J AGEING, V7, P37, DOI 10.1007/s10433-010-0141-9; Derckx E., 2006, TIJDSCHRIFT VERPLEEG, V3, P26; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Elkan R, 2001, BMJ-BRIT MED J, V323, P719, DOI 10.1136/bmj.323.7315.719; Fletcher AE, 2004, LANCET, V364, P1667, DOI 10.1016/S0140-6736(04)17353-4; Fletcher AE, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-21; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Glasgow RE, 2006, HEALTH PROMOT INT, V21, P245, DOI 10.1093/heapro/dal017; Hallberg IR, 2004, J CLIN NURS, V13, P112, DOI 10.1111/j.1365-2702.2004.01054.x; Huss A, 2008, J GERONTOL A-BIOL, V63, P298, DOI 10.1093/gerona/63.3.298; Keating N, 2003, AGEING SOC, V23, P115, DOI 10.1017/S0144686X02008954; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; Kempen GIJM, 1996, SOC SCI MED, V43, P1601, DOI 10.1016/S0277-9536(96)00057-3; KEMPEN GIJM, 1995, SOC INDIC RES, V35, P303, DOI 10.1007/BF01079163; Kempen GIJM, 2006, EPIDEMIOLOGISCH B, V41, P27; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Law M, 1990, Can J Occup Ther, V57, P82; Liebel DV, 2009, MED CARE RES REV, V66, P119, DOI 10.1177/1077558708328815; Markle-Reid M, 2003, J ADV NURS, V44, P58, DOI 10.1046/j.1365-2648.2003.02767.x; Markle-Reid M, 2006, MED CARE RES REV, V63, P531, DOI 10.1177/1077558706290941; Mars GMJ, 2009, QUAL LIFE RES, V18, P1207, DOI 10.1007/s11136-009-9537-4; Metzelthin SF, 2013, INT J NURS STUD, V50, P1184, DOI 10.1016/j.ijnurstu.2012.12.016; Metzelthin SF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-511; Parsons JGM, 2012, HEALTH SOC CARE COMM, V20, P653, DOI 10.1111/j.1365-2524.2012.01081.x; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Pel-Littel RE, 2009, J NUTR HEALTH AGING, V13, P390, DOI 10.1007/s12603-009-0051-8; Pijpers E, 2012, EUR J INTERN MED, V23, P118, DOI 10.1016/j.ejim.2011.09.003; Ploeg J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1480; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; Smeulders ESTF, 2010, J ADV NURS, V66, P1487, DOI 10.1111/j.1365-2648.2010.05318.x; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Steverink N, 2001, GERONTOLOGIST, V41, P236; Stijnen MMN, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-7; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; van Haastregt JCM, 2000, BMJ-BRIT MED J, V320, P754, DOI 10.1136/bmj.320.7237.754; van Weel C, 2012, J AM BOARD FAM MED, V25, pS12, DOI 10.3122/jabfm.2012.02.110212; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033	48	107	110	3	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2013	347								f5264	10.1136/bmj.f5264	http://dx.doi.org/10.1136/bmj.f5264			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	219RR	24022033	hybrid, Green Published			2022-12-28	WOS:000324527000005
J	Watton, R				Watton, Richard			The loss of multidisciplinary primary healthcare teams is bad for patient care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									White House Surg, Sheffield S2 1SL, S Yorkshire, England		Watton, R (corresponding author), White House Surg, 1 Fairfax Rise, Sheffield S2 1SL, S Yorkshire, England.	rjwatton@gmail.com						Draper R, 2011, PRIMARY HLTH CARE TE; Purdy S., 2010, AVOIDING HOSP ADMISS; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6017; Walsh N., 2013, LESSONS EXPERIENCE M; Watt G., 89 ROYAL COLL GEN PR	5	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2013	347								f5450	10.1136/bmj.f5450	http://dx.doi.org/10.1136/bmj.f5450			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219RJ	24016629				2022-12-28	WOS:000324526000017
J	Rosenberg, C				Rosenberg, Charles			The art of medicine Back to the future	LANCET			English	Editorial Material									Harvard Univ, Dept Hist Sci, Sci Ctr 371, Cambridge, MA 02138 USA	Harvard University	Rosenberg, C (corresponding author), Harvard Univ, Dept Hist Sci, Sci Ctr 371, Cambridge, MA 02138 USA.	rosenb3@fas.harvard.edu							0	2	2	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 7	2013	382	9895					851	852		10.1016/S0140-6736(13)61852-8	http://dx.doi.org/10.1016/S0140-6736(13)61852-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	24020069				2022-12-28	WOS:000324240700014
J	Bayer, R; Fairchild, AL; Hopper, K; Nathanson, CA				Bayer, Ronald; Fairchild, Amy L.; Hopper, Kim; Nathanson, Constance A.			Confronting the Sorry State of US Health	SCIENCE			English	Editorial Material							UNITED-STATES; DISADVANTAGE; INEQUALITY; GOVERNANCE; SCOTLAND; DISEASE		[Bayer, Ronald; Fairchild, Amy L.; Hopper, Kim; Nathanson, Constance A.] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Bayer, R (corresponding author), Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA.	rb8@cumc.columbia.edu	Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Bayer R., 2013, INTERVIEWS GIVEN CON; Blackmar E., 1995, HIVES SICKNESS PUBLI, P42; Brown E, 2013, LOS ANGELES TIMES; Calmes J, 2013, NY TIMES, pA1; Council of Hygiene and Public Health of the Citizens' Association of New York, 1865, SAN COND CIT REP COU; Crimmins EM, 2011, EXPLAINING DIVERGENT LEVELS OF LONGEVITY IN HIGH-INCOME COUNTRIES, P1; Donaldson LJ, 2013, PUBLIC HEALTH, V127, P514, DOI 10.1016/j.puhe.2013.04.022; Fairchild AL, 2010, AM J PUBLIC HEALTH, V100, P54, DOI 10.2105/AJPH.2009.163956; Fee E., 1987, DIS DISC HIST J HOPK; Fox DM, 2013, PUBLIC HEALTH, V127, P503, DOI 10.1016/j.puhe.2013.04.019; Galea S., 2013, COMMUNICATION; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Kindig D, 2010, PUBLIC HEALTH REP, V125, P160, DOI 10.1177/003335491012500203; KNOWLES JH, 1977, DAEDALUS, V106, P57; Krugman P., 2013, NY TIMES, pA19; Oppenheimer GM, 2006, INT J EPIDEMIOL, V35, P720, DOI 10.1093/ije/dyl014; Rubenstein G., 2013, ATLANTIC; Smith G. D., 2001, POVERTY INEQUALITY H, P337; Woolf SH, 2013, US HLTH INT PERSPECT	21	6	6	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					962	963		10.1126/science.1241249	http://dx.doi.org/10.1126/science.1241249			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990546				2022-12-28	WOS:000323652300025
J	Mueller, T; O'Hara, RB; Converse, SJ; Urbanek, RP; Fagan, WF				Mueller, Thomas; O'Hara, Robert B.; Converse, Sarah J.; Urbanek, Richard P.; Fagan, William F.			Social Learning of Migratory Performance	SCIENCE			English	Article							DECISION-MAKING; ORIENTATION; MOVE; INFORMATION; EVOLUTION; GENETICS; MODELS; BIRDS	Successful bird migration can depend on individual learning, social learning, and innate navigation programs. Using 8 years of data on migrating whooping cranes, we were able to partition genetic and socially learned aspects of migration. Specifically, we analyzed data from a reintroduced population wherein all birds were captive bred and artificially trained by ultralight aircraft on their first lifetime migration. For subsequent migrations, in which birds fly individually or in groups but without ultralight escort, we found evidence of long-term social learning, but no effect of genetic relatedness on migratory performance. Social learning from older birds reduced deviations from a straight-line path, with 7 years of experience yielding a 38% improvement in migratory accuracy.	[Mueller, Thomas; Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Mueller, Thomas; O'Hara, Robert B.] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Main, Germany; [Mueller, Thomas; O'Hara, Robert B.] Goethe Univ Frankfurt, D-60325 Frankfurt, Main, Germany; [Mueller, Thomas] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA; [Converse, Sarah J.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [Urbanek, Richard P.] US Fish & Wildlife Serv, Necedah Natl Wildlife Refuge, Necedah, WI 54646 USA	University System of Maryland; University of Maryland College Park; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Mueller, T (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	muellert@gmail.com	O'Hara, Bob/A-7499-2008; Mueller, Thomas/A-1740-2014	O'Hara, Bob/0000-0001-9737-3724; Mueller, Thomas/0000-0001-9305-7716; Converse, Sarah J/0000-0002-3719-5441	NSF [1062411]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz programme (Hesse, Germany); Robert Bosch Foundation	NSF(National Science Foundation (NSF)); Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz programme (Hesse, Germany); Robert Bosch Foundation	T.M. and W.F.F. were supported by NSF Advances in Biological Informatics award 1062411, T. M. and R.B.O. were supported by the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz programme (Hesse, Germany), and T. M. was supported by the Robert Bosch Foundation. Data were provided by the Whooping Crane Eastern Partnership and K. Jones and are deposited in the Dryad Repository: http://doi.org/10.5061/dryad.1r0f7. We thank F. Hailer, S. Servanty, E. Grant, J. Calabrese, R. Reynolds, S. Via, E. L. Neuschulz, C. Rushing, D. Bennu, and three anonymous reviewers for helpful comments and discussions.	Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; Alerstam T, 1996, J EXP BIOL, V199, P9; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Chernetsov N, 2004, J EXP BIOL, V207, P937, DOI 10.1242/jeb.00853; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Converse SJ, 2012, J ORNITHOL, V152, pS561, DOI 10.1007/s10336-011-0695-0; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Damgaard LH, 2007, J ANIM SCI, V85, P1363, DOI 10.2527/jas.2006-543; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; Fransson T, 2001, NATURE, V414, P35, DOI 10.1038/35102115; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; Jones KL, 2002, CONSERV BIOL, V16, P789, DOI 10.1046/j.1523-1739.2002.00001.x; Kuyt E., 1992, 74 CAN WILDL SERV, P1; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; Mettke-Hofmann C, 2003, P NATL ACAD SCI USA, V100, P5863, DOI 10.1073/pnas.1037505100; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; O'Hara RB, 2008, J EVOLUTION BIOL, V21, P949, DOI 10.1111/j.1420-9101.2008.01529.x; O'Hara RB, 2009, ANN ZOOL FENN, V46, P124, DOI 10.5735/086.046.0205; Palacin C, 2011, J AVIAN BIOL, V42, P301, DOI 10.1111/j.1600-048X.2011.05395.x; Schuz E., 1950, VOGELWARTE, V1, P239; Schuz E., 1949, VOGELWARTE, V2, P63; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; Urbanek R.P., 2005, N AM CRANE WORK P, V9, P213; Urbanek RP, 2010, BIRD CONSERV INT, V20, P43, DOI 10.1017/S0959270909990153; Waldmann P, 2009, EVOLUTION, V63, P1640, DOI 10.1111/j.1558-5646.2009.00645.x; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x	31	202	205	9	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					999	1002		10.1126/science.1237139	http://dx.doi.org/10.1126/science.1237139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990559				2022-12-28	WOS:000323652300042
J	Muraki, I; Imamura, F; Manson, JE; Hu, FB; Willett, WC; van Dam, RM; Sun, Q				Muraki, Isao; Imamura, Fumiaki; Manson, JoAnn E.; Hu, Frank B.; Willett, Walter C.; van Dam, Rob M.; Sun, Qi			Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; DIETARY FIBER; GLYCEMIC LOAD; VEGETABLE INTAKE; RESVERATROL SUPPLEMENTATION; MEAT INTAKE; INSULIN SENSITIVITY; PHYSICAL-ACTIVITY; IN-VITRO; MELLITUS	Objective To determine whether individual fruits are differentially associated with risk of type 2 diabetes. Design Prospective longitudinal cohort study. Setting Health professionals in the United States. Participants 66 105 women from the Nurses' Health Study (1984-2008), 85 104 women from the Nurses' Health Study II (1991-2009), and 36 173 men from the Health Professionals Follow-up Study (1986-2008) who were free of major chronic diseases at baseline in these studies. Main outcome measure Incident cases of type 2 diabetes, identified through self report and confirmed by supplementary questionnaires. Results During 3 464 641 person years of follow-up, 12 198 participants developed type 2 diabetes. After adjustment for personal, lifestyle, and dietary risk factors of diabetes, the pooled hazard ratio of type 2 diabetes for every three servings/week of total whole fruit consumption was 0.98 (95% confidence interval 0.96 to 0.99). With mutual adjustment of individual fruits, the pooled hazard ratios of type 2 diabetes for every three servings/week were 0.74 (0.66 to 0.83) for blueberries, 0.88 (0.83 to 0.93) for grapes and raisins, 0.89 (0.79 to 1.01) for prunes, 0.93 (0.90 to 0.96) for apples and pears, 0.95 (0.91 to 0.98) for bananas, 0.95 (0.91 to 0.99) for grapefruit, 0.97 (0.92 to 1.02) for peaches, plums, and apricots, 0.99 (0.95 to 1.03) for oranges, 1.03 (0.96 to 1.10) for strawberries, and 1.10 (1.02 to 1.18) for cantaloupe. The pooled hazard ratio for the same increment in fruit juice consumption was 1.08 (1.05 to 1.11). The associations with risk of type 2 diabetes differed significantly among individual fruits (P<0.001 in all cohorts). Conclusion Our findings suggest the presence of heterogeneity in the associations between individual fruit consumption and risk of type 2 diabetes. Greater consumption of specific whole fruits, particularly blueberries, grapes, and apples, is significantly associated with a lower risk of type 2 diabetes, whereas greater consumption of fruit juice is associated with a higher risk.	[Muraki, Isao; Hu, Frank B.; Willett, Walter C.; van Dam, Rob M.; Sun, Qi] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Imamura, Fumiaki] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 2QQ, England; [Manson, JoAnn E.; Hu, Frank B.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Manson, JoAnn E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Manson, JoAnn E.; Hu, Frank B.; Willett, Walter C.; Sun, Qi] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Manson, JoAnn E.; Hu, Frank B.; Willett, Walter C.; Sun, Qi] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [van Dam, Rob M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [van Dam, Rob M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [van Dam, Rob M.] Natl Univ Hlth Syst, Singapore, Singapore	Harvard University; Harvard T.H. Chan School of Public Health; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; National University of Singapore; National University of Singapore; National University of Singapore	Sun, Q (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	qisun@hsph.harvard.edu	Muraki, Isao/ACA-2312-2022; van Dam, Rob M/F-9674-2010; Imamura, Fumiaki/J-1038-2019	Muraki, Isao/0000-0003-0058-7721; van Dam, Rob M/0000-0002-7354-8734; Imamura, Fumiaki/0000-0002-6841-8396	National Institutes of Health [CA87969, CA176726, CA55075, CA50385, CA167552, DK58845, DK082486]; National Heart, Lung, and Blood Institute [R00HL098459]; Medical Research Council [MC_UU_12015/5, MC_UP_A100_1003] Funding Source: researchfish; MRC [MC_UP_A100_1003, MC_UU_12015/5] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA050385, P01CA055075, UM1CA176726, P01CA087969, U01CA167552, UM1CA167552] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703, R01DK058845, R01DK082486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by research grants CA87969, CA176726, CA55075, CA50385, CA167552, DK58845, and DK082486 from the National Institutes of Health. Dr. Sun was supported by a career development award R00HL098459 from the National Heart, Lung, and Blood Institute. The funding sources had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The authors are not affiliated with the funding institutions.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bazzano LA, 2008, DIABETES CARE, V31, P1311, DOI 10.2337/dc08-0080; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; BOLTON RP, 1981, AM J CLIN NUTR, V34, P211, DOI 10.1093/ajcn/34.2.211; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cooper AJ, 2012, EUR J CLIN NUTR, V66, P1082, DOI 10.1038/ejcn.2012.85; Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388; Dong JY, 2011, BRIT J NUTR, V106, P1649, DOI 10.1017/S000711451100540X; Dragovic-Uzelac V, 2007, FOOD CHEM, V102, P966, DOI 10.1016/j.foodchem.2006.04.001; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Gavin JR, 1997, DIABETES CARE, V20, P1183; HABER GB, 1977, LANCET, V2, P679; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Jenkins DJA, 2011, DIABETOLOGIA, V54, P271, DOI 10.1007/s00125-010-1927-1; Kato M, 2013, BR J NUTR IN PRESS; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Liu SM, 2004, DIABETES CARE, V27, P2993, DOI 10.2337/diacare.27.12.2993; Livesey G, 2013, AM J CLIN NUTR, V97, P584, DOI 10.3945/ajcn.112.041467; Lotito SB, 2004, FREE RADICAL BIO MED, V36, P201; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Montonen J, 2005, EUR J CLIN NUTR, V59, P441, DOI 10.1038/sj.ejcn.1602094; Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s; Nettleton JA, 2006, J NUTR, V136, P3039, DOI 10.1093/jn/136.12.3039; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Parmar HS, 2012, DIABETES RES CLIN PR, V97, P105, DOI 10.1016/j.diabres.2012.02.011; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rossato SB, 2009, J MED FOOD, V12, P1119, DOI 10.1089/jmf.2008.0267; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; Schulze MB, 2003, DIABETOLOGIA, V46, P1465, DOI 10.1007/s00125-003-1220-7; SHEKELLE RB, 1982, AM J EPIDEMIOL, V115, P506, DOI 10.1093/oxfordjournals.aje.a113332; Song YQ, 2005, J AM COLL NUTR, V24, P376, DOI 10.1080/07315724.2005.10719488; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Tunnicliffe JM, 2011, APPL PHYSIOL NUTR ME, V36, P650, DOI [10.1139/h11-072, 10.1139/H11-072]; US Department of Agriculture Agricultural Research Service, 2012, USDA NAT NUTR DAT DA; USDA, 2013, USDA DAT FLAV CONT S, P1; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Villegas R, 2008, J NUTR, V138, P574, DOI 10.1093/jn/138.3.574; Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894; Willis HJ, 2011, APPETITE, V57, P38, DOI 10.1016/j.appet.2011.03.006; World Health Organization, 2003, PROM FRUIT VEG CONS; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015	55	299	307	4	128	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2013	347								f5001	10.1136/bmj.f5001	http://dx.doi.org/10.1136/bmj.f5001			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CI	23990623	Green Published, hybrid			2022-12-28	WOS:000323881300001
J	Yamamoto, R; Morita, Y; Ooehara, J; Hamanaka, S; Onodera, M; Rudolph, KL; Ema, H; Nakauchi, H				Yamamoto, Ryo; Morita, Yohei; Ooehara, Jun; Hamanaka, Sanae; Onodera, Masafumi; Rudolph, Karl Lenhard; Ema, Hideo; Nakauchi, Hiromitsu			Clonal Analysis Unveils Self-Renewing Lineage-Restricted Progenitors Generated Directly from Hematopoietic Stem Cells	CELL			English	Article							MOUSE BONE-MARROW; LONG-TERM; MULTIPOTENT PROGENITORS; DIFFERENTIATION; COMMITMENT; RECONSTITUTION; IDENTIFICATION; HETEROGENEITY; PROGRAMS; NOTCH	Consensus holds that hematopoietic stem cells (HSCs) give rise to multipotent progenitors (MPPs) of reduced self-renewal potential and that MPPs eventually produce lineage-committed progenitor cells in a stepwise manner. Using a single-cell transplantation system and marker mice, we unexpectedly found myeloid-restricted progenitors with long-term repopulating activity (MyRPs), which are lineage-committed to megakaryocytes, megakaryocyte-erythroid cells, or common myeloid cells (MkRPs, MERPs, or CMRPs, respectively) in the phenotypically defined HSC compartment together with HSCs. Paired daughter cell assays combined with transplantation revealed that HSCs can give rise to HSCs via symmetric division or directly differentiate into MyRPs via asymmetric division (yielding HSC-MkRP or HSC-CMRP pairs). These myeloid bypass pathways could be essential for fast responses to ablation stress. Our results show that loss of self-renewal and stepwise progression through specific differentiation stages are not essential for lineage commitment of HSCs and suggest a revised model of hematopoietic differentiation.	[Yamamoto, Ryo; Morita, Yohei; Ooehara, Jun; Hamanaka, Sanae; Ema, Hideo; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; [Morita, Yohei; Rudolph, Karl Lenhard] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Hamanaka, Sanae; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Minato Ku, Tokyo 1088639, Japan; [Onodera, Masafumi] Natl Res Inst Child Hlth & Dev, Dept Human Genet, Setagaya Ku, Tokyo 1578535, Japan	University of Tokyo; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Japan Science & Technology Agency (JST); National Center for Child Health & Development - Japan	Nakauchi, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	nakauchi@ims.u-tokyo.ac.jp	Morita, Yohei/N-1260-2014; Yamamoto, Ryo/Y-9464-2018; Yamamoto, Ryo/V-9312-2019	Morita, Yohei/0000-0003-4163-5080; Yamamoto, Ryo/0000-0001-5504-6004; Rudolph, Karl Lenhard/0000-0002-4839-2862	Ministry of Education, Culture, Sports, and Technology, Japan; Grants-in-Aid for Scientific Research [23500490] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Yamazaki, H. Nishikii, and K. Ito for discussions; S. Yamazaki, B. Dykstra, J. Seita, M. Kasai, A. Ieyasu, and A. S. Knisely for critical reading of the manuscript; Y. Yamazaki and Y. Ishii for help with FACS operation, and C. Pronk and D. Bryder for advice on colony assays. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, and Technology, Japan. R. Y. and Y. M. contributed equally to the study. R. Y. designed the study, performed all experiments, analyzed all data, and wrote the manuscript. Y. M. designed the study, performed single-cell transplantations, analyzed related data, and wrote the manuscript. J.O. helped to perform paired daughter cell assays. S. H. and M.O. established the KuO mouse line. K. L. R. edited the manuscript. H. E., and H.N. edited the manuscript and supervised the study. H.N. is a founder, a member of scientific advisory board and shareholder of ReproCELL. H.N. is a scientific advisor of Megakaryon, iCELL and Shionogi & Co.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cornejo MG, 2011, BLOOD, V118, P1264, DOI 10.1182/blood-2011-01-328567; Cumano A, 2001, CURR OPIN IMMUNOL, V13, P166, DOI 10.1016/S0952-7915(00)00200-4; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Hamanaka S, 2013, BIOCHEM BIOPH RES CO, V435, P586, DOI 10.1016/j.bbrc.2013.05.017; Hansen JD, 1998, IMMUNOL REV, V166, P199, DOI 10.1111/j.1600-065X.1998.tb01264.x; Huang H, 2009, J CELL BIOCHEM, V107, P857, DOI 10.1002/jcb.22184; Kawamoto H, 2010, IMMUNOL REV, V238, P23, DOI 10.1111/j.1600-065X.2010.00959.x; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lai AY, 2006, J EXP MED, V203, P1867, DOI 10.1084/jem.20060697; Lai AY, 2005, J IMMUNOL, V175, P5016, DOI 10.4049/jimmunol.175.8.5016; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; SUDA J, 1984, BLOOD, V64, P393; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Vellenga E, 2001, BRIT J HAEMATOL, V114, P319, DOI 10.1046/j.1365-2141.2001.02926.x; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314	35	436	453	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1112	1126		10.1016/j.cell.2013.08.007	http://dx.doi.org/10.1016/j.cell.2013.08.007			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993099	Bronze			2022-12-28	WOS:000323767300023
J	Inouye, SK; Westendorp, RGJ; Saczynski, JS				Inouye, Sharon K.; Westendorp, Rudi G. J.; Saczynski, Jane S.			Delirium in elderly people	LANCET			English	Review							CONFUSION ASSESSMENT METHOD; CRITICALLY-ILL PATIENTS; POSTOPERATIVE DELIRIUM; HIP-FRACTURE; LIFE-PROGRAM; FUNCTIONAL DECLINE; RISK-FACTORS; SYSTEMIC INFLAMMATION; EMERGENCY-DEPARTMENT; CEREBROSPINAL-FLUID	Delirium is an acute disorder of attention and cognition in elderly people (ie, those aged 65 years or older) that is common, serious, costly, under-recognised, and often fatal. A formal cognitive assessment and history of acute onset of symptoms are necessary for diagnosis. In view of the complex multifactorial causes of delirium, multicomponent non-pharmacological risk factor approaches are the most effective strategy for prevention. No convincing evidence shows that pharmacological prevention or treatment is effective. Drug reduction for sedation and analgesia and non-pharmacological approaches are recommended. Delirium offers opportunities to elucidate brain pathophysiology-it serves both as a marker of brain vulnerability with decreased reserve and as a potential mechanism for permanent cognitive damage. As a potent indicator of patients' safety, delirium provides a target for system-wide process improvements. Public health priorities include improvements in coding, reimbursement from insurers, and research funding, and widespread education for clinicians and the public about the importance of delirium.	[Inouye, Sharon K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Inouye, Sharon K.] Hebrew SeniorLife, Inst Aging Res, Aging Brain Ctr, Boston, MA 02131 USA; [Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Saczynski, Jane S.] Univ Massachusetts, Sch Med, Div Geriatr Med, Worcester, MA USA; [Saczynski, Jane S.] Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Worcester, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Hebrew SeniorLife; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Inouye, SK (corresponding author), Hebrew SeniorLife, Inst Aging Res, Aging Brain Ctr, 1200 Ctr St, Boston, MA 02131 USA.	agingbraincenter@hsl.harvard.edu	Inouye, Sharon/R-7216-2019		National Institute on Aging [P01AG031720]; Milton and Shirley F Levy Family Chair; Leyden Academy on Vitality and Ageing; US National Institutes of Health [K01AG033643, U01HL10526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG033643, P01AG031720] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Milton and Shirley F Levy Family Chair; Leyden Academy on Vitality and Ageing; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Margaret Puelle for extensive assistance with literature searches and paper preparation, Jirong Yue for review and ratings of prevention and treatment studies, Jacquelyn Hyde and Benham Sabayan for assistance with literature searches, and Margaret Demille for editorial assistance. This work is dedicated to the memory of Joshua Bryan Inouye Helfand and Mitsuo Inouye. SKI was partly supported by the National Institute on Aging (grant number P01AG031720) and the Milton and Shirley F Levy Family Chair; RGJW by the Leyden Academy on Vitality and Ageing; and JSS by the US National Institutes of Health (grant numbers K01AG033643 and U01HL10526).	Adamis D, 2010, AGING MENT HEALTH, V14, P543, DOI 10.1080/13607860903421011; Agency for Healthcare Research and Quality (AHRQ), NAT QUAL CLEAR MEAS; Alagiakrishnan K, 2004, POSTGRAD MED J, V80, P388, DOI 10.1136/pgmj.2003.017236; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU; [Anonymous], 2001, ANN INTERN MED, V135, P653, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00004; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bickel H, 2008, DEMENT GERIATR COGN, V26, P26, DOI 10.1159/000140804; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Bradley EH, 2005, J AM GERIATR SOC, V53, P1455, DOI 10.1111/j.1532-5415.2005.53451.x; Bradley EH, 2004, J AM GERIATR SOC, V52, P1875, DOI 10.1111/j.1532-5415.2004.52510.x; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; Buurman BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026951; Caplan GA, 2007, INTERN MED J, V37, P95, DOI 10.1111/j.1445-5994.2007.01265.x; Caplan GA, 2010, J GERONTOL A-BIOL, V65, P1130, DOI 10.1093/gerona/glq090; Center for Medicare & Medicaid Services (CMS), 2010, MIN DAT SET VERS 3 0; Chedru F, 1972, Cortex, V8, P395; Chen CCH, 2011, J AM COLL SURGEONS, V213, P245, DOI 10.1016/j.jamcollsurg.2011.05.004; Chester JG, 2012, J HOSP MED, V7, P450, DOI 10.1002/jhm.1003; Choi SH, 2012, AM J PSYCHIAT, V169, P498, DOI 10.1176/appi.ajp.2012.11060976; Cole MG, 2003, J NEUROPSYCH CLIN N, V15, P200, DOI 10.1176/jnp.15.2.200; Cole MG, 2004, AM J GERIAT PSYCHIAT, V12, P7, DOI 10.1176/appi.ajgp.12.1.7; Cunningham C, 2011, BIOCHEM SOC T, V39, P945, DOI 10.1042/BST0390945; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Davis DHJ, 2012, BRAIN, V135, P2809, DOI 10.1093/brain/aws190; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Flaherty JH, 2010, J GERONTOL A-BIOL, V65, P1387, DOI 10.1093/gerona/glq136; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Fong TG, 2006, J GERONTOL A-BIOL, V61, P1294, DOI 10.1093/gerona/61.12.1294; Fong TG, 2012, ANN INTERN MED, V156, P848, DOI 10.7326/0003-4819-156-12-201206190-00005; Gaudreau JD, 2005, J PAIN SYMPTOM MANAG, V29, P368, DOI 10.1016/j.jpainsymman.2004.07.009; Gaudreau JD, 2005, MED HYPOTHESES, V64, P471, DOI 10.1016/j.mehy.2004.08.007; Gross AL, 2012, ARCH INTERN MED, V172, P1324, DOI 10.1001/archinternmed.2012.3203; Han JH, 2010, ANN EMERG MED, V56, P244, DOI 10.1016/j.annemergmed.2010.03.003; Han JH, 2009, ACAD EMERG MED, V16, P193, DOI 10.1111/j.1553-2712.2008.00339.x; Hardy JE, 2008, EMERG MED AUSTRALAS, V20, P420, DOI 10.1111/j.1742-6723.2008.01118.x; Hatherill S, 2010, J PSYCHOSOM RES, V68, P337, DOI 10.1016/j.jpsychores.2009.10.011; Hirano LA, 2006, J AM GERIATR SOC, V54, P587, DOI 10.1111/j.1532-5415.2006.00692.x; Hshieh TT, 2008, J GERONTOL A-BIOL, V63, P764, DOI 10.1093/gerona/63.7.764; Hufschmidt A, 2008, ACTA NEUROL SCAND, V118, P245, DOI 10.1111/j.1600-0404.2008.01006.x; Hughes CG, 2012, CURR OPIN CRIT CARE, V18, P518, DOI 10.1097/MCC.0b013e328357effa; Inouye SK, 2007, ARCH INTERN MED, V167, P1406, DOI 10.1001/archinte.167.13.1406; Inouye SK, 2006, J AM GERIATR SOC, V54, P1492, DOI 10.1111/j.1532-5415.2006.00869.x; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 2005, J AM GERIATR SOC, V53, P312, DOI 10.1111/j.1532-5415.2005.53120.x; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Inouye SK, 2000, J AM GERIATR SOC, V48, P1697; Izaks Gerbrand J, 2003, BMC Geriatr, V3, P7, DOI 10.1186/1471-2318-3-7; Jacobson S, 2000, Semin Clin Neuropsychiatry, V5, P86; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jalleh R, 2012, MED HYPOTHESES, V79, P735, DOI 10.1016/j.mehy.2012.08.013; Jenssen Sigmund, 2005, Am J Alzheimers Dis Other Demen, V20, P159, DOI 10.1177/153331750502000309; Joels M, 2011, PSYCHONEUROENDOCRINO, V36, P406, DOI 10.1016/j.psyneuen.2010.03.004; Jones RN, 2010, AM J GERIAT PSYCHIAT, V18, P117, DOI 10.1097/JGP.0b013e3181b972e8; Khoury M, 1993, FUNDAMENTALS GENETIC; Kolanowski AM, 2010, AGING MENT HEALTH, V14, P232, DOI 10.1080/13607860903167853; KOPONEN H, 1989, J NEUROL NEUROSUR PS, V52, P980, DOI 10.1136/jnnp.52.8.980; Krogseth M, 2011, DEMENT GERIATR COGN, V31, P63, DOI 10.1159/000322591; Lai MMY, 2012, INTERN MED J, V42, P422, DOI 10.1111/j.1445-5994.2010.02400.x; Lauretani F, 2010, AGING CLIN EXP RES, V22, P456, DOI 10.1007/BF03324944; Leslie DL, 2005, ARCH INTERN MED, V165, P1657, DOI 10.1001/archinte.165.14.1657; Leslie DL, 2005, J AM GERIATR SOC, V53, P405, DOI 10.1111/j.1532-5415.2005.53156.x; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Lin SM, 2004, CRIT CARE MED, V32, P2254, DOI 10.1097/01.CCM.0000145587.16421.BB; MacLullich AMJ, 2008, J PSYCHOSOM RES, V65, P229, DOI 10.1016/j.jpsychores.2008.05.019; MacLullich AMJ, 2011, J AM GERIATR SOC, V59, P1151, DOI 10.1111/j.1532-5415.2011.03428.x; Maldonado JR, 2008, CRIT CARE CLIN, V24, P789, DOI 10.1016/j.ccc.2008.06.004; Marcantonio ER, 2006, J GERONTOL A-BIOL, V61, P1281, DOI 10.1093/gerona/61.12.1281; Marcantonio ER, 2012, JAMA-J AM MED ASSOC, V308, P73, DOI 10.1001/jama.2012.6857; Marcantonio ER, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-01006; Marcantonio ER, 2005, J AM GERIATR SOC, V53, P963, DOI 10.1111/j.1532-5415.2005.53305.x; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; McDowell JA, 1998, J AM GERIATR SOC, V46, P700, DOI 10.1111/j.1532-5415.1998.tb03803.x; Milisen K, 2001, J AM GERIATR SOC, V49, P523, DOI 10.1046/j.1532-5415.2001.49109.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neelon VJ, 1996, NURS RES, V45, P324, DOI 10.1097/00006199-199611000-00002; O'Mahony R, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00006; Oldenbeuving AW, 2011, NEUROLOGY, V76, P993, DOI 10.1212/WNL.0b013e318210411f; Organisation for Economic Co-operation and Development, 2012, OECD HLTH DAT 2012; Park M, 2007, J GERONTOL NURS, V33, P9, DOI 10.3928/00989134-20070201-04; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Pfister D, 2008, CRIT CARE, V12, DOI 10.1186/cc6891; Pitkala KH, 2005, DEMENT GERIATR COGN, V19, P158, DOI 10.1159/000082888; Rizzo JA, 2001, MED CARE, V39, P740, DOI 10.1097/00005650-200107000-00010; Rubin FH, 2011, J AM GERIATR SOC, V59, P359, DOI 10.1111/j.1532-5415.2010.03243.x; Rudolph JL, 2010, J AM GERIATR SOC, V58, P643, DOI 10.1111/j.1532-5415.2010.02762.x; Sabayan B, 2012, AGEING RES REV, V11, P271, DOI 10.1016/j.arr.2011.12.009; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Schoen J, 2011, CRIT CARE, V15, DOI 10.1186/cc10454; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Siepe M, 2011, EUR J CARDIO-THORAC, V40, P200, DOI 10.1016/j.ejcts.2010.11.024; Soiza RL, 2008, J PSYCHOSOM RES, V65, P239, DOI 10.1016/j.jpsychores.2008.05.021; Steis MR, 2012, J AM GERIATR SOC, V60, P2121, DOI 10.1111/j.1532-5415.2012.04200.x; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; TRZEPACZ PT, 1988, PSYCHIAT RES, V23, P89, DOI 10.1016/0165-1781(88)90037-6; van den Boogaard M, 2012, INT J NURS STUD, V49, P775, DOI 10.1016/j.ijnurstu.2011.11.016; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Van Rompaey B, 2012, CRIT CARE, V16, DOI 10.1186/cc11330; Veiga D, 2012, REV BRAS ANESTESIOL, V62, P469, DOI 10.1016/S0034-7094(12)70146-0; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wachter RM, 2012, UNDERSTANDING PATIEN; Watt D, 2013, NEUROPSYCHOLOGY PSYC, P425; Wei LA, 2008, J AM GERIATR SOC, V56, P823, DOI 10.1111/j.1532-5415.2008.01674.x; WHO Regional Office for Europe, 2012, EUR HOSP MORB DAT; Wilson RS, 2012, NEUROLOGY, V78, P950, DOI 10.1212/WNL.0b013e31824d5894; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wong CL, 2010, JAMA-J AM MED ASSOC, V304, P779, DOI 10.1001/jama.2010.1182; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Young BK, 1997, DRUG AGING, V10, P367, DOI 10.2165/00002512-199710050-00005; Zampieri FG, 2011, CLINICS, V66, P1825, DOI 10.1590/S1807-59322011001000024; Zhang B, 2012, ANESTH ANALG, V114, P410, DOI 10.1213/ANE.0b013e31823b2602; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536	117	1667	1762	18	248	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					911	922		10.1016/S0140-6736(13)60688-1	http://dx.doi.org/10.1016/S0140-6736(13)60688-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3FC	23992774	Green Accepted, Green Submitted			2022-12-28	WOS:000332399500031
J	Lipshultz, SE; Orav, EJ; Wilkinson, JD; Towbin, JA; Messere, JE; Lowe, AM; Sleeper, LA; Cox, GF; Hsu, DT; Canter, CE; Hunter, JA; Colan, SD				Lipshultz, Steven E.; Orav, E. John; Wilkinson, James D.; Towbin, Jeffrey A.; Messere, Jane E.; Lowe, April M.; Sleeper, Lynn A.; Cox, Gerald F.; Hsu, Daphne T.; Canter, Charles E.; Hunter, Juanita A.; Colan, Steven D.		Pediatric Cardiomyopathy Registry	Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry	LANCET			English	Article							SUDDEN CARDIAC DEATH; CLINICAL-FEATURES; INFANTS; EPIDEMIOLOGY; OUTCOMES; YOUNG	Background Treatment of children with hypertrophic cardiomyopathy might be improved if the risk of death or heart transplantation could be predicted by risk factors present at the time of diagnosis. Methods We analysed data from the Pediatric Cardio myopathy Registry, which collected longitudinal data for 1085 children with hypertrophic cardiomyopathy from 1990 to 2009. Our goal was to understand how patient factors measured at diagnosis predicted the subsequent risk of the primary outcome of death or heart transplantation. The Kaplan-Meier method was used to calculate time-to-event rates from time of diagnosis to the earlier of heart transplantation or death for children in each subgroup. Cox proportional-hazards regression was used to identify univariable and multivariable predictors of death or heart transplantation within each causal subgroup. Findings The poorest outcomes were recorded for the 69 children with pure hypertrophic cardiomyopathy with inborn errors of metabolism, for whom the estimated rate of death or heart transplantation was 57% (95% CI 44-69) at 2 years. Children with mixed functional phenotypes also did poorly, with rates of death or heart transplantation of 45% (95% CI 32-58) at 2 years for the 69 children with mixed hypertrophic and dilated cardiomyopathy and 38% (95% CI 25-51) at 2 years for the 58 children with mixed hypertrophic and restrictive cardiomyopathy. For children diagnosed with hypertrophic cardio myopathy at younger than 1 year, the rate of death or transplantation was 21% (95% CI 16-27) at 2 years. For children diagnosed with hypertrophic cardiomyopathy and a malformation syndrome, the rate of death or transplantation was 23% (95% CI 12-34) at 2 years. Excellent outcomes were reported for the 407 children who were diagnosed with idiopathic hypertrophic cardiomyopathy at age 1 year or older, with a rate of death or heart transplantation of 3% (95% CI 1-5) at 2 years. The risk factors for poor outcomes varied according to hypertrophic cardiomyopathy subgroup, but they generally included young age, low weight, presence of congestive heart failure, lower left ventricular fractional shortening, or higher left ventricular end-diastolic posterior wall thickness or end-diastolic ventricular septal thickness at the time of cardiomyopathy diagnosis. For all hypertrophic cardiomyopathy subgroups, the risk of death or heart transplantation was significantly increased when two or more risk factors were present and also as the number of risk factors increased. Interpretation In children with hypertrophic cardiomyopathy, the risk of death or heart transplantation was greatest for those who presented as infants or with inborn errors of metabolism or with mixed hypertrophic and dilated or restrictive cardiomyopathy. Risk stratification by subgroup of cardiomyopathy, by characteristics such as low weight, congestive heart failure, or abnormal echocardiographic findings, and by the presence of multiple risk factors allows for more informed clinical decision making and prognosis at the time of diagnosis.	[Lipshultz, Steven E.; Wilkinson, James D.; Hunter, Juanita A.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Orav, E. John] Harvard Med Sch, Boston, MA USA; [Towbin, Jeffrey A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Messere, Jane E.; Cox, Gerald F.; Colan, Steven D.] Boston Childrens Hosp, Boston, MA USA; [Lowe, April M.; Sleeper, Lynn A.] New England Res Inst, Watertown, MA USA; [Cox, Gerald F.] Genzyme Sanofi Co, Cambridge, MA USA; [Hsu, Daphne T.] Albert Einstein Coll Med, Bronx, NY USA; [Canter, Charles E.] Washington Univ, St Louis Sch Med, St Louis, MO USA	University of Miami; Harvard University; Harvard Medical School; Cincinnati Children's Hospital Medical Center; Harvard University; Boston Children's Hospital; HealthCore, Inc; Yeshiva University; Albert Einstein College of Medicine; Saint Louis University; Washington University (WUSTL)	Lipshultz, SE (corresponding author), Univ Miami, Dept Paediat, Leonard M Miller Sch Med, Miami, FL 33101 USA.	slipshultz@med.miami.edu	Hsu, Daphne/C-8913-2017; Towbin, Jeffrey A./J-5595-2019; Colan, Steven/ABB-4580-2020	Hsu, Daphne/0000-0002-2654-0430; Towbin, Jeffrey A./0000-0002-6585-714X; WILKINSON, JAMES/0000-0003-1945-5622	US National Institutes of Health; Children's Cardiomyopathy Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053392] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cardiomyopathy Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	US National Institutes of Health and Children's Cardiomyopathy Foundation.	Altarabsheh SE, 2013, ANN THORAC SURG, V95, P663, DOI 10.1016/j.athoracsur.2012.08.011; Bruno E, 2002, CARDIOL YOUNG, V12, P147, DOI 10.1017/S1047951102000306; Christiaans I, 2010, EUROPACE, V12, P313, DOI 10.1093/europace/eup431; Colan SD, 2007, CIRCULATION, V115, P773, DOI 10.1161/CIRCULATIONAHA.106.621185; Decker JA, 2009, J AM COLL CARDIOL, V54, P250, DOI 10.1016/j.jacc.2009.03.051; Dipchand AI, 2009, J HEART LUNG TRANSPL, V28, P1312, DOI 10.1016/j.healun.2009.05.019; Fernandez A, 2011, AM J CARDIOL, V108, P548, DOI 10.1016/j.amjcard.2011.03.083; Gajarski R, 2009, J HEART LUNG TRANSPL, V28, P1329, DOI 10.1016/j.healun.2009.05.028; Grenier MA, 2000, AM HEART J, V139, pS86, DOI 10.1067/mhj.2000.103933; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; Maron BJ, 2013, J AM COLL CARDIOL, V61, P1527, DOI 10.1016/j.jacc.2013.01.037; MARON BJ, 1982, CIRCULATION, V65, P7, DOI 10.1161/01.CIR.65.1.7; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Maskatia SA, 2011, PEDIAT CARDIOL, V1, P141; MCKENNA WJ, 1984, ARCH DIS CHILD, V59, P971, DOI 10.1136/adc.59.10.971; Nugent AW, 2003, NEW ENGL J MED, V348, P1639, DOI 10.1056/NEJMoa021737; Nugent AW, 2005, CIRCULATION, V112, P1332, DOI 10.1161/CIRCULATIONAHA.104.530303; Ostman-Smith I, 2005, CARDIOL YOUNG, V15, P632, DOI 10.1017/S1047951105001824; Ragni L, 2009, PEDIATR TRANSPLANT, V13, P650, DOI 10.1111/j.1399-3046.2008.01022.x; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Sadoul N, 1999, ARCH MAL COEUR VAISS, V92, P65; SCHAFFER MS, 1983, PEDIATR CARDIOL, V4, P113, DOI 10.1007/BF02076335; Schwartz ML, 1996, CIRCULATION, V94, P2021, DOI 10.1161/01.CIR.94.8.2021; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; Suda K, 1997, AM J CARDIOL, V80, P595, DOI 10.1016/S0002-9149(97)00428-1; Wilkinson JD, 2012, AM HEART J, V164, P442, DOI 10.1016/j.ahj.2012.04.018; Wilkinson James D, 2010, Heart Fail Clin, V6, P401, DOI 10.1016/j.hfc.2010.05.002; Yetman AT, 1998, J AM COLL CARDIOL, V32, P1943, DOI 10.1016/S0735-1097(98)00493-8; Yetman AT, 2005, CURR OPIN CARDIOL, V20, P80, DOI 10.1097/01.hco.0000153452.45341.36	30	98	103	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					1889	1897		10.1016/S0140-6736(13)61685-2	http://dx.doi.org/10.1016/S0140-6736(13)61685-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269DX	24011547	Green Accepted			2022-12-28	WOS:000328222400032
J	Dejosez, M; Ura, H; Brandt, VL; Zwaka, TP				Dejosez, Marion; Ura, Hiroki; Brandt, Vicky L.; Zwaka, Thomas P.			Safeguards for Cell Cooperation in Mouse Embryogenesis Shown by Genome-Wide Cheater Screen	SCIENCE			English	Article							STEM; MUTANTS; MULTICELLULARITY; TRANSITION; EVOLUTION; DEATH	Ensuring cooperation among formerly autonomous cells has been a central challenge in the evolution of multicellular organisms. One solution is monoclonality, but this option still leaves room for exploitative behavior, as it does not eliminate genetic and epigenetic variability. We therefore hypothesized that embryonic development must be protected by robust regulatory mechanisms that prevent aberrant clones from superseding wild-type cells. Using a genome-wide screen in murine induced pluripotent stem cells, we identified a network of genes (centered on p53, topoisomerase 1, and olfactory receptors) whose down-regulation caused the cells to replace wild-type cells in vitro and in the mouse embryo-without perturbing normal development. These genes thus appear to fulfill an unexpected role in fostering cell cooperation.	[Dejosez, Marion; Brandt, Vicky L.; Zwaka, Thomas P.] Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA; [Dejosez, Marion; Zwaka, Thomas P.] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Med, New York, NY 10029 USA; [Dejosez, Marion; Ura, Hiroki; Zwaka, Thomas P.] Baylor Coll Med, Houston, TX 77030 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine	Zwaka, TP (corresponding author), Icahn Sch Med Mt Sinai, Black Family Stem Cell Inst, New York, NY 10029 USA.	thomas.zwaka@mssm.edu	Brandt, Vicky L/J-5202-2014; Ura, Hiroki/ABD-8427-2020	Ura, Hiroki/0000-0002-7600-3481; Brandt, Vicky/0000-0002-5512-3724	Huffington Foundation; NIH [R01 GM077442, P01 GM81627]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627, R01GM077442] Funding Source: NIH RePORTER	Huffington Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Shaulsky and J. Gilbert for helpful discussions and experimental suggestions. We thank K. Hochedlinger for providing the Oct4-GFP iPSCs. The work was funded by the Huffington Foundation and by the NIH (grants R01 GM077442 and P01 GM81627). Microarray data have been deposited at Gene Expression Omnibus (GSE49814).	Alvarado AS, 2005, EXP CELL RES, V306, P299, DOI 10.1016/j.yexcr.2005.03.020; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Buckley CD, 2005, CELL IMMUNOL, V236, P29, DOI 10.1016/j.cellimm.2005.08.027; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Dreyer WJ, 1998, P NATL ACAD SCI USA, V95, P9072, DOI 10.1073/pnas.95.16.9072; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Khare A, 2006, NAT REV GENET, V7, P577, DOI 10.1038/nrg1875; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Michod RE, 2007, P NATL ACAD SCI USA, V104, P8613, DOI 10.1073/pnas.0701489104; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Morham SG, 1996, MOL CELL BIOL, V16, P6804; Pankow S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000782; Pfeiffer T, 2003, P NATL ACAD SCI USA, V100, P1095, DOI 10.1073/pnas.0335420100; Rokas A, 2008, ANNU REV GENET, V42, P235, DOI 10.1146/annurev.genet.42.110807.091513; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	27	51	53	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1511	1514		10.1126/science.1241628	http://dx.doi.org/10.1126/science.1241628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24030493				2022-12-28	WOS:000324894600050
J	Hu, LC; Kim, TM; Son, MY; Kim, SA; Holland, CL; Tateishi, S; Kim, DH; Yew, PR; Montagna, C; Dumitrache, LC; Hasty, P				Hu, Lingchuan; Kim, Tae Moon; Son, Mi Young; Kim, Sung-A; Holland, Cory L.; Tateishi, Satoshi; Kim, Dong Hyun; Yew, P. Renee; Montagna, Cristina; Dumitrache, Lavinia C.; Hasty, Paul			Two replication fork maintenance pathways fuse inverted repeats to rearrange chromosomes	NATURE			English	Article							GENOMIC INSTABILITY; HPRT MINIGENE; DNA; GENE; BRCA2; RECOMBINATION; AMPLIFICATION; REPAIR; HLTF; POLYUBIQUITINATION	Replication fork maintenance pathways preserve chromosomes, but their faulty application at nonallelic repeats could generate rearrangements causing cancer, genomic disorders and speciation(1-3). Potential causal mechanisms are homologous recombination and error-free postreplication repair (EF-PRR). Homologous recombination repairs damage-induced DNA double-strand breaks (DSBs) and single-ended DSBs within replication. To facilitate homologous recombination, the recombinase RAD51 and mediator BRCA2 forma filament on the 3' DNA strand at a break to enable annealing to the complementary sister chromatid(4) while the RecQ helicase, BLM (Bloom syndrome mutated) suppresses crossing over to prevent recombination(5). Homologous recombination also stabilizes(6,7) and restarts(8,9) replication forks without a DSB10,11. EF-PRR bypasses DNA incongruities that impede replication by ubiquitinating PCNA (proliferating cell nuclear antigen) using the RAD6-RAD18 and UBC13-MMS2-RAD5 ubiquitin ligase complexes(12). Some components are common to both homologous recombination and EF-PRR such as RAD51 and RAD18(13,14). Here we delineate two pathways that spontaneously fuse inverted repeats to generate unstable chromosomal rearrangements in wild-type mouse embryonic stem (ES) cells. Gamma-radiation induced a BLM-regulated pathway that selectively fused identical, but not mismatched, repeats. By contrast, ultraviolet light induced a RAD18-dependent pathway that efficiently fused mismatched repeats. Furthermore, TREX2 (a 3'-> 5' exonuclease) suppressed identical repeat fusion but enhanced mismatched repeat fusion, clearly separating these pathways. TREX2 associated with UBC13 and enhanced PCNA ubiquitination in response to ultraviolet light, consistent with it being a novel member of EF-PRR. RAD18 and TREX2 also suppressed replication fork stalling in response to nucleotide depletion. Interestingly, replication fork stalling induced fusion for identical and mismatched repeats, implicating faulty replication as a causal mechanism for both pathways.	[Hu, Lingchuan; Kim, Tae Moon; Son, Mi Young; Kim, Sung-A; Holland, Cory L.; Kim, Dong Hyun; Yew, P. Renee; Dumitrache, Lavinia C.; Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [Tateishi, Satoshi] Kumamoto Univ, IMEG, Kumamoto 8600811, Japan; [Montagna, Cristina] Yeshiva Univ Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	University of Texas System; University of Texas Health San Antonio; Kumamoto University; Yeshiva University; Albert Einstein College of Medicine	Hasty, P (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Inst Biotechnol, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.	hastye@uthscsa.edu		Kim, Dong Hyun/0000-0002-8762-1496; Hasty, Paul/0000-0003-3046-0131; Kim, Tae Moon/0000-0001-9715-9568	National Institutes of Health [1 RO1 CA123203-01A1, 2P01AG017242-12, P30CA013330]; Cancer Therapy & Research Center at The University of Texas at San Antonio (CTRC) [P30 CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174, P30CA013330, R01CA123203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy & Research Center at The University of Texas at San Antonio (CTRC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Williams and S. Dodds for technical assistance and the Molecular Cytogenetic Core at Albert Einstein College of Medicine for help with the execution of spectral karyotyping and two-colour FISH. This work was supported by the National Institutes of Health (1 RO1 CA123203-01A1 to P. H., 2P01AG017242-12 to P. H. and C. M. P30CA013330 to C. M.) and with support from the Cancer Therapy & Research Center at The University of Texas at San Antonio (CTRC) (P30 CA054174).	ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Carr A. M., 2013, J MOL BIOL; Carr AM, 2011, SEMIN CELL DEV BIOL, V22, P866, DOI 10.1016/j.semcdb.2011.10.008; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chen MJ, 2007, CANCER RES, V67, P9077, DOI 10.1158/0008-5472.CAN-07-1146; Chen MJ, 2007, NUCLEIC ACIDS RES, V35, P2682, DOI 10.1093/nar/gkm151; DAVISSON MT, 1994, GENE, V147, P157, DOI 10.1016/0378-1119(94)90060-4; Donoho G, 2003, GENE CHROMOSOME CANC, V36, P317, DOI 10.1002/gcc.10148; Dumitrache LC, 2011, GENETICS, V188, P787, DOI 10.1534/genetics.111.129833; Dumitrache LC, 2009, MUTAT RES-FUND MOL M, V662, P84, DOI 10.1016/j.mrfmmm.2008.11.012; Dutra BE, 2006, J MOL BIOL, V356, P300, DOI 10.1016/j.jmb.2005.11.071; Falbo KB, 2009, NAT STRUCT MOL BIOL, V16, P1167, DOI 10.1038/nsmb.1686; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Holcomb VB, 2007, GENESIS, V45, P275, DOI 10.1002/dvg.20300; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kim TM, 2012, MOL CELL BIOL, V32, P3663, DOI 10.1128/MCB.00406-12; Kim TM, 2008, GENESIS, V46, P732, DOI 10.1002/dvg.20439; Krijger PHL, 2011, DNA REPAIR, V10, P438, DOI 10.1016/j.dnarep.2010.12.008; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Mizuno K, 2013, NATURE, V493, P246, DOI 10.1038/nature11676; Mizuno K, 2009, GENE DEV, V23, P2876, DOI 10.1101/gad.1863009; Montagna C, 2002, ONCOGENE, V21, P890, DOI 10.1038/sj.onc.1205146; Morimatsu M, 1998, CANCER RES, V58, P3441; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	47	34	35	0	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					569	+		10.1038/nature12500	http://dx.doi.org/10.1038/nature12500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24013173	Green Accepted			2022-12-28	WOS:000324826300063
J	Labrie, J; Berghmans, BLCM; Fischer, K; Milani, AL; van der Wijk, I; Smalbraak, DJC; Vollebregt, A; Schellart, RP; Graziosi, GCM; van der Ploeg, JM; Brouns, JFGM; Tiersma, ESM; Groenendijk, AG; Scholten, P; Mol, BW; Blokhuis, EE; Adriaanse, AH; Schram, A; Roovers, JPWR; Lagro-Janssen, ALM; van der Vaart, CH				Labrie, Julien; Berghmans, Bary L. C. M.; Fischer, Kathelijn; Milani, Alfredo L.; van der Wijk, Ileana; Smalbraak, Dina J. C.; Vollebregt, Astrid; Schellart, Rene P.; Graziosi, Giuseppe C. M.; van der Ploeg, J. Marinus; Brouns, Joseph F. G. M.; Tiersma, E. Stella M.; Groenendijk, Annette G.; Scholten, Piet; Mol, Ben Willem; Blokhuis, Elisabeth E.; Adriaanse, Albert H.; Schram, Aaltje; Roovers, Jan-Paul W. R.; Lagro-Janssen, Antoine L. M.; van der Vaart, Carl H.			Surgery versus Physiotherapy for Stress Urinary Incontinence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; FREE VAGINAL TAPE; IMPACT QUESTIONNAIRE; WOMEN; METAANALYSIS; VALIDATION; SYMPTOMS; OUTCOMES; PATIENT	BackgroundPhysiotherapy involving pelvic-floor muscle training is advocated as first-line treatment for stress urinary incontinence; midurethral-sling surgery is generally recommended when physiotherapy is unsuccessful. Data are lacking from randomized trials comparing these two options as initial therapy. MethodsWe performed a multicenter, randomized trial to compare physiotherapy and midurethral-sling surgery in women with stress urinary incontinence. Crossover between groups was allowed. The primary outcome was subjective improvement, measured by means of the Patient Global Impression of Improvement at 12 months. ResultsWe randomly assigned 230 women to the surgery group and 230 women to the physiotherapy group. A total of 49.0% of women in the physiotherapy group and 11.2% of women in the surgery group crossed over to the alternative treatment. In an intention-to-treat analysis, subjective improvement was reported by 90.8% of women in the surgery group and 64.4% of women in the physiotherapy group (absolute difference, 26.4 percentage points; 95% confidence interval [CI], 18.1 to 34.5). The rates of subjective cure were 85.2% in the surgery group and 53.4% in the physiotherapy group (absolute difference, 31.8 percentage points; 95% CI, 22.6 to 40.3); rates of objective cure were 76.5% and 58.8%, respectively (absolute difference, 17.8 percentage points; 95% CI, 7.9 to 27.3). A post hoc per-protocol analysis showed that women who crossed over to the surgery group had outcomes similar to those of women initially assigned to surgery and that both these groups had outcomes superior to those of women who did not cross over to surgery. ConclusionsFor women with stress urinary incontinence, initial midurethral-sling surgery, as compared with initial physiotherapy, results in higher rates of subjective improvement and subjective and objective cure at 1 year.	[Labrie, Julien; Fischer, Kathelijn; van der Vaart, Carl H.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Scholten, Piet] Diakonessen Hosp, Utrecht, Netherlands; [Berghmans, Bary L. C. M.] Univ Med Ctr Maastricht, Maastricht, Netherlands; [Milani, Alfredo L.] Reinier de Graaf Gasthuis, Delft, Netherlands; [van der Wijk, Ileana] Groene Hart Ziekenhuis, Gouda, Netherlands; [Smalbraak, Dina J. C.] Amphia Ziekenhuis, Breda, Netherlands; [Vollebregt, Astrid] Spaarne Ziekenhuis, Hoofddorp, Netherlands; [Schellart, Rene P.] Kennemer Gasthuis, Haarlem, Netherlands; [Graziosi, Giuseppe C. M.] Antonius Ziekenhuis, Nieuwegein, Netherlands; [van der Ploeg, J. Marinus] Martini Ziekenhuis, Groningen, Netherlands; [Schram, Aaltje] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Brouns, Joseph F. G. M.] Zaans Med Ctr, Zaandam, Netherlands; [Tiersma, E. Stella M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Groenendijk, Annette G.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Mol, Ben Willem; Roovers, Jan-Paul W. R.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Blokhuis, Elisabeth E.] Hofpoort Ziekenhuis, Woerden, Netherlands; [Adriaanse, Albert H.] Med Ctr Alkmaar, Alkmaar, Netherlands; [Lagro-Janssen, Antoine L. M.] Univ Med Ctr Nijmegen, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Diakonessenhuis; Maastricht University; Maastricht University Medical Centre (MUMC); Reinier de Graaf Hospital; Amphia Hospital; Spaarne Hospital; Spaarne Hospital; Martini Hospital; University of Groningen; Vrije Universiteit Amsterdam; Onze Lieve Vrouwe Gasthuis Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Medical Center Of Alkmaar; Radboud University Nijmegen	Labrie, J (corresponding author), Univ Med Ctr Utrecht, Heidelberglaan 100,POB 85500,Room F05-121, Utrecht, Netherlands.	j.labrie@umcutrecht.nl	Mol, Ben/I-4526-2012; maiza, marisa/L-6168-2013; Fischer, Kathelijn/M-2395-2017; Lagro, A.L.M./H-8066-2014	Fischer, Kathelijn/0000-0001-7126-6613	ZonMw, the Netherlands Organization for Health Research and Development	ZonMw, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	Funded by ZonMw, the Netherlands Organization for Health Research and Development; Dutch Trial Register number, NTR1248.	Abdel-Fattah M, 2010, BJOG-INT J OBSTET GY, V117, P870, DOI 10.1111/j.1471-0528.2010.02544.x; Ballert KN, 2010, J UROLOGY, V183, P1455, DOI 10.1016/j.juro.2009.12.011; Berghmans L, 2003, NED TIJDSCHR FYSIOTH, V115, P1; Biggs GY, 2009, INT UROGYNECOL J, V20, P331, DOI 10.1007/s00192-008-0777-6; Black NA, 1996, BRIT J UROL, V78, P497, DOI 10.1046/j.1464-410X.1996.01422.x; Bo K, 2005, OBSTET GYNECOL, V105, P999, DOI 10.1097/01.AOG.0000157207.95680.6d; Cammu H, 2004, AM J OBSTET GYNECOL, V191, P1152, DOI 10.1016/j.ajog.2004.05.012; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Coyne KS, 2003, BJU INT, V92, P731, DOI 10.1046/j.1464-410X.2003.04463.x; de Leval J, 2003, EUR UROL, V44, P724, DOI 10.1016/j.eururo.2003.09.003; Dumoulin C, 2011, NEUROUROL URODYNAM, V30, P746, DOI 10.1002/nau.21104; Foglia Giovanni, 2007, Archives of Gynecology and Obstetrics, V276, P59, DOI 10.1007/s00404-006-0303-3; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Imamura M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14400; Jelovsek JE, 2008, BJOG-INT J OBSTET GY, V115, P219, DOI 10.1111/j.1471-0528.2007.01592.x; Labrie Julien, 2009, BMC Womens Health, V9, P24, DOI 10.1186/1472-6874-9-24; Lamers BHC, 2007, INT UROGYNECOL J, V18, P301, DOI 10.1007/s00192-006-0153-3; Latthe PM, 2010, BJU INT, V106, P68, DOI 10.1111/j.1464-410X.2009.09051.x; Miller JM, 2001, OBSTET GYNECOL, V97, P255, DOI 10.1016/S0029-7844(00)01132-7; Nager CW, 2012, NEW ENGL J MED, V366, P1987, DOI 10.1056/NEJMoa1113595; Newcombe RG, 1999, STAT MED, V18, P1293, DOI 10.1002/(SICI)1097-0258(19990530)18:10<1293::AID-SIM175>3.0.CO;2-7; Nilsson CG, 2008, INT UROGYNECOL J, V19, P1043, DOI 10.1007/s00192-008-0666-z; Novara G, 2010, EUR UROL, V58, P218, DOI 10.1016/j.eururo.2010.04.022; Ogah J, 2009, COCHRANE DB SYST REV, V4; Padmanabhan P, 2006, CURR OPIN UROL, V16, P212, DOI 10.1097/01.mou.0000232038.72556.b1; Richter HE, 2010, OBSTET GYNECOL, V115, P609, DOI 10.1097/AOG.0b013e3181d055d4; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Staskin D, 2009, INCONTINENCE, P363; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tannenbaum C, 2008, AGE AGEING, V37, P379, DOI 10.1093/ageing/afn108; Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378; van der Vaart CH, 2003, NEUROUROL URODYNAM, V22, P97, DOI 10.1002/nau.10038; van der Vaart CH, 2002, BJU INT, V90, P544, DOI 10.1046/j.1464-410X.2002.02963.x; Yalcin I, 2003, AM J OBSTET GYNECOL, V189, P98, DOI 10.1067/mob.2003.379	35	102	115	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1124	1133		10.1056/NEJMoa1210627	http://dx.doi.org/10.1056/NEJMoa1210627			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047061				2022-12-28	WOS:000324554800010
J	Lu, JX; Qiang, W; Yau, WM; Schwieters, CD; Meredith, SC; Tycko, R				Lu, Jun-Xia; Qiang, Wei; Yau, Wai-Ming; Schwieters, Charles D.; Meredith, Stephen C.; Tycko, Robert			Molecular Structure of beta-Amyloid Fibrils in Alzheimer's Disease Brain Tissue	CELL			English	Article							PROTEIN A-BETA; DISTANCE MEASUREMENTS; SENILE PLAQUES; IN-VIVO; SHEET; OLIGOMERS; POLYMORPHISM; DEPOSITION; A-BETA-40; PEPTIDE	In vitro, beta-amyloid (A beta) peptides form polymorphic fibrils, with molecular structures that depend on growth conditions, plus various oligomeric and protofibrillar aggregates. Here, we investigate structures of human brain-derived A beta fibrils, using seeded fibril growth from brain extract and data from solid-state nuclear magnetic resonance and electron microscopy. Experiments on tissue from two Alzheimer's disease (AD) patients with distinct clinical histories showed a single predominant 40 residue A beta (A beta 40) fibril structure in each patient; however, the structures were different from one another. A molecular structural model developed for A beta 40 fibrils from one patient reveals features that distinguish in-vivo-from in-vitro-produced fibrils. The data suggest that fibrils in the brain may spread from a single nucleation site, that structural variations may correlate with variations in AD, and that structure-specific amyloid imaging agents may be an important future goal.	[Lu, Jun-Xia; Qiang, Wei; Yau, Wai-Ming; Tycko, Robert] NIDDKD, Lab Chem Phys, NIH, Bethesda, MD 20892 USA; [Schwieters, Charles D.] NIH, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Meredith, Stephen C.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Meredith, Stephen C.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Chicago; University of Chicago	Tycko, R (corresponding author), NIDDKD, Lab Chem Phys, NIH, Bethesda, MD 20892 USA.	robertty@mail.nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; Center for Information Technology of the National Institutes of Health; N.I.H. [R01 NS042852]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042852] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Information Technology of the National Institutes of Health; N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the Intramural Research Programs of the National Institute of Diabetes and Digestive and Kidney Diseases and the Center for Information Technology of the National Institutes of Health, and by N.I.H. grant R01 NS042852 (to S.C.M.). We thank Dr. Reed Wickner for assistance with gene sequencing and Dr. Peter Pytel for assistance with histopathology. Calculations were performed on the Biowulf Linux cluster at the N.I.H.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Bayro MJ, 2009, ANGEW CHEM INT EDIT, V48, P5708, DOI 10.1002/anie.200901520; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; De Paepe G, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3036928; Giannakopoulos P, 1997, BRAIN RES REV, V25, P217, DOI 10.1016/S0165-0173(97)00023-4; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gordon DJ, 2001, BIOCHEMISTRY-US, V40, P8237, DOI 10.1021/bi002416v; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Hu KN, 2012, J MAGN RESON, V218, P115, DOI 10.1016/j.jmr.2012.03.001; Ishii Y, 2001, J CHEM PHYS, V114, P8473, DOI 10.1063/1.1359445; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Jaroniec CP, 2002, J AM CHEM SOC, V124, P10728, DOI 10.1021/ja026385y; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Majumdar A, 2008, NEUROBIOL AGING, V29, P707, DOI 10.1016/j.neurobiolaging.2006.12.001; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Sultana R, 2009, ACTA NEUROPATHOL, V118, P131, DOI 10.1007/s00401-009-0517-0; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tougu V, 2011, METALLOMICS, V3, P250, DOI 10.1039/c0mt00073f; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tycko R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2437194; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106	70	796	807	11	412	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1257	1268		10.1016/j.cell.2013.08.035	http://dx.doi.org/10.1016/j.cell.2013.08.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034249	Bronze, Green Accepted			2022-12-28	WOS:000324239300015
J	Rush, RP				Rush, Raphael P.			BECOMING A PHYSICIAN Signal in the Noise	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Hospitals are noisy places, an assault on the ears. Yet as a medical student grows familiar with the array of beeps, whistles, and shouts, cacophony gives way to music. And the rest beats of nighttime allow one to notice and address the softest sounds. The first time I heard an IV pump beeping was my first time in the hospital as a medical student. Sent to examine a loud, cantankerous patient, I became concerned when his IV pump began frantically shrieking. After 30 seconds of panic and uncertainty, I pulled a resident out of the hall into the patient's room, where, in a maneuver that shocked me then but has since become part of my repertoire, she promptly hit the Silence Alarm button and continued with her own work. Hospitals are noisy places, an assault on the ears. As a new visitor, I was ...	Univ Toronto, Dept Internal Med, Toronto, ON, Canada	University of Toronto	Rush, RP (corresponding author), Univ Toronto, Dept Internal Med, Toronto, ON, Canada.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					996	997		10.1056/NEJMp1305849	http://dx.doi.org/10.1056/NEJMp1305849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	24024837				2022-12-28	WOS:000324304200007
J	Chang, KH; Li, R; Kuri, B; Lotan, Y; Roehrborn, CG; Liu, JY; Vessella, R; Nelson, PS; Kapur, P; Guo, XF; Mirzaei, H; Auchus, RJ; Sharifi, N				Chang, Kai-Hsiung; Li, Rui; Kuri, Barbara; Lotan, Yair; Roehrborn, Claus G.; Liu, Jiayan; Vessella, Robert; Nelson, Peter S.; Kapur, Payal; Guo, Xiaofeng; Mirzaei, Hamid; Auchus, Richard J.; Sharifi, Nima			A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer	CELL			English	Article							CELL LUNG-CANCER; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; INCREASED SURVIVAL; ANDROGEN; ABIRATERONE; PROTEIN; TESTOSTERONE; ASSOCIATION; DEGRADATION; INHIBITION	Growth of prostate cancer cells is dependent upon androgen stimulation of the androgen receptor (AR). Dihydrotestosterone (DHT), the most potent androgen, is usually synthesized in the prostate from testosterone secreted by the testis. Following chemical or surgical castration, prostate cancers usually shrink owing to testosterone deprivation. However, tumors often recur, forming castration-resistant prostate cancer (CRPC). Here, we show that CRPC sometimes expresses a gain-of-stability mutation that leads to a gain-of-function in 3 beta-hydroxysteroid dehydrogenase type 1 (3 beta HSD1), which catalyzes the initial rate-limiting step in conversion of the adrenal-derived steroid dehydroepiandrosterone to DHT. The mutation (N367T) does not affect catalytic function, but it renders the enzyme resistant to ubiquitination and degradation, leading to profound accumulation. Whereas dehydroepiandrosterone conversion to DHT is usually very limited, expression of 367T accelerates this conversion and provides the DHT necessary to activate the AR. We suggest that 3 beta HSD1 is a valid target for the treatment of CRPC.	[Chang, Kai-Hsiung; Kuri, Barbara; Sharifi, Nima] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Chang, Kai-Hsiung; Kuri, Barbara; Sharifi, Nima] Cleveland Clin, Taussig Canc Inst, Dept Solid Tumor Oncol, Cleveland, OH 44195 USA; [Chang, Kai-Hsiung; Kuri, Barbara; Sharifi, Nima] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA; [Chang, Kai-Hsiung; Li, Rui; Sharifi, Nima] UT Southwestern Med Ctr, Dept Internal Med, Div Hematol Oncol, Dallas, TX 75390 USA; [Chang, Kai-Hsiung; Li, Rui; Sharifi, Nima] UT Southwestern Med Ctr, Simmons Canc Ctr, Dallas, TX 75390 USA; [Lotan, Yair; Roehrborn, Claus G.] UT Southwestern Med Ctr, Dept Urol, Dallas, TX 75390 USA; [Kapur, Payal] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA; [Guo, Xiaofeng; Mirzaei, Hamid] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Liu, Jiayan; Auchus, Richard J.] Univ Michigan, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Ann Arbor, MI 48109 USA; [Vessella, Robert; Nelson, Peter S.] Univ Washington, Sch Med, Dept Urol, Seattle, WA 98109 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Sharifi, N (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA.	sharifn@ccf.org	高, 雨莉/HGU-8187-2022; Chang, Kai-Hsiung/K-3048-2013	Chang, Kai-Hsiung/0000-0002-8392-8319	Howard Hughes Medical Institute; Prostate Cancer Foundation; American Cancer Society [12-038-01-CCE]; U.S. Army Medical Research and Materiel Command [PC080193]; National Cancer Institute [1R01CA168899, 1R01CA172382-01];  [PO1-CA85859];  [PC093509];  [P01CA163227];  [P50CA097186]; NATIONAL CANCER INSTITUTE [R01CA168899, P01CA163227, R01CA172382, P50CA097186, P01CA085859] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Prostate Cancer Foundation; American Cancer Society(American Cancer Society); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Ralph Deberardinis, Mike Brown, Kevin Courtney, George DeMartino, and Eugene Frenkel for helpful comments, Russell DeBose-Boyd for the anti-AFMR antibody, J.T. Hsieh for the anti-SKP2 antibody, Cheng-Ming Chiang for the anti-His antibody and Actinomycin D, David Trudgian for assistance with protein mass spectrometry, and An Jia and Chul Ahn for assistance with statistical analysis. This publication has been funded in part by a Howard Hughes Medical Institute Physician-Scientist Early Career Award (to N. S.), by the Prostate Cancer Foundation (to N. S., R. V., and P. S. N.), by an American Cancer Society Research Scholar Award (12-038-01-CCE [to N. S.]), by a grant from the U.S. Army Medical Research and Materiel Command (PC080193) (to N. S.), and additional grants from the National Cancer Institute (1R01CA168899 and 1R01CA172382-01 [to N. S.]). The acquisition of metastatic tumors through the UW Rapid Autopsy Program was funded in part by grants (PO1-CA85859 [to R. V. and P. S. N.], PC093509 [to P. S. N.], P01CA163227 [P. S. N.], and P50CA097186 [R. V. and P. S. N.]).	Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; BARRIE SE, 1994, J STEROID BIOCHEM, V50, P267, DOI 10.1016/0960-0760(94)90131-7; Chang BL, 2002, CANCER RES, V62, P1784; Chang KH, 2012, NAT REV UROL, V9, P721, DOI 10.1038/nrurol.2012.175; Chang KH, 2011, P NATL ACAD SCI USA, V108, P13728, DOI 10.1073/pnas.1107898108; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Evaul K, 2010, ENDOCRINOLOGY, V151, P3514, DOI 10.1210/en.2010-0138; GELLER J, 1978, J CLIN ENDOCR METAB, V46, P440; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li R, 2012, CLIN CANCER RES, V18, P3571, DOI 10.1158/1078-0432.CCR-12-0908; LORENCE MC, 1990, ENDOCRINOLOGY, V126, P2493, DOI 10.1210/endo-126-5-2493; Luu-The V, 2008, BEST PRACT RES CL EN, V22, P207, DOI 10.1016/j.beem.2008.01.008; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Penning TM, 2010, CURR OPIN ENDOCRINOL, V17, P233, DOI 10.1097/MED.0b013e3283381a31; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Sharifi N, 2013, MOL ENDOCRINOL, V27, P708, DOI 10.1210/me.2013-1007; Shimodaira M, 2010, EUR J ENDOCRINOL, V163, P671, DOI 10.1530/EJE-10-0428; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021	35	210	227	2	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 29	2013	154	5					1074	1084		10.1016/j.cell.2013.07.029	http://dx.doi.org/10.1016/j.cell.2013.07.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993097	Green Accepted, Bronze			2022-12-28	WOS:000323767300020
J	Miles, BWJ; Stokes, CR; Vieli, A; Cox, NJ				Miles, B. W. J.; Stokes, C. R.; Vieli, A.; Cox, N. J.			Rapid, climate-driven changes in outlet glaciers on the Pacific coast of East Antarctica	NATURE			English	Article							ICE-SHEET; SEA-ICE; ANNULAR MODE; MASS-LOSS; GREENLAND; VARIABILITY; PENINSULA; MARGINS; SHELVES; ADELIE	Observations of ocean-terminating outlet glaciers in Greenland and West Antarctica(1-6) indicate that their contribution to sea level is accelerating as a result of increased velocity, thinning and retreat(7-11). Thinning has also been reported along the margin of the much larger East Antarctic ice sheet(1), but whether glaciers are advancing or retreating there is largely unknown, and there has been no attempt to place such changes in the context of localized mass loss(7,9) or climatic or oceanic forcing. Here we present multidecadal trends in the terminus position of 175 ocean-terminating outlet glaciers along 5,400 kilometres of the margin of the East Antarctic ice sheet, and reveal widespread and synchronous changes. Despite large fluctuations between glaciers-linked to their size-three epochal patterns emerged: 63 per cent of glaciers retreated from 1974 to 1990, 72 per cent advanced from 1990 to 2000, and 58 per cent advanced from 2000 to 2010. These trends were most pronounced along the warmer western South Pacific coast, whereas glaciers along the cooler Ross Sea coast experienced no significant changes. We find that glacier change along the Pacific coast is consistent with a rapid and coherent response to air temperature and sea-ice trends, linked through the dominant mode of atmospheric variability (the Southern Annular Mode). We conclude that parts of the world's largest ice sheet may be more vulnerable to external forcing than recognized previously.	[Miles, B. W. J.; Stokes, C. R.; Vieli, A.; Cox, N. J.] Univ Durham, Dept Geog, Durham DH1 3LE, England	Durham University	Stokes, CR (corresponding author), Univ Durham, Dept Geog, Sci Site,South Rd, Durham DH1 3LE, England.	c.r.stokes@durham.ac.uk	Stokes, Chris R/A-1957-2011	Stokes, Chris R/0000-0003-3355-1573; Miles, Bertie/0000-0002-3388-4688				Amundson JM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001405; Arblaster JM, 2006, J CLIMATE, V19, P2896, DOI 10.1175/JCLI3774.1; Bjork AA, 2012, NAT GEOSCI, V5, P427, DOI [10.1038/NGEO1481, 10.1038/ngeo1481]; Blair RC., 1980, J ED STAT, V5, P309, DOI [10.2307/1164905, DOI 10.2307/1164905]; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Ferraccioli F, 2009, TECTONOPHYSICS, V478, P62, DOI 10.1016/j.tecto.2009.03.013; Frezzotti M, 1998, ANN GLACIOL, V27, P643; Frezzotti M, 2002, ANN GLACIOL-SER, V34, P235, DOI 10.3189/172756402781817897; Hall A, 2002, J CLIMATE, V15, P3043, DOI 10.1175/1520-0442(2002)015<3043:SVITSH>2.0.CO;2; Jacobs S, 2006, PHILOS T R SOC A, V364, P1657, DOI 10.1098/rsta.2006.1794; Joughin I, 2011, NAT GEOSCI, V4, P506, DOI [10.1038/ngeo1194, 10.1038/NGEO1194]; Kim K, 2007, INT J REMOTE SENS, V28, P5357, DOI 10.1080/01431160601105850; King MA, 2012, NATURE, V491, P586, DOI 10.1038/nature11621; MacGregor JA, 2012, J GLACIOL, V58, P458, DOI 10.3189/2012JoG11J262; Massom RA, 2009, MAR ECOL PROG SER, V374, P243, DOI 10.3354/meps07734; Moon T, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000927; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Parkinson CL, 2012, CRYOSPHERE, V6, P871, DOI 10.5194/tc-6-871-2012; Pritchard HD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000597; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047109; Rignot E, 2011, MEASURES INSAR BASED; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; van der Veen CJ, 1998, COLD REG SCI TECHNOL, V27, P31, DOI 10.1016/S0165-232X(97)00022-0; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Zwally HJ, 2011, SURV GEOPHYS, V32, P351, DOI 10.1007/s10712-011-9123-5	34	72	73	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					563	+		10.1038/nature12382	http://dx.doi.org/10.1038/nature12382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23985874	Green Accepted			2022-12-28	WOS:000323625900031
J	Paul, DB; Ankeny, RA				Paul, Diane B.; Ankeny, Rachel A.			Patenting the PKU Test Federally Funded Research and Intellectual Property	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								In 1960, Robert Guthrie invented a new assay to detect phenylketonuria in newborns, inspiring hope for treating mental retardation. But efforts to patent and license the test generated controversy, presaging current debates over commercialization in biomedicine. In 1960, microbiologist Robert Guthrie and technician Ada Susi invented a bacterial inhibition assay that reliably detected phenylketonuria (PKU) in newborns. The damage caused by PKU, including often profound cognitive impairment, results from an inability to metabolize phenylalanine, an amino acid necessary for protein synthesis and normal growth and development. To be effective, treatment with a low-phenylalanine diet must begin in early infancy, before the onset of irreversible neurologic impairment. Although a ferric chloride urine test for PKU existed in the 1950s, it was unreliable until the infant was 6 to 8 weeks old. The new assay was also more ...	[Paul, Diane B.] Univ Massachusetts, Boston, MA 02125 USA; [Paul, Diane B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Ankeny, Rachel A.] Univ Adelaide, Sch Hist & Polit, Adelaide, SA, Australia	University of Massachusetts System; University of Massachusetts Boston; Harvard University; University of Adelaide	Paul, DB (corresponding author), Univ Massachusetts, Harbor Campusol, Boston, MA 02125 USA.		Ankeny, Rachel A/I-9298-2018	Ankeny, Rachel A/0000-0002-1547-6031; Paul, Diane/0000-0003-4053-0121				[Anonymous], 1968, COMMUNICATION; Mirowski Philip, 2011, SCI MART PRIVATIZING; Paul DB, 2013, JOHNS HOPK BIOGR DIS, P1	3	0	0	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					792	794		10.1056/NEJMp1306755	http://dx.doi.org/10.1056/NEJMp1306755			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	208KB	23984725				2022-12-28	WOS:000323676100003
J	Stack, CB; Localio, AR; Griswold, ME; Goodman, SN; Mulrow, CD				Stack, Catharine B.; Localio, A. Russell; Griswold, Michael E.; Goodman, Steven N.; Mulrow, Cynthia D.			Handling of Rescue and Missing Data Affects Synthesis and Interpretation of Evidence: The Sodium-Glucose Cotransporter 2 Inhibitor Example	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED-TRIAL; DAPAGLIFLOZIN; EFFICACY; RISK	Confidence in evidence summarized in meta-analyses depends on the strength of the underlying studies. This inherent limitation of syntheses appears in the case of a meta-analysis of sodium-glucose cotransporter 2 inhibitors for the treatment of type 2 diabetes because many of the pertinent randomized trials did not handle patient dropout and "rescue" medication properly. Repudiated statistical methods, such as last observation carried forward, and unsophisticated methods for handling postrescue data produce unreliable summary estimates. Future reports of randomized studies and meta-analyses of those studies must focus on posing precise questions about the treatment effect of interest and then implement appropriate statistical methods to account for missing data, patient dropout, and use of rescue medication.	[Stack, Catharine B.] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	American College of Physicians; University of Pennsylvania; University of Mississippi; University of Mississippi Medical Center; Stanford University	Stack, CB (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	cstack@acponline.org		Goodman, Steven/0000-0002-3872-5723				Bailey CJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-43; Daniels MJ, 2008, MONOGR STAT APPL PRO, V109, P1; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Frangakis CE, 2002, BIOMETRICS, V58, P21, DOI 10.1111/j.0006-341X.2002.00021.x; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Institute of Medicine, 2008, TREATMENT POSTTRAUMA, DOI [10.17226/11955, DOI 10.17226/11955]; Mallinckrodt CH, 2001, DRUG INF J, V35, P1215, DOI 10.1177/009286150103500418; Molenberghs G, 2007, MISSING DATA CLIN ST, P27; Molnar Frank J, 2009, Open Med, V3, pe31; Panel on Handling Missing Data in Clinical Trials National Research Council, 2010, PREV TREATM MISS DAT; Small DS, 2006, STAT MED, V25, P1981, DOI 10.1002/sim.2313; Toh Sengwee, 2008, Int J Biostat, V4, P22, DOI 10.2202/1557-4679.1117; Toh S, 2010, ANN INTERN MED, V152, P211, DOI 10.7326/0003-4819-152-4-201002160-00005; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; White IR, 2003, STAT MED, V22, P781, DOI 10.1002/sim.1369; Wilding JPH, 2012, ANN INTERN MED, V156, P405, DOI 10.7326/0003-4819-156-6-201203200-00003; Yuan Y, 2009, BIOMETRICS, V65, P487, DOI 10.1111/j.1541-0420.2008.01068.x	19	12	12	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					285	+		10.7326/0003-4819-159-4-201308200-00009	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026261				2022-12-28	WOS:000323421700018
J	Massie, J; Castellani, C; Grody, WW				Massie, John; Castellani, Carlo; Grody, Wayne W.			Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function	LANCET			English	Editorial Material							LUNG-FUNCTION; INFANTS		[Massie, John] Royal Childrens Hosp, Dept Resp Med, Parkville, Vic 3052, Australia; [Massie, John] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Massie, John] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Castellani, Carlo] Azienda Osped Univ Integrata, Cyst Fibrosis Ctr, Verona, Italy; [Grody, Wayne W.] Univ Calif Los Angeles, Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Grody, Wayne W.] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; [Grody, Wayne W.] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA USA	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Massie, J (corresponding author), Royal Childrens Hosp, Dept Resp Med, Flemington Rd, Parkville, Vic 3052, Australia.	john.massie@rch.org.au	Castellani, Carlo/AAB-3847-2019		NICHD NIH HHS [P30 HD004612] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004612] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Achterbergh R, 2007, HEALTH POLICY, V83, P277, DOI 10.1016/j.healthpol.2007.02.007; Beutler E, 2007, JAMA-J AM MED ASSOC, V298, P1329, DOI 10.1001/jama.298.11.1329; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Borthwick LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023226; Boyle MP, 2013, LANCET RESP MED, V1, P158, DOI 10.1016/S2213-2600(12)70057-7; Castellani C, 2010, J CYST FIBROS, V9, P165, DOI 10.1016/j.jcf.2010.02.005; Castellani C, 2009, JAMA-J AM MED ASSOC, V302, P2573, DOI 10.1001/jama.2009.1758; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Clancy JP, 2012, AM J RESP CRIT CARE, V186, P593, DOI 10.1164/rccm.201204-0785PP; Cunningham S, 1998, ARCH DIS CHILD, V78, P345, DOI 10.1136/adc.78.4.345; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Grody Wayne W., 2001, Genetics in Medicine, V3, P149, DOI 10.1097/00125817-200103000-00010; Hale JE, 2008, NEW ENGL J MED, V358, P973, DOI 10.1056/NEJMc0707530; Hoo AF, 2012, THORAX, V67, P874, DOI 10.1136/thoraxjnl-2012-201747; Human Genetics Society of Australasia, 2010, CYST FIBR POP SCREEN; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Pillarisetti N, 2011, AM J RESP CRIT CARE, V184, P75, DOI 10.1164/rccm.201011-1892OC; Radhakrishnan M, 2008, HEALTH POLICY, V85, P133, DOI 10.1016/j.healthpol.2007.07.007; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; van Gool K, 2013, VALUE HEALTH, V16, P345, DOI 10.1016/j.jval.2012.12.003; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Witt DWC, 2008, ANN M AM SOC HUM GEN	25	17	17	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					923	925		10.1016/S0140-6736(13)61092-2	http://dx.doi.org/10.1016/S0140-6736(13)61092-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3FC	23992917				2022-12-28	WOS:000332399500032
J	Lee, C; Kang, HJ; von Ballmoos, C; Newstead, S; Uzdavinys, P; Dotson, DL; Iwata, S; Beckstein, O; Cameron, AD; Drew, D				Lee, Chiara; Kang, Hae Joo; von Ballmoos, Christoph; Newstead, Simon; Uzdavinys, Povilas; Dotson, David L.; Iwata, So; Beckstein, Oliver; Cameron, Alexander D.; Drew, David			A two-domain elevator mechanism for sodium/proton antiport	NATURE			English	Article							MEMBRANE-PROTEIN OVEREXPRESSION; NHAA NA+/H+ ANTIPORTER; ESCHERICHIA-COLI; PH; PURIFICATION; TRANSPORT; DYNAMICS; PROTON; SYSTEM; MODEL	Sodium/proton (Na+/H+) antiporters, located at the plasma membrane in every cell, are vital for cell homeostasis1. In humans, their dysfunction has been linked to diseases, such as hypertension, heart failure and epilepsy, and they are well-established drug targets(2). The best understood model system for Na+/H+ antiport is NhaA from Escherichia coli(1,3), for which both electron microscopy and crystal structures are available(4-6). NhaA is made up of two distinct domains: a core domain and a dimerization domain. In the NhaA crystal structure a cavity is located between the two domains, providing access to the ion-binding site from the inward-facing surface of the protein(1,4). Likemany Na+/H+ antiporters, the activity of NhaA is regulated by pH, only becoming active above pH 6.5, at which point a conformational change is thought to occur(7). The only reported NhaA crystal structure so far is of the low pH inactivated form(4). Here we describe the active-state structure of a Na+/H+ antiporter, NapA from Thermus thermophilus, at 3 angstrom resolution, solved from crystals grown at pH7.8. In the NapA structure, the core and dimerization domains are in different positions to those seen in NhaA, and a negatively charged cavity has now opened to the outside. The extracellular cavity allows access to a strictly conserved aspartate residue thought to coordinate ion binding(1,8,9) directly, a role supported hereby molecular dynamics simulations. To alternate access to this ion-binding site, however, requires a surprisingly large rotation of the core domain, some 20 degrees against the dimerization interface. We conclude that despite their fast transport rates of up to 1,500 ions per second(3), Na+/H+ antiporters operate by a two-domain rocking bundle model, revealing themes relevant to secondary-active transporters in general.	[Lee, Chiara; Kang, Hae Joo; Newstead, Simon; Iwata, So; Cameron, Alexander D.; Drew, David] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [von Ballmoos, Christoph; Uzdavinys, Povilas; Drew, David] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Dotson, David L.; Beckstein, Oliver] Arizona State Univ, Dept Phys, Ctr Biol Phys, Tempe, AZ 85287 USA; [Iwata, So; Cameron, Alexander D.] Membrane Prot Lab, Diamond Light Source, Chilton OX11 0DE, Oxon, England; [Iwata, So; Cameron, Alexander D.] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England; [Cameron, Alexander D.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	Imperial College London; Stockholm University; Arizona State University; Arizona State University-Tempe; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Warwick	Cameron, AD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England.	a.cameron@warwick.ac.uk; d.drew@imperial.ac.uk	Beckstein, Oliver/C-9095-2009; Drew, David/D-3243-2018; Drew, David/AAY-3455-2020; Dotson, David/L-7155-2013; Cameron, Alexander/L-7288-2013	Beckstein, Oliver/0000-0003-1340-0831; Dotson, David/0000-0001-5879-2942; Uzdavinys, Povilas/0000-0001-8222-7660; Drew, David/0000-0001-8866-6349; Cameron, Alexander/0000-0001-8776-3518; Newstead, Simon/0000-0001-7432-2270; von Ballmoos, Christoph/0000-0002-4642-6088	Medical Research Council (MRC) [G0900990]; Swedish Research Council; BBSRC [BB/G02325/1]; Wellcome Trust at the Diamond Light Source Limited [062164/Z/00/Z]; Centre for Biomembrane Research (CBR); Swedish Foundation for Strategic Research; XSEDE [TG-MCB120151]; Human Frontiers Science Program (HFSP); Royal Society through the University Research Fellow (URF) scheme; BBSRC [BB/G023425/1] Funding Source: UKRI; MRC [G0900399, G0900990] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish; Medical Research Council [G0900399, G0900990] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust at the Diamond Light Source Limited(Wellcome Trust); Centre for Biomembrane Research (CBR); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); XSEDE; Human Frontiers Science Program (HFSP)(Human Frontier Science Program); Royal Society through the University Research Fellow (URF) scheme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to D. Slotboom for critical reading of the manuscript and N.-J. Hu for assistance in data collection. Data were collected at the European Synchrotron Radiation Facility and Diamond Light Source, with excellent assistance from beamline scientists. This work was funded by grants from the Medical Research Council (MRC grant G0900990 to A. D. C. and D. D.), the Swedish Research Council (to C. v. B. and D. D.) and the BBSRC (BB/G02325/1 to S. I.). The authors are grateful for the use of the Membrane Protein Laboratory funded by the Wellcome Trust (grant 062164/Z/00/Z) at the Diamond Light Source Limited and The Centre for Biomembrane Research (CBR), supported by the Swedish Foundation for Strategic Research. Computer simulations were partially run on XSEDE resources (grant TG-MCB120151 to O.B.). C. L. was a recipient of a BBSRC-funded PhD scholarship, H.J.K. a Human Frontiers Science Program (HFSP) postdoctoral fellowship, and D. D. acknowledges the support from The Royal Society through the University Research Fellow (URF) scheme.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond PJ, 2008, BIOCHEMISTRY-US, V47, P11321, DOI 10.1021/bi800642m; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; DeLano W.L, PYMOL MOL GRAPHICS S; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Furrer EM, 2007, FEBS LETT, V581, P572, DOI 10.1016/j.febslet.2006.12.059; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hisamitsu T, 2006, BIOCHEMISTRY-US, V45, P13346, DOI 10.1021/bi0608616; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Ishmukhametov RR, 2005, BBA-BIOENERGETICS, V1706, P110, DOI 10.1016/j.bbabio.2004.09.012; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; Knight SD, 2000, ACTA CRYSTALLOGR D, V56, P42, DOI 10.1107/S0907444999012913; Kozachkov L, 2013, MOL MEMBR BIOL, V30, P90, DOI 10.3109/09687688.2012.693209; Kuwabara N, 2004, J BIOL CHEM, V279, P40567, DOI 10.1074/jbc.M401132200; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Noumi T, 1997, J BIOCHEM-TOKYO, V121, P661; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PINNER E, 1994, J BIOL CHEM, V269, P26274; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; Schushan M, 2012, J BIOL CHEM, V287, P18249, DOI 10.1074/jbc.M111.336446; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Vinothkumar KR, 2005, EMBO J, V24, P2720, DOI 10.1038/sj.emboj.7600727; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; Wiedenmann A, 2008, BBA-BIOENERGETICS, V1777, P1301, DOI 10.1016/j.bbabio.2008.06.008; Wiedenmann A, 2009, MOL MICROBIOL, V72, P479, DOI 10.1111/j.1365-2958.2009.06658.x; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	69	165	166	1	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					573	+		10.1038/nature12484	http://dx.doi.org/10.1038/nature12484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	23995679	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000324826300064
J	Nishihara, R; Wu, KN; Lochhead, P; Morikawa, T; Liao, XY; Qian, ZR; Inamura, K; Kim, SA; Kuchiba, A; Yamauchi, M; Imamura, Y; Willett, WC; Rosner, BA; Fuchs, CS; Giovannucci, E; Ogino, S; Chan, AT				Nishihara, Reiko; Wu, Kana; Lochhead, Paul; Morikawa, Teppei; Liao, Xiaoyun; Qian, Zhi Rong; Inamura, Kentaro; Kim, Sun A.; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Willett, Walter C.; Rosner, Bernard A.; Fuchs, Charles S.; Giovannucci, Edward; Ogino, Shuji; Chan, Andrew T.			Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COLLEGE-OF-RADIOLOGY; SOCIETY TASK-FORCE; NEGATIVE COLONOSCOPY; AMERICAN-COLLEGE; SCREENING COLONOSCOPY; INTERVAL CANCERS; FAMILY-HISTORY; COLON-CANCER; RISK	BackgroundColonoscopy and sigmoidoscopy provide protection against colorectal cancer, but the magnitude and duration of protection, particularly against cancer of the proximal colon, remain uncertain. MethodsWe examined the association of the use of lower endoscopy (updated biennially from 1988 through 2008) with colorectal-cancer incidence (through June 2010) and colorectal-cancer mortality (through June 2012) among participants in the Nurses' Health Study and the Health Professionals Follow-up Study. ResultsAmong 88,902 participants followed over a period of 22 years, we documented 1815 incident colorectal cancers and 474 deaths from colorectal cancer. With endoscopy as compared with no endoscopy, multivariate hazard ratios for colorectal cancer were 0.57 (95% confidence interval [CI], 0.45 to 0.72) after polypectomy, 0.60 (95% CI, 0.53 to 0.68) after negative sigmoidoscopy, and 0.44 (95% CI, 0.38 to 0.52) after negative colonoscopy. Negative colonoscopy was associated with a reduced incidence of proximal colon cancer (multivariate hazard ratio, 0.73; 95% CI, 0.57 to 0.92). Multivariate hazard ratios for death from colorectal cancer were 0.59 (95% CI, 0.45 to 0.76) after screening sigmoidoscopy and 0.32 (95% CI, 0.24 to 0.45) after screening colonoscopy. Reduced mortality from proximal colon cancer was observed after screening colonoscopy (multivariate hazard ratio, 0.47; 95% CI, 0.29 to 0.76) but not after sigmoidoscopy. As compared with colorectal cancers diagnosed in patients more than 5 years after colonoscopy or without any prior endoscopy, those diagnosed in patients within 5 years after colonoscopy were more likely to be characterized by the CpG island methylator phenotype (CIMP) (multivariate odds ratio, 2.19; 95% CI, 1.14 to 4.21) and microsatellite instability (multivariate odds ratio, 2.10; 95% CI, 1.10 to 4.02). ConclusionsColonoscopy and sigmoidoscopy were associated with a reduced incidence of cancer of the distal colorectum; colonoscopy was also associated with a modest reduction in the incidence of proximal colon cancer. Screening colonoscopy and sigmoidoscopy were associated with reduced colorectal-cancer mortality; only colonoscopy was associated with reduced mortality from proximal colon cancer. Colorectal cancer diagnosed within 5 years after colonoscopy was more likely than cancer diagnosed after that period or without prior endoscopy to have CIMP and microsatellite instability.	[Nishihara, Reiko; Lochhead, Paul; Morikawa, Teppei; Liao, Xiaoyun; Qian, Zhi Rong; Inamura, Kentaro; Kim, Sun A.; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Nishihara, Reiko; Lochhead, Paul; Morikawa, Teppei; Liao, Xiaoyun; Qian, Zhi Rong; Inamura, Kentaro; Kim, Sun A.; Kuchiba, Aya; Yamauchi, Mai; Imamura, Yu; Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Nishihara, Reiko; Wu, Kana; Kuchiba, Aya; Willett, Walter C.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Willett, Walter C.; Giovannucci, Edward; Ogino, Shuji] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rosner, Bernard A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wu, Kana; Willett, Walter C.; Rosner, Bernard A.; Fuchs, Charles S.; Giovannucci, Edward; Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Lochhead, Paul] Univ Aberdeen, Inst Med Sci, Gastrointestinal Res Grp, Aberdeen, Scotland; [Morikawa, Teppei] Tokyo Univ Hosp, Dept Pathol, Tokyo 113, Japan; [Inamura, Kentaro] NCI, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Aberdeen; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chan, AT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St,GRJ 825C, Boston, MA 02114 USA.	achan@partners.org	Chan, Andrew T/P-8293-2014; Kim, Sun A/L-4239-2013; Inamura, Kentaro/G-4229-2018	Chan, Andrew T/0000-0001-7284-6767; Kim, Sun A/0000-0002-0891-2093; Inamura, Kentaro/0000-0001-6444-3861; Ogino, Shuji/0000-0002-3909-2323	National Institutes of Health; Chief Scientist Office [CAF/10/15] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA087969, UM1CA167552, P50CA127003, P01CA055075, R01CA137178, R01CA151993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, K24DK098311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chief Scientist Office; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and others.	[Anonymous], 2008, ANN INTERN MED, V149, P627; Arain MA, 2010, AM J GASTROENTEROL, V105, P1189, DOI 10.1038/ajg.2009.699; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2012, J CLIN ONCOL, V30, P2664, DOI 10.1200/JCO.2011.40.4772; Brenner H, 2012, GUT, V61, P1576, DOI 10.1136/gutjnl-2011-301531; Brenner H, 2012, J CLIN ONCOL, V30, P2969, DOI 10.1200/JCO.2011.41.3377; Brenner H, 2011, J CLIN ONCOL, V29, P3761, DOI 10.1200/JCO.2011.35.9307; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Bretthauer M, 2009, NEW ENGL J MED, V361, P300, DOI 10.1056/NEJMe0903924; Burnett-Hartman AN, 2013, CANCER RES, V73, P2863, DOI 10.1158/0008-5472.CAN-12-3462; Cottet V, 2012, GUT, V61, P1180, DOI 10.1136/gutjnl-2011-300295; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Inadomi JM, 2012, NEW ENGL J MED, V366, P2421, DOI 10.1056/NEJMe1204099; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Lakoff J, 2008, CLIN GASTROENTEROL H, V6, P1117, DOI 10.1016/j.cgh.2008.05.016; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; McFarland EG, 2008, RADIOLOGY, V248, P717, DOI 10.1148/radiol.2483080842; Ogino S, 2013, JNCI-J NATL CANCER I, V105, P130, DOI 10.1093/jnci/djs482; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Pohl H, 2013, GASTROENTEROLOGY, V144, P74, DOI 10.1053/j.gastro.2012.09.043; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Sanduleanu S, 2012, NAT REV GASTRO HEPAT, V9, P550, DOI 10.1038/nrgastro.2012.136; Sarna L, 2008, QUAL LIFE RES, V17, P1217, DOI 10.1007/s11136-008-9404-8; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Shaukat A, 2012, DIGEST DIS SCI, V57, P913, DOI 10.1007/s10620-011-1974-6; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Wark PA, 2009, INT J CANCER, V125, P413, DOI 10.1002/ijc.24288; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	39	937	966	4	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1095	1105		10.1056/NEJMoa1301969	http://dx.doi.org/10.1056/NEJMoa1301969			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047059	Green Accepted			2022-12-28	WOS:000324554800007
J	Dzau, VJ; Cho, A; ElLaissi, W; Yoediono, Z; Sangvai, D; Shah, B; Zaas, D; Udayakumar, K				Dzau, Victor J.; Cho, Alex; ElLaissi, William; Yoediono, Ziggy; Sangvai, Devdutta; Shah, Bimal; Zaas, David; Udayakumar, Krishna			Transforming Academic Health Centers for an Uncertain Future	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE	With a changing health care landscape and a growing gap between the excess costs of fulfilling academic health centers' missions and the available funding, the integrity of those missions is in jeopardy. Profound changes are needed in AHCs' organization and operations. Academic health centers (AHCs) have long led the advancement of science and medicine by pursuing missions of clinical care, research, and education. AHCs have been places where important fundamental and translational research is performed and medical innovations are created and tested. Given the dramatic changes ahead in health care and deteriorating research funding, can this record of achievement continue, or do AHCs in the United States face a growing risk of extinction?(1) Despite their substantial societal value, these centers have an uncertain future. The health care landscape is changing rapidly owing to the Affordable Care Act, state budget deficits, and ...	[Dzau, Victor J.] Duke Univ, Sch Med, Durham, NC 27710 USA; Duke Univ Hlth Syst, Durham, NC USA	Duke University; Duke University	Dzau, VJ (corresponding author), Duke Univ, Sch Med, Durham, NC 27710 USA.							[Anonymous], 2012, FUT AC MED CTR STRAT; Becker BN, 2010, ACAD MED, V85, P759, DOI 10.1097/ACM.0b013e3181d5d00e; Dzau VJ, 2010, LANCET, V375, P949, DOI 10.1016/S0140-6736(09)61082-5; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Rockey S, 2011, DO YOU THINK WE SHOU	5	46	47	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					991	993		10.1056/NEJMp1302374	http://dx.doi.org/10.1056/NEJMp1302374			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	216SK	24024835				2022-12-28	WOS:000324304200005
J	Tosi, A; Haas, C; Herzog, F; Gilmozzi, A; Berninghausen, O; Ungewickell, C; Gerhold, CB; Lakomek, K; Aebersold, R; Beckmann, R; Hopfner, KP				Tosi, Alessandro; Haas, Caroline; Herzog, Franz; Gilmozzi, Andrea; Berninghausen, Otto; Ungewickell, Charlotte; Gerhold, Christian B.; Lakomek, Kristina; Aebersold, Ruedi; Beckmann, Roland; Hopfner, Karl-Peter			Structure and Subunit Topology of the INO80 Chromatin Remodeler and Its Nucleosome Complex	CELL			English	Article							ACTIN-RELATED PROTEINS; CROSS-LINKED PEPTIDES; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; YEATS DOMAIN; CONFORMATIONAL FLEXIBILITY; MASS-SPECTROMETRY; CELL-GROWTH; DNA	INO80/SWR1 family chromatin remodelers are complexes composed of >15 subunits and molecular masses exceeding 1 MDa. Their important role in transcription and genome maintenance is exchanging the histone variants H2A and H2A.Z. We report the architecture of S. cerevisiae INO80 using an integrative approach of electron microscopy, crosslinking and mass spectrometry. INO80 has an embryo-shaped head-neck-body-foot architecture and shows dynamic open and closed conformations. We can assign an Rvb1/Rvb2 heterododecamer to the head in close contact with the Ino80 Snf2 domain, Ies2, and the Arp5 module at the neck. The high-affinity nucleosome-binding Nhp10 module localizes to the body, whereas the module that contains actin, Arp4, and Arp8 maps to the foot. Structural and biochemical analyses indicate that the nucleosome is bound at the concave surface near the neck, flanked by the Rvb1/2 and Arp8 modules. Our analysis establishes a structural and functional framework for this family of large remodelers.	[Tosi, Alessandro; Haas, Caroline; Herzog, Franz; Gilmozzi, Andrea; Berninghausen, Otto; Ungewickell, Charlotte; Gerhold, Christian B.; Lakomek, Kristina; Beckmann, Roland; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Tosi, Alessandro; Haas, Caroline; Herzog, Franz; Gilmozzi, Andrea; Berninghausen, Otto; Ungewickell, Charlotte; Gerhold, Christian B.; Lakomek, Kristina; Beckmann, Roland; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Herzog, Franz; Aebersold, Ruedi] ETH, Dept Biol, Inst Mol Syst Biol, CH-8092 Zurich, Switzerland; [Beckmann, Roland; Hopfner, Karl-Peter] Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland	University of Munich; University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; University of Zurich	Beckmann, R (corresponding author), Univ Munich, Dept Biochem, Marchioninistr 15, D-81377 Munich, Germany.	beckmann@genzentrum.lmu.de; hopfner@genzentrum.lmu.de	Hopfner, Karl-Peter/B-6864-2014; Herzog, Franz/G-4832-2012	Hopfner, Karl-Peter/0000-0002-4528-8357; Herzog, Franz/0000-0001-8270-1449; Gerhold, Christian-Benedikt/0000-0002-9982-9171	German Research Council [GRK1721, SFB 646, SFB/TR5]; Center for Integrated Protein Science; European Research Council; BioSysNet; Ernst Schering Foundation; European Molecular Biology Organization; European Commission	German Research Council(German Research Foundation (DFG)); Center for Integrated Protein Science; European Research Council(European Research Council (ERC)European Commission); BioSysNet; Ernst Schering Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This project was funded by the German Research Council (GRK1721, SFB 646, and SFB/TR5) and the Center for Integrated Protein Science (to K.-P. H. and R. B.). K.-P. H. acknowledges support by the European Research Council (advanced grant ATMMACHINE). F. H. and K. P. H acknowledge support by the BioSysNet. C. H. was supported by the Ernst Schering Foundation. F. H. was supported by the European Molecular Biology Organization (long-term fellowship) and by the European Commission (FP7-PEOPLE-IEF); R. A. and F. H. were supported in part by the EU FP7 project PROSPECTS; and R. A. was supported by European Research Council advanced grant Proteomics v. 3.0 (233226). We thank the Becker's lab for plasmids and protocols for nucleosome reconstitution and the Hurt's lab for plasmids for DID labeling. The INO80-FLAG strain was a kind gift from the Shen lab. We thank the Cramer's and Thomm's group for fermentation.	Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Billon P, 2012, BBA-GENE REGUL MECH, V1819, P290, DOI 10.1016/j.bbagrm.2011.10.004; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Clapier CR, 2008, PROTEINS, V71, P1, DOI 10.1002/prot.21720; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Flemming D, 2010, NAT STRUCT MOL BIOL, V17, P775, DOI 10.1038/nsmb.1811; Gerhold CB, 2012, NUCLEIC ACIDS RES, V40, P11036, DOI 10.1093/nar/gks842; Gorynia S, 2011, J STRUCT BIOL, V176, P279, DOI 10.1016/j.jsb.2011.09.001; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Kapoor P, 2013, NAT STRUCT MOL BIOL, V20, P426, DOI 10.1038/nsmb.2529; Leschziner AE, 2005, STRUCTURE, V13, P267, DOI 10.1016/j.str.2004.12.008; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Leschziner AE, 2011, CURR OPIN STRUC BIOL, V21, P709, DOI 10.1016/j.sbi.2011.10.002; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Lopez-Perrote A, 2012, NUCLEIC ACIDS RES, V40, P11086, DOI 10.1093/nar/gks871; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Petukhov M, 2012, STRUCTURE, V20, P1321, DOI 10.1016/j.str.2012.05.012; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Ray S, 2012, BIOCHEMISTRY-US, V51, P1825, DOI 10.1021/bi201700h; Ray S, 2009, NUCLEIC ACIDS RES, V37, P6389, DOI 10.1093/nar/gkp695; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Saravanan M, 2012, P NATL ACAD SCI USA, V109, P20883, DOI 10.1073/pnas.1214735109; Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110; Schulze JM, 2010, MOL GENET GENOMICS, V283, P365, DOI 10.1007/s00438-010-0523-x; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Skiniotis G, 2007, J BIOL CHEM, V282, P20804, DOI 10.1074/jbc.C700081200; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Walzthoeni T, 2012, NAT METHODS, V9, P901, DOI 10.1038/nmeth.2103; Wang AY, 2009, P NATL ACAD SCI USA, V106, P21573, DOI 10.1073/pnas.0906539106; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang W, 2011, BIOCHEM J, V436, P83, DOI 10.1042/BJ20110004	61	176	180	0	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1207	1219		10.1016/j.cell.2013.08.016	http://dx.doi.org/10.1016/j.cell.2013.08.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034245	Bronze			2022-12-28	WOS:000324239300011
J	Bardach, NS; Wang, JJ; De Leon, SF; Shih, SC; Boscardin, WJ; Goldman, LE; Dudley, RA				Bardach, Naomi S.; Wang, Jason J.; De Leon, Samantha F.; Shih, Sarah C.; Boscardin, W. John; Goldman, L. Elizabeth; Dudley, R. Adams			Effect of Pay-for-Performance Incentives on Quality of Care in Small Practices With Electronic Health Records A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPERIENCE; MORTALITY; COMMUNITY	IMPORTANCE Most evaluations of pay-for-performance (P4P) incentives have focused on large-group practices. Thus, the effect of P4P in small practices, where many US residents receive care, is largely unknown. Furthermore, whether electronic health records (EHRs) with chronic disease management capabilities support small-practice response to P4P has not been studied. OBJECTIVE To assess the effect of P4P incentives on quality in EHR-enabled small practices in the context of an established quality improvement initiative. DESIGN, SETTING, AND PARTICIPANTS Acluster-randomized trial of small (<10 clinicians) primary care clinics in New York City from April 2009 through March 2010. A city program provided all participating clinics with the same EHR software with decision support and patient registry functionalities and quality improvement specialists offering technical assistance. INTERVENTIONS Incentivized clinics were paid for each patient whose care met the performance criteria, but they received higher payments for patients with comorbidities, who had Medicaid insurance, or who were uninsured (maximum payments: $200/patient; $100 000/clinic). Quality reports were given quarterly to both the intervention and control groups. MAIN OUTCOMES AND MEASURES Comparison of differences in performance improvement, from the beginning to the end of the study, between control and intervention clinics for aspirin or antithrombotic prescription, blood pressure control, cholesterol control, and smoking cessation interventions. Mixed-effects logistic regression was used to account for clustering of patients within clinics, with a treatment by time interaction term assessing the statistical significance of the effect of the intervention. RESULTS Participating clinics (n = 42 for each group) had similar baseline characteristics, with a mean of 4592 (median, 2500) patients at the intervention group clinics and 3042 (median, 2000) at the control group clinics. Intervention clinics had greater adjusted absolute improvement in rates of appropriate antithrombotic prescription (12.0% vs 6.1%, difference: 6.0% [95% CI, 2.2% to 9.7%], P = .001 for interaction term), blood pressure control (no comorbidities: 9.7% vs 4.3%, difference: 5.5%[95% CI, 1.6% to 9.3%], P =.01 for interaction term; with diabetes mellitus: 9.0% vs 1.2%, difference: 7.8%[95% CI, 3.2% to 12.4%], P =.007 for interaction term; with diabetes mellitus or ischemic vascular disease: 9.5% vs 1.7%, difference: 7.8%[95% CI, 3.0% to 12.6%], P =.01 for interaction term), and in smoking cessation interventions (12.4% vs 7.7%, difference: 4.7%[95% CI, -0.3% to 9.6%], P =.02 for interaction term). Intervention clinics performed better on all measures for Medicaid and uninsured patients except cholesterol control, but no differences were statistically significant. CONCLUSIONS AND RELEVANCE Among small EHR-enabled clinics, a P4P incentive program compared with usual care resulted in modest improvements in cardiovascular care processes and outcomes. Because most proposed P4P programs are intended to remain in place more than a year, further research is needed to determine whether this effect increases or decreases over time.	[Bardach, Naomi S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Wang, Jason J.; De Leon, Samantha F.; Shih, Sarah C.] New York City Dept Hlth & Mental Hyg, New York, NY USA; [Boscardin, W. John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Goldman, L. Elizabeth; Dudley, R. Adams] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA; [Dudley, R. Adams] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; New York City Department of Health & Mental Hygiene; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bardach, NS (corresponding author), 3333 Calif St,Ste 265, San Francisco, CA 94118 USA.	bardachn@peds.ucsf.edu	Wang, Jason/AAG-8248-2019	Bardach, Naomi/0000-0002-5178-0719	Robin Hood Foundation; Agency for Healthcare Research and Quality [R18 HS17059, R18 HS18275]; National Institute for Children's Health and Human Development [K23 HD065836]; National Center for Research Resources [KL2 RR024130-05]; National Center for Advancing Translational Sciences; National Institutes of Health through the University of California San Francisco-Clinical and Translational Science Institute; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS018275, R18HS017059] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331, K23HD065836] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	Robin Hood Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute for Children's Health and Human Development; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health through the University of California San Francisco-Clinical and Translational Science Institute; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Robin Hood Foundation, grants R18 HS17059 and R18 HS18275 from the Agency for Healthcare Research and Quality, K23 HD065836 from the National Institute for Children's Health and Human Development, and KL2 RR024130-05 from the National Center for Research Resources, the National Center for Advancing Translational Sciences, and National Institutes of Health, through the University of California San Francisco-Clinical and Translational Science Institute.	Amirfar S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-753; An LC, 2008, ARCH INTERN MED, V168, P1993, DOI 10.1001/archinte.168.18.1993; Bacchetti P, 2002, BRIT MED J, V324, P1271, DOI 10.1136/bmj.324.7348.1271; Beek CA, 2005, JAMA-J AM MED ASSOC, V294, P309, DOI 10.1001/jama.294.3.309; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Casalino LP, 1999, NEW ENGL J MED, V341, P1147, DOI 10.1056/NEJM199910073411511; Centers for Medicare & Medicaid Services, FEDERAL REGISTER PAR; Chung S, 2010, HEALTH SERV RES, V45, P553, DOI 10.1111/j.1475-6773.2009.01072.x; Chung S, 2010, AM J MANAG CARE, V16, pE35; Crosson FJ, 2005, HEALTH AFFAIR, V24, P1543, DOI 10.1377/hlthaff.24.6.1543; Dudley RA, STRATEGIES TO SUPPOR; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Frolich A, 2007, HEALTH POLICY, V80, P179, DOI 10.1016/j.healthpol.2006.03.001; Healthy People, 2020, HEART DISEASE AND ST; Houle SKD, 2012, ANN INTERN MED, V157, P889, DOI 10.7326/0003-4819-157-12-201212180-00009; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; McCormick D, 2002, JAMA-J AM MED ASSOC, V288, P1484, DOI 10.1001/jama.288.12.1484; Modern Healthcare, 2010, MODERN HEALTHCARES 1; Mostashari F, 2009, HEALTH AFFAIR, V28, P345, DOI 10.1377/hlthaff.28.2.345; Mullen KJ, 2010, RAND J ECON, V41, P64, DOI 10.1111/j.1756-2171.2009.00090.x; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Parsons A, 2012, J AM MED INFORM ASSN, V19, P604, DOI 10.1136/amiajnl-2011-000557; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rao SR, 2011, J AM MED INFORM ASSN, V18, P271, DOI 10.1136/amiajnl-2010-000010; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; Roski J, 2003, PREV MED, V36, P291, DOI 10.1016/S0091-7435(02)00052-X; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Strokoff SL, PATIENT PROTECTION A; Tollen LA, PHYSICIAN ORGANIZATI; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Woolhandler S, 2012, BMJ-BRIT MED J, V345, P5015; Young GJ, 2007, J GEN INTERN MED, V22, P872, DOI 10.1007/s11606-007-0185-5	36	86	90	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1051	1059		10.1001/jama.2013.277353	http://dx.doi.org/10.1001/jama.2013.277353			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214KZ	24026600	Green Accepted, Bronze			2022-12-28	WOS:000324133400022
J	Chefdeville, S; Kalugina, Y; van de Meerakker, SYT; Naulin, C; Lique, F; Costes, M				Chefdeville, Simon; Kalugina, Yulia; van de Meerakker, Sebastiaan Y. T.; Naulin, Christian; Lique, Francois; Costes, Michel			Observation of Partial Wave Resonances in Low-Energy O-2-H-2 Inelastic Collisions	SCIENCE			English	Article							ORBITING RESONANCES; SCATTERING; STATES; AR	Partial wave resonances predicted to occur in bimolecular collision processes have proven challenging to observe experimentally. Here, we report crossed-beam experiments and quantum-scattering calculations on inelastic collisions between ground-state O-2 and H-2 molecules that provide state-to-state cross sections for rotational excitation of O-2 (rotational state N = 1, j = 0) to O-2 (N = 1, j = 1) in the vicinity of the thermodynamic threshold at 3.96 centimeter(-1). The close agreement between experimental and theoretical results confirms the classically forbidden character of this collision-induced transition, which occurs exclusively in a purely quantum mechanical regime via shape and Feshbach resonances arising from partial waves with total angular momentum (J) = 2 to 4.	[Chefdeville, Simon; Naulin, Christian; Costes, Michel] Univ Bordeaux, Inst Sci Mol, F-33400 Talence, France; [Chefdeville, Simon; Naulin, Christian; Costes, Michel] CNRS, UMR 5255, F-33400 Talence, France; [Kalugina, Yulia; Lique, Francois] Univ Havre, CNRS, Lab Ondes & Milieux Complexes, UMR 6294, F-76058 Le Havre, France; [Kalugina, Yulia] Tomsk State Univ, Dept Opt & Spectroscopy, Tomsk 634050, Russia; [van de Meerakker, Sebastiaan Y. T.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Le Havre Normandie; Tomsk State University; Radboud University Nijmegen	Costes, M (corresponding author), Univ Bordeaux, Inst Sci Mol, F-33400 Talence, France.	francois.lique@univ-lehavre.fr; michel.costes@u-bordeaux1.fr	Lique, François/B-9626-2011; Naulin, Christian/S-3963-2019; Kalugina, Yulia/L-9997-2018; LIQUE, François/ABG-5769-2020; van de Meerakker, Sebastiaan Y.T./D-4581-2012	Lique, François/0000-0002-0664-2536; Naulin, Christian/0000-0002-4356-0484; Kalugina, Yulia/0000-0001-7642-3518; LIQUE, François/0000-0002-0664-2536; 	Agence Nationale de la Recherche [ANR-12-BS05-0011-02]; Conseil Regional d'Aquitaine [2007.1221]; Partenariat Hubert Curien Van Gogh [2013-28484TH]; Netherlands Organisation for Scientific Research (NWO) via a VIDI; High Performance Computing SKIF-Cyberia (Tomsk State University); CNRS national program Physique et Chimie du Milieu Interstellaire; Contrat de Projets Etat-Region Haute-Normandie/Centre National de Recherche Technologique/Energie, Electronique, Materiaux	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Partenariat Hubert Curien Van Gogh; Netherlands Organisation for Scientific Research (NWO) via a VIDI(Netherlands Organization for Scientific Research (NWO)); High Performance Computing SKIF-Cyberia (Tomsk State University); CNRS national program Physique et Chimie du Milieu Interstellaire; Contrat de Projets Etat-Region Haute-Normandie/Centre National de Recherche Technologique/Energie, Electronique, Materiaux(Region Normandie)	This work extends the objectives of ANR-12-BS05-0011-02 contract with the Agence Nationale de la Recherche and contract 2007.1221 with the Conseil Regional d'Aquitaine, for which financial support is gratefully acknowledged. S. C., S.Y.T.v.d.M., C.N., and M. C. acknowledge support of Partenariat Hubert Curien Van Gogh 2013-28484TH contract. S.Y.T.v.d.M. acknowledges support from the Netherlands Organisation for Scientific Research (NWO) via a VIDI grant and from the Universite de Bordeaux for a visiting professorship. Y.K. acknowledges the support of High Performance Computing SKIF-Cyberia (Tomsk State University). Y.K. and F. L. acknowledge the financial support of the CNRS national program Physique et Chimie du Milieu Interstellaire and of the Contrat de Projets Etat-Region Haute-Normandie/Centre National de Recherche Technologique/Energie, Electronique, Materiaux.	ALEXANDER MH, 1983, J CHEM PHYS, V79, P302, DOI 10.1063/1.445578; ALEXANDER MH, 1994, J CHEM PHYS, V101, P2887, DOI 10.1063/1.468431; Chandler DW, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3357286; Chefdeville S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.023201; COLBERT DT, 1992, J CHEM PHYS, V96, P1982, DOI 10.1063/1.462100; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; FESHBACH H, 1958, ANN PHYS-NEW YORK, V5, P357, DOI 10.1016/0003-4916(58)90007-1; GRACE RS, 1977, J CHEM PHYS, V67, P2443, DOI 10.1063/1.435217; Henson AB, 2012, SCIENCE, V338, P234, DOI 10.1126/science.1229141; Hutson J. M, MOLSCAT COMPUTER COD; Kalugina Y, 2012, PHYS CHEM CHEM PHYS, V14, P16458, DOI 10.1039/c2cp42212c; Lara M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.133201; Larsson B, 2007, ASTRON ASTROPHYS, V466, P999, DOI 10.1051/0004-6361:20065500; LEVINE RD, 1987, MOL REACTION DYNAMIC; Lique F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2723733; Lique F, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3299283; Pentlehner D, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3117196; PRATT ST, 1984, CHEM PHYS LETT, V105, P28, DOI 10.1016/0009-2614(84)80408-X; Schatz GC, 2000, SCIENCE, V288, P1599, DOI 10.1126/science.288.5471.1599; SCHUTTE A, 1972, PHYS REV LETT, V29, P979, DOI 10.1103/PhysRevLett.29.979; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; TOENNIES JP, 1979, J CHEM PHYS, V71, P614, DOI 10.1063/1.438414; YOKELSON RJ, 1992, J CHEM PHYS, V97, P6153, DOI 10.1063/1.463724	23	96	96	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1094	1096		10.1126/science.1241395	http://dx.doi.org/10.1126/science.1241395			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009389				2022-12-28	WOS:000323933100039
J	Bates, ER; Jacobs, AK				Bates, Eric R.; Jacobs, Alice K.			Time to Treatment in Patients with STEMI	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bates, Eric R.] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; [Jacobs, Alice K.] Boston Univ, Med Ctr, Boston, MA USA	University of Michigan System; University of Michigan; Boston University	Bates, ER (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA.			Jacobs, Alice/0000-0002-2428-2458				Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2008, CIRCULATION, V118, P2596, DOI 10.1161/CIRCULATIONAHA.108.191099; Menees DS, 2013, NEW ENGL J MED, V369, P899; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]	5	64	64	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					889	892		10.1056/NEJMp1308772	http://dx.doi.org/10.1056/NEJMp1308772			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211KV	24004114				2022-12-28	WOS:000323906900002
J	King, IF; Yandava, CN; Mabb, AM; Hsiao, JS; Huang, HS; Pearson, BL; Calabrese, JM; Starmer, J; Parker, JS; Magnuson, T; Chamberlain, SJ; Philpot, BD; Zylka, MJ				King, Ian F.; Yandava, Chandri N.; Mabb, Angela M.; Hsiao, Jack S.; Huang, Hsien-Sung; Pearson, Brandon L.; Calabrese, J. Mauro; Starmer, Joshua; Parker, Joel S.; Magnuson, Terry; Chamberlain, Stormy J.; Philpot, Benjamin D.; Zylka, Mark J.			Topoisomerases facilitate transcription of long genes linked to autism	NATURE			English	Article							RNA-POLYMERASE-II; DE-NOVO MUTATIONS; SPECTRUM DISORDERS; EXPRESSION SIGNATURES; BETA; CHROMATIN; UBE3A; CAMPTOTHECIN; TEMPLATE; ANGELMAN	Topoisomerases are expressed throughout the developing and adult brain and are mutated in some individuals with autism spectrum disorder (ASD). However, how topoisomerases are mechanistically connected to ASD is unknown. Here we find that topotecan, a topoisomerase 1 (TOP1) inhibitor, dose-dependently reduces the expression of extremely long genes in mouse and human neurons, including nearly all genes that are longer than 200 kilobases. Expression of long genes is also reduced after knockdown of Top1 or Top2b in neurons, highlighting that both enzymes are required for full expression of long genes. By mapping RNA polymerase II density genome-wide in neurons, we found that this length-dependent effect on gene expression was due to impaired transcription elongation. Interestingly, many high-confidence ASD candidate genes are exceptionally long and were reduced in expression after TOP1 inhibition. Our findings suggest that chemicals and genetic mutations that impair topoisomerases could commonly contribute to ASD and other neurodevelopmental disorders.	[King, Ian F.; Mabb, Angela M.; Huang, Hsien-Sung; Pearson, Brandon L.; Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Yandava, Chandri N.; Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Hsiao, Jack S.; Chamberlain, Stormy J.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06032 USA; [Calabrese, J. Mauro; Starmer, Joshua; Parker, Joel S.; Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Parker, Joel S.; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Connecticut; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Philpot, BD (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	bphilpot@med.unc.edu; zylka@med.unc.edu	HSIAO, JACK S/R-6661-2016; Parker, Joel/AAG-1108-2019; Pearson, Brandon/AAC-5261-2020	HSIAO, JACK S/0000-0002-0105-0419; Pearson, Brandon/0000-0003-4807-137X; Mabb, Angela/0000-0002-3000-8690; King, Ian/0000-0003-3405-9767; Huang, Hsien-Sung/0000-0003-2657-3635	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127, R01HD068730, P30HD003110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD068730, R01HD068730, T32 HD040127, P30HD03110, P30 HD003110, T32HD040127] Funding Source: Medline; NIGMS NIH HHS [R01GM101974, R01 GM101974] Funding Source: Medline; NIMH NIH HHS [R01MH093372, R01 MH093372] Funding Source: Medline; NINDS NIH HHS [P30 NS045892, P30NS045892] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Baranello L, 2012, BBA-GENE REGUL MECH, V1819, P632, DOI 10.1016/j.bbagrm.2011.12.007; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Ben-David E., 2012, MOL PSYCHIAT; Betancur C, 2009, TRENDS NEUROSCI, V32, P402, DOI 10.1016/j.tins.2009.04.003; Capranico G, 2010, BBA-REV CANCER, V1806, P240, DOI 10.1016/j.bbcan.2010.06.003; Carson JP, 2004, CANCER RES, V64, P2096, DOI 10.1158/0008-5472.CAN-03-2029; Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; Cook EH, 1997, AM J HUM GENET, V60, P928; Delorme R, 2013, NAT MED, V19, P685, DOI 10.1038/nm.3193; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Groschel B, 2005, J VIROL, V79, P5695, DOI 10.1128/JVI.79.9.5695-5704.2005; Hammer E, 2007, FEBS LETT, V581, P5418, DOI 10.1016/j.febslet.2007.10.040; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Joshi RS, 2012, NUCLEIC ACIDS RES, V40, P7907, DOI 10.1093/nar/gks626; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Landers M, 2004, NUCLEIC ACIDS RES, V32, P3480, DOI 10.1093/nar/gkh670; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Ljungman M, 1996, CARCINOGENESIS, V17, P31, DOI 10.1093/carcin/17.1.31; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; MacIsaac JL, 2012, NUCLEIC ACIDS RES, V40, P1523, DOI 10.1093/nar/gkr871; Meng LY, 2012, HUM MOL GENET, V21, P3001, DOI 10.1093/hmg/dds130; Moreno-De-Luca D, 2012, MOL PSYCHIAT; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Peca J, 2012, CURR OPIN NEUROBIOL, V22, P866, DOI 10.1016/j.conb.2012.02.015; Plaschkes I, 2005, J COMP NEUROL, V493, P357, DOI 10.1002/cne.20793; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; STEWART AF, 1990, CELL, V60, P141; Tiwari VK, 2012, P NATL ACAD SCI USA, V109, pE934, DOI 10.1073/pnas.1119798109; Troester MA, 2004, ENVIRON HEALTH PERSP, V112, P1607, DOI [10.1289/txg.7204, 10.1289/ehp.7204]; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	48	255	266	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					58	+		10.1038/nature12504	http://dx.doi.org/10.1038/nature12504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23995680	Green Submitted, Green Accepted			2022-12-28	WOS:000323888300031
J	Tsai, AG; Wadden, TA				Tsai, Adam Gilden; Wadden, Thomas A.			Obesity	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LIFE-STYLE INTERVENTION; WEIGHT-LOSS; CONTROLLED-RELEASE; BARIATRIC SURGERY; LOW-CARBOHYDRATE; OVERWEIGHT; FAT; MANAGEMENT; GAIN; DIET											Brunner EJ, 2007, AM J EPIDEMIOL, V165, P828, DOI 10.1093/aje/kwk058; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Carlin AM, 2013, ANN SURG, V257, P791, DOI 10.1097/SLA.0b013e3182879ded; Centers for Medicare and Medicaid Services, 2011, DEC MEM INT BEH THER; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Espeland M, 2007, DIABETES CARE, V30, P1374; Farooqi IS, 2008, HDB OBESITY CLIN APP, P45; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Foster GD, 1997, J CONSULT CLIN PSYCH, V65, P79, DOI 10.1037/0022-006X.65.1.79; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Garvey WT, 2012, AM J CLIN NUTR, V95, P297, DOI 10.3945/ajcn.111.024927; Hays JT, 2001, ANN INTERN MED, V135, P423, DOI 10.7326/0003-4819-135-6-200109180-00011; Hendricks EJ, 2011, OBESITY, V19, P2351, DOI 10.1038/oby.2011.94; Heymsfield SB, 2003, INT J OBESITY, V27, P537, DOI 10.1038/sj.ijo.0802258; Hooper L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7666; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Lopez-Zetina J, 2006, HEALTH PLACE, V12, P656, DOI 10.1016/j.healthplace.2005.09.001; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Maciejewski ML, 2011, JAMA-J AM MED ASSOC, V305, P2419, DOI 10.1001/jama.2011.817; McDoniel SO, 2010, PATIENT EDUC COUNS, V79, P185, DOI 10.1016/j.pec.2009.07.034; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; MUNRO JF, 1968, BRIT MED J, V1, P352, DOI 10.1136/bmj.1.5588.352; Nedeltcheva AV, 2010, ANN INTERN MED, V153, P435, DOI 10.7326/0003-4819-153-7-201010050-00006; Padwal R, 2011, OBES REV, V12, P602, DOI 10.1111/j.1467-789X.2011.00866.x; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Wadden TA, 2012, CIRCULATION, V125, P1157, DOI 10.1161/CIRCULATIONAHA.111.039453; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Wirth A, 2001, JAMA-J AM MED ASSOC, V286, P1331, DOI 10.1001/jama.286.11.1331; Wrotniak BH, 2008, AM J CLIN NUTR, V87, P1818, DOI 10.1093/ajcn/87.6.1818	49	31	31	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2013	159	5					ITC1	ITC316		10.7326/0003-4819-159-5-201309030-01003	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-01003			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44NR	24026335				2022-12-28	WOS:000209756200001
J	Hemingway, D; Nimmo, F; Zebker, H; Iess, L				Hemingway, D.; Nimmo, F.; Zebker, H.; Iess, L.			A rigid and weathered ice shell on Titan	NATURE			English	Article							INTERNAL STRUCTURE; TOPOGRAPHY; DYNAMICS; GRAVITY; SURFACE; ORIGIN; OCEAN; SHAPE	Several lines of evidence suggest that Saturn's largest moon, Titan, has a global subsurface ocean beneath an outer ice shell 50 to 200 kilometres thick(1-4). If convection(5,6) is occurring, the rigid portion of the shell is expected to be thin; similarly, a weak, isostatically compensated shell has been proposed(7,8) to explain the observed topography. Here we report a strong inverse correlation between gravity(3) and topography(9) at long wavelengths that are not dominated by tides and rotation. We argue that negative gravity anomalies (mass deficits) produced by crustal thickening at the base of the ice shell overwhelm positive gravity anomalies (mass excesses) produced by the small surface topography, giving rise to this inverse correlation. We show that this situation requires a substantially rigid ice shell with an elastic thickness exceeding 40 kilometres, and hundreds of metres of surface erosion and deposition, consistent with recent estimates from local features(10,11). Our results are therefore not compatible with a geologically active, low-rigidity ice shell. After extrapolating to wavelengths that are controlled by tides and rotation, we suggest that Titan's moment of inertia may be even higher (that is, Titan may be even less centrally condensed) than is currently thought(12).	[Hemingway, D.; Nimmo, F.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Zebker, H.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Zebker, H.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Iess, L.] Univ Roma La Sapienza, Dipartimento Ingn Meccan & Aerospaziale, I-00184 Rome, Italy	University of California System; University of California Santa Cruz; Stanford University; Stanford University; Sapienza University Rome	Hemingway, D (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, 1156 High St, Santa Cruz, CA 95064 USA.	djheming@ucsc.edu	Hemingway, Douglas/F-6332-2014; IESS, Luciano/F-4902-2011	Hemingway, Douglas/0000-0001-5617-207X; IESS, Luciano/0000-0002-6230-5825	NASA [NNX13AG02G, NNX11AK44G]	NASA(National Aeronautics & Space Administration (NASA))	We thank the Cassini radar science team, M. Manga, D. Stevenson, R. Pappalardo and W. McKinnon for their suggestions. Portions of this work were supported by NASA grants NNX13AG02G and NNX11AK44G.	Beghin C, 2010, CR GEOSCI, V342, P425, DOI 10.1016/j.crte.2010.03.003; Behounkova M, 2012, ICARUS, V219, P655, DOI 10.1016/j.icarus.2012.03.024; Bills BG, 2011, ICARUS, V214, P351, DOI 10.1016/j.icarus.2011.04.028; Black BA, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004085; Choukroun M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050747,2012; Grasset O, 2000, PLANET SPACE SCI, V48, P617, DOI 10.1016/S0032-0633(00)00039-8; Iess L, 2012, SCIENCE, V337, P457, DOI 10.1126/science.1219631; Iess L, 2010, SCIENCE, V327, P1367, DOI 10.1126/science.1182583; Kraus H., 1967, THIN ELASTIC SHELLS; Lopes RMC, 2007, ICARUS, V186, P395, DOI 10.1016/j.icarus.2006.09.006; McGovern PJ, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001854; MCKENZIE D, 1994, ICARUS, V112, P55, DOI 10.1006/icar.1994.1170; Mitri G, 2008, ICARUS, V193, P387, DOI 10.1016/j.icarus.2007.07.016; Moore JM, 2011, ICARUS, V212, P790, DOI 10.1016/j.icarus.2011.01.019; Neish CD, 2013, ICARUS, V223, P82, DOI 10.1016/j.icarus.2012.11.030; Nimmo F, 2004, ICARUS, V168, P205, DOI 10.1016/j.icarus.2003.11.022; Nimmo F, 2010, ICARUS, V208, P896, DOI 10.1016/j.icarus.2010.02.020; O'Rourke J. G., 2011, LUNAR PLANET SCI C; Patterson DB, 1999, GEOCHIM COSMOCHIM AC, V63, P615, DOI 10.1016/S0016-7037(99)00077-0; RICHARDS MA, 1984, J GEOPHYS RES, V89, P5987, DOI 10.1029/JB089iB07p05987; Roberts JH, 2008, ICARUS, V194, P675, DOI 10.1016/j.icarus.2007.11.010; Schenk P. M., 2013, LUNAR PLANET SCI C, VXXXXIIII; Stiles BW, 2009, ICARUS, V202, P584, DOI 10.1016/j.icarus.2009.03.032; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Tobie G, 2005, ICARUS, V175, P496, DOI 10.1016/j.icarus.2004.12.007; TURCOTTE DL, 1981, J GEOPHYS RES, V86, P3951, DOI 10.1029/JB086iB05p03951; Wieczorek M., 2007, TREATISE GEOPHYS, V2, P165, DOI [10.1016/B978-044452748-6.00156-5, DOI 10.1016/B978-044452748-6.00156-5, DOI 10.1016/B978-044452748-6/00156-5, 10.1016/b978-044452748-6/00156-5]; Zebker H. A., 2012, AGU FALL M; Zebker HA, 2009, SCIENCE, V324, P921, DOI 10.1126/science.1168905	29	55	55	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 29	2013	500	7464					550	552		10.1038/nature12400	http://dx.doi.org/10.1038/nature12400			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23985871	Green Published			2022-12-28	WOS:000323625900028
J	Sachan, D				Sachan, Dinsa			India's problem with girls	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												dinsasachan@gmail.com						Census of India, 2011, SEX RATIO HAS DECLIN; Census of India, 2011, FEMALE LITERACY HAS; Dubuc S, 2007, POPUL DEV REV, V33, P383, DOI 10.1111/j.1728-4457.2007.00173.x; Guilmoto CZ, 2012, DEMOGRAPHY, V49, P77, DOI 10.1007/s13524-011-0083-7; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Jha P, 2011, LANCET, V377, P1921, DOI 10.1016/S0140-6736(11)60649-1; Krishnan A, 2013, J EPIDEMIOL COMMUN H, V67, P419, DOI 10.1136/jech-2012-201846; Mascarenhas A., 2013, INDIAN EXPRESS; Puri S, 2011, SOC SCI MED, V72, P1169, DOI 10.1016/j.socscimed.2011.01.027; Ray JG, 2012, CAN MED ASSOC J, V184, pE492, DOI 10.1503/cmaj.120165	10	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2013	347								f4149	10.1136/bmj.f4149	http://dx.doi.org/10.1136/bmj.f4149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211CI	23990631				2022-12-28	WOS:000323881300007
J	Szpiro, G				Szpiro, George			Value judgements	NATURE			English	Editorial Material												george.szpiro@nzz.ch							0	0	0	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					521	523		10.1038/500521a	http://dx.doi.org/10.1038/500521a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207TD	23985855	Bronze			2022-12-28	WOS:000323625900010
J	Toyama, BH; Savas, JN; Park, SK; Harris, MS; Ingolia, NT; Yates, JR; Hetzer, MW				Toyama, Brandon H.; Savas, Jeffrey N.; Park, Sung Kyu; Harris, Michael S.; Ingolia, Nicholas T.; Yates, John R., III; Hetzer, Martin W.			Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures	CELL			English	Article							POSTTRANSLATIONAL MODIFICATIONS; PROTEOMIC ANALYSIS; IN-VIVO; LENS; TURNOVER; BRAIN; CELLS; CRYSTALLIN; DYNAMICS; PATTERNS	Intracellular proteins with long lifespans have recently been linked to age-dependent defects, ranging from decreased fertility to the functional decline of neurons. Why long-lived proteins exist in metabolically active cellular environments and how they are maintained over time remains poorly understood. Here, we provide a system-wide identification of proteins with exceptional lifespans in the rat brain. These proteins are inefficiently replenished despite being translated robustly throughout adulthood. Using nucleoporins as a paradigm for long-term protein persistence, we found that nuclear pore complexes (NPCs) are maintained over a cell's life through slow but finite exchange of even its most stable subcomplexes. This maintenance is limited, however, as some nucleoporin levels decrease during aging, providing a rationale for the previously observed age-dependent deterioration of NPC function. Our identification of a long-lived proteome reveals cellular components that are at increased risk for damage accumulation, linking long-term protein persistence to the cellular aging process.	[Toyama, Brandon H.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Savas, Jeffrey N.; Park, Sung Kyu; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Harris, Michael S.; Ingolia, Nicholas T.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; [Harris, Michael S.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Salk Institute; Scripps Research Institute; Carnegie Institution for Science; Johns Hopkins University	Yates, JR (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	jyates@scripps.edu; hetzer@salk.edu		Toyama, Brandon/0000-0002-8355-9138	Hewitt Foundation; National Institutes of Health (NIH) [R01GM098749]; Glenn Aging Foundation; American Cancer Society [P30CA014195]; Ellison Medical Foundation; NIH [F32AG039127, P41 RR011823, P01 AG031097, R01 MH067880]; Searle Scholars Program; NATIONAL CANCER INSTITUTE [R01CA118232, P30CA014195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098749, P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031097, F32AG039127] Funding Source: NIH RePORTER	Hewitt Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Aging Foundation; American Cancer Society(American Cancer Society); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Hetzer laboratory and E. Q. Toyama for critical reading of the manuscript. B. H. T is supported by the Hewitt Foundation; M. W. H by the National Institutes of Health (NIH) grant R01GM098749, the Glenn Aging Foundation, the American Cancer Society Award Number P30CA014195, and the Ellison Medical Foundation; J.N.S. by NIH fellowship F32AG039127; J.R.Y. and J.N.S. by NIH P41 RR011823, P01 AG031097, and R01 MH067880; N.T.I. by the Searle Scholars Program. The RAW files and complete parameter files will be publically available at http://fields.scripps.edu/published/ELLP2/ upon publication. B. H. T. performed all biochemical fractionations, sorted NeuN nuclei and performed validation, conducted pore counting, and determined Nup protein levels in aging. J.N.S. performed isotopic labeling of rats and ran MS samples. B. H. T., J.N.S., and S. K. P, with direction from J.R.Y., analyzed the MS data. B. H. T., M. S. H., and N.T.I. determined protein translation rates. B. H. T. and M. W. H. wrote the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ARBER N, 1988, LIVER, V8, P80; Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DUERRE JA, 1974, J NEUROCHEM, V23, P541, DOI 10.1111/j.1471-4159.1974.tb06057.x; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Li JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002879; LOVTRUPREIN H, 1966, J CELL BIOL, V30, P405, DOI 10.1083/jcb.30.2.405; MASTERS PM, 1977, NATURE, V268, P71, DOI 10.1038/268071a0; McClatchy DB, 2007, J PROTEOME RES, V6, P2005, DOI 10.1021/pr060599n; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; PIHA RS, 1966, J BIOL CHEM, V241, P2397; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; RODRIGUE.G, 1971, BRAIN RES, V31, P179, DOI 10.1016/0006-8993(71)90642-1; ROY D, 1976, P NATL ACAD SCI USA, V73, P3484, DOI 10.1073/pnas.73.10.3484; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910; Tsukada Y, 1992, MYELIN BIOL CHEM, P449; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1	48	332	332	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					971	982		10.1016/j.cell.2013.07.037	http://dx.doi.org/10.1016/j.cell.2013.07.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993091	Bronze, Green Accepted			2022-12-28	WOS:000323767300012
J	Kovesdy, CP; Bleyer, AJ; Molnar, MZ; Ma, JZ; Sim, JJ; Cushman, WC; Quarles, LD; Kalantar-Zadeh, K				Kovesdy, Csaba P.; Bleyer, Anthony J.; Molnar, Miklos Z.; Ma, Jennie Z.; Sim, John J.; Cushman, William C.; Quarles, L. Darryl; Kalantar-Zadeh, Kamyar			Blood Pressure and Mortality in US Veterans With Chronic Kidney Disease A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; RISK-FACTOR; CARDIOVASCULAR OUTCOMES; PULSE PRESSURE; HEART-DISEASE; HYPERTENSION; ASSOCIATION; HEMODIALYSIS; METAANALYSIS; PROGRESSION	Background: The ideal blood pressure (BP) to decrease mortality rates in patients with non-dialysis-dependent chronic kidney disease (CKD) is unclear. Objective: To assess the association of BP (defined as the combination of systolic BP [SBP] and diastolic BP [DBP] at the individual level) with death in patients with CKD. Design: Historical cohort between 2005 and 2012. Setting: All U. S. Department of Veterans Affairs health care facilities. Patients: 651 749 U. S. veterans with CKD. Measurements: All possible combinations of SBP and DBP were examined in 96 categories from lowest (<80/<40 mm Hg) to highest (>210/>120 mm Hg), in 10-mm Hg increments. Associations with all-cause mortality were examined in time-dependent Cox models with adjustment for relevant confounders. Results: Patients with SBP of 130 to 159 mm Hg combined with DBP of 70 to 89 mm Hg had the lowest adjusted mortality rates, and those in whom both SBP and DBP were concomitantly very high or very low had the highest mortality rates. Patients with moderately elevated SBP combined with DBP no less than 70 mm Hg had consistently lower mortality rates than did patients with ideal SBP combined with DBP less than 70 mm Hg. Results were consistent in subgroups of patients with normal and elevated urinary microalbumin-creatinine ratios. Limitation: Mostly male patients, inability to establish causality, and large number of patients missing proteinuria measurement. Conclusion: The optimal BP in patients with CKD seems to be 130 to 159/70 to 89 mm Hg. It may not be advantageous to achieve ideal SBP at the expense of lower-than-ideal DBP in adults with CKD.	Memphis Vet Affairs Med Ctr, Memphis, TN 38104 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; Wake Forest Sch Med, Winston Salem, NC 27157 USA; Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; Semmelweis Univ, H-1089 Budapest, Hungary; Univ Virginia, Charlottesville, VA 22908 USA; Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA; Univ Calif Irvine, Irvine, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Wake Forest University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Semmelweis University; University of Virginia; Kaiser Permanente; University of California System; University of California Irvine	Kovesdy, CP (corresponding author), Memphis Vet Affairs Med Ctr, Div Nephrol 111B, 1030 Jefferson Ave, Memphis, TN 38104 USA.	csaba.kovesdy@va.gov	Kalantar-Zadeh, Kamyar/Q-4734-2018	Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Molnar, Miklos Z/0000-0002-9665-330X; Quarles, L. Darryl/0000-0002-5082-7896	National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078106] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, and U.S. Department of Veterans Affairs.	Agarwal R, 2009, CLIN J AM SOC NEPHRO, V4, P830, DOI 10.2215/CJN.06201208; Arnold N, 2006, 2 AFF INF RES CTR; Bangalore S, 2010, EUR HEART J, V31, P2897, DOI 10.1093/eurheartj/ehq328; Barzilay JI, 2012, DIABETES CARE, V35, P1401, DOI 10.2337/dc11-1827; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; BUSBY WJ, 1994, AGE AGEING, V23, P69, DOI 10.1093/ageing/23.1.69; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Domanski M, 2002, JAMA-J AM MED ASSOC, V287, P2677, DOI 10.1001/jama.287.20.2677; Duranti E, 1996, KIDNEY INT, pS173; FARNETT L, 1991, JAMA-J AM MED ASSOC, V265, P489, DOI 10.1001/jama.265.4.489; Fleischmann EH, 2001, ASAIO J, V47, P74, DOI 10.1097/00002480-200101000-00016; Gasowski J, 2002, J HYPERTENS, V20, P145, DOI 10.1097/00004872-200201000-00021; Greenberg JA, 2003, J HYPERTENS, V21, P49, DOI 10.1097/00004872-200301000-00013; Iseki K, 1997, KIDNEY INT, V51, P1212, DOI 10.1038/ki.1997.165; Kidney Disease Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT SUPPL, V2, P337, DOI DOI 10.1038/kisup.2012.46; KidneyDisease Outcomes Quality Initiative (K/DOQI), 2004, AM J KIDNEY DIS, V43, pS1; Kim JW, 2005, J GEN INTERN MED, V20, P647, DOI 10.1007/s11606-005-0112-6; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Klassen PS, 2002, JAMA-J AM MED ASSOC, V287, P1548, DOI 10.1001/jama.287.12.1548; Kovesdy CP, 2006, NEPHROL DIAL TRANSPL, V21, P1257, DOI 10.1093/ndt/gfk057; Kovesdy CP, 2013, J AM COLL CARDIOL, V61, P1626, DOI 10.1016/j.jacc.2012.11.071; Kovesdy CP, 2012, CIRCULATION, V125, P677, DOI 10.1161/CIRCULATIONAHA.111.065391; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Peralta CA, 2007, HYPERTENSION, V50, P474, DOI 10.1161/HYPERTENSIONAHA.107.088088; Peralta CA, 2012, ARCH INTERN MED, V172, P41, DOI 10.1001/archinternmed.2011.619; Plantinga LC, 2009, HYPERTENSION, V54, P47, DOI 10.1161/HYPERTENSIONAHA.109.129841; Royston P, 2007, STATA J, V7, P45, DOI 10.1177/1536867X0700700103; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Somes GW, 1999, ARCH INTERN MED, V159, P2004, DOI 10.1001/archinte.159.17.2004; Thadhani R, 2006, CLIN J AM SOC NEPHRO, V1, P1117, DOI 10.2215/CJN.00080106; U. S. Department of Veterans Affairs, 2008, VIREC RES US VHA PHA; U. S. Department of Veterans Affairs, 2009, VIREC RES US GUID VH; U. S. Department of Veterans Affairs, 2009, DAT QUAL UPD RAC; U. S. Department of Veterans Affairs, 2007, VIREC RES US GUID FY; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zager PG, 1998, KIDNEY INT, V54, P561, DOI 10.1046/j.1523-1755.1998.00005.x	44	159	164	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					233	+		10.7326/0003-4819-159-4-201308200-00004	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026256	Green Accepted			2022-12-28	WOS:000323421700013
J	McAfee, T; Davis, KC; Alexander, RL; Pechacek, TF; Bunnell, R				McAfee, Tim; Davis, Kevin C.; Alexander, Robert L., Jr.; Pechacek, Terry F.; Bunnell, Rebecca			Effect of the first federally funded US antismoking national media campaign	LANCET			English	Article							SMOKING-CESSATION; PREVALENCE; IMPACT; INTERVENTIONS; ABSTINENCE; ACCURACY; INTERNET	Background Every year, smoking kills more than 5 million people globally, including 440 000 people in the USA, where the long-term decline in smoking prevalence has slowed. The US Centers for Disease Control and Prevention (CDC) delivered a national, 3-month antismoking campaign called Tips From Former Smokers (Tips) that started in March, 2012, in which hard-hitting, emotionally evocative television advertising was featured, depicting smoking-related suffering in real people. We aimed to assess the effects of the Tips campaign. Methods We undertook baseline and follow-up surveys of nationally representative cohorts of adult smokers and nonsmokers. The national effect of the Tips campaign was estimated by applying rates of change in the cohort before and after the campaign to US census data. Findings 3051 smokers and 2220 non-smokers completed baseline and follow-up assessments. 2395 (78%) smokers and 1632 (74%) non-smokers recalled seeing at least one Tips advertisement on television during the 3-month campaign. Quit attempts among smokers rose from 31.1% (95% CI 30.3-31.9) at baseline to 34.8% (34.0-35.7) at follow-up, a 12% relative increase. The prevalence of abstinence at follow-up among smokers who made a quit attempt was 13.4% (95% CI 9.7-17.2). Nationally, an estimated 1.64 million additional smokers made a quit attempt, and 220 000 (95% CI 159 000-282 000) remained abstinent at follow-up. Recommendations by non-smokers to quit grew from 2.6% at baseline to 5.1% at follow-up, and the prevalence of people talking with friends and family about the dangers of smoking rose from 31.9% (95% CI 31.3-32.5) to 35.2% (34.6-35.9), resulting in an estimated 4.7 million additional non-smokers recommending cessation services and more than 6 million talking about the dangers of smoking. Interpretation The high-exposure Tips media campaign was effective at increasing population-level quit attempts. The growth in smokers who quit and became sustained quitters could have added from a third to almost half a million quality-adjusted life-years to the US population. Expanded implementation of similar campaigns globally could accelerate progress on the WHO Framework Convention on Tobacco Control and reduce smoking prevalence globally.	[McAfee, Tim; Alexander, Robert L., Jr.; Pechacek, Terry F.; Bunnell, Rebecca] Ctr Dis Control & Prevent, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; [Davis, Kevin C.] RTI Int, Res Triangle Pk, NC USA	Centers for Disease Control & Prevention - USA; Research Triangle Institute	McAfee, T (corresponding author), Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA 30341 USA.	mtt4@cdc.gov	McAfee, Tim/GXG-1246-2022	Davis, Kevin/0000-0001-8517-1295	CDC; US Department of Health and Human Services	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Department of Health and Human Services	Funding CDC, US Department of Health and Human Services.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Anderson CM, 2007, TOB CONTROL, V16, pI81, DOI 10.1136/tc.2007.020701; Atkin C, 2001, PUBLIC COMMUNICATION; Augustson Erik, 2012, Morbidity and Mortality Weekly Report, V61, P667; Baker L, 2003, JAMA-J AM MED ASSOC, V289, P2400, DOI 10.1001/jama.289.18.2400; Borland R, 2003, TOB CONTROL, V12, P45; CDC, 2012, EARLY RELEASE OF SEL; CDC, 2007, BEST PRACTICES FOR C; CDC National Center for Health Statistics, 2012, NATIONAL HEALTH INTE; Chandra S, 2011, NICOTINE TOB RES, V13, P395, DOI 10.1093/ntr/ntq258; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Davis Kevin C, 2012, Prev Chronic Dis, V9, pE40; Davis KC, 2011, TOB CONTROL, V20, P26, DOI 10.1136/tc.2009.035568; Donovan RJ, 2003, TOB CONTROL, V12, P30; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; Durkin SJ, 2009, AM J PUBLIC HEALTH, V99, P2217, DOI 10.2105/AJPH.2009.161638; Eastwood P., 2013, STATISTICS ON SMOKIN; Farrelly MC, 2012, AM J PREV MED, V43, P475, DOI 10.1016/j.amepre.2012.07.023; Fiore MC, 2008, TREATING TOBACCO USE; Fiore MC, 2008, JAMA-J AM MED ASSOC, V299, P2083, DOI 10.1001/jama.299.17.2083; Hughes JR, 2010, NICOTINE TOB RES, V12, P756, DOI 10.1093/ntr/ntq078; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Hurley SF, 2008, TOB CONTROL, V17, P379, DOI 10.1136/tc.2008.025213; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Koh HK, 2012, JAMA-J AM MED ASSOC, V308, P767, DOI 10.1001/jama.2012.9741; Maarcher Ann, 2011, Morbidity and Mortality Weekly Report, V60, P1513; National Cancer Institute, 2008, THE ROLE OF THE MEDI, V19; Solberg LI, 2006, AM J PREV MED, V31, P62, DOI 10.1016/j.amepre.2006.03.013; US Census Bureau Population Division, 2012, NC EST2011 02; US Department of Health and Human Services, 2010, HOW TOBACCO SMOKE CA; US Department of Health and Human Services, 2012, PREVENTING TOBACCO U; Vallone DM, 2011, AM J PUBLIC HEALTH, V101, P302, DOI 10.2105/AJPH.2009.190454; Villanti AC, 2012, HEALTH AFFAIR, V31, P2708, DOI 10.1377/hlthaff.2012.0277; Wakefield MA, 2011, HEALTH EDUC RES, V26, P988, DOI 10.1093/her/cyr054; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Warner KE, 2012, AM J PUBLIC HEALTH, V102, P2045, DOI 10.2105/AJPH.2012.300771; Wilson LM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/961724; World Health Organization, 2012, WHO GLOBAL REPORT MO; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020; Zhu SH, 2012, TOB CONTROL, V21, P110, DOI 10.1136/tobaccocontrol-2011-050371	40	186	186	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					2003	2011		10.1016/S0140-6736(13)61686-4	http://dx.doi.org/10.1016/S0140-6736(13)61686-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	269EI	24029166				2022-12-28	WOS:000328223700027
J	Lipsitz, LA				Lipsitz, Lewis A.			The 3-Night Hospital Stay and Medicare Coverage for Skilled Nursing Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lipsitz, Lewis A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Hebrew SeniorLife, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Hebrew SeniorLife	Lipsitz, LA (corresponding author), Hebrew SeniorLife Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	lipsitz@hsl.harvard.edu						AARONSON WE, 1994, J HEALTH POLIT POLIC, V19, P753; Birmingham J, 2008, PROF CASE MANAG, V13, P7; Medicare Payment Advisory Commission (MEDPAC), 2013, REPORT TO CONGRESS M; Medicare Payment Advisory Commission (MEDPAC), 2010, REPORT TO CONGRESS A; Segal M., 2011, ELIGIBLE BENEFICIARI	5	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 9	2013	310	14					1441	1442		10.1001/jama.2013.254845	http://dx.doi.org/10.1001/jama.2013.254845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	230PK	24042212				2022-12-28	WOS:000325354100014
J	Sullivan, E				Sullivan, Erin			Shakespeare and the history of heartbreak	LANCET			English	Editorial Material									Shakespeare Inst, Stratford Upon Avon CV37 6HP, England		Sullivan, E (corresponding author), Shakespeare Inst, Stratford Upon Avon CV37 6HP, England.	e.sullivan@bham.ac.uk							0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 14	2013	382	9896					933	934		10.1016/S0140-6736(13)61923-6	http://dx.doi.org/10.1016/S0140-6736(13)61923-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VD	24044124	Bronze			2022-12-28	WOS:000324238000014
J	Almaca, J; Faria, D; Sousa, M; Uliyakina, I; Conrad, C; Sirianant, L; Clarke, LA; Martins, JP; Santos, M; Heriche, JK; Huber, W; Schreiber, R; Pepperkok, R; Kunzelmann, K; Amaral, MD				Almaca, Joana; Faria, Diana; Sousa, Marisa; Uliyakina, Inna; Conrad, Christian; Sirianant, Lalida; Clarke, Luka A.; Martins, Jose Paulo; Santos, Miguel; Heriche, Jean-Karim; Huber, Wolfgang; Schreiber, Rainer; Pepperkok, Rainer; Kunzelmann, Karl; Amaral, Margarida D.			High-Content siRNA Screen Reveals Global ENaC Regulators and Potential Cystic Fibrosis Therapy Targets	CELL			English	Article							EPITHELIAL SODIUM-CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; NA+ CHANNEL; LUNG-DISEASE; ION CHANNELS; HUMAN GENOME; CFTR; TRANSPORT; AMILORIDE; CELLS	Dysfunction of ENaC, the epithelial sodium channel that regulates salt and water reabsorption in epithelia, causes several human diseases, including cystic fibrosis (CF). To develop a global understanding of molecular regulators of ENaC traffic/function and to identify of candidate CF drug targets, we performed a large-scale screen combining high-content live-cell microscopy and siRNAs in human airway epithelial cells. Screening over 6,000 genes identified over 1,500 candidates, evenly divided between channel inhibitors and activators. Genes in the phosphatidylinositol pathway were enriched on the primary candidate list, and these, along with other ENaC activators, were examined further with secondary siRNA validation. Subsequent detailed investigation revealed ciliary neurotrophic factor receptor (CNTFR) as an ENaC modulator and showed that inhibition of (diacylglycerol kinase, iota) DGKi, a protein involved in PiP2 metabolism, downgrades ENaC activity, leading to normalization of both Na+ and fluid absorption in CF airways to non-CF levels in primary human lung cells from CF patients.	[Almaca, Joana; Faria, Diana; Sousa, Marisa; Uliyakina, Inna; Clarke, Luka A.; Amaral, Margarida D.] Univ Lisbon, Fac Sci, BioFIG Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Faria, Diana; Sirianant, Lalida; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Dept Physiol, D-93053 Regensburg, Germany; [Conrad, Christian; Heriche, Jean-Karim; Huber, Wolfgang; Pepperkok, Rainer] EMBL, Cell Biol Biophys Unit, D-69117 Heidelberg, Germany; [Martins, Jose Paulo; Santos, Miguel] EcBio R&D Biotechnol SA, P-2700451 Amadora, Portugal	Universidade de Lisboa; University of Regensburg; European Molecular Biology Laboratory (EMBL)	Amaral, MD (corresponding author), Univ Lisbon, Fac Sci, BioFIG Ctr Biodivers Funct & Integrat Genom, C8 Bdg, P-1749016 Lisbon, Portugal.	mdamaral@fc.ul.pt	Amaral, Margarida D/E-5748-2012; Clarke, Luka A/E-5843-2012; Martins, Paulo/P-5735-2014; Santos, Jorge Miguel/B-9967-2018	Amaral, Margarida D/0000-0002-0828-8630; Clarke, Luka A/0000-0003-3254-9121; Martins, Paulo/0000-0002-2360-403X; Santos, Jorge Miguel/0000-0002-9432-3171; Pepperkok, Rainer/0000-0002-9762-3583; SOUSA, MARISA/0000-0003-2305-4813; Kunzelmann, Karl/0000-0002-4583-7037; Huber, Wolfgang/0000-0002-0474-2218; Almaca, Joana/0000-0002-9316-712X; Uliyakina, Inna/0000-0002-7091-2123; Heriche, Jean-Karim/0000-0001-6867-9425; Faria, Diana/0000-0002-9861-0282	EU [LSH-2005-1.2.5-3-037365, PEst-OE/BIA/UI4046/2011, FCT/POCTI-PTDC/SAU-GMG/122299/2010]	EU(European Commission)	This work was supported by EU-grant TargetScreen2 (LSH-2005-1.2.5-3-037365), strategic grant PEst-OE/BIA/UI4046/2011 (BioFIG), and FCT/POCTI-PTDC/SAU-GMG/122299/2010; DFG SFB699 A6; Vs. 28.12.2010. J.A., D. F., M. S., and I. U. were recipients of PhD fellowships SFRH/BD/29134/2006, SFRH/BD/43313/2008, SFRH/BD/35936/2007, and SFRH/BD/69180/2010, respectively, from FCT, Portugal. We acknowledge the scientific support of Drs. Beate Neumann and Thomas Walter as well as the expert technical assistance by Miriam Reiss, Jutta Bulkescher, Brigitte Joggerst-Thomalla, Marta Palma, Tze Heng, and Volker Hilsenstein, assistance with with microscope programming by Siegfrid Winkler, and data analysis by the electronic workshop from EMBL, Heidelberg. The authors are grateful to Professor J. Fragata and his team at the Cardio-Thoracic Surgery Department of the Hospital de Santa Marta (Lisboa) for access to explanted lungs from CF patients, to Professor Jens Leipziger (Aarhus University, Denmark) for critically revising the manuscript, and to Dr. Michael Gray (Newcastle University, UK) for comments. R. P., K. K., and M. D. A. designed the study; J. A., D. F., M. S., I. U., L. S., L. A. C., J. P. M., and M. S. performed experiments and generated data; J. A., D. F., M. S., I. U., L. S., L. A. C., J.-K. H., C. C., W. H., and R. S. analyzed data; L. A. C., C. C., R. S., R. P., K. K., and M. D. A. interpreted data; J. A., K. K., and M. D. A. wrote the article; R. P., K. K., and M. D. A. revised the article; R. P., K. K., and M. D. A. obtained funding. All authors approved the final manuscript.	Almaca J, 2011, METHODS MOL BIOL, V742, P249, DOI 10.1007/978-1-61779-120-8_15; Althaus M, 2011, PULM MED, V2011, DOI 10.1155/2011/830320; Amaral MD, 2007, TRENDS PHARMACOL SCI, V28, P334, DOI 10.1016/j.tips.2007.05.004; Bonny O, 2000, KIDNEY INT, V57, P1313, DOI 10.1046/j.1523-1755.2000.00968.x; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Clarke LA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-38; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; Filigheddu N, 2011, CELL SIGNAL, V23, P1988, DOI 10.1016/j.cellsig.2011.07.009; Gaillard EA, 2010, PFLUG ARCH EUR J PHY, V460, P1, DOI 10.1007/s00424-010-0827-z; Galvez-Santisteban M, 2012, NAT CELL BIOL, V14, P838, DOI 10.1038/ncb2541; Gentzsch M, 2010, J BIOL CHEM, V285, P32227, DOI 10.1074/jbc.M110.155259; Hirsh AJ, 2006, J MED CHEM, V49, P4098, DOI 10.1021/jm051134w; Holden NJ, 2011, MOL MED, V17, P1242, DOI 10.2119/molmed.2011.00028; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itani OA, 2002, AM J PHYSIOL-LUNG C, V282, pL631, DOI 10.1152/ajplung.00085.2001; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; KNOWLES MR, 1990, NEW ENGL J MED, V322, P1189, DOI 10.1056/NEJM199004263221704; Koehl GE, 2010, ONCOGENE, V29, P1553, DOI 10.1038/onc.2009.435; Kunzelmann K, 2004, FASEB J, V18, P142, DOI 10.1096/fj.04-2314fje; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; Kunzelmann K, 2012, INT J BIOCHEM CELL B, V44, P1232, DOI 10.1016/j.biocel.2012.04.012; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lu M, 2010, J AM SOC NEPHROL, V21, P811, DOI 10.1681/ASN.2009111168; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Marumo M, 2012, J PHARM PHARMACOL, V64, P855, DOI 10.1111/j.2042-7158.2012.01485.x; Moniz S, 2013, ACS CHEM BIOL, V8, P432, DOI 10.1021/cb300484r; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; OBRODOVICH H, 1991, AM J PHYSIOL, V261, pC555, DOI 10.1152/ajpcell.1991.261.4.C555; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Otulakowski G, 2007, AM J RESP CELL MOL, V37, P457, DOI 10.1165/rcmb.2007-0055OC; Ousingsawat J, 2008, PFLUG ARCH EUR J PHY, V456, P847, DOI 10.1007/s00424-008-0451-3; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Ritzerfeld J, 2011, GENOME RES, V21, P1955, DOI 10.1101/gr.116087.110; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stockando JD, 2000, J BIOL CHEM, V275, P25760, DOI 10.1074/jbc.M003615200; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200	57	42	43	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1390	1400		10.1016/j.cell.2013.08.045	http://dx.doi.org/10.1016/j.cell.2013.08.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034256	Bronze			2022-12-28	WOS:000324239300025
J	Labidi, J; Cartigny, P; Moreira, M				Labidi, J.; Cartigny, P.; Moreira, M.			Non-chondritic sulphur isotope composition of the terrestrial mantle	NATURE			English	Article							MID-ATLANTIC RIDGE; CRUST; MORB; CONSTRAINTS; CONSEQUENCES; SYSTEMATICS; EVOLUTION; HISTORY; GLASSES; BENEATH	Core-mantle differentiation is the largest event experienced by a growing planet during its early history. Terrestrial core segregation imprinted the residual mantle composition by scavenging siderophile (iron-loving) elements such as tungsten, cobalt and sulphur. Cosmochemical constraints suggest that about 97% of Earth's sulphur should at present reside in the core(1), which implies that the residual silicate mantle should exhibit fractionated S-34/S-32 ratios according to the relevant metal-silicate partition coefficients(2), together with fractionated siderophile element abundances. However, Earth's mantle has long been thought to be both homogeneous and chondritic for S-34/S-32, similar to Canyon Diablo troilite(3-6), as it is for most siderophile elements. This belief was consistent with a mantle sulphur budget dominated by late-accreted chondritic components. Here we show that the mantle, as sampled bymid-ocean ridge basalts from the south Atlantic ridge, displays heterogeneous S-34/S-32 ratios, directly correlated to the strontium and neodymium isotope ratios Sr-87/Sr-86 and Nd-143/Nd-144. These isotope trends are compatible with binary mixing between a low-S-34/S-32 ambient mantle and a high-S-34/S-32 recycled component that we infer to be subducted sediments. The depleted end-member is characterized by a significantly negative delta S-34 of -1.28 +/- 0.33 parts per thousand that cannot reach a chondritic value even when surface sulphur (from continents, altered oceanic crust, sediments and oceans) is added. Such a non-chondritic S-34/S-32 ratio for the silicate Earth could be accounted for by a core-mantle differentiation record in which the core has a S-34/S-32 ratio slightly higher than that of chondrites (delta S-34=+0.07 parts per thousand). Despite evidence for late-veneer addition of siderophile elements (and therefore sulphur) after core formation, our results imply that the mantle sulphur budget retains fingerprints of core-mantle differentiation.	[Labidi, J.; Cartigny, P.] Univ Paris Diderot, Inst Phys Globe Paris, Lab Geochim Isotopes Stables, Sorbonne Paris Cite,UMR 7154,CNRS, F-75005 Paris, France; [Moreira, M.] Univ Paris Diderot, Inst Phys Globe Paris, Lab Geochim & Cosmochim, Sorbonne Paris Cite,UMR 7154,CNRS, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite	Labidi, J (corresponding author), Univ Paris Diderot, Inst Phys Globe Paris, Lab Geochim Isotopes Stables, Sorbonne Paris Cite,UMR 7154,CNRS, 1 Rue Jussieu, F-75005 Paris, France.	labidi@ipgp.fr	Labidi, Jabrane/AAJ-5062-2021; moreira, manuel/H-5329-2017; Cartigny, Pierre/A-6251-2011; Labidi, Jabrane/GXW-2179-2022	Labidi, Jabrane/0000-0002-5656-226X; moreira, manuel/0000-0001-5845-4660; Labidi, Jabrane/0000-0002-5656-226X	Region Ile de France (Sesame); CNRS (INSU-Mi-lourd); CNRS (SEDIT-CNRS); IPGP (BQR)	Region Ile de France (Sesame)(Region Ile-de-France); CNRS (INSU-Mi-lourd); CNRS (SEDIT-CNRS); IPGP (BQR)	Support from the Region Ile de France (Sesame), CNRS (INSU-Mi-lourd and SEDIT-CNRS) and IPGP (BQR) is acknowledged. We thank M. G. Jackson for a review. We thank D. Calmels and M. Clog for discussion and comments. We also thank P. Richet, M. Chaussidon and P. Agrinier for comments on an early version of the manuscript. This is IPGP contribution number 3415.	Andres M., 2002, GEOCHEM GEOPHY GEOSY, V3, P1; Bonifacie M, 2008, SCIENCE, V319, P1518, DOI 10.1126/science.1150988; Cabral RA, 2013, NATURE, V496, P490, DOI 10.1038/nature12020; Canfield DE, 2009, P NATL ACAD SCI USA, V106, P8123, DOI 10.1073/pnas.0902037106; Caro G, 2010, GEOCHIM COSMOCHIM AC, V74, P3333, DOI 10.1016/j.gca.2010.02.025; Chaussidon M., 1991, J GEOCHEM SOC, V3, P325; Dixon JE, 2002, NATURE, V420, P385, DOI 10.1038/nature01215; DIXON JE, 1991, J GEOL, V99, P371, DOI 10.1086/629501; Douglass J, 1999, J GEOPHYS RES-SOL EA, V104, P2941, DOI 10.1029/98JB02642; Dreibus G, 1996, GEOCHIM COSMOCHIM AC, V60, P1125, DOI 10.1016/0016-7037(96)00028-2; Escrig S, 2005, EARTH PLANET SC LETT, V235, P528, DOI 10.1016/j.epsl.2005.04.035; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3159, DOI 10.1016/0016-7037(93)90300-L; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3171, DOI 10.1016/0016-7037(93)90301-C; Kelley KA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000435; Labidi J, 2012, CHEM GEOL, V334, P189, DOI 10.1016/j.chemgeo.2012.10.028; le Roux PJ, 2002, CONTRIB MINERAL PETR, V144, P206, DOI 10.1007/s00410-002-0376-3; le Roux PJ, 2002, EARTH PLANET SC LETT, V203, P479, DOI 10.1016/S0012-821X(02)00832-4; MATHEZ EA, 1976, J GEOPHYS RES, V81, P4269, DOI 10.1029/JB081i023p04269; MCDONOUGH WF, 1990, EARTH PLANET SC LETT, V101, P1, DOI 10.1016/0012-821X(90)90119-I; Metrich N, 2009, GEOCHIM COSMOCHIM AC, V73, P2382, DOI 10.1016/j.gca.2009.01.025; MOREIRA M, 1995, EARTH PLANET SC LETT, V133, P367, DOI 10.1016/0012-821X(95)00080-V; Plank T, 1998, CHEM GEOL, V145, P325, DOI 10.1016/S0009-2541(97)00150-2; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Righter K, 2008, NAT GEOSCI, V1, P321, DOI 10.1038/ngeo180; Rudnick R.L., 2004, TREATISE GEOCHEMISTR, P1, DOI DOI 10.1016/B0-08-043751-6/03016-4; SAKAI H, 1984, GEOCHIM COSMOCHIM AC, V48, P2433, DOI 10.1016/0016-7037(84)90295-3; Sarda P, 2000, J GEOPHYS RES-SOL EA, V105, P5973, DOI 10.1029/1999JB900282; Shahar A, 2009, GEOCHIM COSMOCHIM AC, V73, pA1201; WALLACE P, 1992, GEOCHIM COSMOCHIM AC, V56, P1863, DOI 10.1016/0016-7037(92)90316-B; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	32	155	157	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					208	+		10.1038/nature12490	http://dx.doi.org/10.1038/nature12490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24005324				2022-12-28	WOS:000324244900038
J	Petit-Zeman, S; Locock, L				Petit-Zeman, Sophie; Locock, Louise			Bring on the evidence	NATURE			English	Editorial Material							PATIENT		[Petit-Zeman, Sophie] Oxford Univ Hosp NHS Trust, NIHR Oxford Biomed Res Ctr, Oxford, England; [Locock, Louise] Univ Oxford, Hlth Experiences Res Grp, Dept Primary Care Hlth Sci, Oxford OX1 2JD, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Petit-Zeman, S (corresponding author), Oxford Univ Hosp NHS Trust, NIHR Oxford Biomed Res Ctr, Oxford, England.	sophie.petit-zeman@ouh.nhs.uk						Brett J, 2012, HLTH EXPECT; CHALMERS I, 1995, BRIT MED J, V310, P1315, DOI 10.1136/bmj.310.6990.1315; European Commission, 2012, FP7 COOP WORK PROGR; Lindow V., 1999, ETHICS COMMUNITY HLT, P154; Petit-Zeman S., 2012, INFANT, V8, P71; Staley K., 2009, EXPLORING IMPACT PUB; Staniszewska Sophie, 2013, Evid Based Nurs, V16, P69, DOI 10.1136/eb-2013-101406	8	19	19	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					160	161		10.1038/501160a	http://dx.doi.org/10.1038/501160a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215XR	24032134	Bronze			2022-12-28	WOS:000324244900016
J	Jones, DA; Timmis, A; Wragg, A				Jones, Daniel A.; Timmis, Adam; Wragg, Andrew			Novel drugs for treating angina	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ISCHEMIC-HEART-DISEASE; CHRONIC STABLE ANGINA; DOUBLE-BLIND; ANTIANGINAL EFFICACY; EXERCISE TOLERANCE; RANOLAZINE; IVABRADINE; PECTORIS; NICORANDIL		[Jones, Daniel A.; Timmis, Adam; Wragg, Andrew] NIHR Cardiovasc Biomed Res Unit, London E2 9JX, England; [Jones, Daniel A.; Timmis, Adam; Wragg, Andrew] Barts Hlth NHS Trust, London Chest Hosp, London, England	Barts Health NHS Trust; University of London; Queen Mary University London	Timmis, A (corresponding author), NIHR Cardiovasc Biomed Res Unit, London E2 9JX, England.	adamtimmis@mac.com	Jones, Daniel/AAQ-6390-2020	Jones, Daniel/0000-0003-1441-0417; Wragg, Andrew/0000-0002-8934-5712				[Anonymous], 2013, SUMM PROD CHAR RAN R; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; Ciapponi A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003614.pub2; Danchin N, 2011, CARDIOLOGY, V120, P59, DOI 10.1159/000332369; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; DISOMMA S, 1993, CARDIOVASC DRUG THER, V7, P119, DOI 10.1007/BF00878320; DORING G, 1992, J CARDIOVASC PHARM, V20, pS74; European Medicines Agency, EUR PUBL ASS REP EPA; European Medicines Agency, 2012, ASS REP TRIM CONT ME; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Gao DF, 2011, HEART, V97, P278, DOI 10.1136/hrt.2010.208751; GUERMONPREZ JL, 1993, EUR HEART J, V14, P30, DOI 10.1093/eurheartj/14.suppl_B.30; HAYASHIDA W, 1994, CARDIOVASC DRUG THER, V8, P741, DOI 10.1007/BF00877121; Kosiborod M, 2013, J AM COLL CARDIOL, V61, P2038, DOI 10.1016/j.jacc.2013.02.011; Majewski S, 2012, AM J CARDIOVASC DRUG, V12, P179, DOI 10.2165/11597400-000000000-00000; Medicines and Healthcare Products Regulatory Agency, 2011, NIC 10MG 20MG TABL; Morozova TE, 2011, KARDIOLOGIYA, V51, P35; Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775; National Institute for Health and Clinical Excellence, 2011, MAN STABL ANG CLIN G; Ruzyllo W, 2007, DRUGS, V67, P393, DOI 10.2165/00003495-200767030-00005; Savelieva I, 2008, DRUG SAFETY, V31, P95, DOI 10.2165/00002018-200831020-00001; Scirica BM, 2007, CIRCULATION, V116, P1647, DOI 10.1161/CIRCULATIONAHA.107.724880; Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Tardif JC, 2005, EUR HEART J, V26, P2529, DOI 10.1093/eurheartj/ehi586; Timmis AD, 2006, EUR HEART J, V27, P42, DOI 10.1093/eurheartj/ehi495	28	8	8	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2013	347								f4726	10.1136/bmj.f4726	http://dx.doi.org/10.1136/bmj.f4726			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219RJ	24018101				2022-12-28	WOS:000324526000002
J	Bush, SR; Belton, B; Hall, D; Vandergeest, P; Murray, FJ; Ponte, S; Oosterveer, P; Islam, MS; Mol, APJ; Hatanaka, M; Kruijssen, F; Ha, TTT; Little, DC; Kusumawati, R				Bush, S. R.; Belton, B.; Hall, D.; Vandergeest, P.; Murray, F. J.; Ponte, S.; Oosterveer, P.; Islam, M. S.; Mol, A. P. J.; Hatanaka, M.; Kruijssen, F.; Ha, T. T. T.; Little, D. C.; Kusumawati, R.			Certify Sustainable Aquaculture?	SCIENCE			English	Editorial Material							SHRIMP AQUACULTURE; CERTIFICATION; SYSTEM		[Bush, S. R.; Oosterveer, P.; Mol, A. P. J.; Kusumawati, R.] Wageningen Univ, NL-6708 LX Wageningen, Netherlands; [Belton, B.] WorldFish, Dhaka 1213, Bangladesh; [Hall, D.] Wilfrid Laurier Univ, Waterloo, ON N2L 3C5, Canada; [Vandergeest, P.] York Univ, Toronto, ON M3J 1P3, Canada; [Murray, F. J.; Little, D. C.] Univ Stirling, Stirling FK9 4LA, Scotland; [Ponte, S.] Copenhagen Business Sch, DK-2000 Frederiksberg, Denmark; [Islam, M. S.] Nanyang Technol Univ, Singapore 639798, Singapore; [Hatanaka, M.] Sam Houston State Univ, Huntsville, TX 77340 USA; [Kruijssen, F.] WorldFish, George Town, Malaysia; [Ha, T. T. T.] Vietnam Forestry Univ, Hanoi, Vietnam	Wageningen University & Research; CGIAR; Worldfish; Wilfrid Laurier University; York University - Canada; University of Stirling; Copenhagen Business School; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Texas State University System; Sam Houston State University; CGIAR; Worldfish; Vietnam National University of Agriculture (VNUA)	Bush, SR (corresponding author), Wageningen Univ, NL-6708 LX Wageningen, Netherlands.	simon.bush@wur.nl	Islam, Saidul/Y-4402-2019; mol, arthur PJ/H-2093-2012	Islam, Saidul/0000-0002-6217-0430; Oosterveer, Peter/0000-0002-3067-3068; Kruijssen, Froukje/0000-0002-9804-3038; mol, arthur/0000-0002-4446-2595; Bush, Simon/0000-0002-6689-2246				Asche F, 2011, MAR RESOUR ECON, V26, P255, DOI 10.5950/0738-1360-26.4.255; Belton B, 2010, AMBIO, V39, P2, DOI 10.1007/s13280-009-0009-4; Bene C., 2005, Development Policy Review, V23, P585, DOI 10.1111/j.1467-7679.2005.00304.x; Bosma R, 2011, INT J LIFE CYCLE ASS, V16, P903, DOI 10.1007/s11367-011-0324-4; Bush SR, 2010, ECOL SOC, V15; Dey M. M., 2005, EC MANAG, V9, P217; FAO. Food and Agriculture Organization of the UN (FAO), 2012, STAT WORLD FISH AQ; Ha T T T, 2010, ENVIRON PLANN C, V28, P1101; Hall SJ., 2011, BLUE FRONTIERS MANAG; Hatanaka M, 2005, FOOD POLICY, V30, P354, DOI 10.1016/j.foodpol.2005.05.006; Lebel L, 2008, GLOBALIZATIONS, V5, P211, DOI 10.1080/14747730802057589; Maertens M, 2009, WORLD DEV, V37, P161, DOI 10.1016/j.worlddev.2008.04.006; Mutersbaugh T, 2005, J RURAL STUD, V21, P381, DOI 10.1016/j.jrurstud.2005.10.003; Parkes G, 2010, REV FISH SCI, V18, P344, DOI 10.1080/10641262.2010.516374; Vandergeest P, 2007, WORLD DEV, V35, P1152, DOI 10.1016/j.worlddev.2006.12.002; Xu P, 2012, FOOD CONTROL, V28, P74, DOI 10.1016/j.foodcont.2012.04.008	16	156	162	7	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1067	1068		10.1126/science.1237314	http://dx.doi.org/10.1126/science.1237314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211TG	24009378				2022-12-28	WOS:000323933100026
J	Joppa, LN; Visconti, P; Jenkins, CN; Pimm, SL				Joppa, L. N.; Visconti, P.; Jenkins, C. N.; Pimm, S. L.			Achieving the Convention on Biological Diversity's Goals for Plant Conservation	SCIENCE			English	Article							BIODIVERSITY HOTSPOTS; EXTINCTION; FUTURE	Identifying which areas capture how many species is the first question in conservation planning. The Convention on Biological Diversity (CBD) aspires to formal protection of at least 17% of the terrestrial world and, through the Global Strategy for Plant Conservation, 60% of plant species. Are these targets of protecting area and species compatible? We show that 67% of plant species live entirely within regions that comprise 17% of the land surface. Moreover, these regions include most terrestrial vertebrates with small geographical ranges. However, the connections between the CBD targets of protecting area and species are complex. Achieving both targets will be difficult because regions with the most plant species have only slightly more land protected than do those with fewer.	[Joppa, L. N.; Visconti, P.] Microsoft Res, Cambridge CB1 2FB, England; [Jenkins, C. N.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27606 USA; [Pimm, S. L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Microsoft; University of North Carolina; North Carolina State University; Duke University	Joppa, LN (corresponding author), Microsoft Res, 21 Stn Rd, Cambridge CB1 2FB, England.	stuartpimm@me.com	Jenkins, Clinton/D-6134-2011; Visconti, Piero/A-3253-2009; pimm, stuart/ABF-1082-2020	Jenkins, Clinton/0000-0003-2198-0637; Visconti, Piero/0000-0001-6823-2826; 				Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; BirdLife International, 2011, BIRD SPEC DISTR MAPS, V2013; Brummitt Neil, 2008, Endangered Species Research, V6, P127, DOI 10.3354/esr00135; Cantu-Salazar L, 2013, BIODIVERS CONSERV, V22, P1033, DOI 10.1007/s10531-013-0467-7; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; International Union for Conservation of Nature, 2013, IUCN RED LIST THREAT; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jenkins CN, 2011, DIVERS DISTRIB, V17, P652, DOI 10.1111/j.1472-4642.2011.00770.x; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paton A, 2011, BOT J LINN SOC, V166, P250, DOI 10.1111/j.1095-8339.2011.01155.x; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schnell JK, 2013, CONSERV BIOL, V27, P520, DOI 10.1111/cobi.12047; Strong D., 1984, INSECTS PLANTS COMMU; WCSP, 2008, WCSP 2008 WORLD CHEC	27	84	92	6	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1100	1103		10.1126/science.1241706	http://dx.doi.org/10.1126/science.1241706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009391				2022-12-28	WOS:000323933100041
J	Lorthongpanich, C; Cheow, LF; Balu, S; Quake, SR; Knowles, BB; Burkholder, WF; Solter, D; Messerschmidt, DM				Lorthongpanich, Chanchao; Cheow, Lih Feng; Balu, Sathish; Quake, Stephen R.; Knowles, Barbara B.; Burkholder, William F.; Solter, Davor; Messerschmidt, Daniel M.			Single-Cell DNA-Methylation Analysis Reveals Epigenetic Chimerism in Preimplantation Embryos	SCIENCE			English	Article							ZINC-FINGER PROTEIN; STEM-CELLS; DISEASE; ZFP57; MAINTENANCE; IMPRINTS; GENE; HYPOMETHYLATION; MAINTAINS; DOMAIN	Epigenetic alterations are increasingly recognized as causes of human cancers and disease. These aberrations are likely to arise during genomic reprogramming in mammalian preimplantation embryos, when their epigenomes are most vulnerable. However, this process is only partially understood because of the experimental inaccessibility of early-stage embryos. Here, we introduce a methodologic advance, probing single cells for various DNA-methylation errors at multiple loci, to reveal failed maintenance of epigenetic mark results in chimeric mice, which display unpredictable phenotypes leading to developmental arrest. Yet we show that mouse pronuclear transfer can be used to ameliorate such reprogramming defects. This study not only details the epigenetic reprogramming dynamics in early mammalian embryos but also suggests diagnostic and potential future therapeutic applications.	[Lorthongpanich, Chanchao; Balu, Sathish; Knowles, Barbara B.; Solter, Davor; Messerschmidt, Daniel M.] ASTAR, Inst Med Biol IMB, Mammalian Dev Grp, Singapore, Singapore; [Cheow, Lih Feng; Quake, Stephen R.; Burkholder, William F.] ASTAR, Inst Mol & Cell Biol IMCB, Microfluid Syst Biol Lab, Singapore, Singapore; [Quake, Stephen R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Knowles, Barbara B.] Jackson Lab, Bar Harbor, ME 04609 USA; [Burkholder, William F.] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Burkholder, William F.] Nanyang Technol Univ, Singapore 639798, Singapore; [Solter, Davor] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Messerschmidt, Daniel M.] ASTAR, IMCB, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Jackson Laboratory; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Burkholder, WF (corresponding author), ASTAR, Inst Mol & Cell Biol IMCB, Microfluid Syst Biol Lab, Singapore, Singapore.	wfburkholder@gmail.com; danielm@imcb.a-star.edu.sg	Solter, Davor/Q-5476-2019; Messerschmidt, Daniel Martin/W-7193-2019; t, lf/AAJ-4924-2020	Messerschmidt, Daniel Martin/0000-0003-2022-4696; Knowles, Barbara B./0000-0002-2597-5619; Cheow, Lih Feng/0000-0003-1766-0024	IMB; IMCB; Joint Council Office, A*STAR [0921100080]	IMB(Centre National de la Recherche Scientifique (CNRS)Agency for Science Technology & Research (A*STAR)); IMCB(Agency for Science Technology & Research (A*STAR)); Joint Council Office, A*STAR	We thank H. Wollmann for scientific input and proofreading the manuscript. This work was supported by IMB, IMCB, and a Visiting Investigator Program grant from the Joint Council Office, A*STAR to S. R. Q. (project 0921100080). S. R. Q. is a founder, consultant, member of the advisory board, and equity holder of Fluidgm.	Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Hajkova P, 2010, CURR OPIN CELL BIOL, V22, P342, DOI 10.1016/j.ceb.2010.04.011; Hirasawa R, 2008, DEV CELL, V15, P487, DOI 10.1016/j.devcel.2008.09.006; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kantlehner M, 2011, NUCLEIC ACIDS RES, V39, pE44, DOI 10.1093/nar/gkq1357; Kelsey G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0336; Kohda T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0353; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Liu YW, 2012, GENE DEV, V26, P2374, DOI 10.1101/gad.202200.112; Lorthongpanich C, 2012, DEVELOPMENT, V139, P3722, DOI 10.1242/dev.086454; Mackay DJG, 2006, HUM GENET, V120, P262, DOI 10.1007/s00439-006-0205-2; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Messerschmidt DM, 2012, EPIGENETICS-US, V7, P969, DOI 10.4161/epi.21337; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Strogantsev R, 2012, BRIEF FUNCT GENOMICS, V11, P227, DOI 10.1093/bfgp/els018; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tomizawa S, 2012, J HUM GENET, V57, P84, DOI 10.1038/jhg.2011.151; Toppings M, 2008, HUM REPROD, V23, P807, DOI 10.1093/humrep/den009; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Zuo XP, 2012, J BIOL CHEM, V287, P2107, DOI 10.1074/jbc.M111.322644	28	119	126	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1110	1112		10.1126/science.1240617	http://dx.doi.org/10.1126/science.1240617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009393	Green Accepted			2022-12-28	WOS:000323933100044
J	Biotti, D; Vighetto, A				Biotti, Damien; Vighetto, Alain			Upper Limb Clonus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Biotti, Damien; Vighetto, Alain] Hop Neurol & Neurochirurg P Wertheimer, Lyon, France	CHU Lyon	Biotti, D (corresponding author), Hop Neurol & Neurochirurg P Wertheimer, Lyon, France.	damien.biotti@chu-lyon.fr							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					E12	E12		10.1056/NEJMicm1206994	http://dx.doi.org/10.1056/NEJMicm1206994			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004142				2022-12-28	WOS:000323906900001
J	Lin, JS; Olson, CM; Johnson, ES; Whitlock, EP				Lin, Jennifer S.; Olson, Carin M.; Johnson, Eric S.; Whitlock, Evelyn P.			The Ankle-Brachial Index for Peripheral Artery Disease Screening and Cardiovascular Disease Prediction Among Asymptomatic Adults: A Systematic Evidence Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; RISK PREDICTION; BLOOD-PRESSURE; EVENTS; MORTALITY; STROKE; ASPIRIN; MARKERS; MEN	Background: Screening for peripheral artery disease (PAD) may reduce morbidity and mortality. Purpose: To review the evidence on the ability of the ankle-brachial index (ABI) to predict cardiovascular disease (CVD) morbidity and mortality independent of Framingham Risk Score (FRS) factors in asymptomatic adults and on the benefits and harms of treating screen-detected adults with PAD. Data Sources: MEDLINE and the Cochrane Central Register of Controlled Trials (1996 to September 2012), clinical trial registries, reference lists, and experts. Study Selection: English-language, population-based prognostic studies evaluating the ABI in addition to the FRS and treatment trials or studies of treatment harms in screen-detected adults with PAD. Data Extraction: Dual quality assessment and abstraction of relevant study details. Data Synthesis: One large meta-analysis (n = 43 919) showed that the ABI could reclassify 10-year risk for coronary artery disease (CAD), but it did not report measures of appropriate reclassification (the net reclassification improvement [NRI]). Four heterogeneous risk prediction studies showed that the magnitude of the NRI was probably small when the ABI was added to the FRS to predict CAD or CVD events. Of 2 treatment trials meeting inclusion criteria, 1 large trial (n = 3350) showed that low-dose aspirin did not prevent CVD events in persons with a screen-detected low ABI but may have increased the risk for major bleeding events. Limitations: Most prognostic studies did not allow for calculation of a bias-corrected NRI. Evidence on treatment benefits and harms was limited to aspirin and was scant. Conclusion: Adding the ABI to the FRS probably has limited value for predicting CAD or CVD. Treatment benefits for asymptomatic individuals with screen-detected PAD are not established.	[Lin, Jennifer S.; Olson, Carin M.; Johnson, Eric S.; Whitlock, Evelyn P.] Kaiser Permanente Northwest, Portland, OR 97227 USA	Kaiser Permanente	Lin, JS (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Abbott RD, 2001, J CLIN EPIDEMIOL, V54, P973, DOI 10.1016/S0895-4356(01)00373-0; Abbott RD, 2000, AM J CARDIOL, V86, P280, DOI 10.1016/S0002-9149(00)00914-0; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bosch J, 2002, BMJ-BRIT MED J, V324, P699, DOI 10.1136/bmj.324.7339.699; Cacoub PP, 2009, EUR HEART J, V30, P192, DOI 10.1093/eurheartj/ehn534; Calonge N, 2006, AM FAM PHYSICIAN, V73, P497; Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2004, LANCET, V363, P757; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cook NR, 2011, BIOMETRICAL J, V53, P237, DOI 10.1002/bimj.201000078; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P816, DOI 10.1001/2012.jama.10456; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Grondal N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-67; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hanssen NMJ, 2012, DIABETES CARE, V35, P1731, DOI 10.2337/dc12-0178; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hendel RC, 2012, J AM COLL CARDIOL, V59, P294, DOI 10.1016/j.jacc.2011.10.860; Hirsch AT, 2002, VASC MED, V7, P323, DOI 10.1191/1358863x02vm453ra; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Lee AJ, 2004, CIRCULATION, V110, P3075, DOI 10.1161/01.CIR.0000143102.38256.DE; Lin J. S, 2013, AHRQ PUBLICATION; McDermott MM, 2011, AM J MED, V124, P557, DOI 10.1016/j.amjmed.2010.11.032; Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037; National Institute for Health and Clinical Excellence, 2006, GUID MAN; O'Hare AM, 2006, CIRCULATION, V113, P388, DOI 10.1161/CIRCULATIONAHA.105.570903; Ostergren J, 2004, EUR HEART J, V25, P17, DOI 10.1016/j.ehj.2003.10.033; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Price JF, 2007, J CLIN EPIDEMIOL, V60, P1067, DOI 10.1016/j.jclinepi.2007.01.011; Rodondi N, 2010, AM J EPIDEMIOL, V171, P540, DOI 10.1093/aje/kwp428; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sutton-Tyrrell K, 2008, STROKE, V39, P863, DOI 10.1161/STROKEAHA.107.487439; Tsai AW, 2001, STROKE, V32, P1721, DOI 10.1161/01.STR.32.8.1721; U.S. Preventive Services Task Force, 2011, AHRQ PUBLICATION, V08-05118-EF; U. S. Preventive Services Task Force, 2005, AHRQ PUBLICATION, V05-0573-A; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Weatherley Beth D, 2007, BMC Cardiovasc Disord, V7, P3, DOI 10.1186/1471-2261-7-3; Wells GA, 2014, NEWCASTLE OTTAWA SCA, DOI DOI 10.2307/632432; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	46	83	89	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2013	159	5					333	+		10.7326/0003-4819-159-5-201309030-00007	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-00007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215YA	24026319				2022-12-28	WOS:000324245900004
J	Li, K; Zhou, T; Liao, LJ; Yang, ZF; Wong, C; Henn, F; Malinow, R; Yates, JR; Hu, HL				Li, Kun; Zhou, Tao; Liao, Lujian; Yang, Zhongfei; Wong, Catherine; Henn, Fritz; Malinow, Roberto; Yates, John R., III; Hu, Hailan			beta CaMKII in Lateral Habenula Mediates Core Symptoms of Depression	SCIENCE			English	Article							DEPENDENT-PROTEIN-KINASE; VENTRAL TEGMENTAL AREA; MAJOR DEPRESSION; BASAL GANGLIA; STRESS; NEURONS; MODEL; NEUROTOXICITY; HIPPOCAMPUS; ACTIVATION	The lateral habenula (LHb) has recently emerged as a key brain region in the pathophysiology of depression. However, the molecular mechanism by which LHb becomes hyperactive in depression remains unknown. Through a quantitative proteomic screen, we found that expression of the beta form of calcium/calmodulin-dependent protein kinase type II (beta CaMKII) was significantly up-regulated in the LHb of animal models of depression and down-regulated by antidepressants. Increasing beta-, but not alpha-, CaMKII in the LHb strongly enhanced the synaptic efficacy and spike output of LHb neurons and was sufficient to produce profound depressive symptoms, including anhedonia and behavioral despair. Down-regulation of beta CaMKII levels, blocking its activity or its target molecule the glutamate receptor GluR1 reversed the depressive symptoms. These results identify beta CaMKII as a powerful regulator of LHb neuron function and a key molecular determinant of depression.	[Li, Kun; Zhou, Tao; Yang, Zhongfei; Hu, Hailan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Li, Kun; Zhou, Tao; Yang, Zhongfei; Hu, Hailan] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Li, Kun; Zhou, Tao] Univ Chinese Acad Sci, Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; [Liao, Lujian; Wong, Catherine; Yates, John R., III] Scripps Res Inst, Dept Mol & Cellular Neurobiol, La Jolla, CA 92037 USA; [Henn, Fritz] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Malinow, Roberto] Univ Calif San Diego, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Scripps Research Institute; Cold Spring Harbor Laboratory; University of California System; University of California San Diego	Hu, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	hailan@ion.ac.cn	zhou, tao/AAH-9986-2020	Hu, Hailan/0000-0002-0425-5057; Wong, Catherine CL/0000-0001-7270-980X	Chinese 973 Program [2011CBA00400]; Strategic Priority Research Program (B) of the Chinese Academy of Sciences [XDB02030004]; Hundreds of Talents Program; Outstanding Youth Grant; Shanghai Pujiang Talent Program; NIH [P41 GM103533, R01 MH067880]; Simon's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091119, R01MH067880] Funding Source: NIH RePORTER	Chinese 973 Program(National Basic Research Program of China); Strategic Priority Research Program (B) of the Chinese Academy of Sciences(Chinese Academy of Sciences); Hundreds of Talents Program(Chinese Academy of Sciences); Outstanding Youth Grant; Shanghai Pujiang Talent Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simon's Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Schulz for communication on cLH rats; D. Xu and J. Xiu for advice on AAV virus packaging; L. Monteggia for gift of the AAV-GFP-Cre plasmid; B. Li for communicating unpublished results; and X. Pan, C. Wang, P. Shen, D. Tong, Y. Zhang, and X. Zhang for technical help. Patent applied for CN2013103479386. The work was supported by Chinese 973 Program (2011CBA00400), the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB02030004), the Hundreds of Talents Program, the Outstanding Youth Grant and the Shanghai Pujiang Talent Program (to H. H.), the NIH P41 GM103533 and R01 MH067880 (to J. R. Y.), the Simon's Foundation (to F.H.).	Aizawa H, 2012, J COMP NEUROL, V520, P4051, DOI 10.1002/cne.23167; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; CHARNEY D, 2005, NEUROBIOLOGY MENTAL; Du J, 2004, INT J NEUROPSYCHOPH, V7, P243, DOI 10.1017/S1461145704004432; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Groth RD, 2011, P NATL ACAD SCI USA, V108, P828, DOI 10.1073/pnas.1018022108; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Maier S. F., 1984, BIOL PSYCHIAT, V8, P435, DOI DOI 10.1016/S0278-5846(84)80032-9; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Novak G, 2006, SYNAPSE, V59, P61, DOI 10.1002/syn.20211; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Popoli M, 2002, BIPOLAR DISORD, V4, P166, DOI 10.1034/j.1399-5618.2002.01159.x; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Sheline YI, 1996, MOL PSYCHIATR, V1, P298; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Suenaga T, 2004, INT J NEUROPSYCHOPH, V7, P299, DOI 10.1017/S1461145704004304; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Vaidya VA, 2001, BRIT MED BULL, V57, P61, DOI 10.1093/bmb/57.1.61; Wayman GA, 2011, CELL CALCIUM, V50, P1, DOI 10.1016/j.ceca.2011.02.007; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; Xing GQ, 2002, NEUROREPORT, V13, P501, DOI 10.1097/00001756-200203250-00029	39	255	292	3	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1016	1020		10.1126/science.1240729	http://dx.doi.org/10.1126/science.1240729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990563	Green Accepted			2022-12-28	WOS:000323652300047
J	Ftouh, S; Thomas, M				Ftouh, Saoussen; Thomas, Mark		Acute Kidney Injury Guideline Dev	Acute kidney injury: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE; RIFLE CRITERIA; MANAGEMENT		[Ftouh, Saoussen] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; [Thomas, Mark] Birmingham Heartlands Hosp, Dept Renal Med, Birmingham B9 5SS, W Midlands, England	Royal College of Physicians; Heart of England NHS Foundation Trust; University of Birmingham	Thomas, M (corresponding author), Birmingham Heartlands Hosp, Dept Renal Med, Birmingham B9 5SS, W Midlands, England.	mark.thomas@heartofengland.nhs.uk	Ostermann, Marlies/B-8777-2015	Ostermann, Marlies/0000-0001-9500-9080				Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; [Anonymous], AC ILL PAT HOSP REC; DAVIDMAN M, 1991, ARCH INTERN MED, V151, P1809, DOI 10.1001/archinte.151.9.1809; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Feehally J, 2012, RCPE UK CONS C MAN A; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; James M, 2013, AM J KIDNEY DIS, V61, P673, DOI 10.1053/j.ajkd.2013.02.350; National Confidential Enquiry into Patient Outcome and Death, 2009, AC KIDN INJ ADD INS; National Institute for Health and Care Excellence, 2013, AC KIDN INJ PREV DET; NSH Improving Quality (NHS IQ), 2011, HLTH SERVICE J, P3; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Stevens PE, 2001, QJM-INT J MED, V94, P533, DOI 10.1093/qjmed/94.10.533; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F	13	38	39	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2013	347								f4930	10.1136/bmj.f4930	http://dx.doi.org/10.1136/bmj.f4930			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CC	23985310				2022-12-28	WOS:000323880700007
J	McWilliams, JM; Landon, BE; Chernew, ME				McWilliams, J. Michael; Landon, Bruce E.; Chernew, Michael E.			Changes in Health Care Spending and Quality for Medicare Beneficiaries Associated With a Commercial ACO Contract	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALTERNATIVE QUALITY; MASSACHUSETTS; COSTS	IMPORTANCE In a multipayer system, new payment incentives implemented by one insurer for an accountable care organization (ACO) may also affect spending and quality of care for another insurer's enrollees served by the ACO. Such spillover effects reflect the extent of organizational efforts to reform care delivery and can contribute to the net impact of ACOs. OBJECTIVE We examined whether the Blue Cross Blue Shield (BCBS) of Massachusetts' Alternative Quality Contract (AQC), an early commercial ACO initiative associated with reduced spending and improved quality for BCBS enrollees, was also associated with changes in spending and quality for Medicare beneficiaries, who were not covered by the AQC. DESIGN, SETTING, AND PARTICIPANTS Quasi-experimental comparisons from 2007-2010 of elderly fee-for-service Medicare beneficiaries in Massachusetts (1 761 325 person-years) served by 11 provider organizations entering the AQC in 2009 or 2010 (intervention group) vs beneficiaries served by other providers (control group). Using a difference-in-differences approach, we estimated changes in spending and quality for the intervention group in the first and second years of exposure to the AQC relative to concurrent changes for the control group. Regression and propensity score methods were used to adjust for differences in sociodemographic and clinical characteristics. MAIN OUTCOMES AND MEASURES The primary outcome was total quarterly medical spending per beneficiary. Secondary outcomes included spending by setting and type of service, 5 process measures of quality, potentially avoidable hospitalizations, and 30-day readmissions. RESULTS Before entering the AQC, total quarterly spending per beneficiary for the intervention group was $150 (95% CI, $25-$274) higher than for the control group and increased at a similar rate. In year 2 of the intervention group's exposure to the AQC, this difference was reduced to $51 (95% CI, -$109 to $210; P = .53), constituting a significant differential change of -$99 (95% CI, -$183 to -$16; P = .02) or a 3.4% savings relative to an expected quarterly mean of $2895. Savings in year 1 were not significant (differential change, -$34; 95% CI, -$83 to $16; P = .18). Year 2 savings derived largely from lower spending on outpatient care (differential change, -$73; 95% CI, -$97 to -$50; P < .001), particularly for beneficiaries with 5 or more conditions, and included significant differential changes in spending on procedures, imaging, and tests. Annual rates of low-density lipoprotein cholesterol testing differentially improved for beneficiaries with diabetes in the intervention group by 3.1 percentage points (95% CI, 1.4-4.8 percentage points; P < .001) and for those with cardiovascular disease by 2.5 percentage points (95% CI, 1.1-4.0 percentage points; P < .001), but performance on other quality measures did not differentially change. CONCLUSIONS AND RELEVANCE The AQC was associated with lower spending for Medicare beneficiaries but not with consistently improved quality. Savings among Medicare beneficiaries and previously demonstrated savings among BCBS enrollees varied similarly across settings, services, and time, suggesting that organizational responses were associated with broad changes in patient care.	[McWilliams, J. Michael; Landon, Bruce E.; Chernew, Michael E.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA; [McWilliams, J. Michael] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Landon, Bruce E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Internal Med & Primary Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	McWilliams, JM (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	mcwilliams@hcp.med.harvard.edu			Beeson Career Development Award Program (National Institute on Aging) [K08 AG038354]; Beeson Career Development Award Program (American Federation for Aging Research); Doris Duke Charitable Foundation (Clinical Scientist Development Award) [2010053]; National Institute on Aging [P01 AG032952]; Commonwealth Fund [20110391]; NATIONAL INSTITUTE ON AGING [K08AG038354, P01AG032952] Funding Source: NIH RePORTER	Beeson Career Development Award Program (National Institute on Aging); Beeson Career Development Award Program (American Federation for Aging Research); Doris Duke Charitable Foundation (Clinical Scientist Development Award)(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Commonwealth Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the Beeson Career Development Award Program (National Institute on Aging grant K08 AG038354 and the American Federation for Aging Research), the Doris Duke Charitable Foundation (Clinical Scientist Development Award 2010053), the National Institute on Aging (grant P01 AG032952), and the Commonwealth Fund (grant 20110391).	Agency for Healthcare Research and Quality, 2013, PREVENTION QUALITY I; Ayanian JZ, 2012, NEW ENGL J MED, V367, P790, DOI 10.1056/NEJMp1208710; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Center for Medicare and Medicaid Innovation, 2011, PIONEER ACCOUNTABLE; Centers for Medicare & Medicaid Services, CHRONIC CONDITION DA; Centers for Medicare & Medicaid Services, 2012, CMS NAMES 88 NEW MED; Centers for Medicare & Medicaid Services, 2012, FIRST ACCOUNTABLE CA; Centers for Medicare & Medicaid Services, BERENSON EGGERS TYPE; Centers for Medicare & Medicaid Services, 2013, MORE DOCTORS HOSPITA; Centers for Medicare & Medicaid Services Office of Research Development and Information, 2009, PHYSICIAN GROUP PRAC; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Commonwealth of Massachusetts, 2013, AN ACT IMPROVING THE; Department of Health and Human Services, 2004, HIPAA ADMINISTRATIVE; Department of Health and Human Services; Centers for Medicare & Medicaid Services, 2011, MEDICARE SHARED SAVI; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Funk MJ, 2011, AM J EPIDEMIOL, V173, P761, DOI 10.1093/aje/kwq439; Ghandi N, 2012, THE ACO SURPRISE; MCGUIRE TG, 1991, J HEALTH ECON, V10, P385, DOI 10.1016/0167-6296(91)90022-F; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; McWilliams JM, 2013, JAMA INTERN MED, V173, P1447, DOI 10.1001/jamainternmed.2013.6886; McWilliams JM, 2013, HEALTH SERV RES, V48, P1526, DOI 10.1111/1475-6773.12032; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; Mechanic RE, 2011, HEALTH AFFAIR, V30, P1734, DOI 10.1377/hlthaff.2011.0264; Medicare Payment Advisory Commission, 2009, REPORT TO THE CONGRE; Medicare Payment Advisory Commission, 2011, REP C MED PAYM POL; Song ZR, 2013, JAMA INTERN MED, V173, P15, DOI 10.1001/jamainternmed.2013.1125; Song ZR, 2012, HEALTH AFFAIR, V31, P1885, DOI 10.1377/hlthaff.2012.0327; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Steinbrook R, 2012, JAMA-J AM MED ASSOC, V308, P1215, DOI 10.1001/2012.jama.11322; US Census Bureau, 2010 AMERICAN COMMUN; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; Zuvekas SH, 2010, HEALTH AFFAIR, V29, P1661, DOI 10.1377/hlthaff.2009.0361	34	100	100	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					829	836		10.1001/jama.2013.276302	http://dx.doi.org/10.1001/jama.2013.276302			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	206YA	23982369	Green Accepted			2022-12-28	WOS:000323561400023
J	Frobert, O; Lagerqvist, B; Olivecrona, GK; Omerovic, E; Gudnason, T; Maeng, M; Aasa, M; Angeras, O; Calais, F; Danielewicz, M; Erlinge, D; Hellsten, L; Jensen, U; Johansson, AC; Karegren, A; Nilsson, J; Robertson, L; Sandhall, L; Sjogren, I; Ostlund, O; Harnek, J; James, SK				Frobert, Ole; Lagerqvist, Bo; Olivecrona, Goran K.; Omerovic, Elmir; Gudnason, Thorarinn; Maeng, Michael; Aasa, Mikael; Angeras, Oskar; Calais, Fredrik; Danielewicz, Mikael; Erlinge, David; Hellsten, Lars; Jensen, Ulf; Johansson, Agneta C.; Karegren, Amra; Nilsson, Johan; Robertson, Lotta; Sandhall, Lennart; Sjogren, Iwar; Ostlund, Ollie; Harnek, Jan; James, Stefan K.			Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ADJUNCTIVE THROMBECTOMY; DISTAL EMBOLIZATION; EMBOLIC PROTECTION; NO-REFLOW; X-SIZER; ANGIOPLASTY; REPERFUSION; RESOLUTION; IMPACT	BackgroundThe clinical effect of routine intracoronary thrombus aspiration before primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) is uncertain. We aimed to evaluate whether thrombus aspiration reduces mortality. MethodsWe conducted a multicenter, prospective, randomized, controlled, open-label clinical trial, with enrollment of patients from the national comprehensive Swedish Coronary Angiography and Angioplasty Registry (SCAAR) and end points evaluated through national registries. A total of 7244 patients with STEMI undergoing PCI were randomly assigned to manual thrombus aspiration followed by PCI or to PCI only. The primary end point was all-cause mortality at 30 days. ResultsNo patients were lost to follow-up. Death from any cause occurred in 2.8% of the patients in the thrombus-aspiration group (103 of 3621), as compared with 3.0% in the PCI-only group (110 of 3623) (hazard ratio, 0.94; 95% confidence interval [CI], 0.72 to 1.22; P=0.63). The rates of hospitalization for recurrent myocardial infarction at 30 days were 0.5% and 0.9% in the two groups, respectively (hazard ratio, 0.61; 95% CI, 0.34 to 1.07; P=0.09), and the rates of stent thrombosis were 0.2% and 0.5%, respectively (hazard ratio, 0.47; 95% CI, 0.20 to 1.02; P=0.06). There were no significant differences between the groups with respect to the rate of stroke or neurologic complications at the time of discharge (P=0.87). The results were consistent across all major prespecified subgroups, including subgroups defined according to thrombus burden and coronary flow before PCI. ConclusionsRoutine thrombus aspiration before PCI as compared with PCI alone did not reduce 30-day mortality among patients with STEMI. (Funded by the Swedish Research Council and others; ClinicalTrials.gov number, NCT01093404.)	[Frobert, Ole; Calais, Fredrik] Orebro Univ Hosp, Dept Cardiol, S-70185 Orebro, Sweden; [Lagerqvist, Bo; Ostlund, Ollie; James, Stefan K.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lagerqvist, Bo; Ostlund, Ollie; James, Stefan K.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Olivecrona, Goran K.; Erlinge, David; Harnek, Jan] Univ Lund Hosp, Dept Cardiol, S-22185 Lund, Sweden; [Omerovic, Elmir; Angeras, Oskar] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Aasa, Mikael] Soder Sjukhuset, Karolinska Inst, Dept Cardiol, Stockholm, Sweden; [Jensen, Ulf] Karolinska Univ Hosp, Dept Med, Cardiol Unit, Stockholm, Sweden; [Danielewicz, Mikael] Karlstad Hosp, Dept Cardiol, Karlstad, Sweden; [Hellsten, Lars] Gavle Cent Hosp, Dept Cardiol, S-80187 Gavle, Sweden; [Johansson, Agneta C.] Sunderby Hosp, PCI Unit, Sunderby, Sweden; [Karegren, Amra] Vasteras Hosp, Dept Cardiol, Vasteras, Sweden; [Nilsson, Johan] Umea Univ, Dept Cardiol, Ctr Heart, Umea, Sweden; [Robertson, Lotta] Boras Hosp, Dept Cardiol, Boras, Sweden; [Sandhall, Lennart] Helsingborg Hosp, Dept Radiol, Helsingborg, Sweden; [Sjogren, Iwar] Falun Cent Hosp, Dept Cardiol, Falun, Sweden; [Gudnason, Thorarinn] Landspitali Univ Hosp Iceland, Dept Cardiol, Reykjavik, Iceland; [Gudnason, Thorarinn] Landspitali Univ Hosp Iceland, Cardiovasc Res Ctr, Reykjavik, Iceland; [Maeng, Michael] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark	Orebro University; Uppsala University; Uppsala University; Lund University; Skane University Hospital; Sahlgrenska University Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska University Hospital; Sunderby Hospital; Vasteras Central Hospital; Umea University; Helsingborgs Hospital; Falun Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Aarhus University	Frobert, O (corresponding author), Orebro Univ Hosp, Dept Cardiol, Sodra Grev Rosengatan, S-70185 Orebro, Sweden.	ole.frobert@orebroll.se	James, Stefan K/J-4554-2014; Maeng, Michael/AAY-2135-2021; Demchuk, Andrew M/E-1103-2012; Dworeck, Christian/N-1123-2014	Maeng, Michael/0000-0002-4310-6433; Demchuk, Andrew M/0000-0002-4930-7789; Christiansen, Evald/0000-0002-8740-4862; Dworeck, Christian/0000-0002-2012-5818; A. Samad, Bassem/0000-0001-9440-5073; Varenhorst, Christoph/0000-0002-8378-3869; Ostlund, Ollie/0000-0001-8028-2308; Gotberg, Matthias/0000-0002-0912-7927; Frobert, Ole/0000-0002-5846-345X; Botker, Hans Erik/0000-0001-6358-8962; Hambraeus, Kristina/0000-0002-0768-2484; Veien, Karsten Tange/0000-0002-3898-9331; Gudjonsson, Thorarinn/0000-0001-9645-9665	Swedish Research Council; Swedish Association of Local Authorities and Regions; Terumo Medical Corporation; Medtronic; Vascular Solutions; Swedish Heart-Lung Foundation [20100178, B0010401]; Biotronik; Stentys; Abbott Vascular; St. Jude Medical; Boston Scientific; EPS Vascular; Cardiac Dimensions; AstraZeneca; Edwards Lifesciences; Novo Nordisk Fonden [NNF13OC0007447] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Association of Local Authorities and Regions; Terumo Medical Corporation; Medtronic(Medtronic); Vascular Solutions; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Biotronik; Stentys; Abbott Vascular(Abbott Laboratories); St. Jude Medical(St. Jude Medical); Boston Scientific(Boston Scientific); EPS Vascular; Cardiac Dimensions; AstraZeneca(AstraZeneca); Edwards Lifesciences; Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by unrestricted research grants from the Swedish Research Council, the Swedish Association of Local Authorities and Regions, Terumo Medical Corporation, Medtronic, and Vascular Solutions for administration, data management, and statistical analyses performed at Uppsala Clinical Research Center at Uppsala University Hospital, Sweden. Drs. Frobert and James were supported by grants (20100178 and B0010401, respectively) from the Swedish Heart-Lung Foundation.; Dr. Frobert reports receiving consulting fees from Biotronik and Stentys; Dr. Gudnason, receiving travel support from Medtronic; Dr. Hellsten, receiving fees for board membership from Abbott Vascular, consulting fees from St. Jude Medical, and lecture fees from Medtronic, Boston Scientific, Abbott Vascular, and St. Jude Medical; Dr. Harnek, receiving fees for board membership from Boston Scientific, consulting fees from EPS Vascular and Cardiac Dimensions, grant support from Medtronic, and lecture fees from AstraZeneca, Boston Scientific, and Edwards Lifesciences and providing expert testimony for Occlutec regarding devices for structural heart disease; and Dr. James, receiving lecture fees from Medtronic. No other potential conflict of interest relevant to this article was reported.	Bavry AA, 2008, EUR HEART J, V29, P2989, DOI 10.1093/eurheartj/ehn421; Beran G, 2002, CIRCULATION, V105, P2355, DOI 10.1161/01.CIR.0000016350.02669.1D; Burzotta F, 2005, J AM COLL CARDIOL, V46, P371, DOI 10.1016/j.jacc.2005.04.057; Burzotta F, 2009, EUR HEART J, V30, P2193, DOI 10.1093/eurheartj/ehp348; De Luca G, 2013, INT J CARDIOL, V166, P606, DOI 10.1016/j.ijcard.2011.11.102; Frobert O, 2010, INT J CARDIOL, V145, P572, DOI 10.1016/j.ijcard.2010.05.044; Frobert O, 2010, AM HEART J, V160, P1042, DOI 10.1016/j.ahj.2010.08.040; Haeck JDE, 2009, JACC-CARDIOVASC INTE, V2, P934, DOI 10.1016/j.jcin.2009.07.013; Ikari Y, 2008, JACC-CARDIOVASC INTE, V1, P424, DOI 10.1016/j.jcin.2008.06.004; Inaba Y, 2009, EUROINTERVENTION, V5, P375, DOI 10.4244/V5I3A59; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Kaltoft A, 2006, CIRCULATION, V114, P40, DOI 10.1161/CIRCULATIONAHA.105.595660; Lefevre T, 2005, J AM COLL CARDIOL, V46, P246, DOI 10.1016/j.jacc.2005.04.031; Lin MS, 2009, CIRC J, V73, P1356, DOI 10.1253/circj.CJ-08-0569; Lipiecki J, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2008.11.017; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Mongeon FP, 2010, CIRC-CARDIOVASC INTE, V3, P6, DOI 10.1161/CIRCINTERVENTIONS.109.904037; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; Noman A, 2012, EUR HEART J, V33, P3054, DOI 10.1093/eurheartj/ehs309; OPIE LH, 1989, CIRCULATION, V80, P1049, DOI 10.1161/01.CIR.80.4.1049; Resnic FS, 2003, AM HEART J, V145, P42, DOI 10.1067/mhj.2003.36; Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017; Stone GW, 2012, JAMA-J AM MED ASSOC, V307, P1817, DOI 10.1001/jama.2012.421; Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416; Tamhane UU, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-10; Vlaar PJ, 2008, LANCET, V371, P1915, DOI 10.1016/S0140-6736(08)60833-8	26	736	767	3	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1587	1597		10.1056/NEJMoa1308789	http://dx.doi.org/10.1056/NEJMoa1308789			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	23991656	Green Published			2022-12-28	WOS:000326031100008
J	Kosaka, Y; Xie, SP				Kosaka, Yu; Xie, Shang-Ping			Recent global-warming hiatus tied to equatorial Pacific surface cooling	NATURE			English	Article							ATMOSPHERIC BRIDGE; PRECIPITATION; VARIABILITY; CLIMATOLOGY	Despite the continued increase in atmospheric greenhouse gas concentrations, the annual-mean global temperature has not risen in the twenty-first century(1,2), challenging the prevailing view that anthropogenic forcing causes climate warming. Various mechanisms have been proposed for this hiatus in global warming(3-6), but their relative importance has not been quantified, hampering observational estimates of climate sensitivity. Here we show that accounting for recent cooling in the eastern equatorial Pacific reconciles climate simulations and observations. We present a novel method of uncovering mechanisms for global temperature change by prescribing, in addition to radiative forcing, the observed history of sea surface temperature over the central to eastern tropical Pacific in a climate model. Although the surface temperature prescription is limited to only 8.2% of the global surface, our model reproduces the annual-mean global temperature remarkably well with correlation coefficient r = 0.97 for 1970-2012 (which includes the current hiatus and a period of accelerated global warming). Moreover, our simulation captures major seasonal and regional characteristics of the hiatus, including the intensified Walker circulation, the winter cooling in northwestern North America and the prolonged drought in the southern USA. Our results show that the current hiatus is part of natural climate variability, tied specifically to a La-Nina-like decadal cooling. Although similar decadal hiatus events may occur in the future, the multi-decadal warming trend is very likely to continue with greenhouse gas increase.	[Kosaka, Yu; Xie, Shang-Ping] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Xie, Shang-Ping] Ocean Univ China, Phys Oceanog Lab, Qingdao 266100, Peoples R China; [Xie, Shang-Ping] Ocean Univ China, Ocean Atmosphere Interact & Climate Lab, Qingdao 266100, Peoples R China; [Xie, Shang-Ping] Univ Hawaii Manoa, SOEST, Int Pacific Res Ctr, Honolulu, HI 96822 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Ocean University of China; Ocean University of China; University of Hawaii System; University of Hawaii Manoa	Xie, SP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr MC206, La Jolla, CA 92093 USA.	sxie@ucsd.edu	Kushnir, Yochanan/B-4472-2013; Kosaka, Yu/C-2792-2009; Xie, Shang-Ping/C-1254-2009	Kosaka, Yu/0000-0001-5575-4668; Xie, Shang-Ping/0000-0002-3676-1325	NSF [ATM-0854365]; National Basic Research Program of China [2012CB955600]; NOAA [NA10OAR4310250]; Grants-in-Aid for Scientific Research [25287120] Funding Source: KAKEN	NSF(National Science Foundation (NSF)); National Basic Research Program of China(National Basic Research Program of China); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Geophysical Fluid Dynamics Laboratory model developers for making the coupled model version 2.1 available and L. Xu, Y. Du, N. C. Johnson and C. Deser for discussions. The work was supported by the NSF (ATM-0854365), the National Basic Research Program of China (2012CB955600), and NOAA (NA10OAR4310250).	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Alexander MA, 2002, J CLIMATE, V15, P2205, DOI 10.1175/1520-0442(2002)015<2205:TABTIO>2.0.CO;2; Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Barriopedro D, 2006, J CLIMATE, V19, P1042, DOI 10.1175/JCLI3678.1; Cohen JL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050582; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; DiNezio PN, 2009, J CLIMATE, V22, P4873, DOI 10.1175/2009JCLI2982.1; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; Fetterer F., 2004, EOS T AM GEOPHYS UN, V85, p163, DOI [DOI 10.1029/2004EO160007, 10.1029/2004EO160007]; Foster G, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044022; Hoerling M, 2013, J CLIMATE, V26, P2811, DOI 10.1175/JCLI-D-12-00270.1; Kaufmann RK, 2011, P NATL ACAD SCI USA, V108, P11790, DOI 10.1073/pnas.1102467108; Lau NC, 1996, J CLIMATE, V9, P2036, DOI 10.1175/1520-0442(1996)009<2036:TROTBI>2.0.CO;2; Ma J, 2013, J CLIMATE, V26, P2482, DOI 10.1175/JCLI-D-12-00283.1; Meehl G. A., 2013, J CLIM; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meehl GA, 2011, NAT CLIM CHANGE, V1, P360, DOI 10.1038/NCLIMATE1229; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Solomon S, 2011, SCIENCE, V333, P866, DOI 10.1126/science.1206027; Solomon S, 2010, SCIENCE, V327, P1219, DOI 10.1126/science.1182488; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tokinaga H, 2012, NATURE, V491, P439, DOI 10.1038/nature11576; TRENBERTH KE, 1984, MON WEATHER REV, V112, P326, DOI 10.1175/1520-0493(1984)112<0326:SVNITS>2.0.CO;2; Trenberth KE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000298; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Wang HL, 2009, J CLIMATE, V22, P2571, DOI 10.1175/2008JCL12359.1; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	30	1118	1223	31	661	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					403	+		10.1038/nature12534	http://dx.doi.org/10.1038/nature12534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	23995690				2022-12-28	WOS:000324545700042
J	Marte, B				Marte, Barbara			TUMOUR HETEROGENEITY	NATURE			English	Editorial Material																			0	41	50	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 19	2013	501	7467					327	327		10.1038/501327a	http://dx.doi.org/10.1038/501327a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048064	Bronze			2022-12-28	WOS:000324545700030
J	Maselli, DJ; Peters, JI				Maselli, Diego J.; Peters, Jay I.			5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Maselli, Diego J.; Peters, Jay I.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Maselli, DJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.							Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2018, GLOBAL STRATEGY DIAG; Walters JAE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006897.pub2	2	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC5	10.7326/0003-4819-159-6-201309170-02005	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042388				2022-12-28	WOS:000325625900004
J	Shaw, DM				Shaw, David M.			Homeopaths Without Borders practice exploitation not humanitarianism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland	University of Basel	Shaw, DM (corresponding author), Univ Basel, Inst Biomed Eth, CH-4056 Basel, Switzerland.	david.shaw@unibas.ch						[Anonymous], 2005, LANCET, V366, P690; Homeopaths Without Borders (Germany), 2013, INT S; Shaw DM, 2010, J MED ETHICS, V36, P130, DOI 10.1136/jme.2009.034959	3	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2013	347								f5448	10.1136/bmj.f5448	http://dx.doi.org/10.1136/bmj.f5448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SB	24046156				2022-12-28	WOS:000324828300003
J	Oswald, R; Behrendt, T; Ermel, M; Wu, D; Su, H; Cheng, Y; Breuninger, C; Moravek, A; Mougin, E; Delon, C; Loubet, B; Pommerening-Roser, A; Sorgel, M; Poschl, U; Hoffmann, T; Andreae, MO; Meixner, FX; Trebs, I				Oswald, R.; Behrendt, T.; Ermel, M.; Wu, D.; Su, H.; Cheng, Y.; Breuninger, C.; Moravek, A.; Mougin, E.; Delon, C.; Loubet, B.; Pommerening-Roeser, A.; Soergel, M.; Poeschl, U.; Hoffmann, T.; Andreae, M. O.; Meixner, F. X.; Trebs, I.			HONO Emissions from Soil Bacteria as a Major Source of Atmospheric Reactive Nitrogen	SCIENCE			English	Article							NITRIC-OXIDE; EMPIRICAL-MODEL; NO EMISSIONS; RAIN-FOREST; NITRIFICATION; TEMPERATURE; DENITRIFICATION; DEPENDENCE; EXCHANGE	Abiotic release of nitrous acid (HONO) in equilibrium with soil nitrite (NO2-) was suggested as an important contributor to the missing source of atmospheric HONO and hydroxyl radicals (OH). The role of total soil-derived HONO in the biogeochemical and atmospheric nitrogen cycles, however, has remained unknown. In laboratory experiments, we found that for nonacidic soils from arid and arable areas, reactive nitrogen emitted as HONO is comparable with emissions of nitric oxide (NO). We show that ammonia-oxidizing bacteria can directly release HONO in quantities larger than expected from the acid-base and Henry's law equilibria of the aqueous phase in soil. This component of the nitrogen cycle constitutes an additional loss term for fixed nitrogen in soils and a source for reactive nitrogen in the atmosphere.	[Oswald, R.; Behrendt, T.; Ermel, M.; Wu, D.; Breuninger, C.; Moravek, A.; Soergel, M.; Andreae, M. O.; Meixner, F. X.; Trebs, I.] Max Planck Inst Chem, Biogeochem Dept, POB 3060, D-55020 Mainz, Germany; [Oswald, R.; Ermel, M.; Hoffmann, T.] Johannes Gutenberg Univ Mainz, Inst Inorgan & Analyt Chem, D-55128 Mainz, Germany; [Behrendt, T.] Johannes Gutenberg Univ Mainz, Inst Geog, D-55128 Mainz, Germany; [Wu, D.] Chinese Acad Sci, Key Lab Agr Water Res, Ctr Agr Resources Res, Inst Genet & Dev Biol, Shijiazhuang 050021, Peoples R China; [Su, H.; Cheng, Y.; Poeschl, U.] Max Planck Inst Chem, Multiphase Chem Dept, D-55020 Mainz, Germany; [Moravek, A.] Univ Bayreuth, Dept Micrometeorol, D-95447 Bayreuth, Germany; [Mougin, E.] Univ Toulouse, Geosci Environm Toulouse GET, Observ Midi Pyrenees, CNRS,Inst Rech Dev, F-31400 Toulouse, France; [Delon, C.] Univ Toulouse, Lab Aerol, F-31400 Toulouse, France; [Loubet, B.] INRA, Unite Mixte Rech INRA AgroParistech, Environm & Grandes Cultures, F-78850 Thiverval Grignon, France; [Pommerening-Roeser, A.] Univ Hamburg, Dept Microbiol & Biotechnol, D-22609 Hamburg, Germany	Max Planck Society; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Max Planck Society; University of Bayreuth; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Hamburg	Oswald, R (corresponding author), Max Planck Inst Chem, Biogeochem Dept, POB 3060, D-55020 Mainz, Germany.	robert.oswald@mpic.de; i.trebs@mpic.de	Andreae, Meinrat O./B-1068-2008; Cheng, Yafang/F-9362-2010; Hoffmann, Thorsten/A-7490-2012; Pöschl, Ulrich/A-6263-2010; Trebs, Ivonne/L-9125-2013; Loubet, Benjamin/AAP-5375-2020; Wu, Dianming/A-6583-2012; Su, Hang/A-6226-2010	Andreae, Meinrat O./0000-0003-1968-7925; Cheng, Yafang/0000-0003-4912-9879; Pöschl, Ulrich/0000-0003-1412-3557; Wu, Dianming/0000-0002-0414-9430; Su, Hang/0000-0003-4889-1669; Moravek, Alexander/0000-0003-4342-8173; Sorgel, Matthias/0000-0003-1745-8221; Loubet, Benjamin/0000-0001-8825-8775; Hoffmann, Thorsten/0000-0003-0939-271X; Trebs, Ivonne/0000-0001-5966-4942	Max Planck Society; Max Planck Graduate Center; Johannes Gutenberg University Mainz (MPGC); European Commission within the framework of PEGASOS [265148]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Graduate Center(Max Planck Society); Johannes Gutenberg University Mainz (MPGC); European Commission within the framework of PEGASOS	This project was funded by the Max Planck Society. The work was supported by the Max Planck Graduate Center with the Johannes Gutenberg University Mainz (MPGC). We are grateful to S. Hohlmann, S. Muller, M. Welling, P. Stella, A. Held, B. L. Simmons, N. Mascher, C. Becker, A. C. Hertel, F. Hertel, and Z. Wu for supporting the experiments and helping to collect the soil samples and to S. Bohnke for assistance in creating the global map. We thank K. Emde and team as well as the company Envilytix for analyzing chemical and physical soil properties. Soil sample S7 was collected in Mali at the Agoufou site belonging to the African Multidisciplinary Monsoon Analysis-Couplage de l'Atmosphere Tropicale et du Cycle Hydrologique (AMMA-CATCH) observatory (www.amma-catch.org). The soil sample S11 from Grignon was collected within the framework of the European Commission project NitroEurope-IP (017841). The work of H.S. was supported by the European Commission within the framework of PEGASOS (265148). Supporting soil data are available in the supplementary materials.	Breuer L, 2002, SOIL SCI SOC AM J, V66, P834, DOI 10.2136/sssaj2002.0834; Breuninger C, 2012, ATMOS MEAS TECH, V5, P955, DOI 10.5194/amt-5-955-2012; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Feig GT, 2008, BIOGEOSCIENCES, V5, P1723, DOI 10.5194/bg-5-1723-2008; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Godde M, 1998, SOIL BIOL BIOCHEM, V30, P433, DOI 10.1016/S0038-0717(97)00197-1; Godde M, 1999, BIOL FERT SOILS, V30, P33, DOI 10.1007/s003740050584; Jiang QQ, 1999, FEMS MICROBIOL ECOL, V30, P171, DOI 10.1111/j.1574-6941.1999.tb00646.x; Kleffmann J, 2007, CHEMPHYSCHEM, V8, P1137, DOI 10.1002/cphc.200700016; Koops HP, 2001, FEMS MICROBIOL ECOL, V37, P1, DOI 10.1111/j.1574-6941.2001.tb00847.x; KUBOTA M, 1985, SOIL SCI PLANT NUTR, V31, P35, DOI 10.1080/17470765.1985.10555215; Levine JS, 1996, J GEOPHYS RES-ATMOS, V101, P23689, DOI 10.1029/96JD01661; Ludwig J, 2001, BIOGEOCHEMISTRY, V52, P225, DOI 10.1023/A:1006424330555; NAGELE W, 1990, FEMS MICROBIOL ECOL, V74, P49, DOI 10.1016/0378-1097(90)90515-R; Park S, 2007, PROCESS BIOCHEM, V42, P1671, DOI 10.1016/j.procbio.2007.09.010; Pilegaard K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0126; QUASTEL JH, 1965, ANN REV PLANT PHYSIO, V16, P217, DOI 10.1146/annurev.pp.16.060165.001245; REMDE A, 1993, J ATMOS CHEM, V17, P249, DOI 10.1007/BF00694400; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Rummel U, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000520; SAAD OALO, 1993, BIOL FERT SOILS, V15, P21, DOI 10.1007/BF00336283; SKOPP J, 1990, SOIL SCI SOC AM J, V54, P1619, DOI 10.2136/sssaj1990.03615995005400060018x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steinkamp J, 2011, ATMOS CHEM PHYS, V11, P6063, DOI 10.5194/acp-11-6063-2011; Stromberger ME, 2005, SOIL SCI SOC AM J, V69, P1987, DOI 10.2136/sssaj2005.0076; Su H, 2011, SCIENCE, V333, P1616, DOI 10.1126/science.1207687; van Dijk SM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000358; Wiesen P., 2002, ENVIRON SCI POLLUT R, V9, P48; Yan DD, 2013, SOIL SCI PLANT NUTR, V59, P142, DOI 10.1080/00380768.2012.754727; YIENGER JJ, 1995, J GEOPHYS RES-ATMOS, V100, P11447, DOI 10.1029/95JD00370	30	212	221	38	499	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1233	1235		10.1126/science.1242266	http://dx.doi.org/10.1126/science.1242266			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031015	Green Submitted			2022-12-28	WOS:000324248800041
J	Pinsky, ML; Worm, B; Fogarty, MJ; Sarmiento, JL; Levin, SA				Pinsky, Malin L.; Worm, Boris; Fogarty, Michael J.; Sarmiento, Jorge L.; Levin, Simon A.			Marine Taxa Track Local Climate Velocities	SCIENCE			English	Article							RANGE SHIFTS; IMPACTS	Organisms are expected to adapt or move in response to climate change, but observed distribution shifts span a wide range of directions and rates. Explanations often emphasize biological distinctions among species, but general mechanisms have been elusive. We tested an alternative hypothesis: that differences in climate velocity-the rate and direction that climate shifts across the landscape-can explain observed species shifts. We compiled a database of coastal surveys around North America from 1968 to 2011, sampling 128 million individuals across 360 marine taxa. Climate velocity explained the magnitude and direction of shifts in latitude and depth much more effectively than did species characteristics. Our results demonstrate that marine species shift at different rates and directions because they closely track the complex mosaic of local climate velocities.	[Pinsky, Malin L.; Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Pinsky, Malin L.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Pinsky, Malin L.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada; [Fogarty, Michael J.] Northeast Fisheries Sci Ctr, Woods Hole, MA 02453 USA; [Sarmiento, Jorge L.] Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Dalhousie University; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University	Pinsky, ML (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	malin.pinsky@rutgers.edu	Pinsky, Malin L./K-2884-2015; Levin, Simon A/J-1218-2014	Pinsky, Malin L./0000-0002-8523-8952; Levin, Simon A/0000-0002-8216-5639; Worm, Boris/0000-0002-5742-8716	David H. Smith Conservation Research Fellowship; Natural Sciences and Engineering Research Council of Canada; Nippon Foundation-University of British Columbia Nereus Program; NSF	David H. Smith Conservation Research Fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Nippon Foundation-University of British Columbia Nereus Program; NSF(National Science Foundation (NSF))	We thank H. Benoit, B. Brodie, D. Clark, L. Col, J. Hare, B. Horness, R. Lauth, M. McClure, N. Peaks, J. Pearl, J. Rester, and M. Wilkins for assistance with data; C. Beaulieu, P. Kareiva, R. Rykaczewski, A. Smith, C. Stock, and J. Watson for helpful conversations; and M. Tingley, O. Jensen, and K. Hunter-Thomson for comments on the manuscript. Funding was provided by a David H. Smith Conservation Research Fellowship (M.L.P.), the Natural Sciences and Engineering Research Council of Canada (B.W.), the Nippon Foundation-University of British Columbia Nereus Program (J.L.S.), and NSF (S.A.L.). M.L.P. designed the study; M.L.P. and M.J.F. assembled the data; M.L.P., B.W., and M.J.F. analyzed the data; and M.L.P. and B.W. wrote the paper. S.A.L. and J.L.S. supervised the project. Locations of source data used in our analysis can be found in the supplementary materials.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Ohlemuller R, 2011, SCIENCE, V334, P613, DOI 10.1126/science.1214215; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	20	784	795	9	302	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1239	1242		10.1126/science.1239352	http://dx.doi.org/10.1126/science.1239352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031017				2022-12-28	WOS:000324248800043
J	Schmiedmayer, J; Berges, J				Schmiedmayer, Joerg; Berges, Juergen			Cold Atom Cosmology	SCIENCE			English	Editorial Material									[Schmiedmayer, Joerg] Vienna Univ Technol, Atominst, Vienna Ctr Quantum Sci & Technol, A-1020 Vienna, Austria; [Berges, Juergen] Heidelberg Univ, Inst Theoret Phys, D-69120 Heidelberg, Germany	Technische Universitat Wien; Ruprecht Karls University Heidelberg	Schmiedmayer, J (corresponding author), Vienna Univ Technol, Atominst, Vienna Ctr Quantum Sci & Technol, Stad Allee 2, A-1020 Vienna, Austria.	schmiedmayer@atomchip.org	Schmiedmayer, Jörg/M-9669-2019; Berges, Jürgen/AAW-6472-2020; Schmiedmayer, Jörg/B-4717-2008	Schmiedmayer, Jörg/0000-0001-7799-5614; Schmiedmayer, Jörg/0000-0001-7799-5614	Austrian Science Fund (FWF) [Z 118] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Berges J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.142002; Berges J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.161601; Berges J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.041603; Gring M, 2012, SCIENCE, V337, P1318, DOI 10.1126/science.1224953; Hung CL, 2013, SCIENCE, V341, P1213, DOI 10.1126/science.1237557; KOFMAN L, 1994, PHYS REV LETT, V73, P3195, DOI 10.1103/PhysRevLett.73.3195; Langen T, 2013, NAT PHYS, V9, P639, DOI 10.1038/NPHYS2739; Linde A.D., 1990, PARTICLE PHYS INFLAT; Neuenhahn C., 1955, ARXIV12082255; Nowak B, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.043627; Sakharov A. D., 1965, SOV PHYS JETP, V49, P345; Tagliacozzo L, 2013, ANN PHYS-NEW YORK, V330, P160, DOI 10.1016/j.aop.2012.11.009; Wilson K.G., 1974, PHYS REP, V12, P75, DOI DOI 10.1016/0370-1573(74)90023-4; Zohar E., ARXIV13035040; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0	16	12	12	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1188	1189		10.1126/science.1243904	http://dx.doi.org/10.1126/science.1243904			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031009				2022-12-28	WOS:000324248800029
J	Dolen, G; Darvishzadeh, A; Huang, KW; Malenka, RC				Doelen, Guel; Darvishzadeh, Ayeh; Huang, Kee Wui; Malenka, Robert C.			Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin	NATURE			English	Article							HYPOTHALAMO-NEUROHYPOPHYSEAL SYSTEM; MEDIUM SPINY NEURONS; CONCURRENT ACTIVATION; AFFILIATIVE BEHAVIOR; FOREBRAIN CIRCUIT; INDIRECT PATHWAYS; GENE-EXPRESSION; EVOLUTION; DOPAMINE; INNERVATION	Social behaviours in species as diverse as honey bees and humans promote group survival but often come at some cost to the individual. Although reinforcement of adaptive social interactions is ostensibly required for the evolutionary persistence of these behaviours, the neural mechanisms by which social reward is encoded by the brain are largely unknown. Here we demonstrate that in mice oxytocin acts as a social reinforcement signal within the nucleus accumbens core, where it elicits a presynaptically expressed long-term depression of excitatory synaptic transmission in medium spiny neurons. Although the nucleus accumbens receives oxytocin-receptor-containing inputs from several brain regions, genetic deletion of these receptors specifically from dorsal raphe nucleus, which provides serotonergic (5-hydroxytryptamine; 5-HT) innervation to the nucleus accumbens, abolishes the reinforcing properties of social interaction. Furthermore, oxytocin-induced synaptic plasticity requires activation of nucleus accumbens 5-HT1B receptors, the blockade of which prevents social reward. These results demonstrate that the rewarding properties of social interaction in mice require the coordinated activity of oxytocin and 5-HT in the nucleus accumbens, a mechanistic insight with implications for understanding the pathogenesis of social dysfunction in neuropsychiatric disorders such as autism.	[Doelen, Guel; Darvishzadeh, Ayeh; Huang, Kee Wui; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Dolen, Gul/J-3073-2015	Dolen, Gul/0000-0003-1780-995X	National Institutes of Health [NIH NS069375]; Simons Foundation Autism Research Initiative; Berry Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, R21DA032955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Berry Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Malenka laboratory for comments; A. Andalman, W. Xu, B. K. Lim and T. Sudhof for technical advice; and the SIM1 Animal Care facility for husbandry support. The OT-neurophysin antibody was a gift of H. Gainer. OTR-Venus reporter mice were a gift of L. J. Young. D1-TdTomato BAC transgenic mice were provided by N. Calakos. The rabies virus complementary DNA plasmid and viral component-expressing plasmids were gifts from K. Conzelmann and I. Wickersham. HHK-B19G cells were a gift from E. Callaway. AAVs were produced by the Stanford NGVVC (supported by National Institutes of Health grant NIH NS069375). The AAV-DJ helper plasmid was a gift from M. Kay. This work was supported by funding from the Simons Foundation Autism Research Initiative (R. C. M.), N. I. H. (R. C. M.), and a Berry Foundation Postdoctoral Fellowship (G.D.)	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; ANDERSON PK, 1965, SCIENCE, V148, P1753, DOI 10.1126/science.148.3678.1753; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; BENBARAK Y, 1985, J NEUROSCI, V5, P81; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Brunner D, 1999, BEHAV NEUROSCI, V113, P587; Capper-Loup C, 2002, J NEUROSCI, V22, P6218; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Furay AR, 2011, BEHAV BRAIN RES, V224, P350, DOI 10.1016/j.bbr.2011.06.016; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; HERMES MLHJ, 1988, J COMP NEUROL, V273, P252, DOI 10.1002/cne.902730209; Hodgson SR, 2010, BEHAV PHARMACOL, V21, P112, DOI 10.1097/FBP.0b013e328337be25; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; Kelley AE, 2002, J NEUROSCI, V22, P3306; Knobloch HS, 2012, NEURON, V73, P553, DOI 10.1016/j.neuron.2011.11.030; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lee HJ, 2008, ENDOCRINOLOGY, V149, P3256, DOI 10.1210/en.2007-1710; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Mathur BN, 2011, J NEUROSCI, V31, P7402, DOI 10.1523/JNEUROSCI.6250-10.2011; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; Nambu A, 2008, CURR OPIN NEUROBIOL, V18, P595, DOI 10.1016/j.conb.2008.11.001; Orabona GM, 2009, BRAIN RES, V1264, P127, DOI 10.1016/j.brainres.2008.11.107; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp J, 2011, SCIENCE, V334, P1358, DOI 10.1126/science.1216480; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Perreault ML, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00031; PHILLIPSON OT, 1985, NEUROSCIENCE, V16, P275, DOI 10.1016/0306-4522(85)90002-8; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Rosen GJ, 2008, NEUROSCIENCE, V155, P809, DOI 10.1016/j.neuroscience.2008.05.039; Ross HE, 2009, NEUROSCIENCE, V162, P892, DOI 10.1016/j.neuroscience.2009.05.055; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; WHITNALL MH, 1985, J NEUROSCI, V5, P98; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Yamasue H, 2012, J NEUROSCI, V32, P14109, DOI 10.1523/JNEUROSCI.3327-12.2012; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	47	641	648	5	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 12	2013	501	7466					179	+		10.1038/nature12518	http://dx.doi.org/10.1038/nature12518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215XR	24025838	Green Accepted			2022-12-28	WOS:000324244900032
J	Sankilampi, U; Saari, A; Laine, T; Miettinen, PJ; Dunkel, L				Sankilampi, Ulla; Saari, Antti; Laine, Tiina; Miettinen, Paivi J.; Dunkel, Leo			Use of Electronic Health Records for Automated Screening of Growth Disorders in Primary Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sankilampi, Ulla] Kuopio Univ Hosp, Dept Pediat, SF-70210 Kuopio, Finland; [Saari, Antti] Univ Eastern Finland, Dept Pediat, Kuopio, Finland; [Laine, Tiina; Miettinen, Paivi J.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Dunkel, Leo] Queen Mary Univ London, Ctr Endocrinol, London EC1M 6BQ, England	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; University of London; Queen Mary University London	Dunkel, L (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Ctr Endocrinol, Barts & London Charterhouse Sq, London EC1M 6BQ, England.	l.dunkel@qmul.ac.uk		Miettinen, Paivi/0000-0002-5184-9616; Sankilampi, Ulla/0000-0002-0789-9720				Craig D, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15110; Maki P, 2011, HLTH CHECKUPS WELL C; SORVA R, 1989, Archives of Disease in Childhood, V64, P1483, DOI 10.1136/adc.64.10.1483; Wit JM, 2007, HORM RES, V68, pVII	4	35	36	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1071	1072		10.1001/jama.2013.218793	http://dx.doi.org/10.1001/jama.2013.218793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	24026604	Bronze			2022-12-28	WOS:000324133400026
J	Peng, SS; Piao, SL; Ciais, P; Myneni, RB; Chen, AP; Chevallier, F; Dolman, AJ; Janssens, IA; Penuelas, J; Zhang, GX; Vicca, S; Wan, SQ; Wang, SP; Zeng, H				Peng, Shushi; Piao, Shilong; Ciais, Philippe; Myneni, Ranga B.; Chen, Anping; Chevallier, Frederic; Dolman, Albertus J.; Janssens, Ivan A.; Penuelas, Josep; Zhang, Gengxin; Vicca, Sara; Wan, Shiqiang; Wang, Shiping; Zeng, Hui			Asymmetric effects of daytime and night-time warming on Northern Hemisphere vegetation	NATURE			English	Article							NET PRIMARY PRODUCTION; CARBON-DIOXIDE; RIDGE REGRESSION; LEAF RESPIRATION; CLIMATE-CHANGE; SATELLITE; TEMPERATURE; IMPACT; GROWTH	Temperature data over the past five decades show faster warming of the global land surface during the night than during the day(1). This asymmetric warming is expected to affect carbon assimilation and consumption in plants, because photosynthesis in most plants occurs during daytime and is more sensitive to the maximum daily temperature, T-max, whereas plant respiration occurs throughout the day(2) and is therefore influenced by both T-max and the minimum daily temperature, T-min. Most studies of the response of terrestrial ecosystems to climate warming, however, ignore this asymmetric forcing effect on vegetation growth and carbon dioxide (CO2) fluxes(3-6). Here we analyse the interannual covariations of the satellite-derived normalized difference vegetation index (NDVI, an indicator of vegetation greenness) with Tmax and Tmin over the Northern Hemisphere. After removing the correlation between Tmax and Tmin, we find that the partial correlation between Tmax and NDVI is positive in most wet and cool ecosystems over boreal regions, but negative in dry temperate regions. In contrast, the partial correlation between Tmin and NDVI is negative in boreal regions, and exhibits a more complex behaviour in dry temperate regions. We detect similar patterns in terrestrial net CO2 exchange maps obtained from a global atmospheric inversion model. Additional analysis of the long-term atmospheric CO2 concentration record of the station Point Barrow in Alaska suggests that the peak-to-peak amplitude of CO2 increased by 23 +/- 11% for a +1 degrees C anomaly in T-max from May to September over lands north of 51 degrees N, but decreased by 28 +/- 14% for a +1 degrees C anomaly in T-min. These lines of evidence suggest that asymmetric diurnal warming, a process that is currently not taken into account in many global carbon cycle models, leads to a divergent response of Northern Hemisphere vegetation growth and carbon sequestration to rising temperatures.	[Peng, Shushi; Piao, Shilong] Peking Univ, Coll Urban & Environm Sci, Sinofrench Inst Earth Syst Sci, Beijing 100871, Peoples R China; [Piao, Shilong; Zhang, Gengxin; Wang, Shiping] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing 100085, Peoples R China; [Ciais, Philippe; Chevallier, Frederic] CEA, CNRS, LSCE, CE, F-91191 Gif Sur Yvette, France; [Myneni, Ranga B.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Chen, Anping] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dolman, Albertus J.] Vrije Univ Amsterdam, Dept Earth Sci, NL-1081 HV Amsterdam, Netherlands; [Janssens, Ivan A.; Vicca, Sara] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Penuelas, Josep] CREAF, Barcelona 08193, Catalonia, Spain; [Penuelas, Josep] UAB, CSIC, CEAB, Global Ecol Unit,CREAF, Barcelona 08193, Catalonia, Spain; [Wan, Shiqiang] Henan Univ, Coll Life Sci, Kaifeng 475001, Peoples R China; [Zeng, Hui] Peking Univ, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Boston University; Princeton University; Vrije Universiteit Amsterdam; University of Antwerp; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona; Henan University; Peking University; University Town of Shenzhen	Piao, SL (corresponding author), Peking Univ, Coll Urban & Environm Sci, Sinofrench Inst Earth Syst Sci, Beijing 100871, Peoples R China.	slpiao@pku.edu.cn; zengh@pkusz.edu.cn	PENG, Shushi/AAS-2603-2020; Vicca, Sara/I-3637-2012; Chen, Anping/H-9960-2014; Janssens, Ivan A/P-1331-2014; Wan, Shiqiang/B-5799-2009; Chevallier, Frederic JM/E-9608-2016; Ciais, Philippe/A-6840-2011; Myneni, Ranga B./AAU-6088-2021; Penuelas, Josep/D-9704-2011; Wan, Shiqiang/L-9166-2019; Myneni, Ranga B/F-5129-2012; Peng, Shushi/J-4779-2014	PENG, Shushi/0000-0001-5098-726X; Vicca, Sara/0000-0001-9812-5837; Chen, Anping/0000-0003-2085-3863; Janssens, Ivan A/0000-0002-5705-1787; Wan, Shiqiang/0000-0003-0631-1232; Chevallier, Frederic JM/0000-0002-4327-3813; Ciais, Philippe/0000-0001-8560-4943; Penuelas, Josep/0000-0002-7215-0150; Wan, Shiqiang/0000-0003-0631-1232; Myneni, Ranga B/0000-0002-0234-6393; Peng, Shushi/0000-0001-5098-726X; Dolman, A.J./0000-0003-0099-0457	National Natural Science Foundation of China [41125004, 31021001]; National Basic Research Program of China [2010CB950601, 2013CB956303]; Foundation for Sino-EU Research Cooperation of the Ministry of Science and Technology of China [1003]; Chinese Ministry of Environmental Protection [201209031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Foundation for Sino-EU Research Cooperation of the Ministry of Science and Technology of China; Chinese Ministry of Environmental Protection	This study was supported by the National Natural Science Foundation of China (grant numbers 41125004 and 31021001), the National Basic Research Program of China (grant numbers 2010CB950601 and 2013CB956303), the Foundation for Sino-EU Research Cooperation of the Ministry of Science and Technology of China (grant number 1003), and a Chinese Ministry of Environmental Protection Grant (number 201209031). We also acknowledge the GLOBALVIEW-CO<INF>2</INF> project based at NOAA ESRL. S. V. is a postdoctoral research associate of the Fund for Scientific Research (Flanders).	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Atkin OK, 2013, PLANT SOIL, V367, P163, DOI 10.1007/s11104-013-1686-0; Baker DF, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002439; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Behera SK, 2005, J CLIMATE, V18, P4514, DOI 10.1175/JCLI3541.1; Beier C, 2008, SCI TOTAL ENVIRON, V407, P692, DOI 10.1016/j.scitotenv.2008.10.001; Chevallier F, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013887; de Jeu RAM, 2008, SURV GEOPHYS, V29, P399, DOI 10.1007/s10712-008-9044-0; Griffin KL, 2002, GLOBAL CHANGE BIOL, V8, P479, DOI 10.1046/j.1365-2486.2002.00487.x; Gu L, 2008, BIOSCIENCE, V58, P253, DOI 10.1641/B580311; HOERL AE, 1975, COMMUN STAT, V4, P105, DOI 10.1080/03610927508827232; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Kim Y, 2012, REMOTE SENS ENVIRON, V121, P472, DOI 10.1016/j.rse.2012.02.014; Kreyling J, 2010, ECOLOGY, V91, P1939, DOI 10.1890/09-1160.1; Ling P. P., GREENHOUSE CONDENSAT; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Prasad PVV, 2008, CROP SCI, V48, P2372, DOI 10.2135/cropsci2007.12.0717; Qian HF, 2010, GLOBAL CHANGE BIOL, V16, P641, DOI 10.1111/j.1365-2486.2009.01989.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; Solomon S., 2007, PHYS SCI BASIS WORKI; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Turnbull MH, 2002, PLANT CELL ENVIRON, V25, P1729, DOI 10.1046/j.1365-3040.2002.00947.x; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang H, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052371; Willmott K., TERRESTRIAL PRECIPIT; Zhang YC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006873; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]; Zhou L, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002510	42	365	421	62	730	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					88	+		10.1038/nature12434	http://dx.doi.org/10.1038/nature12434			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	24005415				2022-12-28	WOS:000323888300037
J	Ladizinski, B; Rukhman, E; Lee, KC				Ladizinski, Barry; Rukhman, Erik; Lee, Kachiu C.			A 4-Day-Old Neonate With a Widespread Vesicular Rash	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ladizinski, Barry] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21201 USA; [Rukhman, Erik] Univ Richmond, Med Ctr, Staten Isl, NY USA; [Lee, Kachiu C.] Brown Univ, Providence, RI 02912 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Brown University	Ladizinski, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 300 N Charles St,Ste 304, Baltimore, MD 21201 USA.	barryladizinski@gmail.com						[Anonymous], 2000, Int J Gynaecol Obstet, V68, P165; James WD, 2006, ANDREWS DIS SKIN, P372; Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004; Marquez L, 2011, PEDIATR INFECT DIS J, V30, P153, DOI 10.1097/INF.0b013e3181f55a5c; Pinninti SG, 2013, PEDIATR CLIN N AM, V60, P351, DOI 10.1016/j.pcl.2012.12.005	5	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					971	972		10.1001/jama.2013.276963	http://dx.doi.org/10.1001/jama.2013.276963			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002284				2022-12-28	WOS:000323885700028
J	Jagannath, A; Butler, R; Godinho, SIH; Couch, Y; Brown, LA; Vasudevan, SR; Flanagan, KC; Anthony, D; Churchill, GC; Wood, MJA; Steiner, G; Ebeling, M; Hossbach, M; Wettstein, JG; Duffield, GE; Gatti, S; Hankins, MW; Foster, RG; Peirson, SN				Jagannath, Aarti; Butler, Rachel; Godinho, Sofia I. H.; Couch, Yvonne; Brown, Laurence A.; Vasudevan, Sridhar R.; Flanagan, Kevin C.; Anthony, Daniel; Churchill, Grant C.; Wood, Matthew J. A.; Steiner, Guido; Ebeling, Martin; Hossbach, Markus; Wettstein, Joseph G.; Duffield, Giles E.; Gatti, Silvia; Hankins, Mark W.; Foster, Russell G.; Peirson, Stuart N.			The CRTC1-SIK1 Pathway Regulates Entrainment of the Circadian Clock	CELL			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; KINASE 1; LIGHT; MELANOPSIN; CREB; PHOSPHORYLATION; PACEMAKER; PERIOD; CONE	Retinal photoreceptors entrain the circadian system to the solar day. This photic resetting involves cAMP response element binding protein (CREB)mediated upregulation of Per genes within individual cells of the suprachiasmatic nuclei (SCN). Our detailed understanding of this pathway is poor, and it remains unclear why entrainment to a new time zone takes several days. By analyzing the light-regulated transcriptome of the SCN, we have identified a key role for salt inducible kinase 1 (SIK1) and CREB-regulated transcription coactivator 1 (CRTC1) in clock re-setting. An entrainment stimulus causes CRTC1 to coactivate CREB, inducing the expression of Per1 and Sik1. SIK1 then inhibits further shifts of the clock by phosphorylation and deactivation of CRTC1. Knockdown of Sik1 within the SCN results in increased behavioral phase shifts and rapid re-entrainment following experimental jet lag. Thus SIK1 provides negative feedback, acting to suppress the effects of light on the clock. This pathway provides a potential target for the regulation of circadian rhythms.	[Jagannath, Aarti; Butler, Rachel; Godinho, Sofia I. H.; Brown, Laurence A.; Hankins, Mark W.; Foster, Russell G.; Peirson, Stuart N.] Univ Oxford, John Radcliffe Hosp, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Couch, Yvonne; Vasudevan, Sridhar R.; Anthony, Daniel; Churchill, Grant C.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Flanagan, Kevin C.; Duffield, Giles E.] Univ Notre Dame, Dept Biol Sci, Galvin Life Sci Ctr, Notre Dame, IN 46556 USA; [Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Jagannath, Aarti; Butler, Rachel; Godinho, Sofia I. H.; Steiner, Guido; Ebeling, Martin; Wettstein, Joseph G.; Gatti, Silvia] pRED Pharma Res & Dev F Hoffmann Roche, CH-4070 Basel, Switzerland; [Hossbach, Markus] Axolabs GmbH, D-95326 Kulmbach, Germany	University of Oxford; University of Oxford; University of Notre Dame; University of Oxford; Roche Holding	Foster, RG (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Levels 5-6 West Wing,Headley Way, Oxford OX3 9DU, England.	russell.foster@eye.ox.ac.uk; stuart.peirson@eye.ox.ac.uk	Anthony, Daniel/F-7765-2010; Jagannath, Aarti/GQA-7297-2022; Vasudevan, Sridhar/B-1841-2015; Wood, Matthew/HDN-1469-2022	Anthony, Daniel/0000-0003-1380-6655; Vasudevan, Sridhar/0000-0003-0516-2984; Jagannath, Aarti/0000-0003-2132-8200; Brown, Laurence/0000-0001-8116-4100; FOSTER, RUSSELL/0000-0001-6055-2067; Wood, Matthew/0000-0002-5436-6011	Wellcome Trust [090684/Z/09/Z]; F. Hoffmann-La Roche Neuroscience DTA grant; F. Hoffmann-La Roche AG postdoctoral fellowship; NIGMS [R01-GM087508]; NSF REU Fellowship; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; Medical Research Council [G0900887] Funding Source: researchfish; Parkinson&quot;s UK [G-0503] Funding Source: researchfish; BBSRC [BB/G008523/1] Funding Source: UKRI; MRC [G0900887] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087508] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); F. Hoffmann-La Roche Neuroscience DTA grant; F. Hoffmann-La Roche AG postdoctoral fellowship; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF REU Fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the Wellcome Trust (090684/Z/09/Z) and a F. Hoffmann-La Roche Neuroscience DTA grant awarded to R. G. F., M. W. H., and S.N.P., which supported R. B. and S. I. H. G. A.J. is a recipient of the F. Hoffmann-La Roche AG postdoctoral fellowship. The work was also supported by a grant from NIGMS (R01-GM087508 to G. E. D.) and an NSF REU Fellowship (to K. C. F.). We are grateful to J. Gamsby and J. Dunlap for provision of PER2::LUC MEFs and Dr. P. Nolan for provision of Per2::Luc U2OS cells. G. S., M. E., J. G. W., and S. G. are employees of F. Hoffmann-La Roche.	Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Aschoff J, 1981, BIOL RHYTHMS; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Butcher GQ, 2002, J BIOL CHEM, V277, P29519, DOI 10.1074/jbc.M203301200; Cagnol S, 2013, ONCOGENE, V32, P564, DOI 10.1038/onc.2012.88; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Chiu JC, 2011, CELL, V145, P357, DOI 10.1016/j.cell.2011.04.002; Doi M, 2007, J BIOL RHYTHM, V22, P127, DOI 10.1177/0748730406298332; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Fukushima T, 1997, NEUROSCI LETT, V227, P45, DOI 10.1016/S0304-3940(97)00297-8; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2000, J COMP NEUROL, V418, P147; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Kanyo R, 2009, ENDOCRINOLOGY, V150, P4221, DOI 10.1210/en.2009-0275; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kim DY, 2001, J NEUROSCI, V21, P4026, DOI 10.1523/JNEUROSCI.21-11-04026.2001; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee B, 2010, J BIOL RHYTHM, V25, P410, DOI 10.1177/0748730410381229; Lin JT, 1997, MOL BRAIN RES, V46, P303, DOI 10.1016/S0169-328X(97)00005-3; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 2006, CHRONOBIOL INT, V23, P167, DOI 10.1080/07420520500545870; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI 10.1177/0748730403253370; Meng QJ, 2010, P NATL ACAD SCI USA, V107, P15240, DOI 10.1073/pnas.1005101107; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; MROSOVSKY N, 1987, NATURE, V330, P372, DOI 10.1038/330372a0; Pendergast JS, 2010, J NEUROSCI, V30, P12179, DOI 10.1523/JNEUROSCI.2607-10.2010; Porterfield VM, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-98; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schwartz WJ, 2011, P NATL ACAD SCI USA, V108, P17219, DOI 10.1073/pnas.1107848108; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; van Oosterhout F, 2012, CURR BIOL, V22, P1397, DOI 10.1016/j.cub.2012.05.032; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	54	125	130	4	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1100	1111		10.1016/j.cell.2013.08.004	http://dx.doi.org/10.1016/j.cell.2013.08.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993098	hybrid, Green Published			2022-12-28	WOS:000323767300022
J	Vasilakou, D; Karagiannis, T; Athanasiadou, E; Mainou, M; Liakos, A; Bekiari, E; Sarigianni, M; Matthews, DR; Tsapas, A				Vasilakou, Despoina; Karagiannis, Thomas; Athanasiadou, Eleni; Mainou, Maria; Liakos, Aris; Bekiari, Eleni; Sarigianni, Maria; Matthews, David R.; Tsapas, Apostolos			Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							INADEQUATE GLYCEMIC CONTROL; SELECTIVE SGLT2 INHIBITOR; LOWERS BODY-WEIGHT; LONG-TERM EFFICACY; ADD-ON THERAPY; TOTAL FAT MASS; DOUBLE-BLIND; JAPANESE PATIENTS; CANAGLIFLOZIN CANA; DAPAGLIFLOZIN MONOTHERAPY	Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs. Purpose: To assess the efficacy and safety of SGLT2 inhibitors in adults with type 2 diabetes. Data Sources: MEDLINE, EMBASE, and the Cochrane Library from inception through April 2013 without language restrictions; regulatory authorities' reports; and gray literature. Study Selection: Randomized trials comparing SGLT2 inhibitors with placebo or other medication for type 2 diabetes. Data Extraction: Three reviewers extracted or checked data for study characteristics, outcomes of interest, and risk of bias, and 3 reviewers summarized strength of evidence using the Grading of Recommendations Assessment, Development and Evaluation approach. Data Synthesis: Sodium-glucose cotransporter 2 inhibitors were compared with placebo in 45 studies (n = 11 232) and with active comparators in 13 studies (n = 5175). They had a favorable effect on hemoglobin A(1c) level (mean difference vs. placebo, -0.66% [95% CI, -0.73% to -0.58%]; mean difference vs. active comparators, -0.06% [CI, -0.18% to 0.05%]). Sensitivity analyses incorporating unpublished data showed similar effect estimates. Compared with other agents, SGLT2 inhibitors reduced body weight (mean difference, -1.80 kg [CI, -3.50 to -0.11 kg]) and systolic blood pressure (mean difference, -4.45 mm Hg [CI, -5.73 to -3.18 mm Hg]). Urinary and genital tract infections were more common with SGLT2 inhibitors (odds ratios, 1.42 [CI, 1.06 to 1.90] and 5.06 [CI, 3.44 to 7.45], respectively). Hypoglycemic risk was similar to that of other agents. Results for cardiovascular outcomes and death were inconclusive. An imbalance in incidence of bladder and breast cancer was noted with dapagliflozin compared with control. Limitation: Most trials were rated as high risk of bias because of missing data and last-observation-carried-forward methods. Conclusion: Sodium-glucose cotransporter 2 inhibitors may improve short-term outcomes in adults with type 2 diabetes, but effects on long-term outcomes and safety are unclear.	Aristotle Univ Thessaloniki, Thessaloniki 54642, Greece; Univ Oxford, Oxford, England	Aristotle University of Thessaloniki; University of Oxford	Tsapas, A (corresponding author), Aristotle Univ Thessaloniki, Dept Med 2, 49 Konstantinoupoleos St, Thessaloniki 54642, Greece.	atsapas@auth.gr	Tsapas, Apostolos/P-5593-2019; Liakos, Aris/H-2630-2016; Karagiannis, Thomas/H-9476-2019	Tsapas, Apostolos/0000-0003-0221-4072; Liakos, Aris/0000-0003-3261-2979; Karagiannis, Thomas/0000-0001-5242-0574; Sarigianni, Maria/0000-0003-4946-0799; Bekiari, Eleni/0000-0001-9975-3835	Boehringer Ingelheim; Novartis; Novo Nordisk; Sanofi-Aventis; National Institute for Health Research [NF-SI-0508-10272] Funding Source: researchfish	Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Novo Nordisk(Novo Nordisk); Sanofi-Aventis(Sanofi-Aventis); National Institute for Health Research(National Institute for Health Research (NIHR))	Potential Conflicts of Interest: Dr. Matthews: Other: Novo Nordisk, Boehringer Ingelheim, AstraZeneca, SB Communications, Merck, Takeda Chemical Industries, Johnson & Johnson, GlaxoSmithKline, Servier. Dr. Tsapas: Grant: Boehringer Ingelheim, Novartis, Novo Nordisk, Sanofi-Aventis; Other: Novo Nordisk. All other authors have no disclosures. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum = M13-0277.	AstraZeneca, 2012, CLIN STUD REP SYN; AstraZeneca, 2012, DIABETOLOGIA S1; Bailey CJ, 2012, DIABETES OBES METAB, V14, P951, DOI 10.1111/j.1463-1326.2012.01659.x; Bailey CJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-43; Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Bode B, 2012, DIABETOLOGIA, V55, pS315; Bolinder J, 2012, DIABETOLOGIA, V55, pS308; Bolinder J, 2012, J CLIN ENDOCR METAB, V97, P1020, DOI 10.1210/jc.2011-2260; Burki TK, 2012, LANCET, V379, P507, DOI 10.1016/S0140-6736(12)60216-5; Cefalu TW, 2012, DIABETES S1A, V61, pLB10; Cefalu WT, 2012, DIABETES, V61, pA271; Clar C, 2012, BMJ OPEN, P2; Del Prato S, 2011, DIABETOLOGIA, V54, pS348; Devineni D, 2012, DIABETES OBES METAB, V14, P539, DOI 10.1111/j.1463-1326.2012.01558.x; Diamond GA, 2007, ANN INTERN MED, V147, P578, DOI 10.7326/0003-4819-147-8-200710160-00182; Dobbins RL, 2012, DIABETES OBES METAB, V14, P15, DOI 10.1111/j.1463-1326.2011.01462.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; European Medicines Agency, 2012, ASS REP; Ferrannini E, 2013, DIABETES OBES METAB, V15, P721, DOI 10.1111/dom.12081; Ferrannini E, 2012, NAT REV ENDOCRINOL, V8, P495, DOI 10.1038/nrendo.2011.243; Ferrannini E, 2010, DIABETES CARE, V33, P2217, DOI 10.2337/dc10-0612; Fonseca VA, 2013, J DIABETES COMPLICAT, V27, P268, DOI 10.1016/j.jdiacomp.2012.11.005; Goto K, 2012, DIABETES, V61, pA269; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Heise T, 2013, DIABETES OBES METAB, V15, P613, DOI 10.1111/dom.12073; Henry RR, 2012, INT J CLIN PRACT, V66, P446, DOI 10.1111/j.1742-1241.2012.02911.x; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Inagaki N, 2011, DIABETES, V60, pA274; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Jabbour S, 2012, DIABETES, V61, pA275; Kadowaki T, 2012, DIABETES, V61, pA22; Kaku K, 2013, DIABETES OBES METAB, V15, P432, DOI 10.1111/dom.12047; Kashiwagi A, 2012, DIABETOLOGIA, V55, pS302; Kashiwagi A, 2011, DIABETOLOGIA, V54, pS68; Kashiwagi A, 2010, DIABETES S1, V59, P75; Kohan DE, 2011, J AM SOC NEPHROL   S, V22, p232A; Komoroski B, 2009, CLIN PHARMACOL THER, V85, P513, DOI 10.1038/clpt.2008.250; Lefebvre C., 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184.CH6; Leiter LA, 2012, DIABETES, V61, pA287; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; Ljunggren O, 2012, DIABETES OBES METAB, V14, P990, DOI 10.1111/j.1463-1326.2012.01630.x; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Matthews DR, 2012, DIABETOLOGIA, V55, pS314; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Mudaliar S, 2011, DIABETOLOGIA, V54, pS349; Musso G, 2012, ANN MED, V44, P375, DOI 10.3109/07853890.2011.560181; Nauck MA, 2011, DIABETES CARE, V34, P2015, DOI 10.2337/dc11-0606; Nucci G, 2011, DIABETOLOGIA, V54, pS347; Panel of Handling Missing Data in Clinical Trials National Research Council, 2010, J CLIN EPIDEMIOL, P65; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Rosenstock J, 2012, DIABETES CARE, V35, P1473, DOI 10.2337/dc11-1693; Rosenstock J, 2012, DIABETES CARE, V35, P1232, DOI 10.2337/dc11-1926; Rosenstock J, 2011, DIABETES, V60, pA271; Schernthaner G, 2013, DIABETES CARE; Schwartz SL, 2011, DIABETES TECHNOL THE, V13, P1219, DOI 10.1089/dia.2011.0012; Scottish Intercollegiate Guidelines Network, 2013, SEARCH FILT; Seino Y, 2011, DIABETOLOGIA, V54, pS68; Seino Y, 2012, DIABETES, V61, pA266; Stenlof K, 2013, DIABETES OBES METAB, V15, P372, DOI 10.1111/dom.12054; Strojek K, 2011, DIABETES OBES METAB, V13, P928, DOI 10.1111/j.1463-1326.2011.01434.x; Strojek K, 2011, INT DIAB FED 21 WORL; U. S. Food and Drug Administration, 2013, FDA BRIEF DOC; U. S. Food and Drug Administration, 2013, FDA APPROVES INVOKAN; U. S. Food and Drug Administration, 2011, FDA BRIEF DOC; Wilding JPH, 2013, DIABETES OBES METAB, V15, P403, DOI 10.1111/dom.12038; Wilding J, 2012, DIABETES, V61, pA262; Wilding JP, 2012, DIABETES, V61, pA267; Wilding JPH, 2012, ANN INTERN MED, V156, P405, DOI 10.7326/0003-4819-156-6-201203200-00003; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Woerle HJ, 2012, DIABETES, V61, P2349, DOI 10.2337/db11-1701; Woo V, 2011, DIAB FED 21 WORLD DI; Yale JF, 2013, DIABETES OBES METAB, V15, P463, DOI 10.1111/dom.12090	73	587	621	3	88	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					262	+		10.7326/0003-4819-159-4-201308200-00007	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00007			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026259				2022-12-28	WOS:000323421700016
J	Bommert, P; Il Je, B; Goldshmidt, A; Jackson, D				Bommert, Peter; Il Je, Byoung; Goldshmidt, Alexander; Jackson, David			The maize G alpha gene COMPACT PLANT2 functions in CLAVATA signalling to control shoot meristem size	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; RECEPTOR-LIKE PROTEIN; ARABIDOPSIS; ENCODES; IDENTIFICATION; PROLIFERATION; SUBUNIT; KINASE; FLOWER	Shoot growth depends on meristems, pools of stem cells that are maintained by a negative feedback loop between the CLAVATA pathway and the WUSCHEL homeobox gene(1). CLAVATA signalling involves a secreted peptide, CLAVATA3 (CLV3)(2), and its perception by cell surface leucine-rich repeat (LRR) receptors, including the CLV1 receptor kinase(3) and a LRR receptor-like protein, CLV2 (ref. 4). However, the signalling mechanisms downstream of these receptors are poorly understood, especially for LRR receptor-like proteins, which lack a signalling domain(5). Here we show that maize COMPACT PLANT2 (CT2) encodes the predicted alpha-subunit (G alpha) of a heterotrimeric GTP binding protein. Maize ct2 phenotypes resemble Arabidopsis thaliana clavata mutants, and genetic, biochemical and functional assays indicate that CT2/G alpha transmits a stem-cell-restrictive signal from a CLAVATA LRR receptor, suggesting a new function for G alpha signalling in plants. Heterotrimeric GTP-binding proteins are membrane-associated molecular switches that are commonly activated by ligand binding to an associated seven-pass transmembrane (7TM) G-protein-coupled receptor (GPCR)(6). Recent studies have questioned the idea that plant heterotrimeric G proteins interact with canonical GPCRs(7), and our findings suggest that single pass transmembrane receptors act as GPCRs in plants, challenging the dogma that GPCRs are exclusively 7TM proteins.	[Bommert, Peter; Il Je, Byoung; Goldshmidt, Alexander; Jackson, David] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Jackson, D (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu		Goldshmidt, Alexander/0000-0001-7468-6779	DFG [Bo 3012/1-1]; BARD [FI-431-2008]; Dupont-Pioneer; National Science Foundation [DBI-0604923]; Division Of Integrative Organismal Systems [1238202] Funding Source: National Science Foundation	DFG(German Research Foundation (DFG)); BARD(US-Israel Binational Science Foundation); Dupont-Pioneer; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank T. Mulligan for plant care; T. Rocheford for growing the ct2 targeted EMS screens; F. Albeanu for help with two-photon microscopy; P. Yin for assistance with genotyping; K. Rivera and D. Pappin for performing proteomic experiments; and T. Zadrozny, Q. Wu and W. Boss for assistance and advice with two-phase partitioning. P.B. was supported by DFG grant Bo 3012/1-1, A.G. was supported by the BARD Postdoctoral award no FI-431-2008, B.I.J was supported by Dupont-Pioneer (CSHL-Collaborative agreement), P.B. and D.J. were supported by the National Science Foundation Plant Genome Program, DBI-0604923.	Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Assmann SM, 2005, SCIENCE, V310, P71, DOI 10.1126/science.1118580; Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; DENNEHEY BK, 1994, PLANT CELL TISS ORG, V36, P1, DOI 10.1007/BF00048308; Fiers M, 2005, PLANT CELL, V17, P2542, DOI 10.1105/tpc.105.034009; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Freeling M., 1994, MAIZE HDB; Gallavotti A, 2008, PLANT PHYSIOL, V147, P1913, DOI 10.1104/pp.108.121541; Harlow E., 1988, ANTIBODIES LAB MANUA; Iyer-Pascuzzi AS, 2010, PLANT PHYSIOL, V152, P1148, DOI 10.1104/pp.109.150748; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Larsson C, 2000, METH BIOTEC, V11, P159; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Mohanty A, 2009, PLANT PHYSIOL, V149, P601, DOI 10.1104/pp.108.130146; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Nimchuk ZL, 2011, PLANT CELL, V23, P851, DOI 10.1105/tpc.110.075622; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Stahl Y, 2010, CURR OPIN PLANT BIOL, V13, P53, DOI 10.1016/j.pbi.2009.09.008; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Taylor P, 2009, J PROTEOME RES, V8, P1610, DOI 10.1021/pr800986c; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	34	176	185	8	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 24	2013	502	7472					555	+		10.1038/nature12583	http://dx.doi.org/10.1038/nature12583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	238YN	24025774				2022-12-28	WOS:000325988400055
J	Saini, N; Ramakrishnan, S; Elango, R; Ayyar, S; Zhang, Y; Deem, A; Ira, G; Haber, JE; Lobachev, KS; Malkova, A				Saini, Natalie; Ramakrishnan, Sreejith; Elango, Rajula; Ayyar, Sandeep; Zhang, Yu; Deem, Angela; Ira, Grzegorz; Haber, James E.; Lobachev, Kirill S.; Malkova, Anna			Migrating bubble during break-induced replication drives conservative DNA synthesis	NATURE			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; HALF-CROSSOVERS; REPAIR; RECOMBINATION; YEAST; BACTERIOPHAGE-T4; TELOMERASE; MUTATIONS; RAD51	The repair of chromosomal double strand breaks (DSBs) is crucial for the maintenance of genomic integrity. However, the repair of DSBs can also destabilize the genome by causing mutations and chromosomal rearrangements, the driving forces for carcinogenesis and hereditary diseases. Break-induced replication (BIR) is one of the DSB repair pathways that is highly prone to genetic instability(1-3). BIR proceeds by invasion of one broken end into a homologous DNA sequence followed by replication that can copy hundreds of kilobases of DNA from a donor molecule all the way through its telomere(4,5). The resulting repaired chromosome comes at a great cost to the cell, as BIR promotes mutagenesis, loss of heterozygosity, translocations, and copy number variations, all hallmarks of carcinogenesis(4-9). BIR uses most known replication proteins to copy large portions of DNA, similar to S-phase replication(10,11). It has therefore been suggested that BIR proceeds by semiconservative replication; however, the model of a bona fide, stable replication fork contradicts the known instabilities associated with BIR such as a 1,000-fold increase in mutation rate compared to normal replication(9). Here we demonstrate that in budding yeast the mechanism of replication during BIR is significantly different from S-phase replication, as it proceeds via an unusual bubble-like replication fork that results in conservative inheritance of the new genetic material. We provide evidence that this atypical mode of DNA replication, dependent on Pif1 helicase, is responsible for the marked increase in BIR-associated mutations. We propose that the BIR mode of synthesis presents a powerful mechanism that can initiate bursts of genetic instability in eukaryotes, including humans.	[Saini, Natalie; Zhang, Yu; Lobachev, Kirill S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Saini, Natalie; Zhang, Yu; Lobachev, Kirill S.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Ramakrishnan, Sreejith; Elango, Rajula; Ayyar, Sandeep; Deem, Angela; Malkova, Anna] IUPUI, Dept Biol, Indianapolis, IN 46202 USA; [Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Haber, James E.] Dept Biol, Waltham, MA 02454 USA; [Haber, James E.] Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Malkova, Anna] Univ Iowa, Dept Biol, Coll Liberal Arts & Sci, Iowa City, IA 52242 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Indiana University System; Indiana University-Purdue University Indianapolis; Baylor College of Medicine; University of Iowa	Malkova, A (corresponding author), IUPUI, Dept Biol, Indianapolis, IN 46202 USA.	kirill.lobachev@biology.gatech.edu; amalkova@iupui.edu	Saini, Natalie/J-4044-2019	Saini, Natalie/0000-0002-1668-5417; RAMAKRISHNAN, SREEJITH/0000-0002-0514-9694; Elango, Rajula/0000-0001-7282-623X; Zhang, Yu/0000-0002-1126-770X; /0000-0003-1178-6806	US National Institutes of Health; National Science Foundation; NSF [MCB-0818122]; NIH [R01GM084242, R01GM082950, R03ES016434, GM76020, GM080600]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES016434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084242, R37GM020056, R01GM082950, R01GM076020, R01GM080600] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank O. Aparicio for the gift of BrdU cassette plasmid. We thank Y. Pavlov for providing ura3-29 cassette plasmid and P. Chastain and A. Hangaard Andersen for providing us with reagents. We are thankful to D. Gordenin and all members of A.M., K.S.L., G.I. and J.E.H. laboratories for discussions throughout the work. This work was funded by grants from the US National Institutes of Health and National Science Foundation (MCB-0818122 from NSF to K.S.L., and NIH grants R01GM084242 to A.M., R01GM082950 to K.S.L., R03ES016434 to A.M. and K.S.L., GM76020 to J.E.H., and GM080600 to G.I.).	Bosco G, 1998, GENETICS, V150, P1037; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Conti C., 2001, CURR PROTOC CYTOM; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Deem A, 2008, GENETICS, V179, P1845, DOI 10.1534/genetics.108.087940; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; FANGMAN WL, 1991, ANNU REV CELL BIOL, V7, P375, DOI 10.1146/annurev.cb.07.110191.002111; Ferguson DO, 1996, P NATL ACAD SCI USA, V93, P5419, DOI 10.1073/pnas.93.11.5419; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guthrie C, 1991, GUIDE YEAST GENETICS; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hashimoto Y, 2011, METHODS MOL BIOL, V745, P437, DOI 10.1007/978-1-61779-129-1_25; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; KREUZER KN, 1995, J BACTERIOL, V177, P6844, DOI 10.1128/jb.177.23.6844-6853.1995; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Le S, 1999, GENETICS, V152, P143; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; Malkova A., 2013, CURR OPIN GENET DEV; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Oh SD, 2009, METHODS MOL BIOL, V557, P209, DOI 10.1007/978-1-59745-527-5_14; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Pohjoismaki JLO, 2011, BIOESSAYS, V33, P290, DOI 10.1002/bies.201000137; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Shcherbakova PV, 1996, GENETICS, V142, P717; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Viggiani CJ, 2006, YEAST, V23, P1045, DOI 10.1002/yea.1406; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Yang Y, 2010, DNA REPAIR, V9, P914, DOI 10.1016/j.dnarep.2010.06.005; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264	37	228	229	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					389	+		10.1038/nature12584	http://dx.doi.org/10.1038/nature12584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24025772	Green Accepted			2022-12-28	WOS:000325706300057
J	Gunderson, EW				Gunderson, Erik W.			Synthetic Cannabinoids: A New Frontier of Designer Drugs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SPICE		[Gunderson, Erik W.] Univ Virginia, Charlottesville, VA USA; [Gunderson, Erik W.] Ctr Wellness & Change, Charlottesville, VA USA; Columbia Univ, New York, NY USA	University of Virginia; Columbia University	Gunderson, EW (corresponding author), Univ Virginia Hlth Syst, Box 800623, Charlottesville, VA 22908 USA.	erikgunderson@virginia.edu						American Association of Poison Control Centers, FACTS SYNTH MAR SYNT; Drug Enforcement Administration, 2013, FED REGISTER, V78, P28735; European Monitoring Centre for Drugs and Drug Addiction, 2009, UND SPIC PHEN; Gunderson EW, 2012, AM J ADDICTION, V21, P320, DOI 10.1111/j.1521-0391.2012.00240.x; Gunderson EW, 2013, SUBST ABUS IN PRESS; Gunderson EW, 2012, S 11 EM DRUGS SYNTH; Hermanns-Clausen M, 2013, ADDICTION, V108, P534, DOI 10.1111/j.1360-0443.2012.04078.x; Johnston L.D., 2013, MONITORING FUTURE NA; Substance Abuse and Mental Health Services Administration  Center for Behavioral Health Statistics and Quality, 2012, DRUG REL EM DEP VIS; United Nations Office on Drugs and Crime, WORLD DRUG REP 2013; Vandrey R, 2012, DRUG ALCOHOL DEPEN, V120, P238, DOI 10.1016/j.drugalcdep.2011.07.011	11	15	16	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 15	2013	159	8					563	+		10.7326/0003-4819-159-8-201310150-00707	http://dx.doi.org/10.7326/0003-4819-159-8-201310150-00707			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	249BH	24018791				2022-12-28	WOS:000326751200021
J	Jukam, D; Xie, BT; Rister, J; Terrell, D; Charlton-Perkins, M; Pis-Tillo, D; Gebelein, B; Desplan, C; Cook, T				Jukam, David; Xie, Baotong; Rister, Jens; Terrell, David; Charlton-Perkins, Mark; Pis-Tillo, Daniela; Gebelein, Brian; Desplan, Claude; Cook, Tiffany			Opposite Feedbacks in the Hippo Pathway for Growth Control and Neural Fate	SCIENCE			English	Article								Signaling pathways are reused for multiple purposes in plant and animal development. The Hippo pathway in mammals and Drosophila coordinates proliferation and apoptosis via the coactivator and oncoprotein YAP/Yorkie (Yki), which is homeostatically regulated through negative feedback. In the Drosophila eye, cross-repression between the Hippo pathway kinase LATS/Warts (Wts) and growth regulator Melted generates mutually exclusive photoreceptor subtypes. Here, we show that this all-or-nothing neuronal differentiation results from Hippo pathway positive feedback: Yki both represses its negative regulator, warts, and promotes its positive regulator, melted. This postmitotic Hippo network behavior relies on a tissue-restricted transcription factor network-including a conserved Otx/Orthodenticle-Nri/Traffic Jam feedforward module-that allows Warts-Yki-Melted to operate as a bistable switch. Altering feedback architecture provides an efficient mechanism to co-opt conserved signaling networks for diverse purposes in development and evolution.	[Jukam, David; Rister, Jens; Pis-Tillo, Daniela; Desplan, Claude] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA; [Xie, Baotong; Terrell, David; Charlton-Perkins, Mark; Cook, Tiffany] Cincinnati Childrens Hosp Med Ctr, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA; [Gebelein, Brian; Cook, Tiffany] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	New York University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	claude.desplan@nyu.edu; tiffany.cook@cchmc.org	Pistillo, Daniela/AAC-2367-2020	Pistillo, Daniela/0000-0002-7665-3783; Charlton-Perkins, Mark/0000-0002-5602-6109; Charlton-Perkins, Mark/0000-0002-7597-1130; Jukam, David/0000-0003-4167-2754; Rister, Jens/0000-0002-0023-7417; Cook, Tiffany/0000-0002-3100-5248; Desplan, Claude/0000-0002-6914-1413	New York University (NYU) Dean's Dissertation Award; University of Cincinnati Postdoctoral Research Fellowship; European Molecular Biology Organization (EMBO) long-term fellowships [ALTF 506-2002, ALTF 462-2008]; NIH [RO1 EY13012, RO1-EY017907]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY013012] Funding Source: NIH RePORTER	New York University (NYU) Dean's Dissertation Award; University of Cincinnati Postdoctoral Research Fellowship; European Molecular Biology Organization (EMBO) long-term fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Bell, S. Britt, R. Carthew, S. Cohen, I. Davis, B. Dickson, R. Fehon, D. Godt, G. Halder, I. Hariharan, K. Irvine, J. Jiang, D. J. Pan, N. Tapon, J. Treisman, T. Xu, C. Zuker, the Bloomington Stock Center, the Kyoto Stock Center, the Vienna Drosophila RNAi Center, and the Exelixis Collection at Harvard Medical School for providing fly stocks and antibodies. G. Mardon generously provided sens-Gal4 flies and S. Sprecher kindly shared Pph13 results prior to publication. We thank T. Blackman and C. Tsanis for transgenic injections and members of the Desplan and Cook labs for discussions and comments. Supported by a New York University (NYU) Dean's Dissertation Award (D. J.), a University of Cincinnati Postdoctoral Research Fellowship (B.X.), European Molecular Biology Organization (EMBO) long-term fellowships (ALTF 506-2002 and ALTF 462-2008) (D.P. and J. R.), NIH grants RO1 EY13012 (C. D.) and RO1-EY017907 (T. C.), and Research to Prevent Blindness (T.C.).	Bunt J, 2012, INT J CANCER, V131, pE21, DOI 10.1002/ijc.26474; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Evans CJ, 2009, NAT METHODS, V6, P603, DOI 10.1038/nmeth.1356; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Frankfort BJ, 2001, NEURON, V32, P403, DOI 10.1016/S0896-6273(01)00480-9; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jukam D, 2011, DEV CELL, V21, P874, DOI 10.1016/j.devcel.2011.10.004; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; McDonald EC, 2010, DEV BIOL, V347, P122, DOI 10.1016/j.ydbio.2010.08.016; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oh H, 2011, DEV CELL, V20, P109, DOI 10.1016/j.devcel.2010.12.002; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Peng HW, 2009, GENE DEV, V23, P2307, DOI 10.1101/gad.1820009; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Rister J, 2013, DEVELOPMENT, V140, P493, DOI 10.1242/dev.079095; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	44	60	60	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 11	2013	342	6155					211	+	1238016	10.1126/science.1238016	http://dx.doi.org/10.1126/science.1238016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VG1HS	23989952	Green Accepted			2022-12-28	WOS:000445355800001
J	Hsia, RY; Brownell, J; Wilson, S; Gordon, N; Baker, LC				Hsia, Renee Y.; Brownell, Julia; Wilson, Suzanne; Gordon, Nicole; Baker, Laurence C.			Trends in Adult Emergency Department Visits in California by Insurance Status, 2005-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hsia, Renee Y.; Brownell, Julia; Gordon, Nicole] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Wilson, Suzanne; Baker, Laurence C.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Hsia, RY (corresponding author), San Francisco Gen Hosp, Dept Emergency Med, 1001 Potrero Ave,1E21, San Francisco, CA 94110 USA.	renee.hsia@emergency.ucsf.edu		Baker, Laurence/0000-0001-5032-794X	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2 TR000143] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Agency for Healthcare Research and Quality, PREV QUAL IND OV; *CA HEALTHCARE FDN, 2006, OV EM DEP INS CAL; Cunningham PJ, 2003, INSURED AM DRIVE SUR; Decker SL, 2012, HEALTH AFFAIR, V31, P1673, DOI 10.1377/hlthaff.2012.0294; FREEMAN HE, 1990, HEALTH SERV RES, V24, P811; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112	6	31	31	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1181	1183		10.1001/jama.2013.228331	http://dx.doi.org/10.1001/jama.2013.228331			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	24045743	Green Accepted, Bronze			2022-12-28	WOS:000324500300025
J	Steg, PG; Mehta, SR; Pollack, CV; Bode, C; Cohen, M; French, WJ; Hoekstra, J; Rao, SV; Ruzyllo, W; Ruiz-Nodar, JM; Sabate, M; Widimsky, P; Kiss, RG; Estrada, JLN; Hod, H; Kerkar, P; Guneri, S; Sezer, M; Ruda, M; Nicolau, JC; Cavallini, C; Ebrahim, I; Petrov, I; Kim, JH; Jeong, MH; Lopez, GAR; Laanmets, P; Kovar, F; Gaudin, C; Fanouillere, KC; Minini, P; Hoffman, EB; Moryusef, A; Wiviott, SD; Sabatine, MS				Steg, Philippe Gabriel; Mehta, Shamir R.; Pollack, Charles V., Jr.; Bode, Christoph; Cohen, Marc; French, William J.; Hoekstra, James; Rao, Sunil V.; Ruzyllo, Witold; Ruiz-Nodar, Juan M.; Sabate, Manel; Widimsky, Petr; Kiss, Robert Gabor; Navarro Estrada, Jose Luis; Hod, Hanoch; Kerkar, Prafulla; Guneri, Sema; Sezer, Murat; Ruda, Mikhail; Nicolau, Jose Carlos; Cavallini, Claudio; Ebrahim, Iftikhar; Petrov, Ivo; Kim, Jae-Hyung; Jeong, Myung-Ho; Ramos Lopez, Gabriel Arturo; Laanmets, Peep; Kovar, Frantisek; Gaudin, Christophe; Fanouillere, Karen C.; Minini, Pascal; Hoffman, Elaine B.; Moryusef, Angele; Wiviott, Stephen D.; Sabatine, Marc S.		TAO Investigators	Anticoagulation With Otamixaban and Ischemic Events in Non-ST-Segment Elevation Acute Coronary Syndromes The TAO Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FACTOR XA INHIBITOR; UNFRACTIONATED HEPARIN; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; ANTIPLATELET THERAPIES; GLOBAL REGISTRY; INTERVENTION; EFFICACY; INSIGHTS; FONDAPARINUX	IMPORTANCE The optimal anticoagulant for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) managed with an invasive strategy remains controversial. OBJECTIVE To compare the clinical efficacy and safety of otamixaban, a novel intravenous direct factor Xa inhibitor, with that of unfractionated heparin plus downstream eptifibatide in patients with NSTE-ACS undergoing a planned early invasive strategy. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, active-controlled superiority trial that enrolled 13 229 patients with NSTE-ACS and a planned early invasive strategy, at 568 active sites in 55 countries and conducted between April 2010 and February 2013. A planned interim analysis was conducted for otamixaban dose selection. INTERVENTIONS Eligible participants were randomized to otamixaban (bolus and infusion, at 1 of 2 doses) or unfractionated heparin plus, at the time of percutaneous coronary intervention, eptifibatide. The otamixaban dose selected at interim analysis was an intravenous bolus of 0.080 mg/kg followed by an infusion of 0.140 mg/kg per hour. MAIN OUTCOMES AND MEASURES The primary efficacy outcome was the composite of all-cause death or new myocardial infarction through day 7. RESULTS Rates of the primary efficacy outcome were 5.5% (279 of 5105 patients) randomized to receive otamixaban and 5.7% (310 of 5466 patients) randomized to receive unfractionated heparin plus eptifibatide (adjusted relative risk, 0.99 [95% CI, 0.85-1.16]; P=.93). There were no differences for the secondary end points, including procedural thrombotic complications. The primary safety outcome of Thrombosis in Myocardial Infarction major or minor bleeding through day 7 was increased by otamixaban (3.1% vs 1.5%; relative risk, 2.13 [95% CI, 1.63-2.78]; P<.001). Results were consistent across prespecified subgroups. CONCLUSIONS AND RELEVANCE Otamixaban did not reduce the rate of ischemic events relative to unfractionated heparin plus eptifibatide but did increase bleeding. These findings do not support the use of otamixaban for patients with NSTE-ACS undergoing planned early percutaneous coronary intervention.	[Steg, Philippe Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, F-75018 Paris, France; [Steg, Philippe Gabriel] INSERM, U698, Paris, France; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, AP HP, Dept Hosp Univ FIRE, F-75877 Paris, France; [Mehta, Shamir R.] McMaster Univ, Hamilton, ON, Canada; [Mehta, Shamir R.] Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON, Canada; [Pollack, Charles V., Jr.] Univ Penn, Penn Hosp, Dept Emergency Med, Philadelphia, PA 19104 USA; [Bode, Christoph] Med Univ Klin, Freiburg, Germany; [Cohen, Marc] Mt Sinai Sch Med, Newark Beth Israel Med Ctr, Div Cardiol, Newark, NJ USA; [French, William J.] Univ Calif Los Angeles, David Geffen Sch Med, Torrance, CA USA; [Hoekstra, James] Wake Forest Baptist Hlth, Winston Salem, NC USA; [Rao, Sunil V.] Duke Clin Res Inst, Durham, NC USA; [Ruzyllo, Witold] Inst Cardiol, Warsaw, Poland; [Ruiz-Nodar, Juan M.] Hosp Gen Univ Alicante, Serv Cardiol, Alicante, Spain; [Sabate, Manel] IDIBAPS, Hosp Clin, Serv Cardiol, Barcelona, Spain; [Widimsky, Petr] Charles Univ Prague, Fac Med 3, Cardioctr, Prague, Czech Republic; [Kiss, Robert Gabor] Mil Hosp, Dept Cardiol, Budapest, Hungary; [Navarro Estrada, Jose Luis] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Hod, Hanoch] Chaim Sheba Med Ctr, Leviev Heart Ctr, IL-52621 Tel Hashomer, Israel; [Kerkar, Prafulla] Seth GS Med Coll, Mumbai, Maharashtra, India; [Kerkar, Prafulla] KEM Hosp Parel, Mumbai, Maharashtra, India; [Guneri, Sema] Dokuz Eylul Univ, Fac Med, Dept Cardiol, Izmir, Turkey; [Sezer, Murat] Istanbul Univ, Istanbul Fac Med, Dept Cardiol, Istanbul, Turkey; [Ruda, Mikhail] Cardiol Res Ctr, Cardiovasc Div, Moscow 121552, Russia; [Nicolau, Jose Carlos] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil; [Cavallini, Claudio] Osped Santa Maria Misericordia, Perugia, Italy; [Ebrahim, Iftikhar] Netcare Unitas Hosp, Centurion, Gauteng, South Africa; [Petrov, Ivo] Tokuda Hosp, Clin Cardiol & Angiol, Sofia, Bulgaria; [Kim, Jae-Hyung] Catholic Univ Korea, Coll Med, Dept Cardiol, Seoul, South Korea; [Jeong, Myung-Ho] Chonnam Natl Univ Hosp, Kwangju, South Korea; [Ramos Lopez, Gabriel Arturo] Hosp Civil Dr Juan I Menchaca, Guadalajara, Jalisco, Mexico; [Laanmets, Peep] North Estonia Med Ctr Fdn, Tallinn, Estonia; [Kovar, Frantisek] Univ Hosp, Internal Clin, Martin, Slovakia; [Gaudin, Christophe; Fanouillere, Karen C.; Minini, Pascal] Sanofi R&D, Paris, France; [Moryusef, Angele] Sanofi, Bridgewater, NJ USA; [Hoffman, Elaine B.; Wiviott, Stephen D.; Sabatine, Marc S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, TIMI Study Grp,Cardiovasc Div, Boston, MA 02115 USA	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; McMaster University; McMaster University; Population Health Research Institute; University of Pennsylvania; Pennsylvania Medicine; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Icahn School of Medicine at Mount Sinai; Newark Beth Israel Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Wake Forest University; Wake Forest Baptist Medical Center; Duke University; Institute of Cardiology - Poland; General University Hospital of Alicante; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Charles University Prague; Hospital Italiano de Buenos Aires; University of Buenos Aires; Chaim Sheba Medical Center; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Dokuz Eylul University; Istanbul University; National Medical Research Center of Cardiology; Universidade de Sao Paulo; Hospital Santa Maria della Misericordia; Catholic University of Korea; Chonnam National University; Chonnam National University Hospital; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Steg, PG (corresponding author), Univ Paris Diderot, Hop Bichat, AP HP, Dept Hosp Univ FIRE, 46 Rue Henri Huchard, F-75018 Paris, France.	gabriel.steg@bch.aphp.fr	Sabatine, Marc/AAJ-6751-2020; Manolis, Antonis/F-5003-2014; Sabate, Manel/AAX-7245-2021; Sezer, Murat/AAE-5807-2020; Wiviott, Stephen/HIK-2534-2022; Nicolau, Jose C/E-1487-2012; Widimsky, Petr/P-8088-2016; STEG, Philippe Gabriel/Z-1567-2019	Sabatine, Marc/0000-0002-0691-3359; Manolis, Antonis/0000-0002-0336-4745; Nicolau, Jose C/0000-0002-9680-3689; Widimsky, Petr/0000-0001-5686-7752; STEG, Philippe Gabriel/0000-0001-6896-2941; Petrov, Ivo/0000-0002-9989-0730; Sabate Tenas, Manel/0000-0002-2316-3705	sanofi	sanofi	This trial was funded by sanofi.	Alexander KP, 2005, JAMA-J AM MED ASSOC, V294, P3108, DOI 10.1001/jama.294.24.3108; Anand SS, 2003, CIRCULATION, V107, P2884, DOI 10.1161/01.CIR.0000077530.53367.E9; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Budaj A, 2003, AM HEART J, V146, P999, DOI 10.1016/S0002-8703(03)00509-X; Chu V, 2001, THROMB RES, V103, P309, DOI 10.1016/S0049-3848(01)00328-0; Cohen M, 2007, CIRCULATION, V115, P2642, DOI 10.1161/CIRCULATIONAHA.106.653428; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Fox KAA, 2010, EUR HEART J, V31, P2755, DOI 10.1093/eurheartj/ehq326; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Gore JM, 2007, AM J MED, V120, P63, DOI 10.1016/j.amjmed.2006.05.047; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Kastrati A, 2011, NEW ENGL J MED, V365, P1980, DOI 10.1056/NEJMoa1109596; Lopes RD, 2010, JACC-CARDIOVASC INTE, V3, P669, DOI 10.1016/j.jcin.2010.03.015; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehta SR, 2007, J AM COLL CARDIOL, V50, P1742, DOI 10.1016/j.jacc.2007.07.042; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Petersen JL, 2004, JAMA-J AM MED ASSOC, V292, P89, DOI 10.1001/jama.292.1.89; Rebello SS, 2001, BRIT J PHARMACOL, V133, P1190, DOI 10.1038/sj.bjp.0704182; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Sabatine MS, 2009, LANCET, V374, P787, DOI 10.1016/S0140-6736(09)61454-9; Steg PG, 2012, AM HEART J, V164, P817, DOI 10.1016/j.ahj.2012.10.001; Steg PG, 2010, JAMA-J AM MED ASSOC, V304, P1339, DOI 10.1001/jama.2010.1320; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Zhang LJ, 2009, CHINESE MED J-PEKING, V122, P502, DOI 10.3760/cma.j.issn.0366-6999.2009.05.004	27	41	43	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1145	1155		10.1001/jama.2013.277165	http://dx.doi.org/10.1001/jama.2013.277165			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	23995608	Bronze, Green Accepted			2022-12-28	WOS:000324500300021
J	Meurer, WJ				Meurer, William J.			Tranexamic acid reduced mortality in trauma patients who were bleeding or at risk for bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Meurer, WJ (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.		Meurer, William J/A-7547-2010	Meurer, William J/0000-0002-1158-5302				Adeoye O, 2011, STROKE, V42, P1952, DOI 10.1161/STROKEAHA.110.612358; Tissue plasminogen activator for acute ischemic stroke, 1995, NEW ENGL J MED, V333, P1581, DOI [DOI 10.1056/NEJM199512143332401, 10.1056/NEJM199512143332401]	2	2	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC3	10.7326/0003-4819-159-6-201309170-02003	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042386				2022-12-28	WOS:000325625900002
J	Rosenberg, SM; Tracy, MS; Meyer, ME; Sepucha, K; Gelber, S; Hirshfield-Bartek, J; Troyan, S; Morrow, M; Schapira, L; Come, SE; Winer, EP; Partridge, AH				Rosenberg, Shoshana M.; Tracy, Michaela S.; Meyer, Meghan E.; Sepucha, Karen; Gelber, Shari; Hirshfield-Bartek, Judi; Troyan, Susan; Morrow, Monica; Schapira, Lidia; Come, Steven E.; Winer, Eric P.; Partridge, Ann H.			Perceptions, Knowledge, and Satisfaction With Contralateral Prophylactic Mastectomy Among Young Women With Breast Cancer	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; BRCA2 MUTATION CARRIERS; CARCINOMA IN-SITU; LOCOREGIONAL RECURRENCE; RANDOMIZED-TRIAL; DECISION-MAKING; FAMILY-HISTORY; PERCEIVED RISK; SURGERY; PREDICTORS	Background: Rates of contralateral prophylactic mastectomy (CPM) have increased dramatically, particularly among younger women with breast cancer, but little is known about how women approach the decision to have CPM. Objective: To examine preferences, knowledge, decision making, and experiences of young women with breast cancer who choose CPM. Design: Cross-sectional survey. Setting: 8 academic and community medical centers that enrolled 550 women diagnosed with breast cancer at age 40 years or younger between November 2006 and November 2010. Patients: 123 women without known bilateral breast cancer who reported having bilateral mastectomy. Measurements: A 1-time, 23-item survey that included items related to decision making, knowledge, risk perception, and breast cancer worry. Results: Most women indicated that desires to decrease their risk for contralateral breast cancer (98%) and improve survival (94%) were extremely or very important factors in their decision to have CPM. However, only 18% indicated that women with breast cancer who undergo CPM live longer than those who do not. BRCA1 or BRCA2 mutation carriers more accurately perceived their risk for contralateral breast cancer, whereas women without a known mutation substantially overestimated this risk. Limitations: The survey, which was administered a median of 2 years after surgery, was not validated, and some questions might have been misinterpreted by respondents or subject to recall bias. Generalizability of the findings might be limited. Conclusion: Despite knowing that CPM does not clearly improve survival, women who have the procedure do so, in part, to extend their lives. Many women overestimate their actual risk for cancer in the unaffected breast. Interventions aimed at improving risk communication in an effort to promote evidence- based decision making are warranted.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Massachusetts Gen Hosp,Sch Publ Hlth, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Memorial Sloan Kettering Cancer Center	Partridge, AH (corresponding author), Dana Farber Canc Inst, D1210,450 Brookline Ave, Boston, MA 02115 USA.	ahpartridge@partners.org	Schapira, Lidia/AAA-1293-2020		National Cancer Institute [NIH 5 R25 CA057711]; NATIONAL CANCER INSTITUTE [R25CA057711] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Partridge and the YWS receive support from Susan G. Komen for the Cure. Dr. Rosenberg receives support from the National Cancer Institute (NIH 5 R25 CA057711).	Abbott A, 2011, ANN SURG ONCOL, V18, P3129, DOI 10.1245/s10434-011-1914-x; ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Apicella C, 2009, BRIT J CANCER, V100, P583, DOI 10.1038/sj.bjc.6604910; Arrington AK, 2009, ANN SURG ONCOL, V16, P2697, DOI 10.1245/s10434-009-0641-z; Baucom Donald H, 2005, Breast Dis, V23, P103; Belkora JK, 2012, PATIENT EDUC COUNS, V86, P195, DOI 10.1016/j.pec.2011.05.011; Boughey JC, 2010, ANN SURG ONCOL, V17, P2702, DOI 10.1245/s10434-010-1136-7; Brewster AM, 2011, ONCOLOGIST, V16, P935, DOI 10.1634/theoncologist.2011-0022; Chung A, 2012, ANN SURG ONCOL, V19, P2600, DOI 10.1245/s10434-012-2299-1; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; Dominici LS, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3197; Ellsworth WA, 2011, BREAST J, V17, P18, DOI 10.1111/j.1524-4741.2010.01020.x; Frost MH, 2011, ANN SURG ONCOL, V18, P3110, DOI 10.1245/s10434-011-1917-7; Frost MH, 2005, J CLIN ONCOL, V23, P7849, DOI 10.1200/JCO.2005.09.233; Geiger AM, 2006, J CLIN ONCOL, V24, P1350, DOI 10.1200/JCO.2005.01.9901; Graves KD, 2007, BREAST CANCER RES TR, V104, P321, DOI 10.1007/s10549-006-9423-5; Hawley ST, 2009, JNCI-J NATL CANCER I, V101, P1337, DOI 10.1093/jnci/djp271; Howard-Anderson J, 2012, JNCI-J NATL CANCER I, V104, P386, DOI 10.1093/jnci/djr541; Janz NK, 2005, QUAL LIFE RES, V14, P1467, DOI 10.1007/s11136-005-0288-6; Jones NB, 2009, ANN SURG ONCOL, V16, P2691, DOI 10.1245/s10434-009-0547-9; Katz SJ, 2005, J CLIN ONCOL, V23, P5526, DOI 10.1200/JCO.2005.06.217; King TA, 2011, J CLIN ONCOL, V29, P2158, DOI 10.1200/JCO.2010.29.4041; Kroenke CH, 2004, J CLIN ONCOL, V22, P1849, DOI 10.1200/JCO.2004.04.173; Legare F, 2010, CAN FAM PHYSICIAN, V56, pE308; LERMAN C, 1995, J NATL CANCER I, V87, P286, DOI 10.1093/jnci/87.4.286; Liu Y, 2010, BREAST CANCER RES TR, V124, P835, DOI 10.1007/s10549-010-0912-1; Liu Y, 2010, CANCER EPIDEM BIOMAR, V19, P675, DOI 10.1158/1055-9965.EPI-09-1051; Mamounas EP, 2012, J CLIN ONCOL, V30, P3960, DOI 10.1200/JCO.2011.40.8369; Metcalfe KA, 2008, J CLIN ONCOL, V26, P1093, DOI 10.1200/JCO.2007.12.6078; Montgomery LL, 1999, ANN SURG ONCOL, V6, P546, DOI 10.1007/s10434-999-0542-1; Murphy JA, 2013, LANCET ONCOL, V14, pE262, DOI 10.1016/S1470-2045(13)70047-0; Nekhlyudov Larissa, 2005, J Natl Cancer Inst Monogr, P55; Nichols HB, 2011, J CLIN ONCOL, V29, P1564, DOI 10.1200/JCO.2010.32.7395; O'Brien MA, 2009, J CLIN ONCOL, V27, P974, DOI 10.1200/JCO.2007.16.0101; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Partridge A, 2008, JNCI-J NATL CANCER I, V100, P243, DOI 10.1093/jnci/djn010; Reiner AS, 2013, J CLIN ONCOL, V31, P433, DOI 10.1200/JCO.2012.43.2013; Sepucha KR, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-51; Sigal BM, 2012, CANCER EPIDEM BIOMAR, V21, P1066, DOI 10.1158/1055-9965.EPI-12-0149; Stucky CCH, 2010, ANN SURG ONCOL, V17, pS330, DOI 10.1245/s10434-010-1259-x; Tercyak KP, 2007, J CLIN ONCOL, V25, P285, DOI 10.1200/JCO.2006.07.3890; Tuttle TM, 2007, J CLIN ONCOL, V25, P5203, DOI 10.1200/JCO.2007.12.3141; Tuttle TM, 2009, J CLIN ONCOL, V27, P1362, DOI 10.1200/JCO.2008.20.1681; Unukovych D, 2012, EUR J CANCER, V48, P3150, DOI 10.1016/j.ejca.2012.04.023; van Sprundel TC, 2005, BRIT J CANCER, V93, P287, DOI 10.1038/sj.bjc.6602703; Waljee JF, 2007, J CLIN ONCOL, V25, P1067, DOI 10.1200/JCO.2006.08.5472; Wenzel LB, 1999, CANCER, V86, P1768, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1768::AID-CNCR19>3.3.CO;2-F; Whelan T, 2004, JAMA-J AM MED ASSOC, V292, P435, DOI 10.1001/jama.292.4.435; Yao K, 2010, ANN SURG ONCOL, V17, P2554, DOI 10.1245/s10434-010-1091-3; Yi M, 2010, CANCER PREV RES, V3, P1026, DOI 10.1158/1940-6207.CAPR-09-0130	50	200	200	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					373	+		10.7326/0003-4819-159-6-201309170-00003	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042365	Green Accepted			2022-12-28	WOS:000325625900013
J	Blendon, RJ; Benson, JM				Blendon, Robert J.; Benson, John M.			The Public and the Conflict over Future Medicare Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								In this analysis of national polling data, the authors conclude that political candidates who favor cuts in Medicare to reduce the federal budget deficit could face negative electoral consequences. Two recent government reports show substantial short-term improvements in the financial outlook for Medicare and in the federal budget deficit.(1),(2) However, these forecasts also suggest the need for further action brought about by a worsening of the financial situation after 2015 as the number of Medicare recipients increases from 52 million to 73 million in the decade following.(1)-(3) This issue is likely to receive considerable attention in the upcoming debate about the federal budget deficit and the national debt. As we reported in the Journal in 2011, there has been little public support for major policy changes aimed ...	[Blendon, Robert J.; Benson, John M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							[Anonymous], 2013, 2013 ANN REP BOARD S; Blendon RJ, 2011, NEW ENGL J MED, V365, DOI 10.1056/NEJMp1107184; Congressional Budget Office, 2013, UPD BUDG PROJ FISC Y; Many Pear R, 2013, NY TIMES; Medicare Payment Advisory Commission, 2012, REP C MED PAYM POL; Multack M., 2012, MEDICARE PROGRAM BRI; Office of Management and Budget, FISC YEAR 2013 HIST; Parlapiano A., 2013, NY TIMES; Viebeck E., 2013, HILL            0205	9	14	14	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					1066	1073		10.1056/NEJMsr1307622	http://dx.doi.org/10.1056/NEJMsr1307622			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	24024846	Bronze			2022-12-28	WOS:000324304200019
J	Douillard, JY; Oliner, KS; Siena, S; Tabernero, J; Burkes, R; Barugel, M; Humblet, Y; Bodoky, G; Cunningham, D; Jassem, J; Rivera, F; Kocakova, I; Ruff, P; Blasinska-Morawiec, M; Smakal, M; Canon, JL; Rother, M; Williams, R; Rong, A; Wiezorek, J; Sidhu, R; Patterson, SD				Douillard, Jean-Yves; Oliner, Kelly S.; Siena, Salvatore; Tabernero, Josep; Burkes, Ronald; Barugel, Mario; Humblet, Yves; Bodoky, Gyorgy; Cunningham, David; Jassem, Jacek; Rivera, Fernando; Kocakova, Ilona; Ruff, Paul; Blasinska-Morawiec, Maria; Smakal, Martin; Canon, Jean Luc; Rother, Mark; Williams, Richard; Rong, Alan; Wiezorek, Jeffrey; Sidhu, Roger; Patterson, Scott D.			Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CETUXIMAB PLUS IRINOTECAN; RANDOMIZED PHASE-III; KRAS CODON 12; 1ST-LINE TREATMENT; LUNG-CANCER; BRAF; CHEMOTHERAPY; SURVIVAL; FLUOROURACIL; LEUCOVORIN	BackgroundPatients with metastatic colorectal cancer that harbors KRAS mutations in exon 2 do not benefit from anti-epidermal growth factor receptor (EGFR) therapy. Other activating RAS mutations may also be negative predictive biomarkers for anti-EGFR therapy. MethodsIn this prospective-retrospective analysis, we assessed the efficacy and safety of panitumumab plus oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) as compared with FOLFOX4 alone, according to RAS (KRAS or NRAS) or BRAF mutation status. A total of 639 patients who had metastatic colorectal cancer without KRAS mutations in exon 2 had results for at least one of the following: KRAS exon 3 or 4; NRAS exon 2, 3, or 4; or BRAF exon 15. The overall rate of ascertainment of RAS status was 90%. ResultsAmong 512 patients without RAS mutations, progression-free survival was 10.1 months with panitumumab-FOLFOX4 versus 7.9 months with FOLFOX4 alone (hazard ratio for progression or death with combination therapy, 0.72; 95% confidence interval [CI], 0.58 to 0.90; P=0.004). Overall survival was 26.0 months in the panitumumab-FOLFOX4 group versus 20.2 months in the FOLFOX4-alone group (hazard ratio for death, 0.78; 95% CI, 0.62 to 0.99; P=0.04). A total of 108 patients (17%) with nonmutated KRAS exon 2 had other RAS mutations. These mutations were associated with inferior progression-free survival and overall survival with panitumumab-FOLFOX4 treatment, which was consistent with the findings in patients with KRAS mutations in exon 2. BRAF mutations were a negative prognostic factor. No new safety signals were identified. ConclusionsAdditional RAS mutations predicted a lack of response in patients who received panitumumab-FOLFOX4. In patients who had metastatic colorectal cancer without RAS mutations, improvements in overall survival were observed with panitumumab-FOLFOX4 therapy. (Funded by Amgen and others; PRIME ClinicalTrials.gov number, NCT00364013.)	[Douillard, Jean-Yves] Inst Cancerol Ouest ICO Rene Gauducheau, Nantes, France; [Oliner, Kelly S.; Williams, Richard; Rong, Alan; Wiezorek, Jeffrey; Sidhu, Roger; Patterson, Scott D.] Amgen Inc, Thousand Oaks, CA USA; [Siena, Salvatore] Osped Niguarda Ca Granda, Milan, Italy; [Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, E-08193 Barcelona, Spain; [Rivera, Fernando] Hosp Univ Marques de Valdecilla, Santander, Spain; [Burkes, Ronald] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Rother, Mark] Credit Valley Hosp, Mississauga, ON, Canada; [Barugel, Mario] Hosp Gastroenterol, Buenos Aires, DF, Argentina; [Humblet, Yves] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Canon, Jean Luc] Grand Hop Charleroi, Charleroi, Belgium; [Bodoky, Gyorgy] Szent Laszlo Hosp, Budapest, Hungary; [Cunningham, David] Royal Marsden Natl Hlth Serv Fdn Trust, London, England; [Jassem, Jacek] Med Univ Gdansk, Gdansk, Poland; [Blasinska-Morawiec, Maria] Copernicus Mem Hosp, Lodz, Poland; [Kocakova, Ilona] Masaryk Mem Canc Inst, Brno, Czech Republic; [Smakal, Martin] Inst Oncol & Rehabil Plesi, Nova Ves Pod Plesi, Czech Republic; [Ruff, Paul] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Amgen; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitario Marques de Valdecilla (HUMV); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Trillium Health Partners; Credit Valley Hospital; Universite Catholique Louvain; Grand Hopital De Charleroi; Szent Laszlo Hospital; Royal Marsden NHS Foundation Trust; Fahrenheit Universities; Medical University Gdansk; Masaryk Memorial Cancer Institute; University of Witwatersrand	Douillard, JY (corresponding author), ICO Rene Gauducheau, Blvd Jacques Monod, F-44805 St Herblain, France.	jean-yves.douillard@ico.unicancer.fr	Tabernero, Josep/AAG-5026-2019; SIENA, SALVATORE/AAC-5806-2019; Smakal, Martin/E-4294-2018	Tabernero, Josep/0000-0002-2495-8139; SIENA, SALVATORE/0000-0002-2681-2846; Smakal, Martin/0000-0002-5618-5986; Cunningham, David/0000-0001-5158-1069; Jassem, Jacek/0000-0002-8875-6747; Bodoky, Gyorgy/0000-0002-5659-2020	Amgen	Amgen(Amgen)	Funded by Amgen and others; PRIME ClinicalTrials.gov number, NCT00364013.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andre T, 2013, ANN ONCOL, V24, P412, DOI 10.1093/annonc/mds465; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Edkins S, 2006, CANCER BIOL THER, V5, P928, DOI 10.4161/cbt.5.8.3251; Farina-Sarasqueta A, 2010, ANN ONCOL, V21, P2396, DOI 10.1093/annonc/mdq258; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Mitani N, 2007, ANN CLIN BIOCHEM, V44, P557, DOI 10.1258/000456307782268174; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Peeters M, 2013, CLIN CANCER RES, V19, P1902, DOI 10.1158/1078-0432.CCR-12-1913; Peeters M, 2013, J CLIN ONCOL, V31, P759, DOI 10.1200/JCO.2012.45.1492; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vaughn CP, 2011, GENE CHROMOSOME CANC, V50, P307, DOI 10.1002/gcc.20854; Wojcik P, 2008, POL J PATHOL, V59, P93; Yuen ST, 2002, CANCER RES, V62, P6451	30	1601	1659	1	113	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					1023	1034		10.1056/NEJMoa1305275	http://dx.doi.org/10.1056/NEJMoa1305275			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	24024839				2022-12-28	WOS:000324304200011
J	Ranjan, A; Mizuguchi, G; FitzGerald, PC; Wei, D; Wang, F; Huang, YZ; Luk, E; Woodcock, CL; Wu, C				Ranjan, Anand; Mizuguchi, Gaku; FitzGerald, Peter C.; Wei, Debbie; Wang, Feng; Huang, Yingzi; Luk, Ed; Woodcock, Christopher L.; Wu, Carl			Nucleosome-free Region Dominates Histone Acetylation in Targeting SWR1 to Promoters for H2A.Z Replacement	CELL			English	Article							CHROMATIN REMODELING COMPLEX; SACCHAROMYCES-CEREVISIAE GENOME; HEAT-SHOCK GENES; VARIANT HTZ1; BIDIRECTIONAL PROMOTERS; CRYSTAL-STRUCTURE; CORE PARTICLE; CELL-CYCLE; YEAST; TRANSCRIPTION	The histone variant H2A.Z is a genome-wide signature of nucleosomes proximal to eukaryotic regulatory DNA. Whereas the multisubunit chromatin remodeler SWR1 is known to catalyze ATP-dependent deposition of H2A.Z, the mechanism of SWR1 recruitment to S. cerevisiae promoters has been unclear. A sensitive assay for competitive binding of dinucleosome substrates revealed that SWR1 preferentially binds long nucleosome-free DNA and the adjoining nucleosome core particle, allowing discrimination of gene promoters over gene bodies. Analysis of mutants indicates that the conserved Swc2/YL1 subunit and the adenosine triphosphatase domain of Swr1 are mainly responsible for binding to substrate. SWR1 binding is enhanced on nucleosomes acetylated by the NuA4 histone acetyltransferase, but recognition of nucleosome-free and nucleosomal DNA is dominant over interaction with acetylated histones. Such hierarchical cooperation between DNA and histone signals expands the dynamic range of genetic switches, unifying classical gene regulation by DNA-binding factors with ATP-dependent nucleosome remodeling and posttranslational histone modifications.	[Ranjan, Anand; Wei, Debbie; Wang, Feng; Huang, Yingzi; Wu, Carl] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA; [FitzGerald, Peter C.] NCI, Genome Anal Unit, NIH, Bethesda, MD 20892 USA; [Mizuguchi, Gaku; Wu, Carl] Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA; [Luk, Ed] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Woodcock, Christopher L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Woodcock, Christopher L.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Ranjan, A (corresponding author), NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA.	ranjana@mail.nih.gov; wuc@janelia.hhmi.org		Luk, Ed/0000-0002-6619-2258	Leukemia and Lymphoma Society fellowship; Janelia Farm Research Campus, Howard Hughes Medical Institute; Center for Cancer Research, National Cancer Institute	Leukemia and Lymphoma Society fellowship(Leukemia and Lymphoma Society); Janelia Farm Research Campus, Howard Hughes Medical Institute; Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Joseph Wall, STEM facility, Biology Department, Brookhaven Laboratories, Upton, NY, and his staff for conducting STEM mass measurements; Karolin Luger's laboratory for sharing unpublished data on Swc2; Wei-Hua Wu for the kind gift of yeast strains; Sameet Mehta for bioinformatics; and Michael Lichten, Sean Eddy, Claude Klee, Joseph Landry, members of our laboratory and reviewers for helpful comments. This work was supported by a Leukemia and Lymphoma Society fellowship (to A.R.), by the Janelia Farm Research Campus, Howard Hughes Medical Institute (to C.W. and G.M.), and by the Center for Cancer Research, National Cancer Institute.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Alkhatib SG, 2011, FEBS LETT, V585, P3197, DOI 10.1016/j.febslet.2011.09.003; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cole HA, 2011, P NATL ACAD SCI USA, V108, P12687, DOI 10.1073/pnas.1104978108; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Durant M, 2007, MOL CELL BIOL, V27, P5327, DOI 10.1128/MCB.00468-07; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; Gallant-Behm CL, 2012, GENE DEV, V26, P2325, DOI 10.1101/gad.198069.112; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HORIKAWA I, 1995, BIOCHEM BIOPH RES CO, V208, P999, DOI 10.1006/bbrc.1995.1433; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kwon SY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000574; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Landry JW, 2011, GENE DEV, V25, P275, DOI 10.1101/gad.2007311; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Ptashne M, 2013, P NATL ACAD SCI USA, V110, P7101, DOI 10.1073/pnas.1305399110; Radman-Livaja M, 2010, DEV BIOL, V339, P258, DOI 10.1016/j.ydbio.2009.06.012; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Weake VM, 2012, TRENDS CELL BIOL, V22, P177, DOI 10.1016/j.tcb.2011.11.005; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; WU C, 1984, NATURE, V309, P229, DOI 10.1038/309229a0; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xi YX, 2011, GENOME RES, V21, P718, DOI 10.1101/gr.117101.110; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	69	121	122	1	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1232	1245		10.1016/j.cell.2013.08.005	http://dx.doi.org/10.1016/j.cell.2013.08.005			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034247	Bronze, Green Accepted			2022-12-28	WOS:000324239300013
J	Reed, M; Huang, J; Brand, R; Graetz, I; Neugebauer, R; Fireman, B; Jaffe, M; Ballard, DW; Hsu, J				Reed, Mary; Huang, Jie; Brand, Richard; Graetz, Ilana; Neugebauer, Romain; Fireman, Bruce; Jaffe, Marc; Ballard, Dustin W.; Hsu, John			Implementation of an Outpatient Electronic Health Record and Emergency Department Visits, Hospitalizations, and Office Visits Among Patients With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFORMATION-TECHNOLOGY; AMBULATORY-CARE; MEDICAL-RECORD; QUALITY; SYSTEMS; IMPACT; PHYSICIANS; BENEFITS; OUTCOMES; COSTS	IMPORTANCE The US federal government is spending billions of dollars in physician incentives to encourage the meaningful use of electronic health records (EHRs). Although the use of EHRs has potential to improve patient health outcomes, the existing evidence has been limited and inconsistent. OBJECTIVE To examine the association between implementing a commercially available outpatient EHR and emergency department (ED) visits, hospitalizations, and office visits for patients with diabetes mellitus. DESIGN, SETTING, AND POPULATION Staggered EHR implementation across outpatient clinics in an integrated delivery system (Kaiser Permanente Northern California) between 2005 and 2008 created an opportunity for studying changes associated with EHR use. Among a population-based sample of 169 711 patients with diabetes between 2004 and 2009, we analyzed 4 997 585 person-months before EHR implementation and 4 648 572 person-months after an EHR was being used by patients' physicians. MAIN OUTCOMES AND MEASURES We examined the association between EHR use and unfavorable clinical events (ED visits and hospitalizations) and office visit use among patients with diabetes, using multivariable regression with patient-level fixed-effect analyses and adjustment for trends over time. RESULTS In multivariable analyses, use of the EHR was associated with a statistically significantly decreased number of ED visits, 28.80 fewer visits per 1000 patients annually (95% CI, 20.28 to 37.32), from a mean of 519.12 visits per 1000 patients annually without using the EHR to 490.32 per 1000 patients when using the EHR. The EHR was also associated with 13.10 fewer hospitalizations per 1000 patients annually (95% CI, 7.37 to 18.82), from a mean of 251.60 hospitalizations per 1000 patients annually with no EHR to 238.50 per 1000 patients annually when using the EHR. There were similar statistically significant reductions in nonelective hospitalizations (10.92 fewer per 1000 patients annually) and hospitalizations for ambulatory care-sensitive conditions (7.08 fewer per 1000 patients annually). There was no statistically significant association between EHR use and office visit rates. CONCLUSIONS AND RELEVANCE Among patients with diabetes, use of an outpatient EHR in an integrated delivery system was associated with modest reductions in ED visits and hospitalizations but not office visit rates. Further studies are needed to quantify the association of EHR use with changes in costs.	[Reed, Mary; Huang, Jie; Graetz, Ilana; Neugebauer, Romain; Fireman, Bruce] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Brand, Richard] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Jaffe, Marc] Permanente Med Grp Inc, Dept Med & Endocrinol, San Francisco, CA USA; [Ballard, Dustin W.] Permanente Med Grp Inc, Dept Emergency Med, San Rafael, CA USA; [Hsu, John] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mongan Inst Hlth Policy, Boston, MA USA; [Hsu, John] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Kaiser Permanente; University of California System; University of California San Francisco; Permanente Medical Groups; Permanente Medical Groups; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Reed, M (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94610 USA.	mary.e.reed@kp.org	Graetz, Ilana/N-1189-2016	Graetz, Ilana/0000-0003-3664-5815; Jaffe, Marc/0000-0002-5049-7815	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK085070]; Agency for Healthcare Research and Quality [R01HS015280]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS015280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085070] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported herein was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award R01DK085070 and the Agency for Healthcare Research and Quality under award R01HS015280.	Adler-Milstein J, 2011, AM J MANAG CARE, V17, P761; Agency for Healthcare Research and Quality, 2004, QUALITY INDICATORS G; Agency for Healthcare Research and Quality, 2012, QUALITY INDICATORS Q; Agency for Healthcare Research and Quality Center for Delivery Organization and Markets, STATISTICS ON HOSPIT; Agency for Healthcare Research and Quality Center for Financing Access and Cost Trends, MEDICAL EXPENDITURE; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Centers for Disease Control and Prevention, 2011, RISING HEALTH CARE C; Centers for Medicare & Medicaid Services, 2010, MEDICARE AND MEDICAI, P44314; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Crosson JC, 2012, ANN FAM MED, V10, P221, DOI 10.1370/afm.1370; Herrin J, 2012, HEALTH SERV RES, V47, P1522, DOI 10.1111/j.1475-6773.2011.01370.x; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Hsiao C-J, 2010, ELECTRONIC MEDICAL R; Hsiao CJ, 2012, HEALTH AFFAIR, V31, P1100, DOI 10.1377/hlthaff.2011.1315; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Linder JA, 2007, ARCH INTERN MED, V167, P1400, DOI 10.1001/archinte.167.13.1400; Martin AB, 2012, HEALTH AFFAIR, V31, P208, DOI 10.1377/hlthaff.2011.1135; O'Connor PJ, 2005, ANN FAM MED, V3, P300, DOI 10.1370/afm.327; O'Reilly D, 2012, J AM MED INFORM ASSN, V19, P423, DOI 10.1136/amiajnl-2011-000310; Reed M, 2012, ANN INTERN MED, V157, P482, DOI 10.7326/0003-4819-157-7-201210020-00004; Romano MJ, 2011, ARCH INTERN MED, V171, P897, DOI 10.1001/archinternmed.2010.527; StataCorp LP, 2007, STATA BASE REFERENCE; Woodridge JM, 2002, ECONOMETRIC ANAL CRO; Zhao Yang, 2002, Health Care Manag Sci, V5, P211, DOI 10.1023/A:1019711617120; Zhou L, 2009, J AM MED INFORM ASSN, V16, P457, DOI 10.1197/jamia.M3128; Zhou YY, 2010, HEALTH AFFAIR, V29, P1370, DOI 10.1377/hlthaff.2010.0048	27	53	53	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1060	1065		10.1001/jama.2013.276733	http://dx.doi.org/10.1001/jama.2013.276733			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214KZ	24026601	Green Accepted, Bronze			2022-12-28	WOS:000324133400023
J	Walker, AW; Parkhill, J				Walker, Alan W.; Parkhill, Julian			Fighting Obesity with Bacteria	SCIENCE			English	Editorial Material							MICROBIOTA; DIET		[Walker, Alan W.; Parkhill, Julian] Wellcome Trust Sanger Inst, Pathogen Genom Grp, Hinxton CB10 1SA, England	Wellcome Trust Sanger Institute	Walker, AW (corresponding author), Wellcome Trust Sanger Inst, Pathogen Genom Grp, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	parkhill@sanger.ac.uk	Walker, Alan W./AAE-8102-2019; Parkhill, Julian/G-4703-2011	Walker, Alan W./0000-0001-5099-8495; Parkhill, Julian/0000-0002-7069-5958				De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Walker AW, 2013, PHARMACOL RES, V69, P75, DOI 10.1016/j.phrs.2012.09.008; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	13	53	59	3	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1069	1070		10.1126/science.1243787	http://dx.doi.org/10.1126/science.1243787			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009379				2022-12-28	WOS:000323933100027
J	Walker, MC; Thuronyi, BW; Charkoudian, LK; Lowry, B; Khosla, C; Chang, MCY				Walker, Mark C.; Thuronyi, Benjamin W.; Charkoudian, Louise K.; Lowry, Brian; Khosla, Chaitan; Chang, Michelle C. Y.			Expanding the Fluorine Chemistry of Living Systems Using Engineered Polyketide Synthase Pathways	SCIENCE			English	Article							ACTIVE-SITE OCCUPANCY; ESCHERICHIA-COLI; NATURAL-PRODUCTS; EXTENDER UNITS; BIOSYNTHESIS; ENZYME; PHARMACEUTICALS; MUTASYNTHESIS; RECOGNITION; CONVERSION	Organofluorines represent a rapidly expanding proportion of molecules that are used in pharmaceuticals, diagnostics, agrochemicals, and materials. Despite the prevalence of fluorine in synthetic compounds, the known biological scope is limited to a single pathway that produces fluoroacetate. Here, we demonstrate that this pathway can be exploited as a source of fluorinated building blocks for introduction of fluorine into natural-product scaffolds. Specifically, we have constructed pathways involving two polyketide synthase systems, and we show that fluoroacetate can be used to incorporate fluorine into the polyketide backbone in vitro. We further show that fluorine can be inserted site-selectively and introduced into polyketide products in vivo. These results highlight the prospects for the production of complex fluorinated natural products using synthetic biology.	[Walker, Mark C.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Thuronyi, Benjamin W.; Chang, Michelle C. Y.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Charkoudian, Louise K.; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Lowry, Brian; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; Stanford University; Stanford University	Chang, MCY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mcchang@berkeley.edu		Walker, Mark/0000-0003-3942-003X; Thuronyi, Benjamin/0000-0003-0821-3791; Khosla, Chaitan/0000-0001-6529-495X	NIH [1S10RR023679-01, S10 RR16634-01, 1 T32 GMO66698, 1 DP2 OD008696, R01 GM087934]; Gerald K. Branch Predoctoral Fellowship; UC Cancer Research Council Committee Predoctoral Fellowship; National Cancer Institute [F32 CA137994]; UC Berkeley; NATIONAL CANCER INSTITUTE [F32CA137994] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023679, S10RR016634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087934, T32GM066698] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008696] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerald K. Branch Predoctoral Fellowship; UC Cancer Research Council Committee Predoctoral Fellowship; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UC Berkeley; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Bond-Watts and I. Aanei for assembly and cloning of the synthetic nphT7 gene, X. Yu for providing plasmids for the E. coli ACCase, C. Harvey for synthetic chemistry assistance, F. T. Wong for helpful discussions, and A. Lingel (Novartis) for QCI-F CryoProbe use. The College of Chemistry NMR Facility at the University of California, Berkeley (UC Berkeley) is supported in part by the NIH (grants 1S10RR023679-01 and S10 RR16634-01). M. C. W. and B. W. T acknowledge the support of a NIH National Research Service Award Training Grant (1 T32 GMO66698) and the Gerald K. Branch Predoctoral Fellowship and UC Cancer Research Council Committee Predoctoral Fellowship (to B. W. T). L. K. C. acknowledges support from the National Cancer Institute (grant F32 CA137994). This work was funded by generous support from UC Berkeley and the NIH (grant 1 DP2 OD008696 to M.C.Y.C. and grant R01 GM087934 to C.K.).	Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Ball ND, 2009, J AM CHEM SOC, V131, P3796, DOI 10.1021/ja8054595; Begue JP, 2006, J FLUORINE CHEM, V127, P992, DOI 10.1016/j.jfluchem.2006.05.006; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bonnett SA, 2011, CHEM BIOL, V18, P1075, DOI 10.1016/j.chembiol.2011.07.016; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Dong CJ, 2004, NATURE, V427, P561, DOI 10.1038/nature02280; Eustaquio AS, 2010, J NAT PROD, V73, P378, DOI 10.1021/np900719u; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Goss RJM, 2010, CHEMBIOCHEM, V11, P698, DOI 10.1002/cbic.200900723; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; Izumikawa M, 2003, J IND MICROBIOL BIOT, V30, P510, DOI 10.1007/s10295-003-0075-8; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Koryakina I, 2013, ORG BIOMOL CHEM, V11, P4449, DOI 10.1039/c3ob40633d; Kumar P, 2003, J AM CHEM SOC, V125, P14307, DOI 10.1021/ja037429l; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Liou GF, 2003, BIOCHEMISTRY-US, V42, P200, DOI 10.1021/bi0268100; Llano-Sotelo B, 2010, ANTIMICROB AGENTS CH, V54, P4961, DOI 10.1128/AAC.00860-10; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; O'Hagan D, 2006, J FLUORINE CHEM, V127, P1479, DOI 10.1016/j.jfluchem.2006.09.006; Okamura E, 2010, P NATL ACAD SCI USA, V107, P11265, DOI 10.1073/pnas.1000532107; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Rauniyar V, 2011, SCIENCE, V334, P1681, DOI 10.1126/science.1213918; Rivkin A, 2002, ORG LETT, V4, P4081, DOI 10.1021/ol0268283; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Runguphan W, 2009, P NATL ACAD SCI USA, V106, P13673, DOI 10.1073/pnas.0903393106; Siskos AP, 2005, CHEM BIOL, V12, P1145, DOI 10.1016/j.chembiol.2005.08.017; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Sundermann U, 2013, ACS CHEM BIOL, V8, P443, DOI 10.1021/cb300505w; Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2326, DOI 10.1021/bi002463n; Walker MC, 2012, ACS CHEM BIOL, V7, P1576, DOI 10.1021/cb3002057; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Weeks AM, 2011, BIOCHEMISTRY-US, V50, P5404, DOI 10.1021/bi200416g; Wong FT, 2011, BIOCHEMISTRY-US, V50, P6539, DOI 10.1021/bi200632j; Wong FT, 2010, BIOCHEMISTRY-US, V49, P95, DOI 10.1021/bi901826g; Wu N, 2000, J AM CHEM SOC, V122, P4847, DOI 10.1021/ja000023d	45	124	130	3	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1089	1094		10.1126/science.1242345	http://dx.doi.org/10.1126/science.1242345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009388	Green Accepted			2022-12-28	WOS:000323933100038
J	Ellis, O				Ellis, Oliver			The agony of choice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												oli.ellis@googlemail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2013	347								f5344	10.1136/bmj.f5344	http://dx.doi.org/10.1136/bmj.f5344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ND	23999802				2022-12-28	WOS:000324216000004
J	Kratky, C				Kratky, Christoph			A coordinated approach is key for open access	NATURE			English	Editorial Material									[Kratky, Christoph] Graz Univ, A-8010 Graz, Austria	University of Graz	Kratky, C (corresponding author), Graz Univ, A-8010 Graz, Austria.	christoph.kratky@uni-graz.at							0	1	1	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					503	503		10.1038/500503a	http://dx.doi.org/10.1038/500503a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207TD	23985837	Bronze			2022-12-28	WOS:000323625900003
J	Molgaard-Nielsen, D; Pasternak, B; Hviid, A				Molgaard-Nielsen, Ditte; Pasternak, Bjoern; Hviid, Anders			Use of Oral Fluconazole during Pregnancy and the Risk of Birth Defects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL-MALFORMATIONS; EXPOSURE; OUTCOMES; ITRACONAZOLE; REGISTRATION; ASSOCIATION; MICONAZOLE	Background Case reports suggest that long-term, high-dose fluconazole treatment for severe fungal infections during pregnancy causes a pattern of birth defects. It is unclear whether commonly used lower doses increase the risk of specific birth defects. Methods In a registry-based cohort of liveborn infants in Denmark, we evaluated first-trimester oral fluconazole exposure and the risk of birth defects overall and of birth defects previously linked to azole antifungal agents. Results The majority of fluconazole-exposed pregnancies were in women who received common therapeutic doses of 150 mg (56% of pregnancies) or 300 mg (31%). Oral fluconazole exposure was not associated with an increased risk of birth defects overall (210 birth defects among 7352 fluconazole-exposed pregnancies [prevalence, 2.86%] and 25,159 birth defects among 968,236 unexposed pregnancies [prevalence, 2.60%]; adjusted prevalence odds ratio, 1.06; 95% confidence interval [CI], 0.92 to 1.21). In addition, oral fluconazole exposure was not associated with a significantly increased risk of 14 of 15 types of birth defects previously linked to azole antifungal agents: craniosynostosis, other craniofacial defects, middle-ear defects, cleft palate, cleft lip, limb defects, limb-reduction defects, polydactyly, syndactyly, diaphragmatic hernia, heart defects overall, pulmonary-artery hypoplasia, ventricular septal defects, and hypoplastic left heart. A significantly increased risk of tetralogy of Fallot was observed (7 cases in fluconazole-exposed pregnancies [prevalence, 0.10%] as compared with 287 cases in unexposed pregnancies [prevalence, 0.03%]; adjusted prevalence odds ratio, 3.16; 95% CI, 1.49 to 6.71). Conclusions Oral fluconazole was not associated with a significantly increased risk of birth defects overall or of 14 of the 15 specific birth defects of previous concern. Fluconazole exposure may confer an increased risk of tetralogy of Fallot. (Funded by the Danish Medical Research Council.)	[Molgaard-Nielsen, Ditte; Pasternak, Bjoern; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Molgaard-Nielsen, D (corresponding author), Statens Serum Inst, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	dnl@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by the Danish Medical Research Council.	Agergaard P, 2011, CLIN EPIDEMIOL, V3, P131; Agergaard Peter, 2011, Clin Epidemiol, V3, P61, DOI 10.2147/CLEP.S15627; Aleck KA, 1997, AM J MED GENET, V72, P253, DOI 10.1002/(SICI)1096-8628(19971031)72:3&lt;253::AID-AJMG1&gt;3.0.CO;2-S; Bar-Oz B, 2000, AM J OBSTET GYNECOL, V183, P617, DOI 10.1067/mob.2000.105962; Briggs GG, 2008, DRUGS PREGNANCY LACT, P994; Carter TC, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.044; Clayton D, 2001, STAT MODELS EPIDEMIO, P227; DANESHMEND TK, 1986, J ANTIMICROB CHEMOTH, V18, P507, DOI 10.1093/jac/18.4.507; Eckert LO, 2006, NEW ENGL J MED, V355, P1244, DOI 10.1056/NEJMcp053720; EUROCAT, 2012, EUROCAT GUID 1 3 REF; Food and Drug Administration, 2011, US LONG TERM HIGH DO; INMAN W, 1994, EUR J CLIN PHARMACOL, V46, P115, DOI 10.1007/BF00199872; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Jick SS, 1999, PHARMACOTHERAPY, V19, P221, DOI 10.1592/phco.19.3.221.30919; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Kazy Z, 2005, REPROD TOXICOL, V20, P89, DOI 10.1016/j.reprotox.2004.11.012; Kazy Zoltan, 2005, Congenital Anomalies, V45, P5, DOI 10.1111/j.1741-4520.2005.00053.x; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knudsen LB, 1998, DAN MED BULL, V45, P320; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; LEE BE, 1992, PEDIATR INFECT DIS J, V11, P1062, DOI 10.1097/00006454-199211120-00017; Lopez-Rangel E, 2005, BIRTH DEFECTS RES A, V73, P919, DOI 10.1002/bdra.20189; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Marotta F, 2010, EXPERT OPIN DRUG MET, V6, P461, DOI 10.1517/17425251003592111; Mastroiacovo P, 1996, AM J OBSTET GYNECOL, V175, P1645, DOI 10.1016/S0002-9378(96)70119-9; Mineshima H, 2012, J APPL TOXICOL, V32, P98, DOI 10.1002/jat.1636; Nilas L, 2012, CANDIDAT VAGINIT; Norgaard M, 2008, J ANTIMICROB CHEMOTH, V62, P172, DOI 10.1093/jac/dkn157; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pursley TJ, 1996, CLIN INFECT DIS, V22, P336, DOI 10.1093/clinids/22.2.336; RITTER W, 1982, CHEMOTHERAPY, V28, P37, DOI 10.1159/000238150; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Tiboni GM, 2006, TOXICOL LETT, V167, P8, DOI 10.1016/j.toxlet.2006.08.004; Tiboni GM, 2005, PEDIATR RES, V58, P94, DOI 10.1203/01.PDR.0000166754.24957.73; Wilton LV, 1998, BRIT J OBSTET GYNAEC, V105, P882, DOI 10.1111/j.1471-0528.1998.tb10234.x	35	64	68	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					830	839		10.1056/NEJMoa1301066	http://dx.doi.org/10.1056/NEJMoa1301066			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208KB	23984730				2022-12-28	WOS:000323676100010
J	Pauwels, E				Pauwels, Eleonore			Mind the metaphor	NATURE			English	Editorial Material									Woodrow Wilson Int Ctr Scholars, Sci & Technol Innovat Program, Washington, DC 20560 USA		Pauwels, E (corresponding author), Woodrow Wilson Int Ctr Scholars, Sci & Technol Innovat Program, Washington, DC 20560 USA.	eleonore.pauwels@wilsoncenter.org						Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Kay L. E., 1999, WHO WROTE BOOK LIFE; Keller E. F., 2002, MAKING SENSE LIFE EX; Thibodeau PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016782	4	18	19	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					523	524		10.1038/500523a	http://dx.doi.org/10.1038/500523a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	207TD	23985856				2022-12-28	WOS:000323625900011
J	Farrell, L				Farrell, Liam			Surgical error	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2013	347								f5269	10.1136/bmj.f5269	http://dx.doi.org/10.1136/bmj.f5269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CC	23985312				2022-12-28	WOS:000323880700008
J	Lieberman, JA; Dixon, LB; Goldman, HH				Lieberman, Jeffrey A.; Dixon, Lisa B.; Goldman, Howard H.			Early Detection and Intervention in Schizophrenia A New Therapeutic Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lieberman, Jeffrey A.; Dixon, Lisa B.] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA; [Goldman, Howard H.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	Columbia University; New York State Psychiatry Institute; University System of Maryland; University of Maryland Baltimore	Lieberman, JA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	jlieberman@columbia.edu	Lieberman, Jeffrey/AAY-8239-2020					Addington J, 2007, EARLY INTERV PSYCHIA, V1, P294, DOI 10.1111/j.1751-7893.2007.00043.x; Baksheev GN, 2012, PSYCHIATR REHABIL J, V35, P421, DOI 10.1037/h0094574; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Goldman HH, 2013, PSYCHIAT SERV, V64, P506, DOI 10.1176/appi.ps.201300106; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stroup TS, 2013, TEXTBOOK OF PSYCHIAT; Wu EQ, 2005, J CLIN PSYCHIAT, V66, P1122, DOI 10.4088/JCP.v66n0906; Zhornitsky S, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/407171	8	47	49	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					689	690		10.1001/jama.2013.8804	http://dx.doi.org/10.1001/jama.2013.8804			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	202XP	23989167				2022-12-28	WOS:000323254500014
J	Degenhardt, L; Whiteford, HA; Ferrari, AJ; Baxter, AJ; Charlson, FJ; Hall, WD; Freedman, G; Burstein, R; Johns, N; Engell, RE; Flaxman, A; Murray, CJL; Vos, T				Degenhardt, Louisa; Whiteford, Harvey A.; Ferrari, Alize J.; Baxter, Amanda J.; Charlson, Fiona J.; Hall, Wayne D.; Freedman, Greg; Burstein, Roy; Johns, Nicole; Engell, Rebecca E.; Flaxman, Abraham; Murray, Christopher J. L.; Vos, Theo			Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010	LANCET			English	Article							SYSTEMATIC ANALYSIS; INJECT DRUGS; RISK-FACTORS; HEPATITIS-C; 21 REGIONS; HEALTH; EPIDEMIOLOGY; MORTALITY; CANNABIS; INJURIES	Background No systematic attempts have been made to estimate the global and regional prevalence of amphetamine, cannabis, cocaine, and opioid dependence, and quantify their burden. We aimed to assess the prevalence and burden of drug dependence, as measured in years of life lived with disability (YLDs), years of life lost (YLLs), and disabilityadjusted life years (DALYs). Methods We conducted systematic reviews of the epidemiology of drug dependence, and analysed results with Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) Bayesian meta-regression technique (DisModMR) to estimate population-level prevalence of dependence and use. GBD 2010 calculated new disability weights by use of representative community surveys and an internet-based survey. We combined estimates of dependence with disability weights to calculate prevalent YLDs, YLLs, and DALYs, and estimated YLDs, YLLs, and DALYs attributable to drug use as a risk factor for other health outcomes. Findings Illicit drug dependence directly accounted for 20.0 million DALYs (95% UI 15.3-25.4 million) in 2010, accounting for 0.8% (0.6-1.0) of global all-cause DALYs. Worldwide, more people were dependent on opioids and amphetamines than other drugs. Opioid dependence was the largest contributor to the direct burden of DALYs (9.2 million, 95% UI 7.1-11.4). The proportion of all-cause DALYs attributed to drug dependence was 20 times higher in some regions than others, with an increased proportion of burden in countries with the highest incomes. Injecting drug use as a risk factor for HIV accounted for 2.1 million DALYs (95% UI 1.1-3.6 million) and as a risk factor for hepatitis C accounted for 502 000 DALYs (286 000-891 000). Suicide as a risk of amphetamine dependence accounted for 854 000 DALYs (291 000-1 791 000), as a risk of opioid dependence for 671 000 DALYs (329 000-1 730 000), and as a risk of cocaine dependence for 324 000 DALYs (109 000-682 000). Countries with the highest rate of burden (> 650 DALYs per 100 000 population) included the USA, UK, Russia, and Australia. Interpretation Illicit drug use is an important contributor to the global burden of disease. Effi cient strategies to reduce disease burden of opioid dependence and injecting drug use, such as delivery of opioid substitution treatment and needle and syringe programmes, are needed to reduce this burden at a population scale.	[Degenhardt, Louisa] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; [Degenhardt, Louisa] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Whiteford, Harvey A.; Ferrari, Alize J.; Baxter, Amanda J.; Charlson, Fiona J.] Queensland Ctr Mental Hlth Res, Policy & Evaluat Grp, Brisbane, Qld, Australia; [Whiteford, Harvey A.; Ferrari, Alize J.; Baxter, Amanda J.; Charlson, Fiona J.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Hall, Wayne D.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Freedman, Greg; Burstein, Roy; Johns, Nicole; Engell, Rebecca E.; Flaxman, Abraham; Murray, Christopher J. L.; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	University of New South Wales Sydney; University of Melbourne; Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Degenhardt, L (corresponding author), Univ New S Wales, Fac Med, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	l.degenhardt@unsw.edu.au	Degenhardt, Louisa J/D-4515-2012; Baxter, Amanda/E-5449-2011; Whiteford, Harvey A/A-4840-2009; Ferrari, Alize J/G-1746-2011; Charlson, Fiona J/F-5290-2011; Hall, Wayne D/A-3283-2008; Charlson, Fiona/R-8963-2019	Degenhardt, Louisa J/0000-0002-8513-2218; Baxter, Amanda/0000-0001-8198-9022; Whiteford, Harvey A/0000-0003-4667-6623; Ferrari, Alize J/0000-0002-7863-9117; Charlson, Fiona J/0000-0003-2876-5040; Hall, Wayne D/0000-0003-1984-0096; Charlson, Fiona/0000-0003-2876-5040; Johns, Nicole/0000-0003-4513-4582	Australian National Health and Medical Research Council; Australian Government Department of Health and Ageing; Bill & Melinda Gates Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	Australian National Health and Medical Research Council, Australian Government Department of Health and Ageing, Bill & Melinda Gates Foundation.	Ali H, 2010, NDARC TECHNICAL REPO; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Australian Bureau of Statistics, 2008, NATIONAL SURVEY OF M; Babor TF, 2010, DRUG POLICY AND THE; Barendregt JJ., 2003, POPUL HEALTH METR, V1, P4, DOI [DOI 10.1186/1478-7954-1-4, 10.1186/1478-7954-1-4]; Bucello C, 2010, NDARC TECHNICAL REPO; Calabria B, 2010, NDARC TECHNICAL REPO; Calabria B, 2009, SEARCHING THE GREY L; Calabria B, 2010, ADDICT BEHAV, V35, P741, DOI 10.1016/j.addbeh.2010.03.019; Calabria B, 2010, DRUG ALCOHOL REV, V29, P318, DOI 10.1111/j.1465-3362.2009.00149.x; Degenhardt L, 2004, COMP QUANTIFICATION, P1109; Degenhardt L, 2010, NDARC TECHNICAL REPO; Degenhardt L, 2008, BENEFITS AND RISKS O; Degenhardt Louisa, 2010, Lancet, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V117, P85, DOI 10.1016/j.drugalcdep.2010.11.032; Degenhardt L, 2011, DRUG ALCOHOL DEPEN, V113, P88, DOI 10.1016/j.drugalcdep.2010.07.026; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Denis C, 2013, COCHRANE DB SYST REV, V6; Ferrari AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-16; Kessler R, 2008, THE WHO WORLD MENTAL; Knapp WP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003023.pub2; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; McAllister WB, 2000, DRUG DIPLOMACY IN TH; Mont D, 2007, LANCET, V369, P1658, DOI 10.1016/S0140-6736(07)60752-1; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 1996, THE GLOBAL BURDEN OF; Nelson P, 2010, NDARC TECHNICAL REPO; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Singleton J, 2009, DRUG ALCOHOL DEPEN, V105, P1, DOI 10.1016/j.drugalcdep.2009.05.028; Srisurapanont M, 2001, COCHRANE DB SYST REV, V4; Swan T, THE HEPATITIS C TREA; The World Bank, 1993, WORLD DEVELOPMENT RE; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; UNODC, 2012, WORLD DRUG REPORT 20; US NIH National Institute on Alcohol Abuse and Alcoholism, NATIONAL EPIDEMIOLOG; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 1993, THE ICD 10 CLASSIFI; WHO, AGE STANDARDIZATION; World Health Organization, 2008, THE GLOBAL BURDEN OF; World Health Organization, 1993, THE ICD 10 CLASSIFIC	47	525	539	3	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 9	2013	382	9904					1564	1574		10.1016/S0140-6736(13)61530-5	http://dx.doi.org/10.1016/S0140-6736(13)61530-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	247NE	23993281				2022-12-28	WOS:000326623900028
J	Abad, M; Mosteiro, L; Pantoja, C; Canamero, M; Rayon, T; Ors, I; Grana, O; Megias, D; Dominguez, O; Martinez, D; Manzanares, M; Ortega, S; Serrano, M				Abad, Maria; Mosteiro, Lluc; Pantoja, Cristina; Canamero, Marta; Rayon, Teresa; Ors, Inmaculada; Grana, Osvaldo; Megias, Diego; Dominguez, Orlando; Martinez, Dolores; Manzanares, Miguel; Ortega, Sagrario; Serrano, Manuel			Reprogramming in vivo produces teratomas and iPS cells with totipotency features	NATURE			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; DIRECT CONVERSION; MOUSE; EXPRESSION; FIBROBLASTS; GENERATION; GENE; DIFFERENTIATION; NEURONS	Reprogramming of adult cells to generate induced pluripotent stem cells (iPS cells) has opened new therapeutic opportunities; however, little is known about the possibility of in vivo reprogramming within tissues. Here we show that transitory induction of the four factors Oct4, Sox2, Klf4 and c-Myc in mice results in teratomas emerging from multiple organs, implying that full reprogramming can occur in vivo. Analyses of the stomach, intestine, pancreas and kidney reveal groups of dedifferentiated cells that express the pluripotency marker NANOG, indicative of in situ reprogramming. By bone marrow transplantation, we demonstrate that haematopoietic cells can also be reprogrammed in vivo. Notably, reprogrammable mice present circulating iPS cells in the blood and, at the transcriptome level, these in vivo generated iPS cells are closer to embryonic stem cells (ES cells) than standard in vitro generated iPS cells. Moreover, in vivo iPS cells efficiently contribute to the trophectoderm lineage, suggesting that they achieve a more plastic or primitive state than ES cells. Finally, intraperitoneal injection of in vivo iPS cells generates embryo-like structures that express embryonic and extraembryonic markers. We conclude that reprogramming in vivo is feasible and confers totipotency features absent in standard iPS or ES cells. These discoveries could be relevant for future applications of reprogramming in regenerative medicine.	[Abad, Maria; Mosteiro, Lluc; Pantoja, Cristina; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumour Suppress Grp, E-28029 Madrid, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr CNIO, Histopathol Unit, E-28029 Madrid, Spain; [Rayon, Teresa; Ors, Inmaculada; Manzanares, Miguel] Spanish Natl Cardiovasc Res Ctr CNIC, Cardiovasc Dev & Repair Dept, E-28029 Madrid, Spain; [Grana, Osvaldo] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, E-28029 Madrid, Spain; [Megias, Diego] Spanish Natl Canc Res Ctr CNIO, Confocal Microscopy Unit, E-28029 Madrid, Spain; [Dominguez, Orlando] Spanish Natl Canc Res Ctr CNIO, Genom Unit, E-28029 Madrid, Spain; [Martinez, Dolores] Spanish Natl Canc Res Ctr CNIO, Flow Cytometry Unit, E-28029 Madrid, Spain; [Ortega, Sagrario] Spanish Natl Canc Res Ctr CNIO, Transgen Mice Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumour Suppress Grp, E-28029 Madrid, Spain.	mserrano@cnio.es	Abad, Maria/I-3911-2015; Martinez, Lola/L-2308-2014; Manzanares, Miguel/E-1702-2015; Dominguez, Orlando/M-7515-2018; Megías, Diego/L-6008-2014; Rayon, Teresa/AAA-6592-2020; Martinez, Lola/ABG-2474-2020; Abad, Maria/AAI-2366-2019; Manzanares, Miguel/AAZ-8305-2021; Serrano, Manuel/H-2634-2015; /AAI-3238-2021; Vivancos, Ana/AAG-8331-2019	Abad, Maria/0000-0002-1462-2498; Martinez, Lola/0000-0001-6273-6724; Manzanares, Miguel/0000-0003-4849-2836; Rayon, Teresa/0000-0001-5173-1442; Abad, Maria/0000-0002-1462-2498; Manzanares, Miguel/0000-0003-4849-2836; Serrano, Manuel/0000-0001-7177-9312; Mosteiro, Lluc/0000-0003-4041-9706; Grana-Castro, Osvaldo/0000-0003-1615-4242; Megias, Diego/0000-0003-0755-0518; Vivancos, Ana/0000-0003-2888-6512; Pantoja, Cristina/0000-0003-0180-5823	CNIO; Spanish Ministry of Economy (MINECO, SAF); Regional Government of Madrid (ReCaRe); European Union (RISK-IR); Botin Foundation; Ramon Areces Foundation; AXA Foundation; MINECO(BFU); Regional Government of Madrid (Cell-DD); ProCNIC Foundation	CNIO; Spanish Ministry of Economy (MINECO, SAF); Regional Government of Madrid (ReCaRe); European Union (RISK-IR); Botin Foundation; Ramon Areces Foundation; AXA Foundation; MINECO(BFU); Regional Government of Madrid (Cell-DD); ProCNIC Foundation	We are grateful to M. Torres for advice, and to K. Hochedlinger and R. Jaenisch for reagents. We also thank F. Beier, R. Serrano and N. Soberon for technical support. Work in the laboratory of M. S. is funded by the CNIO and by grants from the Spanish Ministry of Economy (MINECO, SAF), the Regional Government of Madrid (ReCaRe), the European Union (RISK-IR), the European Research Council (ERC Advanced Grant), the Botin Foundation, the Ramon Areces Foundation and the AXA Foundation. Work in the laboratory of M. M. is funded by grants from the MINECO(BFU), the Regional Government of Madrid (Cell-DD) and the ProCNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039306; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Conley BJ, 2004, FETAL DIAGN THER, V19, P218, DOI 10.1159/000076701; Dieguez-Hurtado R, 2011, GENESIS, V49, P36, DOI 10.1002/dvg.20685; DOMINGUEZ O, 1994, NUCLEIC ACIDS RES, V22, P3247, DOI 10.1093/nar/22.15.3247; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Festing M. F. W., 2002, DESIGN ANIMAL EXPT R; Finch AJ, 2009, MOL CELL BIOL, V29, P5306, DOI 10.1128/MCB.01745-08; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Haenebalcke L, 2013, CELL REP, V3, P335, DOI 10.1016/j.celrep.2013.01.016; Halley JD, 2012, STEM CELL RES, V8, P324, DOI 10.1016/j.scr.2011.11.001; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hughes ED, 2007, MAMM GENOME, V18, P549, DOI 10.1007/s00335-007-9054-0; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Koo TB, 2005, REPRODUCTION, V129, P651, DOI 10.1530/rep.1.00656; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Pease S, 2011, ADV PROTOCOLS ANIMAL; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rouaux C, 2013, NAT CELL BIOL, V15, P214, DOI 10.1038/ncb2660; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thier M, 2012, CELL STEM CELL, V10, P473, DOI 10.1016/j.stem.2012.03.003; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yao XQ, 2012, FEBS LETT, V586, P2522, DOI 10.1016/j.febslet.2012.06.018; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	44	299	313	1	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					340	+		10.1038/nature12586	http://dx.doi.org/10.1038/nature12586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24025773	Green Published			2022-12-28	WOS:000325706300046
J	Nishiyama, A; Yamaguchi, L; Sharif, J; Johmura, Y; Kawamura, T; Nakanishi, K; Shimamura, S; Arita, K; Kodama, T; Ishikawa, F; Koseki, H; Nakanishi, M				Nishiyama, Atsuya; Yamaguchi, Luna; Sharif, Jafar; Johmura, Yoshikazu; Kawamura, Takeshi; Nakanishi, Keiko; Shimamura, Shintaro; Arita, Kyohei; Kodama, Tatsuhiko; Ishikawa, Fuyuki; Koseki, Haruhiko; Nakanishi, Makoto			Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication	NATURE			English	Article							UBIQUITIN LIGASE ACTIVITY; SRA DOMAIN; EPIGENETIC INHERITANCE; STATISTICAL-MODEL; MAMMALIAN-CELLS; GENE-EXPRESSION; UHRF1; PROTEIN; RECOGNITION; DNMT1	Faithful propagation of DNA methylation patterns during DNA replication is critical for maintaining cellular phenotypes of individual differentiated cells(1-5). Although it is well established that Uhrf1 (ubiquitin-like with PHD and ring finger domains 1; also known as Np95 and ICBP90) specifically binds to hemi-methylated DNA through its SRA (SET and RING finger associated) domain and has an essential role in maintenance of DNA methylation by recruiting Dnmt1 to hemi-methylated DNA sites(6-10), the mechanism by which Uhrf1 coordinates the maintenance of DNA methylation and DNA replication is largely unknown. Here we show that Uhrf1-dependent histone H3 ubiquitylation has a prerequisite role in the maintenance DNA methylation. Using Xenopus egg extracts, we successfully reproduce maintenance DNA methylation in vitro. Dnmt1 depletion results in a marked accumulation of Uhrf1-dependent ubiquitylation of histone H3 at lysine 23. Dnmt1 preferentially associates with ubiquitylated H3 in vitro though a region previously identified as a replication foci targeting sequence(11). The RING finger mutant of Uhrf1 fails to recruit Dnmt1 to DNA replication sites and maintain DNA methylation in mammalian cultured cells. Our findings represent the first evidence, to our knowledge, of the mechanistic link between DNA methylation and DNA replication through histone H3 ubiquitylation.	[Nishiyama, Atsuya; Yamaguchi, Luna; Johmura, Yoshikazu; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Sharif, Jafar; Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kawamura, Takeshi; Kodama, Tatsuhiko] Univ Tokyo, RCAST, Lab Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Nakanishi, Keiko] Aichi Human Serv Ctr, Inst Dev Res, Dept Perinatol, Kasugai, Aichi 4800392, Japan; [Shimamura, Shintaro] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita 0108543, Japan; [Arita, Kyohei] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan	Nagoya City University; RIKEN; University of Tokyo; Akita University; Yokohama City University; Kyoto University	Nakanishi, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	anishiya@med.nagoya-cu.ac.jp; mkt-naka@med.nagoya-cu.ac.jp	Arita, Kyohei/AAJ-6402-2020; Nishiyama, Atsuya/D-7894-2017; Koseki, Haruhiko/I-3825-2014; Ishikawa, Fuyuki/AAU-4056-2021	Arita, Kyohei/0000-0002-9762-8405; Nishiyama, Atsuya/0000-0002-8416-3776; Koseki, Haruhiko/0000-0001-8424-5854; Ishikawa, Fuyuki/0000-0002-5580-2305	MEXT Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24113711, 24659137] Funding Source: KAKEN	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to T. S. Takahashi, K. Shintomi, K. Muraki, H. Nakaoka, M. Iwabuchi and K. Ohsumi for reagents and technical advice, J. Maller for Xenopus Orc2 antibody, H. Miyoshi for lentiviral vectors, K. Helin for reading of the manuscript and M. Orii for designing the schematic diagram shown in Supplementary Fig. 1. We thank A. Hosoi and C. Yamada-Namikawa for technical assistance. M.N. was supported by a Grant-in-Aid for Scientific Research on Innovative Areas 'Cell fate control', Scientific Research (A), and Challenging Exploratory Research from MEXT Japan. A.N. was supported by a Research Activity Start-up and Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Daigo K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015073; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Fujinoki M, 2003, J BIOCHEM, V133, P361, DOI 10.1093/jb/mvg048; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Lutzmann M, 2008, MOL CELL, V31, P190, DOI 10.1016/j.molcel.2008.07.001; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Muraki K, 2011, GENES CELLS, V16, P728, DOI 10.1111/j.1365-2443.2011.01520.x; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shimamura S, 2008, CANCER SCI, V99, P1960, DOI 10.1111/j.1349-7006.2008.00913.x; Song JK, 2011, SCIENCE, V331, P1036, DOI 10.1126/science.1195380; Takebayashi S, 2007, MOL CELL BIOL, V27, P8243, DOI 10.1128/MCB.00899-07	35	222	231	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 10	2013	502	7470					249	+		10.1038/nature12488	http://dx.doi.org/10.1038/nature12488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231RU	24013172				2022-12-28	WOS:000325436100054
J	Brown, CJ; Flood, KL				Brown, Cynthia J.; Flood, Kellie L.			Mobility Limitation in the Older Patient A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LIFE-STYLE FACTORS; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; CATASTROPHIC DISABILITY; TRAINING-PROGRAM; CONTROLLED-TRIAL; WOMENS-HEALTH; ADULTS; EXERCISE; BALANCE	IMPORTANCE Mobility limitations are common in older adults, affecting the physical, psychological, and social aspects of an older adult's life. OBJECTIVE To identify mobility risk factors, screening tools, medical management, need for physical therapy, and efficacy of exercise interventions for older primary care patients with limited mobility. EVIDENCE ACQUISITION Search of PubMed and PEDro from January 1985 to March 31, 2013, using the search terms mobility limitation, walking difficulty, and ambulatory difficulty to identify English-language, peer-reviewed systematic reviews, meta-analyses, and Cochrane reviews assessing mobility limitation and interventions in community-dwelling older adults. Articles not appearing in the search referenced by reviewed articles were also evaluated. FINDINGS The most common risk factors for mobility impairment are older age, low physical activity, obesity, strength or balance impairment, and chronic diseases such as diabetes or arthritis. Several tools are available to assess mobility in the ambulatory setting. Referral to physical therapy is appropriate, because physical therapists can assess mobility limitations and devise curative or function-enhancing interventions. Relatively few studies support therapeutic exercise to improve mobility limitation. Strong evidence supports resistance and balance exercises for improving mobility-limiting physical weakness and balance disorders. Assessing a patient's physical environment and the patient's ability to adapt to it using mobility devices is critical. CONCLUSIONS AND RELEVANCE Identification of older adults at risk for mobility limitation can be accomplished through routine screening in the ambulatory setting. Addressing functional deficits and environmental barriers with exercise and mobility devices can lead to improved function, safety, and quality of life for patients with mobility limitations.	[Brown, Cynthia J.] Birmingham Atlanta VA Geriatr Res Educ & Clin Ctr, Birmingham, AL USA; [Brown, Cynthia J.; Flood, Kellie L.] Univ Alabama Birmingham, Birmingham, AL 35294 USA	Geriatric Research Education & Clinical Center; University of Alabama System; University of Alabama Birmingham	Brown, CJ (corresponding author), Univ Alabama Birmingham, Geriatr Med Sect, 1720 2nd Ave S,CH 19,Room 201, Birmingham, AL 35294 USA.	cynthiabrown@uabmc.edu		Brown, Cynthia J/0000-0002-1629-5507	SCAN Foundation	SCAN Foundation	The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Administration on Aging, 2010, PROJ FUT GROWTH OLD; Al Snih S, 2005, J GERONTOL A-BIOL, V60, P1152, DOI 10.1093/gerona/60.9.1152; American Physical Therapy Association, TOD PHYS THER COMPR; Ayis S, 2006, AGE AGEING, V35, P382, DOI 10.1093/ageing/afl004; Baker PS, 2003, J AM GERIATR SOC, V51, P1610, DOI 10.1046/j.1532-5415.2003.51512.x; Bannerman E, 2002, PUBLIC HEALTH NUTR, V5, P655, DOI 10.1079/PHN2002336; Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Bean J, 2002, J AM GERIATR SOC, V50, P663; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Boshuizen HC, 2005, J AGING PHYS ACTIV, V13, P5, DOI 10.1123/japa.13.1.5; Brown CJ, 2009, HAZZARDS TXB GERIATR; Brummel-Smith K, 2009, CLIN GERIATR MED, V25, P61, DOI 10.1016/j.cger.2008.11.003; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Chaves PHM, 2000, ARCH INTERN MED, V160, P2525, DOI 10.1001/archinte.160.16.2525; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Davenport TE, 2005, J ORTHOP SPORT PHYS, V35, P572, DOI 10.2519/jospt.2005.35.9.572; de Vries NM, 2012, AGEING RES REV, V11, P136, DOI 10.1016/j.arr.2011.11.002; DEAN E, 1993, PHYS THER, V73, P494, DOI 10.1093/ptj/73.8.494; Deshpande N, 2013, ARCH PHYS MED REHAB, V94, P994, DOI 10.1016/j.apmr.2012.10.032; Ennis K, 2012, J GERIATR PHYS THER, V35, P148, DOI 10.1519/JPT.0b013e31823ae6d1; Ferrucci L, 1996, J GERONTOL A-BIOL, V51, pM123, DOI 10.1093/gerona/51A.3.M123; Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x; Fried LP, 2001, J CLIN EPIDEMIOL, V54, P889, DOI 10.1016/S0895-4356(01)00357-2; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Gill TM, 2012, ANN INTERN MED, V156, P131, DOI 10.7326/0003-4819-156-2-201201170-00009; Groessl EJ, 2007, AM J PREV MED, V33, P214, DOI 10.1016/j.amepre.2007.04.031; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haley SM, 2002, J GERONTOL A-BIOL, V57, pM217, DOI 10.1093/gerona/57.4.M217; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; HULME JB, 1988, PHYS THER, V68, P26, DOI 10.1093/ptj/68.1.26; Huusko TM, 2000, BRIT MED J, V321, P1107, DOI 10.1136/bmj.321.7269.1107; Iezzoni LI, 2003, WALKING FAILS MOBILI; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Johnson RW, 2006, PROFILE FRAIL OLDER; Koster A, 2008, J AM GERIATR SOC, V56, P636, DOI 10.1111/j.1532-5415.2007.01632.x; Koster A, 2007, OBESITY, V15, P3122, DOI 10.1038/oby.2007.372; Krebs DE, 1998, ARCH PHYS MED REHAB, V79, P1489, DOI 10.1016/S0003-9993(98)90408-7; KUMAR R, 1995, ARCH PHYS MED REHAB, V76, P1173, DOI 10.1016/S0003-9993(95)80129-4; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Liu Hao, 2006, N Am J Sports Phys Ther, V1, P10; Manty M, 2007, ARCH PHYS MED REHAB, V88, P1108, DOI 10.1016/j.apmr.2007.06.016; Marko M, 2012, PHYS THER, V92, P1148, DOI 10.2522/ptj.20110239; Marsh AP, 2009, J AGING PHYS ACTIV, V17, P294, DOI 10.1123/japa.17.3.294; McAuley E, 1997, J AGING PHYS ACTIV, V5, P329, DOI 10.1123/japa.5.4.329; Onder G, 2005, J GERONTOL A-BIOL, V60, P74, DOI 10.1093/gerona/60.1.74; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Parker M, 2002, J GERONTOL NURS, V35, P35, DOI DOI 10.1300/J083V35N04_04; Peel C, 2005, PHYS THER, V85, P1008, DOI 10.1093/ptj/85.10.1008; Peterson MD, 2011, AM J MED, V124, P194, DOI 10.1016/j.amjmed.2010.08.020; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Rantanen T, 1999, J GERONTOL A-BIOL, V54, pM172, DOI 10.1093/gerona/54.4.M172; Reid KF, 2008, AGING CLIN EXP RES, V20, P337; Rivera JA, 2008, J AM GERIATR SOC, V56, P1417, DOI 10.1111/j.1532-5415.2008.01819.x; Rosie J, 2007, AGE AGEING, V36, P555, DOI 10.1093/ageing/afm093; Sabo M, MED DOCUMENTATION GU; Sayers SP, 2004, J AM GERIATR SOC, V52, P2099, DOI 10.1111/j.1532-5415.2004.52571.x; Sherrington C, 2008, CLIN REHABIL, V22, P493, DOI 10.1177/0269215508087994; STANTON PE, 1985, PHYS THER, V65, P27, DOI 10.1093/ptj/65.1.27; Steadman J, 2003, J AM GERIATR SOC, V51, P847, DOI 10.1046/j.1365-2389.2003.51268.x; Stevens JA, 2009, J AM GERIATR SOC, V57, P1464, DOI 10.1111/j.1532-5415.2009.02365.x; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Szturm T, 2011, PHYS THER, V91, P1449, DOI 10.2522/ptj.20090205; VanSwearingen JM, 2011, PHYS THER, V91, P1740, DOI 10.2522/ptj.20100391; Wannamethee SG, 2005, J CLIN EPIDEMIOL, V58, P831, DOI 10.1016/j.jclinepi.2005.01.007; Weinberger Mark I, 2009, Am J Geriatr Psychiatry, V17, P802, DOI 10.1097/JGP.0b013e3181b0481a; Weiss CO, 2007, ARCH PHYS MED REHAB, V88, P1217, DOI 10.1016/j.apmr.2007.07.007; Wolinsky FD, 2005, J GERONTOL B-PSYCHOL, V60, pS146, DOI 10.1093/geronb/60.3.S146; Wolinsky FD, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-43; Yarasheski KE, 2003, J GERONTOL A-BIOL, V58, P918	71	161	164	2	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1168	1177		10.1001/jama.2013.276566	http://dx.doi.org/10.1001/jama.2013.276566			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	24045741				2022-12-28	WOS:000324500300023
J	Stegeman, BH; de Bastos, M; Rosendaal, FR; Vlieg, AV; Helmerhorst, FM; Stijnen, T; Dekkers, OM				Stegeman, Bernardine H.; de Bastos, Marcos; Rosendaal, Frits R.; Vlieg, A. van Hylckama; Helmerhorst, Frans M.; Stijnen, Theo; Dekkers, Olaf M.			Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; V-LEIDEN MUTATION; THROMBOEMBOLIC DISEASE; DIFFERENT PROGESTOGENS; PULMONARY-EMBOLISM; DROSPIRENONE; WOMEN; USERS; LEVONORGESTREL; PROGESTAGENS	Objective To provide a comprehensive overview of the risk of venous thrombosis in women using different combined oral contraceptives. Design Systematic review and network meta-analysis. Data sources PubMed, Embase, Web of Science, Cochrane, Cumulative Index to Nursing and Allied Health Literature, Academic Search Premier, and ScienceDirect up to 22 April 2013. Review methods Observational studies that assessed the effect of combined oral contraceptives on venous thrombosis in healthy women. The primary outcome of interest was a fatal or non-fatal first event of venous thrombosis with the main focus on deep venous thrombosis or pulmonary embolism. Publications with at least 10 events in total were eligible. The network meta-analysis was performed using an extension of frequentist random effects models for mixed multiple treatment comparisons. Unadjusted relative risks with 95% confidence intervals were reported. The requirement for crude numbers did not allow adjustment for potential confounding variables. Results 3110 publications were retrieved through a search strategy; 25 publications reporting on 26 studies were included. Incidence of venous thrombosis in non-users from two included cohorts was 1.9 and 3.7 per 10 000 woman years, in line with previously reported incidences of 1-6 per 10 000 woman years. Use of combined oral contraceptives increased the risk of venous thrombosis compared with non-use (relative risk 3.5, 95% confidence interval 2.9 to 4.3). The relative risk of venous thrombosis for combined oral contraceptives with 30-35 mu g ethinylestradiol and gestodene, desogestrel, cyproterone acetate, or drospirenone were similar and about 50-80% higher than for combined oral contraceptives with levonorgestrel. A dose related effect of ethinylestradiol was observed for gestodene, desogestrel, and levonorgestrel, with higher doses being associated with higher thrombosis risk. Conclusion All combined oral contraceptives investigated in this analysis were associated with an increased risk of venous thrombosis. The effect size depended both on the progestogen used and the dose of ethinylestradiol.	[Stegeman, Bernardine H.] UCL, Dept Epidemiol & Publ Hlth, London, England; [de Bastos, Marcos; Helmerhorst, Frans M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2333 ZA Leiden, Netherlands; [Stegeman, Bernardine H.; Rosendaal, Frits R.] Leiden Univ, Dept Thrombosis & Haemostasis, Einthoven Lab Expt Vasc Med, Dept Clin Epidemiol,Med Ctr, NL-2333 ZA Leiden, Netherlands; [Vlieg, A. van Hylckama] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Einthoven Lab Expt Vasc Med, NL-2333 ZA Leiden, Netherlands; [Helmerhorst, Frans M.] Leiden Univ, Med Ctr, Dept Gynaecol & Reprod Med, NL-2333 ZA Leiden, Netherlands; [Stijnen, Theo] Leiden Univ, Med Ctr, Dept Med Stat, NL-2333 ZA Leiden, Netherlands; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab, Dept Clin Epidemiol, NL-2333 ZA Leiden, Netherlands	University of London; University College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Dekkers, OM (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab, Dept Clin Epidemiol, NL-2333 ZA Leiden, Netherlands.	o.m.dekkers@lumc.nl	Rosendaal, Frits/Q-3842-2017; van Hylckama Vlieg, Astrid/A-3323-2017	Rosendaal, Frits/0000-0003-2558-7496; Dekkers, Olaf/0000-0002-1333-7580	Netherlands Organization for Scientific Research [40-00812-98-07-045]; Capes-Nuffic, Brazil	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Capes-Nuffic, Brazil	This study received no specific funding. BHS was supported by grant 40-00812-98-07-045 from the Netherlands Organization for Scientific Research. MdB was supported by grant from Capes-Nuffic, Brazil. The funding agencies had no role in the study design, implementation, or preparation of results.	ANAND JK, 1961, LANCET, V2, P1146; Andersen BS, 1998, THROMB HAEMOSTASIS, V79, P28, DOI 10.1055/s-0037-1614213; [Anonymous], 1967, J R Coll Gen Pract, V13, P267; Bird ST, 2013, J THROMB HAEMOST, V11, P1059, DOI 10.1111/jth.12224; Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; FARLEY TMM, 1995, LANCET, V346, P1582; Farmer R, 1996, LANCET, V347, P259; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Farmer RDT, 1998, CONTRACEPTION, V57, P67, DOI 10.1016/S0010-7824(98)00002-X; GALLO MF, 2008, COCHRANE DB SYST REV, V8; Goodacre S, 2006, HEALTH TECHNOL ASSES, V10, P1; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; Hedenmalm K, 2004, ACTA OBSTET GYN SCAN, V83, P576, DOI 10.1111/j.0001-6349.2004.0533.x; Heinemann LAJ, 2002, CONTRACEPTION, V65, P207, DOI 10.1016/S0010-7824(01)00309-2; Heinemann LAJ, 2010, CONTRACEPTION, V81, P401, DOI 10.1016/j.contraception.2009.12.014; Henzl MR, 2000, PROGESTINS AND ANTIPROGESTINS IN CLINICAL PRACTICE, P101; Herings RMC, 1999, LANCET, V354, P127, DOI 10.1016/S0140-6736(99)01257-X; INMAN WHW, 1968, BRIT MED J, V2, P193, DOI 10.1136/bmj.2.5599.193; INMAN WHW, 1970, BMJ-BRIT MED J, V2, P203, DOI 10.1136/bmj.2.5703.203; Jick SS, 2006, CONTRACEPTION, V73, P566, DOI 10.1016/j.contraception.2006.02.002; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; Kemmeren JM, 2004, BLOOD, V103, P927, DOI 10.1182/blood-2003-04-1285; Kemmeren JM, 2002, THROMB HAEMOSTASIS, V87, P199; Lewis MA, 1996, CONTRACEPTION, V54, P5, DOI 10.1016/0010-7824(96)00112-6; Lidegaard O, 2002, CONTRACEPTION, V65, P187, DOI 10.1016/S0010-7824(01)00307-9; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; Manzoli L, 2012, DRUG SAFETY, V35, P191, DOI 10.2165/11598050-000000000-00000; Martinelli I, 1999, ARTERIOSCL THROM VAS, V19, P700, DOI 10.1161/01.ATV.19.3.700; MEADE TW, 1980, BRIT MED J, V280, P1157, DOI 10.1136/bmj.280.6224.1157; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; NISCHAN P, 1993, AM J EPIDEMIOL, V138, P697, DOI 10.1093/oxfordjournals.aje.a116907; Norell SE, 1998, INT J EPIDEMIOL, V27, P1033, DOI 10.1093/ije/27.6.1033; Parkin L, 2000, LANCET, V355, P2133, DOI 10.1016/S0140-6736(00)02382-5; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; POULTER NR, 1995, LANCET, V346, P1575; Qaseem A, 2007, ANN FAM MED, V5, P57, DOI 10.1370/afm.667; Raps M, 2012, J THROMB HAEMOST, V10, P992, DOI 10.1111/j.1538-7836.2012.04720.x; Samuelsson E, 2004, ACTA OBSTET GYN SCAN, V83, P674, DOI 10.1111/j.0001-6349.2004.00574.x; SARTWELL PE, 1969, AM J EPIDEMIOL, V90, P365, DOI 10.1093/oxfordjournals.aje.a121082; STOLLEY PD, 1975, AM J EPIDEMIOL, V102, P197, DOI 10.1093/oxfordjournals.aje.a112148; THOROGOOD M, 1993, BRIT MED BULL, V49, P124, DOI 10.1093/oxfordjournals.bmb.a072592; Todd JC, 1999, HUM REPROD, V14, P1500, DOI 10.1093/humrep/14.6.1500; van Vliet HAAM, 2005, HUM REPROD, V20, P563, DOI 10.1093/humrep/deh612; Vandenbroucke JP, 1997, AM J OBSTET GYNECOL, V177, P887, DOI 10.1016/S0002-9378(97)70289-8; Vandenbroucke JP, 2001, NEW ENGL J MED, V344, P1527, DOI 10.1056/NEJM200105173442007; VESSEY M, 1986, BRIT MED J, V292, P526, DOI 10.1136/bmj.292.6519.526; VESSEY MP, 1969, BRIT MED J, V2, P651, DOI 10.1136/bmj.2.5658.651; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921; Vlieg AVH, 2010, ARTERIOSCL THROM VAS, V30, P2297, DOI 10.1161/ATVBAHA.110.211482; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; Wharton C, 1988, POPULATION REP, V16, P1; White IR, 2012, RES SYNTH METHODS, V3, P111, DOI 10.1002/jrsm.1045	56	201	214	0	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2013	347								f5298	10.1136/bmj.f5298	http://dx.doi.org/10.1136/bmj.f5298			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219SU	24030561	Green Published, hybrid			2022-12-28	WOS:000324530500002
J	Liu, SH; Zhang, Y; Moayeri, M; Liu, J; Crown, D; Fattah, RJ; Wein, AN; Yu, ZX; Finkel, T; Leppla, SH				Liu, Shihui; Zhang, Yi; Moayeri, Mahtab; Liu, Jie; Crown, Devorah; Fattah, Rasem J.; Wein, Alexander N.; Yu, Zu-Xi; Finkel, Toren; Leppla, Stephen H.			Key tissue targets responsible for anthrax-toxin-induced lethality	NATURE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; BACILLUS-ANTHRACIS; CRE-RECOMBINASE; INHALATIONAL ANTHRAX; CELLULAR RECEPTOR; KINASE-KINASE; IN-VIVO; CELLS; MOUSE; MICE	Bacillus anthracis, the causative agent of anthrax disease, is lethal owing to the actions of two exotoxins: anthrax lethal toxin (LT) and oedema toxin (ET). The key tissue targets responsible for the lethal effects of these toxins are unknown. Here we generated cell-type-specific anthrax toxin receptor capillary morphogenesis protein-2 (CMG2)-null mice and cell-type-specific CMG2-expressing mice and challenged them with the toxins. Our results show that lethality induced by LT and ET occurs through damage to distinct cell types; whereas targeting cardiomyocytes and vascular smooth muscle cells is required for LT-induced mortality, ET-induced lethality occurs mainly through its action in hepatocytes. Notably, and in contradiction to what has been previously postulated, targeting of endothelial cells by either toxin does not seem to contribute significantly to lethality. Our findings demonstrate that B. anthracis has evolved to use LT and ET to induce host lethality by coordinately damaging two distinct vital systems.	[Liu, Shihui; Zhang, Yi; Moayeri, Mahtab; Crown, Devorah; Fattah, Rasem J.; Wein, Alexander N.; Leppla, Stephen H.] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Liu, Jie; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Yu, Zu-Xi] NHLBI, Pathol Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Liu, SH (corresponding author), NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	shliu@niaid.nih.gov; sleppla@niaid.nih.gov		Wein, Alex/0000-0002-8813-3523; Liu, Shihui/0000-0003-3444-1069; Moayeri, Mahtab/0000-0002-4448-8883	National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the intramural research programs of the National Institute of Allergy and Infectious Diseases and the National Heart, Lung, and Blood Institute, National Institutes of Health. We thank L. Feigenbaum and the staff at SAIC/NCI Frederick for generation of the founder CMG2 transgenic mice. We thank A. Kulkarni, B. Hall, B. Klaunberg, S. Anderson, I. Sastalla, C. Leysath and C. Bachran for discussions, and D. Despres for help with echocardiography.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; ARORA N, 1992, J BIOL CHEM, V267, P15542; Bolcome RE, 2008, P NATL ACAD SCI USA, V105, P2439, DOI 10.1073/pnas.0712195105; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley SV, 2007, HUM MOL GENET, V16, P1279, DOI 10.1093/hmg/ddm076; Braunstein EM, 2002, DEV DYNAM, V224, P90, DOI 10.1002/dvdy.10091; Dal Molin F, 2008, TOXICON, V52, P824, DOI 10.1016/j.toxicon.2008.08.011; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Ghosh CC, 2012, P NATL ACAD SCI USA, V109, P10024, DOI 10.1073/pnas.1120755109; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; Guichard A., 2012, MICROBES INFECT, V5, P48; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Gupta PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003130; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Liu SH, 2012, P NATL ACAD SCI USA, V109, P13817, DOI 10.1073/pnas.1206933109; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Mabry R, 2006, CLIN VACCINE IMMUNOL, V13, P671, DOI 10.1128/CVI.00023-06; Maddugoda MP, 2011, CELL HOST MICROBE, V10, P464, DOI 10.1016/j.chom.2011.09.014; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Moayeri M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000456; Newman ZL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000906; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Rosovitz MJ, 2003, J BIOL CHEM, V278, P30936, DOI 10.1074/jbc.M301154200; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; SIRARD JC, 1994, J BACTERIOL, V176, P5188, DOI 10.1128/jb.176.16.5188-5192.1994; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0	44	77	80	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					63	+		10.1038/nature12510	http://dx.doi.org/10.1038/nature12510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	23995686	Green Accepted			2022-12-28	WOS:000323888300032
J	McWilliams, A; Tammemagi, MC; Mayo, JR; Roberts, H; Liu, G; Soghrati, K; Yasufuku, K; Martel, S; Laberge, F; Gingras, M; Atkar-Khattra, S; Berg, CD; Evans, K; Finley, R; Yee, J; English, J; Nasute, P; Goffin, J; Puksa, S; Stewart, L; Tsai, S; Johnston, MR; Manos, D; Nicholas, G; Goss, GD; Seely, JM; Amjadi, K; Tremblay, A; Burrowes, P; MacEachern, P; Bhatia, R; Tsao, MS; Lam, S				McWilliams, Annette; Tammemagi, Martin C.; Mayo, John R.; Roberts, Heidi; Liu, Geoffrey; Soghrati, Kam; Yasufuku, Kazuhiro; Martel, Simon; Laberge, Francis; Gingras, Michel; Atkar-Khattra, Sukhinder; Berg, Christine D.; Evans, Ken; Finley, Richard; Yee, John; English., John; Nasute, Paola; Goffin, John; Puksa, Serge; Stewart, Lori; Tsai, Scott; Johnston, Michael R.; Manos, Daria; Nicholas, Garth; Goss, Glenwood D.; Seely, Jean M.; Amjadi, Kayvan; Tremblay, Alain; Burrowes, Paul; MacEachern, Paul; Bhatia, Rick; Tsao, Ming-Sound; Lam, Stephen			Probability of Cancer in Pulmonary Nodules Detected on First Screening CT	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG-CANCER; MANAGEMENT; TOMOGRAPHY; MALIGNANCY; STATEMENT; MODELS	BACKGROUND Major issues in the implementation of screening for lung cancer by means of low-dose computed tomography (CT) are the definition of a positive result and the management of lung nodules detected on the scans. We conducted a population-based prospective study to determine factors predicting the probability that lung nodules detected on the first screening low-dose CT scans are malignant or will be found to be malignant on follow-up. METHODS We analyzed data from two cohorts of participants undergoing low-dose CT screening. The development data set included participants in the Pan-Canadian Early Detection of Lung Cancer Study (PanCan). The validation data set included participants involved in chemoprevention trials at the British Columbia Cancer Agency (BCCA), sponsored by the U.S. National Cancer Institute. The final outcomes of all nodules of any size that were detected on baseline low-dose CT scans were tracked. Parsimonious and fuller multivariable logistic-regression models were prepared to estimate the probability of lung cancer. RESULTS In the PanCan data set, 1871 persons had 7008 nodules, of which 102 were malignant, and in the BCCA data set, 1090 persons had 5021 nodules, of which 42 were malignant. Among persons with nodules, the rates of cancer in the two data sets were 5.5% and 3.7%, respectively. Predictors of cancer in the model included older age, female sex, family history of lung cancer, emphysema, larger nodule size, location of the nodule in the upper lobe, part-solid nodule type, lower nodule count, and spiculation. Our final parsimonious and full models showed excellent discrimination and calibration, with areas under the receiver-operating-characteristic curve of more than 0.90, even for nodules that were 10 mm or smaller in the validation set. CONCLUSIONS Predictive tools based on patient and nodule characteristics can be used to accurately estimate the probability that lung nodules detected on baseline screening low-dose CT scans are malignant.	[McWilliams, Annette; Mayo, John R.; Evans, Ken; Finley, Richard; Yee, John; English., John; Lam, Stephen] Vancouver Gen Hosp, Vancouver, BC, Canada; [McWilliams, Annette; Atkar-Khattra, Sukhinder; Lam, Stephen] British Columbia Canc Agcy, Vancouver, BC V5Z 1L3, Canada; [Tammemagi, Martin C.] Brock Univ, Dept Community Hlth Sci, St Catharines, ON L2S 3A1, Canada; [Roberts, Heidi; Liu, Geoffrey; Soghrati, Kam; Yasufuku, Kazuhiro; Tsao, Ming-Sound] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Roberts, Heidi; Liu, Geoffrey; Soghrati, Kam; Yasufuku, Kazuhiro; Tsao, Ming-Sound] Toronto Gen Hosp, Toronto, ON, Canada; [Goffin, John; Puksa, Serge; Stewart, Lori; Tsao, Ming-Sound] Juravinski Hosp, Hamilton, ON, Canada; [Goffin, John; Puksa, Serge; Stewart, Lori; Tsai, Scott] Ctr Canc, Hamilton, ON, Canada; [Nicholas, Garth; Goss, Glenwood D.; Seely, Jean M.; Amjadi, Kayvan] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada; [Martel, Simon; Laberge, Francis; Gingras, Michel] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Johnston, Michael R.; Manos, Daria] Dalhousie Univ, Halifax, NS, Canada; [Tremblay, Alain; Burrowes, Paul; MacEachern, Paul] Univ Calgary, Calgary, AB, Canada; [Bhatia, Rick] Mem Univ Newfoundland, St John, NF, Canada; [Berg, Christine D.] NCI, NIH, Bethesda, MD 20892 USA; [Nasute, Paola] Hosp Univ Austral, Buenos Aires, DF, Argentina	University of British Columbia; British Columbia Cancer Agency; Brock University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; McMaster University; University of Ottawa; Ottawa Hospital Research Institute; Dalhousie University; University of Calgary; Memorial University Newfoundland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Austral University; Hospital Universitario Austral	McWilliams, A (corresponding author), British Columbia Canc Agcy, Dept Integrat Oncol, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.		Berg, Christine/K-1047-2014; Tremblay, Alain/F-3163-2011; Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022	Tremblay, Alain/0000-0002-0025-7426; Tsao, Ming Sound/0000-0002-9160-5405; Liu, Geoffrey/0000-0002-2603-7296; Tammemagi, Martin/0000-0002-4989-5058	Terry Fox Research Institute; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN085188, N01CN035000] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA096109, P01CA096964] Funding Source: NIH RePORTER	Terry Fox Research Institute; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Terry Fox Research Institute and others; ClinicalTrials.gov number, NCT00751660.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ahn MI, 2010, RADIOLOGY, V254, P949, DOI 10.1148/radiol.09090031; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Croswell JM, 2010, ANN INTERN MED, V152, P505, DOI 10.7326/0003-4819-152-8-201004200-00007; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Gould MK, 2007, CHEST, V131, P383, DOI 10.1378/chest.06-1261; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Horeweg N, 2013, AM J RESP CRIT CARE, V187, P848, DOI 10.1164/rccm.201209-1651OC; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mayo JR, 2009, RADIOLOGY, V250, P576, DOI 10.1148/radiol.2502080442; McWilliams A, 2003, AM J RESP CRIT CARE, V168, P1167, DOI 10.1164/rccm.200301-144OC; McWilliams AM, 2006, J THORAC ONCOL, V1, P61, DOI 10.1097/01243894-200601000-00012; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Oliver T, 2012, JAMA-J AM MED ASSOC, V307, P2318; Ost DE, 2012, AM J RESP CRIT CARE, V185, P363, DOI 10.1164/rccm.201104-0679CI; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2009, STATA J, V9, P1; Prokop H, 2012, RADIOLOGY, V265, P611; Royston P., 2008, MULTIVARIABLE MODEL; Ru Zhao Ying, 2011, Cancer Imaging, V11 Spec No A, pS79, DOI 10.1102/1470-7330.2011.9020; Schultz EM, 2008, THORAX, V63, P335, DOI 10.1136/thx.2007.084731; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tammemagi CM, 2011, JNCI-J NATL CANCER I, V103, P1058, DOI 10.1093/jnci/djr173; [The International Agency for Research on Cancer IARC WHO Classification of Tumours], 2004, PATH GEN TUM LUNG PL; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wood DE, 2012, J NATL COMPR CANC NE, V10, P240, DOI 10.6004/jnccn.2012.0022	31	726	772	7	114	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					910	919		10.1056/NEJMoa1214726	http://dx.doi.org/10.1056/NEJMoa1214726			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004118	Bronze, Green Accepted			2022-12-28	WOS:000323906900008
J	Mills, EJ; Kanters, S; Thorlund, K; Chaimani, A; Veroniki, AA; Ioannidis, JPA				Mills, Edward J.; Kanters, Steve; Thorlund, Kristian; Chaimani, Anna; Veroniki, Areti-Angeliki; Ioannidis, John P. A.			The effects of excluding treatments from network meta-analyses: survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SYSTEMATIC REVIEWS; COST-EFFECTIVENESS; REGIMENS; BENEFITS; THERAPY; CHEMOTHERAPY; COMBINATION; PREVENTION; SURVIVAL; TRIALS	Objective To examine whether the exclusion of individual treatment comparators, including placebo/no treatment, affects the results of network meta-analysis. Design Survey of networks with individual trial data. Data sources PubMed and communication with authors of network meta-analyses. Study selection and methods We included networks that had five or more treatments, contained at least two closed loops, had at least twice as many studies as treatments, and had trial level data available. Investigators abstracted information about study design, participants, outcomes, network geometry, and the exclusion of eligible treatments. Results Among 18 eligible networks involving 757 randomised controlled trials with 750 possible treatment comparisons, 11 had upfront decided not to consider all treatment comparators and only 10 included placebo/no treatment nodes. In 7/18 networks, there was at least one node whose removal caused a more than 1.10-fold average relative change in the estimated treatments effects, and switches in the top three treatments were observed in 9/18 networks. Removal of placebo/no treatment caused large relative changes of the treatment effects (average change 1.16-3.10-fold) for four of the 10 networks that had originally included placebo/no treatment nodes. Exclusion of current uncommonly used drugs resulted in substantial changes of the treatment effects (average 1.21-fold) in one of three networks on systemic treatments for advanced malignancies. Conclusion Excluding treatments in network meta-analyses sometimes can have important effects on their results and can diminish the usefulness of the research to clinicians if important comparisons are missing.	[Mills, Edward J.; Kanters, Steve] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N6X1, Canada; [Mills, Edward J.; Thorlund, Kristian; Ioannidis, John P. A.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Thorlund, Kristian] McMaster Univ, Hamilton, ON, Canada; [Chaimani, Anna; Veroniki, Areti-Angeliki] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece	University of Ottawa; Stanford University; McMaster University; University of Ioannina	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, 43 Templeton St, Ottawa, ON K1N6X1, Canada.	edward.mills@uottawa.ca	Ioannidis, John P. A./G-9836-2011; Chaimani, Anna/AAA-3048-2020	Chaimani, Anna/0000-0003-2828-6832; /0000-0001-6388-4825	Drug Safety and Effectiveness Network (DSEN) of the Canadian Institutes of Health Research	Drug Safety and Effectiveness Network (DSEN) of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Drug Safety and Effectiveness Network (DSEN) of the Canadian Institutes of Health Research. No funding agency has seen this study.	Ara R, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13340; Bansback N, 2009, DERMATOLOGY, V219, P209, DOI 10.1159/000233234; Brier G.W., 1950, MON WEATHER REV, V78, P1, DOI [10.1175/1520-0493(1950)0782.0.CO,2, DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2, 10.1175/1520-0493(1950)0782.0.CO;2]; Brown TJ, 2006, HEALTH TECHNOL ASSES, V10, P1; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Coleman CI, 2012, AHRQ PUBLICATION, V12-EHC119-EF; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; Cure S, 2012, CURR MED RES OPIN, V28, P1841, DOI 10.1185/03007995.2012.734798; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dundar Y, 2004, HEALTH TECHNOL ASSES, V8, P1; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Gartlehner G, 2008, ANN INTERN MED, V149, P734, DOI 10.7326/0003-4819-149-10-200811180-00008; Golfinopoulos V, 2007, LANCET ONCOL, V8, P898, DOI 10.1016/S1470-2045(07)70281-4; Imamura M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14400; Ioannidis JPA, 2009, LANCET, V373, P1759, DOI 10.1016/S0140-6736(09)60974-0; Jadad AR, 1997, CAN MED ASSOC J, V156, P1411; Kyrgiou M, 2006, JNCI-J NATL CANCER I, V98, P1655, DOI 10.1093/jnci/djj443; Lam SKH, 2007, BMJ-BRIT MED J, V335, P925, DOI 10.1136/bmj.39343.511389.BE; Linde K, 2003, J ROY SOC MED, V96, P17, DOI 10.1258/jrsm.96.1.17; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Mauri D, 2008, JNCI-J NATL CANCER I, V100, P1780, DOI 10.1093/jnci/djn414; Mills EJ, 2012, ANN MED, V44, P588, DOI 10.3109/07853890.2012.705016; Mills Edward J, 2011, Clin Epidemiol, V3, P193, DOI 10.2147/CLEP.S16526; Mills Edward J, 2011, Clin Epidemiol, V3, P107, DOI 10.2147/CLEP.S16235; Peinemann F, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-41; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P1542, DOI 10.2106/JBJS.F.01292; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sciarretta S, 2011, ARCH INTERN MED, V171, P384, DOI 10.1001/archinternmed.2010.427; Siontis KC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4501; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Thijs V, 2008, EUR HEART J, V29, P1086, DOI 10.1093/eurheartj/ehn106; Thorlund K, 2013, ANN RHEUM DIS, V72, P1524, DOI 10.1136/annrheumdis-2012-201574; Trinquart L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035219; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222; Wang H, 2010, J HOSP INFECT, V76, P1, DOI 10.1016/j.jhin.2010.04.025; Wells G, 2009, INDIRECT EVIDENCE IN	42	49	50	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 5	2013	347								f5195	10.1136/bmj.f5195	http://dx.doi.org/10.1136/bmj.f5195			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215NI	24009242	Green Published, hybrid			2022-12-28	WOS:000324216500001
J	Miyamoto, K; Teperek, M; Yusa, K; Allen, GE; Bradshaw, CR; Gurdon, JB				Miyamoto, Kei; Teperek, Marta; Yusa, Kosuke; Allen, George E.; Bradshaw, Charles R.; Gurdon, J. B.			Nuclear Wave1 Is Required for Reprogramming Transcription in Oocytes and for Normal Development	SCIENCE			English	Article							N-WASP; ACTIN	Eggs and oocytes have a remarkable ability to induce transcription of sperm after normal fertilization and in somatic nuclei after somatic cell nuclear transfer. This ability of eggs and oocytes is essential for normal development. Nuclear actin and actin-binding proteins have been shown to contribute to transcription, although their mode of action is elusive. Here, we find that Xenopus Wave1, previously characterized as a protein involved in actin cytoskeleton organization, is present in the oocyte nucleus and is required for efficient transcriptional reprogramming. Moreover, Wave1 knockdown in embryos results in abnormal development and defective hox gene activation. Nuclear Wave1 binds by its WHD domain to active transcription components, and this binding contributes to the action of RNA polymerase II. We identify Wave1 as a maternal reprogramming factor that also has a necessary role in gene activation in development.	[Miyamoto, Kei; Teperek, Marta; Allen, George E.; Bradshaw, Charles R.; Gurdon, J. B.] Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Miyamoto, Kei; Teperek, Marta; Allen, George E.; Bradshaw, Charles R.; Gurdon, J. B.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Yusa, Kosuke] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; Wellcome Trust Sanger Institute	Miyamoto, K (corresponding author), Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol,Tennis Court, Cambridge CB2 1QN, England.	k.miyamoto@gurdon.cam.ac.uk; j.gurdon@gurdon.cam.ac.uk		Bradshaw, Charles/0000-0002-3528-458X; Teperek, Marta/0000-0001-8520-5598; Miyamoto, Kei/0000-0003-2912-6777; GURDON, JOHN/0000-0002-5621-3799	Herchel Smith Postdoctoral Fellowship; Great Britain Sasakawa Foundation; Wellcome Trust [WT089613, WT077187, 101050/Z/13/Z]; Medical Research Council [G1001690/1]; MRC [G1001690] Funding Source: UKRI	Herchel Smith Postdoctoral Fellowship; Great Britain Sasakawa Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to D. Simpson for preparing eggs and oocytes; to A. Meissner for dox-inducible mouse embryo fibroblasts; to S. Suetsugu, T. Takenawa, and H. Miki for hWAVE1 constructs; and to Gurdon laboratory members for their critical reading of the manuscript. K. M. is a Research Fellow at Wolfson College and is supported by the Herchel Smith Postdoctoral Fellowship and the Great Britain Sasakawa Foundation. M. T. is funded by the Wellcome Trust (WT089613). K.Y. was supported by Wellcome Trust (WT077187). Gurdon laboratory is supported by grants from the Wellcome Trust (101050/Z/13/Z) and Medical Research Council (G1001690/1) to J.B.G. RNA-seq data were deposited in NCBI (SRA091722).	Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Ferrai C, 2009, MOL BIOL CELL, V20, P3543, DOI 10.1091/mbc.E09-02-0114; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; GURDON JB, 1968, J EMBRYOL EXP MORPH, V20, P401; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Hulstrand AM, 2010, METHODS, V51, P75, DOI 10.1016/j.ymeth.2009.12.015; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Rawe VY, 2004, DEV BIOL, V276, P253, DOI 10.1016/j.ydbio.2004.07.043; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Taylor MD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000813; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015	18	59	60	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1002	1005		10.1126/science.1240376	http://dx.doi.org/10.1126/science.1240376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990560	Green Accepted			2022-12-28	WOS:000323652300043
J	Saitta, EKH; Legron-Rodriguez, T; Bowdon, MA				Saitta, Erin. K. H.; Legron-Rodriguez, Tamra; Bowdon, Melody A.			An Inquiry into the Water Around Us	SCIENCE			English	Editorial Material									[Saitta, Erin. K. H.] Univ Cent Florida, Karen L Smith Fac Ctr Teaching & Learning, Orlando, FL 32816 USA; [Saitta, Erin. K. H.; Legron-Rodriguez, Tamra; Bowdon, Melody A.] Univ Cent Florida, Dept Chem, Orlando, FL 32816 USA; [Bowdon, Melody A.] Univ Cent Florida, Dept Writing & Rhetor, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Saitta, EKH (corresponding author), Univ Cent Florida, Karen L Smith Fac Ctr Teaching & Learning, Orlando, FL 32816 USA.	erin.saitta@ucf.edu		Legron-Rodriguez, Tamra/0000-0002-6608-293X				Alliance for Service-Learning in Educational Reform, 1995, STAND QUAL SCH BAS C; Bowdon M. A., 2011, HIGHER ED EMERGING T; Bybee RW., 2006, COLORADO SPRINGS CO, V5, P88; Eyler J., 1999, WHERES LEARNING SERV; Hill C., 2010, WOMEN SCI TECHNOLOGY, DOI [10.1002/sce.21007, DOI 10.1002/SCE.21007]; Leonard W. H., 2009, SCI TEACH, V76, P40; National Research Council (NRC), 1996, NAT SCI ED STAND; Novak J, 2010, J EDUC TEACHING, V36, P121, DOI 10.1080/02607470903462263; President's Council of Advisors on Science and Technology, 2012, PRES BID PROLGBTQ TI; Saitta EKH, 2011, J SCI EDUC TECHNOL, V20, P790, DOI 10.1007/s10956-010-9273-0	10	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					971	972		10.1126/science.1230000	http://dx.doi.org/10.1126/science.1230000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990552				2022-12-28	WOS:000323652300031
J	Aronson, L				Aronson, Louise			"Good" Patients and "Difficult" Patients Rethinking Our Definitions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A physician-daughter accompanies her physician-father to the hospital when his blood pressure plummets weeks after bypass surgery. She suspects internal bleeding, but the ED team apparently doesn't. Lest she be deemed difficult, she performs a rectal exam herself. Four weeks after his quadruple bypass and valve repair, 3 weeks after the bladder infection, pharyngeal trauma, heart failure, nightly agitated confusion, and pacemaker and feeding-tube insertions, and 2 weeks after his return home, I was helping my 75-year-old father off the toilet when his blood pressure dropped out from under him. As did his legs. I held him up. I shouted for my mother. As any doctor would, I kept a hand on my father's pulse, which was regular: no pauses, no accelerations or decelerations. My mother was 71 years old and, fortunately, quite fit. She had been making ...	Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Aronson, L (corresponding author), Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA 94143 USA.								0	17	18	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					796	797		10.1056/NEJMp1303057	http://dx.doi.org/10.1056/NEJMp1303057			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	208KB	23984727				2022-12-28	WOS:000323676100005
J	Coelho, T; Adams, D; Silva, A; Lozeron, P; Hawkins, PN; Mant, T; Perez, J; Chiesa, J; Warrington, S; Tranter, E; Munisamy, M; Falzone, R; Harrop, J; Cehelsky, J; Bettencourt, BR; Geissler, M; Butler, JS; Sehgal, A; Meyers, RE; Chen, QM; Borland, T; Hutabarat, RM; Clausen, VA; Alvarez, R; Fitzgerald, K; Gamba-Vitalo, C; Nochur, SV; Vaishnaw, AK; Sah, DWY; Gollob, JA; Suhr, OB				Coelho, Teresa; Adams, David; Silva, Ana; Lozeron, Pierre; Hawkins, Philip N.; Mant, Timothy; Perez, Javier; Chiesa, Joseph; Warrington, Steve; Tranter, Elizabeth; Munisamy, Malathy; Falzone, Rick; Harrop, Jamie; Cehelsky, Jeffrey; Bettencourt, Brian R.; Geissler, Mary; Butler, James S.; Sehgal, Alfica; Meyers, Rachel E.; Chen, Qingmin; Borland, Todd; Hutabarat, Renta M.; Clausen, Valerie A.; Alvarez, Rene; Fitzgerald, Kevin; Gamba-Vitalo, Christina; Nochur, Saraswathy V.; Vaishnaw, Akshay K.; Sah, Dinah W. Y.; Gollob, Jared A.; Suhr, Ole B.			Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WILD-TYPE TRANSTHYRETIN; LIVER-TRANSPLANTATION; SWEDISH PATIENTS; POLYNEUROPATHY; THERAPEUTICS; LIPOSOMES; RETINOL; RISK; INTERFERENCE; COMPLEMENT	Background Transthyretin amyloidosis is caused by the deposition of hepatocyte-derived transthyretin amyloid in peripheral nerves and the heart. A therapeutic approach mediated by RNA interference (RNAi) could reduce the production of transthyretin. Methods We identified a potent antitransthyretin small interfering RNA, which was encapsulated in two distinct first- and second-generation formulations of lipid nanoparticles, generating ALN-TTR01 and ALN-TTR02, respectively. Each formulation was studied in a single-dose, placebo-controlled phase 1 trial to assess safety and effect on transthyretin levels. We first evaluated ALN-TTR01 (at doses of 0.01 to 1.0 mg per kilogram of body weight) in 32 patients with transthyretin amyloidosis and then evaluated ALN-TTR02 (at doses of 0.01 to 0.5 mg per kilogram) in 17 healthy volunteers. Results Rapid, dose-dependent, and durable lowering of transthyretin levels was observed in the two trials. At a dose of 1.0 mg per kilogram, ALN-TTR01 suppressed transthyretin, with a mean reduction at day 7 of 38%, as compared with placebo (P=0.01); levels of mutant and nonmutant forms of transthyretin were lowered to a similar extent. For ALN-TTR02, the mean reductions in transthyretin levels at doses of 0.15 to 0.3 mg per kilogram ranged from 82.3 to 86.8%, with reductions of 56.6 to 67.1% at 28 days (P<0.001 for all comparisons). These reductions were shown to be RNAi-mediated. Mild-to-moderate infusion-related reactions occurred in 20.8% and 7.7% of participants receiving ALN-TTR01 and ALN-TTR02, respectively. Conclusions ALN-TTR01 and ALN-TTR02 suppressed the production of both mutant and nonmutant forms of transthyretin, establishing proof of concept for RNAi therapy targeting messenger RNA transcribed from a disease-causing gene. (Funded by Alnylam Pharmaceuticals; ClinicalTrials.gov numbers, and NCT01148953 and NCT01559077.)	[Coelho, Teresa; Silva, Ana; Perez, Javier] Hosp Santo Antonio, Unidade Clin Paramiloidose, Oporto, Portugal; [Adams, David; Lozeron, Pierre] Univ Paris 11, Hop Bicetre, AP HP, INSERM,U788,Serv Neurol, Paris, France; [Adams, David; Lozeron, Pierre] Ctr Reference Neuropathies Amyloides Familiales L, Paris, France; [Hawkins, Philip N.] Royal Free Hosp, Natl Amyloidosis Ctr, London NW3 2QG, England; [Mant, Timothy] Quintiles Ltd, Guys Drug Res Unit, London, England; [Warrington, Steve; Tranter, Elizabeth] Hammersmith Med Res, London, England; [Chiesa, Joseph; Munisamy, Malathy] Covance Clin Res Unit, Leeds, W Yorkshire, England; [Falzone, Rick; Harrop, Jamie; Cehelsky, Jeffrey; Bettencourt, Brian R.; Geissler, Mary; Butler, James S.; Sehgal, Alfica; Meyers, Rachel E.; Chen, Qingmin; Borland, Todd; Hutabarat, Renta M.; Clausen, Valerie A.; Alvarez, Rene; Fitzgerald, Kevin; Gamba-Vitalo, Christina; Nochur, Saraswathy V.; Vaishnaw, Akshay K.; Sah, Dinah W. Y.; Gollob, Jared A.] Alnylam Pharmaceut, Cambridge, MA USA; [Suhr, Ole B.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; IQVIA; University of London; King's College London; Umea University	Coelho, T (corresponding author), Hosp Santo Antonio, Unidade Clin Paramiloidose, Instalacoes Ex CICAP, Rua D Manuel II, Oporto, Portugal.	tcoelho@netcabo.pt	da Silva, Ana/GXH-4851-2022	Martins da Silva, Ana/0000-0002-1409-0831; Suhr, Ole/0000-0002-1175-2369; Lozeron, Pierre/0000-0003-0816-6526	Alnylam Pharmaceuticals	Alnylam Pharmaceuticals	Funded by Alnylam Pharmaceuticals; ClinicalTrials.gov numbers, NCT01148953 and NCT01559077.)	Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Ando Y, 2004, TRANSPLANTATION, V77, P345, DOI 10.1097/01.TP.0000111516.60013.E6; Ando Y, 2012, CURR MED CHEM, V19, P2312, DOI 10.2174/092986712800269317; Biesalski HK, 2000, AM J CLIN NUTR, V71, P1010; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Buxbaum J, 2010, AM HEART J, V159, P864, DOI 10.1016/j.ahj.2010.02.006; Chanan-Khan A, 2003, ANN ONCOL, V14, P1430, DOI 10.1093/annonc/mdg374; Coelho T, 1996, CURR OPIN NEUROL, V9, P355, DOI 10.1097/00019052-199610000-00007; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Coutinho P., 1980, AMYLOID AMYLOIDOSIS, P88; Dharmarajan K, 2012, J AM GERIATR SOC, V60, P765, DOI 10.1111/j.1532-5415.2011.03868.x; Dungu JN, 2012, HEART, V98, P1546, DOI 10.1136/heartjnl-2012-301924; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Herlenius G, 2004, TRANSPLANTATION, V77, P64, DOI 10.1097/01.TP.0000092307.98347.CB; HOLMGREN G, 1991, CLIN GENET, V40, P242; Hornsten R, 2010, AMYLOID, V17, P63, DOI 10.3109/13506129.2010.483114; HUANG SK, 1992, CANCER RES, V52, P6774; Jayaraman M, 2012, ANGEW CHEM INT EDIT, V51, P8529, DOI 10.1002/anie.201203263; Lachmann HJ, 2007, NEW ENGL J MED, V356, P2361, DOI 10.1056/NEJMoa070265; Lachmann HJ, 2003, BRIT J HAEMATOL, V122, P78, DOI 10.1046/j.1365-2141.2003.04433.x; Liepnieks JJ, 2010, NEUROLOGY, V75, P324, DOI 10.1212/WNL.0b013e3181ea15d4; Liz MA, 2010, IUBMB LIFE, V62, P429, DOI 10.1002/iub.340; Llado L, 2010, LIVER TRANSPLANT, V16, P1386, DOI 10.1002/lt.22174; NAKAZATO M, 1987, J NEUROL SCI, V79, P111, DOI 10.1016/0022-510X(87)90265-6; Okamoto S, 2009, LIVER TRANSPLANT, V15, P1229, DOI 10.1002/lt.21817; ONG DE, 1994, BIOCHEMISTRY-US, V33, P1835, DOI 10.1021/bi00173a029; Paik J, 2004, J NUTR, V134, p276S, DOI 10.1093/jn/134.1.276S; Plante-Bordeneuve V, 2011, LANCET NEUROL, V10, P1086, DOI 10.1016/S1474-4422(11)70246-0; Rapezzi C, 2010, NAT REV CARDIOL, V7, P398, DOI 10.1038/nrcardio.2010.67; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Saraiva MJ, 2012, CURR MED CHEM, V19, P2304; Sekijima Y, 2008, CURR PHARM DESIGN, V14, P3219, DOI 10.2174/138161208786404155; SENIOR JH, 1987, CRC CR REV THER DRUG, V3, P123; SKINNER M, 1985, AM J MED SCI, V289, P17, DOI 10.1097/00000441-198501000-00003; Stangou AJ, 2004, CURR OPIN NEUROL, V17, P615, DOI 10.1097/00019052-200410000-00012; Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; Yazaki M, 2007, AM J TRANSPLANT, V7, P235, DOI 10.1111/j.1600-6143.2006.01585.x; Yazaki M, 2000, BIOCHEM BIOPH RES CO, V274, P702, DOI 10.1006/bbrc.2000.3203; Yazaki M, 2003, MUSCLE NERVE, V28, P438, DOI 10.1002/mus.10452; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	45	671	710	4	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					819	829		10.1056/NEJMoa1208760	http://dx.doi.org/10.1056/NEJMoa1208760			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208KB	23984729				2022-12-28	WOS:000323676100009
J	Myers, KA; Mrkobrada, M; Simel, DL				Myers, Kathryn A.; Mrkobrada, Marko; Simel, David L.			Does This Patient Have Obstructive Sleep Apnea? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION-BASED SAMPLE; RISK-FACTORS; STOP-BANG; BERLIN QUESTIONNAIRE; PHYSICAL-EXAMINATION; IDENTIFY PATIENTS; MALLAMPATI SCORE; PREDICTIVE-VALUE; ASSOCIATION; HYPERTENSION	IMPORTANCE Obstructive sleep apnea is a common disease, responsible for daytime sleepiness. Prior to referring patients for definitive testing, the likelihood of obstructive sleep apnea should be established in the clinical examination. OBJECTIVE To systematically review the clinical examination accuracy in diagnosing obstructive sleep apnea. DATA SOURCES MEDLINE and reference lists from articles were searched from 1966 to June 2013. Titles and abstracts (n = 4449) were reviewed for eligibility and appraised for evidence levels. STUDY SELECTION For inclusion, studies must have used full, attended nocturnal polysomnography for the reference standard (n = 42). MAIN OUTCOMES AND MEASURES Community and referral-based prevalence of obstructive sleep apnea; accuracy of symptoms and signs for the diagnosis of obstructive sleep apnea. RESULTS The prevalence of sleep apnea in community-screened patients is 2% to 14% (sample sizes 360-1741) and 21% to 90% (sample sizes 42-2677) for patients referred for sleep evaluation. The prevalence varies based on the apnea-hypopnea index (AHI) threshold used for the evaluation (>= 5 events/h, prevalence 14%; >= 15/h, prevalence 6%) and whether the disease definition requires symptoms in addition to an abnormal AHI (>= 5/h with symptoms, prevalence 2%-4%). Among patients referred for sleep evaluation, those with sleep apnea weighed more (summary body mass index, 31.4; 95% CI, 30.5-32.2) than those without sleep apnea (summary BMI, 28.3; 95% CI, 27.6-29.0; P < .001 for the comparison). The most useful observation for identifying patients with obstructive sleep apnea was nocturnal choking or gasping (summary likelihood ratio [LR], 3.3; 95% CI, 2.1-4.6) when the diagnosis was established by AHI >= 10/h). Snoring is common in sleep apnea patients but is not useful for establishing the diagnosis (summary LR, 1.1; 95% CI, 1.0-1.1). Patients with mild snoring and body mass index lower than 26 are unlikely to have moderate or severe obstructive sleep apnea (LR, 0.07; 95% CI, 0.03-0.19 at threshold of AHI > 15/h). CONCLUSIONS AND RELEVANCE Nocturnal gasping or choking is the most reliable indicator of obstructive sleep apnea, whereas snoring is not very specific. The clinical examination of patients with suspected obstructive sleep apnea is useful for selecting patients for more definitive testing.	[Myers, Kathryn A.; Mrkobrada, Marko] Western Univ, Schulich Sch Med & Dent, London, ON N6A 4V2, Canada; [Simel, David L.] Durham Vet Med Ctr, Durham, NC USA; [Simel, David L.] Duke Univ, Durham, NC USA	Western University (University of Western Ontario); Duke University	Myers, KA (corresponding author), Western Univ, Schulich Sch Med & Dent, 268 Grosvenor St, London, ON N6A 4V2, Canada.	athryn.Myers@sjhc.london.on.ca	Myers, Kathryn/G-3338-2011; Mrkobrada, Marko/G-3336-2011					Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; Arand DL, 2006, J CLIN SLEEP MED, V2, P124; Becker HF, 2003, CIRCULATION, V107, P68, DOI 10.1161/01.CIR.0000042706.47107.7A; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Bixler EO, 2000, ARCH INTERN MED, V160, P2289, DOI 10.1001/archinte.160.15.2289; Borenstein M., 2005, COMPREHENSIVE META A; Casale M, 2008, EUR REV MED PHARMACO, V12, P275; Chesson AL, 2003, SLEEP, V26, P907, DOI 10.1093/sleep/26.7.907; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; CROCKER BD, 1990, AM REV RESPIR DIS, V142, P14, DOI 10.1164/ajrccm/142.1.14; Dancey DR, 2003, CHEST, V123, P1544, DOI 10.1378/chest.123.5.1544; Deegan PC, 1996, EUR RESPIR J, V9, P117, DOI 10.1183/09031936.96.09010117; Donadio V, 2008, J SLEEP RES, V17, P458, DOI [10.1111/j.1365-2869.2008.00672.x, 10.1111/j.1365-2869.2008.00682.x, 10.1111/j.1365-2869.2008.00683.x, 10.1111/j.1365-2869.2008.00663.x, 10.1111/j.1365-2869.2008.00667.x]; Drager LF, 2010, AM J CARDIOL, V105, P1135, DOI 10.1016/j.amjcard.2009.12.017; Dreher A, 2005, ARCH OTOLARYNGOL, V131, P95, DOI 10.1001/archotol.131.2.95; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; Farney RJ, 2011, J CLIN SLEEP MED, V7, P459, DOI 10.5664/JCSM.1306; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FLEMONS WW, 1994, AM J RESP CRIT CARE, V150, P1279, DOI 10.1164/ajrccm.150.5.7952553; Friedman M, 1999, LARYNGOSCOPE, V109, P1901, DOI 10.1097/00005537-199912000-00002; GEORGE CF, 1988, SLEEP, V11, P90, DOI 10.1093/sleep/11.1.90; George CFP, 2001, THORAX, V56, P508, DOI 10.1136/thorax.56.7.508; Goksan B, 2009, CEPHALALGIA, V29, P635, DOI 10.1111/j.1468-2982.2008.01781.x; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; Guilleminault C. J., 1978, SLEEP APNEA SYNDROME; GYULAY S, 1993, AM REV RESPIR DIS, V147, P50, DOI 10.1164/ajrccm/147.1.50; HARALDSSON PO, 1992, SLEEP, V15, P261, DOI 10.1093/sleep/15.3.261; Hauri PJ, 2005, INT CLASSIFICATION S; Hessel NS, 2002, EUR ARCH OTO-RHINO-L, V259, P154, DOI 10.1007/s00405-001-0427-9; HOFFSTEIN V, 1993, SLEEP, V16, P118; Hrubos-Strom H, 2011, J SLEEP RES, V20, P162, DOI 10.1111/j.1365-2869.2010.00861.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kang K, 2013, SLEEP BREATH, V17, P803, DOI 10.1007/s11325-012-0767-2; KATZ I, 1990, AM REV RESPIR DIS, V141, P1228, DOI 10.1164/ajrccm/141.5_Pt_1.1228; KAVEY NB, 1985, AM J OTOLARYNG, V6, P373, DOI 10.1016/S0196-0709(85)80015-6; Kirby SD, 1999, CHEST, V116, P409, DOI 10.1378/chest.116.2.409; Kristiansen HA, 2012, CEPHALALGIA, V32, P451, DOI 10.1177/0333102411431900; Lam B, 2005, THORAX, V60, P504, DOI 10.1136/thx.2004.031591; Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479; Liistro G, 2003, EUR RESPIR J, V21, P248, DOI 10.1183/09031936.03.00292403; Lim PVH, 1999, J LARYNGOL OTOL, V113, P336, DOI 10.1017/S0022215100143919; Martinez D, 2011, SLEEP BREATH, V15, P763, DOI 10.1007/s11325-010-0434-4; Martinez-Garcia MA, 2007, EUR RESPIR J, V29, P951, DOI 10.1183/09031936.00048606; McFadyen TA, 2001, EUR RESPIR J, V18, P996, DOI 10.1183/09031936.01.00209301; Morris LGT, 2008, OTOLARYNG HEAD NECK, V139, P615, DOI 10.1016/j.otohns.2008.08.026; Neau JP, 2002, CEPHALALGIA, V22, P333, DOI 10.1046/j.1468-2982.2002.00303.x; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Nuckton TJ, 2006, SLEEP, V29, P903, DOI 10.1093/sleep/29.7.903; Ong TH, 2010, SLEEP BREATH, V14, P371, DOI 10.1007/s11325-010-0350-7; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; PHILLIPS B, 1989, SOUTHERN MED J, V82, P1090, DOI 10.1097/00007611-198909000-00007; Ramachandran SK, 2010, ANESTH ANALG, V110, P1007, DOI 10.1213/ANE.0b013e3181d489b0; RAUSCHER H, 1992, CHEST, V102, P367, DOI 10.1378/chest.102.2.367; Reddy EV, 2009, SLEEP MED, V10, P913, DOI 10.1016/j.sleep.2008.08.011; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 2000, AM J RESP CRIT CARE, V161, P369, DOI 10.1164/ajrccm.161.2.9904031; Robichaud-Halle L, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-60; Rowley JA, 2000, SLEEP, V23, P929, DOI 10.1093/sleep/23.7.929; SANGAL RB, 1992, CHEST, V101, P898, DOI 10.1378/chest.101.4.898; Schafer H, 1997, RESPIRATION, V64, P194; Schellenberg JB, 2000, AM J RESP CRIT CARE, V162, P740, DOI 10.1164/ajrccm.162.2.9908123; Simel DL, 2009, RATIONAL CLIN EXAMIN; Subramanian S, 2011, SLEEP BREATH, V15, P819, DOI 10.1007/s11325-010-0443-3; Sun LM, 2011, SLEEP BREATH, V15, P317, DOI 10.1007/s11325-010-0384-x; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Tsai WH, 2003, AM J RESP CRIT CARE, V167, P1427, DOI 10.1164/rccm.200112-110OC; Vana KD, 2013, RES NURS HEALTH, V36, P84, DOI 10.1002/nur.21512; VINER S, 1991, ANN INTERN MED, V115, P356, DOI 10.7326/0003-4819-115-5-356; WETTER DW, 1994, ARCH INTERN MED, V154, P2219, DOI 10.1001/archinte.154.19.2219; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 2003, AM J RESP CRIT CARE, V167, P1181, DOI 10.1164/rccm.200209-1055OC; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2008, SLEEP, V31, P1071	75	146	153	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					731	741		10.1001/jama.2013.276185	http://dx.doi.org/10.1001/jama.2013.276185			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989984				2022-12-28	WOS:000323254500023
J	Kearon, C				Kearon, Clive			Intermittent pneumatic compression reduced deep venous thrombosis after stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THIGH-LENGTH; STOCKINGS; TRIAL		McMaster Univ, Hamilton, ON, Canada	McMaster University	Kearon, C (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Dennis M, 2010, ANN INTERN MED, V153, P553, DOI 10.7326/0003-4819-153-9-201011020-00280; Dennis M, 2009, LANCET, V373, P1958, DOI 10.1016/S0140-6736(09)60941-7	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC3	10.7326/0003-4819-159-4-201308200-02003	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026279				2022-12-28	WOS:000323421700002
J	White, WB; Cannon, CP; Heller, SR; Nissen, SE; Bergenstal, RM; Bakris, GL; Perez, AT; Fleck, PR; Mehta, CR; Kupfer, S; Wilson, C; Cushman, WC; Zannad, F; Aiub, J; Albisu, J; Alvarez, C; Astesiano, A; Barcudi, R; Bendersky, M; Bono, J; Bustos, B; Cartasegna, L; Caruso, O; Casabe, H; Castro, R; Colombo, H; Cuneo, C; Cura, F; De Loredo, L; Dran, R; Fernandez, H; Pinna, JG; Hrabar, A; de Saleme, MK; Luquez, H; Mackinnon, I; Maffei, L; Majul, C; Mallagray, M; Marino, J; Martinez, D; Martingano, R; Nul, D; Parody, ML; Petrucci, J; Pieroni, M; Piskorz, D; Prado, A; Ramos, H; Resk, J; Rodriguez, M; Rojas, C; Sarjanovich, R; Sarries, A; Sessa, H; Silveiro, S; Liprandi, MIS; Tartaglione, J; Tonin, H; Vallejos, J; Vigo, S; Visco, V; Vita, N; Vogel, D; Vogelmann, O; Zaidman, C; Zangroniz, P; Colquhoun, D; Coverdale, S; Flecknoe-Brown, S; Hii, CSL; Roberts-Thomson, P; Drexel, H; Luger, A; Pieber, T; Cools, F; Ruige, J; Schoors, D; Vercammen, C; Wollaert, B; da Costa, FA; Amodeo, C; Baggenstoss, R; Barbosa, E; de Souza, WKB; Bassan, R; Borges, JL; Botelho, R; Braile, MCV; Castello, H; Chrisman, C; dos Santos, F; Neto, JF; Farsky, P; Da Costa, AF; Fraige, F; Garbelini, B; Garcia, MF; Garzon, P; Guimaraes, AE; Herdy, A; Hernandes, M; Hilgemberg, S; Hissa, M; Jatene, JA; Kormann, A; Leaes, P; Lima, F; Lisboa, HR; Maia, L; da Silva, FM; Franco, DM; Martin, JF; Medeiros, A; Michalaros, Y; Leitao, AM; Montenegro, S; Moraes, J; Gomes, MM; Paiva, MS; Precoma, D; Rabelo, A; Reis, G; Reis, H; Rossi, P; Saporito, W; Leite, RS; Silva, RP; Silva, D; Sousa, L; Sousa, AC; Ueda, R; Vilas-Boas, F; Wainstein, M; Zago, A; Angelova, M; Apostolova, E; Daskalova, I; Delchev, A; Hristozov, K; Ilieva, M; Kovacheva, S; Lucheva, M; Temelkova, M; Toneva, A; Videva, V; Vuchkova, E; Bakbak, A; Carpentier, A; Chan, YK; Cheema, A; Chouinard, G; Conway, J; Dery, JP; Dowell, A; Frechette, A; Jakubowski, M; Kelly, A; Ma, P; Maung, TZ; Mehta, S; Parker, D; Pesant, Y; Polasek, P; Ransom, T; Syan, G; Vizel, S; Albornoz, F; Galvez, PC; Cobos, JL; Conejeros, C; Apablaza, MD; Fajardo, G; Brochet, GI; Lazcano, MO; Pincetti, C; Potthoff, S; Raffo, C; Saavedra, V; Schnettler, M; Sepulveda, P; Stockins, B; Vejar, M; Accini, JL; Aroca, CHC; Ruiz, RLF; Linares, LAO; Angarita, BEV; Aganovic, I; Bagatin, J; Canecki-Varzic, S; Erzen, DJ; Knezevic, A; Maric, A; Milicevic, G; Popovic, Z; Rubes, J; Weiss, SS; Dresslerova, I; Havelkova, J; Kucera, D; Machacek, J; Pumprla, J; May, O; Perrild, H; Aziz, MA; El Badry, M; Hasanein, M; Airaksinen, J; Laine, M; Nyman, K; Vikman, S; Bonnet, J; Elbaz, M; Henry, P; Paillard, F; Petit, C; Tropeano, AI; Behnke, T; Bornstein, S; Busch, K; Ebelt, H; Faghih, M; Fischer, H; Heuer, H; Paschke, R; Porner, TC; Tangerding, G; Vohringer, HF; Adamson, K; Beatt, K; Bellary, S; Chapman, J; Cooke, A; Fisher, M; Gnudi, L; Jones, H; Kumar, S; Nagi, D; Oldroyd, K; Richardson, T; Robertson, D; Robinson, A; Saravanan, P; Viljoen, A; Wilding, J; Wilkinson, P; Wong, YK; Zoupas, C; Arango, J; Castellanos, J; Flores, CC; Corona, V; Granados-Fuentes, A; Haase, F; Montenegro, P; Prado, JHP; Villalobos, R; Chow, F; Li, SK; Li, JN; Yan, PYB; Yeung, V; Abel, T; Benedek, A; Dezso, E; Dudas, M; Edes, I; Fulop, G; Kovacs, A; Lupkovics, G; Merkely, B; Nagy, A; Oroszlan, T; Palinkas, A; Papp, A; Patkay, J; Simon, E; Sitkei, E; Tabak, A; Tomcsanyi, J; Abdullakutty, J; Abhyankar, A; Akalkotkar, U; Alexander, T; Arneja, J; Aslam, N; Babu, PR; Babu, BR; Banker, D; Bantwal, G; Bhimashankar, PR; Calton, RK; Chopda, M; Dande, A; Dani, S; Deshpande, N; Deshpande, N; Dhanwal, D; Dharmadhikari, A; Gadkari, M; Garg, N; Ghaisas, N; Goyal, NK; Gupta, JB; Jawahirani, A; Joseph, S; Kumar, R; Kumble, M; Mathavan, A; Mathur, A; Mohanan, PP; Nair, A; Nair, T; Namjoshi, D; Pinto, R; Prakash, G; Purushotham, R; Raju, S; Ramachandran, P; Ramesh, SS; Rao, B; Ravikishore, A; Reddy, GR; Roy, S; Sadhu, N; Sastry, BKS; Singh, P; Srinivas, A; Thacker, H; Thanvi, S; Thomas, J; Adawi, F; Bashkin, A; Cohen, J; Harman-Boehm, I; Hasin, Y; Hayek, T; Iakobishvili, Z; Katz, A; Kracoff, O; Minuchin, O; Moriel, M; Mosseri, M; Omary, M; Wainstein, J; Weiss, A; Zeltser, D; Calabro, P; Derosa, G; Genovese, S; Novo, S; Olivieri, C; Piatti, P; Violini, R; Volpe, M; Ajioka, M; Amano, T; Arasaki, O; Daida, H; Fujimoto, K; Fujinaga, H; Higashiue, S; Hirohata, A; Hosokawa, S; Ikefuji, H; Inagaki, M; Iseki, H; Iwabuchi, M; Iwasaki, T; Kakishita, M; Katsuda, Y; Kawada, K; Kawajiri, K; Kawamitsu, K; Kobayashi, K; Komada, F; Komura, Y; Machida, M; Maemura, K; Matsubara, T; Matsubayashi, S; Matsumoto, T; Matsumoto, N; Mima, T; Miyamoto, N; Momiyama, Y; Morimoto, T; Murakami, M; Nakashima, E; Niijima, Y; Noda, T; Node, K; Nozaki, A; Nunohiro, T; Ogawa, T; Ono, Y; Saeki, T; Sakota, S; Sakuragi, S; Sasaki, T; Sato, Y; Sueyoshi, A; Suzuki, M; Takagi, G; Tanabe, J; Tanaka, S; Tei, I; Yamamoto, M; Yanagihara, K; Hong, TJ; Jeon, HK; Kang, DH; Kim, CH; Kim, DS; Kim, HS; Kim, JH; Kim, SK; Kim, WS; Kim, YK; Lee, S; Lee, KW; Park, HS; Pyun, WB; Rha, SW; Yoon, J; Yoon, KH; Bennakhi, A; Geldnere, K; Sokolova, J; Teterovska, D; Dautaraite, V; Kakariekiene, V; Kavaliauskiene, R; Kucinskiene, A; Lasiene, J; Mickuviene, N; Palinauskas, A; Urboniene, A; Zilaitiene, B; Manap, HA; Abidin, IZ; Isa, SHM; Khir, AM; Ng, KH; Tan, F; Yusof, Z; Yusoff, K; Zambahari, R; Aguila-Marin, J; Real, MA; Alvarado-Ruiz, R; Lopez, HA; Leon, JA; Llamas, EAB; Vargas, CC; Calvillo, JC; Ibarra, MD; Dominguez-Reyes, CA; Duarte, M; Elizondo, E; Campos, PF; Fanghanel-Salmon, G; Sauceda, SF; Martinez, JG; Garcia-Cantu, E; Ruiz, JAG; Gonzalez, JGG; Garza, MG; Herrera, CH; Munuzuri, JH; Hernandez-Garcia, H; Ramos, SJ; Molina, HL; Villezca, DL; Montano-Gonzalez, E; Ruiz, LN; Lopez, GR; Araiza, RR; Salazar-Gaytan, A; Vazquez, ES; Mijangos, HS; Morales, LS; Benatar, J; Dixon, P; Nirmalaraj, K; Rosen, I; Scott, R; Young, S; Tarco, OA; Caceres, LB; Lopez, CB; Cosavalente, LC; Huapalla, EC; Malaga, AC; Flores, AC; Aspilcueta, JF; Rojas, WG; Cazorla, AG; Caballero, DG; Matheus, JG; Carrasco, EG; Sanchez, JG; Zuniga, JH; Galarreta, LL; Luna, A; Hurtado, HM; Pastor, BO; Alvarez, RMP; Povis, JS; Eguiluz, PT; Portugal, AV; Gonzales, RV; Rincon, LZ; Aquitania, G; Fortinez, JT; Go, A; Gomez, MH; Habaluyas, R; Jasul, G; Magno, M; Manalo, CJ; Mirasol, R; Morales-Palomares, E; Salvador, DR; Sy, RA; Tirador, L; Yao, C; Arciszewska, M; Bartkowiak, R; Czajkowska-Kaczmarek, E; Gil, R; Gniot, J; Janik, K; Janion, M; Jaworska, K; Jozwa, R; Kawecka-Jaszcz, K; Kawka-Urbanek, T; Kondys, M; Korecki, J; Korzeniak, R; Kowalisko, A; Krzeminska-Pakula, M; Kwiecien, J; Nessler, J; Odrowaz-Pieniazek, P; Piepiorka, M; Rajzer, M; Skokowska, E; Spyra, J; Sroka, M; Stasinska, T; Szymczyk, I; Trznadel-Morawska, I; Wysokinski, A; Mateus, P; Matos, P; Mimoso, J; Monteiro, P; Caballero, B; Garcia-Rinaldi, R; Gonzalez, E; Ortiz-Carrasquillo, R; Roman, A; Sierra, Y; Unger, N; Vazquez-Tanus, J; Alexandru, T; Busegeanu, M; Cozman, DC; Fica, S; Minescu, B; Morosanu, M; Negrisanu, GD; Pintilei, E; Pop, L; Szilagyi, I; Teodorescu, I; Tomescu, M; Barbarash, O; Chumakova, G; Churina, S; Dogadin, S; Dvoryashina, I; Esip, V; Glezer, M; Gordeev, I; Gordienko, A; Gratsiansky, N; Grineva, E; Khasanov, N; Kostenko, V; Meleshkevich, T; Mikhin, V; Morugova, T; Motylev, I; Nikolaev, K; Ponomareva, A; Repin, M; Reshetko, O; Shustov, S; Shutemova, E; Shvarts, Y; Simanenkov, V; Sobolev, K; Sukmanova, I; Timofeev, A; Tsyba, L; Varvarina, G; Vertkin, A; Vishnevsky, A; Volkov, D; Vorobiev, S; Vorokhobina, N; Yakhontov, D; Zonova, E; Zrazhevskiy, K; Damjanovic, S; Djordjevic, D; Pavlovic, M; Perunicic, J; Ristic, A; Stojkovic, S; Tasic, N; Bolvanska, N; Buganova, I; Dulkova, K; Dzupina, A; Fulop, P; Gergel, V; Kokles, M; Micko, K; Svoren, P; Urban, M; Vadinova, S; Vargova, A; Burgess, L; Coetzee, K; Du Toit, J; Gani, M; Joshi, P; Naiker, P; Nortje, H; Sarvan, M; Seeber, M; Siebert, M; van Zyl, L; Wellmann, H; Calvo, C; De la Hera, J; De Teresa, L; Melero-Pita, A; Mesa, J; Barona, JP; Serrano, P; Soto, A; Tofe, S; Hornestam, B; Kempe, A; Rosenqvist, U; Rydberg, E; Tengmark, BO; Torstensson, I; Chang, CT; Hsia, TL; Hsieh, IC; Lai, WT; Wu, CJ; Hutayanon, P; Kosachunhanun, N; Marapracertsak, M; Piamsomboon, C; Seekaew, S; Srimahachota, S; Sukhum, P; Suraamornkul, S; Tantiwong, P; Wongvipaporn, C; Amosova, K; Barna, O; Bazylevych, A; Berenfus, V; Dyadyk, A; Fushtey, I; Gyrina, O; Iabluchanskyi, M; Karpenko, O; Kaydashev, I; Korzh, O; Kulynych, R; Legkonogov, O; Mankovsky, B; Mostovoy, Y; Parkhomenko, O; Popik, G; Rudenko, L; Rudyk, I; Shevchuk, S; Sirenko, Y; Suprun, Y; Tryshchuk, N; Tseluyko, V; Vakaliuk, I; Al Mahmeed, W; Acheatel, R; Ahmad, A; Akbar, S; Akhter, F; Albirini, A; Alexander, A; Al-Joundi, B; Al-Joundi, T; Allen, G; Aloi, J; Alvarado, O; Alzohaili, O; Anderson, C; Arastu, A; Arena, C; Argoud, G; Ariani, M; Arora, C; Awasty, V; Barker, B; Barnum, O; Bartkowiak, AJ; Barzilay, J; Behrens, P; Belledonne, M; Bergman, B; Bilnoski, W; Bisognano, J; Bissette, S; Blumberg, E; Bonabi, N; Bradley, A; Breton, C; Britos, M; Broadstone, V; Budoff, M; Burge, M; Butman, S; Carroll, M; Challappa, K; Chepuri, V; Cherlin, R; Cheung, D; Coats, P; Collins, J; Cruz, H; Daboul, N; Damberg, G; David, W; Dean, J; Dedeke, E; Deeb, W; DeHaven, J; Dobs, A; Donelan, T; Dy, J; Dykstra, G; Eisen, H; Farris, N; Fattal, P; Fishman, N; Foster, M; Fredrickson, S; Gabra, N; Gabriel, J; Gatien, L; Giddings, S; Ginsberg, B; Gips, S; Glandt, M; Goldfein, A; Gordon, M; Gould, R; Graf, R; Graham, B; Graves, M; Grena, P; Hahn, R; Hamilton, D; Hamroff, G; Hanke, F; Haque, I; Harper, J; Harris, A; Harris, S; Henson, B; Hermanns, D; Herndon, W; Hershberger, V; Hyman, D; Isserman, S; Iteld, B; Jacob, M; Jaffrani, N; Jamal, A; Johnson, D; Johnson, G; Kaluski, E; Keller, R; Kereiakes, D; Khan, M; Khan, S; Khan, M; Klein, M; Knutson, T; Korban, E; Kozinn, M; Kraft, P; Kroeze, J; Kukuy, E; Lader, E; Laliotis, A; Lambert, C; Landau, C; Latif, K; Lee, K; Lester, F; Levenson, D; Levinson, D; Lewis, D; Litt, M; Littlefield, R; Lo, E; Lovell, C; Mahal, S; Makam, S; Mandviwala, M; Marar, I; Masri, B; Mattson, S; Mays, M; McGrew, F; Meengs, M; Mikell, F; Miller, M; Miranda, F; Moll, D; Multani, P; Munuswamy, K; Nallasivan, M; Nayles, L; Ong, S; Pacheco, T; Paez, H; Patel, S; Phillips, R; Pierpont, B; Prasad, J; Quinlan, E; Quion, J; Qureshi, M; Rahman, A; Raikhel, M; Ramanathan, K; Randhawa, P; Ravi, R; Reddy, R; Rendell, M; Rickner, K; Rictor, K; Rivas, J; Rosenblit, P; Rosenstock, J; Ross, S; Salacata, A; Saririan, M; Schima, S; Schlau, A; Schmedtje, J; Scott, C; Scott, D; Serru-Paez, A; Shah, R; Shah, A; Shaoulian, E; Shomali, M; Shubrook, J; Silver, K; Singh, S; Speer, J; Stevens, J; Stringam, S; Taussig, A; Taylor, A; Tee, H; Teixeira, G; Tilley, A; Toggart, E; Twahirwa, M; Unks, D; Vakili, B; Vora, K; Wang, XB; Warner, A; Wefald, F; Weinberg, B; Weinstein, D; White, L; Wu, P; Yasuda, T; Yazdani, S; Yetman, C; Zarich, S; Zebrack, J; Fonseca, VA; McCullough, PA; Desouza, C; Goff, DC; Harrell, FE; Menon, V; Sila, C; Kalahasti, V; Ahmed, S; Al Solaiman, F; Bennett, M; Cavender, M; Heil, B; Katzan, I; Monteleone, P; O'Brien, B; Oommen, S; Senn, T; Sharma, J; Stegman, B; Uchino, K; Zishiri, E; Pasca, N; Brown, K; Scebbi, T; Atanasovski, I; Mccue, M; Streit, J; Oh, R; Bueno, O; Lee, D; Camisasca, R; Miyata, Y; Rubin, A; Williamson, N; Vara, S; Keeter, K; Ross, B; de los Reyes, A; Donnelly, J; Koshy-Hunt, S; Beers, B; Black, S; Buckley, M; Ephrem, M; Riley, B; West, N; Harre, M; Hsieh, R; Oshinyemi, K; Oka, Y; Matsui, N; Hoang, M; Doyle, C; Koziol, M; Lam, H; Edmonds, A; Azooz, W; Cao, C; Kim, D; Boeshaar, A; Dewindt, A; Nicholson, K; Smith, N; Hisada, M; Harding, S; Cannon, C; Yoshioka, N; Gujral-Sandhu, K; Gans, J; Gresk, C; Kujawski, MR; Villinski, A; Cosner, S; Johannsen, C; Barchha, N; Knapp, B				White, William B.; Cannon, Christopher P.; Heller, Simon R.; Nissen, Steven E.; Bergenstal, Richard M.; Bakris, George L.; Perez, Alfonso T.; Fleck, Penny R.; Mehta, Cyrus R.; Kupfer, Stuart; Wilson, Craig; Cushman, William C.; Zannad, Faiez; Aiub, Jorge; Albisu, Juan; Alvarez, Carlos; Astesiano, Alfredo; Barcudi, Raul; Bendersky, Mario; Bono, Julio; Bustos, Betina; Cartasegna, Luis; Caruso, Orlando; Casabe, Horacio; Castro, Remo; Colombo, Hugo; Cuneo, Carlos; Cura, Fernando; De Loredo, Luis; Dran, Ricardo; Fernandez, Horacio; Garcia Pinna, Jorge; Hrabar, Adrian; Klyver de Saleme, Maria; Luquez, Hugo; Mackinnon, Ignacio; Maffei, Laura; Majul, Claudio; Mallagray, Marcelo; Marino, Javier; Martinez, Diego; Martingano, Roberto; Nul, Daniel; Leonor Parody, Maria; Petrucci, Jacqueline; Pieroni, Mario; Piskorz, Daniel; Prado, Aldo; Ramos, Hugo; Resk, Jorge; Rodriguez, Marcelo; Rojas, Carlos; Sarjanovich, Rodolfo; Sarries, Alejandro; Sessa, Horacio; Silveiro, Sandra; Sosa Liprandi, Maria Ines; Tartaglione, Jorge; Tonin, Hugo; Vallejos, Julio; Vigo, Santiago; Visco, Virginia; Vita, Nestor; Vogel, Daniel; Vogelmann, Oscar; Zaidman, Cesar; Zangroniz, Pedro; Colquhoun, David; Coverdale, Steven; Flecknoe-Brown, Steve; Hii, Chris Sing Loi; Roberts-Thomson, Philip; Drexel, Heinz; Luger, Anton; Pieber, Thomas; Cools, Frank; Ruige, Johannes; Schoors, Danny; Vercammen, Chris; Wollaert, Bart; da Costa, Fernando Alves; Amodeo, Celso; Baggenstoss, Rejane; Barbosa, Eduardo; Barroso de Souza, Weimar Kunz; Bassan, Roberto; Borges, Joao Lindolfo; Botelho, Roberto; Valeria Braile, Maria Christiane; Castello, Helio, Jr.; Chrisman, Carolina; dos Santos, Fabio; Faria Neto, Jose; Farsky, Pedro; Da Costa, Alessandra Fernandes; Fraige Filho, Fadlo; Garbelini, Benito, Jr.; Garcia, Maria Fernanda; Garzon, Pedro; Guimaraes, Artur Eduardo; Herdy, Artur; Hernandes, Mauro; Hilgemberg, Sandra; Hissa, Miguel; Jatene, Jose Antonio; Kormann, Adrian; Leaes, Paulo; Lima, Felipe; Lisboa, Hugo Roberto; Maia, Lilia; da Silva, Francisco Maia; Franco, Daniela Maldonado; Martin, Jose Fernando; Medeiros, Ana; Michalaros, Yorghos; Leitao, Andressa Miguel; Montenegro, Sergio; Moraes Junior, Joao; Gomes, Marco Mota; Paiva, Maria Sanali; Precoma, Dalton; Rabelo, Alvaro; Reis, Gilmar; Reis, Helder; Rossi, Paulo; Saporito, Wladmir; Leite, Rogerio Sarmento; Silva, Ricardo Pereira; Silva Junior, Delcio; Sousa, Luciano; Sousa, Antonio Carlos; Ueda, Ricardo; Vilas-Boas, Fabio; Wainstein, Marco; Zago, Alexandre; Angelova, Mashka; Apostolova, Emilia; Daskalova, Ivona; Delchev, Alexy; Hristozov, Kiril; Ilieva, Mariana; Kovacheva, Sneghina; Lucheva, Maria; Temelkova, Margarita; Toneva, Antoaneta; Videva, Vyara; Vuchkova, Emilina; Bakbak, Asaad; Carpentier, Andre; Chan, Yun Kai; Cheema, Asim; Chouinard, Guy; Conway, James; Dery, Jean-Pierre; Dowell, Anthony; Frechette, Andre; Jakubowski, Marek; Kelly, Allan; Ma, Patrick; Maung, Tun Zan; Mehta, Shamir; Parker, David; Pesant, Yves; Polasek, Petr; Ransom, Thomas; Syan, Gurcharan; Vizel, Saul; Albornoz, Francisco; Castro Galvez, Pablo; Leonardo Cobos, Jorge; Conejeros, Carlos; D'Acuna Apablaza, Mauricio; Fajardo, Graciela; Illanes Brochet, Guillermo; Opazo Lazcano, Marcos; Pincetti, Christian; Potthoff, Sergio; Raffo, Carlos; Saavedra, Victor; Schnettler, Maria; Sepulveda, Pablo; Stockins, Benjamin; Vejar, Margarita; Accini, Jose Luis; Cotes Aroca, Carlos Hernan; Fernandez Ruiz, Ricardo Leon; Orozco Linares, Luis Alejandro; Vesga Angarita, Boris Eduardo; Aganovic, Izet; Bagatin, Jugoslav; Canecki-Varzic, Silvija; Erzen, Dubravka Jurisic; Knezevic, Aleksandar; Maric, Andreja; Milicevic, Goran; Popovic, Zeljko; Rubes, Josip; Weiss, Sonja Slosic; Dresslerova, Irma; Havelkova, Jana; Kucera, Dusan; Machacek, Josef; Pumprla, Jiri; May, Ole; Perrild, Hans; Aziz, Magdy Abdel; El Badry, Mahmoud; Hasanein, Mahmoud; Airaksinen, Juhani; Laine, Mika; Nyman, Kai; Vikman, Saila; Bonnet, Jacques; Elbaz, Meyer; Henry, Patrick; Paillard, Francois; Petit, Catherine; Tropeano, Anne-Isabelle; Behnke, Thomas; Bornstein, Stefan; Busch, Klaus; Ebelt, Henning; Faghih, Marcus; Fischer, Hermann; Heuer, Hubertus; Paschke, Ralf; Porner, Tudor-Constantin; Tangerding, Gerard; Voehringer, Hans-Friedrich; Adamson, Karen; Beatt, Kevin; Bellary, Srikanth; Chapman, John; Cooke, Alastair; Fisher, Miles; Gnudi, Luigi; Jones, Hugh; Kumar, Sudhesh; Nagi, Dinesh; Oldroyd, Keith; Richardson, Tristan; Robertson, Douglas; Robinson, Anthony; Saravanan, Ponnusamy; Viljoen, Adie; Wilding, John; Wilkinson, Peter; Wong, Yuk-ki; Zoupas, Christos; Arango, Juan; Castellanos, Jose; Ceren Flores, Carlos; Corona, Vinicio; Granados-Fuentes, Arnoldo; Haase, Franklin; Montenegro, Pablo; Palencia Prado, Julio Humberto; Villalobos, Renato; Chow, Francis; Li, Shu Kin; Li, June; Yan, Ping Yen Bryan; Yeung, Vincent; Abel, Tatjana; Benedek, Amalia; Dezso, Eniko; Dudas, Mihaly; Edes, Istvan; Fulop, Gabor; Kovacs, Aranka; Lupkovics, Geza; Merkely, Bela; Nagy, Andras; Oroszlan, Tamas; Palinkas, Attila; Papp, Andras; Patkay, Jozsef; Simon, Eva; Sitkei, Eva; Tabak, Adam; Tomcsanyi, Janos; Abdullakutty, Jabir; Abhyankar, Atul; Akalkotkar, Umesh; Alexander, Thomas; Arneja, Jaspal; Aslam, Naved; Babu, Pothineni Ramesh; Babu, Byrapaneni Ramesh; Banker, Darshan; Bantwal, Ganapati; Bhimashankar, P. R.; Calton, Rajneesh Kumar; Chopda, Manoj; Dande, Ajay; Dani, Sameer; Deshpande, Neeta; Deshpande, Niteen; Dhanwal, Dinesh; Dharmadhikari, Aniruddha; Gadkari, Milind; Garg, Nitish; Ghaisas, Nitin; Goyal, N. K.; Gupta, Jugal Bihari; Jawahirani, Anil; Joseph, Stigmon; Kumar, Ravi; Kumble, Mukund; Mathavan, A.; Mathur, Atul; Mohanan, Padnihare Purayil; Nair, Abhilash; Nair, Tiny; Namjoshi, Deepak; Pinto, Robin; Prakash, Guru; Purushotham, R.; Raju, Srinivas; Ramachandran, Padmakumar; Ramesh, S. S.; Rao, Bhaskara; Ravikishore, Amancherla; Reddy, G. Rajashekar; Roy, Sanjeeb; Sadhu, Nehal; Sastry, B. K. S.; Singh, Parvinder; Srinivas, Arun; Thacker, Hemant; Thanvi, Sunil; Thomas, Joy; Adawi, Faiad; Bashkin, Amir; Cohen, Josef; Harman-Boehm, Ilana; Hasin, Yonathan; Hayek, Tony; Iakobishvili, Zaza; Katz, Amos; Kracoff, Oscar; Minuchin, Oscar; Moriel, Mady; Mosseri, Morris; Omary, Muhamad; Wainstein, Julio; Weiss, Avraham; Zeltser, David; Calabro, Paolo; Derosa, Giuseppe; Genovese, Stefano; Novo, Salvatore; Olivieri, Carlo; Piatti, Piermarco; Violini, Roberto; Volpe, Massimo; Ajioka, Masayoshi; Amano, Tetsuya; Arasaki, Osamu; Daida, Hiroyuki; Fujimoto, Kazuteru; Fujinaga, Hiroyuki; Higashiue, Shinichi; Hirohata, Atsushi; Hosokawa, Shinobu; Ikefuji, Hiroyuki; Inagaki, Masayuki; Iseki, Harukazu; Iwabuchi, Masashi; Iwasaki, Toshiya; Kakishita, Mikio; Katsuda, Yousuke; Kawada, Kimiko; Kawajiri, Kenji; Kawamitsu, Katsunori; Kobayashi, Katsuyuki; Komada, Fumihiko; Komura, Yasuo; Machida, Masaharu; Maemura, Koji; Matsubara, Taku; Matsubayashi, Sunao; Matsumoto, Tomoaki; Matsumoto, Naoki; Mima, Tsutomu; Miyamoto, Nobuhide; Momiyama, Yukihiko; Morimoto, Takafumi; Murakami, Marohito; Nakashima, Eitaro; Niijima, Yawara; Noda, Toshiyuki; Node, Koichi; Nozaki, Akira; Nunohiro, Tatsuya; Ogawa, Tomohiro; Ono, Yasuhiro; Saeki, Takahiro; Sakota, Shinichiro; Sakuragi, Satoru; Sasaki, Toyoshi; Sato, Yasuhiro; Sueyoshi, Atsushi; Suzuki, Masahiro; Takagi, Gen; Tanabe, Jun; Tanaka, Seiichi; Tei, Imun; Yamamoto, Masato; Yanagihara, Kaoru; Hong, Taek Jong; Jeon, Hui-Kyung; Kang, Duk-Hyun; Kim, Cheol Ho; Kim, Dong-Soo; Kim, Hyun-Sook; Kim, June Hong; Kim, Soon Kil; Kim, Woo-Shik; Kim, Young-Kwon; Lee, SangRok; Lee, Kwan-Woo; Park, Hun-Sik; Pyun, Wook Bum; Rha, Seung-Woon; Yoon, Junghan; Yoon, Kun-Ho; Bennakhi, Abdullah; Geldnere, Kristine; Sokolova, Jelena; Teterovska, Dace; Dautaraite, Violeta; Kakariekiene, Vaida; Kavaliauskiene, Roma; Kucinskiene, Alina; Lasiene, Jurate; Mickuviene, Narseta; Palinauskas, Algirdas; Urboniene, Audrone; Zilaitiene, Birute; Manap, Hasmannizar Abdul; Abidin, Imran Zainal; Isa, Siti Harnida Md; Khir, Amir Md.; Ng, Kok Huan; Tan, Florence; Yusof, Zurkurnai; Yusoff, Khalid; Zambahari, Robaayah; Aguila-Marin, Javier; Aguilera Real, Manuel; Alvarado-Ruiz, Ricardo; Alvarez Lopez, Humberto; Arenas Leon, Jose; Bayram Llamas, Edmundo Alfredo; Calvo Vargas, Cesar; Carrillo Calvillo, Jorge; De los Rios Ibarra, Manuel; Alberto Dominguez-Reyes, Carlos; Duarte, Manuel; Elizondo, Eduardo; Fajardo Campos, Pedro; Fanghanel-Salmon, Guillermo; Figueroa Sauceda, Sergio; Gallegos Martinez, Jose; Garcia-Cantu, Elias; Garza Ruiz, Jose Angel; Gonzalez Gonzalez, Jose Gerardo; Guerrero Garza, Manuel; Hernandez Herrera, Carlos; Hernandez Munuzuri, Jesus; Hernandez-Garcia, Hugo; Jimenez Ramos, Silvia; Laviada Molina, Hugo; Lopez Villezca, David; Montano-Gonzalez, Efrain; Nevarez Ruiz, Luis; Ramos Lopez, Gabriel; Reyes Araiza, Raul; Salazar-Gaytan, Abel; Salcido Vazquez, Eduardo; Sanchez Mijangos, Hector; Solis Morales, Lucas; Benatar, Jocelyne; Dixon, Paul; Nirmalaraj, Kingsley; Rosen, Ian; Scott, Russell; Young, Simon; Araoz Tarco, Ofelia; Barreda Caceres, Luis; Benites Lopez, Carmen; Camacho Cosavalente, Luis; Chavez Huapalla, Edith; Chois Malaga, Augusto; Copaja Flores, Alex; Farfan Aspilcueta, Julio; Gallardo Rojas, Wilson; Gallegos Cazorla, Alex; Galvez Caballero, David; Garcia Matheus, Julio; Garrido Carrasco, Elizabeth; Gomez Sanchez, Jorge; Hernandez Zuniga, Jose; Lu Galarreta, Libia; Luna, Alejandro; Manrique Hurtado, Helard; Orihuela Pastor, Boris; Maria Pando Alvarez, Rosa; Sanchez Povis, Javier; Torres Eguiluz, Pedro; Valdivia Portugal, Angelica; Vargas Gonzales, Rolando; Zapata Rincon, Luis; Aquitania, Grace; Fortinez, Judy Theresa; Go, Angelita; Gomez, Maria Honolina; Habaluyas, Ramoncito; Jasul, Gabriel; Magno, Marie; Manalo, Carlo John; Mirasol, Roberto; Morales-Palomares, Ellen; Salvador, David Raymund; Sy, Rosa Allyn; Tirador, Louie; Yao, Christy; Arciszewska, Malgorzata; Bartkowiak, Radoslaw; Czajkowska-Kaczmarek, Eugenia; Gil, Robert; Gniot, Jacek; Janik, Krzysztof; Janion, Marianna; Jaworska, Krystyna; Jozwa, Robert; Kawecka-Jaszcz, Kalina; Kawka-Urbanek, Teresa; Kondys, Marek; Korecki, Janusz; Korzeniak, Romuald; Kowalisko, Alicja; Krzeminska-Pakula, Maria; Kwiecien, Jolanta; Nessler, Jadwiga; Odrowaz-Pieniazek, Piotr; Piepiorka, Marek; Rajzer, Marek; Skokowska, Ewa; Spyra, Janusz; Sroka, Michal; Stasinska, Teresa; Szymczyk, Ireneusz; Trznadel-Morawska, Iwona; Wysokinski, Andrzej; Mateus, Pedro; Matos, Pedro; Mimoso, Jorge; Monteiro, Pedro; Caballero, Baruch; Garcia-Rinaldi, Raul; Gonzalez, Elena; Ortiz-Carrasquillo, Ramon; Roman, Amaury; Sierra, Yolanda; Unger, Nestor; Vazquez-Tanus, Jose; Alexandru, Tom; Busegeanu, Mihaela; Cozman, Doina Constanta; Fica, Simona; Minescu, Bogdan; Morosanu, Magdalena; Negrisanu, Gabriela Doina; Pintilei, Ella; Pop, Lavinia; Szilagyi, Iosif; Teodorescu, Iulia; Tomescu, Mirela; Barbarash, Olga; Chumakova, Galina; Churina, Svetlana; Dogadin, Sergey; Dvoryashina, Irina; Esip, Valeria; Glezer, Maria; Gordeev, Ivan; Gordienko, Alexander; Gratsiansky, Nikolay; Grineva, Elena; Khasanov, Niaz; Kostenko, Victor; Meleshkevich, Tatiana; Mikhin, Vadim; Morugova, Tatyana; Motylev, Igor; Nikolaev, Konstantin; Ponomareva, Asya; Repin, Mikhail; Reshetko, Olga; Shustov, Sergey; Shutemova, Elena; Shvarts, Yury; Simanenkov, Vladimir; Sobolev, Konstantin; Sukmanova, Irina; Timofeev, Alexander; Tsyba, Larisa; Varvarina, Galina; Vertkin, Arkadiy; Vishnevsky, Alexander; Volkov, Dmitry; Vorobiev, Sergey; Vorokhobina, Natalya; Yakhontov, Davyd; Zonova, Elena; Zrazhevskiy, Konstantin; Damjanovic, Svetozar; Djordjevic, Dragan; Pavlovic, Milan; Perunicic, Jovan; Ristic, Arsen; Stojkovic, Sinisa; Tasic, Nebojsa; Bolvanska, Nora; Buganova, Ingrid; Dulkova, Katarina; Dzupina, Andrej; Fulop, Peter; Gergel, Vladimir; Kokles, Martin; Micko, Karol; Svoren, Peter; Urban, Miroslav; Vadinova, Silvia; Vargova, Anna; Burgess, Leslie; Coetzee, Kathleen; Du Toit, Jacques; Gani, Mashra; Joshi, Pankaj; Naiker, Puvanesveri; Nortje, Hendrik; Sarvan, Mahomed; Seeber, Mary; Siebert, Mirna; van Zyl, Louis; Wellmann, Holger; Calvo, Carlos; De la Hera, Jesus; De Teresa, Luis; Melero-Pita, Antonio; Mesa, Jordi; Parra Barona, Juan; Serrano, Pedro; Soto, Alfonso; Tofe, Santiago; Hornestam, Bjorn; Kempe, Anders; Rosenqvist, Ulf; Rydberg, Erik; Tengmark, Bengt-Olov; Torstensson, Ingemar; Chang, Chwen-Tzuei; Hsia, Te-Lin; Hsieh, I-Chang; Lai, Wen-Ter; Wu, Chiung-Jen; Hutayanon, Pisit; Kosachunhanun, Natapong; Marapracertsak, Mongkol; Piamsomboon, Chumpol; Seekaew, Samroeng; Srimahachota, Suphot; Sukhum, Pradub; Suraamornkul, Swangjit; Tantiwong, Puntip; Wongvipaporn, Chaiyasith; Amosova, Kateryna; Barna, Olga; Bazylevych, Andriy; Berenfus, Vadym; Dyadyk, Alexander; Fushtey, Ivan; Gyrina, Olga; Iabluchanskyi, Mykola; Karpenko, Oleksandr; Kaydashev, Igor; Korzh, Oleksii; Kulynych, Roman; Legkonogov, Olexandr; Mankovsky, Boris; Mostovoy, Yuriy; Parkhomenko, Oleksandr; Popik, Galyna; Rudenko, Leonid; Rudyk, Iurii; Shevchuk, Sergii; Sirenko, Yuriy; Suprun, Yevgen; Tryshchuk, Nadiya; Tseluyko, Vira; Vakaliuk, Igor; Al Mahmeed, Wael; Acheatel, Roger; Ahmad, Anwar; Akbar, Saleem; Akhter, Faiq; Albirini, Abdulhay; Alexander, Arnold; Al-Joundi, Bassam; Al-Joundi, Tammam; Allen, Gregory; Aloi, Joseph; Alvarado, Odilon; Alzohaili, Opada; Anderson, Corey; Arastu, Anwar; Arena, Charles; Argoud, Georges; Ariani, Mehrdad; Arora, Chander; Awasty, Vivek; Barker, Barbara; Barnum, Otis; Bartkowiak, Anthony J.; Barzilay, Joshua; Behrens, Phillip; Belledonne, Mario; Bergman, Bradford; Bilnoski, William; Bisognano, John; Bissette, Stephen; Blumberg, Edwin; Bonabi, Nagadeh; Bradley, Arden; Breton, Cristian; Britos, Martin; Broadstone, Vasti; Budoff, Matthew; Burge, Mark; Butman, Samuel; Carroll, Mary; Challappa, Krishnan; Chepuri, Vinaya; Cherlin, Richard; Cheung, Deanna; Coats, Peter; Collins, John; Cruz, Humberto; Daboul, Nizar; Damberg, Greg; David, William; Dean, Julius; Dedeke, Eric; Deeb, Wasim; DeHaven, Joseph; Dobs, Adrian; Donelan, Timothy; Dy, Johnny; Dykstra, Gary; Eisen, Howard; Farris, Neil; Fattal, Peter; Fishman, Norman; Foster, Malcom; Fredrickson, Sonja; Gabra, Nashwa; Gabriel, John; Gatien, Lionel; Giddings, Stephen; Ginsberg, Burton; Gips, Sanford; Glandt, Mariela; Goldfein, Aaron; Gordon, Murray; Gould, Randy; Graf, Ronald; Graham, Bruce; Graves, Mark; Grena, Paul; Hahn, Richard; Hamilton, Dale; Hamroff, Glenn; Hanke, Forrest; Haque, Ihsan; Harper, James, Jr.; Harris, Anthony; Harris, Sharon; Henson, Bruce; Hermanns, David; Herndon, William; Hershberger, Vernon; Hyman, Daniel; Isserman, Steven; Iteld, Bruce; Jacob, Moshir; Jaffrani, Naseem; Jamal, Aamir; Johnson, David; Johnson, Glover; Kaluski, Edo; Keller, Robert; Kereiakes, Dean; Khan, Muhammad; Khan, Salman; Khan, Misal; Klein, Michael; Knutson, Thomas; Korban, Elie; Kozinn, Marc; Kraft, Philip; Kroeze, James; Kukuy, Eugene; Lader, Ellis; Laliotis, Aristotelis; Lambert, Charles, Jr.; Landau, Charles; Latif, Kashif; Lee, Kwan; Lester, F.; Levenson, David; Levinson, Dennis; Lewis, Derek; Litt, Marc; Littlefield, Ronald; Lo, Eric; Lovell, Charles; Mahal, Sharan; Makam, Satyaprakash; Mandviwala, Mustafa; Marar, Isam; Masri, Bassem; Mattson, Steven; Mays, Maureen; McGrew, Frank; Meengs, Mark; Mikell, Frank; Miller, Michael; Miranda, Francisco; Moll, David; Multani, Pramod; Munuswamy, Karan; Nallasivan, Mani; Nayles, Lee; Ong, Stephen; Pacheco, Theodore; Paez, Henry; Patel, Shailendra; Phillips, Roland; Pierpont, Brien; Prasad, Jeereddi; Quinlan, Edward; Quion, Jun; Qureshi, Mansoor; Rahman, Aref; Raikhel, Marina; Ramanathan, Kodangudi; Randhawa, Preet; Ravi, Ram; Reddy, Rajneesh; Rendell, Marc; Rickner, Kyle; Rictor, Kenneth; Rivas, Jose; Rosenblit, Paul; Rosenstock, Julio; Ross, Steven; Salacata, Abraham; Saririan, Mehrdrad; Schima, Susan; Schlau, Aron; Schmedtje, John; Scott, Cranford; Scott, David; Serru-Paez, Antonio; Shah, Rakesh; Shah, Anil; Shaoulian, Emanuel; Shomali, Mansur; Shubrook, Jay; Silver, Kevin; Singh, Sanjay; Speer, John; Stevens, Jewel; Stringam, Stanley; Taussig, Andrew; Taylor, Angela; Tee, Howard; Teixeira, Gilbert; Tilley, Absalom; Toggart, Edward; Twahirwa, Marcel; Unks, Dennis; Vakili, Babak; Vora, Kishor; Wang, Xiangbing; Warner, Alberta; Wefald, Franklin; Weinberg, Bradley; Weinstein, Debra; White, Lindsey; Wu, Patricia; Yasuda, Tsunehiro; Yazdani, Shahram; Yetman, Cornelius; Zarich, Stuart; Zebrack, James; Fonseca, Vivian A.; McCullough, Peter A.; Desouza, Cyrus; Goff, David C.; Harrell, Frank E., Jr.; Menon, Venu; Sila, Cathy; Kalahasti, Vidyasagar; Ahmed, Salim; Al Solaiman, Firas; Bennett, Mosi; Cavender, Matthew; Heil, Barbara; Katzan, Irene; Monteleone, Peter; O'Brien, Bridget; Oommen, Santosh; Senn, Todd; Sharma, Jitendra; Stegman, Brian; Uchino, Ken; Zishiri, Edwin; Pasca, Narcis; Brown, Kimberly; Scebbi, Tambria; Atanasovski, Ilija; McCue, Maggie; Streit, Janet; Oh, Richard; Bueno, Orlando; Lee, Douglas; Camisasca, Riccardo; Miyata, Yuuko; Rubin, Anne; Williamson, Nyree; Vara, Sanjay; Keeter, Kraig; Ross, Ben; de los Reyes, Amy; Donnelly, Julie; Koshy-Hunt, Sini; Beers, Brian; Black, Stephen; Buckley, Maria; Ephrem, Maria; Riley, Bill; West, Nicola; Harre, Mark; Hsieh, Roger; Oshinyemi, Keji; Oka, Yumiko; Matsui, Nobuto; Hoang, Minhtri; Doyle, Cassandra; Koziol, Maria; Lam, Hung; Edmonds, Anthony; Azooz, Willow; Cao, Charlie; Kim, Denny; Boeshaar, Amy; Dewindt, Alex; Nicholson, Kim; Smith, Neila; Hisada, Michie; Harding, Sarah; Cannon, Clive; Yoshioka, Norihito; Gujral-Sandhu, Kiran; Gans, Jason; Gresk, Christopher; Kujawski, Michelle R.; Villinski, Allison; Cosner, Sandy; Johannsen, Clint; Barchha, Nina; Knapp, Beth		EXAMINE Investigators	Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR SAFETY; MYOCARDIAL-INFARCTION; INHIBITOR ALOGLIPTIN; MELLITUS; OUTCOMES	BackgroundTo assess potentially elevated cardiovascular risk related to new antihyperglycemic drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive evaluation of the cardiovascular safety profile of new antidiabetic therapies. We assessed cardiovascular outcomes with alogliptin, a new inhibitor of dipeptidyl peptidase 4 (DPP-4), as compared with placebo in patients with type 2 diabetes who had had a recent acute coronary syndrome. MethodsWe randomly assigned patients with type 2 diabetes and either an acute myocardial infarction or unstable angina requiring hospitalization within the previous 15 to 90 days to receive alogliptin or placebo in addition to existing antihyperglycemic and cardiovascular drug therapy. The study design was a double-blind, noninferiority trial with a prespecified noninferiority margin of 1.3 for the hazard ratio for the primary end point of a composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. ResultsA total of 5380 patients underwent randomization and were followed for up to 40 months (median, 18 months). A primary end-point event occurred in 305 patients assigned to alogliptin (11.3%) and in 316 patients assigned to placebo (11.8%) (hazard ratio, 0.96; upper boundary of the one-sided repeated confidence interval, 1.16; P<0.001 for noninferiority). Glycated hemoglobin levels were significantly lower with alogliptin than with placebo (mean difference, -0.36 percentage points; P<0.001). Incidences of hypoglycemia, cancer, pancreatitis, and initiation of dialysis were similar with alogliptin and placebo. ConclusionsAmong patients with type 2 diabetes who had had a recent acute coronary syndrome, the rates of major adverse cardiovascular events were not increased with the DPP-4 inhibitor alogliptin as compared with placebo. (Funded by Takeda Development Center Americas; EXAMINE ClinicalTrials.gov number, NCT00968708.)	[White, William B.] Univ Connecticut, Sch Med, Farmington, CT 06030 USA; [Cannon, Christopher P.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Cannon, Christopher P.] Harvard Univ, Sch Med, Boston, MA USA; [Mehta, Cyrus R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Heller, Simon R.] Univ Sheffield, Sheffield, S Yorkshire, England; [Nissen, Steven E.] Cleveland Clin Fdn, Cleveland, OH USA; [Bergenstal, Richard M.] Pk Nicollet Clin, Int Diabet Ctr, Minneapolis, MN USA; [Bakris, George L.] Univ Chicago Med, Chicago, IL USA; [Perez, Alfonso T.; Fleck, Penny R.; Kupfer, Stuart; Wilson, Craig] Takeda Dev Ctr Amer, Deerfield, IL USA; [Cushman, William C.] Univ Tennessee, Coll Med, Memphis Vet Affairs Med Ctr, Memphis, TN USA; [Zannad, Faiez] Univ Lorraine, INSERM, U9501, Nancy, France; [Zannad, Faiez] Ctr Hosp Univ, Nancy, France	University of Connecticut; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Sheffield; Cleveland Clinic Foundation; International Diabetes Center; Takeda Pharmaceutical Company Ltd; Takeda Development Center Americas, Inc.; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy	White, WB (corresponding author), Univ Connecticut, Calhoun Cardiol Ctr, Dept Med, Sch Med, 263 Farmington Ave, Farmington, CT 06030 USA.	wwhite@nso1.uchc.edu	Shvarts, Yury Григорьевич/AAB-4929-2022; Khasanov, Niiaz/W-7678-2019; Tomescu, Mirela Cleopatra/M-9101-2014; Van Beers, Bernard/N-2816-2016; Chumakova, Galina A/L-5677-2015; Miller, Michael/AGX-6773-2022; Genovese, Stefano/F-9706-2017; Sepúlveda, Pablo/GXF-5175-2022; Budoff, Matthew/ABD-5175-2021; Kaidashev, Igor/L-2606-2019; Calabro, Paolo/AAC-2704-2022; Greiver, Michelle/N-8764-2015; Rudyk, Iurii/AAG-4668-2021; Korzh, Oleksii/E-4291-2016; Menon, Venu/AAF-1871-2019; Costa, FA/E-9691-2016; Saravanan, P/M-6142-2016; Abhyankar, Atul/AAG-4551-2020; Colquhoun, David M/F-9078-2013; Stojkovic, Sinisa/AAD-4977-2022; Rha, Seung-Woon/AGE-5810-2022; Djordjevic, Dragan/ABC-7327-2020; Shevchuk, Sergii/Y-8642-2018; Cannon, Christopher P/AAY-7644-2020; Derosa, Giuseppe/H-8571-2019; Maia, Lilia Nigro/AAV-6938-2021; Barbosa, Eduardo/AAJ-5790-2020; Khan, Shahzeb/AAN-1515-2020; Berenfus, Vadym/J-5076-2014; Bazylevych, Andriy/G-2834-2019; Mankovsky, Boris/W-3061-2018; Tasic, Nebojsa/AAE-1809-2020; VILELA-MARTIN, JOSE/I-8305-2014; Wilding, John/ABB-6443-2020; Nikolaev, Konstantin/P-4750-2017; Jurišić-Eržen, Dubravka/S-1769-2018; Volpe, Massimo/K-5240-2016; Gordeev, Ivan/AAB-5950-2022; Cheema, Asim N./AAA-7676-2020; Reshetko, Olga/I-7011-2013; Sepúlveda, Pablo Espicel/HCI-5123-2022; Bellary, Srikanth/ABA-1977-2020; Precoma, Dalton B/D-5674-2013; Scott, Russell/ABC-8328-2020; Yusof, Zurkurnai/AAA-5893-2021; Piatti, Piermarco/AAN-3115-2020; Airaksinen, Juhani/AAC-7857-2021; Sirenko, Yuriy M/C-8012-2019; Zannad, Faiez/K-4649-2019; Tryshchuk, Nadiya/AAB-6103-2020; Piskorz, Daniel/AAJ-8751-2020; Reis, Gilmar/I-4500-2013; Dvoryashina, Irina/AAE-4533-2019; Poerner, Tudor C/L-1755-2016; Cosman, Doina/L-9087-2013; Uchino, Ken/ABC-1611-2021; Wainstein, Marco Vugman/AAQ-1248-2020; Grineva, Ele N./V-8221-2018; Aleksandr, Legkonogov/P-8914-2015; Braile-Sternieri, Maria Christiane Valeria Braga/P-9461-2018	Shvarts, Yury Григорьевич/0000-0002-5205-7311; Khasanov, Niiaz/0000-0002-7760-0763; Tomescu, Mirela Cleopatra/0000-0003-2117-0474; Van Beers, Bernard/0000-0001-6429-1140; Chumakova, Galina A/0000-0002-2810-6531; Miller, Michael/0000-0002-1679-2095; Genovese, Stefano/0000-0002-6085-437X; Budoff, Matthew/0000-0002-9616-1946; Kaidashev, Igor/0000-0002-4708-0859; Greiver, Michelle/0000-0001-8957-0285; Korzh, Oleksii/0000-0001-6838-4360; Costa, FA/0000-0003-0562-2514; Saravanan, P/0000-0002-9566-2626; Rha, Seung-Woon/0000-0001-9456-9852; Djordjevic, Dragan/0000-0003-4966-0168; Shevchuk, Sergii/0000-0002-5649-2775; Cannon, Christopher P/0000-0003-4596-2791; Derosa, Giuseppe/0000-0003-3573-4760; Barbosa, Eduardo/0000-0002-4361-936X; Berenfus, Vadym/0000-0003-3154-1814; Bazylevych, Andriy/0000-0001-5053-2548; Mankovsky, Boris/0000-0001-8289-3604; VILELA-MARTIN, JOSE/0000-0001-6960-2825; Wilding, John/0000-0003-2839-8404; Nikolaev, Konstantin/0000-0003-4601-6203; Jurišić-Eržen, Dubravka/0000-0002-6614-9778; Volpe, Massimo/0000-0002-9642-8380; Cheema, Asim N./0000-0002-3174-8957; Reshetko, Olga/0000-0003-3107-7636; Bellary, Srikanth/0000-0002-5924-5278; Scott, Russell/0000-0002-2107-6480; Airaksinen, Juhani/0000-0002-0193-568X; Sirenko, Yuriy M/0000-0002-4091-4910; Tryshchuk, Nadiya/0000-0002-6680-2060; Piskorz, Daniel/0000-0002-8615-5446; Reis, Gilmar/0000-0002-4847-1034; Dvoryashina, Irina/0000-0001-9230-0710; Poerner, Tudor C/0000-0001-9303-6165; Cosman, Doina/0000-0001-7102-2432; Uchino, Ken/0000-0001-9468-4172; Wainstein, Marco Vugman/0000-0002-7284-1453; TOFE, SANTIAGO/0000-0003-3034-4667; Aleksandr, Legkonogov/0000-0002-5551-4872; Shutemova, Elena/0000-0002-5324-3570; Braile-Sternieri, Maria Christiane Valeria Braga/0000-0003-2704-2481; Guimaraes, Anthony/0000-0002-9982-2471; Laviada, Hugo/0000-0002-9298-9383; pando, rosa/0000-0002-6112-802X; Pieber, Thomas/0000-0003-3554-0405; Tabak, Adam/0000-0002-6234-3936; Gomes Sarmento Leite, Rogerio Eduardo/0000-0002-9674-8528; ELBAZ, Meyer/0000-0002-3520-7883; Richardson, Tristan/0000-0001-7505-7843; Heller, Simon/0000-0002-2425-9565	Takeda Development Center Americas; National Institute for Health Research [NF-SI-0611-10248] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24591075] Funding Source: KAKEN; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER	Takeda Development Center Americas; National Institute for Health Research(National Institute for Health Research (NIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funded by Takeda Development Center Americas	Abbatecola AM, 2008, DRUG AGING, V25, P913, DOI 10.2165/0002512-200825110-00002; FDA, 2008, GUID IND DIAB MELL E; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Ghatak SB, 2010, CURR DIABETES REV, V6, P410, DOI 10.2174/157339910793499119; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; Holst JJ, 1998, DIABETES, V47, P1663, DOI 10.2337/diabetes.47.11.1663; JENNISON C, 1989, J R STAT SOC B, V51, P305; Jose T, 2012, DIABETES VASC DIS RE, V9, P109, DOI 10.1177/1479164111436236; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Meigs JB, 2003, ACTA DIABETOL, V40, pS358, DOI 10.1007/s00592-003-0120-0; Monami M, 2013, DIABETES OBES METAB; Monami M, 2011, CURR MED RES OPIN, V27, P57, DOI 10.1185/03007995.2011.602964; National diabetes fact sheet, 2007, NAT DIAB FACT SHEET; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Scirica BM, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.006; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; White WB, 2013, DIABETES OBES METAB, V15, P668, DOI 10.1111/dom.12093; White WB, 2011, AM HEART J, V162, P620, DOI 10.1016/j.ahj.2011.08.004; Zannad F, 2012, EUR HEART J, V33, P1049, DOI 10.1093/eurheartj/ehr437	23	1822	1891	7	164	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 3	2013	369	14					1327	1335		10.1056/NEJMoa1305889	http://dx.doi.org/10.1056/NEJMoa1305889			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	227KI	23992602	Green Accepted			2022-12-28	WOS:000325111200010
J	Eikelboom, JW; Connolly, SJ; Brueckmann, M; Granger, CB; Kappetein, AP; Mack, MJ; Blatchford, J; Devenny, K; Friedman, J; Guiver, K; Harper, R; Khder, Y; Lobmeyer, MT; Maas, H; Voigt, JU; Simoons, ML; Van de Werf, F				Eikelboom, John W.; Connolly, Stuart J.; Brueckmann, Martina; Granger, Christopher B.; Kappetein, Arie P.; Mack, Michael J.; Blatchford, Jon; Devenny, Kevin; Friedman, Jeffrey; Guiver, Kelly; Harper, Ruth; Khder, Yasser; Lobmeyer, Maximilian T.; Maas, Hugo; Voigt, Jens-Uwe; Simoons, Maarten L.; Van de Werf, Frans		RE-ALIGN Investigators	Dabigatran versus Warfarin in Patients with Mechanical Heart Valves	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATRIAL-FIBRILLATION; RANDOMIZED EVALUATION; HEALTHY-VOLUNTEERS; ETEXILATE; REPLACEMENT	BackgroundDabigatran is an oral direct thrombin inhibitor that has been shown to be an effective alternative to warfarin in patients with atrial fibrillation. We evaluated the use of dabigatran in patients with mechanical heart valves. MethodsIn this phase 2 dose-validation study, we studied two populations of patients: those who had undergone aortic- or mitral-valve replacement within the past 7 days and those who had undergone such replacement at least 3 months earlier. Patients were randomly assigned in a 2:1 ratio to receive either dabigatran or warfarin. The selection of the initial dabigatran dose (150, 220, or 300 mg twice daily) was based on kidney function. Doses were adjusted to obtain a trough plasma level of at least 50 ng per milliliter. The warfarin dose was adjusted to obtain an international normalized ratio of 2 to 3 or 2.5 to 3.5 on the basis of thromboembolic risk. The primary end point was the trough plasma level of dabigatran. ResultsThe trial was terminated prematurely after the enrollment of 252 patients because of an excess of thromboembolic and bleeding events among patients in the dabigatran group. In the as-treated analysis, dose adjustment or discontinuation of dabigatran was required in 52 of 162 patients (32%). Ischemic or unspecified stroke occurred in 9 patients (5%) in the dabigatran group and in no patients in the warfarin group; major bleeding occurred in 7 patients (4%) and 2 patients (2%), respectively. All patients with major bleeding had pericardial bleeding. ConclusionsThe use of dabigatran in patients with mechanical heart valves was associated with increased rates of thromboembolic and bleeding complications, as compared with warfarin, thus showing no benefit and an excess risk. (Funded by Boehringer Ingelheim; ClinicalTrials.gov numbers, NCT01452347 and NCT01505881.) In a phase 2 trial, patients with mechanical heart valves were randomly assigned to receive either dabigatran or warfarin for anticoagulation. Dabigatran was associated with higher rates of ischemic stroke (5%, vs. 0% with warfarin) and major bleeding (4% vs. 2%). Prosthetic heart-valve replacement is recommended for many patients with severe valvular heart disease and is performed in several hundred thousand patients worldwide each year.(1) Mechanical valves are more durable than bioprosthetic valves(2) but typically require lifelong anticoagulant therapy. The use of vitamin K antagonists provides excellent protection against thromboembolic complications in patients with mechanical heart valves(3) but requires restrictions on food, alcohol, and drugs and lifelong coagulation monitoring. Because of the limitations of vitamin K antagonists, many patients opt for a bioprosthesis rather than a mechanical valve, despite the higher risk of premature valve failure requiring repeat valve-replacement surgery with ...	[Eikelboom, John W.; Connolly, Stuart J.] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada; [Brueckmann, Martina; Lobmeyer, Maximilian T.; Maas, Hugo] Boehringer Ingelheim KG, Ingelheim, Germany; [Brueckmann, Martina] Heidelberg Univ, Fac Med Mannheim, Mannheim, Germany; [Granger, Christopher B.] Duke Clin Res Inst, Durham, NC USA; [Kappetein, Arie P.] Erasmus Univ, Med Ctr, Dept Cardiothorac Surg, Rotterdam, Netherlands; [Simoons, Maarten L.] Erasmus Univ, Med Ctr, Dept Cardiol, Rotterdam, Netherlands; [Mack, Michael J.] Heart Hosp Baylor, Plano, TX USA; [Blatchford, Jon; Devenny, Kevin; Guiver, Kelly; Harper, Ruth] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England; [Friedman, Jeffrey] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Khder, Yasser] Boehringer Ingelheim GmbH & Co KG, Paris, France; [Voigt, Jens-Uwe; Van de Werf, Frans] Katholieke Univ Leuven, Dept Cardiovasc Sci, B-3000 Louvain, Belgium	McMaster University; Boehringer Ingelheim; Ruprecht Karls University Heidelberg; Duke University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; KU Leuven	Van de Werf, F (corresponding author), Katholieke Univ Leuven, Univ Hosp Leuven, Dept Cardiovasc Sci, Herestr 49, B-3000 Louvain, Belgium.	frans.vandewerf@med.kuleuven.be	Eikelboom, John/AAG-6117-2019; Brat, Radim/G-7925-2019; Granger, Christopher B/D-3458-2014; Ponikowski, Piotr/O-6454-2015; Siepe, Matthias/AAF-9846-2019	Eikelboom, John/0000-0003-4126-1285; Brat, Radim/0000-0001-9381-9135; Granger, Christopher B/0000-0002-0045-3291; Ponikowski, Piotr/0000-0002-3391-7064; Siepe, Matthias/0000-0003-3305-9343; Voigt, Jens-Uwe/0000-0002-0575-1888; Van de Werf, Frans/0000-0001-9479-7767; Blatchford, Jon/0000-0001-9354-9657	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Supported by Boehringer Ingelheim.	Ageno W, 2012, CHEST S, V141, pe44S; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dansirikul C, 2012, THROMB HAEMOSTASIS, V107, P775, DOI 10.1160/TH11-09-0656; Dewanjee MK, 1999, J HEART VALVE DIS, V8, P324; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Kaeberich A, 2011, J THROMB THROMBOLYS, V32, P417, DOI 10.1007/s11239-011-0621-6; Lehr T, 2012, J CLIN PHARMACOL, V52, P1373, DOI 10.1177/0091270011417716; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Liesenfeld KH, 2011, J THROMB HAEMOST, V9, P2168, DOI 10.1111/j.1538-7836.2011.04498.x; Maegdefessel L, 2010, THROMB RES, V126, pE196, DOI 10.1016/j.thromres.2010.06.011; McKellar SH, 2011, J THORAC CARDIOV SUR, V141, P1410, DOI 10.1016/j.jtcvs.2011.02.011; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Reilly PA, J AM COLL C IN PRESS; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schomburg JL, 2012, J INVEST SURG, V25, P150, DOI 10.3109/08941939.2011.616256; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Stangier J, 2005, J CLIN PHARMACOL, V45, P555, DOI 10.1177/0091270005274550; Stassano P, 2009, J AM COLL CARDIOL, V54, P1862, DOI 10.1016/j.jacc.2009.07.032; Sun JCJ, 2009, LANCET, V374, P565, DOI 10.1016/S0140-6736(09)60780-7; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Van de Werf F, 2012, AM HEART J, V163, P931, DOI 10.1016/j.ahj.2012.03.011; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4	25	876	901	1	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1206	1214		10.1056/NEJMoa1300615	http://dx.doi.org/10.1056/NEJMoa1300615			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	23991661				2022-12-28	WOS:000324888200007
J	Buzdar, AU				Buzdar, Aman U.			Meta-analysis: Selective estrogen-receptor modulators reduce breast cancer incidence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Buzdar, AU (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.				Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Gail MH, 2011, STAT MED, V30, P1090, DOI 10.1002/sim.4187; Petracci E, 2011, JNCI-J NATL CANCER I, V103, P1037, DOI 10.1093/jnci/djr172	2	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC9	10.7326/0003-4819-159-6-201309170-02009	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042392				2022-12-28	WOS:000325625900008
J	Lee, JW; Mayer-Gall, T; Opwis, K; Song, CE; Gutmann, JS; List, B				Lee, Ji-Woong; Mayer-Gall, Thomas; Opwis, Klaus; Song, Choong Eui; Gutmann, Jochen Stefan; List, Benjamin			Organotextile Catalysis	SCIENCE			English	Article							POLYMER; IMMOBILIZATION; ANHYDRIDES; ACID; PET	Throughout human history, textiles have been integral to daily life, but their exploration in catalysis has been rare. Herein, we show a facile and permanent immobilization of organocatalysts on the textile nylon using ultraviolet light. The catalyst and the textile material require no chemical modification for the immobilization. All of the prepared textile-immobilized organocatalysts (a Lewis basic, a Bronsted acidic, and a chiral organocatalyst) display excellent stability, activity, and recyclability for various organic transformations. Very good enantioselectivity (>95:5 enantiomeric ratio) can be maintained for more than 250 cycles of asymmetric catalysis. Practical and straightforward applications of textile organocatalysis may be beneficial for various fields by offering inexpensive and accessible functionalized catalytic materials.	[Lee, Ji-Woong; List, Benjamin] Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany; [Mayer-Gall, Thomas; Opwis, Klaus; Gutmann, Jochen Stefan] Deutsch Text Forschungszentrum Nord West GGmbH, D-47798 Krefeld, Germany; [Song, Choong Eui] Sungkyunkwan Univ, Dept Chem, Suwon 440746, Gyeonggi, South Korea; [Gutmann, Jochen Stefan] Univ Duisburg Essen, Inst Phys Chem, D-45117 Essen, Germany; [Gutmann, Jochen Stefan] Univ Duisburg Essen, CENIDE Ctr Nanointegrat, D-45117 Essen, Germany	Max Planck Society; Sungkyunkwan University (SKKU); University of Duisburg Essen; University of Duisburg Essen	Opwis, K (corresponding author), Deutsch Text Forschungszentrum Nord West GGmbH, Adlerstr 1, D-47798 Krefeld, Germany.	opwis@dtnw.de; list@kofo.mpg.de	Lee, Ji-Woong/I-8929-2016; Mayer-Gall, Thomas/O-9062-2015; Gutmann, Jochen S/A-5103-2009; Opwis, Klaus/AAX-6248-2021	Lee, Ji-Woong/0000-0001-6177-4569; Mayer-Gall, Thomas/0000-0002-2822-6461; Gutmann, Jochen S/0000-0002-1394-9202; Opwis, Klaus/0000-0002-1255-8568; Song, Choong Eui/0000-0001-9221-6789				Anderson NG, 2012, ORG PROCESS RES DEV, V16, P852, DOI 10.1021/op200347k; Benaglia M, 2003, CHEM REV, V103, P3401, DOI 10.1021/cr010440o; Bleschke C, 2011, ADV SYNTH CATAL, V353, P3101, DOI 10.1002/adsc.201100674; Bredig G, 1935, BIOCHEM Z, V282, P88; Cozzi F, 2006, ADV SYNTH CATAL, V348, P1367, DOI 10.1002/adsc.200606096; Datsevich L. B., 2012, CONVENTIONAL 3 PHASE, P7; Decker C, 2002, POLYM INT, V51, P1141, DOI 10.1002/pi.821; E. I. du Pont de Nemours & Co, 1938, [No title captured], Patent No. [2,130,523, 2130523, U.S.2130523]; Gao SL, 2005, APPL PHYS B-LASERS O, V81, P681, DOI 10.1007/s00340-005-1928-9; Hu LB, 2010, NANO LETT, V10, P708, DOI 10.1021/nl903949m; Kristensen TE, 2010, EUR J ORG CHEM, V2010, P3179, DOI 10.1002/ejoc.201000319; Ley S. V., 2000, J CHEM SOC P1, V2000, P3815; Lima MD, 2011, SCIENCE, V331, P51, DOI 10.1126/science.1195912; List B, 2006, SCIENCE, V313, P1584, DOI 10.1126/science.1131945; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; Merrifield B., 1984, NOB LECT SOL PHAS SY; North M, 2010, GREEN CHEM, V12, P1514, DOI 10.1039/c0gc00065e; Oh SH, 2008, ANGEW CHEM INT EDIT, V47, P7872, DOI 10.1002/anie.200801636; Okuhara T, 2002, CHEM REV, V102, P3641, DOI 10.1021/cr0103569; Opwis Klaus, 2007, Biotechnology Journal, V2, P347, DOI 10.1002/biot.200600168; Park SE, 2010, ADV SYNTH CATAL, V352, P2211, DOI 10.1002/adsc.201000289; Pasta M, 2010, NANO RES, V3, P452, DOI 10.1007/s12274-010-0006-8; Praschak D, 1998, APPL PHYS A-MATER, V66, P69, DOI 10.1007/s003390050639; Sakakura A, 2007, J AM CHEM SOC, V129, P14775, DOI 10.1021/ja075824w; Song C. E., 2009, CINCHONA ALKALOIDS S, DOI DOI 10.1002/9783527628179; Wang CA, 2012, CHEM-EUR J, V18, P6718, DOI 10.1002/chem.201200753; Wang SQ, 2007, J MOL CATAL A-CHEM, V264, P60, DOI 10.1016/j.molcata.2006.08.073; Yoon TP, 2003, SCIENCE, V299, P1691, DOI 10.1126/science.1083622; Youk SH, 2009, CHEM COMMUN, P2220, DOI 10.1039/b821483b; Yu GH, 2011, NANO LETT, V11, P2905, DOI 10.1021/nl2013828	30	104	106	6	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1225	1229		10.1126/science.1242196	http://dx.doi.org/10.1126/science.1242196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031014				2022-12-28	WOS:000324248800039
J	Dunlop, J				Dunlop, Julie			Syntax of Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jdunlop@cnm.edu						Smyth JM, 1999, JAMA-J AM MED ASSOC, V281, P1304, DOI 10.1001/jama.281.14.1304	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1027	1028		10.1001/jama.2013.227192	http://dx.doi.org/10.1001/jama.2013.227192			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	24026595				2022-12-28	WOS:000324133400017
J	Smith, A; Bevan, D; Douglas, HR; James, D				Smith, Antony; Bevan, David; Douglas, Hannah Rose; James, David			Management of urinary incontinence in women: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXTENT		[Smith, Antony] Univ Manchester, Guideline Dev Grp, Manchester M13 9PL, Lancs, England; [Bevan, David; Douglas, Hannah Rose; James, David] Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London NW1 4RG, England	University of Manchester	Bevan, D (corresponding author), Royal Coll Obstetricians & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London NW1 4RG, England.	dbevan@ncc-wch.org.uk						Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; National Collaborating Centre for Women's and Children's Health (UK), 2013, RCOG PRESS, V60, P906; National Institute for Health and Care Excellence, 2013, STAK CONS COMM UR IN; Shaw C, 2006, FAM PRACT, V23, P497, DOI 10.1093/fampra/cml033; Wagg A, 2011, BJOG-INT J OBSTET GY, V118, P1592, DOI 10.1111/j.1471-0528.2011.03100.x; Wagg A, 2012, BJU INT, V110, P1767, DOI 10.1111/j.1464-410X.2012.11023.x	6	39	39	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2013	347								f5170	10.1136/bmj.f5170	http://dx.doi.org/10.1136/bmj.f5170			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219RR	24021756				2022-12-28	WOS:000324527000002
J	Mitchell, PD; Yeh, HY; Appleby, J; Buckley, R				Mitchell, Piers D.; Yeh, Hui-Yuan; Appleby, Jo; Buckley, Richard			The intestinal parasites of King Richard III	LANCET			English	Editorial Material									[Mitchell, Piers D.; Yeh, Hui-Yuan] Univ Cambridge, Div Biol Anthropol, Dept Archaeol & Anthropol, Cambridge CB2 1QH, England; [Appleby, Jo] Univ Leicester, Sch Archaeol & Ancient Hist, Leicester, Leics, England; [Buckley, Richard] Univ Leicester, Archaeol Serv, Leicester, Leics, England	University of Cambridge; University of Leicester; University of Leicester	Mitchell, PD (corresponding author), Univ Cambridge, Div Biol Anthropol, Dept Archaeol & Anthropol, Henry Wellcome Bldg,Fitzwilliam St, Cambridge CB2 1QH, England.	pdm39@cam.ac.uk		Yeh, Ivy Hui-Yuan/0000-0002-4822-2919; Mitchell, Piers/0000-0002-1009-697X				Anastasiou E, 2013, INT J PALEOPATHOL, V3, P204, DOI 10.1016/j.ijpp.2013.04.004; Buckley R, 2013, ANTIQUITY, V87, P519, DOI 10.1017/S0003598X00049103	2	18	18	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 7	2013	382	9895					888	888		10.1016/S0140-6736(13)61757-2	http://dx.doi.org/10.1016/S0140-6736(13)61757-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215WE	24011545	Green Submitted			2022-12-28	WOS:000324240700030
J	Watling, L				Watling, Les			Deep-sea trawling must be banned	NATURE			English	Editorial Material									Univ Hawaii Manoa, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Watling, L (corresponding author), Univ Hawaii Manoa, Honolulu, HI 96822 USA.	watling@hawaii.edu							0	9	9	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2013	501	7465					7	7		10.1038/501007a	http://dx.doi.org/10.1038/501007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211ER	24005380	Bronze			2022-12-28	WOS:000323888300004
J	Mani, A; Mullainathan, S; Shafir, E; Zhao, JY				Mani, Anandi; Mullainathan, Sendhil; Shafir, Eldar; Zhao, Jiaying			Poverty Impedes Cognitive Function	SCIENCE			English	Article							BEHAVIORAL-ECONOMICS; MISSED APPOINTMENTS; WORKING-MEMORY; STRESS; CAPACITY	The poor often behave in less capable ways, which can further perpetuate poverty. We hypothesize that poverty directly impedes cognitive function and present two studies that test this hypothesis. First, we experimentally induced thoughts about finances and found that this reduces cognitive performance among poor but not in well-off participants. Second, we examined the cognitive function of farmers over the planting cycle. We found that the same farmer shows diminished cognitive performance before harvest, when poor, as compared with after harvest, when rich. This cannot be explained by differences in time available, nutrition, or work effort. Nor can it be explained with stress: Although farmers do show more stress before harvest, that does not account for diminished cognitive performance. Instead, it appears that poverty itself reduces cognitive capacity. We suggest that this is because poverty-related concerns consume mental resources, leaving less for other tasks. These data provide a previously unexamined perspective and help explain a spectrum of behaviors among the poor. We discuss some implications for poverty policy.	[Mani, Anandi] Univ Warwick, Dept Econ, Coventry CV4 7AL, W Midlands, England; [Mullainathan, Sendhil] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Shafir, Eldar] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Shafir, Eldar] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08540 USA; [Zhao, Jiaying] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada; [Zhao, Jiaying] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V6T 1Z4, Canada	University of Warwick; Harvard University; Princeton University; Princeton University; University of British Columbia; University of British Columbia	Mullainathan, S (corresponding author), Harvard Univ, Dept Econ, Cambridge, MA 02138 USA.	mullain@fas.harvard.edu; shafir@princeton.edu	Shafir, Eldar/H-9957-2014		National Science Foundation [SES-0933497]; John Simon Guggenheim Memorial Foundation; International Finance Corporation; Institute for Financial Management and Research Trust; ESRC [ES/H021248/1] Funding Source: UKRI; Economic and Social Research Council [ES/H021248/1] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); John Simon Guggenheim Memorial Foundation; International Finance Corporation; Institute for Financial Management and Research Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Authors' names are listed alphabetically; the authors contributed equally to this work. The authors gratefully acknowledge support from the National Science Foundation (award SES-0933497), the John Simon Guggenheim Memorial Foundation, the International Finance Corporation, and the Institute for Financial Management and Research Trust. S. Krishnan, D. Mackenzie, and especially D. Bulla provided able research assistance. The authors declare no conflict of interest.	Ashraf N, 2006, Q J ECON, V121, P635, DOI 10.1162/qjec.2006.121.2.635; Baddeley A.D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Barr MS, 2012, NO SLACK FINANCIAL L; Bertrand M, 2004, AM ECON REV, V94, P419, DOI 10.1257/0002828041302019; Bertrand M, 2006, J PUBLIC POLICY MARK, V25, P8, DOI 10.1509/jppm.25.1.8; Bettinger E. P., 2012, WORKING PAPERS NBER; Blank R, 2009, INSUFFICIENT FUNDS S; BUHMANN B, 1988, REV INCOME WEALTH, P115; Butterworth P, 2012, SOC COGN AFFECT NEUR, V7, P548, DOI 10.1093/scan/nsr027; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Deaton Angus., 2004, WORKING PAPER, DOI 10.2139/ssrn.564001; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Duflo E, 2011, AM ECON REV, V101, P2350, DOI 10.1257/aer.101.6.2350; Edin K., 1997, MAKING ENDS MEET SIN; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Evans GW, 2009, P NATL ACAD SCI USA, V106, P6545, DOI 10.1073/pnas.0811910106; Hermalin B., 2000, C015 USC CLEO; Hunt E., 2010, HUMAN INTELLIGENCE; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; JONES B, 1971, ARCH GEN PSYCHIAT, V24, P71; Karelis C., 2007, PERSISTENCE POVERTY; Karter AJ, 2004, MED CARE, V42, P110, DOI 10.1097/01.mlr.0000109023.64650.73; KATZ SJ, 1994, JAMA-J AM MED ASSOC, V272, P530, DOI 10.1001/jama.272.7.530; Kim J, 2006, J FAM ECON ISS, V27, P458, DOI 10.1007/s10834-006-9024-9; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; LINDE L, 1992, PSYCHOL RES-PSYCH FO, V54, P127, DOI 10.1007/BF00937141; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Milkman KL, 2011, P NATL ACAD SCI USA, V108, P10415, DOI 10.1073/pnas.1103170108; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Mullainathan S., 2013, SCARCITY WHY HAVING; Neal RD, 2001, BRIT J GEN PRACT, V51, P830; Neisser U., 1976, COGNITION REALITY PR; Oswald A., 2012, WORKING PAPER; Ponton M O, 1996, J Int Neuropsychol Soc, V2, P96; Posner MI, 1998, ATTENTIVE BRAIN, P401; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Shah AK, 2012, SCIENCE, V338, P682, DOI 10.1126/science.1222426; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Smith C., 2009, WORKING PAPER; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Thaler RH., 2021, NUDGE FINAL EDITION; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	44	1136	1164	39	715	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					976	980		10.1126/science.1238041	http://dx.doi.org/10.1126/science.1238041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990553				2022-12-28	WOS:000323652300035
J	Hu, JC; Stites, EC; Yu, HY; Germino, EA; Meharena, HS; Stork, PJS; Kornev, AP; Taylor, SS; Shaw, AS				Hu, Jiancheng; Stites, Edward C.; Yu, Haiyang; Germino, Elizabeth A.; Meharena, Hiruy S.; Stork, Philip J. S.; Kornev, Alexandr P.; Taylor, Susan S.; Shaw, Andrey S.			Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers	CELL			English	Article							B-RAF; WILD-TYPE; C-RAF; ONCOGENIC RAS; A-RAF; PHOSPHORYLATION; BRAF; ERK; INHIBITORS; MUTATIONS	Although RAF kinases are critical for controlling cell growth, their mechanism of activation is incompletely understood. Recently, dimerization was shown to be important for activation. Here we show that the dimer is functionally asymmetric with one kinase functioning as an activator to stimulate activity of the partner, receiver kinase. The activator kinase did not require kinase activity but did require N-terminal phosphorylation that functioned allosterically to induce cis-autophosphorylation of the receiver kinase. Based on modeling of the hydrophobic spine assembly, we also engineered a constitutively active mutant that was independent of Ras, dimerization, and activation-loop phosphorylation. As N-terminal phosphorylation of BRAF is constitutive, BRAF initially functions to activate CRAF. N-terminal phosphorylation of CRAF was dependent on MEK, suggesting a feedback mechanism and explaining a key difference between BRAF and CRAF. Our work illuminates distinct steps in RAF activation that function to assemble the active conformation of the RAF kinase.	[Hu, Jiancheng; Stites, Edward C.; Yu, Haiyang; Germino, Elizabeth A.; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Hu, Jiancheng; Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Meharena, Hiruy S.; Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Dept Chem Biochem, La Jolla, CA 92093 USA; [Meharena, Hiruy S.; Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kornev, Alexandr P.; Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Stork, Philip J. S.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Oregon Health & Science University	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem Biochem, 9500 Gilman Dr,Mail Code 0654, La Jolla, CA 92093 USA.	staylor@ucsd.edu; ashaw@wustl.edu	Hu, Jiancheng/ABE-8133-2021; Yu, Haiyang/AAK-3112-2020; Kornev, Alexandr Petrovich/O-7826-2015; Yu, Houyong/R-1592-2016	Hu, Jiancheng/0000-0003-1615-0030; Yu, Haiyang/0000-0003-3460-6716; Kornev, Alexandr Petrovich/0000-0002-1543-3795; Yu, Houyong/0000-0002-6543-5924	Cancer Research Institute; NSF [DGE1144086]; Howard Hughes Medical Institute; NIH [AI57966, GM19301]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI057966, T32AI007163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019301, R01GM019301] Funding Source: NIH RePORTER	Cancer Research Institute; NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jianping Zhao and Alfred Kim for critical reading of the manuscript and Rafi Kopan and Thomas Graham for helpful discussions. E. G. is supported by a fellowship from the Cancer Research Institute, and H. S. M. by NSF (DGE1144086). The work was supported by the Howard Hughes Medical Institute (A. S. S. and S. S. T.) and by grants from the NIH (AI57966/A.S.S., GM19301/S.S.T.).	Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Baljuls A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194167; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Brose MS, 2002, CANCER RES, V62, P6997; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Chiloeches A, 2001, MOL CELL BIOL, V21, P2423, DOI 10.1128/MCB.21.7.2423-2434.2001; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hansen JD, 2008, BIOORG MED CHEM LETT, V18, P4692, DOI 10.1016/j.bmcl.2008.07.002; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hu JC, 2008, MOL IMMUNOL, V45, P1825, DOI 10.1016/j.molimm.2007.11.002; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5455, DOI 10.1021/bi602512e; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Leicht DT, 2013, BBA-MOL CELL RES, V1833, P976, DOI 10.1016/j.bbamcr.2013.01.015; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; McKay MM, 2011, CURR BIOL, V21, P563, DOI 10.1016/j.cub.2011.02.033; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Qjn J, 2012, J MED CHEM, V55, P5220, DOI 10.1021/jm3004416; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rebocho AP, 2013, ONCOGENE, V32, P3207, DOI 10.1038/onc.2012.330; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wimmer R, 2010, TRENDS BIOCHEM SCI, V35, P660, DOI 10.1016/j.tibs.2010.06.001; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhang BH, 2001, EXP LUNG RES, V27, P269, DOI 10.1080/019021401300054046; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	53	183	183	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					1036	1046		10.1016/j.cell.2013.07.046	http://dx.doi.org/10.1016/j.cell.2013.07.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993095	Green Accepted, Bronze			2022-12-28	WOS:000323767300017
J	Zhang, S; Gilbert, I; Nisoli, C; Chern, GW; Erickson, MJ; O'Brien, L; Leighton, C; Lammert, PE; Crespi, VH; Schiffer, P				Zhang, Sheng; Gilbert, Ian; Nisoli, Cristiano; Chern, Gia-Wei; Erickson, Michael J.; O'Brien, Liam; Leighton, Chris; Lammert, Paul E.; Crespi, Vincent H.; Schiffer, Peter			Crystallites of magnetic charges in artificial spin ice	NATURE			English	Article							MONOPOLES	Artificial spin ice(1) is a class of lithographically created arrays of interacting ferromagnetic nanometre-scale islands. It was introduced to investigate many-body phenomena related to frustration and disorder in a material that could be tailored to precise specifications and imaged directly. Because of the large magnetic energy scales of these nanoscale islands, it has so far been impossible to thermally anneal artificial spin ice into desired thermodynamic ensembles; nearly all studies of artificial spin ice have either treated it as a granular material activated by alternating fields(2) or focused on the as-grown state of the arrays(3). This limitation has prevented experimental investigation of novel phases that can emerge from the nominal ground states of frustrated lattices. For example, artificial kagome spin ice, in which the islands are arranged on the edges of a hexagonal net, is predicted to support states with monopolar charge order at entropies below that of the previously observed pseudo-ice manifold(4). Here we demonstrate a method for thermalizing artificial spin ices with square and kagome lattices by heating above the Curie temperature of the constituent material. In this manner, artificial square spin ice achieves unprecedented thermal ordering of the moments. In artificial kagome spin ice, we observe incipient crystallization of the magnetic charges embedded in pseudo-ice, with crystallites of magnetic charges whose size can be controlled by tuning the lattice constant. We find excellent agreement between experimental data and Monte Carlo simulations of emergent charge-charge interactions.	[Zhang, Sheng; Lammert, Paul E.; Crespi, Vincent H.] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Zhang, Sheng; Lammert, Paul E.; Crespi, Vincent H.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Gilbert, Ian; Schiffer, Peter] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Gilbert, Ian; Schiffer, Peter] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Nisoli, Cristiano; Chern, Gia-Wei] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Erickson, Michael J.; O'Brien, Liam; Leighton, Chris] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [O'Brien, Liam] Univ Cambridge, Cavendish Lab, Dept Phys, Thin Film Magnetism Grp, Cambridge CB3 0HE, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Minnesota System; University of Minnesota Twin Cities; University of Cambridge	Schiffer, P (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	pschiffe@illinois.edu	O'Brien, Liam A/H-1994-2012; Nisoli, Cristiano/O-5134-2019; Zhang, Sheng/M-9238-2014	O'Brien, Liam A/0000-0002-0136-8603; Nisoli, Cristiano/0000-0003-0053-1023; Zhang, Sheng/0000-0002-9710-6738; Crespi, Vincent/0000-0003-3846-3193; Schiffer, Peter/0000-0002-6430-6549; Gilbert, Ian/0000-0001-8259-0697	US Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-SC0005313]; US Department of Energy at LANL [DE-AC52-06NA253962]; NSF MRSEC [DMR-0819885, DMR-0820404]; EU Marie Curie IOF [299376]	US Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); US Department of Energy at LANL(United States Department of Energy (DOE)); NSF MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); EU Marie Curie IOF	This project was funded by the US Department of Energy, Office of Basic Energy Sciences, Materials Sciences and Engineering Division under grant no. DE-SC0005313. Lithography was performed with the support of the National Nanotechnology Infrastructure Network. The work of C.N. and G.-W.C. was carried out under the auspices of the US Department of Energy at LANL under contract no. DE-AC52-06NA253962. Work at the University of Minnesota was supported by the NSF MRSEC under award DMR-0819885 and EU Marie Curie IOF project no. 299376. Certain theory elements were supported by the NSF MRSEC under award DMR-0820404.	Baxter R. J., 2016, EXACTLY SOLVED MODEL; Branford WR, 2012, SCIENCE, V335, P1597, DOI 10.1126/science.1211379; Budrikis Z, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/035014; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Chern G.-W., 2012, PREPRINT; Chern GW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.207202; Farhan A, 2013, NAT PHYS, V9, P375, DOI [10.1038/nphys2613, 10.1038/NPHYS2613]; Fennell T, 2009, SCIENCE, V326, P415, DOI 10.1126/science.1177582; John Greaves S., 2012, J APPL PHYS, V112; Kapaklis V, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/035009; Ke X, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037205; Ladak S, 2010, NAT PHYS, V6, P359, DOI 10.1038/NPHYS1628; Lammert PE, 2010, NAT PHYS, V6, P786, DOI 10.1038/NPHYS1728; Mengotti E, 2011, NAT PHYS, V7, P68, DOI [10.1038/nphys1794, 10.1038/NPHYS1794]; Moller G, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.140409; Moller G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.237202; Morgan JP, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024405; Morgan JP, 2011, NAT PHYS, V7, P75, DOI 10.1038/NPHYS1853; Morris DJP, 2009, SCIENCE, V326, P411, DOI 10.1126/science.1178868; Morrison MJ, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/4/045009; Newman M., 1999, MONTE CARLO METHODS; Nisoli C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.047205; Pollard SD, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.180402; Porro JM, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/5/055012; Qi Y, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094418; Remhof A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.134409; Rougemaille N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.057209; Ryzhkin IA, 2005, J EXP THEOR PHYS+, V101, P481, DOI 10.1134/1.2103216; Silva RC, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/015008; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447	30	172	173	2	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 29	2013	500	7464					553	557		10.1038/nature12399	http://dx.doi.org/10.1038/nature12399			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207TD	23985872				2022-12-28	WOS:000323625900029
J	Murad, MH; Haydour, Q; Benkhadra, K				Murad, M. Hassan; Haydour, Qusay; Benkhadra, Khalid			Review: In patients with chronic diabetic foot ulcers, hyperbaric oxygen reduces major amputations	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Murad, M. Hassan; Haydour, Qusay; Benkhadra, Khalid] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Murad, MH (corresponding author), Mayo Clin, Rochester, MN 55905 USA.		Murad, M. Hassan/AAW-4367-2020					GESSELL LB, 2008, HYPERBARIC OXYGEN TH; Margolis DJ, 2013, DIABETES CARE, V36, P1961, DOI 10.2337/dc12-2160	2	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC9	10.7326/0003-4819-159-4-201308200-02009	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026285				2022-12-28	WOS:000323421700008
J	Elias, J				Elias, Johannes			Loosening the grip of meningococcal disease in Africa	LANCET			English	Editorial Material							CONJUGATE VACCINE; SEROGROUP; IMPACT; MENINGITIS; CARRIAGE; EPIDEMIOLOGY; EUROPE		Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany	University of Wurzburg	Elias, J (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany.	jelias@hygiene.uni-wuerzburg.de	Elias, Johannes/F-8241-2013	Elias, Johannes/0000-0002-5878-7040				Alcala B, 2002, EMERG INFECT DIS, V8, P1512, DOI 10.3201/eid0812.020081; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; DAUGLA D, 2013, LANCET; Greenwood B, 2013, VACCINE, V31, P1453, DOI 10.1016/j.vaccine.2012.12.035; JONES DM, 1990, J INFECTION, V21, P21, DOI 10.1016/0163-4453(90)90577-U; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Kriz P, 2011, EXPERT REV VACCINES, V10, P1477, DOI [10.1586/ERV.11.117, 10.1586/erv.11.117]; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; Perez-Trallero E, 2002, LANCET, V360, P953, DOI 10.1016/S0140-6736(02)11061-0; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Tartof S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063605; Thorsteinsdottir H, 2012, SCIENCE, V338, P1546, DOI 10.1126/science.1233318; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P101, DOI 10.1111/j.1574-6976.2006.00053.x	15	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2014	383	9911					6	8		10.1016/S0140-6736(13)61898-X	http://dx.doi.org/10.1016/S0140-6736(13)61898-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	284SP	24035221	hybrid			2022-12-28	WOS:000329341200008
J	Depoorter, MA; Bamber, JL; Griggs, JA; Lenaerts, JTM; Ligtenberg, SRM; van den Broeke, MR; Moholdt, G				Depoorter, M. A.; Bamber, J. L.; Griggs, J. A.; Lenaerts, J. T. M.; Ligtenberg, S. R. M.; van den Broeke, M. R.; Moholdt, G.			Calving fluxes and basal melt rates of Antarctic ice shelves	NATURE			English	Article							SOUTHERN-OCEAN; MASS-BALANCE; BENEATH; GREENLAND; ICEBERGS; IRON; FLOW	Iceberg calving has been assumed to be the dominant cause of mass loss for the Antarctic ice sheet, with previous estimates of the calving flux exceeding 2,000 gigatonnes per year(1,2). More recently, the importance of melting by the ocean has been demonstrated close to the grounding line and near the calving front(3-5). So far, however, no study has reliably quantified the calving flux and the basal mass balance (the balance between accretion and ablation at the ice-shelf base) for the whole of Antarctica. The distribution of fresh water in the Southern Ocean and its partitioning between the liquid and solid phases is therefore poorly constrained. Here we estimate the mass balance components for all ice shelves in Antarctica, using satellite measurements of calving flux and grounding-line flux, modelled ice-shelf snow accumulation rates(6) and a regional scaling that accounts for unsurveyed areas. We obtain a total calving flux of 1,321 +/- 144 gigatonnes per year and a total basal mass balance of -1,454 +/- 174 gigatonnes per year. This means that about half of the ice-sheet surface mass gain is lost through oceanic erosion before reaching the ice front, and the calving flux is about 34 per cent less than previous estimates derived from iceberg tracking(1,2,7). In addition, the fraction of mass loss due to basal processes varies from about 10 to 90 per cent between ice shelves. We find a significant positive correlation between basal mass loss and surface elevation change for ice shelves experiencing surface lowering(8) and enhanced discharge(9). We suggest that basal mass loss is a valuable metric for predicting future ice-shelf vulnerability to oceanic forcing.	[Depoorter, M. A.; Bamber, J. L.; Griggs, J. A.] Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England; [Lenaerts, J. T. M.; Ligtenberg, S. R. M.; van den Broeke, M. R.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands; [Moholdt, G.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Bristol; Utrecht University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Depoorter, MA (corresponding author), Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England.	mathieu.depoorter@bristol.ac.uk; j.bamber@bristol.ac.uk	Bamber, Jonathan/C-7608-2011; Ligtenberg, Stefan/AAF-8290-2020; Van den Broeke, Michiel R./F-7867-2011; Lenaerts, Jan/D-9423-2012	Bamber, Jonathan/0000-0002-2280-2819; Van den Broeke, Michiel R./0000-0003-4662-7565; Lenaerts, Jan/0000-0003-4309-4011	European Union [226375]; Netherlands Polar Programme; NERC [NE/I027401/1]; Natural Environment Research Council [NE/I027401/1] Funding Source: researchfish	European Union(European Commission); Netherlands Polar Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by funding from the ice2sea programme of the European Union Seventh Framework Programme, grant number 226375. This work is ice2sea contribution number 139. M.R.v.d.B., J.T.M.L. and S.R.M.L. acknowledge funding from the Netherlands Polar Programme. J.L.B. was supported by NERC grant NE/I027401/1.	Alderkamp AC, 2012, DEEP-SEA RES PT II, V71-76, P32, DOI 10.1016/j.dsr2.2012.03.005; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; Determann J., 1998, ANTARCT RES SER, V75, P285; DOAKE CSM, 1991, NATURE, V350, P328, DOI 10.1038/350328a0; Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; Fricker HA, 2001, GEOPHYS RES LETT, V28, P2241, DOI 10.1029/2000GL012461; Griggs JA, 2011, J GLACIOL, V57, P485, DOI 10.3189/002214311796905659; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Hellmer HH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019506; Holland PR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038162; JACOBS SS, 1992, J GLACIOL, V38, P375, DOI 10.3189/S0022143000002252; JENKINS A, 1991, J GEOPHYS RES-OCEANS, V96, P791, DOI 10.1029/90JC01952; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017609; King MA, 2012, NATURE, V491, P586, DOI 10.1038/nature11621; Lenaerts JTM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050713; Ligtenberg SRM, 2011, CRYOSPHERE, V5, P809, DOI 10.5194/tc-5-809-2011; Nicholls KW, 1997, GEOPHYS RES LETT, V24, P167, DOI 10.1029/96GL03922; Orheim O., 1985, GLACIERS ICE SHEETS, P210; POTTER JR, 1984, J GLACIOL, V30, P161, DOI 10.3189/S002214300000589X; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Raiswell R, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-7; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Silva TAM, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002843; Smith KL, 2007, SCIENCE, V317, P478, DOI 10.1126/science.1142834; Timmermann R, 2012, ANN GLACIOL, V53, P303, DOI 10.3189/2012AoG60A156; Whitehouse MJ, 2012, DEEP-SEA RES PT II, V59, P47, DOI 10.1016/j.dsr2.2011.05.010; Yu JY, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007456; ZOTIKOV IA, 1980, SCIENCE, V207, P1463, DOI 10.1126/science.207.4438.1463; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007	31	392	402	10	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					89	+		10.1038/nature12567	http://dx.doi.org/10.1038/nature12567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24037377				2022-12-28	WOS:000325106000036
J	Burrell, RA; McGranahan, N; Bartek, J; Swanton, C				Burrell, Rebecca A.; McGranahan, Nicholas; Bartek, Jiri; Swanton, Charles			The causes and consequences of genetic heterogeneity in cancer evolution	NATURE			English	Review							CHROMOSOME SEGREGATION ERRORS; INTRA-TUMOR HETEROGENEITY; DNA-DAMAGE RESPONSE; MUTATIONAL PROCESSES; CLONAL EVOLUTION; BREAST-CANCER; COLON-CANCER; GENOMIC INSTABILITY; COLORECTAL ADENOMAS; REPLICATION STRESS	Recent studies have revealed extensive genetic diversity both between and within tumours. This heterogeneity affects key cancer pathways, driving phenotypic variation, and poses a significant challenge to personalized cancer medicine. A major cause of genetic heterogeneity in cancer is genomic instability. This instability leads to an increased mutation rate and can shape the evolution of the cancer genome through a plethora of mechanisms. By understanding these mechanisms we can gain insight into the common pathways of tumour evolution that could support the development of future therapeutic strategies.	[Burrell, Rebecca A.; McGranahan, Nicholas; Swanton, Charles] Canc Res UK London Res Inst, Translat Canc Therapeut Lab, London WC2A 3LY, England; [McGranahan, Nicholas] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London WC1E 6BT, England; [Bartek, Jiri] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Bartek, Jiri] Palacky Univ, Inst Mol & Translat Med, CZ-77515 Olomouc, Czech Republic; [Swanton, Charles] UCL Canc Inst, London WC1E 6BT, England	Cancer Research UK; University of London; University College London; Danish Cancer Society; Palacky University Olomouc; University of London; University College London	Swanton, C (corresponding author), Canc Res UK London Res Inst, Translat Canc Therapeut Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	charles.swanton@cancer.org.uk	damiani, chiara/R-4256-2016; McGranahan, Nicholas/ABD-6561-2021; Bartek, Jiri/G-5870-2014	McGranahan, Nicholas/0000-0001-9537-4045; Swanton, Charles/0000-0002-4299-3018	Cancer Research UK; The Medical Research Council; EU; Prostate Cancer Foundation; Breast Cancer Research Foundation (BCRF); Danish Cancer Society; European Commission; MRC [G0701935] Funding Source: UKRI; Medical Research Council [G0701935] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); The Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); Prostate Cancer Foundation; Breast Cancer Research Foundation (BCRF); Danish Cancer Society(Danish Cancer Society); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to apologize to those whose work we have not been able to cite owing to space limitations. C. S. is funded by Cancer Research UK, The Medical Research Council, EU FP7 (projects PREDICT and RESPONSIFY), Prostate Cancer Foundation and the Breast Cancer Research Foundation (BCRF). J.B. is funded by the Danish Cancer Society and the European Commission (projects DDResponse and Biomedreg). We thank E. Gronroos and P. Gorman for the use of the tumour section image in Fig. 1.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Cahill DP, 1999, TRENDS BIOCHEM SCI, V24, pM57, DOI 10.1016/S0968-0004(99)01466-8; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chen ZY, 2012, ONCOLOGIST, V17, P978, DOI 10.1634/theoncologist.2011-0385; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dereli-Oz A, 2011, MOL ONCOL, V5, P308, DOI 10.1016/j.molonc.2011.05.002; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; DUMAZ N, 1993, P NATL ACAD SCI USA, V90, P10529, DOI 10.1073/pnas.90.22.10529; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gatenby RA, 2011, NAT REV CANCER, V11, P237, DOI 10.1038/nrc3036; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gutenberg A, 2010, CANCER GENET CYTOGEN, V198, P47, DOI 10.1016/j.cancergencyto.2009.12.006; HAHN PJ, 1993, BIOESSAYS, V15, P477, DOI 10.1002/bies.950150707; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Ishikawa T, 2003, CANCER RES, V63, P5564; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaseda K, 2012, BIOL OPEN, V1, P12, DOI 10.1242/bio.2011012; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Loeb LA, 2010, SEMIN CANCER BIOL, V20, P279, DOI 10.1016/j.semcancer.2010.10.006; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Martinez P, 2013, J PATHOL, V230, P356, DOI 10.1002/path.4214; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McBride DJ, 2012, J PATHOL, V227, P446, DOI 10.1002/path.4042; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Merlo LMF, 2010, CANCER PREV RES, V3, P1388, DOI 10.1158/1940-6207.CAPR-10-0108; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ng CKY, 2012, J PATHOL, V226, P703, DOI 10.1002/path.3980; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nikolaev SI, 2012, CANCER RES, V72, P6279, DOI 10.1158/0008-5472.CAN-12-3869; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pampalona J, 2010, GENE CHROMOSOME CANC, V49, P368, DOI 10.1002/gcc.20749; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Shah SN, 2010, CANCER RES, V70, P431, DOI 10.1158/0008-5472.CAN-09-3049; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; STRAUSS M, 1995, NAT MED, V1, P1245, DOI 10.1038/nm1295-1245; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Tomlinson IPM, 1996, P NATL ACAD SCI USA, V93, P14800, DOI 10.1073/pnas.93.25.14800; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; Varley KE, 2009, NUCLEIC ACIDS RES, V37, P4603, DOI 10.1093/nar/gkp457; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang Jing H, 2012, Front Med, V6, P263, DOI 10.1007/s11684-012-0215-5; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weigelt B, 2009, NAT REV CLIN ONCOL, V6, P718, DOI 10.1038/nrclinonc.2009.166; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317	125	1405	1446	10	377	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					338	345		10.1038/nature12625	http://dx.doi.org/10.1038/nature12625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048066				2022-12-28	WOS:000324545700032
J	Wald, DS; Morris, JK; Wald, NJ; Chase, AJ; Edwards, RJ; Hughes, LO; Berry, C; Oldroyd, KG				Wald, David S.; Morris, Joan K.; Wald, Nicholas J.; Chase, Alexander J.; Edwards, Richard J.; Hughes, Liam O.; Berry, Colin; Oldroyd, Keith G.			Randomized Trial of Preventive Angioplasty in Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; FRACTIONAL FLOW RESERVE; HEART-ASSOCIATION; TASK-FORCE; MULTIVESSEL; VESSEL; REVASCULARIZATION; CULPRIT; THERAPY; REPERFUSION	BackgroundIn acute ST-segment elevation myocardial infarction (STEMI), the use of percutaneous coronary intervention (PCI) to treat the artery responsible for the infarct (infarct, or culprit, artery) improves prognosis. The value of PCI in noninfarct coronary arteries with major stenoses (preventive PCI) is unknown. MethodsFrom 2008 through 2013, at five centers in the United Kingdom, we enrolled 465 patients with acute STEMI (including 3 patients with left bundle-branch block) who were undergoing infarct-artery PCI and randomly assigned them to either preventive PCI (234 patients) or no preventive PCI (231 patients). Subsequent PCI for angina was recommended only for refractory angina with objective evidence of ischemia. The primary outcome was a composite of death from cardiac causes, nonfatal myocardial infarction, or refractory angina. An intention-to-treat analysis was used. ResultsBy January 2013, the results were considered conclusive by the data and safety monitoring committee, which recommended that the trial be stopped early. During a mean follow-up of 23 months, the primary outcome occurred in 21 patients assigned to preventive PCI and in 53 patients assigned to no preventive PCI (infarct-artery-only PCI), which translated into rates of 9 events per 100 patients and 23 per 100, respectively (hazard ratio in the preventive-PCI group, 0.35; 95% confidence interval [CI], 0.21 to 0.58; P<0.001). Hazard ratios for the three components of the primary outcome were 0.34 (95% CI, 0.11 to 1.08) for death from cardiac causes, 0.32 (95% CI, 0.13 to 0.75) for nonfatal myocardial infarction, and 0.35 (95% CI, 0.18 to 0.69) for refractory angina. ConclusionsIn patients with STEMI and multivessel coronary artery disease undergoing infarct-artery PCI, preventive PCI in noninfarct coronary arteries with major stenoses significantly reduced the risk of adverse cardiovascular events, as compared with PCI limited to the infarct artery.	[Wald, David S.; Morris, Joan K.; Wald, Nicholas J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England; [Wald, David S.] London Chest Hosp, London E2 9JX, England; [Chase, Alexander J.] Morriston Hosp, Swansea, W Glam, Wales; [Edwards, Richard J.] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Hughes, Liam O.] Norwich Univ Hosp, Norwich, Norfolk, England; [Berry, Colin; Oldroyd, Keith G.] Golden Jubilee Natl Hosp, Glasgow, Lanark, Scotland	University of London; Queen Mary University London; University of London; Queen Mary University London; Morriston Hospital; Newcastle Freeman Hospital; Newcastle University - UK; Golden Jubilee Hospital	Wald, DS (corresponding author), Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med CEPM, Charterhouse Sq, London EC1M 6BQ, England.	d.s.wald@qmul.ac.uk	Oldroyd, Keith G/C-2281-2014; Wald, Nicholas/AAY-2814-2021; Morris, Joan/AAT-9211-2020; Wald, Nicholas/AAY-8924-2021; Berry, Colin/AAF-5268-2020	Oldroyd, Keith G/0000-0002-7842-3463; Morris, Joan/0000-0002-7164-612X; Foley, Paul/0000-0002-4856-832X; Wragg, Andrew/0000-0002-8934-5712	Barts; London Charity; British Heart Foundation [FS/12/55/29695] Funding Source: researchfish	Barts; London Charity; British Heart Foundation(British Heart Foundation)	Funded by Barts and the London Charity; PRAMI Current Controlled Trials number, ISRCTN73028481.	Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016; Chen LY, 2005, AM J CARDIOL, V95, P349, DOI 10.1016/j.amjcard.2004.09.032; Corpus RA, 2004, AM HEART J, V148, P493, DOI 10.1016/j.ahj.2004.03.051; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Di Mario Carlo, 2004, Int J Cardiovasc Intervent, V6, P128; Glaser R, 2005, CIRCULATION, V111, P143, DOI 10.1161/01.CIR.0000150335.01285.12; Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Khattab AA, 2008, CLIN RES CARDIOL, V97, P32, DOI 10.1007/s00392-007-0570-4; Kong JA, 2006, CORONARY ARTERY DIS, V17, P71, DOI 10.1097/00019501-200602000-00012; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Patel MR, 2009, CIRCULATION, V119, P1330, DOI 10.1161/CIRCULATIONAHA.108.191768; Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162; Qarawani D, 2008, INT J CARDIOL, V123, P288, DOI 10.1016/j.ijcard.2006.12.013; Roe MT, 2001, AM J CARDIOL, V88, P170, DOI 10.1016/S0002-9149(01)01615-0; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Toma M, 2010, EUR HEART J, V31, P1701, DOI 10.1093/eurheartj/ehq129; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Varani E, 2008, CATHETER CARDIO INTE, V72, P927, DOI 10.1002/ccd.21722; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492	23	684	729	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1115	1123		10.1056/NEJMoa1305520	http://dx.doi.org/10.1056/NEJMoa1305520			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	23991625	Green Published			2022-12-28	WOS:000324554800009
J	Weaver, M				Weaver, Meaghann			Recon Man	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Weaver, Meaghann] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Weaver, M (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1129	1129		10.1001/jama.2013.276137	http://dx.doi.org/10.1001/jama.2013.276137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	24045738				2022-12-28	WOS:000324500300017
J	Nguyen, VQ; Ranjan, A; Stengel, F; Wei, D; Aebersold, R; Wu, C; Leschziner, AE				Nguyen, Vu Q.; Ranjan, Anand; Stengel, Florian; Wei, Debbie; Aebersold, Ruedi; Wu, Carl; Leschziner, Andres E.			Molecular Architecture of the ATP-Dependent Chromatin-Remodeling Complex SWR1	CELL			English	Article							NUCLEOSOME CORE PARTICLE; ACTIN-RELATED PROTEINS; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; HISTONE H2AZ; DOMAIN; REVEALS; TILT; RSC	The ATP-dependent chromatin-remodeling complex SWR1 exchanges a variant histone H2A.Z/H2B dimer for a canonical H2A/H2B dimer at nucleosomes flanking histone-depleted regions, such as promoters. This localization of H2A.Z is conserved throughout eukaryotes. SWR1 is a 1 megadalton complex containing 14 different polypeptides, including the AAA+ ATPases Rvb1 and Rvb2. Using electron microscopy, we obtained the three-dimensional structure of SWR1 and mapped its major functional components. Our data show that SWR1 contains a single heterohexameric Rvb1/Rvb2 ring that, together with the catalytic subunit Swr1, brackets two independently assembled multisubunit modules. We also show that SWR1 undergoes a large conformational change upon engaging a limited region of the nucleosome core particle. Our work suggests an important structural role for the Rvbs and a distinct substrate-handling mode by SWR1, thereby providing a structural framework for understanding the complex dimer-exchange reaction.	[Nguyen, Vu Q.; Leschziner, Andres E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ranjan, Anand; Wei, Debbie; Wu, Carl] NCI, Lab Biochem & Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Stengel, Florian; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, Dept Biol, CH-8092 Zurich, Switzerland; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Wu, Carl] HHMI Janelia Farm Res Campus, Ashburn, VA 20147 USA	Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Howard Hughes Medical Institute	Leschziner, AE (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	aleschziner@mcb.harvard.edu		Leschziner, Andres/0000-0002-7732-7023; Stengel, Florian/0000-0003-1447-4509	National Science Foundation (NSF) [ECS-0335765]; Harvard's FAS Science Division Research Computing Group; National Institutes of Health (NIH) [GM007598]; NSF Graduate Research Fellowship; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092895, T32GM007598] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Harvard's FAS Science Division Research Computing Group; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Sjors Scheres (LMB-MRC, Cambridge), Pawel Penczek (University of Texas, Houston), John Rubinstein (University of Toronto), and Niko Grigorieff (Janelia Farm) for technical advice, Katerina Toropova, Rogelio Hernandez-Lopez, and Michael Cianfrocco in the Leschziner Lab for contributions during this work, Samara Reck-Peterson (Harvard Medical School), Andrew Richardson, Yoel Stuart, Beka Buckman, and Steve Klosterman (Harvard University) for feedback on the manuscript, Rachelle Gaudet and Nicole Francis (Harvard University) for advice, and Locksley for moral support. EM data were collected at Harvard's Center for Nanoscale Systems, a member of the National Nanotechnology Infrastructure Network and supported by the National Science Foundation (NSF) (ECS-0335765). Computation was performed in part on the Odyssey cluster supported by Harvard's FAS Science Division Research Computing Group. V. Q. N. was supported by the Joint Training Program in Molecules, Cells and Organisms funded by the National Institutes of Health (NIH) (GM007598) and a NSF Graduate Research Fellowship. A. R. was supported in part by a fellowship from the Leukemia and Lymphoma Society. F. S. is a Sir Henry Wellcome Fellow (Wellcome Trust Grant 095951). A. E. L. was supported in part by a fellowship from the Alfred P. Sloan Foundation. This project was supported by grants from the NIH (R01 GM092895A) (to A. E. L.), ETH Zurich (to R. A.), the Commission of the European Communities through the PROSPETS consortium (EU FP7 projects 201648 and 233226 to R. A.), the European Research Council (ERC-2008AdG 233226 to R. A.), the Center for Cancer Research, National Cancer Insti-tute (to A. R., D. W., and C. W.), and the Howard Hughes Medical Institute (C. W.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Altaf M, 2010, J BIOL CHEM, V285, P15966, DOI 10.1074/jbc.M110.117069; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Cheung KLY, 2010, J MOL BIOL, V404, P478, DOI 10.1016/j.jmb.2010.10.003; Cheung KLY, 2010, BIOCHEM CELL BIOL, V88, P77, DOI [10.1139/O09-159, 10.1139/o09-159]; Chittuluru JR, 2011, NAT STRUCT MOL BIOL, V18, P1196, DOI 10.1038/nsmb.2128; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; De Carlo S, 2010, METHOD ENZYMOL, V481, P127, DOI 10.1016/S0076-6879(10)81006-7; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Draker R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003047; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Gorynia S, 2011, J STRUCT BIOL, V176, P279, DOI 10.1016/j.jsb.2011.09.001; Gribun A, 2008, J MOL BIOL, V376, P1320, DOI 10.1016/j.jmb.2007.12.049; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hota SK, 2011, BBA-GENE REGUL MECH, V1809, P476, DOI 10.1016/j.bbagrm.2011.05.007; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Kapoor P, 2013, NAT STRUCT MOL BIOL, V20, P426, DOI 10.1038/nsmb.2529; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Leschziner A, 2010, METHOD ENZYMOL, V482, P237, DOI 10.1016/S0076-6879(10)82010-5; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Leschziner AE, 2011, CURR OPIN STRUC BIOL, V21, P709, DOI 10.1016/j.sbi.2011.10.002; Lewis R, 2008, NUCLEIC ACIDS RES, V36, P1881, DOI 10.1093/nar/gkn040; Lopez-Perrote A, 2012, NUCLEIC ACIDS RES, V40, P11086, DOI 10.1093/nar/gks871; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Pamblanco M, 2001, FEBS LETT, V496, P31, DOI 10.1016/S0014-5793(01)02397-3; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Puri T, 2007, J MOL BIOL, V366, P179, DOI 10.1016/j.jmb.2006.11.030; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Sunada R, 2005, YEAST, V22, P753, DOI 10.1002/yea.1239; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; Torreira E, 2008, STRUCTURE, V16, P1511, DOI 10.1016/j.str.2008.08.009; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	71	110	113	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1220	1231		10.1016/j.cell.2013.08.018	http://dx.doi.org/10.1016/j.cell.2013.08.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034246	Green Published, hybrid			2022-12-28	WOS:000324239300012
J	Chiu, HY; Chiu, HC				Chiu, Hsien-Yi; Chiu, Hsien-Ching			Scalp Pustules in a Patient Receiving Chemotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EPIDERMAL-GROWTH-FACTOR; LUNG-CANCER; INHIBITOR; GEFITINIB; ALOPECIA; KINASE		[Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Dept Dermatol, Hsin Chu Branch, Hsinchu, Taiwan; [Chiu, Hsien-Ching] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chiu, HC (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, 7 Chung Shan South Rd, Taipei 100, Taiwan.	hcchiu1003@ntu.edu.tw		Chiu, Hsien-Yi/0000-0002-0493-9707; CHIU, HSIEN-CHING/0000-0002-1409-8470				Costa DB, 2007, J THORAC ONCOL, V2, P1136, DOI 10.1097/JTO.0b013e31815ba7f9; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giovannini M, 2009, J ONCOL, V2009, DOI 10.1155/2009/849051; Graves JE, 2006, J AM ACAD DERMATOL, V55, P349, DOI 10.1016/j.jaad.2005.12.016; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lacouture ME, 2006, NAT REV CANCER, V6, P803, DOI 10.1038/nrc1970; Osio A, 2009, BRIT J DERMATOL, V161, P515, DOI 10.1111/j.1365-2133.2009.09214.x; Peuvrel L, 2012, SUPPORT CARE CANCER, V20, P909, DOI 10.1007/s00520-012-1404-0; Robert C, 2005, LANCET ONCOL, V6, P491, DOI 10.1016/S1470-2045(05)70243-6; Shin JU, 2012, DERMATOLOGY, V225, P135, DOI 10.1159/000342203	10	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1068	1069		10.1001/jama.2013.276214	http://dx.doi.org/10.1001/jama.2013.276214			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214KZ	24026603				2022-12-28	WOS:000324133400025
J	Cole, TB				Cole, Thomas B.			Parallel Manipulation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					884	885		10.1001/jama.2013.5288	http://dx.doi.org/10.1001/jama.2013.5288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002256				2022-12-28	WOS:000323885700001
J	Singh, S				Singh, Sonal			Valproate use during pregnancy was linked to autism spectrum disorder and childhood autism in offspring	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Singh, S (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.		Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X; Christensen, Jakob/0000-0002-9385-6435				Banach R, 2010, DRUG SAFETY, V33, P73, DOI 10.2165/11317640-000000000-00000; Galbally M, 2010, AUST NZ J PSYCHIAT, V44, P967, DOI 10.3109/00048674.2010.506637; Singh S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-138	3	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC13	10.7326/0003-4819-159-4-201308200-02013	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026277				2022-12-28	WOS:000323421700012
J	Qureshi, AI; Caplan, LR				Qureshi, Adnan I.; Caplan, Louis R.			Intracranial atherosclerosis	LANCET			English	Article							TRANSIENT ISCHEMIC ATTACK; CEREBRAL-ARTERY STENOSIS; HEALTH-CARE PROFESSIONALS; RISK-FACTORS; STROKE PATIENTS; RECURRENT STROKE; CT-ANGIOGRAPHY; CEREBROVASCULAR-DISEASE; TRANSCRANIAL DOPPLER; SECONDARY PREVENTION	Atherosclerotic disease often involves the intracranial arteries including those encased by cranial bones and dura, and those located in the subarachnoid space. Age, hypertension, and diabetes mellitus are independent risk factors for intracranial atherosclerosis. Intracranial atherosclerosis can result in thromboembolism with or without hypoperfusion leading to transient or permanent cerebral ischaemic events. High rates of recurrent ischaemic stroke and other cardiovascular events mandate early diagnosis and treatment. Present treatment is based on a combination of antiplatelet drugs, optimisation of blood pressure and LDL cholesterol values, and intracranial angioplasty or stent placement, or both, in selected patients.	[Qureshi, Adnan I.] Zeenat Qureshi Stroke Inst, St Cloud, MN 56303 USA; [Qureshi, Adnan I.] CentraCare Hlth, St Cloud, MN USA; [Caplan, Louis R.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Qureshi, AI (corresponding author), Zeenat Qureshi Stroke Inst, 519 2nd St N, St Cloud, MN 56303 USA.	qureshai@gmail.com		Qureshi, Adnan/0000-0003-4962-540X	National Institutes of Health [RO1-NS44976-01A2, U01-NS062091-01A2]; American Heart Association [0840053N]; Minnesota Medical Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Minnesota Medical Foundation	AIQ has received funding from the National Institutes of Health (RO1-NS44976-01A2; drugs provided by ESP Parma), the American Heart Association Established Investigator Award (0840053N), the National Institutes of Health (U01-NS062091-01A2, drugs provided by Cornerstone Therapeutics), and the Minnesota Medical Foundation. LRC declares that he has no conflicts of interest.	Adams RJ, 2003, CIRCULATION, V108, P1278, DOI 10.1161/01.CIR.0000090444.87006.CF; Amarenco P, 2007, STROKE, V38, P3198, DOI 10.1161/STROKEAHA.107.493106; [Anonymous], 2012, FDA REV SAF INF LIM; AOKI S, 1995, RADIOLOGY, V194, P477, DOI 10.1148/radiology.194.2.7824729; Arenillas JF, 2005, STROKE, V36, P1201, DOI 10.1161/01.STR.0000166045.12976.af; Arenillas JF, 2005, STROKE, V36, P92, DOI 10.1161/01.STR.0000149617.65372.5d; Arenillas JF, 2003, STROKE, V34, P2463, DOI 10.1161/01.STR.0000089920.93927.A7; Arenillas JF, 2001, STROKE, V32, P2898, DOI 10.1161/hs1201.099652; Arenillas JF, 2009, CEREBROVASC DIS, V28, P95, DOI 10.1159/000222660; Bae HJ, 2007, CEREBROVASC DIS, V24, P355, DOI 10.1159/000106982; BAKER AB, 1959, NEUROLOGY, V9, P321, DOI 10.1212/WNL.9.5.321; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Barnes DE, 2012, ARCH GEN PSYCHIAT, V69, P493, DOI 10.1001/archgenpsychiatry.2011.1481; BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; Bash S, 2005, AM J NEURORADIOL, V26, P1012; Bos Daniel, 2012, Alzheimers Dement, V8, pS104, DOI 10.1016/j.jalz.2012.01.008; Bos D, 2012, STROKE, V43, P1878, DOI 10.1161/STROKEAHA.111.648667; Boyle PJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.07.003; Cai ZY, 2009, NEUROCHEM RES, V34, P1226, DOI 10.1007/s11064-008-9899-y; de Andrade SPC, 2012, ARQ NEURO-PSIQUIAT, V70, P341, DOI 10.1590/S0004-282X2012005000012; CAPLAN LR, 1986, STROKE, V17, P648, DOI 10.1161/01.STR.17.4.648; Carson AP, 2011, HYPERTENSION, V57, P1101, DOI 10.1161/HYPERTENSIONAHA.110.168005; Chen HB, 2011, J NEUROL SCI, V307, P79, DOI 10.1016/j.jns.2011.05.012; Chen XY, 2008, CEREBROVASC DIS, V25, P74, DOI 10.1159/000111525; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Cho AH, 2012, J NEUROL SCI, V312, P127, DOI 10.1016/j.jns.2011.08.004; Cho KH, 2009, J NEUROL NEUROSUR PS, V80, P48, DOI 10.1136/jnnp.2007.143354; Choi HY, 2009, EUR NEUROL, V62, P72, DOI 10.1159/000222776; Chung GH, 2012, EUR J RADIOL, V81, P4069, DOI 10.1016/j.ejrad.2012.07.001; Diethrich EB, 2007, J ENDOVASC THER, V14, P676, DOI 10.1583/1545-1550(2007)14[676:VHIUAO]2.0.CO;2; Dolan H, 2010, ANN NEUROL, V68, P231, DOI 10.1002/ana.22055; Douen Andre G, 2008, J Stroke Cerebrovasc Dis, V17, P356, DOI 10.1016/j.jstrokecerebrovasdis.2008.04.003; Erten-Lyons D, 2013, NEUROLOGY, V80; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1; Fiorella D, 2007, STROKE, V38, P881, DOI 10.1161/01.STR.0000257963.65728.e8; Fu JH, 2010, CEREBROVASC DIS, V30, P51, DOI 10.1159/000313614; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gao S, 2004, STROKE, V35, P2832, DOI 10.1161/01.STR.0000147035.31297.b6; Georgiadis AL, 2013, J STROKE CEREBROVASC, V22, P100, DOI 10.1016/j.jstrokecerebrovasdis.2011.06.017; Grool AM, 2011, J NEUROL NEUROSUR PS, V82, P1093, DOI 10.1136/jnnp.2010.232413; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Halkes PHA, 2008, J NEUROL NEUROSUR PS, V79, P1218, DOI 10.1136/jnnp.2008.143875; Halkes PHA, 2007, LANCET NEUROL, V6, P115, DOI 10.1016/S1474-4422(06)70685-8; Halkes PHA, 2006, LANCET, V367, P1665; Halkes PHA, 2009, J NEUROL NEUROSUR PS, V80, P437, DOI 10.1136/jnnp.2008.147918; Hallevi H, 2012, CEREBROVASC DIS, V33, P64, DOI 10.1159/000333388; Han JH, 2008, STROKE, V39, P1340, DOI 10.1161/STROKEAHA.107.500132; HASS WK, 1968, J AMER MED ASSOC, V203, P961; Hassan AE, 2012, J STROKE CEREBROVASC, DOI [10.1016/j.jstrokecerebrovasdis.2012.03.020, DOI 10.1016/J.JSTR0KECEREBR0VASDIS.2012.03.020]; Hirai T, 2002, AM J NEURORADIOL, V23, P93; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Honig LS, 2005, NEUROLOGY, V64, P494, DOI 10.1212/01.WNL.0000150886.50187.30; Hoshino A, 2008, INTERNAL MED, V47, P1775, DOI 10.2169/internalmedicine.47.1314; Hou WH, 2009, CEREBROVASC DIS, V27, P479, DOI 10.1159/000210095; Huang HW, 2007, CEREBROVASC DIS, V24, P111, DOI 10.1159/000103125; IRVING S, 1992, CIRCULATION, V85, P1083; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Jokinen H, 2011, NEUROLOGY, V76, P1872, DOI 10.1212/WNL.0b013e31821d752f; Kang DW, 2007, ARCH NEUROL-CHICAGO, V64, P50, DOI 10.1001/archneur.64.1.50; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Kern R, 2005, NEUROLOGY, V65, P859, DOI 10.1212/01.wnl.0000175983.76110.59; Khan A, 2012, STROKE, V43, P1230, DOI 10.1161/STROKEAHA.111.641696; KIEFFER SA, 1967, AMER J ROENTGENOL RA, V101, P94, DOI 10.2214/ajr.101.1.94; Kim BJ, 2008, J NEUROL, V255, P1176, DOI 10.1007/s00415-008-0864-0; Kim DE, 2012, STROKE, V43, P1824, DOI 10.1161/STROKEAHA.112.653659; Kim HJ, 2011, CLIN IMAG, V35, P413, DOI 10.1016/j.clinimag.2011.03.001; Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500; Kim YD, 2011, STROKE, V42, P930, DOI 10.1161/STROKEAHA.110.602987; Komotar RJ, 2009, J NEUROSURG, V110, P896, DOI 10.3171/2008.9.JNS17658; Kozak O, 2011, NEUROSURGERY, V69, P334, DOI 10.1227/NEU.0b013e31821789ad; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Kremer C, 2004, J NEUROL NEUROSUR PS, V75, P1300, DOI 10.1136/jnnp.2003.017863; KULLER L, 1971, AM J EPIDEMIOL, V93, P1; Kwon SU, 2005, STROKE, V36, P782, DOI 10.1161/01.STR.0000157667.06542.b7; Kwon SU, 2011, STROKE, V42, P2883, DOI 10.1161/STROKEAHA.110.609370; Labadzhyan A, 2011, J NEUROL SCI, V307, P97, DOI 10.1016/j.jns.2011.05.004; Lau AYL, 2012, CEREBROVASC DIS, V33, P517, DOI 10.1159/000337332; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; Lee DK, 2005, STROKE, V36, P2583, DOI 10.1161/01.STR.0000189999.19948.14; Lee EJ, 2011, J AM COLL CARDIOL, V57, P1811, DOI 10.1016/j.jacc.2010.12.026; Lee JS, 2011, NEUROSCI LETT, V489, P84, DOI 10.1016/j.neulet.2010.11.071; Leifer D, 2011, STROKE, V42, P849, DOI 10.1161/STR.0b013e318208eb99; LEUNG SY, 1993, STROKE, V24, P779, DOI 10.1161/01.STR.24.6.779; Licht-Strunk E, 2004, J AFFECT DISORDERS, V83, P155, DOI 10.1016/j.jad.2004.06.007; Liebeskind DS, 2011, J CEREBR BLOOD F MET, V31, P1293, DOI 10.1038/jcbfm.2010.224; Liebeskind DS, 2011, ANN NEUROL, V69, P963, DOI 10.1002/ana.22354; Lin WH, 2012, STROKE, V43, P3007, DOI 10.1161/STROKEAHA.112.659144; Lokk J, 2009, EUR NEUROL, V62, P109, DOI 10.1159/000222782; Lopez-Cancio E, 2012, STROKE, V43, P2712, DOI 10.1161/STROKEAHA.112.661702; Man BL, 2010, CEREBROVASC DIS, V29, P236, DOI 10.1159/000267847; Man BL, 2009, STROKE, V40, P3211, DOI 10.1161/STROKEAHA.109.557041; Manzano JJF, 2012, ATHEROSCLEROSIS, V223, P219, DOI 10.1016/j.atherosclerosis.2012.04.009; Masuoka T, 2010, NEUROL MED-CHIR, V50, P179, DOI 10.2176/nmc.50.179; MATHUR KS, 1963, CIRCULATION, V27, P929, DOI 10.1161/01.CIR.27.5.929; Mazighi M, 2006, NEUROLOGY, V66, P1187, DOI 10.1212/01.wnl.0000208404.94585.b2; Mazighi M, 2008, STROKE, V39, P1142, DOI 10.1161/STROKEAHA.107.496513; MCGARRY P, 1985, LAB INVEST, V52, P533; Meseguer E, 2010, ANN NEUROL, V68, P9, DOI 10.1002/ana.21921; Miao ZR, 2012, STROKE, V43, P3284, DOI 10.1161/STROKEAHA.112.662270; Min WK, 1999, STROKE, V30, P2376, DOI 10.1161/01.STR.30.11.2376; Moftakhar R, 2005, AM J NEURORADIOL, V26, P1772; Mok VCT, 2009, CEREBROVASC DIS, V28, P18, DOI 10.1159/000215939; Mok VCT, 2009, J NEUROL, V256, P750, DOI 10.1007/s00415-009-5008-7; Moreno PR, 2004, J AM COLL CARDIOL, V44, P2293, DOI 10.1016/j.jacc.2004.07.060; Mull M, 1997, STROKE, V28, P118, DOI 10.1161/01.STR.28.1.118; Naarding P, 2007, PSYCHOL MED, V37, P383, DOI 10.1017/S0033291706009196; Nahab F, 2008, STROKE, V39, P1039, DOI 10.1161/STROKEAHA.107.499475; NARITOMI H, 1985, STROKE, V16, P214, DOI 10.1161/01.STR.16.2.214; Nguyen-Huynh MN, 2008, STROKE, V39, P1184, DOI 10.1161/STROKEAHA.107.502906; Ois A, 2008, STROKE, V39, P1717, DOI 10.1161/STROKEAHA.107.505438; Ovbiagele B, 2006, NEUROLOGY, V66, P1344, DOI 10.1212/01.wnl.0000210530.46058.5c; Park JH, 2007, EUR J NEUROL, V14, P379, DOI 10.1111/j.1468-1331.2007.01682.x; Powers WJ, 2011, JAMA-J AM MED ASSOC, V306, P1983, DOI 10.1001/jama.2011.1610; PUDDU P, 1995, ARCH GERONTOL GERIAT, V20, P15, DOI 10.1016/0167-4943(94)00600-C; Qureshi AI, 2012, J NEUROIMAGING, V22, P1, DOI 10.1111/j.1552-6569.2011.00685.x; Qureshi AI, 2004, LANCET, V363, P804, DOI 10.1016/S0140-6736(04)15697-3; Qureshi AI, 2003, NEUROSURGERY, V52, P1033, DOI 10.1227/01.NEU.0000057744.96295.9F; Qureshi AI, J VASC INTE IN PRESS; Ravalli S, 1996, J NEUROIMAGING, V6, P71, DOI 10.1111/jon19966271; Resch JA, 1970, STROKE, V1, P77, DOI 10.1161/01.STR.1.2.77; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2011, LANCET, V377, P1681, DOI 10.1016/S0140-6736(11)60516-3; Ryu CW, 2009, CEREBROVASC DIS, V27, P433, DOI 10.1159/000209238; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Sacco RL, 1998, STROKE, V29, P380, DOI 10.1161/01.STR.29.2.380; Saczynski JS, 2009, STROKE, V40, P677, DOI 10.1161/STROKEAHA.108.530212; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Schneeweiss S, 2012, CIRC-CARDIOVASC QUAL, V5, P480, DOI 10.1161/CIRCOUTCOMES.112.965988; Siddiq F, 2012, NEUROSURGERY, V71, P68, DOI 10.1227/NEU.0b013e3182518575; Siddiqui FM, 2012, J NEUROIMAGING, V22, P243, DOI 10.1111/j.1552-6569.2011.00611.x; Skutta B, 1999, AM J NEURORADIOL, V20, P791; SOLBERG LA, 1972, ATHEROSCLEROSIS, V16, P141, DOI 10.1016/0021-9150(72)90048-2; STEHBENS WE, 1975, ARCH PATHOL, V99, P582; Stevens J, 2008, AM J EPIDEMIOL, V167, P1365, DOI 10.1093/aje/kwn060; Sun RH, 2012, J CELL PHYSIOL, V227, P784, DOI 10.1002/jcp.22790; Suri MFK, 2011, NEUROEPIDEMIOLOGY, V37, P64, DOI 10.1159/000327757; Suri MFK, 2009, J NEUROIMAGING, V19, p11S, DOI 10.1111/j.1552-6569.2009.00415.x; Takaba M, 1998, ACTA NEUROCHIR, V140, P411, DOI 10.1007/s007010050118; Thijs VN, 2000, NEUROLOGY, V55, P490, DOI 10.1212/WNL.55.4.490; Thomas GN, 2008, CEREBROVASC DIS, V25, P261, DOI 10.1159/000116303; Thomas GN, 2004, DIABETES CARE, V27, P1121, DOI 10.2337/diacare.27.5.1121; Troncoso JC, 2008, ANN NEUROL, V64, P168, DOI 10.1002/ana.21413; Tsivgoulis G, 2012, J NEUROIMAGING; Tulamo R, 2010, AM J PATHOL, V177, P3224, DOI 10.2353/ajpath.2010.091172; Turan TN, 2012, CIRC-CARDIOVASC QUAL, V5, pE51, DOI 10.1161/CIRCOUTCOMES.112.966911; Turan TN, 2009, STROKE, V40, P505, DOI 10.1161/STROKEAHA.108.528281; Uehara T, 2005, EUR J NEUROL, V12, P218, DOI 10.1111/j.1468-1331.2004.00959.x; Uehara T, 1998, CEREBROVASC DIS, V8, P267, DOI 10.1159/000015864; VELICAN C, 1982, ATHEROSCLEROSIS, V43, P59, DOI 10.1016/0021-9150(82)90099-5; VELICAN D, 1982, REV ROUM MED-MED INT, V20, P215; Vergouwen MDI, 2011, ARCH NEUROL-CHICAGO, V68, P338, DOI 10.1001/archneurol.2011.20; Vernooij MW, 2009, ARCH GEN PSYCHIAT, V66, P545, DOI 10.1001/archgenpsychiatry.2009.5; Waddy SP, 2009, STROKE, V40, P719, DOI 10.1161/STROKEAHA.108.526624; Wang X, 2013, INT J STROKE, V8, P663, DOI 10.1111/j.1747-4949.2012.00828.x; Wang YJ, 2012, CNS NEUROSCI THER, V18, P93, DOI 10.1111/j.1755-5949.2011.00290.x; White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0; Wong KS, 2007, NEUROLOGY, V68, P2035, DOI 10.1212/01.wnl.0000264427.09191.89; Wong KS, 2007, LANCET NEUROL, V6, P407, DOI 10.1016/S1474-4422(07)70079-0; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong KS, 2003, STROKE, V34, P2361, DOI 10.1161/01.STR.0000089017.90037.7A; Wong KS, 1998, NEUROLOGY, V50, P812, DOI 10.1212/WNL.50.3.812; Wong KS, 2000, STROKE, V31, P2641, DOI 10.1161/01.STR.31.11.2641; Xu WH, 2012, ANN NEUROL, V71, P195, DOI 10.1002/ana.22626; Xu WH, 2011, STROKE, V42, P2957, DOI 10.1161/STROKEAHA.111.618132; YANAI T, 1994, VET PATHOL, V31, P546, DOI 10.1177/030098589403100506; Yoo J, 2012, CEREBROVASC DIS, V33, P286, DOI 10.1159/000334980; Yoon BW, 2001, STROKE, V32, P94, DOI 10.1161/01.STR.32.1.94; Zacharatos H, 2010, AM J NEURORADIOL, V31, P586, DOI 10.3174/ajnr.A1810; Zaidat OO, 2008, NEUROLOGY, V70, P1518, DOI 10.1212/01.wnl.0000306308.08229.a3; Zhang J, 2011, AM J HYPERTENS, V24, P304, DOI 10.1038/ajh.2010.246	173	219	235	13	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 15	2014	383	9921					984	998		10.1016/S0140-6736(13)61088-0	http://dx.doi.org/10.1016/S0140-6736(13)61088-0			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MR	24007975				2022-12-28	WOS:000333520700029
J	Carraretto, L; Formentin, E; Teardo, E; Checchetto, V; Tomizioli, M; Morosinotto, T; Giacometti, GM; Finazzi, G; Szabo, I				Carraretto, Luca; Formentin, Elide; Teardo, Enrico; Checchetto, Vanessa; Tomizioli, Martino; Morosinotto, Tomas; Giacometti, Giorgio Mario; Finazzi, Giovanni; Szabo, Ildiko			A Thylakoid-Located Two-Pore K+ Channel Controls Photosynthetic Light Utilization in Plants	SCIENCE			English	Article							MEMBRANE; FLUORESCENCE; VOLTAGE; MEMBERS; ROLES; TPK1; PH	The size of the light-induced proton motive force (pmf) across the thylakoid membrane of chloroplasts is regulated in response to environmental stimuli. Here, we describe a component of the thylakoid membrane, the two-pore potassium (K+) channel TPK3, which modulates the composition of the pmf through ion counterbalancing. Recombinant TPK3 exhibited potassium-selective channel activity sensitive to Ca2+ and H+. In Arabidopsis plants, the channel is found in the thylakoid stromal lamellae. Arabidopsis plants silenced for the TPK3 gene display reduced growth and altered thylakoid membrane organization. This phenotype reflects an impaired capacity to generate a normal pmf, which results in reduced CO2 assimilation and deficient nonphotochemical dissipation of excess absorbed light. Thus, the TPK3 channel manages the pmf necessary to convert photochemical energy into physiological functions.	[Carraretto, Luca; Formentin, Elide; Teardo, Enrico; Checchetto, Vanessa; Morosinotto, Tomas; Giacometti, Giorgio Mario; Szabo, Ildiko] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Checchetto, Vanessa; Tomizioli, Martino; Finazzi, Giovanni] CNRS, Lab Physiol Cellulaire & Vegetale, UMR 5168, F-38054 Grenoble, France; [Checchetto, Vanessa; Tomizioli, Martino; Finazzi, Giovanni] Commissariat Energie Atom & Energies Alternat, Inst Rech Technol & Sci Vivant, F-38054 Grenoble, France; [Checchetto, Vanessa; Tomizioli, Martino; Finazzi, Giovanni] Univ Grenoble Alpes, F-38041 Grenoble, France; [Checchetto, Vanessa; Tomizioli, Martino; Finazzi, Giovanni] INRA, USC 1359, F-38054 Grenoble, France	University of Padua; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE	Finazzi, G (corresponding author), CNRS, Lab Physiol Cellulaire & Vegetale, UMR 5168, F-38054 Grenoble, France.	giovanni.finazzi@cea.fr; ildi@civ.bio.unipd.it	Padova, Ildiko/K-5344-2016; Szabo, Ildiko/AAW-5972-2021; Morosinotto, Tomas/AAC-3188-2019; checchetto, vanessa/ABI-6145-2020	Szabo, Ildiko/0000-0002-3637-3947; Morosinotto, Tomas/0000-0002-0803-7591; checchetto, vanessa/0000-0001-8911-6146	Italy's PRIN (Research Projects of National Interest) [2010CSJX4F_005]; European Molecular Biology Organization Young Investigator Program; Aldo Gini Program; Italian Ministry of Education [L170]; French National Agency [ANR-2010-GENOM-BTV-002-01, ANR-NT09_567009]; Marie Curie Initial Training Network "AccliPhot" [316427]; Labex GRAL (Grenoble Alliance for Integrated Structural Cell Biology)	Italy's PRIN (Research Projects of National Interest); European Molecular Biology Organization Young Investigator Program(European Molecular Biology Organization (EMBO)); Aldo Gini Program; Italian Ministry of Education; French National Agency(French National Research Agency (ANR)); Marie Curie Initial Training Network "AccliPhot"; Labex GRAL (Grenoble Alliance for Integrated Structural Cell Biology)	The authors are grateful to M. Zoratti and N. La Rascio for useful discussion and to J. Barber, N. Uozumi, P. Joliot, and N. Rolland for critical reading of the manuscript. We thank A. Spena for the pBIN RolC plasmid, L. Leanza for help with antibody production, and M. Simonetti for help with artwork. We thank Italy's PRIN (Research Projects of National Interest) (2010CSJX4F_005 to I. S.) and European Molecular Biology Organization Young Investigator Program for financial support (to I. S.) and the Aldo Gini Program for a short-term grant to V. C. to work in the laboratory of G. F.; the Ph.D. fellowship for L. C. was provided by the Italian Ministry of Education (L170). M. T. was supported by the French National Agency (ANR-2010-GENOM-BTV-002-01 Chloro-Type). G. F. was funded by the French National Agency "Project PhytAdapt" (ANR-NT09_567009), the Marie Curie Initial Training Network "AccliPhot" (FP7-PEPOPLE-2012-ITN, grant agreement number 316427), and the Labex GRAL (Grenoble Alliance for Integrated Structural Cell Biology) grants. Author contributions: expression and purification of AtTPK3: L.C. and E. T.; electrophysiology: L. C., E. T., and I. S.; localization: L. C., E. F., and M. T.; silencing: L. C. and E. F.; pigment analysis: L. C. and T. M.; analysis of visible phenotype: L. C., T. M., I. S., and G. F.; electron microscopy and transmission electron microscopy service: L. C.; pmf measurements: M. T., V. C., and G. F. The study was designed by I. S., G. F., and G. M. G.; the paper was written by I. S. and G. F. This paper is dedicated to G. Franchin and E. Vaccher at Centro di Riferimento Oncologico (CRO), Aviano. Authors declare no conflict of interest. Additional data are in the supplementary materials.	Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; Bailleul B, 2010, PHOTOSYNTH RES, V106, P179, DOI 10.1007/s11120-010-9579-z; Becker D, 2004, P NATL ACAD SCI USA, V101, P15621, DOI 10.1073/pnas.0401502101; BENDALL DS, 1982, BIOCHIM BIOPHYS ACTA, V683, P119, DOI 10.1016/0304-4173(82)90008-8; Bihler H, 2005, PLANT PHYSIOL, V139, P417, DOI 10.1104/pp.105.065599; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; de Bianchi S, 2011, PLANT CELL, V23, P2659, DOI 10.1105/tpc.111.087320; Dunkel M, 2008, MOL PLANT, V1, P938, DOI 10.1093/mp/ssn064; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Ioannidis NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029864; Isayenkov S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24665; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Marcel D, 2010, FEBS LETT, V584, P2433, DOI 10.1016/j.febslet.2010.04.038; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Paramonova NV, 2004, RUSS J PLANT PHYSL+, V51, P86, DOI 10.1023/B:RUPP.0000011307.95130.8f; Rintamaki E, 2000, P NATL ACAD SCI USA, V97, P11644, DOI 10.1073/pnas.180054297; SCHONKNECHT G, 1988, NATURE, V336, P589, DOI 10.1038/336589a0; Schonknecht G, 2002, FEBS LETT, V511, P28, DOI 10.1016/S0014-5793(01)03273-2; TESTER M, 1989, PLANT PHYSIOL, V91, P249, DOI 10.1104/pp.91.1.249; Voelker C, 2010, PLANT BIOLOGY, V12, P56, DOI 10.1111/j.1438-8677.2010.00353.x; Voelker C, 2006, PLANT J, V48, P296, DOI 10.1111/j.1365-313X.2006.02868.x; WITT HT, 1979, BIOCHIM BIOPHYS ACTA, V505, P355, DOI 10.1016/0304-4173(79)90008-9; WRAIGHT CA, 1970, EUR J BIOCHEM, V17, P319, DOI 10.1111/j.1432-1033.1970.tb01169.x; Zanetti M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010118	28	119	123	3	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 4	2013	342	6154					114	118		10.1126/science.1242113	http://dx.doi.org/10.1126/science.1242113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227PP	24009357				2022-12-28	WOS:000325126100058
J	Lappalainen, T; Sammeth, M; Friedlander, MR; 't Hoen, PAC; Monlong, J; Rivas, MA; Gonzalez-Porta, M; Kurbatova, N; Griebel, T; Ferreira, PG; Barann, M; Wieland, T; Greger, L; van Iterson, M; Almlof, J; Ribeca, P; Pulyakhina, I; Esser, D; Giger, T; Tikhonov, A; Sultan, M; Bertier, G; MacArthur, DG; Lek, M; Lizano, E; Buermans, HPJ; Padioleau, I; Schwarzmayr, T; Karlberg, O; Ongen, H; Kilpinen, H; Beltran, S; Gut, M; Kahlem, K; Amstislavskiy, V; Stegle, O; Pirinen, M; Montgomery, SB; Donnelly, P; McCarthy, MI; Flicek, P; Strom, TM; Lehrach, H; Schreiber, S; Sudbrak, R; Carracedo, A; Antonarakis, SE; Haesler, R; Syvaenen, AC; Van Ommen, GJ; Brazma, A; Meitinger, T; Rosenstiel, P; Guigo, R; Gut, IG; Estivill, X; Dermitzakis, ET				Lappalainen, Tuuli; Sammeth, Michael; Friedlaender, Marc R.; 't Hoen, Peter A. C.; Monlong, Jean; Rivas, Manuel A.; Gonzalez-Porta, Mar; Kurbatova, Natalja; Griebel, Thasso; Ferreira, Pedro G.; Barann, Matthias; Wieland, Thomas; Greger, Liliana; van Iterson, Maarten; Almloef, Jonas; Ribeca, Paolo; Pulyakhina, Irina; Esser, Daniela; Giger, Thomas; Tikhonov, Andrew; Sultan, Marc; Bertier, Gabrielle; MacArthur, Daniel G.; Lek, Monkol; Lizano, Esther; Buermans, Henk P. J.; Padioleau, Ismael; Schwarzmayr, Thomas; Karlberg, Olof; Ongen, Halit; Kilpinen, Helena; Beltran, Sergi; Gut, Marta; Kahlem, Katja; Amstislavskiy, Vyacheslav; Stegle, Oliver; Pirinen, Matti; Montgomery, Stephen B.; Donnelly, Peter; McCarthy, Mark I.; Flicek, Paul; Strom, Tim M.; Lehrach, Hans; Schreiber, Stefan; Sudbrak, Ralf; Carracedo, Angel; Antonarakis, Stylianos E.; Haesler, Robert; Syvaenen, Ann-Christine; Van Ommen, Gert-Jan; Brazma, Alvis; Meitinger, Thomas; Rosenstiel, Philip; Guigo, Roderic; Gut, Ivo G.; Estivill, Xavier; Dermitzakis, Emmanouil T.		Geuvadis Consortium	Transcriptome and genome sequencing uncovers functional variation in humans	NATURE			English	Article							GENE-EXPRESSION; LANDSCAPE; VARIANTS	Genome sequencing projects are discovering millions of genetic variants in humans, and interpretation of their functional effects is essential for understanding the genetic basis of variation in human traits. Here we report sequencing and deep analysis of messenger RNA and microRNA from lymphoblastoid cell lines of 462 individuals from the 1000 Genomes Project-the first uniformly processed high-throughput RNA-sequencing data from multiple human populations with high-quality genome sequences. We discover extremely widespread genetic variation affecting the regulation of most genes, with transcript structure and expression level variation being equally common but genetically largely independent. Our characterization of causal regulatory variation sheds light on the cellular mechanisms of regulatory and loss-of-function variation, and allows us to infer putative causal variants for dozens of disease-associated loci. Altogether, this study provides a deep understanding of the cellular mechanisms of transcriptome variation and of the landscape of functional variants in the human genome.	[Lappalainen, Tuuli; Giger, Thomas; Padioleau, Ismael; Ongen, Halit; Kilpinen, Helena; Montgomery, Stephen B.; Antonarakis, Stylianos E.; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Padioleau, Ismael; Ongen, Halit; Kilpinen, Helena; Antonarakis, Stylianos E.; Dermitzakis, Emmanouil T.] Univ Geneva, iG3, CH-1211 Geneva, Switzerland; [Lappalainen, Tuuli; Padioleau, Ismael; Ongen, Halit; Kilpinen, Helena; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Sammeth, Michael; Griebel, Thasso; Ribeca, Paolo; Beltran, Sergi; Gut, Marta; Kahlem, Katja; Gut, Ivo G.] Ctr Nacl Anal Genom, Barcelona 08028, Catalonia, Spain; [Sammeth, Michael; Friedlaender, Marc R.; Monlong, Jean; Ferreira, Pedro G.; Bertier, Gabrielle; Lizano, Esther; Guigo, Roderic; Estivill, Xavier] CRG, Barcelona 08003, Catalonia, Spain; [Sammeth, Michael; Friedlaender, Marc R.; Monlong, Jean; Ferreira, Pedro G.; Bertier, Gabrielle; Lizano, Esther; Guigo, Roderic; Estivill, Xavier] UPF, Barcelona 08003, Catalonia, Spain; [Sammeth, Michael; Friedlaender, Marc R.; Monlong, Jean; Ferreira, Pedro G.; Lizano, Esther; Guigo, Roderic; Estivill, Xavier] CRG Hosp del Mar Res Inst, Barcelona 08003, Catalonia, Spain; [Friedlaender, Marc R.; Lizano, Esther; Estivill, Xavier] CRG CIBERESP, Barcelona 08003, Catalonia, Spain; ['t Hoen, Peter A. C.; van Iterson, Maarten; Pulyakhina, Irina; Buermans, Henk P. J.; Van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Rivas, Manuel A.; Pirinen, Matti; Donnelly, Peter; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Gonzalez-Porta, Mar; Kurbatova, Natalja; Greger, Liliana; Tikhonov, Andrew; Stegle, Oliver; Flicek, Paul; Brazma, Alvis] EBI, EMBL, Hinxton CB10 1SD, England; [Barann, Matthias; Esser, Daniela; Schreiber, Stefan; Haesler, Robert; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Wieland, Thomas; Schwarzmayr, Thomas; Strom, Tim M.; Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Almloef, Jonas; Karlberg, Olof; Syvaenen, Ann-Christine] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, S-75185 Uppsala, Sweden; [Sultan, Marc; Amstislavskiy, Vyacheslav; Lehrach, Hans; Sudbrak, Ralf] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [MacArthur, Daniel G.; Lek, Monkol] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [MacArthur, Daniel G.; Lek, Monkol] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Buermans, Henk P. J.] Leiden Genome Technol Ctr, NL-2300 RC Leiden, Netherlands; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7BN, England; [Strom, Tim M.; Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Lehrach, Hans; Sudbrak, Ralf] Dahlem Ctr Genome Res & Med Syst Biol, D-14195 Berlin, Germany; [Carracedo, Angel] Univ Santiago de Compostela, CIBERER, Genom Med Grp, Fdn Publ Galega Med Xen SERGAS, Santiago De Compostela, Spain; [Meitinger, Thomas] Deutsch Forschungszentrum Herz Kreislauferkrankun, Partner Site Munich Heart Alliance, D-81675 Munich, Germany	University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Uppsala University; Max Planck Society; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Technical University of Munich; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidade de Santiago de Compostela; Munich Heart Alliance	Lappalainen, T (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	tuuli.e.lappalainen@gmail.com; emmanouil.dermitzakis@unige.ch	Sammeth, Michael/C-1157-2014; Padioleau, Ismaël/AAE-8927-2019; Antonarakis, Stylianos E/N-8866-2014; Hoen, Peter A 't/D-3950-2018; Rosenstiel, Philip/A-5137-2009; Estivill, Xavier/A-3125-2013; Häsler, Robert/A-4908-2009; Rivas, Manuel/ABE-8173-2020; Lappalainen, Tuuli/AAE-6532-2020; Almlöf, Jonas/E-1608-2017; Beltran, Sergi/I-3408-2015; Guigo, Roderic/D-1303-2010; Ferreira, Pedro/HDO-1346-2022; Stegle, Oliver/AAU-9177-2020; Carracedo, Angel/D-4257-2012; Esser, Daniela/ABB-9383-2020; Sudbrak, Ralf/HHZ-8821-2022; Meitinger, Thomas/O-1318-2015; Ferreira, Pedro G/J-6379-2013; Gut, Ivo/ABF-3188-2020; Veltman, Joris A/F-5128-2010; Monlong, Jean/AAZ-8589-2020; Topolsky, Ivan/W-1929-2018; McCarthy, Mark/M-3763-2015	Sammeth, Michael/0000-0002-6528-9883; Padioleau, Ismaël/0000-0003-4935-3248; Antonarakis, Stylianos E/0000-0001-8907-5823; Hoen, Peter A 't/0000-0003-4450-3112; Rosenstiel, Philip/0000-0002-9692-8828; Estivill, Xavier/0000-0002-0723-2256; Häsler, Robert/0000-0003-4174-8229; Rivas, Manuel/0000-0003-1457-9925; Lappalainen, Tuuli/0000-0002-7746-8109; Almlöf, Jonas/0000-0002-1211-9821; Beltran, Sergi/0000-0002-2810-3445; Guigo, Roderic/0000-0002-5738-4477; Stegle, Oliver/0000-0002-8818-7193; Carracedo, Angel/0000-0003-1085-8986; Ferreira, Pedro G/0000-0003-3838-8664; Gut, Ivo/0000-0001-7219-632X; Veltman, Joris A/0000-0002-3218-8250; Monlong, Jean/0000-0002-9737-5516; Pirinen, Matti/0000-0002-1664-1350; Gonzalez-Porta, Mar/0000-0002-1661-7254; Bertier, Gabrielle/0000-0002-3319-3721; Lizano, Esther/0000-0003-3304-9807; Ongen, Halit/0000-0002-4197-5790; Flicek, Paul/0000-0002-3897-7955; Kilpinen, Helena/0000-0001-6692-6154; Topolsky, Ivan/0000-0002-7561-0810; Montgomery, Stephen/0000-0002-5200-3903; Kurbatova, Natalja/0000-0002-3973-2909; Friedlander, Marc/0000-0001-6577-4363; Meitinger, Thomas/0000-0002-8838-8403; MacArthur, Daniel/0000-0002-5771-2290; McCarthy, Mark/0000-0002-4393-0510; Brazma, Alvis/0000-0001-5988-7409	European Commission [261123]; Swiss National Science Foundation [130326, 130342, 127375, 144082]; Louis Jeantet Foundation; ERC [260927, 294653, 249968]; NIH-NIMH [MH090941]; Spanish Plan Nacional (NOVADIS) [SAF2008-00357]; Generalitat de Catalunya AGAUR [2009 SGR-1502]; Instituto de Salud Carlos III (FIS/FEDER) [PI11/00733, PS09/02368]; Spanish Plan Nacional [BIO2011-26205]; ESGI; READNA [2008-201418]; Spanish Ministry of Economy and Competitiveness (MINECO); Generalitat de Catalunya; DFG Cluster of Excellence Inflammation at Interfaces; INTERREG4A project HIT-ID; BMBF IHEC project DEEP [SP 2.3]; German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research [01GR0802, 01GM0867, 01GR0804, 16EX1020C]; EurocanPlatform [FP7 260791]; ENGAGE [HEALTH-F4-2007-201413]; CAGEKID [241669]; Centre for Medical Systems Biology; Swedish Research Council [C0524801, A028001]; Knut and Alice Wallenberg Foundation [2011.0073]; German Federal Ministry of Education and Research [01GS08201]; Max Planck Society; Wellcome Trust [WT085532, 081917, 090367, 090532, 098381, 076113, 083270]; European Molecular Biology Laboratory; Medical Research Council UK [G0601261]; Wellcome Trust Centre for Human Genetics [090532/Z/09/Z, 075491/Z/04/B]; WTCCC2 project [085475/B/08/Z, 085475/Z/08/Z]; Royal Society Wolfson Merit Award; Wellcome Trust Senior Investigator Award [095552/Z/11/Z]; EMBO long-term fellowship EMBO-ALTF [2010-337]; NIH-NIGMS [R01 GM104371]; Marie Curie; Clarendon Fund of the University of Oxford; Nuffield Department of Medicine; EMBO long-term fellowship [ALTF225-2011]; Emil Aaltonen Foundation; Academy of Finland; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090941] Funding Source: NIH RePORTER; Medical Research Council [G0601261] Funding Source: researchfish; MRC [G0601261] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Louis Jeantet Foundation; ERC(European Research Council (ERC)European Commission); NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Spanish Plan Nacional (NOVADIS); Generalitat de Catalunya AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Instituto de Salud Carlos III (FIS/FEDER); Spanish Plan Nacional(Spanish Government); ESGI; READNA; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); DFG Cluster of Excellence Inflammation at Interfaces(German Research Foundation (DFG)); INTERREG4A project HIT-ID; BMBF IHEC project DEEP; German Centre for Cardiovascular Research (DZHK); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EurocanPlatform; ENGAGE; CAGEKID; Centre for Medical Systems Biology; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Centre for Human Genetics(Wellcome Trust); WTCCC2 project; Royal Society Wolfson Merit Award(Royal Society of London); Wellcome Trust Senior Investigator Award(Wellcome Trust); EMBO long-term fellowship EMBO-ALTF; NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marie Curie(European Commission); Clarendon Fund of the University of Oxford; Nuffield Department of Medicine; EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Emil Aaltonen Foundation; Academy of Finland(Academy of Finland); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank E. Falconnet, L. Romano, A. Planchon, D. Bielsen, A. Yurovsky, A. Buil, J. Bryois, A. Nica, I. Topolsky, N. Fusi, S. Waszak, C. Bustamante, J. Rung, N. Kolesnikov, A. Roa, E. Bragin, S. Brent, J. Gonzalez, M. Morell, A. Puig, E. Palumbo, M. Ventayol Garcia, J. F. J. Laros, J. Blanc, R. Birkelund, G. Plaja, M. Ingham, J. Camps, M. Bayes, L. Agueda, A. Gouin, M.-L. Yaspo, E. Graf, A. Walther, C. Fischer, S. Loesecke, B. Schmick, D. Balzereit, S. Dokel, M. Linser, A. Kovacsovics, M. Friskovec, C. von der Lancken, M. Schlapkohl, A. Hellmann, M. Schilhabel, the SNP&SEQ Technology Platform in Uppsala, S. Sauer, the Vital-IT high-performance computing centre of the SIB Swiss Institute of Bioinformatics, B. Goldstein and others at the Coriell Institute, and J. Cooper, E. Burnett, K. Ball and others at the European Collection of Cell Cultures (ECACC) and the 1000 Genomes Consortium. This project was funded by the European Commission 7th Framework Program (FP7) (261123; GEUVADIS); the Swiss National Science Foundation (130326, 130342), the Louis Jeantet Foundation, and ERC (260927) (E. T. D.); NIH-NIMH (MH090941) (E. T. D., M. I. M., R. G.); Spanish Plan Nacional SAF2008-00357 (NOVADIS), the Generalitat de Catalunya AGAUR 2009 SGR-1502, and the Instituto de Salud Carlos III (FIS/FEDER PI11/00733) (X. E.); Spanish Plan Nacional (BIO2011-26205) and ERC (294653) (R. G.); ESGI, READNA (FP7 Health-F4-2008-201418), Spanish Ministry of Economy and Competitiveness (MINECO) and the Generalitat de Catalunya (I. G. G.); DFG Cluster of Excellence Inflammation at Interfaces, the INTERREG4A project HIT-ID, and the BMBF IHEC project DEEP SP 2.3 (P.Ro.); German Centre for Cardiovascular Research (DZHK) and the German Ministry of Education and Research (01GR0802, 01GM0867, 01GR0804, 16EX1020C) (T. M.); EurocanPlatform (FP7 260791), ENGAGE and CAGEKID (241669) (A. B.); FP7/2007-2013, ENGAGE project, HEALTH-F4-2007-201413, and the Centre for Medical Systems Biology within the framework of The Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific and Research (NWO) (P. AC. H and G.-J.v.O.); The Swedish Research Council (C0524801, A028001) and the Knut and Alice Wallenberg Foundation (2011.0073) (A.-C. S.); The Swiss National Science Foundation (127375, 144082) and ERC (249968) (S. E. A.); Instituto de Salud Carlos III (FIS/FEDER PS09/02368) (A. C.); German Federal Ministry of Education and Research (01GS08201) (R. S.); Max Planck Society (H. L.); Wellcome Trust (WT085532) and the European Molecular Biology Laboratory (P. F.); ENGAGE, Wellcome Trust (081917, 090367, 090532, 098381), and Medical Research Council UK (G0601261) (M. I. M.); Wellcome Trust Centre for Human Genetics (090532/Z/09/Z, 075491/Z/04/B), Wellcome Trust (098381, 090367, 076113, 083270), the WTCCC2 project (085475/B/08/Z, 085475/Z/08/Z), Royal Society Wolfson Merit Award, Wellcome Trust Senior Investigator Award (095552/Z/11/Z) (P. D.); EMBO long-term fellowship EMBO-ALTF 2010-337 (H. K.); NIH-NIGMS (R01 GM104371) (D. G. M.); Marie Curie FP7 fellowship (O.S.); Scholarship by the Clarendon Fund of the University of Oxford, and the Nuffield Department of Medicine (M. A. R.); EMBO long-term fellowship ALTF225-2011 (M. R. F.); Emil Aaltonen Foundation and Academy of Finland fellowships (T.L.).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gonzalez-Porta M, 2012, GENOME RES, V22, P528, DOI 10.1101/gr.121947.111; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hindorff LA, CATALOG PUBLISHED GE; Hoen P. A. C., NATURE BIOT IN PRESS; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002998; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Seaghdha CM, 2010, HUM MOL GENET, V19, P4296, DOI 10.1093/hmg/ddq342; Pantano L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1127; Parts L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002704; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027	35	1172	1185	5	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 26	2013	501	7468					506	511		10.1038/nature12531	http://dx.doi.org/10.1038/nature12531			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223RP	24037378	Green Accepted, Green Submitted			2022-12-28	WOS:000324826300049
J	Li, XD; Wu, JX; Gao, DX; Wang, H; Sun, LJ; Chen, ZJJ				Li, Xiao-Dong; Wu, Jiaxi; Gao, Daxing; Wang, Hua; Sun, Lijun; Chen, Zhijian J.			Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects	SCIENCE			English	Article							CYCLIC GMP-AMP; CYTOSOLIC DNA; RIG-I; INNATE; 2ND-MESSENGER; SENSOR; DINUCLEOTIDE; RECOGNITION	Invasion of microbial DNA into the cytoplasm of animal cells triggers a cascade of host immune reactions that help clear the infection; however, self DNA in the cytoplasm can cause autoimmune diseases. Biochemical approaches led to the identification of cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) as a cytosolic DNA sensor that triggers innate immune responses. Here, we show that cells from cGAS-deficient (cGas(-/-)) mice, including fibroblasts, macrophages, and dendritic cells, failed to produce type I interferons and other cytokines in response to DNA transfection or DNA virus infection. cGas(-/-) mice were more susceptible to lethal infection with herpes simplex virus 1 (HSV1) than wild-type mice. We also show that cGAMP is an adjuvant that boosts antigen-specific T cell activation and antibody production in mice.	[Li, Xiao-Dong; Wu, Jiaxi; Gao, Daxing; Wang, Hua; Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, LJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	Lijun.Sun@UTSouthwestern.edu; Zhijian.Chen@UTSouthwestern.edu	Gao, Daxing/J-4733-2017; Chen, Zhijian/C-6039-2012; Sun, Lijun/ABD-4470-2021; Wu, Jiaxi/K-3322-2016	Gao, Daxing/0000-0002-1493-4467; Chen, Zhijian/0000-0002-8475-8251; Wu, Jiaxi/0000-0002-6976-4784; Li, Xiao-Dong/0000-0002-4349-6996	NIH [AI-093967, 5T32AI070116]; Cancer Prevention and Research Institute of Texas [RP110430]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967, T32AI070116] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Hammer and the transgenic core facility at University of Texas Southwestern Medical Center for performing in vitro fertilization, S. Murray for technical assistance in HSV1 infection in mice, and N. DeLuca and D. Knipe for providing HSV1 strains d109 and 7134, respectively. This work was supported by grants from NIH (AI-093967) and the Cancer Prevention and Research Institute of Texas (RP110430). H.W. was supported by an NIH postdoctoral training grant (5T32AI070116). Z.J.C. is an investigator of Howard Hughes Medical Institute. The University of Texas has filed a patent on using cGAMP and its derivatives as vaccine adjuvants (U.S. patents 61/829,251 and 61/739.072; pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway). Materials including the cGas<SUP>-/-</SUP> mice may be requested upon signing a materials transfer agreement. The data presented in this manuscript are tabulated in the main paper and the supplementary materials.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Chen WX, 2010, VACCINE, V28, P3080, DOI 10.1016/j.vaccine.2010.02.081; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Ishikawa H, 2011, CELL MOL LIFE SCI, V68, P1157, DOI 10.1007/s00018-010-0605-2; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; O'Neill LAJ, 2013, SCIENCE, V339, P763, DOI 10.1126/science.1234724; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	21	668	711	8	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1390	1394		10.1126/science.1244040	http://dx.doi.org/10.1126/science.1244040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	23989956	Green Accepted			2022-12-28	WOS:000324597200046
J	Srinivas, SK; Manjunath, C				Srinivas, Sunil K.; Manjunath, Cholenahally			Pulsatile Chest Swelling	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 45-year-old man presented with swelling on the right side of the chest, which he had had for the previous 3 months. Examination revealed pulsatile swelling in the right infraclavicular area. A 45-year-old man presented with swelling on the right side of the chest that he had had for the previous 3 months. Examination revealed pulsatile swelling in the right infraclavicular area (Panels A and B, and Video). Cardiac examination was normal. Radiography of the chest showed mediastinal widening. An echocardiogram revealed mild aortic regurgitation with an aneurysm of the ascending aorta. Computed tomography of the chest with the use of contrast material showed a large saccular aneurysm (9.2 cmx11.3 cmx5.8 cm) (Panel C, asterisks in images, from left to right, of the right anterior oblique view, the anteroposterior view, and ...	[Srinivas, Sunil K.; Manjunath, Cholenahally] Sri Jayadeva Inst Cardiovasc Sci & Res, Bangalore, Karnataka, India		Srinivas, SK (corresponding author), Sri Jayadeva Inst Cardiovasc Sci & Res, Bangalore, Karnataka, India.	sunilbmc98@gmail.com							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					E16	E16		10.1056/NEJMicm1215039	http://dx.doi.org/10.1056/NEJMicm1215039			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047081				2022-12-28	WOS:000324554800001
J	Lenzer, J; Hoffman, JR; Furberg, CD; Ioannidis, JPA				Lenzer, Jeanne; Hoffman, Jerome R.; Furberg, Curt D.; Ioannidis, John P. A.		Guideline Panel Review Working Grp	Ensuring the integrity of clinical practice guidelines: a tool for protecting patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONFLICTS-OF-INTEREST; AGREE II; AUTHORS; INCENTIVES; SPECIALTY; QUALITY		[Hoffman, Jerome R.] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA; [Furberg, Curt D.] Wake Forest Sch Med, Wake Forest, NC USA; [Ioannidis, John P. A.] Stanford Univ, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Wake Forest University; Stanford University		jeanne.lenzer@gmail.com	Ioannidis, John P. A./G-9836-2011	Radecki, Ryan/0000-0001-8590-6618				Abramson J, 2007, LANCET, V369, P168, DOI 10.1016/S0140-6736(07)60084-1; [Anonymous], 2002, Prescrire Int, V11, P190; Antonuccio DO, 2003, AM PSYCHOL, V58, P1028, DOI 10.1037/0003-066X.58.12.1028; Avraham R, 2011, AM J LAW MED, V37, P7, DOI 10.1177/009885881103700101; Bari D Study Grp, 2009, NEW ENGL J MED, V360, P2503, DOI 10.1056/NEJMoa0805796; Berger E, 2008, ANN EMERG MED, V52, P137, DOI 10.1016/j.annemergmed.2008.06.009; Bindslev JBB, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-19; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Brouwers MC, 2012, J CLIN EPIDEMIOL, V65, P526, DOI 10.1016/j.jclinepi.2011.10.008; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Chan PS, 2011, JAMA-J AM MED ASSOC, V306, P53, DOI 10.1001/jama.2011.916; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Collier R, 2011, CAN MED ASSOC J, V183, pE141, DOI 10.1503/cmaj.109-3781; Cosgrove L., 2012, SCIENTIST; Cosgrove L, 2013, J EVAL CLIN PRACT, V19, P674, DOI 10.1111/jep.12016; Dachs R, 2012, AM FAM PHYSICIAN, V86, P514; Detsky AS, 2006, CAN MED ASSOC J, V175, P1033, DOI 10.1503/cmaj.061181; Gale EAM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5728; George JN, 2014, AM J MED QUAL, V29, P53, DOI 10.1177/1062860613481618; GOOZNER M, 2004, UNREVEALED NONDISCLO; Gotzsche PC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7031; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Holloway RG, 2008, NEUROLOGY, V71, P57, DOI 10.1212/01.wnl.0000316319.19159.c3; Ingelfinger JR, 2007, CLIN J AM SOC NEPHRO, V2, P415, DOI 10.2215/CJN.01340307; Johnson AJ, 2012, MED J AUSTRALIA, V196, P244, DOI 10.5694/mja11.11371; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Lenzer J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a930; Lenzer J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3830; Mehlman MJ, 2012, J LAW MED ETHICS, V40, P286, DOI 10.1111/j.1748-720X.2012.00664.x; Mendelson TB, 2011, ARCH INTERN MED, V171, P577, DOI 10.1001/archinternmed.2011.96; Mitchell JM, 2008, MED CARE, V46, P732, DOI 10.1097/MLR.0b013e31817892a7; Morris AH, 2013, CHEST, V143, P1127, DOI 10.1378/chest.12-1908; National Cholesterol Education Program, 2002, 3 NAEPP NAT HEART LU, pI; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047343; Norris SL, 2012, J CLIN EPIDEMIOL, V65, P725, DOI 10.1016/j.jclinepi.2011.12.011; ROTHMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P2782, DOI 10.1001/jama.269.21.2782; Sniderman AD, 2012, J CLIN EPIDEMIOL, V65, P705, DOI 10.1016/j.jclinepi.2012.01.009; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Welch SJ, 1997, CHEST, V112, P865, DOI 10.1378/chest.112.4.865-a	43	114	114	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2013	347								f5535	10.1136/bmj.f5535	http://dx.doi.org/10.1136/bmj.f5535			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223SB	24046286	Green Published			2022-12-28	WOS:000324828300004
J	Kagan, JC				Kagan, Jonathan C.			Sensing Endotoxins from Within	SCIENCE			English	Editorial Material							TLR4; ENDOCYTOSIS		[Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI103082, R01AI093589] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI093589, R56 AI103082] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Meng JM, 2011, J IMMUNOL, V187, P3683, DOI 10.4049/jimmunol.1101397; Ng TM, 2013, CELL HOST MICROBE, V14, P9, DOI 10.1016/j.chom.2013.06.009; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	15	10	12	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1184	1185		10.1126/science.1243939	http://dx.doi.org/10.1126/science.1243939			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031006	Green Accepted			2022-12-28	WOS:000324248800026
J	Buscombe, CP; Lin, SY; Wilson-Holt, NJ				Buscombe, Charlotte P.; Lin, Siying; Wilson-Holt, Nicholas J.			Blurred vision: targeting a diagnosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYDROXYCHLOROQUINE; CHLOROQUINE; TOXICITY		[Buscombe, Charlotte P.; Lin, Siying; Wilson-Holt, Nicholas J.] Royal Cornwall Hosp, Truro TR1 3LJ, England	Royal Cornwall Hospital	Buscombe, CP (corresponding author), Royal Cornwall Hosp, Truro TR1 3LJ, England.	charlotte.buscombe@cornwall.nhs.uk	Lin, Siying/AAL-8667-2020	Lin, Siying/0000-0003-1122-8396				Marmor MF, 2011, OPHTHALMOLOGY, V118, P415, DOI 10.1016/j.ophtha.2010.11.017; Michaelides M, 2011, ARCH OPHTHALMOL-CHIC, V129, P30, DOI 10.1001/archophthalmol.2010.321; The Royal College of Ophthalmologists, 2009, HYDR OC TOX REC SCRE; Yam J. C. S., 2006, Hong Kong Medical Journal, V12, P294	4	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2013	347								f5209	10.1136/bmj.f5209	http://dx.doi.org/10.1136/bmj.f5209			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219SU	24030560				2022-12-28	WOS:000324530500001
J	Grinnell, F				Grinnell, Frederick			It is time to update US biomedical funding	NATURE			English	Editorial Material									Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Grinnell, F (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	frederick.grinnell@utsouthwestern.edu		grinnell, frederick/0000-0001-5337-3087					0	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 12	2013	501	7466					137	137		10.1038/501137a	http://dx.doi.org/10.1038/501137a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215XR	24025803	Bronze			2022-12-28	WOS:000324244900004
J	Kuroki, S; Matoba, S; Akiyoshi, M; Matsumura, Y; Miyachi, H; Mise, N; Abe, K; Ogura, A; Wilhelm, D; Koopman, P; Nozaki, M; Kanai, Y; Shinkai, Y; Tachibana, M				Kuroki, Shunsuke; Matoba, Shogo; Akiyoshi, Mika; Matsumura, Yasuko; Miyachi, Hitoshi; Mise, Nathan; Abe, Kuniya; Ogura, Atsuo; Wilhelm, Dagmar; Koopman, Peter; Nozaki, Masami; Kanai, Yoshiakira; Shinkai, Yoichi; Tachibana, Makoto			Epigenetic Regulation of Mouse Sex Determination by the Histone Demethylase Jmjd1a	SCIENCE			English	Article							GENE-EXPRESSION; SRY; MICE; JHDM2A; SPERMATOGENESIS; TRANSCRIPTION; ACTIVATION; OBESITY; SOX9	Developmental gene expression is defined through cross-talk between the function of transcription factors and epigenetic status, including histone modification. Although several transcription factors play crucial roles in mammalian sex determination, how epigenetic regulation contributes to this process remains unknown. We observed male-to-female sex reversal in mice lacking the H3K9 demethylase Jmjd1a and found that Jmjd1a regulates expression of the mammalian Y chromosome sex-determining gene Sry. Jmjd1a directly and positively controls Sry expression by regulating H3K9me2 marks. These studies reveal a pivotal role of histone demethylation in mammalian sex determination.	[Kuroki, Shunsuke; Akiyoshi, Mika; Matsumura, Yasuko; Miyachi, Hitoshi; Tachibana, Makoto] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, Kyoto 606, Japan; [Matoba, Shogo; Mise, Nathan; Abe, Kuniya; Ogura, Atsuo] RIKEN Tsukuba Inst, Bioresource Ctr, Tsukuba, Ibaraki, Japan; [Wilhelm, Dagmar; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Nozaki, Masami] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Kanai, Yoshiakira] Univ Tokyo, Dept Vet Anat, Bunkyo Ku, Tokyo 1138657, Japan; [Shinkai, Yoichi] RIKEN Adv Sci Inst, Cellular Memory Lab, Wako, Saitama 3510198, Japan; [Tachibana, Makoto] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto, Japan	Kyoto University; RIKEN; University of Queensland; Osaka University; University of Tokyo; RIKEN; Kyoto University	Shinkai, Y (corresponding author), RIKEN Adv Sci Inst, Cellular Memory Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yshinkai@riken.jp; mtachiba@virus.kyoto-u.ac.jp	Shinkai, Yoichi/N-3909-2014; 名丹, 三瀬/AAD-1036-2021; Koopman, Peter A/C-9416-2009; Ogura, Atsuo/J-3916-2014; MATOBA, Shogo/D-9995-2016; Wilhelm, Dagmar/B-6915-2009	Shinkai, Yoichi/0000-0002-6051-2484; Koopman, Peter A/0000-0001-6939-0914; Ogura, Atsuo/0000-0003-0447-1988; MATOBA, Shogo/0000-0003-0474-232X; Wilhelm, Dagmar/0000-0002-7757-4075; Kanai, Yoshiakira/0000-0003-2116-7806; Tachibana, Makoto/0000-0001-7977-1120	Funding Program for Next Generation World-Leading Researchers; Grants-in-Aid for Scientific Research [25112001] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are especially grateful to T. Nakano for critical advice during the manuscript preparation. We thank K. Morohashi for antibodies to Nr5a1; H. Kimura for antibodies to histone; and T. Hara for fluorescence-activated cell sorting analysis support. We are also grateful to T. Matsui, G. Nagamatsu, and the members of the Tachibana laboratory for technical support. This work was supported by grants from the Funding Program for Next Generation World-Leading Researchers (M.T.). The microarray data have been deposited in the Gene Expression Omnibus and given the accession number GSE49513.	Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Bullejos M, 2001, DEV DYNAM, V221, P201, DOI 10.1002/dvdy.1134; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Katoh-Fukui Y, 2012, ENDOCRINOLOGY, V153, P913, DOI 10.1210/en.2011-1055; Kent J, 1996, DEVELOPMENT, V122, P2813; Kidokoro T, 2005, DEV BIOL, V278, P511, DOI 10.1016/j.ydbio.2004.11.006; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Loffler KA, 2003, ENDOCRINOLOGY, V144, P3237, DOI 10.1210/en.2002-0095; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	19	170	177	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1106	1109		10.1126/science.1239864	http://dx.doi.org/10.1126/science.1239864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009392	Green Published			2022-12-28	WOS:000323933100043
J	Spijkerman, J; Veenhoven, RH; Wijmenga-Monsuur, AJ; Elberse, KEM; van Gageldonk, PGM; Knol, MJ; de Melker, HE; Sanders, EAM; Schouls, L; Berbers, GAM				Spijkerman, Judith; Veenhoven, Reinier H.; Wijmenga-Monsuur, Alienke J.; Elberse, Karin E. M.; van Gageldonk, Pieter G. M.; Knol, Mirjam J.; de Melker, Hester E.; Sanders, Elisabeth A. M.; Schouls, Leom.; Berbers, Guy A. M.			Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine Administered According to 4 Different Primary Immunization Schedules in Infants A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STREPTOCOCCUS-PNEUMONIAE; DISEASE; RESPONSES; CHILDREN; VALIDATION; CARRIAGE; IMMUNITY; ASSAY	IMPORTANCE Immunization schedules with pneumococcal conjugate vaccine (PCV) differ among countries regarding the number of doses, age at vaccinations, and interval between doses. OBJECTIVE To assess the optimal primary vaccination schedule by comparing immunogenicity of 13-valent PCV (PCV13) in 4 different immunization schedules. DESIGN, SETTING, AND PARTICIPANTS An open-label, parallel-group, randomized clinical trial of healthy term infants in a general community in the Netherlands conducted between June 30, 2010, and January 25, 2011, with 99% follow-up until age 12 months. INTERVENTIONS Infants (N = 400) were randomly assigned (1: 1: 1: 1) to receive PCV13 either at ages 2, 4, and 6 months (2-4-6); at ages 3 and 5 months (3-5); at ages 2, 3, and 4 months (2-3-4); or at ages 2 and 4 months (2-4), with a booster dose at age 11.5 months. MAIN OUTCOMES AND MEASURES Primary outcome measure was antibody geometric mean concentrations (GMCs) against PCV13-included serotypes 1 month after the booster dose measured by multiplex immunoassay. Secondary outcomes included GMCs measured 1 month after the primary series, at 8 months of age, and before the booster. RESULTS The primary outcome, GMCs at 1 month after the booster dose, was not significantly different between schedules for 70 of 78 comparisons. The 2-4-6 schedule was superior to the 2-3-4 schedule for serotypes 18C (10.2 mu g/mL [95% CI, 8.2-12.7] vs 6.5 mu g/mL [95% CI, 5.4-7.8]) and 23F (10.9 mu g/mL [95% CI, 9.0-13.3] vs 7.3 mu g/mL [95% CI, 5.8-9.2]) and superior to the 2-4 schedule for serotypes 6B (8.5 mu g/mL [95% CI, 7.1-10.2] vs 5.1 mu g/mL [95% CI 3.8-6.7]), 18C (6.6 mu g/mL [95% CI, 5.7-7.7]), and 23F (7.2 mu g/mL [95% CI, 5.9-8.8]). For serotype 1, the 3-5 schedule (11.7 mu g/mL [95% CI, 9.6-14.3]) was superior to the other schedules. Geometric mean concentrations for all 13 serotypes ranged between 1.6 and 19.9 mu g/mL. Secondary outcomes demonstrated differences 1 month after the primary series. The 2-4-6 schedule was superior compared with the 3-5, 2-3-4, and 2-4 schedules for 3, 9, and 11 serotypes, respectively. Differences between schedules persisted until the booster dose. CONCLUSIONS AND RELEVANCE The use of 4 different PCV13 immunization schedules in healthy term infants resulted in no statistically significant differences in antibody levels after the booster dose for almost all serotypes. The choice of PCV schedule will require a balance between the need for early protection and maintaining protection between the primary series and the booster.	[Spijkerman, Judith; Sanders, Elisabeth A. M.] Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat Immunol & Infect Dis, NL-3508 AB Utrecht, Netherlands; [Spijkerman, Judith; Veenhoven, Reinier H.] Spaarne Hosp, Res Ctr Linnaeus Inst, Hoofddorp, Netherlands; [Wijmenga-Monsuur, Alienke J.; Elberse, Karin E. M.; van Gageldonk, Pieter G. M.; Knol, Mirjam J.; de Melker, Hester E.; Schouls, Leom.; Berbers, Guy A. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Spaarne Hospital; Netherlands National Institute for Public Health & the Environment	Spijkerman, J (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat Immunol & Infect Dis, POB 85090, NL-3508 AB Utrecht, Netherlands.	j.spijkerman@umcutrecht.nl		van Gageldonk, Pieter/0000-0003-2753-9674	Dutch Ministry of Health	Dutch Ministry of Health	This study was performed by order and for the account of the Dutch Ministry of Health by additional immunization program research funding. Pfizer kindly provided 1400 PCV13 vaccines.	BROWN GC, 1964, PUBLIC HEALTH REP, V79, P585, DOI 10.2307/4592199; Burton RL, 2006, CLIN VACCINE IMMUNOL, V13, P1004, DOI 10.1128/CVI.00112-06; de Voer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023497; de Voer RM, 2009, CLIN VACCINE IMMUNOL, V16, P433, DOI 10.1128/CVI.00364-08; Elberse KEM, 2010, CLIN VACCINE IMMUNOL, V17, P674, DOI 10.1128/CVI.00408-09; European Centre for Disease Prevention and Control, VACC SCHED; Goldblatt D, 2010, PEDIATR INFECT DIS J, V29, P401, DOI 10.1097/INF.0b013e3181c67f04; Ingels H, 2012, VACCINE, V30, P3944, DOI 10.1016/j.vaccine.2012.03.060; Melin M, 2009, INFECT IMMUN, V77, P676, DOI 10.1128/IAI.01186-08; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Palmu AA, 2013, LANCET, V381, P214, DOI 10.1016/S0140-6736(12)61854-6; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Rodenburg GD, 2010, VACCINE, V28, P1391, DOI 10.1016/j.vaccine.2009.10.151; Rozenbaum MH, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2509; Scheifele DW, 2006, VACCINE, V24, P2057, DOI 10.1016/j.vaccine.2005.11.021; Scott JAG, 2011, CLIN INFECT DIS, V53, P663, DOI 10.1093/cid/cir444; Scott P, 2011, VACCINE, V29, P9711, DOI 10.1016/j.vaccine.2011.07.042; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; van Houdt R, 2009, VACCINE, V27, P3530, DOI 10.1016/j.vaccine.2009.03.072; World Health Organization, REC ASS QUAL SAF EFF	30	55	56	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					930	937		10.1001/jama.2013.228052	http://dx.doi.org/10.1001/jama.2013.228052			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002279				2022-12-28	WOS:000323885700023
J	Xu, Y; Wang, LM; He, J; Bi, YF; Li, M; Wang, TG; Wang, LH; Jiang, Y; Dai, M; Lu, JL; Xu, M; Li, YC; Hu, N; Li, JH; Mi, SQ; Chen, CS; Li, GW; Mu, YM; Zhao, JJ; Kong, LZ; Chen, JL; Lai, SH; Wang, WQ; Zhao, WH; Ning, G				Xu, Yu; Wang, Limin; He, Jiang; Bi, Yufang; Li, Mian; Wang, Tiange; Wang, Linhong; Jiang, Yong; Dai, Meng; Lu, Jieli; Xu, Min; Li, Yichong; Hu, Nan; Li, Jianhong; Mi, Shengquan; Chen, Chung-Shiuan; Li, Guangwei; Mu, Yiming; Zhao, Jiajun; Kong, Lingzhi; Chen, Jialun; Lai, Shenghan; Wang, Weiqing; Zhao, Wenhua; Ning, Guang		2010 China Noncommunicable Dis Sur	Prevalence and Control of Diabetes in Chinese Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED FASTING GLUCOSE; RISK-FACTORS; CANCER; MELLITUS; DISEASE; HEALTH; WOMEN; MEN	IMPORTANCE Noncommunicable chronic diseases have become the leading causes of mortality and disease burden worldwide. OBJECTIVE To investigate the prevalence of diabetes and glycemic control in the Chinese adult population. DESIGN, SETTING, AND PARTICIPANTS Using a complex, multistage, probability sampling design, we conducted a cross-sectional survey in a nationally representative sample of 98 658 Chinese adults in 2010. MAIN OUTCOMES AND MEASURES Plasma glucose and hemoglobin A(1c) levels were measured after at least a 10-hour overnight fast among all study participants, and a 2-hour oral glucose tolerance test was conducted among participants without a self-reported history of diagnosed diabetes. Diabetes and prediabetes were defined according to the 2010 American Diabetes Association criteria; whereas, a hemoglobin A1c level of <7.0% was considered adequate glycemic control. RESULTS The overall prevalence of diabetes was estimated to be 11.6% (95% CI, 11.3%-11.8%) in the Chinese adult population. The prevalence among men was 12.1% (95% CI, 11.7%-12.5%) and among women was 11.0% (95% CI, 10.7%-11.4%). The prevalence of previously diagnosed diabetes was estimated to be 3.5%(95% CI, 3.4%-3.6%) in the Chinese population: 3.6%(95% CI, 3.4%-3.8%) inmen and 3.4%(95% CI, 3.2%-3.5%) in women. The prevalence of undiagnosed diabetes was 8.1% (95% CI, 7.9%-8.3%) in the Chinese population: 8.5%(95% CI, 8.2%-8.8%) inmen and 7.7%(95% CI, 7.4%-8.0%) in women. In addition, the prevalence of prediabetes was estimated to be 50.1%(95% CI, 49.7%-50.6%) in Chinese adults: 52.1% (95% CI, 51.5%-52.7%) in men and 48.1%(95% CI, 47.6%-48.7%) in women. The prevalence of diabetes was higher in older age groups, in urban residents, and in persons living in economically developed regions. Among patients with diabetes, only 25.8% (95% CI, 24.9%-26.8%) received treatment for diabetes, and only 39.7%(95% CI, 37.6%-41.8%) of those treated had adequate glycemic control. CONCLUSIONS AND RELEVANCE The estimated prevalence of diabetes among a representative sample of Chinese adults was 11.6% and the prevalence of prediabetes was 50.1%. Projections based on sample weighting suggest this may represent up to 113.9 million Chinese adults with diabetes and 493.4 million with prediabetes. These findings indicate the importance of diabetes as a public health problem in China.	[Xu, Yu; Bi, Yufang; Li, Mian; Wang, Tiange; Dai, Meng; Lu, Jieli; Xu, Min; Chen, Jialun; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, State Key Lab Med Genom,E Inst Shanghai Univ, Rui Jin Hosp,Sch Med,Minist Hlth, Shanghai 200025, Peoples R China; [Xu, Yu; Bi, Yufang; Li, Mian; Wang, Tiange; Dai, Meng; Lu, Jieli; Xu, Min; Chen, Jialun; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China; [Wang, Limin; Wang, Linhong; Jiang, Yong; Li, Yichong; Hu, Nan; Li, Jianhong; Mi, Shengquan; Zhao, Wenhua] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [He, Jiang; Chen, Chung-Shiuan] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Li, Guangwei] Fuwai Hosp, Dept Endocrinol, Beijing, Peoples R China; [Mu, Yiming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Zhao, Jiajun] Shandong Prov Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China; [Kong, Lingzhi] Minist Hlth, Dept Dis Control, Beijing, Peoples R China; [Lai, Shenghan] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese People's Liberation Army General Hospital; Shandong First Medical University & Shandong Academy of Medical Sciences; Johns Hopkins University	Ning, G (corresponding author), Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Dept Endocrine & Metab Dis, Rui Jin Hosp,Sch Med,Minist Hlth, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China.	wqingw@hotmail.com; whzhao@ilsichina.org; gning@sibs.ac.cn	wang, lin/GSE-3040-2022; He, Jiang/AAF-5303-2020; mi, shengquan/GQI-0129-2022; Li, Yichong/A-3559-2019; Zhao, Jiajun/W-2963-2018	He, Jiang/0000-0002-8286-9652; mi, shengquan/0000-0003-3470-5458; Li, Yichong/0000-0003-3842-475X; Zhao, Jiajun/0000-0003-3267-9292; Hong, Tianpei/0000-0002-5744-5129	Chinese Ministry of Finance from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Ministry of Health [201002002]; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology [2012ZX09303006-001]; National High Technology Research and Development Program of China (863 Program) [2011AA020107]; National Natural Science Foundation of China [81030011, 81222008, 81130016]	Chinese Ministry of Finance from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Ministry of Health; National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Chinese Ministry of Finance grants 1994DP131044 from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; 201002002 from the Sector Funds of Ministry of Health; 2012ZX09303006-001 from the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology; 2011AA020107 from the National High Technology Research and Development Program of China (863 Program); and 81030011, 81222008, and 81130016 from the National Natural Science Foundation of China.	Alcorn T, 2012, LANCET, V379, P2227, DOI 10.1016/S0140-6736(12)60963-5; Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 1981, Zhonghua Nei Ke Za Zhi, V20, P678; [Anonymous], 2011, FACT SHEET; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; International Diabetes Federation, DIABETES ATLAS, V9th; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levitzky YS, 2008, J AM COLL CARDIOL, V51, P264, DOI 10.1016/j.jacc.2007.09.038; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; VOSS EM, 1992, DIABETES CARE, V15, P700, DOI 10.2337/diacare.15.5.700; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; World Health Organization, PREV DIAB MELL; World Health Organization, 1997, OB PREV MAN GLOB EP; World Health Organization Western Pacific Region International Association for the Study of Obesity International Obesity TaskForce, AS PAC PERSP RED OB; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	34	2095	2950	22	549	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					948	958		10.1001/jama.2013.168118	http://dx.doi.org/10.1001/jama.2013.168118			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002281	Bronze			2022-12-28	WOS:000323885700025
J	Zlotkin, S; Newton, S; Aimone, AM; Azindow, I; Amenga-Etego, S; Tchum, K; Mahama, E; Thorpe, KE; Owusu-Agyei, S				Zlotkin, Stanley; Newton, Samuel; Aimone, Ashley M.; Azindow, Irene; Amenga-Etego, Seeba; Tchum, Kofi; Mahama, Emmanuel; Thorpe, Kevin E.; Owusu-Agyei, Seth			Effect of Iron Fortification on Malaria Incidence in Infants and Young Children in Ghana A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MICROENCAPSULATED FERROUS FUMARATE; SERUM TRANSFERRIN RECEPTOR; ACUTE-PHASE RESPONSE; SPRINKLES; INDICATORS; ABSORPTION; FERRITIN; ACID; ZINC	IMPORTANCE In sub-Saharan Africa, malaria is a leading cause of childhood morbidity and iron deficiency is among the most prevalent nutritional deficiencies. In 2006, the World Health Organization and the United Nations Children's Fund released a joint statement that recommended limiting use of iron supplements (tablets or liquids) among children in malaria-endemic areas because of concern about increased malaria risk. As a result, anemia control programs were either not initiated or stopped in these areas. OBJECTIVE To determine the effect of providing a micronutrient powder (MNP) with or without iron on the incidence of malaria among children living in a high malaria-burden area. DESIGN, SETTING, AND PARTICIPANTS Double-blind, cluster randomized trial of children aged 6 to 35 months (n = 1958 living in 1552 clusters) conducted over 6 months in 2010 in a rural community setting in central Ghana, West Africa. A cluster was defined as a compound including 1 or more households. Children were excluded if iron supplement use occurred within the past 6 months, they had severe anemia (hemoglobin level <7 g/dL), or severe wasting (weight-for-length z score <-3). INTERVENTIONS Children were randomized by cluster to receive a MNP with iron (iron group; 12.5 mg/d of iron) or without iron (no iron group). The MNP with and without iron were added to semiliquid home-prepared foods daily for 5 months followed by 1-month of further monitoring. Insecticide-treated bed nets were provided at enrollment, as well as malaria treatment when indicated. MAIN OUTCOMES AND MEASURES Malaria episodes in the iron group compared with the no iron group during the 5-month intervention period. RESULTS In intention-to-treat analyses, malaria incidence overall was significantly lower in the iron group compared with the no iron group (76.1 and 86.1 episodes/100 child-years, respectively; risk ratio (RR), 0.87 [95% CI, 0.79-0.97]), and during the intervention period (79.4 and 90.7 episodes/100 child-years, respectively; RR, 0.87 [95% CI, 0.78-0.96]). In secondary analyses, these differences were no longer statistically significant after adjusting for baseline iron deficiency and anemia status overall (adjusted RR, 0.87; 95% CI, 0.75-1.01) and during the intervention period (adjusted RR, 0.86; 95% CI, 0.74-1.00). CONCLUSION AND RELEVANCE In a malaria-endemic setting in which insecticide-treated bed nets were provided and appropriate malaria treatment was available, daily use of a MNP with iron did not result in an increased incidence of malaria among young children.	[Zlotkin, Stanley] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Newton, Samuel; Azindow, Irene; Amenga-Etego, Seeba; Tchum, Kofi; Mahama, Emmanuel; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Zlotkin, Stanley; Aimone, Ashley M.; Thorpe, Kevin E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Zlotkin, Stanley; Aimone, Ashley M.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Zlotkin, Stanley; Thorpe, Kevin E.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Zlotkin, Stanley] Univ Toronto, Dept Pediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Kintampo Health Research Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Zlotkin, S (corresponding author), Hosp Sick Children, Execut Off, 555 Univ Ave,Ste 1421 Black Wing, Toronto, ON M5G 1X8, Canada.	stanley.zlotkin@sickkids.ca	AImone, Ashley Mariko/AAC-7227-2022; Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899; Owusu-Agyei, Seth/0000-0002-0807-1781; Thorpe, Kevin/0000-0002-7586-3893	National Institutes of Health [5U01HD061270-02]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Office of Dietary Supplements; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD061270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The National Institutes of Health (grant 5U01HD061270-02), Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the Office of Dietary Supplements provided funding for this study.	[Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], 2008, WORLDW PREV AN 1993; BAYNES R, 1986, SCAND J CLIN LAB INV, V46, P695, DOI 10.3109/00365518609083733; BERGDAHL B, 1983, EUR J CLIN PHARMACOL, V25, P207, DOI 10.1007/BF00543792; Brock J.H., 1999, IRON IFNECT MOL PHYS, P289; Christofides A, 2006, MATERN CHILD NUTR, V2, P169, DOI 10.1111/j.1740-8709.2006.00060.x; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; De-Regil LM, 2011, COCHRANE DB SYST REV, V9; Doherty CP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002133; Feelders RA, 1998, EUR J CLIN INVEST, V28, P520; Hurrell R, 2010, INT J VITAM NUTR RES, V80, P279, DOI 10.1024/0300-9831/a000035; Institute of Medicine, 2013, DIET REF INT TABL AP; International Nutritional Anemia Consultative Group World Health Organization, 1998, GUIDELINES USE IRON; Koj A, 1985, ACUTE PHASE RESPONSE, P139; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; McDonald C., 2010, SCALING NUTR WHAT WI; Northrop-Clewes CA, 2008, ANN CLIN BIOCHEM, V45, P18, DOI 10.1258/acb.2007.007167; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Ojukwu JU, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub2; Olver JS, 2004, HUM PSYCHOPHARM CLIN, V19, P9, DOI 10.1002/hup.551; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; PEPYS MB, 1981, LANCET, V1, P653; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Thurnham DI, 2012, INFLUENCE INFECT INF; United Nations Children's Fund (UNICEF), 2000, MAL PREV TREATM; Verhoef H, 2001, AM J CLIN NUTR, V74, P767; Weiss G, 2002, EUR J CLIN INVEST, V32, P70, DOI 10.1046/j.1365-2362.2002.0320s1070.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2010, WHO HDB GUID DEV; World Health Organization, 2006, IR SUPPL YOUNG CHILD; World Health Organization, 2011, US MULT MICR POWD HO; World Health Organization, IR SUPPL CHILDR MAL; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615; Zlotkin S, 2001, AM J CLIN NUTR, V74, P791; Zlotkin SH, 2006, J NUTR, V136, P920	36	116	116	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					938	947		10.1001/jama.2013.277129	http://dx.doi.org/10.1001/jama.2013.277129			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002280	Bronze			2022-12-28	WOS:000323885700024
J	Spence, D				Spence, Des			Compulsory preschool jabs would fan the antivaccination lobby's fire	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VACCINATION PROGRAM					destwo@yahoo.co.uk						Aaby P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3769; Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; BBC, 2013, BBC; Centers for Disease Control and Prevention, SOM COMM MISC VACC R; Hamza H, 2012, APOPTOSIS, V17, P516, DOI 10.1007/s10495-011-0690-1; Health Protection Scotland, MEN MEN INF; Salleras L, 2005, VACCINE, V23, P2181, DOI 10.1016/j.vaccine.2005.01.068; UNICEF and World Health Organization, 2012, IMM SUMM STAT REF CO	8	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2013	347								f5263	10.1136/bmj.f5263	http://dx.doi.org/10.1136/bmj.f5263			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ND	23999852				2022-12-28	WOS:000324216000002
J	Lam, S; Liew, H; Khor, HT; Dalan, R; Kon, YC; Jong, M; Chew, DEK; Leow, MKS				Lam, Stanley; Liew, Huiling; Khor, Hong Tar; Dalan, Rinkoo; Kon, Yin Chian; Jong, Michelle; Chew, Daniel E. K.; Leow, Melvin Khee-Shing			VIPoma in a 37-year-old man	LANCET			English	Editorial Material							EXPERIENCE; TUMORS		[Lam, Stanley; Liew, Huiling; Khor, Hong Tar; Dalan, Rinkoo; Kon, Yin Chian; Jong, Michelle; Chew, Daniel E. K.; Leow, Melvin Khee-Shing] Tan Tock Seng Hosp, Singapore 308433, Singapore	Tan Tock Seng Hospital	Lam, S (corresponding author), Tan Tock Seng Hosp, Dept Endocrinol, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	stanley_lam@ttsh.com.sg	Leow, Melvin/AAJ-1168-2020; Dalan, Rinkoo/C-1099-2019; Leow, Melvin/H-3129-2019	Dalan, Rinkoo/0000-0001-9769-2696; Leow, Melvin/0000-0002-2837-5889				Baum RP, 2012, THERANOSTICS, V2, P437, DOI 10.7150/thno.3645; Ghaferi AA, 2008, J GASTROINTEST SURG, V12, P382, DOI 10.1007/s11605-007-0177-0; PERRY RR, 1995, J CLIN ENDOCR METAB, V80, P2273, DOI 10.1210/jc.80.8.2273; PRIEST WM, 1957, LANCET, V2, P1145; Strosberg JR, 2011, CANCER CONTROL, V18, P127, DOI 10.1177/107327481101800207	5	5	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					832	832		10.1016/S0140-6736(13)61217-9	http://dx.doi.org/10.1016/S0140-6736(13)61217-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VP	23993192				2022-12-28	WOS:000324239200033
J	Bainer, R; Weaver, V				Bainer, Russell; Weaver, Valerie			Strength Under Tension	SCIENCE			English	Editorial Material							CYTOSKELETON; CANCER; LAMIN		[Bainer, Russell; Weaver, Valerie] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Bainer, Russell; Weaver, Valerie] Univ Calif San Francisco, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Bainer, Russell; Weaver, Valerie] Stanford Univ, Phys Sci Oncol Ctr, Palo Alto, CA 94304 USA; [Weaver, Valerie] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Weaver, Valerie] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Weaver, Valerie] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Weaver, Valerie] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Bainer, R (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.	valerie.weaver@ucsfmedctr.org		Weaver, Valerie marie/0000-0003-4786-6752	NATIONAL CANCER INSTITUTE [U01CA151925] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA151925] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Foster CR, 2011, NUCLEUS-PHILA, V2, P434, DOI 10.4161/nucl.2.5.17775; INGBER DE, 1993, J CELL SCI, V104, P613; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Mazumder A, 2010, J R SOC INTERFACE, V7, pS321, DOI 10.1098/rsif.2010.0039.focus; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014	7	11	12	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					965	966		10.1126/science.1243643	http://dx.doi.org/10.1126/science.1243643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	208BZ	23990548				2022-12-28	WOS:000323652300027
J	Ford, AC; Moayyedi, P				Ford, Alexander C.; Moayyedi, Paul			Dyspepsia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PROTON PUMP INHIBITORS; 10-YEAR FOLLOW-UP; HELICOBACTER-PYLORI ERADICATION; LIFE-STYLE FACTORS; QUALITY-OF-LIFE; FUNCTIONAL DYSPEPSIA; DOUBLE-BLIND; GASTROESOPHAGEAL-REFLUX; NONULCER DYSPEPSIA; DIAGNOSTIC-TESTS	Definitions of the term dyspepsia vary but generally describe pain or discomfort in the epigastric region. People with dyspepsia have a normal life expectancy,(1) but symptoms impair quality of life,(2) (3) and affect productivity.(4) Dyspepsia is estimated to cost the United Kingdom more than 1bn pound ((sic)1.16bn; $1.55bn) annually,(5) so it is important to manage the condition appropriately. We summarise recent systematic reviews, meta-analyses, and randomised controlled trials to provide the general reader with an update on how to deal with this disorder effectively.	[Ford, Alexander C.] St James Univ Hosp, Leeds Gastroenterol Inst, Leeds, W Yorkshire, England; [Ford, Alexander C.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Moayyedi, Paul] McMaster Univ, Hlth Sci Ctr, Div Gastroenterol, Hamilton, ON, Canada	Saint James's University Hospital; University of Leeds; McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Ford, AC (corresponding author), St James Univ Hosp, Leeds Gastroenterol Inst, Leeds, W Yorkshire, England.	alexf12399@yahoo.com	Ford, Alexander/K-5491-2012; Moayyedi, Paul/M-6178-2014	Ford, Alexander/0000-0001-6371-4359; Moayyedi, Paul/0000-0002-3616-9292	Shire Pharmaceuticals; Forest Canada; AstraZeneca	Shire Pharmaceuticals; Forest Canada; AstraZeneca(AstraZeneca)	We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: ACF has received speaker's fees from Shire Pharmaceuticals; PM has received speakers fees from Shire Pharmaceuticals, Forest Canada, and AstraZeneca; his chair is funded in part by an unrestricted donation from AstraZeneca to McMaster University.	Abraham NS, 2004, ALIMENT PHARM THER, V19, P631, DOI 10.1111/j.1365-2036.2004.01878.x; Agrawal NM, 2000, ARCH INTERN MED, V160, P1455, DOI 10.1001/archinte.160.10.1455; Allison JA, 2005, GASTROENTEROLOGY, V129, P1756, DOI 10.1053/j.gastro.2005.09.020; Aro P, 2009, GASTROENTEROLOGY, V137, P94, DOI 10.1053/j.gastro.2009.03.039; Brook RA, 2010, CLIN GASTROENTEROL H, V8, P498, DOI 10.1016/j.cgh.2010.03.003; Choung RS, 2012, NEUROGASTROENT MOTIL, V24, P229, DOI 10.1111/j.1365-2982.2011.01845.x; Feinle-Bisset C, 2013, NAT REV GASTRO HEPAT, V10, P150, DOI 10.1038/nrgastro.2012.246; Ford AC, 2008, ALIMENT PHARM THER, V28, P534, DOI 10.1111/j.1365-2036.2008.03784.x; Ford AC, 2009, ALIMENT PHARM THER, V30, P28, DOI 10.1111/j.1365-2036.2009.04008.x; Ford AC, 2009, GUT, V58, P367, DOI 10.1136/gut.2008.163162; Ford AC, 2005, GASTROENTEROLOGY, V129, P1910, DOI 10.1053/j.gastro.2005.09.016; Ford AC, 2005, GASTROENTEROLOGY, V128, P1838, DOI 10.1053/j.gastro.2005.03.004; Ford AC, 2004, AM J GASTROENTEROL, V99, P1833, DOI 10.1111/j.1572-0241.2004.40014.x; Ford AC, 2007, GUT, V56, P321, DOI 10.1136/gut.2006.099846; Ford AC, 2012, AM J GASTROENTEROL, V107, P912, DOI 10.1038/ajg.2012.69; Ford AC, 2010, CLIN GASTROENTEROL H, V8, P830, DOI 10.1016/j.cgh.2010.05.031; Ford AC, 2010, CLIN GASTROENTEROL H, V8, P401, DOI 10.1016/j.cgh.2009.07.020; Ford AC, 2010, GASTROENTEROLOGY, V138, P1727, DOI 10.1053/j.gastro.2010.01.043; Ford AC, 2009, ARCH INTERN MED, V169, P651, DOI 10.1001/archinternmed.2009.22; Haag S, 2007, ALIMENT PHARM THER, V25, P973, DOI 10.1111/j.1365-2036.2007.03277.x; Harvey RF, 2010, ALIMENT PHARM THER, V32, P394, DOI 10.1111/j.1365-2036.2010.04363.x; Koloski NA, 2012, GUT, V61, P1284, DOI 10.1136/gutjnl-2011-300474; Liebregts T, 2011, AM J GASTROENTEROL, V106, P1089, DOI 10.1038/ajg.2010.512; Locke GR, 2013, GASTROENTEROLOGY, V144, pS140; Ma TT, 2012, ALIMENT PHARM THER, V35, P552, DOI 10.1111/j.1365-2036.2011.04979.x; Madisch A, 2004, DIGESTION, V69, P45, DOI 10.1159/000076546; Mahadeva S, 2010, ALIMENT PHARM THER, V31, P1141, DOI 10.1111/j.1365-2036.2010.04270.x; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Marwaha A, 2009, GASTROENTEROLOGY, V136, pA182; May B, 2000, ALIMENT PHARM THERAP, V14, P1671, DOI 10.1046/j.1365-2036.2000.00873.x; Moayyedi P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001960.pub3; Moayyedi P, 2006, JAMA-J AM MED ASSOC, V295, P1566, DOI 10.1001/jama.295.13.1566; Moayyedi P, 2004, GASTROENTEROLOGY, V127, P1329, DOI 10.1053/j.gastro.2004.08.026; Moayyedi P, 2002, GUT, V50, P10, DOI 10.1136/gut.50.suppl_4.iv10; Moayyedi P, 2000, AM J GASTROENTEROL, V95, P1448, DOI 10.1111/j.1572-0241.2000.2126_1.x; Moayyedi P, 2006, LANCET, V367, P2086, DOI 10.1016/S0140-6736(06)68932-0; Moayyedi P, 2012, CURR OPIN GASTROEN, V28, P602, DOI 10.1097/MOG.0b013e328358ad9b; Moayyedi P, 2012, NAT REV GASTRO HEPAT, V9, P132, DOI 10.1038/nrgastro.2011.272; Mujakovic S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-140; National Institute for Clinical Excellence, 2004, DYSP MAN DYSP AD PRI; Ngamruengphong S, 2011, AM J GASTROENTEROL, V106, P1209, DOI 10.1038/ajg.2011.113; NHS Scotland, 2021, SCOTT REF GUID SUSP; Pilichiewicz AN, 2009, CLIN GASTROENTEROL H, V7, P317, DOI 10.1016/j.cgh.2008.09.007; Raghunath AS, 2007, ALIMENT PHARM THERAP, V25, P585, DOI 10.1111/j.1365-2036.2006.03234.x; Soo S, 2005, COCHRANE DB SYST REV, V2; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Talley NJ, 2006, GUT, V55, P933, DOI 10.1136/gut.2005.078634; Talley NJ, 2007, CLIN GASTROENTEROL H, V5, P1175, DOI 10.1016/j.cgh.2007.05.015; Tan VPY, 2012, WORLD J GASTROENTERO, V18, P6127, DOI 10.3748/wjg.v18.i42.6127; Vakil N, 2006, GASTROENTEROLOGY, V131, P390, DOI 10.1053/j.gastro.2006.04.029; van Marrewijk CJ, 2009, LANCET, V373, P215, DOI 10.1016/S0140-6736(09)60070-2; von Arnim U, 2007, AM J GASTROENTEROL, V102, P1268, DOI 10.1111/j.1572-0241.2006.01183.x; Wu JC, 2011, GASTROENTEROLOGY, V140, pS50; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104; Zeng F, 2012, AM J GASTROENTEROL, V107, P1236, DOI 10.1038/ajg.2012.53; Zeng F, 2011, GASTROENTEROLOGY, V141, P499, DOI 10.1053/j.gastro.2011.05.003; Zhou GY, 2013, AM J GASTROENTEROL, V108, P260, DOI 10.1038/ajg.2012.405	57	5	6	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2013	347								f5059	10.1136/bmj.f5059	http://dx.doi.org/10.1136/bmj.f5059			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CI	23990632				2022-12-28	WOS:000323881300006
J	Tuck, AC; Tollervey, D				Tuck, Alex Charles; Tollervey, David			A Transcriptome-wide Atlas of RNP Composition Reveals Diverse Classes of mRNAs and lncRNAs	CELL			English	Article							POLY(A) TAIL LENGTH; BINDING PROTEIN; BIDIRECTIONAL PROMOTERS; STRUCTURAL BASIS; NUCLEAR EXOSOME; TERMINATION; DEGRADATION; EXPORT; GENE; SPECIFICITY	Eukaryotic genomes generate a heterogeneous ensemble of mRNAs and long noncoding RNAs (lncRNAs). LncRNAs and mRNAs are both transcribed by Pol II and acquire 5' caps and poly(A) tails, but only mRNAs are translated into proteins. To address how these classes are distinguished, we identified the transcriptome-wide targets of 13 RNA processing, export, and turnover factors in budding yeast. Comparing the maturation pathways of mRNAs and lncRNAs revealed that transcript fate is largely determined during 3' end formation. Most lncRNAs are targeted for nuclear RNA surveillance, but a subset with 3' cleavage and polyadenylation features resembling the mRNA consensus can be exported to the cytoplasm. The Hrp1 and Nab2 proteins act at this decision point, with dual roles in mRNA cleavage/polyadenylation and lncRNA surveillance. Our data also reveal the dynamic and heterogeneous nature of mRNA maturation, and highlight a subset of "lncRNA-like" mRNAs regulated by the nuclear surveillance machinery.	[Tuck, Alex Charles; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Tollervey, D (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Michael Swann Bldg,Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	d.tollervey@ed.ac.uk	Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772; Tuck, Alex/0000-0003-0748-9913	Wellcome Trust [086587, 077248, 092076]; European Commission [201142]	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank Sander Granneman and Grzegorz Kudla for help with analyses and Ola Helwak and Jai Tree for comments on the manuscript. This work was supported by Wellcome Trust grants (086587 and 077248) and European Commission 7th Framework Programme (UNICELLSYS, Grant No. 201142). Work in the Wellcome Trust Centre for Cell Biology is supported by Wellcome Trust core funding (092076). A. C. T. and D. T. designed the experiments; A. C. T. performed experiments and analyzed the data; A. C. T. and D. T. wrote the paper.	Batisse J, 2009, J BIOL CHEM, V284, P34911, DOI 10.1074/jbc.M109.062034; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Brockmann C, 2012, STRUCTURE, V20, P1007, DOI 10.1016/j.str.2012.03.011; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Castelnuovo M, 2013, NAT STRUCT MOL BIOL, V20, P851, DOI 10.1038/nsmb.2598; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Ciais D, 2008, NUCLEIC ACIDS RES, V36, P3075, DOI 10.1093/nar/gkn160; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Faza MB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002915; Geisler S, 2012, MOL CELL, V45, P279, DOI 10.1016/j.molcel.2011.11.025; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; Gonzalez-Aguilera C, 2011, MOL BIOL CELL, V22, P2729, DOI 10.1091/mbc.E11-01-0055; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Gudipati RK, 2012, EMBO J, V31, P2427, DOI 10.1038/emboj.2012.81; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hasegawa Y, 2008, RNA, V14, P2333, DOI 10.1261/rna.1016508; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Iglesias N, 2010, GENE DEV, V24, P1927, DOI 10.1101/gad.583310; Ji XJ, 2011, EMBO J, V30, P2622, DOI 10.1038/emboj.2011.171; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; Larochelle M, 2012, NUCLEIC ACIDS RES, V40, P10240, DOI 10.1093/nar/gks838; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Mauchi N, 2010, CELL STRUCT FUNCT, V35, P95, DOI 10.1247/csf.10011; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mitchell SF, 2013, NAT STRUCT MOL BIOL, V20, P127, DOI 10.1038/nsmb.2468; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Perez-Canadillas JM, 2006, EMBO J, V25, P3167, DOI 10.1038/sj.emboj.7601190; Porrua O, 2013, BBA-GENE REGUL MECH, V1829, P604, DOI 10.1016/j.bbagrm.2013.02.012; Reis CC, 2007, GENETICS, V175, P993, DOI 10.1534/genetics.106.065987; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rondon AG, 2010, BBA-GENE REGUL MECH, V1799, P533, DOI 10.1016/j.bbagrm.2010.06.002; Roth KM, 2009, RNA, V15, P1045, DOI 10.1261/rna.709609; Schmid M, 2012, MOL CELL, V47, P267, DOI 10.1016/j.molcel.2012.05.005; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Schwer B, 2011, NUCLEIC ACIDS RES, V39, P6715, DOI 10.1093/nar/gkr279; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Viphakone N, 2008, NUCLEIC ACIDS RES, V36, P2418, DOI 10.1093/nar/gkn080; Vogel C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009217; Wagschal A, 2012, CELL, V150, P1147, DOI 10.1016/j.cell.2012.08.004; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Wolf JJ, 2010, GENETICS, V185, P513, DOI 10.1534/genetics.110.113944; Wong CM, 2007, MOL CELL BIOL, V27, P6520, DOI 10.1128/MCB.00733-07; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	60	160	162	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					996	1009		10.1016/j.cell.2013.07.047	http://dx.doi.org/10.1016/j.cell.2013.07.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993093	Green Published, hybrid			2022-12-28	WOS:000323767300014
J	Wilson, MD; Harreman, M; Taschner, M; Reid, J; Walker, J; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Wilson, Marcus D.; Harreman, Michelle; Taschner, Michael; Reid, James; Walker, Jane; Erdjument-Bromage, Hediye; Tempst, Paul; Svejstrup, Jesper Q.			Proteasome-Mediated Processing of Def1, a Critical Step in the Cellular Response to Transcription Stress	CELL			English	Article							RNA-POLYMERASE-II; DAMAGE-INDUCED UBIQUITYLATION; DNA-DAMAGE; NUCLEAR EXPORT; PROTEIN LOCALIZATION; UBIQUITIN LIGASE; LARGE SUBUNIT; DEGRADATION; ELONGATION; ELONGIN	DNA damage triggers polyubiquitylation and degradation of the largest subunit of RNA polymerase II (RNAPII), a "mechanism of last resort" employed during transcription stress. In yeast, this process is dependent on Def1 through a previously unresolved mechanism. Here, we report that Def1 becomes activated through ubiquitylation- and proteasome-dependent processing. Def1 processing results in the removal of a domain promoting cytoplasmic localization, resulting in nuclear accumulation of the clipped protein. Nuclear Def1 then binds RNAPII, utilizing a ubiquitin-binding domain to recruit the Elongin-Cullin E3 ligase complex via a ubiquitin-homology domain in the Ela1 protein. This facilitates polyubiquitylation of Rpb1, triggering its protea-some-mediated degradation. Together, these results outline the multistep mechanism of Rpb1 polyubiquitylation triggered by transcription stress and uncover the key role played by Def1 as a facilitator of Elongin-Cullin ubiquitin ligase function.	[Wilson, Marcus D.; Harreman, Michelle; Taschner, Michael; Reid, James; Walker, Jane; Svejstrup, Jesper Q.] Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Mol Biol Programme, New York, NY 10021 USA	Cancer Research UK; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Mech Transcript Lab, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk		Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Wilson, Marcus/0000-0001-9551-5514; Svejstrup, Jesper/0000-0003-4964-6147; Taschner, Michael/0000-0002-8881-3705; Taschner, Michael/0000-0002-3789-5077	Cancer Research UK; European Research Council; Cancer Research UK [11567] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by grants from Cancer Research UK and European Research Council (to J.Q.S.). We thank Fermentation Services and the Protein Analysis and Proteomics Laboratory at the London Research Institute (LRI) for their expert assistance. We thank William Tansey, Raymond Deshaies, Pamela Silver, Anita Corbett, and Frank Uhlmann for providing reagents. We thank Peter Verrijzer, Helle Ulrich, Kay Hofmann, Nico Dantuma, Anita Corbett, James Omichinski, and members of the Svejstrup laboratory for comments on the manuscript.	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bassermann F, 2014, BBA-MOL CELL RES, V1843, P150, DOI 10.1016/j.bbamcr.2013.02.028; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Brykailo MA, 2007, NUCLEIC ACIDS RES, V35, P6862, DOI 10.1093/nar/gkm776; Chan WM, 2011, HUM MOL GENET, V20, P1738, DOI 10.1093/hmg/ddr049; Chen YB, 2005, J BIOL CHEM, V280, P24784, DOI 10.1074/jbc.M413562200; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Gaillard H, 2013, BBA-GENE REGUL MECH, V1829, P141, DOI 10.1016/j.bbagrm.2012.09.008; GARRETT KP, 1995, P NATL ACAD SCI USA, V92, P7172, DOI 10.1073/pnas.92.16.7172; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jordan PW, 2007, PLOS GENET, V3, P2368, DOI 10.1371/journal.pgen.0030222; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Koth CM, 2000, J BIOL CHEM, V275, P11174, DOI 10.1074/jbc.275.15.11174; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Reid J, 2004, J BIOL CHEM, V279, P29875, DOI 10.1074/jbc.C400185200; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Schlacher K, 2007, NAT REV MOL CELL BIO, V8, P587, DOI 10.1038/nrm2198; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Strom AC, 2001, GENOME BIOL, V2; Suzuki T, 2011, J BIOSCI BIOENG, V112, P107, DOI 10.1016/j.jbiosc.2011.04.007; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Wilson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046398; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249	56	49	49	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 29	2013	154	5					983	995		10.1016/j.cell.2013.07.028	http://dx.doi.org/10.1016/j.cell.2013.07.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	209OE	23993092	hybrid, Green Published			2022-12-28	WOS:000323767300013
J	Adam, SS; McDuffie, JR; Lachiewicz, PF; Ortel, TL; Williams, JW				Adam, Soheir S.; McDuffie, Jennifer R.; Lachiewicz, Paul F.; Ortel, Thomas L.; Williams, John W., Jr.			Comparative Effectiveness of New Oral Anticoagulants and Standard Thromboprophylaxis in Patients Having Total Hip or Knee Replacement A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							VENOUS THROMBOEMBOLIC DISEASE; RANDOMIZED CONTROLLED-TRIALS; MOLECULAR-WEIGHT HEPARIN; ELECTIVE HIP; METAANALYSIS; ARTHROPLASTY; RIVAROXABAN; ENOXAPARIN; PREVENTION; DABIGATRAN	Background: Pharmacologic thromboprophylaxis reduces the risk for venous thromboembolism after total hip replacement (THR) or total knee replacement (TKR). New oral anticoagulants (NOACs), including direct thrombin inhibitors and factor Xa inhibitors, are emerging options for thromboprophylaxis after these procedures. Purpose: To compare the benefits and risks of NOACs versus standard thromboprophylaxis for adults having THR or TKR. Data Sources: MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews from January 2009 through March 2013. Study Selection: English-language systematic reviews. Data Extraction: Two independent reviewers abstracted data and rated study quality and strength of evidence. Data Synthesis: Six good-quality systematic reviews compared NOACs with low-molecular-weight heparin (LMWH) for thromboprophylaxis after THR or TKR. Risk for symptomatic deep venous thrombosis, but not risk for death or nonfatal pulmonary embolism, was reduced with factor Xa inhibitors compared with LMWH (4 fewer events per 1000 patients). Conversely, the risk for major bleeding increased (2 more events per 1000 patients). Outcomes of dabigatran did not significantly differ from those of LMWH. Indirect evaluation of NOACs by common comparison with LMWH showed nonsignificantly reduced risks for venous thromboembolism with rivaroxaban compared with dabigatran (risk ratio [RR], 0.68 [95% CI, 0.21 to 2.23]) and apixaban (RR, 0.59 [CI, 0.26 to 1.33]) but increased major bleeding. New oral anticoagulants have not been compared with warfarin, aspirin, or unfractionated heparin. Limitations: Head-to-head comparisons among NOACs were not available. Efficacy is uncertain in routine clinical practice. Conclusion: New oral anticoagulants are effective for thromboprophylaxis after THR and TKR. Their clinical benefits over LMWH are marginal and offset by increased risk for major bleeding.	Duke Univ, Med Ctr, Durham, NC 27710 USA; Durham Vet Affairs Med Ctr, Durham, NC USA; King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; King Abdulaziz University	Adam, SS (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3939, Durham, NC 27710 USA.	soheir.adam@duke.edu	Williams, John/AAM-4572-2020	Williams, John/0000-0002-5267-5558	U.S. Department of Veterans Affairs	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs.	Adam SS, 2012, COMP EFFECTIVENESS N; Agency for Healthcare Research and Quality, METH GUID EFF COMP E; Alves C, 2012, J CARDIOVASC PHARM T, V17, P266, DOI 10.1177/1074248411427402; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Eriksson BI, 2005, J THROMB HAEMOST, V3, P103, DOI 10.1111/j.1538-7836.2004.01100.x; Ettema HB, 2009, ACTA ORTHOP, V80, P109, DOI 10.1080/17453670902807441; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Fareed J, 2012, ANNU REV PHARMACOL, V52, P79, DOI 10.1146/annurev-pharmtox-010611-134633; Friedman Richard J, 2010, Am J Orthop (Belle Mead NJ), V39, P14; Gomez-Outes A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3675; Guyatt GH, 2013, J CLIN EPIDEMIOL, V66, P158, DOI 10.1016/j.jclinepi.2012.01.012; Hill J, 2007, BMJ-BRIT MED J, V334, P1053, DOI 10.1136/bmj.39174.678032.AD; HIRSH J, 1994, EUR J SURG, P9; Jacobs JJ, 2012, J BONE JOINT SURG AM, V94A, P746, DOI [10.2106/JBJS.K.01602, 10.2106/JBJS.9408.ebo746]; Kwok CS, 2013, CHEST; Li XM, 2012, CHINESE MED J-PEKING, V125, P2339, DOI 10.3760/cma.j.issn.0366-6999.2012.13.018; Lieberman JR, 2005, J BONE JOINT SURG AM, V87A, P2097, DOI 10.2106/JBJS.D.03033; Loke YK, 2011, J CLIN PHARM THER, V36, P111, DOI 10.1111/j.1365-2710.2010.01162.x; Marinopoulos Spyridon S, 2007, Evid Rep Technol Assess (Full Rep), P1; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mont MA, 2011, J AM ACAD ORTHOP SUR, V19, P768, DOI 10.5435/00124635-201112000-00007; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Neumann I, 2012, ANN INTERN MED, V156, P710, DOI 10.7326/0003-4819-156-10-201205150-00421; Nutescu E, 2011, AM J MANAG CARE, V17, pS27; Ringerike T, 2011, 13 NORW KNOWL CTR HL; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shojania K G, 2001, Eff Clin Pract, V4, P157; Sobieraj DM, 2012, COMP EFFECTIVENESS R; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Turpie AGG, 2001, AM HEART J, V142, pS9, DOI 10.1067/mhj.2001.117032; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Wilke T, 2010, EXPERT REV PHARM OUT, V10, P691, DOI [10.1586/erp.10.77, 10.1586/ERP.10.77]	34	43	49	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4					275	+		10.7326/0003-4819-159-4-201308200-00008	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00008			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026260				2022-12-28	WOS:000323421700017
J	Mushlin, AI				Mushlin, Alvin I.			In patients with sciatica, MRI at 1 year did not differentiate between a favorable or unfavorable outcome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Weill Cornell Med Ctr, New York, NY USA	Cornell University	Mushlin, AI (corresponding author), Weill Cornell Med Ctr, New York, NY USA.			van den Hout, Wilbert B./0000-0002-6425-0135				Deyo RA, 2013, NEW ENGL J MED, V368, P1056, DOI 10.1056/NEJMe1215599	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC12	10.7326/0003-4819-159-4-201308200-02012	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026276				2022-12-28	WOS:000323421700011
J	Rogers, E; Sherman, S				Rogers, Erin; Sherman, Scott			Review: Cytisine increases smoking abstinence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Rogers, Erin] VA NY Harbor Healthcare Syst, New York, NY USA; NYU, Sch Med, New York, NY USA	New York University	Rogers, E (corresponding author), VA NY Harbor Healthcare Syst, New York, NY USA.		Rogers, Erin/L-9312-2019; McRobbie, Hayden/B-4552-2018	Sherman, Scott/0000-0003-1752-7303; McRobbie, Hayden/0000-0002-7777-1845				Cahill K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub6; Walker N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-880	2	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC11	10.7326/0003-4819-159-4-201308200-02011	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026275				2022-12-28	WOS:000323421700010
J	Shapiro, GD; Fraser, WD				Shapiro, Gabriel D.; Fraser, William D.			Review: Psychosocial and psychological interventions reduce postpartum depression	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shapiro, Gabriel D.] CHU St Justine, Montreal, PQ, Canada; Univ Montreal, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal	Shapiro, GD (corresponding author), CHU St Justine, Montreal, PQ, Canada.							Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis CLE, 2004, CAN J PSYCHIAT, V49, P467, DOI 10.1177/070674370404900708; Pearlstein T, 2009, AM J OBSTET GYNECOL, V200, P357, DOI 10.1016/j.ajog.2008.11.033	3	2	2	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC8	10.7326/0003-4819-159-4-201308200-02008	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	205DM	24026284				2022-12-28	WOS:000323421700007
J	Stefanini, GG; Baber, U; Windecker, S; Morice, MC; Sartori, S; Leon, MB; Stone, GW; Serruys, PW; Wijns, W; Weisz, G; Camenzind, E; Steg, PG; Smits, PC; Kandzari, D; von Birgelen, C; Galatius, S; Jeger, RV; Kimura, T; Mikhail, GW; Itchhaporia, D; Mehta, L; Ortega, R; Kim, HS; Valgimigli, M; Kastrati, A; Chieffo, A; Mehran, R				Stefanini, Giulio G.; Baber, Usman; Windecker, Stephan; Morice, Marie-Claude; Sartori, Samantha; Leon, Martin B.; Stone, Gregg W.; Serruys, Patrick W.; Wijns, William; Weisz, Giora; Camenzind, Edoardo; Steg, Philippe G.; Smits, Pieter C.; Kandzari, David; von Birgelen, Clemens; Galatius, Soren; Jeger, Raban V.; Kimura, Takeshi; Mikhail, Ghada W.; Itchhaporia, Dipti; Mehta, Laxmi; Ortega, Rebecca; Kim, Hyo-Soo; Valgimigli, Marco; Kastrati, Adnan; Chieffo, Alaide; Mehran, Roxana			Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials	LANCET			English	Article							CORONARY-ARTERY-DISEASE; LONG-TERM OUTCOMES; BARE-METAL STENTS; BIODEGRADABLE POLYMER; DURABLE POLYMER; DOUBLE-BLIND; SLOW-RELEASE; FOLLOW-UP; MULTICENTER; THROMBOSIS	Background The safety and efficacy of drug-eluting stents (DES) in the treatment of coronary artery disease have been assessed in several randomised trials. However, none of these trials were powered to assess the safety and efficacy of DES in women because only a small proportion of recruited participants were women. We therefore investigated the safety and efficacy of DES in female patients during long-term follow-up. Methods We pooled patient-level data for female participants from 26 randomised trials of DES and analysed outcomes according to stent type (bare-metal stents, early-generation DES, and newer-generation DES). The primary safety endpoint was a composite of death or myocardial infarction. The secondary safety endpoint was definite or probable stent thrombosis. The primary efficacy endpoint was target-lesion revascularisation. Analysis was by intention to treat. Findings Of 43 904 patients recruited in 26 trials of DES, 11 557 (26.3%) were women (mean age 67.1 years [SD 10.6]). 1108 (9.6%) women received bare-metal stents, 4171 (36.1%) early-generation DES, and 6278 (54.3%) newer-generation DES. At 3 years, estimated cumulative incidence of the composite of death or myocardial infarction occurred in 132 (12.8%) women in the bare-metal stent group, 421 (10.9%) in the early-generation DES group, and 496 (9.2%) in the newer-generation DES group (p=0.001). Definite or probable stent thrombosis occurred in 13 (1.3%), 79 (2.1%), and 66 (1.1%) women in the bare-metal stent, early-generation DES, and newer-generation DES groups, respectively (p=0.01). The use of DES was associated with a significant reduction in the 3 year rates of target-lesion revascularisation (197 [18.6%] women in the bare-metal stent group, 294 [7.8%] in the early-generation DES group, and 330 [6.3%] in the newer-generation DES group, p<0.0001). Results did not change after adjustment for baseline characteristics in the multivariable analysis. Interpretation The use of DES in women is more effective and safe than is use of bare-metal stents during long-term follow-up. Newer-generation DES are associated with an improved safety profile compared with early-generation DES, and should therefore be thought of as the standard of care for percutaneous coronary revascularisation in women.	[Stefanini, Giulio G.; Windecker, Stephan] Univ Hosp Bern, CH-3010 Bern, Switzerland; [Baber, Usman; Sartori, Samantha] Mt Sinai Hosp, Mt Sinai Sch Med, New York, NY 10029 USA; [Leon, Martin B.; Weisz, Giora] Columbia Univ, Med Ctr, New York, NY USA; [Wijns, William] Onze Lieve Vrouwziekenhuis Ziekenhuis, Cardiovasc Ctr Aalst, Aalst, Belgium; [Camenzind, Edoardo] Univ Geneva, Geneva, Switzerland; [Jeger, Raban V.] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Steg, Philippe G.] Univ Paris Diderot, INSERM U698, Assistance Publique Hopitaux Paris, Dept Hosp Univ Fibrose, Paris, France; [Smits, Pieter C.] Maasstad Hosp, Rotterdam, Netherlands; [von Birgelen, Clemens] Thoraxcentrum Twente, Enschede, Netherlands; [Kandzari, David] Piedmont Heart Inst, Atlanta, GA USA; [Galatius, Soren] Gentofte Univ Hosp, Hellerup, Denmark; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Mikhail, Ghada W.] Imperial Coll Healthcare NHS Trust, London, England; [Kim, Hyo-Soo] Seoul Natl Univ, Main Hosp, Seoul, South Korea; [Valgimigli, Marco] Univ Ferrara, Ferrara, Italy; [Kastrati, Adnan] Deutsch Herzzentrum Munich, Munich, Germany; [Serruys, Patrick W.] Erasmus MC, Rotterdam, Netherlands; [Itchhaporia, Dipti] Mem Hosp Presbyterian, Newport Beach, CA USA; [Ortega, Rebecca] Soc Cardiovasc Angiog & Intervent, Washington, DC USA; [Morice, Marie-Claude; Stone, Gregg W.; Mehta, Laxmi; Chieffo, Alaide; Mehran, Roxana] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA	University of Bern; University Hospital of Bern; Icahn School of Medicine at Mount Sinai; Columbia University; Cardiovascular Center Aalst; University of Geneva; University of Basel; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Maasstad Hospital; Piedmont Heart Institute; University of Copenhagen; Herlev & Gentofte Hospital; Kyoto University; Imperial College London; Seoul National University (SNU); University of Ferrara; German Heart Centre Munich; Erasmus University Rotterdam; Erasmus MC; University System of Ohio; Ohio State University	Stefanini, GG (corresponding author), Univ Hosp Bern, CH-3010 Bern, Switzerland.		Jeger, Raban/ABG-1678-2021; Stefanini, Giulio G/K-7406-2016; Sartori, Samantha/E-6396-2015; STEG, Philippe Gabriel/Z-1567-2019; Kim, Hyo Soo/J-2753-2012; Stefanini, Giulio/GZG-4754-2022; Valgimigli, Marco/AAE-9103-2019; Mehran, Roxana/ABF-4160-2021; , Kastrati/Y-2389-2019; sartori, samantha/AAL-8884-2020	Jeger, Raban/0000-0003-1290-5491; Stefanini, Giulio G/0000-0002-3558-6967; Sartori, Samantha/0000-0003-0618-9409; Stefanini, Giulio/0000-0002-3558-6967; Valgimigli, Marco/0000-0002-4353-7110; STEG, Philippe Gabriel/0000-0001-6896-2941; chieffo, alaide/0000-0002-3505-9112; Mehta, Laxmi/0000-0003-3493-1930; Wijns, William/0000-0002-7267-4376	Women in Innovation Initiative of the Society of Cardiovascular Angiography and Interventions	Women in Innovation Initiative of the Society of Cardiovascular Angiography and Interventions	Women in Innovation Initiative of the Society of Cardiovascular Angiography and Interventions.	Anderson ML, 2012, CIRCULATION, V126, P2190, DOI 10.1161/CIRCULATIONAHA.112.111369; [Anonymous], SCAI WOM INN AM COLL; Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Byrne RA, 2009, EUR HEART J, V30, P2441, DOI 10.1093/eurheartj/ehp352; Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Fajadet J, 2006, CIRCULATION, V114, P798, DOI 10.1161/CIRCULATIONAHA.105.591206; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Glidden DV, 2004, STAT MED, V23, P369, DOI 10.1002/sim.1599; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; Kramer DB, 2010, AM J THER, V17, P2, DOI 10.1097/MJT.0b013e3181ca8105; Lansky AJ, 2005, J AM COLL CARDIOL, V45, P1180, DOI 10.1016/j.jacc.2004.10.076; Leon MB, 2010, J AM COLL CARDIOL, V55, P543, DOI 10.1016/j.jacc.2009.08.067; Mikhail GW, 2010, JACC-CARDIOVASC INTE, V3, P1250, DOI 10.1016/j.jcin.2010.08.020; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Naggara O, 2011, AM J NEURORADIOL, V32, P633, DOI 10.3174/ajnr.A2442; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park KW, 2011, J AM COLL CARDIOL, V58, P1844, DOI 10.1016/j.jacc.2011.07.031; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Solinas E, 2007, J AM COLL CARDIOL, V50, P2111, DOI 10.1016/j.jacc.2007.06.056; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stefanini GG, 2012, JACC-CARDIOVASC INTE, V5, P301, DOI 10.1016/j.jcin.2011.11.011; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2011, CIRCULATION, V124, P893, DOI 10.1161/CIRCULATIONAHA.111.031070; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; U.S. Food and Drug Administration, DRAFT GUID IND FOOD; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1	48	91	98	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 7	2013	382	9908					1879	1888		10.1016/S0140-6736(13)61782-1	http://dx.doi.org/10.1016/S0140-6736(13)61782-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269DX	24007976				2022-12-28	WOS:000328222400031
J	Mehran, R; Baber, U; Steg, PG; Ariti, C; Weisz, G; Witzenbichler, B; Henry, TD; Kini, AS; Stuckey, T; Cohen, DJ; Berger, PB; Iakovou, I; Dangas, G; Waksman, R; Antoniucci, D; Sartori, S; Krucoff, MW; Hermiller, JB; Shawl, F; Gibson, CM; Chieffo, A; Alu, M; Moliterno, DJ; Colombo, A; Pocock, S				Mehran, Roxana; Baber, Usman; Steg, Philippe Gabriel; Ariti, Cono; Weisz, Giora; Witzenbichler, Bernhard; Henry, Timothy D.; Kini, Annapoorna S.; Stuckey, Thomas; Cohen, David J.; Berger, Peter B.; Iakovou, Ioannis; Dangas, George; Waksman, Ron; Antoniucci, David; Sartori, Samantha; Krucoff, Mitchell W.; Hermiller, James B.; Shawl, Fayaz; Gibson, C. Michael; Chieffo, Alaide; Alu, Maria; Moliterno, David J.; Colombo, Antonio; Pocock, Stuart			Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study	LANCET			English	Article							ELUTING STENT IMPLANTATION; TERM CLINICAL-OUTCOMES; THERAPY; THROMBOSIS; CLOPIDOGREL; DISCONTINUATION; DURATION; PREDICTORS; PRASUGREL; TRIALS	Background Dual antiplatelet therapy (DAPT) cessation increases the risk of adverse events after percutaneous coronary intervention (PCI). Whether risk changes over time, depends on the underlying reason for DAPT cessation, or both is unknown. We assessed associations between different modes of DAPT cessation and cardiovascular risk after PCI. Methods The PARIS (patterns of non-adherence to anti-platelet regimens in stented patients) registry is a prospective observational study of patients undergoing PCI with stent implantation in 15 clinical sites in the USA and Europe between July 1, 2009, and Dec 2, 2010. Adult patients (aged 18 years or older) undergoing successful stent implantation in one or more native coronary artery and discharged on DAPT were eligible for enrolment. Patients were followed up at months 1, 6, 12, and 24 after implantation. Prespecified categories for DAPT cessation included physician-recommended discontinuation, brief interruption (for surgery), or disruption (non-compliance or because of bleeding). All adverse events and episodes of DAPT cessation were independently adjudicated. Using Cox models with time-varying covariates, we examined the effect of DAPT cessation on major adverse events (MACE [composite of cardiac death, definite or probable stent thrombosis, myocardial infarction, or target-lesion revascularisation]). Incidence rates for DAPT cessation and adverse events were calculated as Kaplan-Meier estimates of time to the first event. This study is registered with ClinicalTrials.gov, number NCT00998127. Findings We enrolled 5031 patients undergoing PCI, including 5018 in the final study population. Over 2 years, the overall incidence of any DAPT cessation was 57.3%. Rate of any discontinuation was 40.8%, of interruption was 10.5%, and of disruption was 14.4%. The corresponding overall 2 year MACE rate was 11.5%, most of which (74%) occurred while patients were taking DAPT. Compared with those on DAPT, the adjusted hazard ratio (HR) for MACE due to interruption was 1.41 (95% CI 0.94-2.12; p=0.10) and to disruption was 1.50 (1.14-1.97; p=0.004). Within 7 days, 8-30 days, and more than 30 days after disruption, adjusted HRs were 7.04 (3.31-14.95), 2.17 (0.97-4.88), and 1.3 (0.97-1.76), respectively. By contrast with patients who remained on DAPT, those who discontinued had lower MACE risk (0.63 [0.46-0.86]). Results were similar after excluding patients receiving bare metal stents and using an alternative MACE definition that did not include target lesion revascularisation. Interpretation In a real-world setting, for patients undergoing PCI and discharged on DAPT, cardiac events after DAPT cessation depend on the clinical circumstance and reason for cessation and attenuates over time. While most events after PCI occur in patients on DAPT, early risk for events due to disruption is substantial irrespective of stent type.	[Mehran, Roxana; Baber, Usman; Kini, Annapoorna S.; Sartori, Samantha] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Steg, Philippe Gabriel] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Ariti, Cono; Pocock, Stuart] London Sch Hyg & Trop Med, London WC1, England; [Weisz, Giora; Alu, Maria] Columbia Univ, Med Ctr, New York, NY USA; [Witzenbichler, Bernhard] Charite Hosp, Berlin, Germany; [Henry, Timothy D.] Univ Minnesota, Minneapolis Heart Inst Fdn, Minneapolis, MN USA; [Stuckey, Thomas] LeBauer Cardiovasc Res Fdn, Moses Cone Heart & Vasc Ctr, Greensboro, NC USA; [Cohen, David J.] Univ Missouri Kansas City, St Lukes Mid Amer Heart Inst, Kansas City, MI USA; [Berger, Peter B.] Geisinger Med Ctr, Danville, PA 17822 USA; [Iakovou, Ioannis; Dangas, George] Onassis Cardiac Surg Ctr, Athens, Greece; [Waksman, Ron] MedStar Washington Hosp Ctr, MedStar Hlth Res Inst, Hyattsville, MD USA; [Antoniucci, David] Careggi Hosp, Florence, Italy; [Krucoff, Mitchell W.] Duke Univ, Sch Med, Durham, NC USA; [Hermiller, James B.] St Vincents Heart Ctr Indiana, Indianapolis, IN USA; [Shawl, Fayaz] George Washington Univ, Washington Adventist Hosp, Sch Med, Takoma Pk, MD USA; [Gibson, C. Michael] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Chieffo, Alaide; Colombo, Antonio] Hosp San Raffaele, I-20132 Milan, Italy; [Moliterno, David J.] Univ Kentucky, Lexington, KY USA	Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; London School of Hygiene & Tropical Medicine; Columbia University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Minneapolis Heart Institute Foundation; University of Minnesota System; University of Minnesota Twin Cities; LeBauer-Brodie Center for Cardiovascular Research & Education; Saint Luke's Mid America Heart Institute; Geisinger Medical Center; Onassis Cardiac Surgery Center; MedStar Health Research Institute; University of Florence; Azienda Ospedaliero Universitaria Careggi; Duke University; George Washington University; Harvard University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Kentucky	Mehran, R (corresponding author), Icahn Sch Med Mt Sinai, 1 Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	roxana.mehran@mountsinai.org	Witzenbichler, Bernhard/ABC-2525-2021; sartori, samantha/AAL-8884-2020; Mehran, Roxana/ABF-4160-2021; Sartori, Samantha/E-6396-2015; Gibson, C. Michael/AAE-8212-2019; Colombo, Antonio/N-2960-2015; STEG, Philippe Gabriel/Z-1567-2019	Sartori, Samantha/0000-0003-0618-9409; Colombo, Antonio/0000-0002-2940-2455; chieffo, alaide/0000-0002-3505-9112; Witzenbichler, Bernhard/0000-0001-9322-1926; STEG, Philippe Gabriel/0000-0001-6896-2941	Bristol-Myers Squibb; Sanofi-Aventis	Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis)	Funding Bristol-Myers Squibb and Sanofi-Aventis.	Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049; Brar SS, 2008, J AM COLL CARDIOL, V51, P2220, DOI 10.1016/j.jacc.2008.01.063; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Eisenberg MJ, 2009, CIRCULATION, V119, P1634, DOI 10.1161/CIRCULATIONAHA.108.813667; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Ferreira-Gonzalez I, 2012, J AM COLL CARDIOL, V60, P1333, DOI 10.1016/j.jacc.2012.04.057; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kandzari DE, 2009, JACC-CARDIOVASC INTE, V2, P1279, DOI 10.1016/j.jcin.2009.09.012; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehran R, 2009, EUR HEART J, V30, P1457, DOI 10.1093/eurheartj/ehp110; Michael P, 2007, AM HEART J, V154, P846, DOI 10.1016/j.ahj.2007.08.028; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Pocock SJ, 2010, CIRCULATION, V121, P43, DOI 10.1161/CIRCULATIONAHA.109.878017; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589	27	440	451	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1714	1722		10.1016/S0140-6736(13)61720-1	http://dx.doi.org/10.1016/S0140-6736(13)61720-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259PX	24004642				2022-12-28	WOS:000327539900028
J	Penmatsa, A; Wang, KH; Gouaux, E				Penmatsa, Aravind; Wang, Kevin H.; Gouaux, Eric			X-ray structure of dopamine transporter elucidates antidepressant mechanism	NATURE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; HIGH-LEVEL EXPRESSION; SEROTONIN TRANSPORTER; BINDING-SITE; NEUROTRANSMITTER TRANSPORTERS; STRUCTURE REFINEMENT; BACTERIAL HOMOLOG; N-GLYCOSYLATION; CHLORIDE; SODIUM	Antidepressants targeting Na+/Cl--coupled neurotransmitter uptake define a key therapeutic strategy to treat clinical depression and neuropathic pain. However, identifying the molecular interactions that underlie the pharmacological activity of these transport inhibitors, and thus the mechanism by which the inhibitors lead to increased synaptic neurotransmitter levels, has proven elusive. Here we present the crystal structure of the Drosophila melanogaster dopamine transporter at 3.0 angstrom resolution bound to the tricyclic antidepressant nortriptyline. The transporter is locked in an outward-open conformation with nortriptyline wedged between transmembrane helices 1, 3,6 and 8, blocking the transporter from binding substrate and from isomerizing to an inward-facing conformation. Although the overall structure of the dopamine transporter is similar to that of its prokaryotic relative LeuT, there are multiple distinctions, including a kink in transmembrane helix 12 halfway across the membrane bilayer, a latch-like carboxy-terminal helix that caps the cytoplasmic gate, and a cholesterol molecule wedged within a groove formed by transmembrane helices 1a, 5 and 7. Taken together, the dopamine transporter structure reveals the molecular basis for antidepressant action on sodium-coupled neurotransmitter symporters and elucidates critical elements of eukaryotic transporter structure and modulation by lipids, thus expanding our understanding of the mechanism and regulation of neurotransmitter uptake at chemical synapses.	[Penmatsa, Aravind; Wang, Kevin H.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 South West Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Penmatsa, Aravind/AAQ-2688-2020	Gouaux, Eric/0000-0002-8549-2360; Penmatsa, Aravind/0000-0001-9519-5055	American Heart Association; National Institute of Mental Health; National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Cawley for generating monoclonal antibodies and S. Amara for providing the wild-type Drosophila DAT construct. We would like to thank H. Wang and D. Claxton for comments and suggestions along with other Gouaux laboratory members for discussions during manuscript preparation. We thank L. Vaskalis for assistance with figures and H. Owen for help with manuscript preparation. We thank the staff of the Northeastern Collaborative Access Team (NECAT) at the Advanced Photon Source (APS) for assistance with data collection. This work was supported by a postdoctoral fellowship from the American Heart Association (A. P.), a National Institute of Mental Health research award (K. H. W.) and by the National Institutes of Health (E. G.) E. G. is an investigator with the Howard Hughes Medical Institute.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; AXELROD J, 1961, SCIENCE, V133, P383, DOI 10.1126/science.133.3450.383; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Buck KJ, 1995, MOL PHARMACOL, V48, P1030; Cao YW, 1998, J NEUROSCI, V18, P7739; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; GIROS B, 1992, MOL PHARMACOL, V42, P383; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Hong WC, 2010, J BIOL CHEM, V285, P32616, DOI 10.1074/jbc.M110.150565; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; Kantcheva AK, 2013, P NATL ACAD SCI USA, V110, P8489, DOI 10.1073/pnas.1221279110; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KUHN R, 1958, AM J PSYCHIAT, V115, P459, DOI 10.1176/ajp.115.5.459; Kurian MA, 2009, J CLIN INVEST, V119, P1595, DOI 10.1172/JCI39060; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Masson J, 1999, PHARMACOL REV, V51, P439; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELDRUM BS, 1995, EPILEPSIA, V36, pS30; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; NORTH P, 1983, J BIOL CHEM, V258, P1242; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLETSCHER A, 1991, EXPERIENTIA, V47, P4, DOI 10.1007/BF02041242; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; RADIAN R, 1986, J BIOL CHEM, V261, P5437; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rudnick G, 1998, METHOD ENZYMOL, V296, P233; Scanlon SM, 2001, BIOCHEMISTRY-US, V40, P10507, DOI 10.1021/bi010730z; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shannon JR, 2000, NEW ENGL J MED, V342, P541, DOI 10.1056/NEJM200002243420803; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; TALVENHEIMO J, 1983, J BIOL CHEM, V258, P6115; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	61	432	435	4	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 7	2013	503	7474					85	+		10.1038/nature12533	http://dx.doi.org/10.1038/nature12533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247AS	24037379	Green Accepted			2022-12-28	WOS:000326585600036
J	Adelman, CA; Lolo, RL; Birkbak, NJ; Murina, O; Matsuzaki, K; Horejsi, Z; Parmar, K; Borel, V; Skehel, JM; Stamp, G; D'Andrea, A; Sartori, AA; Swanton, C; Boulton, SJ				Adelman, Carrie A.; Lolo, Rafal L.; Birkbak, Nicolai J.; Murina, Olga; Matsuzaki, Kenichiro; Horejsi, Zuzana; Parmar, Kalindi; Borel, Valerie; Skehel, J. Mark; Stamp, Gordon; D'Andrea, Alan; Sartori, Alessandro A.; Swanton, Charles; Boulton, Simon J.			HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis	NATURE			English	Article							CROSS-LINK REPAIR; FANCONI-ANEMIA; HEMATOPOIETIC STEM; DNA-REPAIR; CONFER SUSCEPTIBILITY; OVARIAN; MUTATIONS; GENE; DEFICIENCY; DROSOPHILA	Repair of interstrand crosslinks (ICLs) requires the coordinated action of the intra-S-phase checkpoint and the Fanconi anaemia pathway, which promote ICL incision, translesion synthesis and homologous recombination (reviewed in refs 1, 2). Previous studies have implicated the 3'-5' superfamily 2 helicase HELQ in ICL repair in Drosophila melanogaster (MUS301 (ref. 3)) and Caenorhabditis elegans (HELQ-1 (ref. 4)). Although in vitro analysis suggests that HELQ preferentially unwinds synthetic replication fork substrates with 3' single-stranded DNA overhangs and also disrupts protein DNA interactions while translocating along DNA(5,6), little is known regarding its functions in mammalian organisms. Here we report that HELQ helicase-deficient mice exhibit subfertility, germ cell attrition, ICL sensitivity and tumour predisposition, with Helq heterozygous mice exhibiting a similar, albeit less severe, phenotype than the null, indicative of haploinsufficiency. We establish that HELQ interacts directly with the RAD51 paralogue complex BCDX2 and functions in parallel to the Fanconi anaemia pathway to promote efficient homologous recombination at damaged replication forks. Thus, our results reveal a critical role for HELQ in replication-coupled DNA repair, germ cell maintenance and tumour suppression in mammals.	[Adelman, Carrie A.; Lolo, Rafal L.; Matsuzaki, Kenichiro; Horejsi, Zuzana; Borel, Valerie; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Birkbak, Nicolai J.] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Murina, Olga; Sartori, Alessandro A.] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Parmar, Kalindi; D'Andrea, Alan] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Skehel, J. Mark] Canc Res UK, London Res Inst, Prot Anal & Prote Lab, S Mimms EN6 3LD, Herts, England; [Stamp, Gordon] Canc Res UK, London Res Inst, Expt Histopathol Lab, London WC2A 3LY, England; [Swanton, Charles] Canc Res UK, London Res Inst, Translat Canc Therapeut Lab, London WC2A 3LY, England; [Swanton, Charles] UCL Canc Inst, London WC1E 6DD, England	Cancer Research UK; Technical University of Denmark; University of Zurich; Harvard University; Dana-Farber Cancer Institute; Cancer Research UK; Cancer Research UK; Cancer Research UK; University of London; University College London	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	Sartori, Alessandro/AAK-7840-2021	Sartori, Alessandro/0000-0003-2770-0333; Licenikova Horejsi, Zuzana/0000-0002-9943-1649; Murina, Olga/0000-0003-1650-2892; Birkbak, Nicolai/0000-0003-1613-9587; Swanton, Charles/0000-0002-4299-3018	Swiss National Science Foundation [PDFMP3_127523]; Vontobel Foundation; National Institutes of Health [R01-DK43889]; Cancer Research UK; European Research Council; Royal Society; MRC [G0701935] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER; Cancer Research UK [11581] Funding Source: researchfish; Medical Research Council [G0701935] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Vontobel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank S. West for purified BCDX2 complexes and antibody reagents; O. Fernandez-Capetillo for ATR inhibitors; D. Cox, G. Martin and H. Chapman for assistance with mouse breeding and maintenance; E. Nye, T. Bunting and B. Spencer-Dene for histopathology services; I. Rosewell for transgenic services; H. Flynn for mass spectrometry services; and M. Petalcorin for assistance with BAC recombineering. O.M. and A.A.S. are supported by grants of the Swiss National Science Foundation (PDFMP3_127523) and the Vontobel Foundation. The laboratory of A.D. is supported by National Institutes of Health grant R01-DK43889. The laboratories of S.J.B. and C.S. are funded by Cancer Research UK. The S.J.B. laboratory is also funded by a European Research Council advanced investigator grant (RecMitMei). S.J.B. is a Royal Society Wolfson Research Merit Award holder.	Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; BOYD JB, 1981, GENETICS, V97, P607; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Dupuy AJ, 2001, GENESIS, V30, P82, DOI 10.1002/gene.1037; Gonzalez-Reyes A, 1997, DEVELOPMENT, V124, P4927; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Huehls AM, 2012, MOL PHARMACOL, V82, P767, DOI 10.1124/mol.112.080614; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Masson JY, 2001, P NATL ACAD SCI USA, V98, P8440, DOI 10.1073/pnas.111005698; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Mirzoeva OK, 2003, MOL CANCER RES, V1, P207; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Muzzini DM, 2008, DNA REPAIR, V7, P941, DOI 10.1016/j.dnarep.2008.03.021; Osher DJ, 2012, BRIT J CANCER, V106, P1460, DOI 10.1038/bjc.2012.87; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Parmar K, 2009, MUTAT RES-FUND MOL M, V668, P133, DOI 10.1016/j.mrfmmm.2009.03.015; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; Ward JD, 2010, MOL CELL, V37, P259, DOI 10.1016/j.molcel.2009.12.026; Wickramanyake A, 2012, GYNECOL ONCOL, V127, P552, DOI 10.1016/j.ygyno.2012.09.009	35	64	69	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					381	+		10.1038/nature12565	http://dx.doi.org/10.1038/nature12565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24005329	Green Accepted			2022-12-28	WOS:000325706300055
J	Hansen, SG; Piatak, M; Ventura, AB; Hughes, CM; Gilbride, RM; Ford, JC; Oswald, K; Shoemaker, R; Li, Y; Lewis, MS; Gilliam, AN; Xu, GW; Whizin, N; Burwitz, BJ; Planer, SL; Turner, JM; Legasse, AW; Axthelm, MK; Nelson, JA; Fruh, K; Sacha, JB; Estes, JD; Keele, BF; Edlefsen, PT; Lifson, JD; Picker, LJ				Hansen, Scott G.; Piatak, Michael, Jr.; Ventura, Abigail B.; Hughes, Colette M.; Gilbride, Roxanne M.; Ford, Julia C.; Oswald, Kelli; Shoemaker, Rebecca; Li, Yuan; Lewis, Matthew S.; Gilliam, Awbrey N.; Xu, Guangwu; Whizin, Nathan; Burwitz, Benjamin J.; Planer, Shannon L.; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Frueh, Klaus; Sacha, Jonah B.; Estes, Jacob D.; Keele, Brandon F.; Edlefsen, Paul T.; Lifson, Jeffrey D.; Picker, Louis J.			Immune clearance of highly pathogenic SIV infection	NATURE			English	Article							RHESUS MACAQUES; VIRUS; HIV; PROTECTION; RESPONSES; MODEL; ASSAY; CURE	Established infections with the human and simian immunodeficiency viruses (HIV and SIV, respectively) are thought to be permanent with even the most effective immune responses and antiretroviral therapies only able to control, but not clear, these infections(1-4). Whether the residual virus that maintains these infections is vulnerable to clearance is a question of central importance to the future management of millions of HIV-infected individuals. We recently reported that approximately 50% of rhesus macaques (RM; Macaca mulatta) vaccinated with SIV protein-expressing rhesus cytomegalovirus (RhCMV/SIV) vectors manifest durable, aviraemic control of infection with the highly pathogenic strain SIV mac239 (ref. 5). Here we show that regardless of the route of challenge, RhCMV/SIV vector-elicited immune responses control SIV mac239 after demonstrable lymphatic and haematogenous viral dissemination, and that replication-competent SIV persists in several sites for weeks to months. Over time, however, protected RM lost signs of SIV infection, showing a consistent lack of measurable plasma-or tissue-associated virus using ultrasensitive assays, and a loss of T-cell reactivity to SIV determinants not in the vaccine. Extensive ultrasensitive quantitative PCR and quantitative PCR with reverse transcription analyses of tissues from RhCMV/SIV vector-protected RM necropsied 69-172 weeks after challenge did not detect SIV RNA or DNA sequences above background levels, and replication-competent SIV was not detected in these RM by extensive co-culture analysis of tissues or by adoptive transfer of 60 million haematolymphoid cells to naive RM. These data provide compelling evidence for progressive clearance of a pathogenic lentiviral infection, and suggest that some lentiviral reservoirs may be susceptible to the continuous effector memory T-cell-mediated immune surveillance elicited and maintained by cytomegalovirus vectors.	[Hansen, Scott G.; Ventura, Abigail B.; Hughes, Colette M.; Gilbride, Roxanne M.; Ford, Julia C.; Lewis, Matthew S.; Gilliam, Awbrey N.; Xu, Guangwu; Whizin, Nathan; Burwitz, Benjamin J.; Planer, Shannon L.; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Frueh, Klaus; Sacha, Jonah B.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Hansen, Scott G.; Ventura, Abigail B.; Hughes, Colette M.; Gilbride, Roxanne M.; Ford, Julia C.; Lewis, Matthew S.; Gilliam, Awbrey N.; Xu, Guangwu; Whizin, Nathan; Burwitz, Benjamin J.; Planer, Shannon L.; Turner, John M.; Legasse, Alfred W.; Axthelm, Michael K.; Nelson, Jay A.; Frueh, Klaus; Sacha, Jonah B.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Piatak, Michael, Jr.; Oswald, Kelli; Shoemaker, Rebecca; Li, Yuan; Estes, Jacob D.; Keele, Brandon F.; Lifson, Jeffrey D.] SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Vaccine & Infect Dis Div, Seattle, WA 98109 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Fred Hutchinson Cancer Center	Lifson, JD (corresponding author), SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD 21702 USA.	lifsonj@mail.nih.gov; pickerl@ohsu.edu		Frueh, Klaus/0000-0001-8014-3877	AIDS Vaccine Research in Nonhuman Primates Consortium of the National Institute of Allergy and Infectious Diseases (NIAID) [U19 AI095985]; NIAID [RO1 AI060392, R37 AI054292, P01 AI094417, U19 AI096109]; Bill & Melinda Gates Foundation; International AIDS Vaccine Initiative (IAVI); US Agency for International Development (USAID); National Center for Research Resources [P51OD011092]; National Cancer Institute [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095985, R37AI054292, R01AI060392, P01AI094417, U19AI096109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021291] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD010426, U24OD010850, P51OD011092] Funding Source: NIH RePORTER	AIDS Vaccine Research in Nonhuman Primates Consortium of the National Institute of Allergy and Infectious Diseases (NIAID); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International AIDS Vaccine Initiative (IAVI); US Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the AIDS Vaccine Research in Nonhuman Primates Consortium of the National Institute of Allergy and Infectious Diseases (NIAID; U19 AI095985), as well as other NIAID grants (RO1 AI060392, R37 AI054292, P01 AI094417 and U19 AI096109); the Bill & Melinda Gates Foundation-supported Collaboration for AIDS Vaccine Discovery (CAVD); the International AIDS Vaccine Initiative (IAVI) and its donors, particularly the US Agency for International Development (USAID); the National Center for Research Resources (P51OD011092); and the National Cancer Institute (contract HHSN261200800001E). We thank A. Sylwester, A. Okoye, C. Kahl, S. Hagen, R. Lum, Y. Fukazawa, S. Shiigi and L. Boshears for technical or administrative assistance; C. Miller, N. Miller and T. Friedrich for provision of SIV stocks; K. Reimann for provision of the CD8-depleting monoclonal antibody; D. Watkins for MHC typing; D. Montefiori for neutralizing antibody assays; and A. Townsend for figure preparation.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Cline AN, 2005, J MED PRIMATOL, V34, P303; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Lewin SR, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-4; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sacha JB, 2010, NAT PROTOC, V5, P239, DOI 10.1038/nprot.2009.227; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Shen AD, 2007, J VIROL, V81, P1660, DOI 10.1128/JVI.01396-06; Tabb B, 2013, J INFECT DIS, V207, P880, DOI 10.1093/infdis/jis643; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Wolfe D. A., 1973, NONPARAMETRIC STAT M	28	430	450	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					100	+		10.1038/nature12519	http://dx.doi.org/10.1038/nature12519			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24025770	Green Accepted			2022-12-28	WOS:000325106000039
J	Okada, Y; Serbyn, M; Lin, H; Walkup, D; Zhou, WW; Dhital, C; Neupane, M; Xu, SY; Wang, YJ; Sankar, R; Chou, FC; Bansil, A; Hasan, MZ; Wilson, SD; Fu, L; Madhavan, V				Okada, Yoshinori; Serbyn, Maksym; Lin, Hsin; Walkup, Daniel; Zhou, Wenwen; Dhital, Chetan; Neupane, Madhab; Xu, Suyang; Wang, Yung Jui; Sankar, R.; Chou, Fangcheng; Bansil, Arun; Hasan, M. Zahid; Wilson, Stephen D.; Fu, Liang; Madhavan, Vidya			Observation of Dirac Node Formation and Mass Acquisition in a Topological Crystalline Insulator	SCIENCE			English	Article							PHASE-TRANSITION; SNTE; SUPERCONDUCTIVITY; REALIZATION; MECHANISM; GRAPHENE	In topological crystalline insulators (TCIs), topology and crystal symmetry intertwine to create surface states with distinct characteristics. The breaking of crystal symmetry in TCIs is predicted to impart mass to the massless Dirac fermions. Here, we report high-resolution scanning tunneling microscopy studies of a TCI, Pb1-xSnxSe that reveal the coexistence of zero-mass Dirac fermions protected by crystal symmetry with massive Dirac fermions consistent with crystal symmetry breaking. In addition, we show two distinct regimes of the Fermi surface topology separated by a Van-Hove singularity at the Lifshitz transition point. Our work paves the way for engineering the Dirac band gap and realizing interaction-driven topological quantum phenomena in TCIs.	[Okada, Yoshinori; Walkup, Daniel; Zhou, Wenwen; Dhital, Chetan; Wilson, Stephen D.; Madhavan, Vidya] Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA; [Okada, Yoshinori] Tohoku Univ, World Premier Int Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Serbyn, Maksym; Fu, Liang] MIT, Dept Phys, Cambridge, MA 02139 USA; [Lin, Hsin; Wang, Yung Jui; Bansil, Arun] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Neupane, Madhab; Xu, Suyang; Hasan, M. Zahid] Princeton Univ, Dept Phys, Joseph Henry Lab, Princeton, NJ 08544 USA; [Sankar, R.; Chou, Fangcheng] Natl Taiwan Univ, Ctr Condensed Matter Sci, Taipei 10617, Taiwan; [Hasan, M. Zahid] Princeton Univ, Princeton Ctr Complex Mat, Princeton, NJ 08544 USA	Boston College; Tohoku University; Massachusetts Institute of Technology (MIT); Northeastern University; Princeton University; National Taiwan University; Princeton University	Madhavan, V (corresponding author), Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA.	madhavan@bc.edu	Raman, Sankar/AAQ-1043-2021; Serbyn, Maksym/P-5691-2019; HASAN, M. Zahid/D-8237-2012; Zhou, Wenwen/K-9854-2016; Serbyn, Maksym/O-9803-2018; Lin, Hsin/F-9568-2012; Dhital, Chetan/O-5634-2016; Neupane, Madhab/ABE-8747-2020; Dhital, Chetan/AHB-1558-2022; Wilson, Stephen D/O-7001-2017; Okada, Yoshinori/A-1731-2014	Raman, Sankar/0000-0003-2817-0952; Serbyn, Maksym/0000-0002-2399-5827; Serbyn, Maksym/0000-0002-2399-5827; Lin, Hsin/0000-0002-4688-2315; Dhital, Chetan/0000-0001-8125-6048; Dhital, Chetan/0000-0001-8125-6048; Wilson, Stephen D/0000-0003-3733-930X; Okada, Yoshinori/0000-0001-9172-0844	U.S. Department of Energy (DOE), Scanned Probe Division [DE-FG02-12ER46880]; DOE Office of Science, Basic Energy Sciences [DE-FG0207ER46352]; DOE Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0010526]; DOE Office of Basic Energy Sciences [DE-FG-02-05ER46200];  [NSF-ECCS-1232105];  [NSFDMR-1056625];  [NSF DMR 1104498]; Directorate For Engineering [1232105] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [25886004] Funding Source: KAKEN	U.S. Department of Energy (DOE), Scanned Probe Division; DOE Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); ; ; ; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	V.M. gratefully acknowledges funding from the U.S. Department of Energy (DOE), Scanned Probe Division under award DE-FG02-12ER46880 for the support of Y.O. and D.W. and NSF-ECCS-1232105 for the partial support of W.Z. S.D.W. acknowledges NSFDMR-1056625 for support of C.D. The work at Northeastern University is supported by the DOE Office of Science, Basic Energy Sciences contract DE-FG0207ER46352 and benefited from Northeastern University's Advanced Scientific Computation Center. L.F. is partly supported by the DOE Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award DE-SC0010526. M.S. was supported by P. A. Lee via grant NSF DMR 1104498. The work at Princeton and Princeton-led synchrotron x-ray-based measurements (angle-resolved photoemission spectroscopy) are supported by the DOE Office of Basic Energy Sciences, grant DE-FG-02-05ER46200. M.Z.H. acknowledges visiting-scientist support from the Lawrence Berkeley National Laboratory and support from the A. P. Sloan Foundation. We thank Y. Ran and I. Zeljkovic for useful discussions.	Adouby K, 1998, Z KRISTALLOGR, V213, P343, DOI 10.1524/zkri.1998.213.6.343; Dziawa P, 2012, NAT MATER, V11, P1023, DOI [10.1038/nmat3449, 10.1038/NMAT3449]; Fleck M, 1997, PHYS REV B, V56, P3159, DOI 10.1103/PhysRevB.56.3159; Fu LA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.106802; Gonzalez J, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.205431; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hanaguri T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081305; Hsieh TH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1969; IIZUMI M, 1975, J PHYS SOC JPN, V38, P443, DOI 10.1143/JPSJ.38.443; LIFSHITZ IM, 1960, SOV PHYS JETP-USSR, V11, P1130; MARKIEWICZ RS, 1990, J PHYS-CONDENS MAT, V2, P665, DOI 10.1088/0953-8984/2/3/015; Okada Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.166407; RICE TM, 1975, PHYS REV LETT, V35, P120, DOI 10.1103/PhysRevLett.35.120; SNYKERS M, 1972, MATER RES BULL, V7, P831, DOI 10.1016/0025-5408(72)90133-X; Tanaka Y, 2012, NAT PHYS, V8, P800, DOI [10.1038/nphys2442, 10.1038/NPHYS2442]; Xu SY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2191	19	230	232	5	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2013	341	6153					1496	1499		10.1126/science.1239451	http://dx.doi.org/10.1126/science.1239451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	23989954	Green Published, Green Submitted			2022-12-28	WOS:000324894600045
J	Steinberg, DI				Steinberg, Daniel I.			Aspirin after dalteparin was noninferior to continued dalteparin for preventing VTE after total hip arthroplasty	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center	Steinberg, DI (corresponding author), Beth Israel Deaconess Med Ctr, New York, NY 10003 USA.			Anderson, David/0000-0003-0845-1722	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Mont MA, 2011, J AM ACAD ORTHOP SUR, V19, P768, DOI 10.5435/00124635-201112000-00007	2	0	0	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC12	10.7326/0003-4819-159-6-201309170-02012	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042383				2022-12-28	WOS:000325625900011
J	Lloyd, AC				Lloyd, Alison C.			The Regulation of Cell Size	CELL			English	Review							SKELETAL-MUSCLE HYPERTROPHY; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; ORGAN SIZE; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; UBIQUITIN LIGASES; MAMMALIAN-CELLS; GROWTH-CONTROL; CYCLE	An adult animal consists of cells of vastly different size and activity, but the regulation of cell size remains poorly understood. Recent studies uncovering some of the signaling pathways important for size/growth control, together with the identification of diseases resulting from aberrations in these pathways, have renewed interest in this field. This Review will discuss our current understanding of how a cell sets its size, how it can adapt its size to a changing environment, and how these processes are relevant to human disease.	[Lloyd, Alison C.] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Lloyd, Alison C.] UCL, UCL Canc Inst, London WC1E 6BT, England	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London	Lloyd, AC (corresponding author), UCL, MRC Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	alison.lloyd@ucl.ac.uk			Cancer Research, UK; Cancer Research UK [11244] Funding Source: researchfish	Cancer Research, UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	I apologize for citing many reviews rather than primary works due to space constraints. I would like to thank Sinead Roberts, Martin Raff, Nic Tapon, Ewa Paluch, Rob de Bruin, and Jody Rosenblatt for useful comments about the manuscript. My research is funded by a program grant from Cancer Research, UK.	Bellon A, 2010, NEURON, V66, P205, DOI 10.1016/j.neuron.2010.04.006; BIOLO G, 1995, AM J PHYSIOL, V268, P514; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; BROOKS RF, 1985, EXP CELL RES, V156, P1, DOI 10.1016/0014-4827(85)90255-1; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Chilton JK, 2006, DEV BIOL, V292, P13, DOI 10.1016/j.ydbio.2005.12.048; Collins MJ, 2012, CURR BIOL, V22, P1765, DOI 10.1016/j.cub.2012.07.040; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Conlon Ian, 2003, J Biol, V2, P7, DOI 10.1186/1475-4924-2-7; Conlon IJ, 2001, NAT CELL BIOL, V3, P918, DOI 10.1038/ncb1001-918; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Csibi A, 2012, NAT CELL BIOL, V14, P1244, DOI 10.1038/ncb2634; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Di Talia S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000221; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; Echave P, 2007, CELL CYCLE, V6, P218, DOI 10.4161/cc.6.2.3744; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; ELLIOTT SG, 1978, P NATL ACAD SCI USA, V75, P4384, DOI 10.1073/pnas.75.9.4384; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Franklin JL, 1998, J CELL BIOL, V142, P1313, DOI 10.1083/jcb.142.5.1313; Godin M, 2010, NAT METHODS, V7, P387, DOI [10.1038/NMETH.1452, 10.1038/nmeth.1452]; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; HUTSON NJ, 1982, J BIOL CHEM, V257, P9548; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kafri R, 2013, NATURE, V494, P480, DOI 10.1038/nature11897; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; LORD PG, 1983, J CELL SCI, V59, P183; LORD PG, 1981, J CELL SCI, V50, P361; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Mitchison JM, 2003, INT REV CYTOL, V226, P165, DOI 10.1016/S0074-7696(03)01004-0; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Moon JI, 2008, DEV BIOL, V315, P404, DOI 10.1016/j.ydbio.2007.12.041; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; O'Farrell PH, 2004, CELL GROWTH CONTROL; Otto A, 2010, EXP CELL RES, V316, P3059, DOI 10.1016/j.yexcr.2010.04.009; Park K, 2010, P NATL ACAD SCI USA, V107, P20691, DOI 10.1073/pnas.1011365107; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Roberts SA, 2012, CURR OPIN CELL BIOL, V24, P852, DOI 10.1016/j.ceb.2012.10.003; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Su TT, 1998, CURR BIOL, V8, pR687, DOI 10.1016/S0960-9822(98)70436-1; Tipton KD, 1998, ACTA PHYSIOL SCAND, V162, P377, DOI 10.1046/j.1365-201X.1998.00306.x; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Tumaneng K, 2012, CURR BIOL, V22, pR368, DOI 10.1016/j.cub.2012.03.003; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Umen JG, 2005, CURR OPIN CELL BIOL, V17, P435, DOI 10.1016/j.ceb.2005.06.001; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WHEALS AE, 1982, MOL CELL BIOL, V2, P361, DOI 10.1128/MCB.2.4.361; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; ZETTERBERG A, 1965, EXP CELL RES, V39, P22, DOI 10.1016/0014-4827(65)90003-0; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	81	227	231	2	111	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1194	1205		10.1016/j.cell.2013.08.053	http://dx.doi.org/10.1016/j.cell.2013.08.053			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034244	Bronze			2022-12-28	WOS:000324239300010
J	Nabel, EG; Ferris, TG; Slavin, PL				Nabel, Elizabeth G.; Ferris, Timothy G.; Slavin, Peter L.			Balancing AMCs' Missions and Health Care Costs - Mission Impossible?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								U.S. academic medical centers will soon feel pressure to control costs even as they balance the imperatives of clinical care with missions in research, teaching, and community health. Two large Massachusetts AMCs have begun addressing this challenge. When major provisions of the Affordable Care Act (ACA) are implemented next January, few institutions will feel the pressure to control costs more acutely than academic medical centers (AMCs), which must balance the imperatives of clinical care with cost-intensive missions in research, teaching, and community health. Massachusetts AMCs don't have to guess at the law's likely impact: in 2006, our state launched its own health care reform involving principles and policy solutions similar to the ACA's. Massachusetts therefore provides a laboratory for gauging the effects of such reforms. Having largely solved the insurance problem, Massachusetts passed sweeping cost-control legislation in ...	[Nabel, Elizabeth G.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ferris, Timothy G.; Slavin, Peter L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Nabel, Elizabeth G.; Ferris, Timothy G.; Slavin, Peter L.] Partners HealthCare, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System	Nabel, EG (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							Mechanic RE, 2003, HEALTH AFFAIR, V22, P130, DOI 10.1377/hlthaff.22.6.130; Milford CE, 2012, MAYO CLIN PROC, V87, P717, DOI 10.1016/j.mayocp.2012.05.009; Schoen Cathy, 2012, Issue Brief (Commonw Fund), V31, P1	3	11	11	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					994	996		10.1056/NEJMp1309179	http://dx.doi.org/10.1056/NEJMp1309179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	216SK	24024836				2022-12-28	WOS:000324304200006
J	Petersen, LA; Simpson, K; Pietz, K; Urech, TH; Hysong, SJ; Profit, J; Conrad, DA; Dudley, RA; Woodard, LD				Petersen, Laura A.; Simpson, Kate; Pietz, Kenneth; Urech, Tracy H.; Hysong, Sylvia J.; Profit, Jochen; Conrad, Douglas A.; Dudley, R. Adams; Woodard, LeChauncy D.			Effects of Individual Physician-Level and Practice-Level Financial Incentives on Hypertension Care A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PAY-FOR-PERFORMANCE; IMPROVE QUALITY; HEALTH-CARE; DESIGN	IMPORTANCE Pay for performance is intended to align incentives to promote high-quality care, but results have been contradictory. OBJECTIVE To test the effect of explicit financial incentives to reward guideline-recommended hypertension care. DESIGN, SETTING, AND PARTICIPANTS Cluster randomized trial of 12 Veterans Affairs outpatient clinics with 5 performance periods and a 12-month washout that enrolled 83 primary care physicians and 42 nonphysician personnel (eg, nurses, pharmacists). INTERVENTIONS Physician-level (individual) incentives, practice-level incentives, both, or none. Intervention participants received up to 5 payments every 4 months; all participants could access feedback reports. MAIN OUTCOMES AND MEASURES Among a random sample, number of patients achieving guideline-recommended blood pressure thresholds or receiving an appropriate response to uncontrolled blood pressure, number of patients prescribed guideline-recommended medications, and number who developed hypotension. RESULTS Mean (SD) total payments over the study were $4270 ($459), $2672 ($153), and $1648 ($248) for the combined, individual, and practice-level interventions, respectively. The unadjusted baseline and final percentages and the adjusted absolute change over the study in patients meeting the combined blood pressure/appropriate response measure were 75% to 84% and 8.84%(95% CI, 4.20% to 11.80%) for the individual group, 80% to 85% and 3.70% (95% CI, 0.24% to 7.68%) for the practice-level group, 79% to 88% and 5.54%(95% CI, 1.92% to 9.52%) for the combined group, and 86% to 86% and 0.47%(95% CI, -3.12% to 4.04%) for the control group. The adjusted absolute estimated difference in the change between the proportion of patients with blood pressure control/appropriate response for individual incentive and control groups was 8.36%(95% CI, 2.40% to 13.00%; P=.005). The other incentive groups did not show a significant change compared with controls for this outcome. For medications, the unadjusted baseline and final percentages and the adjusted absolute change were 61% to 73% and 9.07%(95% CI, 4.52% to 13.44%), 56% to 65% and 4.98%(95% CI, 0.64% to 10.08%), 65% to 80% and 7.26%(95% CI, 2.92% to 12.48%), and 63% to 72% and 4.35%(95% CI, -0.28% to 9.28%), respectively. These changes in the use of guideline-recommended medications were not significant in any of the incentive groups compared with controls, nor was the incidence of hypotension. The effect of the incentive was not sustained after a washout. CONCLUSIONS AND RELEVANCE Individual financial incentives, but not practice-level or combined incentives, resulted in greater blood pressure control or appropriate response to uncontrolled blood pressure; none of the incentives resulted in greater use of guideline-recommended medications or increased incidence of hypotension compared with controls. Further research is needed on the factors that contributed to these findings.	[Petersen, Laura A.; Simpson, Kate; Pietz, Kenneth; Urech, Tracy H.; Hysong, Sylvia J.; Profit, Jochen; Woodard, LeChauncy D.] Michael E DeBakey VA Med Ctr, Hlth Policy & Qual Program, Hlth Serv Res & Dev Ctr Excellence, Houston, TX 77030 USA; [Petersen, Laura A.; Simpson, Kate; Pietz, Kenneth; Urech, Tracy H.; Hysong, Sylvia J.; Profit, Jochen; Woodard, LeChauncy D.] Baylor Coll Med, Dept Med, Sect Hlth Serv Res, Houston, TX 77030 USA; [Simpson, Kate] Southwest Affiliate, Amer Heart Assoc, Houston, TX USA; [Conrad, Douglas A.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Dudley, R. Adams] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Dudley, R. Adams] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Baylor College of Medicine; Baylor College of Medicine; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Petersen, LA (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd, Houston, TX 77030 USA.	laura.petersen@va.gov	Hysong, Sylvia J./B-8420-2008	Hysong, Sylvia J./0000-0002-9063-5207; Profit, Jochen/0000-0002-3782-9248	Veterans Affairs (VA) Health Services Research & Development (HSR&D) Investigator-Initiated Research (IIR) program [04-349]; National Institutes of Health [RO1 HL079173-01]; American Recovery and Reinvestment Act (National Heart, Lung, and Blood Institute [NHLBI]) [1R01HL079173-S2]; Houston VA HSR&D Center of Excellence [HFP90-020]; American Heart Association [0540043N]; Robert Wood Johnson Foundation [045444]; NHLBI [1R01HL079173-S1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [1 K23 HD056298-01]; Robert Wood Johnson Foundation Health Care Financing and Organization Program [63214];  [CDA 07-0181]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD056298] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079173] Funding Source: NIH RePORTER	Veterans Affairs (VA) Health Services Research & Development (HSR&D) Investigator-Initiated Research (IIR) program(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act (National Heart, Lung, and Blood Institute [NHLBI]); Houston VA HSR&D Center of Excellence; American Heart Association(American Heart Association); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Robert Wood Johnson Foundation Health Care Financing and Organization Program(Robert Wood Johnson Foundation (RWJF)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by the Veterans Affairs (VA) Health Services Research & Development (HSR&D) Investigator-Initiated Research (IIR) program (04-349; Principal Investigator [PI] Laura A. Petersen, MD, MPH), a National Institutes of Health grant (RO1 HL079173-01; PI Laura A. Petersen, MD, MPH), the American Recovery and Reinvestment Act of 2010 (National Heart, Lung, and Blood Institute [NHLBI] 1R01HL079173-S2), and the Houston VA HSR&D Center of Excellence HFP90-020; PI Laura A. Petersen, MD, MPH). Dr Petersen was a recipient of the American Heart Association Established Investigator Award (grant 0540043N) and was a Robert Wood Johnson Foundation Generalist Physician Faculty Scholar (grant 045444) at the time that this study was planned and funded. Dr Hysong was a recipient of an NHLBI Investigator Research Supplement to Promote Diversity in Health-Related Research (1R01HL079173-S1) during the early stages of the study and is currently a VA HSR&D Career Development Awardee (CDA 07-0181). Dr Profit's contribution was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1 K23 HD056298-01; PI Jochen Profit, MD, MPH). Dr Conrad is an awardee of the Robert Wood Johnson Foundation Health Care Financing and Organization Program (grant 63214). Dr Dudley is a Robert Wood Johnson Investigator Awardee in Health Policy.	[Anonymous], THINKING OUTSIDE THE; [Anonymous], ROADMAP FOR IMPLEMEN; Bandura A., 1997, SELF EFFICACY EXERCI; Benjamini Y, 2001, ANN STAT, V29, P1165; Bonner SE, 2002, ACCOUNT ORG SOC, V27, P303, DOI 10.1016/S0361-3682(01)00052-6; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Colla CH, 2012, JAMA-J AM MED ASSOC, V308, P1015, DOI 10.1001/2012.jama.10812; Conrad DA, 2009, ANNU REV PUBL HEALTH, V30, P357, DOI 10.1146/annurev.publhealth.031308.100243; Department of Veterans Affairs, 2009, FED REGISTER, V74, P39734; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; Epstein AM, 2012, NEW ENGL J MED, V367, P1852, DOI 10.1056/NEJMe1212133; Fields D, 2010, HEALTH AFFAIR, V29, P819, DOI 10.1377/hlthaff.2010.0009; Fletcher RD, 2012, CIRCULATION, V125, P2462, DOI 10.1161/CIRCULATIONAHA.111.029983; Frolich A, 2007, HEALTH POLICY, V80, P179, DOI 10.1016/j.healthpol.2006.03.001; Gillespie C., 2011, Morbidity and Mortality Weekly Report, V60, P103; Hartocollis A, 2013, NY TIMES, pA1; Houle SKD, 2012, ANN INTERN MED, V157, P889, DOI 10.7326/0003-4819-157-12-201212180-00009; Hysong Sylvia J, 2012, Am J Manag Care, V18, pe378; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Kerr EA, 2003, MED CARE, V41, P1173, DOI 10.1097/01.MLR.0000088453.57269.29; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Klein S, 2011, THE VETERANS HEALTH; Kuhn M, 2003, QUALITY IN PRIMARY C; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; Lester H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1898; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; O'Connor PJ, 2003, ARCH INTERN MED, V163, P2677, DOI 10.1001/archinte.163.22.2677; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Petersen LA, 2012, ANN INTERN MED, V156, P728, DOI 10.7326/0003-4819-156-10-201205150-00011; Petersen LA, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-114; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Verbeke G, 2009, SPRINGER SER STAT, P1; Weissman NW, 2001, ACHIEVABLE BENCHMARK; Werner RM, 2011, HEALTH AFFAIR, V30, P690, DOI 10.1377/hlthaff.2010.1277; Woodard LD, 2010, J GEN INTERN MED, V25, P100, DOI 10.1007/s11606-009-1198-z	38	82	86	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 11	2013	310	10					1042	1050		10.1001/jama.2013.276303	http://dx.doi.org/10.1001/jama.2013.276303			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214KZ	24026599	Green Accepted, Bronze			2022-12-28	WOS:000324133400021
J	Ridaura, VK; Faith, JJ; Rey, FE; Cheng, JY; Duncan, AE; Kau, AL; Griffin, NW; Lombard, V; Henrissat, B; Bain, JR; Muehlbauer, MJ; Ilkayeva, O; Semenkovich, CF; Funai, K; Hayashi, DK; Lyle, BJ; Martini, MC; Ursell, LK; Clemente, JC; Van Treuren, W; Walters, WA; Knight, R; Newgard, CB; Heath, AC; Gordon, JI				Ridaura, Vanessa K.; Faith, Jeremiah J.; Rey, Federico E.; Cheng, Jiye; Duncan, Alexis E.; Kau, Andrew L.; Griffin, Nicholas W.; Lombard, Vincent; Henrissat, Bernard; Bain, James R.; Muehlbauer, Michael J.; Ilkayeva, Olga; Semenkovich, Clay F.; Funai, Katsuhiko; Hayashi, David K.; Lyle, Barbara J.; Martini, Margaret C.; Ursell, Luke K.; Clemente, Jose C.; Van Treuren, William; Walters, William A.; Knight, Rob; Newgard, Christopher B.; Heath, Andrew C.; Gordon, Jeffrey I.			Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice	SCIENCE			English	Article							DIET-INDUCED OBESITY; RESISTANT STARCH; BODY HABITATS; WEIGHT; DIVERSITY; BALANCE; FAT; AGE	The role of specific gut microbes in shaping body composition remains unclear. We transplanted fecal microbiota from adult female twin pairs discordant for obesity into germ-free mice fed low-fat mouse chow, as well as diets representing different levels of saturated fat and fruit and vegetable consumption typical of the U.S. diet. Increased total body and fat mass, as well as obesity-associated metabolic phenotypes, were transmissible with uncultured fecal communities and with their corresponding fecal bacterial culture collections. Cohousing mice harboring an obese twin's microbiota (Ob) with mice containing the lean co-twin's microbiota (Ln) prevented the development of increased body mass and obesity-associated metabolic phenotypes in Ob cage mates. Rescue correlated with invasion of specific members of Bacteroidetes from the Ln microbiota into Ob microbiota and was diet-dependent. These findings reveal transmissible, rapid, and modifiable effects of diet-by-microbiota interactions.	[Ridaura, Vanessa K.; Faith, Jeremiah J.; Rey, Federico E.; Cheng, Jiye; Kau, Andrew L.; Griffin, Nicholas W.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Duncan, Alexis E.; Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Duncan, Alexis E.] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA; [Lombard, Vincent; Henrissat, Bernard] CNRS, F-13288 Marseille, France; [Lombard, Vincent; Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR 7257, F-13288 Marseille, France; [Henrissat, Bernard] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Bain, James R.; Muehlbauer, Michael J.; Ilkayeva, Olga; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Semenkovich, Clay F.; Funai, Katsuhiko] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hayashi, David K.] Mondelez Int, Glenview, IL 60025 USA; [Lyle, Barbara J.; Martini, Margaret C.] Kraft Foods Grp, Glenview, IL 60025 USA; [Ursell, Luke K.; Clemente, Jose C.; Van Treuren, William; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Walters, William A.] Univ Colorado, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Biofrontiers Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Copenhagen; Duke University; Duke University; Duke University; Washington University (WUSTL); Mondelez International; Kraft Heinz; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Knight, Rob/D-1299-2010; Kau, Andrew/AGX-9881-2022; Cheng, Jiye/K-2722-2013; Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Bain, James R./0000-0002-8917-9187; Kau, Andrew/0000-0002-9386-3766; Lombard, Vincent/0000-0002-9684-7067; Semenkovich, Clay/0000-0003-1163-1871; Knight, Rob/0000-0002-0975-9019	NIH [DK078669, DK70977, P30-AG028716, DK58398]; Crohn's and Colitis Foundation of America; plus Kraft Foods; Mondelez International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK091044, P30DK020579, K01DK095774, P01DK058398, R01DK070977, P01DK078669, R01DK076729, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; plus Kraft Foods; Mondelez International; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank D. O'Donnell, M. Karlsson, S. Wagoner, J. Guruge, R. Chamberland, M. Meier, and S. Deng for superb technical assistance; P. Ahern for help with FACS analysis; D. Hopper and S. Marion for their contributions to the recruitment of discordant twins from the MOAFTS cohort and for obtaining fecal samples for the present study; I. Halatchev for help in performing diet experiments; plus A. Reyes and N. McNulty for many helpful suggestions. S. Baumann and S. Fischer (Agilent Technologies, Santa Clara, CA) provided technical support for some of the metabolomics analyses including a gift of the Fiehn metabolite library. This work was supported in part by grants from the NIH (DK078669, DK70977, P30-AG028716, and DK58398), the Crohn's and Colitis Foundation of America, plus Kraft Foods and Mondelez International. Bacterial 16S rRNA pyrosequencing reads have been deposited in the European Bioinformatics Institute under accession numbers ERP003513 and ERP003512, as have shotgun pyrosequencing data sets from cecal microbial community DNA (ERP003514), microbial community RNA-Seq data sets (ERP003551), and draft genome data sets from cultured bacterial isolates (PRJEB3728-PRJEB3780). RNA-seq data sets have also been deposited in Gene Expression Omnibus (GEO) under accession number GSE48861. Author contributions: V. K. R. and J. I. G. designed the mouse experiments; A. C. H., A. E. D., and J. I. G. designed and implemented the clinical data collection; N. W. G., J. I. G., D. K. H., B. J. L., and M. C. M designed the NHANES-based mouse diets; V. K. R., J. J. F., J. C., M. J. M, J. R. B., K. F., and O.I. generated the data; V. K. R., J. J. F., F. R., J. C., J. C. C., W. V. T, L. K. U., W. A. W., A. L. K., R. K., A. E. D., A. C. H., B. H., V. L., M. J. M., J. R. B., C. B. N., and J. I. G. analyzed the data; and V. K. R. and J. I. G. wrote the paper.	Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Duncan AE, 2009, OBESITY, V17, P1040, DOI 10.1038/oby.2008.643; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Hakala P, 1999, INT J OBESITY, V23, P746, DOI 10.1038/sj.ijo.0800923; Handelsman Y, 2011, DIABETES CARE, V34, pS244, DOI 10.2337/dc11-s237; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Kuribayashi H, 2012, EUR J PHARMACOL, V697, P132, DOI 10.1016/j.ejphar.2012.09.048; Lessard JP, 2009, ECOLOGY, V90, P2664, DOI 10.1890/09-0503.1; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Rissanen A, 2002, INT J OBESITY, V26, P973, DOI 10.1038/sj.ijo.0802014; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Waldron M, 2013, J STUD ALCOHOL DRUGS, V74, P337, DOI 10.15288/jsad.2013.74.337; Webb CO, 2002, SYST BIOL, V51, P898, DOI 10.1080/10635150290155944; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157; Zhou J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1160, DOI 10.1152/ajpendo.90637.2008; Zhou J, 2009, J AGR FOOD CHEM, V57, P8844, DOI 10.1021/jf901548e; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	48	2253	2420	40	981	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1079	U49		10.1126/science.1241214	http://dx.doi.org/10.1126/science.1241214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009397	Green Accepted			2022-12-28	WOS:000323933100034
J	Chiang, CJ; Yang, YW; You, SL; Lai, MS; Chen, CJ				Chiang, Chun-Ju; Yang, Ya-Wen; You, San-Lin; Lai, Mei-Shu; Chen, Chien-Jen			Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VACCINATION PROGRAM; INFANTS		[Chiang, Chun-Ju; Lai, Mei-Shu] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yang, Ya-Wen] Taiwan Canc Registry, Taipei, Taiwan; [You, San-Lin; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan	National Taiwan University; Academia Sinica - Taiwan	Chen, CJ (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	chencj@gate.sinica.edu.tw	Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008	You, San-Lin/0000-0002-3192-3356; CHIANG, CHUN-JU/0000-0002-1330-5319; Lai, Mei-shu/0000-0001-6130-3468; YANG, YA-WEN/0000-0003-0412-584X				Centers for Disease Control Department of Health ROC (Taiwan), 2013, CDC 2012 ANN REP CTR; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; CHEN D-S, 1987, Journal of the American Medical Association, V257, P2597, DOI 10.1001/jama.257.19.2597; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Chien YC, 2006, EPIDEMIOL REV, V28, P126, DOI 10.1093/epirev/mxj010; Kao JH, 2001, J PEDIATR-US, V139, P349, DOI 10.1067/mpd.2001.116277	6	138	146	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 4	2013	310	9					974	976		10.1001/jama.2013.276701	http://dx.doi.org/10.1001/jama.2013.276701			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211DT	24002285				2022-12-28	WOS:000323885700029
J	Granovetter, M				Granovetter, Michael			Let's talk therapy: treatments for children with autism	LANCET			English	Editorial Material							SPECTRUM DISORDERS		Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Granovetter, M (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	mgranove@princeton.edu		Granovetter, Michael/0000-0002-8103-2439				Clark GJF, 2013, AM J OCCUP THER, V67, P425, DOI 10.5014/ajot.2013.006163; Dove D, 2012, PEDIATRICS, V130, P717, DOI 10.1542/peds.2012-0683; Dua V, 2012, J CAN ACAD CHILD ADO, V21, P165; Glaser K, 2013, PSYCHOPHARMACOLOGY B; South M, 2013, J AUTISM DEV DISORD; Storch EA, 2013, J AM ACAD CHILD PSY, V52, P132, DOI 10.1016/j.jaac.2012.11.007; Turner EH, 2013, CNS DRUGS, V27, P457, DOI 10.1007/s40263-013-0067-9	7	0	0	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 31	2013	382	9894					753	753		10.1016/S0140-6736(13)61677-3	http://dx.doi.org/10.1016/S0140-6736(13)61677-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215VP	23993177				2022-12-28	WOS:000324239200009
J	Hermans, J; Luime, JJ; Meuffels, DE; Reijman, M; Simel, DL; Bierma-Zeinstra, SMA				Hermans, Job; Luime, Jolanda J.; Meuffels, Duncan E.; Reijman, Max; Simel, David L.; Bierma-Zeinstra, Sita M. A.			Does This Patient With Shoulder Pain Have Rotator Cuff Disease? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUBACROMIAL IMPINGEMENT SYNDROME; PHYSICAL-EXAMINATION TESTS; DIAGNOSTIC-ACCURACY; DISORDERS; TEARS; FULL; STRENGTH; CLASSIFICATION; RELIABILITY; POPULATION	IMPORTANCE Rotator cuff disease (RCD) is the most common cause of shoulder pain seen by physicians. OBJECTIVE To perform a meta-analysis to identify the most accurate clinical examination findings for RCD. DATA SOURCES Structured search in MEDLINE, EMBASE, and CINAHL from their inception through May 2013. STUDY SELECTION For inclusion, a study must have met the following criteria: (1) description of history taking, physical examination, or clinical tests concerning RCD; (2) detailing of sensitivity and specificity; (3) use of a reference standard with diagnostic criteria prespecified; (4) presentation of original data, or original data could be obtained from the authors; and (5) publication in a language mastered by one of the authors (Danish, Dutch, English, French, German, Norwegian, Spanish, Swedish). MAIN OUTCOMES AND MEASURES Likelihood ratios (LRs) of symptoms and signs of RCD or of a tear, compared with an acceptable reference standard; quality scores assigned using the Rational Clinical Examination score and bias evaluated with the Quality Assessment of Diagnostic Accuracy Studies tool. RESULTS Twenty-eight studies assessed the examination of referred patients by specialists. Only 5 studies reached Rational Clinical Examination quality scores of level 1-2. The studies with quality scores of level 1-2 included 30 to 203 shoulders with the prevalence of RCD ranging from 33% to 81%. Among pain provocation tests, a positive painful arc test result was the only finding with a positive LR greater than 2.0 for RCD (3.7 [95% CI, 1.9-7.0]), and a normal painful arc test result had the lowest negative LR (0.36 [95% CI, 0.23-0.54]). Among strength tests, a positive external rotation lag test (LR, 7.2 [95% CI, 1.7-31]) and internal rotation lag test (LR, 5.6 [95% CI, 2.6-12]) were the most accurate findings for full-thickness tears. A positive drop arm test result (LR, 3.3 [95% CI, 1.0-11]) might help identify patients with RCD. A normal internal rotation lag test result was most accurate for identifying patients without a full-thickness tear (LR, 0.04 [95% CI, 0.0-0.58]). CONCLUSIONS AND RELEVANCE Because specialists performed all the clinical maneuvers for RCD in each of the included studies with no finding evaluated in more than 3 studies, the generalizability of the results to a nonreferred population is unknown. A positive painful arc test result and a positive external rotation resistance test result were the most accurate findings for detecting RCD, whereas the presence of a positive lag test (external or internal rotation) result was most accurate for diagnosis of a full-thickness rotator cuff tear.	[Hermans, Job; Meuffels, Duncan E.; Reijman, Max; Bierma-Zeinstra, Sita M. A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Orthopaed Surg, NL-3000 CA Rotterdam, Netherlands; [Luime, Jolanda J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Rheumatol, NL-3000 CA Rotterdam, Netherlands; [Simel, David L.] Durham Vet Affairs Med Ctr, Dept Internal Med, Durham, NC USA; [Simel, David L.] Duke Univ, Durham, NC USA; [Bierma-Zeinstra, Sita M. A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Erasmus University Rotterdam; Erasmus MC	Hermans, J (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Orthopaed Surg, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.hermans@erasmusmc.nl	Bierma-Zeinstra, Sita/AAF-2122-2019; Reijman, Max/AFO-6451-2022; Meuffels, Duncan E/O-2127-2017	Meuffels, Duncan E/0000-0002-5372-6003				Alqunaee M, 2012, ARCH PHYS MED REHAB, V93, P229, DOI 10.1016/j.apmr.2011.08.035; American Academy of Orthopaedic Surgeons (AAOS), 2010, OPTIMIZING THE MANAG; Ardic F, 2006, AM J PHYS MED REHAB, V85, P53, DOI 10.1097/01.phm.0000179518.85484.53; Bak K, 2010, ARTHROSCOPY, V26, P734, DOI 10.1016/j.arthro.2009.11.005; Barth JRH, 2006, ARTHROSCOPY, V22, P1076, DOI 10.1016/j.arthro.2006.05.005; Bartsch M, 2010, KNEE SURG SPORT TR A, V18, P1712, DOI 10.1007/s00167-010-1109-1; Beaudreuil J, 2009, JOINT BONE SPINE, V76, P15, DOI 10.1016/j.jbspin.2008.04.015; Bot SDM, 2005, ANN RHEUM DIS, V64, P118, DOI 10.1136/ard.2003.019349; Calis M, 2000, ANN RHEUM DIS, V59, P44, DOI 10.1136/ard.59.1.44; Castoldi F, 2009, J SHOULDER ELB SURG, V18, P529, DOI 10.1016/j.jse.2008.11.007; CHARD MD, 1991, ARTHRITIS RHEUM-US, V34, P766, DOI 10.1002/art.1780340619; Chew K., 2010, PHYSIOTHERAPY SINGAP, V13, P12; Codman EA, 1965, THE SHOULDER RUPTURE; de Jesus JO, 2009, AM J ROENTGENOL, V192, P1701, DOI 10.2214/AJR.08.1241; de Winter AF, 1999, ANN RHEUM DIS, V58, P272, DOI 10.1136/ard.58.5.272; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; DeFranco MJ, 2009, ARTHROSCOPY, V25, P305, DOI 10.1016/j.arthro.2008.07.023; Fish DE, 2011, PHYS MED REH CLIN N, V22, P395, DOI 10.1016/j.pmr.2011.03.009; Fodor Daniela, 2009, Ortop Traumatol Rehabil, V11, P120; Fowler Elizabeth M, 2010, Sports Med Arthrosc Rehabil Ther Technol, V2, P2, DOI 10.1186/1758-2555-2-2; GERBER C, 1991, J BONE JOINT SURG BR, V73, P389, DOI 10.1302/0301-620X.73B3.1670434; Gillooly JJ, 2010, INT J SHOULDER SURG, V4, P41, DOI 10.4103/0973-6042.70822; Gomoll AH, 2004, ARTHRITIS RHEUM-US, V50, P3751, DOI 10.1002/art.20668; Green S, 1998, BRIT MED J, V316, P354, DOI 10.1136/bmj.316.7128.354; HAWKINS RJ, 1980, AM J SPORT MED, V8, P151, DOI 10.1177/036354658000800302; Hegedus EJ, 2012, BRIT J SPORT MED, V46, P964, DOI 10.1136/bjsports-2012-091066; Hertel R, 1996, J Shoulder Elbow Surg, V5, P307, DOI 10.1016/S1058-2746(96)80058-9; Hess SA, 2000, MANUAL THER, V5, P63, DOI 10.1054/math.2000.0241; Holleman DR, 1997, J GEN INTERN MED, V12, P165, DOI 10.1007/s11606-006-5024-6; Iannotti JP, 2005, J BONE JOINT SURG AM, V87A, P1305, DOI 10.2106/JBJS.D.02100; Itoi E, 2006, AM J SPORT MED, V34, P256, DOI 10.1177/0363546505280430; Itoi E, 1999, AM J SPORT MED, V27, P65, DOI 10.1177/03635465990270011901; Jackson D W, 1976, Am J Sports Med, V4, P231, DOI 10.1177/036354657600400601; Jia XF, 2008, CLIN ORTHOP RELAT R, V466, P2813, DOI 10.1007/s11999-008-0331-3; JOBE FW, 1982, AM J SPORT MED, V10, P336, DOI 10.1177/036354658201000602; Kelly BT, 1996, AM J SPORT MED, V24, P581, DOI 10.1177/036354659602400504; Kelly SM, 2010, CLIN REHABIL, V24, P149, DOI 10.1177/0269215509346103; KESSEL L, 1977, J BONE JOINT SURG BR, V59, P166, DOI 10.1302/0301-620X.59B2.873977; Kim E, 2006, ACTA MED OKAYAMA, V60, P223; LEROUX JL, 1995, REV RHUM, V62, P423; Litaker D, 2000, J AM GERIATR SOC, V48, P1633, DOI 10.1111/j.1532-5415.2000.tb03875.x; Luime JJ, 2004, JAMA-J AM MED ASSOC, V292, P1989, DOI 10.1001/jama.292.16.1989; Luime JJ, 2004, SCAND J RHEUMATOL, V33, P73, DOI 10.1080/03009740310004667; LYONS AR, 1992, J BONE JOINT SURG BR, V74, P414, DOI 10.1302/0301-620X.74B3.1587891; MacDermid JC, 2004, J SHOULDER ELB SURG, V13, P593, DOI 10.1016/j.jse.2004.03.009; MacDonald PB, 2000, J SHOULDER ELB SURG, V9, P299, DOI 10.1067/mse.2000.106918; Martin-Hervas C, 2001, J SHOULDER ELB SURG, V10, P410, DOI 10.1067/mse.2001.116515; Matava MJ, 2005, AM J SPORT MED, V33, P1405, DOI 10.1177/0363546505280213; Michener LA, 2009, ARCH PHYS MED REHAB, V90, P1898, DOI 10.1016/j.apmr.2009.05.015; Miller CA, 2008, ARCH PHYS MED REHAB, V89, P1162, DOI 10.1016/j.apmr.2007.10.046; Nanda R, 2008, EUR J ORTHOP SURG TR, V18, P495, DOI 10.1007/s00590-008-0341-6; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Oh LS, 2007, CLIN ORTHOP RELAT R, P52, DOI 10.1097/BLO.0b013e31802fc175; Ottenheijm RP, 2010, ARCH PHYS MED REHAB, V91, P1616, DOI 10.1016/j.apmr.2010.07.017; Park HB, 2005, J BONE JOINT SURG AM, V87A, P1446, DOI 10.2106/JBJS.D.02335; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Rechardt M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-165; REKOLA KE, 1993, J EPIDEMIOL COMMUN H, V47, P153, DOI 10.1136/jech.47.2.153; Rockwood C.A., 2009, SHOULDER; Salaffi F, 2010, JCR-J CLIN RHEUMATOL, V16, P105, DOI 10.1097/RHU.0b013e3181cf8392; Shahabpour A, 2008, EUR J RADIOL, V65, P194, DOI 10.1016/j.ejrad.2007.11.012; Silva L, 2008, RHEUMATOLOGY, V47, P679, DOI 10.1093/rheumatology/ken101; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simel DL, 2009, THE RATIONAL CLINICA; Swen WAA, 1999, ARTHRITIS RHEUM, V42, P2231, DOI 10.1002/1529-0131(199910)42:10<2231::AID-ANR27>3.0.CO;2-Z; Teefey SA, 2004, J BONE JOINT SURG AM, V86A, P708, DOI 10.2106/00004623-200404000-00007; Tennent TD, 2003, AM J SPORT MED, V31, P154, DOI 10.1177/03635465030310011101; Toprak U, 2013, KNEE SURG SPORT TR A, V21, P424, DOI 10.1007/s00167-012-1969-7; VANDERHELM FCT, 1994, J BIOMECH, V27, P551, DOI 10.1016/0021-9290(94)90065-5; Warren RF, 1993, MANUAL RHEUMATOLOGY, P99; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Wolf EM, 2001, J SHOULDER ELB SURG, V10, P470, DOI 10.1067/mse.2001.117126; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835; Zaslav KR, 2001, J SHOULDER ELB SURG, V10, P23, DOI 10.1067/mse.2001.111960	77	108	112	1	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 28	2013	310	8					837	847		10.1001/jama.2013.276187	http://dx.doi.org/10.1001/jama.2013.276187			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206YA	23982370				2022-12-28	WOS:000323561400024
J	Brito, JP; Morris, JC; Montori, VM				Brito, Juan P.; Morris, John C.; Montori, Victor M.			TOO MUCH MEDICINE Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNITED-STATES; PAPILLARY; CARCINOMA; THERAPY; PREVALENCE; MORTALITY; NODULES; IMPACT; US		[Brito, Juan P.; Morris, John C.; Montori, Victor M.] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA; [Brito, Juan P.; Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Montori, VM (corresponding author), Mayo Clin, Div Endocrinol Diabet Metab & Nutr, 200 1st St SW, Rochester, MN 55905 USA.	montori.victor@mayo.edu		Montori, Victor/0000-0003-0595-2898				Alexander C, 1998, J NUCL MED, V39, P1551; Almeida J, 2009, ARCH OTOLARYNGOL, V135, P342, DOI 10.1001/archoto.2009.16; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Baker LC, 2008, HEALTH AFFAIR, V27, P1467, DOI 10.1377/hlthaff.27.6.1467; Brito JP, 2013, THYROID, V23, P449, DOI 10.1089/thy.2012.0156; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cronan JJ, 2008, RADIOLOGY, V247, P602, DOI 10.1148/radiol.2473072233; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Dal Maso L, 2009, CANCER CAUSE CONTROL, V20, P75, DOI 10.1007/s10552-008-9219-5; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.21076; Davies L, 2010, ARCH OTOLARYNGOL, V136, P440, DOI 10.1001/archoto.2010.55; Ferlay J., IARC CANCERBASE; Giordano D, 2012, THYROID, V22, P911, DOI 10.1089/thy.2012.0011; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Haselkorn T, 2000, CANCER CAUSE CONTROL, V11, P163, DOI 10.1023/A:1008932123830; HAY ID, 1993, SURGERY, V114, P1050; Howlader N, 2011, SEER CANC STAT REV 1; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Leenhardt L, 2004, EUR J ENDOCRINOL, V150, P133, DOI 10.1530/eje.0.1500133; Mandel SJ, 2003, THYROID, V13, P265, DOI 10.1089/105072503321582060; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; McIver B, 2001, SURGERY, V130, P1028, DOI 10.1067/msy.2001.118266; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Negri E, 1999, CANCER CAUSE CONTROL, V10, P143, DOI 10.1023/A:1008880429862; Pellegriti G, 2004, J CLIN ENDOCR METAB, V89, P3713, DOI 10.1210/jc.2003-031982; Roche L. M., 2011, J ENV PUBLIC HLTH, V2011; Ross DS, 2006, J CLIN ENDOCR METAB, V91, P4253, DOI 10.1210/jc.2006-1772; Sprague BL, 2008, CANCER CAUSE CONTROL, V19, P585, DOI 10.1007/s10552-008-9122-0; Sun GH, 2013, THYROID, V23, P727, DOI 10.1089/thy.2012.0218; Van Nostrand D, 2009, THYROID, V19, P1381, DOI 10.1089/thy.2009.1611; Xing MZ, 2013, JAMA-J AM MED ASSOC, V309, P1493, DOI 10.1001/jama.2013.3190; Yoon DY, 2008, J COMPUT ASSIST TOMO, V32, P810, DOI 10.1097/RCT.0b013e318157fd38; Yousem DM, 1997, AM J NEURORADIOL, V18, P1423	36	204	209	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2013	347								f4706	10.1136/bmj.f4706	http://dx.doi.org/10.1136/bmj.f4706			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211BW	23982465				2022-12-28	WOS:000323880100006
J	Colbert, RA; Ward, MM				Colbert, Robert A.; Ward, Michael M.			17 and 23: prime numbers for ankylosing spondylitis?	LANCET			English	Editorial Material							CELLS; SECUKINUMAB; ANTIBODY		[Colbert, Robert A.; Ward, Michael M.] NIAMSD, Intramural Res Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Colbert, RA (corresponding author), NIAMSD, Intramural Res Program, Bethesda, MD 20892 USA.	colbertr@mail.nih.gov			Intramural NIH HHS [ZIA AR041184-04] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041184] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Appel H, 2013, ARTHRITIS RHEUM-US, V65, P1522, DOI 10.1002/art.37937; Appel H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3370; Baeten D, 2013, LANCET; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; Davis JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Dick AD, 2013, OPHTHALMOLOGY, V120, P777, DOI 10.1016/j.ophtha.2012.09.040; Genovese MC, 2013, ANN RHEUM DIS, V72, P863, DOI 10.1136/annrheumdis-2012-201601; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; McInnes IB, 2013, ANN RHEUM DIS; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Reveille JD, 2012, NAT REV RHEUMATOL, V8, P296, DOI 10.1038/nrrheum.2012.41; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Sieper J, 2012, NAT REV RHEUMATOL, V8, P280, DOI 10.1038/nrrheum.2012.40	17	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1682	1683		10.1016/S0140-6736(13)61913-3	http://dx.doi.org/10.1016/S0140-6736(13)61913-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259PX	24035251	Green Accepted			2022-12-28	WOS:000327539900006
J	Neuhausen, K; Spivey, M; Kellermann, AL				Neuhausen, Katherine; Spivey, Michael; Kellermann, Arthur L.			State Politics and the Fate of the Safety Net	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A proposed rule for reducing disproportionate-share-hospital payments encourages states to focus DSH funds on the hospitals that need it most. But if states not expanding Medicaid don't reallocate their DSH funds, safety-net hospitals and their patients will suffer. Only 2% of acute care hospitals nationwide are safety-net facilities, but they provide 20% of uncompensated care to the uninsured. Because most are in low-income communities, they typically generate scant revenue from privately insured patients. The Medicaid Disproportionate Share Hospital (DSH) program was established to help defray their costs for uncompensated care.(1) Currently, Medicaid DSH disburses $11.5 billion annually to the states, which have considerable latitude in allocating these funds. Some states carefully target their DSH payments to hospitals providing large volumes of uncompensated care, but others, such as Ohio and Georgia, spread their payments broadly, transforming the program into ...	[Neuhausen, Katherine] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90095 USA; [Spivey, Michael] Spivey Harris Hlth Policy Grp, Washington, DC USA; [Kellermann, Arthur L.] RAND, Publ Hlth Syst & Preparedness, Arlington, VA USA	University of California System; University of California Los Angeles; RAND Corporation	Neuhausen, K (corresponding author), Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA 90095 USA.							Centers for Medicare and Medicaid Services, 2013, FED REG, V78, P28551; Congressional Budget Office, 2012, EST INS COV PROV AFF; Kaiser Family Foundation, 2013, STAT STAT ACT MED EX; Price CC, 2013, HEALTH AFFAIR, V32, P1030, DOI 10.1377/hlthaff.2012.1019; Spivey M, 2009, NEW ENGL J MED, V360, P2598, DOI 10.1056/NEJMp0900728	5	11	11	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 31	2013	369	18					1675	1677		10.1056/NEJMp1310572	http://dx.doi.org/10.1056/NEJMp1310572			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	243IY	24047402				2022-12-28	WOS:000326311300003
J	Wilson, MA; Kwon, Y; Xu, YY; Chung, WH; Chi, P; Niu, HY; Mayle, R; Chen, XF; Malkova, A; Sung, P; Ira, G				Wilson, Marenda A.; Kwon, YoungHo; Xu, Yuanyuan; Chung, Woo-Hyun; Chi, Peter; Niu, Hengyao; Mayle, Ryan; Chen, Xuefeng; Malkova, Anna; Sung, Patrick; Ira, Grzegorz			Pif1 helicase and Pol delta promote recombination-coupled DNA synthesis via bubble migration	NATURE			English	Article							BREAK-INDUCED REPLICATION; SACCHAROMYCES-CEREVISIAE; POLYMERASE-DELTA; HOMOLOGOUS RECOMBINATION; RAD51-MEDIATED RECOMBINATION; MITOTIC RECOMBINATION; HALF-CROSSOVERS; YEAST; PROTEINS; RAD51	During DNA repair by homologous recombination (HR), DNA synthesis copies information from a template DNA molecule. Multiple DNA polymerases have been implicated in repair-specific DNA synthesis(1-3), but it has remained unclear whether a DNA helicase is involved in this reaction. A good candidate DNA helicase is Pif1, an evolutionarily conserved helicase in Saccharomyces cerevisiae important for break-induced replication (BIR)(4) as well as HR-dependent telomere maintenance in the absence of telomerase(5) found in 10-15% of all cancers(6). Pif1 has a role in DNA synthesis across hard-to-replicate sites(7,8) and in lagging-strand synthesis with polymerase delta (Pol delta)(9-11). Here we provide evidence that Pif1 stimulates DNA synthesis during BIR and crossover recombination. The initial steps of BIR occur normally in Pif1-deficient cells, but Pol delta recruitment and DNA synthesis are decreased, resulting in premature resolution of DNA intermediates into half-crossovers. Purified Pif1 protein strongly stimulates Pol delta-mediated DNA synthesis from a D-loop made by the Rad51 recombinase. Notably, Pif1 liberates the newly synthesized strand to prevent the accumulation of topological constraint and to facilitate extensive DNA synthesis via the establishment of a migrating D-loop structure. Our results uncover a novel function of Pif1 and provide insights into the mechanism of HR.	[Wilson, Marenda A.; Chung, Woo-Hyun; Mayle, Ryan; Chen, Xuefeng; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kwon, YoungHo; Xu, Yuanyuan; Niu, Hengyao; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Chung, Woo-Hyun] Duksung Womens Univ, Coll Pharm, Seoul 132714, South Korea; [Chi, Peter] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Chi, Peter] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Malkova, Anna] IUPUI, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA	Baylor College of Medicine; Yale University; Duksung Women's University; National Taiwan University; Academia Sinica - Taiwan; Indiana University System; Indiana University-Purdue University Indianapolis	Ira, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	patrick.sung@yale.edu; gira@bcm.edu	Chi, Peter/AAI-1580-2019; Niu, Hengyao/AAE-9269-2020; Huang, Wenchi/F-3981-2010; Niu, Hengyao/B-5026-2014	Chi, Peter/0000-0001-9229-8729; Huang, Wenchi/0000-0001-5556-1460; Wilson, Marenda/0000-0003-1610-1044	US National Institutes of Health [GM080600, ES007061, GM057814, ES015632, GM084242, T32GM07526-34]; National Research Foundation of Korea [NRF-2012R1A1A1009917]; Academia Sinica; National Taiwan University; National Science Council of Taiwan; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, R01ES015632, R03ES016434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814, R01GM080600, R01GM084242, T32GM007526, T32GM008307] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); Academia Sinica(Academia Sinica - Taiwan); National Taiwan University(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank V. Zakian, K. Labib, W.-D. Heyer, J. Haber, C. Wittenberg, R. Johnson and L. Prakash for the gift of antibodies, strains or plasmids, and D. Camerini-Otero for providing DinG. We are grateful to J. Griffith and S. Wilcox for training in metal shadowing electron microscopy. This work was funded by grants from the US National Institutes of Health (GM080600 to G.I.; ES007061, GM057814, ES015632 to P.S., GM084242 to A.M., T32GM07526-34 to M.A.W.), National Research Foundation of Korea (NRF-2012R1A1A1009917), Academia Sinica, National Taiwan University, and the National Science Council of Taiwan.	Acharya N, 2011, P NATL ACAD SCI USA, V108, P17927, DOI 10.1073/pnas.1109981108; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Busygina V, 2008, GENE DEV, V22, P786, DOI 10.1101/gad.1638708; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Deem A, 2008, GENETICS, V179, P1845, DOI 10.1534/genetics.108.087940; Dewar JM, 2010, EMBO J, V29, P4020, DOI 10.1038/emboj.2010.267; Ferguson DO, 1996, P NATL ACAD SCI USA, V93, P5419, DOI 10.1073/pnas.93.11.5419; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Janke R, 2010, NUCLEIC ACIDS RES, V38, P2302, DOI 10.1093/nar/gkp1222; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Malkova A, 2000, P NATL ACAD SCI USA, V97, P14500, DOI 10.1073/pnas.97.26.14500; Malkova A, 2013, CURR OPIN GENET DEV, V23, P271, DOI 10.1016/j.gde.2013.05.007; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Raschle M, 2004, J BIOL CHEM, V279, P51973, DOI 10.1074/jbc.M410101200; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Sabouri N, 2012, GENE DEV, V26, P581, DOI 10.1101/gad.184697.111; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sebesta M, 2011, DNA REPAIR, V10, P567, DOI 10.1016/j.dnarep.2011.03.003; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	38	212	215	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					393	+		10.1038/nature12585	http://dx.doi.org/10.1038/nature12585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	24025768	Green Accepted			2022-12-28	WOS:000325706300058
J	Herzog, BH; Fu, JX; Wilson, SJ; Hess, PR; Sen, A; McDaniel, JM; Pan, YF; Sheng, MJ; Yago, T; Silasi-Mansat, R; McGee, S; May, F; Nieswandt, B; Morris, AJ; Lupu, F; Coughlin, SR; McEver, RP; Chen, H; Kahn, ML; Xia, LJ				Herzog, Brett H.; Fu, Jianxin; Wilson, Stephen J.; Hess, Paul R.; Sen, Aslihan; McDaniel, J. Michael; Pan, Yanfang; Sheng, Minjia; Yago, Tadayuki; Silasi-Mansat, Robert; McGee, Samuel; May, Frauke; Nieswandt, Bernhard; Morris, Andrew J.; Lupu, Florea; Coughlin, Shaun R.; McEver, Rodger P.; Chen, Hong; Kahn, Mark L.; Xia, Lijun			Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2	NATURE			English	Article							VASCULAR INTEGRITY; STROMAL CELLS; VE-CADHERIN; LYMPH-NODES; MICE; SPHINGOSINE-1-PHOSPHATE; LYMPHOCYTES; SELECTIN; MOUSE; BLOOD	Circulating lymphocytes continuously enter lymph nodes for immune surveillance through specialized blood vessels named high endothelial venules(1-5), a process that increases markedly during immune responses. How high endothelial venules (HEVs) permit lymphocyte transmigration while maintaining vascular integrity is unknown. Here we report a role for the transmembrane O-glycoprotein podoplanin (PDPN, also known as gp38 and T1 alpha)(6-8) in maintaining HEV barrier function. Mice with postnatal deletion of Pdpn lost HEV integrity and exhibited spontaneous bleeding in mucosal lymph nodes, and bleeding in the draining peripheral lymph nodes after immunization. Blocking lymphocyte homing rescued bleeding, indicating that PDPN is required to protect the barrier function of HEVs during lymphocyte trafficking. Further analyses demonstrated that PDPN expressed on fibroblastic reticular cells(7), which surround HEVs, functions as an activating ligand for platelet C-type lectin-like receptor 2 (CLEC-2, also known as CLEC1B)(9,10). Mice lacking fibroblastic reticular cell PDPN or platelet CLEC-2 exhibited significantly reduced levels of VE-cadherin (also known as CDH5), which is essential for overall vascular integrity(11,12), on HEVs. Infusion of wild-type platelets restored HEV integrity in Clec-2-deficient mice. Activation of CLEC-2 induced release of sphingosine-1-phosphate(13,14) from platelets, which promoted expression of VE-cadherin on HEVs ex vivo. Furthermore, draining peripheral lymph nodes of immunized mice lacking sphingosine-1-phosphate had impaired HEV integrity similar to Pdpn- and Clec-2-deficient mice. These data demonstrate that local sphingosine-1-phosphate release after PDPN-CLEC-2-mediated platelet activation is critical for HEV integrity during immune responses.	[Herzog, Brett H.; Fu, Jianxin; McDaniel, J. Michael; Pan, Yanfang; Sheng, Minjia; Yago, Tadayuki; Silasi-Mansat, Robert; McGee, Samuel; Lupu, Florea; McEver, Rodger P.; Chen, Hong; Xia, Lijun] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Herzog, Brett H.; Pan, Yanfang; McEver, Rodger P.; Chen, Hong; Xia, Lijun] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Fu, Jianxin; Xia, Lijun] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou 215006, Jiangsu, Peoples R China; [Fu, Jianxin; Xia, Lijun] Soochow Univ, Affiliated Hosp 1, Minist Hlth, Key Lab Thrombosis & Hemostasis, Suzhou 215006, Jiangsu, Peoples R China; [Wilson, Stephen J.; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Hess, Paul R.; Sen, Aslihan; Kahn, Mark L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Hess, Paul R.; Sen, Aslihan; Kahn, Mark L.] Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA; [May, Frauke; Nieswandt, Bernhard] Univ Hosp Wurzburg, D-97080 Wurzburg, Germany; [May, Frauke; Nieswandt, Bernhard] DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, D-97080 Wurzburg, Germany; [Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40502 USA; [Morris, Andrew J.] Lexington Vet Affairs Med Ctr, Lexington, KY 40502 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Soochow University - China; Soochow University - China; University of California System; University of California San Francisco; University of Pennsylvania; University of Pennsylvania; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Xia, LJ (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA.	Lijun-Xia@omrf.org	Lupu, Florea/AAV-3257-2021; Lupu, Florea/C-3162-2009	Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278; Fu, Jianxin/0000-0002-3067-8539; Silasi, Robert/0000-0001-9590-6160	National Institutes of Health [GM103441, GM097747, HL085607, HL093242, HL103432, HL065590, HL112788]; VA Merit Award [BX001984]; American Heart Association [SDG7410022]; Deutsche Forschungsgemeinschaft [SFB688]; National Natural Science Foundation of China [30928010]; Jiangsu Provincial Special Program of Medical Science [BL2012005]; Jiangsu Province's Key Medical Center [ZX201102]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR018758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093242, P01HL085607, R01HL065590, R01HL103432, R01HL112788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103441, P20GM103527, R01GM097747] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; Jiangsu Province's Key Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank P. Kincade and L. Thompson for critical reading of the manuscript; R. Adams for providing PdgfrbCre mice; and M. Kinter and M. C. Marlin for technical assistance. Work was supported by grants from the National Institutes of Health (GM103441, GM097747, HL085607, HL093242, HL103432, HL065590, HL112788), VA Merit Award (BX001984), the American Heart Association (SDG7410022), the Deutsche Forschungsgemeinschaft (SFB688), National Natural Science Foundation of China (30928010), Jiangsu Provincial Special Program of Medical Science (BL2012005) and Jiangsu Province's Key Medical Center (ZX201102).	Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Camerer E, 2009, J CLIN INVEST, V119, P1871, DOI 10.1172/JCI38575; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Diacovo TG, 1996, SCIENCE, V273, P252, DOI 10.1126/science.273.5272.252; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Goerge T, 2008, BLOOD, V111, P4958, DOI 10.1182/blood-2007-11-123620; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Kamala T, 2007, J IMMUNOL METHODS, V328, P204, DOI 10.1016/j.jim.2007.08.004; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; May F, 2009, BLOOD, V114, P3464, DOI 10.1182/blood-2009-05-222273; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Selim S, 2011, CLIN SCI, V121, P565, DOI 10.1042/CS20110236; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; Ulrych T, 2011, J THROMB HAEMOST, V9, P790, DOI 10.1111/j.1538-7836.2011.04194.x; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Xia LJ, 2002, J CLIN INVEST, V109, P939	38	210	222	4	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 3	2013	502	7469					105	+		10.1038/nature12501	http://dx.doi.org/10.1038/nature12501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	23995678	Green Submitted, Green Accepted			2022-12-28	WOS:000325106000040
J	Gurnett, DA; Kurth, WS; Burlaga, LF; Ness, NF				Gurnett, D. A.; Kurth, W. S.; Burlaga, L. F.; Ness, N. F.			In Situ Observations of Interstellar Plasma with Voyager 1	SCIENCE			English	Article							WIND TERMINATION SHOCK; GALACTIC COSMIC-RAYS; SOLAR-WIND; MAGNETIC-FIELDS; OUTER HELIOSPHERE; RADIO-EMISSION; HELIOSHEATH; REGION; WAVE; INTENSITY	Launched over 35 years ago, Voyagers 1 and 2 are on an epic journey outward from the Sun to reach the boundary between the solar plasma and the much cooler interstellar medium. The boundary, called the heliopause, is expected to be marked by a large increase in plasma density, from about 0.002 per cubic centimeter (cm(-3)) in the outer heliosphere, to about 0.1 cm(-3) in the interstellar medium. On 9 April 2013, the Voyager 1 plasma wave instrument began detecting locally generated electron plasma oscillations at a frequency of about 2.6 kilohertz. This oscillation frequency corresponds to an electron density of about 0.08 cm(-3), very close to the value expected in the interstellar medium. These and other observations provide strong evidence that Voyager 1 has crossed the heliopause into the nearby interstellar plasma.	[Gurnett, D. A.; Kurth, W. S.] Univ Iowa, Iowa City, IA 52242 USA; [Burlaga, L. F.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Ness, N. F.] Catholic Univ Amer, Washington, DC 20064 USA	University of Iowa; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Catholic University of America	Gurnett, DA (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.	donald-gurnett@uiowa.edu	Kurth, William/AAA-7334-2019	Kurth, William/0000-0002-5471-6202	NASA [1415150, NNG11PM48P, NNX12AC63G]; JPL	NASA(National Aeronautics & Space Administration (NASA)); JPL	We thank E. C. Stone, S. M. Krimigis, and J. D. Richardson, for their helpful comments. We also thank R. B. Decker, L. J. Granroth, J. C. Hall, A. Persoon, O. Santolik, and R. F. Wong for help in various data processing issues. The research at Iowa was supported by NASA through contract 1415150 with the JPL. The research at GSFC was supported by NASA contract NNG11PM48P, and the research at CUA was supported in part by NASA grant NNX12AC63G.	AXFORD WI, 1990, COSPAR COLL, V1, P7; Bale SD, 1999, GEOPHYS RES LETT, V26, P1573, DOI 10.1029/1999GL900293; Burlaga LF, 2008, NATURE, V454, P75, DOI 10.1038/nature07029; Burlaga LF, 2013, SCIENCE, V341, P147, DOI 10.1126/science.1235451; Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; CAIRNS IH, 1992, GEOPHYS RES LETT, V19, P2187, DOI 10.1029/92GL02632; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; Drake JF, 2010, ASTROPHYS J, V709, P963, DOI 10.1088/0004-637X/709/2/963; Ergun RE, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.051101; Florinski V, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010879; Frisch PC, 2011, ANNU REV ASTRON ASTR, V49, P237, DOI 10.1146/annurev-astro-081710-102613; Guhathakurta M., 2013, Eos, Transactions American Geophysical Union, V94, P165; Gurnett DA, 2008, NATURE, V454, P78, DOI 10.1038/nature07023; Gurnett D. A., 2005, INTRODUCTION TO PLAS, P11; Gurnett DA, 2005, SCIENCE, V309, P2025, DOI 10.1126/science.1117425; GURNETT DA, 1993, SCIENCE, V262, P199, DOI 10.1126/science.262.5131.199; Krimigis SM, 2013, SCIENCE, V341, P144, DOI 10.1126/science.1235721; Kurth WS, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2003JA009860; KURTH WS, 1984, NATURE, V312, P27, DOI 10.1038/312027a0; McComas DJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048763; Pogorelov NV, 2006, ASTROPHYS J, V644, P1299, DOI 10.1086/503703; Richardson JD, 2012, ASTROPHYS J LETT, V759, DOI 10.1088/2041-8205/759/1/L19; Richardson JD, 2008, NATURE, V454, P63, DOI 10.1038/nature07024; SCARF FL, 1977, SPACE SCI REV, V21, P289, DOI 10.1007/BF00211543; Stone EC, 2013, SCIENCE, V341, P150, DOI 10.1126/science.1236408; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; Washimi H, 2012, ASTROPHYS J LETT, V757, DOI 10.1088/2041-8205/757/1/L2; Washimi H, 2011, MON NOT R ASTRON SOC, V416, P1475, DOI 10.1111/j.1365-2966.2011.19144.x; Webber WR, 2013, GEOPHYS RES LETT, V40, P1665, DOI 10.1002/grl.50383; Zank GP, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/20; Zank GP, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009689; Zank GP, 1999, SPACE SCI REV, V89, P413, DOI 10.1023/A:1005155601277	32	230	232	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 27	2013	341	6153					1489	1492		10.1126/science.1241681	http://dx.doi.org/10.1126/science.1241681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24030496				2022-12-28	WOS:000324894600043
J	Ross, JS; Kesselheim, AS				Ross, Joseph S.; Kesselheim, Aaron S.			Prescription-Drug Coupons - No Such Thing as a Free Lunch	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Many websites for brand-name drugs available in the United States contain links to drug coupons. But since many are for medications for which lower-cost alternatives are available, this marketing practice threatens to increase societal costs in the long run. Visit nearly any official website for a brand-name drug available in the United States and, mixed in with links to prescribing and safety information, you'll find links to drug coupons, including copayment-assistance programs and monthly savings cards. Most offers are variations on Why pay more? With the [drug] savings card, you can get [drug] for only $18 per prescription if eligible or Get a free 30-capsule trial of [drug] with your doctor's prescription and ask your doctor if [drug] is right for you. Why do manufacturers offer drug coupons? Are they good for patients in the long run? Are they ...	[Ross, Joseph S.] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Yale University; Yale University; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ross, JS (corresponding author), Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA.			Ross, Joseph/0000-0002-9218-3320				Grande D, 2012, JAMA-J AM MED ASSOC, V307, P2375, DOI 10.1001/jama.2012.5603; IMS Institute for Healthcare Informatics, 2012, US MED US REV 2011; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V294, P2436; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Pharmaceutical Care Management Association, 2011, COP COUP COULD RAIS; Shrank WH, 2010, HEALTH AFFAIR, V29, P1383, DOI 10.1377/hlthaff.2009.0424	6	51	51	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1188	1189		10.1056/NEJMp1301993	http://dx.doi.org/10.1056/NEJMp1301993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	224LT	23984672				2022-12-28	WOS:000324888200003
J	Newhouse, JP; Garber, AM				Newhouse, Joseph P.; Garber, Alan M.			Geographic Variation in Health Care Spending in the United States Insights From an Institute of Medicine Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Newhouse, Joseph P.; Garber, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Newhouse, Joseph P.; Garber, Alan M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Newhouse, Joseph P.; Garber, Alan M.] Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA; [Garber, Alan M.] Harvard Univ, Off Provost, Cambridge, MA 02138 USA; [Garber, Alan M.] Harvard Univ, Dept Econ, Fac Arts & Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University	Newhouse, JP (corresponding author), 180 Longwood Ave, Boston, MA 02115 USA.	joseph_newhouse@harvard.edu	Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022					Chernew ME, 2010, AM J MANAG CARE, V16, P131; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Gawande A., 2009, COST CONUNDRUM NEW Y; Graham RP, VARIATION IN HEALTH; Institute of Medicine, INTERIM REPORT OF TH; Pear R., 2009, NEW YORK TIMES; The Trustees of Dartmouth College, THE DARTMOUTH ATLAS	7	112	112	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 25	2013	310	12					1227	1228		10.1001/jama.2013.278139	http://dx.doi.org/10.1001/jama.2013.278139			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	222SO	24008265				2022-12-28	WOS:000324751800014
J	Baker, JP				Baker, Jeffrey P.			HISTORY OF MEDICINE Autism at 70-Redrawing the Boundaries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SPECTRUM DISORDERS	Though the DSM-5 definition of autism refers to it as a spectrum, in important ways it represents an effort to define the syndrome more sharply. It thus reflects one of the central themes in the history of autism: a debate over where to set its boundaries. This year's revision of the diagnostic criteria for autism is among the most contentious of any in the new Diagnostic and Statistical Manual of Mental Disorders (the fifth edition, or DSM-5), provoking widespread fears among parents and advocacy groups that children who have received a diagnosis of autism will lose their eligibility for services. Coincidentally, this year also marks the 70th anniversary of psychiatrist Leo Kanner's first clinical description of autism in 1943.(1) Though the DSM-5 definition explicitly refers to autism as a spectrum, in important ways it represents an effort to define the syndrome more sharply. In this respect, ...	Duke Univ, Sch Med, Trent Ctr Bioeth Humanities & Hist Med, Durham, NC USA	Duke University	Baker, JP (corresponding author), Duke Univ, Sch Med, Trent Ctr Bioeth Humanities & Hist Med, Durham, NC USA.							EISENBERG L, 1956, AM J ORTHOPSYCHIAT, V26, P556, DOI 10.1111/j.1939-0025.1956.tb06202.x; Grinker R.R., 2007, UNSTRANGE MINDS REMA; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Kanner L, 1943, NERV CHILD, V2, P217; Ozonoff S, 2012, J CHILD PSYCHOL PSYC, V53, P1092, DOI 10.1111/j.1469-7610.2012.02614.x	5	28	29	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1089	1091		10.1056/NEJMp1306380	http://dx.doi.org/10.1056/NEJMp1306380			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	220BD	24047057				2022-12-28	WOS:000324554800004
J	Meacham, CE; Morrison, SJ				Meacham, Corbin E.; Morrison, Sean J.			Tumour heterogeneity and cancer cell plasticity	NATURE			English	Review							ACUTE MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; HEMATOPOIETIC STEM-CELLS; INITIATING CELLS; BCR-ABL; LYMPHOBLASTIC-LEUKEMIA; CLONAL EVOLUTION; MELANOMA-CELLS; PHENOTYPIC HETEROGENEITY; PROPAGATING CELLS	Phenotypic and functional heterogeneity arise among cancer cells within the same tumour as a consequence of genetic change, environmental differences and reversible changes in cell properties. Some cancers also contain a hierarchy in which tumorigenic cancer stem cells differentiate into non-tumorigenic progeny. However, it remains unclear what fraction of cancers follow the stem-cell model and what clinical behaviours the model explains. Studies using lineage tracing and deep sequencing could have implications for the cancer stem-cell model and may help to determine the extent to which it accounts for therapy resistance and disease progression.	[Meacham, Corbin E.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dallas, TX 75390 USA; [Meacham, Corbin E.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Childrens Res Inst, Dallas, TX 75390 USA.	sean.morrison@utsouthwestern.edu	damiani, chiara/R-4256-2016; Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; Cancer Prevention and Research Institute of Texas	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Prevention and Research Institute of Texas	This work was supported by the Howard Hughes Medical Institute and the Cancer Prevention and Research Institute of Texas. We apologize to authors whose papers could not be cited owing to space restrictions.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buchstaller J, 2012, CANCER CELL, V21, P240, DOI 10.1016/j.ccr.2011.12.027; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chiu PPL, 2010, BLOOD, V116, P5268, DOI 10.1182/blood-2010-06-292300; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Held MA, 2010, CANCER RES, V70, P388, DOI 10.1158/0008-5472.CAN-09-2153; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jiang X, 2007, LEUKEMIA, V21, P926, DOI 10.1038/sj.leu.2404609; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Krivtsov AV, 2013, LEUKEMIA, V27, P852, DOI 10.1038/leu.2012.363; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kummermehr Johann, 1997, P363, DOI 10.1016/B978-012563455-7/50013-1; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Meyer JA, 2013, NAT GENET, V45, P290, DOI 10.1038/ng.2558; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oravecz-Wilson KI, 2009, CANCER CELL, V16, P137, DOI 10.1016/j.ccr.2009.06.007; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Rehe K, 2013, EMBO MOL MED, V5, P38, DOI 10.1002/emmm.201201703; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Savona M, 2008, NAT REV CANCER, V8, P341, DOI 10.1038/nrc2368; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Stewart JM, 2011, P NATL ACAD SCI USA, V108, P6468, DOI 10.1073/pnas.1005529108; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	115	1497	1544	21	447	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 19	2013	501	7467					328	337		10.1038/nature12624	http://dx.doi.org/10.1038/nature12624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XT	24048065	Green Accepted			2022-12-28	WOS:000324545700031
J	Bjelakovic, G; Nikolova, D; Gluud, C				Bjelakovic, Goran; Nikolova, Dimitrinka; Gluud, Christian			Antioxidant Supplements to Prevent Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bjelakovic, Goran; Nikolova, Dimitrinka; Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Cochrane Hepatobiliary Grp,Copenhagen Trial Unit, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Bjelakovic, G (corresponding author), Rigshosp, Dept 7812, Ctr Clin Intervent Res, Cochrane Hepatobiliary Grp,Copenhagen Trial Unit, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	goranb@junis.ni.ac.rs	Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022	Gluud, Christian/0000-0002-8861-0799; Nikolova, Dimitrinka/0000-0001-5976-6762; Bjelakovic, Goran/0000-0002-3796-9945				Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Copenhagen Trial Unit, TSA TRIAL SEQ AN; McGinnis JM, 2006, ANN INTERN MED, V145, P364, DOI 10.7326/0003-4819-145-5-200609050-00136; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; US Department of Agriculture US Department of Health and Human Services, 2010, REP DIET GUID ADV CO	5	81	87	0	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1178	1179		10.1001/jama.2013.277028	http://dx.doi.org/10.1001/jama.2013.277028			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	24045742				2022-12-28	WOS:000324500300024
J	Heleno, B; Thomsen, MF; Rodrigues, DS; Jorgensen, KJ; Brodersen, J				Heleno, Bruno; Thomsen, Maria F.; Rodrigues, David S.; Jorgensen, Karsten J.; Brodersen, John			Quantification of harms in cancer screening trials: literature review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIALS; FOLLOW-UP; PROSTATE-CANCER; LUNG-CANCER; CLINICAL-TRIALS; AGE 40; MORTALITY; MAMMOGRAPHY; BENEFITS; QUALITY	Objectives To assess how often harm is quantified in randomised trials of cancer screening. Design Two authors independently extracted data on harms from randomised cancer screening trials. Binary outcomes were described as proportions and continuous outcomes with medians and interquartile ranges. Data sources For cancer screening previously assessed in a Cochrane review, we identified trials from their reference lists and updated the search in CENTRAL. For cancer screening not assessed in a Cochrane review, we searched CENTRAL, Medline, and Embase. Eligibility criteria for selecting studies Randomised trials that assessed the efficacy of cancer screening for reducing incidence of cancer, cancer specific mortality, and/or all cause mortality. Data extraction Two reviewers independently assessed articles for eligibility. Two reviewers, who were blinded to the identity of the study's authors, assessed whether absolute numbers or incidence rates of outcomes related to harm were provided separately for the screening and control groups. The outcomes were false positive findings, overdiagnosis, negative psychosocial consequences, somatic complications, invasive follow-up procedures, all cause mortality, and withdrawals because of adverse events. Results Out of 4590 articles assessed, 198 (57 trials, 10 screening technologies) matched the inclusion criteria. False positive findings were quantified in two of 57 trials (4%, 95% confidence interval 0% to 12%), overdiagnosis in four (7%, 2% to 18%), negative psychosocial consequences in five (9%, 3% to 20%), somatic complications in 11 (19%, 10% to 32%), use of invasive follow-up procedures in 27 (47%, 34% to 61%), all cause mortality in 34 (60%, 46% to 72%), and withdrawals because of adverse effects in one trial (2%, 0% to 11%). The median percentage of space in the results section that reported harms was 12% (interquartile range 2-19%). Conclusions Cancer screening trials seldom quantify the harms of screening. Of the 57 cancer screening trials examined, the most important harms of screening-overdiagnosis and false positive findings-were quantified in only 7% and 4%, respectively.	[Heleno, Bruno; Thomsen, Maria F.; Brodersen, John] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, DK-1014 Copenhagen K, Denmark; [Heleno, Bruno; Thomsen, Maria F.; Brodersen, John] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, DK-1014 Copenhagen K, Denmark; [Rodrigues, David S.] Nova Med Sch, Family Med Dept, P-1169056 Lisbon, Portugal; [Jorgensen, Karsten J.] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Heleno, B (corresponding author), Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Oster Farimagsgade 5,POB 2099, DK-1014 Copenhagen K, Denmark.	bruno.heleno@sund.ku.dk	Heleno, Bruno/AAE-3849-2019	Heleno, Bruno/0000-0002-3943-1858; Brodersen, John Brandt/0000-0001-9369-3376; Jorgensen, Karsten/0000-0001-8554-0388; Rodrigues, David/0000-0001-6785-1510				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alibhai SMH, 2006, CRIT REV ONCOL HEMAT, V57, P215, DOI 10.1016/j.critrevonc.2005.08.002; Andersson I, 1997, J Natl Cancer Inst Monogr, P63; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Barratt A, 1999, JAMA-J AM MED ASSOC, V281, P2029, DOI 10.1001/jama.281.21.2029; Brawley OW, 2005, J CLIN ONCOL, V23, P293, DOI 10.1200/JCO.2005.06.107; Breau RH, 2010, J UROLOGY, V183, P1693, DOI 10.1016/j.juro.2010.01.030; Brodersen J, 2010, POL ARCH MED WEWN, V120, P89, DOI 10.20452/pamw.895; Bryant J, 2002, J ENDOCRINOL, V175, P545, DOI 10.1677/joe.0.1750545; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Chowers MY, 2009, J ANTIMICROB CHEMOTH, V64, P239, DOI 10.1093/jac/dkp191; Croswell JM, 2010, SEMIN ONCOL, V37, P202, DOI 10.1053/j.seminoncol.2010.05.006; Dans LF, 2011, J CLIN EPIDEMIOL, V64, P231, DOI 10.1016/j.jclinepi.2010.09.009; de Koning HJ, 2000, LANCET, V355, P80, DOI 10.1016/S0140-6736(99)00419-5; de Vries TW, 2010, ARCH DIS CHILD, V95, P1023, DOI 10.1136/adc.2009.175562; Deeks J., 2011, COCHRANE HDB SYSTEMA; Edwards JE, 1999, J PAIN SYMPTOM MANAG, V18, P427, DOI 10.1016/S0885-3924(99)00093-7; Ethgen M, 2005, ANN INTERN MED, V143, P20, DOI 10.7326/0003-4819-143-1-200507050-00006; Gotzsche PC, 2013, COCHRANE DATABASE SY; Haidich AB, 2011, J CLIN EPIDEMIOL, V64, P124, DOI 10.1016/j.jclinepi.2010.03.005; HARDCASTLE JD, 1985, BRIT J SURG, V72, pS69, DOI 10.1002/bjs.1800721337; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harris R, 2011, EPIDEMIOL REV, V33, P20, DOI 10.1093/epirev/mxr005; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Ioannidis JPA, 1998, LANCET, V352, P1752, DOI 10.1016/S0140-6736(05)79825-1; Irwig L, 2006, BMJ-BRIT MED J, V332, P1148, DOI 10.1136/bmj.332.7550.1148; Jorgensen KJ, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-12; Lee PE, 2008, J CLIN EPIDEMIOL, V61, P1152, DOI 10.1016/j.jclinepi.2007.09.012; Levin B, 2006, CANC EPIDEMIOLOGY PR; Loke Y K, 2001, BMC Clin Pharmacol, V1, P3, DOI 10.1186/1472-6904-1-3; Marcus PM, 2006, J NATL CANCER I, V98, P748, DOI 10.1093/jnci/djj207; Marshall KG, 1996, CAN MED ASSOC J, V155, P169; Martin RCG, 2002, ANN SURG, V235, P803, DOI 10.1097/00000658-200206000-00007; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Newman TB, 2009, EVIDENCE-BASED DIAGNOSIS, P116, DOI 10.1017/CBO9780511759512.007; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Papanikolaou PN, 2004, AM J MED, V117, P582, DOI 10.1016/j.amjmed.2004.04.026; Papanikolaou PN, 2004, AM J PSYCHIAT, V161, P1692, DOI 10.1176/appi.ajp.161.9.1692; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Raffle AE, 2003, BRIT MED J, V326, P901, DOI 10.1136/bmj.326.7395.901; Raffle AE, 2007, SCREENING EVIDENCE P; Robinson MHE, 1999, GUT, V45, P588, DOI 10.1136/gut.45.4.588; Sandblom G, 2004, EUR UROL, V46, P717, DOI 10.1016/j.eururo.2004.08.011; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SEMIGLAZOV VF, 1992, EUR J EPIDEMIOL, V8, P498, DOI 10.1007/BF00146366; Stewart S, 2005, SCREENING DIS PREVEN; TABAR L, 1984, RECENT RES CANCER, V90, P105; VARENHORST E, 1992, ACTA ONCOL, V31, P815, DOI 10.3109/02841869209089713; Vera-Badillo FE, 2013, ANN ONCOL, V24, P1238, DOI 10.1093/annonc/mds636; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Woolf SH, 2003, FULFILLING POTENTIAL, P156; Wun YT, 2003, COCHRANE DATABASE SY; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	60	76	76	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2013	347								f5334	10.1136/bmj.f5334	http://dx.doi.org/10.1136/bmj.f5334			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	223RV	24041703	hybrid, Green Published			2022-12-28	WOS:000324827300001
J	Granovetter, M; Boyce, N				Granovetter, Michael; Boyce, Niall			Kevin Fong: medicine at the final frontier	LANCET			English	Biographical-Item														Granovetter, Michael/0000-0002-8103-2439				FONG K, PUBLICATION LIST	1	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 14	2013	382	9896					932	932		10.1016/S0140-6736(13)61922-4	http://dx.doi.org/10.1016/S0140-6736(13)61922-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VD	24034288	Bronze			2022-12-28	WOS:000324238000013
J	Hawkes, N				Hawkes, Nigel			Hospitals without walls	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Future Hospital Programme, 2013, FUT HOSP COMM	1	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 12	2013	347								f5479	10.1136/bmj.f5479	http://dx.doi.org/10.1136/bmj.f5479			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219SU	24030563				2022-12-28	WOS:000324530500008
J	Hoffmann, TC; Erueti, C; Glasziou, PP				Hoffmann, Tammy C.; Erueti, Chrissy; Glasziou, Paul P.			Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONSORT STATEMENT; CLINICAL-TRIALS; ELABORATION; EXPLANATION; ONCOLOGY	Objectives To evaluate the completeness of descriptions of non-pharmacological interventions in randomised trials, identify which elements are most frequently missing, and assess whether authors can provide missing details. Design Analysis of consecutive sample of randomised trials of non-pharmacological interventions. Data sources and study selection All reports of randomised trials of non-pharmacological interventions published in 2009 in six leading general medical journals; 133 trial reports, with 137 interventions, met the inclusion criteria. Data collection Using an eight item checklist, two raters assessed the primary full trial report, plus any reference materials, appendices, or websites. Questions about missing details were emailed to corresponding authors, and relevant items were then reassessed. Results Of 137 interventions, only 53 (39%) were adequately described; this was increased to 81 (59%) by using 63 responses from 88 contacted authors. The most frequently missing item was the "intervention materials" (47% complete), but it also improved the most after author response (92% complete). Whereas some authors (27/70) provided materials or further information, other authors (21/70) could not; their reasons included copyright or intellectual property concerns, not having the materials or intervention details, or being unaware of their importance. Although 46 (34%) trial interventions had further information or materials readily available on a website, many were not mentioned in the report, were not freely accessible, or the URL was no longer functioning. Conclusions Missing essential information about interventions is a frequent, yet remediable, contributor to the worldwide waste in research funding. If trial reports do not have a sufficient description of interventions, other researchers cannot build on the findings, and clinicians and patients cannot reliably implement useful interventions. Improvement will require action by funders, researchers, and publishers, aided by long term repositories of materials linked to publications.	[Hoffmann, Tammy C.; Erueti, Chrissy; Glasziou, Paul P.] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia	Bond University	Hoffmann, TC (corresponding author), Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia.	thoffmann@bond.edu.au	Hoffmann, Tammy/E-8029-2010; Glasziou, Paul/A-7832-2008	Hoffmann, Tammy/0000-0001-5210-8548; Glasziou, Paul/0000-0001-7564-073X	National Health and Medical Research Council of Australia (NHMRC)/Primary Health Care Research Evaluation and Development Career Development Fellowship [1033038]; Australian Department of Health and Ageing; NHMRC Australia Fellowship [527500]	National Health and Medical Research Council of Australia (NHMRC)/Primary Health Care Research Evaluation and Development Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	TCH is supported by a National Health and Medical Research Council of Australia (NHMRC)/Primary Health Care Research Evaluation and Development Career Development Fellowship (number: 1033038), with funding provided by the Australian Department of Health and Ageing. PPG is supported by a NHMRC Australia Fellowship (number: 527500). The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Aronson JK, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5415; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Chalmers I, 2003, BRIT MED J, V327, P1017, DOI 10.1136/bmj.327.7422.1017; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Davidson KW, 2003, ANN BEHAV MED, V26, P161, DOI 10.1207/S15324796ABM2603_01; Duff JM, 2010, JNCI-J NATL CANCER I, V102, P702, DOI 10.1093/jnci/djq117; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Glasziou P, 2013, AUST FAM PHYSICIAN, V42, P35; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Glasziou PP, 2009, MED J AUSTRALIA, V191, P52, DOI 10.5694/j.1326-5377.2009.tb02686.x; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hupperets MDW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2684; Jacquier I, 2006, ANN SURG, V244, P677, DOI 10.1097/01.sla.0000242707.44007.80; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Peron J, 2012, JNCI-J NATL CANCER I, V104, P982, DOI 10.1093/jnci/djs259; Pino C, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-63; Robb SL, 2009, J HEALTH PSYCHOL, V14, P490, DOI 10.1177/1359105309103568; Schroter S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001978	19	233	234	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2013	347								f3755	10.1136/bmj.f3755	http://dx.doi.org/10.1136/bmj.f3755			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219RR	24021722	Green Published, hybrid			2022-12-28	WOS:000324527000001
J	McNamara, BR				McNamara, B. R.			Feedback on Galaxy Formation	SCIENCE			English	Editorial Material							ACTIVE GALACTIC NUCLEI; BLACK-HOLES		[McNamara, B. R.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 5M3, Canada; [McNamara, B. R.] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada	University of Waterloo; Perimeter Institute for Theoretical Physics	McNamara, BR (corresponding author), Univ Waterloo, Dept Phys & Astron, 200 Univ Ave West, Waterloo, ON N2L 5M3, Canada.	mcnamara@uwaterloo.ca						Alexander DM, 2012, NEW ASTRON REV, V56, P93, DOI 10.1016/j.newar.2011.11.003; Combes F., 2004, IAU S, V217, P440; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Fabian AC, 2012, ANNU REV ASTRON ASTR, V50, P455, DOI 10.1146/annurev-astro-081811-125521; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Forman W, 2007, ASTROPHYS J, V665, P1057, DOI 10.1086/519480; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Kormendy J, 2013, ANNU REV ASTRON ASTR, V51, P511, DOI 10.1146/annurev-astro-082708-101811; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; Morganti R, 2013, SCIENCE, V341, P1082, DOI 10.1126/science.1240436; Veilleux S, 2005, ANNU REV ASTRON ASTR, V43, P769, DOI 10.1146/annurev.astro.43.072103.150610	11	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1073	1075		10.1126/science.1243114	http://dx.doi.org/10.1126/science.1243114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009382				2022-12-28	WOS:000323933100030
J	Spence, D				Spence, Des			Doctor bashing and the brain drain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Cooper C., 2013, INDEPENDENT; Davies M., 2013, PULSE; Doyle J., 2012, GENEROUS PAY AND PER; Ipsos MORI, 2011, DOCTORS ARE MOST TRU; Martin D., 2013, DAILY MAIL; Tanner F., 2010, PRIM HEALTH CARE RES, V11, P405; Walters S., 2013, DAILY MAIL	7	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2013	347								f5358	10.1136/bmj.f5358	http://dx.doi.org/10.1136/bmj.f5358			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215NK	24014340				2022-12-28	WOS:000324216700003
J	Aberle, DR; DeMello, S; Berg, CD; Black, WC; Brewer, B; Church, TR; Clingan, KL; Duan, F; Fagerstrom, RM; Gareen, IF; Gatsonis, CA; Gierada, DS; Jain, A; Jones, GC; Mahon, I; Marcus, PM; Rathmell, JM; Sicks, J				Aberle, Denise R.; DeMello, Sarah; Berg, Christine D.; Black, William C.; Brewer, Brenda; Church, Timothy R.; Clingan, Kathy L.; Duan, Fenghai; Fagerstrom, Richard M.; Gareen, Ilana F.; Gatsonis, Constantine A.; Gierada, David S.; Jain, Amanda; Jones, Gordon C.; Mahon, Irene; Marcus, Pamela M.; Rathmell, Joshua M.; Sicks, JoRean		Natl Lung Screening Trial Res Team	Results of the Two Incidence Screenings in the National Lung Screening Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANCER	BACKGROUND The National Lung Screening Trial was conducted to determine whether three annual screenings (rounds T0, T1, and T2) with low-dose helical computed tomography (CT), as compared with chest radiography, could reduce mortality from lung cancer. We present detailed findings from the first two incidence screenings (rounds T1 and T2). METHODS We evaluated the rate of adherence of the participants to the screening protocol, the results of screening and downstream diagnostic tests, features of the lung-cancer cases, and first-line treatments, and we estimated the performance characteristics of both screening methods. RESULTS At the T1 and T2 rounds, positive screening results were observed in 27.9% and 16.8% of participants in the low-dose CT group and in 6.2% and 5.0% of participants in the radiography group, respectively. In the low-dose CT group, the sensitivity was 94.4%, the specificity was 72.6%, the positive predictive value was 2.4%, and the negative predictive value was 99.9% at T1; at T2, the positive predictive value increased to 5.2%. In the radiography group, the sensitivity was 59.6%, the specificity was 94.1%, the positive predictive value was 4.4%, and the negative predictive value was 99.8% at T1; both the sensitivity and the positive predictive value increased at T2. Among lung cancers of known stage, 87 (47.5%) were stage IA and 57 (31.1%) were stage III or IV in the low-dose CT group at T1; in the radiography group, 31 (23.5%) were stage IA and 78 (59.1%) were stage III or IV at T1. These differences in stage distribution between groups persisted at T2. CONCLUSIONS Low-dose CT was more sensitive in detecting early-stage lung cancers, but its measured positive predictive value was lower than that of radiography. As compared with radiography, the two annual incidence screenings with low-dose CT resulted in a decrease in the number of advanced-stage cancers diagnosed and an increase in the number of early-stage lung cancers diagnosed.	[Aberle, Denise R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90024 USA; [DeMello, Sarah; Duan, Fenghai; Gareen, Ilana F.; Gatsonis, Constantine A.; Jain, Amanda; Sicks, JoRean] Brown Univ, Biostat Ctr, ACRIN, Providence, RI USA; [Berg, Christine D.; Fagerstrom, Richard M.] NCI, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Marcus, Pamela M.] NCI, Hlth Serv & Econ Appl Res Grp, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA; [Brewer, Brenda; Clingan, Kathy L.] Westat Corp, Rockville, MD USA; [Jones, Gordon C.; Rathmell, Joshua M.] Informat Management Serv Inc, Rockville, MD USA; [Black, William C.] Dartmouth Med Sch, Dept Radiol, Lebanon, NH USA; [Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Gierada, David S.] Washington Univ, Sch Med, Dept Radiol, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Mahon, Irene] ACRIN, Philadelphia, PA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Brown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Westat; Information Management Services, Inc.; Dartmouth College; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL)	Aberle, DR (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, 924 West Wood Blvd,Suite 420, Los Angeles, CA 90024 USA.	daberle@mednet.ucla.edu	Aberle, Denise R./D-5699-2014; Gareen, Ilana/I-2816-2014; Duan, Fenghai/J-3709-2014; Berg, Christine/K-1047-2014; Church, Timothy/AAH-7017-2020	Aberle, Denise R./0000-0002-8858-3401; Gareen, Ilana/0000-0002-0457-5595; Duan, Fenghai/0000-0002-5084-0070; Church, Timothy/0000-0003-3292-5035; Blevins, Meridith/0000-0002-3861-9859; Donnelly, Edwin/0000-0003-0740-3075; fishman, elliot/0000-0002-2567-1658; Rendas-Baum, Regina/0000-0003-1772-1819	National Cancer Institute; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025524, N01CN025513, N01CN025518, N01CN025514, N01CN025512, N01CN025476, N01CN075022, N01CN025522, N01CN025511, N01CN025516, N01CN025515] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA080098, N01CA025522, N01CA025516, N01CA025514, N01CA025515, N01CA025513, N01CA025524, N01CA075022, U01CA079778, N01CA025511, N01CA025512, N01CA025518, U10CA079778] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute; NLST ClinicalTrials.gov number, NCT00047385.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; Barba M, 2011, J CELL PHYSIOL, V226, P2213, DOI 10.1002/jcp.22558; Cagnon CH, 2006, ACAD RADIOL, V13, P1431, DOI 10.1016/j.acra.2006.08.015; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Davison AC, 1997, BOOTSTRAP METHODS TH; El-Baz A, 2013, INT J BIOMED IMAGING; Fritz APC., 2013, INT CLASSIFICATION D; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Lam S, 2013, ANN INTERN MED, V158, P289, DOI 10.7326/0003-4819-158-4-201302190-00011; Marcus PM, 2011, CONTEMP CLIN TRIALS, V32, P834, DOI 10.1016/j.cct.2011.07.003; Pedersen JH, 2009, J THORAC ONCOL, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Travis WD., 2004, TRAVIS WB WHO CLASSI; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Young RP, 2011, APPL CLIN GENET, V4, P99, DOI 10.2147/TACG.S20083	20	342	357	3	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					920	931		10.1056/NEJMoa1208962	http://dx.doi.org/10.1056/NEJMoa1208962			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004119	Green Accepted			2022-12-28	WOS:000323906900009
J	Garattini, S; Bertele, V; Bertolini, G				Garattini, Silvio; Bertele, Vittorio; Bertolini, Guido			DRUG DEVELOPMENT A failed attempt at collaboration	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Garattini, Silvio] Mario Negri Inst Pharmacol Res, IRCCS, Milan, Italy; [Bertele, Vittorio] Mario Negri Inst Pharmacol Res, IRCCS, Lab Drug Regulatory Policies, Milan, Italy; [Bertolini, Guido] Mario Negri Inst Pharmacol Res, IRCCS, Lab Clin Epidemiol, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, IRCCS, Via Eritrea 62, Milan, Italy.	silvio.garattini@marionegri.it	Garattini, Silvio/AAA-6390-2020; Bertele, Vittorio/AAA-6461-2020; Bertolini, Guido/AAA-8005-2020	Garattini, Silvio/0000-0003-0647-9297; Bertele, Vittorio/0000-0002-0032-7033; Bertolini, Guido/0000-0002-3101-4259				Innovative Medicines Initiative, 2007, INT PROP RIGHTS POLI; National Institute for Health and Clinical Excellence, 2013, 8 SESS 2012 13 16 JA; Nisen P, 2013, NEW ENGL J MED, V369, P475, DOI 10.1056/NEJMsr1302541	3	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2013	347								f5354	10.1136/bmj.f5354	http://dx.doi.org/10.1136/bmj.f5354			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215NL	24004996				2022-12-28	WOS:000324216800015
J	Sokol, DK				Sokol, Daniel K.			The judge as medical ethicist	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London, England	University of London; King's College London	Sokol, DK (corresponding author), Kings Coll London, London, England.	daniel.sokol@talk21.com						Gould M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5208	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 29	2013	347								f5299	10.1136/bmj.f5299	http://dx.doi.org/10.1136/bmj.f5299			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211CI	23990635				2022-12-28	WOS:000323881300005
J	Feenstra, B; Geller, F; Carstensen, L; Romitti, PA; Korberg, IB; Bedell, B; Krogh, C; Fan, RZ; Svenningsson, A; Caggana, M; Nordenskjold, A; Mills, JL; Murray, JC; Melbye, M				Feenstra, Bjarke; Geller, Frank; Carstensen, Lisbeth; Romitti, Paul A.; Korberg, Izabella Baranowska; Bedell, Bruce; Krogh, Camilla; Fan, Ruzong; Svenningsson, Anna; Caggana, Michele; Nordenskjold, Agneta; Mills, James L.; Murray, Jeffrey C.; Melbye, Mads			Plasma Lipids, Genetic Variants Near APOA1, and the Risk of Infantile Hypertrophic Pyloric Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERSTITIAL-CELLS; CHOLESTEROL; ASSOCIATION; EPIDEMIOLOGY; METAANALYSIS; NERVES; CAJAL	IMPORTANCE Infantile hypertrophic pyloric stenosis (IHPS) is a serious condition in which hypertrophy of the pyloric sphincter muscle layer leads to gastric outlet obstruction. Infantile hypertrophic pyloric stenosis shows strong familial aggregation and heritability, but knowledge about specific genetic risk variants is limited. OBJECTIVES To search the genome comprehensively for genetic associations with IHPS and validate findings in 3 independent sample sets. DESIGN, SETTING, AND PARTICIPANTS During stage 1, we used reference data from the 1000 Genomes Project for imputation into a genome-wide data set of 1001 Danish surgery-confirmed samples (cases diagnosed 1987-2008) and 2371 disease-free controls. In stage 2, the 5 most significantly associated loci were tested in independent case-control sample sets from Denmark (cases diagnosed 1983-2010), Sweden (cases diagnosed 1958-2011), and the United States (cases diagnosed 1998-2005), with a total of 1663 cases and 2315 controls. MAIN OUTCOMES AND MEASURES Association of genetic variation with the presence of infantile hypertrophic pyloric stenosis. RESULTS We found a new genome-wide significant locus for IHPS at chromosome 11q23.3. The single-nucleotide polymorphism (SNP) with the lowest P value at the locus, rs12721025 (odds ratio [OR], 1.59; 95% CI, 1.38-1.83; P = 1.9 x 10(-10)), is located 301 bases downstream of the apolipoprotein A-I (APOA1) gene and is correlated (r(2) between 0.46 and 0.80) with SNPs previously found to be associated with levels of circulating cholesterol. For these SNPs, the cholesterol-lowering allele consistently was associated with increased risk of IHPS. CONCLUSIONS AND RELEVANCE This study identified a new genome-wide significant locus for IHPS. Characteristics of this locus suggest the possibility of an inverse relationship between levels of circulating cholesterol in neonates and IHPS risk, which warrants further investigation.	[Feenstra, Bjarke; Geller, Frank; Carstensen, Lisbeth; Krogh, Camilla; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; [Romitti, Paul A.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Korberg, Izabella Baranowska; Svenningsson, Anna; Nordenskjold, Agneta] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Korberg, Izabella Baranowska; Svenningsson, Anna; Nordenskjold, Agneta] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Bedell, Bruce; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Fan, Ruzong; Mills, James L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Caggana, Michele] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12237 USA	Statens Serum Institut; University of Iowa; Karolinska Institutet; Karolinska Institutet; University of Iowa; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); State University of New York (SUNY) System; Wadsworth Center	Feenstra, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	fee@ssi.dk		Geller, Frank/0000-0002-9238-3269; Nordenskjold, Agneta/0000-0001-6638-4631; Feenstra, Bjarke/0000-0003-1478-649X; melbye, mads/0000-0001-8264-6785; Mills, James/0000-0003-4496-332X	Lundbeck Foundation [R34-A3931]; Novo Nordisk Foundation; Danish Medical Research Council [271-06-0628]; Swedish Research Council; Centers for Disease Control and Prevention [5U01DD000492]; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health Genes, Environment, and Health Initiative [U01HG004423]; Oak Foundation Fellowship; MRC [G1001799] Funding Source: UKRI; Medical Research Council [G1001799] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008792] Funding Source: NIH RePORTER; National Center on Birth Defects and Developmental Disabilities [U01DD000492] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Genes, Environment, and Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Foundation Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by grants from the Lundbeck Foundation (R34-A3931), the Novo Nordisk Foundation, the Danish Medical Research Council (271-06-0628), the Swedish Research Council, the Centers for Disease Control and Prevention (5U01DD000492), and the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The GWAS data for the control samples were generated for our study of preterm birth within the GENEVA consortium with funding provided through the National Institutes of Health Genes, Environment, and Health Initiative (U01HG004423). Dr Feenstra is supported by an Oak Foundation Fellowship.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; CARLSON LA, 1977, EUR J CLIN INVEST, V7, P133, DOI 10.1111/j.1365-2362.1977.tb01585.x; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; de Laffolie J, 2012, PEDIATRICS, V129, pE901, DOI 10.1542/peds.2011-2845; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fan QW, 2002, J NEUROCHEM, V80, P178, DOI 10.1046/j.0022-3042.2001.00686.x; Feenstra B, 2012, NAT GENET, V44, P334, DOI 10.1038/ng.1067; Funfschilling U, 2012, J NEUROSCI, V32, P7632, DOI 10.1523/JNEUROSCI.1352-11.2012; Hennekam RCM, 2001, AM J MED GENET, V99, P256, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1148>3.0.CO;2-Q; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Honein MA, 1999, LANCET, V354, P2101, DOI 10.1016/S0140-6736(99)10073-4; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kelley RI, 2000, J MED GENET, V37, P321, DOI 10.1136/jmg.37.5.321; Krogh C, 2012, PEDIATRICS, V130, pE943, DOI 10.1542/peds.2011-2785; Krogh C, 2010, JAMA-J AM MED ASSOC, V303, P2393, DOI 10.1001/jama.2010.784; Lagerstedt-Robinson K, 2009, J HUM GENET, V54, P706, DOI 10.1038/jhg.2009.101; LANGER JC, 1995, J PEDIATR SURG, V30, P1535, DOI 10.1016/0022-3468(95)90151-5; Magi R, 2010, GENET EPIDEMIOL, V34, P846, DOI 10.1002/gepi.20540; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MITCHELL LE, 1993, AM J DIS CHILD, V147, P1203, DOI 10.1001/archpedi.1993.02160350077012; NAT'L HUMAN GENOME RES. INST, CAT PUBL GEN WID ASS; Nielsen JP, 2000, DAN MED BULL, V47, P223; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Owen CG, 2002, PEDIATRICS, V110, P597, DOI 10.1542/peds.110.3.597; Pedersen RN, 2008, J MATERN-FETAL NEO M, V21, P599, DOI 10.1080/14767050802214824; Peeters B, 2012, NAT REV GASTRO HEPAT, V9, P646, DOI 10.1038/nrgastro.2012.133; Persson S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e70; Piotrowska AP, 2003, ARCH PATHOL LAB MED, V127, P1182; Pisacane A, 1996, BRIT MED J, V312, P745, DOI 10.1136/bmj.312.7033.745; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranells Judith D, 2011, Adv Pediatr, V58, P195, DOI 10.1016/j.yapd.2011.03.005; Ryan AK, 1998, J MED GENET, V35, P558, DOI 10.1136/jmg.35.7.558; Saur D, 2004, P NATL ACAD SCI USA, V101, P1662, DOI 10.1073/pnas.0305473101; Schechter R, 1997, PAEDIATR PERINAT EP, V11, P407, DOI 10.1046/j.1365-3016.1997.d01-32.x; Sommerfield T, 2008, ARCH DIS CHILD, V93, P1007, DOI 10.1136/adc.2007.128090; Svenningsson A, 2008, J PEDIATR SURG, V43, P443, DOI 10.1016/j.jpedsurg.2007.10.006; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P279, DOI 10.1053/gast.1996.v111.pm8690192; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yngve A, 2001, PUBLIC HEALTH NUTR, V4, P1306, DOI 10.1079/PHN2001147	42	22	22	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					714	721		10.1001/jama.2013.242978	http://dx.doi.org/10.1001/jama.2013.242978			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989729	Green Accepted, Bronze			2022-12-28	WOS:000323254500021
J	Ng, KH; Oczkowski, W				Kuan Huei Ng; Oczkowski, Wieslaw			Review: Treatment options for asymptomatic carotid artery stenosis were compared	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ENDARTERECTOMY		[Kuan Huei Ng; Oczkowski, Wieslaw] McMaster Univ, Hamilton, ON, Canada	McMaster University	Ng, KH (corresponding author), McMaster Univ, Hamilton, ON, Canada.			MOORTHY, DENISH/0000-0003-2818-6102				Chaturvedi S, 2012, STROKE, V43, P929, DOI 10.1161/STROKEAHA.111.641514; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rudarakanchana N, 2009, EUR J VASC ENDOVASC, V38, P239, DOI 10.1016/j.ejvs.2009.05.010; Woo K, 2010, STROKE, V41, P975, DOI 10.1161/STROKEAHA.110.578856	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC6	10.7326/0003-4819-159-4-201308200-02006	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026282				2022-12-28	WOS:000323421700005
J	Steg, PG; Bhatt, DL; Hamm, CW; Stone, GW; Gibson, CM; Mahaffey, KW; Leonardi, S; Liu, TP; Skerjanec, S; Day, JR; Iwaoka, RS; Stuckey, TD; Gogia, HS; Gruberg, L; French, WJ; White, HD; Harrington, RA				Steg, Philippe Gabriel; Bhatt, Deepak L.; Hamm, Christian W.; Stone, Gregg W.; Gibson, C. Michael; Mahaffey, Kenneth W.; Leonardi, Sergio; Liu, Tiepu; Skerjanec, Simona; Day, Jonathan R.; Iwaoka, Robert S.; Stuckey, Thomas D.; Gogia, Harinder S.; Gruberg, Luis; French, William J.; White, Harvey D.; Harrington, Robert A.		Champion Investigators	Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data	LANCET			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ORAL ANTIPLATELET THERAPY; ASSOCIATION TASK-FORCE; PLATELET INHIBITION; CARDIOVASCULAR EVENTS; UNIVERSAL DEFINITION; ISCHEMIC EVENTS; CLOPIDOGREL; PRASUGREL; TICAGRELOR	Background Cangrelor is a potent, rapid-acting, reversible intravenous platelet inhibitor that was tested for percutaneous coronary intervention (PCI) in three large, double-blind, randomised trials. We did a pooled analysis of data from three trials that assessed the effectiveness of cangrelor against either clopidogrel or placebo in PCI. Methods This prespecified, pooled analysis of patient-level data from three trials (CHAMPION-PCI, CHAMPION-PLATFORM, and CHAMPION-PHOENIX) compared cangrelor with control (clopidogrel or placebo) for prevention of thrombotic complications during and after PCI. Trial participants were patients undergoing PCI for ST-elevation myocardial infarction (11.6%), non-ST-elevation acute coronary syndromes (57.4%), and stable coronary artery disease (31.0%). Efficacy was assessed in the modified intention-to-treat population of 24 910 patients, with a prespecified primary efficacy composite of death, myocardial infarction, ischaemia-driven revascularisation, or stent thrombosis at 48 h. The primary safety outcome was non-coronary artery bypass graft-related GUSTO (Global Use of Strategies to Open Occluded Coronary Arteries) severe or life-threatening bleeding at 48 h. Findings Cangrelor reduced the odds of the primary outcome by 19% (3.8% for cangrelor vs 4.7% for control; odds ratio [OR] 0.81, 95% CI 0.71-0.91, p=0.0007), and stent thrombosis by 41% (0.5% vs 0.8%, OR 0.59, 95% CI 0.43-0.80, p=0.0008). Cangrelor reduced the odds of the secondary triple composite (all-cause death, myocardial infarction, or ischaemia-driven revascularisation at 48 h) by 19% (3.6% vs 4.4%, OR 0.81, 95% CI 0.71-0.92, p=0.0014). Efficacy outcomes were consistent across the trials and main patient subsets. These benefits were maintained at 30 days. There was no difference in the primary safety outcome (0.2% in both groups), in GUSTO moderate bleeding (0.6% vs 0.4%), or in transfusion (0.7% vs 0.6%), but cangrelor increased GUSTO mild bleeding (16.8% vs 13.0%, p<0.0001). Interpretation Compared with control (clopidogrel or placebo), cangrelor reduced PCI periprocedural thrombotic complications, at the expense of increased bleeding.	[Steg, Philippe Gabriel] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Steg, Philippe Gabriel] Dept Hosp Univ FIRE, Hop Bichat, AP HP, INSERM U 698, Paris, France; [Bhatt, Deepak L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA USA; [Hamm, Christian W.] Kerckhoff Heart Ctr, Bad Nauheim, Germany; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Gibson, C. Michael] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Mahaffey, Kenneth W.] Duke Clin Res Inst, Durham, NC USA; [Leonardi, Sergio] Fdn IRCCS Policlinico San Matteo, Pavia, Italy; [Liu, Tiepu; Skerjanec, Simona; Day, Jonathan R.] Med Co, Parsippany, NJ USA; [Iwaoka, Robert S.] Presbyterian Hosp Cardiac Catheterizat Lab, Charlotte, NC USA; [Stuckey, Thomas D.] Moses Cone Heart & Vasc Ctr, Greensboro, NC USA; [Gogia, Harinder S.] Anaheim Mem Hosp, Anaheim, CA USA; [Gruberg, Luis] Stony Brook Univ Hosp, Hlth Sci Ctr, Stony Brook, NY USA; [French, William J.] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [White, Harvey D.] Green Lane Cardiovasc Serv, Auckland, New Zealand; [Harrington, Robert A.] Stanford Univ Med Sch, Stanford, CA USA	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Kerckhoff Clinic; Columbia University; Cardiovascular Research Foundation (CRF); Harvard University; Beth Israel Deaconess Medical Center; Duke University; IRCCS Fondazione San Matteo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Steg, PG (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.		STEG, Philippe Gabriel/Z-1567-2019; Leonardi, Sergio/AAK-1490-2020; Leonardi, Sergio/K-4334-2018; Gruberg, Luis/ABF-8926-2021; Hamm, Christian W./I-3155-2017; Gibson, C. Michael/AAE-8212-2019	Leonardi, Sergio/0000-0002-4800-6132; Leonardi, Sergio/0000-0002-4800-6132; Hamm, Christian W./0000-0001-6763-4161; STEG, Philippe Gabriel/0000-0001-6896-2941; Day, Jonathan/0000-0002-0955-3176	Medicines Company	Medicines Company	The Medicines Company.	Agrawal K, 2013, NAT REV CARDIOL, V10, P121, DOI 10.1038/nrcardio.2012.199; Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Antman EM, 2005, AM HEART J, V149, P217, DOI 10.1016/j.ahj.2004.08.038; Bellemain-Appaix A, 2012, JAMA-J AM MED ASSOC, V308, P2507, DOI 10.1001/jama.2012.50788; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Biscaglia S, 2013, J THROMB HAEMOST, V11, P192, DOI 10.1111/jth.12049; Bonello L, 2011, J AM COLL CARDIOL, V58, P467, DOI 10.1016/j.jacc.2011.04.017; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Desai NR, 2010, JACC-CARDIOVASC INTE, V3, P571, DOI 10.1016/j.jcin.2010.04.008; Frelinger AL, 2013, J AM COLL CARDIOL, V61, P872, DOI 10.1016/j.jacc.2012.11.040; Gurbel PA, 2009, CIRCULATION, V120, P2577, DOI 10.1161/CIRCULATIONAHA.109.912550; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Harrington RA, 2009, NEW ENGL J MED, V361, P2318, DOI 10.1056/NEJMoa0908628; Heestermans AACM, 2008, THROMB RES, V122, P776, DOI 10.1016/j.thromres.2008.01.021; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Leonardi S, 2012, AM HEART J, V163, P768, DOI 10.1016/j.ahj.2012.02.018; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Steg PG, 2013, CIRCULATION, V128, P1055, DOI 10.1161/CIRCULATIONAHA.113.002589; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2004, AM HEART J, V148, P764, DOI 10.1016/j.ahj.2004.04.036; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Valgimigli M, 2012, JACC-CARDIOVASC INTE, V5, P268, DOI 10.1016/j.jcin.2012.01.006; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; White HD, 2012, AM HEART J, V163, P182, DOI 10.1016/j.ahj.2011.11.001; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	32	213	218	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 14	2013	382	9909					1981	1992		10.1016/S0140-6736(13)61615-3	http://dx.doi.org/10.1016/S0140-6736(13)61615-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	269EI	24011551				2022-12-28	WOS:000328223700025
J	Bullen, C; Howe, C; Laugesen, M; McRobbie, H; Parag, V; Williman, J; Walker, N				Bullen, Christopher; Howe, Colin; Laugesen, Murray; McRobbie, Hayden; Parag, Varsha; Williman, Jonathan; Walker, Natalie			Electronic cigarettes for smoking cessation: a randomised controlled trial	LANCET			English	Article							NICOTINE DELIVERY; PREFERENCES; PROTOCOL	Background Electronic cigarettes (e-cigarettes) can deliver nicotine and mitigate tobacco withdrawal and are used by many smokers to assist quit attempts. We investigated whether e-cigarettes are more effective than nicotine patches at helping smokers to quit. Methods We did this pragmatic randomised-controlled superiority trial in Auckland, New Zealand, between Sept 6, 2011, and July 5, 2013. Adult (>= 18 years) smokers wanting to quit were randomised (with computerised block randomisation, block size nine, stratified by ethnicity [Maori; Pacific; or non-Maori, non-Pacific], sex [men or women], and level of nicotine dependence [>5 or <= 5 Fagerstrom test for nicotine dependence]) in a 4:4:1 ratio to 16 mg nicotine e-cigarettes, nicotine patches (21 mg patch, one daily), or placebo e-cigarettes (no nicotine), from 1 week before until 12 weeks after quit day, with low intensity behavioural support via voluntary telephone counselling. The primary outcome was biochemically verified continuous abstinence at 6 months (exhaled breath carbon monoxide measurement <10 ppm). Primary analysis was by intention to treat. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12610000866000. Findings 657 people were randomised (289 to nicotine e-cigarettes, 295 to patches, and 73 to placebo e-cigarettes) and were included in the intention-to-treat analysis. At 6 months, verified abstinence was 7.3% (21 of 289) with nicotine e-cigarettes, 5.8% (17 of 295) with patches, and 4.1% (three of 73) with placebo e-cigarettes (risk difference for nicotine e-cigarette vs patches 1.51 [95% CI -2.49 to 5.51]; for nicotine e-cigarettes vs placebo e-cigarettes 3.16 [95% CI -2.29 to 8.61]). Achievement of abstinence was substantially lower than we anticipated for the power calculation, thus we had insufficient statistical power to conclude superiority of nicotine e-cigarettes to patches or to placebo e-cigarettes. We identified no significant differences in adverse events, with 137 events in the nicotine e-cigarettes group, 119 events in the patches group, and 36 events in the placebo e-cigarettes group. We noted no evidence of an association between adverse events and study product. Interpretation E-cigarettes, with or without nicotine, were modestly effective at helping smokers to quit, with similar achievement of abstinence as with nicotine patches, and few adverse events. Uncertainty exists about the place of e-cigarettes in tobacco control, and more research is urgently needed to clearly establish their overall benefits and harms at both individual and population levels.	[Bullen, Christopher; Howe, Colin; Parag, Varsha; Walker, Natalie] Univ Auckland, Sch Populat Hlth, Natl Inst Hlth Innovat, Auckland 1142, New Zealand; [Laugesen, Murray] Hlth New Zealand, Christchurch, New Zealand; [McRobbie, Hayden] Queen Mary Univ London, UK Ctr Tobacco Control Studies, Wolfson Inst Prevent Med, London, England; [Williman, Jonathan] Univ Otago, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand	University of Auckland; University of London; Queen Mary University London; University of Otago	Bullen, C (corresponding author), Univ Auckland, Sch Populat Hlth, Natl Inst Hlth Innovat, Private Bag 92019, Auckland 1142, New Zealand.	c.bullen@nihi.auckland.ac.nz	Bullen, Chris/E-4594-2017; McRobbie, Hayden/B-4552-2018; Williman, Jonathan/E-8206-2016	Bullen, Chris/0000-0001-6807-2930; McRobbie, Hayden/0000-0002-7777-1845; Williman, Jonathan/0000-0001-5080-4435	Health Research Council of New Zealand; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1B, MR/K023195/1] Funding Source: researchfish	Health Research Council of New Zealand(Health Research Council of New Zealand); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Health Research Council of New Zealand.	Bullen C, 2010, TOB CONTROL, V19, P98, DOI 10.1136/tc.2009.031567; Bullen C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-210; Burstyn I., TECHNICAL REPORT; Caponnetto P, 2011, EUR RESPIR J, V38, P1005, DOI 10.1183/09031936.00109610; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Cobb NK, 2013, LANCET RESP MED, V1, P431, DOI 10.1016/S2213-2600(13)70160-7; Cormack D., 2010, CLASSIFICATION OUTPU; Dawkins L, 2013, ADDICTION, V108, P1115, DOI 10.1111/add.12150; DiFranza JR, 2009, PSYCHOL ADDICT BEHAV, V23, P656, DOI 10.1037/a0017439; Etter JF, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-231; Fagerstrom K O, 1997, Tob Control, V6, P311; Fiore MC, 2008, TREATING TOBACCO USE; Glover ED, 2005, AM J HEALTH BEHAV, V29, P443, DOI 10.5993/AJHB.29.5.7; Goniewicz M, 2013, TOB CONTROL, V6, P6; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Hajek P, 2013, LANCET RESP MED, V1, P429, DOI 10.1016/S2213-2600(13)70124-3; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Mariner DC, 2011, REGUL TOXICOL PHARM, V61, pS39, DOI 10.1016/j.yrtph.2010.05.006; Ministry of Health, 2007, NZ SMOK CESS GUID; Polosa R, 2014, INTERN EMERG MED, V9, P537, DOI 10.1007/s11739-013-0977-z; Price E, 2003, NZ EFFECTIVE ACCESS; Purkayastha D., 2013, BAT RAMPS UP E CIGAR; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shiffman S, 2002, ADDICTION, V97, P97, DOI 10.1046/j.1360-0443.2002.0050b.x; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Ursprung WWSA, 2011, J ADOLESCENT HEALTH, V48, P338, DOI 10.1016/j.jadohealth.2010.07.011; US Food and Drug Administration, SUMM RES LAB AN EL C; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; Walker N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-880; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R., 2012, SMOKING TOOLKIT STUD	31	821	837	14	497	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1629	1637		10.1016/S0140-6736(13)61842-5	http://dx.doi.org/10.1016/S0140-6736(13)61842-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	254CN	24029165				2022-12-28	WOS:000327140700021
J	Wise, RA; Anzueto, A; Cotton, D; Dahl, R; Devins, T; Disse, B; Dusser, D; Joseph, E; Kattenbeck, S; Koenen-Bergmann, M; Pledger, G; Calverley, P				Wise, Robert A.; Anzueto, Antonio; Cotton, Daniel; Dahl, Ronald; Devins, Theresa; Disse, Bernd; Dusser, Daniel; Joseph, Elizabeth; Kattenbeck, Sabine; Koenen-Bergmann, Michael; Pledger, Gordon; Calverley, Peter		TIOSPIR Investigators	Tiotropium Respimat Inhaler and the Risk of Death in COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SAFETY; METAANALYSIS; SALMETEROL; EFFICACY; TRIAL	BackgroundTiotropium delivered at a dose of 5 g with the Respimat inhaler showed efficacy similar to that of 18 g of tiotropium delivered with the HandiHaler inhalation device in placebo-controlled trials involving patients with chronic obstructive pulmonary disease (COPD). Although tiotropium HandiHaler was associated with reduced mortality, as compared with placebo, more deaths were reported with tiotropium Respimat than with placebo. MethodsIn this randomized, double-blind, parallel-group trial involving 17,135 patients with COPD, we evaluated the safety and efficacy of tiotropium Respimat at a once-daily dose of 2.5 g or 5 g, as compared with tiotropium HandiHaler at a once-daily dose of 18 g. Primary end points were the risk of death (noninferiority study, Respimat at a dose of 5 g or 2.5 g vs. HandiHaler) and the risk of the first COPD exacerbation (superiority study, Respimat at a dose of 5 g vs. HandiHaler). We also assessed cardiovascular safety, including safety in patients with stable cardiac disease. ResultsDuring a mean follow-up of 2.3 years, Respimat was noninferior to HandiHaler with respect to the risk of death (Respimat at a dose of 5 g vs. HandiHaler: hazard ratio, 0.96; 95% confidence interval [CI], 0.84 to 1.09; Respimat at a dose of 2.5 g vs. HandiHaler: hazard ratio, 1.00; 95% CI, 0.87 to 1.14) and not superior to HandiHaler with respect to the risk of the first exacerbation (Respimat at a dose of 5 g vs. HandiHaler: hazard ratio, 0.98; 95% CI, 0.93 to 1.03). Causes of death and incidences of major cardiovascular adverse events were similar in the three groups. ConclusionsTiotropium Respimat at a dose of 5 g or 2.5 g had a safety profile and exacerbation efficacy similar to those of tiotropium HandiHaler at a dose of 18 g in patients with COPD. (Funded by Boehringer Ingelheim; TIOSPIR ClinicalTrials.gov number, NCT01126437.)	[Wise, Robert A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA; [Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Anzueto, Antonio] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Cotton, Daniel; Devins, Theresa; Joseph, Elizabeth] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Dahl, Ronald] Odense Univ Hosp, DK-5000 Odense, Denmark; [Disse, Bernd; Kattenbeck, Sabine; Koenen-Bergmann, Michael] Boehringer Ingelheim KG, Ingelheim, Germany; [Dusser, Daniel] Univ Paris 05, Hop Cochin, AP HP, Serv Pneumol,Sorbonne Paris Cite, Paris, France; [Calverley, Peter] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England	Johns Hopkins University; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Boehringer Ingelheim; University of Southern Denmark; Odense University Hospital; Boehringer Ingelheim; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Liverpool	Wise, RA (corresponding author), Johns Hopkins Univ, Sch Med, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	rwise@jhmi.edu	Korzh, Oleksii/E-4291-2016; Vrbica, Zarko/Q-2705-2015; Zadionchenko, Vladimir/A-7445-2016; Cilli, Aykut/C-7681-2016; POLATLI, MEHMET/A-3516-2017; Barbara, C./AAF-3397-2020; Saryal, Sevgi/AAP-7879-2020; Emelyanov, Alexander/P-6774-2014; Wiemer, Stefan/E-5033-2015	Korzh, Oleksii/0000-0001-6838-4360; Zadionchenko, Vladimir/0000-0003-2377-5266; POLATLI, MEHMET/0000-0001-7917-4297; Barbara, C./0000-0003-0915-4105; Saryal, Sevgi/0000-0001-5062-5226; Emelyanov, Alexander/0000-0002-8574-6869; Brutsche, Martin/0000-0002-1612-3609; Van de Werf, Frans/0000-0001-9479-7767; Gaga, Mina/0000-0002-9949-6012; Epton, Michael/0000-0003-4644-366X; Krull, Matthias/0000-0001-7034-2119; mcelvaney, Noel/0000-0002-0152-4370; Field, Stephen/0000-0002-6682-4155; Wise, Robert/0000-0002-8353-2349; Pogue, Brian/0000-0002-9887-670X; Sushko, Viktor/0000-0001-6893-8642; Castillo Vizuete, Jose Antonio/0000-0002-5712-7534	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Funded by Boehringer Ingelheim; TIOSPIR ClinicalTrials.gov number, NCT01126437.	Albert RK, 2013, AM J RESP CRIT CARE, V187, P1173, DOI 10.1164/rccm.201212-2187OE; Barr RG, 2007, THORAX, V62, P191, DOI 10.1136/thx.2006.063271corr1; Bateman ED, 2010, RESP MED, V104, P1460, DOI 10.1016/j.rmed.2010.06.004; Boehringer Ingelheim, 2012, SUMM PROD CHAR SPC S; Boehringer Ingelheim, 2010, TIOTR SPIR RESP EV F; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli B, 2010, CHEST, V137, P20, DOI 10.1378/chest.09-0011; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; Cooper CB, 2013, CHEST, V144, P490, DOI 10.1378/chest.12-2613; Dong YH, 2013, THORAX, V68, P48, DOI 10.1136/thoraxjnl-2012-201926; Ichinose M, 2010, RESP MED, V104, P228, DOI 10.1016/j.rmed.2009.11.011; Idem, 2013, SUMM PROD CHAR SPC S; Karner C, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009285.pub2, 10.1002/14651858.CD009285.pub3]; Kesten S, 2009, JAMA-J AM MED ASSOC, V301, P1224, DOI 10.1001/jama.2008.949; Loke YK, 2012, THER ADV DRUG SAF, V3, P123, DOI 10.1177/2042098612438388; Michele TM, 2010, NEW ENGL J MED, V363, P1097, DOI 10.1056/NEJMp1008502; Rodrigo GJ, 2009, RESP MED, V103, P1421, DOI 10.1016/j.rmed.2009.05.020; Salpeter SR, 2009, DRUGS, V69, P2025, DOI 10.2165/11318580-000000000-00000; Singh S, 2013, THORAX, V68, P114, DOI 10.1136/thoraxjnl-2011-201275; Singh S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3215; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; van Noord JA, 2009, RESP MED, V103, P22, DOI 10.1016/j.rmed.2008.10.002; Verhamme KM, 2013, EUR RESP J; Vestbo J, 2011, CLIN RESPIR J, V5, P44, DOI 10.1111/j.1752-699X.2010.00198.x; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378; Wise RA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-40	26	253	266	2	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1491	1501		10.1056/NEJMoa1303342	http://dx.doi.org/10.1056/NEJMoa1303342			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	23992515				2022-12-28	WOS:000328101700006
J	Dupuy, TJ; Kraus, AL				Dupuy, Trent J.; Kraus, Adam L.			Distances, Luminosities, and Temperatures of the Coldest Known Substellar Objects	SCIENCE			English	Article							COOLEST BROWN DWARFS; EXTRASOLAR GIANT PLANETS; L/T TRANSITION; MASS FUNCTION; T-DWARFS; Y DWARFS; SPECTRA; DISCOVERY; BINARIES; MODELS	The coolest known brown dwarfs are our best analogs to extrasolar gas-giant planets. The prolific detections of such cold substellar objects in the past 2 years have spurred intensive follow-up, but the lack of accurate distances is a key gap in our understanding. We present a large sample of precise distances based on homogeneous mid-infrared astrometry that robustly establishes absolute fluxes, luminosities, and temperatures. The coolest brown dwarfs have temperatures of 400 to 450 kelvin and masses almost equal to 5 to 20 times that of Jupiter, showing they bridge the gap between hotter brown dwarfs and gas-giant planets. At these extremes, spectral energy distributions no longer follow a simple correspondence with temperature, suggesting an increasing role of other physical parameters, such as surface gravity, vertical mixing, clouds, and metallicity.	[Dupuy, Trent J.; Kraus, Adam L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Kraus, Adam L.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Texas System; University of Texas Austin	Dupuy, TJ (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	tdupuy@cfa.harvard.edu			NASA [NAS 5-26555]; Hubble Fellowship [HST-HF-51271.01-A]; Space Telescope Science Institute; Clay Fellowship	NASA(National Aeronautics & Space Administration (NASA)); Hubble Fellowship; Space Telescope Science Institute(Space Telescope Science Institute); Clay Fellowship	We thank M. C. Liu for many helpful suggestions for improving this article; C. V. Morley for fruitful discussions regarding her and collaborators' model atmospheres, particularly the Vega zero points; K. N. Allers for assistance in computing photometry from our IRAC data; and M. C. Cushing for making available published spectra of our targets. This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. T.J.D. acknowledges support from Hubble Fellowship grant HST-HF-51271.01-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy for NASA, under contract NAS 5-26555. A.L.K. is supported by a Clay Fellowship. Our imaging data are available in the Spitzer Heritage Archive at http://sha.ipac.caltech.edu/applications/Spitzer/SHA, and the astrometric measurements we derived are given in table S1.	Allen PR, 2005, ASTROPHYS J, V625, P385, DOI 10.1086/429548; Anderson DR, 2011, ASTROPHYS J LETT, V726, DOI 10.1088/2041-8205/726/2/L19; Baraffe I, 2003, ASTRON ASTROPHYS, V402, P701, DOI 10.1051/0004-6361:20030252; Burgasser AJ, 2006, ASTROPHYS J SUPPL S, V166, P585, DOI 10.1086/506327; Burgasser AJ, 2010, ASTROPHYS J, V725, P1405, DOI 10.1088/0004-637X/725/2/1405; Burgasser AJ, 2004, ASTROPHYS J SUPPL S, V155, P191, DOI 10.1086/424386; Burrows A, 2003, ASTROPHYS J, V596, P587, DOI 10.1086/377709; Chabrier G, 2000, ASTROPHYS J, V542, pL119, DOI 10.1086/312941; Chabrier G, 2000, ANNU REV ASTRON ASTR, V38, P337, DOI 10.1146/annurev.astro.38.1.337; Cushing MC, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/50; Deleuil M, 2008, ASTRON ASTROPHYS, V491, P889, DOI 10.1051/0004-6361:200810625; Dupuy TJ, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/19; Hellier C, 2009, NATURE, V460, P1098, DOI 10.1038/nature08245; Kirkpatrick JD, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/156; Kirkpatrick JD, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/19; Leggett SK, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/130; Liu MC, 2006, ASTROPHYS J, V647, P1393, DOI 10.1086/505561; Liu MC, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/57; Liu MC, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/108; Luhman KL, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/135; Luhman KL, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/1/L9; Molliere P, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219844; Morley CV, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/172; Saumon D, 1996, ASTROPHYS J, V460, P993, DOI 10.1086/177027; Saumon D, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/74	25	117	117	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 27	2013	341	6153					1492	1495		10.1126/science.1241917	http://dx.doi.org/10.1126/science.1241917			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	224NS	24009359	Green Submitted			2022-12-28	WOS:000324894600044
J	Tan, QX; Zhu, Y; Li, J; Chen, ZX; Han, GW; Kufareva, I; Li, TT; Ma, LM; Fenalti, G; Li, J; Zhang, WR; Xie, X; Yang, HY; Jiang, HL; Cherezov, V; Liu, H; Stevens, RC; Zhao, Q; Wu, BL				Tan, Qiuxiang; Zhu, Ya; Li, Jian; Chen, Zhuxi; Han, Gye Won; Kufareva, Irina; Li, Tingting; Ma, Limin; Fenalti, Gustavo; Li, Jing; Zhang, Wenru; Xie, Xin; Yang, Huaiyu; Jiang, Hualiang; Cherezov, Vadim; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili			Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex	SCIENCE			English	Article							CRYSTAL-STRUCTURE; SMALL-MOLECULE; CORECEPTOR; BINDING; DISCOVERY; TERMINUS; ANTIBODY	The CCR5 chemokine receptor acts as a co-receptor for HIV-1 viral entry. Here we report the 2.7 angstrom-resolution crystal structure of human CCR5 bound to the marketed HIV drug maraviroc. The structure reveals a ligand-binding site that is distinct from the proposed major recognition sites for chemokines and the viral glycoprotein gp120, providing insights into the mechanism of allosteric inhibition of chemokine signaling and viral entry. A comparison between CCR5 and CXCR4 crystal structures, along with models of co-receptor-gp120-V3 complexes, suggests that different charge distributions and steric hindrances caused by residue substitutions may be major determinants of HIV-1 co-receptor selectivity. These high-resolution insights into CCR5 can enable structure-based drug discovery for the treatment of HIV-1 infection.	[Tan, Qiuxiang; Zhu, Ya; Li, Jian; Li, Tingting; Ma, Limin; Li, Jing; Zhang, Wenru; Xie, Xin; Liu, Hong; Stevens, Raymond C.; Zhao, Qiang; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Chen, Zhuxi; Yang, Huaiyu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Han, Gye Won; Fenalti, Gustavo; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Kufareva, Irina] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Scripps Research Institute; University of California System; University of California San Diego; ShanghaiTech University	Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	beiliwu@simm.ac.cn	Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8673-2022; Han, Gye Won/GLQ-8724-2022	Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Kufareva, Irina/0000-0001-9083-7039	National Basic Research Program of China [2012CB518000, 2012CB910400]; NIH [R01 AI100604, U54 GM094618]; National Science Foundation of China [31270766, 81161120425, 81025017]; Shanghai Science and Technology Committee [11JC1414800, 12PJ1410500];  [U01 GM094612];  [R01 GM071872]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, U01GM094612, R01GM071872] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Wilson, V. Katritch, and T. Handel for careful review and scientific feedback on the manuscript; A. Walker for assistance with manuscript preparation; C. Wang and D. Wacker for help on collection of x-ray diffraction data; and E. Kellenberger for providing the CCR5 model. Atomic coordinates and structure facors have been deposited in the Protein Data Bank with identification code 4MBS. This work was supported by "National Basic Research Program of China" grants 2012CB518000 and 2012CB910400; NIH grant R01 AI100604; National Science Foundation of China grants 31270766, 81161120425, and 81025017; and Shanghai Science and Technology Committee grants 11JC1414800 and 12PJ1410500. Additionally, V.C. and R.C.S. acknowledge support from NIH grant U54 GM094618 (Target GPCR-28); I.K. acknowledges support from U01 GM094612, U54 GM094618, and R01 GM071872. The data presented in this paper are tabulated in the main paper and in the supplementary materials.	Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Biscone MJ, 2006, VIROLOGY, V351, P226, DOI 10.1016/j.virol.2006.03.017; Blanpain C, 1999, BLOOD, V94, P1899; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Coakley E, 2005, CURR OPIN INFECT DIS, V18, P9, DOI 10.1097/00001432-200502000-00003; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; FDA notifications, 2007, AIDS ALERT, V22, P103; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Imamura S, 2006, J MED CHEM, V49, P2784, DOI 10.1021/jm051034q; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Muniz-Medina VM, 2009, MOL PHARMACOL, V75, P490, DOI 10.1124/mol.108.052555; Palani A, 2006, J MED CHEM, V49, P2851, DOI 10.1021/jm060009x; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Speck RF, 1997, J VIROL, V71, P7136, DOI 10.1128/JVI.71.9.7136-7139.1997; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xiang SH, 2013, VIROLOGY, V438, P5, DOI 10.1016/j.virol.2013.01.002	27	499	522	7	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 20	2013	341	6152					1387	1390		10.1126/science.1241475	http://dx.doi.org/10.1126/science.1241475			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	220PK	24030490	Green Accepted			2022-12-28	WOS:000324597200045
J	Cole, TB				Cole, Thomas B.			Landscape With Two Poplars	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1100	1101		10.1001/jama.2013.5314	http://dx.doi.org/10.1001/jama.2013.5314			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	24045725				2022-12-28	WOS:000324500300001
J	Hollingsworth, JM; Rogers, MAM; Krein, SL; Hickner, A; Kuhn, L; Cheng, A; Chang, R; Saint, S				Hollingsworth, John M.; Rogers, Mary A. M.; Krein, Sarah L.; Hickner, Andrew; Kuhn, Latoya; Cheng, Alex; Chang, Robert; Saint, Sanjay			Determining the Noninfectious Complications of Indwelling Urethral Catheters	ANNALS OF INTERNAL MEDICINE			English	Review							SPINAL-CORD-INJURY; CARE-ASSOCIATED INFECTIONS; URINARY-TRACT-INFECTIONS; BLADDER MANAGEMENT; INTERMITTENT CATHETERIZATION; CARDIOVASCULAR-SURGERY; TERM CATHETERIZATION; RANDOMIZED-TRIALS; FOLEY CATHETERS; GRAFT-SURGERY	Background: Although the epidemiology of catheter-associated urinary tract infection is well-described, little is known about noninfectious complications resulting from urethral catheter use. Purpose: To determine the frequency of noninfectious complications after catheterization. Data Sources: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, CINAHL, Conference Papers Index, BIOSIS Previews, Scopus, and ClinicalTrials. gov were searched for human studies without any language limits and through 30 July 2012. Study Selection: Clinical trials and observational studies assessing noninfectious complications of indwelling urethral catheters in adults. Data Extraction: Relevant studies were sorted into 3 categories: short-term catheterization in patients without spinal cord injury (SCI), long-term catheterization in patients without SCI, and catheterization in patients with SCI. The proportion of patients who had bladder cancer, bladder stones, blockage, false passage, gross hematuria, accidental removal, urine leakage, or urethral stricture was then pooled using random-effects models. Data Synthesis: Thirty-seven studies (2868 patients) were pooled. Minor complications were common. For example, the pooled frequency of urine leakage ranged from 10.6% (95% CI, 2.4% to 17.7%) in short-term catheterization cohorts to 52.1% (CI, 28.6% to 69.5%) among outpatients with long-term indwelling catheters. Serious complications were also noted, including urethral strictures, which occurred in 3.4% (CI, 1.0% to 7.0%) of patients with short-term catheterization. For patients with SCI, 13.5% (CI, 3.4% to 21.9%) had gross hematuria and 1.0% (CI, 0.0% to 5.0%) developed bladder cancer. Limitations: Although heterogeneity existed across studies for several outcomes, most could be accounted for by differences between studies with respect to quality and sex composition. Evidence published after 30 July 2012 is not included. Conclusion: Many noninfectious catheter-associated complications are at least as common as clinically significant urinary tract infections.	Univ Michigan, Ctr Healthcare Outcomes & Policy, Vet Affairs Ann Arbor Med Ctr, Ann Arbor, MI 48109 USA; Univ Michigan, Patient Safety Enhancement Program, Ann Arbor, MI 48109 USA; Vet Affairs Ann Arbor Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; Univ Calif Los Angeles, Los Angeles, CA USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of California System; University of California Los Angeles	Hollingsworth, JM (corresponding author), Univ Michigan, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA.	kinks@med.umich.edu	Krein, Sarah L/E-2742-2014; Saint, Sanjay/AAF-5126-2019	Krein, Sarah L/0000-0003-2111-8131; Hickner, Andy/0000-0003-1922-3813; Rogers, Mary/0000-0001-5519-3223	Agency for Healthcare Research and Quality [1K08HS020927-01A1]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020927] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	In part by the Agency for Healthcare Research and Quality (grant 1K08HS020927-01A1; Dr. Hollingsworth).	Aaronson DS, 2011, J UROLOGY, V185, P1756, DOI 10.1016/j.juro.2010.12.041; ABDELHAKIM A, 1983, J UROLOGY, V130, P1100, DOI 10.1016/S0022-5347(17)51702-4; BENNETT CJ, 1995, J UROLOGY, V153, P1458, DOI 10.1016/S0022-5347(01)67432-9; Botsios D, 1997, DIGEST SURG, V14, P404, DOI 10.1159/000172583; BROECKER BH, 1981, J UROLOGY, V125, P196, DOI 10.1016/S0022-5347(17)54963-0; BUCHHOLZ NP, 1993, HELV CHIR ACTA, V60, P341; BURR RG, 1995, BRIT J UROL, V76, P61, DOI 10.1111/j.1464-410X.1995.tb07833.x; Cook J B, 1968, Paraplegia, V6, P11; DEVIVO MJ, 1985, ARCH INTERN MED, V145, P428, DOI 10.1001/archinte.145.3.428; Dinneen M D, 1990, Eur J Vasc Surg, V4, P535, DOI 10.1016/S0950-821X(05)80798-4; ELHILALI MM, 1986, J UROLOGY, V135, P275, DOI 10.1016/S0022-5347(17)45608-4; FERRIE BG, 1989, BRIT J UROL, V64, P162, DOI 10.1111/j.1464-410X.1989.tb05979.x; FERRIE BG, 1986, BRIT J UROL, V58, P549, DOI 10.1111/j.1464-410X.1986.tb05465.x; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Garcia M P, 1998, Enferm Intensiva, V9, P102; Gokula RRM, 2004, AM J INFECT CONTROL, V32, P196, DOI 10.1016/j.ajic.2003.08.007; Gould CV, 2010, INFECT CONT HOSP EP, V31, P319, DOI 10.1086/651091; GUPTA S, 1994, PARAPLEGIA, V32, P531, DOI 10.1038/sc.1994.85; HALL MK, 1989, UROLOGY, V34, P126, DOI 10.1016/0090-4295(89)90245-8; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HORGAN AF, 1992, BRIT J UROL, V70, P149, DOI 10.1111/j.1464-410X.1992.tb15693.x; Huang Wei-yao, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P1026; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; JAIN P, 1995, ARCH INTERN MED, V155, P1425, DOI 10.1001/archinte.155.13.1425; Kashefi C, 2008, J UROLOGY, V179, P2254, DOI 10.1016/j.juro.2008.01.108; Katsumi HK, 2010, SPINAL CORD, V48, P325, DOI 10.1038/sc.2009.134; KATZ G, 1992, UROLOGY, V39, P433, DOI 10.1016/0090-4295(92)90240-W; KENNEDY AP, 1983, J ADV NURS, V8, P207, DOI 10.1111/j.1365-2648.1983.tb00315.x; Khoubehi B, 2000, BJU INT, V85, P1033, DOI 10.1046/j.1464-410x.2000.00666.x; KLARSKOV P, 1986, ACTA OBSTET GYN SCAN, V65, P295, DOI 10.3109/00016348609157348; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008; Ku JH, 2006, SPINAL CORD, V44, P165, DOI 10.1038/sj.sc.3101825; KUNIN CM, 1989, J CLIN EPIDEMIOL, V42, P835, DOI 10.1016/0895-4356(89)90096-6; Leuck AM, 2012, J UROLOGY, V187, P1662, DOI 10.1016/j.juro.2011.12.113; LOCKE JR, 1985, J UROLOGY, V133, P1034, DOI 10.1016/S0022-5347(17)49366-9; MCGUIRE EJ, 1986, J UROLOGY, V135, P730, DOI 10.1016/S0022-5347(17)45833-2; Meddings J, 2010, CLIN INFECT DIS, V51, P550, DOI 10.1086/655133; Mudgal K C, 1992, J Indian Med Assoc, V90, P52; MUNCIE HL, 1990, J UROLOGY, V143, P507, DOI 10.1016/S0022-5347(17)40003-6; MUNCIE HL, 1989, ARCH INTERN MED, V149, P441, DOI 10.1001/archinte.149.2.441; NACEY JN, 1985, BRIT J UROL, V57, P325, DOI 10.1111/j.1464-410X.1985.tb06354.x; NDIRANGU K, 1994, E AFR MED J, V71, P132; Ozawa Hideo, 2005, Nihon Hinyokika Gakkai Zasshi, V96, P541; ROMANLOP.JJ, 1973, AM J OBSTET GYNECOL, V115, P81, DOI 10.1016/0002-9378(73)90092-6; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; RUUTU M, 1984, SCAND J UROL NEPHROL, V18, P9, DOI 10.3109/00365598409182157; Saint S, 2009, JT COMM J QUAL PATIE, V35, P449, DOI 10.1016/S1553-7250(09)35062-X; Singh R, 2011, INDIAN J ORTHOP, V45, P141, DOI 10.4103/0019-5413.77134; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thomas AZ, 2009, BJU INT, V104, P1109, DOI 10.1111/j.1464-410X.2009.08494.x; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; TIMONEY AG, 1990, PARAPLEGIA, V28, P556, DOI 10.1038/sc.1990.75; Umscheid CA, 2011, INFECT CONT HOSP EP, V32, P101, DOI 10.1086/657912; Wells G., NEWCASTLE OTTAWA SCA; Wilde MH, 2010, J WOUND OSTOMY CONT, V37, P301, DOI 10.1097/WON.0b013e3181d73ac4; WYNDAELE JJ, 1985, PARAPLEGIA, V23, P18, DOI 10.1038/sc.1985.4; Ziemann L K, 1984, Home Healthc Nurse, V2, P22, DOI 10.1097/00004045-198409000-00008; 최원준, 2006, Investigative and Clinical Urology, V47, P807	59	98	107	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6					401	+		10.7326/0003-4819-159-6-201309170-00006	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00006			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042368				2022-12-28	WOS:000325625900016
J	Margo, K				Margo, Katherine			A high- or low-dose triamcinolone injection improved pain and function in adhesive capsulitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SHOULDER		Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Margo, K (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.			Yoon, Seung-Hyun/0000-0003-1787-7282				Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Maund E, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16110; Shin SJ, 2013, J SHOULDER ELB SURG, V22, P521, DOI 10.1016/j.jse.2012.06.015	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 17	2013	159	6							JC6	10.7326/0003-4819-159-6-201309170-02006	http://dx.doi.org/10.7326/0003-4819-159-6-201309170-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	234EY	24042389				2022-12-28	WOS:000325625900005
J	Aguzzi, A; Gitler, AD				Aguzzi, Adriano; Gitler, Aaron D.			A Template for New Drugs against Alzheimer's Disease	CELL			English	Editorial Material							TAU INCLUSIONS	Alzheimer's disease (AD) is associated with the deposition of beta-amyloid (A beta) plaques in the brain. In this issue, by cleverly processing patient samples, Lu et al. define a novel structural model of A beta fibrils from AD brain, revealing surprising differences from in vitro fibrils. These findings may lead to structure-specific inhibitors and more selective amyloid-imaging methods.	[Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Gitler, Aaron D.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	University of Zurich; University Zurich Hospital; Stanford University	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch; agitler@stanford.edu		Aguzzi, Adriano/0000-0002-0344-6708	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073660, R01NS065317] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417] Funding Source: NIH RePORTER; NIH HHS [DP2OD004417] Funding Source: Medline; NINDS NIH HHS [R01NS073660, R01NS065317] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Gandy S, 2013, ANNU REV MED, V64, P367, DOI 10.1146/annurev-med-092611-084441; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131	10	14	15	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1182	1184		10.1016/j.cell.2013.08.049	http://dx.doi.org/10.1016/j.cell.2013.08.049			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034239	Bronze			2022-12-28	WOS:000324239300005
J	Finkelstein, JS; Lee, H; Burnett-Bowie, SAM; Pallais, JC; Yu, EW; Borges, LF; Jones, BF; Barry, CV; Wulczyn, KE; Thomas, BJ; Leder, BZ				Finkelstein, Joel S.; Lee, Hang; Burnett-Bowie, Sherri-Ann M.; Pallais, J. Carl; Yu, Elaine W.; Borges, Lawrence F.; Jones, Brent F.; Barry, Christopher V.; Wulczyn, Kendra E.; Thomas, Bijoy J.; Leder, Benjamin Z.			Gonadal Steroids and Body Composition, Strength, and Sexual Function in Men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANDROGEN-DEPRIVATION THERAPY; BONE-MINERAL DENSITY; HEALTHY-YOUNG MEN; MUSCLE STRENGTH; SERUM TESTOSTERONE; HYPOGONADAL MEN; PROSTATE-CANCER; OLDER MEN; FAT DISTRIBUTION; ADIPOSE-TISSUE	BackgroundCurrent approaches to diagnosing testosterone deficiency do not consider the physiological consequences of various testosterone levels or whether deficiencies of testosterone, estradiol, or both account for clinical manifestations. MethodsWe provided 198 healthy men 20 to 50 years of age with goserelin acetate (to suppress endogenous testosterone and estradiol) and randomly assigned them to receive a placebo gel or 1.25 g, 2.5 g, 5 g, or 10 g of testosterone gel daily for 16 weeks. Another 202 healthy men received goserelin acetate, placebo gel or testosterone gel, and anastrozole (to suppress the conversion of testosterone to estradiol). Changes in the percentage of body fat and in lean mass were the primary outcomes. Subcutaneous- and intraabdominal-fat areas, thigh-muscle area and strength, and sexual function were also assessed. ResultsThe percentage of body fat increased in groups receiving placebo or 1.25 g or 2.5 g of testosterone daily without anastrozole (mean testosterone level, 4413 ng per deciliter, 19178 ng per deciliter, and 337173 ng per deciliter, respectively). Lean mass and thigh-muscle area decreased in men receiving placebo and in those receiving 1.25 g of testosterone daily without anastrozole. Leg-press strength fell only with placebo administration. In general, sexual desire declined as the testosterone dose was reduced. ConclusionsThe amount of testosterone required to maintain lean mass, fat mass, strength, and sexual function varied widely in men. Androgen deficiency accounted for decreases in lean mass, muscle size, and strength; estrogen deficiency primarily accounted for increases in body fat; and both contributed to the decline in sexual function. Our findings support changes in the approach to evaluation and management of hypogonadism in men. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00114114.)	[Finkelstein, Joel S.; Burnett-Bowie, Sherri-Ann M.; Pallais, J. Carl; Yu, Elaine W.; Borges, Lawrence F.; Jones, Brent F.; Barry, Christopher V.; Wulczyn, Kendra E.; Leder, Benjamin Z.] Massachusetts Gen Hosp, Endocrine Unit, Dept Med, Boston, MA 02114 USA; [Lee, Hang] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA; [Thomas, Bijoy J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Finkelstein, JS (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Thier 1051,50 Blossom St, Boston, MA 02114 USA.	jfinkelstein@partners.org	Finkelstein, Joel/M-6463-2019	Barry, Christopher/0000-0001-6275-1844; Burnett-Bowie, Sherri-Ann/0000-0002-0064-096X	National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00114114.	Bhasin S, 2005, J CLIN ENDOCR METAB, V90, P678, DOI 10.1210/jc.2004-1184; Bhasin S, 2001, J ANDROL, V22, P718; Bhasin S, 2001, AM J PHYSIOL-ENDOC M, V281, pE1172, DOI 10.1152/ajpendo.2001.281.6.E1172; Callewaert F, 2009, FASEB J, V23, P232, DOI 10.1096/fj.08-113456; Carani C, 2005, PSYCHONEUROENDOCRINO, V30, P413, DOI 10.1016/j.psyneuen.2004.10.004; Cawthon PM, 2009, J BONE MINER RES, V24, P1728, DOI [10.1359/JBMR.090419, 10.1359/jbmr.090419]; CLEARY PD, 1995, QUAL LIFE RES, V4, P207, DOI 10.1007/BF02260860; DAVIDSON JM, 1979, J CLIN ENDOCR METAB, V48, P955, DOI 10.1210/jcem-48-6-955; Falahati-Nini A, 2000, J CLIN INVEST, V106, P1553, DOI 10.1172/JCI10942; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Grinspoon S, 1999, J CLIN ENDOCR METAB, V84, P201, DOI 10.1210/jc.84.1.201; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Jones MEE, 2001, J STEROID BIOCHEM, V79, P3, DOI 10.1016/S0960-0760(01)00136-4; Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358; Khosla S, 2008, OSTEOPOROSIS INT, V19, P1465, DOI 10.1007/s00198-008-0591-5; Khosla S, 2001, CALCIFIED TISSUE INT, V69, P189, DOI 10.1007/s00223-001-1044-8; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001; KWAN M, 1983, J CLIN ENDOCR METAB, V57, P557, DOI 10.1210/jcem-57-3-557; Leder BZ, 2003, J CLIN ENDOCR METAB, V88, P204, DOI 10.1210/jc.2002-021036; Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581; Liverman CT, 2004, TESTOSTERONE AGING C; LONGCOPE C, 1969, J CLIN INVEST, V48, P2191, DOI 10.1172/JCI106185; MACDONALD PC, 1979, J CLIN ENDOCR METAB, V49, P905, DOI 10.1210/jcem-49-6-905; Maffei L, 2007, CLIN ENDOCRINOL, V67, P218, DOI 10.1111/j.1365-2265.2007.02864.x; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; Simanainen U, 2011, MOL CELL ENDOCRINOL, V342, P81, DOI 10.1016/j.mce.2011.05.011; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Smith MR, 2001, NEW ENGL J MED, V345, P948, DOI 10.1056/NEJMoa010845; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Steidle C, 2003, J CLIN ENDOCR METAB, V88, P2673, DOI 10.1210/jc.2002-021058; Stoch SA, 2001, J CLIN ENDOCR METAB, V86, P2787, DOI 10.1210/jc.86.6.2787; STONE MH, 1981, J SPORT MED PHYS FIT, V21, P342; van den Beld AW, 2000, J CLIN ENDOCR METAB, V85, P3276, DOI 10.1210/jc.85.9.3276; Vermeulen A, 2001, J CLIN ENDOCR METAB, V86, P2380, DOI 10.1210/jc.86.6.2380; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Woodhouse LJ, 2004, J CLIN ENDOCR METAB, V89, P718, DOI 10.1210/jc.2003-031492	41	425	443	4	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					1011	1022		10.1056/NEJMoa1206168	http://dx.doi.org/10.1056/NEJMoa1206168			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	24024838	Green Accepted			2022-12-28	WOS:000324304200010
J	Reith, C; Landray, M; Devereaux, PJ; Bosch, J; Granger, CB; Baigent, C; Califf, RM; Collins, R; Yusuf, S				Reith, Christina; Landray, Martin; Devereaux, P. J.; Bosch, Jackie; Granger, Christopher B.; Baigent, Colin; Califf, Robert M.; Collins, Rory; Yusuf, Salim			Randomized Clinical Trials - Removing Unnecessary Obstacles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK; QUALITY; CONSENT; CONDUCT	The authors, who are experienced clinical trialists, propose a framework for expediting the conduct of clinical trials and reducing what they perceive as unnecessary bureaucracy in current trial regulations. Since their widespread introduction in the middle of the 20th century, randomized trials of sufficiently large size have provided reliable assessments of the safety and efficacy of treatments that have produced substantial improvements in health.(1) During the past decade, however, increasingly onerous regulation and related bureaucracy have made trials much more difficult and costly to conduct, slowing further improvements.(2),(3) This adverse regulatory environment hinders important research and urgently needs to be changed for the benefit of patients and public health. As one example of the current problems (Table 1), the requirement to obtain approval from many different bodies before ...	[Reith, Christina; Landray, Martin; Baigent, Colin; Collins, Rory] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Reith, Christina; Landray, Martin; Baigent, Colin; Collins, Rory] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England; [Devereaux, P. J.; Bosch, Jackie; Yusuf, Salim] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Devereaux, P. J.; Bosch, Jackie; Yusuf, Salim] McMaster Univ, Hamilton, ON, Canada; [Granger, Christopher B.; Califf, Robert M.] Duke Univ, Duke Clin Res Inst, Durham, NC USA	University of Oxford; University of Oxford; McMaster University; Population Health Research Institute; McMaster University; Duke University	Reith, C (corresponding author), Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	christina.reith@ctsu.ox.ac.uk	Bosch, Jacqueline/AAP-6910-2021; Granger, Christopher B/D-3458-2014; Devereaux, PJ/AAF-2862-2019; Devereaux, PJ/AAY-1757-2021; Collins, Rory/ABA-8487-2020	Bosch, Jacqueline/0000-0001-6292-4207; Granger, Christopher B/0000-0002-0045-3291; Landray, Martin/0000-0001-6646-827X; Yusuf, Salim/0000-0003-4776-5601; Devereaux, PJ/0000-0003-2935-637X	MRC [MC_U137686860] Funding Source: UKRI; Medical Research Council [MC_U137686860] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 1996, INT C HARMONISATION; Baigent C, 2008, CLIN TRIALS, V5, P49, DOI 10.1177/1740774507087554; Brosteanu O, 2009, CLIN TRIALS, V6, P585, DOI 10.1177/1740774509347398; Califf RM, 2006, CLIN TRIALS, V3, P496, DOI 10.1177/1740774506073173; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Coxib and traditional NSAID Trialists' (CNT) Collaboration, 2013, LANCET; Drazen JM, 2013, NEW ENGL J MED, V368, P1929, DOI 10.1056/NEJMe1304996; Duley L, 2008, CLIN TRIALS, V5, P40, DOI 10.1177/1740774507087704; European Medicines Agency, 2011, REFL PAP RISK BAS QU; FDA, 2013, GUID IND OV CLIN INV; Grimes DA, 2005, LANCET, V366, P172, DOI 10.1016/S0140-6736(05)66875-4; Guidance for Industry and Investigators, 2012, GUID IND INV SAF REP; Institute of Medicine (US), 2012, ENVISIONING TRANSFOR; Kass NE, 2013, HASTINGS CENT REP; Landray MJ, 2012, DRUG INF J, V46, P657, DOI 10.1177/0092861512464372; Lang T, 2011, LANCET, V377, P1553, DOI 10.1016/S0140-6736(10)62052-1; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Magnus D, 2013, NEW ENGL J MED, V368, P1864, DOI 10.1056/NEJMp1305086; McMahon AD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000131; Medical Research Council/Department of Health/Medicines and Healthcare Products Regulatory Agency Joint Project, 2011, RISK APPR MAN CLIN T; Morrison BW, 2011, CLIN TRIALS, V8, P342, DOI 10.1177/1740774511402703; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; PCAST, 2012, REP PRES PROP INN DR; Petersen LA, 2012, ANN INTERN MED, V156, P728, DOI 10.7326/0003-4819-156-10-201205150-00011; Sherman RB, 2011, NEW ENGL J MED, V365, P3, DOI 10.1056/NEJMp1103464; The Academy of Medical Sciences, 2011, NEW PATHW REG GOV HL	27	79	78	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					1061	1065		10.1056/NEJMsb1300760	http://dx.doi.org/10.1056/NEJMsb1300760			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	24024845				2022-12-28	WOS:000324304200018
J	Wang, C; Liu, Q				Wang, Chen; Liu, Qian			A turning point for clinical research in China?	LANCET			English	Editorial Material									[Wang, Chen] Beijing Hosp, Beijing Inst Resp Med, Natl Clin Res Ctr Resp Dis, Beijing 100730, Peoples R China; [Wang, Chen; Liu, Qian] Natl Hlth & Family Planning Commiss Peoples Repub, Beijing, Peoples R China	Beijing Hospital	Wang, C (corresponding author), Beijing Hosp, Beijing Inst Resp Med, Natl Clin Res Ctr Resp Dis, Beijing 100730, Peoples R China.	cyh-birm@263.net						Clive K, 2012, CHEST, V141, pe419S; Wang C, 2010, CHEST, V137, P254, DOI 10.1378/chest.09-0765; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yuan HF, 2013, LANCET, V381, pE4, DOI 10.1016/S0140-6736(13)60174-9	4	17	22	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					835	836		10.1016/S0140-6736(13)61804-8	http://dx.doi.org/10.1016/S0140-6736(13)61804-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	24012257				2022-12-28	WOS:000324240700005
J	Anderson, JS; Rittle, J; Peters, JC				Anderson, John S.; Rittle, Jonathan; Peters, Jonas C.			Catalytic conversion of nitrogen to ammonia by an iron model complex	NATURE			English	Article							MOLECULAR NITROGEN; REDUCTION; MOLYBDENUM; DINITROGEN; N-2; HYDROGENATION; MECHANISM; TRANSFORMATION; CLEAVAGE; CARBON	The reduction of nitrogen (N-2) to ammonia (NH3) is a requisite transformation for life(1). Although it is widely appreciated that the iron-rich cofactors of nitrogenase enzymes facilitate this transformation(2-5), how they do so remains poorly understood. A central element of debate has been the exact site or sites of N-2 coordination and reduction(6,7). In synthetic inorganic chemistry, an early emphasis was placed on molybdenum(8) because it was thought to be an essential element of nitrogenases(3) and because it had been established that well-defined molybdenum model complexes could mediate the stoichiometric conversion of N-2 to NH3 (ref. 9). This chemical transformation can be performed in a catalytic fashion by two well-defined molecular systems that feature molybdenum centres(10,11). However, it is now thought that iron is the only transition metal essential to all nitrogenases(3), and recent biochemical and spectroscopic data have implicated iron instead of molybdenum as the site of N-2 binding in the FeMo-cofactor(12). Here we describe a tris(phosphine) borane-supported iron complex that catalyses the reduction of N-2 to NH3 under mild conditions, and in which more than 40 per cent of the proton and reducing equivalents are delivered to N-2. Our results indicate that a single iron site may be capable of stabilizing the various NxHy intermediates generated during catalytic NH3 formation. Geometric tunability at iron imparted by a flexible iron-boron interaction in our model system seems to be important for efficient catalysis(13-15). We propose that the interstitial carbon atom recently assigned in the nitrogenase cofactor may have a similar role(16,17), perhaps by enabling a single iron site to mediate the enzymatic catalysis through a flexible iron-carbon interaction(18).	[Anderson, John S.; Rittle, Jonathan; Peters, Jonas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Peters, JC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	jpeters@caltech.edu	Anderson, John/ABF-3019-2021	Anderson, John/0000-0002-0730-3018	NIH [GM 070757]; Gordon and Betty Moore Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (GM 070757) and the Gordon and Betty Moore Foundation. A. Takaoka is thanked for developing the calibration curves used for ammonia and hydrazine quantification. D. Rees and D. Newman are acknowledged for many discussions.	Anderson JS, 2013, J AM CHEM SOC, V135, P534, DOI 10.1021/ja307714m; Arashiba K, 2011, NAT CHEM, V3, P120, DOI 10.1038/NCHEM.906; BELL LG, 1970, J AM CHEM SOC, V92, P4464, DOI 10.1021/ja00717a059; BROOKHART M, 1992, ORGANOMETALLICS, V11, P3920, DOI 10.1021/om00059a071; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; CHATT J, 1978, CHEM REV, V78, P589, DOI 10.1021/cr60316a001; Crossland J. L., 2011, COORDIN CHEM REV, V255, P949; Eady RR, 1996, CHEM REV, V96, P3013, DOI 10.1021/cr950057h; Fong H, 2013, ORGANOMETALLICS, V32, P3053, DOI 10.1021/om400281v; Fryzuk MD, 1997, SCIENCE, V275, P1445, DOI 10.1126/science.275.5305.1445; Hall DA, 1996, J CHEM SOC DALTON, P3539, DOI 10.1039/dt9960003539; Hendrich MP, 2006, P NATL ACAD SCI USA, V103, P17107, DOI 10.1073/pnas.0604402103; HILLS A, 1993, J CHEM SOC DALTON, P3041, DOI 10.1039/dt9930003041; Hoffman BM, 2009, ACCOUNTS CHEM RES, V42, P609, DOI 10.1021/ar8002128; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; KERN RJ, 1962, J INORG NUCL CHEM, V24, P1105, DOI 10.1016/0022-1902(62)80255-3; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Lee Y, 2010, NAT CHEM, V2, P558, DOI [10.1038/NCHEM.660, 10.1038/nchem.660]; Moret ME, 2011, J AM CHEM SOC, V133, P18118, DOI 10.1021/ja208675p; Moret ME, 2011, ANGEW CHEM INT EDIT, V50, P2063, DOI 10.1002/anie.201006918; Peters J. C., 2006, ACTIVATION SMALL MOL, P81; PICKETT CJ, 1985, NATURE, V317, P652, DOI 10.1038/317652a0; Pool JA, 2004, NATURE, V427, P527, DOI 10.1038/nature02274; Rodriguez MM, 2011, SCIENCE, V334, P780, DOI 10.1126/science.1211906; Schrock RR, 2011, NAT CHEM, V3, P95, DOI 10.1038/nchem.977; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; SHILOV A, 1971, NATURE, V231, P460, DOI 10.1038/231460a0; Smil V., 2001, ENRICHING THE EARTH; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; WEITZ IS, 1993, J CHEM SOC PERK T 1, P117, DOI 10.1039/p19930000117; Yandulov DV, 2002, J AM CHEM SOC, V124, P6252, DOI 10.1021/ja020186x; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326; Yuki M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2264	35	673	675	22	1004	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 5	2013	501	7465					84	+		10.1038/nature12435	http://dx.doi.org/10.1038/nature12435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211ER	24005414	Green Accepted, Green Published			2022-12-28	WOS:000323888300036
J	Hogerzeil, HV				Hogerzeil, Hans V.			Big Pharma and Social Responsibility - The Access to Medicine Index	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Groningen, Univ Med Ctr Groningen, Dept Global Hlth, Groningen, Netherlands	University of Groningen	Hogerzeil, HV (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Global Hlth, Groningen, Netherlands.								0	19	19	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					896	899		10.1056/NEJMp1303723	http://dx.doi.org/10.1056/NEJMp1303723			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	211KV	24004116				2022-12-28	WOS:000323906900005
J	Oreskes, N				Oreskes, Naomi			How plate tectonics clicked	NATURE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Oreskes, N (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	oreskes@fas.harvard.edu						DIETZ RS, 1961, NATURE, V190, P854, DOI 10.1038/190854a0; Nye Mary Jo, 2004, BLACKETT PHYS WAR PO; Oreskes N., 1999, REJECTION CONTINENTA, DOI [10.1093/oso/9780195117325.001.0001, DOI 10.1093/OSO/9780195117325.001.0001]; Oreskes N, 2001, PLATE TECTONICS INSI; VINE FJ, 1963, NATURE, V199, P947, DOI 10.1038/199947a0	5	9	9	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2013	501	7465					27	29		10.1038/501027a	http://dx.doi.org/10.1038/501027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211ER	24010145	Bronze			2022-12-28	WOS:000323888300013
J	Chesterton, LS; Lewis, AM; Sim, J; Mallen, CD; Mason, EE; Hay, EM; van der Windt, DA				Chesterton, Linda S.; Lewis, A. Martyn; Sim, Julius; Mallen, Christian D.; Mason, Elizabeth E.; Hay, Elaine M.; van der Windt, Danielle A.			Transcutaneous electrical nerve stimulation as adjunct to primary care management for tennis elbow: pragmatic randomised controlled trial (TATE trial)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTHY-HUMAN PARTICIPANTS; CORTICOSTEROID INJECTIONS; LATERAL EPICONDYLALGIA; PARAMETER MANIPULATION; EXPERIMENTAL PAIN; TENS; PHYSIOTHERAPY; INTERVENTIONS; PREVALENCE; INTENSITY	Objective To investigate the effectiveness of supplementing information and advice on analgesia and exercise from a general practitioner with transcutaneous electrical nerve stimulation (TENS) as a non-drug form of analgesia to reduce pain intensity in patients with tennis elbow. Design Pragmatic randomised controlled trial in primary care. Setting and 38 general practices in the West Midlands, UK. Participants 241 adults consulting with a first or new (no consultation in previous six months) clinical diagnosis of tennis elbow. Interventions Participants were randomly allocated to either primary care management alone, consisting of a consultation with a general practitioner followed by information and advice on exercises, or primary care management plus TENS to be used once a day for 45 minutes over six weeks (or until symptom resolution) for pain relief. Outcome measures The primary outcome was self reported intensity of elbow pain (0-10 rating scale) at six weeks. Primary and secondary outcomes were measured at baseline and at six weeks, six months, and 12 months by postal questionnaire. Analysis was by intention to treat. Results 121 participants were randomised to primary care management plus TENS and 120 to primary care management only (first episode, n=197 (82%); duration <1-3 months, n=138 (57%)). Adherence to exercise and TENS recommendations reported at six weeks was low; only 42 participants in the primary care management plus TENS group met a priori defined adherence criteria. Both intervention groups showed large improvements in pain and secondary outcomes, especially during the first six weeks of follow-up. However, no clinically or statistically significant differences were seen between groups at any follow-up timepoint. At the primary endpoint (six weeks), the between group difference in improvement of pain was -0.33 (95% confidence interval -0.96 to 0.31; P=0.31) in favour of the primary care management only group, with adjustment for age, sex, and baseline pain score. Conclusions This trial does not provide evidence for additional benefit of TENS as an adjunct to primary care management of tennis elbow. Poor adherence to interventions is evidence of the challenges of implementing self management treatment strategies in primary care. Trial registration Current Controlled Trials ISRCTN87141084.	[Chesterton, Linda S.; Lewis, A. Martyn; Sim, Julius; Mallen, Christian D.; Mason, Elizabeth E.; Hay, Elaine M.; van der Windt, Danielle A.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Sim, Julius] Keele Univ, Sch Hlth & Rehabil, Keele ST5 5BG, Staffs, England	Keele University; Keele University	Chesterton, LS (corresponding author), Keele Univ, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	l.s.chesterton@keele.ac.uk		Mallen, Christian/0000-0002-2677-1028; Chesterton, Linda/0000-0002-1639-4441	National Institute for Health Research (NIHR) [PB-PG-0407-13189]; Arthritis Research UK [20202]; National Institute for Health Research [PB-PG-0407-13189, NF-SI-0611-10078] Funding Source: researchfish; Versus Arthritis [19634] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Arthritis Research UK(Versus Arthritis); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	This paper presents independent research funded by the National Institute for Health Research (NIHR) under the Research for Patient Benefit Programme (grant reference No PB-PG-0407-13189). CDM is supported by an Arthritis Research UK clinician scientist award. EMH is an NIHR senior investigator. The Institute for Primary Care and Health Sciences at Keele has been awarded the Arthritis Research UK Primary Care Centre of Excellence (grant No 20202). The NIHR had no role in the conduct of the study; collection, management, analysis, and interpretation of the data; or preparation and review of the manuscript. The conclusions and views expressed in this article are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health.	ALLANDER E, 1974, SCAND J RHEUMATOL, V3, P145, DOI 10.3109/03009747409097141; [Anonymous], EX MAN TENN ELB; Barlas P, 2005, WALL MELZACKS TXB PA, P583; Bisset L, 2005, BRIT J SPORT MED, V39, P411, DOI 10.1136/bjsm.2004.016170; Bisset L, 2006, BMJ-BRIT MED J, V333, P939, DOI 10.1136/bmj.38961.584653.AE; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Chartered Society of Physiotherapy, 2006, GUID US EL AG; Chen CC, 2011, CLIN J PAIN, V27, P434, DOI 10.1097/AJP.0b013e318208c926; Chesterton LS, 2011, OPEN ACCESS J SPORTS, V2, P53, DOI 10.2147/OAJSM.S10310; Chesterton LS, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-156; Chesterton LS, 2003, PAIN, V106, P73, DOI 10.1016/S0304-3959(03)00292-6; Chesterton LS, 2002, PAIN, V99, P253, DOI 10.1016/S0304-3959(02)00118-5; Claydon LS, 2013, CLIN J PAIN, V29, P533, DOI 10.1097/AJP.0b013e318262330f; Claydon LS, 2011, CLIN J PAIN, V27, P635, DOI 10.1097/AJP.0b013e31821962b4; Coombes BK, 2009, BRIT J SPORT MED, V43, P252, DOI 10.1136/bjsm.2008.052738; Coombes BK, 2013, JAMA-J AM MED ASSOC, V309, P461, DOI 10.1001/jama.2013.129; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Cyriax JH, 1936, J BONE JOINT SURG, V18, P921; DeSantana Josimari M, 2008, Curr Rheumatol Rep, V10, P492; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Gabel Gerard T., 1999, Current Opinion in Rheumatology, V11, P138, DOI 10.1097/00002281-199903000-00010; Gladwell PW, 2013, THESIS U W ENGLAND; Halle J S, 1986, J Orthop Sports Phys Ther, V8, P62; HAMILTON PG, 1986, J ROY COLL GEN PRACT, V36, P464; Hay EM, 1999, BRIT MED J, V319, P964, DOI 10.1136/bmj.319.7215.964; Hudak PL, 1996, ARCH PHYS MED REHAB, V77, P586, DOI 10.1016/S0003-9993(96)90300-7; Hughes N, 2013, CLIN J PAIN, V29, P146, DOI 10.1097/AJP.0b013e3182579919; Johnson MI, 2011, EXPERT REV NEUROTHER, V11, P735, DOI [10.1586/ern.11.48, 10.1586/ERN.11.48]; Johnson M, 2007, PAIN, V130, P157, DOI 10.1016/j.pain.2007.02.007; Kennedy A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2882; Khadilkar A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003008.pub3; Lewis M, 2005, CLIN J PAIN, V21, P330, DOI 10.1097/01.ajp.0000125268.40304.b3; Lewis M, 2002, SCAND J WORK ENV HEA, V28, P109, DOI 10.5271/sjweh.654; Moran F, 2011, J PAIN, V12, P929, DOI 10.1016/j.jpain.2011.02.352; Moss-Morris R, 2002, PSYCHOL HLTH, V17; Murtagh J E, 1988, Aust Fam Physician, V17, P90; Murtagh JE, 1988, AUST FAM PHYSICIAN, V17, P5; Murtagh JE, 1988, AUST FAM PHYSICIAN, V17, P91; Nnoaham KE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003222.pub2; Overend T J, 1999, J Hand Ther, V12, P31; Pantaleao MA, 2011, J PAIN, V12, P581, DOI 10.1016/j.jpain.2010.11.001; RANNEY D, 1995, ERGONOMICS, V38, P1408, DOI 10.1080/00140139508925198; Rutjes AWS, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002823.pub2, 10.1002/14651858.CD007321.pub2]; Shiri R, 2006, AM J EPIDEMIOL, V164, P1065, DOI 10.1093/aje/kwj325; Sluka KA, 2003, J PAIN, V4, P109, DOI 10.1054/jpai.2003.434; Sluka KA, 2013, PHYS THER; Smidt N, 2002, LANCET, V359, P657, DOI 10.1016/S0140-6736(02)07811-X; Smidt N, 2006, BMJ-BRIT MED J, V333, P927, DOI 10.1136/bmj.39017.396389.BE; Sun X, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3949; Vitolins MZ, 2000, CONTROL CLIN TRIALS, V21, p188S, DOI 10.1016/S0197-2456(00)00077-5; Walsh DM, 1997, 10S CLIN APPL RELATE; Watson T, 2000, MANUAL THER, V5, P132, DOI 10.1054/math.2000.0363; Weng CS, 2005, BIOMED ENG-APP BAS C, V17, P236, DOI 10.4015/S1016237205000354; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	56	23	23	0	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2013	347								f5160	10.1136/bmj.f5160	http://dx.doi.org/10.1136/bmj.f5160			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ND	23999980	Green Published, hybrid			2022-12-28	WOS:000324216000001
J	Chan, BCY; Maurice, P				Chan, Bob C. Y.; Maurice, Paul			Staphylococcal Toxic Shock Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chan, Bob C. Y.; Maurice, Paul] Christchurch Hosp, Christchurch, New Zealand	Christchurch Hospital New Zealand	Chan, BCY (corresponding author), Christchurch Hosp, Christchurch, New Zealand.	chanchoyui@gmail.com							0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					852	852		10.1056/NEJMicm1213758	http://dx.doi.org/10.1056/NEJMicm1213758			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208KB	23984732				2022-12-28	WOS:000323676100012
J	Jaffe, MG; Lee, GA; Young, JD; Sidney, S; Go, AS				Jaffe, Marc G.; Lee, Grace A.; Young, Joseph D.; Sidney, Stephen; Go, Alan S.			Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMBINATION THERAPY; CARE; IMPLEMENTATION; STRATEGIES; GUIDELINES; MANAGEMENT; BARRIERS; COSTS	IMPORTANCE Hypertension control for large populations remains a major challenge. OBJECTIVE To describe a large-scale hypertension program in Northern California and to compare rates of hypertension control in that program with statewide and national estimates. DESIGN, SETTING, AND PATIENTS The Kaiser Permanente Northern California (KPNC) hypertension program included a multifaceted approach to blood pressure control. Patients identified as having hypertension within an integrated health care delivery system in Northern California from 2001-2009 were included. The comparison group comprised insured patients in California between 2006-2009 who were included in the Healthcare Effectiveness Data and Information Set (HEDIS) commercial measurement by California health insurance plans participating in the National Committee for Quality Assurance (NCQA) quality measure reporting process. A secondary comparison group was included to obtain the reported national mean NCQA HEDIS commercial rates of hypertension control between 2001-2009 from health plans that participated in the NCQA HEDIS quality measure reporting process. MAIN OUTCOMES AND MEASURES Hypertension control as defined by NCQA HEDIS. RESULTS The KPNC hypertension registry included 349 937 patients when established in 2001 and increased to 652 763 by 2009. The NCQA HEDIS commercial measurement for hypertension control within KPNC increased from 43.6% (95% CI, 39.4%-48.6%) to 80.4% (95% CI, 75.6%-84.4%) during the study period (P<.001 for trend). In contrast, the national mean NCQA HEDIS commercial measurement increased from 55.4% to 64.1%. California mean NCQA HEDIS commercial rates of hypertension were similar to those reported nationally from 2006-2009 (63.4% to 69.4%). CONCLUSIONS AND RELEVANCE Among adults diagnosed with hypertension, implementation of a large-scale hypertension program was associated with a significant increase in hypertension control compared with state and national control rates. Key elements of the program included a comprehensive hypertension registry, development and sharing of performance metrics, evidence-based guidelines, medical assistant visits for blood pressure measurement, and single-pill combination pharmacotherapy.	[Jaffe, Marc G.; Lee, Grace A.] Kaiser Permanente South San Francisco Med Ctr, Dept Endocrinol, San Francisco, CA 94080 USA; [Young, Joseph D.] Kaiser Permanente Oakland Med Ctr, Dept Med, Oakland, CA USA; [Sidney, Stephen; Go, Alan S.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Go, Alan S.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Go, Alan S.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Jaffe, MG (corresponding author), Kaiser Permanente South San Francisco Med Ctr, Dept Endocrinol, 1200 El Camino Real, San Francisco, CA 94080 USA.	marc.jaffe@kp.org	Go, Alan S./AAE-7745-2019; s, s/GYR-2278-2022; s, s/HIK-1178-2022; s, s/HHD-0404-2022	Jaffe, Marc/0000-0002-5049-7815	National Heart, Lung, and Blood Institute through the Cardiovascular Research Network [U19 HL91179-01, RC2 HL101666]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101666, U19HL091179] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute through the Cardiovascular Research Network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Hypertension control data and program implementation was under the clinical patient care domain of Kaiser Permanente Northern California. No funding was used for the acquisition of data, statistical analysis, or the preparation of the manuscript. This work was supported, in part, by funding from the National Heart, Lung, and Blood Institute through the Cardiovascular Research Network (U19 HL91179-01 [Dr Go] and RC2 HL101666 [Dr Sidney]).	[Anonymous], HEDIS PERFORMANCE ME; [Anonymous], STATE AND COUNTY QUI; [Anonymous], CALIFORNIA HEALTH IN; Aucott JN, 1996, J GEN INTERN MED, V11, P139, DOI 10.1007/BF02600265; Carter BL, 2009, ARCH INTERN MED, V169, P1748, DOI 10.1001/archinternmed.2009.316; Casey Patricia E, 2006, Perm J, V10, P13; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choma NN, 2009, CIRC-CARDIOVASC QUAL, V2, P392, DOI 10.1161/CIRCOUTCOMES.109.862714; Department of Veterans Affairs Veterans Health Administration, 2010, 2010 VHA FACILITY QU; Department of Veterans Affairs Veterans Health Administration Office of Quality and Safety, 2009, 2009 VHA FACILITY QU; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Epstein M, 1996, ARCH INTERN MED, V156, P1969, DOI 10.1001/archinte.156.17.1969; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Gordon NP, 2012, SIMILARITY OF THE AD; Gradman AH, 2010, J AM SOC HYPERTENS, V4, P90, DOI [10.1016/j.jash.2010.03.001, 10.1016/j.jash.2010.02.005]; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Handler J, 2011, J AM SOC HYPERTENS, V5, P197, DOI 10.1016/j.jash.2011.03.002; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Luders S, 2010, EUR J CARDIOV PREV R, V17, P271, DOI 10.1097/HJR.0b013e328330be62; Neutel JM, 2008, CURR MED RES OPIN, V24, P2389, DOI 10.1185/03007990802262457; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Sherrill B, 2011, J CLIN HYPERTENS, V13, P898, DOI 10.1111/j.1751-7176.2011.00550.x; Siegel D, 2005, VASC HEALTH RISK MAN, V1, P9, DOI 10.2147/vhrm.1.1.9.58940; Teleki S, 2006, PROVIDING PERFORMANC; Walsh JME, 2008, J CLIN HYPERTENS, V10, P311, DOI 10.1111/j.1751-7176.2008.07425.x; Weir MR, 2008, J CLIN HYPERTENS, V10, P146, DOI 10.1111/j.1751-7176.2008.07439.x	28	304	315	2	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					699	705		10.1001/jama.2013.108769	http://dx.doi.org/10.1001/jama.2013.108769			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23989679	Bronze, Green Accepted			2022-12-28	WOS:000323254500019
J	Kornecki, KP; Briones, JF; Boyarskikh, V; Fullilove, F; Autschbach, J; Schrote, KE; Lancaster, KM; Davies, HML; Berry, JF				Kornecki, Katherine P.; Briones, John F.; Boyarskikh, Vyacheslav; Fullilove, Felicia; Autschbach, Jochen; Schrote, Kaitlin E.; Lancaster, Kyle M.; Davies, Huw M. L.; Berry, John F.			Direct Spectroscopic Characterization of a Transitory Dirhodium Donor-Acceptor Carbene Complex	SCIENCE			English	Article							SUBSTITUTED RHODIUM CARBENOIDS; C-H ACTIVATION; METAL-CARBENE; CYCLOPROPANATION REACTIONS; CRYSTAL-STRUCTURE; INSERTION; TETRACARBOXYLATE; MECHANISM; BOND; REARRANGEMENT	A multitude of organic transformations catalyzed by dirhodium(II) (Rh-2) complexes are thought to proceed via the intermediacy of highly reactive, electrophilic carbenoid intermediates that have eluded direct observation. Herein, we report the generation of a metastable Rh-2-carbenoid intermediate supported by a donor-acceptor carbene fragment. This intermediate is stable for a period of similar to 20 hours in chloroform solution at 0 degrees C, allowing for an exploration of its physical and chemical properties. The Rh=C bond, characterized by vibrational and nuclear magnetic resonance spectroscopy, extended x-ray absorption fine structure analysis, and quantum-chemical calculations, has weak sigma and pi components. This intermediate performs stoichiometric cyclopropanation and C-H functionalization reactions to give products that are identical to those obtained from analogous Rh-2 catalysis.	[Kornecki, Katherine P.; Berry, John F.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Briones, John F.; Boyarskikh, Vyacheslav; Fullilove, Felicia; Davies, Huw M. L.] Emory Univ, Dept Chem, Atlanta, GA 30322 USA; [Autschbach, Jochen] SUNY Buffalo, Dept Chem, Buffalo, NY 14226 USA; [Schrote, Kaitlin E.; Lancaster, Kyle M.] Cornell Univ, Baker Lab, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	University of Wisconsin System; University of Wisconsin Madison; Emory University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Cornell University	Davies, HML (corresponding author), Emory Univ, Dept Chem, 1515 Dickey Dr, Atlanta, GA 30322 USA.	hmdavie@emory.edu; berry@chem.wisc.edu	Autschbach, Jochen/S-5472-2016; Davies, Huw M. L./C-5598-2018	Autschbach, Jochen/0000-0001-9392-877X; Davies, Huw M. L./0000-0001-6254-9398; Berry, John/0000-0002-6805-0640	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (DOE) [DE-FG02-10ER16204]; Center for Chemical Innovation Center for Selective C-H Functionalization; NSF [CHE-1205646, CHE-0952253]; Cornell University; DOE Office of Biological and Environmental Research; NIH, National Institute of General Medical Sciences (NIGMS) [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1048642, 0952253] Funding Source: National Science Foundation; Division Of Chemistry [1205646] Funding Source: National Science Foundation	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Center for Chemical Innovation Center for Selective C-H Functionalization; NSF(National Science Foundation (NSF)); Cornell University; DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (DOE) (grant DE-FG02-10ER16204 to J.F.B.) and the Center for Chemical Innovation Center for Selective C-H Functionalization, supported by the NSF (grant CHE-1205646 to H. M. L. D. and J.F.B.) (grant CHE-0952253 to J.A.) for support. K. M. L. gratefully acknowledges Cornell University for startup funding. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the DOE Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH, National Institute of General Medical Sciences (NIGMS) (including grant P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, National Center for Research Resources, or NIH. Metrical data for the structure of 1 are available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC-956575.	Autschbach J, 2001, J AM CHEM SOC, V123, P5320, DOI 10.1021/ja003866d; Autschbach J, 2007, J AM CHEM SOC, V129, P11093, DOI 10.1021/ja073166+; Berry JF, 2012, DALTON T, V41, P700, DOI 10.1039/c1dt11434d; Bezuidenhout DI, 2011, DALTON T, V40, P6711, DOI 10.1039/c1dt10183h; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; Che CM, 2001, J AM CHEM SOC, V123, P4119, DOI 10.1021/ja001416f; Cohen R, 2003, J AM CHEM SOC, V125, P6532, DOI 10.1021/ja028923c; Davies HML, 2004, SYNTHESIS-STUTTGART, P2595, DOI 10.1055/s-2004-834876; Davies HML, 2003, CHEM REV, V103, P2861, DOI 10.1021/cr0200217; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Davies HML, 2007, CHEM SOC REV, V36, P1109, DOI 10.1039/b607983k; Davies HML, 2012, ACCOUNTS CHEM RES, V45, P923, DOI 10.1021/ar300013t; Davies HML, 2011, CHEM SOC REV, V40, P1857, DOI 10.1039/c0cs00217h; Deng QH, 2009, CHEM-EUR J, V15, P10707, DOI 10.1002/chem.200901895; Doyle M. P., 1998, MODERN CATALYTIC MET, P1; Doyle MP, 2010, CHEM REV, V110, P704, DOI 10.1021/cr900239n; DOYLE MP, 1993, J AM CHEM SOC, V115, P9968, DOI 10.1021/ja00075a013; FISCHER EO, 1970, CHEM BER-RECL, V103, P1273, DOI 10.1002/cber.19701030430; Hansen J, 2009, J ORG CHEM, V74, P6555, DOI 10.1021/jo9009968; Herrmann WA, 2002, ANGEW CHEM INT EDIT, V41, P1290, DOI 10.1002/1521-3773(20020415)41:8<1290::AID-ANIE1290>3.0.CO;2-Y; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Koch W.H., 2001, CHEM GUIDE DENSITY F, Vsecond; Lebel H, 2003, CHEM REV, V103, P977, DOI 10.1021/cr010007e; MAXWELL JL, 1992, SCIENCE, V256, P1544, DOI 10.1126/science.256.5063.1544; Nakamura E, 2002, J AM CHEM SOC, V124, P7181, DOI 10.1021/ja017823o; Nugent W. A., 1988, METAL LIGAND MULTIPL; Padwa A, 2009, CHEM SOC REV, V38, P3072, DOI 10.1039/b816701j; PAULISSEN R, 1973, TETRAHEDRON LETT, P2233; Pelphrey P, 2010, CHEM SCI, V1, P254, DOI 10.1039/c0sc00109k; PIRRUNG MC, 1994, J AM CHEM SOC, V116, P8991, DOI 10.1021/ja00099a017; Sheehan SM, 1998, TETRAHEDRON LETT, V39, P949, DOI 10.1016/S0040-4039(97)10667-0; Shishkov IV, 2009, ORGANOMETALLICS, V28, P1049, DOI 10.1021/om8007376; Snyder JP, 2001, J AM CHEM SOC, V123, P11318, DOI 10.1021/ja016928o; Sole S, 2001, SCIENCE, V292, P1901, DOI 10.1126/science.292.5523.1901; YATES P, 1952, J AM CHEM SOC, V74, P5376, DOI 10.1021/ja01141a047; Zhang Y, 2010, COORDIN CHEM REV, V254, P941, DOI 10.1016/j.ccr.2009.12.005	37	132	134	2	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 18	2013	342	6156					351	354		10.1126/science.1243200	http://dx.doi.org/10.1126/science.1243200			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235XG	24030489				2022-12-28	WOS:000325755100042
J	Kabeche, L; Compton, DA				Kabeche, Lilian; Compton, Duane A.			Cyclin A regulates kinetochore microtubules to promote faithful chromosome segregation	NATURE			English	Article							ERROR-CORRECTION; CELL-CYCLE; MITOSIS; ORIENTATION; ANAPHASE; DESTRUCTION; ANEUPLOIDY; ATTACHMENT; METAPHASE; DYNAMICS	The most conspicuous event in the cell cycle is the alignment of chromosomes in metaphase. Chromosome alignment fosters faithful segregation through the formation of bi-oriented attachments of kinetochores to spindle microtubules. Notably, numerous kinetochore-microtubule (k-MT) attachment errors are present in early mitosis (prometaphase) 1, and the persistence of those errors is the leading cause of chromosome mis-segregation in aneuploid human tumour cells that continually mis-segregate whole chromosomes and display chromosomal instability(2-7). How robust error correction is achieved in prometaphase to ensure error-free mitosis remains unknown. Here we show that k-MT attachments in prometaphase cells are considerably less stable than in metaphase cells. The switch to more stable k-MT attachments in metaphase requires the proteasome-dependent destruction of cyclin A in prometaphase. Persistent cyclin A expression prevents k-MT stabilization even in cells with aligned chromosomes. By contrast, k-MTs are prematurely stabilized in cyclin-A-deficient cells. Consequently, cells lacking cyclin A display higher rates of chromosome mis-segregation. Thus, the stability of k-MT attachments increases decisively in a coordinated fashion among all chromosomes as cells transit from prometaphase to metaphase. Cyclin A creates a cellular environment that promotes microtubule detachment from kinetochores in prometaphase to ensure efficient error correction and faithful chromosome segregation.	[Kabeche, Lilian; Compton, Duane A.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Kabeche, Lilian; Compton, Duane A.] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Norris Cotton Cancer Center	Compton, DA (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA.	duane.a.compton@dartmouth.edu		Compton, Duane/0000-0002-4445-9118; Kabeche, Lilian/0000-0001-9917-856X	National Institutes of Health [GM51542, GM008704]; John H. Copenhaver Jr and William H. Thomas, MD 1952 Junior Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051542, R01GM051542, T32GM008704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John H. Copenhaver Jr and William H. Thomas, MD 1952 Junior Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM51542 (D. A. C.) and GM008704 (L. K.) and the John H. Copenhaver Jr and William H. Thomas, MD 1952 Junior Fellowship (L. K.). We thank J. Pines and J. DeLuca for providing reagents.	Bakhoum SF, 2012, CURR OPIN CELL BIOL, V24, P64, DOI 10.1016/j.ceb.2011.11.012; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Di Fiore B, 2010, J CELL BIOL, V190, P501, DOI 10.1083/jcb.201001083; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Indjeian VB, 2007, CURR BIOL, V17, P1837, DOI 10.1016/j.cub.2007.09.056; Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Loncarek J, 2007, NATURE, V450, P745, DOI 10.1038/nature06344; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Pagliuca FW, 2011, MOL CELL, V43, P406, DOI 10.1016/j.molcel.2011.05.031; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	28	97	99	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					110	+		10.1038/nature12507	http://dx.doi.org/10.1038/nature12507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	24013174	Green Accepted			2022-12-28	WOS:000325106000041
J	Ng, KM; Ferreyra, JA; Higginbottom, SK; Lynch, JB; Kashyap, PC; Gopinath, S; Naidu, N; Choudhury, B; Weimer, BC; Monack, DM; Sonnenburg, JL				Ng, Katharine M.; Ferreyra, Jessica A.; Higginbottom, Steven K.; Lynch, Jonathan B.; Kashyap, Purna C.; Gopinath, Smita; Naidu, Natasha; Choudhury, Biswa; Weimer, Bart C.; Monack, Denise M.; Sonnenburg, Justin L.			Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens	NATURE			English	Article							CLOSTRIDIUM-DIFFICILE; ESCHERICHIA-COLI; CARBON NUTRITION; SIALIC ACIDS; MOUSE MODEL; TYPHIMURIUM; TRANSMISSION; DIVERSITY; DISRUPTS; PROVIDES	The human intestine, colonized by a dense community of resident microbes, is a frequent target of bacterial pathogens. Undisturbed, this intestinal microbiota provides protection from bacterial infections. Conversely, disruption of the microbiota with oral antibiotics often precedes the emergence of several enteric pathogens(1-4). How pathogens capitalize upon the failure of microbiota-afforded protection is largely unknown. Here we show that two antibiotic-associated pathogens, Salmonella enterica serovar Typhimurium (S. typhimurium) and Clostridium difficile, use a common strategy of catabolizing microbiota-liberated mucosal carbohydrates during their expansion within the gut. S. typhimurium accesses fucose and sialic acid within the lumen of the gut in a microbiota-dependent manner, and genetic ablation of the respective catabolic pathways reduces its competitiveness in vivo. Similarly, C. difficile expansion is aided by microbiota-induced elevation of sialic acid levels in vivo. Colonization of gnotobiotic mice with a sialidase-deficient mutant of Bacteroides thetaiotaomicron, a model gut symbiont, reduces free sialic acid levels resulting in C. difficile downregulating its sialic acid catabolic pathway and exhibiting impaired expansion. These effects are reversed by exogenous dietary administration of free sialic acid. Furthermore, antibiotic treatment of conventional mice induces a spike in free sialic acid and mutants of both Salmonella and C. difficile that are unable to catabolize sialic acid exhibit impaired expansion. These data show that antibiotic-induced disruption of the resident microbiota and subsequent alteration in mucosal carbohydrate availability are exploited by these two distantly related enteric pathogens in a similar manner. This insight suggests new therapeutic approaches for preventing diseases caused by antibiotic-associated pathogens.	[Ng, Katharine M.; Ferreyra, Jessica A.; Higginbottom, Steven K.; Lynch, Jonathan B.; Kashyap, Purna C.; Gopinath, Smita; Monack, Denise M.; Sonnenburg, Justin L.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Naidu, Natasha; Choudhury, Biswa] Univ Calif San Diego, Glycobiol Res & Training Ctr, San Diego, CA 92093 USA; [Weimer, Bart C.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	Stanford University; University of California System; University of California San Diego; University of California System; University of California Davis	Sonnenburg, JL (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	jsonnenburg@stanford.edu	Weimer, Bart C/G-6928-2012; Weimer, Bart/AAK-8501-2021	Weimer, Bart C/0000-0002-7471-1978; Weimer, Bart/0000-0002-7471-1978; Monack, Denise/0000-0003-3804-2209; Lynch, Jonathan/0000-0001-5221-7090; higginbottom, steven/0000-0002-4609-6840; Ng, Katharine Michelle/0000-0003-3494-5697; Gopinath, Smita/0000-0003-3672-3780	NSF [R01-DK085025]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089722, T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085025] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Sonnenburg for comments on the manuscript; M. St. Onge for technical assistance; and A. Shen, N. Minton and R. Knight for valuable help and reagents. This research was supported by R01-DK085025 (to J.L.S.), NSF graduate fellowships (to K. M. N. and J.A.F) and a Stanford Graduate Fellowship (to K. M. N.). J.L.S. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Adams CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003165; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Doorduyn Y, 2006, EPIDEMIOL INFECT, V134, P617, DOI 10.1017/S0950268805005406; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; HOYER LL, 1992, MOL MICROBIOL, V6, P873, DOI 10.1111/j.1365-2958.1992.tb01538.x; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Maltby R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053957; MANZI AE, 1990, ANAL BIOCHEM, V188, P20, DOI 10.1016/0003-2697(90)90523-C; Marcobal A, 2010, J AGR FOOD CHEM, V58, P5334, DOI 10.1021/jf9044205; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Stevens JR, 2008, P C APPL STAT AGR KA, P47; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	39	610	628	8	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 3	2013	502	7469					96	+		10.1038/nature12503	http://dx.doi.org/10.1038/nature12503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	227IM	23995682	Green Accepted, Green Submitted			2022-12-28	WOS:000325106000038
J	Pizzo, PA				Pizzo, Philip A.			Lessons in Pain Relief - A Personal Postgraduate Experience	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A year-long journey with chronic pain offers a physician new insights into pain relief in the United States, clarifying the debilitating, depressing, highly individual, and hard-to-measure nature of chronic pain and the health care system's limitations in addressing it. When I chaired an Institute of Medicine (IOM) committee on Relieving Pain in America(1) and then coauthored a Perspective article about the vast human toll and financial burden imposed by chronic pain,(2) I believed I understood the impact of chronic pain. Not only did I have experience caring for children with life-threatening and frequently painful disorders, I also had relatives with chronic pain syndromes and had witnessed the limitations of the medical care system. But it wasn't until my own year-long journey with chronic pain that I received a higher-level education on the topic. I was loading a suitcase onto ...	[Pizzo, Philip A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Pizzo, Philip A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Pizzo, PA (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.							Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Pizzo PA, 2012, NEW ENGL J MED, V366, P197, DOI 10.1056/NEJMp1109084	2	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 19	2013	369	12					1092	1093		10.1056/NEJMp1306467	http://dx.doi.org/10.1056/NEJMp1306467			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	220BD	24047058				2022-12-28	WOS:000324554800005
J	Rangamani, P; Lipshtat, A; Azeloglu, EU; Calizo, RC; Hu, MF; Ghassemi, S; Hone, J; Scarlata, S; Neves, SR; Iyengar, R				Rangamani, Padmini; Lipshtat, Azi; Azeloglu, Evren U.; Calizo, Rhodora Cristina; Hu, Mufeng; Ghassemi, Saba; Hone, James; Scarlata, Suzanne; Neves, Susana R.; Iyengar, Ravi			Decoding Information in Cell Shape	CELL			English	Article							SIGNALING NETWORK; DYNAMICS; PROTEIN; FIBROBLASTS; MECHANISMS; CURVATURE; SURFACES; RECEPTOR; CASCADE; MODEL	Shape is an indicator of cell health. But how is the information in shape decoded? We hypothesize that decoding occurs by modulation of signaling through changes in plasma membrane curvature. Using analytical approaches and numerical simulations, we studied how elongation of cell shape affects plasma membrane signaling. Mathematical analyses reveal transient accumulation of activated receptors at regions of higher curvature with increasing cell eccentricity. This distribution of activated receptors is periodic, following the Mathieu function, and it arises from local imbalance between reaction and diffusion of soluble ligands and receptors in the plane of the membrane. Numerical simulations show that transient microdomains of activated receptors amplify signals to downstream protein kinases. For growth factor receptor pathways, increasing cell eccentricity elevates the levels of activated cytoplasmic Src and nuclear MAPK1,2. These predictions were experimentally validated by changing cellular eccentricity, showing that shape is a locus of retrievable information storage in cells.	[Rangamani, Padmini; Lipshtat, Azi; Azeloglu, Evren U.; Neves, Susana R.; Iyengar, Ravi] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Rangamani, Padmini; Lipshtat, Azi; Azeloglu, Evren U.; Neves, Susana R.; Iyengar, Ravi] Icahn Sch Med Mt Sinai, Syst Biol Ctr, New York, NY 10029 USA; [Hu, Mufeng; Ghassemi, Saba; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Calizo, Rhodora Cristina; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Iyengar, R (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu	Lipshtat, Azi/B-9268-2008; Hone, James C/E-1879-2011	Lipshtat, Azi/0000-0002-4421-4997; Hone, James C/0000-0002-8084-3301; Azeloglu, Evren/0000-0001-6137-109X; Neves-Zaph, Susana/0000-0002-3388-0054	NIH [GM-072853, 1 S10 RR0 9145-01]; Systems Biology Center Grant [GM-071558]; NIH-NCI [5R24 CA095823-04]; NSF [DBI-9724504]; NIDDK [DK007645]; NIH from NIGMS [P41-GM103313]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072853, P41GM103313, P50GM071558] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Systems Biology Center Grant; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH from NIGMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Robert Blitzer, Marc Birtwistle, and the anonymous reviewers for very useful comments on the manuscript. We also thank T. Raymond Solano and Rumana Huq for their technical assistance. Primary cardiac fibroblasts were a kind gift from Dr. Kevin D. Costa; EGFR-eGFP was a kind gift from Linda Pike. This work was supported by NIH Grant (GM-072853 to R.I. and S.S.) and Systems Biology Center Grant (GM-071558). E.U.A. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. Confocal laser scanning microscopy was performed at the MSSM Microscopy Shared Resource Facility, supported with funding from NIH-NCI shared resources (5R24 CA095823-04), NSF Major Research Instrumentation (DBI-9724504), and NIH shared instrumentation (1 S10 RR0 9145-01) grants. Virtual Cell is supported by NIH grant P41-GM103313 from NIGMS. P.R. was supported by a fellowship from training grant (DK007645) from NIDDK.	Ahmed I, 2007, MOL CELL BIOCHEM, V301, P241, DOI 10.1007/s11010-007-9417-6; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Asthagiri AR, 2001, BIOTECHNOL PROGR, V17, P227, DOI 10.1021/bp010009k; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115; Dean JL, 2010, ONCOGENE, V29, P68, DOI 10.1038/onc.2009.313; Dobereiner HG, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108105; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Freche D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025122; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gera L, 2011, J PHARMACOL EXP THER, V337, P33, DOI 10.1124/jpet.110.177147; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Iglic A, 2006, J THEOR BIOL, V240, P368, DOI 10.1016/j.jtbi.2005.09.020; James J, 2008, CELL MOTIL CYTOSKEL, V65, P841, DOI 10.1002/cm.20305; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kim YS, 1999, ONCOGENE, V18, P5936, DOI 10.1038/sj.onc.1203005; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Loew LM, 2001, TRENDS BIOTECHNOL, V19, P401, DOI 10.1016/S0167-7799(01)01740-1; McLachlan N.W., 1947, THEORY APPL MATHIEU; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Rangamani P, 2011, BIOPHYS J, V100, P845, DOI 10.1016/j.bpj.2010.12.3732; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Ten Klooster JP, 2006, BIOCHEM J, V397, P39, DOI 10.1042/BJ20051957; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Xiong YG, 2010, BIOPHYS J, V98, P2136, DOI 10.1016/j.bpj.2010.01.059; Young B, 2006, WHEATERS FUNCTIONAL	40	101	101	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1356	1369		10.1016/j.cell.2013.08.026	http://dx.doi.org/10.1016/j.cell.2013.08.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034255	Green Accepted, Bronze			2022-12-28	WOS:000324239300022
J	Frisch, S				Frisch, Suzy			Healing with an eye on the clock	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERNS; CARE					suzyfrisch@yahoo.com						Desai SV, 2013, JAMA INTERN MED, V173, P649, DOI 10.1001/jamainternmed.2013.2973; Goitein L, 2013, JAMA INTERN MED, V173, P655, DOI 10.1001/jamainternmed.2013.740; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Schwartz SI, 2013, JAMA SURG, V148, P829, DOI 10.1001/jamasurg.2013.2677; Sen S, 2013, JAMA INTERN MED, V173, P657, DOI 10.1001/jamainternmed.2013.351	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2013	347								f5436	10.1136/bmj.f5436	http://dx.doi.org/10.1136/bmj.f5436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215NK	24014342				2022-12-28	WOS:000324216700005
J	Fields, RD				Fields, R. Douglas			Map the other brain	NATURE			English	Editorial Material									US Natl Inst Hlth, Nervous Syst Dev & Plast Sect, Bethesda, MD USA	National Institutes of Health (NIH) - USA	Fields, RD (corresponding author), US Natl Inst Hlth, Nervous Syst Dev & Plast Sect, Bethesda, MD USA.	fieldsd@mail.nih.gov			Intramural NIH HHS [Z01 HD000713-13] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Fields R. D., NEUROSCIENT IN PRESS; FIELDS RD, 2009, OTHER BRAIN; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Kettenmann H., 2013, NEUROGLIA; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	9	21	22	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 5	2013	501	7465					25	27		10.1038/501025a	http://dx.doi.org/10.1038/501025a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211ER	24010144	Bronze, Green Accepted			2022-12-28	WOS:000323888300012
J	Levy, BD				Levy, Bruce D.			Sphingolipids and Susceptibility to Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Levy, Bruce D.] Brigham & Womens Hosp, Dept Internal Med, Pulm & Crit Care Med Div, Boston, MA 02115 USA; [Levy, Bruce D.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Internal Med, Pulm & Crit Care Med Div, 75 Francis St, Boston, MA 02115 USA.				NIGMS NIH HHS [P01 GM095467] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Worgall TS, 2013, SCI TRANSL MED, V5	5	20	22	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 5	2013	369	10					976	978		10.1056/NEJMcibr1306864	http://dx.doi.org/10.1056/NEJMcibr1306864			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211KV	24004126				2022-12-28	WOS:000323906900016
J	Keplinger, C; Sun, JY; Foo, CC; Rothemund, P; Whitesides, GM; Suo, ZG				Keplinger, Christoph; Sun, Jeong-Yun; Foo, Choon Chiang; Rothemund, Philipp; Whitesides, George M.; Suo, Zhigang			Stretchable, Transparent, Ionic Conductors	SCIENCE			English	Article							ACTUATORS; FILM	Existing stretchable, transparent conductors are mostly electronic conductors. They limit the performance of interconnects, sensors, and actuators as components of stretchable electronics and soft machines. We describe a class of devices enabled by ionic conductors that are highly stretchable, fully transparent to light of all colors, and capable of operation at frequencies beyond 10 kilohertz and voltages above 10 kilovolts. We demonstrate a transparent actuator that can generate large strains and a transparent loudspeaker that produces sound over the entire audible range. The electromechanical transduction is achieved without electrochemical reaction. The ionic conductors have higher resistivity than many electronic conductors; however, when large stretchability and high transmittance are required, the ionic conductors have lower sheet resistance than all existing electronic conductors.	[Keplinger, Christoph; Sun, Jeong-Yun; Foo, Choon Chiang; Rothemund, Philipp; Suo, Zhigang] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Keplinger, Christoph; Sun, Jeong-Yun; Foo, Choon Chiang; Rothemund, Philipp; Whitesides, George M.; Suo, Zhigang] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA; [Keplinger, Christoph; Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Foo, Choon Chiang] Inst High Performance Comp, Singapore 138632, Singapore; [Whitesides, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA.	GWhitesides@gmwgroup.harvard.edu; suo@seas.harvard.edu	Sun, Jeong-Yun/AAR-4630-2020; Foo, Choon Chiang/F-8442-2010; Keplinger, Christoph/E-5553-2011; Rothemund, Philipp/V-7037-2019; Suo, Zhigang/B-1067-2008; Foo, Choon Chiang/AAA-2869-2020	Foo, Choon Chiang/0000-0002-4423-3055; Keplinger, Christoph/0000-0001-9151-4100; Suo, Zhigang/0000-0002-4068-4844; Foo, Choon Chiang/0000-0002-4423-3055; Rothemund, Philipp Josef Michael/0000-0002-0588-6993	NSF Materials Research Science and Engineering Centers [DMR-0820484]; Army Research Office [W911NF-09-1-0476]; Department of Energy [ER45852]; A*STAR graduate scholarship	NSF Materials Research Science and Engineering Centers(National Science Foundation (NSF)); Army Research Office; Department of Energy(United States Department of Energy (DOE)); A*STAR graduate scholarship(Agency for Science Technology & Research (A*STAR))	This work is supported by the NSF Materials Research Science and Engineering Centers (DMR-0820484) and by the Army Research Office (W911NF-09-1-0476). We acknowledge Department of Energy award number ER45852 for salary support of C. K.; C. C. F. acknowledges support from A*STAR graduate scholarship (Post-Doctoral Fellowship). The authors (J.-Y.S., C. K., Z.S., and G. M. W.) have filed a patent application relating to stretchable, ionic, ultratransparent conductors capable of operation at high frequency and voltage. We acknowledge the discussions with D. Bwambok and H. Ardebili and her students on ionic liquids.	Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Carpi F, 2010, SCIENCE, V330, P1759, DOI 10.1126/science.1194773; De S, 2010, SMALL, V6, P458, DOI 10.1002/smll.200901162; De S, 2009, ACS NANO, V3, P1767, DOI 10.1021/nn900348c; Dickey MD, 2008, ADV FUNCT MATER, V18, P1097, DOI 10.1002/adfm.200701216; Heydt R., 2006, P SOC PHOTO-OPT INS, V616; Hu LB, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3114463; Hu WL, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/34/344002; Jager EWH, 2000, SCIENCE, V290, P1540, DOI 10.1126/science.290.5496.1540; Keplinger C, 2012, SOFT MATTER, V8, P285, DOI 10.1039/c1sm06736b; Keplinger C, 2010, P NATL ACAD SCI USA, V107, P4505, DOI 10.1073/pnas.0913461107; Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Lacour SP, 2003, APPL PHYS LETT, V82, P2404, DOI 10.1063/1.1565683; Lee KH, 2012, ADV MATER, V24, P4457, DOI 10.1002/adma.201200950; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Lipomi DJ, 2011, ENERG ENVIRON SCI, V4, P3314, DOI 10.1039/c1ee01881g; Manandhar P, 2012, IEEE SENS J, V12, P2052, DOI 10.1109/JSEN.2011.2181993; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Quilliet C, 2001, CURR OPIN COLLOID IN, V6, P34, DOI 10.1016/S1359-0294(00)00085-6; Rosset S, 2013, APPL PHYS A-MATER, V110, P281, DOI 10.1007/s00339-012-7402-8; Scardaci V, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462317; Shahinpoor M, 1998, SMART MATER STRUCT, V7, pR15, DOI 10.1088/0964-1726/7/6/001; Someya T., 2013, STRETCHABLE ELECT; Sugimoto T, 2011, J ACOUST SOC AM, V130, P744, DOI 10.1121/1.3605561; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Xu SC, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4802079; Yu X, 2006, SENSOR ACTUAT A-PHYS, V132, P626, DOI 10.1016/j.sna.2006.02.045; Yu ZB, 2011, ADV MATER, V23, P664, DOI 10.1002/adma.201003398; Zhao QB, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3691930	30	1141	1187	103	1485	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					984	987		10.1126/science.1240228	http://dx.doi.org/10.1126/science.1240228			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990555	Green Submitted			2022-12-28	WOS:000323652300037
J	Caruso, TJ; Fuzaylov, G				Caruso, Thomas J.; Fuzaylov, Gennadiy			Severe Vitamin D Deficiency Rickets	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 12-year-old girl from Ukraine was hospitalized for evaluation of a history of long-bone fractures and failure to thrive. On initial presentation, she had hypocalcemia (calcium level, 6.7 mg per deciliter [1.7 mmol per liter]), a low 25-hydroxyvitamin D level (5 ng per milliliter [12 nmol per liter]), an elevated parathyroid hormone level (435 pg per milliliter), an elevated alkaline phosphatase level (546 U per liter), and a normal phosphorus level (4.1 mg per deciliter [1.3 mmol per liter]). These findings were consistent with vitamin D-deficient rickets. She also showed multiple sequelae of long-standing rickets, including costochondral swelling (rachitic rosary), ...	[Caruso, Thomas J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Fuzaylov, Gennadiy] Shriners Hosp Children, Boston, MA USA	Harvard University; Massachusetts General Hospital	Caruso, TJ (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.			Caruso, Thomas J./0000-0002-0723-5262					0	4	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					E11	E11		10.1056/NEJMicm1205540	http://dx.doi.org/10.1056/NEJMicm1205540			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208KB	23984751				2022-12-28	WOS:000323676100001
J	Iyengar, SR; Ebb, DH; Yuan, Q; Shailam, R; Bhan, AK				Iyengar, Shuba R.; Ebb, David H.; Yuan, Qian; Shailam, Randheer; Bhan, Atul K.			Case 27-2013: A 6.5-Month-Old Boy with Fever, Rash, and Cytopenias	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; IMMUNE THROMBOCYTOPENIC PURPURA; SYNDROME ALPS; T-CELLS; CHILDREN; EXPRESSION; MANAGEMENT; APOPTOSIS; ONSET		[Ebb, David H.; Yuan, Qian] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Shailam, Randheer] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Bhan, Atul K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ebb, David H.; Yuan, Qian] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Shailam, Randheer] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Bhan, Atul K.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Iyengar, SR (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							Blanchette V, 2010, HEMATOL ONCOL CLIN N, V24, P249, DOI 10.1016/j.hoc.2009.11.004; Bleesing JJH, 2001, CELL IMMUNOL, V213, P72, DOI 10.1006/cimm.2001.1865; Bleesing JJH, 2001, SEMIN HEMATOL, V38, P100, DOI 10.1053/shem.2001.21922; Bowen RAR, 2012, CLIN BIOCHEM, V45, P490, DOI 10.1016/j.clinbiochem.2012.01.016; Bristeau-Leprince A, 2008, J IMMUNOL, V181, P440, DOI 10.4049/jimmunol.181.1.440; BUSSEL JB, 1991, BLOOD, V77, P1884; D'Orazio John A, 2013, J Pediatr Hematol Oncol, V35, P1, DOI 10.1097/MPH.0b013e318271f457; Kuhne T, 2003, J PEDIATR-US, V143, P605, DOI 10.1067/S0022-3476(03)00535-3; Lim MS, 1998, AM J PATHOL, V153, P1541, DOI 10.1016/S0002-9440(10)65742-2; Magerus-Chatinet A, 2011, J CLIN INVEST, V121, P106, DOI 10.1172/JCI43752; Magerus-Chatinet A, 2009, BLOOD, V113, P3027, DOI 10.1182/blood-2008-09-179630; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Ohga S, 2002, BRIT J HAEMATOL, V119, P535, DOI 10.1046/j.1365-2141.2002.03848.x; Oliveira JB, 2010, BLOOD, V116, pE35, DOI 10.1182/blood-2010-04-280347; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Seif AE, 2010, BLOOD, V115, P2142, DOI 10.1182/blood-2009-08-239525; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Turbyville JC, 2010, AUTOIMMUN REV, V9, P488, DOI 10.1016/j.autrev.2010.02.007; Yong PL, 2010, PEDIAT ALLERG IMM-UK, V21, P852, DOI 10.1111/j.1399-3038.2010.01004.x	20	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					853	863		10.1056/NEJMcpc1209277	http://dx.doi.org/10.1056/NEJMcpc1209277			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208KB	23984733				2022-12-28	WOS:000323676100013
J	Briggs, JP; Killen, J				Briggs, Josephine P.; Killen, Jack			Perspectives on Complementary and Alternative Medicine Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Briggs, Josephine P.; Killen, Jack] NIH, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Briggs, JP (corresponding author), Natl Ctr Complementary & Alternat Med, 31 Ctr Dr,Bldg 31,Ste 2B11, Bethesda, MD 20814 USA.	briggsj@mail.nih.gov						[Anonymous], 2012, NBJS SUPPLEMENT BUSI; [Anonymous], SPOTLIGHTED RESEARCH; [Anonymous], 2010, PAIN MANAGEMENT TASK; Barnes P. M., 2007, COMPLEMENTARY ALTERN; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Offit PA, 2012, JAMA-J AM MED ASSOC, V307, P1803, DOI 10.1001/jama.2012.518; Schultz AM, 2009, INTEGRATIVE MEDICINE	7	21	22	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 21	2013	310	7					691	692		10.1001/jama.2013.6540	http://dx.doi.org/10.1001/jama.2013.6540			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202XP	23990064				2022-12-28	WOS:000323254500015
J	Sjauw, KD; Piek, JJ				Sjauw, Krischan D.; Piek, Jan J.			Is the intra-aortic balloon pump leaking?	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; CARDIOGENIC-SHOCK; CONTROLLED-TRIAL; MANAGEMENT		[Sjauw, Krischan D.; Piek, Jan J.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Piek, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands.	j.j.piek@amc.uva.nl						Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2003, CIRCULATION, V107, P2998, DOI 10.1161/01.CIR.0000075927.67673.F2; Hochman JS, 2007, JAMA-J AM MED ASSOC, V297, P1657; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Perera D, 2013, CIRCULATION, V127, P207, DOI 10.1161/CIRCULATIONAHA.112.132209; Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Thiele H, 2013, LANCET; Thiele H, 2007, EUR HEART J, V28, P2057, DOI 10.1093/eurheartj/ehm191; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410	12	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1616	1617		10.1016/S0140-6736(13)61811-5	http://dx.doi.org/10.1016/S0140-6736(13)61811-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254CN	24011549				2022-12-28	WOS:000327140700008
J	Imazio, M; Brucato, A; Cemin, R; Ferrua, S; Maggiolini, S; Beqaraj, F; Demarie, D; Forno, D; Ferro, S; Maestroni, S; Belli, R; Trinchero, R; Spodick, DH; Adler, Y				Imazio, Massimo; Brucato, Antonio; Cemin, Roberto; Ferrua, Stefania; Maggiolini, Stefano; Beqaraj, Federico; Demarie, Daniela; Forno, Davide; Ferro, Silvia; Maestroni, Silvia; Belli, Riccardo; Trinchero, Rita; Spodick, David H.; Adler, Yehuda		ICAP Investigators	A Randomized Trial of Colchicine for Acute Pericarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECURRENT PERICARDITIS; CONVENTIONAL THERAPY; ETIOLOGIC DIAGNOSIS; MANAGEMENT	BackgroundColchicine is effective for the treatment of recurrent pericarditis. However, conclusive data are lacking regarding the use of colchicine during a first attack of acute pericarditis and in the prevention of recurrent symptoms. MethodsIn a multicenter, double-blind trial, eligible adults with acute pericarditis were randomly assigned to receive either colchicine (at a dose of 0.5 mg twice daily for 3 months for patients weighing >70 kg or 0.5 mg once daily for patients weighing 70 kg) or placebo in addition to conventional antiinflammatory therapy with aspirin or ibuprofen. The primary study outcome was incessant or recurrent pericarditis. ResultsA total of 240 patients were enrolled, and 120 were randomly assigned to each of the two study groups. The primary outcome occurred in 20 patients (16.7%) in the colchicine group and 45 patients (37.5%) in the placebo group (relative risk reduction in the colchicine group, 0.56; 95% confidence interval, 0.30 to 0.72; number needed to treat, 4; P<0.001). Colchicine reduced the rate of symptom persistence at 72 hours (19.2% vs. 40.0%, P=0.001), the number of recurrences per patient (0.21 vs. 0.52, P=0.001), and the hospitalization rate (5.0% vs. 14.2%, P=0.02). Colchicine also improved the remission rate at 1 week (85.0% vs. 58.3%, P<0.001). Overall adverse effects and rates of study-drug discontinuation were similar in the two study groups. No serious adverse events were observed. ConclusionsIn patients with acute pericarditis, colchicine, when added to conventional antiinflammatory therapy, significantly reduced the rate of incessant or recurrent pericarditis. (Funded by former Azienda Sanitaria Locale 3 of Turin [now Azienda Sanitaria Locale 2] and Acarpia; ICAP ClinicalTrials.gov number, NCT00128453.)	[Imazio, Massimo; Beqaraj, Federico; Demarie, Daniela; Forno, Davide; Ferro, Silvia; Belli, Riccardo; Trinchero, Rita] Maria Vittoria Hosp, Dept Cardiol, I-10141 Turin, Italy; [Brucato, Antonio; Maestroni, Silvia] Osped Papa Giovanni XXIII, Dept Internal Med, Bergamo, Italy; [Cemin, Roberto] San Maurizio Reg Hosp, Dept Cardiol, Bolzano, Italy; [Ferro, Silvia] Osped Infermi, Dept Cardiol, Rivoli, Italy; [Maggiolini, Stefano] S Leopoldo Mandic Hosp, Cardiovasc Dept, Merate, Italy; [Spodick, David H.] St Vincent Hosp, Dept Internal Med, Worcester, MA 01604 USA; [Adler, Yehuda] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Adler, Yehuda] Sacker Fac Med, Tel Aviv, Israel	Maria Vittoria Hospital; ASST Papa Giovanni XXIII; Krankenhaus Bozen; Hospital of Rimini; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Imazio, M (corresponding author), Maria Vittoria Hosp, Dept Cardiol, Via Luigi Cibrario 72, I-10141 Turin, Italy.	massimo_imazio@yahoo.it	brucato, antonio/U-6879-2019	brucato, antonio/0000-0002-7566-5600; Imazio, Massimo/0000-0002-5722-0245	Azienda Sanitaria Locale 2; Acarpia	Azienda Sanitaria Locale 2; Acarpia	Funded by former Azienda Sanitaria Locale 3 of Turin [now Azienda Sanitaria Locale 2] and Acarpia; ICAP ClinicalTrials.gov number, NCT00128453.	Adler Y, 1998, CIRCULATION, V97, P2183, DOI 10.1161/01.CIR.97.21.2183; Brucato A, 2008, AUTOIMMUN REV, V8, P44, DOI 10.1016/j.autrev.2008.07.024; Caforio ALP, 2010, HEART, V96, P779, DOI 10.1136/hrt.2009.187138; Cocco G, 2010, EUR J INTERN MED, V21, P503, DOI 10.1016/j.ejim.2010.09.010; Imazio M, 2005, CIRCULATION, V112, P2012, DOI 10.1161/CIRCULATIONAHA.105.542738; Imazio M, 2005, ARCH INTERN MED, V165, P1987, DOI 10.1001/archinte.165.17.1987; Imazio M, 2004, J AM COLL CARDIOL, V43, P1042, DOI 10.1016/j.jacc.2003.09.055; Imazio M, 2008, CIRCULATION, V118, P667, DOI 10.1161/CIRCULATIONAHA.107.761064; Imazio M, 2007, J CARDIOVASC MED, V8, P613, DOI 10.2459/01.JCM.0000281702.46359.07; Imazio M, 2012, HEART, V98, P1078, DOI 10.1136/heartjnl-2011-301306; Imazio M, 2012, CURR OPIN CARDIOL, V27, P308, DOI 10.1097/HCO.0b013e3283524fbe; Imazio M, 2011, ANN INTERN MED, V155, P409, DOI 10.7326/0003-4819-155-7-201110040-00359; Imazio M, 2010, CIRCULATION, V121, P916, DOI 10.1161/CIRCULATIONAHA.108.844753; Imazio M, 2009, J CARDIOVASC MED, V10, P217, DOI 10.2459/JCM.0b013e328322f9b1; Imazio M, 2009, EUR HEART J, V30, P532, DOI 10.1093/eurheartj/ehn608; Lange RA, 2005, NEW ENGL J MED, V352, P1155; Lange RA, 2004, NEW ENGL J MED, V351, P2195, DOI 10.1056/NEJMcp041997; Little, 2007, CIRCULATION, V115, pE406, DOI 10.1161/CIRCULATIONAHA.107.182028; Little WC, 2006, CIRCULATION, V113, P1622, DOI 10.1161/CIRCULATIONAHA.105.561514; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; MILLAIRE A, 1991, CIRCULATION, V83, P1458, DOI 10.1161/circ.83.4.2064652; PERMANYERMIRALDA G, 1985, AM J CARDIOL, V56, P623, DOI 10.1016/0002-9149(85)91023-9; Soler-Soler J, 2004, HEART, V90, P1364, DOI 10.1136/hrt.2003.026120; ZAYAS R, 1995, AM J CARDIOL, V75, P378, DOI 10.1016/S0002-9149(99)80558-X	24	301	317	3	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 17	2013	369	16					1522	1528		10.1056/NEJMoa1208536	http://dx.doi.org/10.1056/NEJMoa1208536			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	267MJ	23992557				2022-12-28	WOS:000328101700009
J	Mangravite, LM; Engelhardt, BE; Medina, MW; Smith, JD; Brown, CD; Chasman, DI; Mecham, BH; Howie, B; Shim, H; Naidoo, D; Feng, QP; Rieder, MJ; Chen, YDI; Rotter, JI; Ridker, PM; Hopewell, JC; Parish, S; Armitage, J; Collins, R; Wilke, RA; Nickerson, DA; Stephens, M; Krauss, RM				Mangravite, Lara M.; Engelhardt, Barbara E.; Medina, Marisa W.; Smith, Joshua D.; Brown, Christopher D.; Chasman, Daniel I.; Mecham, Brigham H.; Howie, Bryan; Shim, Heejung; Naidoo, Devesh; Feng, QiPing; Rieder, Mark J.; Chen, Yii-Der I.; Rotter, Jerome I.; Ridker, Paul M.; Hopewell, Jemma C.; Parish, Sarah; Armitage, Jane; Collins, Rory; Wilke, Russell A.; Nickerson, Deborah A.; Stephens, Matthew; Krauss, Ronald M.			A statin-dependent QTL for GATM expression is associated with statin-induced myopathy	NATURE			English	Article							LIPID-LOWERING RESPONSE; SIMVASTATIN THERAPY; GENE-EXPRESSION; CHOLESTEROL; TRANSFORMATION; DISCOVERY; RISK; LOCI	Statins are prescribed widely to lower plasma low-density lipoprotein (LDL) concentrations and cardiovascular disease risk(1) and have been shown to have beneficial effects in a broad range of patients(2,3). However, statins are associated with an increased risk, albeit small, of clinical myopathy(4) and type 2 diabetes(5). Despite evidence for substantial genetic influence on LDL concentrations(6), pharmacogenomic trials have failed to identify genetic variations with large effects on either statin efficacy(7-9) or toxicity(10), and have produced little information regarding mechanisms that modulate statin response. Here we identify a downstream target of statin treatment by screening for the effects of in vitro statin exposure on genetic associations with gene expression levels in lymphoblastoid cell lines derived from 480 participants of a clinical trial of simvastatin treatment(7). This analysis identified six expression quantitative trait loci (eQTLs) that interacted with simvastatin exposure, including rs9806699, a cis-eQTL for the gene glycine amidinotransferase (GATM) that encodes the rate-limiting enzyme in creatine synthesis. We found this locus to be associated with incidence of statin-induced myotoxicity in two separate populations (meta-analysis odds ratio = 0.60). Furthermore, we found that GATM knockdown in hepatocyte-derived cell lines attenuated transcriptional response to sterol depletion, demonstrating that GATM may act as a functional link between statin-mediated lowering of cholesterol and susceptibility to statin-induced myopathy.	[Mangravite, Lara M.; Mecham, Brigham H.] Sage Bionetworks, Seattle, WA 98109 USA; [Engelhardt, Barbara E.; Howie, Bryan; Shim, Heejung; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Medina, Marisa W.; Naidoo, Devesh; Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Smith, Joshua D.; Rieder, Mark J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Brown, Christopher D.] Univ Penn, Dept Genet, Philadelphia, PA 19103 USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Preventat Med, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; [Feng, QiPing; Wilke, Russell A.] Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, Dept Med, Nashville, TN 37232 USA; [Chen, Yii-Der I.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90502 USA; [Hopewell, Jemma C.; Parish, Sarah; Armitage, Jane; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Hopewell, Jemma C.; Parish, Sarah; Armitage, Jane; Collins, Rory] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Washington; University of Washington Seattle; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; Vanderbilt University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of Oxford; University of Oxford; University of Chicago	Mangravite, LM (corresponding author), Sage Bionetworks, 1100 Fairview Ave North, Seattle, WA 98109 USA.	lara.mangravite@sagebase.org; mstephens@uchicago.edu; rkrauss@chori.org	Rotter, Jerome/AAY-6598-2021	Hopewell, Jemma/0000-0002-3870-8018; Brown, Christopher/0000-0002-3785-5008; Mangravite, Lara/0000-0001-7841-3612; Shim, Heejung/0000-0002-1375-9310; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Engelhardt, Barbara/0000-0002-6139-7334	US National Institutes of Health (NIH) [U01 HL69757]; Bioinformatics Research Development Fund; NIH [K99/R00HG006265, HG002585]; Medical Research Council; British Heart Foundation; National Health Service Genetic Knowledge Park; Centre National de Genotypage; Merck; Roche Vitamins; BHF Centre of Research Excellence, Oxford, UK; AstraZeneca; MRC [MC_U137686853] Funding Source: UKRI; Medical Research Council [MC_U137686853] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757, R01HL104133] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG006265, K99HG006265, R01HG002585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bioinformatics Research Development Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Health Service Genetic Knowledge Park; Centre National de Genotypage; Merck(Merck & Company); Roche Vitamins; BHF Centre of Research Excellence, Oxford, UK; AstraZeneca(AstraZeneca); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was funded by a grant from the US National Institutes of Health (NIH), U01 HL69757. B.E.E. was funded through the Bioinformatics Research Development Fund, supported by K. and G. Gould and NIH grant K99/R00HG006265. M.S. was funded by NIH grant HG002585. We acknowledge the efforts of T. Kitchner and R. Mareedu for case validation in the Marshfield cohort. SEARCH was supported by the Medical Research Council, British Heart Foundation, National Health Service Genetic Knowledge Park, Centre National de Genotypage and Merck. The Heart Protection Study was funded by grants from the Medical Research Council, British Heart Foundation, Roche Vitamins and Merck. J.C.H. acknowledges support from the BHF Centre of Research Excellence, Oxford, UK. Genetic analysis in JUPITER was funded by a grant from AstraZeneca to D.I.C. and P.M.R.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Caliskan M, 2011, HUM MOL GENET, V20, P1643, DOI 10.1093/hmg/ddr041; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Choe CU, 2013, HUM MOL GENET, V22, P110, DOI 10.1093/hmg/dds407; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Edvardson S, 2010, MOL GENET METAB, V101, P228, DOI 10.1016/j.ymgme.2010.06.021; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Grundberg E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001279; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Hopewell JC, 2013, EUR HEART J, V34, P982, DOI 10.1093/eurheartj/ehs344; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Mangravite LM, 2010, ARTERIOSCL THROM VAS, V30, P1485, DOI 10.1161/ATVBAHA.110.203273; Maranville JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002162; Mareedu Ravi K, 2009, Prev Cardiol, V12, P88, DOI 10.1111/j.1751-7141.2009.00028.x; Mecham BH, 2010, BIOINFORMATICS, V26, P1308, DOI 10.1093/bioinformatics/btq118; Medina MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019420; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; PRESSMAN S, 1991, AM J HUM GENET, V49, P467; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Smirnov DA, 2012, GENOME RES, V22, P332, DOI 10.1101/gr.122044.111; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trompet S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-131; Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423	40	156	157	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 17	2013	502	7471					377	+		10.1038/nature12508	http://dx.doi.org/10.1038/nature12508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	235GY	23995691	Green Accepted, Green Submitted			2022-12-28	WOS:000325706300054
J	Buller, HR; Decousus, H; Grosso, MA; Mercuri, M; Middeldorp, S; Prins, MH; Raskob, GE; Schellong, SM; Schwocho, L; Segers, A; Shi, MG; Verhamme, P; Wells, P				Bueller, Harry R.; Decousus, Herve; Grosso, Michael A.; Mercuri, Michele; Middeldorp, Saskia; Prins, Martin H.; Raskob, Gary E.; Schellong, Sebastian M.; Schwocho, Lee; Segers, Annelise; Shi, Minggao; Verhamme, Peter; Wells, Phil		Hokusai-VTE Investigators	Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACTOR XA INHIBITOR; PULMONARY-EMBOLISM; STROKE PREVENTION; EPIDEMIOLOGY; DYSFUNCTION; DABIGATRAN; COMMUNITY	BackgroundWhether the oral factor Xa inhibitor edoxaban can be an alternative to warfarin in patients with venous thromboembolism is unclear. MethodsIn a randomized, double-blind, noninferiority study, we randomly assigned patients with acute venous thromboembolism, who had initially received heparin, to receive edoxaban at a dose of 60 mg once daily, or 30 mg once daily (e.g., in the case of patients with creatinine clearance of 30 to 50 ml per minute or a body weight below 60 kg), or to receive warfarin. Patients received the study drug for 3 to 12 months. The primary efficacy outcome was recurrent symptomatic venous thromboembolism. The principal safety outcome was major or clinically relevant nonmajor bleeding. ResultsA total of 4921 patients presented with deep-vein thrombosis, and 3319 with a pulmonary embolism. Among patients receiving warfarin, the time in the therapeutic range was 63.5%. Edoxaban was noninferior to warfarin with respect to the primary efficacy outcome, which occurred in 130 patients in the edoxaban group (3.2%) and 146 patients in the warfarin group (3.5%) (hazard ratio, 0.89; 95% confidence interval [CI], 0.70 to 1.13; P<0.001 for noninferiority). The safety outcome occurred in 349 patients (8.5%) in the edoxaban group and 423 patients (10.3%) in the warfarin group (hazard ratio, 0.81; 95% CI, 0.71 to 0.94; P=0.004 for superiority). The rates of other adverse events were similar in the two groups. A total of 938 patients with pulmonary embolism had right ventricular dysfunction, as assessed by measurement of N-terminal pro-brain natriuretic peptide levels; the rate of recurrent venous thromboembolism in this subgroup was 3.3% in the edoxaban group and 6.2% in the warfarin group (hazard ratio, 0.52; 95% CI, 0.28 to 0.98). ConclusionsEdoxaban administered once daily after initial treatment with heparin was noninferior to high-quality standard therapy and caused significantly less bleeding in a broad spectrum of patients with venous thromboembolism, including those with severe pulmonary embolism. (Funded by Daiichi-Sankyo; Hokusai-VTE ClinicalTrials.gov number, NCT00986154.) The anticoagulant edoxaban, an oral inhibitor of activated factor X, does not require monitoring. As initial treatment for acute venous thromboembolism, heparin-edoxaban was noninferior to heparin-warfarin and caused less bleeding. Venous thromboembolism is the third most common cardiovascular disease after myocardial infarction and stroke, affecting at least 700,000 persons annually in North America.(1)-(3) The standard treatment consists of low-molecular-weight heparin followed by vitamin K antagonists.(4) A number of studies have established that new oral anticoagulants with or without initial heparin therapy are effective alternatives.(5)-(8) Edoxaban is a direct inhibitor of activated factor X with a rapid onset of action. It is administered orally once daily and has proven antithrombotic efficacy.(9)-(11) The Hokusai-VTE study was a randomized, double-blind clinical trial that was conducted to evaluate edoxaban for the ...	[Bueller, Harry R.; Middeldorp, Saskia] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, F4-275,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Decousus, Herve] Univ St Etienne, Ctr Hosp Univ, INSERM CIE3, St Etienne, France; [Grosso, Michael A.; Mercuri, Michele; Schwocho, Lee; Shi, Minggao] Daiichi Sankyo Pharma Dev, Edison, NJ USA; [Prins, Martin H.] Maastricht Univ Med Ctr, Dept Epidemiol, Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Raskob, Gary E.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA; [Schellong, Sebastian M.] Municipal Hosp Friedrichstadt, Dresden, Germany; [Segers, Annelise] Int Clin Trial Org, Amsterdam, Netherlands; [Segers, Annelise] Management Acad Res Org, Amsterdam, Netherlands; [Verhamme, Peter] Katholieke Univ Leuven Hosp, Dept Vasc Med & Hemostasis, Leuven, Belgium; [Wells, Phil] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wells, Phil] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Amsterdam; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Daiichi Sankyo Company Limited; Maastricht University; Maastricht University Medical Centre (MUMC); University of Oklahoma System; University of Oklahoma Health Sciences Center; KU Leuven; University Hospital Leuven; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Buller, HR (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, F4-275,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	h.r.buller@amc.uva.nl	Apartsin, Konstantin A/B-9179-2017; Ferrari, Emile/R-2917-2016; DOMINGUEZ, Helena/ABC-1905-2021; Shesternya, Pavel/M-3898-2014; Beyer-Westendorf, Jan/K-7569-2019; Traby, Ludwig/ABC-2338-2020; Apartsin, Konstantin/ACA-8088-2022; Bredie, Sebastian JH/L-4226-2015; Lazo-Langner, Alejandro/E-6993-2011; Pasca, Samantha/AAM-5310-2020; Apartsin, Konstantin/ABC-5678-2020; Quere, Isabelle/AAB-8519-2020; Kovacs, Michael/G-3315-2011; Lodigiani, Corrado/AAW-1964-2020; Middeldorp, Saskia/ABI-8197-2020	Apartsin, Konstantin A/0000-0003-0577-9001; DOMINGUEZ, Helena/0000-0002-7089-2636; Shesternya, Pavel/0000-0001-8652-1410; Beyer-Westendorf, Jan/0000-0002-6983-9993; Traby, Ludwig/0000-0003-2861-5771; Apartsin, Konstantin/0000-0003-0577-9001; Bredie, Sebastian JH/0000-0002-6973-7540; Lazo-Langner, Alejandro/0000-0001-6869-8431; Pasca, Samantha/0000-0002-0954-013X; Apartsin, Konstantin/0000-0003-0577-9001; Quere, Isabelle/0000-0002-1492-9764; Lodigiani, Corrado/0000-0002-9152-9385; Middeldorp, Saskia/0000-0002-1006-6420; Gladchenko, Mikhail/0000-0003-3627-9747; Couturaud, Francis/0000-0002-1855-8032; Ozkan, Serir/0000-0001-5460-8300; Farkas, Katalin/0000-0001-5577-6808; Mahuad, Carolina/0000-0002-3862-8122; Ritchie, Bruce/0000-0003-4754-1050; Dees, Adriaan/0000-0001-9164-4538; Lacut, Karine/0000-0002-4849-0454; SANCHEZ, Olivier/0000-0003-1633-8391; Meijer, Karina/0000-0001-9447-0465; Picchi, Chiara/0000-0002-7240-3920; Marschang, Peter/0000-0002-8239-3447; Kolossvary, Endre/0000-0003-4507-6175	Daiichi-Sankyo; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Isis Pharmaceuticals; ThromboGenics; Pfizer; GlaxoSmithKline; Bristol-Myers Squibb-Pfizer; Portola; Sanquin; Janssen; Johnson Johnson; Sanofi-Aventis; Takeda; Leo Pharma; Biomerieux	Daiichi-Sankyo(Daiichi Sankyo Company Limited); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Isis Pharmaceuticals; ThromboGenics; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Bristol-Myers Squibb-Pfizer(Bristol-Myers SquibbPfizer); Portola; Sanquin; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Sanofi-Aventis(Sanofi-Aventis); Takeda(Takeda Pharmaceutical Company Ltd); Leo Pharma(LEO Pharma); Biomerieux	Supported by Daiichi-Sankyo.r Dr. Buller reports receiving consulting fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Isis Pharmaceuticals, and ThromboGenics, and grant support from Bayer and Pfizer. Dr. Decousus reports receiving fees for board membership from Bayer and Daiichi Sankyo, lecture fees from GlaxoSmithKline, and grant support from Bayer, Bristol-Myers Squibb-Pfizer, Boehringer Ingelheim, and Portola. Drs. Grosso, Mercuri, Schwocho, and Shi report being employees of Daiichi Sankyo. Dr. Middel-dorp reports receiving consulting fees from Bayer and Bristol-Myers Squibb-Pfizer, lecture fees from Bayer, GlaxoSmithKline, Bristol-Myers Squibb-Pfizer, and Boehringer Ingelheim, and grant support from GlaxoSmithKline, Bristol-Myers Squibb-Pfizer, and Sanquin. Dr. Prins reports receiving consulting fees from Bayer, Pfizer, and Boehringer Ingelheim, and lecture fees from Bayer. Dr. Raskob reports receiving consulting fees and travel support from Bayer, Bristol-Myers Squibb, Janssen, Johnson & Johnson, Pfizer, Sanofi-Aventis, and Takeda. Dr. Schellong reports receiving consulting fees from Bayer and Boehringer Ingelheim, and lecture fees from Bayer, Boehringer Ingelheim, and Bristol-Myers Squibb-Pfizer. Dr. Segers reports receiving fees for the scientific management of the studies as director of the International Clinical Trial Organization and Management (ICTOM) academic research organization from Bayer, Isis Pharmaceuticals, and Pfizer. Dr. Verhamme reports receiving consulting fees from Bayer, Boehringer Ingelheim, ThromboGenics, and Pfizer, lecture fees from Bayer, Boehringer Ingelheim, Leo Pharma, Sanofi-Aventis, and Pfizer, and grant support from Bayer, Boehringer Ingelheim, Leo Pharma, and Sanofi-Aventis. Dr. Wells reports receiving lecture fees from Bayer, Boehringer Ingelheim, Biomerieux, and Bristol-Myers Squibb-Pfizer. No other potential conflict of interest relevant to this article was reported.	Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Fleming TR, 2011, ANN INTERN MED, V154, P113, DOI 10.7326/0003-4819-154-2-201101180-00010; Fuji T, 2010, J THROMB HAEMOST, V8, P2458, DOI 10.1111/j.1538-7836.2010.04021.x; Furlan A, 2012, RADIOLOGY, V265, P283, DOI 10.1148/radiol.12110802; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Kearon C, 2012, CHEST, V142, P1075, DOI 10.1378/chest.12-1303; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Lega JC, 2009, THORAX, V64, P869, DOI 10.1136/thx.2008.110965; Lu MT, 2012, AM J ROENTGENOL, V198, P1353, DOI 10.2214/AJR.11.7439; Ranganathan N, 2010, ADV THER, V27, P634, DOI [10.1007/s12325-010-0059-9, 10.1007/s12325-010-0056-z]; Raskob G, 2013, J THROMB HAEMOST, V11, P1287, DOI 10.1111/jth.12230; Raskob G, 2010, THROMB HAEMOSTASIS, V104, P642, DOI 10.1160/TH10-02-0142; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sanchez O, 2008, EUR HEART J, V29, P1569, DOI 10.1093/eurheartj/ehn208; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Weitz JI, 2010, THROMB HAEMOSTASIS, V104, P633, DOI 10.1160/TH10-01-0066; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Willey VJ, 2004, CLIN THER, V26, P1149, DOI 10.1016/S0149-2918(04)90187-7	24	1213	1256	2	117	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 10	2013	369	15					1406	1415		10.1056/NEJMoa1306638	http://dx.doi.org/10.1056/NEJMoa1306638			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	231QE	23991658	Green Published			2022-12-28	WOS:000325431500008
J	O'Donoghue, G				O'Donoghue, Gerard			Cochlear Implants - Science, Serendipity, and Success	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[O'Donoghue, Gerard] Queens Med Ctr, Natl Inst Hlth Res, Nottingham Hearing Biomed Res Unit, Nottingham NG7 2UH, England; [O'Donoghue, Gerard] Queens Med Ctr, Dept Otolaryngol, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	O'Donoghue, G (corresponding author), Queens Med Ctr, Natl Inst Hlth Res, Nottingham Hearing Biomed Res Unit, Nottingham NG7 2UH, England.							BURIAN K, 1979, ACTA OTO-LARYNGOL, V87, P190, DOI 10.3109/00016487909126406; CLARK GM, 1969, EXP NEUROL, V24, P124, DOI 10.1016/0014-4886(69)90010-7; House WF, 2011, CREATESPACE; Kral A, 2013, NEUROSCIENCE, V247, P117, DOI 10.1016/j.neuroscience.2013.05.021; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0	5	35	35	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 26	2013	369	13					1190	1193		10.1056/NEJMp1310111	http://dx.doi.org/10.1056/NEJMp1310111			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224LT	24015974				2022-12-28	WOS:000324888200004
J	Nicholls, SJ; Bakris, GL; Kastelein, JJP; Menon, V; Williams, B; Armbrecht, J; Brunel, P; Nicolaides, M; Hsu, A; Hu, B; Fang, H; Puri, R; Uno, K; Kataoka, Y; Bash, D; Nissen, SE				Nicholls, Stephen J.; Bakris, George L.; Kastelein, John J. P.; Menon, Venu; Williams, Bryan; Armbrecht, Juergen; Brunel, Patrick; Nicolaides, Maria; Hsu, Amy; Hu, Bo; Fang, Hui; Puri, Rishi; Uno, Kiyoko; Kataoka, Yu; Bash, Dianna; Nissen, Steven E.			Effect of Aliskiren on Progression of Coronary Disease in Patients With Prehypertension The AQUARIUS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANGIOTENSIN-ALDOSTERONE SYSTEM; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE; RENIN; ATHEROSCLEROSIS; INHIBITION; PREVENTION; MORTALITY; THERAPY; RISK	IMPORTANCE Blood pressure reduction and renin-angiotensin-aldosterone system inhibition are targets for treatment of atherosclerosis. The effect of renin inhibition on coronary disease progression has not been investigated. OBJECTIVE To determine the effects of renin inhibition with aliskiren on progression of coronary atherosclerosis. DESIGN, SETTING, AND PARTICIPANTS A double-blind, randomized, multicenter trial (Aliskiren Quantitative Atherosclerosis Regression Intravascular Ultrasound Study) comparing aliskiren with placebo in 613 participants with coronary artery disease, systolic blood pressure between 125 and 139 mm Hg (prehypertension range), and 2 additional cardiovascular risk factors conducted at 103 academic and community hospitals in Europe, Australia, and North and South America (enrollment from March 2009 to February 2011; end of follow-up: January 31, 2013). INTERVENTIONS Participants underwent coronary intravascular ultrasound (IVUS) imaging and were randomized to receive 300 mg of aliskiren (n = 305) or placebo (n = 308) taken orally daily for 104 weeks. Disease progression was measured by repeat IVUS examination after at least 72 weeks of treatment. MAIN OUTCOMES AND MEASURES The primary efficacy parameter was the change in percent atheroma volume (PAV) from baseline to study completion. Secondary efficacy parameters included the change in normalized total atheroma volume (TAV) and the percentage of participants with atheroma regression. Safety and tolerability were also assessed. RESULTS Evaluable imaging data were available at baseline and follow-up for 458 participants (74.7%). The primary IVUS efficacy parameter, PAV, did not differ between participants treated with aliskiren (-0.33%; 95% CI, -0.68% to 0.02%) and placebo (0.11%; 95% CI, -0.24% to 0.45%) (between-group difference, -0.43%[95% CI, -0.92% to 0.05%]; P=.08). The secondary IVUS efficacy parameter, TAV, did not differ between participants treated with aliskiren (-4.1 mm(3); 95% CI, -6.27 to -1.94 mm(3)) and placebo (-2.1 mm(3); 95% CI, -4.21 to 0.07 mm(3)) (between-group difference, -2.04 mm(3) [95% CI, -5.03 to 0.95 mm(3)]; P=.18). There were no significant differences in the proportion of participants who demonstrated regression of PAV (56.9% vs 48.9%; P=.08) and TAV (64.4% vs 57.5%; P=.13) in the aliskiren and placebo groups, respectively. CONCLUSIONS AND RELEVANCE Among participants with prehypertension and coronary artery disease, the use of aliskiren compared with placebo did not result in improvement or slowing of progression of coronary atherosclerosis. These findings do not support the use of aliskiren for regression or prevention of progression of coronary atherosclerosis.	[Nicholls, Stephen J.; Kataoka, Yu] South Australian Hlth & Med Res Inst, Adelaide, SA 5001, Australia; [Bakris, George L.] Univ Chicago Med, Dept Med, ASH Comprehens Hypertens Ctr, Chicago, IL USA; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Menon, Venu; Nissen, Steven E.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Menon, Venu; Hsu, Amy; Hu, Bo; Puri, Rishi; Uno, Kiyoko; Bash, Dianna; Nissen, Steven E.] Cleveland Clin, Coordinating Ctr Clin Res, Cleveland, OH 44106 USA; [Williams, Bryan] Univ Coll London Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Armbrecht, Juergen; Brunel, Patrick; Nicolaides, Maria; Fang, Hui] Novartis Pharmaceut, Basel, Switzerland	South Australian Health & Medical Research Institute (SAHMRI); University of Amsterdam; Academic Medical Center Amsterdam; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University College London Hospitals NHS Foundation Trust; University of London; University College London; Novartis	Nicholls, SJ (corresponding author), South Australian Hlth & Med Res Inst, POB 11060, Adelaide, SA 5001, Australia.	stephen.nicholls@sahmri.com	Kastelein, John/AAF-7950-2020; Lavi, Shahar/G-3317-2011; Menon, Venu/AAF-1871-2019	Lavi, Shahar/0000-0002-6105-8084; Williams, Bryan/0000-0002-8094-1841; Nicholls, Stephen/0000-0002-9668-4368	Novartis Pharmaceuticals; MRC [MC_PC_13090] Funding Source: UKRI; Medical Research Council [MC_PC_13090] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10222] Funding Source: researchfish	Novartis Pharmaceuticals(Novartis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by Novartis Pharmaceuticals.	ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Bakris GL, 2013, J CLIN HYPERTENS, V15, P92, DOI 10.1111/jch.12032; BRUNNER HR, 1972, NEW ENGL J MED, V286, P441, DOI 10.1056/NEJM197203022860901; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Durante A, 2012, CURR PHARM DESIGN, V18, P981, DOI 10.2174/138161212799436467; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; Gheorghiade M, 2013, JAMA-J AM MED ASSOC, V309, P1125, DOI 10.1001/jama.2013.1954; Imanishi T, 2008, HYPERTENSION, V52, P563, DOI 10.1161/HYPERTENSIONAHA.108.111120; Kuhnast S, 2012, J HYPERTENS, V30, P107, DOI 10.1097/HJH.0b013e32834ddd8e; Lu H, 2008, J CLIN INVEST, V118, P984, DOI 10.1172/JCI32970; Muhlestein JB, 2010, AM J CARDIOL, V106, P764, DOI 10.1016/j.amjcard.2010.04.040; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Nicholls SJ, 2010, J AM COLL CARDIOL, V55, P2399, DOI 10.1016/j.jacc.2010.02.026; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1547, DOI 10.1001/jama.299.13.1547; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Nussberger J, 2002, HYPERTENSION, V39, pE1, DOI 10.1161/hy0102.102293; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; SANCHO J, 1976, CIRCULATION, V53, P400, DOI 10.1161/01.CIR.53.3.400; Sipahi I, 2006, J AM COLL CARDIOL, V48, P833, DOI 10.1016/j.jacc.2006.05.045; Verma S, 2011, EUR HEART J, V32, P2135, DOI 10.1093/eurheartj/ehr066; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Yusuf S, 2000, NEW ENGL J MED, V342, P145	29	52	53	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 18	2013	310	11					1135	1144		10.1001/jama.2013.277169	http://dx.doi.org/10.1001/jama.2013.277169			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	219IU	23999933	Bronze			2022-12-28	WOS:000324500300020
J	Margolis, HS				Margolis, Helen S.			Opportunities Knock with a More Stable Optical Clock	SCIENCE			English	Editorial Material							LATTICE CLOCKS; METROLOGY		Natl Phys Lab, Teddington TW11 0LW, Middx, England	National Physical Laboratory - UK	Margolis, HS (corresponding author), Natl Phys Lab, Teddington TW11 0LW, Middx, England.	helen.margolis@npl.co.uk	Margolis, Helen/AAN-3253-2020	Margolis, Helen/0000-0002-8991-3855				Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Gill P, 2011, PHILOS T R SOC A, V369, P4109, DOI 10.1098/rsta.2011.0237; Hinkley N, 2013, SCIENCE, V341, P1215, DOI 10.1126/science.1240420; Jiang YY, 2011, NAT PHOTONICS, V5, P158, DOI [10.1038/nphoton.2010.313, 10.1038/NPHOTON.2010.313]; Katori H, 2011, NAT PHOTONICS, V5, P203, DOI [10.1038/nphoton.2011.45, 10.1038/NPHOTON.2011.45]; Kleppner D, 2006, PHYS TODAY, V59, P10, DOI 10.1063/1.2195297; Margolis HS, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/154017; Predehl K, 2012, SCIENCE, V336, P441, DOI 10.1126/science.1218442; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Santarelli G, 1998, IEEE T ULTRASON FERR, V45, P887, DOI 10.1109/58.710548	11	1	1	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1185	1186		10.1126/science.1243654	http://dx.doi.org/10.1126/science.1243654			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031007				2022-12-28	WOS:000324248800027
J	Plaks, V; Koopman, CD; Werb, Z				Plaks, Vicki; Koopman, Charlotte D.; Werb, Zena			Circulating Tumor Cells	SCIENCE			English	Editorial Material							SURVIVAL; DISSEMINATION; PROGRESSION		[Plaks, Vicki; Koopman, Charlotte D.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Plaks, V (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu			NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057621] Funding Source: Medline; NIEHS NIH HHS [U01 ES019458] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alix-Panabieres C, 2013, CLIN CHEM, V59, P110, DOI 10.1373/clinchem.2012.194258; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Hayashi N, 2012, INT J CLIN ONCOL, V17, P96, DOI 10.1007/s10147-011-0260-0; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Pantel K, 2012, CLIN CHEM, V58, P936, DOI 10.1373/clinchem.2011.175570; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Strati A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3395; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	16	457	491	11	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 13	2013	341	6151					1186	1188		10.1126/science.1235226	http://dx.doi.org/10.1126/science.1235226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215ZA	24031008	Green Accepted			2022-12-28	WOS:000324248800028
J	Hood, LE; Lazowska, ED				Hood, Leroy E.; Lazowska, Edward D.			Every Life Has Equal Value	CELL			English	Editorial Material								The 2013 Lasker similar to Bloomberg Public Service Award will be given to Bill and Melinda Gates "for leading an historic transformation in the way we view the globe's most pressing health concerns and improving the lives of millions of the world's most vulnerable.''	[Hood, Leroy E.] Inst Syst Biol, Seattle, WA 98109 USA; [Lazowska, Edward D.] Univ Washington, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle	Hood, LE (corresponding author), Inst Syst Biol, 401 Terry Ave North, Seattle, WA 98109 USA.	lhood@systemsbiology.org		Lazowska, Ed/0000-0003-0645-8787					0	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1178	1179		10.1016/j.cell.2013.08.046	http://dx.doi.org/10.1016/j.cell.2013.08.046			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034238	Bronze			2022-12-28	WOS:000324239300003
J	Levitt, J; Bernardo, S; Whang, T				Levitt, Jacob; Bernardo, Sebastian; Whang, Talley			How to Perform a Punch Biopsy of the Skin	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The punch biopsy is used to obtain a sample of the full thickness of the skin for histologic diagnosis. This video reviews the techniques and equipment required to perform a punch biopsy.	[Levitt, Jacob; Bernardo, Sebastian; Whang, Talley] Mt Sinai, Icahn Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Levitt, J (corresponding author), Mt Sinai, Icahn Sch Med, New York, NY 10029 USA.								0	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 12	2013	369	11					E13	E13		10.1056/NEJMvcm1105849	http://dx.doi.org/10.1056/NEJMvcm1105849			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216SK	24024863				2022-12-28	WOS:000324304200001
J	Nakashima, A; Takeuchi, H; Imai, T; Saito, H; Kiyonari, H; Abe, T; Chen, M; Weinstein, LS; Yu, CR; Storm, DR; Nishizumi, H; Sakano, H				Nakashima, Ai; Takeuchi, Haruki; Imai, Takeshi; Saito, Harumi; Kiyonari, Hiroshi; Abe, Takaya; Chen, Min; Weinstein, Lee S.; Yu, C. Ron; Storm, Daniel R.; Nishizumi, Hirofumi; Sakano, Hitoshi			Agonist-Independent GPCR Activity Regulates Anterior-Posterior Targeting of Olfactory Sensory Neurons	CELL			English	Article							ODORANT RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; MAP; GENE; EXPRESSION; MUTAGENESIS; DISRUPTION; ACTIVATION; G(S)ALPHA; DOMAINS	G-protein-coupled receptors (GPCRs) are known to possess two different conformations, active and inactive, and they spontaneously alternate between the two in the absence of ligands. Here, we analyzed the agonist-independent GPCR activity for its possible role in receptor-instructed axonal projection. We generated transgenic mice expressing activity mutants of the beta 2-adrenergic receptor, a well-characterized GPCR with the highest homology to odorant receptors (ORs). We found that mutants with altered agonist-independent activity changed the transcription levels of axon-targeting molecules-e.g., Neuropilin-1 and Plexin-A1-but not of glomerular segregation molecules-e.g., Kirrel2 and Kirrel3-thus causing shifts in glomerular locations along the anterior-posterior (A-P) axis. Knockout and in vitro experiments demonstrated that G(s), but not G(olf), is responsible for mediating the agonist-independent GPCR activity. We conclude that the equilibrium of conformational transitions set by each OR is the major determinant of expression levels of A-P-targeting molecules.	[Nakashima, Ai; Takeuchi, Haruki; Imai, Takeshi; Saito, Harumi; Nishizumi, Hirofumi; Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Nakashima, Ai; Takeuchi, Haruki; Sakano, Hitoshi] Univ Fukui, Sch Med Sci, Dept Brain Funct, Fukui 9101193, Japan; [Imai, Takeshi] RIKEN Ctr Dev Biol, Lab Sensory Circuit Format, Kobe, Hyogo 6500047, Japan; [Imai, Takeshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan; [Chen, Min; Weinstein, Lee S.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; [Yu, C. Ron] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Tokyo; University of Fukui; RIKEN; Japan Science & Technology Agency (JST); RIKEN; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Stowers Institute for Medical Research; University of Washington; University of Washington Seattle	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Kiyonari, Hiroshi/N-7936-2015; Imai, Takeshi/L-2201-2013; Weinstein, Lee S/I-5575-2015	Imai, Takeshi/0000-0002-8449-0080; Nakashima, Ai/0000-0002-2274-5009; Takeuchi, Haruki/0000-0003-4911-4060	PRESTO program of Japan Science and Technology Corporation; Toray Science Foundation; Sumitomo Foundation; Nakajima Foundation; Mitsubishi Foundation; Japan Foundation for Applied Enzymology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT of Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24000014, 23680038, 23300140] Funding Source: KAKEN	PRESTO program of Japan Science and Technology Corporation; Toray Science Foundation(Toray Industries, Inc.); Sumitomo Foundation; Nakajima Foundation; Mitsubishi Foundation; Japan Foundation for Applied Enzymology; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank R. Axel for G<INF>olf</INF>-KO mice; R. Kobayakawa and K. Kobayakawa for Omacs-cre mice; T. Hirata for antibodies against Nrp1; H. Ueno for antibodies against Kirrel3; F. Suto and Y. Hiromi for antibodies against PlxnA1; S. Suzuki and A. Miyajima for FACS analysis; A. Katsuyama for technical assistance; J.-P. Changeux, L. Luo, O. Nureki, and H. Kato for insightful discussion; and J. Ngai, L. Buck, and our laboratory members for valuable comments. This research was supported by the PRESTO program of Japan Science and Technology Corporation (T.I.), Toray Science Foundation (H.S.), Sumitomo Foundation (T.I.), Nakajima Foundation (T.I.), Mitsubishi Foundation (H.S. and T.I.), Japan Foundation for Applied Enzymology (T.I., H.T., H.N., and H.S.), grants in aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (T.I., H.N., H.T., and H.S.), and a Specially Promoted Research Grant from MEXT of Japan (H.S.).	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Chen Y, 2006, CELL, V127, P881, DOI 10.1016/j.cell.2006.11.017; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Connelly T, 2013, J NEUROPHYSIOL, V110, P55, DOI 10.1152/jn.00910.2012; COPPOLA DM, 1989, NEUROSCI LETT, V106, P241, DOI 10.1016/0304-3940(89)90170-5; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Johns DC, 1999, J NEUROSCI, V19, P1691; Kato A, 2008, J NEUROCHEM, V107, P1261, DOI 10.1111/j.1471-4159.2008.05693.x; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Liu HY, 2001, J NEUROCHEM, V78, P325, DOI 10.1046/j.1471-4159.2001.00422.x; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Milligan G, 2000, TRENDS PHARMACOL SCI, V21, P24, DOI 10.1016/S0165-6147(99)01404-2; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reisert J, 2010, J GEN PHYSIOL, V136, P529, DOI 10.1085/jgp.201010528; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; SAVARESE TM, 1992, BIOCHEM J, V283, P1; Seifert R, 1998, J BIOL CHEM, V273, P5109, DOI 10.1074/jbc.273.9.5109; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Tsuboi A, 2011, EUR J NEUROSCI, V33, P205, DOI 10.1111/j.1460-9568.2010.07495.x; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	57	93	94	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 12	2013	154	6					1314	1325		10.1016/j.cell.2013.08.033	http://dx.doi.org/10.1016/j.cell.2013.08.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034253	Bronze, Green Accepted			2022-12-28	WOS:000324239300019
J	Puri, C; Renna, M; Bento, CF; Moreau, K; Rubinsztein, DC				Puri, Claudia; Renna, Maurizio; Bento, Carla F.; Moreau, Kevin; Rubinsztein, David C.			Diverse Autophagosome Membrane Sources Coalesce in Recycling Endosomes	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; TRANS-GOLGI NETWORK; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; TRANSFERRIN RECEPTOR; TOMOGRAPHY REVEALS; MDCK CELLS; ENDOCYTOSIS; RAB11; PATHWAY	Autophagic protein degradation is mediated by autophagosomes that fuse with lysosomes, where their contents are degraded. The membrane origins of autophagosomes may involve multiple sources. However, it is unclear if and where distinct membrane sources fuse during autophagosome biogenesis. Vesicles containing mATG9, the only trans-membrane autophagy protein, are seen in many sites, and fusions with other autophagic compartments have not been visualized in mammalian cells. We observed that mATG9 traffics from the plasma membrane to recycling endosomes in carriers that appear to be routed differently from ATG16L1-containing vesicles, another source of autophagosome membrane. mATG9- and ATG16L1-containing vesicles traffic to recycling endosomes, where VAMP3-dependent heterotypic fusions occur. These fusions correlate with autophagosome formation, and both processes are enhanced by perturbing membrane egress from recycling endosomes. Starvation, a primordial autophagy activator, reduces membrane recycling from recycling endosomes and enhances mATG9-ATG16L1 vesicle fusion. Thus, this mechanism may fine-tune physiological autophagic responses.	[Puri, Claudia; Renna, Maurizio; Bento, Carla F.; Moreau, Kevin; Rubinsztein, David C.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England	University of Cambridge	Rubinsztein, DC (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Hills Rd, Cambridge CB2 0XY, England.	dcr1000@hermes.cam.ac.uk	Rubinsztein, David C/C-3472-2011	Renna, Maurizio/0000-0001-6522-1750; Bento, Carla F./0000-0001-8377-4543	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Dr. H.G. Wang, Dr. J.A. Mercer, Prof. DeCamilli, and Dr. B. Beau-melle for kindly providing reagents. We thank Drs. Fiona Menzies and Mariella Vicinanza for critical reading and Dr. J.D. Cooper for the statistics. We are grateful to the Wellcome Trust (Principal Research Fellowship to DCR and Strategic Grant to Cambridge Institute for Medical Research) for funding.	Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hayashi-Nishino M, 2010, AUTOPHAGY, V6, P301, DOI 10.4161/auto.6.2.11134; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Moreau K, 2012, J CELL BIOL, V196, P483, DOI 10.1083/jcb.201110114; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Orsi A, 2012, MOL BIOL CELL, V23, P1860, DOI 10.1091/mbc.E11-09-0746; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Puri C, 2010, ONCOGENE, V29, P188, DOI 10.1038/onc.2009.328; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Thompson HM, 2006, NAT CHEM BIOL, V2, P355, DOI 10.1038/nchembio0706-355; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Warren RA, 1997, J BIOL CHEM, V272, P2116; Warren RA, 1998, J BIOL CHEM, V273, P17056, DOI 10.1074/jbc.273.27.17056; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; Yamazaki Y, 2013, EMBO J, V32, P524, DOI 10.1038/emboj.2013.1; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b	40	294	302	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 12	2013	154	6					1285	1299		10.1016/j.cell.2013.08.044	http://dx.doi.org/10.1016/j.cell.2013.08.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	215VQ	24034251	Green Published, hybrid			2022-12-28	WOS:000324239300017
J	Fung, I				Fung, Inez			A Hyperventilating Biosphere	SCIENCE			English	Editorial Material							NORTHERN ECOSYSTEMS; PERMAFROST CARBON; CO2		Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fung, I (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	ifung@berkeley.edu						Barichivich J, 2013, GLOBAL CHANGE BIOL, V19, P3167, DOI 10.1111/gcb.12283; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Graven HD, 2013, SCIENCE, V341, P1085, DOI 10.1126/science.1239207; Koven CD, 2011, P NATL ACAD SCI USA, V108, P14769, DOI 10.1073/pnas.1103910108; Miller C. E., 2012, AER C, DOI [10.1109/AERO.2012.6187026, DOI 10.1109/AERO.2012.6187026]; PEARMAN GI, 1981, J GEOPHYS RES-OCEANS, V86, P9839, DOI 10.1029/JC086iC10p09839; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807	9	5	5	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 6	2013	341	6150					1075	1076		10.1126/science.1242004	http://dx.doi.org/10.1126/science.1242004			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211TG	24009383				2022-12-28	WOS:000323933100031
J	Tucker, BE				Tucker, Brian E.			Reducing Earthquake Risk	SCIENCE			English	Editorial Material									GeoHazards Int, Menlo Pk, CA 94025 USA		Tucker, BE (corresponding author), GeoHazards Int, 687 Bay Rd, Menlo Pk, CA 94025 USA.	tucker@geohaz.org						Bilham R., 2009, B EARTHQ ENG, V2009, P1; Bilham R, 2013, SCIENCE, V341, P618, DOI 10.1126/science.1238476; Di Mauro M, 2013, NAT HAZARDS, V68, P373, DOI 10.1007/s11069-013-0632-z; Earthquake Engineering Research Institute, 2011, LEARN EARTHQ JAP TOH; Erdik M, 2013, SCIENCE, V341, P724, DOI 10.1126/science.1238945; Gawande A., 2013, NEW YORKER, V29; Geohazards International, VULN COMM; Gilbert D, 2006, STUMBLING HAPPINESS; Global Humanitarian Assistance, GHA REP 2011; Holzer TL, 2013, EARTHQ SPECTRA, V29, P155, DOI 10.1193/1.4000106; LATROBE S, 2003, NATURAL DISASTER RIS; OECD, 2005, REC COUNC GUID EARTH; Stein RS, 2013, SCIENCE, V341, P850, DOI 10.1126/science.1238944; The United Nations Department of Economic and Social Affairs, WORLD URB PROSP 2011; TUCKER BE, 1994, NATO ADV SCI INST SE, V271, P1; United Nations Office for Disaster Reduction, HYOG FRAM ACT; USGS, EARTHQ HAZ PROGR PAG; USGS, SIGN EARTHQ WORLD; von Hillebrandt-Andrade C, 2013, SCIENCE, V341, P966, DOI 10.1126/science.1238943; Wyss M, 2005, NAT HAZARDS, V34, P305, DOI 10.1007/s11069-004-2073-1	20	17	20	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 6	2013	341	6150					1070	1072		10.1126/science.1239236	http://dx.doi.org/10.1126/science.1239236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	211TG	24009380				2022-12-28	WOS:000323933100028
J	Moyer, VA; LeFevre, ML; Siu, AL; Peters, JJ; Baumann, LC; Bibbins-Domingo, K; Curry, SJ; Ebell, M; Flores, G; Garcia, FAR; Cantu, AG; Grossman, DC; Herzstein, J; Nicholson, WK; Owens, DK; Phillips, WR; Pignone, MP; Wilt, T				Moyer, Virginia A.; LeFevre, Michael L.; Siu, Albert L.; Peters, James J.; Baumann, Linda Ciofu; Bibbins-Domingo, Kirsten; Curry, Susan J.; Ebell, Mark; Flores, Glenn; Garcia, Francisco A. R.; Cantu, Adelita Gonzales; Grossman, David C.; Herzstein, Jessica; Nicholson, Wanda K.; Owens, Douglas K.; Phillips, William R.; Pignone, Michael P.; Wilt, Timothy		US Preventive Serv Task Force	Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index in Adults: U.S. Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; PRACTICE GUIDELINES; MARKERS; ANGIOGRAPHY; PREDICTION; MANAGEMENT; MORTALITY; EVENTS; TRIAL	Description: Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for peripheral artery disease (PAD). Methods: The USPSTF reviewed the evidence on the use of resting ankle-brachial index (ABI) as a screening test for PAD or as a risk predictor for cardiovascular disease (CVD). The review focused on resting ABI as the sole screening method; the diagnostic performance of ABI testing in primary care populations, unselected populations, and asymptomatic populations; the predictive value of ABI testing for major CVD outcomes in primary care or unselected populations; and the effect of treatment on general CVD and PAD-specific morbidity in patients with asymptomatic or minimally symptomatic PAD. Population: This recommendation applies to asymptomatic adults who do not have a known diagnosis of PAD, CVD, severe chronic kidney disease, or diabetes. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for PAD and CVD risk assessment with the ABI in adults. (I statement)	[Moyer, Virginia A.; US Preventive Serv Task Force] Amer Board Pediat Inc, Chapel Hill, NC 27514 USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO 65211 USA; [Siu, Albert L.] Mt Sinai Sch Med, New York, NY USA; [Peters, James J.] Vet Affairs Med Ctr, Bronx, NY USA; [Baumann, Linda Ciofu] Univ Wisconsin, Madison, WI 53706 USA; [Bibbins-Domingo, Kirsten] Univ California, San Francisco, CA 94143 USA; [Curry, Susan J.] Univ Iowa, Coll Publ Hlth, Iowa City, IA 52242 USA; [Ebell, Mark] Univ Georgia, Athens, GA 30602 USA; [Flores, Glenn] Univ Texas Southwestern, Dallas, TX USA; [Garcia, Francisco A. R.] Pima County Dept Hlth, Tucson, AZ USA; [Cantu, Adelita Gonzales] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; [Grossman, David C.] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Herzstein, Jessica] Air Prod, Allentown, PA USA; [Nicholson, Wanda K.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Owens, Douglas K.] Veteran Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Pignone, Michael P.] Univ N Carolina, Chapel Hill, NC USA	University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; University of Iowa; University System of Georgia; University of Georgia; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health San Antonio; Group Health Cooperative; Air Products & Chemicals; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Stanford University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Moyer, VA (corresponding author), Amer Board Pediat Inc, Chapel Hill, NC 27514 USA.		Phillips, William R./V-1065-2017	Phillips, William R./0000-0003-2802-4349; Pignone, Michael/0000-0002-6657-7342	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	Cassar K., 2011, CLIN EVID, V2011; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Joosten MM, 2012, JAMA-J AM MED ASSOC, V308, P1660, DOI 10.1001/jama.2012.13415; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Lee AJ, 2004, CIRCULATION, V110, P3075, DOI 10.1161/01.CIR.0000143102.38256.DE; Lin SY, 2013, AHRQ PUBLICATION; McDermott MM, 2011, AM J MED, V124, P557, DOI 10.1016/j.amjmed.2010.11.032; Mohler ER, 2004, VASC MED, V9, P253, DOI 10.1191/1358863x04vm559oa; Pande RL, 2011, CIRCULATION, V124, P17, DOI 10.1161/CIRCULATIONAHA.110.003954; Rodondi N, 2010, AM J EPIDEMIOL, V171, P540, DOI 10.1093/aje/kwp428; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; U. S. Preventive Services Task Force, 2005, AHRQ PUBLICATION, V05-0573-A; Wikstrom J, 2008, ACTA RADIOL, V49, P143, DOI 10.1080/02841850701732957; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	17	76	76	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 3	2013	159	5					342	348		10.7326/0003-4819-159-5-201309030-00008	http://dx.doi.org/10.7326/0003-4819-159-5-201309030-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215YA	24026320				2022-12-28	WOS:000324245900005
J	Bhogaraju, S; Cajanek, L; Fort, C; Blisnick, T; Weber, K; Taschner, M; Mizuno, N; Lamla, S; Bastin, P; Nigg, EA; Lorentzen, E				Bhogaraju, Sagar; Cajanek, Lukas; Fort, Cecile; Blisnick, Thierry; Weber, Kristina; Taschner, Michael; Mizuno, Naoko; Lamla, Stefan; Bastin, Philippe; Nigg, Erich A.; Lorentzen, Esben			Molecular Basis of Tubulin Transport Within the Cilium by IFT74 and IFT81	SCIENCE			English	Article							FLAGELLAR LENGTH CONTROL; INTRAFLAGELLAR TRANSPORT; CHLAMYDOMONAS; PROTEIN; COMPLEX; TURNOVER; CILIOGENESIS; MOTILITY; DYNEIN; CELLS	Intraflagellar transport (IFT) of ciliary precursors such as tubulin from the cytoplasm to the ciliary tip is involved in the construction of the cilium, a hairlike organelle found on most eukaryotic cells. However, the molecular mechanisms of IFT are poorly understood. Here, we found that the two core IFT proteins IFT74 and IFT81 form a tubulin-binding module and mapped the interaction to a calponin homology domain of IFT81 and a highly basic domain in IFT74. Knockdown of IFT81 and rescue experiments with point mutants showed that tubulin binding by IFT81 was required for ciliogenesis in human cells.	[Bhogaraju, Sagar; Weber, Kristina; Taschner, Michael; Mizuno, Naoko; Lorentzen, Esben] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Cajanek, Lukas; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Fort, Cecile; Blisnick, Thierry; Bastin, Philippe] Inst Pasteur, Trypanosome Cell Biol Unit, F-75015 Paris, France; [Fort, Cecile; Blisnick, Thierry; Bastin, Philippe] CNRS, URA2581, F-75015 Paris, France; [Lamla, Stefan] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	Max Planck Society; University of Basel; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Max Planck Society	Lorentzen, E (corresponding author), Max Planck Inst Biochem, Dept Struct Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.	lorentze@biochem.mpg.de	Mizuno, Naoko/AAY-1926-2021; Lorentzen, Esben/AAX-8077-2020; Bastin, Philippe/B-1402-2014; Cajanek, Lukas/ABG-6559-2020; Bastin, Philippe/O-4230-2019; Bastin, Philippe/E-6688-2017	Mizuno, Naoko/0000-0002-1594-2821; Cajanek, Lukas/0000-0003-2914-8589; Bastin, Philippe/0000-0002-3042-8679; Taschner, Michael/0000-0002-8881-3705; Taschner, Michael/0000-0002-3789-5077; Lorentzen, Esben/0000-0001-6493-7220; nigg, erich/0000-0003-4835-5719; Bhogaraju, Sagar/0000-0001-9998-5927	DGF [LO1627/1-1]; European Research Council (ERC) [310343]; European Molecular Biology Organization; Agence Nationale de la Recherche [ANR-11-BSV8-016]; Ministere de l'Enseignement et de la Recherche [ED387]; University of Basel; Swiss National Science Foundation [31003A_132428/1]; Austrian Science Fund [J3148-B12]; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS); FEBS long-term fellowship	DGF(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement et de la Recherche; University of Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS); FEBS long-term fellowship	We thank the staff at SLS for help with x-ray diffraction data collection; the crystallization facility of the Max Planck Institute of Biochemistry (Munich) for access to crystallization screening; the staff at Biozentrum Imaging Core Facility for assistance; C. Basquin for static light-scattering experiments; C. Jung for help with microscale thermophoresis; and S. Chakrabarti, A. Cook, and B. D. Engel for carefully reading and correcting the manuscript. B. D. Engel is additionally acknowledged for assistance with Fig. 4 and for many valuable discussions concerning ciliary length control. We thank the Plateforme d'Imagerie Dynamique for providing access to their equipment and Jean-Yves Tinevez for technical advice. We acknowledge M. Morawetz and M. Stiegler for technical assistance with molecular biology. This work was funded by an Emmy Noether grant (DGF; LO1627/1-1), the European Research Council (ERC grant 310343), and the European Molecular Biology Organization Young Investigator program. Work at the Institut Pasteur was funded by Agence Nationale de la Recherche grant ANR-11-BSV8-016. C. F. is funded by a fellowship from the Ministere de l'Enseignement et de la Recherche (ED387). E.A.N. acknowledges support from the University of Basel and the Swiss National Science Foundation (31003A_132428/1). M. T. is the recipient of an Erwin Schroedinger stipend granted by the Austrian Science Fund J3148-B12, S. B was supported by the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS), and L. C. was supported by the FEBS long-term fellowship. The authors declare that they have no conflict of interest. The data presented in this paper are tabulated in the main paper and the supplementary materials. Structural coordinates have been deposited at the Protein DataBank, accession nos. 4LVP and 4LVR.	Buisson J, 2013, J CELL SCI, V126, P327, DOI 10.1242/jcs.117069; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; JOHNSON KA, 1992, J CELL BIOL, V119, P1605, DOI 10.1083/jcb.119.6.1605; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sharma N, 2011, MOL BIOL CELL, V22, P806, DOI 10.1091/mbc.E10-03-0269; Song L, 2001, J BIOL CHEM, V276, P29754, DOI 10.1074/jbc.M103184200; STEPHENS RE, 1977, DEV BIOL, V61, P311, DOI 10.1016/0012-1606(77)90301-3	23	197	206	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 30	2013	341	6149					1009	1012		10.1126/science.1240985	http://dx.doi.org/10.1126/science.1240985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	208BZ	23990561	Green Accepted			2022-12-28	WOS:000323652300045
J	Badgett, RG				Badgett, Robert G.			Review: Diagnostic testing does not reassure patients with low probability of serious disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Kansas, Sch Med Wichita, Wichita, KS USA	University of Kansas; University of Kansas Medical Center	Badgett, RG (corresponding author), Univ Kansas, Sch Med Wichita, Wichita, KS USA.		Badgett, Robert/AAD-3429-2021	Badgett, Robert/0000-0003-2888-3303; Burton, Christopher/0000-0003-0233-2431				Howard L, 2005, J NEUROL NEUROSUR PS, V76, P1558, DOI 10.1136/jnnp.2004.057851; KIRMAYER LJ, 1993, AM J PSYCHIAT, V150, P734; Kroenke K, 2013, JAMA INTERN MED, V173, P416, DOI 10.1001/jamainternmed.2013.11	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 20	2013	159	4							JC2	10.7326/0003-4819-159-4-201308200-02002	http://dx.doi.org/10.7326/0003-4819-159-4-201308200-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205DM	24026278				2022-12-28	WOS:000323421700001
J	Calis, J; van Woensel, J; Lemson, J				Calis, Job; van Woensel, Job; Lemson, Joris			Severe Sepsis and Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter								To the Editor: We would like to address two potentially confusing issues concerning venous oxygen saturation (Svo(2)) as presented in Table 1 of the review by Angus and van der Poll (Aug. 29 issue).(1) First, Table 1 suggests that Svo(2) is raised in sepsis, severe sepsis, and septic shock. Depending on the timing of patient presentation and the type of sepsis and septic shock, Svo(2) may indeed be elevated as a result of microcirculatory shunting or mitochondrial dysfunction. However, in septic shock, Svo(2) can be depressed, reflecting an increase in the extraction of oxygen due ...	[Calis, Job; van Woensel, Job] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lemson, Joris] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Calis, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	job.calis@gmail.com	Lemson, J./L-4486-2015; Angus, Derek C/E-9671-2012					Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; De Blasi RA, 2013, INTENS CARE MED, V39, P636, DOI 10.1007/s00134-012-2725-7; de Oliveira CF, 2008, INTENS CARE MED, V34, P1065, DOI 10.1007/s00134-008-1085-9; Deep A, 2013, INTENS CARE MED, V39, P1602, DOI 10.1007/s00134-013-3003-z; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]; Di Mario A, 2009, J INFECTION, V59, P201, DOI 10.1016/j.jinf.2009.07.007; Ganesan A, 2013, CLIN CHEST MED, V34, P307, DOI 10.1016/j.ccm.2013.01.011; Japiassu AM, 2010, CRIT CARE, V14, DOI 10.1186/cc9221; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Silva JM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17344; Tyml K, 2011, MICROCIRCULATION, V18, P152, DOI 10.1111/j.1549-8719.2010.00080.x	11	2211	2397	13	315	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 21	2013	369	21					2062	2062		10.1056/NEJMc1312359	http://dx.doi.org/10.1056/NEJMc1312359			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254KE	24256391	Green Published			2022-12-28	WOS:000327163000021
J	Angus, DC; van der Poll, T				Angus, Derek C.; van der Poll, Tom			Severe Sepsis and Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACTIVATED PROTEIN-C; INTENSIVE-CARE; ANTIMICROBIAL THERAPY; ORGAN DYSFUNCTION; UNITED-STATES; MORTALITY; EPIDEMIOLOGY; INFECTION; RESPONSES; EFFICACY		[Angus, Derek C.] Univ Pittsburgh, CRISMA Clin Res Invest & Syst Modeling Acute Illn, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Angus, DC (corresponding author), Univ Pittsburgh, Dept Crit Care Med, 614 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu; t.vanderpoll@amc.uva.nl	Lemson, J./L-4486-2015; Angus, Derek C/E-9671-2012		Eisai; Idaho Technology; Pfizer; MedImmune; BioAegis; Ferring; Eli Lilly; Sirtris Pharmaceuticals	Eisai(Eisai Co Ltd); Idaho Technology; Pfizer(Pfizer); MedImmune(AstraZenecaMedimmune); BioAegis; Ferring(Ferring Pharmaceuticals); Eli Lilly(Eli Lilly); Sirtris Pharmaceuticals	Dr. Angus reports receiving grant support through his institution from Eisai, consulting fees from Idaho Technology, Pfizer, Eisai, MedImmune, BioAegis, and Ferring, and fees from Eli Lilly for serving as a member of a clinical-trial data and safety monitoring board. Dr. van der Poll reports receiving grant support through his institution from Sirtris Pharmaceuticals and consulting fees from Eisai. No other potential conflict of interest relevant to this article was reported.	Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; [Anonymous], CRIT CARE MED; [Anonymous], 2004, CRIT CARE MED; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brunkhorst FM, 2012, JAMA-J AM MED ASSOC, V307, P2390, DOI 10.1001/jama.2012.5833; Carson WF, 2011, EPIGENETICS-US, V6, P273, DOI 10.4161/epi.6.3.14017; Cerra F B, 1985, Crit Care Clin, V1, P591; Chan JK, 2012, J CLIN INVEST, V122, P2711, DOI 10.1172/JCI62423; Chung LP, 2011, CRIT REV CL LAB SCI, V48, P250, DOI 10.3109/10408363.2011.641517; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Funk DJ, 2009, CRIT CARE CLIN, V25, P83, DOI 10.1016/j.ccc.2008.12.003; Galley HF, 2011, BRIT J ANAESTH, V107, P57, DOI 10.1093/bja/aer093; Goldenberg NM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002011; Heenen S, 2012, CRIT CARE MED, V40, P1404, DOI 10.1097/CCM.0b013e3182416ecf; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2002, J IMMUNOL, V168, P2493, DOI 10.4049/jimmunol.168.5.2493; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Laupland KB, 2007, CRIT CARE MED, V35, P2686, DOI 10.1097/01.CCM.0000295312.13466.1C; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; MAJNO G, 1991, J INFECT DIS, V163, P937, DOI 10.1093/infdis/163.5.937; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayr FB, 2010, JAMA-J AM MED ASSOC, V303, P2495, DOI 10.1001/jama.2010.851; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Namath A, 2011, CRIT CARE NURS CLIN, V23, P181, DOI 10.1016/j.ccell.2010.12.011; Opal SM, 2003, CLIN INFECT DIS, V37, P50, DOI 10.1086/375593; Paul M, 2004, BMJ-BRIT MED J, V328, P668, DOI 10.1136/bmj.38028.520995.63; Paul M, 2010, ANTIMICROB AGENTS CH, V54, P4851, DOI 10.1128/AAC.00627-10; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Ruf W, 2010, J CLIN INVEST, V120, P3084, DOI 10.1172/JCI44266; Safdar N, 2004, LANCET INFECT DIS, V4, P519, DOI 10.1016/S1473-3099(04)01108-9; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Torgersen C, 2009, ANESTH ANALG, V108, P1841, DOI 10.1213/ane.0b013e318195e11d; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Webster NR, 2009, BRIT J ANAESTH, V103, P70, DOI 10.1093/bja/aep128; Wong HR, 2012, CRIT CARE, V16, DOI [10.1186/cc10537, 10.1186/cc10811]; Yende S, 2011, CRIT CARE MED, V39, P1871, DOI 10.1097/CCM.0b013e31821b8290; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; [No title captured]	66	2211	2397	13	315	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 29	2013	369	9					840	851		10.1056/NEJMra1208623	http://dx.doi.org/10.1056/NEJMra1208623			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208KB	24256391				2022-12-28	WOS:000323676100011
